>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 1; Drug: Control Apo 0.5 然
bRsbRgbLsbRibRibRiLsLsmbRgbRgRsmbRgbRgbRibRgbRsbRgbRgbRgbLjbRibRiLsLsm
bLcbLcbRsbRsbLsbLgbLibLsbLsbLgbRsbLsbLgbRsbLibLsbLgLsbLsLebLgbRsLsbRgb
RcRsmbLsRgbLgbRiRsmbLgbRiRsmbLgbRiRsmbLsbRibRcbLibRebRgbLgRsbRebLgbRib
LsbLsbRgRsmbRgRsmbLgbRibRgbRibLgbLibLcbLgbRsbLgLsbLgbLgbLsbLgbLsbLgbLs
bLgbLgbLsRsbLgLsbLsbLgbRebRcbRsbRiRsmbRsbRsbLsbRibLgbRgbRgbLsbRgRsmbLs
bRsLgbLsbRgRsmbLjbRcbRsbLibLcRsbLcbRibRgbRibRgbLsbRcbLibRibRhbRibRibRg
bRsbLgbLibLgbLsbLgLsbLobRibRebRhbRsbRibLcbLobLibLgLsbLgbLsbRsbRsbLibLg
bLgbRibLibLgbLgRsbLsRsbLgbRsbRsbLibRjbRcbRhbLsRsbRsbRibRgbRgbLgbRcbLjb
RoRsLsmbRgbLgbLgbLsbLibLgbLhbRibLoLsmbRibRhbRhbRsbRcbRibLibLibLgbLsbLs
bLsbLsbLsbLsbLsbLsbLsLsmbLsbLgbRsbLgbLcRsbLibRgbLcbRgbRgLsbRgbRgbRhbLg
bRgbRcbLgRsbLsbRibRsbRcbRibLgbRsbLgbLibLgbRsbLgbRsbLsbRsbLibLgbLsbLsbL
gbLgLsbLsbLgbLsbLgbLgbLsbLgbRibRhbLcbLobRhbLsbRibRibLebLcbRibRgbRgbLob
LsbLgbRsbRsbLgbLgbLgbLibLobLgbLibLgbLibRjRsmbLibRsbLgLsbLsbLsbLsbLsbLs
bLgbLgbLibLsLsmbLgbLgbLsbLgbLsbRsbLgLsbLgbLsbLgbLsbLsbLgbLsbLgbRsbLibR
jLsbRcbRsbRibLibLebLiLsbLgbLgbLsbLgbLsLsmbLsLsRsmbLsLsmbLsbLgbLgbLgbLs
bRgbLjLsmbRjbRsbRhbsbRhbLcbsbLobRiRsmbLobLibRgbRgbRgbRibLibLgbLsbLgbLs
bLgbLsbLsLsmbLgbLsbLsbLsbLsbLsLsmbLsbLsbLgbRebRcbLibRibRibRsbRgbRgbRgb
LgbRhbLibRcbLjbRgbRibLgbRgbRobRibLsbLgbLgbLsbLgbLsbLgbLsbLgbLsbLgbLsbL
gbLsbLgbLsbLsbLgbLgbLsbLgbLsbLsbLgbLgbLsbLgbLibRibLibLsbLgbLsbLgbLsbLg
bLsbLsbLhRsbRcbRibLjbRibLjbRiLsbRjRsmbLibRebLibRhbLibReRsmbLcbLibRsbLi
LsbRjbLjLsmbLgbLgbRcbRcbRgbLsbRgbRsbLcbLgbLgbLsRsbLsbLsbLgbRsbLgbLgbLg
bLgbLgbLgbLsbLsbLgLsbLgbLsLsmbRgbLibRjbRcb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 2; Drug: Control Apo 0.5 然
bsbLgbRgbRgRsmbRgbLgbLsRibRibRgbRsbRgbLsbRgbRgbRgRsmbRgRsmbRsRsmbRgbRg
bLsbRgbLsbRibLsRsbLcbLgbLibRibLibLibRgbLgLsbLgbLgbLgbRsbRsbLhbRjbLhbLg
LsbLgbLgbRsbRgbRsbLcbLsbLibRgbLiLsbRgbLibRsbRjbLhbLhbRgbRibLsLsmbLgbLi
bRsbLgLsbRgbLibLsbLibRjbLibRgbLibLsbLibRsbRsbLibRgbLibRgbLiLsbRjbLibLg
bRgLsbLibRjRsmbLibRsbLsbRgbLibRibLibRsbLgbRgbLiLsbRgbLibRsbLsbLgbLgbLc
bRibLibLgbRsbLhbRibRjbRibRgbRsbLjbRhbLcbLcbRiRsmbLibRsbLgbRgbLsbLgbLsL
gbLsbLgbLsbRsLsbLgLsbRsbRsbLibRjRsmbLhLsbLsbRgLsbLibRsbLhLsbRibLcbRibR
jbRcbRibLiLsbLsbLcbLsbRibRhLsbRgbRibLgbLcbLgbLgbLgbRgbLhbRgbRjbRhbRhbR
ibLibRgbLsRibRsbRibLjbRcbLsbLibRibRgLsbRsbRsbRgbLsbLsbRibRibLsbLsbLjbL
ibLsbLsbLsbLgLsbLgLsbLiRsbLgbRsbLgbLsbLsRsbLibRjbLibRgbLibLibRgLsbRgbR
hbRibLsbRgbLsLoLsmbLibRgLsbLibRiRsmbLiLsRsbRibLiLsbRgbLgbRsbRsLsbLsbLs
bLsLsmbLgbLsbRsRsRsmmbLsbLgbLgbLgbRgbLiRsbRhbRcRsmbRibRsbLgbRibLgbRgbR
gRsmbLsbRsbRiLsRsbLgRsbRibRibRibRgbLsbRgLsbRgbLsbRjbRgbLibRibRsbRgbRgb
RsbRsbRgbRsbLsbRgRsmbRgbRsbRsbRsbRgbLsbRibRibLibRibRgRsmbLgbRgbLsRsbRg
bLsbRgbRsbRgbRsbLsbLebLhbRibRcbRibLibLgbRibRibRgbLiLsbRgbRiLsbRgLsRsbL
jbRibLsbRsbRgbLjLsmbRgLsbRibLsbRgbLsbRgbRgbLsbRsbRgbRsbRgRsmbRsbRsbLgb
RiRsmbRgLsbLsbRgRsmbLsbRgbRgLsbLjLcbLibRibLhbRcbRgbLgbRsbRgbLsbRibRgRs
mbLsbRgbRsbRgbRsbRsbRsbRsbRsbRgbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 3; Drug: Control Apo 0.5 然
bLsbRgbRsbRsbRsbRsbRgbLgbRgbRgbRsbRsbRsLsbRibRsbLibLjbLibLsbLgbLgbRgbL
gbRgbLgbLsbLgbRgbLgbRsbLgbRsbLgbLsbLsbLsbLsLsmbRgbLgbRsbLgbRsbLsbLsbLs
bLsbLgbLsbRsbLgbLsbRgbLgbRsbLgbLsbLsbLsbLsLsmbRsbLsbLsbRgbLgbRgLsbLibR
gbLibRgbLgbLsbLsbLibRgbLgbLsbLibLsbRsbLgbLgbRgbLibLsbRgbLgbRsbLgbLsbRs
bLgbLsbLsbLsbRsbLgbLsbLsbLsbRsbLgbRgbLgbLsbRcbRibLgbRibLgbRibLgRsbRibL
gbLjbRhbRsbRsbRgbRsbLsbRgbLsbRgbRsbRsbRsbLgbRibRgRsmbRsRsmbRgbLibLsbRi
bRgbLjbRiLsRsbLgbRibRibRgLsbRsbLjbRibRibRsbLiLsbLhbLibLibLibRibLgbLiLs
bLibLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 4; Drug: Control Apo 0.5 然
bRibsbLgbRsRsmbRgbLsbRgRsmbRsbRgbRsbRsRsmbRsbRsbRsbRsRsmbLsbRgbRsbRsbR
sbLsbRgbLsbRgRsmbLgbRgbLsbRsbLsbRgbRgbLsbRgbRsbRgbLgbRgbRsbLsbRgLsbLsb
RgRsmbLsbRsRsmbRgLsbLsbRsbRgbRgbLsRsbRgRsmbLsbLsLsmbRsbRgbRsbRgbLsbRsb
RsbLgRsbLsbRsbRiRsmbLjbRgbLgbRgbLsLsmbRgbRgbRgbLsbRgbRsbLjbLgbLibRjbLi
bLibLsbLsbLgRsbLgbLsRsbLgbLsbLgbRsbRsbLgbLgLsbRsbLgbLsbLsbLgbLibRjbLob
LgbLibRsbRsbRgbLgbLhbLibRgbLgbLsbLsbRsbLibLgbLsbRgRsmbLiLsbLsbLsbLsRsb
LgLsbLsbLgbRgbLgLsbRsbLgLsbLgLsbLgbRsbLgbRjRsmbLibRjbLiLsbLgbRsbLibLsb
LsbLsbLgbLsbLgLsbLsbLgbLsbLsbLsbLsbLsbLgbRsbLgbRsbRgbLgbLgbRcbLjbLsLhb
LibRgbLibLsbLgRsbLgbLsbLsbLsbLgbLsbLsbLsbRsRsmbLgbRgbLibRsbLgbLsbLgbLs
bLgbRsbLgbRjbRcbRibLgbRibRgbLgbRibLjbRgbLgbRibLgbRgbRsbRgbRgbRsbRgbLjb
RgbRgbRibRibRgRsmbRibRgbLgbRgRsmbLgbRibLgbRgRsmbRsbRgbLgRsbRibLsbRgbLc
bLibLgbRsbLibRjbLibLhLsbRibLibLgbRjbLibRgbLibLibRibRhbRibLjbLiLsbLgbRj
bLibRjbLibRjbLibRsbRgbLgbLsLsmbLsbLsbLsbLsbLsbLsbLsLsmbLsbRsbLsLsmbLsb
LsbLsbLibRgbLibRjbRjbRiRsmbRsbRgbRgbLjbRibRibRgbRgbLsRsbRgRsmbRibLjbsb
RsbRsbRsbRsbRgbLsbRgbRsbRgbLibRibRibRibRgbRgbLcbLibLiRsbRsbLgbLgbLsbLs
bLsbLsbLsRsbLgbRgbLgbLibRgbLgbLgbLsbLgbRgbLibLgLsbLsbLgbRsbLgLsbLgLsbL
gLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 5; Drug: Control Apo 0.5 然
bRsbRjbRibRgbRgRsmbRsbRgbRgbRsLsbRgbRgbRgbRsbRgbRsbRsbRgbRiRsmbRibRsbR
sRsmbRgRsmbRgbRsbRsbRgbLsbRibLgbRiLsbRgRsmbLibLjLibRoRsmbRiLsLsmbRibRg
bRgbLgbLgbRibRibLjbLobLibLiLsbRgbLsbLibRibRobRhbRgbRsbRibRibRibLsbRsbL
cbLhbRibRibLcbLcbLibLibRcRsmbLcLsmbLibRsbLgbRsbLgLsbLgbLibRsbLibRebRob
RgbLgbRibRibRibRibRgbRgRsmbLgbLsbLibLiLsbLibRibLcbLgbRsbRgbLibLsbLsbRj
bLsbLgbLcbLcbLibRgbRgbLibLgRsbLibRjbLhbLgbLgbRgbRsbLcRsbLcbLiLsbLgbLsb
RiRibRsRsmbLgbRibLobLibLiRsbRsRsmbLibLibLibRebRgbLiLsbRcRsmbRgbRsbRsbR
gbRsRsmbRgbRsbRgbRgLsRsbRsbRsbRgbLgbRibLjbRibRsbRsbRgbRsbRsRsmbRgbRsbR
sbRsbRgRsmbRgRsmbLjbRibLgbLcbLibRcbRhbRsbRsbRgbRsbRsbRsbLsbRgbLsbRibRc
bLibRibRgbLgbRhbLibRibLjbLcbRjbRcbLjbLhbLhbRiRsmbLcRsbLgLsbRgbRjbLhbLg
bLibRcbRobLgbRobRhbLibLibLgbLsbRibRgRsmbRsbRsbRgbLjbLcbLibRjbLibLsbLib
RjbLibRcbRibLgRsbLsbRiRsmbRsbRgbRsbRsbRgbRsbRsbLsbRgbRgbRgbLhbRobLcbRo
bRsbLsbRsbRgbLsbRibLgbRibLibLcbLibRcbLibLibRjbLcLsmbLibLgbLgbLgbRcbRsb
RibRsRsmbRgbRgbRsRsmbRsbRibLjbLjbLibRcbRsRgbRsbRsbRsbRgbRgbLjbRcbLebLc
RsbRibLibLibRgbLgbRcbRiRsmbLgbRgbRsbLjbLibRobRibLgbRibRgbLsbRsbRsbRgbR
sbRibLjbLibLibRcbLcbLibRcbRcbLjbLibLgbRgbLgbRsbRcbRiLsbLgbRibRsbRgbRgb
RsbRgbRgbLsRsbRgbRgRsmbLsbLjbLhbRcbRcRsLsmbRgbLgbRgbRsbRsbRsbRsbRsbRsb
RgbRsbRgbRgbRsbRgbLsRgbRsbRgbRgRsmbLsRsbRibLjbLjbLhbRibLcbRcbLoRsbLibR
cbRcbLcbLcbRcbLcbRsbLgbLgRsbRgbLgbLgbRobRgbRsbRsRsmbRsbRsRsmbRgbRgbRgb
RsbRsbRsbRsbRgbLjbRiLsbLsbRsbRgbRgLsbLjbLibRcbRhbLibRobLiRsbRhbLsbLsbR
ibRibRsbRgbRgbRsbRsbLjbLibRcbRibLgbRiLsLsmbLjbRibRibLgbRgbRgbRgbRsRsmb
RgbRsbRgbRsbLsbRgbRsbRsbRibLhbLibRjbLibLibRibRgbRgbRsRsmbRsbRsbRgbRgbR
sbRgbRgbLjbLcbLhbRcbLhbRcbsbRhbLgbLsbRibLgbLjbLhbLibRcbLgbLgbLgLsbRsbL
ibRcbRhbLjbRhbLibRibLjbRibLgRsbRgbRgbRgbRsbRgbLsbRgbRgbRgbRsbRsbRgbRgb
LcLsmbLcbRcbLibLibRhbLcbLgbRcbLcbRsbLibRgbLibRjbRhbLgbRibRsbRgbRsbRgbR
gbRsbRgbLsbRsbRhbLjbLcb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 6; Drug: Control Apo 0.5 然
bLsbRsbLsbLobLsbLgbLsbLgbLgbLgbRgbLgbRibRhbRhbRibRibRibLgbRgbLsbRgbLgL
sbLjbRjbLcbLibRibRibLgLsbLjbRgbLiRsbRjbLibLgbLsbRgbLgbLgbRibLibRsLsbLg
bLsbLgRsbLsbLgbLgbLsbRgbLsbLsRsbLsLsRsmbLsRsbLsLsmbLsbLsbLgbLgbRsLsbRs
LsRsbLgbLsbRgbLgRsbLsLsmbLgbLsbLsbRsbLsbsbLsbLgbsbsbLsbLsbLsbLgRsbLsbL
sbLsbLsbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bLsbLsbLgRsLsbLsbLibLgbLgbLgbLsbLsbLsbRsbRhbRgRsLsmbRgbRsbRiRsmbLsbRgb
RgbLgbRibRgbLjbLcbLgRsbRibLcbRcbRsRsmbRgbRgbRgbRgbLsbRibLcbRcbRibLsbRs
RsmbRibLcbRibRibRgbLcbRibRibRgLsbLjbRibRgbRgbRgbRgRsmbLobLibRsbRsLibRg
bLgbLgbLibRgbLibRgbLcbRgLsbLibRsbLibRcbRgRsmbLsbRgbLsRsbRiRsmbLgbRgbRg
bRibRibLcbRgbRgRsmbRgbRibRibLibRibRgbRgbRsLsbRgbRsbRgbLsbRsRsmbRgbRgbR
gbLsbRibLsbLibRibRgbRibLjbRgbLjbRibRgbRgbRgbRsbRsbRgbRgbLgbRibLibRjbLi
bRibRgRsmbRsbRgRsmbRsbRgbLgbRibRibLiRsbRibLgbRibRgbLsbLsbRibRgbLgbRcbR
cRsmbLebLgbLgbLibLsbRobLsRibRibLhbLjbRoRsmbRgbRhbLgbLibLiRsbLibLibRibR
cbRhLsbRibLhbLgbRsbRibRibLgbRibRgbLibRhbLibRhbRibLibRibRibLgbLjbRgbRsR
smbRgbRgbRgbLsRsbRibLibRsbRcbRcbLebRcbLibRiRsmbLhLsbRgRsmbLjbLhbLgbRsb
RibRebRgbRgbLgRsbRgbLsbLjbLcbLiRsbRibLibRgbLibRibRcbRibRgbLcRsbLibLgbR
gbLsbLgbLgbRebRcbLgbRibLjbRcbLhbRebLgRsbLsbRibRsRsmbRsbRgbRgbLgbRsbRgb
RgbRsRsmbRgRsmbRsbRibRsbLgbLjbLcbLgbLgbLgbLsbRgbLibLgbRgbLhbLgRsbRgbLs
bLsbLgbLgbLgbLgbLibRibRgbLibLsbLgbLgRsbRjbRjbRcRsmbRgbRsbLgbRhbLsbRsbR
sbRgbRgbLjbRebRibLgbRgbRsbRsRsmbRsbRsbRgRsmbLgLsbRgbRsRsmbRsRsRsmmbRsR
sLsmbRsbRsbRsbRsRsmbRsbRgRsmbRgbRgbRgbRsbRgRsmbRsRsmbRsbLgbRibLsbLgbRi
bRsRsmbRsbRgbRgbRgbRsbRgbRgbLcbRhbRgRsmbLsbRgbRsbRgbRgbRsbRgbRgbLgbRgR
smbRsbRsbRsbRsbRsbLgbRiLsbLibRsRsmbsbLhbLiRsbLgbRsbLgbLgRsbLsbLgbLsbLs
bLgbLiRsbRcRsmbLgbRibRsbLsbRgbRgbRgbRgRsmbRgbRgbRsbRgbRsLsbRsbRibRsbRg
bRgbRgLsbRgbRgbLjbLcbLibRgRsmbLibLgLsbLgbLsbLgbRgbLiRsbRebRobLibRibRgb
LgRsbRcbLibLgbRcRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bLgbLgRsbLsbLsbLsLsmbLsbLgbLgbLsbLsbLsbLgLsbLsbLgbLgbLgbLgbRsRsmbLgbLs
bLgLsbLgbLsbLgbRsbLgbLsbLsbLgbLsbLgbLgbRsbLiLsbLgbRiRsmbRgbLjbLibRgbLi
bLgLsbRjbLibLibRjbLgbLgbRgbLgbLgbRgbLgbRgbLgbLgRsbLsbLgLsbRgbLgbRgbLib
RgbLibRjbLgbLgbRsbLgbRsbLgbRsbLgbRgbRcbLjbLibLibRgbLibRgbRjRsmbRibRsbR
ibLjbLhbRibLibLgRsbRgbRiRsmbRibLsbRgbRibLgbRgbRgbLgLsbLcbLsLsmbRsbRjbL
ibLiLsbRjbLibLgbRjbLjbLibLibLcbRjbLiLsbRgLsbLsRsbLibRsbRjbLgbLgbRsLsbL
gbLsbRsbLsbLibRgLsbLibLsbLibLsbRgbLsLsmbLgbLsbLiRsbRjLsbLiLsbLsbRsbLib
RgbLibRsbLsbLgbRsbLsbLgbLgbLsLsmbLgbLgRsbRgbLhbRjbLibLiLsRsbRsbRsbLgLs
bLgbLsbLgLsbRgbRsRjRsmbLibLibRjbLibLibLsbLsbLsbRgbRibRgbLcbRgLsbLibLsR
sbRsLsbRgbLibLgbRgLsbRsLsbLgbLgbLsbRhbRhbLibLibLgbRgLsbLiLsbLgbLsbLgLs
bLgbLsbLsbLgbLibRgbLjLsLsmmbRgbLgbRsLsbLsbLsbLgbLsbLgbRgbLgbRsRsmbLgbR
sbLsbLgbLgbRgbLibRjRsmbLibLibLibLgLsbRgbRgbRibLjbLibRgbRjbRibRgbLcbLib
RgbLibLgbLgbLibRjLsbLibLgbRsLsbRgbRibRgbLjbLebRibLhbRgbLibRgbRiLsbLjbR
ibLjLsmbRibRgbLjbLebRjbsbLibRgRsmbLibLgbRgbLgbLibRjbLibLsbLsbLsbRsbLgb
LsbRgbLgLsbRsbLgbLibRjLsbRjbLibLhbRgbLgLsbLgLsbRsbRsbRsLgbLgbLgbLgbRjb
LjbRjRsmbRibRgRsmbRsbRgbRsbLsbRgbRgbRsbRgbRsbRsRsmbRsbRgbRsbRgbRgbLsbR
gbLsbRgbLgbRgbRgbLsbLhbRjbLhbRgbLibRgbLgbLgLsbRgbLsLsmbRibRgbRsRsmbLsb
RgbLsbRgbRgRsRsmmbLgbRibRibRsbRgbLgLsbRgbRsbRsRsmbRsbRsbRgbRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bRobRgbRgbRjRsmbRgbLsbLgbRsLsbRgRsmbLgbLibLibLibRsbRgbLgbLgbLgbLsbLgbL
sRsbLsbLgRsbLsLsmbLibLibLibRibRcbRibLibRibLsbRibLjbRibLsbRhbLgRsbRhLsb
LgbRgbLsRsbRibLgRsbRibLjbLobLgbLibLgbRsbLibRjbLibRsbLsbLobLcbLibRgbLsb
LgbLiRsbLgbLgbRjbRcRsmbRgbLsbLsbRgbRgbRgLsRsbRgbRsbLgRsbLhbLgbLgbLgbLg
bRcbLcbLobLebRjRsmbReRsmbRhbLjLsmbLcbLcbLibLibLgbLcRsRsmbLhbRgbLsbRsbL
ibLcbRcRsmbRcbRibRibRcbLebLcbLsbLgbLcbRcbRhbLsbRibRsbRsLsbLgbLgbLibLgb
LibRgbLibLibLsbRobRibLibLjbLibLiRsbRcRsmbRobRibLcbLhbLhbLcbLgbRgbLsLsm
bRsbRgbLibLgbRsbLgLsbLgbLsbLgbRjbLcLsRsmbRhbRcbRibLjbRcbLebLcbLibLgbLs
bRgbLsbLibLgbLgbLgbRgbLibRebRcbRsRsmbLibRhbLcbLcRsbRhbRcbLjbLhLsbLgLsb
RsbLibLsbRsbRgRsmbLibLgbLsbRsbLgbLgbLgbRsbLsbLgbLgbLgbRgbLsbLsbLgbLgLs
bLgbRgbLgbLsbLgbLgbLsbRgRsmbLgbLibLcRsbRsbLibRibRibLsbLsbRsbLjbLgbLsbL
sbLgbLgbLibLiLsRsbRibRgbRsbRibLgbLjbLcbLiLsbLibRiRsmbRgbLibLgbLgLsbLgb
LgbLgbLgbLgbLsbLsbLsLsmbLgbLgbLgbRsRsmbRjbLhbRcbRcbRibLgbLjbLiLsbLibLg
bRgbLsbRgRsmbRsbLsbLgbLgbLgRsbLgbRgbRgbLgbLgbLgbLsbLsLsmbLsbLgLsbLsbLs
bLsbLsbLsbLgbLgbLgbLsbLsbLsLcbLoLsmbLjbLiRsbLhbRgLsbRibLhbLiLsbLgbRsbR
gbRsbRiRsmbRgRsmbRsbLsbRsbRsbLsbRcbRgbLcbLgbRibLsbLsbLcbRgbLibLgbLgLsb
LsbLsbLgbRsbLgbLgbLgbLgbLgbLgbRcbRibLibLgbRgbLibLgbRgbRcbRgbRsbRsLsbRg
bRsbRsbRsbRsbRsbRibLcbLobLjLsmbRibLgbLibLgbLibLiLsbRgbRgbRgbLsRibLcbLh
bLibLibRibRgbRgbLibLibLgbLgbRsbRsbRgbLgbLgbLgbRgbLgbLgbLgbLgbLibRsbRgb
LsRsbLgLsbLgbLgbLsLsmbLgbLsLsmbRgbLibRgbLgbLgRsLsbLsRobRgbLgbLcbLibLgL
sRsbLgbRgbRgbRgbRibRibRgbRgbRgbLcbLibLgbLsbRgbLgbLgbLsbLsbLsbLgbLsbLgR
sbRsbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bRgbLsbLgLsbLgbLibLgbLsbLsbLsbLsLsmbLgbLsbLsRsbLgbRcbLjbReLsbRibLibLib
RjbLibLgbRsRsmbRsbLsbLgbRsbLgbRgLsbLgbLgbLgbLgbRgbLibRjbLibRhbLjbLjbRc
bLjbLibLgbRcbRcbRibRibLjbLcbLibLgbRjbLjbLgbLgbLjbLjbLgbRsbRgbLgbRibLsb
LgbLgbLgbLgbLsbLgbRsbLgbLsbLjbRcbRcbRibLgbRibLibLcbLiLsbRjbLhbLcbLhbLj
bLibRjbLibLgbLgLsbLsbRhbRcbLhLsbLgLsbLgbRcRsmbRhbRsbRgbLsbRgbRsbRsbRgb
LsbRgbRsbRsbRgbRsbRsLsbRgbLjLsmbRibRiLsbLibLjbRhbRibLhbLjLsmbRhbRsbRhb
RcbRgbLsbRgbLgbLgbLgbLsbLibLgbRgbRjbRcbRibRibLibRibLgbRsbRsbRsbRsbRibR
hLsbRhbLjLsmbRhbLgbLsbRsbLhbRcbRcbRhbLgbLgbLsRsbLsRsbLsbLsbLiRsbLsbLib
LjRsbRibLiRsbRjbLgbLsbLsbLgLsbLsbLjbLgbLsbLgbLsbLsbRibLgbLgbRgbLibLgbL
gbRsbLsbLgbRsLsbLibLgbRjbLibLgbRjbRcbLjbLcbRcRsmbLibRjbLibLgbLgbLsbLsb
LsbLsbLsbLgbLsbLsbLsbLsbLsbLsbRjbLibRcbRhbLjbLhbRjbLhbRobRcbLhLsbRcbLg
bLgbLcbLsbLgbRsbLibLibLgbRgbRsbLibRgbLgbLibLgbLhRsbLibRsbRgbLsbRsbLiRs
bRjbLgbLibLgbRjbLjbRhbLcbLcbRgbLsbRgbRgbLhbLgbLgbLsbLsbLgRsbLgbLsbRibL
hbRcbRcbLibRiLsbLsbRibRgbLjbLcbLibRjbLgbLibRjbRcbRsbRgRsmbLsbRibRsbLsb
RgLsbRsbRgbRsbRgbRibRhbRhbRibRgRsmbRsbLebRjbLhbRgbLgbLsbLsbLsbLsbLsbRs
bLsbLsbLsbLibRjbRcbLjLsmbLibLjbLsRsbRsbRgbRsbLsbLibLgbLgbLsbRsbLsbLibL
sbRcbLjLsmbLibLgbLgbLgbLgbLgbLsbLgbLgbRibLgbLgbRsLsbLgbLsbRebRibLgbLjb
LsbLgbLgbLsbLsbLsbLsbLsbLjbRcbsbsbLjbLiLsbRsbRsbLgbLsbLsLsmbLsLsmbLsbL
sbLsLsRsmbLsbLsbLsLsmbLsbLgbLgbLibLgbRjbLgbRobRcbRcbLsbRiLsbLibRibLgbR
ibLjbRibRhRsmbLcbLhbLcbLibLsbRsbLsbLgbLgbRsLsbLsbLsbLsLsmbLsbLsbLsbLsb
LgLsbLsbLgRsbLgbLsbLsbLgbLsbRgbLsbLgbRjbRebRjbLcbLcbRibRibLgbLgbLgbLsb
LgbLgbLsbLgbLibLiRsbLibLibLiLsbLsbRjbRibLjbLibRcbRjbLebLhbLsRjbLsLjbLg
LsLsmbLsbRsLgbLsbLgbLsbLgbLsbLgbLsbLsbLsbLsbLgbLsbLsLsmbLsbLgbRjbRcbLj
bLiLsbLibLiRsbLhLsbLebLibLgRsbLsbLsbLibRjbLibLsLsmbLsbLsbLsbLgbLsLsmbL
gRsbRsbLsbLsbLsbLsbLgbLsbLgbLsLsLsmmbLsbLgbRcbRcbRibLibLjLsmbLibRjbRcb
RsLhbRcbRibLjbRcbLcbLcRsbRgbLgbLsLsmbLsLsmbLgbLgbLgbLsbLgbLsbLsbLsbsbL
sLsmbLgbLgLsbRsbLsbLsbLgbLsbLgbLsbLsRsbLgbLsLsmbLsLsmbLsbLgbLgLsbLsLsm
bLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bRobRsbRsbRsbRsbRsbRgbRsbRsLsbRgbRgRsmbRsbLsbRgbLsbLsLsmbRsbRgbRgbRibR
gbRsbLsbLsbRgbLibLgbLgbLjbLcLsmbLsbLsbRsbRgbRgbLsbLhbLiRsbLiRsbRibLiLs
bRgbLibLibLgbLiLsbLsbLgLsbRgbLsbLibLiLsbRcbRobRcbLibRgbLiLsbLgLsbLibLs
bLgLsbLgbLsbLsbLsbRcbRcbRibRibLhbLcbLibLibLibLsbRsbRgbLgbLsbLcbLcRsbLi
LsbLibLsLsmbLcbLibLgbRiRsmbLjbLibRobLcbRobRibRgbLibRibLjbLibLiRsbRsbRc
bLibRcbLcbLcbLiLsbRsbRsLsbLgbLsbLgbLibRibRjbLgbLgRsbLgbLjRsbLoLsRsmbRi
bLgbRgbLibRsbLgbLibLibRcbLcLsmbRibLcbLcbLibLgbLhbLsbLsbLgbLsbLsbLsbsbL
sbLgLsbLsbLgbLsbRsLsbRsbLsbLgbRsbLgbLgbLsbRgbLgbLgLsbLgbRjRsmbLibLgbRg
bLgbLibLgbLibLgbLgbLibLibLsbLibLgLsbLgbLgbLibLsbRsbLgbLgLsbRebsbRcbLsb
RibLcbRoLsbRibLsbLibLsbLgbLibLsbLgbLsbLsbRgbLibRsLsbRsbLgbsbLgbLsbLsbL
sLsmbLgbLsbLsbLsbLsbRjbLgbLsRsLsbLsbLsLgRsbLsbLgbLsbLsbLsbLgbLsbLsbRcb
RiRsmbLcbRobLibLobLibLibRgbLgLsbLgLsbsbLsbRsbLgbRsRsmbLgLsbRsRsmbLgLsb
LgbLgbRebRhbRibLgbLcbLhbLibLhLsbRgbLibLibLibRjbLhbLibLibLgbLibRgbLibRg
bLibLgbLgbRsbLgbLgbRsbLgbRsbLgbLgLsbReLsbRcbLcbLgLsLsmbLgbLsRsbLgbRjbL
sRobRibLjbRibLcbLgbLsbLgbLgbLsLsLsmmbRgbLgLsbLsbLsbLsbLgbLgbLgbRsbRcbR
gbRgbRgbRgbLcRsbLibLgbRsLsbLsbLgbLgLsbLsbLgRsbLsbRsLsbRsbLsbLsbLsbLgbL
gbLsbLsLsmbLsbLgLsbRcLsbRobLgbLiLsbLgbLibRibRcbRibLjbLobLhLsbRibLgbRsb
LibLgbLgbRgbLibLgbLsRsbLgbRgbLgbLibLcbLjbRgbLgbRibLhbLibLgLsbLgbLgbLsb
LgRsbLgbLibRibRcbLgbRsRsLsmbLjbLibLjbLgRsbLsbRsbLsbLgbLgbLsLsmbLsbLsbL
gbLgbLgbLgbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bRibLsbRgbRgbRgbRgbRgbRgbRsbLsbRgbRsbRgbRgbRsbRgbRgbRsRsmbRsRsmbRgbRsL
sbRsRsmbRgbRsbRsbRgbLsbRgbLsRsbRgbRsbRgbRsRsmbRsbRsbRgRsLsmbRsbRibLjbL
cLsRsmbLgbLgbLsbLgbRgLsbLiLsbRhbRiRsmbLsbRgbRgRsmbLsLsmbRibLgbRibLebLc
RsLgLebLsbLibLgbRibLibLgbLsbLiLsbLsLsRsmbLsbLgbLgbRgbLibRgbLibLgbLsbLg
bLgbRsbLgbLsbLgbLsbLgbRsbLibRsbLsbLgLsbRsbLgLsbRsbLgbLsbLsbLgbLsRsbLgb
LsLsmbLgRsbRjLsbRcbRiRsmbLjbRiRsmbRsbLcbRobRiLsbLibLgRsbRsbLsbLsbLsbLg
bRsbLibRgRsmbLsbLhbRsbRibLibLcbRgRsmbLcLsmbLgbLsbRsLsRsbLibRgbRjRcLsbR
gbLgLsbRcbLgbRsbRibRcbRgbRhbRibRsbRgbRgbLjbRibRcbRsbLgbLgbRcbRibLsbRgb
RsbRsbRgbRgbRgbRsbRgbRibRibRgbLcbLgbLsbLsbRsbLsbLibRsbLgbLsbLsbLsbRsbL
gbLsbLsbRsbRsbLibRjLsbRcRsmbRibRibLgbRhbLgbRiRsmbLjbRiRsmbRsbRgbRsbRsb
RsLsbRgbLobLibRgbLsbLgbRgbLgbLsbLsbLgbRsbLgRsbLsLsmbLsbRsbLsbLsbLsLsmb
LgbRsbLsRsbLsLsmbLsbLgbLsLsmbLgLsbLgbLgbLgbLgbLsbLsbLsbLsbRsbLiLsbRsbL
sbLsbLsbLsbLsLsLsmmbLgRsbLsbLsbLgbLgbLgLsbLgbLgbLgbLgLsbLgbRgbLibRibLi
bRsbLgLsbRsRsmbsbLibLoRsbLibRibLibLibRsbRibLibLsbLsbRsbLiLsbRgbLgbLibR
sbRcbRhbLibRibRgRsmbLsbRsbRgbLgbRibRsbRsLsbLjbRcbLjbLcLsmbLgbLgbRgbLsb
LsbLhbRibRcbRibLsbRibLsRsbRsbRgbRgbLcbLibLsbLsbLsbRsbRsbLibRcbRibLgbRi
bRsbsbRsbRgbRgbRsbLebLibRsbRsbLibRsbLgbLsbLsbRsbLibRjbLibRjbRoLsbLibRi
RsmbRibLsbRgRsmbRsbRgbLsbRgbRgbRsLsbRibLgbLcbLibRjbRhbLobLibLgbLgbRgbL
iLsbLsbLsbRsbRebRibRibLiLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bLsbRsbLgbLsbLgbLsbLgRsbLgbLgbLgbLgbLgLsLgLgbLgLsbLgLibLiLeLsbLgbRsbLg
bLsbLgbRsbLiLsLsmbLgbLsbLgbLgbLsbLgbRsbLgbLsbLgbLsbLgbLsLsmbLsbLsbLsbL
gbLsbLsbLsbLsbLgbLgRsbLsLebLgbRsbLsbLsbLgbRsbLgbLsbLgLsbLgbLgbLsbLsbLs
bLsbLibRibRsbRgbRsbRsbRgbRgbRsbRgRsmbRgbRsbRgbRgRsmbRgbLjbRsbRibRibReb
LsbLibRjbLobRcbRebRgbRgLsbRgbRgbLsbRgLsbRjbLibRjbLibRebLobLjbLsbRgbLjb
RgbRhbLjbRoLsbRibRsbLsbLgbRsbRebLcbLobLjbRibLsbLsbLcbRjbRcbRsbLsbRsbRs
bRgbRiLsbLgbRjbLibRcbRibLsbRsbLebLsbRibRcRsmbLcLsLcmbLcbRjbLcbLcLsmbRi
LsbLjbRcbRcbRjbLsbLgbLsbRjbLcRsbLgbLibLcbRibRibLhRjbLgbLgbRsbLgbLgbRsL
sbLibRcbLjbRcbLibRcbLgbRcbLsLsmbLjbRebRibRgbRsbLibRgbLiLsbRjbLibRjbRhb
RsbLsbRgbLsbLsbRibRgRsmbRgbRjbLcbLcbRibRsLgbRsbRsbRjbLibRibRibLgbLcbRe
bLgbLgLsbRjbRebLibLsbLiRsbRebLcbLibRgbLcbRsbLjbLiRsbLibLsbLsbLsbLgbLgb
LgbRgbRjbRebRiLsbRjbLgbRiRsLsmbLjbRsbRibRsbRsbLcbRcbRcLsbLjbsbRcbLibRi
bLsbRsRibsbLsbRgbRgbRsbLsbRgRsmbRgbLjLsmbRgbRgbLgbRibLgbRiRsmbLsRsbRgR
smbLsbRiRsmbRiLsbLibLjbLiLsbLibLgbRgbLibLsbLibRcRsRsmmbRiLsbLgbRibRgbR
gRsmbRsbRsbLsRgbRgbRsbRsbRsbLsbRsbRgbLcLsmbLhbRibRibRibRsRsmbRsRsmbRsb
RgbRsbRgbRgRsmbRsbRsRsRsmmbRgbRgbRjLsbRsbLsbRgbLgbRgbRsbLsRsbRgRsmbRiL
sbLcbLcRsbRibLibRgbLibLgbRcbRibLsbRgbRsbRsbRsbRsbRgbRsbRsbRsbRgbRsbLsb
RgbLsbRgbRgbRsRsmbRgbRgbRsbRgbRgbRsbRgbLjbLoRsbRjbLiLsbRgbLcbRgbLsbLgb
LgLsbLsbLsbRsbLsbLgbLgLsbRjLsbRcLsbRhbLsbLsbRiRsmbRgbRgbLgbRgbLsbRibRg
bLibLcbLgbLsLsmbLsbLgbLsbLgbRjbRjbRcbRibLsbLsbRsbLjbRiLsbRibLibLhbLibR
jbLibRsbLgbLgbLsRsbLgbLsbLsLsmbLsbLsbRsRsmbLiRsbRgLsbLibRcbRibRgbRgbRg
bRsbRgbRhRsmbLhbLcbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bRcbRibLsbLgbRgRsmbRgbRsbRgRsmbLjbRhLsbRgLsLsmbLsbRsbRgbLgbRibLjbLcLsm
bLgLsbRsLsbLibLgbRhbLgbLibLgbLgLsbLibLsbLgbRsbLgbRjbRibRgbLiLsbRgbRsbR
gRsmbLsbRibsbsbLebLgbLibLibLgbLsRsbLgbRgbRibRibRgbLsbLjbLcbLibLgbLgbRi
bLibLgbRsRsmbRsbLhbLgbLibLibLgbRibRcbLibLibLgbLgbLsbLibRgbLibLgbLsbLib
LgbRsbLibRsbLhbLibLibRsbRgbRgbLsbLgbRjRsmbRgRsmbRiRsmbLgRsbRcbRibLibLs
bLjbLibLibRsbRibRibLjbsbLibLibLgRsbRgbLibRibRhbRibRgbRsbLibRgRsmbRgLsR
sbLsRsbRgbLgbLcbLebLibLgbRgRsmbRsbRibLsbLsRsbLibLibLgRsbRsbLsbLsbRgbLi
bLgRsbLjbLibLibRsbRsbRibLgbLsbRibRsbRgbLgbRgbLcbLcRsbLibRhbRgbRgLsbRgb
RcRsmbLjbRcbLhbLhLsbRcRsmbLcbLcbRibLibLibRcbRcbLhbLhbLibRebLhbLibRcbLi
bRjbLhbLcRsbLibRgbRgbRibLgbLgbLibLgbLibRcbLcbLhbLiRsbRgbLgbLibLibRjbsb
LibLiLsbRgbLibLibRibLibRiRsmbRgbRibLcbLhbRjbLibLibRjbLibRgbLibRgbLibLs
bLibRcbLhbLibRjbLibRjbLsbLebRcbLiLsbLsbLibRjbRsRsmbLibRsLsbLhbLhbLgbRs
bRgbRibRgbLibLhbLgbLgbLgbRsbRjbLcbRcbLhbLjbRhbLhbRcRsmbLhbRcbLcbLcRsbL
ibLsbRsbRjbLibLgbRcbLibLibRhbLcbLibRjbLhbsbRsbRibLibLibLibRjbRebRibLcb
LcbRiRsmbRjbLibLgbRjbLcbLhbLibLgbRgbRiRsmbRsbRibLjbRhbLcbLcbLibLgbLibL
ibRsbRsbRgbLsbRsbRjbRgLsbLgRsbRgbLsbRgRsmbLsbRibRgbLcbRibLibRjbRjbRsbR
gbLjbRibRibLsbLsRsbLibRjbLibLsbLgbRebsbRibLjbRibRgbLjLsmbLcbLibRjbLgbL
sbLsbLsRsbLsbLsbLgbLsbLsbLsbLsRsbLgbLsbLsbLsbLsbLgbLiRgbLibLiLsbRgbRgb
LgbLibRcbLcbLgbLgbRcbLhbRjbLiRsbLibRgbRjbRiRsRsmmbRgbsbRgbRsbRsbRgbRsb
RgbRgbRsbRsbRsbRgRsmbRsRsmbRsbLsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRgbR
sbRsRsmbRsbRsbRsbRgbRgbRsbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bRsbRgbRsbRsLsbLsbRsbRgbRsRsmbRgRsmbRsbRsRsmbRgbRgbLsbRsbRgbRgbRsbRgbR
gRsmbRibRcbLcbLiLsbRcbRgRsmbRgbRhbLsbLgbLjLsmbRjbRhbRibLgLsLsmbRgbLgbR
ibLgbRibRgbRgRsmbRgbLsbLgbLcbLiRsbRgbRjbRcbLgbRhbLgbRibRgbLsbRsbRiLsbR
gbRsLsbLjRsbLcbRjbLiLsbRgbLibLsbLsbLsbLgbRgbLgbLgbLgbLgbLgbRibRjbRibRg
RsmbRsbLsbRiLsbLgbRibRgbLibRsRsmbLcbLibLibLhbLhbLhbLibRsbLibLibLgLsbLs
bRsbLgbLsbRsbLsbLgbLgRsbRsbLibRsbLsbLsbLgbLgbLsbLgbRsLsbLsbLsbLgbLsbLs
RsbLsLsmbLgbLgbLgbLsLsmbLgbLsbLsLsmbLgbLgbLgbRgbLgbLsLsmbLsbLgbLsLsmbL
sbLsbLgbLsLsmbLsbLsbLsLsmbLsbLgLsbLgbLsbLsbLgbLsbRsLsbLgbLsbLsbLgbLsRs
bRjbLibLgbLsbLsbLsbLsbLgbLgRsbRjRsmbLgbRobRibRgRsmbLibLcbRjbRhbRgbRibR
hbRcRsRimbRibLsbLsbRcbLiRsbRibRgbRgLsbRiLsbLibRibRgLsbLsbLgbLcbLhbLiRs
bLibLgbRsLsbRsbLibRgbLhbRsLsbLsbLgbLgbLgbLsbLsLsmbLsLsmbLgbLsbLgbLgbLs
bLsLsmbLgbLsLsmbLsbLsbLsbLsRsbLgLsbLgbLgbLgbLgbLsbLgbLsbLsbLsbLgRsbLsb
LgRsRsmbLgbLsbLsbLsbLgbRsLgbLgLsbLgbRsbLgbRjbRcbRibLhbLcLsmbRjLsbLgbLs
LsmbLgbLsbLgbLsLsRsmbLsbLsbLsbLsbLsbLsbLgbLsbLsbLgRsbLgLsbLgbLgbLsbLgR
sbLgbRjbLibRcbLhbLgbRsbLsRsLiLsbLgRsbLibLcbLibLibRibRibLhLsbLcbRibRibR
ibLibLgbLgLsbLsbLsbLgLsbLsbLgbLsbLgLsbLgLsbLsbLsLsLsmmbLsbLgRsbLibRibR
cbLjbLcbRcbRiRsmbRgbLjbLhbLibRgRsmbLgbLgbLgbLsbLsLsmbLsbLsbLgbLsbLgbLg
bLgbLgbRjbLhbLhbLhbLibLhbLgbLsLsmbRsbLgLsbLgbLgbLgbLgLsbRsRsmbLgbRsRsm
bLsbLgbLsRsbLsbLgRsbRsbLsLsmbLgbLsbLgLsbLgLsbLibRhbRjbRsLcbLgbLgbRsbLi
bRsLsbLsLsmbLgbLsbLiLsbRcbRcbLhLsbLhbRgbLgbLsLsmbLgbLsbLsbLsbLsbLgbLgb
LsbLsbLsLsmbLsLsmbLgbLsbLsbLgbLsbLgbLsbLgbLsbLgbRjbLgbLgbLgbLgbRsbLgbL
sbLsLsmbLgbLgbLsbLgRsbRebRhLsbLgbLibLibLibLgbLgbRgbLibRjbRcbLcbRcbLjbL
ibLgbRjbLibLsLsmbRsLsbLsLgbLgbLsbLsbLsbRsbLiRsbRibRsRsmbLgbLsbLsbLgbLg
bLgbRgbRsbLiLsbLsbLgbLsLsmbLgbLgbLsbLsLsmbLgbLgbLsbLgbLsbLsbLsLsmbLgbL
gbLgbRsbLsbLgbLsbLsbLsbLgRsbLgbLgbLgbRsbLgLsbRsbLsbLgbLsLsmbLgLsbLsbLs
bLsLsmbLgbLsbLgbLsbLsLsmbLsLsLsmmbLsLsmbLgLsbLgLsbLgbLgbRjbLhbRjbLhbLs
bLsbLgLsbLsbLgbLsbLgRsbLibRjbRcLsbLebLcbLibRiRsmbRibsbsbLcbLhbLiLsbLiL
sbLibLibLiLsbLgLsbLgbLgbLgbRsbLgbRjbRcbRiLsbLcbLjLsmbLgbLsbLsLsmbLsbRj
bRibLeLsbLhbRgbLgLsbRsbRsbLgRsbLgbLsbLsLsmbLsLsmbLsbLgLsbLsbLsbLsbLgbL
sbLgbLgbLgbLgbRjbRoRsRsmmbRgbLcbLcLgRsRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bLgLsbLsLsmbLsLsmbLgbLgbLgbLgbLsLsmbLsLsmbLsbLsbLgbLgbLsbLgLsbLsLsmbLs
bLgbLsbLsLsmbLgLsRsbLsLsmbLgbLsbLgRsbLgRsbLgLsbLgLsbLgbLsbLsbLsbLgLsbL
gbRsbLgbLgLsbLsbLgbLgbLgbRcRsmbLsRhbLgbLsbLhLsbRsbLibRgbRoRsmbRibLjbRi
bRiRsmbLsbRibLjbRibLcLsmbLiLsbLgRsbLsbsbLsbLgbLcbLcbLsbLgbLcbLhbLcbRiR
smbRsbLsbRsbRhbRgbLgbLgbRcbRsbRibRobLgbLgbLgLsbLgbLgbRobRhbRgbRgbRibRh
bRsbRibRsbRgbRsbRgbRgbRgbRhbRgbLsbLsbLibLibLcbLhbLgbLsbLgbLibLhbLsbRgb
RibRibRcbRcbRgRsmbRgRsmbRibRsbLsRsbRgbLsbRgbRibLcLsmbLibLibLgbLsbRsRsm
bLibRsbLgbLgbLgLsbLgRsbLgbLcbLhbRgbRibLgbRibLsbRibRsbLgbRcbLibRibLsRsR
smbLsbRibRsbLsbRgbLsbRiLsLsmbRgbRsbRcbLsbRibLgbRiRsmbRibLibLgbLsbLgbRc
bLsbRibRibLhbRcbRsbLsbRhRsmbRsRsmbLsRsbRhbRsLsbRiRsmbRiLsbRibLsbLsbLgb
LsbRcbRgbRhbRgbLgbRsbRhRsmbRgbRgbLcRsLsbLibLsbLsbLgbLgbLgbLgbRgLsbLgbR
obRgbRcLsbRcRsmbRsRibRibRgbRgbLsRgRsmbRsbRgbLsLsmbRsbRgbRsbRgbRsbRgbRs
bRsRsmbRsbRsbRgbRsRsmbRsRsmbRsbRiRsmbRgRsmbRgbRgbLjbRiRsmbLjbLcbRjbLgb
LibLsbLgbLgbRcLsbRgbRsbRiLsbRoRsmbRhbRibRibLgRsbRsbRgbRgbRsbRsbRgbRsbR
sbRgbLsbRsRsmbRsRsmbLsLsmbRgbRgbRgbRgbLsRsbRsbRsbRgRsmbRsbRgLsRsbRgbRs
RsmbRgbRgbRsbLsbRsRsmbRgbRgbLsRsbRgbLsRsbRgbRgbLsbRsRsmbRsbRsbRgRsmbRs
RsmbLsRsbRsLsbRgbRsRsmbRgbRgbRsRsmbRsbRgRsRgRsmmbRgbRgRsmbLsRgLsbRsRsm
bRgbRgRsmbRgRsmbRsbRgbRsbRgRsmbRgbLcbLhbLibRsbLibLgbLibRcbRcbLsbRibLsb
RgbRgbLsRgbRgbLgbRibLsRsbRsbLsbRgRsmbRgbRgbRgRsmbLsbLsbRibRgbRgRsmbRsb
RgbRsbRgbLjbRcbLjbLhbLgLsbLsbLiRsbLcbLgbLgbRgRsLsmbRgbRhbLgbRgbRgbRibL
gbRsLsbRgbRoRsmbRgbLgbLgLsbRobRgRsmbLsbRsbRgbRgbRsRsLsmbLsRsRsmbRsbRgb
RsbRgbRgbRgbRgbRgRsmbLsbRsbRgbRgRsmbRgbRsRgRsmbRgbRgRgRsmbRiRsmbRgbRsb
RgbRsRsmbRgbRgbLsRsRsmbRgRsmbRgLsbLjbLcbLibRjbLibRoRsmbRibRcRsmbRibRib
RiRsmbRgRsmbLsbRgbRsbRsbRgRsmbRsbRsRsmbRgbRgLsRsbRgbsbRgRsmbRgbRsbRgbR
gbRgbRgRsmbRgbRgRsmbRsbRgbRgbRgbRgbRgRsmbRgbLcbLibLgbRobRibLsbRgbRsbRg
bRsbRgbRgbRsbRgbRgRsmbRgRsRgRgRsmmbRiRsmbRgbRsbRgbRgbRgbRgbRsbRsbRsbLs
bLhLsbLibRjbRcbLjLsmbRgbRibLsRsbLsbRgbRsbLobRgRsmbLsbRgbRgRsmbRgbRgRsm
bRsbLsbRgbRsRsmbRsRsmbRgbRsbRgbLsLsmbRsRgbLgbRibLgRsbLcLsmbLibLgbLibLc
bLcbLhbLgbLibRibRcbLsLsmbRgbRgbRgbRsLsbRgbRiLsbRob

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bRgbRsbRjbRsbRgbLsbRjbRgbRibLsbLgbLhbRsbLcbRibLibLiLsbRgbRjbLibLsbLgLs
bRsbLgbRgLsbLgbRgLsbLibRgbRjbLsbLhbRiRsmbRcbRibLjbRibRsbLsbRibRgbLjLsm
bRibRsbRgbLjbRibLjbRgbRcbRsbRhbRibRsbLgbRcbRsbRibLgbRsRsmbRgbLsRsbLsbR
sbRgbRgbRgbRgbLibLcbLhLsbRjRsmbRsbLgbLibLhbLsbRgbLhbRgbLcbLsbLsbLgLsbR
cbRibRsbRhLsbLjbLcLsmbRcbRobRibRibRgRsmbRgbLibLibLgbRgbLsbLibRsbRjbLib
LsbLiLsbLsbLgbLibLibLgbRgbRibRcbRcbRjRsmbLsLsmbLsLsmbLgRsbRsbRsbRhbRgR
smbRibRsbRiLsbLsbLcbLibRsbLgbLgbLibLgbLgbLgbsbRsLsbLsLsmbLsbLibLibLibL
sbLgbLibLsbRgbLibLsbLgbLsbLsbRsbRcbRibRibRibRsbLibLibLgbLsLsmbLcRsbLib
RgbRgbRsbLgbRgRsmbRgbRgbRgbRibLcbRsLcbRsbRjbLcbLgbRsRsmbLgbLsbLsbLsbLg
bLsbLsbLgbLsbRsbLsLsmbLgbLsbRsbLgbLsRsbLsbLsbLsbLsbLgbLsbLgbLgbLgbLgRs
bRjbRibLsbRibRibLgbRgbRibRsbRhbLibRgbRgbRgbLcbLgbLhbLhbRsbLgbLgbLgbRjb
RibRgRsmbRsbRgbRibLjbLcbLibRibRibLsbRgbRsRsmbRgbRsRsmbRgbRsbRibRibRhbL
ibRiRsmbRsbRsbRsbRsbRgbRgbRhRsmbLibLibLhbRjbLibLibRcbRibRcRsmbRcbRibLi
bLgbRibRiLsbRsbRgRsmbsbRsbRgbRgbRgbRsLsRebRgbRsbRgbRgLsbLsbRgbLcbLibLi
bRgbLgbLgbLgbLgRsbLsbLsbLsbLgbLgbLsbLgbRgbRsbLgbLibRjbLibLsbLgbLgbLgbL
sRsbLgbLsRsLsbLsbLsbLsbLgbLgbLgbLsbLsbLibLsbLsbLgbRgbRcbRgbLgbRibLgbRi
bLgbRgRsmbRsbLcLsmbLsbLsbRcbRgbRgbLsbLcbLgLsbLibRcbRibRhbLsbRgbLgbLgbL
gbRjbRcLsbRiRsmbLsbLcbLgbLgbRjbLibLgbRjbRcbRibLgRsbRibRsRsmbLjbRgbRsbR
gRsRsmmbRsRsmbRsbRsbRgbRsRsmbRgbRgbLgbLjbLgbLgbRsbLhbRcbRcLsbRhbLgbLib
LgbLgRsbLcbRgRsRsmmbRjbLibLibRsbLgbRibLsbLibLgbLgbLiRsbLgRsbRgbRsbLiLs
b

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bRgRsmbRibRgbRgbRsbRsbRgbLjbRgbRiRsmbLgbLsRsbRgbRgbRsbRgbLjLsmbRgbRgRs
mbLgbRibLsbRibLsbRgbRsbRgRsRsRsmmmbRsLsbRgbRgbLgbRiRsmbRgbLsRjbLsbLibL
gLsbLibRgbRjbRibRgbRgbLgbRsbRibRgbLsbRibRgbRsbRgbLgbRgbRsbRgbLgbRgbRsb
LsbRsbLsbLgbsbRsRgRsmbRgbRgbRgbLsbLsbRiRsmbLsbRgbRsRsmbRgRsmbRjbLjbReR
smbRgbRibRgbLsbRgbsbsbLsbRsbRgbLgbRibLsbRgbRgbLgbRgbRsbRgbRsbRsbRsRsmb
RgbRsbLgbRgbRgbRgbLgbsbLsbLebLibRjbRcbRgbRsbRjbLsRsbRgLsbLsbsbRgbRgbLj
bLibLibRjbRcbRsLsbLibLsbLsbLeLsbRsbRjbLcbLcbRiLsbLibRibRibRiRsmbLgbRib
RibLgbRiLsbRgRsmbRsbRibLibLhbLibRiLsbLibRgbLhbRiRsmbRcbRibRibRsbRgbLsb
RsbRgbLjbRiRsmbRibLibRjRsmbLjbRhbRgbLjbRibRgbLgbLsbRibsbLgbRibRiRsmbLg
bRibRgbLjbRhbRhbLhbRibLiLsbLsbRibLjLsmbRhRsmbRiRsmbsbRjbRsbLsbRsbLsbRs
bRsbLsbLsbLebLiLsbRsbLibRsbLsbLibRgbRgbRiRsmbRibLjbRhbRsbRibRsbRgRsmbR
sbRiRsmbRibLibLcbLibRiRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bLibRibLsbLsLsmbRsLsbLgbLgbRsbLsRsbLgbLsbLgLsbRsbLgbLsbLsbLjbRjbLgbLgb
LibLibRsbLgbLibLgbLsbRsbRgbLgbLjbsbRsbRsbRsbLsbLgbLsbLgbLsbLsRsbLsbRsL
gbLgbLgLsbRsLsbLgbLsbLgbRsRsmbRsbLgbLsLsRsRombLsbRibRgbRsbRgbRgbLgRsbR
gbRsbRjbRsLsbRsbsbLgbRgRsRsmmbLgbRibLjbRsbsbRibLjLsmbLcbLgbLsbLsbLgLsb
RsbsbLgbRsRgbRsbLgbRgbLgbLsbLgbLsLsmbLsbLgbLsbLsbLsbLsbRsLsbRsLsbLgRsb
LjbLsLsmbRsbLsbLsbLsLsmbLgbLgbRsbLgbLgLsbLgbLsLsmbLsbsbLsbsbLjbLsbLsbL
gbLsbLgbLsbLsbLgbLgbLgbLgbLsLgLsbRcbRibRgbRgbLcbLibRgbLgbLgLsbRjbLiLsb
LibRibLibLiRsbLgbLgbLsbRjbLhbLibLgbRgbLiLsbRgbRcbRibLgbRibRgbLibRsbRgb
RgbLjbRibLjbLhbLibRgbLiLsbLgbLsbLibLibRgbRcbRhbLjbLhbLgbsbLgbRcbRcbsbR
ibLgLsbLsbLhbLgbLgbLgbRjbRhbLjbRcbLhbRibRsbRibLsLsmbLcbLiLsbLgbRsLsbRs
bLgbLgLsbRgbLgbLgbRjbRebRjbLgLsbRibLjbsbRibRibLibRibLsbRsbRgbRgbLgbRgb
RgbLsbLjbLibLgbLgLsbRsLsbLgbLsbRgbLgbRobRgbLibLgbRibRgbRgRsmbRibLjbRib
LibRibLibsbsbRsbLcRsbLgbLgbLgbRsbLgbRsbRsbLsbLibLgbRsbRcLsbLebRjbLhbRj
bLibLgbLsbRsbRgbsbLsbLsbLsLsRsmbLsbLsbLsLsmbLsbLsbLsbLsbLgbRsbLsbLsLsm
bLgbLsbLgbLsbLgbLsbRsbLsbLsbLsbLsbLgbLjbLsbLsbRsbRsbLgbRsbLgbLgbLsbLsb
RgbRgbRjbLsbLjbsbLsbRsbLjbRsbLjbLsLsmbLsbsbLgRsbLsbLgbLgbLgLsbLsbRsbLs
RsbRoLsbLjbRibRgRsmbRgLsRsbRibLibRibLibRibLjbRiRsmbLjbRibRgbLjbLcbLgLs
bLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bsbLiRsbLsLgLsbLgbLsbLsLsmbRsbLjbLgLsbLgbLgbLsbLsbLgbLsbLsbLsbLgbLsbLs
bLgbRgbLsRsbLsbsbsbLsbLgbLsbLsbRsbLsbLsbRsbLsbLgbRgbLiLsbLsbsbRjbLiLsb
LgbLgbRsbLibsbRjbLhbRhbRjbRsRibRsRsmbLgbRsbRgLsbRgRsmbLjbRgRsmbLgRsbRg
bRsLsbRsbRsbRsbRsbLsbRsbRsbRjbLsbRsbRsbRgbRsRhRsRiRsmmbRgbRibRibLsbLiL
sbLgbLibRgRsmbLcbLhLsbRibLsbRsbRgbRcbLibRhbRgbLgbRibLsbRgbRgLsbRsbLsbR
gbLsbRgbRcbLhbLibRibLsbRgbLsbLcLsmbLibRgLsbLsRsbLsbLibLsbLsbLsbLgbLgbL
iRsbLibLibLibLibLibLgbLgbRjbLgbRsLsbLsRsbLgLsbLgRsbRobLgbsbLhbsbLgbRsb
LgbLsbLsbLsbLsbLsbLsbLsbLsbLgbRsRsmbLibLsbRsbRibRhbRsbRgbRgbLgbLjbLibL
sbLgbLsbLsbLsbRsbLsLsmbLsRsbLibLcbLgbLhbLibLibRgbLgbRsbLgLsbLgbLsbLsbL
sbLsbLsbLsbLsbRebRhbLgbRsLsbRhbLgbLsbRgbRsRsmbRgRsmbRsbRgbRsbRsbRgRsmb
RsbRgbRgbRgbLgbRgRsmbRgbRgbRsbRsbRsbRiLsbLeRsbLibLiLsbLiLsbRcbRiRsmbRs
bRsbRsbRsbRgbRsLsbRsbRsbRgRsmbRsbRgbRibRgbLjbRibLjbLcbRcbLjbLhRsbRcRsm
bRibRgbLsbLgbRgbRsbRsbRgbLsbRsbRsbRsbLsRsRsmbLsLsmbRgbRsbRsbRsbRgbRsRs
mbRsbRsbRsLsbLsbRsbLjbRjRsmbLcbLcbRsbLgbLgLsbLsbRobRibRsbLsbRgbRsbLgRs
bRibRsbLsbRsbLsbRsbRgbRsbLsbRsRgbRsRsmbRsbLsbRsbRsbRsbRsbRgbRsbRsRsmbR
sbRsbLsbRsbRibRsbLsRsbRgbRgbLgbRgRsmbRgbLsbRsbRjRsmbLcbLcLsmbRibLibLgb
LsbRsbLgbRjbRcbLjbRhbLsbLsbRibLsbLsbRgbLsRsbRiRsmbLsbRgbLsbRgbRgbRgLsb
RibLgbLhbRcbRibLibRibLgbRjbLibRgbRsbRsbRsbRsbRsRsmbLsRgbRsRgRsmbRsbRsb
RsbRsRsmbRsbRsLsbRgRsRsmmbRsRsmbRsbRgbRjbRsbRsbRgbRsbRsbRgbRsbRgbRsbLs
bLjbLhbRjbRhRsmbLibRjbRsbRgbRgbLgbRibLgbRgbRsRsmbRgLsbRsbRsbRsbLsbLsbR
ibRibRgbLhbLcbRsRsmbRsbRsRsmbRgRsLsmbLsbRgbRobLsLsmbRsbRgbLcLsmbRjbRcb
RhbRjbLibRjbLhbLcbLhbRibLsLsmbLgbLibRjbLibLgLsbLibRjbRebLgbRibLibLibRe
bRgbRhbLibLjbLgbLsbRsbLsbLgbLgbLgbLgbLgLsbLsRsbRjbRcbLsbRjbLebLibLjbRc
bRgbRgbRsbRsbLsbRgbRsbRgbLsbLcbLibRjbRcbLjbLjbLibLsbLsbLsbLgbRcbLhbLib
LgLsbLsbLgbRcbRibLiLsbLgbLsbRcbRcbRsbsbLgbLsbLsbLsbLgbLsbRjbRcbRibLgbL
obRgbRsbRsRiLsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bRsbRjbRgbRgbRgRsmbRsbRsbRsbRgbRsRsmbRgbRsbLsbRibLsLsmbRibLjbRibLsbRgb
LsRsbRgbLsRsbRgbRsbRgbRsRsRsmmbRgbLsbRgbRsbRgbLsbRgRsLsmbLgbRibRgbRgbL
sbRsLsbLgbRgLsbRibLobLiRsbLibRgbLibRgbLhbRgbLibRgRsmbLhRsbRjbRibRibLsb
RibLsbRibRgbLgbLcbLibLgbLibRgbRibLcbLiRsbRgbLibLibLibLgbLgbRjbLhbRjbRh
RsmbRibLgbRsbRgbRgbRibLobLgbRgLsbLibLgbRjbLhbLibRjbRhbRibLsbRibLsRsbRg
bRgbRgbLcbLobRibRjbRgRsmbRgLsbLsbRibLsbRgbRgRsmbRsbRgbRsbRibLibRibLjbL
cbLibLgbRsLsbLiLsbLibLcbRibRcbRibLgLsbRsbRibRgbRsbLsbRgLsbLsLsmbRiRsmb
LsLsmbRgbRgbRgbRsbRibLgbLhbRebRibLjbRibRgbLgbRgbRgbRsbRgbLsbRgRsmbLsLs
mbRgbRsLsLsmbRgbRsbRgbRgRsmbRgbRsbRgbRgRsRsmmbRsbRgRsmbRsbRgbRgbRsbRsb
RgbRsRsmbRgLsbRgbRgbRsbRsbRgbRgbRgbRsbRsbRgbRsbRgbRgbRgbRsbRgbRgbRgbLs
bLsLsmbRgRsRsmmbRsbRgbRsRsmbRgbRgbRsbRsRsmbRgbRgbRgbRgbRgbRgRsmbRgbRgR
smbRgLsbRgbRgbRsRsmbRgRsmbRgbRgbRibRgbRgRsmbRgbRgbRgbRgRsRsmmbRsbRgbRs
RsmbRgRsmbRgbRgbRgLsbRgbRsLsbRgbRsbRsLsbLsbRibRgRsmbLsRsbRgbRgbRgbRgbR
sbRgbRsbRgRsmbRsbRsbRgbRgLsbRsRsmbRgRsRsRsLsLsmmmmbRsbRgbRgRsmbRsbRgbL
sbRgRsmbRgbRsbRgbRgbRsLsbRgbRsbLgbRibRgbLsLsmbRiRsmbLsbRsbRgRsmbRsRsmb
RgbLcbLibRjbLiRsbLibLiLsbLgbRibLcRsbLgbRjbRcbLgLsbRibRiRsmbLibRibRjbLj
bLcbLgbLgLsbLsbLgbLibRibLcbRhbLibLiLsbRjbLcbRhbRcbRibLgbLsbRcbRgbRgbRg
bLiLsRsbLhLsbLibRjbLcbRjbLcbLgbLibRjbLibRjbLhbLhRsbRhbLcbLiRsbRibLhbLi
bLgbRcRsmbRibLsbRgbRgbRsbLcbLibLiRsLsbRgbRiLsbRgbRgbRgRsmbRsbRsbRgbRgb
RgbLjLsmbLcbLgbLgbRcbRibLgLsbRgbRgbRgbLcbLibRibLibLiLsbLibRibRibRiLsbL
ibRcRsmbLibRibLgbRgbRgbLcbLibRjbRibRibLsbRgRsRsRsmmmbRgbRgbRsbRsbRsRsm
bRgbRgbRgbRsbRsbRgbLsbRibRgbRsbRsbRgbRgRsmbRsbRsRsmbRgRsmbRsbRgLsbRsbR
gRsmbRgbLsbRibRsbRsbRibLsbRgLsbRgbLgLsRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bRsbLgbLgbLgbLgbLgbLgLsbLsbLsLsmbLgbLsbLgbLgbLgbLgbLgRsbLgbRsLsbRsbLjb
RibLibLgbLgbRsbLsbLsbLsbLsbLibRgbLgbRgbLibLgRsbRsbRsbRsbLsbLibRjRsmbLi
LsbLibRgbLgbRgbRsbLsbLhbRibLibRsbLhbLsbLsbLsbLsLsmbLibLsRsbLsRsbLgbRsb
RsRsmbLgbRsbLsbLgbLsbsbRjLsbLibLgbLsbLsbLsbLsbRgbRsbLsbLgbLgbLsbLsbLgb
RgbLibLebRibLgbLsbLgbLsbRsbLsbLcbRgbLgbLsbRibLgbLgbLsbRsbRjbLsLcbRgbLg
bLsbLsbLcbRgbLibRibsbLsbLgbLsbLgbRgLsbLjLsmbRgbRoRsmbLsbLsbLsLsmbRgbRg
bRgbRgbRgbRsbRsbRsbLgbLgbLibLgbLsbLsbLgbLsbLsLsmbLsbRsbLgbLgbLgbLsbsbL
sbLsbLsbRgbLjbRibLebLsbLgbLgLsbLgbLsLsRsLsmbRgbLibLibLsbLsbLsbLsbLsbLg
bLsbRgbLgbLsbLsbRsbLiLsbLgLsbLiLsbLgbLsbRhbRiRsmbRsbRibRsRsmbRsbRsbLjb
RcbRgbLsbRsRsmbRsbRgRsmbRsbLgbLsbRcLsbRsbLsbLgbRhbRgRsmbLsbRsbLgbRiRsm
bRsbRsbRsbRibRgbRsbRsbRsbRsbRgRsmbLsbRibRsbLsbRibLsbRsbRsbRgbRsbRgbRsb
RsbLsbLsbRgbRsbLsbLsbRgbRgbRsbLgbRibRsbLsbRibLsbLgbLsbRibRsbRgbLsbLsbR
sbRgbRsbLsbLsLsmbRgbsbLsbRgbsbRsbLsbRgbRsRsmbRibRsbRibLgbRsbRgbRsbRsbR
ibRsbLgbRibLgbRibLibLsbRhbLsbLsbRibRsbLsbLjbRobRgbLsbLsbRibRsbRibRsbRs
bLsbRsbRsbRgLsbRgbRsRsmbRsbRsbRsbLsbRgRsmbRsbsbsbLsbRsRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bLibLobRsbRibRgbRgbRgbRgRsmbRgbRgbLjLsmbLibLgbLsbLsbLgRsbRgRsmbLibLgbL
ibLsbLsbLgbLgbRjbLibLgbRjbLibLgbRjbLjbLgbRgbRsbLibLgbRgbLjbRsbLibLibRg
bLsbLiLsbLgbLgbRsbRsLsbRsbRibRgbRsbLgbLcbLibLsbLibLibLibLgbLibRibRhbLh
bRcbLcbLobLibLsbLibLibLgbLsbLibLgbLgbLgbLgbRgbLgbLgbLgbLgbLibRiRsmbRgR
smbRgbRcRsmbRhRsmbLhLsbRibRibRibLgbRcbRsbRhbRibRgbRibLgbLgbLgbLgbLgbRi
bRibRibRgbRgbRsbRiLsbLibLhbLgbLgLsbLgbLgLsbRgbLgbRibLgbLgbLgbLsLsmbLgb
LgbLibLibLsbRgbRgbRibRsbRsRsmbRibLjbLcLsmbLibLgLsbLgbRgbLsbLgbLgbRsLsb
LgbLgbRibRcbRgbRgbRgbLsLsmbRsbRsbRiRsmbRgbLjbLobLibLsbLsbRsbRgbLibLgbL
sbLgbLgbLgbLsbRsbLgbRsbLgbRsLgbLgbLgRsbRcbRcbRibRsbLgbLcbRgbRjbRobLgRs
bRibRcbLibRsbLgbLgbLgbLibLgbLgbLsbLsbLsbLsbRcbRibRgRsmbRsbLsRsbRgbRsbL
sRsbRgLsbLjbLcbLiLsbLgLsbRsbLsbLgbLgbLsLsmbRsbLgbLsbLgbLgbRgbLcbLibLhb
RgbLhbRgbRgbRibLgbRcbLjbRhbLgbRibRsbRgbLgbRibLjbLcRsbLgbLsbRsbLgbRsbLs
bLiLsRsbLsLsmbLgbLsbRsbRjbRcbRibLjbRibLibRibLcbLgbLiRsbLibRgbRibRhbRib
LsbRibLsbRsbRsbLsbRsbRsbLcbRgbRsbLgLsbLsbLjbRgLsbRsbLgLsbRsbLsbLjbsbsb
RsbLsbLjbRsbLsbLsLsmbLsbLsbLgbRcbRiLsbRibRibRgbLgbLibLgbLibLsbLgLsbRsR
smbLgbLgbLsbLgbLgbLgbLsbLsbLsbLgbLsbLsbLsbLgbRgbLgbLgLsbLgbRibRcbRibRs
bRgbRsbLsbRsbRsbRsbRsRsmbLsbRsbRgRsmbRgbRsbRsRsmbRsbRsRsmbRgbRgbRgbRgb
RsRsmbLsRsbRgbLsRsbRsbRgbRsbRgbLgbRibRgbLgbRgbRgbLgbRiRsmbRibRhbRgbLsb
RgbLgbLibRjbLibLgbLibRjbRebLsRibRsbRgRsmbRsbRsbRsbRsbRsbRsbRgbRgLsbLgb
RibLhbLcbLiLsbLsbLgbLgLsbLgbRgbRcbRgbRgRsRsmmbLsbRgbRgbRsRsmbRsbRgbRsb
RsLsbRiLsbLcbLhLsbLgbLsbLsbLgbLgbLsbLsbLsbLsbLsbLsLsmbLsbRsbLgRsbLsLsm
bLsbLsbRsbRsbLsbLsbLsbRcbRibRsbRsbLsbRsbRgbRibLjbLibLgbLgbRgbLgRsbLsLs
mbRsbLgbLgbLsbLgbRjLsbLgbRjbRcbRgRsmbRsbLsbRgbLsbLsbLsbRgbRiRsmbLcbLoR
sbLsbRibLibLgbLgbRgbLibRgbLgbRcbRsbRsbRsbRsbRsRsmbRsbRgbLsLsmbRsbLsbLe
bLiRsbLgbLsbLgbRsbLgbLsbRoRsmbRgbLsbLsbRjbRibLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bRibLibRcbLsbRsbRiRsmbLsbRgbRsbRsbRsbRsbRsbRsbRjbsbRsbLsbRsbLsbRsbLjRi
bRsbLsbLsRsbRibRgbRgbLcLsmbLgbLsbLsbLibLebRgbLibLsbRibLsbRgbLsRsbLsbRc
bLibRiLsbLcbLiLsbLibRiLsbLsbRgbLsbLgbLibLibLhLsbLsLsmbRsbRibLgbRibLsbR
jRsmbRsbRsbLsbRsLsbRsLsbLsbLsbRibRhLsbRibLibsbRgbRgRsmbRsbRgbRsLsbRgbL
sbLjbLgbLibLiLsbRibLcbRjbLgbLgLsbRjbLibLsbLibLgLsbRibRiRsmbRibRibLibRh
bsbLgbRjbLhbRgbLiRsbLibRibLgbLsbLiRsbLgbRjRgbRiLsbRibRsbsbLjbRsLsLsmbL
jRsbLhbRcbLebRjbLgbLgbLibRibLib

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 25; Drug: Control Apo 0.5 然
bRsbRsbRsbRgRsmbRsbRgbRgbRgbLgbRgLsbLsbRsbRsbRsbRgbRsbRsbRgbRsbRgbRgbR
gLsbLiLsbLjbRibRibRgLsbRgbRsbRgbRsbRsRsmbRsbLgbLjLsmbLibRjbRcRsmbRibRi
bRibLgbLgbLgbLgLsbLgbRgbLgbRcRsmbLsbRiRsmbRgbRsbRibRsbRsbLsRsbRibRgLsb
LjLsmbRgbLcbLcbRgbRibRibRgRsmbRgbRsbRgbRsbLsbRcLsbRhbRhbRhbRibRibRgbRs
LsbLgbLgbLsbLibRgbLcbLibLgbLsbLsbLgbLibLgbLsbLgbLsRsbRsbLgbLsRsbLibLib
LsbLsbRsLsbLsbLhbLhbRgbRibLjbRgbRgbLcbsbRsbRibLibRgbLgbLjbLsbRsLsbLsbL
sLsmbLsbLsbLgbLsbLsLsmbLsRsbLgbLsLsmbLsbLgbLsbLgbLsRsbLgbLibRgRsmbRsbR
jbRibLsbRsbRgbRibLgbRgbRgRsmbRibLjbLobRcbRgRsmbRsbRgbRsbRsbRsbRsbRsbRs
bRsbRsbRgbRsbsbRsbRsbRsbRsbRsbRsbRsbRsLsbRsbRsbRsbRgbRsbRgRsmbRsbRsbRs
bRsbRgbRgbRsRsmbRsRgLsbsbRsbRgRsmbRgLsbRcbRebRcRsmbRibRibRibLgbLgLsbRs
LsbRgbRgbRsbRsbRsbRgbRsbRiRsmbLsbRsbLsbRgbRgbRsRsmbLsbRsbRsbsbRsLsbRsb
RsbRsbRsbRsbRsbRgbRsbRsbRsbLsbRgbRgbRsbRsbRsbRsbRsbRsbRsRsmbRgbRsLsbRs
bRsbLsbsbRsRsmbRsbRsbRgRebRiLsbLjbLcbLgbRcbRibLgbRiLsbLsbsbRgbRsLsbRjb
sbLsbsbRsbRsbRsbsbRgLsbRgbRiLsbLgbLsbRsbRibRgbLsbRgbsbRsRsmbRsRsmbRgbR
sbRsbRsbRgbRgLsbRgbRgbRgbRsbLibRsbRgbRgRsmbRibRgbRgbLibRcbLibRibRgbRgb
RsLsLsmbRsbLgLsbRibLgbLjbRcbLibRgbRgbRibLjbLcbLhbRjbRjLsbRibLcbLhbRjbR
cbRibRgbRsLsbRsbRsbRsbRiRsmbRsbLsbRcbRcbRgbRgbRgbRgbRibRibRibLsbLcLcbR
sbLibRgbLgbLgbLsbLgbRsbLgbLsbLsbLsbRsLsbLsbLsbLibLgbLibLibRgbRibRgbRsb
RsbLjbLibRjbRibLcbLcLsmbLibLgbLsbLibRsbLsbLibLgbLibLibRsbLsbLgbLsbLsbL
sbLsbLgbLsbLgbLsbLgbLgbRgbLgbLibRsbLgbRsbRsLsbLhRsbLiLsbRibRgbLiLsbLsb
LibLgbRsbLsbLibLsbRsbLsbLgbLsbLsbRjbRibLjbRcbRgbRibLjbLcbRjbLhbRibRjbR
iRsmbRiLsbLjbLcbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 26; Drug: Control Apo 0.5 然
bRsbRsbRgbRsRsRsmmbRgbRgbRgbRgbRiRsmbRgbRsbRsbRsbRgbLsbRgbRsbLebLgbRsb
LgbLsbLgbLsbRsbLgbLgbLsbRsbLibLgbLgbLsbLgbLibRibLhbLibLgbLgbLsbLgLsbLs
bLsbLibRgbLhbRjbLibLcbLibRsbRsbLgbLibLsbLgbRjbRcbRsbRibLsbRgbRsbRgbRgb
LjbRcbRhbRiRsmbLsbLibRsbLsLibRsbRgbLhbLsbLgbRibRobRibRsbRgbLsbRgRsmbLg
bRcbLibRhbRibRcRsmbRibRsbLsbRcbRibLsbRibLsbRibLsRsbRgbRgLsbLsbLibLobLi
bLsbRsbLgbRibLibLgbRibLhbLgbRgbRgbLcRsbLsbRsbLgRsbLcbRibLhbLiLsbLgbRcb
RcbRgbRgbRgbRsbLgLsbLhbLibLgLsbLsbLgbLsRsbRgbLcbRibLhbLsbRsbLibRcbRhbR
ibLgbLibLiLsbLibLgbRiRsmbRebRcLsbLiLsbRibLgbRibLsRsbRsbRgbRgbLibLcbLib
RgbLiLsbLiLsbRjbLibLiLsbLhLsbLsRsbLsbLibRgbLcbLgbLgbLgbLgbRjRsmbLibLiL
sbRcbRhbRsRsmbRiRsRhLsmbLsRsbRgbRgbRsbRsbRhbRibLgbLgbLibRgbRjbLjbLcbRs
bRibRhbRibRgbLibLjbLcbLgbRgbRjbRibLjbLcbLsbLgbLgbRsRsmbRgbLcbLgbRgbLhb
LsbRgbRjbRibRibRibLsbLibRhbRibLsbLgbLjbLibLgbLsbRgbRsbLibLgLsbLibLsbRs
bRsbRgbRcbRibLiLsbRgbRsbRsbRhbLibRibLjbRiRsmbRgbLgbLgbRjRsmbRiRsmbLsbL
sbRiRsmbRsbRsbRgbRhbRibRsbLsbRsbLcbLsbLgbRsbLgbLsbLgbLgbLsbLibLibRsbRi
bRsbRsbLibLsbLgbLgbRgbLhbRhbRhRsmbLsbRibRsbRsbRsbLsbLsbRsbRgbLjbRiRsmb
RgbLibRcbLgbRibRgbRsbLsbLgbRibLsbLgbRibRsbRsbRgbRibLsRsbRsbLobRsbRsbRg
bLsLsmbRibRsRsmbLsbRgbRgbRsbRgbRgbRsbLcbLgbsbRsbLiLsbRgbLibLsbRgbLgbLi
bLhRsbLsbLsbRgbLsbLibLgLsbLibRgbLibLsbRsbLibRsbRsbLibLsbRgbLgbLibLibLg
bLsbRgbLcbLgLsbLsbLgbRsbLgbRgbLgbLgbRsRsRsmmbLibLsbRgLgbLibRgbLgRsbLib
LsLsmbLsbLgbLsbLgbLgbLsbLgbLsLsmbRsbLibLsbRsbLgbLsLsmbLsLsmbLgbLgbLgbR
ibRhbLsLcbRgLsbLibLsbLsbLsbLgLsbRsbLgbLsbLsbRsLsbLgbLsbLgbRsLgbLsbLsbR
sb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 27; Drug: Control Apo 0.5 然
bRsbRsbRjbRgbRgbRsbRsbRsbRsbRgbRgbRgbLsbRgbRgRsmbRsbRgbRsbRsRsmbRgbLsR
sbRgbLsbRgbRgbRgRsmbRgbLgbRibLjbRibRsbLcbLibLibRgLsbLibRjbLibRgbRcbLsR
sbRgbRsbRgbLsRsbLjbLibLibRsbLiLsbLgbRgbLibRgbLibLgbRibLibLibLgbRgbRjbR
cRsmbLgbRhbRhbLgbLgbLgbRcbRibRcbLibRsbRcbRgRsmbRsbLgbRjbRibRgbLsbLsbRi
bLjbRhbRgbRgbLsbRhbLgbRcbLibLibLgbRgbLibLhbLhbLibLibRcbRgRsmbRcbRibRib
RibLibLsbLibLgbLibLibLhbLgbRgbRibLibLcbLgbRhbRibRgbLgbRibRgbLgbRgbRgbR
gbRgbRgbLcbLibRgbLgLsbLgbLsbLgRsbLgbLgbRibLibLsbLgbLgbRgbLibLsbLgbLgbL
gbLgbLgbRibLibRibRgbLsbRsbRgbRgbRsbRgbRgbLsbRgbRgbRgbRgbLgbRibRsbRibLg
bLjLsmbLibLgbLsbLsbRsbLgbLsbRsbLgRsbRgbLiLsbLsbLgbLsRsbLsbLsbLgbRsbRsb
LgbRsbLgRsbLgbLgbLgbLgbLsLsmbLsbLsbLgbLgbLgbRsbLsbRsRsmbLgLsbLgLsbLgbR
sRsmbLibRgbLibRibRgbRgbRsRsmbLobRibLgLsbRgbLiLsbRsbLibLibRsbLgbLsbLgbL
sbLgbLgbRsbLsLsmbLgLsbLgbRgbLsbLibRsbLibRgbLgbRsRsmbLgRsbsbLgbRgbLibLs
RsbLgbRsbRsbLibRsbLibLhbRibRgbRibRibLjbRgbRgRsmbRgbRsRsmbRgbRsbRgbRgbR
sLsbRgLsbRhbLebRibLcbRibLcbLibLgbRibRgbRibRgRsmbLsbLebLiRsbsbRiLsbRibL
sbRsbLsbRsbRsbRgbRgbLhbLobLsbLibLsbLsRsbLibLgbLgLsbLsLsmbLsbLsbRsbRsbL
gbLgbRgbLgbRgbLhbLcbLcbLhbRsbRibRgbLebRhbRibRgbLhbRjbRibLcbLibRsbLgbLh
bRsbRjbLgbLgbRsbLgbLgRsbLgLsRsbRgbLgbLgLsbLsbLsLsmbLsbLgbRsbLgbLgLsbRs
bLsbLgbLsLsmbLsbLsbLgbRsRsmbLgbRgbLgbLgbRsbRsRsmbLgLsbLgbRjbLibRsbRsbL
ibLsbLsbLjbLgbRsbLgbRgbLgbLgLsbLsbLsbLsbLsbRsbLibLgbRibLibLsbLsbLgbRsb
LsbLsbRgbLgLsbLgbLgbLsLsmbsbLgbLibRgbLgbLgbLsbRibRibRgbLsbLsRsbRgbRgbR
gbLjbLsLobLgLsbLgbLsbLsbLsbLsbLgbLgbLgbRsbLsbLgbLsbLsRsbRjbRibRgbLsRsb
RgbRsbLjbRibRgbLjbRcbLhbLibLgbRgbLgLsbLgbRsbLgbLgRsbLgLsbRjbRibRgbRgbR
gbRsbRgbLiLsbLgbLgbRsbLsbLgLsbRgbRjbRiRsmbRiLsbLjbLibRgbRjRsmbRgbRgbRs
bLgbLebLsLsmbRsbLibRgbLgbLiRsLsbLsbLsbLgLsbRsbLsbLgbLsbLgbLsbLsbLgbLsb
LgbRgbLibRsbLgbRsbLgbRgbLgbRsbLgbRgbLgbLgbRsbRsbLiRsLsbRgbLibLgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 28; Drug: Control Apo 0.5 然
bRsbRgLsbRsRsLsmbRsRsmbLsbRsbRsbRgLsbRsbRsbRgbRgbRsbRgLsbRsbRgbRsbRgbR
sbRsbLsbRgbLgbRgbRgbLsbRgbRgbRgbRgbRibLjLsmbRgbRsbRsbRsbRsLsbRsRsmbRgb
RgbLhbLcbLibRgLsRsbLibLiRsLsbRsbLibRiRsmbRgbRgbRsbRgbRsbRgbRgbRgbRgbRs
bRsbRsbRsbRsLsbRgbRgbRgbRsbLgbRibRgbLsbRgbRsbRgbRsbRgbRsbLsbRgbRsbRgbR
sbRsbRsbRgbRhbRjbRsbLsbLsRsbLcbLhbRibRjRsmbRgLsbRgRsmbRgbRsbRsbRsbRgbR
sbRgbRsbRsbRgbLgbRgbRgRsmbRsbRgbLsbRgRsmbRsbRgbRsbRsbRsbRgbLgbRgbRgbRg
bLcbLibLiRsbLibLgLsbRsbLsbLgbLsbLhbRjRgbRhRsmbRgbRgRsmbRgbLsbLsbRgRsmb
RgbRgbRgbRsbLgbLibLibLibLgbLgbRgbLibRsLsbRsbLibLibLsbRgRsmbLibLibRgbLi
bLgbRsbLgLsbLsbLgbLsbLsbLibLgbRgbRsbLhLsbRsbLiLsbRgbRgRsmbLhbLgbLsLsmb
RsbRgbLgbLibLsbLsbRgbLibLsbRgbLibRgbLibLgRsbLgbRgbLgLsbLsbLgbRgbLibLib
RgbRgbRgbLibLibRjbLhbLgbLsbLgbLgbRsbLgLsbRsbLsLsmbLgLsbRsbRcbLgbLsbRsR
sLsmbLgbLsbLgbLgbRsbLgLsbRsbLgbLsbLsbLgbLsbLgbLsbLsbLsbLsbLgbRsbLgbRsb
LibRsbLibRsbLgRsbLsbLsbLsbLgbLgbLgbLgLsbRgbLibRsbLgbRsbLgbLsbLsbLgbLsb
RsbLsLsmbLsbLgbLsbLsLsmbLgbLsbLsLsLsmmbLsbLgbLsbLgbLsbLsbLgbLsbLgRsbLg
bLsLsmbLsbLsbLsbLgbLgbRsbRgLsbLiLsbLgbRsLsbLgbLsbLsbLsbLsbLgbLsbLgbLgb
LgbLgbLgbLgbRsbLibLgbRgbLiRsbLsbRsRsmbLgLsbLgbRsbLgbLsbLgbLsbLsbLsbLsb
LiLsbLsbLiRsLsbLibLibLgbRsbRsbLibLgLsbLgbLsbLsbLsbLsbLsLsmbLgbLsbRsbLg
bLsLsmbRsbLhbRsbLgbLsbLgbRsbLgLsbLsbLgbLsbLsbLgbRsbLgbLsbLgbLgbLsbLsbL
gbLgbRgbLibLsbRsbLgLsbLsbLgbLsLsmbLgbLsbLgbLsbLgLsbLgbRsbLgbRsbLibRgLs
RsbRsbLsbRcbLgbRgbRsbRgbRsbRsbRgbRsLsbRgbRgbRgbRgbLsLsmbLsbRgbRibLgbLj
bRgbLiLsbLcbLcbRhLsbLsbRgbRcbRgbRgbRsbRsRsmbRsbRgbRgbRsbRgbRgRsmbRsLsb
RsbRgbRgbRsRsmbRgbRsbRgbRibLsbLgbLjbLibRjbLibRjbRobRibRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 29; Drug: Control Apo 0.5 然
bLsbRibRibRsbRsbLgbLgbLsbLgbLgbLsbLiLiLsLgLsbLgRsbLgbRjbRhbRhRsmbLgbRc
bLsbLgbRibLibLgbRcbRibRibLgLsbLgbLgbLsbRhRsmbRgbRgbRgbLgbRgRsmbLgbRiRs
mbLgbRibRgbRsbLsbLsbRgbRgbRgRsmbRsbLsbLgbRibRibRhRsmbRibRibRgbLgbLgbRi
bRibRgbRgbLgbRibRgbRiRsmbLsbLgbLgbLgbLjLsmbLgbLjbLgbLsbRgbRgbLgbRibRib
RgbRibLjbRibLibRibLgbLjbLgbLgbLsbRjbRgRsmbRibLsbLibLibsbLsbReLiRsbRgbL
gbLgbLgbLsbRgbRibRibRgbLibRibRibRsbRsbLgbLgbLgbRibRjbLjbLgbLibLgbRibRi
bRibRcbRibLgbRibRgbRibRgRsmbLibLhbLgbLgbLsbsbLiLsbLsbLgbLsbLsbLgbRibRi
bRgbRjRsmbRibRgbRibRgbRsbLsbLgbLgbLsbLsbRjbRebRhbRgbRsbRibRibRibLibLib
RsbRgbRibRibRgbRgbLsLsmbRsbRsbRgbRgbRgbRibRibLsbLibRgbRhbRibRibLgbLjbL
gRsbLgbLgbRgbRgbRibRgbRsbRsbRgbLgbRgRsmbRgbLsRsbLsbRsLsbRgbRgLsbRsRsmb
LsLsmbLsbRgbLsbRgbRsbRgRsmbRsbRgbLsRsbRgbRgLsbRibRibRgbRibRgbLgLsbRgRs
mbRibRgbLsbRgbRhbRcbRibRgbRgbLjbLgbLsbLsbLsbLgbLsbLsbLsbRsLsbLgbLsbLsb
LgbLsLsmbLsLgbLsLsmbLgbLsbLsbRgbRsbLgbLgbLsbLgbLsbLgbLgLsbRcbRibRgbLsb
LgbRgRsmbLgbRcbRhbRhbRhbRibRiRsmbLgbLjbLjLsmbLcRsbLibLsbRsbRgbRibRhbRi
bLgbLgbRibLsbRsbLibLibLgbLsbLsbLsRsbRsbRsLsbLgbLsbLsbLsbLgbLsbLgbLgbRi
bLibLgLsbLsbLgbRgbLgbLsbLgbLgbRsbRgbRibRgbRgbLgbRgbRibRibRgRsmbLgbLsbR
sbRsbRgbRgbRsbLibLgbLsbLsbLsbLsbLsbRgbLibRjbLgbLgbLgbRjbRcbRgRsmbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 30; Drug: Control Apo 0.5 然
bRjbRsbRgbRgLsbRgRibRibRgbRgbRibRgRsmbRgbRgbRibRgbRibRgbRgbRgbRsRsmbRg
bRsbRsLsbLgbRgbsbRgbRgbRsbRsbLhLsbLgbLiLsbLgbRgbRsbRgbLibLibLsLsmbRsbR
jRsmbRjbsbRcbRibRgbRsbRsbRgRsmbRgbRsbRiRsmbLsbRibLsbRsbLjbLsRsbRjbLgLs
bsbRgbRsbRibRsbRsbRibLsRsbLsbLcbLiLsbLibRibRsbRgbLgbLibLgbRsbLsbLsbRsb
RsRsRsmmbRsbRsbLibRjbLgRsbLibLiLsLsmbLcbLiLsbLibLcLsmbLibLsLsmbRibLsbL
cbLibRibRsbLsbLibRsbLsbLsbRsbLsbLjbLobRcLsbRsbRgbLsbRsbRgbRsbRsRsmbLsb
RibRsbRgbLsbRsRgbLsbRsbRsbRgbRsbRsbRgbRsRsmbsbLsbRgbRsbRgbLgRibRgbRsbL
gbRiRsmbRsbLsbRibLsbsbLsbsbLsbLjbRsRsmbRsbRsbRsbRsbLsbLsbRsbLsbRsbRgbR
sbLsbRibRgbRsbRgbRsbRsbLgbLebLibLsbRsbLibRebLibRoLsRsbRibLsbRsbRibLsbR
sbRiLsbLgbLsbRsbRgbLsbLsbRsbsbRsbRsbRgbRgbRgbRsbRgbRsRsmbRgbRgbRgLsbRs
bRgbRsbRsRsmbRsbRgbRgbRgbRsbRgbRgbLsbRgbLsbsbLjbLcbLibRibRibRibRgbLgbs
bRsbRgbRsbRgbRsRsmbRsLsbRsbLsbRsbRsbRgbRgbRsbRgbRsbRgbRgbLgbRibLsbRsbL
sbLsbRibLcbRibRcLsbRjbLobLibLjbRsbRibLjbLsbRgbRibLcbLibLibLgbLjbLibLib
RsbRgbRibLibLcbLgLsbLjbRibRgbLjLjbLobRgbRibRhbRgbRsbRgbRibLcbLobLibRgb
RjbRhbRibRcLsbRcbRibRibRgbLgbRibRsbRgbRgbRsLsbRsbRgbRgbRobRcbRibRgbRib
LjbLcbRgbLibRgbLgbLgbLhbLsbRgbRsbRgbLibRsLibLibRsbRgLsRsbLibLsbLsbLgLs
bRsbLgbLgbRsbRsbLibLgbRgbLibRgbLgbLgbLsbLsbLgbRgbLibLgbRgbRgbRsbLebLib
RsbLibLgbRgbRsbRgbRibRsbLhLsbLibLiLsbLgbRsbRsLsbRibRgbRibRgbRgbRgbLgbL
cbLiLsbLsbLsbLsbLgbRsbRjbLhbLibRgRsmbLibRsRsmbLibLgLsbRgbRibRibLjbLhbL
gRsbLgbRsbsbLsbLibLiRsbRsbRibRibRibRgLsbRsbLsbRiRsmbLjbLcbLibLsbRgbRsb
RjbRjbRjbLebLcbRsbRsbRgLsbRjbLcbLsbLibLgbRsLsbRgbLibLgbLgbRsLsbRibRibR
ib

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bRcbRsbLibRsbRgbLjbLibLibLgbLgLsbLgbLsbLgbLsbLgbLgbLgbLgbLgbLgbRsbLsbL
gbLgbLgbLgbRjbLibLjRsbLibLiLsbRjbLcbRjbLgLsbLgbLgRsbLsbLsbRsbLsbLgbLgb
LgbLsbRsbLsbLgbLgbLibRibLsLsmbLibLsbLibLgbLsLibRobRibLsbLgbRibRsbLjbRi
bLgbLcbRsbRsbLgbRibRsbRibLjbRhbLgLsbRibLgbRibLjbRibRgRsmbRsbRgbLsbLsbR
iLsbLjbRibLgbRgbRgbRsbLjbRcbRcbRibRsRsmbLsRsbLibRhbLeLsbRsbLibLsbLgbRs
bRsbRsbLebRgRsmbRgbLgLsbLibLsbRsbLjbLgbLsbRgRsmbRsbLibLsbRsbLibRjbRjRs
mbRcbRgbRibRibLsbRsbRibLhbRcbRiRsmbLgbLsRsbLibLibLsbLgbLiLsbRjbRcbRiLs
bLibRibLsbRsbRsbRibRgbLsbLsbLgLsbLsbLgbLcbRibLsRibRibRibLgLsbRibLibRib
RgRsmbLsbLgLsbLibLhbLsbRgbLibRgbRgbsbRsbRjbRibRibLebRjRsmbRsbRsbRgbRgb
RgbRgbRjRsmbRsbRsbRgbRsbRiRsmbRhRsmbLibLsbRiRsmbRgbRsbRibLcbLsbLibLsbR
sbRsbLibLjRsbLsbRibLsbLibRsbLsbLgbsbRcbRebRcbRsbRibRsbRsbLibLiLsbLibRh
bRhRsmbLjbRibRibLibRibRgbLjbLsbRibRibRsbRgbsbsbRiRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bRsbRsbRsbRsRsmbRsbRgLsbRsbRsbRsbRsbRsbRsRsmbRsbRsbRsbRsbRsbRsbRgbLgbR
gbRgbLgbRibLgbRjbLjbLcbLgbRsbLgbRibRjbRcbRsbRibLsbLsbRibRgbLgbLjbLhbRj
bRcbLsbRcLsbRsbRsbLgbLsbRibRgbRsLsbLsbLsbLsbLsbRsbLcbLibLgbLsbLgbLgbLg
bLsbsbLsbLsLsmbRoRsmbRibRsbsbRsRsmbLsbRsLsRsbRgbRgRsmbLsRsbRsbRgbLsbLc
LsmbLibLsbLgLsbLgLsbLsbLsbRsbLsLsmbLsbRcbLsbRcbRsbRgbLsbLsLsmbLsbLebLi
bsbLsbLgLsbLsbLsbLgLsbLsbLgbLsbLsbLsbLsbLsbLgbLcbLibRjbRcbLibLiLsbLgLs
bRjRsmbLibLhLsbLjLsmbLiLsbLjLsLsmmbLsLsmbLsbLsLsmbRsbLsbRcbLsRsbLsbsbL
gbLsbLsbRibRhbRcbLgLsbLsbLgbLsbLiLsbLibRsbRjbRebRcRsmbLibLgbLgbLsbLsbR
sbLgbLgLsbLgbLsLsmbsbRcbRobLibLgbLibLcLsmbLsbLibLsbLsbLhbRsbLibRsbRsbR
sbLibLsbLsbLgbRsbLgbLsbLsbLsbLsbLsbLgbRsbLibLgLsbLgbRsbLsbLsbRcbLjbRib
LibLgbLibRebRibLgbRibLgbLsbLibRhRsmbRibLibRhbLibLsbRcbRgbRgbRgbLjbRhbR
cbLiLsbLsbRsbLgbLgLsbLsLsmbLgbLgbLgLsbLsbLsbLsLsmbLsbLsbLsbLsbRsbLgbLi
bLsbRsbLgbLsbLsLsmbLsbLgbLgbLgbLgbRibLibLgbLgbLsbLgbRsbRsRsmbRsbLiLsbL
sbLgbLsbRsbLiLsLcLsRsmbLibLgbLgbLgbLsbLgbLgLsbLsbLgbLgbLsbLgbRobRibLhR
sbsbLibLgbLsbLsbsbRsbLsLsmbLsLsmbLgbLsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLgbL
sbLsbRsbLgbLcbLibLibLgbLsbLsbRcRcLsbLhbLgbLgbLgbLsbLsbRsbsbLgbLsbLsbLs
bLsbLsbLsbLsbLsbLibRjbLibLsbLibRcbRcbLcbLcbLgLsbRsbLsbLsbLsbLsbLsbLsbL
gbLsbLsbLsbLsbLsbLsbLsbLgbLsbLsbLsbLgbLsbRsbLsbLsbLgbLgbLgbLgbLsbLsbRs
LsbRsbLgbLibRgbLgbRsbRsLsbLsbRsLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bLgLsbRgbLgbLgbRgbLgbLsbLibRgbLgLsbRgbLibRjbRcbRibRsbRsbRgLsbRsLsbRsbR
gbRgbRsbRgbRsbRsbRsbRgLsbRgRsmbRsbRsbRgLsbRsbRsbRsbLsbLibLgbRgbRsbLiLs
LsmbLiRsbLibLgbRsbLsbLsbRsbLsbLcLsLsLsmmmbLsbRsbRiLsbLgbRibRgbLsbRgbRs
bRgbLsbLsbRgbLsbRsbRsbRgbRsbRgbRsbRsbRsbRsbRsRsmbRsbRsbRgbRgRgLgbLcbLc
bLibRgbLibLsbRibRgRsmbLsbLsbRgbRibRjbRgbRiLsLsmbRcbRibLiRsbRhbRibLcbLc
bLibRgLsbRgbRsbLhbLibRgbLibLibRgbRibRgbLcbLibLsRsbRgbLsRsbLsLiLsbLhbRi
bRgbLhbLgbLibRibRcLsbRibRibRibRibLibRibRcbRcbRcLsbLcbLcbLibRibRibRgbRs
bRiRsmbRsbRgbRibLiLsbLsbRibRiLsbRcbLjbLcbRcbRcbRibRibLgbRgbRcbRjbRibRg
bRgbLibRsbLgbRibRiRsmbLcbLsbRcbRiLsbLjRsbRcbRibLgbRsbRgbRsbRgbRibRibLj
bRhbLcbLcbRjbLcLsmbLcbRibRibRgbLgbLsLibLibLiRsbRibRibLsbRsbRgbRgbLsbRg
bLcbLcRsbRsRsmbLhbRgbLgbRsbRsbLhbsbLibLsbRsbRsbLibRjbLsbLjLsmbRibRsbRg
bLcbRjbLhbLhbLgLsbRsbRgbLiLsbRsbLcbLcbLibRgRsmbRjbRgbRgbLibLibRibRjbLc
bRibLibLgbRsbLgbLgbLjRsbLibRibLgbRgbRgbRsbRsbLjbRsbLsbRcbRhLsbLjbRibLs
bRibRgbRsbLgbRgbRsbRsbRsbLsbRsbRsbRsbRgbRgbLjLibLibRgbRsbRcbLjbRibRibR
sbLgbRibRsbLsbRgbLsbRgRsmbRgbRgbRgbRgbRhbRjbLcbLjbRgbRsbLsbRgbRgbRgbRs
bLsbRsbRibLsbLsbRgbRgbRsLsbRsbRsbRgbRsbRgLsbLgbRgbLjbLibRjbsbRsbRgbRgb
RcbRgbRgbRsbLsbLibLgbLibLjbRebLjLsmbRobRibRgbRsbRsLsbRsLsbRsbRibLjbLcL
smbLcbLibLibRibRgLsbLibRibRsbRsbsbRjLsbRsbRgbLsbLsbRgbRsbRsbLsbRgbRsbR
sbRibLjbRhbLcbLcbLcbRgbLibRgbRgbRjbRiLsbRgbRgbRsbRsbRgbRgbRibRcbLcLsmb
LcbLcbRjbRcLsbRgRsmbRibRiRsmbRibRgbRsbLgbRsbRgbRibLsbLjbRcbLjbRcbLibLs
LsmbRjbRcLsbRgbRgbLsLsRsmbLibRsbRgLsbLhbRjbRcbRibRgbRsbRgbRgLsbRgRsmbL
ibRibLcbLcbLibLgbRgbRsbRgbRgbRsbLsbRibRibLjbLjLsmbLibRjbLibLgbLibRjbLi
bRsLcbRsbRsbRsbRsbRgbRgbRgbLgbLsbLgLsbLcRsbLgbRibRsRsmbRgbRgLsbRobRibL
sbLgbLsbRibLsRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bLsbLsbRsbRgbRgbRibRgbRsbRsbRsLsbRsRsmbRgbRsbRsbRsbRsbRsbRsbRsRsmbRgbR
sbRsRsmbRsbRsbRsbRsbRgbRsRsmbRgbRsbRsbRgbRsbRsbLgbRiRsmbLsRsbLsRsbRgbR
gbLgbRgbRgbLjbRibLsbRgbLgbLjbLcLsmbRgbLibLibLsbRjbLhbsbRjbLibLiRsbRsLs
bLsbLibRgbLibRibLgbLiRsbLsbLsbRgbLibLgbRibLibLgbRgbLiLsbLsbLgbRgbLibLg
bRgbLibRgRsmbLgbRsRsmbRcbRobLiLsbLsLsmbRibRcbRcbRibLgbRiLsbLcbLcbLgbRh
bLibLcbLibLhbRhbRibLibRcbRcRsmbLibRhbRibLsLsmbRsbRsbRgbRsbLgbRibRgbLsb
LgbLsbLsbLgbRibRibRgRsmbRhbLebLcbLibLsLsRsmbLibsbLgbLgbRibLhbRibLibLjR
sbLibRsLsbRgbRsRsmbLsRsbRgbLsbRcbLsbRsbRibLsbRsbLsLsmbRgbRgbLibRibRibR
ibRsbLsbLsbsbRsbLgbLcbLibRiRsmbLibLsbRsbRgbRsbRsbRsbRsbRiRsmbLsbLgbRib
LsbRsbRsbRiLsRsbLibRhbRibRgbsbRsRsmbRgRsmbRgbRsbRgbLsRsbLsbRibLsRsbRgb
RsbLgbRibRibRiRsmbRsbRsbLsbRsbRgRsmbLjbLibLjbLgbLsbRsbLsbRsbLgbLgbLibL
ibRgLsbLibLsbLsbLsbLsbLgLsbLsbLgbRsbLsRsbLsbLsbLsbLjLsmbLgbLgbLsbLgbsb
RsbRsbLsbLsbRsbLgbRsbRsbLsbRsbRsLsbRiRsmbRibRsbLsbRgbRsbLsbsbRibRsRsmb
LsbRgbRgbLibRebLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bRsLsLsLsLsLsLsmmmmmbLsLsLsmmbLsLsmbLsLsLsmmbsbLsbRsRsmbLsbLsbRibLibLi
bLgbLgbLiLsbLgbLobRobLgbLjbLibLgbLgbLgbLgbLgbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bLibLsbRgRsmbRgbLibLgbLgbLjbRjbLiLsbRsbLsbLsbLgbLgRsbLgbRgbLgbLgbLibLg
RsbLgLsbRsLsbRsbLiLsRsbRsbLibLgbLgRsbRibLibLgLsbLgbLsbRsbLibRjbLgbLibR
gbLibLibLgbLgbRibLibLibRiRsmbLiLsbLgbRjbLibLibRcbLibLibRjbLcbRibLhbRiL
sbLibRjbLcbLsRsbRsbLibRcRsmbRcRsmbRiRsmbLgbRibRgbRgbLjbLibLibRjbRhbLjb
LcbRebLcbLiLsRsbLcbLgbRibRebRcbRsRibRibLsRsbRibLgbLsbLsbRcbRiRsmbLibRi
bRhbLibRgbRgbLibLgbLgbLgbLsbRgbLibRjbLibLibLsLsRsmbLsLsmbRjbLiLsbLgbLs
bRsbLiLsbRcRsmbRiRsLsmbRgbRgbLjbRhbLgbRiRsmbRgbRsbRsbRgbLgbRgbLsbRiRsm
bRgbRsbRgbRsbRsbRgbLsbRgbRsbLgbRibLgbRiRsmbRibRgRsmbLgbRgbRgbRibLgbRiR
smbLgbRiRsmbRgbRsbRsbLsbRsbRgbRgLsbRsbRsbRsbRsRhb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bRjbLsbLgRsbLgLsbRjbLibRjbLgbRcbRgbRgbRgLsbRgbsbRhbLgbRgbLsbRgbLgbRibR
sLsbLsbRibLibLibRibLjbRjbLibLjbRibLibRgbRsbLibRgbLgLsbLsbLibLsbLsbLsbR
gbLibRgbRgbLibLsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bRiLsbRibRsbRgbRsbRsbRgbRgbLsbRgbRgbRsbLsbRsbRsbRsbLsbRgbLsbRsbRgbRoRs
mbLsbLgbLgbLsbRsbLgLsbLgLsbLgbRcbLjbLgbLibLibLsbLsbLsbRsbLgbLcbLgbLgbL
gbLibLsbRsbLsLsmbLgbLgbLsLsmbLsbLgbLsbLsbLsbLgbLsbLgbLgbRjbLgbLgbLgLsb
RgbLgbLgbRgbLibRgbLibLgbRgLsbLibLgRsbLsbRgbLgbLgbRsbLgbLgbLsbLsbLsbRgb
LgbLgbRcbLgbRibLgbRhbLgbRibRibLgRsbRibRibLibRibRgbRsbLibLibLibRgbLibRs
bLgbLgbRsbRgbLgbLgbRsbLgbLgbLgbLgbLsbLgbLsbLgLsbLsbLgbRsbLgbLsbLgbRjbL
ibLsLsmbRsbLgLsbLsbRsbLibRgbLibRjbLgbLgLsbLsbLgbLgbLsRsbLgbRsbLgLsbLsb
LgbLsbLgbRsbRgbLiLsLsmbRsbLgLsbLibRgbLibLgbRcbRibLgbRibLgbRgbLgbRibLgL
sbRibRsbRsRsmbRgbRsbLgbRibRgbLgbLgbRgbsbLibRcbRibRibLibRibLgbLsbRibLgL
sRsbRgbRibRibLgbRgbRgbLgbRibRgbLgLsbLsbRibRgLsbRsbRgbRgbLgbRgbLgbRgbRg
bRgbRgbLsbLgbRgbRgbRgbRgbRsbRgbRsLsbLgbRgbLgbRgbRibLgRsbRibRsRsmbRgbRg
bRgbRibLgbRgbLsbRgbRibRibRgbLibRibRsbLgbRgbLibRjLsbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bRgbRgbRgRsmbRsbRsRsmbLsbRgbLsbRgbRgbLjbRibRgbRgbLgbRgbLsbRgbLcbRjbRiR
smbRgbLsbRgbLgbLsRgbRgbLgbRibLgRsbRibLhLsbLibRsbLsbRjbRgbRibLhLsbRgbLg
bLgbRsbLiLsbRgbRjbRibRiRsmbLjbRhbRiLsbRgbLsLsmbLgbRibRgRsmbLgbRgRsmbRg
bLgbRibLjbRibLhLsbRibRgbRsbRgbLsbRgbRsbRsbRsbRsbRgbRgbRgbLgbRgbLgbRibR
iRsmbLgbRibLgbRiRsmbRibRgbLsbLjbRibRibLsbRibLgbRibLjbRibLjbRibRgbLgbRi
bLgRsbRgLsbRgbRsbRgbLgbLibLibRjbRhbRibLsbRgbRgbRgbRgbLgRsbLcbLcbLiLsbR
sbLibRgbLibLgbRibLhbRgbLibRgbLiLsRsbLiLsbRibRibLhbLgbRsbLibLhbLgbRgbRs
bRsbLcbLibLgbRibLcbLsbLsbLcbRibLibLibRgbLiLsLsmbLsbLsbRsbLgbRgbLsbLgLs
bLiRsbRjbLiLsbLgbLsbLsLsmbLibRgbLibLibLgbRsbRgbLhbRsbLiLsbRgbLiLsbLgLs
bLgbRibLibRgbLibLibRgbLsbRgbLibLibRgbLibLsbRibLibRsbLibRgbLgbLsbLgbLgb
LgRsbRgbLibRsbLgLsbRsbLgLsbRgbLgbLsbLgbLsbLgbRjbLibRjbLibLsbLgbLibLgbL
sbRgbLiLsLsmbLsbLgbLsbLgbRsLsbLsLsmbLgLsbLsbLsbLgbLsbLsbLgbRgbLiRsbRsb
LiLsbRsLsbLgbLsbLgLsLsmbRgLsbLibRsbRsbLibRsbLgbLcRsbRibLibRibRjbRcbLjb
LcLsmbLibRgbRgRsmbRcbRibLibRhbLjbRcbLibRibRgbLsbRgLsbLsbRgRsmbLgbRibRs
bLcbLibRjbLcbRibLhLsbLsRsbLibLsbRgbLibRibLibRsbLsbLgbLgbLsbLgbLsbLsbLg
LsbRsbRcbRiLsbLhbRiRsmbRibLibRibRibLjbRiRsmbLjbRibLjbRcLsbLhbRhRsmbRib
LgbRibRsbRibRibRgbLgbRibRibRibLjbLcbLsbLibRjbLibRjbLiLsbRjbLibRgbLibRg
bLibRgbLibRjbLiLsbRibLibLsbLsbLibRsLsbLgbLgbRjbLibRibLibRcbRcbRhbLgRsb
RibRgbRgRsmbRsbLgbRibRsbRiLsbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bRsbLgbLgbLsLsmbLsbLgLsbLgbLsbLsbLsbLsbLsbLgbLgbRjbLibRjbLibRcbRsRibRg
RsmbLsbLsRsbRgbRgbLsbRsbRsbRsbLsbRgbLsbRgbLjbRjbRibLcbLsLcRsRsmbRiRsmb
LsbLjbRjbLibLsbLsbLibRjbLiRsbLsbLsbLgbLsbLgbLiRsbRsbRsbLibLeLsbsbRsRsm
bRsbLjbLibLsbLsLsmbLgbLibRsRsmbRjbRcbLsbLgbRhbRcbRgbLsbRgbRcbRgbLgbRib
RgbLsbLjbLsbRibRgbLsbLsbRgbLibRgbRibRhbRhbRsRsmbRgbLsbLsbLsbLcbLcbLibR
sbRsbLsbRjbRibRgbLsbLsbLsbRiRsmbLibRjbRibRgbRgbRgbRgbLsbRgbRgbRgbLgbLs
bRsbRsbLibLgbRcbRibLjbRcbRibLgbLibRcbRibLsbRgbLsbLsbRsbRgbRibRsbLsbRgb
RgbRsRgbRgbRgbRsbRibRibLgbLibLgbLsbRibLcbLcbLibLsbLgRsbLsbLibLsbLgbLsL
smbLgbRsbLsbRsbLgbLgbLhbLibLgbRiRsmbRgbLgbLgbRjbRsbRgbLsRsbLsLsmbRgbLs
RsbRgbRsbRsbRsbRgbRsbRgbRsbLsbRiLsbLgbRibLgbLsLcbLgRsbLibRibRibRcbRcRs
mbRibLibRsbRgbRjbRiRsmbRobRibRgbRiRsmbRibLibLjbLibLiRsbRibLibLsbRgbLib
RsbRgbLcbLgbRsbRsbRsbRsbLsbRsbLsbLcbLsbRgbLgbLgbLsbLsbLsbLsbLsbLgbRibL
ibLjbLcbRjbsbRcbRcbRibRibLibLebRiRsmbRiRsmbRibRhbRiRsmbRibLgbRsRsmbRgR
smbRgbLsbRsRsmbRsbRgbRsbRgbLgRsbRcbRibRsbLsbRsbRgbLsbRgRsmbLgbLgbRgbLh
bLgbLcbRibLibRjbRhbLjbLebRjbLjLsmbLibRjbLjbRjbLcbRjbRsbLiLsbLhbRgbRibR
gbRibRibLibRibRgbLgbLjbRsbLibsbLgbLgbLsRebsbRcbLhRsbLhbRjbLsbLcbRibLcb
RgbRjbRiRsmbRgbRsbRsbRgbRsbRsbRgbRsbLjbLjbLhbLgbRsbRgbLibRsbLgbLgbRgbL
iLsbRsbLibRjbLhbLsbLgbLgbRjbRhbLjbRiRsmbRibRibRgbLsbLsbLsbLsRsbLsRsbRi
bLgbRhbRsRsmbRgbLgbRsbLgbLgbRcbRgbRsbLsbRgbRsbRgbRsbRsRsmbRsbRsbRsbRgb
RsbRsbRsbRsbRsbRgbLoRsbLiRsbLsbRsLsbLgbLgbRgbLsbLgLsbLgbLibRibsbRgbRsR
smbRiRsLsmbRgbRibRgbLiLsbRgbRsbRgbRgbLjbLjbLsbLibLsLsmbLsbRgLsbLibLsbL
ibLibRgbLibRgRsmbLgbLgbLsRsbLsbLsbLgbLsbLsbLsbLgbLsbLsbLsbLsbLsbLgbLgR
sbLsbLgbLgbRgbLiRsbRgbLibRjbLhbRgbLibReRsmbRhbRibLsbLsbLgbLgbRjRsmbRgb
LsbRsbRsbRgbRiRsmbLgbRgbRgbLjbRgbRgbRsbLgbRgbRsRsmbRgbLibRiRsmbRibRgbL
sbLgLsLsmbLsLsmbLgRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bLsbLgbRibRgbRgRsmbRsbRsbRsbRgbRsRsmbRsbRibLjbRgbLcbRibRgbLibRhbLibRjb
LsbRgbRibRibRibRibLjLsmbRibRibLjbRibRibLgbRjbLibRebRiLsbRiLsbRibLsbRgL
sbRsbRgbLcbLibRgbRibRgbRgbLibRgbRgbRgbRibLgbLsbLgbLgbLibLibRgbLibLibRg
bLibRsbLgbLiRsbLgRsbLibLgbLsbLsbLibLsbRgbLibLsbRgbRcbRibLibLiRsbLibLib
RibLgbLhbLgbLgLsbLgbRsbRsbRgbRgbLibLibLsbLgbLgbRgbLhbsbLibRsbRsbLgbRsb
LgbLsbLibRibRgbRgLsbRibLibLgbLgbRibRibLgbRiLsbLsbLhbLibRibLibRibLcbRib
LgbLsbLgbLibRsbLgbLgbRsbRsbRebLcbLgbRibLgbRsbLgbRsbLcbLsbLgbLsbLsbLgRs
bRjbRebRcbLibLgbRibRsbRgbRsbRgRsmbRgbRgbLjLsLgmbLgbLgbLjbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bsbLibRgbRgbLgbRjbRsRsLsmbRibRgbRgbRgbRgbRsbRgbRgbRsRgbRsbRgbRgbRgRsmb
RsbRsbRsLsbRgLsbRgRsmbRgbRsbRgbRsbRsbRsbRgbRsbRgbRsbRsbRgbRgbRgLsbRgbR
gbRgbRgbRgbLibRiRsmbLsbRibLhbLgbLgbRsRsmbLiLsbLibRsbLiLsbLgbLgbLsbLgbL
sbLgbLsLsmbLsbLsbLgbRgLibLsbLiRsbRjbLhbRjbRcLsbLibRsbRhbLgbRibLsbRjbRs
bLcbLgbLsbRgbLiRsbLibLgbLsbLsbLsbLsbLgLsbLgbLsLiLsLsmbLgbRsbLibRsbLibR
gLsbLibRgbLibLgbRhbLhbLgbRgbLgbLgLsbRsbLgbLsbLsbLgLsbLgbLgLsbLsbRgRsmb
LhbLgbRgbLhbLibRgbRiRsmbLhbRcbRcbLcbRcbLsbLgbRgbRibRgbLgbRsbRiLsbRsbRg
bRsbLsRsbRgbRgbLsbRgbRgbLjbLcbLibLgbRgbRsbRcbLhbLiLsbRibLibLgbLsbLsbLs
bLibLcbRhbLgbLsbLsbLibRcbLjbLcbRhbLhbLibLsbLgbLsbLgbLgbRsRsmbRibLgbLib
RgbLgbLcbLgbRcbLibRibRgbRgbRsbRiRsmbLgbRibLgbRgbRsbRsbLsbRibRibLibRibR
ebLhRsbRibRibLgRsbRgbRibRgbRcbRcbLgbRgbLgbLgbRibRgbRsbRgRsmbReLsbLibLj
bLhbRjbLhbLgbLsbLgbLsbLsbLsLsmbLsbLgbLsLsmbLgbRcbRcbLibLjbRibRiRsmbRsb
RsbRsbRgbRgRsmbRsbRsbRgbLsbLcbRjbRcbLibRibLjRsbRibLjbLhbLibRgbLgbLgbRc
bRcbRgbLibLibLiLsbLsbRsbLgbLhbRebLibsbRebRsRibRsbLsbLhbLibRgbLgbLgbLgb
LgbRcbRsbRgbRsbRsbRgbLcbLhbRjbLibRsbLibRhbRibLsbRgbLgbLjbLcbRsbLgbLgbL
gbLsbLjbRcRsmbRcbLhbLibRjRsmbRibRgbRsbLibRibRgbRibRsLcbLcbRibLhbLsbRsL
sbLibLsbLgbRsbLsbLgbLsbLgbLibRjbLibRsbRgbLgbLgLsbLsbLsbLsLsmbLsbLsbLjb
LgLsbLsbLsbLsbRgbRcbRibLjbRibRgRsmbLgbRibLsbRgbRsbRgbRgbRsbRsbLsbRgbRg
bLgbRgRsmbRgbRgbRsbRibLcbRgbLgbLgbLgbLgbRjbLhbLgbRiLsbLibRgbLgbRsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bRsbLgbsbLsbLibLgbLgbLgbLgbLsbLgbLgbLgbLgbLgbLsbLgbLsbLgbLgbLsbLgbLsbL
sbLgbLgbLsbLgLsbLgbLgLsbLsbLgbLsbRsbLgbLgbLsbLsbRcbRibLsRsbRiRsmbRgRsm
bLgbRiRsRsmmbLsbRgRsmbLsbRibRsbLsbRiRsmbRsbLsbRibRhRsmbRsbLiLsbRsLsRsL
sbsbLiLsbLsbLgbLgbLgRsLsbRgLsbRsbRjbRibRiLsbLsRsbLgbLgbRcbRcbRgbRsbRgb
LsbRibRibRgbRiRsRsmmbRgRsmbLsbLjbLcbLsbLgbLsbLsbLsbLgbRsbRsbLgbRcbRgbL
gbRibLgbRibLgbRibLsbLsbRiRsmbLgbRibRgRsmbRgbRsbRcRsmbLgbLibLibLgRsbRib
LibRjbLiLsbRsbLgbLsbLsbLgbLiLsbLcRgRsRsmmbRgLsbLsbLjbLgbLgbLibRjbRibRi
bRibRgbRsbLebLibRsbLgLsbRcbRsbLgbLgbRibRiLsbRibRibLgbLsbLsbRgbRsbRibRi
bLsRsbLsbLjbRhRsmbRibRsbRgbRsbRsbRgbLsbRibRsRsmbRgbRgRsRsLsmmbLsbRibLs
RsbRgbRsbRgbLgbRibLsbRibRgbLsbRibLgbRibLsbRgbLsbRibRsbRgRsmbLgRsbRiRsm
bRsbRibLsLsmbLsbRgbRgbLsbRgbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bRsbRsbRsbRsRsmbLsbRsbRsbRgbRsbRgbRsbRgbRgbRgbRgbRsbRgRsmbRsRsmbRsbRsb
RgRsmbRgbRsbRsbRsbRgbLsbRgbLsbRgbLsbRgbLsbRgRsmbLsbRgbRsbRsbLjbLjbLhbR
iRsmbLibLiRsbRsLsbLibRgbLibRsbLsbLibLsLsmbRgbLibRsbRgbLibRgbLiLsbRgbLi
bLibRgbLibLjbLsbLgbLcbLgbLsLhbRhRsmbLhbRgbRibLsbLibRibRebLibRcbRibLsbR
gbRgbRgbRibRjRsRsmmbLibLibRibRgbRgbLibLcbRsbLsbLgbRgbLibRibLebRibLhbLg
bLsbLsbLgLsbLiRsbRsLsbRhbRhbRgRsmbLsbRgbRgbRsbLsbLjbLcbRsbRgbLgbLgbLsb
RsbsbLsLsmbLgbLgbLgbRgbRebRibRgbRsbRsbRgLsbRsbRsbRsRsRsmmbRgRsmbLhbLib
LgbLgbLcbRibRjbRibRgbLsRsbLsbLsbRgbRsbRsbLjbLobRsbLhbLgbRgbLibLibRcLsb
RibRsbRsbLcbLcbLibLibRibLjbLibRjbLgbLgbLgbRjbLgbLsbLgbRsbLgbLsbLgbLsbL
sbLsbRsbLgbLsbLgbLsbLsbLsLsmbLsbLsbLiLsbLcLsmbLibRibRiRsmbLcbRibRgbRsb
LsbRsbRgbRsbRgbsbRsbLsRsbRsbRibRibLsbRgbRsbLsbLsbRgbRibLsbRgbRsLsbRgbL
gbLcbLibRsbLgbLsLsmbLsbLgLsbLgbRjbRhbLgbRgbRibLsbLsbRibLgbRgbRsbLcbLgb
LsLsmbLgbRsbLsbLgbLsbLsbLsbRsbLgbLsbLsbLsbRsRsmbLgbLgbLgbLgbLsbLsbLsbL
gbLgbLsbRsLsRsbLgbLgbRgRsmbRcbRgbRgbRsbRgLsbRsbRgbRsbLcbLibRsbRgbLibLg
bLgbLsbLsbLsbRsbLsbLsbLsLsLsmmbLsbLgRsbRsRsmbLgbRsbLsRsbLgbLsbLgbLsbLs
bLsbLsbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bLsbRsbLsbRsbRgbRgbRgbLgbRgRsmbRgbRgRsmbRsbRsRsmbRsbRsbRsbRsLsbRgbLsbR
sbRgbRsbRgRsmbRsbRgbRsbRsbRgbRsbRsbRsLsbRgbLsbRibRsbLhbLiRsbLibRgbRcbR
ibRibLgbRsbRcbRhbRhbRgbRsRsmbRsbLibRsbRiRsmbRibRiRsmbRgbLsbRgbRgRsmbRs
bRgbLobLibRjbRjbRhRsmbLgbRibLgbRhbLibLhbLhbRsbLibRcbRhbLibRibRsbRobRib
LsbRsbRsbRsbRgbRibRsbLhbLhbRhbRcbRsRsmbRsbRgbRsRsmbRsRsmbRgbRgbLsbRgRs
mbRsbRsbRgbRsbRgbRsbRgbLsbLsRsbRgbRgbLgbLcbLibLibRcbRibLsRsbRsLsbRibLs
bLsbRgbRsbRgbLsRsbRsbRsbRgbRsbLsbRsbRsbRgRsmbLsbLsbRgbRsbLsbRgbRsbRgbL
sbLcbLcbRjbLhbRhbRiRsLsmbLjbLcbLhRsbRcbLiRsbRhbLjbLibRjbLibLibRsbRhbRs
bRsbRsbRsbRgbRsLsbRsbRgbRgbRsLsbRgRsmbRsRsmbRgbLsRsbRgLsbLcbRhbRiRsmbR
iLsbRsbLsbRgbRgRsmbRsbRsbRsbRgbLcbLsbLibRjbRhbRgRsmbRsbRgbLsbRsbRgbRgb
RsRsmbRsbRgRsmbRsbRgbRgLsbRsRsmbLgbRgRsmbLsbRgbRsRsmbRgRsmbRgbLsbRgbLs
bRgRsmbLsRsbRgbRsbLcbLgbRsbLiRsbRjbRcbRcbRsbLgbRhLsbLgbRibRibLsbLgbRcb
LhbLjbLibRcbRoRsmbLjbRhbLsRsbRgbLsbRgbRgbRsbLsLsmbRibsbRiRsmbRibRhbLib
RhRsmbRibRgbRgRsmbLibRcbRiRsmbRsRsmbRgRsmbRgbRsbRsbRgbRsbRsbRgbLsbRgRs
mbRhbRcbRhbLgbRibRibLgbRiRsmbLsbRsbRgbRsbRsbRsRsmbRsbRsbRsbRgbRsbRgLsb
LgbRgbRsbRsbRgbRgbLsbRibRsbRsbLibLibLsbLgbLsRsbLsbLsbLibRcbRcbLsbRibLs
bRgRsmbRgRsmbLsbLsbRgbRsbRsRsmbRsbRgbLsbRgbLsbRgRsmbLsRsbRgbLgbRiRsmbL
cbLibRsbLsRjbRcbLjbRiRsmbRsbRsbRsbRsbRgbLobLiRsbRjbLhRsbRjbRhbRgRsmbRs
bRsbRsbRgbRgLsbRgRsmbRsbRsRsmbRgbRgbLjbRgbRsRsmbRgbLsbsbRgbRgbRsLjRsbR
gRsmbRsbRgbLsbLsLsmbRgRsmbRsbRgbRsbRgbRgRsmbRgbRsbRiLsbLibLhbLgLsbLgbL
ibRcbRcbLjbLcbRjbRcbLgRsbRiRsmbRsbRsbRgbRsRsmbRgbRgRsmbLsRsbRgbLsRsbRg
bRsbRiLsbLjbLjbLibLgRsbRcbRibRgbRsRsmbRgRsRsmmbLsbRibLsLsmbRgbLsRsbRgb
RsRsmbLsbRsbRsbRgbLgbRibRsbLgbRibLsRsbLjbLhbLgRsbLibRcbRcbLibRibLsRsbR
gbRgbRibRsRsRsRsmmmbRsbRiLsbRsbLsbRiLsbLjbRgbLjbLcbLibRgLsbRcbLjbRhbRi
bLsbRibRsbRgbRsbRgbRsbRgRsmbRsRsmbRsbRgbLjbLcLsmbLibRjbRcbLjbLhRsbLibR
jbLibRhbRobLgLsbRiLsbLsbRibLsbRsRiRsmbLsbRgbLsbRgbRsLgbRgRsmbLsLsmbRgb
RsbRgbRsbRgbRsbRgbLjbLhbLibRjbRibRibRsRsmbRgbLgbRgbRsbRsbRgbReLsLibLib
LibRibRibRgRsRsmmbLgbRiRsmbLgbRibLsRsbRgRsmbRgbRsbRgLsbRsbLhbLibRjbRcb
LjbLcLsmbRjbLhbRcb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bLgbLgLsbLsbLgLsbLgLgbLgbRjbLibRibLgLsbLgLsbRjbLibRcbLjbRibRgbRsbRsbRs
RsmbLgRsbRgbLsbRgbLsbRibRgbLgbRgbRsRsmbLgbRiRsmbRiLsbRiRsmbRsbLsbRibRs
bRsbLgbRibLsbRgbRsbRsbRgLsbRsbRsbRsbRsbRgbRsbLgRsbLcbLiLsbLibLsbRsbLib
RsbLgbLibLsbRgbLiRsbRjbRcbLibRhbLgbRibLgbRibLgbRsbRibRsbRsbRgbLcbLibLg
bReRsmbLibLibsbLibRgbLgbLgbLsbLsbLgbLsLsmbRobRgbLsbLsbRibRgbLsbRsbRsbR
sbRsbRgRsmbRsbLsbLcbsbLibLibRjbRcbRcbRgbLgRsbRibRgbLgbRibLsbRgbRsbRsbR
sbRsLsbRgbRsbRsbRsRsmbLsbRibRsbLgbRgbRsbRsbLsLsmbRhbLibRibRsbLgbsbRsbs
bRibLgbRibLsbLjbsbsbsbRobRgbLgbLsbLgbLibLibRsbLgbLsbLcRsbRibLibLibLgbL
sbRibLibLgbLgbRsbLibLgbLsbLsRsbLgbRgbLibLsbLgbRjbLcbLibLibRgRsmbLgLsbL
ibLgbRgbLgbLgbRobLgbLgLsRsbRsbLgbRgbLoLsmbLibRsbLsbRibRgRsmbLsbRgbRsbL
cLsmbLibLgbLgRsbLgbRiRsmbRobRgbRsbRsbRgbRsbRsbRsbRsbRgbLsbRsRsmbRsbRsb
RgbRgLsbLibLcbRjbRhbRsbRgbRsbRgbRgRsmbRgbRsRsmbRsbRgbRsbRsbRsbRsbRsbRs
RsRsmmbRsRsmbRsbRsbRsbRsRsmbLsbRgRsmbRgLsbLcbLhbLibLgbRgRsmbRgbLibLibR
ibLgbRibLgRsbRcbRgbLgbRebLsbRgbLsbRhbRsbRsbRsbLsbRgbRsbRsLsbRsbRsbRsLs
bRgbRsbLsbLsbRibRsbRsbRgRsmbRgbRsbRsRsmbRsbRsbRsbLsbRgbRsbRsbRsbRsRsmb
RsbRgbLsbRgbRsbRsbRgbRsbRgRsmbReRsmbRgbRgbRiRsmbLjbRiLsbLgbRhRsmbRgbRs
bLgbRcbRgbLgbRibLgbRibLgbRibLgbRgbLsbRgbRsbRsbRsbRsRsRsmmbRsRsmbRsbRgb
RsbRgbRsRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bRibRsbLsbRsbRsbRsbLsbRsbRibRgbRgRsmbRsbRsRsmbRgbRsRsmbRsRsmbRsLsbLsRs
bLsLsmbRgbLsbRsbRsRsmbRgbRgbRsbLsbRsbLsRsbRgbRiRsmbLsbRgRsmbRgbRgbRsbL
gbRgbLsbRibLgbLgbLgbLgbLgLsbLibLgRsbLsRsbLgLsRsbLsbRgbLsbLgbLcbLibLgLs
bRsbLsbLsbRgbRgRsmbRsbRsbRgbRsbRsbRgLsbLgbRgbLgbRgRsmbRgRsmbRsRsmbRsRs
RsmmbRsbRsbRsbRsRsmbRsbRsbRgbRgbRsbRgLsbLjbLibLibLibRsLgbLgbLgLsbLsbLs
bRgRsmbLcbLhbLsbLgbRibRcLsbLsbLibLgbLgbLibLgLsbRsRsmbLgbLgRsbLgbRsbLib
LiRsbLgLsbRsbRgbRgbLobLibLgbLgbLsbRgbRibRibRsRsmbRgbLsbRgRsmbRsbRgbLsb
RsbRgbRgbRsbRsbRgbRsbRsbRsbRsbRsRsmbRsbRgbRsbRsbRsRsmbRgbRsbRsbRsRsRsm
mbRsbRsbRsbRsbRsbRgbRgbRoLsbLibLcbLibLsbLsbLsLsmbLgLsbLgbRcbLiRsbLibLc
bRjbLcbRsbRgbLibRsbLgbRsbRsbRcbRcRsmbLibLsbRgRsmbRsbRgbRsbRsbRsbRsbRgb
RsbRgbRsbRsbRsbRgbRgbLsRsbRgbLjbLobRobRsbRsbLgbRiRsmbLgbRibRhbRibLgbRi
bRgbLgbRgbLgbRibRibRsbLsbRibLgLsbRgbRsbRgbRsbRgRgRsmbRgbRsbRsbRgbRsbRg
bLsbRgbLgbLsRgRsmbRsbRgRsmbLsbRibLcbLcbLsbLsLsmbLsbLiLsbLgLsbRsbLgbReb
RcbRiRsmbLgbRgbRsbRgbLsbRgbRsRsmbRsbRsbRgbRsbRgRgLsbLiRsbLcbLibLsbLebR
gbLcbLgbLgbLgRsbLibLibRsbRgbRgbLibRcbLsRsbLsbLgbLibLsbRsbLgbRsLsRsbLsb
LgbLsbRsbRcbRcbLgbLibLgbLgbLsLsmbLsLsmbRsbLgbLgbRsbLgbLsbLgbLsbRsLsbLg
bRjbRcbRibLgRsbRgbRgbRsbRgbLsbRiLsbLjbLhbLgRsbLsbLsLsmbLsbLgRsbLgbLsbL
gbLsbLgbRsRsmbLgbLsbLsbLgbRsbRhRsmbRgbRsbRsbRsbLsbRibLgbRibLgRsbRibLjR
sbRcbRcbRgbLsbRsbLsbLgbLibLgbRibLgbLgLsbLgbLibRgbRcbRcbLgbLsbLgbRibLib
LgbLgbLgbLsbLsbLsbLgRsbLsbLgbLgbRgbLgbRsbLgRsbRcbRsbRsbRgbRsbRsbRsbLsR
sbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsbRgbRgbLsbRsbRsLsbRgbRsbRsbRsbRgbRsbRsb
RsbRsbRsbRsRsmbRsbRsbRgbRgbRgRsmbRsbRsbRgbRsbRgbRgbRgbRgRsmbRgbRgbLjbL
jbLhbLgbLgbLsbLsbRsbLgbLsbLsbRsLibRjbRibRgbRgbLgbRgbRgbRsbRsbRsbRsbRsb
RsbRsLsbRsbRsbRgbLsbRgbLsbRgRsmbRsbRgbRsRsmbRsRsmbRsbRsbRsbRgbRgbRsbRs
bRgbLebLoRsRsmbLgbLsbRsbLibLgRsbRcbRobLgbRsbRgbRgbRsbRsbRsbLsRsbRgbRsb
RsbRsbRgbRsbRsbRsbRsbRsbRsbRsbRgbLsbRgbRsbRgbRgbRsbRsbLsRsbRsbRsbRsbRg
bRsbRsbRsbRgbRsRsmbRsbRsRsmbRgbRsbRgbRsbRsbRsbRsbRgbRsbRsbRsRsmbRsRsmb
RgbRsbRsbRgbLsbRgbRsbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120458; End: 120958;
Recording: 1-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bLgbLgbLgbLgRsbLsbLsbLsbLsbLgbLsbLgbRsLsbLgbLsbLsbLsbLgbLgbLgbLsbLgbLg
bLgbRgLsbLibLgbLgbLgbLgbLsbLgbRsbLgbLgbLsbLsbRsRsmbLgRsLsbLgbLgbLsLsmb
LgbLgbRsbLibLgbLiLsbRsbRsbRsRsmbRhbRgbRgbRsbRgbRgbRsbLsbRibRgbRsbLsbRg
RsmbRsbLgbRibRsbRsbRsLsbRgbRsRsmbRsbRgbRsbRgbRsbRgbRsbRsbRsbRsRsmbLsbR
ibRsbRsbRgbRsbRibRhRgbRgbRsbLibLcbRibRsLibRcRsmbRgRsmbRsbRgbLsbRgbRiLs
bRiLsbRhbLiLsbLgbLibLgbRcbRsbRhbLsLsmbRgbRgbRgbRgbLgbLsRiRsmbRsbLsbRgb
RgbRsRsmbRgbRgLsbRhbRibRibRsbRsLjbLgbLgbLgbLgbRsbLsbLgbRsbRgbLgbLgbLgL
sbLsbLgbLsbLsbLgbLsbLgbLhbLgbLibLibLsRsbLgbLhLsbLibRgRsmbLgbLgbLsbRobR
ibRgLsbLgbLibRoLsRsRibRgLsbRgbRgbRsbRsbLsbRibRsbRsbRsbRgbRgbRsbRsbRsbR
sbRibRiLsbRibLsbRgbRgbRsbRibRsbLsbLcLsmbRhbRcbRhbLgbRibRsLsbsbRgLsbRsb
RcbRsbLsbRcbRgbRsbLgbLibLgbRcbRcbLsLibLibRcbRcbLsLsmbRgbRgbRgbRsbRsbsb
RgbRsbRsbRsRsmbRgbRsbRgbRgRgRgbRgRsmbRgbRgbRsbRsbRgbRsRsmbRsbRgRsmbRgR
smbRsRsmbRgbRgRgRsmbRgbRgbRgRsmbRgbRgbRgbRgbRgRsmbRsRsRsmmbRsbRgbRgLsR
sbRsbRgbRgRsRgRsmmbRibRgbLsRsbRgbRsRgRgRsRsmmbRgbRgbRgbRgRgRsRgmbRgbRg
bRgbRsbRsbRjLsbRibRcRsmbRiRsmbRibLjbLhbRibLhbLibLhbLhbRsbRgbLibRhbRgbR
ibLgbLgbRcbRhRsmbLgRsbRibLsbRhbLjbLjbLibRjbRibRgbRsbLsbRibRsRsmbRsLsRs
bRsbRsLsbRgbRgbLsbRgbRsbRsbRgbRgRsmbRgbRgLsbRgbRgbRsbRsbRgbRgRsRgmbRgb
RsbRsRsmbRgbRsLsbRgLsbRgbRgRgRgbRgbRgRsmbRgbRgbRgLsRgRgRsRsmmbRsbRgbRg
RgbRibRgbRgbRiRsRimbRgRibRgbRibRibRibLibLibRhbRcbRcbLibLhbLcLsmbLibLib
RgbRibLibLibLcbLgbLgLsbLgbRjbLibLgbLgbRjbRcbRsbRsLsbRgbRgbRgbRgbRgRsmb
RgbRsbRsbRsbRsbRgRsmbRsbLsbRsbRsRsmbLsbRgbRgbRgRsmbRgRgRsRgRgRsmmbRgRs
RgmbRgbRgLsbRgLsLsmbLcbRgbsbRcbRibRibRibRhbLibRibRibRgbRgbRsRsLsmbRsbR
sRsmbRgRsmbLsRsbRgbRsbRgbRsbRsbLsLsmbRgbRgbRsbRsbRibRgbRhbRhbRibRibLib
LjbRjbRcbLgbRcbRcbLibRhbRcbRibLibRcbLjbRcbLibLcbLibLgbLgbRibLgLsbRcbLj
bLcbRcbLibLibLcbLibLibRgbRcbLsbLibLibLgbRcbRcRsmbLsRsbRiRsmbLjbLibLibL
sbRsbsbLgbLgbRjbLibLcbLibLibLjbLgbLgbLgbLgbLsbLgbRgbLhbLsbLcLsmbLsLsmb
RibRhbRgbLgbRgbRgbRgbRsbRsbRsRsmbRgLsRsbRsbRgRsmbRgRgbRgbRgRibRgbRsbRg
RgRsRgRgmbRsbRgbRsbRsbRgRsmbRgbRsbRsbRgRsmbRgbRgbRgRsmbRibLcbLcLsmbRib
RjbRsbRgbRgbRsbRsbRsRsmbRgbRgbRsRgbRgbRsbRibLobLcbRhbLcbRjbRcLsbRsbRgb
RgbRgRgbRsbRgRsmbRgbRsbRsbRgRsmbRsLsRsbRsbRgbRgbRgbRsRgRsmbRgRgRibRgbR
gbRiRsmbRgRiRsmbRgbRgbRibLcbLcLsmbLibRjbLhbLibRibRhbRcbRibLsbRibRibLib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 1; Drug: Control Apo 0.5 然
bRgbLjbRcbLjRsbLcbLgbRgbLcRsbRgbRgbRcbRibRibLebLgbRibRibLgbLsbRgbRibRg
bRgbRsbLgbRgbRgbRsbRgbRgbRgbRsbRibLgbRibLsbRibLgbRibRsbRgbRsbRibLgbRcb
RibLsbLgbLgbLibRjbRibRgbLgLsbRgbRgbRsbLsbRibLgbRsbRibLsbRibLjbRcbRsbLg
bLgbLjbLibRgbLgbLgbRsbLgbRgbRcbRgbRgbRhbRibLgbLsbLsbLgbLibLgbLgbLgbLgb
RgbLgbLgbRsRsmbRjbLsbRobRgLsbRiRsmbLsLgbRibLibLsbRiRsmbRiRsmbRibRhbLhb
RibLgbLgbLgbRgbRcbLsbLcbLsbLibRjbLsbLgRsbRsbLgbLsbLgLsbRjbRsLsbRobRgbL
ibRibRibLgbRsbLhbRhbRgbRgbRsbRgbLsbRgbRebLgbRgbRsbLsbRjbRibLsbLjbLsRsb
LhbRgbLibLgbLsbLgbLgbLibRebRcbRibLjbLibLsLsmbRsbRsbLibLgbLgLsbLsbRsbLs
bLsbLgbLgbLsbLsbLgLsbLgbLgbLsbLsbLsbLsLsmbLgLsbLgRsbLsLsLsLsmmmbLgbLsL
smbLgbLsbLgbRsbLsLsmbLsbLgbLsbLgLsbLgbLsbLsbRebRibRgbLgbRibLjbLcbLibLg
bRibLibLsLsmbRsbLgbLsbLsRsbLgbLgbLsbLgbLgbLsbLgbLgbLgbLgbLgbLiLsbLgbLs
bLgbRsbRhbRcbLsbRgbRebLhbRibLibLibRhbRhbLhbLobRgbLibLgbLsbLsLsLsmmbLsb
LgbLgbLgbLgRsbLgbLsbLgbLsbLgbLsbLgbLgbLgbLsbLgLsbLgbLsbLgbLgbLgbLgLsbL
gbLsbLsbLsbLgLsbLcbRcbRobRhbRhbRcbLibLhbRjbRcbRgbLgbRibLjbLjbLgbLgbLgb
LgbLgbLgbLgbRsbLibLgbRsbRcbRibLgbLebRcbRcbLgbRibRcRsmbRsbLgbLjbLibLgbL
sbLgbRsbLgbLsbLgbLgLsLsmbLgbLgbLsbLgbLgbLgbLsbLgbLsbLsbLebLibRgRsmbRjb
RcbRsbRsbRibLjbRibRgLsbRibLgbRcLsbLgbRibRsbRcbLhbLgbRcbLgbRgbRibRgbRcb
RsbRgbLgbLibRsbRibRcbRsbRsbRibLgbRibLgbRibRebRibLibRgbLibLgbRgbLgbLgLs
bLgLsbLgLsbsbLgbRiLsbRcbRhbRgbRcbRebRibRjLsbLsbRsbRsbRsbRsLsbRgbRsbRgb
RsbRgbRsbRsbRsbLsbRgbRibLibLibRgbRibRibRobRibRcbRebLgbLcbLiLsbRgbLibLg
bLsbLsLsmbLsbRsLsbRsLsbLgbLsbLsbLgbLgbLsbLgRsbLgbLsRsbLgLsbLgbRjRsLsmb
RobRsbLsbRibLgbLebLcbRibRsbLgbRgbRhbLsbRjbRsbLsRgbRgbLcbRibRiRsmbRibRc
bLoRsbLobLibRgbLgbLgbLgbLsbLsbLgbLsbLsLsmbLgbsbsbsbRjbRjbRcbRcbRhbLibL
ibRcbRoLsbLgbRgbRibLgbLcbLhb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 2; Drug: Control Apo 0.5 然
bRibRgbRibLsbRibRgbRsbRsbLibRibRgLsbLgbRhbLgbRhbRibRibRibRibRibRhbRiRs
RsmmbLgbRhbLgbRibLgbRiRsmbLsbRgbRsbLsbRibLjbRibRibLsbRibLgbRibLgbRsbRg
RsmbRsbRsbRgLsbRsbRgbRgbRsbRgbLsLsmbRiRsmbRgbLcbLibRjbRcbRibRsbRsbRsbR
gLsbLgbRibLsbRibLsbRgbLsRsbRibRsbRsRsmbRgbRgbRsbRgbRsbLsbRibRgRsmbRgbL
jbLcbRjbRcRsmbRibRibRgbLibLiLsbRibRsRsmbRgbRibLgbRgbRgLsbRsLsbRgbLsbRg
bRsbLsbRgbRgbRsbRgbRsRsmbRgRsmbRsRsmbRsbRgbLsbRgbRsbRgbRsbRgbRgRsmbRgR
smbLsRsbRgbLsbLsbRgbRgbRsbRgbRgbRjbLcbLgbLibRjbRjbRibLcLsmbLiLsbRgbLhL
sbRjbLcRsbLsbRibLcbRiLsbLcLsmbRibLcbRiLsbLhLsbRsbRgbLobLibRibLsbLibLib
RibLhbRgbLcbRibLibRgbLibRjbLcbRibLibLgbLgbLgLsbRgbLibRgbLibRgbRcbRgbRs
bRsRsmbLsbRibLjbRibLgbRibLsbRibLgbRgbRsbRgbRgbRsbRgbLsbLgbRibLsbRgbRgb
RsLsbRsRsmbRgbRgRsmbRgbRgbRgbLibRhbLjbLcLsmbRgbLhbRibLhLsbRjbLibRgbLib
RgbRcbRibLibRibRsbRsbRgbRsbRsRsmbRgbRsbRsbRgRsmbRsbRsbRsbLsbLsbRibRgLs
bLsbRgbRgbLsbRsRsmbRgbRgbRsbRgbRsbRgbRsbRgbRsRsmbRsbRsbRgbRgLsbRgbRsbR
gbRsbRgbRsbRsbRsbRsbRsbLsbRgRsmbRsbRgbRgbRgbLsbRgbRsbRgRsmbRsbRsbRgbRg
bRsRsmbRgbLsbRsRsmbRsbRsbRgbRgbRsbRsbRsbRgbRsbRgbRgbRgbRsbRgbRsbRgbLsb
RgLsbRsbRgRsmbRgbRgbRgbRgbLsbRgbRsbRgRsmbRsbRgbRsbRgRsRsmmbRsbRgRsmbRs
bRgbRsbRgLsbLjbLcLsmbLibLibRgbRjbRcRsmbLcbLcLsmbRgbRsbLgbLgbRcRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 3; Drug: Control Apo 0.5 然
bsbLgbLhbLgbLsbLibLibRhbRibRgbRiRsmbRgbRgbLibLgbLibLgbLcbLhbLsbRjbRibR
gbRgRsmbRsbLibRgbRgbRgbRsbRgbRibRgbRgbRiLsbRibRsbRgbRgbRsbRsbRibRibRgR
smbRgbRibRsbRgbRsbLibRjbRjLsbRsLsbLibLsbRgbRgbRsbLgbRibRgbLgbLsbLgLsbL
gbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 4; Drug: Control Apo 0.5 然
bLsbsbRsbLgbLsbRsbLgbLsbLgLsbLsbRsbLsRsbLsLsmbLsbLgbLsbLsbLsbLsbLsbLsb
LsbRsbLgRsbRsLsbLgbRsbLgbLsbsbLsbLsRsbRsbLgRsbLsLgbLsbLsLsmbRsbLgbRsbR
sbLgbRgbLgbLsbLsbLsbLgRsbLsbLsbLgbLsbLsbLsbLgbRsbLgbRjbLgbRsbLgbRsbLgb
RgbLibRjbRjbLibLgbLibRibLibLjbLibRjRsmbLgbRjbRibRjbLjRsbRjRsmbRgbLgbLj
bRgbLsbRsbRjRsRsmmbLjLgbLjbRgRoRsmbRibRibRgbLibRjbRjbLhbLcbLjbRgRsmbRg
bLibLjLsmbLsbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 5; Drug: Control Apo 0.5 然
bRcbLibLcbLgbRgbLgRsbLsbLgbRgbRcbLsbRibRsbRgRsmbRsbRgbRsbRgbRgbLjbRcbL
ibRiRsmbLjbLcbLibLsLiRsbLibRhbLiLsbLgbRjbLibRjbLiLsbLiLsLsmbRjbRcbRgbR
iRsmbLsRsbLsbRgbRsbRsbRgRsmbRsbRgRsmbRsbRsbRgbRgRsmbRgbRsbRgbRgbRgbRgb
RsRsmbRsLsbRsbRsbRgRsmbRibLcbLibRgbLibLgbLibRcbLibRcbRcbRgRsmbRgbRgbLi
bRiRsmbRsbRibLgRsbRibRgbLgbRhbLsbLcbRjbRobRibLibLibLibLiLsbLibRjbRibRi
bRgbRsbsbRgbRgbRsbRsbLsbRibLsbRgbRsbRsbRsLsbRgbRgbRsRsmbRsbRsbRgbRgbLi
bRcbRsbLibLcLsmbLibRcbRcbLjbRgbRiRsmbRsbRgbRsbLsbRgbRgbRgbRgbLsbLsbRib
LsbRibRgbLsbRibRibLgbLsbLjbLgbRcbRcLsLsmbRgbLsbRibRsRsmbRgbRsbRsbRsLsb
RgbRsbRgbLsbRgbLjbRsbLcbLhRsbRcbRoLsbLgbLibLibLiLsbLsRsbRjbLibLibRcbRc
bLibRibRsbRgbRsbRgbRgLsbRibRgbLhbLcLsRsmbLibRcbLcbLibRhbLibRjbRcbLjbLg
LsbLgbLgbRcbRobLgbLgbRsbLsRsbRibRibLsbRibLsbRgbLgbRgLsbRgbLgbRgRsmbLsb
RsRsmbLjLsmbRcbLjbLibRebLcbLibRhbLcbRjbLhbLiLsbRcbRibLibLibRcbRcLsbLib
RobRsbRgbRsRsmbRgbRsbLgbRcbLibLibLiRsbLgLsbLibLsRsbLgbRcRsmbRibLsbRsbR
sbRgbRibRsbRgbRibLgbLjbRcbLjbLhbLgbRgRsmbRebRgbRsbRsLsbRsRsmbRgbRgbRgb
RsbRsRsmbRsbRsbRsbLsbRibRsbLgbRibRsLcbRjbRcbLibLibLcbRhbLcbLibLibLhbLi
LsbLsbRjLsbRgbRgRsmbRgbRgbRgbRgbLjbLcbLibRhRsmbLcbLgbRjbLcbLibLgbRgbLs
bLibRgbLibLibRcbRobLibLgbLibLiRsbRebRebLjbLcbLgLsbLsRsbLiRsbLsbRsbLgRs
bLgbLsbLgbRcbRgbRgbRsbRgbRsbLsbLsbLjbRcbRsbRsbRgbRgbRsbRgbRgbLsbRgRsmb
RsbRsRsmbRsbRsRsmbRgbRsbRsRsmbRgbRsbRgbRibLjbLcLsmbLibRiRsmbLhbRobRcbL
ibLcbRsbLiLsbRjbLcbRhbRhbLcbRcbRgbRgRsmbRsbRsbRsbRsbRgbLsRsbRgbRgRsmbL
jRsbRibRgbLjbLiLsbLibRjbLibLgbLibRjbRcbRgRsmbRgbLsRgbRsbRsRsmbRgRsmbRs
RsmbRsbRsbLsbRgbRgLsbRsbRgbLcbLiRsbRcbLhbLiRsbRjbRcbRgbRsbRsLsbRsRsmbR
gbRgbRsbRsbRsbRgbRsbRgbRgbRgRsmbRsbRsbRgbRgbLgbRgbRsbRsRsmbRgbRgbRgbRg
RsmbRgbRsbRsbRgbRgLsbLjbLcbLibLibRcRsmbLhbRibRcbLhbLgbLgbLsbLsbLsbRsbR
cbRcbLebLcbLgbRibLibRgbLgbRsbLgbLsLsmbLgbLsbLgbRsbLibRcbRhRsmbRgbRgbRg
bRgbRgbRgbRsbRgRsmbRsRsRsmmbRsbRgbRgbRgbRgbLhbLcbLhbReLebRjRsmbLcbRsbL
gbRgbLibLhbRcbRobRcRsmbLibRiRsmbRsbLjbRobLebLibRjLsbLibRjbLhbRgLsbLcbR
cRsmbRibRibRsbLjbLibRcbRoLsbLiLsbLjbLhbLsbLgbLgbRsbLsbLgbRcbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 6; Drug: Control Apo 0.5 然
bLsLsmbsbLsbLsLsmbLgbLsLsmbRibRhbRgbLibRhbRgbsbRgbLsLsmbLibRcbRgbsbRgb
RgbRgbRgLsbRgbLiLsbLeLsbLgbLsbsbLgLsbLsbLgbLsbLgRsbLsbLgLsbLsbLsbLsbLg
bLhbLibRibRibRibLsbRibRgbRgbRgbsbRibRgbRgbRgbRsbRgbRgbRgbLsbRgRsmbRgbR
ibLsbLgbLcbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bLgbLibRiRsmbRibRsbLgbRibRgbLsbRgbRgbRgbRsbRgbLgbRibRgRsmbLgbRibLgRsbR
gRsmbRgLsbRgbRsbRsRsmbRsbRgbRgbRgRsmbRgbLcbLhbRgbLibLgbRibRcbRiRsmbLjb
RcRsmbLcbRcbLibRibRsbRgbRgbLsLsmbRgbRgbLgbRibRgbLgbRibLgbRsRsmbRiRsmbR
sbRsbRgbRgbRgbRsbRgbRgbRgbLjbRibRgbRsbLsLsmbLgRsbRhRsmbLcbLcbLiLsbLibR
gbRibRiRsmbRgRsmbLjbRibLibRibLgRsbRiRsRsmmbLgbRgbRgRsmbRsbRsbRsbRsbRgb
RgbRgbRgbRsbRgbLjbRibRibLibRjbRcbRibLibRiRsmbRibLibRibLhbLibLsbLibLgLs
bRibRcLsbRibLsbRsRsRsmmbRgbRsRsmbRsbRgRsmbRgbRgbLsbLsbRhRsmbLibRhbLgRs
bRsbRgbRgRsmbRgLsbLsbRgbRsbRgRsmbLsRsbRibRsbRsbRgRsmbRsbRsbRsbRsbRgbRg
bRgRsmbLsLsmbRgbRgbRgbLibRcbLibRhbRibRsbLhbLibLgRsbLgbRcbRhbLgRsbRibLi
bRhbLjbRiRsmbRgbLebLibLgbLgbRgbLgbLgbLibLgbRiRsmbLibLsbRebRcRsmbRibLgb
RsbRsbRibRgbRgbLiRsbRibRibLgbRiRsmbLjbRhbRsbLgbRibLsbLjbLibLgbRjbRebLg
bRibLsbRgRsmbRsbRgbLsbRgRsRsmmbRgbRibLibRibRibLgbLjbLgLsbRcbRcbLgbLibL
jLsmbRiRsmbLgbLibLibLibRsbLsRsbRjbRcRsmbRgbLsbLibRcbLgbRcbLibRibRcbLgb
LgbLibLgbLsbLibLgbLgLsbLgbLsbLgRsbLgRsLsbRjbLibLgbsbRoRsmbRsbRsLsbRsbR
sbRsbRibLjbRibLgbRgRsmbRgbRsbRgbRsRgbRiRsmbLhbLcRsbLibLsbLgbLibLgLsbRj
bRcRsmbRiRsmbRsbRgbRsbRsbRgbRgbRgbRgbRgbLsbRibRibRgbLjbLhbLibRjbLibLiL
sbLibLgRsLsbRibRjbLibLgbRcbRjbLibRjbRsRsmbRsbRsbRgbRsRsmbRsRsmbRgbRsbR
gbLibLsbLgbRsbLjbRcbRibRgbLsbLgbLgbLibLibLgbRjbLibRibLgbLsLibLgbRgbLib
RsRsmbLiLsbLibLgbLsbLsLsmbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bRsbRgbRgbRgbRibLsbRibRgbRsRsmbRgbRgbRsbRsbRgbRgbRgLsbRsbRgLsbRgbRsbRs
bRsbRgbLgbRgbLgbLjLsmbRjRsRsmmbRgbRgbLgLsbRibLgbRgbRgbLgbRgLsbLsbRgbRs
bRgbRsbRsbRsbRgbRgbRgbRsbRgbLgRsbRibRgbLsbRgbRsbRgbRsbLsbRgbLjbRgRsmbR
gbRgbRgbRgbRsbRgbLsbRiRsmbRsbLjbRibRiRsmbRgbRgbLgbRgbRgRsmbLsRsbRgbRsb
RgbRsbRgbRsbRsRsmbLsbRgbRsbLgLsbRgbLsRsbRgbLsbRgbRgbRsbRsbRsbRsbRibRgR
sRsmmbLgRsbRgbLsbRgbRgbLsRsbRgbRibRgRsmbLgRsbRgbLsbRibRibRibRsbLsbRibL
jbRibLjLgbRhRsmbRibLibRiRsmbRsbRibRgbLgbLhbLsLsmbLiLsbRsLsbLgbRcRsmbLh
bLibRibLgbLgbLgbRsbRgbLgbLsbLibRjbLibLibLgbLibRgbRibRgbRsbRgbRibLgbRgb
LsLsmbRgbRsbRsRsmbRgbLjbLjbLsbsbLsbRhbLsbRgbRibLjbRgbRsRsmbRgbLsbRgbRg
bRiRsmbRgbRibRiRsmbRsbRgbLhbLcbLibRjbLgbLibLiLsbLsbLgRsbLgbRibLgbLsbLg
bLgbRjbLibLgbLgbLgbRgbRsbRsbLgbLibRgbLjLsmbLgbRgRsmbLsRiRsmbRibRgbLhLs
bRibLcbLhbRibLgbLibLcbRjbLhbLibRiRsmbRibLgbLiLsbLibRgRsmbRgbRgbRibRibR
sRsLsmbRibRiRsmbLgbRibLsbRgbRgbLsbRgbRgbRsbRgRsmbRsbRgbRsbRgbRsRsmbLsb
RgbLgbRibRgbRgbRsRsmbRsbRgRsmbLsbRgbRgbLsbRgbRgbLgLsbRgbRgRsRsmmbLgLsR
sbRibRgbRsbRgbRgRsmbRsbRgbLgLsbRiRsmbRsRsmbLsbRgbRgbRgbRgbRsbLgbRgbRgb
LgbRgbRgbLsbRgLsbRgbRsbRgbRsRsmbRgbRsbRgbLgbRibRibRgbRibLgbRibRsRsmbRs
RsmbRgbRsbRsbRgRsmbLsbRgbLsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bLgbLsbLsbLgbLgLsbRcbLibRibLibRgbRibLjbLoLsmbLgbLgbLgbLsbLsbRgbRgbRhbR
sbRibLcbLiRsbLgbLgbRgRsmbLsRsbRgRsmbLgbLgbLgbLgbLgbRjbLibRcbRcbLcbLibL
gbRsRsmbLgbLsLsmbLsbLgbLgbLgbLgbLgbRibRcbRsbRgbLgbLibRgbRsbLgbRibRgbLg
bRibLgbRgbRsbRjbLsRsbRgbLgRsbRibLebLhbLibRhbsbLibLibLibLsbRgbRsbRsbRsR
smbRjbRgbRgbLhbLiLsbLgbRibLgbLiRsbLibLsbRgbRgbRgbRjbRibRsbLcbLhbLibRib
RjbRgbRgRsmbRgbRgbRgbRgbLoRsbLibRjRsmbLhbRjbLibRsRebLcbLibRgbRgbLgbLgb
RsbLgbLgbLsbLsbLsbLsbRsbLgbLgbLgbLgbLsbLsbLsbRsbLgbLgbLgbLgbLgLsbLgbLg
bLgbLsLsmbLsbLsbLgbLgbLsbLsbLsbLgLsbLgbLsbLsbLsbRcbLjbLibLibLsLsmbLibL
gbLgbRsbRsbLgbLsbLgbLsbLsbLsRsbLgbLsbLgbLgLsbRsbLgbLsbLgbLgbLgbLsbLsbL
sbLgbLsbLgbRebRgbRsRsmbRsbRsRsmbRsbLsbLjbLibLibLsLsmbLsLsmbLgLsbLsbLsb
LsbLsbLgbLsbLsbLgbLsbLsbLsbLsbLgbLgbLgbLsbLsbRsbLgbLgbLgbRgbLgbLgbRsbL
gbLsRsbLgbLgLsbRcbRgRsmbRgbLjbLobLibRibLhbRgbLcRsbLsbLsbLsbLgbsbLsbLgb
RsbLgbLhbLgbLcbLgbLsLsmbLgbLibLibRsbLgbLgbLgbLgbLsbLsbLsbLibRcbRcbLjbL
ebRgbLibLgLsbRsbLgbRsbLgbLgbLsRsbLsLsmbLsbLsbRsbLgbLgbRsbLgLsbLsbLsbLg
bLsbLgbRgLsbRgbLibRcbRebLibLcLsmbLibRibRjbLcbRjbLoLsRsmbLibLgbLsbLsbLs
bLjbLibLibRsbRsbLcbRhbLibLibRgbRsbLgbLgLsbLsbLsLsmbRsLsbLsbLsbLgbLsbLs
bLgbLgbLsbLsLsmbLsbLgbLgbLgbLsbLsbRsbLgbLgbLsbLgbRsbLibRgbRgbRgbLgbLgb
LgbLsbLgRsbRsbLsbLgbLsbLgbLgbRjbLibLgLsbLsbLgbLgbLsbLsbLsbLgbRgbLgbLgb
LsLsmbLsRsbLsbLsRsbLsbLsLgbLgbLsbLgRsbLgbLsbLgbLsbLgbLgbLgbLgLsbRjbRcb
RibLjbLebRjbRcbLcbRcbLcbLobLibLgbLsbLsLsmbLgbLsbLjbLibLsbRcbRhbLibRiRs
mbLjbLhbLibRsbLgbLgbLsbLsbLgbLgbLsbLgbLgbRcbRcbRgbLhbRibLcbLibRcbRjbLc
bLhbRjRsmbLhbLibLhbRgbRgbRsbRsbRsbRgRsmbRgbRsbRgbLcbLgLsbLgbRsbLsbLgbL
gbLgbLsbRsbLsbLsbLsbLsbLgbLgbRsbLsbLgbLsbLsbLsbLgRsbRjbLibLibRcbRcbLhb
LcbRsbLgbLgbRgRsmbRsLgbLgbLgbLsbLsbLsbLgbLsLsmbLgLsbLsbLsbLgbRsbRcbRgL
sbRsbRgbRcbRebLsbLibLsbLsLsmbLsbLsLsmbLsbLsLgbLgbRsbLgbRsbLgbLsbLgbLgb
LsbLsbRsbLsbLgbRsLsbLsbLgbLsbLgbLgbLgRsbLsLsmbLgbLsbLsbLgbLsbLgbLsbLgb
LgRsbLsbLgbLgbLgbLcb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bLgbLsbLsbRjbLgbLibLibLibLcbLhbLibRjbLcbRiLsbLiLsbLsLsmbLgbLsbLgbLsbLs
bLgbLsbLgbLsbLsbLgbLsbRsbLgbLsbLgbLgbRcbRhbRsbRgbLcbLgbLgbRgbLibLibRjb
LibRgbLibLgLsbLgbLsbLsLsmbLgbLsbLgRsbLsbRjbLibRhbLibLgbRcLsbRhbLibRsbR
cbLcbLhbRjbRhbLsLjbsbLibLiLsbRgbLgLsbLsbLgbRsLsbLsbLsbLsbLsbLibLgbLsbL
gbLgbLsbLgbRjbRcbRsbRibLjbLcbLgLsbLsbRsbLsbLsbLgbLgbLsbLgbLsbLsbLsbLsb
LgbLsbLsbLsbLeLsbLgbRebRcRsRiLsmbLjbLcbLcbRcbLibRsbRjbLiLsbRsLsbLgbLsb
LgLsbLgbLsbLsbLgbRgbLgbRjbLgbLgbRsbLsLsmbLsbLsbLgbLgRsbLgbRhbRcbRcbRib
RiRhbRgRsmbLsbRibLjbLcbLibRsbRjbLibLsbRgbLibRsbLgbRsbLgbLsbLsbRsLsbLgb
LgbLgbRhbLcbRcRsmbLhbLiRsbRibLhbRjbLcbLibRebLjLsmbRibLibRibRiRsmbLjLsm
bLhbLibRjRsmbLibLibRibLgbLgbLhbLgLsbLsbLgRsbLsRsbLgbLgLsLsmbLsLsmbLsRs
bLsbLsbLgbRsbLsbLgbLsbLgbLgbLsbLgbLgbLgbRgbLgLsbRsbLgbLsbLsLsmbLgbLgbL
gRsbRcbRhbLgbLsbsbRjLsbRgbLjbLibLsbLgbRjbRcbRibLjbRcbLjLsmbLgbLibRsbRs
bLgbRsbLsbLsbLsbLgLsbLsLsmbLgbLgLsLsmbLgLsbLsbLsbLsbRsLsbLgbLibRsbLsbL
sbLsbLgbLsbLgbRjbRcbLjLsmbLibLgLsbLgbRsbLsbLgbLsbLgbRjbRibLjbRcbRcbRcb
RibLjbLsbLiLsbLsbLgbLgbRibRsbLibLgbRsbLsbLgbLsbLgbLsbLgbLsbLsbLiLsbLgb
LgbLgbLsbLsbLgbLsbLsbLsbLsbLgLsbLsbLgRsbLsbLsbRsbLsbLsbLsbRebRcRsmbRib
LjbLjLsmbRibRibLjbLcbLgLsbLsbLgLsbLsLsRsmbLsbLgbLsbLgbLgbLsbRsLsbLgbLs
bLsbLsbLsbLsbRjbRcLsRsbLjbLjLsmbLjLsmbRgbRsbLsbRsbLjLsmbLgLsbLsbRsbLgb
LiLsbRsbLgbLsbLsbLsLsmbLsbLsbRcbLjbLibLibLgbLsbLsbLsbLgbLgbLsbLsbRsbLg
bLibLibLgbRcbsbRgbRhbRibLjbLjbRjbRibLjbLcbLgbLgLsbLsLsmbRgbLibRsbLsbLs
LsmbLsbLsbLgbLsbLgbLgbLsbLsbLsLsmbRgbLgbLibRsbRsbLgLsbLsbLgLsbLsbLsbLs
bLsbLsbLsbLgbRgbRjbRibRgbRsLebLebLsbLsbLgbRibLgbLsbLsbRjbLibRhbRibLhbL
ibRsbRgbRgbLibRibRibRsbRgbLsbRgbRgbsbRsbRgbRgbRibRibLsbRibRibRgbRgbLib
LgbRgbLjbLgbRsbLgLsbRsbLgLsbLsLsmbLsbLsbLsbLsbLgbLsbLsbLsLsmbLsbRsLsbL
gbLsLsmbLsbLsbLgLsbLsbLgbLsbLsbLgbRjbLgbLsbLgbLsbLsLsmbLgbRjbRibRiRsmb
RibLcbLhLsbRibLibRibLiLsbLgbLsbRibRjbRibLebLcbRjbRcbRibLhbLebLibRgbLgL
sbLsRsbLsbLsbLgLsbRsbLgbLsbLgbLibRibRhbRibLsbRsbRibRibLhbLibLjbLgbLibL
gbRgbLsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bRgbRsbLcLsmbLgbLgbLsbLsbLgbLsbRsbLgLsRsbLsLsmbLgbLsbLsLsmbLgbLgbLgbLg
LsbRiRsmbLgbLgbLgbLsbLsbLsbLgbLsbLsbLsbLgbLgbLsbLgbLgbRsbLgbLgbLsbLsbL
gbLsbLsbLgbLsbLsbLsbLgbLgRsbLgRsbRjbRcLsbRhbRgbLcbLobLibLibLgbRcbRibRi
bRgbLsbRgbRsbRgbRgbRibLhbLcRsbLgbRsbLiRsLsbRsbLgLsbLsbLsbLgRsbLgRsbLgR
sbRgLsbLibRebLsLsmbRcbLcbLcbLhLsbRsbRgRsmbLsbLibLiLsbRiLsbLibRsbRsbLgb
LgLsbLgLsbLsbRebRobLibLibLibRgLsbLibLgbLgRsbLgbLsbRcLsbLcbLibRibLibReb
RcbRsRsmbRhbLjbRibRsRgbRsbRgbLgbRibRibLibLjbLhbLcbLhbRgRsmbLgbLgbLgbLg
RsbLgbLgbRgbRgbLgbLgbLgRsbLsRsbLsbLsbLsbLsbRgbLsLsmbLgbLsRsbLsbLsbLgbL
gbLgbLgLsbLsLsmbRsLsbLsLsmbLsLgLgbLsbLgbRcbsbLcbLhLsbRobRcbLsLjbLcbRcb
RibRgbLibRcbRcbLsbLibLsbRsbRjbLcbLgbRsbLsbLsbLsbLgbLsbLgbLgLsbLgRsbRjb
RcbRgbRgbRgbRibRjbLcbLibRibLibLgbLsbRgbsbRsLgbLgLsbRgbLsRsbLgRsbLgbLgb
RjbLsbLibLgbRsbRsbLibRjbRobRibLibRsbLjbLibLibLgbRcRibLjbLibLibRcbRcbLj
bRsLsLsmbLibLsRsbLjbLgbLcbLsbLgbLgbLgbRsbLibsbLibLgbLgbLiRsbRibRibLhbL
ibRgLsRsbLgbRsbLgbLgRsbLsbLsbLsbLsLsmbLgbLgbRcbRcbLjbLhbLgbLgbLsbsbLib
LibRcbLibLsbLgbLsbLgbLsbLsbLgLsbLgbLgbRcbRcLsLsmbRgbRgbRgbLjbRcbLcbRcb
RgbRsbLgbLjbLibLsLsRsmbLsRsbLgbRsbLgbLgbLgbLsbLsLsmbLgbLsLsmbLgbLgbLsb
LgbLgbLgbLsLsmbLgbLsbLgbLgbLhbRjbRcbLcbLcbRgbLibRgbRgbLibRgbLgbRgbLsbL
gbLibLsbLgbLsbLgbLgLsbLsbLgbLgbLibRcRcbLhbRcbRibLgbLgbRcbRgbLsRgbRgbRi
bLgbRcbRibLgbRgbRibRibRsbRgbRgbLcLsmbLgRsbLiRsbLgbLgbRsbLiLsbLgbLgbLsL
sLsmmbLsbLsLsmbLsbLgbLsbLgbLgLsbLsbLgbLgbRsbLgbLgbRsbLgbLgRsbLsbLgbLgR
sbLgLsbLsbLsbRsbLibLgbLsbLgbLgbLgbLgLsbLgbLhbRhbLhbLsbRjbLcLsmbRibLcbL
ibLsbLibLgbLiLsbLgbLsbLgbRsLsbLgbLgbLgLsLsmbLsLsmbLgbLgLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bRgbRsbRgbRsbLsbRgbRgbLobLibLsbRsbLgbRsbLiLsbLsbLgbLgRsbLsbRsbLibRebRg
bRsbRgbRsbRsbLsbRsbRgbRsbRsbRsLsbRgbRgbLsRsbRibLsLsmbsbRgbLjLsmbRibLjb
RibLcbLibLsbRibRiRsmbRgbRsbRgbRsRsmbRgbRsRsmbRsbRgbRsbRsbRgbRsbRibLjbL
cLsmbLibLibLsbLibRjbRcbRiRsmbLsLsmbLsbRgbRgbRgRsmbRsbRgbRgbRgbRgbRgbRg
bRsbRgRsmbRsbRgbRgbRgbRgbRgbLcbLgbLsbRgbRjbRgbRsbRsRsmbRgRsmbRsbRsbRgb
RsbRsRsmbRgbRgbRgRsRgmbRgbRgRsmbRgRsmbRsbRgbRsbRgLsbRgbRgbLsbRibLibLcb
LibLsbRsbRsLsbLibRsbLsbLsbRsbRsRsmbLibRjbRcbRibRsbRgbRgRsmbRsbRsbRgbRg
bRsbRgLsbRsbRgRsmbRgbRgbRgbRsRsmbRsbRgbRsbRgbRgbRgbRgbRgbRsbRgbLsRsLsb
RsbRgbRgbRgRsmbRibRgRsmbRgRsmbRgbRsbRsRsmbRgbRsbRiRsmbLhRsbLcbLibRjbRi
bRgbRgbLgRsbRgRsmbRsbRgbRgbRgbRgbRgbRgbRsbRgRsmbRgbRgbRsbRsbRgbRgbRgbR
sbLsbRibRgbRgbRgbRgbRgbRsbRgbRgbRgbRgRsmbRgbRgLsbRsbRsbRgbLjbLibLibLsR
sbRgbLoLsmbLcLsmbLibRhRsmbLibLiRsbRgbLibRsbRgbLsReLsbRibLibRhbRsbRcbLh
bLoLsmbLibRsbRgbRhbRcbLcbLoRsbRibLoLsmbRsbLsbLibRgbLiLsbRsRsLsmbLsbRjb
RibRiRsmbLgbRgbRgbRgbRiLsbRsbRgbRgbRgbRibRgbRgbRsbRgbRsbRgRsmbRgbLobLc
LsmbLcLsLsmmbLgbRsbLhbRibRebRibRsbLjbRibRgbRsbRgbRsbRsbRgbRgRsmbRgbsbR
gbRgbRsbRgbRgbRgbRgbRgRsmbRgbRsbRgRsmbRgbRsbRsRsmbRibLsRgRsmbRgRsmbRgb
RgbRgbRgbRsbRgRsmbRsbRgbRgbRibRsbLibLcbLibLsbLsbLgbLsbLgbLsbLsbLgbRibR
ebRibLjbRibLsbRgbRsRsmbRgRsmbRsbRgRsmbRgbRgbRgRgbRgbRsRsmbRsbRgbRsbRgb
RibLgbRhbLebRobLcbRibRgbRgbRgbRgbRgbRsbRsbRgbRgbLgbRhbLgbRibLsbLjbRcbR
ibLhbLiLsbLiLsbLcbRibLcbLiLsbRiRsmbLibLibRiRsmbLhLsbLsbRsbLsbLibLsbRsb
RjbLobLibLiLsbRgbRgbLjbLibLsLsmbLsLsmbLgbRgRsmbLibRgLsbLibRsLsbRsbLgbL
sLsmbLsbLsbLgbLgLsbLsbLsbLsbRsbLgbLsbLsLsmbLgbLsbLsLsmbLsbRjbLhbRibRcb
RibLsbRgbLsbRsbRgbRgbLgbRiRsmbLiLsbLhbLibRsbRjbRibRibRsRsmbRgbRsbRsLsb
RsRsmbRsbRsbRgbRsbRgbRsRgbRibRgbRgbRgbRgbRgbRgbRsRsmbRgbRgLsbRgbRgbRsb
RsbRgbRibRgbRgbRgbRgbRsbRsbRgbLgLsbLsRsbLjLibLgbLsbLsbRjbRibRhbLgbRgbR
gbRgbRsbRsbRgbLgbLjbLibRjbLhbRebRiLsbRgbRgRsmbRsbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bRgbLjLsmbLgbLgLsbLgLsLsmbRsbLibRjRsmbRcbRibRsbRsbRgbRgbRgbLsbRsbRcbLj
bRcbLibRibRsbRsbRgbRsbRsbRsbLsRsbRgbLsbLsbRgbLsbRgbRgRsmbRsLsRsbRgRsmb
RsbRgbRsbRsLsbRsbRsRsmbLsbRibLjbRibRgbLsbRgbRibLcbLoRsRsmbRibRibRgRsmb
RgbLsbRsbLsbLjbRgbLibLcbLibRgRsmbRjbLobRjbLcbRjbRcLsbRsbLjbLibLgbLgbLs
bLsRsbLgbLsbLgbLsbRsRsmbLgbLsbLibRgbsbLgLsbLgbRjRsmbRcRsmbRibLgbRibLjb
RhbLibRibRibLibRiRsmbLjbLhbRjbRcbLsbRsbRgbRsbRsbRsbRgbRgbRgbRgRsmbRgbR
sbRsbRgLsbRsbRgbLgbRibLjbLcbLibRcbRhbRgbLsbLsbRgbRgbRgbLsbRgRsmbRsbRgb
RgbRsbRsRsmbRgbRgLsbRsbRsRsmbRgbRgbLgbLcbLibRjbRcbLcbLibRcbRibLgRsbRgb
RsbRsbRgbRgbLcbLibRgbRcbRcbLgbLibLibRcRsmbRibLgbRiLsbRgbLjLsmbRibLjLsm
bRibLsbRibLsbRibLjbLcRsbLgbLsbLgLsbLgbRgbLibLsbRcRsmbRibRiLsbLgbRgbRib
LjbLjLsmbRjbLcbRhbRhbsbRibRsbLjbRibRgbLgbRgRsmbRsbRgbRsbLsbRgbLsbRsLsb
RgbLgbRibLsLsmbRgbRsbRsbRsbRsRsmbRsbRsbRgbRsbRsbRgbRsbRsbRgbRsbLcbLiRs
bRjbRobRsbRsLsbRsbRsbLsbRgbLsRsbRgRsmbRgRsmbLsbRgbRsbRgbRsRsmbRsRgbRgb
RgbRibRgbRgbRsbRgbRsbLsbRgbRsbLsbRgbLsbRgbLsbRgbRgRsmbRgbRsbRgbRsbRgbR
sbRsbRsbRsRsmbRsbRsbRsbRgbLsbRgRsmbLsbRgbRgbRsbRgRsmbRsbRsRsmbRsbRgbRg
bRsbRsbRsbRgbRsbRsLsbLsbRsbLjbRibRsbRsbRsbLsRsbRsbRsbRgbRsRsmbRsbRgRsm
bRgRsmbRgbRgRsRsmmbRgbRsbRsbRsbRgbLsbRgbRibRjbLcbRibLibRebRhbRibRgbLgb
LcLsmbLibRhbRibRsLsbRgbRgbRsbRsbRgbRsbRsbRsbRsbRsbRsRsmbRgbRsRsRsRsmmm
bRgRsmbRgbRgbRgbRgbLsbLjbRcbLjbLibLoRsLsRsbLibRgbLsbLgRgRsmbLiRsbLibLs
bRcLsbRgbRgbRgbRsbRgRsmbRgbRgbRsbRgbLcbLibLsbLgLsbLsbLsbLgbRsbRsbRhbRi
bLsbRibLjbRcbRgbLsbLsbLgbLiLsbLgbLgbRsbLgbLsbLgbLgbLsbRebRibLiLsbRibRg
bLgbRibRsRsmbRsbRsbRgbRsbRsbRsbRgbRsbRsbRsbRgbRgbRgbRsbRsbRgbLsbRgbLsb
RgbRsbRsbRsRsmbRsbRsbLsbRgbRsbRsbRsbRsLsbRsbRgbRgbRsbRsbRsbRgRsmbRsLsb
RgRsmbRsbRgbRgRsmbRgLsbRsbLsbRgbRhbLibRiRsmbRsbRsbRsbRsRsmbRsbRsbRgbRs
RsmbsbRsRsmbRgRsmbRgLsbRsbRsbRsLsbRsbRgbRsRsmbRgRsmbRgbLgbRibLcbLiLsbR
sbLgRsbRsLsbLiRsbRsbLibRjbRcbRgbLgbRiRsmbRsbRgbRgbRgbRgbRgbLcbLibRgbLi
bRjbLgbLsLibLsbLhbLhRsbLsbLsbLgbLibRgbLibLgbLsbLibRibRcbRhbLgbRgbLgbLc
bLhRsRsmbRibRcbRibRsLsbRsRsmbRgbRsbRsLsbRsbRgRsmbRgRsmbRsbRgbRsbRgbRsb
RgbRgbRgRsmbRibLjbLcbLiLsLsmbRsLsbLsRsbLgbLsRgLsbLgbsbRgbLibRjbRcbRibL
sbLsbRgbLgbRibRgRsmbRsbRsbRgbRgbRsLsbLsbRgbLsbRsLsbRgbRgbRsbRgbRsbRiLs
bRsbRsbRsbRgbRsbRhbRgbLjbLcbLiRsbRsbLibLgbRjLsbRibRgRsmbRjbLiRsRsmbRgb
LobRsLsbLgbLgbLsbLsbLsbLgbRgbLsLibRjbLsbLsbLcbRibRjRibRibLibRsbRibLgbR
ibLsbRibLgbRsbRgRsmbRsbRsRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bRgbLjRsbLsLhbLibLhbRjRsmbLibRjbLsbLeRsbRjbRjbRsbRibRjbLjbRcbLjbRcbLjb
RcbLjbRhbLcbRcbLjbRibLcbRcbLjbRcbLjbLcbRcbLhbRcbRibLgbRgbLsRsbLsbRgbRg
bRsRsmbRgbRsbRsbRgbRsbLsbRgLsbRsbRsLsbRsbRsbLsLsmbLhbLhbRiRsmbRebRsbRi
bLjbLhbRjbRsbRebLhbRebsbsbsbRgLsbRsbRsbLsRsbRgbLsRsbRgbRsbRgbRsbRsbLsb
LebLibRjbLibRibLhLsbRjbRcbLjbLibLgbLibLhbRiRsmbLhbLjbLibRgbRgLsbRsbRgb
RgRsmbRgbLibRiRsmbRsLjbRcbLjbRcbLhbRhbRebRsbRhbLibLibRcbLsbRibLjRobRhb
RsbLsbLgbLcbLibLgbRgbRgbLibLsbLjRsbReRsmbLcRsbRhbRiRsmbLjbRcbRibLsbRsb
LsbLsbLsbLibRgbLhbRhbLhbRcbLibLibLibLsbLsbLsbRsbRgbsbRsbLjbLgbRhRsmbRi
bLjbRebLibRibLcbLhbRjbLcbRjbLcbLiRsbRgbRgbRibRibLjbRibRgbLibLhbLiLsbLc
bRjRsmbRibRcbLjbLhLsbLibRjbRcbLcbRjbLcbLibRiRsmbRjbRgbRiRsmbLjbRgbRsbR
gbRsbRsbRsbRsbRsbLsbRsbRgbRsbRsbRsbRsbRsLsbRsbRsbRgbRsbRsbRsbRsbRsbRsb
RgbRsbsbRgbRsbRsbRsbRsbRsbLeLsbLsbLibRjbLibRsbRsbLibRjbRjbRjRsmbLjbLjb
RcbLjbLcbRhbLcbLibLibRibLibLgbRgbLjLsmbLgbLibLsbLgRsbLsbLsbLgbRgbLsbLg
bRgbRjbLjbRjbRibLgbLsbRgbRgbRgbRsbRsbRsbRsbRgRsmbRsLsbRgRsmbRsbRsbRgbR
gRsmbLjbRhbLcbRjbLcbLgbLhbLibRibRibLjbLibRjbLcbRcbRhbLibRibLhbLcbRibLc
LsmbRsbRjLsbLjbLiLsbLjLsmbRjbLhbRjbLibLhbLhbLgRsbLsLsmbRjbLgbRgbLgRsbL
sbRcbLjbRibLjbRcbLjbRhbLjbRibRgbLgbRjbRgbRsRsRsmmbLsbRjbLsbRgbLebLgbRs
RjbRsbLgbLsbRibLsbRcbRibLibRjbLsbRgbRsbRsbRsbRsbRsbRsbRsbRgbRsbRsbRgbR
sbRsRsmbRgLsbRsbRsbRsbRgbLsLsmbRgbLjbRjbRibLgRsbLhbRhRsmbLibLhbRjbRcbL
jLsmbRibRgbRsbRsbRgRsmbRgbRsbRsbRsbRgbRsbRsbRsbRsbRsbLebLsLsmbLibLsbRg
bRibRibLjbRibLjbLhbLibRhbRcbLibLibRjbLhbLcbLiRsbRgbLgbLsbLcRsbRgbLibLg
bRgbRjbRiLsbRibRgbRsbLjbLjbLiLsbLgbRjbLibLibLgbLgRsbLcbLebLsbRjbRsbLsb
LsbLsRsLsLsmbRjbLibLhbLibRcbsbLcbLibLibLibLibLiRsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bLsbLebRjbRoLsbLcbLhbRgbLiLsbLibRgbLgLsbLsbLgbLgbLsbLgbLgbLgbLsbLgbRgb
RjbLjbLibLsbLgbLsbLsbLgbLgbLgbLsbLgbLgbLiLsbRgbRibsbLjbLibRcbLcbRcbRcb
LcbLcbLibLibLibLibLibLgbRsbLcbLgbRibLhbLgbLgLsbLjbRiRsmbLsbRgbRgbLgLsL
ibLibRsbRsbLgbLsbLsbLsbLsbLsbLgLsbLsbLsbLsbLsLsmbLgLsbLgbLgbLgbLsbLgbL
gbLgbLgRsbRibLjLsmbLgbRcbRcbLcbLgbRsbLgbLsbLgbLsbLsbLgRsbLgLsbLsLsmbLg
bLgbLgLsLsmbLsbRsbLsLsmbLgLsLsmbLgbLsbRsbLsbLsbLsbLgLsbLgbLgbRjbLibLiL
sbRjbLiLsbRgbLiLsbLgbLgbRcbRcbLjbLgbLgbLsbLsLsmbLgbLsbLgbLsbLgbLgbLsbR
jbLibLgbLsbLgbLsbLsbLsbLgbLgbLgbLsbLsbLgbLsbLgLsbLgbLsbLsbLsbLgbLsbLiL
sbLgLsbLgbRobLjbLibLgbRsbLiLsbRsbLgbLsbLsbRsbLgbLgbLgbRcbRcbLjbLibLgLs
bLgbLsbLgLsbRgbLgbLibRsRsmbLsbLsbLsbLgbLgLsbLsbLsbLsbLgbLgbLgbLsbLsLsm
bLgbLsLsmbLgbLsbLgbLgbLgbLgbLgbLgLsbLgbLsRsbLgbRgLsbLjbRcbLibLibRcbRcb
LjbLobRobLcbRibRcbLjbsbRcbLiRsbLcLsmbRjbLgbLgbLgbRibLiLsbLsLsmbLsRsbLg
LsbLsbLgbRsbLgbLgbLsbLsbLgbLibLgbRcbRcRsmbLhbLjbLibRsLsRsbLibRjbRsbLib
LsbLsbLsbLgbLgbLgbLsbLgbLgRsbLjRsbLibRjRsmbRibLibRsLsbRjbRibRiLsbLibLc
bLibLibRibRjbLhbLibLibLgbLsbRsbRhbRibRgbLibLhbLiLsbRibLibRcRsmbRgbRsbR
ibLjbLhbLgbLgbRsbRsLsbRjbLobRcbLgbLibRjbRcRsmbRiRsmbLjbRibLjbLcbLgbLsb
LsbLsbLsbLgbLgbLgLsbLsbLgbLgbLgbLgbLgbLibLsRobLjbLibRjbLibRgbLibLsbLgb
LsbRsbLsbLsbLsbLsbLgbRsLsbRsbLgbLgRsLsbLgbLgbLsLsmbLgbLgbLgbLgbLsLsmbL
sLsmbLgbLgbLsbLgbLgbLsbLgbLobLsbLgbLgRsbRcbRibLjbRcbLibLcbLibLgbRsbLgL
sRsbLgbLsbLsbLgbLsbLsbLsbLsbLgLsbLgLsbLgbLgbLcRsbLibLibLibLiLsbLgbLsbL
gbLgLsbRsbLebLgbLsbLgRsbLsbLgbLsbLgbLgbRsbRcbRibLcbLiLsbRsbRsbLgbLsbLg
LsbLsbLgLsbLibLgbRibLibLgbLgbRcbLiLsbLsbLsLsmbLsbLgLsRsbLsbLgLsbLgbLsb
LgbLgbLsbLgbLsRsbLgbRjbRcbLjbLibLiRsbLgbLgbRibLiRsbLsbRsbLibRcbRgbRgbR
gbLsbRhbLebLhLsbLgbLsLsmbRsbLgbLiRsbLsbRsbLiLsbLgbLibRiRsmbLiRsbRibLib
LgbRgbLcbRibLibRsbLgbLsbLgbLsbLsbLsbLsbLgLsLsmbLsbRgbLiLsLsmbLsbLgbLgb
LsbLgbLgbLsbLgbLsbLgbLsbLgbLsbLibLsbRjbLibLgbRgLsbLgbLsbLsbLsbLgLsbLgb
LsbLgLsbLgbLgbLgbLgLsbLgbLsLsmbLsbLsbLgbLsbLgbRjbLibRcbRgbRibLjbLebLib
RgLsbLgbLsbLsbLgLsbLgbLsbLsbLgbLgbLgbLgbRsbLgbLgbLgbRcbRcLsbLibLhbRjbL
ibLiLsbRsLgLsbRcbLiLsbLibLgLsbLsbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bRgbRgbRgbRsRsmbRgbRsbRgbRsbRgRsmbRsbRiLsbLjbLobLibRjbRebsbRsbRgRsmbRs
bLsRsbRgbRsRsmbRgbRsbRsbRsbRsRsmbRgbRgbRgbLsRsbLsbRgbLjbLjbLiRsbLgLsbR
obRhLsbLibRcbRcbLsbRsLsbsbRsbsbLsbRsbRgLsbRiLsbLjbLoRsbLibsbRsbLgLsbLi
LsLsmbRcRsmbRsbLgbLcbRhbLcbRcbRcbRhbLsbLhbRjRsmbRcLsbLibRcLsbRsLsbRsbR
sRgbRsbRgbRgbRsbRgbRgbLgbRsbRhbLjbLhbLgLsLsmbLgLsbLgbRcbRhbsbRiRsmbRsb
RgbRgbRsbRgbLsbRsbLsbRhbRcbRibRibLgbLibLgLsbRjRsmbLibLgbLobLcbRiRsmbRi
bRibRgbRgbLgbRgbRgRsmbRgRsmbRsbRgbLsbRgbLsbRgbRsLsbRgRsmbRgbRgLsbLcbLg
bLgLsbLgRsbRsbLsbLsRsbLibRcbRgLsbLsbRgbRsbRsbRibRgbLgbRgRsmbRgRsRsmmbR
sbRsbRgbRsRsmbRsRsmbRsRsmbRsbRsRsmbLsRsbRsbRsRsmbRsbRgRsmbRsbRebLcbRoR
sLsRsmbRgbLsbRibRgbLibLcRsbLsLsLsmmbLgbRjbRhbRibRgbRgbLibLibLgLsbRsbLi
LsbLgbRjbRhbRgbRsbRgRsRsmmbRgbRsbRsbRsbRsRsmbRsbRgbRsbRsbRgbRsRsmbRgRs
mbRgbRsbRsbRsbLsRsbRgbLgbRgbRgbRsRsmbRsbRsbRsbRsbRsbRsbRgbRgbLsbRgbRgb
RgbRsRsmbRgRsmbRgbLhbLibLcbLcbLibRgRsmbRibRebRgbRsRsmbRsbRsbRsRsmbRsbR
iRsmbRgRsmbRgRsRgmbRsRsmbRgRsmbRgRsmbRgbRebRibRgRsmbRsbRsbRsRsmbRsbRgb
RgbRjbRhbRibRsbRebRsRsmbRgbLsbRsLsbRgbLsbRsbRgbRsRsRsmmbRsbRgbRgbRsbRi
bRgbRsbRgLsbLsRsbRgRsmbRgRsmbRsRsmbRgRsmbRgRsmbRsbRgLsbRsRsmbRgbRgbRib
RgbRgbRsbRsRsmbRgRsmbRgRsmbRgRsmbRgbLsbRsbRjbRsbsbRgRsmbRgRsmbRgbRibRs
bLiLhbLsLsmbLibLgbRibRjbRiLsbRsRsmbLsbRjbLcLsmbLcRsLsbLjbRibRcbLsbRjbL
gLsbRibRgbLsbRgbRsRsRsmmbRsbRsRgbRsbRsbLgLsbLcbLjbLsbLjbRcbRsbLsRgRsmb
RsbRgbRgbLsRsbRgbRibRsRsmbRgbRsbRgLsbRgbLcbLcbRibRgbRcbRcbRibRgbRibRgb
RgbLsbLjbsbRhbLsbLsbRgbRgbRsRsmbRgRsmbRsbRgRsmbRsRsmbRgRsmbRsRsmbRgbRg
bRgbRgRsmbRgbRgbRsRsmbRgRsmbLsRgbRgbRsbRgRsRsmmbRgbLebRgRsmbRcbLgbRsbR
gRsmbRgbRsRsmbRsRsmbRibLjbRgRsLsmbRgbRgLsbLcbLhbRjbRgbRsbRsbRsRsRsmmbR
gbRsLsRsbRgbRsbRgbRgbRibLhbRibRiLsbLibRobRgbRibRgbRiLsbRibRgRsmbRsRsRs
mmbRsbRsRsmbRgRsmbRgbRgbRgRsmbRgbRgbRibRgbRgLsbLcbLcRsbLibLibRgbRcbRgb
RgRsmbRgbRsbRgbRgbRgbLsbRgbRgbRsRsRsmmbRsRsmbRgbRgbRsRsmbRsbRgRsmbRgbR
gbLebLiRsbRebRibRgbRsRsmbRgbRsbRgbRsbRgbRgbRgbRsRsmbRgbRsbRgRsmbRgbRgb
RgbRgbLcbLhRsbLiRsbLsbRcbRobLgbLjbLibLibRjbRobLsbRibRibsbLgRsbLgLsbRcb
RhbRsbRsRsmbRgbRgbRgRsRsmmbRgbLsRsbRgbRsbRgbLsbLsbRgbRgbRsRsmbRsRgRsmb
RgbLsbRgbLsRgbRsbRgRsmbRgbRgbRibRgRsmbRgRsmbRgRiRsmbRgRsmbRiRsmbLsbRgR
smbRsLsbRsRsmbRgRsmbRgRsmbRgbRgbRcRcbRibRsbRiRsmbRsRsmbRsbRsbRsbRgbRgb
RgRsLsmbRgRsRsRgRimmbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bLgbRebRibLjbLibLgbLgbLgLsbLsbLsbLgbLsbLsbRsLsbRsbLsLsmbLgbLsbLgbLsLsm
bLsbLgRsbLgbLgRsbRibRhbLgLcbLiLsbLgbLgbLgbLgbLsbRsbLgbLsbRsbLsbLgbLgLs
bRsbLgbLsbLgbLsbLsRsbRsbLgbLsbLgbLgbLibLibLibRgRgbRgbRgbLcLsmbLgbLsLsm
bLgbRgbLgbLsbLsLsmbLsbLsbLgbRsbLsbLsbLsbLsbLsLsRsmbLgbLgLsbRgbLgRsRsmb
LgbLsbLsbLsbLibLgbRsbRcbLjbLeLsbLgbLgbRsbLsbLgbLsbLgbLgbLgbLgbLgbLjbRc
bRcbLjbLcLsmbLibRgbRsLsbLgbLsbLgbLsbLsbLsbLsbLsLsRsmbLsbLgLsbLgbLsbLgR
sbRsbLgbLibLgbLsbLsbRsbLgLsbLsbLgbRcbRiRsmbLjbLibLgbLgbLgLsbLsbLsbLsbL
gbLsbLgbLgbsbLgbRjbRcRsmbRibRibLcbLibRsbLsbLgbLsbLgbLgbRjbRibRgRsmbLgb
RgbLcbLgbLjRsbLibLgbRsLsbRsRgbLhbRgbLgbLsbLgRsbLgbLgbRsbLsbLsLsmbLgLsb
LsbRsbLsbLsbLgbLsbRsbLsbLgbLsbLgbLjbLibRgbRgbRjbRiRsmbRsbLsbRibLsbRibL
cbLgbLsbLgbRsLsbLgbLgbRcbRibRibRsbLjLsmbLibLgbRgbLgbLgbLgbRgbLsbRsRsmb
LgbLgbRsbsbLsRsRsmbLebRgbLgbLsbLibLgbRibRjbLibLgbLibLsbLsbLsbLsbLsbLgb
LgbRibRjbRcbRjbRibRibLgbRsbRibLcbLhbLhbRgbLgbLsLsmbLgbLgbLgbLgbLgbLgbs
bRoRsmbLiRsbLgbRsbRsbRsbLsLsmbLibLgbRgbRsbRsbLsRsbRsLsbLgbLsbRsbLgbLgR
sbLsRsbRsbLgbLsbLsbLsbRsbLsbLiRsbLgbLsbLsLsmbLsbLsbLgbRcbRibRgbLsbLgbR
ibRgbLjbLgbRjRsmbRgbRibRibRgbRsbLgbLjbRcbRcbRsbLsbLsbLsRsbLsbRibRgbLjb
RiRsmbRibRsbRsbRsbRgbRsbRibRgbRgbLgLsbLsbLjbRgbRebRcRsmbLsbsbLsbRibLgb
RjRsmbRibLgbLibRcb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bRhbRhbLibRiRsmbRebRiRsmbRhbRibRhbLebRgbRibLgbRebRsbRgRsLsmbRgbLsRsbRs
bLhbLcbRibLhbRibRcRsmbRsbRsbRsbRgbRsbRgLsbRgbRsbLgbRsbRibsbLjLibRcRsmb
RibRsbRsbLsbRsbLhbRibLcLsmbRhbLjbRgRsmbRsbRiLsbRgbLgbLibLgbLibLsbRibRs
bRgbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bLgbLsbRsbsbRsLgbRsLsbLsbLsbsbLsbLsbLsbLjbsbLsbLgLsbLgbLsbLgbLsbLsbLsb
RgbsbRsbsbLgbLsbsbLsbLjbLsbLsbLsbsbLsbLgbLgbLgLsbLsbLgRsbLsbLsbsbLsRcb
RsbRibRibLjbLsRsbRgbLgLsbRgbRibLhbRibRgbLsbLibRjRsmbRibLhbRjLsbRcbLibR
jbLjRsbRgbLsbLibLibLsLsmbLibLsLsmbLibLsLsmbLgbLgbLibRjbLebLibRibLiLsbL
sbLsbsbLsbLsLsmbLsbLsLsmbLgbLjbsbRgbRjbsbLhbRebRhbsbLsbsbRgbLjbRibLibR
hbLibLsbLjbRsRsmbRgbLjbRsbLsbLibLibRjbRjbRhbLgbsbsbRjbRsbRgbRgRsmbRgbR
gbRcbLebRibRsbRsRsmbLsbRsbsbsbLcbLsbsbsbRibsbLhbRjbLgbLgbRsbLcbRibLgbL
gbLsbLsbLgLsbsbLsbLsbLsbLsbLsbLsLsRsLsmbLgLsbLjbRsbsbRsbLsbLgbLgbLgLsb
LgbLsbLgbLsbLgbLgLsbRsLsbLsbLsbsbLsbLsbRobLgbsbsbLsbsbsbRsbLgbsbLcbLib
LsbRgbLibRsbLgbLsbLsbLsbLgbLsbLsbLsbsbLjbsbRjbLsbRcbRjbLsLsmbLsbRgbLgb
RgbLsbRgbRibLcbLgLsbRsbLgbRhbRhbLibRibRsbRgbRsbLsbRgbLsbLsbLjbRcRsmbLi
bLcbLsbsbLgLsbLjbLsbsbLsLsmbLgbLsbLsbLsbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bLsbsbRgRsmbRsbRsRsmbRsbRgRsmbRibLgbLebLibRsbRsbLibRsbRsbRgbLgLsbLsbsb
RsbLsbLgLsbLgbRgbRsbLsbLgLsbLsLgbLgRsbRcbRcbLibLsbLjbLibLgbLsLsRsmbLgb
RsbLsbRsbLsbLibLibRibLiLsbLsbLsbLsbLsbLsbRsbLsbRcRsmbRgbLsbRsbRgbRsbLc
LsmbLibLsbRsbLsRsbRgbLgbLsbLgbLsbLsbsbRgbLgbLgbLgbRsbLgbLsbLsbLgbLsbLs
bLsRsbLjbRcLsbLibLibRgbLgRsbLsbLsbLsbLsbRsbLsbRsbLsbLgbRcbRibLjLsmbRib
LibLgbLgbRsbRsbLgbLgbLgRsbRcbRhbLsLsmbRibLjLsmbLjbLibRsbLsbLgbLsbLsLsm
bLsbLjbRcbRcbRsbRsbRgRsmbRgbLgbRibLsbLcbLibRgbLsbLgbsbRsLgbRgbLsbRjbLs
RsRsRimbRsbLcbLcRsbRibLsLsmbLgbLgbLsbRsLsbLsbLsbRjbRhbRsbRgbRsbLgbRibR
sbLsbLgbLebLhbRgbLgbLsRsbLgRsbLsbLsbLsbLsbLsLsmbLsbLsbLsbLgbLsbLsbRsbL
gLsbRgbLibRcbRgbLsbRsbRgbRsbRsbLsbRgbRsbRgbRgbLsbLjbLcbLgbLsbLgbLgbRjb
RhbRsbLibLibLgbLsbRgbLgbRjbRibLjLsmbRibLjbLjbLibLgbRsbLgbLgbRsbLibRsbR
sbLgbLgbLsbLsbLsLsmbLsbRjRsmbRcbRgbLjbLhbLgbRsbLjbLsRsbLsbLsbLsLsRsmbL
sbLsbLsbLsbLsbLsbLgbLgbLsbLgbLgbRjbRcbLjbLjLsmbLsbLsbRsbRsbLgLsbRgRsmb
LibRgbLgbRcbLjbLibLgbLsbLgbLsbRsLsbLsbLsbLsbLgbLsbLsbLgbLibLhRsbRiRsmb
RibLgbLsbLibRsbLsbLsbLgbLgbLsbRsbLgbRcbRcbLgbRibLgbRibLjbLhbLgbLgbRsbL
sbRsbLsbLgbLgbLibRjbRhbLcLsmbLibLgbRgbRsbLsRjbLjbLgbLsLsmbLgbLsbLsbLsb
LgbRjRsmbLhbRjRsmbLcbRsbRgRsmbLsbLibLsbRsbLsbLsbLsbLgbLgbLsbLsbLgbRsbL
sbLibRgbLibLgbRsLsbRsbLsbLgLsbLsbLsLsmbLsbLgbLgbRibRhbRiRsmbLsbLgbLjbL
ibRgbLgLsbLsbLsbLgbLsbLsbLsbLgbLgbRcbRibLcbLibRsLsbLgbLsbLsLsmbLsbLsbL
sbLgbLgbRjbRcbRgRsmbLjbLcbLgbsbRsbLgLsbsbLsbLsbLsbLsbLsRsbLsLsmbLgbLsb
LsbLgbLsbLgbLgbLsbRibLhbRibLibLgbLsbLsbLsRsbLsLsmbsbLsRsbLsbRsLjbRsbLs
bLsbRsbsbRsbLsbLsLsmbLgbLgbLsbLgbLsbLsLsmbLibLgbLsbLsbRsbsbRhbRhLsbRsb
RibLgbRjbLcbLibRjbRgbLcbLgbRsbRsbLjbRcbLsbRhbRsbRgbLgbRibRebLebLibLjbL
sbLgbLgbLsbLgbRjbRibLgbLgbLgbRgbLgLsbLsbLsLsmbLgbLsbLsLsmbRsbLjbRibRcb
RibLibLcbRsbLgbLgbLsbLgbLsbLsbLsbLgbLgRsbRgbLsbLjbsbRsbLsLsmbLsbLgbLgR
sbLgbLgbLgbLgbLgbLgbRibLiLsbLgbLsbLsbLsbRob

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bRsbRsbRgRsRsmmbLcbLibLgbLgbRsbRebRibsbRgbRsbRsbRgbLsbRgbLsbRibLgbRibR
sbRgbRsRsmbRgbRgbRsbRgbRgRsmbRgbRsbRsRsmbRgbRgbRsbRgbRgbRgbRsbRgbRgbRg
bRgRsmbRibRsbRgbRgbRgRsmbRgbRgRsmbRgbRgbRibRgbRgbRibRgRsRsmmbRgRgbRsbR
gbRgbRgbRsbRgbRsbRgbLgbLebLgLsbLgbRgbRcRsRsmmbRiRsmbRgRsmbLgbRibLjRcbL
cRsLsbsbLhbRebRoLsbLgbRibRsbRgbLgbRgbRgbRgbLgbRgbLcbLibRjbLibLgbLsbLib
LgbRcRsmbRgbRgbRsbRgbLsbRgbRsbRgRsmbRsbRgLsbRgbRsbRgbRsbRgbRgbRgbRgRsm
bRsbRgbRgbRsRsmbRsbRgbRgbRgbRsbRgRsmbRgbRsbRibLjbLcbLgbLgbLgbRjbRibLgb
RibLsRsbRgbRgbRgRsmbRgRsmbRsbRgbLsRgRsmbRgbRgbRgRgbRgRsmbRsbRsRsmbRgbR
gbRgbRgbRgbRgLsbRgbRgbRgRsmbRgbRgRsmbRgbRgbLsbRgbRgRsmbLgbLcbLibLibRcb
RibRgLsRsbLsbRgbLsbRibLgbRgbRgbRgRsmbLcbLhbRhbLcbRcbRcbLgbRgbRibLjbRgb
RgbLgbRgLsbRgRsmbRgbRgbRsRsmbRgbLsbRgRsmbRsLsRsbRgRsmbLsLsmbRgRsmbLsLs
mbRgbRsbRgbRsRsmbRgRsmbRgbRsbRsbRgbRgbRsRsmbRgbRsbRgbLsbRgbLcLsmbLibRc
LsbLsbRibLsbRibRsbRgbRsbRgbRgbRgbRgbRgRsmbRgbRgbRgRsmbRgRsmbRgbRgbRgbR
sbRgbRsRsmbRgbRgbRgbRgbRgbRgRsmbRgRsLsmbRsbRgRsmbRgbRsRsmbRsbRgRsmbRgL
sbRsbRgRsmbRgLsbRsRsmbRgbRsbLsLsmbRiRsmbLjbRcbLibRhbRgRsmbLgbRsbRibRgR
smbLsbRgbRgbLgbLjbLibLibLgLsbLgbLgbRcRsmbLsbRgbRsLsbRgbRgbRsRsmbRsRsRs
mmbRsRsRsmmbRgRsmbRsbRgbLhbLgLsbLibRcbRgbRgbRsLsRsbRgbRsLgLsbRibRibLjb
RcbLgbRiLsbRgbLsbRsbRsbRiRsmbRgbRgbLgbLjbLibLgbLgbLibRcRsmbRibLsRsRsmb
RibRgbRsbRgbRsbRsbRsbRsRsmbRsbRiRsmbRsRsmbLjbLibLgLsbLgLsbLsLsmbRsbLgb
LgbRcRsmbRibLibRibRsbRgLsbRsRsLgRsmbRgbRsRsmbRgbLgbLcbLibLgbLgLsbLgbLg
bRcbRiLsbRsbLjbLjbLgbRjbRibRiRsmbLsbLcbLibLibLsbLgbRhbRiRsmbRiRsmbLgbR
ibLsLsmbRjbLgbRibLjbLibLgbLgbLgbLgbLsbRcbRsbRgbReRsmbLcbRibRsbLgbRgLsb
RgbRsRsmbRibRsRsmbRgbLsLsRsmbRhbLjbRhbLsbRibLjbLcbLgbLgbLsbLsbLsbRcbLs
bRhbLsbRiRsmbLgbRgbRsbRgRsmbRgRsLsmbRgbLsbRgRsmbLsbRibLjRsbRiRsmbRgbRs
bRsbRgbRsbRgbRgLsbRsbRgRsmbRgRsmbRgbRgRgbRgbRgbRsbRgbRsbRgbRsbRgRsmbRs
bRgbLsRsbRgbRsbRsbRgbRsbRgbRgbRsRsmbRgbRsbRgbLsbRhbLibLhbLibLgbLgLsbRs
LsbLgLsbRsbLgbRcbRgbRsbRgRsRsmmbRgbRsbRgbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bRgbRgbRsbRsbRgbRsbLsbRgbRsbLsbRsbRgbLsbRsbRsRsmbRgbRsbsbRgbRgbLibRibR
sbLgbRibRgbLsbLibRhRsmbLsbRibRsbLsbRsbRgLsbLsRsbRgbRsbRsbRsbRsbRgbLjbL
cbLibLsLsmbLsRsbLibLsbLibRsRsmbRgbRsRsmbRibRiRsmbLjbRgbRibLgbRibLgbRoR
smbLibLibLcbLgbRsbLsbLibRsbRsbLgbLgbLsbLsbLgLsLsmbLsbLsbLsbsbLgLsbLsbR
sLibLgbLgbLsbRgbRgbRsbLhLsbRsbLibLsbLsbRsbLiLsbRsbRjbLebLsbLsbLsbLibLs
bRsRsmbLsbLibLsbLgbLsbLsbLgbLsbLsLsmbLgbLsbRsbLsbLsbLibLgbLgRsbLsbLsbL
gbLgLsbLsbRgbLibRjbLibLsbLibRsLsbRsRsmbLibLibLibLibLibLgbLgbLibRgLsbLi
bLsbRsbLsbLsbLgbLsLsmbLgbLsbRsbLgLsbRsbLibLsbRsbLgbLsbLsbLgbRsLsbLgbLs
bRgbLibLibLsbLiLsbLsbRsLsbLgbLsbLiLsbLgLsbLsLsmbRgbLgbLibLsbRsbRsbLiLs
bRgbLibLsbLsbLsbLsbLsbLgbRsbLgbLsbRsbLgbRgbLibRibLibLsbLsbLiRsbLsbRgbL
ibLsbRsbLgbLsLsmbLsbLibRibLibLsLsmbRsbLibLsbLsbLgbLsLsmbLsLsmbLgbRsbLg
bLsbLsbLsbLsLsmbLgbLsbLsbRsbsbRsbLgbLsLsmbRjbLobRibLibLsbRsbRsbRsbLcbL
gbRsRsmbLgbLsbLibRgRsmbRibRgbRgbLsbRgbLsbRgbRsbRgRsmbRibLsbLgbRiRsRsmm
bRsbLgbRibLsbRsbRgbLgRsbRibLgbRibLsbRibLibRgRsmbRibRsbRgLsbLgbRibLsbLs
bRiRsmbLgbRsbRgbLsbRibRibRgbLibRiRsmbRsRsmbLgbRibRgbLgbRibLgbRiRsmbLsb
RsbRgbRsbRsbRsRsmbRsLsbRsbRgbRgLsRsbRgbLgbLoLsmbLibLsbLsbRgbLibLgbRgbL
gbRsbLsbLgbLsbLgLsbLsbLsbLsbLsRsbLgLsbLsbLgLsbRjbRcRsmbRgRsmbRgRsmbRsb
RgbLsbRgbRsbRgbRsbRsbRsbRsbRsRsmbRsLsbRgRsmbRsbRsLsbLsbLjbLcbRgbLibLgb
RibLibRgbLhbRibLiLsLsmbLgLsbRibLgbLgbRsbLgbLsbLsLsmbLgbLsbLgbLgbLsbLsb
LgRsbRjbLeLsbLiRsbRibRgbRibRibLgbLjbRcRsmbLsbRsbRgbRsbRsbRsbRsbRsbRsbR
sbRgRsRsmmbRebRibRgbRgbRgbRibRhbLibLibLibLsbRsbLibRsbRsLsbLgbRsLsbLgbR
sRsmbLibRgbLibRsbLgbRsbLgbRsbLgbRsbLgbRsbLgRsbRsbLgbsbLsbRgRsmbLgRsbRg
bLjbLsLsmbRsbRsbLgbRsbRsbLibLsbRsLsbLgbRsbLsbLsbLgbLsbLgLsbRsbRjbRibRs
bRsbRsbRgLsbLjbLcbLsbLsbLgbLsbLsbRsLsLsmbLgbRsbLgbRsbLibRgbLibRgbLgLsb
LsbLsbLsbLsbLgRsbLgbLgbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bRjbLcbLhbRibRcbLjbRibLgbRgbRsbRgbLgbRgbRgbLibLcbLiRsbRgbLibLgbLgbLsLs
mbRsLsbLgbLsRsbLsbRjbRgbRsbRgbRgbLsRsbLsLsmbRsRsmbLsbRgLsbRsbRgbLsbRgR
smbLgbRgbRiLsbRobRgbLgbLgbRcbLsbsbLcbLgbLsLsmbRsbLsbLsbLsbLsbRsRsmbRcb
RsRibLsbRgRsmbRsbRsbRsbRgLsbRgbRsRsmbRsbLsbLcbLibLsbLgbLsbLgLsbRsbLgbL
gbRsbLibRgbRgbLsbRgbRsRsmbLsbRsRsmbRgbRsbLgbRibLcRsbLcRsbRjLsbLibLgbLg
bLgbLsbLsbLsbLsbLsbLsbRsbLgbRsbRebRibRgbRgbRsbRsbRsbRsbRgbRsRsmbRsRsmb
RsbRsbLgbLcbLibLgbLsbLgbLsbLsbLsbRsbLgbLsbRsbLgbLgbLsbLgbLsbRgbRjbRhRs
mbRsbRsbRsbRsbLebLcbLgbLjbLgbRgbLgbLgbRgbRcbLibLcbRgbLibLsbLsbRsbLgbRs
bRibLsbLhbLibLsbLjbLgbRjbLjbRebRebRiLsbLibLhbRjbLgbRibRgbLjbRgbLjbRibR
gbLgbLgbRibRibLgbRibLjbRiLsbRgbLgbRjbLibRebRgbRgbRgbRsbLibRibRibRsbLgb
RibLgbLsbLgbRgbLsbLgLsbLgbLgRsbRebLsbLgbLibLiRsbLsLsmbRsbLibLiRsbRibRi
bLibLgbRsbsbRibRgbRiLsbRsRsmbRgRsmbLgbRgbRgRsmbRgbLjbRhbRgbLjbLjbLebRs
bRgbRgbLgbLjbLibLgbLgbLgbRsRsmbRsbLgbRgbLgbRgbRgbsbRsbRgbsbLgbLgbLcbLc
bLgLsbRsLsbLsbLgbLsbLsLsmbLsLsmbLsbLsbLsbRsbLgbRcbLcbLibLgbRgbRibRcbLs
bLsbRgRsmbLgLsbLjbLibLgLsbLsLsmbLgRsbLgbRsbLgbLsbRjbRhRsmbRibLsbRgLsbR
sbRgbLcbLcbLhbLgbRibRibRgbRibLjLjbLhbLibLgbRgbLjbLgbRgbLibRgbLibLgbRgb
LsLsmbLibRgbLibLgbRjbLjbRibLibRgbLcbRjbRcbRgbLcbLcbLibRibRgbLibLgbLgbR
sbLgRsbLsbRgbLgbLgbRgbLgbRsbLgLsbRsRsmbLgbRsRsmbRibRgbRsbLsbRgbRsbRgbR
sbRjbRsbLsbLsbRsbRsbRgbRgbLhbLibRsbLgbLgbRgbLgbLgbRgbLgbLgRsbRgbLhbRiR
smbLhbRibLibLgbLsbLsbRsbLsbLgRsbRcbsbRiLsbRgRsmbLjbLjbLibLibRsbRsbLgbL
sbRsbLgbRcLsbRsbLsbsbLsbRsbLebLiLsLsmbLsbLgbLsbLgbLsbRgbRobRibLsbLsbRg
bLsbRsbLsbLebLibLgbRsbLgRsbLsRsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bLjLsmbLjbLsbLjbRcbLjbLgLsbLjbRhbLibLjbLsbRcLsbLibLibRgRsmbLibLiLsbRhb
RjRsmbRsRsmbLibLiLsbLsbRjbLjLsmbRgbLibRsLsbLebLsbRsLsbLcLsRsmbRsbLjbLs
RiLsbRgRsmbsbsbsbsbLsbLcbRjbRgbLiRsbLsbLebRhbLibLgbLsbLsbLjbRibLebLjbL
ibLgbRjRsmbLibLgbRibLsbsbsbsbsbsbsbLhLsbRjbsbsbsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 25; Drug: Control Apo 0.5 然
bLibLibRgbLiRsLsbRsbsbLibRsbLgbLibRsbRsbLgbLgbLgbLsbLsRsbLsbLsbLsRsbLs
bLgbLgbLsbLsbLsbLsbLgbLsbRgbLibRsRsmbLgbRiRsmbRibLoLsmbLibRgbLiRsbRsbR
sbRobRgbLsLibLsbLibLgbLibsbRsbRgbRgRsmbRgbRhbLibRiRsmbLsbLsbRhbRibRgbL
gbLsbRcbRsLsbLgbLibLjbRcbRiRsmbLgLsbLjbRjbRgbRibLibRsbRgbRibLjbRsbRibR
sbLsbLsRsRgbRgbRiRsmbLcLsmbLcbLhbRibRsbLhbRsbLibLsbsbLsbLgbLsbLgbLgbRs
bLgLsbRsbLgbRsLsbLgbRgRsmbRsbLiRgbLsLsmbLibRsbLibLhbRebRibRgbRibRibLib
RhbLibRibLsbRgbRibLgbRcbRsbRgbRcbLgbLgbRsbRibRsbLsbLibRibRibRgbRgbRgbR
gbLibRibRibLsbLsLsmbsbRsRsmbRsbRsRsmbRsbRsbsbsbRsLsbRsbRsRsmbRsbRsbRsb
RsbRgbRsRsmbRsbRsbRsbRsbRgbRsbRsbRsbLsRsbRsbsbRsbLsbRsbRsbRsbLgLsbRgbR
ibLsbLibRibRgbRgbLsbRsbRgRsmbRsbRgbLsRsbRgbsbRsLsbRsbRsRsmbRsbRsbRgLsb
RgbLibRibRgbRgbLsbRgbLsbRsbRgbRsbRsbRsbRsbRsbRgbRsbRsbLsbRsRsmbRgRsmbR
sbRsbRsbRsbRsbsbRgbRgRsmbRgbRgbRgRsRsLsmmbRgbRsRsmbRsRsmbRgbLgLsbLjRcb
RcbLibLgbLcbRjRgbLibLibRsbLibLibLgbRibRiRsmbRsbRgbRsbRsbRsbLsLsmbRsbRs
bLsbLgbLsRsbLibLsbLhbRhbRcbsbLibRiLsbLsLsmbLgbRibLsbsbLjLsmbLcbLibRjbL
cbLibRgbRgbLgbRgbLibLiLsbRibRjbRibRgbRgbRgbRgbLhbLcbRjbRcbRiRsmbLiRsbR
sRibRgLsbRgbRgbRsbRsbRgbRgRsmbRsbRsbRgbRgbRsRsmbRgbRsbLgbRsbRibLsRiLsb
RhbRibRibLhbLibLhbRibLibRibRibLibLcbLibLibLibRibRsbLsbRibRibLgbRibRsRs
mbRsbRsbRgbRsbRsbRsRsmbRsRsmbRsbRgRsmbRgRsmbRsbRsLsbRgbRsbRsbRsbRgbLsb
RgbLsbsbRsbRsRsmbRsRsmbRgbRsbRgbRgbRgRsRsRsmmmbRsbRsbRsbRsbRsbLgbRgbRs
bRsbRgbRsbRsRsmbRgbRsbRgRsmbRgbRsbRsbsbLsbRgbLhbLhbRcLsbRcbLibRibLhbLc
bRebRcbRhbRgbLhbRhbRhbLgbRcbRibLibRibLgbRhbRcbRsbRibLibRibRsRsmbLsbRgR
smbRgbLjbLsbRcbLibLgbRsbRgRsmbRsbRgbRgbRgbRgbRgbRibLcbLcbRcbRiLsbRgRsm
bLhbRibsbLgbLjbRiRsmbLibRibRgRsLsmbRsRsmbRsbRgbRsbRgbRgbRsbRgbRsbRsbRs
bRsbRgbRsbRsbRsbRsbRgbLgbLsbRibRgbRgbRgbRgbRgbRgRgRsmbRgbRsbRsbRsbRsbR
sRsmbRsbRsLsbRsRsmbRsbRsbLgbRgbLgbRgbRsbRsbRgbRgbRgRsmbRgbRgbRgLsbRsbR
sbRgbRgbRsbRsbRsRsmbRgLsbRiLsbLibLhbLibLhbRhbRibLhbRjbLcbLibLhbLgbRibL
iLsbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 26; Drug: Control Apo 0.5 然
bLibLgLsbRibRjbRsRhbLjbLhbLibLsbRgbLibLsbLsbLgbLsLsmbLsLsmbLgbLgbLgbRg
bLgLsbRsLsbLsRsbLgbLsbLgbRgbRjbRibLsbRiRsmbRibRsbLgbRiLsbLgbLgbRcbRgbL
ibLcbLibRgRsmbLhbLibLgbRgRsmbLibRsLsbRsbLibRjbLibRibLibLsbLsbLgbLgbLsb
LsbLsbLgbLgbLgbRjbLibLsbLibRgbLibRgRsmbRcbRibLgbRgLsbRsbRgbLsbLcbRjbRi
bRibRhRsmbLibLhbLcbRsbRsLsbLhbRhbRcbRcbLhbRibRibLobLgbRgbLgbLgRsLsbLsb
LgbRgbRhbRcbLjbRibLjbLcbRgbLibRgbLhbLsbRsbLsbLgbLsbLsbLgbRcbRiLsbLgbRi
bRgbLsbRiLsbRcbRgRsmbLgbRibRhbRhLsbRhbRgbRibLgbLibRjbRhRsmbLgbRcbLgbLh
bLibLhbRgbLsbLibRsLsbLgbLgbLsbLgbRjbRjbLhbLcbLsbLsbRgbRjRsmbRibLjLsmbL
cLsmbRibRsRhbRibLgbLsbLobLibRjbLiLsbRsbLibLsRsbLgLsbLsbLsbLibRjbRjbRib
RibLjbLcLsmbLgLsbLsbLsbLsbLgbLgbLsbLsbLsbLgbLsbLsbLsbLgLsbLsbLsbLgbLgb
LgbLgbLsbLgbLsbLsbLgbLgbLiRsbLibRhbRhRsmbRcbLgbLcbLgbLsbLsbRsbLgbLgLsb
LsbLsbLgbLsbLsbLsbLsbLsbLsbLgbRibLibRjbRhbRiRsmbLsbRhbLibLcbLiRsbLsbsb
LsbLsbLsbLsLsmbLgLsbLgLsbLsLsmbLgbLsbLsLsmbLgbLsLsmbLsbLsbLgbLsbLgbLsb
LgbLgbLsbLsbLsbLsbLsbLgbLgbRgbLibRjRsmbLhbRhbRcbLgLsbRibsbRiRsmbRcbRhb
LgbRibRibRibRibLsbLgbRibLjbLcLsmbLiLsbRsbLibRsbLgLsbLgbLgbLibRhbLibLsb
LgbLsbLsbLgbLsbLsbLgbLgbLgbRjbLibLsbLsbLibRsbLibLgbRgbLiLsbLgbLsbLgbRc
bRibLgbRcbLgbLibLibLiRsbLsbRjRsmbLibRgbLsbLiLsbRsbLgbLsbLsbLgbLsbLsbLs
bLsbLsbLsbLsbLsbLgRsbLsLsmbLsLsmbLgbLsbRsbLgbLsLsmbLgbLsbLsbLsbLgbLgbL
gbRgbLiLsbLgbLsbRsRsmbLsbLgLsbRsLsbLsbLsbLgbRsbLiLsbRsbLgbRsLsbRsbLibR
gbLsbLibLgbLsbLsbLgbLsLsLsmmbRsbLgbRsbLibRsbLgbRsbLsbLgbLgbLgbLgbLsbLg
LsLsmbLsbLgbLsbLgbLiRsbRjbLgbLibRjbRhbRibRgRsmbLsbLgbRcbLgbRhbRgbRsbLi
bRcbRsRsmbRibRgRsmbLibRcbLsbLgbRcbRsRsmbLjbRhbLgbRibRgbLgbRsbRibLsRsbL
gbRibRgbLgbLsbRibLgbRibLgbLjbLcbLibLibRgRsmbRgbLiRsbLhbLgbLsbRibLibLsb
RsbLiRsbLgbLgRsbLgbLsbLgbLsbLgbLgbRgbLgLsbLsbLsLsmbLsbLibLsLsmbLgbLgbL
sbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 27; Drug: Control Apo 0.5 然
bsbRgbLsbLsLsmbLsbLsbLsbLgbRgLsbLiLsbRsbLgbsbRhbRgbRsbRgbRgRsmbRsLsbRg
bRgbRsbRgbLibLcbLibRsLsbLibLibLhbRiRgbRibRobLcbLibLgbsbLgRsbRjbLebRhbR
jLsbLsbLjbRibLhbLgbRsbLgbRsbLsbLgbLgbRgbLsbRhLsbRiRsmbRibLjbRibRsbRgbL
jbRibRsbRgbLsbRibLgbRibLcbLibRgbLgbLgRsbLgbRsbLgbRjbRibRgbRsbRgbRgbLsb
RgbLsbLsbRgbRgbRgbRibLcbRsbLibLsbLgbLgbRgbLgbRsbLgbLsRgbLiLsbLgbLsbLgb
LibLcbLibLgbRibRgLsbsbRgbRibLsbRibLgbRibLsbLcbLibRgbLibRsbLibRgbLibRsb
LgbRsbLgbRsbLibRsbRsRsmbLgLsbLsbRsbRsbRjbRibRgbRgbRsbRsbRsbLsLsmbRgbRg
LsbRgbLcbRsLiLsbLgLsbLgbRgbLgbLsbLgbLsRsbLibsbLgbLgbRsbRcbRibLsbRgbRgb
RsbRgbLjbRibRgbRsbLgbRgbRgbRsbRsbRsbLsbRgbLsbLcbLiLsbLgbRsbRsLsbRhbRgb
RsbRgbRsbRgbRgRsmbRsRsLsmbRsbRsbRsbRgbLgbRibLgbRgbRsbRsbRgbLgLsbRgbRgb
RgbLgbRibLjbRibRgbLjbRibRgbRsbRgbRibRcLsbRibRhbLebRgbLibLgbRjbRebRsbLh
bLibLibRibLgbLibLgbLgbRgbLibRsLsbLgbLsbLjbLsbLsbRsLsbLsbLibRsbsbLgLsbR
sbLsbLgLsLsmbRsbRsbLgbLgbRsbLgLsbRsLsbLgbRsbLibLgbLsLsmbRgLsbRjbRibLjb
LiLsbRhbRgbRgbLsLsmbLsbRgbRgbLsbLsbRgbLgbLibLgbLgbRsbLgbRgbLgbLsbLgbLg
bLsbRgbLsbLgRsbLgbLsbRgbLibLsbRsbLgLsbRsbLgLsbRgbLgbRsbRjbLibLibLgbLgb
LsbLsbRsbLgbLgbRhbRjbRibRgRsmbRgbLsbRsbRsbRgbRsbLibLgbLsbLsbLiLsbRgbLi
LsbLgRsRsmbRjbRhbRibRibLjbRgbRgbRsbRibLcbLibLibRsbLgbLsbRsbLsbLibRjbLi
bLsbRgbLibRgbLibRgbLgbLsbLgbLsbRsbLgbLgbLibRjbLjLsmbLibLsbLsbLsbLsbLgb
LsbRsRsmbLsbLgRsbRsbLgbLsbLsbLsbLgLsRsbRsbLsbLsbLgbLsbLgLsbLsbLgbLsbLg
bLsbLgbLsbLsbRsLsbLgLsbRsbLsbLgbLgbRcbRibLjbLibRhLsbRibRgbRsbLgbRhbLcb
LcbLgbLsbLgbRsbLgbLgRsbRjbLiLsbRjbLibRsbRhbRiRsmbRgRsmbRgbLcLsmbRjLsbR
cbLcbRhbRiRsmbLsbRibLjbRhbLcbLibLsbLsbLibRgbLgLsbLsRsLsbLsbLsbLsbLsbLj
LsmbRjbRibRibLsbLibLgbLsbLsbLgLsbRsbLgbLsbLsbRsbsbLsRsbLsbLgLsbRsbLgbR
gbLgbRsbLgbLgLsbLsbLsbLsbRcRsmbLebLcbRjRsmbRgbRjbRcbLebLhbLgbLsbLgbRsb
LgbLsbLgbLgbRsbLgbLgbLsbLgbRsbLgbRsbLgLsbLgbLgbLsbRsbLsbLgRsRsmbLobLib
RjbLibLgbLiLsbRhb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 28; Drug: Control Apo 0.5 然
bRgbRsbRgbRsbRgbRsRsmbRsRsmbRgbRgbRsbRgRsmbRgbRgbRgRsmbRsbRsbRgbRgbRgb
RgbRsbRgbRibLiLsbRiRsmbRgbRsbLgRsbRjbRsbRgbLgbRgbRgbLsRgbRsbRsbRsbRsbR
gbRgbRgbLsbRgbRsLsbRsbRgRsmbRsLsbRjbLsbRsbRsbRsbRsRsmbRgbRgbRgbRgbRsbR
sbRgbRgRsmbRgbRgRsmbLcLsmbLibLgbLgbLjRsbRgbRjbLcbRsbLgbLgbRgRsmbLibLsb
RibLiLsbLsbRibLjbRsbLsbsbLibLsbLgbRsbLgbRsbLgbLgbLsbLgbLgbLsbLgbRgLsbL
ibLibLgbLgbRgbRgbLibLsbLibRsbRsbLiRsbLgbRgRsLsmbLibRsbLgbLsbLsbLsbLgbL
sbRsLsbRsbLgbLsLsmbLgbLsbLgbLgbRsLsRsbLgbLgbRgLsbLgbLgbLsbLgbRsbLgbLgb
LsbRsbLgLsbLsbLsbLgbRsbLsbLgbLgbLsbRgbLgLsbLsRsbLgbLgbRsbLgbLsbLsbLsbL
gLsbLsbLgLsbLsbLsbLsbLsbLgbLgbLsbLgbRgbLiLsbLgbRgbLgbLsLsRsmbLgbLgbLsb
LsbLgbRsRsmbRsbLgLsbRsbLgbLsbLsbLsbLgbLsbLgbLsbLgbRsbLsbLgbLsbLgbLgbRg
LsbLgbLgbLsbLgLsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLsbLgLsbLgbLsbRsbLsbLgRsbL
gbLgbLsRsbLgbRsRsmbLibLgbRgbLibRsbLgbLsbLsbRsbLgbLgbRgbLibLgLsbRsbLgbR
gbLsbLibRsbLgRsbLgLsbLgbRsLsRsbLgbLsbLsbLgbRsbLgbLgbLsbLsbLgLsbLsbLsbL
sbLgbLsbRsbLgbLsbLgLsbLsbLgLsLsmbLgLsbLsLsmbLgbLsbLsbLsLsmbLgbLgbLgLsb
LsbLsbLsbLgbLsLsmbLgLsbLsLsmbLsbLgbLgLsbLgbLgbLgbLsRsbLsbLsbLgbLgbLsbL
sbLgbRsbLgbLsbLibLgbRgbLjbRcbRcRsmbLjbRjbRibLgbRgbRiLsbLgbRgbRsbRgbLsL
smbRgbRgbLgbRgbRsbLjbRibRibLibRgbRgbRiRsmbRgbRgbRibRgbRiRsmbRjbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 29; Drug: Control Apo 0.5 然
bRgbRgbRgbRibRibLibLgbLgbLsbLsbRsbLjbLgbLgLsbRgbLibLsbLgbRsbLsbLgbLsbL
gbLsbLsRsbRsbLsbLsbLsbLsbLgbLgbLgbLsbLgbLsbRsRsmbLgbLsbLgbLgbLsbLsbRsb
RjbRiRsmbRsbRibLsbRibRgbLibRibRibLjRsbRibLgbRsLsbLsbRibRgbRgbLgbLgbLsb
RibRgbRiLsbLgbRgbLgbLsbRibRgbRibRibLgbLgbLgbLibLgbLgbRibRgbRibRgbRgbRi
bRibLgbRgbRgbRgbRibLibLgbLsbLgbLsbLsbLsbLsbLsbLsbLsbRjbRcbRhRsmbRjRsmb
LhbLjbLhbLsbRjbRibLsbRgbRgbRhbLeLsbLjbLcbLgbRgbRsbLgbLgbLsbLgbLsbLsbLs
LsmbLgbRsbLibLcbRibLcbRsbLgbRsbRjbRibRiLsbLgbRhLsbLgbRibLgbLibRgbRjbRi
bRsbRsbRgbRibRiLsbLgbRiRsmbRgbLsbRgRsmbRgbLgbRibLgbRiRsmbLgbRcbRibLiRs
bRibRgbRgbRibLsbRgbRsLsbLgbRgbRsbLsbRgbRsbRgbLsLsmbRsbRsbRsbRsbRsbRgbL
sbLsRgbRgbRsbRsbRgbRsbRgbLsbRgbRgbLjLsmbLcLsmbLibLsbLsbRgbLgbLsbLsbLsb
LsbLsLsmbLsLsLsmmbLsbLgbLgbLsbLsbRsbLsbLsLsmbLsbLsbLgbLgbRsLgbLgbRgbRj
bRibRibRibLibLhbLgbLgbLgbLibRgbLgbLgLsbLsbRsbLsbLsbLgbLsbLgbLsRsbLsbLs
bLsbLsbRcbRibLsbRgbLcLsLsmmbLibLsbRsbLgbLsbLsbLsLsmbLsbLgbLsbLsLsmbLsb
LsLsmbLsLsmbLgbLsbLsbLsbLsbRhbRiRsmbLjbLjLsmbRsbLiLsbLsbRsbRsbLgbLgbLs
bLsbLsbLsbLsbLsbLgbLgbLgbRsbLgbRsbLsLsmbLgbLsbLgbLgbLsbsbRsbLsbLsbRjbR
sRhRsmbRibLibRibLjbLhbLibRgbLibLgbRsbLgLsRsbRjbLjbLhbRjbLgbLgbLsbLsbRg
bRjbRibRibLibRhbLjbLjbLhLsbRgbLgbLsbLgbLsbLsbLsbLsbLgbRsbLjbRsbRsLsbLs
LsmbLsLsmbLgbLgbsbLsbLgLsbLsbRsbLgbLsbLsbLsbLsbRsLsbRhbLjbRcbRcbRcRsLs
mbRibLgbLibLgbRgbRhbRgbLgbLjbLibLsbLgbRsbRsLsbLgLsbsbLsbLsbLsbRsbLgbRc
bRgbRgLsbRgbLgbLsRibLjbLjLsmbRibRgbRhbLibLibRibRibRgbRgbLgbLjbLibLibLs
bRsbLgbRsLsbLibLgRsbRsbRjRgbRgbRsbRgbRgbRgbRibRgbRhLsbRibRsbRgRsmbRgbR
sbRgbRsbRsbLsRsbRgbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 30; Drug: Control Apo 0.5 然
bLibLjbLcbRsbLgbRsbRgbLgbLgbRgbLibRgbRgbLgbLibLgLsbRgbLibLibRsLsbRsbLg
bLsbLgbLgbLsbLsbLsbLsLsmbLsbLsRsbLsbLsbRgbLgbLsbLsbLsLsmbLsbRsLsbLsbLs
bLsbRcbRibsbLsRsbLjbLebLiLsbLgbLsLsRsmbLsLsmbLgLsbRhbRibRiLsbLibLgbLhb
LgbLgbLsbLgbRsbLgbRgbLgbLsbLgbLsbLsbLsbLsbLgbRibLibLgbRibLgbRobLgLsbLi
RsbRiLsbLcbLibRibRsbRgbLhbRhbLhbLibLsbLsbRsbRibRibsbLjbRibRcbLibLibRcb
LhbLcbLhLsbLibLgbRgbLibRsbRsbLjLsmbLgbLgRsbLibLsbLsbRibRgbRgbRsbLebLgb
LsRsbLgbLgbRsbLgbLsbRgbRsbLibLgLsbLsbLgbLsbLgbRsbLgbLgbRgbRsbLibRiLsbL
cbRgLsbRibLibLgLsbLgbLgbRgbRsbLibLgbRgbRsbLibLsbRgbLgbLsbLgbRsLsbLgbLg
bLgbRgbRgbLjLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bRgbRsbLsbLgbLsbLsbRjbRibRcbRgbRgbLhbRgRsmbRsbRsbRsbRibRsbRsbRsbRibLib
RibLsbLgbLsbLsbLibRjbRibRcbRsbRsbRsbRsbRsbRgbLgLsbRgbRgLsbLjbRjRsmbRib
RjRgRsmbLebRibRsbRjRsRsmmbLibLsbLsbLsbRhRsmbLcLsmbsbLsbRsbRjRsmbLibLsL
smbLgLsbLiLsbLsLsmbLgbLgbLsbRsbLgLsbLsLsmbLgbLsbLibLsbLgbRibRjRsmbRsbR
sbLsbsbLgLsbLsLsmbRsbRsbRsRsmbsbLjbsbLgbLgbRjbLcLsRsmbLsbLibLsLsmbLsbR
sbLgbLsLsmbLibRgRsmbLibRiRsmbRhbLcbLsbLibRsbRsbLsbRsbLibsbLiRsbLsbRsbL
sbLsbLgbRjbLgbsbLsRsbLsLsmbRsLsbLgLsbLsLsmbLsbLsbLgbLgbLibLcbLibLgbLgb
LgbLsbLgbLsbRsLsbLgbLgbRibLebLjLsmbLsbRjRsmbRsbLsbLsbLgbLsbLsbLjbRibRs
bLgbLgbLsLgbLsRsbRsRsRsmmbLgbLsLgbLsbLsLsLsmmbRsbRsbRsbLsbLibLsbLsbLsb
LgbLsbLgbLsbLsbLsbLgbLsbRcbRcLsbRsbRsbRsbRsbRsbRgbRibLsbLgbRibLsbLsbRs
bRsbLgbLsbRhbLsbRsbLgbRibLsbRgbLsbRibRsbsbsbRgbRsbRhbRibRibLgbRibRgbLg
bLgLsbRhbRhRsmbLgbLgbLjbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bLsRsbLsbLsbLsbLsLsmbRsbLsbLgbLsLsmbLgbLsbLsbLgbLsLsmbLsbLsRsbLgLsbLsL
smbLsbLsbLsbRsbLgbRsbLsLgLsbLgbRsbLibLgbRsLsbRsbLibRebLhbLibRcbRhbLibL
hbLsbLgbRsRsmbLgLsbRsbRsbLgLsbLgbRcbLjbRcLsRsbLcbLcbRgbLsbLibLsbLsbLsb
LsbLgbRsbLsbLgLsbLsbRsbLgbRsbLsbLsbLsbLsbLsbLsbLsbLgbRsbLsbLsbLsbLsLsm
bLiRsbLsbLgbLgbRsbLsbLsbLsLsmbLsbLsbLgbLsbLgbLsbLsbLsbLsbLgbLgbRsbLsRs
bRgLsbLsbLgbRsbsbLgbLsLsLsmmbLsbLsbLgbLsbLsbLgbLsLsmbLsbLsbLsbLgbLgLsb
RsbLgbLsbLsbLsbLsbRsbLibLsbLsbLsbLsLsmbLgbLsbLgbLsbLgbLsbLgbLsbLsbLsbL
sbLsbLsLsmbLsbLsbLsbLgLsbLgbLgbLsbLgbLsbRoRsmbRiLsbRcLsbRgbRiLsbRibLhb
RjbRgbLhbRcRsmbRcbLcbLsbLcbRsbRsbLibLsRsbLibRsLsbLgbLsbLgbLsbLgbRsbLgb
LsbLsbLgbLsLsmbLgbLsbLgbLibRibLibLcbRibLiLsbLibLsRsbLgbLgbLsbLsbsbsbLs
LsmbLgbLgbRsLsbLsLsmbLsLsmbLsbLsLsmbLgbLsbLgbLsbLsbLsLsmbLgbLsbLsbLgbL
sbLgbLsbRsbLgbRsbLgbLgbLsbLgbLgbRgbRcRsmbRibRibLebRgbLibLsbRsbLhbRgbRg
bLcbLcbRibRgbRgbLobLibLgbLgbRiLsbLibsbLibLsbRsbLibLsbLgbLgbLgbLgbRsbLs
bRsbLgbLsbLsbLsbLsbLgbLsbLgRsbRgbLgbLibRgbRsbLgbLgbLsbLsbLsbLibRsbLsLs
mbLgbLgbLgbLgbRcbLcbLhbRibLhbLsbLibLsbRgbRsbsbRhbLjbLhbLcbLibRibLgbRsb
RgbRgbRgbRsRobLsbRsRibLgbRgbLibLibRsbLgbLgbLsbLsbRsbLgbLgbRsbRjLsbLibL
gbRsbRgbLgbLibRsbRsbLibLcbLgbRsbLgbLgbLgbLgbLgbRsbRcbRhbLibLibLgLsbLsb
LgLsbLsLsmbRsLsbLgbRsLsbLsbLsLsmbLgbLsbLsLsmbLsbLsbLgLsbLibRgbRgbLibLi
LsbLsbRgbLibLgbLhRsbLcbLibLibLsbRgLgbLibRgbRgbLhLsbRsLsbLsbLgbRsRsmbLg
bRsbRsbLgRsbLsbsbLsbLgLsbRsbLsbLsbLsbLsLsmbLgbLgbRsLsbRsbLgbLgbLsbLsbL
sbLsbLsLsmbLibRgbLibRsbLgbRsLsbsbLgbRsbLsbsbLgbLsbLgbLsbLsbLsbLsbLgRsb
RgbLiLsbRgbLgLsbLgRsbLgbLsbLgbLsLsmbLgLsbRjbLibLsLsmbLgLsbLsbLgbLsbLsL
smbLgbLsbLsbLsbLsbLgbLsbLgbLgbLibRsbRsbRsLiLsbRjbLhbLgbRgbLibLgbRsbLgb
LsbRsbLsbLgbLsbLsbLgLsbLgbLsbLgbLsbLsbRsbLsbLgbLgbRsbLgLsbLsbLgbLsbLsb
LgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bLsLsmbRgbRgbRsbRsbRsbRgbLsbRgbRsbRsbRsRsmbRsbRgbRsbLsbRsbRsbRsbRsbRgb
RsbRgbRsbRgbRgbLsbRgRsmbRsbRsbRsbRgbRsbRgbRsbLgbRgbRsbRgbRsbLsRsbRsbLs
bRgbRsbRgbRgbLsbRsbRsbRgbRjbsbLcLcbLhbRjbRjbRebRhbRibLcLsmbRibLibLibLs
LsmbRsbRgbLgbRsbRgbRgbRsbRgbRgbRgbRsbRgbLsLsmbRgRsmbLsLsmbRsbRsbRsbRgb
RgbRgbRsbRsbRgbRibLjbRjbRibLibLibRgbRibRhbRibRibRibLsbLcbRgbLcbLcbRsbR
ibRgbRgbLibRgLsbLibRgbLgbLhbLibLgbLsbRgbLgbLgbRgbRibRibRiLsbRgRgbLhbRi
bRgbLjbRjbLcbRcbLjbRibLcbLcbRsLiLsbLiRsbRgbRjRsmbRgbRgbRgbLgbRgbRsbRgL
sbRsbRsbRgbRsbRgbRsbRsbRgbRgbRgbRibLhLsbLcbLibLsbLsbLsRsbRgbLsbRgbLsbR
sbRgbLsRsbRsbRgbRsbRsbRibRibLhbLcbLsbRgbLcLsmbRibRjRsmbLcbRgbRgLsbRgbR
sbRsbRgbRgbLgbRgbLhbRgbRgbRsbRsbRibRiRsmbLebLcbLgbRjbRoLsbRibRgLsbLjLs
mbRgbRgbLsLsmbRgbRgRsmbRgbRgbRgbRgLsbRsbLsbLgbRsbRgbLsbRgbLsbRgbRgbRsL
sbRgbsbLsbRsbLibLgbLhbRcbRibRgbRgbRsRgbRsbRgRsmbRibLcbLhbLibRsbRiRsmbL
ibRsbRgbRcLsbRibRibLiLsbRgbRsbRgbRgbRgbRsbRsbLsRsbRsbRgbRgbRsbRsbLsbRg
bRgbRsbRgbRgbLjbRgbRgbRibRsbRiLsLsmbRsbRsbRsbRgbRsRsmbLsbRgbRgRsmbRsbR
sbRsbRgLsbLcbLcbRgbRgbRjbRgbRiRsmbRgbLjbLcbLhbLgbLjbRibRhbRhbRiRsmbRib
RgbLibRsbRsbRgbRsbRgbRgbRgbLgbRgbRsbLsbRgbRgbRsbRsbRgbRsbRsRsmbRgRsmbR
sbRsbRsbRsbRgbRsbRsbRsbRsbRsbRsLsbRgbLsbRgbRgbLeLsbLcbLcbRgbRibRibRgbR
gbRsbRgRsmbRsbRsbRgbRsbRsbRsbRsbRsbRsbRsbRgbRsbRsbLsbRhbRibLjbRhbRhbRi
bLhRsbRgbRjbRgbLoLgbRcbLcbRcbLcbRcbRibRibRgbRgbRgbRsbRibRsLsbLcbRsbRgb
RgbRgbRgbRgRsmbLsbRsbRsbRsbRsbRsbRgRsmbRgbRsbRsbRgbRsbRgbRsbRgbRsbRsbR
sRsmbRgbRsbRsbRgbRsbRgbRgbRsbRsbRsbRgLsbLjbLcbLibRibRjbLcbLhLsbRgbRjbR
cbRibRcbRebRcbRibRibLhbLcbLibRgbRjbRcbRhLsbRiLsbRgbLcLsmbsbRsRsmbRgbRg
bRgbLibLsbLibLgbRcbLhbLibLjbLcRsLsbLibLhbLsbRibRcbLcLsmbRgbLjbsbLcbRjb
RcLsbLibRgbRgbRgbRsbLsbRgbRgRsmbRsbRibLcbLcbLibRhbLiLsbRibRibRgbRgbRsR
smbRsbRsbLsbRgbRgbRsbRsbRsbRsRsmbRsbRsbRsbRgbRsbRsRsmbRsbRsbRsbRsbLsbR
gLsbLsbRgbLjbLcbRjbLcbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bsbLsbRsbRsbsbLsRsbRgbRsbLsbLsRsbRgbLgbRgbRsbRsbRsRsmbRgbsbRgbRsbsbRsb
RgbRsbRsbRsRsmbRsbRsbRebRsbLsRsbRibRsbLsRsbLsbRsbLsbRgbRsbRgbRsbRsRsmb
RsbRgLsbRgbLsRsbRgbRsRsmbRgbRsbRsbRsbRsbRgRsmbRgRsmbRsbRsRsmbLsRsbLsRs
bRibRsbRsRsmbRsbRgbRsbRgbRsbRsbRsbRgbRgbRsbRsbRsbLsRsbLsbRiRsRsmmbRsRs
mbLsRsbRsbRgbRgRsmbRsbRgRsmbLsbLjLsmbRibRsbRsbRgbLsbLjbLibLibRjbLibLgb
LsLsmbLsbLgbLgRsbLibRiRsmbLsbRgbRgbRsbRgbRsbRgbLsRsbRhbRibLsbLibRiLsbR
gbLsLsmbRsbRgRsmbRsRsmbRsbLsbRibLsbLsbLsbRgbRsbRgbRsbRsbLsbRgRsmbLsbRs
bRhRsRsRsmmmbRgbRsbLsRsbRibLsbRibRsbLsbsbRgRsmbRsRsmbLjbRcbLsbLsbLsbLc
bLibRsbRgbLsbLibLgbLgbRsRsmbLgbRjbRgbRibLsbLsLsmbRibRgLsbRibRsbLibRibR
sbRsbLsbRsbRibRibLsbLsbLsbLsbLsRsbRsbRsbLsbRgbLgbRgbRsbRsRgRsmbRgbRsbR
ibRsbLgbLsbRsRsmbRgbRgbRsLsbRgbRgbRgbRjbRibRgbLsRsbLsbRsbRgbRiRsmbLsbR
gbLgbLgbRgbRgbRgbLibLibLibLgbRgbLcbLgbRgbRgbRgbRgbRgbsbLsbLjbLiLsbLibL
iRsbRgbLibRgRsmbLibLiRsbRgbLgLsbRsRsmbRgbRibRgbRsbRibRiRsmbRsbLsbsbLsR
sbRgbRibRgbRsbLjbLsLsmbLsbRibRgbRibRibRibRgbRjRsRsmmbLsbLgbLsbLgbLsbLh
bRgbLibLibLsbRgRsmbLsbLsbLsbLsbLjLsmbLibLsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bLgbLgbLsbLgbLsbLsbLgbLgbLsbLsbLsbLgbLsbLsbLsbLsbLsbLsRsbLsbLsbLgbLgbL
sbLsbLgbLgRsbLgLsbLsbLgbLgbLgbLgbLgbLsbLsbLsbLgbLsbLgbLsbLsbLsbLgbLsbL
sbRsLsbLsbLgbLsbLsbRsbLgbLsbLsbLsbLgbLgRsbLsbRsbLgbLsbLsbLsbRsbLgbLsbL
sbLgRsbRgbRgbRgbRibLsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bLjbLibRibLibLgbRibLgbLgbRsbLiLsbRgbLibRgbLibRgbLiLsbRsbLibLsbRsbLgLsb
RsbLsbLgbRgbLibLgbLsbRgbLibLgRsbLibLsbRsbLiRsbLsbRgbLibLgbLgbRsbRgbLiL
sbLgbRgbLgLsbRsbLibLgbRsbLsbLgbLsRsbLsRsbLibLgbRsbLibLsbRsbLibRgbLibRi
bLibLgbRgbLibLgbLgbRjbLhbsbLgbRgRsLsmbRsLsbLsbLgLsbRcbRibRhbLjbRibLgbR
ibRsbRibLgbRibRhbLgbRibRgbLgbRibLjbRibRgbLgRsbRibLgbRgRsmbRibLibRibRgb
LjLsmbRibLsRibRcbLibRhbLsbRibLjbRibLjbRiRsmbRgbRgLsbRgbRibLjbRibRibLhb
LgbLgbRsLsbLgbLsbLibRhbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bLsLsmbRsbLjbLcLsLsmmbLgbLibLibRjbRibLibLjbLsbRibRsbLibRgRsmbLgbsbLsbR
sLsbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bRjbLjbLhbLibRjRsmbLibRibRjbRjbLjbLhbLhbRgbLibLgRsbRibLiLsLsmbRiRsmbLi
bLgbRibRibRcbLibRjRsmbRebLibRgbLibRibRgbLibRjRsmbLgbLibRibRibRgbRjbLjb
LjLsmbRjbRibRgbRgbRgbRgbRibLgbRibRgbRsbRibRgbLsLsmbRjbRjRsLsmbRibRsbLg
bRibRsbRsRsmbRiLsbRibRibRgbRgRsmbRsbRibLsbLgRsbLsbRgRsmbRibRsbLgbRjRsR
smmbLgLsbRibRiRsmbLgbRgRsmbLjLsLsmmbLibLgbLjLsmbRgLsbLibRjbLibRjRsmbRi
bRibLib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bLgbLcbLcbRibRhbRiRsmbRsbRgbRgbRgbLjbLjbLibRgbLibRgbLibRibLiLsbRgbLibR
gbLiLsbRgbLibRgbLibRsbLgLsbLsbLgLsbLsbLsbLsbLsbLgbLgbLgbLgbLgbLsbLsbLs
bLgbLsbRebRibRcbLgbRibRibRsbRsbRgbRsbRsbRsbRgbLsLsmbRgbRgRsmbRsRsmbRgb
RgbRgbRsbRgbRsbRsbLsbRgbRsbRgbRsbRgbRsbRsbRgbRsbRsbLsLsmbRgbRsbRgbLsbR
gbRgbRgRsmbRsbRsbRsbRgbRgbLcbLgbRsbLgbLsbLgbLsbLgbLgbLsbLsbRsbRhbRibLg
RsbRibLibLibRgbLibRjRsmbLhbRsbLsbLgbLsbLgbLsbLgbLsbLsbLsbLsbLsbLgLsbLg
bLgbLgbRsbLgLsbRsbLsbLibRgbLgbLsbLsbLsbRsbLgLsbLgbRsbLgbLsbLsbLgbLgbLs
bLsbLsbLgbLsbLgbLsbLgRsbLgbLgbRhbRibRibLjbLcbRsbLsbLsbLibRsbLibRgbLibL
sbLgLsbLgbLsbLgbLsLsmbLsbLgbRsbLgbRgRsmbLgbLibLgRsbLsbLgbRsbLsbLsLsmbL
sbLgbLsbLsbLgLsbLgRsbLgbLgbRgbLiLsbLsbLsbLsbLgbLsbLgbLsbLgbRsLsLsmbLgb
LgbRsbLgLsbLgRsbLgLsbLgbLgbLsbLgbLsbLgbLsbLgbLsbLgLsbRsbLgLsbRsbLgbRsb
LgLsLsmbRsLsbLgbRsbLgbLsbLgbLsbLgbLsRsbLgbRgbLibRgbLiLsLsmbRgbLiLsbRsb
LgbRsbLgbRsbLgbLsLsmbLgbLsbLgbLgbLgbLsbLgbLiLsbRgbLibRgbLibLgLsbRgbLib
LsbRsbLgbLsLsmbLgbLgbLgbLgLsbLgbLgbLgbLgbLgbLgbRgbRjbRibLobLcLsmbLcbRg
bRgLsbLibRsbLiLsbRsbLibRjbLibRgLsbLibRgbLibRgbLiLsbLgLsbRgbLhbRgbLiRsb
RibLibRibLiLsbLhbRsbLibLsbLsbLgbRsbLibLibRibLibLsRsbLgLsLsmbLgbRgbLgLs
bLsbLibRibRjbRcbLjbRcbLjbLcbLgbRgbLgbLgbRsRsmbLhbRgbLibRibLibRsbLibRgb
LibLibLsbLsRgLsbLiLsLsmbRsbLibLsbLsbLgLsbRgbLibRgbLiLsbRgbLhbLibRibRjb
RibLebLcbLsbRgbRgbRibRibLjbRcLsbRcbRibRgLsbRgbRiRsmbRiLsbLcbLhLsbRibLi
bRgbLhbRibLibRgLsbLiLsbRgbLiLsbLgLsbRgbLibRgbLcbRgbRibLsLibLibRgRsmbLi
bRibLibLiLsbRibLhbLgbRibLibLgbRgbLiLsLsmbLgLsbRjbLibRgbLiRsLsbLiLsbRiL
sbLiLsbLiLsbRibLhbLiRsbLgLsbRibRgbRgbRibLjLobLgLsbRibLibLibRgbLibRsbLi
bRgbLibRjbLibRgbLibRgbLibRgbLibLibLsbRsbLgbRgbLibRibLibRibLiLsbLgbRgbL
ibLsLsmbLiLsbRgbLhbRgbRsbLibRsbLsLsmbLiLsbRgbLibLgbLgbRgbLgbLgbLibRjbL
iLsbRjbLibRgbLiLsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bLibRjbRhbRgbRiRsmbLibRibRjRsmbRibRgbLjbRibRgbRgbLgbRgbRsbRsbRgLsbRsbR
sbRsRsmbRsbRsbRsbRsbRsbRsbRsbRgbRsRsmbRsbRsbRsbRsRsmbRsbRsbRgbRsbRgbLg
bLibLgRsbRgbLibLgbLsbLsbLsLsmbLgbRgbLgbLgbLsbLcRsbRibRgbLibLgbLsbLgbLs
bLsbLsbLsbLsbLgbLsbLsbLgbLsbLgRsbRjbLiRsbRjbLibRsbLsbLgbLgbRcbRiLsbLjb
LsbLjbRcbRcbLjbLjbLsbLibRebsbRhbLibRsbRiRsmbRgLsbRibRgLsbLibLhLsbLgbRg
bLgbLgbRgbLgbLibLgbRjbRhbRgbRibRgbLibRibLgbRgbRgRsmbRsbRsbRgbRsbRsbRsb
RgbRsbRsbRsbRsbRsbRsLsbRsbRsbRgbRcbRiRsmbLhbLsbRsbRibRgbRsbLgbRsbRibRg
LsbLsbLsbRgbRgRsmbRgbRgLsbRsbRgbLjbsbRibLjbRcbLgLsbLcbLcbRgRsLsmbRgRsm
bLibRibRjbRibRibRgbLibLibLgbLgbLgbLsLsmbLsLsmbLgbLgbLsbLgbLsbLsbLgbLsb
LsbLgbLsbLgbLgbLsbRcbRgbRibLjbRgbRgbRgbLibLcbLibRibLibLsbLiLsbRjbRhbRg
bLjbRcbRhbLjbLgbLibRjbRhbLgbLcbLibRgbLgbRibLibRcbRhbLjbRhbLgbLjbLgbLsb
LsbLgbLgbLgbLsbLsLsmbLsbLsbLsbLgbLsbLgbLsbLsbLsbLgbRjbLibLgbRibLibLsbR
jbRcbRibLgbRibLgbRgbRgbLgbRgbRibLgRsbRibLsRsbRibLjbRsbRgLsbRjLsbRgRibL
gbLsbLgbLibLgbLgbLgbRjbLibLsbLsbsbLsbLgbRsbLgbLsLsLsmmbLsbLgbRsbLsLsmb
LsbLsbLsbLgbRjbLibRjRsmbsbLgbRsbRjbRsRsmbRcbRibLgbRsRsmbRgbRsbRsRsmbRs
RsmbRsRsmbRgbRibLhbLjbLibLgbRsbLgbLsbLgbLgbLsbLsbLsbLgbLsbLsbLsbLsbLsb
LgbLgbLsbLgbLgbRjRsmbLibRjbLibRjbRjRsmbRibLjbRjbRgbRgbRhbLibRhbRhRsmbL
iLsbLgbLgbRsbRhRsmbRibLibRibRibRsbLibRcbRibLgbLibRsbRjbRgbRsbLjbRsbRsR
gbRgbRgbRsbRsbRsbRsbRsbRsbRgbRgbLsbRhbLibLhbLibRjbLibLibLsbRgbRgbRjbRg
bsbLsbRibRibLibLsbRibLgbRibRgbLgbLsbRibRgbLsbRibRgbLgbLsbRibRgbLsbLsbR
gbRgbRsRsmbRgbRgbRsbRsRsmbRgbLsbRgbLibLhbLjbRgRsmbLibRgbLiRsbRjbLjbRjb
RsbRcbRibRibLhLsbRhbLjLsmbRibLjLgbRiRsmbRiRsmbLhbRhbLjbLcbLcbRiRsmbLcb
RjRsmbRibRibLjLsmbRcRsmbLibLibLhbRgbLcbLsRsbRibRjbRhbLgbRibRibRgbLibLg
bLgbRcbRsbRgRsmbRgbRgbRgbRgbRsbLsbLgbRgbLibLgbLjbRgbLgbLgbRsbLgbRobRsR
ibRiRsmbLsbRibRgbRsbLsRsbLgbLsbLiRsbRjbRibRibLjbRhbLibRibLiLsbRsbLcbLg
bRsbLibLgRsRsmbRgbLibLgbLiRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bLgbRibLibRgbLibLsbLsbLgbLgbLgbLsbRgbLgbLsLsmbLgbLsbLsbLsbLgbRjbsbsbLi
bLsbLgbLsbLsbLsbLsbLsbLsbLsbLgLsbLsbLgbLsbLgbRsbRhbRibRgRsmbLibLgbLsbR
jbLjbRebRgRsmbRgLsbLjbRibLgbRibRgbLgbRgbRgbRgbLjbRjbLsRsbRibLcbLobRibL
ibLgbRgbsbLgbRsbLgbRjbLgbLibLibLgbLsbLsbLsbLsbRsbLgbRgbRcbRgRsmbRgbRgb
RgbRsbLjbRgbRgbRgbRsbRsbRsbRsRgbRsbRgbLsbRgbRgbRgbRgLsbRibRgbRibRgbRgb
RgbLibRibRgbLsbLsbLgbRgRsmbRgbLgbRgbRgbLsbRgbRgbLsbLjbLgbRjbRibRibRgbL
jbRibRgbLgbRgbRgbLsbRgbLgbLsbRsbLsbRsbRgRsmbLsbRgLsbLsbRibLgbRgbRgbRib
LgbRgbRgbRgRsmbLsbRgbRibRgbLsbRgbLsbRgbLjbRgbRibLjbRgbRibLgbLcbRhbLibL
ibRgbRsRsmbLgbRhbsbRgbLgbLgbRjbRhbLsbLsbRgbLgbRibRgbRsbRgbRibRsbRibLgb
LgbRibRgbRgbRsRsmbRgbRgbRsbRgbLjbRgRsmbLsbRgRsmbRgRsmbRgbLgbRgRsmbRgbR
gbRgRsmbRgbRsbRgbLgbRibLjbRibLjbRibRsbLsbRgbLsRsbRsbRgbRgRsmbRgbRsbRgb
RgbLsbRgbRgRsmbRgbRgbLsbRgbRgbLsbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bLgbLhbRjbRibRibRgbLibRibRiLsbLebLibRsLsbLsLsmbLsRsbLgbLsbLsLsmbLsLsmb
RsbLibRsbLcbRjbLibLgbLsbLsbLsbLsbLsbLsbLsbLsbRsbLsbRjbLibLibRsbLgbLsbL
sbLsbLsbLsbLgbLgLsbLsbLsbLgbLibRebLcbLgLsbRsRsmbRgbLgbLgLsbLgbLgbRsRsm
bLsbLgbRsbLgbLgLsbRsbLgbLsbLgbLsLsmbLgbLgLsRsbRsbLgbRsbLgbLsbLsbLsLsmb
LgbLsLsmbLsbLgbRgbRcbRibLsbRgbRgbRiLsbLjbLhbLibRgbLsbLgLsbRcRsmbRiRsLs
mbRibLgbRibLgbRibLcbLibLsbLhbRjbLgbLgbRsbLgbRsbLgbLsbLsLsmbLsbLsbLgRsb
LgbLgbLibRcReLcbLgbRsLsbRgbRibLjbRibRsRsmbRibLjbLobLcbLsbLsbLgbLsbLsbL
sbLsbLgbLsbLgbLsbLibRjbRcbRibRgbRgLsLsmbRgbLcbLebRibRgbLhLsbLibRsbLibR
sbLgbRsbRebRibLjbRgbRgbRgRsmbRgbRsbRgbLebLcRsbRibLjbLibRgLsbLibLgbLsbL
ibLsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLsbRsLsbLsbLsLsmbLgRsbLgbLgbLsLsmbLsbL
sbLsbLgbLsbLsbLgbRsbLgbRgbLgbLsbLgbLsbLsbLsbLsbRsLsbLgbRobLsRsbRsRgbRs
bRsbRgbLgbRgbRgRsmbLjLsmbRgbLcbLibLsbLsbLgbLibLgbRibRcbRibRibRiRsmbRgb
RgbRsRsmbRsbRsbRgRsmbRsRsmbRgbRsbRgbLjbsbLcbLiLsbLsbLsbLibLsbRsbLgbLsb
LgbRsbLgbLgbRsbRjbLibLsLsmbLsbLgbLsbLsbRsbLgbLgbLsbLsbLsRsbLgbLgbLgbLi
bLgbLsbLsbsbRjbRibLsbRgbRgbRcbLibLibLsLsmbLiLsbLgLsbLgLsbLsbLsbLsbLgbL
sbLhLsLsmbRjbRcbLjRsbRibRsbLcbLibRsbLgbLhLsbLgbLgbRjbLibRjbRcbRhbLibRi
bLcbLgbLsbLsbLgbRcbLjbLcbLgbLsbLgbRibRcbLsbRgbRgbLgbRsbRgbLibLibLhbRhb
RcbRibLiLsbRibRgbRibLcbLibRibRsbLibLsbLgbLsbLsbLsLsmbLsLsmbLsbLsRsbRcb
RibLjbRiRsmbRgbLjbRibRibRsbRgRsmbLsbRgbRsbRsbRsLsbRsbRsbRgbLgbLsbRsLeL
ibLsbLgbRjbLibLhbRcbLcbRgbLiLsbLsbLsbLsbLsbRsbLgbLsbLsbRsLsbRsLgbLsRsb
RsLsbLgbLsbLgbLgbLsbLsbLgLsbLgbLgbLsbLsLsmbLsbLsbLsbRgbLgbLibRsbLibRjb
RebRhbLibRibLcbLibLgbLsbRsbLgbLsLsmbLsRsbLgbLsLsmbLsRsbLgbLsbLgbLsbLsb
LgbRsbLgLsbRsLsbLgbLsbLsbLgbLgbRgbLgbRsbLgbLjbLgRsbRiRsmbRcbRiLsbRgbRs
bRibRgbRibLhbLibRcbLhbRjbLcbLgbRsRsLsmbLgbLgbLgbRsbLgLsbLsbLgbRsLsbRjb
LcbRhbLebLibLhb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bLgRsbRcbRibRjRgRsmbLsRsbLgbRibRsbRgbRsbRgbLjbLjbLiLsbLibLgbLgbLsbRsbR
sbRgbRibRibRgRsmbLjbRsbRsbRsbRsbRgbLsbRiRsmbLgbRhbRibRsbLsbRibLsLsmbRg
RsmbRsbLsbRibLgbRiRsmbLsbRibLjbRibLgbRibLgbRibLgbRibRsbRsbLgbRebRjbRib
RsbLgbLgLsbLgbLsRsbLibLgbLgbLgbLgbLibLhbLgbsbRhbLgbRgbRibLgbLgbLibLcbL
ibLhbLibLgbLhRsbLcbRsbRjbRcbLjbRibRgbLgbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bRgbLsbRsbRsbRsbRgbRibRsbRgbRibRibLgbRibLibRgbRibRgbRgbRsbRsRsmbRsbRsb
RsbRgbRgbRsbRsbRsbRsbLsbRsbRsbRgbRsRsmbRsbRsbRsbRsbRsbRgbRgbRsbRsbRsRs
mbRsbRgbRgbLcbLgbLgbRsLsbLsbLsbLsbLsbLsbLsbLsbLsbLgRsbLsbLsbLsbLsbLgbR
sbLjbRcbRgbRgRsmbRgbLsbRgbRsbRsRsmbRsbRgbRibRgbLjbRibLjbRhbLcbLebRibRg
bRgbRgbRsbRgbRsbRsbRgbRsbRsbRgRsmbLsbRgbLsRgbRsbRgbLcbLebLibRgbRiRsmbR
ibRibRgbLibRgbRibRibLsbLsbRsbRgbRgbRgbRgbRsbRsbRsbRsbRsbRsRsmbRsbRgbRs
bRgbRsbRsbRsbRsbRsbRgbRsbRgbRsbRsbRgbRsbRsbLsbRgbLhbRibRgbRgbRsbRgbLcb
LiLsbRebRiRsmbRgLsRsbLibRibRsbRgbLsbRgbLsbRgbRsbRsbRgRsmbRsbRgbRsbRgbR
gbRgbRsbRgbRsbRsbRsbRgbRsbRsbRgbLcbRibRibLsbLsRgbLsbRgbLsbRsbRgbRsbRsb
RsbRgbLsbRgLsbRsbRgbRsbRsbRgbRsbRgbRsbRsbRgbRsbRgbRsbRgRsmbLsbRgbLsbRg
bLsbRgbRsbRgbRsbRgbRsRsmbRsbRsbLsbRgbRsbRsbRsbRsRsmbRsbRsRsmbRsbRsbRgb
RsbRgbRgRsmbLcbLgbLgbLgbRjbRjbRibLibRibLsbLcbLibLsbLgRsbLhbRhRsmbLgbLi
LsbLgbLcbRgbLibRsbRsbRsbRsbRgbRgbRsbRsbRgbLgLsbRiRsmbRibRhbLibRibRibLi
bRhbRibRibRiRsmbLibRiRsmbRsLsbRibRgRsmbLiLsbLiLsbLibLhbLebRgbLgLsbLibL
iRsbLgbRibRgbRsbLibLgbLibRjbRcRsmbRibRsRsmbLgbLgbLsbRsRsmbLsbRgbRibRsb
RsbRsbRsbRgbRibLhbRgbRibLcbLsbLsLsmbLiLsbLsbLgbLgbLsbLsbLgbLsLsmbLsbLg
bLsbLsbLsbRsbLgbLsbLgbLsbLsbRsbRjbRhRsmbRsbRgbRsRsmbRgbRsbRsRsmbRgbRsb
RsbRgbLgbRgbRgRsmbRiRsmbLgbRgbRsbRgbLsbRgbRgbRsbRsLsbRsbRgbLgbRgbRsbRs
RsmbRgbRsbRgbRgbRsRsmbRsbRsbRsRsmbRsbRsRsmbRgbRsLsbRsbRsbRsbRsbLsbRsbR
gbRsLsbRgbRsbRsbRgbRsbLjLsmbLibLgbLibRjbRjbRhb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bRsbRibRsbRsbRgbRsbRsbRgbRibLhbLjbLsLibLibRcbRcLsbLjbLibLibRcbRibLsbRg
bRsbRgbRgbRgbLsbRgbRgbLsbRgbLhbLibLgbLsbRjbRibLobRsbRgbRgbRsbRgbRgbLcb
RjbRcbLibLcbLiRsbLibLhbRgbLibRibRsbRibRhbLgbLsLsmbRibLsbRgRsmbRsbRgbRg
RsmbLgRsbRsRsmbRgbRgLsbRsbRcbRsbRgbLsLsmbLibLcbRsRsmbLibRcbRibRgbRsbLs
bRibRibRsbRgbRgbLjbLcbLibRjbLibRcbRcbLgbRcbRsRsmbRgbRsbRgbRgbLcbRhRsmb
RiRsmbRsbRsbRgbLsbRgRsmbLcRsbLgbRsbRcRsmbRibRgbRsRsmbRsbRgbRgbRgbLsbRg
bLgRsbRgbRsLsbLsbRsbRgLsbRiRsmbRgbRsbLsbRibRsRsmbRsbRsbLsbRsbRgbLjbLcb
LsbLibLsbLgbLgbRibRcbRibRsRsmbRsbRsbRgbRgbRgbRgbLjbLcbLibLibRjbLhbRcbL
cbRibRcbLebRjbRsbRcbRibLsRsbRgbLsbRgbLgbRiRsRsmmbLsbRsbRgLsbsbRibRsbLg
bRsRibRsbRgRsmbLgbRgbRgbLjbRgLsbRgRsmbRsbRsbRgbRgbRsbRsbRgbRsbRsbRsbRg
bRsbRsbRgbLgbRiLsbLjLsmbLhbLibRjbLibLibLcRsLibRgbRsRibRgLsbLcLsmbLibRj
bLcbRcbRcRsmbRgRsmbLsRgbRsbRsRsmbRsbRsbRsbRgbLhbLibRgbRcbRgbRsbRsbRgRs
mbRgRsmbRsLsbRgbRsbRgbRibLjbLcbLhbRcLsbRibRsbRgbRgbRsRsmbRsbRgbRsRsmbL
hLsbLibRgbLhbRhbLibRjbRjbRiRsmbRiRsmbRsbRgbRsbRsbRgbRsbRsbRsbRsbRgbLcL
smbLibRgbRcbRiRsRsmmbRsbRsbRsbRgbRgbLgbRgbRsbRsbRgbLjbLhbLibLsbLgbsbLi
bRcbRcbRiLsbLsbLsRsbRgbRgbRiRsmbRsbLjbRibRgbLsbRsbRsbRgbRsbRsbRsbRgbLj
bRibLjLsmbLhbLgRsbLsbRcbRibLibRiRsmbRgbRsRsmbRsbRgbRibLjbLcbLsbLgbLgbR
cbRibRsRsmbRgbRsbRsbRsbRgbLgbRgRsmbRsRsmbRsRsmbRgbLsRsbRgRsRsmmbLsbRgb
RsbRsbRsRsmbRsbRsbRsbRgbRgbRsbRgbRsbLjRsbRibRgbRsbRiLsbLibLjbLibLsbLgb
LgbsbLibRcbRhRsmbLibLibRhbRcbRsbRgbLsbRhbRsbRsbRgbRgbRsbRsbRsRsLsmbLsb
RgbLgRsbRgbRgRsmbRgbRgbRgbRgbLcbLiLsLsmbLgbLgbLgbRcbRibRgbRsbRgbRgbRsb
RsbRgLsbLgbRgbRsbRgbRgbsbLcLsmbLibLibRjbLhbRjbRcRsmbRgbRsbRsbRsbRsbRsb
RgbRsRsmbRgbRsbRsRsmbRgbRgbLhbLibLgbRcbRgRsmbRsbRgbRsbRsbRgbRsbRsbRsbR
sbRgbLjbLcbLiLsbRsbRsLibRcbRcbLsbRgbsbRgbRsbRgbLsLsmbRgbLcLibLsbLgRsbL
gbRjbRcbRsLsbRibRsRsmbRsbRsbRsbRgRsmbLsbRsbLsRgbRsbRsbRsbRsbRgbsbRsbRs
bRgbRsbRsbRgbRsLcbLhLsbRhRsmbRhbRgRsmbRgbLsbRgbRsbRsRsmbRgbRibLibRibRs
bRsbLsbRsbRgbRsbRsbRgbLgLsbRibRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bLjbLcbRsLiLsbLsbLgRsbRgbLibLsLsmbLibsbLsbLgbRcbLgRsbRibRgbLgRsbRgbRsb
RsbsbRsRsLsmbLsbLsLsmbRgLsbRsbRsRsmbRsbRsbRsbRgbRgbRgLsbRsbRsbRsbRibLg
bLjbRibLsbLsbRsbRgbLsbLsbRibLgbRibLsRibLgbRibLgbRsbRgbRsbRsbRsRsmbLsLs
mbLsbLibLibRcbRcbsbRcbLibRibLjbRibRgbLsbRgbRsbRsRsmbLsbRgbLsbRibRsbRsb
RsbRgbRsLsbLsbLsbsbLhbRcRsmbRgRsmbRsRsmbRgRsmbRsbLsbRgbRgbRsRsmbRsbRsb
RsbRgbRsbRsbRsbRsbRgbRsbLgbRgbRgbRsbRsbRgbLsbRgRsmbLcbLibLibRhbRibLgbR
ibLgbRgRsmbRsbRgbRsbRsRsmbRsbRsbRgbRsbRgbRsbRsbRsbLsbRibLsbRgbLsbRgbRg
bRsRsmbRsbRgbRsbRsbRsbRgbLsbRibLjbRibLjRsbLcbLibLiRsbLibRiRsmbLibRibRg
RsmbRgRsmbRsbRsbRgRsmbRsbRgRsmbRsbRsbRsbRsLsbRsbRsRsmbRsRsRsmmbRsRsLsm
bRjbLsRibRgbRibLibsbRgbRsbRsbRibLjbRibLibRhRsRsmmbRibsbRgbRgbRsRsmbRsb
RsbRsbLsbRgbRsbRsbRgbRsbLjbLeLsbLgLsbLsbLibRcbLsbRibRgLsbLibLibLibRhbL
cbRiRsmbRhbRcRsmbLsbRgRsmbRgbRiRsmbRsbLsbRgbLsbRgbLsbRgbLgbRgbRibLgbRi
RsmbRgRsmbRibLgbLibLgbLgbLgbLsbLsbLgbLgbRjbLibRjbRibRiRsmbLsbRgbRsbRgb
LgbRgbRjbLjbLcbLibRgbLibRcLsbRibRgRsmbRsbRgbRgbRgRsmbLibRhbLibRgbRgbLg
bRibRsbLgbRibRgbLsbRsbRgRsmbLsbRgRsmbRsbRsRsmbRgbRsbRgLsbRsRsmbRsbRgbR
gbRgbLgbRiLsbLibRjRsmbRhbLjbRibLgbRsbRgRsmbRsbRgbRsbRsRsmbRgbRgLsbRsRs
mbRsbRgbRsbRsRsmbRgbRgbRsbLsbRibLsbLgbRibRsbLsbRgbLgbRiRsmbLjbRibRgbRs
bLsbRibLsbRibLgbRibLgbRibLjbRibLgRsbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bRcbLobLcbLgbLsLsmbLsbLsbLsbLgbRgbLibRhbRjbRibRsRsmbRsRsmbRgbRgbRsbRsb
RgbRgbLsbRgbRgRsmbLsbRibLcbLobLibRsbLgbLsbLgLgbLgbLgRsbLibRjbRobRhbLgb
LsbLsbRsbRsbRgbRsRsRsLsmmbRsbRsbRsbLcbLgbLsbLgbLgbLsbLsbLsbLgRsbLgbLsb
RsbLgbLgbRcbRgRsmbRgRsmbRsbRsbRgbRsRsmbRsLsbRsbRsbRsbRsbRsbRgbRgbLcLsm
bLgbRsbLgbLgbRsbLgLsbLsbLsbLsbLsbLgbLgbRsLsbLgbLsbRgbRsbRgbRsbRgbRsbRs
bRsbRgLsbRcbRibRsbRibRgbRsbRgLsbRgbLgbRiRsmbRibLjbLhbLsbLgbLgbLsbLsbLg
bLsLsmbLsbLsbLgLsbLsbLsbLgbLgRsbRcbLsbRhRsLsmbLsRsbRsbRsbRgbRsRsmbRgRs
mbRsbRsbLsbRsbRgbRcbRoLsbRibRibRgbLgbRiLsbLsbLsLsRsmbRibLsbRgbRsbRgbRi
bLgLsLsmbLgbLgLsbRsbLgLsbLsbLsbLgbLgbLsLsmbLsbLsbRgbLgLsbLgbRsbLjRsbRe
bRibLsbLsLsmbRjbLibLgbLsbLsbLsRsbLgbLgLsbLsbLsbLsLsmbRsbLsbRcbLsbRgbLs
bRibLibLibLgbRsbLsLsmbLgLsbRgbLjbLsLsmbRgRsmbLsbRgbRgbLgbRgbRgbLsbRgbR
sbRsbRgbRjbRsbLsbLobRsRsmbRsbLibLgbLsbLsbLgRsbLgbLsbLsbLsLsmbLsbRgbLjb
RibRcbRsbRgbLsbLgLsbRgbLibLibLsbLgbLsbLsbRgbLgbLsbLsbLsbRibRobLsbLgbRj
RgbRgRsmbRsbLgbLgbLgbLsbLgbLgbLsbLsbLsbRsbLgbLgLsbLgbLsLsmbLgbLsbRgbLg
bRgbLhbRibLibLibRibRebRsbRgbRsbRgbRsbRsbLjbLcbLgbLgbRsbRjbRgLsRsbLcbLs
bRgbLibLgbLsbLsbLgbLgbLsbLsbLsbLsRsbLsbLsbLgbLsbLgbLsbLsbRsbLibRsbLgbL
sbLgbLgbLgbsbLgRsbLgbRgbRcbRebLsbLibRjbLgbLgLsRsbLgbRsbLsbLgbLsRsbRsbL
gbLsbLsbLsbLsbLsbLsbLsbLsbRgbRebLcbLibLibRibLhbRgbLibRsbLjbRsbLsLsmbLs
bLgLsbRgbLgbLjRsbRsbRsbLsbLibRgLsbLibLgbRgbLcbRibRjbRhbRjbRsbRgbRsbLgb
LobLgbLgbRsbLgbLsbLgbLgbRsbLgbLgbLgbLsbRsbLsbLsbLsbLsbLsbRsbLgbLsbLsbL
sbLgbLsLsRsmbLgLsLsmbRjbRcbLibLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 120959; End: 121459;
Recording: 2-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bRcbRiRsmbLibLsbRhbLjbRibLgLsbRiRsmbRsbRibRgbLsbRcRsRiRimbLiLsbRhbRhbL
gbRobRgbLgbRibRgbLgbRgbRgbLgbRgbRgbRsbLsRsRsmbRgbRgbRsbRgbRgbRgbRsbRgR
sRgRgmbRgRsmbRgbLsbLjbLhbRcbLcbLhbRjbRhRsmbRibLcbLhbRsbLibLibLibLhbLib
LibLibLgbLgbRibRgbRcbRsbRgbRsRsmbRgbRsbRsbRgbRgRsmbRgRsmbRgbRgbRgRgRgR
smbRgbRgbRiRsmbRiRibRgbRgRsmbRgbRgbRgbRgbLhbLibRjbRhbLhbLibRjbLibRcLsb
RcbLhbRcbRsRsmbRgRsmbRsbRsbRgbRgbRsRsmbRsbRsbRsRhRsLsRiRhmbRgbRsbRgbRg
RiRsRsmmbRgbRgRsmbRgRgRsRgRiRsmmbRgbRgbRgbRgbRgRsmbRsbLjbLibLibRjbLhbR
cbLcbLibLcbLcbLhbLibRgbRjbRhbRcbRibRibLibRibLgbRcbLsbRgbRsbRgbRgRsRgRi
RiRimbRiRsRsmmbRgbRgRsmbRhRiRhRibRgbRgbRgbLobRcLsbRcRsmbsbRibRiRsmbLiL
sbRcbRibLjbRcbLibLibLibRjbLibLibLgbRjbLhLsbLgbLgbRibLibLibRgbRcbLibLib
LibLgbLgbLgbLsbRhbRibLgbRibRibLgbLjbRcbLibLibLibLobLibLebRgbRibLsRsbRi
bRsRjbLsbRgbRsRsmbRsbRsbRsbRgRsmbLsbLhbRcbLjbLhbRcLsbLhRsbLsbLhbLhLsbL
ibLsbLgbRibRgbRiRsmbRibLjbRibLjbLiLsbLgbRsbLgbLgbLgbRjbLiLsbLibRibRcbR
ibRiLsbRibLsbRgLsbRgbRiRsRgmbRgRsRgRiRsRsRiRsmmmmbRgRsRsmmbRgbRgbLsbRg
bRgRsmbRgbRgRsRsmmbRgRsmbRsbRsRsmbRgbRgbRgRsmbRgbRgRgbRgbRgbRgbRgLsbLs
bRgRsmbRibLjbLcbRcbRibLcbLcbLibLibLibRibLsbLgbLgbLsLjbLgbLibLsbRgbLjbL
gbRgbRgbRgbRgbRgLsbRgbRsbRgbRgbRgbRgbRgbRgbLsbLhLsbRjbLibLiLsbLgbLibRe
bRhRsmbLhbLibLgbRcbRcbRibLsbRibRiLsbLgbRcLsbLibRcbRibRcbRgLsbLgbLibLib
LgbLibLibLgbLibRgbRgLsbRgbLcLibLibRibLsbLhbRgLsbLibRsbLsbLgbLsbLgbLiRs
bRcRcbRgbRgRsmbRsbRsbLsbRgRsmbLsbRgbRgbRsbRsbRgbRsbRsRsmbLsbRsbRgbRsbR
gbRgbRsbRsbRsbRsbRsbRgRsmbRgbRsbRsbRsbRsLsbRgbRgbRgbRsbRsRgbRsRgbRiRsR
gRsmmbRibRgbRibRgRsmbRsRsmbRgRsmbRgRsRgmbRgbRgbRgbRgRsRgmbReLsbRgRsmbR
sbRgbRgbRgbLjbRibLcbLhbLibLibLhbLibLibLgbLibRgbLgbLgbLgbLibRhbLgbRibRc
RsmbRibLjRsbRgbRsbRgbRsbRgbRgRsRsmmbRgbRsRsmbRgRgRsRsRgRsmmmbRgRiRiRgb
RibRgRgRiRgRiRgRsmbRsRgRsRiRsmmbRiRsmbRgbRsbRgbRgbRsbLcbLsLhbRcbLcbLhb
RhbRcbLjbLiLsbLhRsbRiLsbLiLsbLgbLcbLibLgbRgbLgbRibLsbRibRgbRibRgbRibLg
bLgbLgbRgbLibRjbRcbRsRsmbRsRsmbRsbRgbRsbRsbRgbRgRsmbLsRsbRsRgbRgbRgRgR
sRgReRsRhRgmmbRgbRgbRsbRsbRsbRsbRsbRgbRsLsbRgbLsbRgbRgRsmbRsRgbRgRiRiR
gbRiRiRgRsmbRibRgRiRsRiRgRiRsmmbRgbRsbRgbRgLsLsmbsbRibLjbRibRcbRcbRibR
ibRiRsmbLjbRsbRibLjbLcbRcbRcbLibRcbLjbRhbLibRibRsbLsbRibRibLjbLibRjbRi
bRibRgRsmbRsbRsRsmbRsbRsbRgbLsbRgRsRsmmbRgLsbRgbRsbRsbRsbRgRsmbRgbRgbR
sbRsbRgbRgbRsbLjbLjbRhbRgRsmbRsbRgRsmbRsbRgbRgRgRgRsRgRimbRibRgbRgRsmb
RgbLsbRgbRibRibLjbLcbRjbRiRsmbRgbLsLsmbRgbRjbRsbRsbRsLsbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 1; Drug: Control Apo 0.5 然
bLgbLsLsmbLgbLgbLgbLgbLsbLgbLgbLgbLsbLgbLgbLsbLgbLgbLgbLgbLgbRgbLibLgL
sbLsbLgbLgbRjbRcbLebLcLsmbRibLcbRsbRjbLcbLibLiLsbRgbLgbLgLsbLgLsbLgLsb
RjbRcbRcbRibRcbRiRsmbRibRgbRibRgbRsbRsbRgbRgbLsbRgbLgbRibLgbRibLsbRiRs
mbRgbLgbRgbRsbRgRsmbRibLiRsbLjbLjbLgbLibRjbLibRjbLhbRgbLibLsLsmbLgbLgb
LsLsmbLgbLsbLgbLgbRjbRcbRibRibRhbLsRsbLibLobRibLibLcRsRsmbRsbRsbLibLsb
LgbLsLsmbLgLsbLgRsbLsbLgbLgbRsbLgbLsbLsbLgbLsbLgbRebRhbLgbLcbLcbRgbLib
RgbRjbLibLgbLgbRsbLgbLgbLgbLgbLgbLgbLsbLsbLgbLgbRsbLgbRobLjbLibRgbLibL
gLsbLsbLgbLsbLgbLsRsbLsbLgbLgbLgbLgLsbLgbLgbLsbLgbLsbLgbLgbRhbRcRsmbRh
bLgbLibRhbRgbLgbLcbLgbLsbLgbLsbLgbLgbLsbLsbLgbLsbLsbLgbLgbRjbRcbRibLgb
RibLsbRgbRsbRgbLcLsmbLibRibRjbRiRsmbRibRsbLsbRsRsmbRsbRsbRgRsRsmmbLsbR
gbLsbRsRsmbRgbRsRsLsmbRsbRsbLsbRgbRgbRgbRsbRgRsmbLsbRibLcbLoRsbRibRcbL
sbRiLsRsbLgbRsbRsbRsbRsbLcbLiLsbRgbLgbLgbLgbRjbRcbRgbRgRsmbRgbRgbRgbLi
bLjbLibLsbLgbLgbLgbLsLsmbLsRsbLsbLsbLgbLsbLsbLgbLgbLsbLsbLsbLgbLgbLsbL
sLgbLgbLsbLsbLsbLiRsbRhbLiLsbRsbLibLsbLibLsbLgbLgbLgbLgbLgbLgbLsLsmbLs
RsbLsbLgbLgRsbLsLsmbLgbRsLgbLsLsmbLobRcbLgbRgbRgbRgLsbRhbRibRibRibLcbL
gbLgbLgbLsbRsbLgbLgbRsbRsbLgbLgbRgbLiRsbRibLibLibRjbLcRsbRgbLibLgbLgbR
ibsbLgLsbLgbRsbLgbLsLsmbLsLgbLgLsbLsLsmbLsLsmbLgbLgbLsbLgbLsbLibLsLhbR
hRsmbRebRhbLgbRiRsmbLgbLcbLgbLsLsLsmmbLgbLsbLgbRgbLgbLgbLgbRsbLgbLsbLg
bLgbLgbRsbLgbLoRsRsmbRebLibLobRhbLjbLiLsLsmbLgbRjRsmbRcbsbsbRiRsmbLsbR
gbLcbLgLsbRsbLibLgbLsbLgbLsLsmbLsLibRibRjbLobLgbRgbLgbLgbLsbLsbLgRsbLg
bLsbRsbsbLobRcbLcbLibRibLgbRsbRsbRgbLcbLcbRibRgbLsbRsbRobLgbLgbLsbRsbL
gbLsbRibRibRjbLibLcbsbsbLibRgbLgbLsLsmbLgbLsbLgbLgLsbLgLsbLgRsbLsbLsbL
gbLsbsbLsbLgbLsbLgLsbLsbLgbLsbLsLsmbRsLsRsbLsRsbLsLsLsmmbLsLsmbLgbLsLs
LsmmbLgLsbLgbLsbLsLgLsLsmbLsbLgbRsbLsLsmbLsbsbLsLgbLsbLgbLgbLgbLsbRjRs
mbRobRibRibLibLibLibLgbLgbRsbLgbLsbLgbLsbLgbLgbLsbLgbLsbLgbLgbLgbLgbLs
bLsbRgbLibRgbRjRhbRibLibRsRiRsmbRibLjbRhbRibRibLgbLibLibLibLsbLsbLiLsb
LsLsmbLgbRsbLibRjbRebRibLibLibLhbLgbLsbLgRsbLsbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 2; Drug: Control Apo 0.5 然
bLhbLibLsbRsbLsbLgbLgbRsLsbRjbRcRsmbRsRgbRgbRgbRgbRsbRgbRsRsmbRgLsLsmb
RgbRsbRgbRgbRsbRgRsmbLsbRgRsmbLjbRhbLjbRibRgbRsbRsbRiLsbRsbRiRsmbRsbRg
bRgbRsbRgbRgbRsbRgRsmbLsRsbRibLsbRiRsmbLsbRsRgbRsbRgbRsbRgbRgbRgRsmbRg
bRgbLsbRibLcbLiRsbRjbRcbRibLibRibLsbRgbRhLsbLibRibRgbRgbRsbRsRsmbRsRsR
smmbRsbRgbRgbLgbRgbRgbRgbRgbRsbRsbRgbLsbRibLgbRibLjbLcbLsbLgbRsbLibRcb
RgRsmbRibRgbRsLsbLibLibLibRibRcbRgbRsbRsbRgbRsbRsRsmbRsbRgbLsbRgbLsRsb
RsbRsbRgbRgbRgRsmbLsbRibLsbRgbRgLsbRgRsmbLsbRgbRsbRgbLsRsRsmbRsbRgRsLs
mbRsbRsRsmbRsbRsbRgRsmbRgLsbRgbRsbLgbRibRgbRgbLobLibRibLiLsbLsbLibLcLs
mbRsbLsbLsLsmbLjLsmbLebRgbRjRsmbRjRgbLeLsbLebLebLhbRibRebRhbRibRsRibRg
LsbRsbRgbRibLjLsmbRibRgRsmbLjbLebLgLsbLsbLsbLgbRsbLsbLgbLgbLibRjbRcbRi
bLsbRgbRgbRgbLjbRibLjbRibRsbRgbRsbRgbRgbRsbRsbRsRibLjbRibLgbRibRcbLhbL
cbLgbRsbRsRjbRobLiRsbLhbRcbRgbRgRsmbRgLsbRgbRgbRgbRgbLsbRgRsmbRiRsmbRi
bLcbRibRebLebLcbRibLhbRjbRcbRsbRgbRgbRsRsmbRsbRgbRgbRgRsmbRgbRsbRgLsbR
sbRgbRgbRgRsmbLcbLibRcbRibRibLeLsbRibRgbLgbRibRgbRsbRgbRsRsmbRgbRsbRgb
RsRsmbRgbRgbRsbRgbRgRsmbRsRgbLgbRibLjbRibRsbRgbLsbRibRgLsbLibRibLsbRgb
RgbLsbRgbLsRsbRgbLsbRibRsbRgbRgbRgbRsbRsbRgRsmbLsbRgRsmbRgbRibLibLcbLg
bLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 3; Drug: Control Apo 0.5 然
bRjLgbLgbLgbLgbRjRsmbRjbRsbRgLsbRgLsbRgbRsbRgbRibRsbRsbLgbRgbRibRgbLgb
RgLsbRgbRsbRsbRsbLsbLsbRgbLsbRsbRibRsbRsbRgbRibRsbRgbRsbLibLgbLgLsbLgb
LsbLsbLsbLsbLiRsbLgbLgLsbLgbLsbLiLsbLibLib

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 4; Drug: Control Apo 0.5 然
bLibLgbLjbLgbRibLgbLgbLibLhbLgbLgLsbLibLgLgbLgbLjLsmbRhbLgbRjbLjbLibLg
bLibLgbLsbLibRsbRibRibRjRsmbLibLjbLjbRjbRibRjRgbRjbLibLgbLibLiLsbLgbLg
bLgbLgRsbLjLsLsmmbRsbLgbLgbLsbRsbRgLsbRsbLjLsmbRjbRibLgbLcbLibLgbRsLsb
LibLgbRibLjbLibLgbLsbLgbsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 5; Drug: Control Apo 0.5 然
bsbLcbLcbLcbRcbLibRibLibLibRcbLcbRjbLsbLgbLgbLgbRebRibLgbRibLgbRibsbLj
RsLiLsbLibRjbLibLiRsbRsbLgbRsbLsbLgbLgbRobRsbRgRsmbRsRsmbRsRsmbRgbRgbR
gbRsbRgLsbRsRsmbRsbRsbRsbRsbLsbRsbRsbRgbRgRsmbRgLsbLsRsbRsbRgLsbRgRsmb
RsbRsbRsbRsbRgbLgbRibLhbLcbLgLsbLsbLgLsbLgbRcbRgbRsbRgRsmbRsRsmbRgbRsb
RgbRsbRgbRgbRsbRgRsmbLgbLcbLcbRcbLcbLibRhbLjbLibRibRgbRibRgbRsbRgbRgbR
gbRgbRsbRgbRsbRsbRgbRsRsRsmmbRgbRgbRgbRsbRgbRgbRgbLsRsbRgbLsbRiRsRsmmb
RgbRgbRsRsmbRsRsmbRgbRsRsmbRgbRgbLibRhbLibLcLibLsbLibRcbRgbRsbRgbRgbRg
bLgRsbLjbLhbRibLibLiLsbLsRsbLgbRsbRsRhbRiRsmbRsbRgbRgbRgRsmbRgbRsbRgRs
mbRsRsmbRgbRgbRgbRsbRsRsmbRsRsmbRsbRsbRgbRgLsbLhbRibLcbLobRibLibRebLcb
RcbRhLsbLcbLobLibRibLibRjbLibRcbRibLjbLhbLibLgbLgbRgbLibRjbLibLgLsbLgb
LsLgbRebRobLjbLcbRjbLibLibLsbLgbLsbLgbLsbReRsmbRgbRgRsmbRsRsmbRgbRgbRs
bRsbRgbLsbRgbRgbRsbRsbRsRsmbRsbRgbRsbRgbRsbRgbLjbLibRcRsmbLcbLcbRcbLcb
LgbLgbRibLibRcbLcbLibRiLibLgbRibRcbRgbRgbRgRsmbRsbRgRsmbRsbRjLsbRgbRsb
RsbLgbRiLsbLebLibRjbLgbLgbLsbLsbLgbRgbLgRsbLgbRcbRgRsmbRgbRsbRsbRgbRgR
smbRgbRibRsbRgbLgbRibRgbRgbRsRsmbRgbLsRsbRgbRsbRsbRgRsmbRsRsmbRsRsmbRg
bRgbRsbRsLsbRgbRgRsmbRgbRgbRgbRgRsmbLebLcbRibLibRebRibRgbRgbRsbRgbRgRs
mbRgRsmbRsbRgbRsbRgbRsbRgbLsbRibLjbLcbLiRsbRcbLcbRcbLcbRcbLibLibLhbRib
LibRjbRcbLcbLcRsbRjbLgLgbLgLsbLsbRhbRgbRgbRgbRgbRgbRgRsmbRsRgRsmbRgbRs
bRgbLgbRgbRgbLsbRsbRgbRsbRsbRgbLsRsbRgRsmbRsbRsbRgbRgbRsRsmbRgRsmbRsbR
gbLcbLcbRibLibRgbLiLsbRsLsbLgbRcbRsLsbRibLsbRgbRgRsmbLsbRgbRsbRgbRsbRg
bRgbRgbRsRsmbRgbLgbRibLgLsbLebLgbLibRhbRobRgbRgbRgbRsRsmbRsbRgbRsbRgbR
gbRibLgbRsbRibRgbLsbRgLsbRgbRgbRsbRsbRsRsmbRgbRsRsmbRsbRgbRiRsmbRgbRgb
RgRsmbLsbRgbRsbRgLsbRsbRsbRsbRgbRgbRsbRgbRsbRgbRsbRgbRsbLsbRgbRgbLgbLh
bRcbRibRgbLjbLjbRoLsbRibLsRsbLcbLcLsmbRhbLcbRgbLgbLsbLgbLgbRsbLgbRcbRc
bRsLsbRgbRsbRsbLsbRsbRgbRsbRsbRgbRsbRsRsmbRgbRsbLgbRiRsmbLjbLcLsmbLibL
ibRjbLibLibRhbLiLsbLgbRcbLebLibRhbLibRjbRhbLhLsbLibRgbLibLgbLgbLsLsmbL
gbRoRsmbRgbRsRgbRgbRgbLgRsbLhbLibRibLiRsbLgbRjbRcbRibLjbLiRsbLibRcbRcb
RgbLgRsbRibLsbRsbRgbLsRsbRgbRsbLsbRibRiRsmbLebLcbRebRcbLibLcbRjbLcbRsb
RgbLgLsbsbLsbLgbLsbLgbLgbLgbLsbRcbRibRsbRgbRsbRgbRgbRsbRsRsmbRgbRgbRsL
sbRgRsmbLcbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 6; Drug: Control Apo 0.5 然
bLgLsbRsbLibLibLsLsmbLsbLsbLgbLsLsmbLgbRgRsmbRgbLsbLgbLgbsbRsbLsbRgbLg
bLsbLsbLsbLsbLsbLsbLsbLgbRgbRsbLgbLgbLsbRsbRgbRgbLgbLsbLsbRsbsbLgLsbLg
bLsbLsLsmbRsRsmbLgbLsLsmbLsbLgbLsbRgbsbsbLsbLsbLgbsbLsbLsLsmbsbLsbLsbL
gbLsLsmbLsbLgbLsbLgbLsbRgbLjRsbLsbLgbRgbLibRibLjbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bLgbLiLsbLibRjbLgbLgLsRsbRcbLjbRgbRgLsbRsbRsbRsbRgbRsbRsbRsbRgbRgRsmbR
gbRgbRhbLjbRebLgRsRsmbLhbLibLgbLsbLgbLsbLgRsbLgbRjbRobRgbLjbRibLjbRibR
gRsmbRsLsbRgbRgRsmbRsbRsRsmbRgLsbRsbRgbRgbRibRiRsmbRgbLibRibRibLgbRibR
gRsmbRsbRsbRsbRsbRgLsbRgLsbRsbRsbRgbRsbRgRsmbRsbRsbRsbRgbRgbRgbRgbRsbR
sbRgbRgbRibLjbRhbLsbLgbRibRgbRsbRgLsbLsbRgRsmbRsbRsRsmbRsbRsbRsbRgbRgb
RgbRsbRsRsmbRgLsbRgbLjbRiRsmbRiRsmbLibRiRsmbRgbRgRsmbRgbRgbRsbRgbRsbRg
RsmbRgbRgbRsbRgLsRsbRgRsmbLgLsbRgbRsbRsRsRsmmbRgbRgbRgbRsbRsbRgbRgbLob
LgbRcbRgbLgbRgbRibRgRsmbLgbRhbRgRsmbLiLsLsmbsbRiRsmbRsbRsbRsbRsbRgbRgb
RgbRiRsmbRjbLjbLcbLibRebRiRsmbRgbLgbRibRsbRgbRgbRgbRgbRsbRgbRgbRgbLjRs
bRsbRgbRsbRgbRgbLgRsRsmbRiRsRsmmbLgbRgbRgRsmbRsbLsRsRsmbRsbRgRsLsmbRsb
RsbRsRsmbRsbRgbRgbRgbRgbRgbRgbRsbLgLsbRibRgRsmbRsbRgbRiRsmbRgbRsbRgRsm
bRgbRgbRsbRgbRsbRgbRgbLgbRibRsRsmbLsRsbRiRsmbRibRgbLjbRibLsbRiRsmbRgLs
bLibRiRsmbLgbRgbRgbRgbRsbLsRgbRsRsmbRsbRgRsmbRsbRgRsmbRgbRgbRgbRsbRgbL
gbRsbRgbRgbRgbRibLibLgLsbRgRsmbRibRibsbRcbRibLgbRgbRgbRibLsLsmbRibRibR
gbLibLgbLgbLgbLibRjbRcbRgbRgRsmbRibLibLgbRjbRibRibLgbRsbRibRiRibLibLsL
smbLgbRiRsmbRcbLsbRsbRibRgRsmbLibRiRsRsmmbLgLsbLjLsmbRibLsbLgbRcRsmbRc
bRibLibRhbRcbRibLibRiRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bRsbRgbRsbRgbRgbLsbRgbLgbRgbRgbRsbRgbRsbRgbLgbRibLsRsbLsbRgbRsbRsRsmbR
gbRgRsLsmbRgbRgbRgbRsbRgLsbRsRsmbLsbRiRsmbRsbRsbRsbRgbLsbRibLsbRgRsmbL
sLsmbRiRsmbRgbRgbRsbLsbRgRsmbRsbRibRgbRibRsbRgbRsbLsbRgRsmbRgbRgbRgbLg
bRibLsbsbRsLsbRgbRsbLsRsbRgbRgbRgbRsbRgbLsbRgbRsbRgbRsbRgbRsbRgbRgbLgb
RibLjbRibLsbRiRsmbLsRsbRgbRgbLsLsmbRgbLjbLhbRgbLibLibRjRsmbLibRsbRsbLi
bRgbLjbLibRhbLibLiLsbRgbRgbRgRsmbLebLibRsbLgbRjbLcLsmbLsbLibRgbLibLgbL
sbRgbLgbLibLsLsmbLsbLgbLsbRgbRcbRibRiRsmbLgRsbRibRibRibLjbRiRsmbLgbRgb
LsbRibRgbLjRsbRibRgLsbRgbRsRsmbRgbRsbRgbRsRsmbRgbRgbRgbRsbRgbRibLhbLgb
RjbLiLsbRjRsmbLgbLibRgbRgbRgbRgbRgbLjbLcbRhbLjbLhbRgRsmbRjbRsbRiRsmbRi
bRsbRgbRibRibsbRibLgbRgbRsbRgRsRsmmbRgbLsbRgbRsRsmbRsbRsRsmbRsbRgbRgbR
sbRsbRgbRsbRgbRsbLsbRibLsbRgbRsbLsRgbRgbLsbRgbRsbRsbRgbRsbRsbRgbRsbRgR
smbRsbRgbRibRibLsbLsbRgbRgLsbRgbRgbRsRsmbRgRsmbRgbRsbRsbRsbRgbRsbRgbRg
bRsbRgbLgbRibRgbRsbRsbRgLsbRgbRsbLgbRibLsbRgRsmbLsbRgbRsbRgbRgbRgRsmbR
gbRsbRsbLsbRgbRsbRsRgRsmbRgbRsbRgbRgbRsbRgbLsbLjLsmbRsbRjbRhbRiRsmbLib
RibRibRgbLgRsbRiRsmbRsLsbRgbRsbRsbRgbRgbLsbRibLsbRgRsmbRsRsmbRgbRsbRgb
RgbRgbRgbRsbRgbRsbRgbRsbLsRgbRsbRgbRsbRgRsmbLsbRibRsbRsbRgbRsbRsbRgbRs
bRgbLgbRiRsmbLiLsbLgRsbLibRgbLgRsbLcRsRsmbLibLgbRgbRgbRibRibRibRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bRsbLgRsbLibRcbRiRsmbRgbRgbLcbLgLsbLsbLgLsbLgLsbLgbLgbLsbLsLsmbLgRsbLc
RsbLcbLibLibLgbLgLsbLgbLgbRsbRibLcbLgbLgbLsbLsRsbLgbLsLsmbLsbLsbLgbLgL
sbLgbLgbRgbLgbLgbLsbLgbLsbRsbLgbRsLsbLgbLgbLgbRjbLeLsbLobRsbRgbLjbLsLi
bLibRsbLgbLgbLgbLsbLsbLgLsbLgbLsbLsbLgLsbLgbLgbLgLsbLgbLgbLgbLgbLsbRsb
LgbLsbLibLgbRjbLcRsbRiRsmbRibRhbLsbRibLsbLgbRibRgbRgbLgbLgbRjbRgbRibLi
bLsbRibRibLibRgbRibLebLebRgbLibLsbLsbLgbLsbLgbLgLsbLsbLsbLgLsbLgbLsbLs
bLgbLsbLgbLsbLgRsbLsbLsbLgbLsbLgbLsbLsLsmbLgbLgbLgbRibRcbRibLibLcbLgbL
gRsbLgbLsbRsbLsbLgbLgbRgbLibRibLibLiRsbRibLiLsbLsbLsbLsbLsbLgbLgbLsbLg
LiLsbLgbRsbLgbLgbLgbLgbLhbRibLibLibLibLgbLgbRsbRgbLgbLjbLsLibLsbLsLsmb
LibLgbLsbLcbLgbRsbLgbRsbLgbLibLgbRjRsmbLibLgbLgbRgbLsLsmbLibLgbLsbRsbL
gLsbLgbLsbLsbLsbLgbLgbLgbRcbLhbRjbRcbLibRibLcbRobRhbRibLgbLibLsbRsbRsb
LsbLibLgbLsbLsbLsbLgbLgbLsbLsbLgbLgbLgbLgbLgRsbLgRsbLcbLcbLhbLhbLibLgb
RsbLibLsbLibLgbLgbLsbLsRsbRsbLgbLgbLgbLgbLsbLgbLgbRsbLgbLgbRsbLgLsbRsL
sbLgbLgbRgbRobLsbLgbLsbRsbLgbLgRsbLgbLgbLgbRgbRsbLgbLgbLgbLsbLsRsLsbLg
bLgbLsbRsbLibLgbRiLsbRcbRsbRgbRgbRgbRgbRsbRsbLjRsbLobRibLcbLsbLgbLsbLs
bLsbLsbRsbRsbLsbLgLsbLgbLsbLsbLgbLsbRcLsbRibLgbRjbLibRebLibRibLcbLcbLj
bLsbRsbRibRgbRgbRgbRibRgLsbLobLobLgbLsbLsbLsbLsbLsbLgbLgbLsbLsLsmbLsLs
mbRgbRibLjbRhbLjbRcbLgbRsbRsbLsbRgbRhbLiLsbRjbLiLsbRgbLgbLgbLgbLgbRsRs
mbLsbRsbLsbLgbLsLsmbLgbLsbLgbLsbLsbLsbLsbLsbLgbLgbLgbLsbLsbLgbLsbLgbLs
bLgbLsbLgbLsbLgbLgbRibRibRgbLobRibLibLgbLsbLsbLsLsmbLgbLgbLsbLsLsmbLgb
LgbLsbLgbLgbLibLhbRsbRibRibRgLsbRgbLsbRsbLcbLgbLgbRsbLibLibLgbLgbRibLs
bLgbLgbLgbLgbLsbLsbLsbRsbLgbLgLsbLgbLsbLsbLgbRsbLsLsmbLgbLgbRgbLibRgbL
gbLgbLgbLgbLsbLgbLgbLsRsbRgbLgbLgbRsbLgbLgbLsbLgLsbLsbLgbLsbLsbLgbLsbL
sbLsbLsbLsbLgbLsLsmbLgbLsbLsbLgbLgbRsLsbLibLibLgLsbRsbLibRgbRjbRibRibL
ebLhbLjbRgbLsbRsbRsRsmbLibLgbRgbLibRcRsmbLebLobRgbLgbLsbLgLsLsmbRsbLsb
LsbLgbLsbRsbLsLsmbLsbLgbLsbLsbLsbLsbLsLsmbLsbLgLsbLsLsLsmmbLsbLgLsbLsb
LsbRsLgbLsbLsbLibLsbRiLsbLgbLgRsbRsbLgbLjbRibLgbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bRcbRibLjbRibLjbRibRsbRsbRsbRsbRsbRgbRsbRsbRsbRsbRsbRsbRgLsbRibLcbRcbL
cLsmbLhbRibRjbRibRgbLibLhbRgbLibRsbRhbRgbLgbRgbRgbLcbRibRiRsmbLibLibRi
bRcbLebLhbRsbRcbLeRsbLcbRibLibLibRgbRgbRhRsmbRhbRsbLgbRgbRibLjLsmbLjbL
gbLsbRiLsbLibLgbRsbRgbRjbLhbLiRsbRjRsmbLgbLsbRsbRgbLibLgbRcbRibRgbLibR
ibLibLibLgbLgbLsbLgbLsbLsbLsLsmbLsbLsRsbLsbLsbLsLsmbLgbLsbLgbLsbRsbLsb
LsbLsLsmbLsLsmbRcLsbRhbLhbLgLsbRgbRjbLgbLibLibRjbRcbRibLjbLjbLibLgbLsb
LsbLsbLsbLgbLsLsLsmmbLsbLgbLsbLsbRjbRcbRibLsbRibLsbRgbRsbRsbRsbRsbRsbL
cbLsbLgbLgbRibLgLsbRsbLsLsmbLgbRsbLgbLsbRsLsLsmbLsbLgbLsLsLsmmbLsbLgbL
sLsmbLsRsbLsLsmbLsLsmbLgRsbLsbLsRsbLsbRsbLgbLgbRsbRhbRibLibRibRgbRibLc
bLcbRjbRibLjLsmbRjbRgbLjbLibLsbRgbLgbLjbLcbLibLibLibLjbRsLsbRgbLgRsbLs
bLsLsmbLgbLsLsmbLsRsLsbLgLsbLsbLsLsmbLsbLgbRebLsRsbLgbLgbLsbRsLsLsmbLs
bRgbLgbLsbLsbLsLsLsmmbLsbLgbLgbLsbLsbLsbLsbLsbLgbLsbLsbRgbLgbLjbRcbRib
RiLsbLjbLhbLibRibLibLgbLgLsbRjbLgbLgbLsbLsLsmbLsLsmbLsbLgLsbRjbRibRgLs
bsbRibLjbRibLjbLibLgbLibRsbLgbLsbLgbLgbRsbLsRsbLsbLsbRcbLibLsbLgbRcbRi
bLgbLgbLgbLsbLsbLgbLgbLsbLsbLsbLsbLgLsbRjbRibRgbRgbLsbRgbLjbLibLgbRjbL
gbLgbLsbLgbRgLsbLgbRcbRibRgbLjRsbRjbLgLsbRibLgbRjLsbLjbRiRsmbLgLsbLibR
ibRibLjbLhbLibLgLsbLsbRsbLibLgbLsbRibLgbLgLsbLsbLibRgbRibRibLjLsmbRibR
iLsbLibLjbsbRibRsLsbRiRsmbRsbRgbLsbRgbLgbRiRsmbLjbRibRgbLgbRibLsbRgbRs
bRgbLjbRgbRsbRsbRsbRsbRsbLhbLibLsLsmbLgbLsbLsbLsbRcRsmbRgbRibRgbRibLib
LibLjbLsbRibRgRsmbRibLebLjbRsLsbLsbRsbLibRjbRhbRgbRgbRgbRgbRgbRjbLsLjb
LhbLiLsbLgbLsbRgbLgbRcbRgbLibRjbRibLibLgbLgbRgLsbLgbLgbLsbLsbRsbRjbRib
RibRgbLjbLjbRibRibLgbRibRgbLjRsbRibRibRibRsbRgbRsRsmbRgbRgbLjbRgbRgbRs
LsbRsbRsbRsbLsLsmbRgRsmbRgbLsbLsRibLcbLibLsRibLibLgbLgRsbRgbLgbLgbRjbR
cbLgRsbRcbLibRibLgbRibRgbLgbLgbLibLcbRibRgLsbLibRjbLibRibLibLiLsbLsLsm
bLsbLsbLgbLsRsbLsbLsbLgbLgbRjbLgbLgLsbLgLsbLsbLsbLgbLsbLsLsmbLgbRibRib
RibRgRsmbRgbRgbRgbLhbLsbLsLsRsmbLsbLgLsbRsbLgbLgbLgLsbLgbLsbLsbLsRsbLg
bLgbRibLgbLgbLsbLsbLgbLsbLgLsLsmbRsbRsbLgbLgbLsbLgbLgbLgbLgbLsbLsbLsRs
bLgbLsbRjbLsbLibLsbRjbRhRsmbRibRsbRgbRsLcbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bLgbRsbLgbLgbRsbLsbLsbLgbLsLsmbLgbLgbRsbLgbLsbLgbLgbRsbRsbLgRsbLsbRcbR
ibLsbLgbRhbRibLibLiLsLgLsLsmbLsbLgbLgbLgbLgLsbLsLsmbLgbLsbRsbLgbLgLsbL
gbRcbRhbRibRcbLiRsbRcRsmbRhbRgbRiLsbRibRgbLgRsRibRgbRgbRgbLjbLcLsRsLgL
gmbLsbLgbLgbLsbRsLsbLgLsbRjbLgbLgbLgLsbRgbLgbLsbLsbLsbLsbLgbLsbLsRsbLs
bLgbLgbLsbLgbLsbLgbLgLsbRsbLsbLgLsbRsLsbLgbRsLsbLgbLgbLsbLsbLgbRoRsmbL
sbsbRibRcbRibLsbRgLsbLiLsbLsbLgLsbLgbRcbRibLsbRgRsmbRsbRsRibRgbRsbLsbR
ibRgbRgbLsbRibLiLsbRcbRgbLibLsbRhbRiLsbLsbLgbRhRsmbRgbRgbRsbRsbRibLjbR
gbRibRibRhbLibRibRgbRgLsbLgbLibRibRgbRsbRsbRsbRgRsmbRgbRgbRsbRgbLgbRiL
sbLjbRibLgbRibRibLibRhbLsbRiLsRsbRsbRgbRgbRgbRgbLebLibRsbLgbLsbRgbLibL
gbRsbRsbLibRsbLgbRsbLgbLsbLsbLsbLgbLsbLgbLsbLsbLsLsLsmmbLsbLgbLsbRsLgb
LgLsbRcbLsLsmbLsbRibLjbRibRsbRsbRsbRgbRsbRgbRgbRgbRsbRgbRsbRsLsbRsRsmb
RgbRgbRgbRgbLjbLcbLibRiLsbLibLgbRgRsmbLibRsbLgLsbLgbRgLsbLgbLsbLgLsbLg
RsbRcbLsRibLgbRibLsLsmbRgRsmbRsbRgbLcbLibLsbLsbLsbLsbLsbLgbLgbLsbRsbLg
bLsbLgbLsbLgRsbRsbLsbLsbLsbLgbLgbRcbRibLgLsbLsRhbRsbLjbRsbRcbLibRcbRhb
RibLgbLcbLcbRgbRiLsbLobLibLgbLgbLsbLsbRsbLgbLsLsmbLsLsmbLgRsbLsbLsbLsb
LsbLsbLsLgbRsbLgbLsLsmbRsLsbLgbLsbLsbLsLsmbLgbLgbLsbLgbLsbLgLsbLsbRsLs
bLgbLgbLhbLoLsLsmmbLiRsbLibLsbLgLsbLgRsbLgbLgLsbLgbLsLsmbLsbLgbLsbLsbL
gbRgbLgbLsbLgbLgbRcbRcbLjLsmbRhbLcbLhbLibLibLsbLgbLsbLsbLsbLgbLgbLgLsb
LsbLsbLgbRsbLgLsbRsLsbLsbLsLsLsmmbLgbLgbLgRsbRjbRobLjbLcLsmbLgbLsbLgbL
sbLsbLgbLgbLsbLgbLgbLgbRsbLgbLiLsbLibRibLgbLgLsbRjbRcbRiRsmbRibRhbLsRs
LsbRgbLibLsLsmbLgbRsbLibLiRsbRgbLibLsbLsLsmbLgbLgbLgbLgbLgbLsbLsRsbLsL
smbLgRsbLgbRsbLgbLgbLgbRsLsbLgbLgbLsbLsbLgbLgbLgbLgbLsbLsbRsbLgbLgbLsL
smbRgbLibLgbLgRsbLgbLsbLgbRgbRcbRiRsmbLjbRibLjbLcbLgLsbRgbLiLsbLgbRjbL
cbLcLsmbLgbLgbLhbLgbRsbLgbLgbRsLsbLgLsbLsbLsbLibLgbLsbLgbLsbLgbLgbLgbs
bLgLsbLsbLibLgbRgRsmbLibLsbLgbLsbLsbLsLsmbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bRgbRgbRsbRgbRibRgbRsbLsbLgLsbRibRsbLsbRgbRgbRsbRsbRgRsmbRobRhbRibRibR
gLsbRsbRgbRgbRsbRgbRgRsmbLsbRsbRgRsRgRsmmbRgbRgbRgRgbRgbRsbRgbLjbRgRsm
bRibLgbRibLsbRgbLsLsmbRibRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRsRsmbRgRsmb
RgbRsbRgbRsbRgbRsbRgbRgbRsbRsbRgbRgRsmbRsbRsbRsbRsbRsbRsbRsRsmbRgbLjbL
ibLibRjbRcbRibLibLibLhRsbRsLsbRjbRibRhbLcbLjbLibRsbRjbRibRgbRgbRsbLjbR
ibRgbRsbRsbRgbRibRibLgbLibLibRcbRhRsmbRsbRsbRsbRsbLgRsbRibLgbRibLgbRib
RgbRsbsbRsbRgbRgbRgbRgbRsbRgbRgbRgbRgbRsLsbRsbRsbRsbRsbRgbRsbRgbRgbRgb
RgbRgbRgbLsbRgbRgbRsbRgbRgbRgbRgbRsbRgbLsbRibRsbRsbRsbRgbRgbRgbRgbRsbR
sbRcbLcbLcLsmbRcbRgbRsbRgbRsbLsbLsRsbRibRibLcbLobLibRsRjbLcbLibRibRsbL
hLsbLibRiRsmbLibLgbRjbRcbRibLgbRibLgLsbRibLsbRgbRsbRsbRsbRsbRgbRgbRgRs
mbRsbRsbRgbRgbRibRgbRsbRgbRgbRsbRgRsmbRgbRsbRsbRgRsmbRgbRgbRibRsRgbRsb
RgRsmbRsbRsbRgbRgbRgbRgbRgRsLsmbRgbRgbRgbRsRsmbRgRiRibRgbRgbRsbRsbRsRs
mbRsbRgRsmbLsbRgRsRsmmbRsbRgRsmbRcbLiLsbLcbLibLsRsbRgbLibLibRjRibRibRs
LsbLhbLibLgbLgbRgbRhRsmbRiLsbRgbRsbRgLsbRgbRgbRgbRgbRibRibRgbRgbRgbRgL
sbRgRibRgbRgbRgRiRsmbRibRgbRsbRgbRgbLsbRiRsmbLibLsLcbLibLsbLsbRsbRsbRi
bRibRgbRsbRgRsmbRsbsbRgRgbRgLsbRsbRsbRsbRgbRsbRgbRsbRgbRgbLsRgLsbRgbRg
bRgbRgbRgbRgbRgLsbRgbRgRsmbRgbRgbRgbRgbRgbRibRgRsmbRgbRgbRgLsbRsbRgbRg
bRgbRsbRibRsbRgbRgbRsbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgLsbRsRsmbRiLsbRsbRg
bRsbRgRibRgbRgbRgbRibRiRsmbRgbRgbRgbRgbRgbRgbRgbRgbRsRsmbRgbRsbRgbRsbR
gRsmbRsbRgbRgbRgbRgbRsbRgbRgRsRsmmbRgbRgbRgbRgbRsbRsbRgRsmbRgbRgbRgbRg
bRgbRgbRgbRgbRgRsmbRgbRgbRgRsmbRgbRgbRsRsmbRgbRgbRsbRjbRgbRgbRgbRgbRgb
RsbRgbRsbRgRsmbRsbRgbRgbRgLsbLsRgbRgbsbRgbRgbRgbRibRgbRgbRgbRgRsmbRgbR
gbRgbRibRibLjbLjbRcbRibLibRibRgbRgbLiLsbLjbLhbRjbRcbLgbRibLsbRibLgbRib
LibRcRsmbReLsbLeLsbRiRsmbRgbLsbRgbRsbRgbRgbRsbRgbRsbRgbRsRsmbRsbRgbRsb
RgLsbRgLsbRsbRgbRsbRsbRsbRgbRsbRsbRgbRgbRgbLcbLibRcRsmbRibRiRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bRgbRgLsbRgbRgbRsbRsRsmbRgLsbLsbRibRgbLcbLcbLsbsbLgbLgbLsbLsbLsRsbLsbL
gbLsLsmbLsbRsLsbLgLsbRgbRoRsmbRgbLsbRgbLsbRiRsmbLcbRcbRibLibLcbLgbRgbR
jRibRibLcbLobRibLcbRjLibRjbRsRhbRcRsmbLibRhRsmbsbRiLsbLibRcbRcbRibRibL
cLsmbLsLgLsRsbLgbRsbRjRsmbLibLsbRsLsbLgbLsbLsLsmbRsLsLsmbRsbLgLsbLgbRg
RsmbLhRsRibLcbRsbRgbLhbLoRsbRibLibRjLsbLcbLibLibLsbRsbRcbRcbRibLsbLjbL
ibRjbRcbRibLgLsbRiRsmbRibLsbRgbLsbRgbRgbLsbRgbLsbRgbRgbRsLsbRgbRiLsbRg
RsmbRsbRsLsbRgbLsbRibLjbLcbRgbLgRsbRsLgbLgbRgbLgbRgbLgbLsbLgbLsbLsbLgb
RjbRcbRibLsbRgRgbRibRibLjbLibRcRsmbRibRgbRibLgbLjbRiRsmbLobRgbRgbLsbRi
RsmbLsbRgRgbRsbRgbRsbRgbLgbRsbRiLsbRibRgbLcbLcbRjbLibLgLsbLibRjbRhbLsb
RibLgLsbLsRgbRgbRgbRsbRsbRgbRgbLjbRibRsbRsbRsbRgbRsbRsbRsbRgbRgRsmbLsb
RsbRsbLsbRsbRgbRsbRgbRsbRsbRgbLobLibRgbRebRgbLsbRgbLsRsbRgbRsbRsbRsbRg
bRgbRgbRsRsmbRgbRsbRgbsbRsbRgbRsbRgbRgbRsbRgbRgbLsbLcbLcbRibLhLsbRjbRc
bRiRsmbRgbRgbLjbRibLcLsmbRsbLibRsbLibRjbRcbRibLgbRibRgbRsbRsbRsbRgbRsb
RsbRsbRgLsbRsRsmbRsbRgbRgbRgbRsRsmbRsRsmbRgbRsbRsbRsbRsbRgbLjbRibRibLi
bLibLcRsbLgbLgbLgbLgbLsbRsbRjbRibLgbRibLgLsbRibRsRsmbRgbLjLsmbRhbLhbLo
bLsbLsbLgbRsbLgbLgbRjbRibRibLgbRiLsbLgbRibLsbRgbRgbRsbRsbRgbRsRsmbRsbR
gbRgbRsbRsbRgbRsbRgbLsbRgbRsbRgLsbLjbLcbLgbRsbLsLibRcbLsRobRcbLgbRsbLs
bRgbLsbRjbLjbLcbRjbLobLibLibLibRgbLiLcbRjbLhbLsRsbLcbRjbRcbRgbLsbRgbRs
bRgbLsbRgLsbRsbRgbRsbRsbRsbRsRsmbRgbLsLsmbRgRsmbLjbRcbLhbLcbLibLgbRibR
cbRhLsbRgbRcbRibLsbLibLiLsbRgbRsLibRsbLcbLhbRgbRgbLsRsbLjLsmbLgbRiRsmb
RsbLibLsRsLgLsbLsbLgLiLsbLgbLgbLgRsbRobRsRgbRsbRgbRsbRgbRsLsbRgbRsbRgb
RsbRsbRsbRsRsmbRgRsLsRsmbRgbRsbRgbRsbRsbRsbRgRsmbRsRsmbRgbRsbRsRsmbRgb
RsbRgbLsbRgbLgRsbRiRsmbRibLjbRibRgbRsbRsLsRsbRsbRsbRgRsmbRsbRgRgRgRsmb
RgbRgRsmbRgLsbLsRsbRgbRsbRsbRgRsmbLcbLoRsbRsbRjbLibLibRgbLgbRsbRibLjbL
ibLibLsbLgbRsbLgbLsbLgLsbLsbLgbLgbLgbLsLgbLsbLgbLgLsbLsLsLsmmbLsLsmbLi
bLcbLibRsbLgbLjbLibLgbLgbLsbLgbRsbLgbLsbLgLgbLsLsmbRsbRjbRibRibRsbLgbR
ibRgbRsbRgRsmbRsbRsbRsbRsbRgbLsbReLjLeLsLibLgbLgbRgRsmbRcbRgRsmbRgbRsb
RgRsmbLsbRgRsRsmmbRgbRsbRsbRsbRgbRsbRsbRsbRgbRsbRgRsLsmbRsRsmbRgRsmbRs
RsmbRsbRgbLebLibLsbLgbRgbRcbRibLibRibRgRsmbLsbRibRsbRgbRsbRsbRsbRsbRsb
RsbRgbRsRsmbRsbRsbRsRsmbRsLsbRsbRsRsmbRsbRgbRgbRsbRsbRgRsmbRsbRgbLgbLj
bLibLsbRsbLgbLgbLsbRsbRjbRibRgbRibRgbRsbRsLsbRsbRsbLsbRgbLsLsmbRgbLsbR
gRsRsmmbRsbRsRsRsmmbRsbRgRsmbRgRsmbLsbRgbLsbsbRgbLsbRgLsbLcbLgLsbLgLsb
LsbLsRsbLgbRgbLgbLgbRgbLgbLsbRcbRibRsbRgbRgbRsbRsbRsRsmbRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bRjbRcRsmbLebLibRibLibRcbLjbLhbLibRhLsbRgbLcbRgbLgbRsbRsbLgbLgLsbRgRsm
bLsbLibLibRhbLibLgbLgbRibRjbLibLibLibLgRsbRhRsmbLgbRsbRgbRsbRibRsbRgbR
gbRgbLibRgbsbRgbRgbRgbRsbRgbsbRgbRsbLjbRgbLsbRgbRgbRsbRgbLcbLhRsbRiRsm
bRgbRgbLsbRgbRgbRgbRsbRsbRsbRsbRgbRsbLsRsbRgLebRjbLhbLjLsRsmbLibRcbLjb
RgbRgbLsbLgbLsbRibLjbRibRgbLgbRgbRgbRsRsmbLsbLcbLibRjbLgbLsbLsbLsbLgbL
sbLsbLjbRsbRjbRibRsbLjbLjbLjbLjbLibRcbLibLiLsbLgbLsbLsbLsbLsbLsbRibRjb
RiLsbLcbRjbLibLjbLibLgbRjRsmbLjbRcbRiRsmbRjbRsbRgbRsbRsbRsbRsbRibLgbRj
bLcbLebRjLsRsRsmbLcbLibRibRcbLgbRjbRgRsmbRsbRsbRsbRgbRgbLsLsmbLsRiRsmb
LcbRcRsmbLjbRcRsmbRibRsbRibLjbRibRibRgbRgbLjbLibRjbLibLcbRibLibLibRjbL
hbRjbRjRsmbRibLjbLgbLibLibRjbRjbLjbRcbRsbRibLhbRcbLcbReLsbRibRgbRgbLsb
RsbRsbRgbRgbRgbRsbLjRsbLibLibRjbLiLsbRjbLjLsmbLibRjbRcbLjbLjbLibLsRhbL
iLsbLgLsbRsRsmbLgbLgbLsbLsbLgbLsbRsbLsbLgbLgbLibLiRsbRcbLibRcbLsLcLsmb
RibLcbRjbRsbLcRsbRcbLibLiRsLsbLibLsbLsbLsbLhbLjbLibLgbLgbLgbRgbLsbLibL
jbLgbLgbLgbLsbsbLsbLsbLsbLsbLsbLibLgRsbLgbLgbLsbLgbRjRsmbsbLjRsbLsLsmb
LsRsLsLsRsmbRsLsbRsRsLgmbRebRcbLjbLibRiRsmbLibLcbLibRibRgbRgbLgbLsRsbR
gbRgbLsbLjbRjbRgbRgbRgbLsbLsRsbRgbRgbLsbLjbLibLjbLibRibLcbLsbRibLsLibL
gbRgbRsbLibLibRibLibRjbLcbLibRebLhbLhbRgbRsbRgbRjLsbRgbLsbLsbRhbLjbRib
RibLjbLcbLgbLibRjbLcbRibRsbLgbLgbLsLgbRsbRsLsbLgRsbRsbLgbRcbLjbLibRjbL
sRsbLhbRiLsLobRibLsbRsbRjbsbLibLibRgbLgbLhbLibLhbLhbRiRsmbLsbLjbLibLgb
RibLhbRibLgbLgbRgbLgbRgbLgbLcRsLsbRhbLiLsbRjRsmbRcbLjbLibLibRibRjbRibL
jbLhbLsbLibLibRjbLibLgbRcbLhbLibLhbLgLsLsmbLgbRgRsmbRsbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bLsbLgbLgbLsbLsbLsbLgbLgbLgbLgLsbLsLsmbLsLsmbLgbLsbLibRjbLibLgbLgbLsbL
ibLgbLibRiRsmbLibLgLsbLgLsbRgbLsbLibRjbRjbLgbRiRsmbLjbsbLcbLiLsbRcbLib
LgbLgbLgbLsbLgbLsbLgbLgLsbLsbLsbLgbLgbLsbLsbLgbLsbLsbLgbRsbRsLsbLgbLgb
LsbLsbLgbLgRsbLsLsRsmbLsbLsbLiLsbLibRjbLhbRgbLiRsbLibRibRgbLsbLiLsbLsb
LgLsbRhbRcbLibRsLjLsLsmmbLibRjbRcbLhbRjbRhbLjbLhLsbRjbRibRgRsmbLcbLiLs
bRsbLiLsbRgbLibRsbLgLsbLsbLsbLgbLgbLsbLgbLsbLgbLsRsbLsbLgbRjRsmbRhbRhb
LgbRsRcbLibLcbRjbLeLsbLiLsbLgLsbLsLsmbLsLsLsmmbRjbRhbLibLhbLibLsbRjbLi
bLgLsbRibRebRibLibLcbLibLgbLgbLsbRsbLsbLgLsbLibLibRcbLibLsbLgbLgbLsbLg
bLgbRjLsRsbRjbRibLjbRgbLcbLgLsbLsbLgLsbLsbLsbLgbLibRgbLibRsbRsbLgbLgbL
sbLsbLgbLsbLsbLgRsbRcbLebLibLgRsRsmbRsbLgbLsLsmbLgRsbLgbLgbRsbLgRsbLsL
smbLsbLsbLsbLgLsbLgbLgbLsbLgbLsbLgLsbLsbRsbLibRsbLgRsbLgbLsLsmbLgbLsbL
sbLgLsbLgbLgbLsbLgbLgbLgbLgbLgbLibLgbRibLibLgRsbLsbLgbLsbLgLsbLsLsmbLs
bLsbLgbLgbRjbRibLjbLcLsmbRsbLsRsLgbLsbLsLsmbLgbLgbLsbLsbLsbLsLsmbLgbLg
bRjbRibRgbLcbLibRibLibLgLsbLgbRgbLibRsbLgbLsbLsbLgbLsLsmbLgbLgbLgbLsbL
ebLgbLcbLgLsbLgbLsbLgLsbLgbLgbLsbLgbLsRsbLsbLgbLsLibRgbRgbLjbLiRsbRhbL
gLsbLgbLsRsbLgbLgbRsbLgLsbLsbLsbLsbLsbLgLsbLsLsmbLgbLsbLsbLgbLgRsRsmbL
ibRjbLsbLibLsLsmbLgbLsbLsbLsbLgLsbLgbRjRjbRcbLebLibLgLsbRsLsbLgbLsbLsb
LgLsbLgbLgRsbLgRsbLibRibLibLgbRgbLiLsbRgbLgLsbLsRsbLsbLsbLgbLgLsbLsbLs
bLgLsbLgLsbLsLsmbLsbLgbLgbLgbLgbLsbLsbRsbLgbLsbLgbLgbLgbLgbLsbLsbLgbLg
bLgbLiLsbLgbRibLibLgbRjbLiLsbLibLgbRsRsmbRjbLibLgbRgbLiRsbLgbRibLgbLgL
sbLsbLsbLsbLsLsmbLgbLgLsbRcbRibLjbRhRsmbLgbLeLsbLibRgLsbLgbLgbLsLsmbLs
bLgbLgbLsbLsbLgLsbLgbLgbLsRsbLsbLgbLgbLgbRsLsbLgbLgbLgbLgbLsbLgbLgbRcL
sbLjbLibLgbLgbLsbLgbRsLgbLgbLsRsRsmbLsLsmbLgbLsbLgRsbLsLgRsbLsbLgbLgbL
gLsbLgbLgbLgbLgRsLsbRjbLsRjbRgbLjbRgbRibRgbLcLsmbLibRgbLiLsbRjbRhLsbLj
LgLsbLiLsbRgbLgRsLsbLibLgLsbLgbLgbLsLsmbLsbLgbRsbLibLsbLgbLsLsmbLsbLsL
gbLgRsRsmbRsbLgLsbRsLsLsmbLsbLgbLgbLgbLgbLgRsbLgbLsLsmbLsbLgbLgbLsbLgb
LgRsbLhLsbLcbLhbLibLsbLgbLgbLgRsbLgRsbLgbLgbLgbLgbLgbLgbLgbLgRsLsbLgbL
ibLjLsmbLgbRjbRhbLjbLcbRcbLibLibRgbLgbLsbLgbLgbLsbLibLsbLgRsbLsbLgbLsb
LsbLsbLgbLgbLsLsmbRsbLgbRgbLiRsLsbRjRsmbLibRgLsbLibRjLsbRibLebLsLibLgb
RgLsbLgbLgLsbLsLsmbLgbLgLsbLgbLgbLsLsmbLsLsmbLgbLgbLsbLsbLsbLgRsbLsbLs
bLgbLsbLgbLgbLgbLgbLgbLgbLgbLgbLgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bsbRgbRsRsmbRsRsmbRgbRsbRgRsLsmbRgbRobRgRsmbRsbRgbRgbRsbLgbLcbLibRsLgL
sbLibLiRsRsmbRcbRhbsbRibRsbRsbsbRsbRgbRgbRgbRgbRsRsmbRsbRsbRgbRgbRsbRg
bRgbRgRsmbRgbRgbRgbRgRsLsmbRgbRgRsmbRgRsmbRgbRsRsmbRgbRgbRgbRsRsmbRgbL
sRsbRibRsbRgRsmbRibRibRgbRgbRgbRgRsLsmbRgbRgbLgbRibRgbLibLcLsmbLiRsbLs
bLgbLibRcbRcbRoRsRsmmbRgRsmbRiRsmbRgbRsRibRgbRgbLgbsbRibLgLsbLsbRhbLsb
LgbRibRgbLsRsbRibLsbRgbLsbRibLsbRibRgbLibLcbLibRsbLgbLgbRsbLgbsbLibRcb
RoRsmbRsbRibLsbRsbRsRgbRsRsmbRgbLsRsbRsbRsbLobLibRgRsmbRgbRsbRgbRgbRsb
RgbLsbRgbRsbRgbRsRsmbRsbRsRsmbRgbRsRsLsmbRsRsmbRebRgbRgbLsbRgbRgRsmbLs
bRgbRsbRgbRsbRsbRgbRsRsmbLsRgbRsbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbR
iLsbLcbLcLsmbLsbLgbLiRsbRsLsbLiRsbRjbRcbRhbLgbRhbLibRibRgLsbLsRsbRgbRs
bLgbRiRsmbRsbRiLsbLcbRsLcbLgbLgbLsbLgbLgbLgbRjbLgLgbLgbLgbRcbsbRcbRsbL
sbRiLsbsbLsbRgbRgbRgbLsbRsbRgbRgRsmbLsRsbRgRsRsmmbRsRgbRsbRgbRsbRsRsmb
RgRsmbRgRsmbRgRsmbRgRsmbLsbRgbRgbLebLibRjRsmbRcbLibLcbLgLsbLgRsbsbsbRg
bLjbRcbLsLcLsmbLhbRjbRcbLsLgbRhbLgbRgbRsbRgbLsbRgbRsRsmbRgRsmbLsbRgbRg
RsmbRgbLsRsRsmbRsbRgLsbRgRsmbRsbRgbRgbRgbRgbRsbRgbRgbRibRgbRgbRgbRibRg
bRgbRibLcbLcbLiRsRsmbLsbLibLgbsbRoRsmbLsbRebLjbRcbLgbRibRgbRgbLsbRiLsb
LsbRgbRsbRgbRgRsmbRsRsmbRgbRgRsmbRsbRsbRgbRsbRgbRgbLcbLgbLsbLgbLibLibL
gbLjbsbRjRsLsLsmmbRibRiLsbRjbRgbRsRsmbRgbRgbRgRsmbRgbLeLsbLibRjbRjbRgR
sLsmbRibRgRsmbRgRsmbLibRsbLsbRibLsRsbRgbRsbRgbRgbRsbRgbRgbRcLcbRibLibL
ibLgLsbLgbLsbLgbLgbLgbRcbRiRsmbRgbRgbRgbLgbRiLsbRsbRgbRgLsbRsbRsbRgRsm
bRgbLsbRgbRgbLsbRgbRgRsmbRgbRsbRsbRgbRsbRsRsmbRsbRsLsbRgbRsRsmbRgbRsRs
mbRsbRgbRgbLgbRcbLgLsbLibLhbLiLsbLsbLgbLgbRjbRcbRgRsmbRgbLsbRgbRgbRsbR
sbRsbRgbLsbLcbLgbLgbLgbLsLsmbLgbLgbLsbLsRsbLgbRobRgbRsbRsbRsRsmbRgRsRs
mmbRgbRgbLhbLhbLgbLgbLgbLgbLsbLsbRebRibRgRsmbRsbRsbRgRsmbRgbLsbRgbRgbR
sRsmbRsbRgRsmbRsbRiRsmbRgRsmbLsRgbRgbRgbRsbRgbRgbRsbRsRsmbRgbRsbRgLsbR
gbRsbRgRsmbRgbRgLsbRsLcbLsLibsbLgLsbLsbRgbLsRsRsmbRgbRgRsmbRgbRgbRsbRg
bRsbRsbRgbRsbRsRsmbRgbRgbRgRsmbRgbRsbLibLgbLgRsbLgLsbLsbLgbRcbRsbRgbRs
bRsbRgRsmbRgbRgbRgbLgLsbRjbRsbRgbRgbRgbRgbRsRsmbLibLobRcbLgbsbRibLgLsR
sbRibLsRsbLsbRsRsRsmmbRsbRsRgbRgRsmbRgbRgbLsRsbRsbRgbRsbRsRsmbLsbRibLg
bLhbLsbRibRsbRsbRgbRsbRgbRgbRsbRsbRsRgbRgRsmbRgRsmbRsbRibRiRsmbRibLcbL
ibRjbRcbLjbLhbLiRsbLgbLgbRcbRibRgRsmbRsbRgRsmbRsRsmbRgbLsRsbRgRsmbRgRs
mbLsRgRsmbRsbRgbRsbRsbRsLsbRsLsbRgbLgLsbLsRgLsbLgRsbRcbLcbLcbLibRjbRsR
smbRcbRibLsbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bsbRjbRsbRsbRsRsmbLsbLhbLsbRsbLgLsbLgLsbLsbLcbLgbRsbLsbLsbRgRsmbRgbRcR
smbRsbRibRibsbLgbRhRsmbRsbRsbLibLiLsbLcbLsbRgbLibLgbsbRgbRsbLibRibLgbL
gbLgbLgbRsbLjbLgbRsbRsbLsbRsbRgbRsbRibRsbRibRgLsbRiRsmbLsLsmbsbRcRsRsm
mbRibRibRibRgbRsbRgbLsbsbsbLgbRibLhbRhbLjbLcbLibRgbRgbRsLcbLibRgbLcLsm
bRgbLgbLgbLgbRsbLibsbLcRsLsbLibRsbRgbRibRcbRcbLhbLsbLcbLgbRgbRgRsmbRgb
LhbLgbLgbLgbRgbLgbLgRsbRgbLgbLibLsbRsbLgbLsbLsbLsbLgbLgbLgbRsbRsbRsbLs
bsbsbLibRcbRobLgbRibRgbLsbRibLsbLsbRgbRsRsLsmbRgbRgbLgbRibRiLsbRgbRgRs
mbLgbRibLgbLgbLibLsRsbLibRgbLsbLsbLgbRsLsbLgbRsbLgRsbLsLsmbLsbLsbLsLsm
bLsbLsLsmbLsbLsbsbLsLsmbRsLsbLsbLgbLgbLgbRsRsmbLgbLsbLsbLsbLsbLgbLgRsb
RjbRoRsmbRiRsmbLibLgbLibRgbLgbRgbLgbLgbRjbLgbLsbLgbRsbLgbLsbLsbLgbLsbL
sbLsbLgbLsbLsbRsLsbLgbRsRsmbLgbRgbLsLsmbLgLsbLsbLgbLsbLsbLsbLsbRsLsbLs
bLsbLgLsbLsbLsbLsbLsbLsbLsRsbLgbLgRsbLsbLgRsLsbLsbLsbLsbLsbLsbLgbLsLsm
bLsbRsbLsbLsbLgRsbLsbLgbLgbLsbLsbLsbLsbRsbLsbLgbLgLsRsbLsbLsLsmbLsbLgb
LsbLsbLsbLsbLgbLsbLgbLgbLgbLiLsbLibRsbLsbRibLsbRsRsmbRsbRsRsmbRgbRjRsm
bRsbRgbsbLsbLgbLgLsbRcbRibRibLsbRibLsbRjbRiRsmbRgbLsbLsbLhbLsLsmbLsbLi
LsbLsRsbLsbLibLsbLibLgbRiRsmbLsbRsbLsbLjLsmbLgRsbRsbLsbsbRsbLsbLsbLsbL
sbLsbLsRsbLsRsbLsbLgbLsbsbLsbLgbLhbLsbLgbLsLsRsmbLsbLsbsbRgbsbLhbLsbRs
LsbLgbLgbLsbLsLsmbLsLsmbLhbLsbLsbLsbLsLsmbLsbRgbLibRsbLiRsbLgbLibLsbLs
bLgbLsbRgbRsbRhbLsbRibRgbLsbLibLgLsbLgLsbLsbLgLsbLgbRsbLsLsmbRsbLsbsbR
sbLgbLiLsbLgbLsbLgbLgbLsbRiRsmbRgbRcRsLsLsmmbLsbLiLsbLibLsLsmbRsbLibLs
bLsbLsbLsRsbLsbRsbRsbRhbLsbRibRgbRsbLibRsRcRsmbRgRsmbLsbLsbLjLsmbRcbRi
LsbRibRsbLsbLsbLsLsmbLsbRibRgbRsbRsRsmbsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bRibLibLibLcbLcbLibLsbRcbRibLibRgLsbLibLgbLgbLgbRibLebRibRibRsbRsRsmbL
jbsbLibLgbRhbLjLsLsmmbRiRsmbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bLsbLsbRjbLhbRgbLsbLsbRsbLgbRsbRsbLjbLsLsmbLsbLsLsmbLgbLsLsmbLsbLgbLsb
LsbRgbRsbLsRsbRjbLibLsbRhbsbRibRsbsbLsbLcbLjbRsbLsbRsbLsbLsLsLsmmbsbRs
bLsbLgbLsbLsLsmbLgbLgbLsbLsbLsLsmbLgLsbLsbLsbLgLsbLjbLsbLsbLsbLsbLsRsb
LsRsbLsbLgLsbLsbLgbLsbLsbLgbsbLsbsbLsbLsbLsLsmbLgbRsLsbRsbsbLsbLsLsmbL
gbLgbLgbLsbLsbRcbRibLgbRjLsbReRsmbRcbRhLsRsbLcbLcbLhbRhRsmbRsbLibRjRsm
bLcbLcbLibRibRibLhbRgbLhbLjLsmbLiLsbRsbRsbLgbRibRjbLcbRsbLsbsbsbRsbsbL
sbsbsbLsLsmbLgbRiRsmbsbsbRjbRsbLhbLibRibLsbLsLsmbLsbLsbLgbRsbLgbLgbRsR
ibLgbLibRsLsbLibRjRgbLhbRjbRgbLgbRjRsmbLhbRibRgbLgLsbLgbRsRsmbLsbRgbLi
bLgbRgbRsbRsbLsbRjbRsbLsbRjbRsbRgRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bLgbRgbLiLsbLsbLjbLsLsmbRsbLsbLsbLgLsbRgbLsbLibLibLgbLsbLsLsmbLsbLgbRo
bRjbLsRcbLjbsbLcbLibLgbLsbLsbLiLsbLibRcbLibLibLgLsbLsbLsbRsbsbRcRsmbRi
bLsbLjRsbLcLsmbLgbRsbLsLgbLgbLgbLgLsbRsbLsbRsLsbLgbLgbLgbRcbLjbLcbLgbL
gbLsbLsRsbsbLsbLibRsbLobLgRsLsbLgbLgbRgbLsbLsbLibLsbLsbLgbLsbLgLsbLsbL
sbLsbLsbRsbLgbRcbRibLibLibLsbLgbLjbLsbLgbLsbLsbLsbLgbLgbLcbRcbLibLhbLc
bLibLgbRsbLsbLgLsbLsbLgbLgbRsbLgbLibRsbRjbRibRibRsbRgbRsbRgbRgbLjbLcbL
ibLgbRgbLgLsbLgbRsbLgbRjbRibLhRsbRjbLibRsbLsbLsbLsbLgbLsbLsRsbLsbLgbLg
bRjbLcbRgbLgLsbLgbRsbLgbLgbLsbLsbLgbLgbRcbRiRsmbRibLjbLcbLgbLsbLsbLgbs
bLsbLsbRsbLgbLsbLgLsbLgbLsbLgbLsbLgbRhbLibLiLsbLsbLgLsbLsbRcbRsbRcRsmb
RgbLcbLgbLgbLsbRsbLgbLgbRibRcbRsbRgbLsbLhbLcbLsbLgbLsbRgbRsbRjbRibRhbL
sbRibLjbLcbLgbLsLsmbLsbLsLsmbLsbLsbLsLsmbLgLsbLsbLsbRjbLsbLibRgRsmbLgL
sbLsbLgbLsbLgbLgbLsbLsbLsbLsbRjbRibLcbRhbRibLcbRsbLsbLsbLsLsRsmbLsRsbL
sbRsbLsLgbLgbLgbLgbLsLgbLgbLgbLgLsbLgbLsbLgbLgLsbLibRsbRgbRcLsbRibLsbR
gbRgRsmbLjbLhbLiLsbRjbLibRjbLgbLsbLjbLsbRsRsmbLsbLsLsmbLgLsbLgbLsbLsLs
LsmmbLgbLgbLgLsbLsbLsLsmbLsbLsbRjbRsbRjRsmbRjbLcbLcbLgLsLsmbLgbLsbRsbL
gbLsbLgbLsbLsRsbLsbLgbLgbLgRsbLsbLsbRsbLgbRjbLibLsbLgbLgbRsbRibRjbRsRs
RsmmbRsRsmbRibLjbLcbLsLsLsmmbLsbLgbLgRsbLgRsbLgbLgbRsbLgbLsbLgbLibLgbL
gRsbRjLsbLiLsbRibLsRsRjbRjbLsbsbRibLgbRsbRgbRgbLjbLcbRsbLgLsbLsbLgbLgb
LsbLsbLsbRsbLgLsbLgLsbLgbLgbLgbRjbRsRsmbRibRgbRgbRgRsmbLjbLcbLgLsbRsbL
iLsbRsbLgbRjbLibLsbRsbLsbLsbLgbLgbLgbLsbLgLsbRjbLhLsbLgbLgbLsbLsbLgbLs
bLsbLsbLsbLgbRcbRibRiRsmbLcbLgbRsbLsLsmbRsbLsLsmbLsbLgbLgbLgbsbRjbRcbR
jbRsRsmbLjbLsbLobRebRibLsbLibLibRjbLibLsbRsbRsRsmbLgbsbLsbLgbLsbLgbLsb
RsbRsbRjbRcRsLsmbLjbLiLsbLsbLibLsbLsbLgbLsbLsLsRsmbLsbLgRsbRsbRsbLibRc
bRebRgRsmbLsbLgbsbRsRibLjbRibLjbLcbRgbLsbLgbRgbLsbLsbLsLsmbLsbLsbLgbRc
bRhbLgbLgbLibLsLibRsbLgbLsbLsbLsbLgbLsbLgbLsbLgbLgbLibLgbLsbLsbLsbsbLs
LsmbRsRsmbLsbRjbLibsbLsbLgbLsbLsbLsbLibLsbLgRsbLjbRiRsmbRibRibLcbLsbLg
bLgbLsbRsbLibRibLibRgbLibRgbRibRhbLsbRibLgbRsRgRsmbRsRsmbRsbRgbRsbRgbR
gbLjbRhbLhLsbRgRsmbLibRsRsmbRsLibsbLsbLgbLsbRsbLsbLsbLgbLgLsbRgbLjbLsb
LgbLsbLsbLsbLsbRgbRcb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bRgbRgRsmbRsRsmbRgbRgbRgbRgbRgbRgbRgbRsbRsbRgRsRsmmbRsbRgbRgRsmbRsRsRs
mmbRgbRsbRsbRsRsmbRgbRsbRgRsmbRgbRsbRgRgbRgbRgbRsbRsRsmbRgbRsbRgbLsRsb
RgRsRsRsmmmbRsbRgbRgbRgbRgbLsbRgRsmbRsbLcbLgbLgbRjbLibLgbRcRsmbRiRsmbR
gbLsbRibLgbRiRsmbRsbLsbRiRsmbLjbsbRibLsbRibLsbRibLsbRiRsmbLgbRiRsmbLgL
sbRgbRgLsbRgLsbLsbRibLsbRibLsbRgbRgbRgbRgbLgLsbLcbLibRebLcbRcbRgRsmbRg
RsmbRsbRgRsmbLsbRgbLgRsbsbRiRsmbLgbRsRibLgbRibLgbRibLsbRibRgRsmbRgbLsb
LhbLgbLgbLgbLgbRobLsbRibLsbRgbRsLsRsbRibRsbRgbRsbRgbLsRsbRgbRsRsRsmmbR
sRsmbRgRsmbRsbRsbRgRsRsmmbRsbRgbRsRsmbRgRsmbRsbRgbRsRsmbRgbRgbLsbRsRib
LjbLhbLibLgbLgbLgbLgbLgbLgbLgbLgbLgbRjbRobRibRibLcbLibRjbRcbRibLibRcbR
sbRiRsmbLsbRgRsRsmmbRsbRgbRgRsmbRsLjbRibRsRsmbRgbRgbLsbRgRsmbLsbRgbRgb
RsbRgRsRsmmbLsbLjbLcLgbLgbLgbRsbRjbRibRgLsbRgbRsRsRsmmbRgbsbRsRsLsRsmb
RgbLsbRgbRibRgRsmbLsbRgbLsLsmbRgRsmbRgRsmbRsLsbRsRsmbRgRsmbRsbRgbRsbRg
RsmbRsRsmbRgbRgbRsRsmbRgRsmbRsbRgbRsbRgRsmbRgbRgbRsRsmbRsbRgLsRsbLsbRi
bLsbRibLgLsbRibRsbRgRsmbRsRsmbRgbRsbRgbRgbRgbLsbRgbRsbRsLsbRgbsbLgbRib
LjbLcbsbLiLsbLgbLgbLgLsbLsRcbRibLjbRiRsmbRgLsbRsbRgbRgbRsLsbRgRsmbLsRs
bRgbLsbRibLjbLcbLgbLgbLsbLgbLgbRcbRibRsbRgRsmbLsRsLsbRgRsmbLsbRgbRsbRg
bRgbRsbRsRsmbRsbRgbRgRsmbRgbRgRsRsmmbRiRsmbRgbLjbRgbRgbRgbLjbLcRsbLgbR
sbLsLsmbRcRsmbRgRsRsRsRsRsmmmmmbRsRsmbRsbRgbRsbRgRsmbRsbRgbRgbRgbRsLsb
RgRsmbRsRsmbRgbRgbRsbRsbRgbRsbRgbRgbRsbRgRsmbRgbRsbRgbRsbRgRsmbRsbRgRs
mbRsbRgRsmbRgbRsbRgRsRsmmbRibLjbsbRiLsbRgbRsbLsbRgRsmbRsRsmbRgbRsbRgbR
sbRsRsmbRgRsmbRgbRgRsRsmmbRgbRgbsbRhRsmbRgbRgbLsRsbRibRgbLgLsbLcLsmbLg
bLgbLsbRcbRgbRgbRgRsmbRsbRgbRgbRgbRgbRsbRgbLcRsbRjbRiRsmbRgRsmbRgbRgRs
mbRgbRsbRgRsmbRsRsLsmbRgRsRsmmbRgRsmbRgbRgbRgbRgLsbRgRsmbRsbRgbRgbRsbR
sbRgRsmbRgbLgbRhbLibLcbLiLsbLgLsbLgLsbLgbLgbLsbLsbLsbLcRsLsbLibLgbRhbR
hbLsbRibRgbRsRsmbRgbLcbLgbLgbRsLgbReRsmbRibRgbRgbLsRsbRgbLcbLibLgbLgRs
bRcbRgbRgbRgbRgbLgbRjbRgbLsbRgbRsbRgbRsbRgbRsRsmbRgbLsbRsbRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bLibRcbLibRibRsbRsLsbRsbRsRsmbRsLsbRgLsbLjbLcbLibRsbLgbRsbLsbLsLsmbLsb
LgbLsbRsbLibRgbLsbRibRgbRibLgbRiRsmbLsbLgbLcbLibRgRsmbLibLsbRsbLibRgbL
iRsbRgbLgbLsbLgLsbRsLsbLgbLsbLgbRsbRgbLibRsbRsbLibRsLsbLgbRsRsmbLgbLgL
sbLsbLsbLsbLgbLsbLgbRjbRcLsbLsbRiRsmbRgbRgbLsbRgbLobLsLsmbLsbLsRsbRsbL
iLsLsmbRgbLjbLsbLsbRsbLiLsbRgbLhbRgbRjbLiLsRsbRsbLibRsbRgbRcRsmbRgRsmb
RsbRgRsmbRhbLgbLibLebRgbLiRsbLsLsLsmmbRsbLgbRsbLgbLsbLsbLsLsmbLgbLsbLs
bLsbRsbRebRibRibLsbRcbLsbRgbLsbRgbLsbRsbRsbRsRsmbRsbRsbRsbRsbRsbRgbRsR
smbRsLsbRsbRgbLjbLobLsRsbLsbLgbRsbLibRgbLgbLgbLsbLsbLsbLsbLgbLsbLgbLsb
LsbLgbRjbRjbRibLgbRibLgbRibRgbLgLsbLebLebRgbLibRsbRsbRjbLcbRgbLibRsbLg
LsbLsRsbLsbLgbLsbRgbLibLsbLsbLiRsbRsbLgbLsbLsbLgLsbLsbLgbLsbLsLsLsmmbL
sLsmbRsLgbLgbLsbLsbLsbLsbLgbLcbLibLhbLibRgbRcLsbLjbRcbLjbLcbLsbLgLsbLs
bLgLsbLsbLsbLibRsbLibRsbLsLsmbLsbLgLsbRsbLgbLsLsmbLsbLgRsbLsbLsbLgbLsb
LgbLsbLgbLgbRgbLiRsbRgbLibRsbLgbLsLsmbLgbLsbLgLsbLsLsmbLgbLsLsmbLsbLgb
LsbLsbLsbLgLsbLsLsmbLgbLsLsmbLgbLsbRgbLibRgbLibRsbLgLsbLsbLsbLgbLsbLsb
LsbLsbLsbLgbLgbRsRsmbRgbLibRgbLibLsLsmbRgbLibRgbLibLsbRgbLibLsLsmbLsbL
sbLgLsbLsbLgLsbLsbLsbLsbLgLsbLsbLsbLgbRsbLibLsbRgbLibLsbLsbRsbLibLsbLs
bLgbLsLsmbLgRsbLsbRsbLgbLsbRsbLgbLsbLsbRsRsmbRsLsbLsLsmbLgLsbLgLsRsbLs
LsmbLgbRsbLsbRsbLgLsbRsbLgbLsbLgLsbRgbLibLsbRgbLibLsbLsbLgbRsRsmbsbLsb
LsbLgbLsbRgbLibRsbRgbLsLibLsbRsbLgLsLsmbLsLsmbLgbLsbLgRsbRsLsbLgbLsLsm
bLgbLsLsLsmmbLgbLgLsbLsbLjbRsbLsbLgbLsbLsbLgbLsbLgLsbLsbLgLsbRsbLsbRsL
sbLsbLsRsbLgbRsLsbLibLsbRgbLibLsLsmbRsbLibLsbRsLsbLgLsbLsbLsbLgbLsbLsb
LgbLsbRsbLjbRsLsbLsLsmbLgLsbLgbLsbLsbLgbLsbLsbLsbLgLsLsmbRsLsbLsbLibLs
LsmbRsLsbLsbLgbRsLsRsbRsbLibLsbLsLsmbRsbLibRgbLhbLsbLsbLgbRsbLsbLgbRsb
LgbLsbRsbLsbLgbLsbLsLsmbLiRsbRgbRsLibLsbRgRsmbLhbRgbLibLgbRgbLibLsbRsL
sbLgbLsbLsbLgbLsbRsbLgbLsbRsLsbLjbLsbsbLsbsbRsbLgbsbsbLsRsbLgbsbLsbRsb
LiLsbRsLsbLsbLgbLsLsLsmmbLgLsLsmbLsbLgRsbLgbLsbLsLsmbLsbLsRsLsbLgLsbLs
LsLsmmbRsbRsbLjbLsbLsLsmbRsbLibRibLhbLsLsmbLsbRsbLgbLsbRsbLgbRsbLgbLsb
LsbLsbRgbLsbLsbLgbLgLsbLsRsbRgbLibLsbRgbLibRsbRsbLibLsbRsbLgbLsLsmbLgL
sbLsbRsbLgbLsLsmbLsbLsbsbLsbLsRsbLsbsbLsLsmbsbRsbLiLsbLgbLsbRgbLibRsbL
sbLsbLgLsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bRgbLgbRhbRgbRgLsbsbLjbLiLsRsbLgbRsLsbLgLsbRgbLgbLsbLgbRgbLsbRcbLgbRsb
LsbLsbRgbLjbLcbLgbLgbLsbLgRsbLsRsbRsbLgbLgbLsLsmbRjbRibRgLsRsbRgbRsLsb
LsbRsbLsbRsbRgbRsbRsbRsbRsbLgbRgbLsbLcbLibLgbRsRsmbLgbLsbLsbLsbRjRsmbR
gRsmbRsbRgbRsbRgbRsbRgbLsbRhbLibRsbLgLsbRsLsbLgbRsbLgbsbRsbRjbRcbLsbRs
RsmbLgbRiRsmbLsbLsbLibLibLsbLgbLgRsbLgbLsLgbRsbLsbLsbLsbRcbRgbRgbLsRsb
sbLsbRsRsmbRgbRsRsmbRsbRgbRsbRsbRsbRsbRsbLsbRgbRgbLcbLibRgbRcbLcbLibRj
bLsLcbRgbRcbRibRgbLjbRibLjbsbRsRgRsmbRsbRjbLsRsbLgbLhbLgbLsbLsbLsbLgbR
sLsbLgLsbLsbLsbRgbLgbLjbRibLjbLiRsbRjbsbLgLsbRsbLgLsbLsbLgbRgbLgbLsbLs
bLsbLsbRsRsmbRgRgbRgbLhbLgLsbLsbLgbRgbLibRgbLgbLgbLsbLsLsmbLsbLsbRsbRc
bRibRgbLsbRsbLsbLgbLhbLhbLgbRsbLibLsbLsbLsbLsbLsbRsbLsbLsRsbRobRibRibL
gbRgbLibRgRsmbLgbRsbLsLsmbLsbsbLsbLsLsmbLsbLsLsRsmbLsbLsRsbLsbLsbLsbLg
LsbRsbLgbLsbLgbRsbLibRebRibRgLsbLcbLsLibRgbLgbLsbRsLsbLgbRsbLgbRsbRsbR
ebRhbRsbLsbRsbRgbLcRsbLgbLsbLgbRsbLgLsbsbLgbRibLsbRsbRsbLgbLsLsLsmmbLs
bLsbRsbLgbLsLsmbRsbLgbLgbLsbLgbRsLsbLgbLsLsmbLgbLgbLsLsmbLsbsbLsbLsbRs
bLjbRsbRgbLibLsbLgbLsbsbRsbLgbLsbLgbLsbLgbRcbRhbRibLgbLgbLibLgbLsbLsbL
sbLsbLgbRobLjbLhbRibLibLsRsbLgbRsbLgbLgbLsbRgbLibRsLsbLibRjbLibsbLsbLs
bLsbLgLsLsmbLsbLsbLgbRsRsmbLgbRgbLiRsbRcbRhbRhbLibLcbLiLsbRgbLgbRgRsmb
LgbRjbRcbLebRcbRsbLsRsbLcbLhbRibLcbRibLibLgbRsbLsbsbLsbLjbRsbLsbLsLsmb
LsbsbRsbLgbLsbLsLgRsbRjbLgLsbLibLsbLibLsbRoRsmbRgbRgRsmbLoLsmbLgbLgbRg
bLgLsbLsbLsbLgRsbLsbRsbLgbLibRgbRsbRgbLhbLcbRgbLibLibRgbLibLgbLgbLsLsm
bLgbRsbLsbLsbLsbRsbRjbRsbRsbRibRsbRgbRsbRgbLgbRibLcbLcbLibRgLsbLibRjbL
ibRgLsbLibRsbLgLsbRgbLjbRsRsLsmbLsbLgbLgbsbRsbLjbRsbLsbLgbLsbLsLsLsmmb
LgLsbRsbLgbRcbRhbLjbLcbLgbLgbLgbRsbLgbRsbLgbLsbLgbRjbsbLgbRgbLjbLsbRsb
LsLjbLsbLgRsLsbRgbRhbRibRiRsRsmmbLhbLibLiLsbLgbLgbRsbLibLsbLgbLgbLsbLg
bRsbRgbLjbLgLsbLsbLsbLgbRsbLsbLsbLsbLsbRsbLsLibLibsbLsbLjbLsbLsbLsLsmb
LgbRsbRcbRgbLjbLcbLibRsLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bRcbLcbRjRsmbRsbLhbLibRcbLibLibLsbRiRsmbRhbRhLsbLsbLcbLsbLibLgLsbRhbLh
bRibLjbLjbRjbLjbRgbLcbRjbLsbLsbLibRibLcbLibLsRsbRhbLcbLebRgbLgbRjbsbLe
LsbRcbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 25; Drug: Control Apo 0.5 然
bLsbLgbLjbRcbRgbRgbRgRsmbLcbLcbRcbRgbLsbRsbRgbLsRsbLjLsmbRibRgLsbRsbLi
bRcRsmbLjbRibRcbLgbLjbRibRibRgbRsbRsbRgbLsRsbRgbLgbRgbRibLgbRibLgbLsbL
sbRgbsbRgbRsbRsRsmbRsRsmbRsbRsbRsRsmbRsLsbRsbRsbRsbRsbRgbLsbRgbLjbRibL
jbLcbRobRhbRibLiLsbRhbLgbRsbRgbRibLgbRgbRibRgbRsbRsbLjbLcbLcbLcLsmbRsb
RibLcbLibLhbRhRsmbRcbLgbRibsbLsbRsbRsLsbsbRsRsmbRgbRgbRgbRsbRsbRsbRgbR
gbsbRsRsmbRgbLsbRibRgbLgbsbLhbsbsbLhbRcbRiLsbRhbLgbRibRibRibLibRhRsmbL
gbRibRgbRgRsmbRgbRgbLgbRcbLgbRibRsbRsbRsbRsbRgRsmbRsbRsRsmbRsbRsbRgbRg
RsmbRsbRsRsmbLsbRgbLgbLsLsmbRibRgbLjbRibRsbLsbRgbRsbRsRsmbRsbRgbRsbRsb
RgbRsbRsbsbRsbRgbLgLsbLjbLcbRsbRcbRgLsbLjbRsbRgbRibRiLsbLjbRibLsbRibLg
bRibLgbRibRsbLsbLgbRibLsbRibLgbLsbRibRibRsbLgbRsbRgLsbRibRsbRgbRsbRiRs
mbLcbLhLsbRcbRibRgbLibRgbRgbRsRsmbRsbsbRsbLebLibRiLsbLcbLgbLsbRgbRgbLc
bLibLibRibRgbRgbRjbRhRsmbRgbLhbLcbLgbRgbLibLgbRsLsbRcbLjbRsRsLcRsmbLhb
LibLgbLiRsbRgbLcLsLsmmbLibLsbRsbRsbRgbRgbRsbRjbLibRgbLgLsbLsbLgbRsbLsb
LgbRsbLgbLsbLsbLsbLsbRgbRsbLibRiRsmbRibRjbsbRsbRsRsmbLsbRhbLibLjbRebRi
bLebRibLsbRgbLsRsbRgbRsbRsRsmbRsbRsbRsRsmbLsbRgRsmbLgRsbRsbRsbRsbRsbRs
bRgbRsRsmbRsRsmbRsbRgbRsbRsRsmbRsRsmbRsbsbRsbLsbRsbLibLgLsbLjbRsbRiLsb
LgbRibLgRsLsbRgbRgbRsbRsbRgbRsbRsbRgbsbRsRsmbsbRsbRsbRsbRgRgbRsRsmbRgR
smbRgbRgbRsbRsbsbRgRsmbLjbLobLibLcbLibRibLsbLibRebRibRgbRsbRgbLibRhbRi
bLibRcbLiRsbRibLibRibRhbLgbRibLeLsRsbLibLibLiLsbRibRgbLgbLibLgbLgbRjbR
ebRibLibRibRibLibRibLgbsbRsbRgbsbRgRiLsLsmbLibLibLibLgbLgbRsbLhbRibRcb
RcbLgbRiRsmbLsRsbRgRsmbRsbRsRsmbRgbRgbsbRgRsmbRsRsRsmmbRsbRsLsbRsbLsRg
bRsbRsbRsbRsbRsRsmbRsbRsbRgRsmbRgRsmbRsRsmbRgbRgbRsRsmbRgbsbRgbRibLibL
cbRgbLhbLibLgbLhbLhLsbLibRibRibLibRiRsmbRsbRibLgLsbRgbRsbRgbLsbsbRsbRs
bRgbRsbRgbLsbRgRsmbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 26; Drug: Control Apo 0.5 然
bLgbLsbLsbLsRsbLibLgbRgbLibLsbLiRsbRibLibLsbLgbRsbLgbLgbRgbLibLgbRibRh
bRibLgbRibLgbRiRsRsmmbRsbRibRsbRsbRgbRsbRgbRgRsmbRgbRgbRibLhbLhbRsbLgb
RjbRcbRibLibRhbLgbRiRsmbRsbRsbRgbRsbRgbRgbLgbRiRsmbLgbLsbRibRsbLgbRgRs
mbRgbLgbRibLjbRibLgbRibLsbRsRsmbRgRsmbRsbRsbRsbRgbRgbRsbRgbRgbRgbLgbRi
bRhRsmbLgRsbRibRsbRgbRsRsmbRsbRgRsmbRgbLjbLcbLgbLgbLgbLsbLibLgLsbRsbRs
RsmbLibLsLsmbLgbLgbLsLsmbLiRsLsbRsbLibLsbLsbLgLsbLgbLsbLgbLsbLsbLibRib
RhbRgbRsbRsbRgbRsbRgbLgbRibLgbRibLgbRsbRgRsmbRsbRgbRgbRgbRsbRgbRgbRgbL
sbRsRibRsbRgRsmbRsbRgbRgbRgbRgbLsbRgRsmbRgbRgRsmbRgLsbLsbLjbLcbLibLibL
sbLgbLibRgbLsLibLsbLgbLgbRsLsbLgbLsbLibLgbLsbRsbLgLsbLsbLgbLgbLgbLsbLs
LsmbLgbLsbLgbLgLsbLsbLgbLgbLgbRsbLgbLgbRibLibLgbRgbLibLibLgbLibLsbLibR
sbLgbLgbLgbRsRsmbRjbRcbRsbRgbLsbLsbRibRsbRsbRibRsbRsbRgbRsRsmbRgRsmbLs
bRibRgRsmbLgbRibRibLgbRhbLgbRibLgRsbRibLsbRgRsmbLgbRgbRibRsbLsRsbRhLsb
RibRsbLsbLgbLibRcbRibLjbRcLsbRsLsbLsbRibRsbRsbRsRsmbRgbRibRibLgbLgbRib
RgbLsbRiLsbRgRsmbLgbRibRgbLsbRsbRgbLsbRgbRgbRgbRgbLjbLobLiLsbLgbLsbRsb
RgbLibLsbLgbLsbLgbLsbLgbRgbLibLsLsmbLsbLgbLgbLiLsbRsbLibRgbLhbRjbRcbLc
bRjbRiLsbRibRsbRgbLjbsbLoLsmbLiLsbRsbLsbLgLsbLsbLsbLibRsbLgbRgbLgbLsLs
mbLsbLibRsbLgbLibLibLgbLgbRgbLgLsbLgbLsbLsLsmbLgbLgbRsbLibLgbRsbLsRsbL
ibRgbLgbLgbLsbLsbLgbLsRsbLsbLsLsmbLgbLsbLsbLsbLsbLiRsbRsLsbLsbLibLsLsm
bRgbRoRsmbRsbLibRjLsbLibLgbRsbLgLsbLgbLsbLgbLsbLsLsmbRsbLsbRhbRgRsmbRg
bLcRsbLibRjRsmbLcbRsRsmbLgbRibLcbLgbLsbLibLiLsbLibRjbLhbLsRsbLibLgbRsb
LibLibLsbLgbLgbLgbLgbLgbLibRibLibLgbLsLsmbLiRsbRsbLibRsbLiLsbLsbRsbLhb
LsbRgbLibLgbRsbLgLsbLsbLsbLgbLgbLgbRsbRjbRcbLcbLibLgbRibRjbLibRgbLcbRs
bLibLibLsRsbLsbRsbLhbLgbLgbRgbLibRibLhbRsbLibLgbLsbLibLsbRibLhbLibRsbL
gRsbLsbLibRgbRibLibLibLgbLsbLgbRgbLiLsbLgbLsbLsbLibRsbRgRsmbLhbLgLsbRg
bRgbLibLgbLsbLibRsbRibLhLsbLibRsbRgbLsbRcbLsbRsbLibLsbLibLsbRgbRjbLhRs
bLsbLsbLgbLsbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 27; Drug: Control Apo 0.5 然
bLibRjbRibRsbRibLgbRibRgbLibLjLsmbRjbRibLsRsbRgbRgbLcbLibLsRsbRsLsbLib
LgLsbRsbLgbLgbRsbsbRsbLgLsbLgbRsbLgbLsLsmbLsLsmbRsbLsbLsbLgbLsbLsbLibR
gbsbLgbRjLsbRibLebLibLgbRsbLgbLgbRsbRsLsbLgbRsbLgbLsbLgbLsbLgbRsLsbsbL
gbRsbLgLsbRsbLgbRjbRhbLjbLibLgbLsbLsbRebRibRgRsmbRgbRsbRsbLsbRgbRgbRgb
LsbLjbLiLsbRsbLibRsbLibLsRsbRjbLibLiRgLibRcRsmbRgbRgbRgbLjbLebLgLsbRsb
LibRgbLgbLgbRgbLiRsbRjbLibRsbLgbRsbLgbLsbRsRsmbLibRjbLibLgbLgbsbLgRsbR
sbRjbRgbRgbLsLsmbLibRjbRiRsmbLcbLibLibRsbRgbLsbRiRsmbRgbRibLgbRgbRgbLh
bLibLsLsmbLsbLgbLgbLibRcbLhbLibLsbRgbRsbLgRsbLibRjbLibRgbLibRgbLibLgbL
gbRjbLcLsmbLgbRsbLgbRsbLgbLibRibRibLjbLibLgbRgbLgbLibLiLsbRibRjbLibLib
LhLsbRgbRsbLiLsbRjRsmbRibRibRgbRiRsmbLgbLibLgbRjRgbRibLsbRgbRibLibLebL
ibRsbLgbLsLsmbRsLsbRibRibLjbRjbRibRgbLsbRgRsmbLsbRgRsmbLjbLcbLibLgbLsb
LibLsbRgbLgLsbLgRsbRgLsbLgbLsbLsbLsbLsbLsbsbsbLgbLsbLsbLsbRsLsbLsbLsbL
sbLsbLsbLgbLgbLgbRsbLsbLsbLgbLgRsbLgbRgbLibRgbLibRgbLgRsbRgbLibLsbLsbL
sbLsbLsLsmbLgbLsbLsbRsLsbRsbLgbLsbLibLsbRsbLibLgbLsbRibRjbRgRsLsRsmbRg
bRsbLjbLhbLsbLgbLgbLsbLgRsbLsbRsbLsbLgbRsbRsLsbLgbLgbLsbLsLsmbRsLsbsbL
ibRsbLsbLgLsbRsbRsbLibRjbRibLjbRhbLjbLibLgbLgLsbLibLgbLsbRsbLgbLsbLobR
gbLeLsbRjbLcLsmbLibRgLsbRsbLgbLibLjbRibLibRcbRiLsbLebRjbsbLhbRgbLibLgR
sbRsbLgbRsLsbLgbLsbRsbLgbRsLsbLgbLibRjbRebRibRgbRiLsbRcbRiRsmbLibRsbLs
LsmbRsbLibLgbRsbRgbLibRsbLgbLsbRsLsRsbLjbLsLsmbLgLsLsmbRsbLgbRsbLgbLgb
RgbLgbLgbRsbLsbLgbLgbLgRsbLgbRcbRcbLsLsmbRgbRgbRsbRiLsbLjbLjLsmbLibLgb
RsbLgbLgbRgbLibLgbRsbRgbLgbLgLsbRgbLgbLsbLsbRsLsbLgbLgbRjbRgLsbLjbLibL
gbLgbLgRsbLsbLgbLgbLgbRsbLsbLsbRsbLgbLsbLsLsmbRsbLgbLgLsbsbLgbLgRsbRjb
LsLsmbRibLjbLiLsbLgbLibRgbLgbLsbLiLsbRsLsbLgbRsbRhbLebLhbRgbRsLsbLiLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 28; Drug: Control Apo 0.5 然
bsbRgbLgbRgbRsbLibRsLsLsmbRsbRjbRjRgbsbLgbLhbLsLsmbLgbLibRibRsRsmbLiLs
bLsbLibRibLiLsbLgbLgbLibRibRjRsRsRsmmmbLibLhbLibRsbRjRsmbRibLibLhbRibR
cbRgbRgLsbRgbRibLgRsbRibRsLsbLgbRgbLibRgbRibRgbRgbRgbLgbRibRgbRgLsbRgL
sbRgbRgRsmbRgbLgbRgbRgbLiRsbLibRgbLsbRgbRiRsLsmbRiLsbRsbLgbRibRgbLsbRg
bRgbRgbRibLibRgbLibRgbRgbRgbRgbRgbRibRibLsbRibLsRgbRgbRgbRgbRgbRgbRsbL
obLcbLobRibRibRsbLsRgbRiLsbRiRsmbRsbLsbRgbRgbRgbRgbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 29; Drug: Control Apo 0.5 然
bLsbLgbLsbLsbLgbLgbLgRsbLgbLgbRcbRibRibLibRibLgbLibRibRibRibRibLibLiLs
bLibLsbRsbRjbRgbRgbRgbLsbRibRcbRibLgbLiLsbLgbRsbRiRsmbRibRibRibRgbRibR
hLsbRibRgbRgbRsbLgbLjbLgbLsbLsbLsbLgbLsbLgbLsbsbRebRhbRhbLjLsmbLjLsmbR
sbRsbRibLgbRgbRgbRsbRsbRsbRgLsbLgbLjbLibLgbLsbRsbRgbLgbLgbLhbLgRsbRibL
hbLgbLgbRibRibLsbLgbLibRsbLgbRsbLgbLsbLgbRgbLibRgbLgbLsbLsbLsbLsbLsbLs
bLsbLsbLgbLibRjbLibLibLgbLsbLsbLgbRgbRgbRsbRibRgbLgbRgLsbRjbRhbRcbRgbL
ibRgbLgbLgbLgbRsbLsbLsbLsbLsbLsbLsbLgbLsbRsbLgbRcbRibRsbRsbLsbRgbLsbRg
bRgbLsbLebLhbRjbLgbLgbLsbLsbLgbLsbLgbLsbLgbRgbLgbLgbRgbLgbLgbLgbRgbLgb
LgRsbLgbRgbLgbLsbLsbLsbLsbLsLsmbLsbLsbLsbRsbLgLsbLsbLsbLsbLsbLsbLsbLsb
LgbLsLsmbRsbRsbLsbLsbLsbLgbLsLsmbLsRsbLsLsmbLgbLsbRsLsbLgbLsbLgbLsbLsb
LsbLsLsmbLsbLsbLgLsbLsbLgbLsbLsbLsbLsLsmbLsbLgbLsLsmbLsbRcRhbRgbLsbRib
LgbRhbLiRsbLjbLibRgbLibLgbRsLsbLgbLsbLsbLsbLgbLsbLgLsRsbLsbRsbLsbLgbLs
bLgbLsbRgbRjbRcbRiRgRibRgbLibLjbLibLgbLsbLsbRsbRsLgLsbLgbLsbLsbLsbLgbL
sbLsbLiLsbLgbLgbLsRsbLsbLsbLsLsmbLsbLsLsmbRgbRcbRgRsLsmbRgbRgbRgbRgLsb
LsbRibLgLsbRiRsmbLiLsbLgbLsbLgLsbLsbLsbLgbLsLsmbLsbLsbLsbRsbLgbLgbRsRs
mbRjbLibLgbRgbLibLibRgbRgLsbLibLgbLsbLsbLgbLsbLsbLsbLsbLsbLgbLgbLgLsbL
sbLgbLsRsbLsbLsLsmbLgbLgbLsbLgbLgbRsbLsRsbLgbLsbLsbLgbLsbLsbLsbLsbLsbL
sbLsbLsbLsbLsbLsbLsbLsbLsbRcbRibRibRibRhbRgbLsbRibRibRgLsbRgbLgbRgbRib
RibRgbRsbRgbRgbRgbRgRsmbRsbRgbRgbLsbRsbRgbRsbRsbRgLsbLcbLgbLgbLsbLsbLg
bLgbLgbLsbLsbLsbLsbLsbLsRsbLsbLsbLsbLsbLgbLgbLsbRsbLsbLgbLgbLgbLgLsbLs
bLgbLsbLsbLsbLgbLsbLsbLsbLsbLsbLgbLsbLgbLsLsmbLgbLsbLsbRsRsmbLsbLgbLsL
smbLsbLsbLgbLsLsmbLsbLgbLsbLsbLsbLsbLgbLgbRjbRcbRiRsmbLsbRibRgbRsbRgbL
jbLebLgLsbRsbLgbLgbLsbLsbLsbLsbLsLsmbRgbRjRibRiRsmbLgbRibLgbRibRibLibL
gbRsbLgLsbLgbLgbRjbRcbRibRsRsmbRgbRsbRsbRsbLcLsmbLibLsLsLsmmbLsbLsLsmb
LsbLsbLgbRgRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 30; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bRhbRiLsbRhbRgbRgbRsbRcbRibRgbLgbRgbLsbLjbRiRsmbRgbRibRgbRgbRsbRgbRgbR
ibRgbRgbLjbRibRgRsmbLjLsmbRibRsbRgbLjbRcRsmbLhbRibRgbRsbsbRgbRgbRsbsbR
sbRgLsbRgbLebRgbRiRsmbRgbRgbRsbRsLsbRjbsbRibLgbRibLjLjbRgbRsbRgRsmbLjL
smbRsbRiLsbRibRsbRsbRsbRsbRsbRgbRsbRibLjRsbRgRsmbRgbLgbRiRsmbRsbLsbRgb
RsbLsbRsLsbRsbRgbRgbRibLiLsbRibRsbRsbRsbRsbRibLsbLsbsbRgbRsbRgbRsbLsbL
gbRsRsmbLjLsmbRsbRibRsbRgbRsRsmbLsbLsbRiRsmbsbLgbRibRgbRgbRcbLibRsbRgb
RgbRgbRsbRgbRgLsbLgbRgbRsbRgbLgbRibRsbLsbRgRsmbLsbRgRsmbRsRsmbRgRsmbRg
bLgbRibRgbLsbRsbLgbRgbRsbRgbRsRsmbRibRibLsbLgbsbRsbLibRibRgbRibLgLsbLj
LsmbRibRiRsmbRsbRibRhbRsbRsbRibLjbRjbRjRsmbRibLjbLibRiRsmbLhbRsbRgbLgb
RiRsmbLiLsbLjbRibRjLsbRgbRgbLjbLjLsmbRiLsbRgbRgbRsLsbRjbRgRsmbLjbRsRsm
bRjbLhLsbRgbRjRsmbsbLgLsbLgbLjLsmbLgbRsbRsbLibLsbLjLsmbLgbLgbRjRsRsmmb
Lib

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bRcLsbRibLjbLebRibLcLsmbRebRhbRiRsmbRgbRgbRgbRgbRgbRsbRsbRsbRsbRsbRsRs
mbRsbRsRiRsRsmmbRibRiRsmbRgbRgbRsRsmbRsbRsbRsbRgbRgRsmbRgbLcbLcbRhbLcb
LcbRebLcbLhbLhbLibLsbLsbRibRgbRgbLgbRgbRgbRgbLcLsmbLsbLsbLsLsmbRsbLgbR
sbLibLcbLcbLibRgbRibLcbLhbRsbLsbRgbLsbLcbRsbRgLsbRcRsmbRgbRgbRgbRgbRgb
RgbRgbRsbRsRsmbRsbRgbRgbLsbLsbRjbRgbRgbLsbRgbRgbLjbRcbRgbLsRsbRiRsmbLs
bRsbRibLjbRcbLgLsbRibLhbRibRsbRsbRsbRsbRgbLsbRsbRsRsmbRsbRgLsbRgbRibRi
bLiLsbLcbLibRsbLsbLsbLsbLsbLibLsbRsbRsbLgbLsbLgbLgbLsbLsbLsbLsbLsbLsbL
sbLsbLgbLsbLgbLsbLgbLgbLgbRsbLgLsbRsRsLsmbLgbRsbLgLsbLsbLgbLgbLsbLsbLs
bLsbLgLsbLsbLsbLsbLsbLsbLsbLsbLgbLgLsbLibLgbLgbLsLsmbLsbLgbRsbLsbLgbLs
bLsbLsbLgbLgbLsbRcbRibLjbLcbRjbLhRsbLsLsmbLgbLsbLsLsmbLsbLsbLsbLsbLsbL
sbLsbLsbLsbLgbLsbLsbLgbLsbLsbLsbRsbLgbLgLsbLgbLsLsmbLsbLgbLsLsLsmmbLsb
LsLsmbLsbLsbLsbLsbLsbLsbLsbLsbLgLsbLgbLsbLsbLsLsmbLgbLgbLsbLgLsbLsbLsL
sRsmbLsRsbLgbLgLsbLsbLsbLsLsmbLsLsmbsbLsLsmbLgbLsbLgbLsbLsbLsLsmbLsbLg
bLsbLsbLgbLibRsbLgLsbLsbLgbRgbLgbRgbLibLgbLsbLsbLsbLsbLsbLgbLsbLsRsbLg
bLgbLsbLgbLsLsmbLsbLgbRjbLibRsbRhbRibLhbLibRsbRsLsbLibRsbLgbRsbLgbLsbL
sbLgLsbLsbLgbLsbLgLsbRsLsbLsbLgbLsbLsbLgLsbLgbLsbLsbLsbLsLsmbLgbLsLsmb
LsbLsbLsbLsbLsbLsbLsbLsLsmbLsbRsLsbLsbLgbLibLsbLsbRsbLibLgbRsbLsbLsbLg
bLsbLgbLsbLsbLsbLgbLsbLsbLsbLgbLsbLgLsbLsbLsLsmbLsbLgLsbLsLsLsmmbLsbLg
bLgbRsbLgLiLsbLgbLsbLgbLsbLgbLsLsmbLsbLsbLgbLgLsbLsbRsbLibRgbLibLibLgb
LgbRibRgbRibRgRsmbRgbRsbRgRsmbRsbLibLgbLgbLgbLibLsbLgbRsLsbLsbLgbRsbLg
bLgbLsbLsbLsRsbLgLsbLsbLsbLgLsbLsbLgbLsbLsbLgbLsbLgRsbLsbLgbLsbLsbLgbL
sbLsbLsbLgbLsbLsbLgLsbLsbLgbLsbLgbLgbRcbRibLjbLcbRibLcbLsbLsbLsbLsbLgb
LsbLgbLsbLsbLsbLsbLgbLsbLsbLgbLsbLsbLgLsbLsbLgbRsbLiLsbRsLsbLgbLsbLsLs
mbLsLsmbLgRsbLgLsbLsbLgbLsbLsbLgbLsbLsbLsbLgbLsbLgLsbRgbRcbRgbLebLsbLs
LsmbLjbLhbRsbRsbRsbRsLgbRhbLcbLcbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bLibRibLgbLjbLibRgbRibLsbLsRibRgbRgbRibLibRiLsbRgbRsLsbLhbRibRsbRgbRgb
LsbRsbRsbLsbRgbRgbRgbRgbRgRsmbRgRsmbRsbRgbRgbRsbRsRsmbRgbRsbRgbRgbRgbR
sbLgRsbLebRobRcbLgbLhbLibRgbLhbRgbRhbRhbRiRsmbRgbRibLgbRgbRgbLcbLcLsmb
RibRiRibRgRsRsmmbRgbRsbRgbRgbRsbRsbRgRsmbRgbRgbLgRsLcbLhbLcLsmbLcbLibR
cbRibLcbRebRhbRibRibLcbRsbLgbLsbRjbLibRjbRcbLjbRobRcbRibLjbRcbRjbLebLh
bRhbRcbLjRsbLcbLcbLibLhbRibLibLcRsbRjbRcbRgbRsbRgbRsbRsbLsbRgbRgbRgRsm
bsbRsbRhbLjbRibRgbRsbRsbRgbRsLsbRsbRgbRsbRgbRgbRcbLjbRjbLjbRiRsmbLibRc
bLcbRhbRgbLibRgbRgbRgbRsbRsRsRsmmbLgbRgbRibLjbLcbRcbRcbRibLibRsbRsbRgb
RsbRsbRsbLsbRsbRgbRgbRsbRgbRsbRsbRsbRsbRgbRgRsmbRgbRgRgbsbRgbLsbRjbLcb
LcbRhbRibRgbRiRsmbRsbRsbRsbRgbRsbLsbRgbRsLsbRgbRgbLjbLcbLsRjbRibLcbRjb
RcbLhbLcbLibLiRsbLibLgLsbLgbRjbRibRgbLjbLgbRsbLibRgbRgbLgbRgbRibRiRsmb
RsRhbRhbLebRsbLgbLgRsbRhbRjRsmbLjbLcbRjbLhbLcbLibLgbLgbLgbRjbRibLcbRob
RcbLhbRibRsRsmbRgbLsbRgbRsbRgbRsRsmbRsbLsbRsbRgbRsbLsbRgbRgbRsbRgbRgbR
sbRibLcbRcLsbRcbLhbRjbRsbRgbRsbRsRsmbRsbRsbRgLsbLcbRjbLibRcbLcbLcbLibL
sbRgbRgbRgbLibLgbLgbRibRgbLibRjbLcLsmbRcbLcbLhbLibLiLsbLibLsbLgbRibRgb
RgbRsbRsRsmbRgbRsbRgbRsbRsbRgbRsbRgRsmbRgbRgbRsbRsbLsbRgbRgbRgbRgbLjbL
cbRgbRcbRibLjbLcLsmbRcbRcbRcbLibRibLgbRibRcbRibRgbRibRgbRsbRgRsmbRsbRs
bRgbRgbLjbLjbRcbLebRcbLjbsbRcbLgbRibRsRsmbRsbRgbRsbRsbRgRsmbRsbRsbRsbR
sLsbRsbLsbRgbRgbRsbRgbRgbRsbRsbRgbLjbLcbLgbRgbRsbRobRibRgbLibLsbRjbRib
RgRsmbLhbRibLjLebLibLibLsbLibLsbRjbRibLibLjbLibRibRjbRibLibRibRgbLsbRi
bLibLjbRoLsbRcbLibRgbRibRgbsbLjbRjbLibRibRgbRsbRsbRsbLsbRgbRgbRgbRibRg
bRsbRsbLsbLsbRgbRgbRgbRsbLsbRsbRsbsbRgbRgbRsRsmbRgbLcLibRibRjbRibRsRsm
bRsRsmbRsRsmbRsbRgbRsRsRsmmbRgbRsbRgbRsbRsbRsbRsbRgbRgbRgbRgRsmbRsbLsb
RgbRjbLjbRibRgbLhbRibRgbRgbRgbRibLjbRgbRsRsmbRgbRsbRsRsmbRsbRsbRgbRsbR
gbRsbRgRgbRgRsmbRsbRgbRsbRsRsmbRsbRgRsmbRsbRsbLsbLjbLiLsbRjbRibLhbRcbL
cbRjbLhbRobRhbRibRibLibRhbRhbLjbRcbRibRgbLiLsbRgbRsLsbRgRibRibRgbLjbLc
bLhLsbLibRsbRgbRsbRibRgbLjbLhbRjbRibRgbLsRsbRibRsbLsbRsbRgbRsbRgbRsbRs
RsmbRsbRsbRgbRsbRsbRsbRsbRsbRsbRgRsmbLsbLsbRgbRcbLjbLcbRjbRcbLhbRgRsmb
RiLsbLjbRoLsbRibsbLjLsmbRibRgbLhbRjRsmbRgbRsRsmbRgbRibRsbRgbLsbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bLsbLgbRsbLgbRsbLibRgbLibLsbLsbRgbLibLibLibLgbLgbLgLsbLgbLsbRibLgbLsbL
sbLgLsbsbsbRsbRsbLhbRsbLsLsmbLsbLgbLgRsbsbRjRjbLsLsmbLsbLsbLibLsbLgbLs
bLgbRsbsbRgRsmbRsbRgbRsbLjbLgbLsbLsbLsbLibLsbLsbLsbLibRgbRsbRsbLsbLsbR
ibRibRsbLsbLgbRibRgbLsbLgLsbRgbRsbLsbLsbRibRibLsbLibRgbLsbsbLsbRibRsRs
mbRiRsmbsbRgRsmbRsRsmbRsbLjLsLsmmbRibRsbRgbRibRsbLsbRibRiRsmbsbLsRsbRi
RsmbRsLsbRjRsmbLgbLgbRiRsmbRsbRgRsmbRibLsbRiRsmbRsbLsbRibRsRsLsmbLsbLs
LsmbLsRsbLjLsmbRsbRgbRcbLjLsmbRsbRsbRsbRgbRgbRgRsmbRibRsbLgbLsbLgbLsbR
sbLibLsbLibRsRsmbLibRgbLsRsbRsbLibLsbRsbRjRsRsmmbLcbLibRsbLsLsmbRgbLsb
LibLsbLsbRsbLjLsLsmmbLgbLsbLgbLiLsbLgbRsbLsbLgLsbLgbRsbRgbRibRgbRsbLgb
LsbLgbRgbRibLsbRibLgbRsbRgbRsbLibRgbRgbRgbRgRsmbRsbLgbRiRsmbRsbRgbLsbR
gbLgbRgbRsbLgbRibRibRsbLsbRgRsmbRgbLsbLgbLsbRgbRibRgbRsbRibLsbLgbRgRsm
bLgbRsbLgbLhbLgLsbLsbLibRsbRgbLiLsbRsbRsLsbLsbLibLsbRsbRgbLibLgRsbRgbR
sRsmbLibLsbLgbLibLsLsmbLsbLsbLgbLgbLgbRgbLibRsRsLsmbLgbLsbLsbLgbLhbLgb
LsbRgbRgbRiRsmbRsbRgbLhbLibLsbRsbRgbLibLibRsbRsbLibLsbLsbLgLsbRgLsbLib
RgbLibRgbLgbLgbRgbLibRgbLibLsbLgbLsbLgLsbRgbRsbRsbLsbRibRgbRsbRiRsmbLs
bLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bRibLibLgbLsLsmbReLsbRibRibsbRibRgbRsbLjbLgbRgbRgbRgbRgbRsbRgbRsRsmbRs
bRsbLgbLsLsmbLgLsbLsbRsbRgRsmbRjRgbRiRsmbRibRgbLgLsbLgbRibRgbRsbLgbRib
RibRsbRgbRgbLsbLsbRibRgbRgbRsbLjbRibRsbRsbLsbRjbRjRsmbRibRibRgbRsbRsbR
sbLsbLgbRgbRibRgbLibRgbsbsbRgbRgbRgbRsbRsbLsbLsbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bRibLsLsmbLibLiLsbRgbRsbRgRsmbRibLgLsbLjbLibRibRgbLibsbLsbLsbLiLsbRgbR
ibLibRhbRgbRibRhRsmbRgbLebLhbLibRgbRibRibLgbRsbRgbLibLibRsbRhbLhbLsbRg
bLibLibLhbLhbRibRjRsmbLgbLiRsbLibLgbRobLibLibRsbRgbLiLsbLgbLsLsmbLgbLs
bLsbLgbLgbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bLgbLgRsbLsbRibRsbLsbRibLibsbsbLsbLsbRsLsbRsbRsLsbRsbLsbLgLsbLsLsmbLib
RibLgbRjbsbLibLibLibLibLsLsLsmmbLjbRiRsmbLsbLsLsmbLiLsbLsbLiLsbLsbLsLs
mbLsbLjLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bRibRgbRsbLsRsbLgLsbLsbLsbLibLgbLsLsmbsbLsbLgbLiLsbLgbRibLjbRjRsmbLibL
ibRjRsmbRibLgLsbLibRibRibRgbRiRsmbLgbRgbRsbRgbLgbRhbRibLgLsbLgbRibRjRs
LsmbRjRsmbRibLgbRsbLsbLgbLibRsbLibLibLgLsbLjbRibsbLsbLjLsmbRibLibLgbRc
bRjRsmbLibRjbLibRgRsmbRgbLibRibRibRgbsbLibRibLjbRibLjLsmbRgbRgbLibLgbR
gbRjbRibRibLibRibLibRiRsmbLibRcRsmbRibLgbRibRiRsmbLibRibLgbRibLibLibRg
RsmbLgLsbRibRiRsmbLibLgbRgbLibRgRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bLsbLsbLgbLsbLgbLgbLsbRibLhLsbRsbLibRgbLibLgbRibLiLsbRgbLibLsLsmbRgbLi
bLsbRgbLibRsbLibLsbLsbLgbRjbLibRgbLibRgbLgLsbRsbLgbLsbLsbLsbLsbLgbRgbL
ibLgLsbRiRsmbRhbRibLjbLoLsLsmmbRiRsmbRibLobRgbRjbLcLsmbRiRsmbLibRgbLhL
sbRgbLibRgbLibRgbLibRgLsbLibRgLsbLibLgbRgbLiRsbRgRsmbLibRsbLgbRsbLgbLs
bLsbLsbLgbLgLsbLgbRibLhbRgbLibRsbLibRgbLiLsbRgLsbLibRsbLibRsLsbLgbLsbL
sbLgLsbLsbLgbLsbLsbLsbLsbLsbLgbLsbLsbLsbLsbLgRsbRgbLebRiLsbLcbRibRsbLh
bRjbLobRibRsbRgbRibRcRibRibRgbLibLibLebRibLcLsmbRibLibRgbLibRgbLgLsLsm
bLsbLsLsmbLgbLsbLgLsbLsbLgbRsbLgbRgbLgbLsbLibRgbLibLgLsbRibLibLgLsLsmb
RgbLiLsbLiLsbLgLsbRiLsbLiLsbRgbLebRjbLhbRjLsbLebRibLibRjbLhbRgbLiLsbLg
LsbRibLibLgbRgLsbRgbLiLsbLebRibRjbRiLsbRhbLjbLcbRsbLibLcLsLsmmbRgbLiLs
bRibLhbLgbLsbRsLsbLgLsbLgbRgbLibLibRgLsbLibRsbLiLsbRgbLibRgbLibLgbRsbL
ibLsLsRsmbRgbLiLsbLgbRibLibLsLsmbLgbLsLsmbLsbLiRsbRgbLiLsbRsbRsLibLsLs
mbLsbLgbLsbLgbLgbLsbLgbLsbLgbRjbLiLsbLgbRsbLgbRsLsbLgbsbLibLibRibLhbLg
LsbRsRsmbRgbLcLsmbRsbRjbLhbLsbLgLsbLgbLsbLgbLsLsLsmmbLgbLgbLsbLsbLgLsb
RgRsmbLiLsbRjbLibLgbLibLsbRiLsbLibLibRgbLibLsbRgbLiLsbRgbLiLsbRsLsbLib
RsbLgLsbRgbLibRgbLibLsLsLsmmbLgbLgLsbLgbLgbLgbLsbLsbLsbLgbLsbLsbLibRgL
sbLibRibLibLsbLibRgbLiLsbRsbLgbLgbLsbLgbLgbLgbLsbLsbLsbLsbLgbRjbLiLsbR
gbLibLsbRgbLiLsbRsbLibLsbLgLsbLgbLsbLsbLgbLsbLgLsbLsbLibRebRibRgbRibLj
bRibLcLsRsmbLgLsbRgbLibLsbLgLsbRsbRgbLiLsbLsbLsbLgbLgbLgbLgbLgbLgbRgbL
iLsbRgbLiLsbLsbLsbLgbLsbLgbRsbLibRgbLgbLgLsbLsbLgbRgLsbLibRgbLibLgbLsb
LgbLgbLsRsbLgbLsbRsbLibRgbLibLsLsmbLgbLsbLgbLgbLsbRsbLibLsLsmbLsLsmbLg
bLgbLsbLgbRgbLibRibLibLsbLsbLgbLsbLgbRsbLibLsLsmbRsbLgLsbLsbLsbLsbLgbL
gbLgbLgbRsbLibRgRsmbLiLsbRjbLibLhbRgbLhbRibLiLsbLsLsmbLgbLsLsLsLsmmmbL
sbLgbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bLgbRibRiLsbLibLjRsbRjbLhbRjbRcbRibRsbRsbRibsbRgbLjbRgRsmbRsbRsRsmbRsb
LsbRsbRsbsbLsbsbRgLsbLgRsbRgbRsbLsbRgRsmbLsbLsbRibRsbLsbLgbRgbRsbRgbRs
bRsbRsbRgLsbLgbRgbRgbRgbRsbRsbRsRsmbRsbRsbRsRsmbRibRibRibRibRgbLjbRiRs
mbLjbLjbLhbRjbLhbRjbLjRsbLgbLgLsbRjbRobLsRsbLgRsbRibLgbRgbRgRsmbLjbRib
RgbRsbRgbRsbLsRsbLsRsbRsbRibRgbLsbRgbLgbRibLsbRgbLgbRibLjbRibLgbRibLsb
RsRsmbRsRgRsmbRiRsmbLibLhbRcbRcbRgbRgRsmbRibRibRibRsLibLibLibRiRsmbLgb
LgbRcbRibRsRsmbLsbRsbRiRsmbRgRsmbRsRsmbRgbRsbRsbRsbRsbRsbRgbRsbRgbRibL
sbRgbRsbRhbLibLcbLcLsmbRibLiRsbRgbsbLcbRibRsbLibLsbLcbLcLsmbRibRgbRsRg
bRgbRjbRibLgbLsbRsRsmbRgRsmbRsbLsRsbRsbRsbRsRsmbRsbRsRsmbRsbRsbRgbLsRs
bLsbRsbRgbLsbRjbRibLjbRibRgbLjbLibLgLsbLsbRsbLgbLgbLsbLsbLibLgbLsbLsbL
gbLgbLgbRgbRcbRibLgRsbLjbLhbLgbRcbRgbRsbRsbRsbLsLsmbRsbRgbLsRsbRsRsmbR
sbRsbRsRsmbRsbRsbRgbRsbRsRsmbsbsbRgbRsbLsbRgbRsRsmbRgbRsbRsbRgbLjbsbsb
RibLjbLsLjbRibRibLsbLsRsbLsbLsbLjbLibLgbLsLsmbLgbLgbLsbLgbLibRibRcbRib
LibRgbRgbRsbRsbLsRsbRsbRsRsLsmbRsbRsRgRsLsmbRgLsbRsbRsbRsbRsRsmbRsbLsR
sbRsbRsbRsRsRgRgLsmbRsbRsbRsbLsbLhRsbLgLsbLgbLsbLsbLsbsbRcbRgbRsbRibLs
RsbLsbRgRsmbRsRsmbRgbsbRsRsmbRsbLsbRsbLsbRsRsmbRsbRsbRsbRgbRsbRsbRsbRs
bLsRsbLsbRgbRsbRsRsRsmmbRgRgRsmbRsbRsbRsbRsbRgbRsbRgbRgbRgRsRgRsmmbRgb
RsbRgbLjbLhRsbRjbRiRsmbRibLsbRsbRgbRsRsmbRsbRgbRsbRsbRgRgRgRgRgbRgRsmb
RgRsLsmbRjRsmbLcbRcbLcbRcbLcbLcbLhRsbLibLgbLgbLibLiLsbLgbRjRsRsmmbRhRs
mbRhRsmbLiRsbLibRjbRhbLjbRiRsmbRgbRgbLgbLibLibRcbLjbRcbLgbRsRsmbRibLsR
sbRsbLsRsbRsbRsbRsRsmbLsRgRgRgRsmbLsbRgbRsbRsRgbRgbRgRsmbRsbRsbRgbRsRs
RsRgRsLsmmmbRsbRgRiRsmbRsbRgbRgRsRgRgmbLjbLibRjbRibLibLhbRcbRhbRcbRcbR
cbRcbLcbLcbLcbRhbRcbRibRsRsmbLsbLsbLibLibRjbLibLcbLibLibLiRsbLibLiLsbL
gbLgRsbRgbLibRjbRcbRibRgbRgbRsbLsbRsbLsLsmbsbRgbRsRsmbLsbRsRsmbRsbRgbR
gbRsRsmbLsbRgbRsRsmbRsbRgbRsbRsbRgbRsbRgRgbRgRgRgRgRgRgbRsbRgRgbRgbRgR
gbRsbRsbRgbLgbRgbLjbLcbRcbRcbLibRhbRiRsmbRhbRhbRibLgbRibLibLcbLhRsbRgb
RjbLcbLcbLgbLibLgbLgRsbRjRsmbRgbRsbLsbRgbRsbRgbRsRgRiRiLsbRgbRgbRgbRib
LiLsbRgbRgLsbRsbRsbRgbRsbRgRgbRgRgbRgRsRgReRimbRcbRcbRcbRcbRibLibRibRg
bRibRcbRibRiRsmbRibRsbRgbRsbRgbRsbRgbRgRgRibRibLsRsRgRgRiRgRiRiRsRimbR
gRibRgbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bRgbRsbRsbRsLsbRsbRgbLgbRibLgbRibLgbRgbRgLsbLsbRgbLsbRsbRsbRsbRsbLsRsb
RgbRsbRgLsbRgbLsbLsRgbLjbLibRcbRebRsbLsbRsbRiRsmbRiRsRsmmbRgbLsbRsbRgb
LjbRibLgbRibLsbRgbLsbRsbRsbRgbLsbRgbLsbLjbLgbRjbRgbRibLgLsbRgbRsbRgLsb
LsbLsbRgbRgbRgbLsRsbRsbRgRsmbLsbRgbLjbRibRgRsmbLibRgbRsbRsbLsbLgbLjbRc
bRgbLgbRgbRgLsbLsbRgbLgbRgbLsbRgbLsbRgbRsbRsbRgbLgbRibLgbRibLsbRgbRsbR
sRsmbRibRgbLibRibLsbRgbLsbRgbRsbLsbRgbLgbRgbLsRsbRgbRsRsLsmbRgbLibRjbL
jbRibLgbRibLgbRibRsbRsRsmbRgbRgbLgbRibLgRsbRibRgbRgbRgbLcbRsbRgbRgbRgb
RsbLgbRibRsbLsbLgbRiRsmbLsRsbRgbLsbRgbRgbLsbRgbLsbRgbRgbRgbLgbRsbRgbLg
bRibRsbLibRibRsbRsbRsbLgbRgbRgbRgbRgbRibLiLsbLgbRibRsbRiRsmbLsbRgbRsbR
gbLjbRibLibRibRgLsbLgbLgbRibsbRgbRgbLgbRgRsmbLsbLsbRibRgLsbLjbRibRibRg
bLibLgbLsbRhbRgbRgbLibRiRsmbRibRsbLgbRgbLsbLgbLsbRhRsmbRsbRsRsmbRsRsRh
LsLgmbLcbLgbRsLsbRibLgbRsbLsbRiRsmbRgbLgbRibLsbRgbRgRsmbLibRcbRsbRiRsm
bRgbRgbLgbLgbRibRibRgbLibRibLgbRgbRgLsbRgbRgbLjbRiRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bLibLibLiLsbLiLsbLsbLsbLgbLsbLgbLsbLsbLsbLsbLsbLsbLgbLsbLsbLgLsbLgbLgb
LibRsRsmbLgbLsLsmbLsbLgLsRsbRsLsbLgbLibRgbLibLgbLgbLgbLgbLgbLsbLsbLsbL
gbRsbRjbLiRsbLgbRsbLgLsLsRsmbRgbLibLsbRsbLibLsbLsbLsbLsbLgRsbRgbLgbLsb
LibRsbLgbRsbLgbRsbLgLsbLsbLgbRsLsbLgLsbLsbLgLsbLsbLsLsmbLgLsbLsbLsbLgb
LsbLgbLgbLjLsmbLgbRgbRgLsbRibLjbLhbLiLsbLcbRcbLhbRsLgbLgbLsbLgbRgbLibL
sbRsbLgbLgbLhRsRsmbLcbLibRibRibLgbRgbRgbRsbRsbRgbRgbRgbLcbLhbLibLibRib
LgbRgbRibRiRsmbLsbRsRsmbRiRsmbRsbRgbRibLjbLhbLiRsbRgbLibRjbRcbRiRsmbLj
bLcbLgbLgbRsbLsbLgbRebRiRsmbRsbRgbRsbRgbRsbRgbRsbRsbRsRsmbRgbRgbLgRsbR
ibLcbLcbLibLsbLsbLsbLgbLgbRcbLgbRsLibLgbLgbLgbRgbLibLgbLsbLgbLsRsbLgbL
sbLgRsbLsbLgbLgbLgbRgbLibLsbLsbLibLgbRsbLgbLsbLsbLsLsmbLsbLgLsLsmbLsbL
gbLgLsbLgbLibRcbRiRsmbRibRsbRiLsLsmbRjbRgbRgbRsbRgRsRsmmbRsbRsLsbRgRsm
bRsbRsbRsbLsRsbRgbRsbRgbRsbRgbLoLsmbLsbLibRgbLgLsbLibRsLsbLibRgbLibRgb
LibRsLsbLgbLgbLsLsmbLsLsmbLsbLsbLgbLsbLgbLgbLsbLsbLsbLgbRgbLgbRsbRsbLs
LgbLgbLsbLgbLibRcRsmbRibRgbLgbRibRgbLibRibRgbLsbRgRsmbRsbRsbRsbRsbRsbR
sbRgbLjLsmbLcLsmbLibRgbLibRjbLibLgbRsbLgbLsbLsbLsbRsbLibRsbLsLsmbLgbLg
bLgbLsbLhbLsLsmbRcbRibLjbLhbLiRsbRjbRjbLibRjbRhbRgbLjbLibLgbRsbRsbRgbR
jRsmbRibLgbRgbRsbRgbRsbRgbRsRsmbRgbRgbLcbLgbRgbLibLsbLsbLsbLsbLgbLsbLg
bLsLsmbLgbLsbLgbLsbLsbRsbLgLsbLgbLgbLsbRsLsbLgbLsbLsbRsbLgbLsbLsbLsbRc
bRibLcLsmbLgLsbRgbLgbLgLsbRsbRjbRcLsbLcbLibLgbRsbLgbLsbLsbLibLebLcbRgb
RgbRgbLgbRibLhbLgbLgbLsbLsbLsbLsbLsbLsLsmbLgbLsbLgLsbLgbLsbLgbLgbLsbLs
bRsbLgbLsbLsbLsbLsbLsLsmbLgbLsbLgbLsbRgbLiLsbRcbRibRgbRgRsmbRsRsmbRgbR
sbLgbLcbLhbRhbLiLsRsbLjbLsbLsbLsLsmbLsLsmbLsbLsbLgbLsbRsbLgbLsbLsbRsbL
gbLsLsLsmmbLsbLsbLsbLsLsmbRsbLgLsbLgbLsRsbLgbLsbRcbRiLsbLjbRibRgRsmbLs
RsbRgbRsbRgbRsbRgbRsRsmbRsbRgbRgbRsRsmbRsLsRgRsmbLgbRibLgbLhbLibRjbRcb
Lhb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bLjbLibLsbRgbLibLgbRcbLjbLhbReRsmbRjbLibLibLibLibLjbLibLibLjbLhbLhbRhb
RibLebLibLgbLibLgbLgRsbRsRsmbLibRibRhbRhbRgbRjLsbLjbLcbLibsbLiLsbLebRj
b

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bRgRsmbLsRsbRgRsmbLibLjbLibRebRgbRgRsLsmbRsbRsbRsRgbRsbRsbRgbRsLsbRsbR
sbRsbRgbRsbRsbRsbRsRsmbRsbRsbRsbLsbRgRsmbRibRgbRsbRsbRsbRsbRsbRsbRsbRs
RsmbRgbRgbLsbRsbRsbRsbRgbRsbRsbRsbRsbRsbRsbRsbRsbRgbRsbRsLsbRsbRsbLcbL
sbLgbLgLsbRsbLsbLsbLsbLsbLsbLsbLsbLgbRcRsmbRgRsmbRgbLgbRibRsbRsRgbRsbR
gbRsbRgLsbLgbRgbRsbRibLjbRgbRgbLgbLhbLiRsLsbRgbRgbRibRiRsmbRgbLgbLsLsm
bRgRsmbRgbRsbRsbRsbRsbLsbRgbRsLsbRgbRsLsbRgbRgbLsbRsbLsbRsbRsbRsbRsbRs
bRsbRsbRsbRgbLcbLibLgRsbRsRsmbRsbLibRgLsbLibRebRibRgbRgbLgbRgbRsbsbRgb
RsbRibLibRgbRsbRgRsmbRgbRgbRgbRibRgbRsbLsbLsbRsbRibRsbRsbRgbRsbRgLsbRs
RsmbRgbRgbRsbRsbRsbRsRsmbRsbRgbRsbRsbRgbLsbRgRsmbLsRsbRgRsmbRgbRgbRsbR
gbRgbLgbRgbLgbRgbRsLsbRgbRsbRsbRsbRsbRgbRgbRsbRsbRsbRsbRsbRsbRsbRibRgb
LgbRgbRgbLsRsbRgbLgbRgbRsRsmbRgbRsbRgbRsRsmbRgbRsbRsbLgbLhbLibLsbLgbRs
bLgbRsbLsbLgbRsRsmbLgbRjRjbRhbRsLsRsbRgbRsbRsbRgbLsbRgLsbRsLsbRgbRsbRs
bRgbRgbRsbLsbRgbRibLjbLibLgbLgbLsbLsbLsbRsbLsbLgbLgbLsbLsbRsbLcbRibsbR
gbRsbRgbRsbRsbLsbRsRsmbRsbRgbRsbRsbRgbRsbRgbRgbRsbRsbRsbRsbRsLsbRgLsbR
sRsmbRsbRsbRsbRsRsmbRgbRgbRsbRsRsmbRsbRgRsmbRsbRsbRgLsbRsbRsbRsbRsbRsb
RsbRsbRsRsmbRgbRsbLgbRgbLjbsbRjbLjbLcLsmbLgbLgbLsbLsbLgbLibRobRgbRgRsm
bRsbLsbRgbRsbRgbRsbRsbRibLjbRiRsmbRgLsbRgRsmbLgbRsbRibLgbRgbRsbRgbRgbR
gbRgbRsbRgbRgbLjbRibRgbLsbRgbRsbRsbRsRsmbRsbRsbRgbRsbRsbRsbRsRsmbRgbRg
bRsbRsbRgbRsbRsbRgRsRsmmbRgbLsbLsbRgbRsbRsbRsLsbRsbRgbRgRsmbRsbRsbRsbR
gRsmbRgbRsbRsbRsbRsbRsbLcbLiRsbLibLibLibRjbRhbRibRsbRgbRsbRsbRgbRsbRgb
RsbRsbRgbRsLsbRsbRgbLsbRgbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bRibRsLsbRgRsmbRsbRsbRsbLsbRgbRibLhbLiLsbRsbLsbLgbsbLibRjbRhbRibRsbLsb
sbRgbRsbsbRgbRsbRgbRhbLgbLgLsbRiRsmbRgbRgbRsbRgbLjbLibRgbLibRjbLibRjbL
ibRhbRcbLcbRhbRibRiRsmbLgbRibRsRsmbLsbRgbRsbRsbRgbRiRsmbLsbRsbRgbRsbRs
bLsbRgRsmbRsbRgbLjbLcbLibLsbLgRsbRjbRcbRcbLgbRibLsbRgRsmbRsbRgbRgbRsbR
gbRibRsbLsRsbRgbRsbRgRsmbRibRsbRsRsRsmmbRiRsmbLsbRibRgbRsRsRsmmbRsbRgb
RsRsmbRsbRsbRgRsmbRsbRsbRsLsbRsbRsbRgbLcRsbLiLsRsbRsLsbLgbLgbRcbLsLsmb
RibRgbRsRsmbRsbRsRsmbRgbRibRsbLsbRgbRsbRsbRsbRgbRiRsmbRgbLgRsbRgbRgbRg
bRsbRsbRgbRgbRhbLibRhbRsbLsRsbRgbRgbRsRsmbRibLsRsbRsRsmbRgbLcbLibLsbLg
bRsbLibRibRcbRiRsmbRgRsmbLgbRibRsLsbRgbLsbRgbLsRsbRsbRgbRgbLcbLgbLgRsb
LgbLgbRsbLiRsbRjbRcbRibRgbLsbRgbRgbLsLsmbRgbRgbRgbLgbRibLcLsmbLibLgRsb
LsbLibRsbLgbLsbLgLsbLgbRcbRsbRhbRsbLsbRsbRiRsmbRgbRsbRsbRsbRsbRgbRgRsm
bRgLsbLjbLhbLibRjbLhbRjRsmbLhLsbRjRsmbLcbRibLhbRibLibRsLgbRjbRsLibRcbR
gbRsbRgRsmbRsbRgbRsbRsbRsRsmbRsRsmbRgbRgbLsRsbRiRsmbLgbRgRsmbRgbRsLsbR
sbRibLcbLgRsbRjbRiRsmbRgbRgRsmbRgbRibRsbLjbRcbLgbsbRiRsmbLsRsbRgbRsbRg
bLjbRibRsbRsbRgbRgbRgbRgbLsbRsRsmbRgbRgbLsRsbRgbLcbRjbRhbRgbRgbRsbRsbR
gbLgbRgbRibRgbRsbRgbRsRsmbLsRsbRsbRgbRgbRsbLcRsbLibLsbLgbRsbLgbRcbRgbR
sbLsbRgbRgbRsbLgbLsbRsbRibRsbRibRgbLibRibLgbRsbRgbLsbRgbLsbRgbRsbLsRsb
RgbRgbRsbLcbLiLsbRcbRsRsRimbLcLsmbRhbRcbRsbRibLgbRgbRgbLsbRgbRibRgbRgR
smbLjbRiRsmbRsLsRsbRsbRsbRgbRsbRibRgbLgbRsbRgbRgbRibRsRsmbLsbRgbRsRsmb
RsbRsRsmbRgbLsbRgbRgLsbLgbLsbRibRgbRgbRsbLsbRgLsbLsbRibLsbLsbRgbRgbRsR
smbRsbRgbLjbLibLsbLibLsbLgbLsbLsbLsbLgLsbLgbRhbRhbRgbRsRsRsmmbRgbRsbRg
bRsbRibLsRsbRgbRsbLsbRgbLsbRgbRsbRgRsmbRgbRibRsRsmbLsbRgbRgbRibRgbRgbR
sbRgbLhLsbLhRsbRsbRsLsbLibLsbLgbRjbRcRsmbRgbRsbRgbLsbRgbRsbRsbRsbRgbRs
bRsbRsbRgbRgbRgbLgbLsbRgRsmbRgbRsbLsRsbRsbRgbRgbRsbRgbRgbRsbRgbLcbLibR
jRsRsmmbRiRsmbRsbRgbRsbRsbRgbRsbRgbLsbRgbRgbRsbLgbRibRsbRsbRgbRsbRsRsm
bRsbRsbRsbRgbRgRsmbRgbLobLibRsbLibRjbRhbLjbLibRebRibRsbRsbRgbRsbRsbRsb
RsbRgbRibRgbLsRsbRgbLgbRibRsbRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bRibLsbRgbLsbLsbRsbRgRsmbRsbRsRsmbRsLsbRsbRsbRsRsmbRsbRsbRsbRsbRsbRgbR
gbLgbRibLjbRibRibLsbLsRsRsmbsbsbRjbLjbRibRibLjbRebLibRibLgbLjbLsbRcbLj
bRibLsbRgbLgbRibRsRsmbLsbRgbLsbRgbLgbRsbLjbRsbLhLsbRsLsbLgbLgRsbRjLsbL
ibLiLsbLibRibLgbLgbRibRibLgbRiRsmbRsbsbLcbLsbLcRsbRjRsmbLibLsbLgbRsbLi
bLibRjbLibLiLsbRgbLcLsmbRjbLhbLibRibRhbLhbLibLsbLibLibLsbLiRsbLgbLgbLs
bLsRsbLsbLgRsbLgbLsRsRobRibLsbLgbRibLgRsbRgbRsbRsbRgbRsbRgRsmbLsLsmbLc
bLiRsbRsbLibLsbLibRjRsmbLeLsbLcbRebLcbRjbLibRjbLibLgbLsbRjbRsbLhbRibLi
bLgbsbLiRsbRjbRcRsmbRibLjbsbRiRsmbLsbRgbRsbRsRsmbRsLsbRsbLsRsRsmbRsbRs
bRgbRgRsmbRsbRsbRgbRsbRgbLjbLcLsmbLibRjbLgbLibLibReRsmbRiRsmbRsRsmbRsb
RsbRsbRsbRgbRgbRsbRgbRsbRsRsmbRsbRgbRsbRgRsmbRgbRsbRgbRsbRsbRgbRsbLsbR
gbRgbRgbRsbRsbRsbRsbRgRsmbRibRiRsmbRsbRgbRgbRgbLsRsbLsbsbLsbLjbLibLgbL
gbRjbRsbLgbLgbRcbRibRsRsmbsbLgRsbRsbRgRsmbRgbRgRsmbRsLsbRsbRgbRsbLsbRg
bRsbRsbRgbRsbRsbLsbRgbLsbRgRsmbRsbRsbRgbRgbRsbRsLsbRgRsmbLsbRjbLjbLjbL
ibRibRibRjLsbRgRsmbLibRgRsmbRgbLgLsbRibRgbRsbRsbRibRgbLjbRiRsmbRgbRgbR
gRsmbLsbLjbRibRgRsmbRgbRsRsmbLsbRsbRgbRsbRgbRjbLibRibLjbRiRsmbLsbLsbLg
bRibRgRsmbLibRibRgLsRsbRsbLgbRgRsmbLgbRiRsmbLgbRgbLsbRgbRsbRsbRgbRgbRs
LsbLsbRgbRsbLgbRibRgbLiRsbRibLsbLgbRibRgbLjbRibRgbRsbLgbRibRgbRibRibLg
bLgbRibLsbLgbRiLsbLjbRebLibRibRgRsmbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bRcbRibRgbRcbLjbRibRgbRgbLsbRgbLjbRhRsmbLiLsbLjbLgbLgbLsLsmbLsLsmbLsbL
sbLsbLgbLgbLoLebRhbRhbLgbRgbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRgbLjbRsR
sLombLgLsbLsLsmbLsbLsbLsbLgbLsbLgbLsbRsbLgbRgRsmbLgbLgbLsbLsbRsbLsLsmb
LgbLsLsmbLsLsmbLgbLsRsbLgbLgbRjbLhbRgbLsbLibRgbLgbRsbLgbLsbLsbRsbLgbLs
bRsRsmbLsbLgLsbRsbRhbRgbRgbRsbRsRsmbRgbRsbRiLsbLibRibLsbRgbLsbRsbRsbRs
bRgbRsbRsbRsRsmbRgRsmbRsRsmbRgbRgbRgbRsbRsbRsbRgbRgbRsbRsbRgRsmbRsbRsb
LsbRgbLgRsbRibLjbLcbLgbLgbLgbLsbLgbLsbLsbLsbLsbLgLsbLgbLsbRsbLgbLgLsRs
bLsbLsbLgbLsLsmbLgbLsbLsbLsbLsbLsbLgbLgbLgLsbLsbLsbLsbLsbLgRsbLgbLgbRg
bLgbRcbRcRsmbLsbLsbRgRsmbRgbRsbRsbRsbRsbRsbRsbRsbRgbRsbRsbRsRsmbRgbRsb
RsbRsbRsbRgRsmbRsbRsbRsbRgbRsbRgbRgbRsbRgbRgbRgbRgbRsbRgbRsRsmbRgbRgbR
gbRsbRgbRsbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgbRsbLgRsbLcLsmbLsLibLsbLgbL
sbLgbLsbLsbLgbLgRsbRoRsmbRgbRsbRgbRsbRgLsbRsbRgbRsbLsbRibLgbLcbLibLgbL
gLsbLsbLgbLsbLsbLsbLsbLgbLgbLgbLgbLgbRgbLsRebRibRgbRsbRgbRsbRsbRsbRsRs
mbRsbRsRsmbRsbRsbRsbRsbRgbRgbRgbRsbRsbRgbRsRsmbRgbRgbRgbRgbRgbRgbRsbRg
bLsRsbRgRsmbLsbRgbLcbRsbLibLiLsbLsbLgbRgbLgbLsbLsLsmbLgbLgbLgbLsbLsbLs
LsmbLgRsbLsbLgbLgLsbLsbRobRgbLsbRgbRsbRgRsmbRgbRgRsmbRgbRsbRgRsmbRgbRs
bRgbRgLsbRgbRgbLsbRgbLcbLiRsbRsbRsbLgLsbLgbLsbLsbLgbRsbLgbRsbLgbRcbRgb
RsRsLsmbRsbRgbRgbRgbRgbRgbRsbRsbRgbRsRsmbRgbRsbRsbRgbRgbRgbRgbRgbRgRsm
bRgbRgbRgbRgRsmbRgbRgbRsbRgbRsbRsRsmbRgLsbLsRgbRgbRgbRgbLebLibLibLsbLs
bRsLsbLgbLgbLsRcbRibLsLsmbRgLsRsbRsbRsbRsbRgLsbRsbRgbRgbRgbLjbRiRsmbRg
bRiRsmbLgbLcbLhbLsbRsRsmbLgbLsbLgbLgbLsbLgbLgbLsbLsbLgbRcbRibLgbRgbRsb
RsbRsbRsRsmbRsRsmbRgbRsbRsbRgbLgbRibRiLsbRibRgbRgbRsbRibRibRsbLsbRsbRg
bRgRsmbRsbRsbRgbRgbRgbRsbRsbRsbRgRsmbRgbRsbRgbRsbRgbRsbLhbLibLsbLibLsb
LibRjbRcbRsbRgbLsbRibLgRsbRsbRgbRsbRsbRgbRibRibRsRsmbRgbRsRsmbRgbLgbLj
bLgbLgbLgLsbLsbLgbLsLsLsmmbLsLsmbLgbLsbRsbLgbLsLsmbLsLsmbLsLsmbLsbLgbL
gbLsbLgbLsbLgbLsbLsbLsbLsbLsLsmbLgbLgbLsbLgbLsbLsbLsRsbLgbRsbLgLsbLsbL
gRsbLsLsmbLgLsbLsbRjbRcbRiRsmbLsRsbRsbRgbRsRsLsmbRgbRgbRsbRsbRgRsmbRgb
RsbRgbRsbRgbRgbRsbRgbRsRsmbRibLhbLcRsbLibLsbRgbLgbLgLsbLsbLsbLsbLsbLgb
LsbLgbLsbLsbLgbLsLsmbLsbLsLsmbLgbLsbLsbLsLsmbLgLsbLsLsmbLgbLgbLsLsmbLs
LsmbLsbRsLsbLgbLsbRobRcbRibLsbRgbLsbLsbLcbLibLgbLsbLsbLgbLgbLsbLgbLsbL
gbLsbLsbLsbLsbRhbLsbRsbRibRgbRsbRsbRgbRgbRgbRgbRsbRgbRsRsRsmmbRgbRgbRs
bRgbRsbRsbLsRsbRgbRsbRsbRsLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 121501; End: 122001;
Recording: 3-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bLjbLcbRhbLibLibRhbLsbLhbLcbLibLibLgRsLsbLsbLgLsbLibRibLgLsbRebLjRsLsb
RcbLibRibRsbRgbRgRsmbLjbLibLibRcbRcbLjbRcbRibRgbLjbLcbRgbLgbLgLsLsmbLg
RsbLgbLsbLjRsbRgbRibRcbLgbRibRsbRsbRsbRgbRiRsRgRhRgRimbRgbRgbRgbRgbRgb
RsbRsbRgbRsbLebLcbLebRcbRhbLibLibLgbRjbLibLgbLibLibLibLgbLsLsmbRibRibL
sbRibRsbRsbRgbRsbRsRsmbRsbRgbRgbRgbLsbRjbLsbRgbLsbRgbLgbRibRsbLsbRgRsR
smmbLgRsbRgbLsLsmbRgbLgbRibLjbRibLjbLhbLgbLsbRjbLibLgbLsbLgbRebRcbRibR
ibRgbRsbRgLsbLjbLjbLibRcbLhbLiLsRsbLsLgLsbLsbLgbLsbLgRsbLgbLibRjbRcbRs
bRiLsRsbLgRsbLjbLsLibLgbLgbLgbRgbLsbLgbLgbRgbRcbRibLiRsbLsRiRgbRgbRgbL
sbRgbLsRsbRsbRgbRsRsmbRsbRgRgRiRsRiRiRsRiRiRsmmmbRsbRgbRgbRsbRsbRgbLjb
RibLhbLiLsbLibRjbLibRjbRcRsmbLjbLhbLibLgLsbLsbLsbLsbLsbLgbRjbLgbRjbRcb
LjbRibRsbRsbRsLsRgbReRiRsRiRgmbRiRsRsRgRsRgRsRgmmmmbRgbLsRgRsRgRsRimmb
RibRsbRgbRsbRgbRsbLgRsbLsLsLsmmbLjbLcbRjbLcbLibRjbLhbRjbRcbRcbRibLibRs
bRibRibRgbLibRhbRsbRiRsmbRsRsmbRgbRgbRsbRgbRsbRgbRsbRsbRsbRsbRsRsRsmmb
RsbRsRsmbRgRgLsbRjbRsbLsLsmbRgbRgbRgbRsbRgbRsbRsbRsbRsbRsbRsbRgbRsbRgb
RsbLsbRsRgbLjbLcbRhbRibLibRibLibRibRgbRgbLsbRsRsmbRgbRgbRsbRgbRgbRgbRs
bRgbRgbRsbRsbLiLsbLibRjbLibRcbRibRibLgbLjbLibRjbLibRjbLcbLibRhbLibLgbR
ibLibLgbRsLsbLibRjbRcbLsbRgbRgbRgbRgbRgbLjbLibRjbRibLhbLgbLibRjbLhbRib
RjbRibLsbRiRsmbRgLsbRiRgbRgRsRgRsmmbRgbRgbRgRsRgRsRiRgRsmmmbRgbRgbRsbR
gbRsbRsbRgbLsbRsbRgRsRsmmbRgRsmbRgbRgbRgbRsbRsbRgbRsbRsbRgbRgbRibRgLsb
LibRgbRibRgbRsbLsbRgbRgbRsbRsbRsbRsbRgbRgbRsbRsbRsbRgbRsbRsbRgRsmbRgbR
sbLgbLcbLibRjbLibLgbLgRsbRjbLsbLgRsLsbLgbLhLsbRibRebRibRgbRsRsmbRsbRgb
RgbRsbRgbRibLiRsbRcbLgbRibLjbRibRibRhbRhbLgbRcbLsRsbRgbRsbRsbRsbRsbRsL
sbRsbLsbRsLsRsbRgbRsbLgbLsbRgbRgbRsLjbLhbRcRsmbRibLsbRgbRgbRsRsmbLsRsb
RgbRsbRgbRsbRgbRsRsmbLsLsRsmbRgbRibRgbRsRsmbLsRsRsRgmbRgbRsbRgRgRsRiRs
RiRgmmbRgRgRgRiRsReRsRhRsRhmmmbRgbRgbRsbRgbRsbRgbRgbRgbRjbLsbRgbRgbRgb
LsbRibLjbRibRibRibLibLhLsbLibRjbLgbLgbLsbLgbsbRhbRibRgbLgbRibRsbRgbRsb
RgbRgbRgbLjRhLsbLibLjbLibRsLiLsbLgbLsLsmbLsbLsbLsbLgbLgbRjbRcbRiRsmbRs
bRsbRgRgRiRhRiRsmbRibRgbRsbRgbRsbRsbRsbRsbRgRgRsRiRsRiRsRiRsRimmmmbRgb
RsRgRsRgmbRiReRsmbRibRgbRsbRgbRgLsbRgRsmbLgLsRsbLjbRibRcbLibLibRcbRibR
ibRibLibLgbRiRsmbLsbLgbLcbLgbLsRsbLibLibRibLjbRjbLibLibRibLibLgbRcbRgb
RsbRsbRsbRgbRsbRsbRsbRsbRsbRgRsmbRibRgbRsbLjbRiRsmbsbLsbRiLsRsbRjbRgbR
sRsmbRgRsmbRgRsRgmbRsbRgRsmbRsRsmbRgRgbRgbRgRgbRgRsmbRsRsmbRiRsRiRiRsm
mbRiRsmbRsbRgbRgRsRsmmbRgbRsRsmbRgbRgbRibLjbLcLsmbLibRgbLibRhbRcbRsbLs
bRjbRsbRgbRsRsRsmmbRgbRsbRsbRgbRgbRsbLsbRgbRsbRgbRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 1; Drug: Control Apo 0.5 然
bLsbRjbRcbLibRhbRibRsLsbLiLsbLjRsbLhbRgbLsbRsbLsbsbLgbLgLsbRsbLsbRsbLs
bRsbLsbLgRsbLsbLgLsbLsbLsbLsbLgbLgLsbLsLsmbLgbLgbLsLsmbLsbLgLsbLgbLgbL
sbLsbLsbLsbLsbLsbLsbLgLsbLsLsmbLsbLsLsmbLgbLgLsbLgbLgbLsbLgbRsbRsbLgbL
gbLgbLsLsmbLsbLgbLcRsbRhbRcbRgbRgbLgbRibLsbRcbRgbRcbRibRsbRcbRgbRgbRgb
LsbLsRibLsLsmbRgRsRsmmbRgbLsbRgbLgbRibLgbRgRsRsmmbRsRsmbRgRsmbRgbRsbLg
bRsbRsbRgbRgbLjbLobLibLgLsbRibRhbRibLgLsbLiRsbLgLsbRsbLgLsbLgbLsbLgLsb
LgbLgbLgbLgbLgbLsbLgbLgbLgbLsbLsbLgbLgbLgbLgbLgbLsbLgbLgbLgbLgbLgbLgbL
gbLsbLgLsbLgbLsRsbLgRsbLgbLgbLgLsbLgbLsLsRsmbLgLsbLsbLgbLgRsbRcbsbRoLs
bRhLsbLgbRhbLibLoRsbRibLiLsbLibRibRcRsmbRgbsbRsbRsbRsbRsbRsbRsbLsbLcbL
ibLsbLgbLgbLgbLsbLsbLgbRibRgbRhbRgbLibLebLibRjbRebRibRsbRsbRgbRsbRgRsm
bRgbRgLsLsmbLgbLoRsRgbLibLibLsbLgbLsbLsLsmbLsbLsbLsLsmbLsbLgbLsLsRsmbL
sbsbLsRsbLgbLsbLsbLsbLgbLsbLsLsLsmmbLgbLgbLgbLsLsmbLgbLgbLgbRsbLgbLsbs
bLgbLsbLsbLgRsbLgbLsbLgLsbLgbLgbLgbLgbLibLibLgLsbLgRsbLsbLsbLsLsLsmmbL
gLsbLsbLgLsbLgbLgbLgLibsbLgbLsLsmbLgbLsbLgbLgbLgRsbLgbLgLsbRjbRoLsbRib
LibRibRsbRsbRibLjbRibLibLcbLibRgbsbLsbLgbLsbLsbLsbLgLsbLgbLsbLgbLgLsbL
gbLsbLiLsbsbLgbLgbLgLsbLsbLgbRjbRobRhbLgbRibLhbLgbLibLsbLgbLsbLsbLgbLs
bLsLsmbLgbLsbLgLsbLgbLgLsbLgbLgLsbLgbLgLsbRsbLibLgbLibLhLsbLibLibLgbLg
bLsbRsbsbLibRcbRcbRibRibLibLhbLibLgbRgbLibLgbLgbLsbLgLsbLgbLgbLibLgbLi
bLgbLgbLibLgbLsbLgbLgbLgbRjbLcbRiRsRhmbRhbLiLsbsbsbsbRibLgbRcbLibLibLo
RsbLgbRgbLibLgbRgbLibLgbLgbLgbLsbLgbLsbLgbLgbRgbLibRcbRgbLgbRhbLgbsbRh
bLibLcbRibRjbRjbRgbLsbRsbRsRsLsRsmbRsbLcbLibLgbRsbLgbLgLsbRsbLgbLgbLsR
sbLgbLgLsbLgbLgbLsbLgRsbRgbLibLibRsbRcRsLsmbRsRsmbRgLsLsmbRgbRsbRgbRgb
RsbRsbRgbRgbRgbLjLsmbRoLsbRcRsmbRibRibRhbLsbRibLgbRibLsbRgbRgbRsbRsbLj
LcbLibLgbLgbLgbLgbLgLsbLsRsbLgbLsbLsbLsbLgbRgbRcbRibLsbRiRsmbLsbLjbLhb
LsbLsbRsbLsLsLsmmbLgbLsbLsbLgbLgbLgLsbLibLgbLiLsbLgbLgbLsbLgbLgbRcbRib
RibRsbLhbLgbLgLsbLibRsbLgLsbLsbLgbLsbLgbLgbLgbLsLsmbRsbLibLhbRibRcbLgb
RibRsbRsbRsLsbRsLsbRgbLsRsbLebLgbRgbLgbLgbLgbLgRsbLgbLsbLgbLgbLgLsbLib
LsLsmbRcbRibLgRsbRibLsbRibLjbLcbLgLsbRsbLgbLsbLgbLgbLsbLgbLsbLsbLgbLeb
LibRibLibRgbRibLjbLjbRjbRibLob

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 2; Drug: Control Apo 0.5 然
bLhRsbRjbRibsbRiRsmbLsbRgbRsbRgbRsbRgbRgRsmbLibLibRcbLsbRhbLibRsRibLgb
RgbRsbRsbRgbRgbRibLebLibLgbRibLcbRjbLcbRibLiLsbLgbRgbLgLsbRjbRcRsmbLsb
RgbRsRsmbRgbLsRsbRgbLsbRgbRgbRgbRgbLjLsmbRibRgbLsbRibRgbRsbLobLjLsmbLi
bRjbRebRhRsmbLgbRgbLsbRibRgbLsbRgbRsbRsRsmbRgbRsRsmbLsbRibRsRsmbRgbLsb
RgbLsbRgLsbLsbRgRsLsmbRsbRgbRsRsmbRgbRsbRsbRgbRgbLsbRgLsbRsbRsbRgbRsRs
mbRgbRsbRgbRgbLgbsbLhbRebRcbRiRsmbRgbLibLibLgbRsbLibRhbLcbRjbLhRsbRjbR
cbRibRgbLgbRibsbLcbLibLiLsbLcbRhbLhbRgbLibRjbLibRjbLcRsbRibLhLsbRjbLib
LibRsbRjbLhbRgbLhbRgbLsbLiLsbRgbLiLsbRsbLibRjbLibLsLsRsmbRsbLibRjbLibR
gbLiLsbRgbLiLsbRsLsbLsbLsbLsbLsbLgbLhbRibLcbLsbRibLcbRibLcLsmbRibLhbRi
bLhbRibLcLsmbRgbLhbLsbRsbLgLsbRsLgbRsbLgbLsbLgbLgbRcbRibLsbRgRsmbRgbRs
bRsLsRsbRsRsmbRsbRibRsbRgbRgLsbRibRsbRgbLibRiLsbRibLgbRgbRgbRsRsmbRsbR
gLsbRgbRsbRgbLsRsbRgRsmbLsbRsbRgbRsbRibRsbRgbRgbLsRsbRgRsmbLjbLcbLsbLg
bLsbLgbLsRcRsmbRibLgbRibRsbRgLsbRgbRgbRgbRsbRgbLsbRgRsmbRgbRgRsmbRsbRg
bRgLsbRsbRgbLsbRibLgbRgRsmbRsRsmbRgLsbRsRgbRgRsmbRsbRsbRgRsmbRgRsmbLsR
sbRgbRgbRgRsmbRgbLsRsbRgRsmbRgbRgbRgbRsbRgbRsbRgbLgbRgbRibLsRsbRibLsbR
gRsmbRgbRsbRgbRsbRibRiRsmbLsbRgRsmbLsRgbRgbRibRiLsbLgbLsbLibLhbRibLsbL
ibLsbLgbRjbRcbRibRsbRgbLibRibRgbLsbRgbLsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 3; Drug: Control Apo 0.5 然
bLibLibLgbRjRsmbLibLibRjRsmbLibLibLsbLsbLsRsbLsLsmbLsbLgbLgbLgbLibLibR
jRsmbRsRsmbRgbRibRebRsbRgbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 4; Drug: Control Apo 0.5 然
bsbLibLjLsmbLibRsbRibLgbLibLibsbLibRsbRibRjRsmbRhbLgbRibLjLsmbRjRsmbRg
bRibRjRsmbLgbLgbLsbRgbLibLibRgbLjbLibLcRsbRgbRsbLgbLibLgbRibLibLsbRsbR
gbLhbLibRgbRgbLibLgbRsLiRsbLgbLsbRibLsRsbLgRsbLibLsbRgbLibRgbLiRsLsbRs
bRjbLibLsbLgbLsbRgbLibLsbRgbLibLgbRgbLgbLsRsbLgbRgbLgbLibRibLsbRibLjbL
cbLibLgbRsbRsbRgbLjbLibLgbRgRsmbRgbLgbLsbLgbRsbRsbLgbRsRsmbLgbRsbLgbLs
bLiLsbLgbRibRibRgbRgRsmbRsbRgbRibRgbLsbRsbRsbRgbLjbRibRgbLjbRgbRgbLsRs
bRibRsbRiLsLsmbRgRsmbLsbRsbLsbLgRgbRiRsmbRibRgbLjbRibRibLsbLsbRibRibLs
bRgRsmbLsbRibLjbRibRgbRgbRibRibLhbRibRgbLibRibRgbRgbRsbLibRgbRibRibRib
LibRibRgbRibRgbRgbLibLsbRibRgRsmbLsbLsRgbRgbRibLjbRibRibLibRibRgbLjbRi
RsmbRsbRgbLcbLgbRsbLgbLgbLgbLsbLsRsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbR
sbLgbRsbLgRsbRgbLgbLgbLgbRsbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 5; Drug: Control Apo 0.5 然
bRoLsbLcbLjbLibRiRsmbLhbRgLsbLibsbRgbLibRjbRebRgbRsbRsbLsRsbRsbLjbLcbR
cbLcbLibRiRsmbRibRibLsRsbRgbRsbRgRsmbRgbRgbRibLjbLcbLibLsRibLebRibRjbR
ibLjRsbLibRcbLjRsbLhbLsLsmbLibRjbLcbRhbRcbLjbRibLjbLibLsbLsbLsbLsbLgLs
bLgbLgbRsbLgbLsRebRibLgbRgbRsbRgbRsbRsbRgbRgbRgRsmbRsbRsRsmbRsbRsbLcbL
ibRcbLcbRjbLcbRibLibRsbRsbLgbRsbLgbLsbLsLsmbRsbLjRsbRcbRibRibRsbRgbRsb
LsbRgbRsbRsbRsbLjLsmbLibRcbRsbLibLibRjbLiLsbRebRcRsmbLgLsbRibRsbRiLsbL
jbRsLibLcbRhbRsbLibLsbLgbLgRsbRsLsbLsRsbLgbLsbLgbLgbLgbLsLsmbLsbRcbRgb
RgbRgbRsbRsbRgbRgbRsRsmbRgbRsbRgbRgbRsbRgbRgRsmbLsLsmbRgbRsbRsbRgbRgbR
sbRgbRgbRgbRsbRsbRgbRsbRgbRsbRsbRgRsmbRgbLjbRcbLcbLsLobRcbRgbRgRsmbRgb
RgLsbLjbLibRcbRiLsbLibLhbLhbRebLcbLgbLgLsbRsRibLibLgbLjbLgbRjbLibLibRc
bLcbRgbLibLgbLgbRhbRibRgbRsbRgbRgLsbRsbRsbRsbRsbRsbRsbRsRsmbRgbRgbRsRs
mbRsbRsRsmbRgbRgLsbLjbRibLhbLcbLibRhbLobLsbRsbLgbLgbLsbRsLsbLsbLsbLgbL
sLibRcbRcbLgbRibRsbRsbRgbRgbRgbRgbRgbRiRsmbRsbRgbRgbRgbRgbRsbRsbRgLsRs
bRsbRgbRsRgbRgbRgbRsbRsbRsbRsbRsbRsbRgbLibLcLsmbRibLcbRgbLibLgbRibLibL
gbRjbRibRgRsmbRsbRgbRgbRgbRgbRgbRgbRsbRgbLcbLibRcbRoLsbLebLcbRjbLibLgb
RcbRgbRsbRsRsmbRsRsmbRgbRgbRgLsbRsbRsbRgbRgbRgLsbRsbRgLsbRsbRsbRsbRgRs
mbRsbRsbRgbLsLsmbRgbRgRsmbRgbRgbLibRgRsRsmmbRsLsbLsRsbRgbRsbRgbRsRsmbR
gbRgbRiLsbLiRsbRgbLjbLiLsbRcbRibRgbRsbRsbRsbRsbRsbRgbRgbRgRsmbRgbRsbRg
bRsbRsbRsbRgbRsbRsRsmbRsLsbRgRsmbLsbRsbRgbRsRsmbRsbRgbRsbLsLsmbLsbRibL
jLsmbRibRsbRgRsmbRgbRsLsbRgLsbRsbRsbRgbRsbRsbRgRsmbRgbRgbLsRsbLsbRgbRs
bRgLsbRsbRgbRgRsRsmmbRgbRsbRsbRgbRgbRsbRgLsbLsbRgbRgLsbRsbRgbRsbRsbRgb
RsbRgbRsbRibRibLibRsbRibRgbRsRsmbRsRsmbRgbRsbRgbRgbRgbRgbLgbRiRsmbLsbR
iRsmbLgRsbLcbLebLibRgbRsbRsbRgbRgbRgbRsbRsbRsbRgbRsbRgbRsbRgbRsbRsbRgb
RgbLjbRgbRibLgbRgbRgbRgbLsbLibLcbLgbLsbLibRjbRcbRibLsRsbRgbRsbRsRsmbRg
bLsRgbRgbLgbRgbRgbRsRsmbRsbRgbLsRsRsmbRiLsbRgbRgRsRsmmbLsRsbRsRsmbRsbR
sRsmbRgbRsbRgbRgLsbRsRgbRgbLgbLjbLcbRcRsmbLobLibRiRsmbLgbLjbLcbRibRebR
gbRsbRgbLsbRgbRgbRsbRsbRgbRgbRgbRgRsmbLhbLcbRcbRcbLebLcbLhbRibLcbRibLi
LsbLibLibRcbRsbRgbRsbRgbRibRgbRsbRgRsmbRsbRibRgbRsbRgbRgbRsbRsbRsLsbRg
bRsbRgbRgbLcbLcLsmbRcbLcbLhbRgbLibRsbLibLgbRcbRiRsmbsbRiRsmbLgbLsRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 6; Drug: Control Apo 0.5 然
bLsbLsLsmbLsbLsbLsbLsbLgbLsbRsbLsbLsbLsbLsbLsbLsbLsbLgbLgbLsbLsbLgLsbL
sbLhbLsbLsbLhbLgbLgbLsbRgbRibLjbRsbRsbRgbLsbRgbLiLsbRgbRgbLsbLgbLeLsbL
ibLsbLsbLsLsmbLsbLgbLgbRgbLgbLgbLgLsbLgbRgbLgbLgbLgbRgbLsLsmbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bRibLgbLiLsbRsbRcRsmbRgbLibRibRjRsmbRgbRibLsbLgbRhRsmbReRsmbRgbRsbLgbL
ibRiRsmbRgRsmbRiRsmbRgRsmbRgbLibRibRgbLgLsbRgbRibRhRsmbRjRsRsmmbRiRsmb
LibLhbLsbLsbRgbRgbRsbRjRsRsRsmmmbRibRsbRgRsmbLsbLiRsbLibLsbLgLsbLgLsbL
sbLsbRgbRgbRiRsRsmmbsbRsbLsRsbRibRgbLgbRibLsbRgbLsbLsbRibRiLsbRgRsmbRs
LsbRsRsmbRsbLsbRgbRsRsmbRsbRsRsmbRgbRsbRsRsmbLsbLsbRjRsRsmmbsbLsbRsbRg
bRgbLgbRgRsmbRgbRgbRgbRgbRgRsRsmmbRgbRsbRsbRjRsmbRsbLgbRgbRgbLgLsbLsbR
ibRjRsRsmmbRgRsmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bRgLsbRgbLjbLgbLsbRgbRibRgbLibLsbRsbRibLjbRibRibRgRsmbLsbRsLsbRgbRgbRs
bRsbLsbRgbRibLcbLibLsbLsbsbLibRgRsmbLibLhbLibRsbLibRibRsbRibLjbRibLsbL
sbRibLgbRgbRgbRsbRgRsmbRsRsmbRsbLsbRgbLsbRibLsbRgbRiRsmbRibRsbLsbRiRsm
bLsbRgRsmbRgbRsbRgbRsbRgbLsbRibLgbRibRsbRgbRsbRgbRsbRgbRgbLsRsbRgbRgLs
bLsbRgbRgLsbRsbRgRsmbRsbRgbRsbRgbRsbRgbLcbRjbRiRsmbRibRibRgRsmbLgbRgRs
mbLsbRgbRibRsbRsbRibRgbLgRsbRsbRiRsmbLjbRsLsbRibLsbRgbRgRsmbLjbRibRgRs
mbRsbRgbLsbRiRsRsmmbLgbRibRsbRgRsmbRsbRgbLsbRgbRsRsmbRgbRsbRgRsmbLsbRi
RsmbLsbRgbRgbRsLsbRsRsmbRgRsmbRsbRgbRgbRgLsbRsRsmbRsbRgbRsbLjbRjbRcbLc
bLibRgbLiRsbRgbLgbRibRsRsmbRjbRjbRsbLsbRibRgbLibRgRsmbRsbRsbRiRsRsmmbL
jbRibRibRgbRiLsbLibLibLsbRcbRibLgbRibRgLsbRgRsmbRsbRgbLjLsmbRiRsmbRgbL
gbRibRgbLsbRgLsbRsbRgbRsbRsbRsbRgbRgbRgbRsbRgRsmbRgbRsbRgbLsbRibLjbRib
LsbRgbRsbRgbRsbRgLsbRsbRgbLsbRgbRsbRgbRgbRsbRsbRsbRgbRsbLsbRibLgbRgbLs
bRibLsbRgbLsbRgbLsRsbRgbRsbRgbRsbRgRsmbRibLsbRibLsbRgbRsbRgbLsRsbLsbRi
bRsRsmbLgbRiRsmbLsbRgbRsbRsbRgbRsbRsbRgbRsRsmbRsRsmbRgbRgRsRsmmbRsbRgb
RgRsmbRgbLsbRibRsbRgbRgbRsbRsbRgbRsbRsbRgbRsbRgRsmbRsbRsbRgbRsbRgbLsbR
gbRsbRsbRgbRgbRgbLsbRgbRsbLsbRsbRgbRsbRgbRgbLsbRiRsmbRsbRsbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bLgbRoLsbRiLsbLjbLsbRsbLobLgLsbLgbLsbLsbLgbLsbLgbLgbLgbLgLsbLsbLgbLgbL
gbLsbRgbLgLsbLgRsbLgbLcRsbLsbRgbLgbLgRsbLsLsmbLsbLsbLgbLgbLgbLgRsbRcbR
cbLjbLhbLhbRgbRsbLsbLgbLgbLsbLgbLsbLgbLsbLsbLgRsbLgbLgbLsbLsbRsbLgbLgb
LgbLsbLsbLsLsmbLgbLgbRobRibLjbRibRgbLgbRibLjbLobLibRgbRgbLiLsbLgbLgbLg
bLgbLsbRsbLgbLgbLsbLsbLsbLsbLsbLgbLgLsbLsbLgbLgbLsbLgbLsbLgbLsRsbLgbRs
bLgbLgbLgbLgbRjbLgLsbLgbLgbLgbLgbLsbLsbLsLsmbLsbLsbLsbLgbLgbLgbLgbLsbL
gRsbLsbLgbRjbLeRsbRibLibLgbRibRjbRcRsmbLjbRibRcbLibRibLibLgbLsbLsbRsbR
sbRibRgbLsbLjLsmbLoLsmbLiLsbRibLibLgbLsbLsbRebLiLsbLibRibLibLsbLsbLgbL
sbLgbLgbRebLebRibLgbLgLsbLsbLgbLgLsbLibRsbLgbLgLsbLgbLsbLgbRcbRebLobLh
bLgbLgbLgLsbLgbLibLibLgLsbLsbLsbLgbLgbLsbLsbLsbLsbLsLsmbLsbLgbLsRsbLsb
LgbLgbLsbLsbLsRsbLsbLgbLgRsbRibLibLgbRsbLgbLgbLgbLsbLgbRsbRjbRcbLebLib
LibLiRsLsbRgbRsbRsbRgbRibRsbRgbRsbRgbRgbRsbLcbLibLiLsbRsbRsRsmbLsbLibL
ibRgbRgbLibRsbLiLsbLsbLsLsmbLgbLgbLsbLgbLgLsbLsbLsbLgbLgbRgbLgbLibRgbR
hbRgbRgbRgbRsbRgbRsRsmbRsbRgRsmbRsbRgbLcLsLsmmbLcbRsbLibLgbLsbLgbLsbLs
bLhbRjbLcbLibLibRgbRgbLsbLgbLgbLjLsmbLgLsbLgbLsbLsbLsRsbLsbLsbLgbLgbLg
bLsbLsbLsbLgLsbLsbLsRsbLgbLsbLgbLsbLgbLsbLgbLgbLgLsbLgbLsRsbLgLsbLgbLg
bLsbLibRibLjLsmbLibLgLsbLgLsbLsbLsbLsbLiLsbLibLibLsbLgbLgbLgbLgLsbRgbL
ibLgbRgbLibLibLgLsbLsbLsbLgbRsbLibLgLsbRsbLsbLgbLsbLgbLsLsmbLsRsbLgbLg
bLsbLgbLgbRhbRibRgLsbRibLgbRgbRgbRgbRibLjbLhbLibLgbRsbLgbLibLsbLsbRgbL
hbRjbRhbRibLcbLjbLgbLgbLsbLsLsmbLsbLsLsLsmmbLgbLgbLgbLgbRsLsbLgLsbLgbL
gbLgbLgbRoRsmbRiLsbRibLjbLcbLhbRcbLibLibRsbLsbRsbLibLibRgbLgbLgbLsbLgb
LsLsmbLgbLsbLsbLgLsbLsbLgbLsbLgbLsbLsLsmbLsbLgbLgbLsbLgbLsRcLsbRgbRgbR
iLsbLebLcbLiLsbRgbLgbLgLsbLgbLsbLgbLibRibLibLibLgbRgRsmbRsRsmbLgLsbLgb
LgbRsbLgbLsbLgRsbLsbLgbLgbLsbLgbRhbLhbRjbRhbRibLjbRhbLebLcbLibRgbLgbLg
bLgbLibLibLsbLgbLsbLsbLgbLsbLgbLgbLgbLsbLgbLsbLgbLgbLgbLoRsbLobLibLhRs
bLibLgbLgbLibLibLgbRgbLgLsLgbLibLgRsbLsbLgRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bsbLsRsbRgbLgLsbRsbLgbLgbLsbLsbLgbLsbLgbLjbLcbLhbLibLibLgbLgbRgbLgbRgb
LibRibLibRsLibRsLsbLsbLgbLsbLsbLgbLsbLsbLsbLsLsmbLsbRgbLsbLibRjbLsRcbR
ibRgRsmbRgbRgbLsbRgLsbLjbLeLsbLiRsbLsbLgbLsbLsbLsbLsbLgbLgLsbLsbLsRsbL
sbLsbRsbLgbLsLsmbLgLsbLsbLsbLsRsbRcbRibRgbLjbLhbRjbRibLebLibRjbLibLsbL
iRsbLgbLsbLsbLgbLsLsmbRjbLiRsbLgbLsbLsbLsbLgbLsbLgbRsbLjLsmbLgbLgLsRsb
RjbLibLgbRgbLgLsLsmbLsbLsbLsbLsbLgbLsbLsLsRsmbLsbLsbLsLsmbLgbLsbLsbLsL
smbLsbLsbLjbLgLsbLsLsmbRibLibLgbRsbLgLsbLsbLsbLgbLgbRjbLgbLgLsbLsbLgLs
bLsLsmbLsbLgLsLsmbRsbLgbLgbLgRsbRjbRcbLsRibRgLsbLibRibLjbRibLjbRibLebL
ibLiRsbRjbLibRsbLgbRsbLsbLsbLsLsmbRsbLibRsLsbLgbLsRsbLsLsmbLsLsmbLsLsm
bLsLsmbRsLgbLsbLgbRsLsRsbLgbLsbLgbLsbRjbLibRibLibLsbLgbLsbLsbLsLsmbLgb
LgLsbLsLsmbLsbLgbRsbLgRsbRjbLgbLgbLsbLsbLgbLsbLgLsbRsbLgbRsLsbRsLgbRsb
LsLsmbLgbLsbLsbLsLsmbLsbLsLsmbLsbLgbRcbRibRibRibLibRibRgbLebLeLsbLibLg
bRgbLibLgbRsbLgLsbRsbLgLsLsmbLgbLsLsmbLgbLsbLsbLgbLsLsmbLsbLgbLsbLsbLg
bLsbLgRsbLgbLgRsbLsbLgLsbLgbRjbRcLsbRibLibRibLibRibLcRsbLibLsbLgbLgbLg
RsbLsbLsbLsLsmbLsLsmbLsLsmbLsRsbLsbLgLsbLgbLsbLsbLsbLgLsbLsbLgbLgbLsbL
ibLgLsbLsbLgbLsbLjbRhbLiLsbLgbLsbLgbLsbLsLsmbLsbLsbLsLsmbLjbLibRcbLibL
gbRsbLsbLsLsmbLgRsbLgLsbLsLsmbLsbLsbLgLsLsmbLsbLsRsbLgbLsbRsbLgLsbLsLs
mbLgbLsbLgRsbRjbRibLsLsmbLhbLgbRsRsmbLibRibLibLgbsbLgbLsLsmbLibRibRjbR
ibRgbLjbLibLgbLsbLgbLsLsmbLgbLsbLgbLsbLgbLsLsmbLsbLgbLsbLgbRcbRibRgbLi
bRibLjbLibLibsbLgbRsbRgbLgbRsbLibRgbLibRcbRhbLjbLsbLjbLgbLsbRsbRgbLiRs
bRjbLibLibRibLgbRsLsbLibLgbRsbRhbLibLgbRsbLgbLjbRsbLsLsmbLgRsbLsbLsLsm
bsbLibRcbRcRsmbRibRsbRgbRgbRgbLcbLibLsbLibLjbLibRgbLibRibLibRhLsbLjbRj
bLibLiRsLsbLgLsLsmbLgLsbLsbLgbRsbRsLsLsmbLsbRsLsbLgbLsbRjbRcbRibLjbRib
RgbLcbLibRibLibRsbLgbRgbLgLsbLibLgbRjbLibLgbsbLgbRibRsbLhbLibRsbLgbRsL
sbLsLsmbLgLsbLsbLsbLsRsbLsRsbLsbLsbLgbLsbLsbLgbRjbRcRsmbLibLiLsbLibRsb
LibLgbLsLsmbLsbLgbLgRsbRhRsmbRgbRibRgbRsbRsbRsLsRsbRsbRsbRgbRsbRsbRsbL
cbLibRjbLibLgbRibLibLsbLsbLgbLsbLgbLsLsRsmbLgbRjbLibLgbLgbLsRsbLsLsmbL
sbLsbLsbLsbLgbLibLgbRjbLgbLibLgLsbLgbRsbLgbLsbLsbLsbLsbRjbRcbRibRiRsmb
LjbRjbRibRjbLjLsmbLjbRsbLsbLsbLgbRgbLibRcbRibLsbRsbRgbLhbLibLsbLgbLsbL
sbLsbsbRcb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bLgbLgbLgbRcbRcbRibLgbRibsbLgbRibRgRsmbRsbLcbLibRjbLcbRgbRjbLibLibLsbL
sbLgRsLsbRsRsLsmbLgbLgbRcbRgRsmbRsbRgbRgbRgbRcbRcRsmbLjRsRsmbRibLibLgb
RgbRjbRiRsmbRgLsbRhbLsbLibLibLgbLgbRgbLibRsbLgbLsbLgbRsbLgLsbLsbLsbLib
LsLsmbLgbLgbRsbLgbLsbLgbLsbLsbLgbRsbLgbRsbLgbRsbLgLsbLgbRcbRibRgbRgbRs
bRsbRsbRgbRsbRgRsmbRsbRgbRsbRgbLcbLibRoLsbRjbRibRgbRsbRibLcbLcbLibRgbL
ibLsLsmbLsLsmbLgbLgbLgbLgbRiLsbRgbLiLsbRsbLibLsbLgLsbLsbLsLsmbLsbLgbLg
bLsbLgbLsLsmbLgbLgLsRsbRsbLgLsLsmbRgbLgbLgLsbLsLsmbLgLsLsmbRcRhbLjbRib
RobLcbLcbLgbLgbRsbRsbLsbLibLgLsbRsLsbLgLsbLgbLsbLgbLsbLgbLsbLgLsbLgbLs
bLsbLsRsbLgbLsLsmbLgbLgbLgbLgbRibRcRsmbRibLibLcRsbLhbRjbsbLcbRibLhbRjb
RcbRibRsbRgbLjbRgLsbRgLsbRsbRsbRgbRsLsbRgLsbRgbRgbRgbRgbRsRsmbRgbRgbLc
LsLimbRgbLibRsbLgLsbLsbLgbRcRcbLibLibLibLgbLgbRsLsbRjbRhbsbRsbLjbLhbLg
bLsbLgRsbLsbLsLsmbLsRsbLgLsbLsbLsbLgbLsbLgbLsLsmbLsbLsbLsbLgbLgLsbRsbR
sbLgLsbLgbLgbRhbLhbLiLibLgbLsbRcbLgLsRcbRiRsmbRsbLgbLgbLibRjbLibRcbRcb
RibRibRgbRgbRgbRgbRgbRsbRgLsbLobLibLibLgRsbLjbRiLsbRsbLibLibLgbRsbRibL
ibLibRgbLibLsbLsbLgbLsLsmbLgbLgLsbRsbLgbLsbLsLsmbLsbLgbLsbLgbLsbLsbLsb
LgLsLsmbLgbLgbLgbLsLsmbLgRsbLsbLsbLibLgbRsbRgLsbLibLsbLsLsmbLgbRgRsmbL
sLgbLgbRjRcRsRsmmbLcbLgLsbLgbLsbLsbRgbLgbLsbLgbRgbLgLsRsbLsbLgLsbLsbLs
LsmbLgbLgbLgbLsbLgbLsbLgbLgbLgbLsbLsbLsbLsbLgbLsbLsLsRsmbLgbLgbLgbLgbL
sbLgbRsbRcbRibLjbLjbLgbLgbRjbRcRsmbRgRsmbRsbRsbRsbRgRsmbRsLsbLjbLsLcbL
gbLsbLgLsRsbLgbLgbLsbLsbLgbRsbRsbLibLsbLgbLsbLgbLsLsmbLgbLsbLsbLibLibL
ibRhbRcbRibLsLsmbRiRsmbLgbRibLsbLgbLcbLibLgbLsbRgbLibLgbRcbRcbLsRsbRgb
RgbRsRsmbRgLsbRsbRgbLjLsRsmbLcbLibRgbLibLgRsbLgbLsLsmbLgbLgLsbLsbRsLgL
sLsmbRgbLibLgbLgbRcbRcbRibLjbLcRsbLiLsbLgbLsbRcbRibRsbRsbRsbRsbRgbRgbR
sRsmbRgbRibLcbLibRsLsbLibRsbLgLsbLsbLgbRgbLgbLsbLgbLsLsmbLgLsbRsbLgLsb
LgLsbLgbLsbLgbLgbLsbRcbRgbLgbRibRgbRibLcbLhbLsLsmbLgbLgbLgbLgbLgbLsbLs
bLsbLsbLgbLsbLjRsRsmbRjbRcbLcbLobRiLsbRsbLhbRgbLiLsbRsbLcRsbRgbLibLgbL
sbLgRsbLgLsbLgbRjbLibRsbLgLsRsbLgbRgbLibRcbRcbRgbRgbRsbRsRsmbRgbRsRsmb
RgbLcbLhLsbLgbLsbLgbLsbLsbLgbLsbLsbLgbLsbLgbRsbLgRsbLgbLgbRsbLgbRsbLgL
sbRsbLgbRsbLgbLgbLgbRcbRcbLjbLibLibRgbLgbLgbLsbLibRsRsmbLibLsLsmbLgbLg
bLsbLgbLgRsbRjRsmbRcbRibRibLhbLcbLibLsbLgbLgbLsbLgLsbLsbLgbRsbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bRcbRsRgbRsbRgRsmbLsbRsbRsLsbRsbRsLsbRsbsbRgbRgbRgbRsbRgbRsbRgbRgbRgbR
sbRsbRgRsmbRgbRgbRgRsLsmbRgbRsbRjbRgbRgbRgbRgbRgbRsbRsbRgbRgLsbRiRsmbR
gRsRsmmbRiRsmbRgbRsLsbRgbLsbRibRsbLjbLcbRjbRibLjbRibRgbRsbRsbRsbRgbRsb
RsbRsRsmbRsbRgbRgbRsbRsbRsbRgRgbRgbRgbRgbRgbRgbRsbRgbRsbRsRsmbRsRsmbRs
bRgbRgbRgRsmbLsRgRsmbRsLsbRgbRgRsmbRgbRgbRgbRsbRgbRgbRgbRsbRgbRgbRgLsb
RgbRsbRsbRsbRibRgbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRsbR
gbRsRsmbRsbRsbRgbRgRsmbRsbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRsbRg
bRsbRsbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbRgRsmbLsRgbRgbRibRgbR
sLoRsbLgbLobRcbRsbRgbRsbRgbRgbRsbRsbRsbRsLsbRgbRgRsmbRgbRgbRgRsmbRsbRg
bRgbRgbRgbRgbLgbLhLsbRcbRsbLsbRgbLsbRibLsbRibLjbRhRsmbRgbRsLsRsbRgbRgb
LhbRibRgRsmbRgbRgbRgbRsbRsbRsbLsbRgbRsbRsbRgbRsbRsRsmbLsbRsbRgRsmbRgbR
gbRgbRsbRgbRsbRsbRgbRgbRsbRsLsbRgbRgbLsbRsbRgRsmbRsRsmbRgRsmbLsbRsbRgb
RgbRsbRsbRgbLgbRgbRsbRsbLsbRgbLsbRcbLibRiRsmbRgbLhbRibRibRibRibLjbLiRs
bLsbLibLibLsbRsbRibRsbLjbLcbRebRcRsmbRibLcbRhbLsbLsbRibRgbLsbLgbRibLgb
RibLsbRgbRsbLsbLsbRgbRsbRgbLgbRcRsmbLcbLcbLibRcLsbLsbLiLsbRibRgbLjbRib
RsbLjbLcRsbLiLsbLsbRcbRgbRsbRsbRsbLsbRibLjbLcbRjbRcbRiRsmbRsbRsbLgbLob
LibLsbRsbRsbLsbRgbRiRsmbRgbLsbRsbRsbRsbRsRsmbRsbRsbRgbRgbRsbRsbRsbLsbL
sbRibRsbRsbRgbRgbRsbRgbRsbRgbRsbRsbRgbRsbRgLsbLgbRibLjbLobLgbLgbRcbRgb
RgbRsbRgbRsbRgbRsbRsbRsbRsbRsbRsbRgbRgbRsbRgLsbRsbRsbRgbRgbRsbRsbRsRsm
bRsbRgbRsRgbRgbRsbRgRsmbRsbRsbRsLsbRgbRgbRgbRsbRgbRgbRgbRsRsRsmmbRgbRs
bRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bRsbRgbRsbRsRsmbRsbRibRsRsmbRgbRsbRsLsbRsbRsbRgbLsbRibLgbRibLgbRgbLsbR
ibLsbRibLjRsbRibLgbLobLibRgbLibLibRjbRcbRibLsbRgRsmbRsbRgbRsbRsbRibLsR
sbRgbRgbRgbRsbRgbRsbLsbRibRsbRgbRsbRsbRgRsmbRsbRgbRsRsmbRjbLsRsbRgbRgb
RgbRsRsmbRgbRsbRsbRgLsbRgbRsbRsbRsbRgbRsbRibLgRsbRibLgbRiRsmbLsRsbRgRs
mbRgRsmbRgbRgbRsbRgbRsbRsbRsbRsbRsbRsbRsbLgbLcLibRjbRhbRgbRgRsmbRsRsmb
RgbRsRgbRgRsmbRsbRgRsmbRgbRsRsmbRsbRgbRsbRgbRgbRsbRgbRsbRgbRsbRgbLsbRg
bRsbRgbRgLsbRgRsmbLsRsRsmbRgbRgbRsbRgbRgbLgbRibLjbLcbLibLsLsmbLgLsbLgb
LsbRjbRhbRiRsmbRgbRgLsbRsbRgbRgbRsbRsbRgLsbRgbRgbRgbRsbRgbRsbRsbRsbRgb
RsbRgbRsbRgRsLsmbLgbRiRsmbLgbRibRcbLgbRsRsmbRsbRgbLhbLibLibLiRsbLcbLib
RgbLcbRgbLoRsbRgbLibLibLhbRibRhRsmbRibRsbRgbRgbRsbLsLsmbRgbRgRsmbRgbRg
bRsbRgbRgbRgbRgbRsbRsbRsbRsLsbRgbRgbRsRsmbRgRsmbRsbRgbRsRsmbRgbRgbRsRg
bRgbRsbRgLsbLobLibLibRjbLhbLcbLcbRibRgbRiRsmbRibLgbLgLsbLgbLhLsbRjLcbR
ibRiRibRgbRsbRgbRgbRsbRgbRgbRgbRsbRgRsmbRsbRsRsmbRsbRsbRgbRgbRgbRgbRsb
RgbRsbRgRsmbRgbRgbRgbLoRsRsmbLibLgbLgRsbLgLsbRcbRibRgbLibRibRgbLsbRgRs
mbRsbRsRsmbRgbRsbRsbRgRsmbRgRsmbRsbRgbRgLsbRgRsmbRsRsmbRsbLsRgbRgbRgbR
sbRgbRsbRgbRsbRgbRgbRsbRgbRsLsbRgbRsLsbRsRsmbRgRsmbRgbRgbRgbRsbRsbRsbR
gbRgbRsbRsbRgbRsbRiRsLsmbRgbRsbRgRsmbLsbRsbRibRgbRgbLsbRgbRsbRjbLjbLcb
LibRjbLibRgbLiLsbLgbRsbLgbRjRsmbRcbRiRsmbRsbRsbRgbRgbRsbRsbRgbRgbRsRsm
bRsbRsRsmbRsbRgbRsbRgbRsbRgbRsbLsbLsRsbRgbRsbRsbRsbRgRsmbRsbRsbRsbRgRs
mbRsbRgbRgbRgbLsRgRsmbRsbRgbRsbRsbRgbRgbRgbRgbRgbLcbRsbLgLsbLsLsmbRsLg
bLsbLiRsbRhbRgRsmbRgbRsRsmbRsbRgbRgbRibRgbRgbRsbRsbRgRsmbRsbRgRsmbRsbR
sRsmbRgbRsLsbRsbRgbRgbRsbRsbRgbRsbRsbRsRsmbRgbRsbRgbRsbRgbRgbRgbRjbRsR
smbRgbRgbRsbRgbRsbRgbLsRsbLobLgbLsbLgbLsRsbRcRsmbRibLsbRgbRsbRgbRsbRsb
RgbRsRsmbRgbRgbRgRsmbRgRsmbRgbRgbRgbRgbRgbRsbRsbRgbRgRsmbRgbRgbLsRsbRg
bLsbRgbRgbRgLsLsmbRgLsbRgbRgbLobRibRjbRibLjbRsbRhbLibRibLcbLcbRhbRjLsb
RhbRsbRsRsmbRsbRsRgbRsbRgbsbRgRsLsmbRgbRsbRgRsmbRgRsmbRgbRsbRgbRsbRgbR
sbRgbRsbRgbRsbRgbRsRsmbRgRsmbRsRsmbRgRsmbRgLsbRsbRsbRgbRgRsmbRgbRgbRgb
RsRsmbRsRsmbRgRsRgRsmmbRgbRgbRgbRgRsmbRgbLsbRibLibRibLjbLcbLibLgbLsLsm
bLgbRjbLcbRhbRibRibLsLjbRjbRibLgbLgbRjbRobLcLcbLobLgbLibLgbLgbLgLsLsmb
LgLsbLsbRsbRcRsRimbLibLhbLgbRgbLsLcbRhbRcbRsRsmbRgLsbRgbRsRsmbRgbRgbLs
bRgbRgbRsbRgbRgbRgbRsbRgbRsbRgbRsRsmbRsLsbRsRsmbLsbRibRsLsbRhbLjbLhbLi
bRjbLcRsbLhbRibRcbRcbLsbLgbLibLibRoRsmbLsbRibLgbRibLgbRibRsbRgbRgRsmbR
sbRsRsmbRgbRgbRgbRgRsmbRsRsmbRgbRgbRibRsbRgbRgbRgRsmbRgbRsbRgbRsRsmbRg
bLgLsbRibLgbRhbLgRsbRibRsbRgbRsLsbRgbLsLcbLgRsLsbLgLsbLgbLgbLsbRebRiRs
mbRsbRcbLjbRcLsbRiLsbLsbLjbLgLibLsbLgbLgLsbLgbLgRsbRcRsmbRibLibRiRsmbR
sbRgbRgbRsRsmbRsbRsbRgbRsRsmbRgbRsRsmbRsbRgbRgbRsbRgbRsbRgbRgbLsbRibRs
RsmbRsbRgbRsbRgbRsbRgRsmbRsRsLsmbRgRsmbRgRsmbRsbRgbRjbRgbRgRsmbLsRsRsm
bRgbRgRsmbRgbRsbRgbLsRsbRgbLsbRgbRsbLsRiLsbRgLsbRsbRgbRsbRgRsmbRsRsmbR
gb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bLgbRjRsmbLibLibRjbRibLibRibRgbLsbRibRjLsbLcbLhbRjRsmbLibRjbLcbRcbLcbR
jbLcLsmbLibLibRgbLsbLhbLsbLsbLsbRjbsbRibRibLebRjRsmbLcbLhbLgbRsLsbLsbL
gbLcbRibLjLsmbRjbLibRjbLeLsbLiRsbLibLsbRsbRiRsmbLsRsbLhbLibRsbLgbLibRg
bLhbRjbRibLibLibRgbRsbLibRgbLcbLhbRhbRjbLhbLhbLgbLsbRjRsmbLjbLgLsbLibR
gbLsbLibRgbRibRjRsmbLibLjbLhLsbRhRsmbLcbLibRgbLibRjbLibLibRjbLibLibLib
LsbRgbRibLjbRibLsLsLsmmbRjRsmbLsbLcbLgbLsLsmbLgbLgbRibLibRhbLibLibLsbL
gbRsbRibRibRsbRiRsmbLibRgbRibLibRibRhbRibRsbRsbRjbLibLjLsmbLibLibLibsb
RibLibRebLsbLsbRsbRjRsmbLsRsbRgbsbLiLsbRibRsbRibReLsbLsbLgbLsbLjbRhbRh
bRhbRibLsbRiRsmbLhbLebLgbLsbLsbLjLsmbRjRsmbLgbLcbRjbLhbRgbRjbLhbLhLsbL
iLsbRjbLsbLjLsmbRibRhbRjRsRsmmbLgLsbLsbLsbRibLsbRibRcbLgbLgbLsbRcbRibR
ibRibLibLgbLsbRgRsmbLsbRebRgbsbRgbRsLsbLgLsbRibLjbRibLibLgbRgbRgbLcbRh
RsmbLcbLibLibRibLgbRibRgbRgbRgRsmbRibRibRibLgLsbRgbLsbRebRcbLibRgbRibR
jbLsLsmbLsLsmbRibLgbLgbLhbLibLsbLibLiLsbRgRsmbRgbLiLsbLibRibLibLibRgbL
sbLjLsmbRsbRgbLibLibRsbLgbRgbLibLgbRsbLgbLgRsbLibLibLibRiRsRsmmbRibLsb
LgbLgbLibLsbLibRgbRgbLiRsbRjbLibLsbRjbRjRsmbLgbLhbLgbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bLsbLibRjbRsbLibLgLsbRjLsbRcbRibLjLsmbLiLsLsmbLibRgbRsLsbLibRcLsbRgbRg
bLjbRibLjbLjbLiLsbLiLsbRhbLhbLibLgbRsbRgbLibRsbRsbRhRsmbLiLsbLgLsbLhbR
sbRgbLgLsbLgbRsbLgbLsbRgbLgbLgLsbLsbLsLsmbLsLgLsbLsbLsbLsbLgbLgbLgbLsb
LgbLgbLgbLsLsmbLgLsRsbLibRgLsbLibLsbLgbLgbLsRsbLgbLgbLgbLgbLgbLgbLgbLs
LsmbLsbLsLsmbLgLsbLsbLgbLgbLgbLsbLgLsbLgbLsLsRsmbLgbRsbLgbRgRsmbRcLsbL
ebLibLsbLgRsbLgbLsbLsRsbLsbLgLsbLgbLsbLgRsbLgbLgbLsbLgbLgbLgbRcbRcbLiL
sbLibLibLgLsbLsbLsbLsLsmbLgLsbLgbRjbLsLibLgLsLsmbLgbLsLsLsmmbLgbLgbLgb
LsLsmbLgLsbLgbLsRsbLgbLgbLgbLsbLsbLgRsbLgLsbLsbLsbLgbLsbLgbLgLsbLgRsbL
gbLgLsbLgbLsbLibRcbRhbLjbLjbLibRgbRjbRcbLibLhbLgLsbLgLsbLgbLgbRjRsmbRj
bRcbLhbLibLibRjbLibLgbRcbLibLgbLsLsmbLgLsbLgbLgLsbLsLsRsmbLgbLgbLsbLgb
LsbLibRcbRcbLebLibLgLsbLsLsmbLgbLsbLgbLgbLgbLgRsbLibLcLsmbLibLibLiLsbs
bLibRsbLgbRsbLgbLsRsbLgbLgLsbLsbLgbLsbLgbLsLsmbLsLsmbLsbLgbRcRsmbRibRh
bLcbLibRjbLhbLibLibRiRsmbLgLsbLgLsLsmbLiLsbLgbLgbLgbLgLsbLgbLsLsmbLgbL
sbLgbLiLsbLsLibLibLibLiLsbLibRibLibLsbRjbLibRgbLiLsbRjbsbRcRsmbRibLhbL
ibRsbLgLsbLsRsbLgbLsbLsbLsbLgbLgbRgbRjRsmbLcbLgbLgbLsLsmbLsbLgbLgbLsbL
sbLsbLgLsbLsbLgbLsLsmbLsbLsbLgbLsbLsbLgbLgbLsbLgbLgbLgbLgbLgbLgbLsbLsb
LgbRgbLhbRhbRhbRibLjbRibLhbRjbRibRiRsmbLsbLjbLibRgbLiLsbLsbLsbLgbLsLsm
bLgLsbLsbLgbLsbLgbLsbLsbLgbLsbLsbLgLsbRsbLgbRcbRiLsbRibLcbLsbLgbRsLsbL
sbLgbLsLsmbLgRsbLgbLgbLgLsbLgbLgLsbLgbLgbLgbLgbLgbLgRsbRcbLibLibLsLsmb
LgLsbLsbLgLsbLgbLgLsbLgbLsLgbLgbLgbLsLsmbLgLsbLgLsbLgbLsRcbRgbRgbLhLsb
LiLsbRjbRibLiLsbRjbRcbRhRsmbLjbLhbRhbRebLebLibLgbLibLgbRjbRcbRibRgRsmb
LiLsbLebLiLsbLibRgbLgbLgbLgbLsbLsbLgbRsbLgbLgLsbLsbLsbLgbLsbLgLsbLsbLg
bLsLsmbLgbLgbLsbLgbLsbLsbLgbRjbRcbRibLhbsbLgbRebLjLsmbLhbRiLsbRibRibRg
bRsbRgbRsbRsbRgbLgbLcbLcbRhbRhRsmbLcLsLsmmbLebRiLsbRjbRcbLhbLhbLibRgbL
ibLsbLgbLsbLsLsRsmbLgbLgbLgbLsbLgbLgbLsbLsbLsbRebRhbLebLibRsbLgbLgLsbL
sLsmbLgbLsbLsRsbLgbLgbLsbLgbLgbLgRsbLgbLgLsbLgbLgbLsbLgbLgbLgbLsbLsLsm
bLgbRsbLiLsbRsbRsbLibLgbLsbRibRibRgRsRsmmbRgbRsbRsbRsLsbRgbRsRsmbRgbLj
bLcbRgRsmbRhbRiRsmbLjbRiLsbLcbRjbRhbRgbLcbRjbLjbRgbLhbLibLcbLibLibLiLs
bRsRsmbLibRsbLiLsbRjbRhbRibLjbLeLsbLgLsRsbLsLsmbLgbLgRsbLgbLgbLgbLsRsb
LsbLgbLsbLgbRhbRhbLhbLibLibRcbRibLjbRibRgbLsLsmbRibLjbLibRjbRibLebLibL
sbLibLgbLsbLsLsmbLgRsbRebRibLhLsbRsLgbLgbLsLsmbLgbLsLsmbLsbLgbLgbLgbLs
LsmbLgbLgLsbLgbLgLsbLgLsbLsbLgbLsLsmbLgbLsbLgbLsbLsbLgbLgLsbLsbLsbLsbL
gbLgbLsbLgLsbLgbLgbLgLsbLgLsbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bRsbRgbRsbRgbLjbsbLcbLibLgbLsbRgRsmbLgbRcbRgRsmbLsbRibLgbRibLsbRsbRgbR
sbLsRhbLsRsbRsRsmbRsRgbRgbRgbRgbRsRsmbRgRsmbRgbRgbRgbRibLibRcbLjbLcLsm
bLiRsbLgLsbRsRsmbLgbLibRjbRcbRibRsRsmbLsbsbRhbLsbRgRsmbRgbRgRsmbRsRsmb
RsbRsbRgbLsbRgbLsRsbRgRsmbLsbRcbLibLsbRcbLsbRiRsmbRgbRgbRibLibLibLibRj
bRcbRsRsRsmmbRibRgbRgbRgbLibRiRsmbRsbRibLsRsbLobRsbRsbRgbRsbRgRsmbLgRs
bRiRsmbLgbRibLsRsbRibLsbRgRsmbLsbRgbRsRsmbRsRsmbRsbRgRsmbRgbRgbRgbRsbR
gbRgbRsbRsbRgbRsRgbLcbLhbLgRsbLgbRsbLiLsbLsbLgbLgbLiRsbRhbRcbRgbRsbRgR
smbRgbRsbRgbRsbRsbRsbRgbRgbRsbRsbRsbRsRsmbRgbRgbRsbRsLsRsbRsRsmbRgRsmb
RgbRsbRsbRgbRgbLoRsbLgRsbLgbLgbLsbLibRjbLibLsbLsbRsbRsLibRjbsbLibRsRgb
RgRsmbRsbRsRsmbRgbRgbRsRsRsmmbsbRgRsmbRsbRsbRgbRgRsmbRsbRibRgRsmbLjbLi
bLgbRibRibLgbLjbRcLsbRhbLibLjbLsbLsbLsbLsbLsLsmbLsRsbLsbLsbLgbRsbLgLsb
LgbRcRsmbRsbRsLsbRsbRsbRgbRgRsmbRsbRgbRgbRgbRsbLibLgLsbLgLsbLgbLgbLsbL
sbRibRcbRgbRgRsRsmmbRgbRgbRsLsbLgbRjbRcbLsRsbRsLsbRsLsbRgbRgRsLsmbRgRi
bRgbRgRsmbRgbRgbRgbRgbRsbRgbRsbRgbRsbRgRsmbLgbRgRsmbRgbRsbRgbRsbRgbRgb
LjbLcbLgbLgbLsbLsbRobRibRibRsbRsbRgbRsbRsRsmbRgbRgbRsRsRsmmbRgRsmbRgRs
mbRgRsmbRgRsmbRgbRibRgbRibRcbRcRsmbRcbRiRsmbRsbRibRgbRsbRgbRgbLjbLibLi
bLgbLgbLhLsbRcbRcbLsbRgbRgRsmbRsbRsbRsRsmbRgbRgbLobRgRsmbRgbRsbRgbLgbR
ibLjbRcbLibRcRsmbLibRgbLsRsbRcbLgbRcbLsbRsbRibRibRsRsmbLgbRibRgbLsbRgL
sbRgbRgbRsbRgRsmbRsRsmbRgbRgbRsbRsbRsRsmbRgbRgbRgbRgbRsbRgRsmbRgbRgRsm
bRsbRgRsmbRsbRsRsmbRgbRsbRgbRibLibLcLhRsbLgbLsbLgbLhbRcRcbRibRsbRsbLgR
sbRgRsmbRgbRgbRgbLgbRibRgbRsbRgbRgbRsbRsbLsLsmbRsbRsRsmbRibLgbRhbLgbRh
bLibRhbLgRsbRgbRgbLgbRibLcbLcRsbRcbRsbRgRsmbRgbLsbRgbRsLsbRsbRgbRsbRsL
sbRhbLgbRebRoRebRgRsmbRsbRgbRgbRsbRgLsbLsbRgbLsRsbRgbRgLsbLsbRgRsmbRsL
sbRgbRgbRsbRgRsmbsbRgLsbLsbRiRsmbRgbLsbRgbLcbLgbLgRsbRcRsmbRgRsmbRgbLs
bRgbRgbRsRsmbRsbRsbRgbRsbRsbRsbRgbRgbRgbRgbRgRsLsmbRgRsmbRgbRsbRsbRgbL
cRsbLibRjbRcbLhbLibLibLcLsmbLgbRibRibRibRgbRgbRsRsmbRgRsRsmmbRsbRsbRgL
sbRgRsmbRsbRgbRsRsmbRgbRgbRsbRgbRgRiRiRiRsRsmmbRibRgbRgbRgbRgLsbRgbRgb
LcbLibLgbLgbLgRsbLgbRcRsmbRgbLsbRgbRgLsbRgbRsRsmbRgRsRsRsmmmbRsRsLsmbR
sbRgRsmbRsbRgbRgbRgLsbRgbRgbLsbLcbLgbLgbLgbRobRiRsmbRgbLsbRgbRgRsRsmmb
RsRsRsmmbRsbRsRsmbRgRsRsmmbRsbRgbRgRsRiRimbRgRsmbRgbRsbRgbRsbRsbLsbRgb
LgbRibRibRsbLsbLjbLhbLgLsRsbLgbLgbLgbLsbLgbRcbLsbRcRsmbLsbRebLgRsbRgbR
sbRgbRgbRsRibRgbRsbRgbRgbRgRsmbRsbRgRsmbRgRsmbRgbRgRsmbRgLsbRsbRgbLsLs
mbRgbRgRsmbLsbRgRsmbRsbRgRsmbRsRsmbRgbRsRsmbRsbRgbRgbRsbLsRgbRgbRsRsmb
RsRsmbRgbLsRsbRgbRgbRsLsbRsbRgbRsRsmbRsbRgRsRsmmbRgbRsRsmbRgRsmbRgbRsb
RgbRgbRgbRgbLjbLcbLibLgbLgRsbRebRcbRibRgbLsbRgbRibLhbLcbLibRsbLiRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bRgbRiRsmbRgRsmbRsbRsbRsbsbLsLsmbRhbsbLgbRcbLgbsbLjLsmbLhbLsLsmbLibLgL
sbRgbRsbLsbLibRjbLcLsRsmbRsbRsbLobRsbLsbLgbLsLsmbLsbRsRsmbLibLsbLgLsbL
sbLsbLgbLsbLgbRsbLgbLsbLgbLsbLsbLsLsmbLgbLsbLsbLsbRsbLsLsmbLgbLibLibRs
bLsbRsRsmbLsbRgRsmbRebRsbRsbRiLsbLsbRibsbRsbLsbRibRgbLsRsbRsbRsbRsbRsb
RsbRsRsRsmmbRsbRgbRsbRsbRsbRiRsmbRibRiRsmbLgbLsbRsbRgbLsbRsbRgbRsbRhLs
bsbRsbLsbRsbLsbRsbRibRgbLgbRsLsbRibRsbRsbRgbRsbRhbRgbLgbRsbRibRgLsbRsb
RsbRgbRgbRgbLsbLgbLibsbRiRhbLsbRhbRsbRgbLgbLibRcbLsbRiRsmbRgbRsbLsbLsb
RsbRiRsmbRgbLgbRibRgbRsbLibRibRibRsRsmbLsbRgRsmbRgbLgbRibRsbLjbLgbLgbL
gbLgbRgbLgbRsbRcbLibRiRsmbLgbLgLsRsLsLsmbLgbRsbLgbLsbRsbLgLsbRsLsbLgbL
sbLgbLgbLgbLgbRsbLgbsbLibsbLibRsbRgbLsbLibLgLsbLsbLgbLsbLsLsmbLsbLsLsm
bLsbLgbRjbLibLgLsbLgbLgbLgbLgbLgRsbRcbLsRiRsmbLibRhbRgRsmbLcbLgbLgRsbR
jbLgbLsLsLsmmbLgbLgbRsbLsbLgbLgbLsbLgLsbLhbRgbLgbLsLsmbLsbLgbLsbLsbLsL
smbLsbLsLsmbRsbLsLsmbLsbLgbLgbLgbRcbRhbLgbRiLsRsbLgbLhbLsbLhbRgbLibLgb
RgbRgbLibLgbLsbRsLsbLgLsbLgbRsbLibLsbLsLsmbLsbLsbLsbLgbLsbLgbLsbLgbRsb
LgbLsbLgbRsbLgRsbLgbLsbLsbRibLgbLsbRjbRobRiRsmbLibRsbsbRsbRgbRgbRsbRsb
LsbRgbRibRcbLjbLsLsmbLgbLsbsbRibRibRsbRsbRibRgbLibRcbLgbRgbRgbRsbRgbRs
bsbRgbLgbRiRsmbRsbRgbRgbRsbRsbLgbLcbLibLgLiRsbRgbLgbLibLibLgbRsbLgRsbL
sLsmbLsbLsLsmbLgbLsbLgbLsbLsLsmbLgLsbLsbLgbLsbRsbLgbLgbLsbLsbLsbLgbLsb
LgbLgbLsbRsbLsbLgbLsbLsbRsbLgbLgbLsbLsbRsbLsLsmbLgbRsLsbLgbLsbLsLsmbLs
bLsbRsbLibLibRgbLsbLibLhbLsbRsbRsbRgbLibLgbLsbRgbLcbLsbLebRsbLgbRgbLib
LsbLgbRgbRgbLjbLibRibLibRsbLgbLsbLsLsmbLsRsbLgbLgRsbLgbRgbLgbLgbRgbLgL
sbLsRsbRsbLgbLgbRsbLgbRsbLgLsbLiLsbLibRibLjbRsbsbRsbRsbLsbLibLgbLsLsmb
LsbLsbLsbLgbLsbRsbLgbLsbLgRsbLgbRsRsmbLsbLsLsmbLgbLgLsbLsRsbLgbLsbLgbL
sbLsbLsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bRsbLsbRsbsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bLjbsbLhbsbsbsbsbsbsbLibLsLsmbRgbLsbLjbRsbRsbLsbRjbsbLgbLgbLsbLsbLgbRs
bLgbRjbRcbLebLgbLgbRjbRcRsmbRsbRgbLgbRiRsmbLjbRgbRgbRgbLibRgbRsbLsbRjb
LgLsbRsbRsbLjbRsbLsRibRgbLgbRibRgbLsbRgbLgbLebRhbRsbRgbsbLcLsmbLsbsbsb
LsbLgbRsbLgbLsbLgLsbRsLsbsbLgbLgbLgLsbRgbRhbLibRsbRsbLsLsmbLibLsbRsbRg
bLjbLsbLgRsbLsbLsbLgbLgbLgRsbLjbRcbRibRibRjRgbLibRgbRsbLsbRgbRsRsmbRsL
sbLsbsbRsbLsRsbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bLjbLcbLibLgbLsbLgbLsbLsbLsbLsbLsbLsbLsbLgbRcbRibLjbRgbRobRsRgbRgbRsbR
sbRgRsmbRsbRsbRsbRsbRsbRgbRsbLcLsmbRsLgbLgbRjbLhbLiLsbRibLiLsbLgLsbRsb
LgbLsRsbLsbLibRhRsmbRibLsbRiRsmbLgbRgbRgbLsbRgbRgbLjbLcbLibRgbLsRsbLgL
sbLsbLgRsbRjbRcbRgbRiRsmbLsRsbRgbLgRsbRgbLsbRgbRsRsmbLcbLibLsbLsbLsbLs
bLsbLgbLsbRsLsbRibRjbLgbRobLibRsbLjbRsbRsLsbRjbRibRgbLgbRgRsmbLsbLcbLg
bLsbLjbRsbLibRgLsbLjbLsbLsbLsbLsbRsbLsLsmbLgbLgbLsbLgbLsbLgLsbLsbLsbLs
bLsbLgbLiRsbRjbLhbLgbLsbLjbLsbLgbLgbLgbLsbsbLsbLsbLgbLsbLgRsbRhLsbLcbL
ibLsLsmbLsbLgbRsbLgbLsbLibRsbLsbLsLsmbLiLsLsmbLjbLsbLsbLsbLsbLsbLsbLsR
sbLsbLgbLgbLgbLcbLgbLsbLsbRgLsbRsbRsLibLsbLsbLsbLjbLsLsmbRsbLsLsmbLsbL
sbLsbRsbsbLsbLgbLsbLgbLsLsmbLgbLgbLsbRobLsbRsLsbLgbRebRsbRcbRibLsbRsbR
gbRgbLjbLcbLgbLsbsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLgbRgbRsbRsbLsbLgRsbLsbL
gbLgbLgbRhbLcbLgbRhbRgbRgbLsbLebLcbLgbRgbLibLsbLgbRsRsLsmbLjbLsLsmbLsb
LgLsbLsbLsbRsbLsbLsLsmbLgbLsLsmbRgbLibRgbLgbRobLsbLsbRhbRgbsbLgbLjRsbL
cbLsbLibLsbRgbLiLsbsbLsbLsbLsbRgLsbLsbLsLsmbLgbLgbLsbRgbRcbLibLibLsbLs
bLsbLgbRsbLgbLgLsRsbLgbRjbLcLsmbRgbLsbLgLsbLsbLgbLsbLgbLsbLsbLgbRgbRcb
RibRibLgbLjbLcbLgRsbLsbLibRsbLgbLiLsbRgbLsLsmbLiRsbRgbLiLsbRsbLgbLsbLg
LsbLgbRjbRjbLhbRgLsbLibLgbLgbLibRibLibRgbsbRsLibRgbRhbLjbLcbRgbLiLsLsm
bLsbLsbLgbLsbLsbLgbRjbRcbRibLgbRibLjbLjbLhbLsRsLsLjbLjbLsbRsbLgbLgbLgb
LgbLgLsbLhLsbRsbLiRsbLgbLgbRsbRhbLebLibRsbLibRgbLgbRjbRcRsmbRgbLgbRgbR
iLsbLjbLcbsbLsbLsLsmbLsbLgbLgbLgbsbLgLsbRjbRjbLjbLibLgbLgbLsbLsbLgbLsb
LsbLsbLsbLsbRgbLibLjbLcbLjbRsLsbLsbLsbLsbLsbLgbLgbLsbLsbLgbLibLgbRsbLi
LsbLgbRjbRcbRgbRgbLgbRgbLgbRjbLsRsbLebLgbLsbLsLsmbRsbRsbsbLsbLsbRsbLsL
smbLsLsmbLgbLsbRcbRibLjbLcbRgbLsbLibRsbLsbLsLgbLsbLgbLgLsRsbRgbLiLsbRj
bRibLcLsLsmmbLibLgbLgbRibLgbLibLgLsbRgLsbLibRsbLsbLsbLgbLsbLsbLgbLgLsb
RcbRgbRgLsbRgbRsRsmbRgbLjbLcbLhbRibLibLgLsbRsbLgbLsbRgbLgbLgbRgbRjbsbR
gRsRgmbsbRsbsbRsRsmbRgRsmbRsbRsbLgbLcbLibLsLsRsmbLsbLgbLsbsbLsbLsbLsbL
sLgbLsbLsbLsbLibLsbRsbLcbRsbRgLsbLibLsbLibLsLsmbLgbRsbLgbLsRsbLiLsRsbR
jbRibLsbRgbLsRsbRgbRgbRsbLjbLcbRsbLgbLsbLsbRsbsbLsRsbLgbLgbLgbLjbLsbRs
RsRsmmbRsbLsbLsbLgbLsbLgbLgbLsbRjbLibLgbLgbRibLsbRcbLsbRiRsmbRsbRiRsmb
RsbLjLsmbLcbsbLsbLsbRsLsbLsbLsbLsbRsRsLsmbLsbLsLsmbLgLsLsmbLsbRsbLsbLs
LsmbLgbLgbLgbLsLsmbLgbLgbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bLsbRiRsRsmmbLcbLgbLgbLgbLsbLsLsmbLgbLsbLgRsbLgLsbRcbRibLsbRibRgbRgbRs
bRsbRsbRgLsbRgRsmbRsRsmbRsRsRsmmbRgbRsbRgbRgbRgRsmbRsbRgRsmbRsRsmbRgRs
mbRsbRsbRgbRibLiLsLsmbRibRiRsmbRsbRgbRgRsmbRsbRgbRgbRsbRgbRgbRgRsmbRsb
RsRsmbRsRsmbRgbRgbRgbRibRgbRsbRgRsmbRgbRsbRgbRsRsmbRsbRsbRgRsmbRgbRgLs
bRsbRsRsmbRgRsmbRgbRgbRsRsmbRgbRgbRgbRgRsmbRgbRgbRgbRgRsmbRgbRsbRgbRgb
RgbLsbRgbRsRsmbRibRsbRgRsRsmmbRgbRgbRgbRgLsbRgbRsRsLsmbRgbLjbLcbLibLgL
sbLgbLgbRjbRibLibLiRsbLibRjbRcbRgbRsbRgRsmbRsRsmbRsbRgbRgRsmbRsbRgbRsR
smbRsRsmbRgbRgRsmbRgRsmbRgbRgbLsRgbRgbRsbRsbRgbRgbRgbRgbRgbRgbLsbRiLsb
LjbRcRsmbLibRiRsRsmmbRgbRgbRgbRgbRgbRgLsbRgRsmbRgbRgbRsLsbRgbRgbRgbRgb
RgbRibRibLibRibRsbRgbLsbRgRsmbRgbRsbRsbsbRsRsRsmmbRgbRsbRgbRgbRgRsmbRg
bLsbRgbLsbRgRsRsmmbRsRsmbRsRgRsmbRsbRgRsmbLgbLgbRibRgbLgbLobLibLgbLgbL
ibRsbRobRibRibRgRsmbRsRsmbRgbLsbRibLsbRsbRgbRgLsbRgRsmbRgbRsRsmbRgRsmb
RgRsmbRgbRsRsmbRgbRsbRsRsmbRgbRibLgRsbRibLsbRgbRsbRgbRgbRsRsmbRsRgbRgb
RgbRsbRgbRsbRgbLgbRiRsmbRsRsmbRiRsLsRsmbRsbRibLjbLobLebLsbLibRebRsbLjb
RcbLjbLsbsbLgbLibRebLgbLsbLgbLibRhbRjbRgbLsbLjbRgbRgRsmbLsbRibLgbRibRs
bRibLsRsbLcbLgbRebRibLsbRibLgbRiRsmbLibRibLgbRibLsbRibLjbRibLgbRibLjbR
sLcbRebRiRsmbRsbRgbRgbRgRsRsmmbRgRsmbLsbRsbRibLsbRsLsbLsRiRsLsRsmbLsbL
gbLgbLibReRsmbRibRgbRgbRsbRgbLibRibRjbLjbRebLibLsbLgbLsbLgbLgbLgRsRsmb
RsbRsRsmbRsbLsRcbRsRsmbRsbRsbRsRsmbRgbRgRsmbRgbLgbRibRgbRgbRgRsmbLsbRi
bRsbRgbRgbRgbRibLhbRibRibLibRibLsbRibRsRsmbRgbRsRsmbRsbRgbRgbRsbRgbRgb
RsbRgbsbsbLsbRibRibLgbRsbRibRgbLsbRgRsmbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bLgbLsbRsbLgbLsbLgbRgbLjbLgbRgbLgbLsbRgbLibLgbRgbLhbLsbRibLibLgbLsbLsb
LgbLgbLsbRsbsbLiRsbLsbRgbLibLsbLgbLsbLsbLsbLgbLsbLgbRjRsmbRgRsmbLibRib
RcbReRsmbRsbLibRjbRjRsmbRjRsmbLibLibRcRsmbLjLsmbRibLibLibRiLsbRgbLgbRi
bRgbRibRsbLibLgbLgbLsbLibLgbLiLsbLsbLibLgbLjbRibLibRibLibRibLibLibRjbL
ibRebLibLjLsLsmmbLsbRsbRsbLibLgbLjbLibLibRhbLibLjLsmbRibRibLgLsbRjbLhb
LsLsmbLsbLsbLgbRibLibRsRsmbRibLsbLsLsmbLsbLibLsbRibLibLgbLibLgbLibLsbL
ibLgbLsbRsbLibLiLsbLibLibLsbLsLsmbLgbLibLibLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bRsbLgbLsbLsbLgbLsbLgbRsbLsbRsLsbLsbLsRsbRsbLsbRsbLiLsbLsbsbLsbLsbsbsb
RsbLiRsbLobLgbRgbLiRsbLcbRhbLibLgbLgbRsbRgbRjbRhbRibRgbRibLcbLhbLibRgb
RgbLcbRiLsbLibLsbRsRsmbLgbsbLsbLgRsbLsbLgRsbLsbLiRsbRcbRgbLsbRiRsmbLjb
sbLibLibLsLgbLsbLsbLgbLsbLgbRsbLgbLsbLibRgbLgbLsbLsLsLsmmbLsbLsRsbLgbL
sbLsbLsbLsbRsbLgbLsbLsbLsbLsbLibRsbLgRsbLsbLgLsbLsbLsbLgbLsbLsLsmbLgbR
cbRibRibLibLhbLibRgbLibLgbLgbRibLibLibRgbLgLsbLsbLgbRsbLgbLsbLsbLsRsbL
gbLsbLgbLsbLsbLgbLibRgRsmbLgbRsbLgbLsbLjbRsbRsbRsLsbLsbLgbLsbLgbLsbLsb
RsbRsbLibRsRsmbLibRcbRhbRibLgbRibLjbRsLcbLcbRsRsmbLsbLgbLsLsmbLgbLsbLs
RsbRsLsbRibRibRgbLcbLibLsbLgbLsbLsbLsbLsbLsbLsbLsRsbLsbsbLsbRgbLjbLsbL
sLsmbLsbRsbLsbLgLsbRsbLsbLgbLsbRgbLgbRsbsbsbLsLsmbRsbLsbLsbLgbLsbLsbLs
bsbRsbRsbLjbLsbRsLsbLgbRsLsbLsbLsbRsbLgLsbLgbRgbLgbLgbLgbLsbRsbLsLsRsm
bLgbLsLsmbLgbLsbLsbLgbLgbLgbLgbsbRsbLsbRjbRhbRgRsmbRgRsmbRibRsbLibLcLs
mbLgbRsbLibLsbLgLsbLgLsbRsbLgLsbRgLsbLibRgbLibRgbLsbLgbRgbLibRiLsbLcLs
mbRibLgbLgbRsbLgbLsbLsbRsbLgbLsbLsbLsLsLsmmbLgbLgbRibLgbLgbLsbLgbLgbLs
bRjbLgbLgbRgLsbLjbRgbLibLgbLjbRibLsbLgRsbsbLsRsbLsbLibRgbLibRgbLibLibL
ibLsbRsbRsbLgbLgbLgbLgbRsbRgbRsbLibRgbLibLgbsbRibRjLsbRcbRgbRgbLsbLsRs
bLgbRobRiRsmbLjbsbRibRibRgbRgbLgbRibRgbRibRgbRgbLgbRibLgbRibLsbRgRsmbL
gLsbRjbRsbRjbRsbRibLsbRgbRsbLsbLgbRiRsmbRibRgbLgbRibLsLsmbRiRsRsmmbLsb
RgbLsbRiLsbRgbRgbRgLsRsbLsbRgbRibRgLsbLgbRgLsRsbRgRsmbLgbLcLhbLgbRgLgb
LgbLibRgbLiRsLsbLgbRgbLjbsbLsbRsbLsLsLsmmbLsbRsbLsbLgbLsbLgbLsbLsbLsbL
sbLgbRgbRcbRibRsbLsbLcbLibLsbLgbLsbLsbLsbLsLsmbLgLsbLsbLsbLsbLsbLgbRsL
sRsbLsbRsLsRsbRgbLsbRsRsmbLibRgbLibLsbLgbLsbLgbLsbLgbRgbLiRsbRcbRcbRib
LsbRsbLhbLgbLsbLgbLgbRsbLgbLgbRgbLibRsLsbRsbLsRsbLgbLsbLgbLsbLsbRsbLgb
LsbLsbRgbLibRibLibLgbLgbRcbRgbRgLsbRsbLjbLcbLibRsLsbLsbLsbLsbLsbLgbLsb
LsbLebLsbLjbRsbLibRgRsmbRsbRgbLjbLibLsbLgbRgbLibRgbLsbsbRsbLjbLsbRsbLj
bLsbLsbLgRsbLsbLsLsmbLsLsmbLgbLsbLgbLsbLgbRsbLcbLsbRsbLibLsLsmbLgbRsbR
sbRgbLiLsbRjLsbLibLgLsbsbLsbLsbLsbLsbLsbLsbLsbLsbLsLsLsmmbLgbLsbLsLsmb
LsbLsbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bLibLgbLgbRgbLhbLgbLjLsmbLgbLibLsbRibLgLsbLibRibLjLsLsRsmmbLebLibLibLs
bRiRsmbLjLsmbLiLsbLjRsbRjbLebLiLsbLjLsmbRjbRsbRebRjbRhbRsbRcbRsbRgbRgL
sbRgbLeLsbLibRsbLibRjbLsbRsbRsbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 25; Drug: Control Apo 0.5 然
bRsbRsbRgbRgbRsRgbRsbRsbLsbRsLsbLcLcbLibLibLhbLibRibRhbRhbRcbRhbRibLhb
LhLsbLgbRgbRibRibRsbLjbLcbLsbRjbLiRsbRjbRcbRsRsRsmmbRsbLgbLjbsbLhbLsLi
bLsbsbRjbRcbRsbLsbLsbLsbRibLsbRibRsbRsRsmbRgbRsLsbRsbRsLsbRgbRsRsmbRsb
RsbRsRsmbRsbRgbRgbLsbLjbRhbLhbRibLjRsbRiRsmbRgbLsRsbRgbRsLsbRgbRgLsbRs
bRgbRsbRsbsbRsbRgbLsbRsbRsbsbRsbLgbRgbRgRibRgRgbRgbRsbsbRibRsbsbRibRib
RiRsmbRgRsmbLibRibRibLhLsbLibLibLiLsbRjbRcbRgbRsRsmbRgRsRgmbRgbsbRgRgR
gbRgbRgbRgbRgbsbRsbRiLsLsmbLhbLiLsbLcbRebRcbRhbRibRgbLiLsbRibRsbLgbLiL
sbLibLiRsbLibRiRsmbRibRcbRcbLibLibRcRsmbRibRibLibRgbRgbRsbRgLsbLgLsbRi
bLgRsbRcbRgbRibRgbLgbRibRgRsRsmmbLjLsmbLcLsmbRcbRhbRgbLibRcbLgbLgbRibL
jbRsbLibsbRcbsbsbRjbLsRsLsbLjbRibRsbRsLsbRsbRsbRgbRgbRsbRsbRsbRgbRgbRg
bRgRsRsmmbRgbRsbLsbLjbRhRsmbLiLsRiRsmbRsbRgbRsRgbRgbRgbRsbRibRgbRgRgRs
mbRgRsRsmmbRsbRsbRgbLjbLcLsmbLibLgbLibLgbLsbLibRhbRhbRgbLibLgbRhbRcbRe
bRhbLibLgbLibRebLibLgLsbRsbLibLcbRibRgbLibLgbLibLibRjbRibRgbRsbRsbRgbR
gbRsRsmbRsbRgRsmbRsbRsbRsRsmbRsbRgbLgbRgbRsLsbRsLsbRsbRsbRsbRgbRsbRsbR
gLsbRgbRsbRgbRsbRgbRibLhbReRsmbLsbRgbRgRsmbRsbRgbRsRsmbLsRsRsmbRsbRgbR
gRsmbRgbRgbRsbRsbRsbRgbRgbRgbRgbLibRibRsbRgbRgbRsbRsbRsRsmbRsbRsRsmbRs
bLsbsbRsbRsbRgbLsbRgbRgRsmbRgRsRsRsmmmbRgbRgRsRgmbRgRsRgmbRgbsbRgRsRsL
smmbRibRibLibLibLiLsbLibLhbLibRibLibRhbRibRcbRibRibRgbRgbRiLsbRgbRiRsm
bLibRhbLibRiRsmbRibLsRsbLsbRibRsRsmbRsbRsbRsbRsbRgbRsbRsbRgbRgRsmbRgbR
sbRsbRjbLoRibRgbRgbRsbRgbRsbRgbRsbRgRsmbRgbRsbRsbRsbRgbRibRgbRgRgbRgbL
gbLjbRsbRgbRgbRsbRgbRgRsmbRsbRgbRsbRgbRgbsbRgLsbLibLsbLjbsbRiRsmbLibRi
bRiRsmbLgLsbRcbRgbLcbLibLibRcRsmbRibRgRsmbRgbRgbRgbLibRsRhbLibRibLgbRs
bLgbRgbLsbRgRsmbRsbRgbRgbRgbRsbRsbRsRsRsmmbRsRsRsRsmmmbRsbRsRsmbRsRsRs
mmbLgRsbLjbRgbLjbRiRsmbRgbRgbRgbLibRsRibRgbRgbLhbLcbLibRjRsRsmmbRcbRiR
smbRsRsmbRsRsmbRsbRgbRgbRsbLsbRgbsbRiRsRsmmbLsbsbRsbRgbRgRsmbRgbRgbRgR
smbRsbRsbRsbRsbRsbRsbRsbLsRsbLsbsbLsbLcbsbLibLibLcbLibLibLibRebRcbRibL
jbRibRibRgbRibLibRgbRgbRgRsmbRsbLsbRiRsmbLsbRgbRgbRsbRsRsmbRibRhRsmbRs
bRsbRgbRsbRgRsmbRsbLgbRibRsbRgLsbRgbRsbRibLjbRgbRibLjbRcRsmbLibRibRsbR
sbRsbRgbRgbRsbRgbRsRsmbRsbRsbRsRsmbRgRsmbRgbRsbRsbLsbRgbRgbLibRibRibRg
bRsbRsbRgbLsbsbRgbLsbRsbsbRgRsmbRgbRgRsmbRgRgbRgRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 26; Drug: Control Apo 0.5 然
bRgRsmbRsbRgbLcbLhbRjbLibLgbLgRsbRjbLibLgbLsbLiRsbRgbLsbLgbLgbRsbRebRh
bRhRsmbLsbRgbRsbRibLgbRsbRgRsmbLsbRibRsbLjbLjbLcbLsbRibRsbLcbLgbLsbRgb
LibLgbRsbLibRgRsmbLcbRgbRsbLhbLsbLhbLsbRgbRgbLcbLibRsbRgbLibLsbLsbLgbL
gbRcbRibRsbRsbRibRgbLsbRgRsmbLsbRibLgbRibLsRsbRsbRgbRsbRgRsRsRsRsmmmmb
RsRsmbRgbRgbRgbRsbRgRsmbRsbRsbRgbRgbLgbRibLibLeRsbLibLibLhLsbLsbRgbLsb
RsbLsbLhbLibRcbRsRsRsmmbRsbRgbRsbRsbRgbRgbRgRsRsmmbRgbRgbRgbRgbRgbRgRs
mbRgRsmbRgbRgbRgLsbRgLsbRgRsmbRgRsmbRgbLsbRgbRgbRgbLjbRjRsmbRgbLibRgbR
ibRsRsmbRgbRgbRsbLgLsbRibLjbLcbReRsmbRgRsmbRgbRgbRgbRsbRgbRsRsmbRgbRsb
RgbRgbRgRsmbRsbRgRsmbRgbRgRsRsmmbRsbRgRsmbRgbRsbRgbRiRsRsmmbRgbLjRsbRi
RsmbRsbRgbRgLsRsbRgLsbRgRsmbRsbRgRsmbRsbRsbRgbRgbRsbRsbRgbRgbLgbRibLib
LsRhbLsRsbLsbRhbLgbRibLsbRgbRgbRgRsmbLgbRibRibRgbLsbsbRibRsRsmbRgbRgbR
gbRgbRgbLgbRgbRgbRsbRgbRgbRgbRgbRibRibRgbLsbLgbRibRgbRsRsmbRgRsmbRgRsm
bRsbRgbRsbRsbRsbRsbRgbRgbRgbLibRsbRiRsmbLjbRsLjbLcbLibRibRiRsmbRgbRibR
gbLgRsRsmbRibLgbLhbLibLhbLibLsbLgbLgbLgLsbRjbRcbLgbRibRsRsmbRgbRsbRgbR
sbRgbRgbRgRsmbRgbRjbLsbRgbRgRsmbRgbRgRsmbRgbRgRsRgmbRgbRsbRgbRsbRsbRgb
LjbRibLibRiRsmbRgbLsbRgbRgLsbRsRsmbRgbRgbRgbRgbRsbRsbRgbRibRgbLsLsmbRi
bLgbRcbLsbLibLgbLhbLhbLibLibRsbLgbLiRsbRebRcLsbLibRhRsmbLgbRibLgbRibLg
bRibRsRsmbLsbRibRgRsmbLibRibRsbRgRsmbRsRsmbRgbRgbRsbRgbRgbRgbLgbRiRsmb
RsbRsbRsRsmbRgRsmbRgbRgbRgbRgbRgRsRsRgmmbRsbRgbRgRsmbRibRsbRibLgbRsbRi
bRgbRgRsmbRgbRgbRsLsbRgRsmbRsbRgbRsbRsbRgbRsRsmbRibRgbRsbLgRsbRhbLibRh
RsmbRsbLgbRiRsmbRsbRgbRgbRgbRgbRsbRgRsmbRsbRgbRgbRgbRgbRgRsRgRsRsmmmbL
gbRibLjbRiRsmbRsbRibLsRsbRgbRgbRsRsmbRsLsbRgbRgRsRsmmbLgbRiRsmbLgbRiRs
mbRsbLgLsbRgRsmbRgRsmbRgbRgbRgbRgRsmbRsbRsbRgbRhbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 27; Drug: Control Apo 0.5 然
bLgLsbLgbLgbLgbLgbRsbLsbLgbLibLibRibLhbLgbLsbLgbLsbRsbLibRgbLibLgRsbRg
bLgbLgbRsbLgbLsRsbRibLjbLibLibRgbLgbRgbLsbLsbLgRsbLibRsLsbLgLsbRsbLsLs
mbLgbRsbRsbRibRibRgbLcbLebLibLgbRsbRibLgbRsbRibRsLsbRibLjbRgbRjbRgbLsb
RgbRibRsbRgbRsbRgbRibRgbLjbRgbLibLgbRsbLgbRsLsbLiLsbRgbLibRsbLgbRsbLgL
sbRgbLgbRsbLsbLgbLsbLgRsbLgbLsbLgbLgbLgbLgbRibLgbLibRibRgbLibLgbLsbRsb
RsbLsbRhbRgRsmbRgbLcbLebRsbLiLsbRsRsmbLgbRsbLgbRjbLiLsbRgbLgbRsLsbLgbR
sRsmbLgbLgbLsbLsbRcbRibRsbRibRsbRgbRgbRibRhRsmbRibLgbRgbLibLgbRgbLgbRs
bLgbRjbRibRibRgbLjbLebLibLgbLgbRgbRgbLibLgbRjbRibLebLibLgbRgbLibRsbLgb
RgbLgLsbLgLsbLsLsmbLgbRsbRjbLhbRibLcbLgbLgLsbLgbRgLsbLgbLgbLgbRjbLgbLg
bRsbRsbLgbLsbLgbLsbLgbRsbLsbRsbRsLsbLgbRgbLgbLsbLgbRsbLgbLsLsmbLsbLsLs
mbLsLsmbLgbRsbLgbLibLsbLiLsbRgbRjbRgbRgbLebLhbLiRsbRgbLibRsbRiRsmbRsbR
jRsmbRgbRsbRgbLgbLcLsmbLgbLsLsmbLibRsbLgbRgbLgLsbLgbLgbLgbLsbRsbLgbRib
RibRgRsmbLgRsbRgbRgbRsbRsbRgLsbLgbRgbLebLgLsbLgbLsbRsbRsbLgbRsbLgLsbLg
bRsbRsbRsLsbLibRgbLgbLgbLgLsbLsRsbLgbRsbsbLgbRsbLsbLsbRsbLsbLsbLsbLsbL
gbLsbLsbLsbLsLsmbLsbLsbLgbRjbRibRibLcbRsbLibLgbRsLsbLgbRsRsmbLgbRsbLgb
LgbRsbLgbRsbLsbLgbLsbLsbLgbRsbRsbLgbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLgRs
LsbRsbLgbRsbLibLgbRibLibLsbRgbLibRsbRsbLibRsbLgLsbLsbRebRgbLibLibRsbLi
bLgbLgbRgbLibLsbLgbRsbLibRjbLibLgbRgbRsbLibRgbLibRjbLjbRgbLibLsbLgLsbR
sbLsbLsbLsbLsbLsbLgbRgbLgbRjbLibLibLgbLsbRsbLgbLsbLgbLibRjbLibRsbLgLsL
smbLsbLgLsbLsbRsbLsbLsbLsbLibLibRgbLgbLsbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 28; Drug: Control Apo 0.5 然
bRsbLibRjbRgbRgLsbRibRsbRgbRgbRgbLiLsbRibRiRsmbRgbRgbRgbRiRsmbRibRgbRi
bRgbsbRgbRjRsmbRibRibLibLjLsmbLibLibLsbRgbRsbRsbRgbLjbLibLgbLsRsbLjbLe
bRgbLibLsbLgbLgbLhbLgbRgbLibLgbLsbRjRsmbLiLsbLibRgbLiLsbLiLsRsbRgRsmbs
bRgbLibRibLibLhbLgbLsbRgbLibLgbLsbLsbLgbLsbLsbLsbLsbLgbLsbLgbLgbLsbRgb
LsbLgLsbRgbLhbRsLsbRgbLgLsbLgbLgbLgbRsbLsbRsbLgbLsLsmbLgbRsbLibRgbLibR
sbLiRsbRsbRjbLhLsbRgbLibLsbLgRsbRsbLibLibLgbLsLsRsmbRgbRiRsmbLibLibRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 29; Drug: Control Apo 0.5 然
bLsLsmbLgbLsLsmbLsbLsbLsbLsbLsLsmbLsbLgRsbLgbLgbLsbLsbLsbLsbLgbLsbLgLs
bLsbLsbLsRsbLgbRsbRsbsbLgbLgbRsbLsbLgRsbLsRsbLsbLgbLsbLjbRsbLsbLsLsmbL
gbLsbLsbLsbLsbLsbLgbLsbLsbLsbLsbLsbLgbRjbRcbRibRibLjbLjbLibLgbLgbLgbLg
bLsbLsbLsbRsRsmbRsLgbRsLsbLgbLsbLsLsmbLgLsbLsbLsbLgbLsbsbLsbLsLsmbLsLs
mbLsbLgbLsbLsLsmbLgbLgbLsbLsbLsbLgbRgbLgbLgbLsbLsbLsbLsbLsRsbLsbRsbLsL
smbLsbLsbLgbsbLsRsbLsbLsbLsbLgbLsLsmbLgbLgbLgbLgbLgbLsbLgbLsbLsbLsbRgb
RebRhbRiRsmbLibLhbLgbLgbRibLibLgbLsbLgbLsbLgLsbRsbLgbLgbLsbLgbLgbLsbLs
bLgbLgbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLgbLsbsbLsbLgbLsbLsLsmbLsbL
sbLsbLsbLsbLsbLgbLsbLsLsmbLsbLsbRgbRjRsmbRcLsbRhbRhRsmbRibRgbRsRjbRgbR
gbLjbLibLibLhbRsLgbLgbLgbLibLibLgbLgbLsbRgbRjRsmbRibRibRsbLibRhbRibLgR
sbLibLibLcbLibLgbRsbLgbRiRsRsmmbRsbRgbRgbRibLsbLjbLibLsbLgbLsbLsbLsLsm
bLsbLsbLsRsbLsbLsbLsLsmbLgbLgbRsbLsbLsbLgLsbLsbLgbLgbLsbLsbLgbLsLsmbLs
bLsbLsbLsbRcbRiRsmbRgbLgbRibLjbLjbLibLibLgbLsbLsbLgRsbRiRsmbRibRibLibL
jbRibRcbLgbRhbRibLibRcRsmbLibLcbLiLsbLgbLsbLibLsbLgbLgbLgbRgLsbRjRsmbR
ibLebLhbLgRsbLsbLsLgbLsbLgLsbLsbLsbLsbLsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLg
bLsbLgbLsbLgbRgbLgbLgbRgbRobLgbLsbLgbLsbLgbLsbLsbLsbRcbRhbRibLibLjLsmb
LgbLgbLibLgbLsbLsbLsLsmbLsbLsbLsbLsbLsbLsbLsbRsbLgLsbLsbLgbRgbRjbRcbRi
bRibLibRcbRhbRibRhbRiRsmbRibLgbLiLsbLibRgbLgbLsbLsbRsbLsbRsLsbLgbRsbLg
bRgLsbLgbLgbLsbRgbRcbRhbRgbLjLsmbRhLsbRhbLgbLgbLgbRibRibRgbLsbRibRsbRs
bLsbRgbRsbLgbRibRsbRsbLsbRsbRgbRsbRgbLjbRgbRgbLibRgbRgbLsRsLsbRgbRgRsm
bLibRibRgbRgbRgbRsbLsbLgbLjbLhbRjbRibRibRibRibRgbLsbLibLibRgbRsbLgbLsb
RsbLgbLsbLsbRsbLibRibRcbRibRgbLibRibRibRgbLgbLgLsbRsbRgbRibRibRsbRibLg
bLsbLsbLsbLsbRibRibRibLibRibRgbLsbLgbLsbRibRsbRsbRsbRsbRsbRgbLgbRgbLgb
RibRibLibLiLsbRjbRibRgbLsbRsRsRsmmbRjbLsbRsbRsbRsbsbRsbRgbRsbRgbRgbRsb
RgbRsbRsbRsbLsbRgbLgbRgRsmbRgbRsbRsbRgRsLsmbLgbRibLgbRibLgRsbRibRsRgbR
gbRgbLgbRibRgRsmbLsbRgbRsbRsbLsbRgbLsbRgbRgbRgbRgbRibLib

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 30; Drug: Control Apo 0.5 然
bLebLobLcbLobLebRobRebRsbLcbRsbLcbRebRgbLcbLobRsbRobLobLobLebRibLobLsb
RobRcbRsbLhbLcbRibLobLsbRgbLhbRobLebRebLsbRgbRobLebRobRobLebLibLjbRobL
cbRobLobLcbLcbLebLsbRebRgbRgbRobLobLibRgbRebLobLibLobRebRgbRobRobRcbRi
bLobRobRebLibRobLebRcbRebRcbLobLobLcbRobRcbLobLebLebRebLhbRgbRhbRibLib
RobRibRhbRobLobRebRobRgbRhbRsbLebLobLhbRebRebLgbLebLobRobRebLobLcbLobR
ebRgbLcbRobLibLsbRebLebLibLobLobRobRcbRcbLebLebRibLhbLcbLibLcbLobLcbLe
bLibLgbLgbLobRobRgbLobRobRcbRcbLhbRcbRcbRgbRobRcbRobLobRebRebRebLcbRcb
LobLcbRobRcbRebRobLgbRebRibRebRebRgbRobLibLcbLobRobRebLobRebLobLebLibL
obLcbRgbRibLibRebLebRobRcbRobRobLebLobLebRgbLhbRsbRobRcbLobRcbRebLebLo
bRobRobLobRobRcbLobLcbRcbLebLebLobLibRcbRobLibRebRcbRobLebLebRebRcbRcb
LebRibLebLcbLebLgbLebLobRibLobLobRibLgbRcbLebRsbLobLebLebLibLebLobRcbR
ibRebLobLobLebLobRibRebRebLgbRcbRobRebRebRobLebRobLobLebLebLgbLobLobRg
bRebRobRcbLobRhbLobLobRjbRsbLobRgbLcbRibLgbLobRobLobLhbLsbRgbRcbLebRob
LebLibLcbRgbRcbLsbLcbRibRobRobRobRebLgbRobRsbLebRobRobRobLobLibLebLebL
sbLebRebLebRcbLebRsbRibLobLobRcbLcbRobRibRebRgbLibLhbLobRibRobLobRobLi
bLobLcbLebRobRobRobLhbRcbRebRobLobRcbLsbRobLebLgbLsbLobRebLebRobLobLob
RsbLobRobLobRobLcbRobLobRcbLebLebRcbRobLebRobLobLsbLobRebRobLobLcbLobL
sbRebLebRibRobRcbLobLebLcbLobLsbRobRcbLebLebRibLobRobRsbLsbRobLgbLsbLo
bRebLsbRobRobLgbLgbRcbRgbRibRobRobRobRcbLsbRsbRcbRobLibRobRcbLebRobLib
LobLebRobLebRobLobRobRobRcbRcbRgbLcbRobRobLebRebRebRobLobLgbLebRcbRcbL
obLebLobLebLebRebRcbLibLebLobRebRcbLgbLobRobRgbRobLcbLebLobLebLebLgbLe
bLcbRgbRcbLebRobRgbLobLcbRcbLgbRobLibLobLebRcbLebLebRobLobLobRobLebRob
LcbLebRgbRebRobRibRcbLobRobLebRibLobRobRobRobLgbRobLebLgbRobRobLobLgbR
obLobRibLcbLobLcbLcbRobRobLobLebRjbLcbRebLcbRebRebRobRobLcbLobLebLibRo
bLebRcbRebLcbLgbRibRobRobRebRcbLobLjbLobRebRobRcbRebRcbLebLibRebRebRgb
LcbRobLobRhbLcbLobRgbLibRebLebLcbRibLobRobLobRsbLebLebLcbLgbRebRobLebR
gbRgbRgbRobRobLebRcbRebLobLsbRsbRobLobLebLebRebRebRcbLebLebLobRcbLebLo
bLsbLobLgbLjbRsbLhbRobLebRobRobRobRobRebLsbRjbLjbLjbLebRsbLhbLobRobRjb
LcbLebRsbLobLobRobLebRebRjbLsbLgbRobLhbRebLgbLgbLobRcbLobRebRebRobLobL
cbLobRobLebLobLobRibLibLobRebRsbRjbRibRobRsbLobRobRobRebLobLhbRebLobRi
bLibRhbRebRobRobLgbRcbLebRjbLsbLjbRobRsbLibRsbLgbRjbRebLibLebRgbLebRob
LobRcbLebRjbLsbLobRobLgbLcbRebLobRcbLebRebRcbRsbRsbRobLcbRebLjbLebLjbL
jbLcbRebLjbRebRebRobRsbLobRebRibRgbRgbRcbLebRebRebRgbLebRebRobRebRjbRs
bRcbRobRobRebLebLebLjbRgbRebLcbRobRobRobRobLcbRjbRgbLobLebRcbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bLjLsmbLibLgbLgbLjLsLsmmbRgbLibLgLsbLsbLsbRsbRjbRhbRsbRgLsbRgRsmbLgbRj
bLibLgbRibRibRsbRgbRibRibLjbLjbLgbLgbRjRsmbRcRsmbsbRibRsbRsbRibLibLsbL
sbLsbRibRibRhbRibRsRsmbRsbRsbRiRsmbRgbRgbRiRsmbRgbRgbRsbRsbLibLsbRibRi
bRibRibLibRgbRibRsbRsbLsbLsRiRsmbRsbRgbRsRsRsmmbLsbRgbRsbRjbRjbLgbLsbR
ibRsRsmbLjbRgbRhbRsbRgbRsbLsbRibRibRgbLsbLsbLsbLsbLebLgbLsbRgbRcRsmbRi
bLsbRsbRiRsmbLsbRgbRsbRgbRjbRsbsbRsbLgbRjbRsRsmbRhbLgbLsbLsLsmbLsbLgbL
sbLsbLsbLsbRjRsmbRibRibRsbRibRgLsbRsbRsbLsbRgbRsbRsbLsRsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bRibRibRibLgbRibLibLhLsbLibLgbLgbLsbLsbRgLsbRgbLibLsbLgLsbLsLsmbLgLsbL
sbLgbLsbLsRsbLgbLsbLsbLgbLsbLsbLsbLsbLsLsmbLsbLsbLsbLgbLgbRsbLgbLgbLsb
RsbLgbLsbLsbLgbLsbLgbLsbLgbLsbLsbLsbLgbLsbLgLsbRsbLgLsbRsbLgbRsbLgLsbL
sbLgbLibRhbLgbLibLgbLsbLsbLsbLsLsmbLsbLgbLsbLsbLgbLsbLgbLsbLsbLsbLsLsm
bLgbRsbRsbLibLgbLgbRgbLgbLsbLgbLsbLgbLgbLsLsmbLgbRgbLgLsbLsbLgbLsbLgLs
bRsbLibRsLsbRsbLibLsLsmbRgbLibLsbRsbLgbRsRsmbLiLsbRjbLhbLibRgbRgbLcbLi
bLsLsmbLsbRsRsmbRsbRhbRibLiLsbLcbLibRgbLibRsbLibRgbLibRgbRsbLibLgbRsbL
gbRsbRgbLibLsLsmbLgbLsbLsbLgbLgbLgbLsbLsbLgbLsbLgbLsbLgLsRsbRsbLiLsbRg
RsmbLgbLgbLgbLgbLsbLgLsbLsbLsbLgbLgLsbLsbLsbLgbLsbLgbLsbLgbLgbLibRibRh
bRsbRgbLjbRhbLcRsbLhbLiLsbLibRgbLsbRsbLibLgbLgbRsbLsbLgbRgbLgbLsbLgbLs
LsmbLgbLsRsbLgbLsbLsbLsbLsbLsbLgbLgbLgbRsLsbRsbLiLsbLgLsbLgbLgbLsbRsbL
gbLsbLsbLgLsbLsbLsLsmbLgLsbLsbLsbLsbLsbLsbLibRsbLgbLsbLgbLgbLsbLsbLgbL
gbLsbLgbRsbLgbRjbRcbRhLsbRcLsLsmbLgLsbRibLsbRgbRgbRgbRsbRsbRsbRgbRgLsb
LjbLjbLibLsbLsbLsLsmbLhbRsbLsbLibLgbRgbLibLsbLgbLgbLsbLsbLgbLgbLsbLgbL
sbLsbLsbLsbRsbLsbRsbLsbLgRsbLibLsbLgbLgbLsLsmbLsbLgbLsbRsRsmbLgbRsbLsb
LsLsmbLsbLgLsbLgbLsbLsbLgbLsLsmbLgbLsbLgbLsbLgLsbLsbLsbLsbLgbLgLsbLgbL
gbLgbRsbLsbLibRsbLgbLgbLsbLsbLsbLsbRsbLsbLgbLsLsmbLsRsbLsRsbLsbLgbLgbL
sbLgbLgbLsbLsbRsbLsbLgbRsbLsbLgLsbLsbLsbLsbLsLsmbLgbLsbRsbLgLsbLsLsmbL
sLsmbLsLsmbLsbLsbLsbLgLsbLsbLsbLgbRgLsRsbLibRsbLgbLgbRsLsbLsbLibLsbLsb
LgbLsbLsbLgbLgbLsbLgbLsLsmbLsbLgLsbLgbLsbLgbRgLsbLibLsLsRsmbLsbLgLsRsb
LsbLgbRsbLgbLsbLsRsbLsbLgLsbLsbLsbLsbLgbLsbLgbLsbLgbLgbLsbRcbRiLsbLjbL
ebLsbRsbLsbLiLsbLgbLcLsLsmmbLgbLsbLgbRgbLgbLsLsmbLsLsmbLgLsbRsbLibLsLs
mbLgbLsbLgbLsLsmbLgLsbLsbLgbLsbLgbLsbRsbLibRsbRsLibRsLsbLsbLgbLsbLgbLs
LsmbLsbLgbLsLsmbLsLsmbLgbLgbLgbLsbLgLsbLsbLsRsbLgbLgbLsbLibRobRgbRibRs
bRibRgLsbRsbRgbLjbLhbLiLsbRibLibRsbRsLsbLibRsLsbLgbRsbLgbLsRsbLgbLsbLs
LsmbLsbLsbLsLsmbLsbLsbLsbLgbLgbLsLsmbRsLsbLibRsbLgbLsbLgbRsbLgbLsbLsbL
gbLsbLsbLsbLsbLsbLgbLsbLgbLsbLgLsLsmbLsRsbLgbRsbLgLsbLsbLgLsbLsbLsbLsL
smbLsLsmbLgbLgbLsbLgbLsbLgbLsLsmbLgbLsLsLsmmbLsbLgbRsbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bRsbRgbRsbRsbRgbRsbRgbRgbRgbLgbRgRsmbRsbRsbRsbRgbRsbRsbRgbRsbRsbRsbRsb
RgLsbLcbLiLsbRjbLhLsbLibLibLibLgbLibRsRsmbRgbLibLhbLibRgbRibRgbLcLsmbL
hbLhbLhbRsbRsbsbRgbLsbRibRgbRgbRgbRibRhbRsbRsLsRgbLhbRcRsmbRsbRibLgbRg
bRgbRsbRsbRsbRsbRgbRgbRsbRgbRgbRgbRsbRsbRgbRsRgbLhbLebLiLsbLibLibRgbRi
bRgbRgbRgbRhRsmbLibRiRsmbRgbRsbRgRsmbRgbRsbRgbRgbLsLsRiRsmmbRgRsmbRgbR
sbLjbRcbRibRsbRgbRgbRgbRsbRsbRgbRsbRgbLsbRgbLsRsbRgbRsbRsbRibRgbRsbRsb
RsbRgRsmbRgbRsbRgbLjbRcRsmbRjRsmbRcRsmbRcbRibRjbLibRibRgbRgbLsbRsRsmbR
gbRsbRsbRsbRsbRsbRgbRsbRsbRgbLgbLjbRibLhbRibRobLhbRibLebLcLsmbRgbRgbLc
bRsLhbRgbRibRibRibLebRcbRhbLibRhbRgbLsbLsbRsbRgbLjbLcbRcbRcbRibLgbRgbR
gbRsbRsbRsbRgbLsRsbRgbRsbRgbRgbRibRgbLhbLjbLgbLgbRgbRcbLjbRcbRgbRsLsRs
bRsbLsbRibLcRsbRjRsmbRibRgbRiRsmbLgbRgRsmbRgbRsRsmbRsbRsbRsbRsbRsbRsbR
gRsmbLsbLjbLibRjbRcbLjbLcbRcbRjbRobRgbLibRibRibLibLcLiRgbRcbRibRgbLsbL
sbRgRsRsmmbRgbRsbRgbRsbRsbRsbRsbRsRsmbRgbRgbRsRsmbRsbRsbRsbRgLsbLcbLib
RibLcbRibRcRsmbRgbLjbRibLjbRibRgbLcbLhbRjLsbRcbLoLsmbLibLibLjbLjbLibLg
LsRsbLgbLiRsbLgbLsbLsbRcbLsbRgbRsRsmbRsbRsbRsbLsbRsbRgbRgbRgbRgbRgbRgb
RsbRsbRsbRgbLgbRgbRgbLjLsmbRgbRibLjbRjbLcLsmbRjRsmbLcbRjbLcbRebLcbRjbL
cbLebRjbRhbRibRgRsmbRsbRsbRsbRsbRsbRsRsmbsbRsbRsbRsbRsRsmbRgbRsbRgbLjb
LcbRcbLcbRebRibLcbRcbLjbsbLibLhbLibLcbRsbRsbRiLsbRibRibRibRibLibLibLsb
LgLsbRibRibRjbRgbLjLsmbLjLsmbRcbRibLjbRibLgbLibRjbRhbRibLibRsbRsbRgbRs
bRgbRgbRsbRgbRgbRsbRsbLsbRgbLsRsbRgbRgbRsRsmbRsbRgbRgRsmbRgbLjbLcbRhbR
ibRibRcRsmbRibRibRibRgbRgbLibLsRjbLjbRcLsbLhbRcbLhbRhbRgbLgLsbRsbRsbRg
bRgbRsbRsbRsRsmbRgbRgbRibLjLsmbLjbLsbsbRhbRcbLibRsRsmbRsbRgbRgbRgbRgbR
gbRgbLgbRgRsmbRsbRgbRsbLsbRgbLsbRgbLsbRgbRsbRgbRsbRsLsbRgRsmbRsbRsRsmb
RsbRgbRgbRsRsmbRsbLsbRgbRgbRsbRsbRsbRgbRgbLgbRgbLcbLhbLhbLibLibLjRsLsb
RibRjbRibRjbRibLcbRgbRgbRibLgbRjbRhbRgbRsbRgbLsbLgbLibLgbRcbLhbRcbRcbR
ibRibLiLsbRibLsbsbRsbRibRgbRgbLjbRjRsmbLibRhbLibRiRsmbLgbRibRgbRsbRgbR
sbRsbRsbRgbRsbRgbLsLsmbRgbRgbRibRcbLjbRhbRibRsbLgbRsbLibRjbRibRgbRgbRs
bLgbRgLsRsbRsLsbRhRsmbRsRsmbRgbRgbRsbRgbRgbRgbRgRsmbRsbRgbRsbRsLsbRsbR
gbRsbRgbRgbLjbLhbRjbLibLcbLibLgbLibLgLsbRibRgbRgRsmbRsbRgbRgbLibLgbRgb
RgRsmbRgbRgbRgbRgLsbLgbRgbRgbRibLsbLgbLsbRibRgbRgbRgbRsbRgbRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bRibLgbLgbLcbLgbLsbLsbLsbRsRsmbLibRgbLibRsbLgbLsbLgbRgbLibLsLsmbLgbsbR
sbRgbRibRgbRsbRibRsbRgbRsbLsbRgbLsbLsbRgbRgbLgbRibLgbRibLibRibRsRsmbLs
bRibRgbLibRibLibRibRiRsmbRibLsbsbLsbLjLsLsmmbLsRsbRiRsmbRgRsmbRibRsbRi
bRgbRibRgbLsbLgbLgbRgbLsbLgbLibLgbRgRsmbLibLsbRsbLgbLcbRgRsmbRsbLibLgb
RsRsmbRsRsmbLsbLibLgLsbRsLsbRsbRgbLgbLgLsbLsLsmbLgbRsLsbLgbLgbRgbLibRc
bRibRsbLsbLjLsmbRhbLsbLsbRgRsmbRgbRsbRgbRiRsmbLibLsbRiRsmbLsbRibLsbRgb
LsbRsbRgbLsbLebLibLgLsRsbRibLsbLsbRsbLibLsbRsbRgbLibLgbRjRsmbRsbLgbLgb
RebRhRsmbRgbRgRsmbLgbRibRgbRsbRibRsbLsbRgbLsbLsbRgbRsbRgLsbRsbRgbLsbRs
bRibLsbLgbRsbLgbRgbLjbLibLgbRibLibLsbLsbLsbLibLsRsbLibRhbLsbLsRsbRsbLi
LsbLgbRgbLibLsbLibLsbLgLsbRibLibLgbRjbLibLibLibLgbRsbRgbRibLsbLsbRgbLc
bLiLsbLgbRjbLhbLgbLgbLibRgRsmbRsbRgbRsbRgbsbRibLsbRgRsmbLsLsmbRgbRsbRg
bRgbsbRsbLibRsbLibLibLsbLsbRgbLhbRibLgbLibLibRibLibLgbRibLgbLjLgbLsLsm
bRcbRibRsbRibRgRsmbLsbRgbRsbRibRsbRsRsmbRgRsRsmmbRsRsmbRsbRsRsmbLsbLgb
RibLjbRibRsbRsbRgbRsbLgbRgbLsbRsbRsbRsbRgbRsbRsbRsbRsbRgbLjbLcbLgbLgbL
sbLsbLgbRjRsmbLsLiLsbLsbLsbLgbRgLsbLiLsbLsbLsbLgLsbRsbLibLgbRgRsmbLibL
hLsbLgbRjbLsbLgbLibLsbLsbLgbLsbRsbLgbRjbLgbRsbLiLgRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bRibLiLsbRhRsmbRhLsbRibRiLsbRgbLsLsmbRjbRibRhbRibRsbRsbRsbRgbRgLsbRibR
gbRgbRebReRsmbRibRhbRcRsmbLjbRebReRsmbRsbRcbRjbRsbRgbRibLsbLsbRsbRgRsm
bLjbReLsbLgbLjbRibRgbRibLhbReRsmbRhbRibRibRsRsmbRgbRgbRgbRgRsmbLibLibR
ibRibsbRgRsmbLsbsbRsbRsbRsbLsbRsRsmbRgbRsbRgbRsbRsbRsbRgLsbRsbRgbRsbRs
bRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bRibRsbRsbRjRsmbLsbRsbRgbLiLsbRibLsbsbRjbRsbRibLibRsbRgbLibRibLibLsbRg
bRgbLibRgbRhbRgbRgbRsLsbRiRsmbLiLsbRibLibRgbRibRibLgbRibRjbLebRiRsmbLs
bRsbRsbLsbLibLibLsbsbLibLgbRsbLibRjbLibLsbLhbRibRsbLsbLsbLgbRibRsbLsbs
bRsbRsbsbsbRsbRibRsbLgbRibRgRsmbLsLsmbLcbRjRsmbLsLsLsmmbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bLibRjbLjbLhbLjLibLgbRjbLjLsmbLgbRgbLgbRsbLgLsbRsbRgRsmbRsbLibLgbLsbLg
LsbsbLsLsmbRjbLsLsmbRsLsbRgbLgLsLsLsmmbRgbLgbLsbRsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bLibRjbLibRgRsmbLgbLgbRgbLgbRibRsbLgbLibRgbLibLgbRjbLibLsbLsbRgbLiLsbL
gRsbLibLibLibLgbLhbRibLiLsbLgbRibLgRsbLibRibLgLsbLgbLsbsbLgbLgbLgbRibL
gbLgbRgLsbRibLibLsbLgbLsbLgbLgbLsbRibLgbLgbLsbLibRgbLgbRiRsmbRibRibRib
RgbLiRsbRgbRgbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bLibRjbLibRsbLsbLgbLgbLgbLsbLgbLsbLgbLsbLgbRjbLiLsbRjbLcbRgbRibRcbRibR
ibLibRibRgbRibRiRsmbRibLibRibRiRsmbRgbLjbRiLsbRiLsbLjbLhbLiLsbRsbLibRs
bLiLsbRjbLibRgbLibRgbLiLsbRgbLibLgbLgbLsbLgbRcbRiRsmbRibLcbLibRgbLgLsb
RebRibRibRgbRsbRgbRsbRgbRgbRgbLsbRgbRgbRgbRgbRsbRgbRgbLgLsbRgRsmbRgbLj
bRiRsmbLgbRiRsmbRgbRgbRgbRgbRgLsbRgRsmbRiRsmbRsbLcbLiLsbRgRsmbLiLsbRsb
LibRgRsmbLibRjbLibRsbLibRjbRjRsmbRibRibRsbRibRgRsmbRgbRgRsmbRsbRibRibR
gRsmbLgbRibRibRgbRgbLjRsLsbRibRgbRsRsmbRgbRsbRsbRgbRsbLcbLgbRgbLibRsLs
bLibRjRsmbLibLgLsbLgLsbRgbLibRgbLgbLsbLsbLgbLsbLgbRcbRibLjbRiRsmbLjbLc
bLgbRgbRgbLebLgbLibRibLibLsbLsbLgbRjbLiLsbRgbLibLsbLgbLsbLgbRsbLgLsbLs
bRsbLgRsbLsLsmbLgLsbLsbRsbLgLsbLsbLgLsbRsbLsbLgLsbLgbLsbLgbRjLsbLhbRgb
LibRibLcLsmbRibLhbRsbRgbLiLsbLgLsLsmbRgbLibLsbLsbLiLsbLsbRgbLibRgbLiLs
bRgbLibLsLsmbLgbLgbRgbLgbLsLsmbRgRsmbLibLgbLgbRgbLibLgLsbRibLibRgbLiLs
bRsbLsbLgbRgbLibLsLsLsmmbLibRsbLgbRsLgbRgbLibRgbLiRsbRjbLiLsbLsbLhbLgL
sbRgbRibLhbLiLsbRsLsbRgbLibLgLsbRgbLiLsLsmbRsbLsRsbLgLsbRgbLgLsbRgbLib
RsbLsbLgbLsbLgbLsbRsbLgLsbLsbRsbLgLsbLsbLgbRsbLibRsbLibRsLsbLiLsbRsbLg
RsbLsbRgbLibRgbLiLsbLibRgbRsbRsRjbRibLcLsmbLibRgbRibLhbLgbRgbRjbRibLjb
LcRsbRgbRgbLiLsbLgbLgbLgbLgLsbRgbLiLsbRjbLibRgbLibRgbLibLgbLgbRgbLibRg
bLiLsbLsbRsbLibRgLsbLibLsLsmbRsLsbLsbLibRgbLibRgbLibLhbRgbLiLsbLsLsmbR
gbLibRjbLgbRgbLibLgLsbRibLcLsRsmbRibLhbRgbLibLsbRgbLibRsbLgbRsLsbLibRs
bLhLsbLibLgbRgRsmbRgbLiLsbLibRgbLibLgbLsbRibLibLgbRsbLsbLiLsbRsbLiLsbR
gRsmbLibRgbLhbRibLibRgLsbLgbLiLsbRgbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bRgbLibLcbLibRibRjRsRsmmbRibRgbRsbRgbRsbLsbRibRgRsmbRibRgbRsbRgbLibLcb
LcbLgbRsbLibLibLgbRsRsmbLibRsbRgbLhbLsbLsbLgbLibRsbRoRsmbRibLgbRgbRsbR
sRsLsmbRsbLsbRgRiRiReRibRgLsbRgRsmbLjbLibRjRsmbRibLjbRhbLgbLjbRibLsRgb
RsbRsRsmbLsbRgbRgRgRsRgRgRgRsmmbRgbLsLsmbRgRsmbRgRgRgRgLsbRgRsLsmbRgbR
gRgRgRgRsRgRgRsRiRgRgRgRsRgmmmbRgLsbRgbRgRiRiRsmbRgRsRsmmbRgRgbRgRsmbR
gRsmbRgRgRibRgbRibLjbRhbLibLcbLibLcbLgbLsbLibLibRibRcbRhbRhbRibRiRsmbR
hLsbRsbLibLsbRhbLgbLjbRibRgbLsbRsbRsbRgRsRgRsmmbRgRsmbRgbRgLsbRgRsmbRs
bLsbRgRsRsmmbReRgRsRiRimbRgRgRgbRgRsmbRgLsbRgbRgLsbRgLsbRibLjbRibLhbRh
bRcbRhbRebRcbRibRsbLgbRibLhLsbLibRcbLibRcbRhbRgRsmbLibLhbLibLgbLgbLsbR
gbRibRgbLsbRgRsmbRgRiRgRiRgRsRiRiRgRsRsmmmbRgLsbLsRgbRsbRgbRsbRsRsRsmm
bRsRsmbRgRgbRgbRsbRgRsRsRgRgRimmbRgbLjbLcbLcbLibLibLcbLcbRibRjbRcbLgbR
hbRsbLsbRgRsmbLsbRsbRsbRsbRsRsmbRgRgRsReRiRiRsmmbRgRsRsmmbRgRsRsmmbRgb
RgLsRsbRgRsmbRgRsRsRgmmbRgRgRgRsRgRgRsmmbRgbLsRsbRgbLjbRibLjbLcbLibLib
LibLibLibLibLibRibRjbRiRsmbRibLgbLsRsRsmbRsbRsRsRgRgRsRgRgRsRgRgRiRgRi
mmmbRgRsmbsbLsRsRiRgRiRibRgbRsRsmbRgbRibLgbLjLibLhbRiRsmbRhbRhbLjbLcbL
ibRebRcbRiRsmbLibLgbLgbLibLiRsbRjbRjRsmbRcbRcbLgbLsbLgbLebRibLsbRibRhb
RhbRgbRiRsmbRsRsmbRgbRgbRsbRgReRsmbRgRsRsRsReRhRimmmbRgbRibLjbRjRsmbRh
bLcbLcbLibRjRsmbRjbRibRsbRsRsmbRsbRgRgRsmbRgbRsbRsbRsRsmbRgRsRgmbRgbRs
bRgRsRsmmbRgRgRgRsmbRiRsRgmbRiRsRgRsmmbRgRgRgRsRsmmbRibRgRsmbRgRsmbRgb
RgRgbRgbRsbLhbRibRiRsmbLhbRibRhRsmbRibRhbRhbRibLhbRibRibRsbRsbRgRsRsmm
bRgRsmbRgbRgbRgRsmbLsbRibLgbRibRibRsRsmbRgbRsRiRsRgmbRhRhRiRsmbRgRgRgb
RgRsLsRsmbRgbRgbLjbRiRsmbLjbLjbLibRjbRcbLgbLibLibLcbRibRiRsmbRsbRsbRcb
LgRsbRgbLsbRsbRgRgRsRgRgRiRiRgmbRgRsmbLsbRgRsmbRibRgRgRgRsmbRgbRgRgRiR
gRsRgRgRsmmbRgbLsbRgbRsbRgRsRgRgRgRimbRgRgRgRgbRibLjbLhRsbLiRsLsbLibLi
bRibRiRsmbRiRsmbRsbRsbRibLjbRibRsRsmbLgRsbRgbRsbRsRgRgbRsbRibLhbRsRibL
jbLcbLibLibRibRsLcbRgbLibLgRsbLgbRgbRjRsmbRjRsmbRibRgRsLsmbRsbRsRsRgRg
RgRgRgmbRgRsmbRgRgRsRgRiRgRsmmbRgbRibLibLhbLibRjbLhbLcRsbLebLibRibRibR
iRsmbLsbLibRibRgbLsRsbRgbRsRsRgRgRgmbRgbRsRgRgRgRsRgRsmmbRgRgRgbRgRgRg
RgRgRgRiRiRsmbRgRsRsmmbRgbRgbRsRsmbRgRgRgRgRebRgRsmbLgbRjbLjbLjRsbRhbR
cbLcbRcRsmbRcbRibRibRibLibLeLsbLsLibRjRsmbRcbsbRibLgbRgbRsbRgRgRgbRgbR
sRsmbRgbRgbLsLsmbRgbRgRsRsRsmmmbRsRsRgRsRgRgRgRgRiRgmmbRgRsmbRgRsRgmbR
gRsRgRsRsRsRgRgmmmmbRgbRgbRsbLjbLhbLibLhbRhbRhLsbRiRsmbRibLibLsbRiRsmb
RgbRgRsmbRgbRsbRgRsRgRsRgRiRsmmmbRgLsbRibLibLhbLiLsbRibRcbRcbRiRsmbLhb
LcbLibRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bRibLsbRsbRgbLsbRgRsmbLgbRgbRsbRgbRsbRgbRgbRgbRibLgbRibRgbLgbRsbRjbLgL
sbRgRsmbLsbRgbRsbRgbRsbRgbRibLibRibRsbLgbRgbRgbRsbRsbRsbRsbRgbRsbRsbRs
bLgLsbRgbLsbRgbRsbRsRsmbLsbRgbLsbRsbRgbLsbRgbLsRsbLsRgbLsbRgbRgbLcbLib
RhbLgbRgRsmbRgbLgbRgbRgbRsbRgbLsbRgbRsbRsbRsbRsbRgbLsbRibLibRibRgbLsbR
gbRsbLgbRibLgbRibRsbRsbRsbRgbRsbLgbRibRgbLibRsbRgRsmbRgbRsbRibRgbLgbRi
bRsbLgbRibLsbRsbRgbRiLsbRgbRsRsmbLibRibRsbRgRsLsmbRsbLgbRibLibRibLgbRg
bRsbRgbRgbLibRjbRjRsmbLgbLgbRibRgbsbRgbRsbRsbsbRgbRsRsmbLsbRgbRsbLjbRc
RsmbLgLsbRibRsbRgbRiRsmbRgbRsbRgRsmbLgbRibRgbRsbRgbRgbLibRibRibLibLsbL
sbRiRsmbRgbLsRsbLsbRsbRsbRgbRibLibRibRgbLgRsbLgbRgbRiRsmbLgbRibLgbRgbR
ibLjLsmbRibRibLgRsbRgbLsbRsbRsbRgbsbRgbLsbRgbLsbRgbRsbRgLsbRgbRsbLgbRi
bLjbRibRiLsbLsbRsbLgbRgLsbRsLsbRgbRsbRgbRsLsbRsRsmbRgRsmbRsbRsbRsbRsbR
sbRgbRsbRsbRsbRsbRsbRgbLsbRiRsmbLsRsbLsbRgRsmbLsbRgbLsbRgbLsbRgbLsbRgb
LsbRgbLjbRibRgbLiLsbRibRiLsbRgbLibLsbLsbRsbRibRsbRgbRgbRgbLgLsbRibRsbL
sRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bLcbLhbLgbRjbLibRsbLgbLsbLgbRgbLibRcbRcbLcbRibRgbLcbLibRibLhbLsbLgbRsb
LgbLgbLsbRsbLgbRsbLgbRjbLibLgLsbLsbLgbLsbLsbLsbLgbLsbLsLsmbRsbLgLsbLgb
LsbLgbLibRoRsmbRgbRgbRsbRsbRsRsmbRsbRibLjbLhbLibRjbRcbLcbLibLibLibLsbR
sbRgLsbRgbRibLjbLcbLgLsbLsbLgbLsbLsbLsbLgLsbLgbLsbLgbLgbLgbLsbRsRsmbLi
bRjbLibLgLsbRsRebLobRibLhbRibRgbRsbRibLcbLcbRibLibRgbLgbLgLsbLsbLsbLsb
LsbLsbLgRsbLsbLsLsmbLsbRsLjbLsbLebLgbLgbLgbLgbLgbLsbLsbLsbLsLsRsmbLsLs
mbLgbLsLsmbLsbLgRsbLsbRsbLgbLgbLgLsbLgbLgbRsbLibRjbRhbLcbLibLgbLsbRiRs
mbLibLgRsbRsbLgbLsbLsbLsRsbRgbLgbLgbLgbRgbLhbRcbLebLibLsRsbRgbRgbLcbLs
bRsbRgbLibLgbLsbLgbLgRsbLsbLsbLgbRgbLcbRibRibRhbRgbRhLsRsLsbRgbLsbLgbR
gbRibLibLiLsbRsbLibLgbLsbLsbLgbRgRsmbLhbRebRhbLjbLcLsmbLsbRgbLibLgbLsb
LsbLgbRsbLgbLsbLsbLsbLgbLgbLsLsmbRsbLiLsbLgbRobRibLjbRibLgbRibsbRhbLcb
RibRibRhbLcbLcbLgbLsbRsbLgbLsbLsbLgLsbRsbLgbLsbLgLsbLgbRjbLibRjbRcbRib
LjbRiLsbRsLsbsbLsbRibsbRcbLcbLiRsbLgLsbLgbLsLsmbLsbLgbLsbLsbLgbLsbRjbR
cbLjbLobLgbLgbLsbLsbLgbLsbLgbLsLsmbLsbLsbLgbLsbRsbLsLsmbLgbLgRsbRsbRsb
LgbLgLsbLgbLgbLgbLsbLgbLgbLgbRsbLgbRgbRcbRcbLibRjRsmbLcbLcbLibRsbRgbLg
LsbLsbLsbLsbLsbLsbLgbLsLsmbLsLsmbLgbLgbLsbLgbLsbLsbLgbLsbLgbLsbLsbLgbR
sbLgbLsLsmbLsbLgbLgLsbLgbRobRgRsmbRibRjbsbLjbLcbLibLsbLiRsbRibLgRsbLgL
sbLgbLsbLsbLsbLgbLgbLsbLsRsbLsbLsbLsbLsLsmbLgbLsbLgbLgbLsLsmbLsbLsbLgb
LgbLsbLsbLgbLsbLsRsbLsbLgbLhbLsbRsbRjRsmbRiRsmbRcbRibLcRsbLcbLibLgbLgb
RgRsmbLibRgbRibRibRcbRhbLibLgbRsbRiRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bLibLhbLebRjbLgbLgRsbRjbLiLsbRebsbRcbRgbRiRsmbRibRibLibLibLsbLsbRjbLjb
LsbRsbLgbLgbLibLjLgbLgLsbLibLcbLibLibLgLsbLgLsbLibLibLgbRgbRhbRibRgRsm
bLibRsbRgbsbLgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bRsbLsbLsbRgbRgbRgRsmbRgRsmbRsLsbRgbRgbRgbRsbRsbRsbRsbRgbRsbRsRsmbRgbR
ibLsbRgRsmbRsbRgbRgbRsbRgRsmbRgRsmbRgbRgbRgbRsbRgRsmbRsbRsRsmbRgbRgbRg
bRsbRgbRsRsmbRgbRgbLcbLiRsbLhbRcbRgbRsbRgbRgbRsbLsbRsbRgbRgRsmbRsbRgbR
gbRsbLsbRsbRgbLsbRgbRsbRsbRsbRgbRsbRsbRsbRgbLhbLgLsbLgbRgLibRjLsbLhbRj
bRibRibRsbRsbLsbRgbLsbRgRsmbLsbRgbRsbRsbRsbRgbRsbRgbRibLjbRibRiRsmbLgb
RsbRgRsmbRgbLsbRsbRsbRgbRgbRgbRgbRsLsbRgbRgbRgbLjbRhbLibLgbLibLsbLibLi
bLiLsbRgbRiRsmbRibRgRsmbRsRsmbRibRgRsmbRgbsbLgbRgRsmbRgbLsRsbLiLsbRgbR
gRsmbRgbLgbLsbRgbRgbRgbRgbRsbRgbRsbRsbRsRsmbRsbRsbLsbRibRgRsmbLjLsmbRi
bRsRsmbRgRsmbRibLibRibRgbRgbLgbLgRsbRibRgRsmbLgbRsbRgbRgbLsbRgbRibRibR
iRsmbLgbLgbLgbRsbRibLgbLjbRhRsmbRibRgbLibRibRgRsmbRgbLibRibRgbRhbRibRg
bRsRsmbRsbLibLibRibRjRsmbRibRgbRgRsmbLgbLsbLsbRiRsmbRgbRiRsmbLibLsbRgb
RgbRgbRsbRgRsRsmmbRsbRsbRgbRgbRsbRsbRsbRgbRgbLsRsbRsbRsbRgLsbRsbRgLsbR
sbRgbRsbRgbRibLsbRsbRgRsmbRsRsmbLjbRibLsbRsbRgbRsbRsbRgbRgLsbLsbRgbRgb
RgbRsbRsbRsbRgRsmbRsbRgbRgbRsbRgbRgbLsbRgbRsLsbRgLsbRsbRgbLsbRgbRsbRsR
smbRgbRsbRsbRgbRgbRgbRgbRsbRgbRgbRsbRgbLsRsbRgbLsRsLsbRsRsRsmmbRgbRgbR
gbRgbRgbRsbRgbRsbLsbRgbRgbRsbRsbRsbRsbRsRsmbRgbRsLsbRgbLjLcbLgbLgbLsbR
jbLibLgbLibRcbRsbRibRsbRsbRgbRgbRsRsmbRgbRgbRgbRgbRsbRgbRgbRsbRsbRgbRg
bRsbRsbRsbRsbRsbRgbRgbRgLsbLcbLibRjbRjbRibLgbRgbRsLsbRsbRgbRsbRsbRgbRs
bRgbRsRsmbRsRsmbRgbRgbRgbRgbRsbRgbLgbRgbLsbRsRsmbRsbRgLsbRgbRsbRsbRsRs
mbRgbRgbRgbRgbRgbRgbRsbRsbRsRsmbRsbRsbRgbRsbRsRsmbRgbRgbRsbRsbRgLsbRgL
sbRgbRsbRgbRgbRsbRsbRgbRsbRgbRsbRsRsRsmmbRgbRgbRsbRsbRgbLsbLjLebLgRsbL
gbLgbLsbLiRsbRjbRhbLibRibRibRgRsmbLgbLcbLgbLgbLsbLsbLgbRebRibRgRsmbRsb
LsbRgRsmbRsbRsbRgbRsbLsbRgbLsbRgbRsbRgbRsbRsbRsbLsbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bRgbLjbLibLhbLgLsbRsbRcbLjbRcbRgbRgbRgbRsbRgLsbRsbRgbRsbRgbLsbRibLsbRg
bRsbRgbLcbLibLsLgRsbLiLcbLsbRjRsmbRjbRibLjbRibRgbsbsbRsRsmbRsbRsbRgbRs
LsbLjLsmbRibRgbLibRibRgbsbLsbRibLgbRibLsRsbRgbRsbLcbLibRgbLibLgbRjbLjb
RjbLhbLibRcbRsbRsbLgbLsbRjbRibRibRhRsmbLgbRibRgLsbRgbLgbRsbRgRsmbRsbLs
bRibLsLsmbRibRibRgbLibRsbRibLjbRhbLsbRsbRgbRgbRibLsbLsbRibRgbRsbRsbRsL
sbRsbRgbRsRsmbRibRcRsRsmmbLgRsbRhRsmbRsbRsRsmbLgbRibRsbLgbRcbLsbRgbRgb
RsbRgLjbLibLgbLsbLgbRgRsmbLgbLsbRcbRibRgbRsbRsbRgbRgbRsbRgbLsbRgbRibRs
bRibLsbRgbLsbRibRsbLgRsbRibLsbRiRsmbRsbRgbRsbRsbRsbRsbRsRsmbRgbLgbRibR
sbLjbRibRsbRgbLsbRgbLsbRibRgbRsbRgbLjbRibRgbLjbLcbLibLsbLgLgbRsbLgbRsb
LgbLsbLgbLsbLgbLgbLgbLgbLsbLgbLgLsbLgbReRsmbRgbRsRsmbRsLsbRsbRsbRgbRgb
RgRsmbRgbLgbRsbRgbRgLsbRibRiRsmbRgbRibRsbRsbRjbLjbLibLgLsbRsbLsbLgbLsb
LgLsbLgbLsbLsbLsbLsbLgRsbLgbLgbLsbLsbLsbLsbLsbLgbLgbLsbRcbRsRsmbRibRgR
smbRsbRsbRsbRgbRgbLsRsbRgbRgbLsbRgbLsbRgbRgbLgbRibLsbLjbLhbLgbLgLsbLsb
LgbLgbLgbLgbLsbLsbLsbLsbLsbLsbLgRsLsbLgbLgbLsbLsbLgbLsbLsbLsbLsbLsbLgR
sbLsbRcbRiRsmbRsbRsbLsbRsbRsbRgbRiRsmbLsbLsbRgbRgbLgbLjbLibLiRsbLsRjbL
ibLsbLgbLsbLgLsbLsbLsbLsbLsbLgbRsbRsbLgbLsbLgbLgbLsRsbLgbLsbLsLsmbLsbL
sbLsbLsbLgbLsbLgbLsbLsbLgbLsbLsbLgbLsbLsbLgRsLsbLsbLsbLsbRjbLibRjbLibL
gbRcbRibLgbRgbRgbRgLsbRgbRsbRibLsbRgbLsbRgbRsRsmbRgbLibLgbLibLsbLsLgbL
gbLgbLsbLsbLsbRsbLsbLgbLgbLgbLgbLsbLsbLsLsmbLgLsbLgLsbLgbLsbLsbLgbLgbL
sbLsbLsbLsLsmbLgbRsLsLsmbLsRsLsbLgbLsbLsbLsbLsbLsbLsbLsbLsbLgbLgbLsbLs
bLgRsbLsbLsbLgbLgbLgbLgbRsbRcbRibRsbRsbRsbRsRsmbRsbRsLsbRgbRsRsmbRsRsm
bRsbRibLsbLjbLibLsbLgbLsbLsbLsLsLsmmbLsbLsbLgbRsbRhbRiRsmbRgRsmbRsbLcb
LsbLgbLsbLgRsbLsbLsbLgbLsbRibRibLjbLjbRcbRgbLsbRsbRgbRsbRsbRsbRsbLsbRg
bLibLsLsmbLsbLsbLsbLgbLgbLsbLsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bLsbsbRsbRgbLsbRgbLsLsmbRsRibLibLjbLjbLcLsLsLsmmmbLsbRgbRhbRibLjbRiRsm
bRsbRgbRsbRsbRsRsmbLsRsbRsbRgbRsbRsbLsbRgbLsbRgbLjRsbRcbLgbLgbRibRgbRs
bRsbRgbRsbRgbRgbRsbLsLsmbRjbRgLsbLjbRibRsbLsbRgRsmbRgbRgbLiRsbLgbRhbRg
LsbsbRgbRgbRsbRsbRsbRgbRgbLsbRibLjbLjbLibRibLibLibLibRcRsmbRibRgbRsbRs
RsmbRgbLsbLsLsmbRgRsRsmmbLsbRsbRgbRgbRgbRsbLsbRgRsmbLgbRgbLsbRgbRsbRgb
RsbRgLsbRsRsmbLgbRibLsbRgRsmbRsbLsbRgbLsbRgbRsbRsbRsLsbRsbRsbRsLsbLjbL
gbLgbRcbRgbRgbLibRjbLjbRibRsbRsbLgbRgbRsLsbRsbRsbRsRsmbLsRsbRgRsmbRsbR
sbRsbRsbRsbRgRsmbRsbRgbLsbRibLsbRibLsbRgbLsbRgbRsbRgbRsbRsbRsbRsRsmbRg
bRgRsmbLjbRibLgbLjbRcbRgbRgbRibLgbLsbLgbRjbRibRsbRgbRsbLsRsbRsbRgbRsbR
gbRgRsRsmmbLgbRibLjbRibRgbLgbRibRgbRsbRgbRsRsmbRgbLjRsbLcbLgbLibLgbRjb
LibLibRibRebRibRgbLgRsbLsRsbRiRsmbLjbRibRsbLjbRibRhbLjLsmbRibLgbLjLsmb
RgbRgbRiRsmbLgbRibRgLsbLibRgbRgbLcbLibRcbRiRsmbRcbRibLgbRibRibRibLsbRg
bRsbRsbRgbRibLgbLibLibLibLsbRgbLibLsbLsbLgbLsLsmbLsbLgbLsbLsbLibRhbRib
LiRsbRibLsbRgbRsbRgbRsbRsbRsRsmbRsbRsbRsbRsbLsbsbRibRsbLibLhbLibLsbRgb
LibRjbLgbLsLgbLsbLgRsbLsbLsbLgRsbRebRiRsmbLsbRgbRsbRsLsbRsbRsbRsbRsbLj
bLibsbLgbLgbLgRsbLsLsmbLsbLsbLgbLgbLsbLsbLsbLsbLsbLsbLsRsbLgbLsbLsbLgb
LsbLgbLsbLgbLsbLobLcbRsbRibLibRcbRibLgbLjbLibLiLsbLgLsbRsbLsbLsbLsbLsb
LgbLsbLsbRcbRgbRgbLsbRgbLgbLjbLhbRjbRhbRgbRgbRsbRsbRgbRsbRsbRgRsmbLcbL
ibRgbsbLiLsbRhb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bRgbRsLsRsbRgbRsbRgLsbRgbRsRsmbRsbRgbLsbRgbsbRgRsmbRsbRgRsmbRsRsmbRsbR
gbRgbRgLsbRsRsmbRgRsmbRgbRgbRgbRsbRgbLsbRgbRgbRsbRsRsmbRgbRsbRgbRgbRsR
smbRgbRsRsmbRgbRsRsmbRgbRsbRsbRsbRgbLcbLiRsbLgbLsbLsbLsbLgLsbLsbLgbLgb
LgbLgbLgRsbRcbRcbRibLsbRgbRsbRsbRsRsmbRsRsmbRgRsmbRsbRsbRsbRgbRsRsmbRs
bRsbRsbRgRsmbLsbRgRsmbRsRsmbRgbRgbRgRgbRsLsbRgRsmbRgRsmbRgbRgbRsbRgRsm
bLcbRibRibRgLsbRgLsbRgbRsRsmbRgbRgbRgbRgRsmbRsbRgRsmbLsRgbRgbRsbRsbRgb
RgbRgLsbRgRsmbLgbLcbRsLhbLgbLgbLgbLsbLsbLsbLgbLgbLgbLsbLgbLgbLgbRgLsbR
cLsbRibRsbRsbRgLsbRsRsmbRsLsbRsRsmbRgbRgbRgbRgbRgbRgbRsbRsRsmbRsbRsbRg
bRsbRgRsmbRsRsmbRgRsmbRgbRgbRgbRsRsmbRgbRsbRgbRgbRsbRsbRsbRgRsmbRgRsmb
RgbRsLsbLjbLobLiLsbLsbLgbLgbLgLsbLgbLsbLgbLgbLgRsRsmbLgRsbLsbLsLsmbRsb
LibLsbLgbLgbLgLsLsmbLsbLgbLibRjLsbLibLsbRsbLibLsbLgbRsbLgRsbLgbLgbLgbL
sbLsbLgRsbLsbLgbLgbRcbRibRsbRgRsmbRsbRsRsmbRsbRsLsbRgbRsbRgRsmbRgbRsbR
gbRsbRgbRsbLsbLsbRgbLjbLcbLgbLsbLgbLgLsbLgbLsbLgbLsLsmbLgbLgbLsbLgbLsL
smbLsbLgbLsbLgbLsbLgbLsRsbLgbLsbLgbRsRsmbLgbLgbLsbLsbLgLsbLgbLsbLgbLgb
LgbLsbRebLsbRsLsbRhbRibLgRsbRgbRgbLgbLcbLhLsbLibRgbLibLgRsbLgbLsLsRsmb
LsbLgLsbRsbLgbRsLsRsbLgLsbRsbLgbLgbLsbLgbLsbLgbLsbLgbRjbRcbRsbRgbRsbRs
LsbRsbRsbRgbRsbRsbRsbLsbLhbLiLsbLsbLsbLgbLgbLgbLsbLsbLsbLsbLgbLgbLgbLg
bLgRsbLgbRgbLibLsbLgbLgbLsbLgbLgbRjbRobLsbRgRsmbRsbRgbRsbRsbRgbLsbLibL
ibRsLsbLgbLgbRsbLgbLgbLgbLgbLsbLgbLsbLgbLsbRcbRgbLibLibLgbLsbLgbLgbLgb
LsLsmbLsbLgbLsbLsbLgbRsbLsbLgbLsbLgLsbLgbRgbLgbLgRsbLsbLgbLgbLsbLsbLgR
sbLgbRgbLibRibLibLgbRcbRobLibRgbRgbLjbLjbLibLgbLgbLsLsmbLgbLsbLsbLgbLg
bLsbLsbLgbLsbLgbLgbRcbRhbLgLsbLsLsmbLsLsRsmbRibLgbLjbLibLsbLgbLgbLgbLs
bLgbLgRsbLsbLsbLgbRsbLgbLsLsmbLgbLgbLgLsbRsbLgbLsbRsbLgbRsbLgbLgRsbLsb
LgbLsbLgbLgbLsRcbRcLsbRsbRibRgbRsbRgbLcbLibRgbLiLsbRsbLgbLsRsbLgbLgbRs
bLiLsLibLgbLsbLgbLgbLgbRjbRjbLhbLgLsbLiRsbLsbLgbLsLsmbLsLsRsmbLsbLgLsb
LgbLgbLgRsbLgbLgbLgbLsbLgbLgbLgbLsbLsLsmbRjbRobRibLsbRibLsbRhbLgbLjbLi
bLibRsbLgLsbLgbLgbRsbLgbRgbLgbLgLsbLsbLsbLgbLgbLgbRibLgbLsLgbLgbLgbRsL
sbLsbLgRsbLsbLsLsmbLgbLgbRsbRjbRhbLeRsbLgLsbLgbLsbLgLsbLgbLgbRcbRibLgb
RgbLgbRibLgbRibLibRhbLibLcbLibLsbLgbLgbLgbLgbRsLsbLgLsbLgbLgbRsbLgbRsb
LgbRsbLgbRsbLgbLgbLsbRsbLgbLgbLgbLgbRjbLibLgbRgbRjbRibRgbRgbRsbRsbLsbR
sbRgbRsbRsbRsbRgbRsbRsbRgbRsbRsbRgbLsRsbLcbLibLgbLgbLsbLsbLgbLsbLgRsbL
sbLgbLsbLgbRgbLiLsbLgbRjbRcbRibLjbRcRsmbLibRcRsmbLibLsbRcbLibLjbLibLib
LsbRgbLibLibLsbLgbLsbLgbLgbLgbRsbLgbLsbLsbLsbRsbLgbRgbLibLsbLsLsmbLgbL
sbLgbLsbLgbLsbLgLsbLsbLgLsbLsbLgbRjbRjbRcbLgRsbRgLsbRgbRgbRgbRsbRgbRgb
RsRsmbRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122002; End: 122502;
Recording: 4-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bLgRsbRibRsbRsbRgRsmbRgbRgbRgbRgbRgbLsbLcRsbLhRsbRibLibLibRsLiRsbRjbRc
RsmbRibLsbRgRsRsmmbRgReRsmbRgRsRgmbRgbRgRsmbRgbRgbRsbRgRsmbRjbsbLgLsLs
mbRgbLjbRibLibLhbLhbRhbLibRjbRcbRiRsmbRsbRgRsmbRsRsmbRgRgbRgbRgbRgbRsb
LsbRgRsmbRsRsmbRgRsRgRjmbRsRsmbRgRsRgRimbRgbRibRiRsRsmmbRgbLgbsbRibLib
RibRibLjbLcbLibRjbLhbLibRibRjbLibRobLgRsbRgbLibLibLibLibLibLgbLibLgbLg
bLsbLgbRsbLgbRgbLgLsbLsbLsbLsbLsbLgRsbLgbLgbRjbRcRsmbRgbRgRsmbRgbLsbRs
bRgbRsbRgbRsbRsbRsRsmbRgbRgRsReRsReRgmmbRgbRgbRsbRgbRgbRgRsmbRgRsmbRgR
smbRgbRgbRsbRgbLjRsbRibLcbLjbRcbRibRibLjbLjbLibRjbLibRhbRcRsmbLibRcbRi
bLgLsbLjbLibLibRjbRcbLjbLhbLhLsbRibLsbLibLgLsLsmbLibRgbLcbLgbLibLibLgb
RibLgbRibRgbRgbRsbRgbRsbRgbRgbRsbRgRsmbRsbRsRsmbRsRibRgRsRgRsRgmmbRsbR
gbRgbRsLsbRgbRgRgRsRgLsmbRgRsmbRgbRgbRsbRgbRgbRgLsbRgbRgbLjbLjbLibLgbL
sbLgbLgRsbRjbRhbRcbLgbLjbLibLibLgbLsbLgbRjbRcbRgbRgbRsbRgbRgbRsbRgRsmb
RgbRgbRgbRgbRsbRsRsRsRsmmmbsbLjbLgbLibLjbRjbLibLibLibRcRsmbRcbLjbLibLi
bLgbLsbLgbLgbRcbRibRsbRgbRsbRgRgRsLsRgRiReRiRiRsRiRgmmbRgbRgRsmbLsRsbR
gbRgRsmbRsbRgbRgRgbRgRsmbRgbRgbRsbLsbRgbRgRsRsmmbRgbRgbRgbRgbLsbRgRsmb
RsRsmbRsbRgbRgbRgbRsbRsbRsbLgbLjbLcbLgbLibRibLhbLgbLibLibLibLibLsbLsbL
ibLiRsLsbLgbRsbLibLgbLgRiRsmbLibLgbLibRsbRibRhbRiLgbRibLgbRcLsbRiRgbLs
bLgbLsbLgbLjbLsbLjRsbRiRsmbLgLsbLgbLsbRgbLibLgbRcbRiRsmbLjbRibLsbRgRsm
bRgbRgbRsRsmbRgRgRgbRgbRsbRgbRsbRsbRsbRgRsRgmbRiRgRsRiRsmmbRgbRgRgRgRs
mbRiRgRgbRgRsRiRimbRibRsbRgbRsbRsbRgbRibLjbRhbLibRjbRsbRibRgbRsbRsbRsR
sRsmmbRgbRgbRgbRgbRsbRsbRsbRsbRgRsmbRsbRgRgRgbRgRsRiRiRsmmbRgbRgbRgbRs
bRsbRgbRgbRgbRsbRgbLjbLcbLhbLibRjRsmbRcbRibLjbRgRgbRibRgRgRgRibRgRsmbR
gbRsRgRibReRebRgRsmbRsRgbLsbRgbRgRsmbLjbLjbLibLibRgbLibRgbLibLgbLibRib
LgbLibLgbLgbRhbLibLibLgbRibRsbRjbRgbRgRsmbRgbRgRsmbRgRiRiRsmbRgbRgbRsb
RgRsRgRsReRsRgmmmbRgbRgbRgbRgbRgbRgbRgbRgbRgRgRsReRsRsmmmbRibRgbRgbRsb
RgRsmbRgbLgbLjbRibRgRsmbRgbRgbRgbRgbRgbRibLjbRibLgbRhbLibRcbRcbRhbRhbR
sbRiRsmbRsbRgbRgbRsbRgRgbRgRsRgmbRgRsmbRgRgbRgbRiRgRsmbRgRsmbRsbRgbRgb
RgbLjRsbLibLibRhbLcbLibRibLhLsbLibLibLibLgbLgbLsbRgbRibRgRsmbLsbRgbRgR
smbRgbRibRgbRgRsmbRsbRgbRsbRsbRgRsmbRsbRgbRsbRgRiRsRiReRiRiRsmmbRgbRgb
RgbRgbRsRsmbRgbRgbRgbRsbRgRsmbLsRsRsmbRgLsbRgRgbRgRsRgmbRgbRgRsmbRgbRs
bRgbRgRgbRgbRgbLhRsLsLsmbRcbLjbRibLhbRhbLjbRcbLhbRcLsbRibRibRhbRibLiLi
LsbLibLibLibLsbLgbLgbRibLjbLgbLgbLjbLjRsbRiRsLiLsmbRjbLibLgbLsbLgLsLsm
bLsLsmbLgbLsbLgRsbLsbLibLgbLsbRgbLiLgRgbRcbRiLsbRsbRsbRgbRsbRsbRgbRsbR
sbRsbRgbRgRgRsmbRgRsmbRgRsmbRgRibRgbRgbRsbRgRsmbRgRgRsRgRsRgRiRsmmmbRg
RgbRgbRgbRgbRsbRsbRgbLcbLibLgbLibLibLibLibLibLsbRibLgbLgbRibLibLibLgbR
gbLibLibLsbRsbLibRgbLgLsbLsbLgbLgbLcbRiLsbRibRgbRsRgbRsbRgLsRgRsmbRgRi
RsRgmbRgbRgbRgRgbRgRsmbRgRsRsmmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 1; Drug: Control Apo 0.5 然
bLibRsbLgLsbLsbLgbLsbLsLsmbLsbLsbLsbLgbLgbLsbLgbLgbLsLsmbLgbLgbsbLgbRg
bRjbRsbLiRsbRcbRcRsmbRiRsmbRsbsbRsbRgbLsbRsbRsLsbRsbLsbRgbRgbLcbLcRsbL
ibLcbRgbLhbRibLiRsbRgbLibRsbLgbLgbsbRsbLgbLsbLgbLgbLgbLgLsbLsbLsbsbLsb
LsbLgRsbLgbLibRibRsbRgbLsbsbLsLsmbRgbLjbsbLjbLcLsmbRgRsmbRsbsbLibLgbLg
bLsbLsLsLsmmbRsbLgbLgbLgLsbLgbLsbLsbLgbLgbRsbsbLsbLsbLsbRsbLgbLgbLsbLg
bLsbLsbLgbLgLsRsbLgbLsbLsbLgbLsLsmbLgRsbLgbRsbLibRjbRcbRsbLsbsbsbRsLsb
RsRibLgbRcbLcbLibLcbRibLjbLiLsRsbLibLsbRgbLibLibRgbLgLsbLgbRsLsbRsbLgb
LsLsmbLgbLsbLiLsbLibLsbLgbLsbLgbLsbLgbLgbRgLsbLgbRsbLgbLgbLsbLibLgbLgb
LsbLsbLgbRgbLgbLsbLgbLgbRsbLgbLgbLsbLsbLgbRsbLgbRsLsbLgbLgbLsbLgLsLsmb
LsbLgbRcbRiRsmbLjLsmbLcbLibRgbLibRsbLibLcbRcbRcbRhbLhbLibLcbRibLibLgbL
gbLsbRsbLsbLgLsbLgbLgbLsbLsbLgbLgbLgbLgbRcbRibLgbRibRibRgbRibRibRgbLsb
RgbRgbRgbRibRgbLgbRgbRibLibLsRhbRgbRgbRgbRsbRibRibRibLibLibLcbRgbRjbRo
bRibRibRibRgbRibRgbRibRibLgbRibRibLgLsbRgbRibRgbLibRibRibRibRgbLgbRgbL
ibRgbRiRsmbRgbRsbRgbLgbRibLibLjbLcbLgbRibRcbRibRsbLebLhLsbRjbRcbRhbLib
RhbLsbLgbLcbRjbLhbRebRcRsmbRsbRibRsbLsbRgbRsRsmbRsRsmbRgLsbRsbRgbRgbLg
bLsbRgbLjbLsbRibRgbLsbLgbLibLibLiLsbLgbLgRsbLsbLgbRobRgbRgbLsRsbRgbRgb
RibLjbLobLiLsbRsbLsbLgbLgbRibLcbRibRjRsmbRhbRsbLgbLsbRgRsmbRsbRsbRsbsb
RsbRsbRsbRgbRsbLsbRgbLjbLobRjbLobRjbLcbRjbLcbRibLibLsbLgbLsbLsbLgbLsbL
sbLgbLsbLsbLsbLsbLsbLibRgbLibLgbLsbLgbLsbLgbLgbLsbLsbLsbLgbLgbLgbLgbRo
bRibLjbLhbLibRsbLgbLsbLgbLiRsbRebLibLgbLsbLgbLsbRgbLgbLgbLsbLsbLgbLgbR
sbLiLsbRibLcbRgbLibLgbRibLjbRsRjbRcbRgbLsRsbRsbRsbRsRiRsmbLcbLibRjbLib
LgbRgbLgbLgbLsbLgbRsbLsbLgbLgLsbLgbRjbLibLgbLgbLsbLsbLhbRibRgbRjbRibRs
bRhbLibRgbLoLsmbLiRsbLgbRibRibLgbRgbLibLsbLgLsbLgbRjbLibLgRsbLgbLsbLgb
LsbLgLsbLgbLgbLsLsmbLsbLgbLsbLsbLsbLgbLsbLsbLsbLsbLgbRibRsRhbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 2; Drug: Control Apo 0.5 然
bRibLsbRgbLgbRgRsmbRgbLjbLibLgbLcbLcbRjbRcbRibLgRsbRiRsmbRgbRibLhLsbLi
bLgbLgbRibReRsmbRiRsmbRsRsmbRgbRsbRgbRsLsbRgbRgbRgbLsRgbLsbRgbRsbRgbRs
bRgbLgbRibLsbRsbRgbRgbRgbLsbRsbRgbRsbRgbLsbRiLsbRsLsbRgbRgbLsRsbLsbRgR
smbLsbRiRsmbLsbRsRsmbRgbRsbRsRsRsmmbRsbRgRsmbRsbRgRsmbRsLsbRgbLsbRgbRg
RsmbRsRsmbRgLsbRsbRgbRsbRgbLsbRgRsmbRsbRgRsmbLsbRgbRsRsmbRgbRgRsmbLgbL
sRibRsbLsbRibRsbRgbLjbRhbLhbLiLsbLibRgbLibLsbLgbRsLsbLibRsbLgbLiRsbRjb
RcbRibLjbRibRgbRgLsbRsbRibRgbRsbRsbRgRsmbRsbLobLibLibRcbLibRibRgbLsLsm
bRibLsbRsbRgbRsbRgbRgRsmbRsbRgRsmbRsbRgbRsRsmbRsLsRsbRiRsmbRsbRgbRgbRs
bRgbRgbRgRsmbRgLsbRsbRgRsmbLgbRiRsmbRsbRsbRgRsmbRgbRgbRgRsmbRsbRiRsmbL
sbRgbRsbRsbLsRgLsRsbRsbRgRsmbRsbRgbRsRsLsmbRgbRgbLsbRgbRgbRgRsmbRgLsbR
sbRsbRsbLsbRgbRgRsmbRsbRgbLgRsbRibLsbRibRgbRsbRgRsmbRgbRsbRgRsmbRsbRgb
RsbRgbRsbRibRsLsbRgbRsLsbRiLsbRsbRgRsLsmbRgLsbRgRsmbRsbRgbLsbRgRsmbLsb
RibRsbRgbRsRsmbRgbRgbRgbRgbRgRsmbLsbRgbRgbRgbRgbRgLsbLsbRgbRsbRgbRgbRg
bRibRsRsmbRgbRgbLsbRgbRiLsbLsRsLsbRgbRsRsmbRsbRgbRsbRgbRsbRgLsbRsRsmbR
gbRgbLsLsmbRiLsbRgbLjbLibRjbRcRsmbRibLibRsbRibRiLsbLgbRibLgLsbRibLsbRg
bRsbRsbRgbRibRgbRsbLibRibRsbRgLsbRsbRgbRgbRsRsmbRgRsmbRsbRgbRgbRibRgbR
gbLgbRibRsRsmbRsRsmbRgRsmbRgbRgbRgbLsbRibRiRsmbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 3; Drug: Control Apo 0.5 然
bRjRjbRebLsbRsbRgbRsbLiLsbRibRibRgbRgbLsbLibRgbRiLsbRgbLsbLsRsbRsbRsbR
sbRsbRiRsLsmbRibRgbRsbRsbRsbRibRsbRgLsbRgbRsbRibRgbRsbRjbRgRsmbRsbLgbL
iLsbRjbRgbLjLcbLibLgLsbRibLgbLgLsbLgLsbRsbLsbLsRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 4; Drug: Control Apo 0.5 然
bRcbRibRgbRgbRgRsmbRgbRibRsbRgLsRsbRsbRgbLcbLgbLgbLsLsmbLsbLsbLsbLsbLs
bLsbLsbLsbLsbLgbRsbLgbRcbRibRgbRgbRgbRgbRjbRgbRibLgbRgbRgbRgbRgLsbRsbR
gbLjbLjbLjbLsLgbLgbRgbLsbLsbLsbLsbLgbRsLgbLsbLsLsmbLsbLsbLsbLsbLsbLsbL
sbLgbLsbLsbLsbLsbLgRsbLsbLsLsmbLsbRsbLgbLsbLsRsbLsLsmbLsbLsbLsbLsbLgbL
sbLsbLsbLgbRgbLsbLgbRgbLgbRgbLiLsbLgbLgbLgbRgRsmbLgbLsLsmbLibRjbRcbRjb
RgbRgRsmbLsbRgbRjbLibLgbRgbLgbLgbRsbLgbLibRgbLiLsbRsbLgbLsbLsbLsbLsbLs
bLsbLsbLsbLsbLgbLsbLgbRsbLgLsbLgbLsbLgbLsbLsbLgLsbRsbLsRsbRcbRgbRsbRgR
smbLsbRsRsmbRsbsbRgbLsbLjbLibLgbRsbLgbLgbLgbLsbLsbLsbLsbLsbLgbLsbLsbLs
bLsbLsbLsbLsbLgbLsbLsbLsbLsbLsbRsbLgbRgbLgbLsbLsbLsbLsbLsbLsbLgbLgbRsL
gbLsbLgbRgRsmbLibRgbLgbRsLgLsbRgbLgbRsbLgbRsbLsbLsbRsRsmbLgbLsbRsRsmbL
gRsbLsbLibRsbLsLsmbLgbLsbLgbLsLsmbLibRsbRjbLgbsbRgLsbLgbLgbLsbRibRsbLi
bLgbRsbRgbLibLsRsbLibRsbLsbRsbRsbLjbRsLsbLgbLsbRsbLgbLsbLgbRsbLsbLsbLs
bLgbLsbLgbLsbLjLsmbLgbLjLsmbLgbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 5; Drug: Control Apo 0.5 然
bRgRsmbLgRsbRibRgbLgbRibRgRsmbLgbRsbRgbRgbRsRsmbRsbRgbRgbRsbRsbRgbRgbR
gbRsbRsbRsbRsbRsbRgbRgRsmbRgbRgLsbRgbLsbRgbRgbRgRsmbLsbRsLsbRgRsmbRgRs
mbRgbRgbRgbRsbRsRsmbRhbLiRsbLiLsbLibRhbRcRsmbRsbRgbRgbLsbRibRgbRsbRgbR
gbLibLgbLjbLibRcbRobLibLiRsbLcbRibLsbLibLgbLibLibRjbLgbRcbRgbLsRgbRgbR
sbLcbLsLiRsbRgbLgLsbLibLibLgbRcbRiRsmbRgRsmbRgbRsRsmbRgbRsbRgbRgbRsbRg
bRsbRsbRsbRgbRsbRgbRsbRsLsbRgbRsRsmbRgbRgbRgbRsbRsbRgbRsRsmbRgbRsbRgRs
mbRsbRsbRsbRgbRgbRsbRgbRsbRsbRgbLcbLiLsbRcbLibLhbRibLcbRiRsmbRibRibRsb
RsbRsbLsbRsbRibRibRsbRgbRsLsbLjbLibRebLebLiLsbRcbLibRgbLibLsLsmbRsLsbL
gbRsbLgbLgbLsbLgbLgbRcRsmbRiRsmbRgbLsbRibLgLsbRgbRgbLjLoLsmbLibRibLibL
gbLibLsbLgbRsbRcbRgRsRsmmbRsbLsbRsbLjbLcbLgbLsbLsbRjbRcbLibRcRsmbRjbRs
bLsbRsbRgbRgbRsbRsRsmbRgbRgRsmbRgbRgbRsbRgbRgRsmbRgbRsbRsbRgRsmbRsbRsb
LsbRibLjbLhbLibRjbLhbLgbLgbRhbRhRsmbRsbRgbLsbLjbLibLibRgLsbLibRjbRcbRg
bRsbRgRsmbRgbRsbRsbRiLsbRsbLjbLcbLibRgbLhbRiRsmbLibLgbRgbLgbLgbLgbRsRs
mbLgbLgbRsbLgbRjLsbRcbRgbRsbRgbRgbRsbLsRsbRgbRsbRgbRsRsmbRsbRgbRgLsbRg
bRsbRgbRsbRgbRsRsmbRsbRgLsbRsbRgbRsbRgbRgbRgbRgbRgbRgRsmbRgRsmbRgbLjbR
ibRgbLsbRsbRgbRsbRgbRgRsmbRsbRsbRgbRgRsmbRgbRsbRgbRgbRsRsmbRsLsbRgbRgb
RsbRsbRsbRsbRsbRgRsmbRgbRgRsmbRgbRsbRsbRsbRsbRgbRibRgLsbRgbRgbRgRsmbRg
bLjbRhbLgbLjbLibLgLsbLsbLgbLgbRobRgbRsbRgbLsbRgbRsbLsbRibLjbLebLhbRgLs
RsbLibLgbLgLsbLgbLsbLsbRjbRibRsbRsRsmbRgRsmbRgbRsbRgbRsLsbRgbRsRsmbRgb
LhLsbLcbRcbLhbLibRibLgbLgbLgRsbLgRsbRjbRcRsmbRgRsmbRgbRsbRsRsmbRgbRgbR
gbRsbRsbRsbRsbRgbRsbRgbLjbLcbLibRgbLgbRjbLgbLibLsLsmbLgLsbRgbRibRgRsmb
RsbRsRsmbLsbLibLiLsbRjbRcRsmbRsbRsbRsbRgbRsbRgRsmbRsbRgbLsbRgbRsbRgbRs
bRgbRsRsmbLsbLsbRhLibLcbLibRjbLibRsbLgbLsLsmbLgLsbRjbLsbLibRjbRcbRsbRs
LsbRgbRsbRsbRsLsbRibRsRsRsmmbRgbRsbRgbRgbRgbRibRsRsmbLibLjLsmbLibRcbRc
bLibLhbLhRsbRhbRhbRibRgbRsbRgbRsbRsbRgRsmbRgbRgbLgbRiRsmbLcbLgbRsbLibL
hbRibRhbLjbLibLiRsbRjbRcbLgbRibLgbLibLibRgbLgbLgbRcbRgbRgbRsbRgbRsbRgL
sbRgbRgbRgRsmbRgbRsbRgRsmbRsbRgbRgbRsbRgRsmbLsbRgRsmbLsbRsbRgbRgbRgRsR
smmbRsbRsbRgbRgbLsbLjRsRcbLibLibLibRgbLgbLibLiLsbLgbLsRgLgbLgbLgLsbRcb
RiRsmbLjbLhbLibRjbLcbLibRibRebRgRsmbRsbLsbRsbRgbRsbRsRsmbRsbRgbRsbRgbR
gbRgbRsbRsbLsLsmbRibRgbLibLjLsmbLibRjbRibLibLibLibRsbLibRjbRcbRibLjbLc
LibLibRhLsLibLcbRjRsRsmmbLsbRjbRibRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 6; Drug: Control Apo 0.5 然
bLgLsbLgLsbLsbLgLsbLgbLgRsbLsRsbLsbLgbsbLgbRgbRgbLjbsbLsLsmbsbLibLsbLg
bLgbRgbsbLgbLsbLgbLgbLgbLibsbRgbRsbRibRgbLgbRgbRgLsbLsRsbLsbRibRsbRibL
iLsbLsbRgRsmbRebLibRgbRgLsbLgbRgbLibLcbLhbLsbLgbLsbLsbRgbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bRibRsRsRsLsmmbRgRsmbRgbLjbRhbRibRgbRsbRsRsmbLgbRiRsmbRgbRsRsmbRgbRiRs
RsRsLsmmmbLsbRgLsbLsbRsbLgLsbRcbRgbRgbRgbLgbRgbsbRsRsmbRsbRsbRsbRgLsbR
sRsmbLsbRjRsmbRsbLibLsbLsbLibLgLsbLgbRibRibRgbRsbRsbRibRibRsbRgbRsRgbR
gbRjbLgbRibRgRsmbRsbLgbLsbLsbRibLsbRhbRgbRgbRgbRgbRjbRsbRgbLsbLibLsLsL
smmbLgbLgRsbLjLgbLsLgLsLsmbLhbLgbRsbRsRsmbRsbLibRgbLsbLgbLjLsmbRjRsmbL
jLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bRgbRsLsRsbRgbLgRsbRgbRsbRgbLsbRgbRsbRsbRsbRgbRgbRsRsmbRgLsbRgbRgRsmbL
gbRgbRsbRsbRibRgbLsRsbRgbRsbRsbRgbRsRsmbRsbRsbLsbRibLgbRibLsRsbRsbRsbR
gbRsbLsbRgbLsbRibLsbRsbRsRsmbRgbRsbLsbRgbRsbRsbRgbRsbLsbRibRsbRsbRgbRs
bLgbRiRsmbRsbLsbRiRsmbRsRsmbLsRsbRgbRsbRgbLsRsbRgbRsbRgRsmbLsbRibLgbRi
bRgbLgbRibLsbRibLsbRsbRiRsmbRsbRgbRsbRgbRsRsmbRgbRsRsmbRgbRsRsmbRgbRsb
RgRsmbLgbRiRsmbRsbRsbRsbRibRsbRsbRgRsmbLgbRibRgbRsbLgbRibRgbRgLsbRsbLs
RsRsmbRiRsmbLgbRibLgbRiRsmbRsbLsbRgbRsbRgbRgbRgbRsbRgbRgbRgbLsbRibRsbR
gbRsbRgbRsbRsbRgbRsbLsbRgbRsbRgRsmbRsbRgbRsRsmbRsRsmbRgbRsbLsbRibRsbRg
bRgbLsbRgbRsRsmbRsbRgbRgbRgbRsbLsbRgbLsbRiLsbLsbRibRsRsmbRjbLgbRibRsbR
sRsmbRgRsmbRgbRgbRsRsmbRgbRsLsRsbRgRsmbLsbRibLgbRibRgbRsbRsbRiRsRsmmbR
ibLgbRsbRiLsbRgbRsbLsbRgbRgbRsbLgbRgbRgbRsbRibRsbLsbRgbRgbLgRsbRibRgbL
ibRibRiRsmbRsRsmbRsbRibRiRsmbRgRsmbRsbRgRsmbLgbRibLgbRiRsmbRsRsmbRsbRi
bRgRsmbLgbRibRsbLsRsbRgRsmbLsbRibRsbRsRsmbRsbRgRsmbLsbRgRsmbRsbRgbRgbR
sbLgbLebLgbLibLgbLsbRjbRjbRebLibLjbRjbLibLgbRgbLibRgLsbLibRibRjbRjLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bRibLgLsbLibLgbLgbRsbLsRsbLgbRsbLgbLsbLsbLsbLgbLhLsbLsbLgbLsbRsbLgbLgL
sRsbLgbRebRibLgbRiLsbLibLcLsmbLiLsbLsRsbLgbLgbLsbLsbLsbLgLsRsbLsbLsbRs
bLgLsbLsbLsbLgbLsRibLiLsbLhLgRsbRibLibLibLgbLgbLgbLgbLgbLgbLgbLgbLiLsb
LgbLgbLgbRibLibLgbLibLgbRsbLsbLgbLgbLsbLgbLsbLsbLgbLsbLgbLsbLgRsbLgbLg
bRjLsbLibLibLgbRsbRsbLgbRsbLhbLhLsbRgbLgbLibLgbLgbLgLsbLgbLgLsbRgbLgbR
sbRsbLgbLibLgbLgbLgbRgbRgbRgbRjbRgbRgbRsRsmbRsbLgbLcbLhbRibLibLgbLgbLg
bLsbLgbLgLsbLgbLgbRgbLibLgbLibLgbLsbLibLsbLsbRsbLibLgLsbLgbRsbRibRibLj
bLhbLhLsbRgbLcbLgbLsbLgbLsbLsbRsbLgbLsbLsbLgRsbLsbLsLgbLgbLgLsbLsLsmbL
sLsmbLgbRsLgbLsbLsbLgbLgbLsbLgLgbLgLsbLgbLsbLgbLgbLsbRiLsbLibLibLgbRhb
RibRgbRgbRsbRibLjbRibLcbLhbLgbLsLsmbLsbLsbLgLsbLgLsLsmbLgLsLsmbLgbLgLs
RsbLsbLgbLgRsbLgLsbRhbRibRibLibRsRsRsLcmmbRjbLibLibRsbRjbLibLgLsbRsbLs
bLsbLgbLgbLsbLgbLsbLgLsbLgbLgbLsbRgRsmbRibLibLibLibLsbLsbRsLsbLgbLsbLs
bLsLsmbLgLsbLsbLsLsmbLgbLgbLgbLgbLsbLiRsbRcbRibLcbLibLgbLsbLibLgbLsbLg
bLsbLsbLsbLsbLgbLsbLsbLgbLsbLgLsLsmbLgbLgbLsbLcLibLjbLibLgbLgLsbLgbLsb
LgbLgbLgbLsbRgbLiLsbLgbLgbLsbLsbLsbLgbLsbLsRsbLsbLgLsbLgbLgbLsbLsLsmbL
sbLsbLsbRsbLiLsbLsbLsbLsbLgbLsbLsbLgRsbLgbLsbRjbLibRcbLhbLibLgbLgbLgbL
gbLgbLsbLgbLgbLgbRibLgbLibLibLibRgbRgbRsbLsbLcbLhbLibLgbLsbLibLibLgbLi
bLsbLibLgbRibRjbRgRsmbRsbRgbRgbRsbRsbRsRsmbLcbLsbLiLsbLibRsbLgbLgbLgbL
gbLcbRhbLiLsbLgbLibLgLsbLiLsbLibLcbLibLibLsLibLibLibLgbLgbLgbLgbLgbLsb
LgbLsbLgbLsbLgbRsbLsbLgbLsbLsbLgLsbLsbLgLsbLgLsbLsbLgbLoLsLsLsmmmbLcbL
ibLibLgbLgbLcLsmbLgbLgbLsbLgbRgbLsbLibLibLibRjbLibLgbLsbLsbRsLsbLgbLsL
smbLgbLsbLsbLgbLgbRcbRibLcbLibLibRsbRsbRibLsbLhLsbLhbLgbLsbRibLsbRobLi
bLibLgbRjbLjbRibLibLgbRsbLgbLibLsbLgbLsbLgLsbRsLsLsmbLsbLgbLgbLgLsbLsb
LsbLgLsbLgRsbLsLjbLoRsbLcLsmbLibLibRcbLibLgbLgbLgbLcRsbLcLsmbRhbRgbRgb
RsbRgbRibRsbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbsbLcbLibLibRsbLibLgbRsbLsbLsbLgLsbLgbLs
LsRsmbLgbLsLsmbLsRcLsbRibLjbRibRsbRiRsmbLjLsmbRibRsbLsbLsbRibRgbRgbRgb
LebLibLibLsbLgbLsbRsbLibRsbLgbLiLsbLibRgbRsLiLsLsmbRgbLgLsbLgLsbLsRsbL
sbLgbLsLsmbLgbLsbLsbLsbLsbLsbLsbLjLsLsmmbRjbLjbRhbLibLgbLgbLsbRsbRibLi
LsbLgbRgbLibRgbLgbLsbLsbLsRsbLsbLsbLgbLsbLsbLgbLsbLsLsmbLsbRsbsbLgbLgb
LsbLsbRsLsbLsbLsbLsbLgbLsLsmbLsLsmbLsbLsbRsbLgbLsbLgbRjbLgbLiLsbLsbLgb
LsbRsLsbLgLsbLsLsmbLsLgbLgbLgLsbLsLsmbLsLsLsmmbRsLsbLgbLsbLsbLsbRjbLib
LgbLibRibLibLiLsbRjbLibLgbRsbRsbLibLsLibLibRsbRgRsmbLgbRibRsRsmbRgbRsb
RibLcLsmbRsbLgbLsbLsLsmbLsRsbLgbLgLsbLsLsmbLsbLsRsbLsbLgbLjbRcRsmbLibL
ibRjbLibRjbRcRibLjbLcbRsLiRsbLibRjbLibLgLsbRibRjbLiLsbLibLgbRsbLsLsmbL
gbLsLsmbLsbLsbLsbLsbLsRsbLgbLsbLgbLsLsmbLsbLsbLjLsmbLibLgbLsbRjbRibLgb
LgbRhbLiLsbLgbLgbLsLsmbLsLsLsmmbLsbLsbLgLsbRsbLgbRsbLgbLsbLgRsbLgbLgbR
jbsbLiLsbLsbLgLsbLsLsmbLsbLsbRjbsbLibLgbLsRsbLsbLsbLsLsLsmmbLsLsmbLgLs
bLsbLsbRsbLibLgbRgRsmbRibRsbRjbLjbRjbRjbRjbLjLsmbLjbLcbRjbLibRhbLiLsbL
gbLgLsLsmbLsbLgLsRsbLsLsmbLsbRsLsbLgbLsbLsLsmbLsLsmbLgbLsbLsLsmbRsbLsb
LsbLsLsmbRsbLgbLgLsbRjbRhbRgbRibLjbLcbLibRjbLibLsbLiLsbRsbLibLibRjRsmb
RibLgbLibLsbLiLsbRjbLiLsbRjbLibRsLsbLsbLsbLsbLsbLgbLsbLgbRsbLsbLgbLsbR
sbLgbRsbLibRjbRhbRjbLibLibLgbRsbRgbRsLibRsbLgRsbLgbLsbLgLsRsbLsbLsbLgR
sbLsbLsbLgbLsbLgbRjbRcbRhbLhbRgbLjbLsbLibLsbLgbLsbLsRsbLsLsLsmmbLsbLgb
LgbLibLibRjbRcbLhbLcRsbRgbLhbLgbLgbLsbLgbRsbRgbLibRsbLgLsbLgbLsbLsbRsR
smbLgbRjbLibRjbLibLgbLibRibLgLsbRjbRsbLgbLgbLgbLgbLsbLsbRibRiRsmbRgLsb
RsbLjbLhbRgbLjbLsLsmbLsbLgbRgbLiLsLsmbRsbLgbLgbLsbRjbLibLgbRsbLibLsbLs
LsmbLsbLsbLgbLsbLgbLgbLsbLgbLsbLgbLsbLsbLsLsmbLsRsbLgbLsbLgLsbRgRsmbLg
LsbRsbsbLgbLsbLgbLsbLgbLsbRgbLibRjbLgLsbLsbLibRsLsbLgLsbRsLsbLebLhbLib
LhbLibLgLsbLsbLgbLgLsbRgbLibLibLiLsbRibRhbLcbLibLiLsbLibRsbLjbRjbLibLs
bRsbLgbRsbLgbRgbLjbLibRjbLibRjbLibRjbLibRjbLgbLsbLgLsbLsbLsbLsbLsbLsLs
mbLsLsmbLsbLsbLgbLsLsmbLsbLsbLsbRsbLgLsbLsLsmbLgbLsLsmbLsbRibRibLjLsmb
RjbLebRjbLibLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bRgbLiRsbLsbLibLibRsbLgbLsbLgbLsbLsRsbLgbRebRhbRgbRibLgbLcbLiLsbLsLsmb
LsbLgbRobLsLsmbLgLsbLgRsbLgbLgbLgbLgbLgLsbLsbLgbLgbLsbRsbLgbRsbLgbLsbL
obLgLsbRsbRgRsmbLjbRcbLibRgbRibRgRsmbRgbRgbRsbRgbRsbRsLsbLsbLgbLgbLsbL
gLsbRsbLgbLsbLsbLiLsbRjbLibRjbRsbLhbRjbLsbLibLgLsbLsbLsbLgbRsbLjbLgbLs
bLsbLgbLgbLgbLsbLsbLsbLsbLsbLgRsbLibRjbLjbLsbLgbLsbLgbLsbLgbLsbLgbLjbR
sbRcbLgLsbsbsbLibLsLsmbLgbLsbLgLsbLsbLsbLibLgRsbLsbLgbLgbLsRsbRjbRsbLj
bRcbRgbLhbRhbRgLsRsbRjbLhbLibRsbLgbLsbLibRjbRibLsbRiLsbRgbRgbRgbRgbRib
RjbLibLgbRjbLibRsbLgbRgbLjbLsbRibLsRsbRgbRgbRgbRsbRgRsmbRsbRsbRgbLebLi
bRibRsRsmbRgLsbRgbRsbRgbRgbLjbLhbLjbLsbRjbRsRsmbLsbLsLsmbLgbLgbLgLsbLg
bLsLsmbLgLsbLjbLsbLsbLgbLgbLgbRsbRsbLiLsbLgbRibLjbLgbLsbLsbLsbLgbLgbRj
bRebRgLsbRsbRsbRgbRsbRgbRsbRsRsmbRgbRiRsLsmbLcbRsbLsLsRsmbLibLgbLgLsbL
gbLsLsLsmmbLgbRebRsLsbLgbLibLgbLsbLgbLgbLgbRcbRgRsmbLjbRgbRibLgbLjbRsL
jbLgbRibLjbLiLsbLgbLsbLgRsbLsbLgbLsbLgbRgbLibRsbLjbLibRgbLgLsbLgbLgbLs
bLsRsbLjbLsbRgbLjbRgbRibLgbLcbLsLsmbLgbLgbLgbLsbLgbRgbLibRgbLjbRgbLjbL
iLsbRibLibLgbLgbLgbRgbRgbRcbLgbLibLsbLgbLsbLgbRsbLjbRsbRiRsmbLjbRibRgb
RgbRgLsbRgbLhbLibLsbLiLsLsmbLgbLsbLgbLsbLgbLsbLjbLsbRsLiRsRcbRgRsmbRsL
sbRgbRgbRgbLebLibLibLsbRgbLibLgbLsbLgbLsLsmbLsbLsbRgbLibRjbRcRsmbRgRsR
smmbRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bLsbRibRsbRgRgbRgbRsbRgbRgbRgbRgbRgbRgbRgbRgbRsbRgbRsbRgbRgbRsRsmbRgRs
RiRsmmbRibLgRsbRgbRgbRsbRsbRsLsbRgbRgbRsbRgbRgbRgbRsbRibRibRsbRsbRsRsm
bRsbRgbRsbRgbRsbRgbRgbRsbRgbRgbRgbRgbRgbRgbRgRsmbRsbRgbRgbRgbRgbRibRgb
RsbLsbsbLsbLgbLhbLibRsbsbLiLsbRjbLibRgbRiRsmbRhbLibRhbLsbRgbRsbsbRsbRg
bRgbRgbRsbRgbRgbLsbRgbRsbRsbRsbRsbRsRgbRsbRgbRsRgbRsbRsbsbRsbRgbRgbRsb
RgRsmbRsbLsbRiRsmbLgbLjbLibRebRsbRgbRsRsmbRgbRsbRsbRgbRsLsbRgbRibRsRsm
bRsbRsbRibRgbRsRsmbRsLsbRgLsbRgbRsbRsbRsRsmbRgRsmbRgbRgbRsbRgbRsbRgbRg
bRsbRgbRsbRgbRgbRsbRsbRgbRibLsbRgbRsbRsbRgLsbRgbRsRsmbRsbRsbRsbRgbRgbR
sRsmbRgbRgbRsbRibRgbLibLhbLiLsbReRsmbRgRsmbRsbRsbRsbRsbRsbRsbRsbRsRsmb
RgbRgbRgbRgbRgbRsbRgbRgbRsRsmbRgbRgbRsbRsRsmbRgbRsbRgbRgbRsRsmbRsbRgbR
sRsmbRsbRgbRsbRgRsmbRgbRsbRgbRgbRsbRgbRgbRgbRsbsbRgbRgbRgbRgbRgbRgbRgb
RgRgRsmbRgRsmbRsRsmbRsbRgbRsbRsbRgbRgbRgbRsbRsbRgbRsbRgbRgbRsbRgbRgbRg
bRgbRsRsmbRgRsmbRsbRsbRsbRgbRsbRgbRgbLibRibRsbRsbRgbRsbRsbRsbRsRgbRgbR
gbRsRsmbRgbRgbRgbRgbRgbRgbRgbRgbRsbRsbRgbRgLsRsbRgbRgbRsLsRsbRgbRsbRgb
RgbRoRsmbLsbRgLsbLsbRhbRsbLsRsbLgbRibLibLcLsmbLhLsbRjbRhRsmbRibRgbRsbR
sbRsbRgRsmbRgbRsbRgbRsbRsbRsbRgbRsbRgbRsbRsbRsbRgbRsbRsbRgbRgbRsRsmbRs
RgbRgRsmbRgbRgbRsbRibRgbRgRsmbRgbRibLjbRibRsbRgbRgRsmbRsbRsbRgbLgLsbRi
LsbLjbLobLiLsLsmbLsbLsbLgbRjbRcbRiRsmbRsbRsbRsbRsbRsbRsbRsbRgbRsLsbsbR
gbRgbRsRsmbRgbRsLsRsbRgRsmbRsbRgbRgbRsbRgbRsbRgbRgbRsbLgbRibRgbLsbRsbR
gbRgbRsbRsbRsbRgbLsbRgbRgRsmbRsbRgbLsbRibLibRgbRgbRgbRsLsbRsbRsbRsbRgR
smbRsbRgbRgbRgbRgbRsbRgbRsbRsbRgbRsbRgbRsbRsbRgRsmbRgbRsbRsbRgbRgbRibR
gbRgbRsbRgbRsbRgbRsbRibRgbRgbRgbsbRgbRgbRgLsbRgbRgbRgbRsbRsbRsbRsbRsbR
sbRsbRsbRgbRsLsbRgbRsbRgRsmbRgLsbRsbRgbRgbRgbRsbRgbRgbRsbRgLsbRsLsbRgb
RgbRgbRgRsmbRgbRsbRsRsmbRgbRgbRgbRgbRsbRgbRsbRgRsmbRgLsRsbRgRsRsmmbRsR
gbRgbLsbLsbRsbRsRsmbRgbRibRsbRgbRgbLjbRibRibRsbRgbRgbRsRsmbRsbLhbRhbRs
bRgRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bRsbRgbRsbRgbRsbRgbRsRsmbRgbRgRsmbRsbRgbRsbRsRsmbRibLgbRsbLjbLcLsmbLib
LsLsmbLsbLgbsbRsbLgLsbRsbLgbRcRibRgRsmbLgbRibLsbRgbLjbRibLibRibRgbLsbR
iRsmbRsbRgbRgbRgRgbRgRsmbRgbRgbRsbRgbRgbRsbRgRsmbRgRsmbRgRsLsmbRgbRgbR
sRsmbRgbRsRgbRgbRgbRsRsmbRgbLsRsbRibLsLsmbRibLgbRibRsRgbRsbRsLsbRgRsmb
RgbRibRgbLsRsbLsbRsbRgbRgLsbLjbLcbLgbLgRsbLgbRsRsmbLgbLsbLsbRcbRhbLgbR
ibLibLsLsmbLgRsLsbRiRsmbRgbLsbRgbLsbRiLsbLgbRgbRgbLgRsbRiRsRsmmbRsbRgR
smbRsbRgbRgbRsRsmbRgbRsbRgRsmbRsRsmbRsbRgbRgbRgbRgRsLsmbRgbRgbRsbRsRsR
smmbRgbRsbRgRsmbRgbRgbRgbRgbRgbRgbLgbRibLgbRiRsmbLsbRibRsRsmbRibRsbRgb
RsbRibLsbRiRgRgbLjLoRsRsmbLoLsmbRhRsmbRcbRibRsbRgbRibRibRgbRsbRgbRgbRg
bRsRsmbRgbRsRsmbRgRsmbRsbRgbRgbRsbRgbRsRsmbRebRobRibRgbRibRgbRgbRgRsmb
RgbRgbRgbRgbRsbRgbRsbRibRsbRgRsRsmmbRsbRsbRgbRobRsbRgbRgbRsbRgRsmbRsbR
gbRsbRsbRgbRgbRsbRgbRgRsmbRgRsmbRgbRgbRgbRgbRgbRsRsmbRgbRiRgLsbRgRsmbR
sbRgbLobRgbRgbRgbLcbLiRsbRgbRcbRgbRgbRgbsbRgbRgLsbRsLsbLgLsbRsbRsbRgbR
sbLsbRsbRsbsbRgbRgbRsbRgbRsbRgbRiRsmbRibRsRsmbRjbLsbRgbRsbRgbRgbRsbRgb
RgbRgbLcLibLsbLgbLsLsmbRjbRsbRsRsmbRgbRsbRsLsbRgbRgbRibRgbRgRsRsRsmmmb
RjbRgRsmbRgbRjbRgRsmbLsbRibRsbRgbLsRsbRgbRsRsmbRsbRsbLobLgbLgbLgbLgbLg
bLgbRcbRibLsRsLsbRsRsmbRgbRgbRgLsbRgbRsbLsbRsRsmbRibRsbRsbLsLsmbRgbRgb
RsbLjbLcbLiRsbLgbRcbRibLjbRibRgbLjbLcbLsRcRsmbRobLibRsbRiRsmbRibLsbRgR
smbRsRsmbRgbLsLsLsmmbRibLgbRibLsRsLsbRibRsbRgRsmbRsbRibRgbRsRsmbRgRsmb
RgbLsbRgRsmbRgbRgbRsbRgbLjbLoLsmbRebLsRcbRibLgbLhbRjbLcbRebRoRsmbLibLj
bLiRsbRobRgRsmbRsbRgbRsbRibLsLsmbRiLsRsbRsRgRsmbRgRsmbRsRsmbRsbRibLgbR
hbLibRibLsRsbRgbRsbRgRsmbRgbRgbRsLsbRgbRsbRsbRgbRgLsbRgbLgLsbRibLgbRib
LsRsbRgbRgbRsbRgLsbRsRsmbRsbRsbRsbRgbLsbRsbRsLsbRsbRgRsmbRgbRgRibRgbRg
RsmbRgbLsRsbRgbRgbRsbRgbRgbLsRsbRsRsmbLsRgbLgRsbLgbLhbRcbLjbsbLibRebRi
RsmbLsbRibLgbRibLjbRibLgbRebLibRjbRsRsmbRgbRsbRgLsbRsbRsbRgbLgbRibLsbR
gbRsbRiRsmbRjbRgbRgbRgbRsbsbRgbRgbRgbLsRsbRgbRgbRsbRsbRgbRsLsbRjbRsRsm
bRjLsbRsbRsLsbRgRsmbRsbRsRsmbRgbRsbRgbRsbRsbRgRsmbRgbRsLcbRcbRibRsRsmb
RjbRgbRgRsmbRgbRgbRibRgbRgRsmbRsbRgRsmbLjbRsRsmbRhbLibLcbRebRhRsLsmbRg
RsLgmbRcbRhbLgRsRhbLgRsbRibLsbRgLsRsbRsRsmbRibRsbRgRsmbRgbRgbRgRsmbRsR
smbRgbRgbRgbRgbRgRsmbRsbRsbsbRsbRsLsRsbRgbRgbRsbRsbRsbRgbRgbRgbRgbLsbR
gRsmbRsbRgbRsbRgbRgbRgRsmbRsbRgbLsbLcbLibLsLsmbLgbLgbLsbLsbLjbLsbRgbRc
bRjbRsRsmbRsbRgbRgRsmbRsbRsRsmbRsbRsbRsbRgbRgRsmbRsRsmbRgbRgbRgbRgbRsb
RgbRgRsmbRgbRgRsRsmmbRsRsmbRgbLsbLsRsbRgbRgRsmbRsbRgbRsbRsbRgbLsbRibLs
RsbRgbRgbRsLsbRgLsbRsbRibRgbRsbRsRgbRsLsbRgRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bLgbLsbLsbLgbRgLsbLgbLjRsbLgbLibRjbLibLibRcbLibLgbLibRsRsLsmbLiLsbLsRi
bLsbLibLibRsbLibLibLgbLsbRibRhbLgbLibLibLsbLibRgbRjbLjRsbLibLsbRsbRsbR
sbRsLibRsbLgbRjLsbLibLibRgbLibsbLsbLgbRjbLhLsbLgbLgLsbLgbRgbRsbRgbLgbL
iLsbLibLgbRgbLibLgbRhbLibRjbLcbRcbLcbLibRjbLibRsLgbRgbRgbLhLsbRjbLcbLi
bLibLgbLsbRibLibLsbRiRsmbRibLjbRibLgbRgRsmbLsRsLsbsbRsbRgbLsbRsbRgbRsb
RgbLsbRhbLjLsmbRibLjbLibRsbLibLibLgbRgRsmbRibRgbRgbRgRsmbRgbRsbRsbRsbR
sbRsbRsbRsbRsbRgbRsbRsbRsbRsbRsbRsbRsbRgbRsRsmbLsbLjbLibLhLsbRcRsmbRib
LjbRibLjbRibLjbRibRhRsmbLjbRhbLcbLcbLibRgbLibLibRhbRhbRibRsbRiRsmbLjbR
ibLjbLibLgbRsbLgbLgRsbLibLgbLgbRsbLgbLgbsbLsbsbRsbLgbRjbLsbRcbRgbRibLs
bRgbRgbRsbRsRsmbRsbRsbRgbRsbRsRsmbRsbRsbRgbRgRsmbLsRsRsmbRgbLsRgbRgbLg
bRsbRgbLsbRgbRgbLjbRibRiRsmbRcbLjbRibLgbRgbLsbRgRsmbLsbRgbRsbRsLsbRsbR
gbRsLsbRsbRgbRsbRgbRsbRgbRsbRsbRsbRsbRsbRsRsmbRsbRsbRsbRsRsmbRsLsRsbLs
bLjbLiRsbLibLgbLiRgbRgbLsbRgbRgbRsbRsbRsbRgbRsbRgbRsbRgLsbRsbRsbLsbRgb
LgbRgbLjbRgbLgbsbsbsbRsRjbLhbLobRjbLgLsbLjLsmbLiRsbRjbLjbRjbLhbRibRibR
jbLsbLebLibLsbRsRsmbRjbRibLhLsbLjbRibLibRcRsmbLjbRibLjbRjbsbRcbRgLsbRg
bRsbRsbLhbLibLcbLhbLibRsbsbRsbLjbRibLiRsbRcbRcbLjbLjbRjbRgbRjbLgbRjbRs
bRsbRsbRgbRsbRsbRsbLsbRsbRgbRgbLjbRibLgbRibRibRsbRsbsbRsbRjbLjbLjbRcbL
jbLhbRcbLjbLhLsbLiRsbRjbLjbRcbLjbRcbRibLibLibRibLjbRsbRcRsmbRsbLsRibRi
bLhbLhbRhbLibRebRcbLibRgbRjbRgbRsbLgbRjbLhLsbLibRjRsmbLibLibLjbLibRjbR
ibRgLsbRsbRgLsbRsbRgRsmbRgbLsbLjbLiLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bLgbRjbRcLsbRgbRgbLjbLibRgbLibRsbLgbLsbLgRsbLsbLgbLsbLsbLgbLsLsmbLgbLs
bLgRsbLsLsRsmbLgbLsLsmbLgbLsbLgbRgbRjbRcbLjbLibLiRsbRiRsmbRjbRhbLhbLjL
smbRgbLgbLiLsbRgbLibRsRsmbLgbLsbLgLsLsmbLgbLgbLgbLgbLsLsmbLsbLgbLsbLgb
LsLsmbLgbsbsbRjbRjbLsLjbLiLsbRcbRibLjbRiLsbRgbRiRsmbRgbRgRibRgbLsRibRc
bRhbRibRibLjbLhbLgbLibLibRgbLibLgbRgRsmbLibRsbLibLsbRsbLgLsbLgbLsbLgbL
sbLgLsbLgbLgbRsRsmbRgbLibLibRjbLjbRgLsLsLiLsmbRgLsbLgbLsbRsLgbRsbLgbLs
LsmbLgbLgLsbLsbLsbLsbRjbRibLcbLcbRibRgbLibRsbLibLibRiRsmbRgbLgLsbLgbLg
bRsbLgbLgbLsLsmbLsbLgbLsbLgbLgLsbLsbLsbRsbRsbLsbLgbLgLsbLsbLgbRjbRhbLj
bLsLhbRjbLcLsmbRgbLgbLgbRsbLgbRgLsbLsLsmbLsbLgLsbLsRsbLsbLsbLsLsmbLgbL
gbLgbLsRsbLgbLgbLgbLsbLsbLgRsbRcbLcbLibRiRsmbLibLgbLgbLsbLgLsbLsbLgbLg
LsbLgbLsbLsbLsbLsbLgbLibRhbLsbRhbLcbLiLsbRibRsRsmbLiLsbRsbLgLsLsmbRsbL
gRsbLgbLgbLgbLgbLgbLsRsbLsLsmbLgbLgbLgbLsbLgRsbLgLsbLgbLgbLsbLiRsbLsbL
gbLgbLgbLgRsbLgbLsbLgbRsbRjRibRgbLibLgbLiLsbLsbLgbLsbLgRsbLgbLgbLgbLsb
LgLsbLgbLgLsbLgbLgbLgRsbLgbLsbLgLsLsmbLgLsbLgbLsLsmbRsbLibLgbRibLibRjL
sbLibRsbLgbLgbLsRsbLgbLgbLsbLgbLsLsmbRsbLibLsbLgbLsbRsbLgbRjRjbLibLgbL
gbLgLsbLgbLgbLgbLgLsbLgbLgbLgbLgRsbLgbLsbLsbLgbLsLsmbLsLsmbLsbLgbLsbLg
bRgLsbRcbRcbRibRgRsmbRsbRgRsmbRgbLcbLibLsLsmbLsLsmbLibLsLsmbLgLsbLgbLg
bLgbLgbLgRsbLsbLsbLgLsbLsbLibRcbRcbLcLsmbRgbLibRsbLgbRsbLgbLsbLsLsmbLs
LsmbLgLsbLgbLgbLgbLgbLgbRsRsmbLgbLgbRcbLcLsmbLibRibLibLgbRibLhbLiRsbLs
LsmbLsbLgLsbLgbLgbLgbLsbLsbLgbLgLsbLgbLsbLsbLgLsbRebRiLsbLjbLibRsbLgLs
bLgbRsbLiRsbLgRsbLgLsbLgbLgbLgbLsbLgbLgbRjbLibRjbRibRgbRgbLcbLibLsbLib
LgbRgbLibLsbLsbRsLsLsmbRobRsbLgbLgbLgbLsbLgbLgLsbLsbLgbLgbRjbLcbLibLgb
RiLsbLgbLiLsbLgbRgbLibLgbLgbRhbLibLgLsbLsbLgbLgbLsLsmbLsbLsbLgbLgbLgLs
bLgbRsbLgbRjbRcbLjbLiLsbRsLsLsmbLibLsbLgbLsbLsLsmbLgLsbLgbLgbRibsbLibR
ibLibRsbLgbLgbLsbLgbLgRsbLsbLgLsbRgbLiRsLsbLibLgbRibLsLebLsbLibLjRsbRi
bLhbLgbRsLsbLibLgbRgbLiLsbLgbLgLsbLsbLgbLgbLgbLsbLsbLgbLgRsbLgbRebLibL
ibLgLsbLsbLsbLsLsmbLgRsbLgbLsLsmbLgbLgbLgLgbLgbRibLibLgbLgbRibLgLsbLib
LsbLgbLgbLgbLgRsbLgLsbLsbLgLsbLsLsmbLgbLgbLgbLsbLsbLgRsbLgbLgbRcbLgbLg
bLgRsbLgbLgbLgbLsbLgbLgbLgbLgLsbLgbLsbLsbLgRsbLgLsbLsbLgbLgbLgbLgbLgbL
gbLsbLgLsbLgLsbLgbLgbLgbLgbLsbLsbLgbLsLgbLgbLgbLgbRsLgbLgLsbLgbLgLsbLg
bLgbLgbLgbLsbLgbLgLsbLgRsbLsbRsLgbLgLsbLgLsbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bRsRsmbLsRsbRgLsbRgbRsLsbRgbRsRsmbRsLsbRgbRgRsmbRgbRgbRgbRsbRgbRgbRgRs
mbRgbRiRsLsRsmbRiRsmbRibRgbRgbRgbLobLibLgbLgbLibRhbLsbRcbLjLsmbRiRsmbL
sbRgbRsbRsbRgbRgbRsbRgbRgRsmbRgbRsRsLsRsmbRgbRgbRgbRsbRgbRgbRgbRgbRgRs
mbRgbRgbRgRsmbRgRsmbLgbRibLibLhbLibLgbLibRjbRcRsmbRibRibLsbLibRiRsmbRi
bRgbRibLgbRibRibLgbLibLcbLgbLgbLgbLgbLgbRibRiRsmbRsRibRsbRgRsRsmmbRsbR
sRsmbRsbRsbRsRsmbRsbRsRsmbRsRsmbRgbRsRsLsmbRgRsmbRgbRgRsmbRgbRgbRgbRgb
RgRsmbRgbLgbRgRsmbRgbLiRsbRsRibRgbLgLsbRhbLjRsbLjbRsbLgLsbLgbLgbLsLsmb
RsLgRsbRjbRobLjLsLsmmbLibLibRjbLiRsbLibRsbLibRsbLibRjRsmbRobRgbRgbRsbR
sbRsbRgRsRsRsRsmmmmbRgRsmbRgbRsRsmbRgbRiRsRiRsmmbRgbRgbRibLcbLiLsbLgbL
ibRjbRcbRibLgbRsbRibRibLiRsbsbsbRcbRgbLibRibRgbRibRgbLsLsmbRjRsRsmmbRi
bRibRgRsmbRgRsmbRibRgRsmbRsbRgRsmbRsRsmbRsRsmbRgRsmbRgLsbRgbRgRsmbRiRs
mbRgbRgbRgRiRsRsmmbRgRsRsmmbLsRgRsmbRgbRgbRgbRgRsmbRgbRgbRibLibLcLsmbL
gbLgLsbLgbRjbRcbLsbRiRsmbRgRsRsmmbRgRsmbLsbRsRgRsLsmbRsRsmbRgRsmbRgRsm
bRsRsRgmbRgbRgbRgbRgRsRsmmbRgbRgRsmbRsRsmbRiRsmbLobLsbLgbLgRsbRgbRsbRg
bLjbRcbLhbLhbLibLgRsbRcLsbRibLjbRibRgbRgbRsbRsbRsbRsRsmbRgbRgbRgbRgRsm
bRgbRgRsmbRsRsmbRgbRgbRgbLhbLhbLiLsbLibRcbRcbRsbRsbRgbRgbRsbRsbRgbRgbL
sbRgRsmbRgbRsRsmbRsbRgbRgbRsRsmbRgbRgRsmbRsRsmbRgbRsbRgbRsbRgRsLsmbRgb
RhbRgRsmbRgRsmbRgbRgbLcbLhbLgbsbLgbLiRsRsmbRhbRibRgbRsRsmbRgbRsbRgRsmb
RgbRgbRgRsmbRgbRgRsmbRgbRgbRgbRsbRgbRsRsLsmbRsbLcLsLimbLsbRoRsmbRiRsmb
RsbRsRsmbRsbRgbRsbRgbRgbRgbRsbRsbRiRibRgbRgbRgbRgRsmbRgRsLsmbRgbLsLsmb
RgbLsbRiRsmbRsRsmbRgRsmbRsbRsbRgbRsRsmbRiRsmbRgbRgbRgRsmbRgbRsbRgbRsbR
sRgbRoRsLcmbRobLgbRsbLjbRsbRibRsRsmbLgbRibRsRsmbRgRsmbRgLsbRsRsmbRsbRs
RsmbRgRsmbLgbRiRsmbRibLgbRibLgbRibRsbRsRsmbRgRsmbRsLsbRgRsRgLsmbRgLsbR
sRsmbRsbLibLibRjbRebLiLsbLgbLgbRjbLhRsbRcbRjbRiRsRsmmbRgbRgbLibRiRsmbL
sbRjbRsbLcbLgLsbLgbLsbLjbsbRgbRcbRjbRgbRsRsmbRsbRgLsbRsRsmbRsbRsRsmbRs
bRjbLsRsbRsRsmbLcbLibLgbLjbRsbsbRsbRcbRibRsbRgbsbLgbLgbLgbLgbRebRgbLsR
gbRsbRsbRgRsmbRsbRsbRsbRgbLcLsmbLgbRjbRhbLjbRhbLcbLibLgbLgbLsbLsbRsbRs
bRgRsmbRgbRsRsmbRsbRgbRsLsbRsRsmbRjbLebLibLsbLjbRibRgbRsbRgbRsbRsbRsbR
gLsbRgbRgbRsbRsbRsbRsRgRsmbRgRsmbRgbRgRsmbRgLsbRsbLcbLcbRjbRcbLjbLhbLg
bRsLgbLsbLsbRebLibRgLsbRgbRgbRibRiRsRsmmbsbRsbRsbRgRsmbRibLobLhRsbRgLs
bLhbLgRsbRsbRjbRhbRibLcbLgbLsLsmbLsLsmbLgbLsbLsbLgbRebRsRsLsmbRsRsmbRg
RsLsmbRgbRgbRgRsmbLebLgbLgbRhbRcbLibRibRgRsmbRiRsmbLgbRibRgbRgRsmbLcLs
mbLgbLgRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bLgbLgLsbRgbLsbLsbLsbLsbLsbLgbLibLsbLhbLgbLsbLsLsmbLgbLsbLsbLsLsLsmmbL
sbsbLgbRcbRhbLsbRsbRibRjRsmbLgbRsbRsbRgbRgbRgbLsLsmbRibRgbRgRsmbRgbLgb
LhbRibRgbRsbLjbRcbRcbRsbRsbLgbLsbRgbRgbRsbRcbRibRgbRibRgbLibLsbLsbLibL
sbLibLsRsbLsbLsbLsLsRsmbLhbRjbLgbLgbLgbLgLsbRsLsbLsbLsbLgbLsbLgLsbRjbR
cbLebRhbLsbRsbRsbRgRsmbRgbRibLgbLcbLsbLsbLgbLgbRgbLgbLsbLsbLgbLsbRsbRo
bLgbLgbLsLsmbRgbLiRsbRsLsbLiRsbRsRgbLsbLgbLgbRjRsmbRcRsmbLhbLgbRsLsbLg
bLgbLsbLsbLsbLsbLsbLsbLsbRsbLgbLgbLsbLsbLgbRsbLgbLgbLgLsbLgbLgbLsbLgbL
gbLsbLgbLsbLgbLibLhbLibRsbLgbRgbRibLjbLhbRibLibLgbRsbLsbLgbRsbLgbRsRsm
bLgbLgbLsbLsbLgRsbRgRsmbLgbLgbRgbLgLsbLgbLsbLsbsbLsLsRsmbLsRsbLsbLsbLs
RsbRsbLgbLsbRibLgRsbRcbLcbLgbRgbLibLgbLsbLsbLgbLgbLgbLsbLsbLgbsbRobRiR
smbLsbRgbLsbRibLjbRcLsbRiRsmbLsbLgbRsbLsbRgRsmbRhRsmbRsbLsbLsLsmbRibRg
bRsbLgbRibRibRsbLsbLsbRcbRgbRsbLjLsmbLibLgbRsbLibLsbRgbLcbLhbsbLsbLsLs
LsmmbLgbLsbLsbRsbRhbRibRsbLsRsbLsbRgbLgbRibLsbRsbRgbRsbLsbLsbLjbLcRsbL
ibRsbRgbLibsbRsLsbLsbRsLsbLgRsbRsbLsbLgLsbLgbLsbLsbLgbLgbLsbRsbLsbLgbR
sRsmbLgbLgbLsbRgLsLsmbLgbRsbLgLsbLgbLgbLsbLgbLgbLsbLsbLsbLgbLiRsbLsbLs
bLsbLsbLsLgLsbLgLsbRsbLsbsbLgbLsRsbLibLgLsbLsbLsbLsLsmbLgbRsLsbLsLgbLs
bLsbLgbLsLsLsmmbRsRsmbLgbLgbLsbLgbLsbLgbRsbRsbLgbLibLcbRsbLgbLgbRcbRgb
RsbLsbRgbLgbRibLgbLcbLiLsbLsbRsbLibsbLsbLsbLgbLsbLsLsmbLsbLsbLgbLsbLsb
LsLsmbRsbLgbLgbLgbLgbLsbLsbLsbRsbLibRsbLgbLsLsmbLgRsbRsbRsbLgbLgbLsbLg
RsbLgbRgRsmbRibRibLjbRibRgRsmbLsbLsbRiRsmbRsbRgbLsbRibLsbRgbRgbRsRsmbR
sbRsbLebLiLsbRjLiLsbRsbLsLsRsmbLsRsbLsbLgbLgbLsbLsLsmbLsbLsbLgbLsbLgbL
sbLgbLsbLsbLsbLsbLsbLgLsbLgbLsbLgbRsbLsbLgbLsRsbLsbLsbLsbLgbLsbLgbLsbL
sbLsbLgbLsbLgbRsbLiRsbLsbRjbRcbRibRgbRgbRibLsbRsbRgbRsbRsbRibRsbRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bsbLsbRsbRsRsmbRsbRsbRsbLjbLjbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bLibLgbRsbRgbRsbLgbLcLsmbLsLsRsmbLgbLsbsbLsbRsbRjRsmbRsLsLsRsmbLsbLsbL
sRsLsLsmbLibLsbRgRsmbRgRsmbRsRsmbRgRsmbsbRgRsmbRiLsbRsRsmbLgbsbRgRsmbL
sbLjbsbLsRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bRhbRgbRsbRgbRsbRgbLcbLgbLsLsmbRsbLsbsbLsbLsRsbLgbLsbLgbLgbLsbLgbLgbLg
LsbLibRhbLibLgbLgLsbLgbLsbLgbRsbRibRsRsmbRibRgbRibLjbRsLhbLsbLibsbLgbR
gLsbLjbLsbLgbLsbLgbLsbLgbLsLsmbLgLsbLgbLsbLsbLgbRsbRjbRibLjbLcLsmbRibR
jbRgbLcbLsbLsRsbLsRsbLsbLgbLibLibLgLsbLgbLibLibLsbLsbLibLsbLgbRgbLsbsb
LibLsbLgRsbLsbLsLsmbRgbRibLibLibLgbRgbLgbRsbLsbLsLsmbLsbLgbLsbRsbLibRc
bRiRsmbRgbRibLgbLjbLiLsbLsRsbLgbLsbLsbLsbLgbLgbLgbRsbLsbLsbLiLsbRgbLsb
LsbLgbLsbRsbLsbLsbLgLsbRebLibLhbLsbLgbRibLibLsbLsLsmbRsbsbLgbRsbLsbRsL
sbLsbLsbLsbLsbLsbLgLsbLgbRjbLjbLhbRjbLhbLibLsbLsRsbLsbLsbLsbLsbLjbRgbR
cbRibsbRgbLjbsbRcbLibRiLsbRsRsmbRgbLsbRiLsbLibRibLgbRgbLsbRgbLgbRibLgb
RiLsbLibLcbLiLsbLsbLsbLgbLgbLsbLgbLsbRsbLgbLgbLgbRhbRibLiRsbLcLsmbLgbL
gLsbLgbLsbLgbLsbLsLsmbLgbLsbLsLsmbLsbLgbLsLgbLsbLebLgbLsRsbLibRjbRgbLj
bLhLsbLgbRsbRsLjbLgbLsRsbRsLsbLgbLgbRjbLibLgbRgbLibLgbRebRhbLjbsbRibRs
bRgbLgLsbRgbRsbLjbLibLsbLgbLsbLsRsbLgbLgbLsbLgbRhbRcbRibLsbRibLgbRibLj
bLcbLsbLgbLgbLsRsbLsRsbLsbLgbLsLsmbLgbLsLsmbLgbLgbLsbLgbLsbLgbLsbLgbRj
bRsbLibRjRsmbsbLibLsLsmbLgbRsbLsRsbLsbLsLsmbLsLsmbLgLsbLgbLgRsbLgLsbLi
bLgbLgbRiLsbLibLgbRibLhLsbLibRsRsmbRibRsbLsbLibLgbLsRsbLsbLgbLsbLgLsbL
gbLsbLsbLsbLsbLsbLsbLjbLsbRsbLsLjbRsbLibRibRhbRibRsbLgLsbLcbLebLsbLgbL
sbLsbLgbLgbLsbLsbRsbRjbRibRgLsbRgbLcbLiRsbLsbRsbLibLsbLgbLsLsmbLgbLgLs
bLgbsbLgLsbLgbLibLgbLgbRjbLgbLjbRgbRibRhbLgbsbRibRsbRgRsmbLjbLcbLgRsbL
gbLgLsbLgbsbLibLsbLgbRsbLsbLsbLgLsbRjbLsbLibRsbLgbLsRsbLsbLgbLgLsbLgbR
jbRjbRcbLjbLjbLibLgbRsbLgLsbRsLsbLsLsmbLsbLgLsLsmbLsbLgbLsRsbLsbLsbLgb
LgbLgbLsbLsbRsLsbLsbLibRibLsbRcbRibLjbsbRibLsbLjbLibLsbRsbRsbLibRgbLsb
sbLsbsbRsLsbLsbLsbLgLsbLgbLibRibRibLcLsmbLsbLgbLsbLsbLgbRsbsbRjbRcRsmb
RjbRgbLsbRgbLgbRibLcbLgbRsbLsbLsbLgbLsLsmbLsbLjbLsRsbLjbLgbLsLsmbLsbLs
bLsLsmbLsbLibRjbLibRsbLgLsbLsbLgbLgRsbRcbRibRsbRgbLsbRjbLjbLcbRgbLibLg
bLsbLgbLsbLsbLsbLsRsbLsbLsLsmbLsLsmbLsbLsbLsbRsLsbLibRibLibRsbLibRsbLi
bLsbLsbsbRsbLjbLjbRsRsmbLsbLsbRsbLsbRsbRsbLibRjbLibLsbRsbRjbRgRsmbRibL
cbLsbLsbLiLsbLsbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bLgbRsRhbLgbRiRsmbLgbRibLgbRiRsmbLjbRibRgRsmbRsRsmbRgbRibRsbRibLgbRibL
gbRgbRsRsRsmmbRibLgbRiRsmbLgbRiRsmbLgbRgbRsbRgbLsbRgRsRsmmbLsbLebLgbLg
bLsbLgbLgbLgbLgbLgLsbRebRiRsmbRibLgbRibRibRgbLjbLgbLgLsbLgbLsbRcbRibLj
bRhbLgbRibRgbLgbRibLsbRibLgbLeRsbLgRsbLibLgbLgbLsbLgbLgbRcbRiRsmbLgbRi
bRgbRsbLsbRibRsbLjbRibLjbRsRibLgbRibLsbRibLsLsmbRibLsbRibLsbRibRgbRgRs
mbRgbLsbRibRgbLgbLcbLgLsbLgbLsbRcRibRgbRgRsmbLjRsbRibRgbLsbRsbRsbRgbRg
bRgbRsbRsbRsbRgRsLsmbLsbRgbRsbRgbLgbRibRsbLsbRibLgRsRsmbsbLsbRiRsmbLgb
RsbRibLjbLgbRcbRgRsmbRgbRgRsmbRsbRgRsmbRgRsmbRgbRsRsmbRsRsLsmbRgbRgbRs
bsbRgLsbRsbRgbRgbRgbRgRsLsmbLjbRibLgbRiRsmbRgbLgbRgLsbRgLsbLcbLgbLgRsb
LgRsbLsbLgbLgRsbLsRcbRsRgRsmbRgRsRsmmbRgRsmbRsRsmbRsbRgbRgbRgbRgRsLsmb
RgRsmbRsbRgbRsRsmbRsbLsbRsRsmbRgbRsRsRsmmbRgbRgRsmbRgRsmbRsRsmbRiRsmbL
gbRgbRsbRgbRgbRsbRgbRgRsmbRsbRsbRgRgbRsbRgRsRsmmbRgbRgbRgRsmbRgbRgbRsR
smbRsbRgRsmbRgbRgbRsbRgbRgRsmbRgbRsbRgbRsLsRsbLjbLibRcLsbRibLsbRibRgbR
gbLsbLsbRiRsmbRsRsLsmbRgbRgLsbRgbRsbRgRsmbRgbRgbRsbRgbRgRsmbRgbRgRsmbR
gbRgbRgRsmbRgbLsbRsbRgRsmbRgbRgbRgbRgbRsbRgbRgbRsbRsbRgbLsRsRsmbRsbRgb
RgbRgbRgbRgbRgbRgRsmbLsbRibRgRsmbLgbRibRsbsbLgbRibLgRsbRgbRgRsmbRgbRgb
RsbRgbRsbLsbRgRsmbRgbRgRsmbRsRsmbRgRsmbRiRsmbLjRsbLjbLhbRebRiRsmbsbRsb
RgbRibRgbLibRibRgbLgbRibRsbRgbRgbRgbRsbRgbLjbRsRsmbRhbLjbRhbLgbRibRsbR
gbRgbRsbRgbLsbRgbRgRsmbLgRsbRibRgbLgbRibRgbLibRibRibLgbRibRgRsmbLjbLob
LibLgbRjbRcbRgbRgbRgbLgbRibLgbRibsbLgbRhbLgbsbRcbLgbLcbLgbRcbRibLgbRib
RgbRsbRgbLcbLibLgbLgbLgRsbRebRiRsmbRibLgbLibLiLsbRcbRiRsmbRsbLsbRibLiL
sbRiRsmbLgbRibLjbRhRsmbLgbRibLgbRibLsbRibRgRsLsmbRgbLgbRibLgbRibLgbRhb
LiLsbRhbLsbRibLgbRibLgbRiRsmbRgbLibLjbLibLgbLgbLsbLgbRobRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bRsbLibLgLsbLgbLgLsbLgbLgbLibRsbRgbLibLiLsbLsLsmbRsbLgbLsbRsLsbLgbLsbL
sbRsbLcRsbRibLgbLjLsmbRjbRsbLibsbLsbLsbLibLsbLibLsbRgbRhbRcbRgbRsRsmbR
sbRjRsmbRsbLsRsbRgbLibRgbLjbLgbLhbLsbLsbLibRjbLgbLibRgbRgbLibLsbLsbRib
LibRgbRsbsbRgbRgRsmbLgbRibLsbLibLobLiRsbLsbLsbLsLsmbRgbLhbLsbLgbRjRsmb
LibLgbLsbRsRsmbLibLsbRsbLgLgbLsbLibLsLsmbLsbLsLsmbLsbLgRsbLibLsbRgbRgR
smbLibLsbLgbLibLibLibLsbLgLsbLsbLgbLsLsmbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bLsbRcRsmbRibRsRsmbRsbRgLsbRgbLjbRibLebLibRgLibLsbRgbLgbsbLsbRsbLjbRsL
sbLsbRsbsbsbLsbLsbLgRsbRgbLibRcbRhbRhbLsbLhbLgbLsbLgbLsbLsLsmbLsbLsbLs
bLsbLgbLgbRgbLibRgbLibRgbLibRgbLibRgRsmbRsbLsbLsbRsbLsbLsbLsbLgbLsbLgb
LsbLsbLsLsmbLsbLsLsmbLsbLgbRgbLgRsbLcbRibLcbLcLsmbRgbLsbLgbLgbLgbLibRs
bLgbLsLsmbLgRsbRgbLibLsbLgbRgbLibRgbLibRgbLjbRsLsbLsbLjbLsbLibRgbLhbRg
bLibRjbLibLgbRgbLibRsbLgbRjbLgbLsbLibLsbLibLsbLsbLsbRsbLsbLsbLgbRsbLib
LsbLsbLsbLgLsbLgbLibLibRibLibLgbLsbLsbLgbLsbsbsbLsbLiLsbRsRsmbLsbLgbLg
bLsbLsbLgLsbRsbLgbLsbRgbLibLsbLsLsmbLsbLsbLsbLgbLsbLjbsbLsbLsbRjbsbLgR
sbRgbLibRgbLibRsbLgbLiLsbRibLibRgbLibLgbLjbRibRgbLibRsbLgbRsbRgbLibLgb
LgbLsbLgbLgRsbLsbRgbLibRgbLibRgbLibRsLsbLgbRsLsbLgbLjbLsbLsbLsLsmbsbLs
bLjbLsbLsbRsbRsbLsbRsbLgbLgbLgRsbRjbLibRsbLgbLgbLsbLsbLsbRgbRjbRibRibL
gbRibLgbRgbRgRgbLgbRibRibLsbLcbLgbLgbLgbRibLibLgRsbRgbLsbLibLsbRgbLibL
gbLsbLsbLgbLsbLgbLgbLgbLgbRgbLgbRsbLibRgbLibRgbRsLibRgbLsbRgbLibRgbLib
RsbsbLsbLgbLsLsmbLsbLgbRsbLiRsbLgbRgbLgbLgbLgbRgbLibRgbLibLgRsbRgbRjbR
ibLsbRgbLsbRgbRibRgRsmbLjbLibLibRibRgLsbLgLsbLgbLsLsmbLgLsbLgLsbLsbRsb
RcbRibRiLsbRgbLibLcbLsbLiLsLsmbLgbRgbsbLsbLjbRsbLsbLibRgbLibRgbLibRgbL
ibLgbLsbRsbLgbRgbLgLsbLgbRsbLsbRsLsbLgbLsbLsbLsbLsbLsLsmbLsbLsbLgbRsbL
sbLsLsmbLsbLsbLsbLsLsmbLgbLsLsmbLgbLsbLgRsbRgbLgbLgbRjbRcbRgbRgbRsLsbR
gbLcbLibLsbLgbLsbLsLsmbLsbLsbLsbLsbLsbLsbLsbLsbLsbRsLsbRsLsbLgbRgRsmbL
jbLsbRsbLsbRsbLgbRsRsmbLgLsbLsbLgbRsbLgbLgbRsbLjbRcbRcbRsbLjbRcbRibLgb
LjbLcbLgbLsbLsbRsbLibRsbLgbLsbLsbLsbRsLsbRsLsbLsbLsLsmbLsbLsbLgbLjbLsb
LsLsmbLsbLsbRsbLgbLibLgbRhbRcbRibRsbLgbLebLgbLsbLgLsbLsbLsbLgbLgLsbLgL
sbRsbRiLsRoLsbLcLsmbRgbLhbLibLibRsbLibsbLsbLgLsbLjbLsbsbLsbLsbLsLsmbLg
RsbLsbLgbRcbLjbLgbLibLgbLgbRgbLibLgbRiLsbLibLgLsbRibLhbRibLibRjbLibRsb
RibRsbLgbRgbRgbLcbLibLsbLsbLgLsbLsbRgbRgbLjbLsbLsbLsbLsbLsbLgbLsLsmbLs
bRsbLgbRsbLgbLgbLgbRjbRjbRibRibLsRsbLsbLhbLgRsbRsbLibRsbLgLsbRsbLibRjb
RcbRibRgbLsLsmbRsbRgbLcbLgbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bRibRsbLjbLcbRjbRjbRsRjbRibRgbRibRibLibLebRgLsbLgbRibLsbLiLsbLgbRgbLeb
LibsbRiRsmbLiLsRsbRgbRgbLhbLibLsLsmbLibRibLhbLiRsbLgbLsLsLsmmbLibLsLsm
bLsLsLsmmbLsbLsbRsbRgbLebLsRsbsbRibLhbLsLsmbLgLsbLiRsbLibLjbRebRcb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 25; Drug: Control Apo 0.5 然
bRsbRsbRsRgbRgbRgbRsbRgbRgbLsRibLhbLcbRibLjbRiRsmbRgRsmbLgbRibLsbLgbRi
bRgbLibRibRgbRgbLibRibRibRgbLibRibRgbLsbRibRgbRcRsLiRsmbRibRibLibRibRg
RsmbLibRiRsRsmmbRsbRgbRibLgbRibRsbRgbRsbRsbRsbRgbRgbRsbRsbRsbRgRsmbRsb
sbRsbRsbRgbRgbRsbRgbRsbRgbRgRsmbRsbRjbLgRsbLgbRcbLibLsbLsbRjbRsbLjbLcb
LhbRibRcbRibRgbRsRiRsmbRgbRgbRgLsLsmbRgbRsbRsbRgbRgbLsbRsbLjbRibsbRsbR
sRiRgbRgbRgbRgbRgbLsRgbRsbLgbRgbLibRhbRgRsmbRsbRgbLibLcbRjbRcbLsbRgRsm
bRgRsmbRibLiRsbRibRgRsRgmbLsbLjbRibRgRsmbRgbRgbRgbLibRiRsmbRgbRsbRsbRg
bRgbLgRsRsLsmbRgLsRsbRibRgbRgbRsbLibLiRsbLhbRhbRcbRgRsmbRgbRsRsmbLsbRs
bLgRsbsbRsRcbLibRiRsmbRsbRgRsmbRsbRgbRgRgRsLsmbRsbsbRgbLibLjbRhbRibLgb
RgRsmbRgbLibRibRgRsmbRgbLibRcbLibRibRgbLibRcbLibRgbLgbLjbRibRgbRsbRgbR
gbRgRsmbRsRsmbLsbRsRsmbLsbRsbRgbRsbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbLsbRi
bLibRibRibLibRibRgbRsbRsRsmbRiRsmbRgbLsbRibLsbRsbRgbRsbRsbRgbRgbLjRsbR
ibRgbLibLsbRgbRgbLibRibRgbLibLiLsbLibRsbLgbLgbRsbLgbLgbRjbRcRsmbRgRsmb
RgRsmbRsRsmbRsbRgbRsbRsbRsbRgbRsRjbRgbLsLsmbRibLibRiRsmbRibRgbLjbRiRsm
bRgbRsbLsbRgbRgbRgbsbRgbRgRsmbRgRsmbRgbRgbRsbRsbLsbRsLsbLgbLibRibRiRsm
bRgbRgbLibLibLcbRhbReRsmbRibRsbRgbRsbRsbRsbRsbRsRsRsmmbsbRsbRgRsRgRgmb
RgLsRgbRsRsmbRgbRgRsRsmmbRgbRgbRsbRsRsmbRsRsmbRsbRsRsRsmmbRsbLjbRibRgb
RgbRgbRgbRsbRjbRsLjbRgbRgbRgbRgbRgbRsbRgbRgbLsbRsRsmbRgbRgbRsbRgbRsbRs
bRibLiLsbRebLsbRibLgbLjbLhbRsRcbLibLcbRjbRcbRcbLibRsbRibRgbLibLcbLibLs
bRgbLibLgbRhRcbRgbLgbRsbRibLjbRgbRsbRgRsmbRsbRsbRgbRgbRsbRgbRibRgbRgbR
gbRgbRibRgbLibRgbRibRsbRibLsbsbRsRsRsmmbsbRsbLsbLsbLgbRjbRsbRgRsmbRsbR
gbLgbRjbLgbRgbLsbRsbRgbRsbRgbRgbRsbRsbRsbRsbRsRsmbRsbRgRsmbRgbRsbRgbRs
RsmbRsbRgbLjbRibRibLhbLcbRcbRhbRsbLibRhbRsbRgbRgbRibRgbRgbRgbRsRsRsmmb
RsRsmbRsbRgbRgRsmbRsbRgbRgbRgbRgbRgRsRsmmbLsbRsbRgbRgbRgRsmbRgbLcbLjbL
cbLsbLibRhbRibLibRcbLsbRsbRibLgRsbRibRgbRgbRsbRgbRgbRsRsmbLsRgbRsbRgbR
sb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 26; Drug: Control Apo 0.5 然
bLsbRibLsRgbRgbRgbRgbRgRsRsmmbLjbRibRsbRgbLgbRibLjbRiRsmbRgbRsbLgbRsRh
bLiRsbRibRsRsmbLibRcbLgbLsLsmbRgbRibRsbRsbRgRsRsmmbRgbRibRgRsmbLsbRibR
gRsmbLgRsbRiRsmbRgRsRsmmbLsbRiRsmbRsbLgbRgbLsbRgRsmbRsbRgRiLsbLcbLiRsb
LsbLibLgRsbLsbLsbLhbLibLsbLgLsbLhbLibLibLibLibLsbRsbLsbLcLsmbLcbRjbRcb
RsbRgRsmbLsbRibRsbLgRsbRiRsmbLsRsRsRsmmbRsRsmbRgRsmbRgbRgbRgbRsbRgbRsb
RgRsmbRibLgbRgbRgbLsRsbLgbRcbLibRiRsmbRgRsmbLgRsbRiRsRsmmbRsbRsbRgbRsR
smbRsbRgbRibLgRsbRibRgbLsbLgbLcbLibLibRjbRcRsmbRgbRsbRgbRgbRgRsmbLsbLi
bLsRcbRhbLsbLsbRgbRgbRgbRcbLsLgbLsbRgbRibLgbRhbLsbRgbLsRsbRsbRibRsRsmb
RgbRsbRgbLsbRgbRsbRsbRgRsmbRgbRgbRsbRsRsmbRgbRgbRsLsbRsbRgbRgbRgbRsbsb
LcbLibLhLsbRjbRibRcbRgbRsRsmbRsbRgRsmbLsbRgRsmbRgbRsbRsbRgbRsbRsLsbRgb
sbRsbsbRsbRgbRgbRgbRgbRgbRsbRgRsmbRgbRgbRsbRgbRgRsmbRsbRjRsmbRgbLsRsbL
ibLhbLibRjbLebRjRsmbRcbRibRsbRgbRsRsmbRsRsmbRgbRsbRgbRsbRgbRgbRsbRgbRg
bRsRsmbRgbLjbRibRgRsmbLsbRibRibLibLsbLgbLibRjbRhbRiRsmbRsLsbRgRsmbRgRs
mbRsRsmbRsRsmbRibRgbRsbRgbsbRgbRgRsmbLcbLibLiLsbLebRgRsmbLsbRsbRhbRgbR
ibRgbLgRsbRibLjbRcRsmbRsbRibRsbLgbRsbLgbLibRcbRobRgbLsbRgRsmbRgbRsbRib
RgbLibRibRsbLsbRibRsbRgbRsbRgbRgbRgbRsbRsbRgbRsbRsbRgbRsbRsbRgbLsRsbRg
bLgRsbRibLsRsbLsbRibRgbRgbsbRsbRgbRsRsmbRgbLgbRgRsmbRsbRsbRgbLgbRsbLgb
RibLgbRiRsmbRgRsRsmmbLsbRgRsmbRgbRsbRgbRgbRgbLcbLibLibLebLsbLsbLsbRhRs
mbRibLiRsbRgRsmbRgbRsRsmbRgbRsbRgbRgbRsbRgbRgbLjbRibRgbLibRiRsmbLibRcb
LgbLsbRgRsRsmmbRibRsbLgbRibLiRsbRibLjbLcbRjbRcbLsLsmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 27; Drug: Control Apo 0.5 然
bLibLibLsbRsbLibLsbLsLsmbRjbLibRsbLgbLsbLgLsbLgbLsLsmbLibRibRibRibLjbL
sbLebRgbLhbLgbRibLibLsbLgbRsLsLsmbLsbRsbLibLgbLsbLsbLsbLgbRjbLjLsmbLsb
RgbRsbLiLsbRjbLibLgLsbRsLsbLibRgbLibLibRsbLgbLsbRsbLsbLsbLsbRsbLgbRsbR
sbLibRsbLgbLsbLgbRgbLgbRsbLgbLsRsbRjbLibRgbLibLgbRgbLibRsbLgbLsbLgLsbR
sbLgbLsbRsbLsbLsbLgbRsbLgbRsbLgbLgbRsbsbsbLgbLgbLgbsbLsbRsbLgbRibLibRg
bLiLsbRgbLibLgbLsbLsbLsbRsbLgbLgLsbRsbRsbLsLsmbLgbRgbLsbLsbLgbRsbLsLsm
bLsbLgbRjbRiLsbRibLjLhbLgbLsbLsbLiRsbLsbLgbRgbLibRgbLgbLgbLsRsbLgbRsLs
bRsbLsbsbRgbLgbLsbRsbLsbLsbLgbLsbLsbLgLsbLsbLsbLsbLsbLsbLsbLsbLgbRjbRh
bRgbRibLjbRcbRibRhbRgbLsLsmbRibLjbLibLibRjbRcbRiLsbRiLsRsbRgbRgbLsLsmb
RgbLgbRibRibRibRgLsbLsbLsbLgbRgbLsbRjbRgbRcbRhbLgbRsbLibRibLjLsLsmmbRi
bLebLhbRgbLjLsmbLsbRgbLiRsbLgbRsbLgbLibRsbRgLsbRibRgbRibRcbLiLsbRgbRib
LgbLhbLibLgbLibRjbLibLibLsbRgRsmbLsbLgbLsbLgbLgRsRsmbRjbLjbRsbLibLgRsb
LsbLgbRgbLibLgbRgbLiLsbRsbLgbLsRsbLgbLgbLgbLsbLsbLsbLsbLsbLsbRsbLgbLgb
RsbLsbRjbRsbRgbRoLsbRebRibLibRibRibRgbRsbRjbsbRsbRsRsmbLjLsmbRgbRgbRib
RibLjbLhbLiLsbRsbLibRgbLjbsbRsLsLsmbLsLsmbLsLsmbRsbRsbLiLsbLsRsbLsbLsb
LsbLgbLsbRsbLsbLsbLgbRsbRsLgbRsbLsbLsbLsbLsbLsbLsLsmbRjbRibLiLsbLibRsb
LgbLgbLsbLsbLjbLsLsmbRgLsbLgbLsbLsLsmbLsbLsbRsbLgbLgbLsbRsbLiLsbRibLeL
sbLgbLgbLsbRsbRgbLibLgbRgbLgbRsbLjbRsLsbRsLsbLibsbLsbLgbRsbLgLsbRsLsbL
gbRgbLgbLgbLibLibLgbLibLiLsbRiRsmbRgbRjbRgbRgbLgbRgbRibLcbLiLsLsmbRsbL
gLsbLgbRjbLibRsLsLsmbLibRgLsbLgbRsbLsbLsbLgbLsbLsbLsbRsbLgbLsbRsbLgbLs
bRsbLgLsbRsbLgbRsbLgbRjbLibRhRsmbRiRsmbLhLsbLgbLgbRsbLgbLgbRsbLsbLgbLs
bLgbLsLsLsmmbLsLsmbLsbLsbLsLsmbLgbLsbLsbLsbLgbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 28; Drug: Control Apo 0.5 然
bRjbRibRsLsbRsbRsbRsbRsbRsbRibRibRsbsbLjbRibLjbRsRsRsmmbRgRsmbLsRsRsmb
RsbRsLsbLibRjbRsRsmbRgbLgbRjbLgbRibRsbLgbRgbRsbLgbRibLiLsbLsLsmbRsbsbL
hbLibLgLsLsmbRsbLibLsbRgbLibLgbLgbLsLsmbRsbRibRsbLjLsmbLsbLsbRsbRgbLib
LsLsLsmmbRgbLibLgbRgRsmbRjbLibLhbRsLsbLgbLibLgbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 29; Drug: Control Apo 0.5 然
bLsLsmbLgbLgbRibLebLibRsbRsbLibLsbRsbLgbLsbsbLgbRjRsmbRcbRibRgbLiLsbLi
bLhbLgbRgbRjbRibRibLsbLgbLgbLsbRjbRibRgbRgbLgbRibRsbRgbRibLsbRsRsmbLgb
LsbRsRsmbRsRsmbRsbRgRsmbRsbRgbRsbRsbRsbRgbLsLjbLibLgbLgLsbRibRibRgbRib
RgbLgbLgbLjbLgLsbsbLsLsmbLsbRsbLsbLsLsLsLsRsmmmbLsRsbLgLsbLsLsmbLgbRsb
RjbLsbRibLsRsLsRjbRibLgbLebLgbLgbLsLsmbLsbLsbLgbLiLsbLgLsbLsbLsbRsbLib
RibLibRjbLibLgbRgRsmbLjbLsLsmbRsbLsbLsbLsbsbLsbLsbRsbLgbLgbLsbLsbLsLsm
bRsLsbRsbLsLsmbLsbLsbLgLsbRsbRiRsmbRibLgbLcbLgLgbLgRsbLgbLsLsmbLsbRsbL
sRsbLgbLsbLsbLgbLsbLsbRsLgbRjbRiRsmbRibLjRsbLcbLgbLgbLsbLsbLsbLsbLgbLs
bLsRsLgLsbLsbLsRsbLsbLsbLsLsmbLsRsbLgbLsbLsbLsbLgRsbLsbLsbLsbLsbLsbLsb
LsbLsLsmbLsbLsbLsbLsbLsbLsbLsbLgbRsbLsbLsbLsbLsbLsRsbLsbLgbLsLsmbLsbLg
bLsbLsbLsbLgbLsbLsbLgbLsbLsbLsbLsbRhbRibRibLjbLcbLibLgbLgbRibLgbRgRsmb
RgbRibRibLgbLiLsbLibLgbRsbLgbLgbLgbLsbLsbLsbLsbLgLgbLsbLgbLsbLsbLsbLsb
LsbLsbLsLsmbRcbRhbRibLibLibLgbLgbLgbLgLsbLsbLsbLsbLgbsbRsbLsbLsbLsbLgb
LsLsmbLsbLsbLsbLsbLsRsbLgbLsbLsLsmbLsLsmbLgbLsbLsbLsbLsbLsbRgbRibRhbLi
bLhbLgbLgbLgbRgbRgbRhbRibLcLsmbLgbLsLsmbLgbLsbLgbLgLsbRsLsbLgbLsbLsbLs
bLsbLsbRsbLsbLgbLsbLsLsmbLsbLgbLsbLsbLsbLsbRjbRibRibLjbLcbLgbLgbLsLsmb
LsbRgbRibRibRibLgLsbRgbLsbRibLgbRibLsbRsbRsbRsRsmbRsbRsbLcbLibRgbLibLs
bLsbLgbLsbLsLsmbLgbLsbLsbRsbLgbRgbLiLsbLibRibRgbRhbRibRgbLgbLgbLgbLgbL
sbLsbLsbLgRsbRsbLsbLgbRgbLgbsbLgbLsbRsbLgbLsbRsbLgRsbLsLsmbLsbLsbLsbLs
bLsbLsbLsbLsbLsLsmbLsbRcbRibRsbRgRsmbLsbLsbRsLjbLgbLgbLgLsbLsbLgbLgbRi
LsbLgLsbLsbLsbLsbLsbLgbLsbLgbLsbLgbLsbLgbLsbLsbRsbLsbLgbLgbLgbLsLsmbLs
bLsbRgbRjbLsRhLsbRibRibLibLgbLgbLsbLsbLsbLgbRsbLgLsbLsbLsbLsLsmbLsLsmb
RcRibRiRsmbLibRibLsRsbRgbLgbRgbRhbLhbLibLgLsbLsbLsLsLsmmbLgbLsbLsbLsbL
gbLsbLsbLgLsbRsbLjbLsbRsLsRsbLjbLsLsmbLsbLsbLgbLsLsmbLsbLsbLgbLsbLgbLs
bLsbLsbRjbLjbLjLsmbLibLibLgRsbRibLhbLibLibRsbsbLibRsbLgbLsbLsbLgbLsbRs
bLgbLsbLsbLsbRsLsbsbLgbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 30; Drug: Control Apo 0.5 然
bRsbLobLgbLebRobRcbRobLcbRobLcbLcbLcbRsbRebRebLobLobLebRebLobRobRebRob
LobLobRobLobRsbRobLobRebLcbRebLebLebRobLobRobLobRcbRobLcbLcbLebRebLcbL
obRcbLobLebRibRobLhbLebRgbRibLhbRobLobLcbRgbRhbRobRebRcbLgbRobLobLobLh
bRobRcbRobLobRobRebRobRebRgbRebRebRcbRobLobRobRcbLobRcbRebLibLebRebReb
RebLobRcbRebRobRobLcbRcbLcbLcbRibLobRobLobRobLobLobRebRcbLcbRibRcbRobR
ibRibRibLcbRibRobLebRobLibLsbRobLebRobRibRsbLcbLebRobRobRobLcbRobRobRe
bRebRibRobLobLcbRebLebLebRhbRcbLcbRcbRebRcbLcbLobLcbLcbRsbLobRobLobLib
RgbRebRcbRobRobRobRcbLebRibRobLebRgbLgbRobLebRebRibLebLobLobLgbRobLobR
ibLhbRebLebRobRobRobRibRobRobRobLebLebRibLhbLobLcbLobLobRcbRobLobRsbLo
bRebLhbLgbRcbRgbRsbRsbRebRebLobLobRobRobLobRsbRsbLebRibRibRcbLebLebLcb
RebRibLobRobLgbRobLobRobRobLebRcbRcbLcbRhbLebRobRhbLobRebRcbLebLobRobL
obRobRhbRgbLobRobRebLcbRobRobRebLsbRcbRibLobRobRgbRebLobRibLgbRgbRobRo
bLobRcbRcbRobLebRobRebLobLgbLebRibRcbLobLcbLebRcbRibRebLobRibRibLgbRcb
LcbLobRibRebRobLcbLebLobLobLobRobLcbLebLobRebLebLobRgbLebLebRobLobRobR
ebRibRobRebLobRobLsbRsbLobRobLebLobRebLobLobLgbLobRobLsbLebLcbLhbRebRe
bLobRcbLobLobLobRobLobRcbRebLsbLjbRebRibLobLgbRobLibRebLcbRibLebRobLob
RjbRobRsbLcbLobLcbLsbRcbLsbLobLibRobLobRebLcbLebLgbLcbRcbLibRcbRobLsbL
obLcbLebRcbRibLebLibLobLcbLobLsbRgbLebRobRcbRcbLibLibLebLobLebLhbRebLc
bRobRobRobRibRobRibRebRibRsbLcbRobRgbRobRebRebLcbLebLibRobRebLebLobLib
LobLobRobLcbRcbRibRobLobLgbRcbRobRobRobRebLcbLobRobRibRobRobLcbRcbRobR
cbRcbRgbLcbLebRobLibRebLjbRobLcbRgbRsbLibRobLobRobRobLcbRcbLcbLgbLsbRo
bRcbLsbLobRebRcbLcbRebRibRobLebLcbRcbLobRebRobRobRcbRcbLobRobRebLobReb
LgbLcbLsbLobRobRebRibLcbRsbLobRobRibRobLibRebRcbLcbLcbLcbLobRcbRcbLibR
obRebRobLebRibLcbLobRgbRsbLgbLgbRebRebLebLobLobLobLsbLcbRobLebLobRjbLe
bRobLsbLobLcbLibLobRobLobLebRcbLcbRobRobLebLjbLebLobLobLobLhbLobRobLob
LebLcbLcbRhbLcbLibLebRcbLobRibLcbLobLibLibRobRcbRobLobLcbRgbLcbRobRebR
ibRebRebLobRgbLsbRgbRobRhbRebLcbRobRcbRobLcbRsbLobRobRobRebLsbRebLobRe
bLibLobLebLobRebRobRobLebLebRobLobRebRibLsbRcbLebLobLsbLobRcbRsbLobLeb
RobLebLobRebLcbLgbRobRebRcbLebRcbRgbLobRebLebLcbLobLebRibRobRjbRcbRobR
obRobLibLobRobLebRebLebRobLebRobRsbLcbRebRgbRobRobLebLgbRobRsbRibLsbLo
bLobRebLobRsbRebRobRobRcbRebLcbRebLibRcbRobLobRobLibLsbRhbRobRobRebLob
LebLjbLibLibRcbRebLebRcbLcbLibRebRobLobRebRobLcbLibLcbRobRibLobRobRobR
cbLjbRobRobRebRobLobLsbRibRsbLebLobLjbRebRebLibLhbRobRcbLcbLjbLebLcbLo
bLebLobRobRebLcbLcbRjbRobRobLobRobLebRobLebLobRobLebLobLobRobRcbLebRgb
RebLebRgLobRobRcbLobLhbRebRjbLjbLcbRobRcbLobLcbLcbLobRibRobRcbLcbLebRi
bLebLobRcbLobLobRcbRsbLobLebLjbLgbRobLebLsbLsbLibRsbRjbLebRebRobRobLob
LgbLebLobLgbLgbRobRcbRebRebRcbRobLcbRsbLsbLcbRebLobLjbLobLgbLibLibLibL
ebRibRobRobLobRgbLobRobLobLebLobLsbRsbRibRsbLgbRobLsbLobRjbRobRobLebLc
bLobRibLjbRobRsbLob

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bRgRcRsmbRobLgbLibRcbLgLsbLibLibLgbLgbLsbRibRgLsbLgbLsbRgbRsRsmbRibRgb
RibLibLibLsLsmbRjbLhbLibRjbLhbRsbLsbRgRsmbLcbRibLibRibLgbLgbLgbLgbLgbL
hLsbRgbRsbLsbLjLsmbRjbLibLibLsbRebRhbRgbLgbLsbLgbRhbRgbLsbRibRsbLgbRjb
RgbRsbRibRgbRgbRibRsbRgbRibRjbLibRsbLsbLsbRgbLsbRgRsmbRibRibRsbRgbRsbR
sbRibLgbLsbRgRsmbRsRsLsmbLhbRiRsmbRsbRibRsbLibLsbRibRgbRsbRgRsRsmmbRsb
RsbRsbRsbRgbRgbRsbRgbRsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bLsbLgLsbLsLsmbLsbLgbLsbLgRsbLsbLgbLsbLsbLgbLibLgbLsbRgLsLsmbLibRgRsmb
LibLgbRsbLsbLibLgbLsbLgLsbLgbLsbLsbLiLsbLsbLgbLibRsbLibRibRhbRiLsbLebL
jbLibLgbRsbLsbRsbLsbLibLgLsbLgbLgbLsbLgbLsLsmbLgbLsLsmbLsbLgbLsbLgbRgb
LgbLsbLgLsbLsLsLsmmbLgLsbLsbLsbLgbRsbLsbLsLiLsbLsbLgbLsbLgbLsbLgbRcbLj
bLibRibLibRgLsbLibRsbLsbLsLsmbLgbLsLsmbLsbLgbLsbLibRsbLgbLsbLgLsbLsLsm
bLsbLgbLsLsmbLgbLsbLgbLgbLgLsbLgbsbLgbLgLsbLsbLsLsmbLsbRgLsbRjbRgbRgbL
gbRcbLcbLebLibRsbLgbLsbLsbLsLsmbLsLsmbLgLsbLibLgbLsbRgbLibLsbLsbRsbLgL
sLsmbLsbLsbLsLsmbLsbLgbLsbLgbLsLsmbLsLsLsmmbLsbLgbLgLsbLsbLgRsbRsLsRsb
LgbRsbLgLsbRsbLibLsLsmbLgRsbLgbLsbLsbLsbLgbLgbLsbLsbLsbLsbLgbLsbLsbLsb
LgbLgLsbLsbRsbLibRsLsbLgLsbLsbLsbLjRsbRgbLiLsbLsbLgbLsbLsLsRsmbLgbLsbL
sbLgbLsbLsbLgbLgbLsLsmbLgLsbRgbLgLsbRsbLiLsbLsbLgLsLsmbLsbLgbLgbLsbLsb
LsbLgbLgbLgRsbLgbLibRgbRsLsbLgLsbLgbLgbRgbLibLibRgbLgbLgbRhbRcbRgRsmbR
gbRsRsmbRsbRgbRsbRgbLhbLcbLsbLgLsbLibLgbLibLgbLgLsbLsLsmbLiLsbLsbLgbLg
bLgbLgbLgbLsRsbLsbLsbLsbLgbLsLsmbLgbLsbLsRsbLsbLsbLgbLsbsbLeLsLsmbLgbL
sbLgbLgbLsbLsbLsbLsRsbLsbLgbLgbLgbLsbLsbLgbLsLsLsmmbLgbLsbLgbLsbLsbLgL
sbRsbLgbLgLsbLsbLsLsmbLgLsbLgbLsbLsbLgbLsbLsbLgbLsLsmbLsbLsLsLsmmbLsbL
gbLgbLgbLsbLsbLsbLsbRsLgbLsbLsbLsbLsbLsLsmbLgbLsbLsLsmbLgbLgLsbLsLsmbL
sLsmbLsbLsbLgbLsbLgLsbLsbLgbRsbLibRgLsbLibLgbRgLsbLibLgbRgbLibRsLsbLgb
RsbLgbLsbLgbLsbLgbLsbLsbLsbLsbLsRsbLsbLgLsLsmbRgbLiLsLsmbRsRsmbLsbLsRs
bLsbLsbLgbLsbLsbLsbLsbLsbLsbLgbLsbLgbLgbLsbLsbLgLsbRjbLgbRsbLsbLsbLgbR
sLsLsmbLgbLsLsmbLgbLsbLsbLsLsmbLsbLgLsbRsbsbLgLsbRsbLsLsmbLsLsmbLsbLsb
LgbLgbLgLsbLsRsLsbLsbLsbLgbLsLsmbLsLsmbLibLgbLsbRsbRsLgbRsbLgbLsLsmbLg
bLgLsRsbLgbLsbLgbLsbLgLsbRsbLibLsbLgRsbRsRsmbLgbLsbLsbLgbLgbLsbLsbLsbL
sbLgbLsbLsbLsbLsbLsbLgbLsLsmbLsbLgbLsbLgbLsbLsbLsbLgbRsbLsbLgbLsbLgbLs
bLgLsbLsLsmbLgRsbLgbLsbLsbLsbLsbLsbLgbLgbLgLsbLsbLgbLgbLiLsbLgbLhbLebL
ibLibLibLsbLibLiLsbLgbLsbLsbLgbLibLibRsbLgbLsLsmbLgbLgbLsbLgbLsbLsbLgb
RgLsbLibRgbLibLsLsmbLgLsbRsLsbLgbLsbLgbLsbLsbsbLgbLsbLsLsmbLsbLsLsmbLg
bLsLsmbLsbLsbLsbLsbLgbRsbLibLibRgbLiLsbRgbLibRgbLibLsLsmbLgbLsbsbLsbLs
LsmbLgbLsbLsbLsLsmbLsbLsLsmbLgbLsbLgLsLsmbRsbLibRgbLsLiLsbRsbLgbLsbLgb
Lsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bRgbRibRgbRgbRgRsmbRsbRsbRsbRsbRgbRgLsbLgbRgbRgbRsRsmbRsbRgbRgbRsbRsbR
gbRsbRjbLjbLjbRhbRibRgbRgbLibRgbRsbRgRsmbRgbRgLsbLjbRgbRgbRgbRgLsbRsbR
gRsmbRgRgbRgbRgbRgbLsbRgbRgbRsbRsbRsbRsbRsbRgLsbRsbLsbRgbLsRgbRsbRsbRg
bRgbRsbRsbRgbRsbRgbRsRsmbRsbRgbRsbRsbRgbLcbLcLsmbRjRsmbRhRsmbLjbLgbRib
RgbRgbRsbsbRsbRsbRsbRsbRsbRgbRsRsmbRsbRsbLjbLcbRiRsmbLebLibRjbRcRsmbLc
bLcbLebLsbRhRsmbRiRsmbLibRibRibLgbRibRgbRsbRgbLgbLjbRibRsbRgbRsRsmbRsR
smbRgbRsbRsbRsbRgbRgbLsbRgbRgbRsRsmbRgbRsRsmbRsbRsbRsbRsbRsbRsbLsbRgbR
gbRgLsRgLsbLibLsbLsLhbRjbLcbRcLsbLjbRcRobRgLsbRgbRgbRjRsmbLibRgbRgRsmb
LibRhbRibLjbLhbLcbRjbLhbRjbLcbRcbLibLcbRjbRcbRibLsRsbRgbRgbRsbRsbRsbRs
bRsbRsbRsbRsbRsbRgbLsbRsbRgRsmbRsbRsbRgbRgbRgRgRsRgmbRsbRgbLcbLcbRcbLi
bRcbRobLjbLibRibLjbLcbLibLibLiLsbRsLsbRsbRibRsbLgLsbRgbRsbRsbRsbRsbRsb
RgbRgbRsRsmbRsbRsbRsbRgbRgbRgbRgbRgbRsRsmbRsbLcbRcbRibRsbRsbRsbRsbRsRs
mbRsbRsbRsbRsLsbRgbRsbRgbRgbRgbRgbRgbRsbRsbRgbRgbLcbLiLsbRjbRhRsmbRgbR
sbRgbRgbLjbRibLcbLcbRjbLcbLcbLgbRgbRgbRibRibLibLibLjbRibLibLgbLiLsbLgb
RibLhbRebLhbRcbRibLsbLsRibRgbRsbLsbRsbRsbRsbRsbRgbRgbRsbRsbRsbRsbRsbRg
bRgbRgbRsRsmbRgbLcbLibRjRsmbLibRjbLibLibRebRcbLcbLhbRibRjbRcbLjbLjbLhb
RjbRobRsbRgbRsbRsbRsbRsRsmbLsbRsbRgbRgbRsbRsbRgRsmbRgRsmbRsbRsbRgbRsbR
sbRgbRgbRgbRsbRsbRgbRgLsbLjbLcbRcRoLsbLhbLebLcbRibRibRibRgbLgbRgbLsbRg
bRsbRsbRsbRgbLsbRgbRsbRgbRgRsmbRgbLsbRiRsmbLjbLcbRgbsbsbRhbLcbRjRcRsmb
RibLibLibLjbLgbLibRjbRcbLgbRibLjbRibLjbRiRsmbRibRgbRgbLgbRgbRgbRgbLcbR
hbLcbRjRsmbRjbRjRsmbLibRgbRgbRgbRsbRgLsbRibLibLgbRsbLsbRjbRibRibLibRsb
LsbRgbRibRgbLjbRibsbLsbRgRsmbLsbLsbRgbRgbLsbRgbRsbRgbRsbRgbRgbRgbLgbRg
bLsbRgbLgbRgbLgbRgRsmbRgbLgbRsbLsbRgRsmbRgRsmbRsbRsbRgbRgLsbRgbRjLgbLj
bRcbLcLsmbRibRcLsbRibRjRsmbRjbRjbRgbRgbRgbLibRgbRgbRsbLgbRsbRgbRsbRgbR
gbRsbLsbRgbLgbRgLsbRsRsmbRsbRgbRsbRgbRgbRsbRsbRgbRgbRhbLjbLibRjbRibRgb
RibRgbLhbRgbRsbRsbRsbLgbRjbRgRsmbLsbRgbRsbRgbRgbRgRsmbRsbLjbRgbLjLjbLh
bRjbRhbRibLcbLjbLibRjbLibRcbLibLibRibRhbLcbRebsbRhbLhbLsLjbLgbLcbRhbRi
RsmbRcbLhbLjbsbLibRcbLjbLjbRebRibLibLjbLhbsbRsbRjbsbLcLsmbRjbLibRcbRjb
LjbLebRcbLcbRjbLgbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bRgbRsbRgbRgbRsbRgLsbRgbRgbRgbRsbRgbRsbLhbLgbLgbLibLgbLibLsbLjRsbRgbRc
bRiRsmbRgRsmbLsbRgbRgbRsbRsbRgbLcbLiLsbRibLibLibRibLgbLgbLsbLgRsbRgbLg
bLobRibRgbRsbRgbRgRsmbRgbLjbLsbRibRgbRgbRsbRgbRsbRsbRsbLsbRgbLjbLcbLgb
LsRsbLibLgbRjbLibLgbRgbLgbLcbRsbRiRsmbRibRgbRiRsmbRsRsmbRgbRgLsbRsbRsb
RsbRiRgRsmbRsRsmbLcbLgbLsbLgbLjbLsbRjbRibRsbRsbRgbRgbRsbRsbRgbRsbRsRsm
bRsbRgbRsbRgLsbRibLibRibRgRsmbRgbRsbRsbLsbRgRsmbLsbRsbRgbRsbLsLsmbLgbL
jbLgbLgLsbLgbLgbLsbLsbRsbLgbRcbRibRsbRgbLsbRgbRsbRsbRgbRsbRgbRsbRsbRsb
RgbRsbRsbRgbRsbRsbRgbRgRsmbLsbRgbRibRgbRgbRsbRsbRsRsmbRsbRgbRgbRibLjbR
iRsRsmmbRgRsmbRsbRsbLsbLjbLhbLgbLibRgbLibRgbLiLsbLsbLibRsbLgbRgbLgbLgb
LgbLsbLgRsbLgbLibRgbLgbRgLsbLibRgLsRsbLibRsbLgbLgbLsLsmbLgbLsbLsLsmbLg
bLgbLgbRgbLiRsbRibLibLgbLsbRsbLgbRgRsmbRjbRibRgbLsRsbRgbRgbRibLhbLibLs
bLibLsbLgbRsLsbLsRsbLgbRgbLgbRsbLibLsLsmbLsbLgRsbLsbLgbRgbLibRjbLgbLgb
RsRsmbRibRgbRsbRsbRgbLgbLjbLibLgbLibRsbLibLgbRsbRebLgLgbLgRsbRgbLgbLib
RgbLgbLgbLsbLgbRjbLibLgbLgbLgbLgbRsbLgbLgbRgbLgbLibLgbRjbLibLsbLgbLgbR
jRsmbLibRjbLibLgRsbRsbLgbLgbLgbLsbLgbRgLsbLibRsbLgbLgbLgbLsbLsbLsbLsbL
cbRhbLcbRgLsbLibRgbLibRgbLgbLgbLsbLgbLsbLsbLgbLsbLgbLsbRsbLgbLgbLsbLgR
sbRhbRibRibRiRsmbRgbLgbRgbRibLgbLjbLibLsbLsbLgbLsbLgbLsbLsbLsbLsbLsbLs
bLgbLgbLsbLsbLsbLgbRsbRhRhLsRsbLcLsmbLgRsbLsbLgLsbRsbLgLsRsbLsbLgLsbLs
bLgLsbRsbRjRsmbRibRsRsmbRgbRsbRsbRsbLsbLcbLiLsbRjbLcbRibLibLgLsbRsbLgb
LgbLgLsbRsbLgbLsbLgbLsbLgbLsbLsbLgbLsbRsbLgbRcbRgbLeLsbLibRgbLibRgbLiR
sbLgbRgbLgbLsRsbLgLsbRgbLibRsbLsbLsRsbLsbLsbLsbLgbLsbLgbLsbLsbLgbRgbLg
bLibRjbRcbRgbRgbRgbLiLsbLcbLibRgbLgbRsbLgLsbRsbLgbLsbLgbLgbRsbLgbRsbLg
bRsLsbLgbLsbLsLsmbLgbLsbLsbLsbLgbLsbLgLsbRsbLgbRgbLgbLsbLgbLsbLgbLsbLg
bRgbLibRsRsmbLgbLsbRsbLgbRjbLibRjbRhbLsRibLsLsmbRibRgbLsbLgbRsbRibRgLs
bLgbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bRsbRsbRgbsbRiRsmbRgbLibLibLiLsbLsLsmbLsbLsbRsbLgbLsbRsLgbLgLsbLsbRsRs
mbsbLgbLsbLsbLsbLsbLsbRhbRgbRibLsbLsbRsbRsRsmbRgbsbsbRhbLsbLhbLjbRibRi
bLiLsbRiRsmbLhbLibLgbLgbLibLgLsbLibLsbLibLgbLgbLgLsbLsbLgbLgLsbLibLsbR
gbRsbRsbRibLjbLiLsbLgbLsbLsLsmbLibLgLsbLsbLsbLsbRhbRgbLsbLsLsmbLsLsmbs
bLibLsLsmbRsbRgbRibRsbRsbRsbRsbRsbRsbRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bsbLsbLgbLgbRsbRsbRsbRsbRibsbRsbRsbLsbLgbLsbLibLsLsmbLgbRibRgbRgRsmbRs
bLhbLsbRsbLibLsbLsbLsbLgbRgbRsbRgRsmbLsbLibLsRsbRhbRsRsmbRsbLsbsbRjbRi
bLhbLibLsbLibRibRsbRhbLibLsbRgbLsbRsRsmbsbLsbsbRsbLhbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bsbLsbRsRsmbLsbLsbLjbLebRjbLebLibLgbRjRsmbsbLgbRgLsbLgbLsLsmbRsbLsbLgL
sbLsLsmbRgRsmbLibLgbLiLsLsmbLgbRiLsRsbRsbLjbLibLib

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bLibLgbLsbLibRiRsmbLibLsbLgbRsbRgRsmbLgbRsbRsbRsbLcbLgbLiRsbLsbLgbRgbL
gLsbLsbLiLsbLgbLibLgLsbRjbLibRgbLibRsbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bLibRibLgbRjbLcbLibLsbLgLsbRiRsmbLibLibRgbLibRgLsbLibLsLsmbLsbLsbRsLhL
sbRhbLibLgbLgbRibLiLsbLsLsmbLgRsbLsbRgbLibLsbRjbLiLsbLiLsbRgbRsbRgbLib
LgLsLsmbRibRjRsmbRjbLcLsmbLhLsbRibLibRibLibLsbRgbLcbLeLsbRibLibRibLsLs
mbLiLsbLcbLibLsbRgbLcbRgbLhbLsbLgLsbLgbLcbRgLsRsbLhLsbRgbLiLsbLebRgbRg
bLiLsbLibLsRsbLjbLgbLiLsbLgbLsbLsbRgbLcbLibRgbRgRsmbRgbRsbLebLiLsbLsbL
sbLibRsbLhLsbLhbLibRibRibLsbRibRsbLibRsbLcLsmbRjRsmbLebRjbLebLebLcLsmb
LsbRsbRibLsRibRgRsmbRibRibRsRsmbRsbRsbRibRsbLjbRibRcbRhbRibLsbRsbRsRsm
bRgbRsbRibRsbRiRsmbRsbRiRsmbLhLsbRiRsmbRhRsmbRsbRgbRsbLsLsmbRgRsmbRsRs
mbLibLibLsbRibLcbLibRibRgbRibRsbReRsmbRebRsbRsbRgbRsbRsbRibRgbRibRgbLs
bLibLsbRsRsmbRgRsmbRgbRsbRsbRgbLeb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bLsbRibLsbRiRsLsmbRsRsmbRsRgRiRsRiRgRgRiRgRgRgRsmmbRgbRgbRsbRsbRgRsRgR
gRgmbRgRsmbRibLgbRibLjbRibRgbLibRibRgbLgbRibRgbLgLsbRibLsbLjbLcbLcbLcb
RibRibRibRsbRgbRgbRgRsRsRsRsRgRsRiRgRsRgRgRgRsRimmmmmmmbRgbLjbLiLsbRjR
sRsmmbLcbRibLcbLcbLhbLhbRiRsmbRhbRibLibLhbLiLsbRjbRibRibLsbLsRsbRgbRsb
RsRsRgRsRsRgmmmbRgbRgbRgbsbLsbRgRsmbRsbRsbRgRibRsbRsbRsbRgbLsbRgbRsbRg
bRgRgRiRsmbRgbRsbRgRsmbRgRgRgRgRgRgRsRimbRgLsRsbRgbLsbRgRsmbRsRsRgRgRs
RgRgRgRgmmbRsRsRsmmbRgbRsbLsbRgLsLsmbRgRsmbLsbRgRsmbRgbLsRgbRsRiRgbRgb
RgbLibRhbRhbRcRsmbRibRjbRibRgbLsbRgRsmbRgbRgRsRgRiRgRimbRgbLsbRgbRgRsR
gmbRibRgbLgbRsRibRsbLjbRiRsmbLcbLibLsbLgbRjbLibRjbRcbRgbRgbLsbLsbLsbRi
bLsbRsbRgRsmbRgRibRsbRsbLsbRibRgbLgbsbRgbRsRsmbRgRsmbRgRgReRsLsmbRgRsm
bLsRsbRsRgbRgRsmbRgRgRsRsRimmbRgRgRgRgRiRsRgRgRsmmbRgRgRsmbRsbRsRsRgRs
LsRimmbRsRgRsmbRgRgbRgbRgRgRiRgbRgbRgbLsbRiRsmbLibLcbRcbRibLibRiRsmbLi
bRibRibRsbRhbRgRsmbRgbRgbRgbRsRsmbRibRgbLgbRibLsbRsbRsbReRgbRgbLsbRsRs
mbRsRgbRgbRgRsRgLsmbRgRgRsRiRiRiRgmbRgbRsbLjbRcRsmbLcbRibRhbLibLhbLcbR
ibRjbRhbRgbLibLjbRhbRibLgbLjbLiRsbLibLgbLibRhbRcbRibRsRsRsmmbRgRsmbRsR
smbRgRgRgRiRgRsmbRgbLsbLgbRiRsmbLibRibRibRhbLebLebLebRhbRibRibLgbLsbRs
RibRgbLgbRibRgbLsbLgbLsbRibRgbRsRsmbLjbRibLsbLsbRgbRgRsmbLsbRgbRsbRsbR
gbLsbRgbLsbRibRsbRgbRgbLsbLibRgRsmbRgbRgbLgbRjbRsbRsRgbLgRsbRibRgbLsbR
gbLgbRibRgbLsbLsbRsbRgbLgRsbRgbRsbRsbRsbRgbLsbRgRsmbRsbRsbRsbRgbRsbRgR
smbRgbReRgbRgRsmbRgRsmbRgRsmbsbRjbLcbLcbLibRjbRibRibLjbRhbRibLibLjbLhb
LibLgbRjbRcbRibLgbLjbRhRsmbRiRsmbRgbRibLsbLibLgbLgbLgLgbsbLgLsbLgbLibR
hbRcbRsbRiRsmbRgbLsbLgbRibRgbLibRgbRgbRsbRsRsmbRgRsRgRsmmbRsRsmbRgRsLs
mbRgRgRsRiRgRsRgRsmmmbRgRsmbRgRgbRgbRgRgRgbRgRgRsRsRgmmbRgbLsRsbRgbRib
LibRgbLibRcRsmbLibRibRibRgRsmbLibLibRgRsmbLibLgbLibLgbRgbLgbLhbRjbsbRc
bRibRiRsmbLhbLebLibLibRsbRibsbLgbLgbLsbLgbLsbLsbLgbLsbLsbLgbLsbLsbRcbR
ibRibRibRibRjbRibRgRsmbRgRsmbRsRsmbLgbRjbRibRgbLgbRibLsbRibRgbLibRiRsm
bRgbLjbRibRsbRsbRsbRsbRsLsbRsRsRsmmbRgbRgRgRsmbReRsRgRgRgmbRsbRgbRibLh
bRiRsmbLhbRebLibLjbLcRsbLcbLcbLhLsbRjbRibLsRsbRgbLsbRsbRgbRgRgRgbRgRsm
bRgRsReRgmbRsbRsbRiRiLsRsRsmbRgRsLsmbRgbRgLsbLjbRibLjbRibLjbRibLjbLcbs
bLsbLsbLibRjbRsbRhRsmbRebRhbRibRhbRibLibLjbRcbLjbLjLsmbLgbRebsbRcbRgbL
ibLjbLibRsbLiRsbRjbRsLsbRcRsmbRhbLsbRibLibRcbRsbRsbRibRibRgbRgbLsbLjbR
ibRgbLgbLgbRibRgbLgbRsbRsbRgbRsbRsbRsbRgbRsbRsbRgRsmbRgRsRsmmbRsbRsbRs
RgRgRsRiRhRsRimmbRgbRgLsbLiRsbLiRsbRjbRcRsmbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bRibRsbLgbRgbLgbRgbRgLsbRsbRsbRibLibRibRjRsmbRsbLgRsbRibRgbRgbLibLsbRi
bRgbRjLsbLsbRgbRgRsmbLibLsbRibRsbRibLsbRsbRibLgLsbRibLgRsbLsbRibRibRiR
smbRgbLsbLgbsbRiRsmbRsbRibRibRgbLibRsbRgbRibRiRsmbLibRgbRsRsmbLgbRibLs
bRsbRiRsmbRsbRgbRsbLsbRgbRgbRgbLibLgbLcbLibLgbRjRsmbRjbRibRibRsbLhbRib
RibLgbLibLsbRibRgbLsbLsLsmbLsbRibLsRsbRgbRibLsbRgbLibsbRgbRibRsbLsbLgL
sbRibRibRibLiRsbRsbRgbLsbLsbRgbRgbLsbRibRsRsmbRgbRgbRibRsbLgbRsbRibRgb
RibRibRgbRgbRgbRibRiRsmbRgbRsbLgLsbRjbRsbRsbLsLsmbRsRsmbRsbRjRgRsmbLib
LgbRibRibRgbRsRsmbRibLibRsbsbRiRsmbRsbRsRsmbRibRgRsmbRibLsbLsbLibLgLsb
RgbRsbRibRsbRgbRgbRibLibLgbLsbsbRsbRsbRibRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bLgbLibLsbLjLsmbRjbRcbRgbRsbRibLibRcbLjLsmbRcbRcbRgbLibLibLgbLgbLgbLsb
RhbRcbLsbRcbRiRsmbRsbRibRhRsmbRjbLibLsLsmbLibLibLibLibRgbLibRgbLsbLhbL
sbLgbRibLibRgbLhbRjbLcbRgbLhbLgbRsbRgbRgbLibLgbLsRsbLgLsbLgbLcbRsbRibL
gbLgbLgbLgbLibLsbRcbLsRhRsmbRcbRjbRibRsbLgbRebRcbRibLibLsbLsbLsbRibRcb
RiLsbRiLsbLsbLibRibRjLsbLgbLsbRibRjRsRcmbLsbLsbLgbLibLsbLsbLibLgbRsbLg
bRhbLibsbRgLsbRcbRsbLsbLgbLibRjbRcbRibLjLsmbRibRsbRgbRcbRcbLhLsbLsbRhb
LhbLibRiRsmbLibRsbRgbLsbLiLsbRgbLiLsbRgbLibRgbRsLgbRgbLiLsbLsbLgbRgbLi
bLsbLgbRibLibLgbLgbRsbLgbRgbLibLsbRsRsmbLgbLsbLgbLsbLgbLsbLgbLsbLgbLgb
LgbLgRsbRibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bRsbRsRsmbLsbRgbRsbRsbLsbRgLsRsbRgbLsbRgbLibRhbLsbRgbRsbLsbLgbRibRsbLi
bRibLsbLgbRhRsmbLgRibRgRsmbRsRsmbRgbRgRsmbLiLsbRiLsbRsLsbRgbLibRibLgbR
ibRibRgbRgbLcbLjbLibLibsbRiRsmbRgbLibLgbLsbLgLsbLsbLsbLgbRgbLgLsbLgbLs
bsbLsbRsLsbLgbLgbRiRsmbLgbLgbLgbLsbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bLsRgbRgbRgbRgbRgbLsbRgbRsLsbRgbRsRsmbRgbRsbRgbRsLsbRsbRgbRsbRgbRsbRgb
RsbRgbRsbRsbRgbRgRsmbRibLjbLiRsbLibLgbLgbLgbLgbRiRsmbRgbLgbRgbRsbLgbRi
bRsbLjbRhbLibRcbRibRgbRibLiLsbRibLsbRjbRhRsmbLsbLsbRibRgLsLsmbRgbRgbLc
bRibRibRgbRsRsmbRsbLsbRibLsbRgbLsbLjbLibLgbLgbRgbLibRjRsmbLibRsbLsRsbs
bsbRjbRibRgbLsRsbRgRsmbRsbRsbRsbRsbRsbRsRsmbLsbRsbRsbRgbRgbLgbRgbLsRsb
RgbRsbRsbRgbRgbRsbRsbRgbRsbRgbRsbRsbRgRsmbRsbRsbRgbRsbRsbRsbRsbRsbRsbL
cbLgbRsRsmbLibLibLgLsbRsbLgbLsbLgbLsbLsbLgbLsbRsbLgbLgbRebRgbRsbRgRsmb
RsbRsbRgbRsbRsRsmbRgbLgbRgbRsbRgbRgbRgbRsbRgbRsbRsbRsbRsRsmbRsRsRsmmbR
gbRsbRsbRgbLcbLgbRsbLgbLsbLgbLsbLsLsmbLgbRsLsbLsbLgbLsRsbLsbLgbRgbLgbL
sbLsbLgbLsbLgbLsRsbLgbLsbLsbLsbLsRsbLsbLsLsmbLgbLsbRgLsbRcbRgbLsbRgbRg
bRgbRsbRsbRsbRgbRgbLjbRjbRibRgbRsbLgbRsbRsbRibLsbRgbLsbRgLsbRsbRgbRgbR
sRgbRsRsmbRgbLsLsmbRgbLsbRgbRgbRsbRsbRsbRgbRsbRgbRsbRgbRgbRgbLsbRgbRsb
RsLsbRgLsbRgbRgbLsbRgRsmbRgbRgbRgbRsbRgbLsbRgbRgbRgbRgbLsbRgLsbRsbRgbR
gbRsRsmbRsbRsbRgbRgbRgbRgbRgbRsbRsbRgbRgbRgbRgbRsbRgbLsbRgbRgbRgbRgbRs
bRsbRibRgbRgbRsbRsRsmbRgbRsRsmbRgbRgbRgbRsbRgbRgbRsbRgbRsbRsbRgbRsbRgb
RsbRgbRsbRsbRgbRgbRsbRsRsmbRsbRgbRgbRgbRgRsmbLjbRiRsmbRgbLgbRsRsmbRibR
sbRgbRsbRgbRsbRgbRsbRgbRgbRgbLhbLibLsLsmbLgbRsbLgbLibRsbRebRgbLsbRgbLs
bRsbRsbRgbRsbRgbRgbRsbRgbRsLsbRgbRsbRsRsmbRsLsbRgbRsbRgbRsbRsbRsRsmbRg
bRsbRgbRgbRgbRgbLsbRgbRsbRgbRgbRgbRgbRgRsmbLcLsmbLiLsbLibLgbLgbLsbLsRo
RsmbRibLsbRgbLjbRibLjbRgRsmbRiRsmbLsRsbLsbRgbRsbRsbRgbRsbRsbRgbRgbLsRs
bRgbRsbRsbRgbRsbRsbRgbRsbRgbRsbRgbRgbRsbRsbRsbRsbLsbRgRsmbLsbRgbRsbRgb
RgbRsbRsbRsbRgbRsbRsbRgbRsbRsbRsbRsbRsbRsLsbRsbRgbRgbRgbLhLsbLcbLibLib
RjbRibRibLsRsbRgbRsbRgbRsbRgbRgbRsbRsbRgbRgbRsbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bLsbLgbLgbLsLsmbLsbLsbLsLsmbRsLsbLgLsbLsbLsbLsbLgbLgbLsbLsbLgbLsbLgLsb
LsbLgbRgRsmbRcbRibRibLgbLgbLibLgbLiLsbLgbLsLsmbLgbLsbLsRsbLgbLsbLsbLsb
LgbLsLsmbLgbLsbLsbLsbLsbLgbLgLsbLsbLsbLsLsmbLsbLsbLsbLgbLgbLibRhbLibRh
bRhRsmbRibRibLgbRgbRgbRsbRgbLjbRhbLsbLjbLibRhbRibRibLjbLjbRjbRibLhbRjb
RjbRjRsmbLgbLgbLgbRjbLjbLibRsbRebRsbRiRsmbLgbRgbRsbLgbLgbLibRgRsmbRsbR
gbLjbLcbLgbRibLibLibLjbRhbLibLjRsbLibLjLsmbRgbRgbLgbLgbLgbLsbRjbRjbLib
LgbLgbRibRgbRibLjLsmbLibLgbRsbRjbRibRsbLgbLsLsmbLibLjLsmbRhbRibRibRibR
jbRjRsmbRjbLgbRjbLibRgbRjRsmbLjbLgbsbLsbLjLsmbRgbLsbRgbRjRgbRsRsmbRibL
jbLgbLgbLibRjbsbLjbRibRibsbRjbRgRsmbRjRsmbLgLsbLgbLgbLcbLgbLgRsbRjRsmb
LjbLjbLsbLgbRibRgRsmbRibRibRsLsbRsRsmbRgbRgbLgbLsLsmbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bLsRsbRgbRgbRsbRsRsmbRgbRsbRsRsmbRsbRgRsmbLsbLsRhbLibRsLjbLgbLgbLsbLgb
LsbLsbLsbLsbLsLsmbLsLsmbRebRgbRgbRsbRgbLcbLibRjbRiRsmbRibLgbRgRsmbLsbR
sRsmbRsbRgbRsLsbRsRsmbRgbRgRsmbRsbRgbRsbRgbRgbLsbLjbRibLsbRgbLgbRiLsbL
cbLsLibLsbLgbLsbLsLsmbLgbLgRsbLsRsbRsLsbRjbRhbRiRsmbRsbRgRsmbRsbRsbRsb
RsLsbRgbLsbRibLjbLsbRibLgbRibLgbRgbRgbRsRsmbRgRsmbRsbRsbRsbRsbLoRsbLsb
LgbsbLgLsbLsRsbLsRsbLsLsmbLgbLgbLsbRsbRhbRgbRsbRsbRgbRsRsmbRgbRgbRgLsb
LgbRibLgbRiRsmbLsbRsbRgbRgbRgbRgbLiRsbLibRgbLgLsbLgbRjbLgbLgbsbLsbLgbR
gbLgbLsbLsbLsbLsbLgbLsbLsbLsRsbLsRsbRsbRcRsRsmmbRiLsbRibLsRsbRgbRgbLsb
LcbLibRjbLibLhbLgbLsbLsLsmbLsbLgbLiRsbRibLsbLsbRibRsbLsRsbRgbRsbRsbLsR
sbRsbRgbRsbRgbRgbLgbLibLgbLgbRsbLsbRcbRgbRibRsbLsbRsbRgbRsRsmbRsbRsRsm
bRgbRsbRsbRsbRgbRsbRsbLsbRibLsbRgbRsbRsbRgbRsbLgbRibRibLjbRibRsbLsbRsR
smbRgbLsbLsbLgLsbRibLjbRiRsmbsbRsRsmbRgbRsbRsbRgbLgbRgbLgbRibLsRsbRgbR
sbRsbLsbRgRsmbLgbLjbLibRjbRibRgbRsRsmbLsbRgRsmbRsbRsRsmbLsbRsbLgbRgbLg
bRgbLgbRibLsRsbRsRsmbRgbRsbRsbLsbRgbRsRsmbRgbRsbRsbRibRsbLsRsbLsbRgbRg
bLgbsbRibsbRgRsmbRsLsRsbRgbLjbRibRgbLiRsbRiRsmbRgbRsbRgbRsbLgbsbRiRsmb
RgbRsbRibRibRsbRsRsmbRsbRsbRgbRgRsmbRgbLsbRgbRgbRsbRgbLsRsbRgbRgbLsbLg
bRibLsRsRsmbRsRsmbRsRsmbRsbRgbRgbLgbRibLjbRibRsbLsbRiRsmbLsRsbRgbsbLsb
LsbLsbLjbLibLibRjbRcbRgbRgbLgbRibLsbRgbRsbRsbLsbRgbLsbLsbRgbRgRsmbRgbR
sbRgbLibRibLsRsbLsbRgRsmbRgbRsbRsbRgRsmbLsbRibLjbLjbLibRhRsmbLibsbLibR
hbRibRsbRgbRsbRsbRsbRsLsbRgRsmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bRsbLcbLiLsbLgbLsbLgbLsLsmbLgbLgbLsbLsLsmbRsbRgbLiRsbRibRhbRibLjbRibRi
bLgbRgbRibLjbRibRgbLgbRibLibRibLgbRiRsmbRsbRgbRgbRgRsmbRsRsmbRgbRgbRsL
sbRsbRsbRgbRgRsmbLjbsbLhbLibLgbLgbLsbLgbLgLsbLgbLgbLgbLsbLgbLgbLsbLsbL
gbLgbLsbRsbLgbRcbRibLibRcbLibRgbRsbRsRsmbRsbRsbRsbRsbRibLjbLcbLibLgbLg
bLsbLsbLgLsbLgRsbRcbRibLsbRsbRgbRgbRsbLgbRgbRgbLsLsmbLgbLebLgbLsbLgLsb
LsbLgbLgbLgbLgbLsbLsbLgbRjbLibRjbRcbRibLgbRgbRsbRsbRgbRsbRsbRsRsmbRsbR
sbRsbRgbLcbLibRsbLgbLsbLsLsmbLsbLgbRsbLgbLgbLgRsbLgbRsbLgLsbLgbRsbRcRs
mbRhbLjbRgbRgbLsbRibLsbRiLsRsbRibRiRsmbRgbLsbRgbLsbRgbRsbRsbRsRgbRsbRs
bRgbRsbRsbRgbRsbRgLsbRgLsbRsbRsRsmbRgbRgbRsbRsbRsRsmbRgRsmbRsbRsbRsbRg
bLcLsmbLgbLgLsbLgbLsbLgLsbRsbLgbLgLsbLsLsmbLsLsmbLgbLsLsRsmbLsbLsbLgbL
gbRjbLgbLgbLsbLsbLsbLgbLgbLgbRgbLgbLsbLsbLgbLgbLgbLsLsmbLgbLsbLsbLgbLg
bRgLsbRhbLsbLjbLgbRsbLgbRsbLgbLsbRsbRsbLcbRgbRibRjbRibRsLsbLgbRibLsbRs
bLsbRgbLjbLcbLibRjbLgbLgbLgbLsbLsLsmbRsLsbLgbLsbLgbLsbLgbLsbLgbLsbLgbL
sbLgRsbLsLsmbLsbLgRsbLgbLgbLgRsbLgbRgbLgbLgLsbLsbLgbLsLgbLsbLgbRjbRhbR
ibLjLsmbRhbLjbLcLsmbLgLsbLgbLgLsRsbLsbLsbLsbLsbLsbLgLsbRsLgbLsbLsbLsbL
sLsmbLsLsmbLgbLgbLgbLgbRjbRcbRsbLjbLjbLibLsbLgbRsbLgbLsbLgbLgbLgbLgbLg
bRgbLibRsbLgLsbLsbLsLsmbLgbLgLsLgbLsbLgbLgbLsbLgbLsbLiRgRsmbRhbRibLsbR
gbLsbRgbRgbLjbRcbLgbRgbLcbLgbRsbLgLgbLsbLsbLsbLsbLsLsmbLgbLsbLgbLgRsbL
sbLgbLgbLsbLsbLsRsbRsLgRsbLgbRgbLsLgbLsbLgbLgbLsbLsbLgbLgbLgbLgbLsbLgb
LibRcbRgbRibLgbRgbRsbRgbRgbLcbLibLgbLsbLsRsbLgRsbLgbLgbLgLsbLgbLsbLgbL
gbLgbRsbLgLsbLgbLsbLgbLsbLsbLsbLgbLgLsbLsbLsbLgRsbLgbLgbLgbLsLsmbLsbLg
bRjbRcbRibLjRsbRsbRsRibLjbRibRsbLsbLcbLibLsbLgbLsbLgbLsbLgbLsbLgbLgbRg
bLibLsbLgbLsbLsbLsLsmbLsbLgbLgbRjbRcbLibLgbLgbLsLsmbLsLsmbLsbLgbLgbLgb
LgbLsbLgLsbRjbLibRsbLgbLsbLgbLgbLgbLsbLgbLgbLsbLgLsbLgbLgbLgRsbRgbRsRc
bRiRsRsmmbRgbLgRsbRibLgbRgbRsbRsbRsbRsbRsbRgbRgbsbRibRsbRgbRsbRsbRgbLc
bLibLsLsmbLsbLsbLgLsbLgLsbLgRsbLsbLgbLgbLgbLgbLgLsbRjbLhbRgbLsLiLsbRsb
LgbLgbLsbLgbRjbLgbRsbRjbRjbRgRsmbLibLgbLgbLgbLsbLgRsbLgLsbLgLsbLgbLgbL
gbLsRsbLgbLsbLsbLsbLgbLgbLgbLgbLgbLsbLsbLsbLgLsbLgLsbLgbLgRsbLgbLgbLsL
sLsmmbLjRsbRjbRsbLgbLgbRsbLgLsbRsbLgRsbLsbLsRsbLgbLgbLgbLsbLgbRjbRcbRi
bLsbRgRsmbLsbRgbLsbRgbLgbLcbLiLsbLsbLsbLgbLgbLgLsbLsLsLsmmbLgbLsLsRsmb
LsLgbLsbLgRsbLsRsbLsbLgbLgbLgbLgbLgbLgbLsbLgbLgbRcbRcLsbLibRiRsmbRsbRg
bLsbRibLibRhbLsbLgbRibLgbRgbRsbRhbLiLsbRobLibLgbLjbLibLiLsbRsbLgbLsLsm
bLgLsLsmbLsbLsbLgbLgLsbLsLsmbLsbLgbLgbLsLsmbLgbLsbLsLsRsmbLgLsbLsLsmbL
sbLgbRjLsbRcbRiLsRsbRsLsbRsRibLgbRgbLgLsbRiLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 122504; End: 123004;
Recording: 5-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bRgbRsbRsbRsRsmbRsbRgRsmbRgLsRgRgbRiRsmbRgRgRsmbRgbRgRiLsbRgRsLsmbRgbR
gRsRsRgRsRiRimmmbRsbRgbRgbRgbRgbRgRsRsRgRsRimmmbRgRsmbRgLsbRgbRgRsLsmb
LsbRibLjbRibRsbRgLsbLibLibLgRsbRjbRcbRiRsRsRsmmmbRgRgbRgbRgbRgRgRsRgRg
RsmmbRibRsbRsbRgbRgRsmbLgLsbRgbRsbRgRsmbRsbRgRgRsRembRgbRsbRibRgbRsbRi
bLgbRhbRhbLibLgbLgbLiRsLsbLgbLgbRsbLgbLibLsbLgbLgRsLsLsmbLibRibLgbLibL
gbLgbRebRgbLsbRgbRsbRgRsRgmbRgRgRsRsReRiRsmmmbRgbRgRsmbRgbRgRiReRsmbRg
bRgbRiRsmbRiRsmbRibRiRsRimbRibRgbRsbRgbRsbRgbLjbRibLibLibLibLgbRjbRcbR
gbRgbLjbRhRiRsmbLiLsbLiLsbLibLgbLsbLgbLsbLiRsbRcbRsRgRgRiRiReRsRgmbRgb
RsbRsRsmbRgRsRgmbRgbRgbRgbRgbRgLsbRgbRhbLgbRibRgbLibRibRibLibRibRgRsmb
RsbRgbRsRsmbRgbLgbRibLgbRgbRgbRgbRibLsbRibRsbRgbRsbRgbRsbRsbRgbRgbLgbR
ibRgbLjbLjbLibLgbRibLibLgLsbLgLsbLibRgbRgbRibLsRsbRibRgbRgbRsbRgbRsbRg
bRsLsbRsbLsbRgRsmbRsbRgbLjbRibLiRsLhLsbLgbRsLibLsbLgbLsLsmbLgbLgbLgbRj
bLiLsbRsbRjbRcbRibLsbRgRsLsLsmmbRgbRgRsRsmmbRgbRgbRgRgRiRiRsRsRgRiRgmm
bRgbRgRgRsmbRibRgRsRiRsRsRgRsRiRsmmmmmbRgbRgbRgbRibLjbLibRjbLhbLgbLgbL
sLsmbLgbRcbRiRsRsmmbRsReRiRibRgRsRgmbRgbRgbRsbRgbRgbRsbRgRsmbRgRsRgRgR
smmbRiRibRgbRsbRsbRsRsmbRgRgRsRgRsmmbRgRiRsRgRsmmbRgRiRsRgRgRsReRiRhmm
bRgRsRsmmbRgbRgbRgbRgbRhbLibLcbLibRjbLiLsbLgbRjbLibLibRgRsmbLiLsbRgbLi
bRibLibRgLsbRcbRcbLibLjbRcbRibRsbRgbRgbRgbRgbRgbRsbRsbRsbRgLsbRsbLsRgb
RsbLsbRgbRiRgbRgRsRiRsmmbRgbRsbRsbRgbRsLsbRsbRsRsmbRgbRsbRgRsmbRiRsmbR
sRsRsmmbRgbRgRgbRgbRsbRgbRgLsbRsRgbsbRsbRgLsbLgbLiLcbRcbRhbLjbLibRhbRi
RsmbRsbRsRgRsRgRsRiRimmbRiRsRsRgRsReRsRiRsmmmmmbRgRibRgbRiRsReRsRimmbR
gbRiRibRiRsRiRiRsRiRhRiRsRiRsRiRsRiRsReRsRiRsmmmmmmmmbRhLsbRgbRgRsmbRi
bRgRhbRiRsRiLsRiRimbRibRgbRgbLgbLjbLibLgbLgbRjbRcbRgbRgRsmbRgbRsbRgRsm
bRgbRgbRgRiRibRiRsmbRgbReRiRiRsmbRiRsmbRiRsRgmbRhRgRsRsmmbRiRhRibRibRg
RsmbRsbRsbRgbRgbRgRibRiRsmbRgbRgbLsbRgbRibLgRsbRsbRiLsbRgbRsRsmbRsbRgb
RgLsbRhbRgbRgbRsbRsbRsRsmbRgbRgbLsLsmbRibLjbRibLgbRhbRhbLibLibRibLsbLh
bLibLgbRiRsLsmbLibLgbRibLibLibLgLsbLsbLgbLgbLibLsbLgbRcbRgbRsbRgbRsRsm
bRgbRgRgbRgbRgbRgbRsbRgbRgbRsbRgbRsRsmbLsbRgRsmbRsbRgbRgbRgRsmbRsbRgbs
bRgbRgbRgbRgbRgbRsbRgbRsbRgRsmbRgbRsbRgRsmbRsbRgbRgRgRsLsmbRgbRsLsbRgR
smbRsbRsbRgbRsbRgbRgbRsbRsbRgbRgbRgbRgRsmbLjLsmbLcbLibRjbRhbRibRsbRsbR
sRsmbRgbRsbRgbRgbRsbRgbLjLsmbRhRsmbLgbRgbRgbRgbRsbRgbRsbRgbRsLsbRgbRgR
sLsmbLsbRgbRgbRsbRgbLsbRgRsLsmbRgbRgbRsbRgbLsRsbRgRsmbRsbRgRsmbRgbRgbR
gRsmbRgbRgRsmbRgLsbLjRsbLibsbRcRsmbRgRsmbRsbRsbRgbLsbRgRsmbRgbRsbRsRgb
RgbRsbRgRsRsmmbRibRibRgbRsbRgbRgbRgbRgRsmbRsbRgbRsbRsbLsRsbRsRsmbRgRsm
bRibLsbRibRgbRgbRgbRgbRgbRgbRsbRgbRgLsbRsbLsLsmbRibLgbLebLiLsbLgbLgbLg
LgLsbLsLsmbLgbRsbLgbLgbLgbLsbLsbLsbLgbLgLsbLsRcbRibRgbRgRgLsRsbRgRsLsm
bRgRiLsbRgbRgRsLsmbLebRgbRgRsmbRgRsmbRibRgbRgbRsbRsbRgbRgRsmbRibRgRsRg
RsRiRsRsmmmmbRgbRgbRgRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 1; Drug: Control Apo 0.5 然
bLgbRgRsmbLibRjbLibLibRhbLibLibRsbRiLsbRibRibRgbRibRgbRsbLsbRiRsmbLgbR
ibLgbRsbRgbRgbRibLebLcbLibLgbLsbRgLgbLgbLsbLgbsbLsbRcbRibLgbRgbRibRsbR
gLsbRgbLgLsbRibRgbLgbLhbLgbLsbLgbRgbLiLsbRsbLgbLgbLsbLgbLsbLsbLgbRjbRh
bLcbRjbLobRibLibLgbLibLsbRjbLcbRibLibLgbLsbLsbsbRsbLsbLsbRsbRsbLgLsbRj
bRjbRhbLibsbRibRsbRgbRgbRsLgbRgbRsbRsRsmbRibLjbRiRsmbRibLibRhbRoLsbRcb
LgbRsbRgbRiRsmbRibRsbLgbRgbRsbLsLsmbRhbLgbLibLsLsmbLgbLgbLsLsmbLgbLsbL
sbLsbLsbLsbLsbLgLsbRsbRjRcbRgRsLsmbRgbLsbRgbLcbLgbRsLsbLcbRibRibRibRsb
RgbLsbsbRgbRgRsmbLcbLibLgbRjbLsbLibLgbRcbRcbRgRsmbRgbLgbRibLsbRsbRgbRs
bLsbLebRhbLgLsbRsbLgbRsbLgbLgbLgbLsbLsbLsbLsbRcbRgbRibLgRsbLgbLibRibLi
bLgbRsbRsRsmbLsbLgbLgbLgbLgbLgbLgbLsbLsbLsbLsbLgbLgbLsbLsbLgbLsbLsbLgb
RgbRsbLibRjbRebRibLjbLibLgbLgLsbLsbLsbLgbLsbLgbLgbLgbLsbLgbLgbLgbLgbRs
bRjRsmbLiLsbLibRsbLgbRgbLiLsbLgbRsbLgbLsbLgbLsLgbLsbLibRgbLgbRgbLgbLib
LgRsbLibLgbRsbLsbLsbLgbRsbLgLsbLgbLgbLgbRebsbLsbLsRsbRsRsmbLsbRsbLsbRs
bLibRhbRjbLjbLibLgbLgbRibLibRsbLjbLsLsLsmmbLsLsmbLgbLgbLgbLgRsbLgbRjbL
gbLgbsbLgbLgbLsbsbLgbRjbRcLsbLsbRibRibRiRsmbLgbLebLiLsbLcbLcLsmbRgbRib
RcbRcbRgbRgbRgRsmbLcbLebLcbRgbLgbLibLgbRibLibLgbRsbLgbRibLibLgLsbRsbLg
bRsbLsbLgLsbLgbLsbLsbRjbRcbRibLjLjbLjbLibLgbRsbLgbRgbLibLgbRsbLibRiRsm
bLgbLgLsbLsbLsbLsbLgbLsLsmbLsbLgRsbLsbLsbLsLsmbLsbLsbLsbLsbLsbLsbLsbLg
bLsbRsbLgbRjbLhbLibLsbRibLibLgbLgbLsbLgbRibLibLgbLgbsbLsLsmbLgbLgbRjbR
cbRibLjbLjbLibLibRgbLibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 2; Drug: Control Apo 0.5 然
bLsRsbLgbLjbLiLsbLgbRgbLgLsbLgbRcbRiLsbLjbRibRgbRsbRgbLjbRibRiRsmbRgbL
sbRgbRgbRsbRgbRsRsmbRgbRsbRgRsmbLsbRibRsbRiRsmbLgbRibLhbLcbLgLsbLgbRcb
LjbRiRsmbLcRsbLibRcLsbRibLsbRgbRsbRsbRgbRsbRgbRsRsmbLsLsmbRgbLsbRgbLgb
RibLsbLjbLiRsbLgbLgbLsRsbLhbRjbRcbRibLgbRibRsbRgRsmbRsbLsRsbRgbRsbRgbR
sRsmbLsbRiRsmbRsbRgbRiRsmbLsbRgbLgbRibLgbRibLjbLibRjbRcbRsbRibLgLsbRib
LgbRibRsbRsbRgbRsRsmbRgbLsbRiRsmbLsbRgbLgbRibRsbRsbLjbLibLgbRcbRibsbRs
LsbRgbRsLsbRgbRsbRibRgbRsRgbRibRgbRsbRgbRsbRgbRgRsmbRsbRgbRgbRgLsbRsbR
iRsmbLsRsbRgRsmbLsbRgbRsbRgbRsbRgRsmbRsbRgbRgbRsbRgbRgbRgbRgbRgLsbRsbL
sbRgRsmbRsbRgLsRsbsbLgbRiRsmbLsbRgbRsbRgbRgbRgLsbRgbRgbRgRsmbRsLsRsbRg
bRsRsRsmmbRgbRsbRiRsmbLibLibRebRibLgbLsbRibRgLsbRgbRsbRgbRsbRiRsmbLsbR
ibLsRsbRgRsmbLsbRgbRsbRsbRgbRgRsmbRsbLsbRgbRsbRgbRgbRsRsmbRgbRsbRgbRgb
LsbRgRsmbRsRsRsmmbRgRsmbLsbRgLsbLgLsbRibLgbRibRgbRsbRgbRgbLjbRiRsmbRsb
RibRgbRgbRsbLgbRibLgLsbRibRgbRsbRgbRsbRgRsmbRgbRsbRsbRibRgbRsbRsRsRsmm
bRibRsbRgRsmbLgLsbRhbLjbLjbLibRibRcbRibRgbLsRsbLsbRgRsmbLjbRiRsmbRsbLs
bRgbRgRsmbRibRsbRgbRsRsmbLgbLjbLiLsbRjbRebRibLibRibRgbLsbRgbRsRsmbRsbR
ibLsbRgRsmbRgRsRsmmbLsbRibLsbRibLjbRiRsmbRsbRiRsmbLsbRgLsbRsbRsbRsbRgR
smbRgbRgbLhbRjbRebRhbLibRebLib

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 3; Drug: Control Apo 0.5 然
bRcbRsbRsbRsbRsRsmbRgbRgbRsbRgbRsbRibRibRsbRgbLjbRgbLibLsbRsbLsbLgbLgb
LgbLjRsbRjbLibRjbLsbLgbLsbLgbLgbLjbRgbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 4; Drug: Control Apo 0.5 然
bRgbLgbLgbLgbLgbLsbLsbLgbRcbRgbRsbRibRibRgbRgbRsbsbRibLjbRiRsmbRgbRibR
gbLcbLibLgbRjbLhLsbLgbLiLsbRibRsbLsbLibRibLibRjbLjbRibRjbLebLjLsmbLgbL
sbRgbLibRibLibLgbRibLgbRsbLgLsbLgbRgbLibLgRsbLsbLgbLibLibLgbLibRibLgbL
ibLgbLibRibRibRjbLhbLgbLibLsbLgbLjbLsbLgbLgbLibRjbLjbLjLsLsmmbLibRibLi
bLgbRjRsRsmmbLibLsbRsbLibLsbRsbRsbLsbRjRsmbLjbLsbLsLsmbLsLsmbLsbRjRsmb
LiLsbLsbLibLibRib

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 5; Drug: Control Apo 0.5 然
bRgbRsbRgbLsbRgbRgbRsbRgRsmbRgbRgbRibLcbLibLgbReLsbRgRsmbRsbRgbLsbRsbR
ibRgbRgbRgRsmbRgRsmbLgRsbRsbLibLibRcbLjbLibRgbLibRcRsmbRibRgbRsbRsbRgb
RgbRsbRgbRgbRgbRsbRsbLgbRgbRgbRgbLibLcLsmbLgbRibLibLibRebLcbRjbLibLgLs
bRcRsmbRgbRgbRsRsmbRsbRgbRgbRiRsmbLebLhbLibRibRcbLjbLhbLibRjbLgbLsbLiL
sLsmbRsbRcbRgbRsbRgbRsbRgRsmbRsbLjbLjLsmbRobLebRhbLibRcbRiRsmbRgbRgbLs
bLsbLsbLjbRcbLsbRibRgbRsbRsbRgbRsbRgbRgbRgbRsLsbLsbRgbRgbLcLobRibRcbRi
bLsbRibLhbLcbRebRsLcbLibRgbLgbLgbLsbRsbRcLsbRgRsRsmmbRgbRsbRgbRsbRsbRs
bRsbLsbRgbRsRsmbRgbRgbRgRsmbRgbLsbRgbLsbRsbRsbRsbRgRsmbRgbRsbRgbRsbRsR
sLsmbRsRsmbLsRsbRcRsmbRcbLibLsRsbRgbRibRibRibRcbLibRiRsmbLgbRibRhbRsbR
sbRsbRgbRsRsRsmmbRgbLsbRgbRgbRsRsRsmmbRgbRsbRgbRsbRgbRgbRgbRsbRgbLsRsb
RgRsmbRgbRgbRgbRsbRgbRgLsbRsbRsbRsRsRsmmbRsbRsbRgbRsRsmbRgbRsRsmbRibLc
bLcbRobRobLhLsbRobRibLsbLibRibRibLjLsmbLibLcbRibLibRjbLibRjbLibRhbRibR
gbLgRsbRgbRsbRsbRgbRsbRsbRsbRsbLsbRsbRcLsbLeLsbLibLsbLgbRsbRjbRibRsbLs
bRsbRgbRsbRsbRgLsRsbRgbRibLgbRibLsRsbLsbRsbRgbRsbRsRsmbRsbRsbRibRsbRgb
RsbLsbRgbRgbRsbRsbRsbRgbRgRsmbRsbRsbRsbRgbRsRgbRsbRsbRgbRsbRgbRsbRsRsm
bRsLsbRsbRgbRgbRsbRsbRjRsmbRsbRsbRsRgbLjbLjbLibLibRibRcRsmbRsbRsbRsRsm
bRsLsbRgRsmbRgbRsbRgRsmbRgRsmbRgbRsbRgRsmbRgbRgRsmbLsbRgbLsbRibLjbLcbR
jbRcbLebLobLiLsbRebRhRsmbLcbLibRgRsmbLgbLsbLgbRjbRcbRgbRsRsmbRgbRgbRgb
RgbRsbRsbRgbLcbLcbRcbRcbRgbRsbLgRibRgbLgLsbRhRsLsmbLgbLjbRibRgbRgRsmbR
sbRsbsbRgbRgbRsbRgbLsbRsbRsbRsbRgRsmbRgbRgbRsRsmbRsbRsbLsRsRsRsmmbRsbR
sbRsbRgRsmbRsbRgbRsbRsbRsRsmbRsbRsRsmbRsbRgRsmbRsRsmbRsbRsbRsbRsbRgbRg
bRgLsbRsbRsbRsbRsRsmbLsRsbRgbRsbRsbRsbRsbRibLjbLhbRibRjbRibLjbLhbLibRj
bRcbRsbRgbRsbRgLsbRgbLjbLhbLcbRibRibLjbLhbRobLgbRibRsbRsLsbRsbRgRsmbRg
bRsRsmbRgbRsbRgbRsLsbRgbRsRsmbRsbRsbRgbRgLsbRsRsmbRsRgbLsbRgbRgbRgbRgb
RgbRsbRgbRgbRsbRgbRgLsbRsRsmbRsbLsRsbRsbRsbRsbRgRsmbLsbLsbRgbRsbRsbRsb
LsbRgbRsbRsbRgbRgbLibRhbRsbLgbRsbRibRgbRsbRsbRgRsmbRsbRsRsmbRsbRsbRgbR
sbRgbRgbRgbRgLsbRsbRgbLsRsRsmbRsRsmbRsbRsRsmbRsbRsRsmbRsbRsRsmbRgbRgbR
sbRsbRgbRsbRsbRibLsbRsRsmbRgbRsRsmbRgRsmbRgbRsbLsRsLsbRgRsmbLsLsmbLgbR
ibLjbLhbLiLsbLibLibRgRsRsmmbLgLsbLgbRjbRcbRgbRsbRgRsmbLgLsRsbRibLebLhb
RibLhbRibLobRibRibLcbRobRgbRsbLibRcbRgbRgbRgRsmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 6; Drug: Control Apo 0.5 然
bLiRsbRjbLiLsbRgLsbLgbRgRsmbLiLsbLgbRgRsmbRgbLgbRibRiRsLsmbRgbRjRsmbLi
bLiRsbRgbLgbLsbLgbLsbRibLjLsmbLiLsbRgbRgbRgbRgbLibRsbRgRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bRibLiRsbLgLsbLibLgbRsbRgbLsbLsbLgbLgbLgbLgbLgbLsbLsLsRsmbLgRsbLgbLsbL
gbRsRsRsmmbRibRsbRgbRsbRsbRgbRsLsbLsRsbLibRgbLsbRsbRgbLjbRibLgbLjbLsLs
mbLibLgbLgbLibLgbRsbLgbRibRhbRibRsRsRsmmbRgbRgbRjbRsbRsbRsbLjLsmbRibRs
bRgbRgbRgbRgbRgRsmbRgbLibRjRsmbRsRsmbRgbLjLjbRhbRsbRgbRsbRgRsmbLsbRibR
sbRgRsmbRgbRsRsRsmmbRgbRsbLibRibRjRsRsmmbsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bLhbLibRjbLibLgRsbRibRjbLjbRibRebLibRibRsbLjbLibRebRibLibRibRibRsbLsLs
mbRhbRibRsbLjLsmbsbRgbRgbRibRsbRsbRgRsmbRgbLjbRibRsbRsLsbRgbRsbRgbRsbR
gbLcbLibLibLgbRjbLibRjbLiLsbLibLibLgbLgRsbLibRgRsmbLibRsbLibLgbLgbRgbL
ibRsbLgLsbRsbLiLsbRsbLsbLgbLsLsmbLgLsbLgbLgbRgbLgbLibRjbLgbLgbRgbRjbLg
bRibLjbRhbRibLjbRibRhbLiRsbRhbLsbRgRsmbLsbRibLjbRibRsbRgbRsbRsbRgRsmbL
sLsmbRgRsmbLgbRgbRgbRsRsmbRsbRgbRsbRsbRgbRsbRgbRgbRsbRgRsmbRgRsmbRgRsm
bLsbRgRsmbRsbRgRsRsmmbRsbRgbLsbRgRsmbRgbRgbRsbRgRsRsRsmmmbLjbRiRsRsmmb
LsLsmbRibLsbRibRgbRsbRgbRgLsbRgbRgbRsbRsbRgbRgbRsbRgbRgbRsbRibRsbRibRg
LsbRgbRgbRiRsmbRgbRsbRgbRgbRsbRgbRsRsmbLsbRibRgbRsbLgbRiRsmbLsbRibLsbR
sbRgRsmbRsbRsbRgbRsbRsbRgbRsbRsbRgbRsbRgLsbRsRsmbRgLsbRsbRsbRgbRgbRsbR
sbRsbRsbRgbRgbRsRsmbRgbRgbRgbRsbRgbRsbRsbRsbRgbRgbRgbLsbRgbRgRsmbRgbRs
bRsbRgbRsbRsbRgbRgbRsRsmbRgbRsbRsbRgbLsbRgbLgbRiRsmbRgRsmbRsRsmbLgbRib
RgbRibRgbRsbRsbRgbRibRgbLsbRsRsmbLsbRibRgbRsbRgbRsbRgRsmbRsRsmbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bRsbLhbLibLsbLsbLsLsmbLgbLsbLsbLgbLgbLsbLgbLsbLgbLgRsRsmbRcbRibRsRsmbR
gbRgbRsbLcbLibLiRsbLgbRibRgbLiLsbLsbLsLsmbLsbLgRsbLsbRsbRsbLgbLgbLsbLg
LsbLsbLsbLgbLgLgbLgbLsbLsbLgRsbLsbLsbLsbLgbLsbLgbLgbLsbLgbLsbLsbLgbLgb
LsbLgbLgLsbLsbLgLsbLsbLsbLsbLsbLsbLsbLgbLgbLhRsbRibRgbRgbRibRgbRsbLjbL
obLsbLsbRgbRgbRibLcbLhbLgLsbRhbLiLsbLgbLsbLgbLsbLsbLgbLsbLsLsmbLsbLsbL
sbLgbLsbLgbLgbLsbLgbRjbLhbRcbRibLhbLhRsbRibLibLgLsbLiLsbLsbLsbLsLsmbLg
bLsbLsbLgbLgLsbLgbLsRsbLgbLsbLsRsbRjbLhbLibRgbRibLsbLgbLiLsbLgbLsbLgbL
gbLsbLgbLsbLsbLsbLgbLsLsmbLsbLgLsbRoLsbLcbLiLsbLgbRibLibLiLsbLsbLgbLsb
LsLsmbLsLsmbLgbLgbLgbLsbLsLsmbLgbLsbLgbLsLsmbLsbLgbLgbLsLsmbLgbLsbLgbR
obRibRgbRgbLjbLoLsmbLibRiRsmbLgbRjbLibLgbLgbLibLsbRsbRgbLgbLibLibLibLg
RsbLsbRibLgbLiLsbLgbLgbLsbLgbLgbLgbLgbsbRsLsbsbRibRcbLibRibLjbLcbLibLi
bRcbLgbLgLsbLsLgbLgbLsLsmbLgLsbLgbLsLsmbLgLsLsmbLgbLgbLgbLgbRgbRgbRibL
sRsbRibLjbLcLsmbLibLibLsbLsbLsbLgbLgbLgbLsLsmbLsbLgbLsbLsbLsbLgbLgbRgb
LibRjbRcRsmbLjbLcbRgbLibLsbLgbLgbLgbLsbLsbLsbLgLsbLsLsLsmmbLsbLgbLgbLi
bLibRcbLgbLibLgbLgLsbLsbRsbLsbLsbLibLgbLsbLsbLgbLgbLsLsmbLsbLgbLgLsLsm
bLgbLsbLsbLgLsbLsbRsLsbLgLsbLgRsbLgbRsLhbRiRsmbLibLsbLgLsbLgbLsbLgbLsb
LsbLgbLgRsbRcbRibLjbLcbLiLsbLibLibLgbLsbRcbLgbLgbLibLiLsbLsbLgLsbLgbLg
bLgbLgbLgbLsbRgbLibLgLsbLsbLsbLsbLsbLgbLgbRjbLiLsbLgbRjbLibLibLiRsbRcb
RibRhbLebLcbLcbLibLcbLsbRibRibRhbLibRibLhbRibLsbLsbLsLsmbLibLgLsbLgbLg
LsbLibRibLsLsmbLibLibLgbLgbRgRsmbLgbLgbLgbLsbLgbLibLgRsbRsbRgbRgRsmbRg
bLsbRibRgbRsbLsRsbLcbLibRgbRsbLsLibLgLsbLgRsLsbLgbLgbLgbLgbLiRsbRgbLib
RsbLibLibLebLcbLibLsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bLgbLgRsbLsbRsLsLsmbLsbLgbLsLsmbLgbRgbLibRcbRibRibLjbRibLjbLhbLgLsbLsb
LgbRsLsbLgbLsbLhbRibLsLibLibLgbLgbRjbRgbLjbRibLjLsLsmmbLhbLgbLsbRgbRib
LjbLibRjbLhbRjbRjbLcbLiLsbLgbRjbLgbLgbRjbRjbLjbRiRsmbLjbRibRjRsmbLibRi
bLebLeLsbLhbRibLibRibRiRsmbLcbLhbLibRjRsmbLsbLsbRsLgbLgbLsbLgbLgbLibRj
bLgbLgbRsbLgbLgbLsbLsbLsLsmbLgbRcbRjLsbRgbLjbLcbLibRjbLibLgbRsbLiLsLsm
bLsbLsbLsbLsLsmbLsLsmbLgbLgbLsbLsbLibRcbRcbLsbRibRibRibLjbLcbLiLsbRsbL
sbLgLsbLgbLsLsmbLsbLsRsbLsbLsbLgbLgLsbLgLsbLgbRsbLgLsbLsbLsRsbRsRsLgmb
LibLgbLibLgbLibLgbLgbRgbRgbLibLgLsbLsbLsbLsbLsLsLsmmbLsbLgbLsbLsbRsbLg
bLsbLsbLsbLsbLsbLsLgRsbLsbLgLsbRjbRibRibRgbLjbLcbLiLsbLgbRjbLibLsbLsLs
mbLsbLgbLsbLsRsbLsbLgbLsbLsbLgbLsbLgbRgbLgbLsbLgbLsRsbRcbRgbRgbLjbLibL
gbRjbLibLsbLibRjbRibLebLibLibRibLiLsbLsbLgLsRsbLsbLgLsbLsbLgbLsbLsbLsb
LgbRsLsbLsLsLsmmbLgbLsbLgbLsbLgbLsLsmbRgbLibLgbRjbLgbLgbLgbRhbRgbRsLjb
LjLsmbRjbLiLsbLsbLgbLgbLgbLsbLsbLsbRgbLibRjRgbLjbRjbRcbRibLjbRhRsmbLcb
RgbRibLjbRibLgbLcbRjbRibRibLcbLibRibLibRgbLibRjbLibLgbRjbLiLsbRsbLgLsL
smbRsbLgbLgbLsbLsbLgbLsbLgbRjbLibRjRsmbLhbRjbLhbLhbRhbRgbLebRjRsmbLibL
gbRsRsmbRsbLibLgbRjRsmbRjbRgbRiRsmbLjbLsbRibLcbLibLgbRibLibLibRsbLsbLg
LsbLsLsmbLsbsbLsbLsbLgbLsbLsLsmbLibRjbLibLgbLjLsmbRjRsmbLgbLibLgbLibRi
bLgbRibLjbRgbRgbRcRsmbLjbLcbRjbLhbRjbLibLgbRjbLibRsbLiLsbLsbLgbRjbRibL
jbRjbLjbLgbLgbLibRibRsRsmbLsbLgbLsbsbRibLgbLsbRgbRibLibRjbLcbLgLsbRibL
sLibRsbLsbLsbLsbLibRgbLgbLibRhbLibRjbLibLjbLgbLgbLsbLsRsbLsLsmbLgbLsbL
sbLsbLibRjbRjbRibLjbLhRsbRhbLjbLhLsbLjLsmbRjRsmbRjbLibLgRsbLgbLsRsLsbL
gbLgbRsbRibRsbLsbLsbLgbLiLsbsbLgbRsbLgbLsbLgbLgbLsbLsRsLsbLgbRsbLgLsbL
gbLsbLgbRsbLgbRsbLgbLsbRjLsbLibLsbRjbLsbLibLgbRgbRsRsLsmbLibLgbRibLhbL
ibLibLsbLibLibLgbLsLjbLgLsbLgbRsbLgbLsbLjbRgbLjbRjRsmbLgbLsbLsbLsbLsLs
mbLsLsRsmbLsbRsRsmbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bLjbLhbLibLgRsbLgbLgbLgbLgbLgLsbRjbRcbRgRsmbRgbRgRsmbRsLsRsRsmbRsbRgbL
hbLibRsbLgbLsbLgbLgLsbLgbLgLsbRsbLibLibRcbRhbLgbRiRsmbRgbRgbRgbRgLsbRi
bRibLjRsbLcbLgbLgbLsbLgbRsLsbLgbLsbLsbLgbLgLsbLsbLgbRjbLibRcRsmbRgbRgb
RsbRgbRsbRsRsLsRsmbRsbLgbRgLsbRgRsmbRgbRsRsmbLsRsbRgRsmbRgbRsbRsbRsbRs
bRgbLgLobLibRgbLibRgbLibRsbRsLsLsmbLgbLgbRsRsmbLgbLgLsbLsbLgbLsbLsLgLs
bLsbLsbRgRsmbRcbLcbLibRjbLebRibLcbsbLibLsLgbLibRhbRcbRibRgbLhbLibLibLg
bRsLsbLibLcbRgLsbLiLsbLibLibLibRjbLibRjbLibRsbLibLhbRibLhLsbRcbsbRhbRi
bRsLsbRgbRgbRsbRsbRsbLsbRiLsbRsRgbRsRsmbRgbRgbRgbRsLsbRgRsmbLcLsmbLibR
jLsbLibRgLibRsbLiLgbLgLsbLgbRcbRcLsbRiRsmbRjRsmbRgbRgbRgRsRsmmbRobLcbL
ibLibLgbLgbRgbLibLgbRgbLgbLgbLgbLgLsbLsbLgbRgbLgbRjbLcbRgbLibRgbLibLsR
jbLhbRjbLhbRgbLibRjbLiLsbRsbLibRsbLibRsLsbLgbRjbLibLibLibRibLgbLgbRgbR
hbRgbRsbRgbRsbRsbRsbLsbRsbRgbRgbRiLsRsbLjbLhbLibRgbLgbLsLsmbLgLsbLgbLg
RsbLgbLgbRcbRibLjbLhbLibLgbRgLsbLibRgbLgbLgbLsLgbLsbLsbLsbLgLsbRjbRsLg
bLiLsbRjRhbLjLiLsbsbLjbRcbRhbLsbLjbLibLgLsbLsLsmbLsbLgLsbLgLsbLsbLgbLs
bLgbLgbLsbLsbLgbLsbLgbLsLsmbLgbRsbLgbRsbLjbRgbLgbLgLsbLsbsbLibLibRibRs
bLibLgbRsbLiLsbLsbLgbLgbLgbLsbLgbLgLsbLsbLsLsmbLsbRsbLgbRjbLibLgbRsbLg
bRsbLgLsRsbRsRsmbLgbRcLsbLsbLebLibRgbLibRsbLgLsbLsbLgbRsLsbLgbRsbLgbLs
bRsbLsbLgbLsLsmbLsbLgbLsbLgbRsbLgLsbRjbRsbLibRsbLhbRsbLgbLgbLsbLgbLgbR
ibLhbLibRsbLjbLsRcbLgLsbLibRsbLgbLsbRsbLsbRibLsbLgRsbLsbLgbLgbLsbLgbLs
LsmbRsbRsbLiLsRsbsbRgLsbLiLsbLsbLgLsbLgbLsbLgbRgbLgbLgbRsbLgbLsbLgbRsb
LgbRsbLibLsbRgLgbRsLsbLiLsbRsbLgbLsbLgbRsbLibRgbLiLsbLsbLsbLgbLsbLgbLs
bRsbLgRsbLsLsmbLsLsmbLgbRgbLiLsbRgbLiLsbLsbRcbRibRsbRgbRsbRgLsbRsbRgRs
mbRsbRgbLjbRibRcbRhbRgbRibLebRibRiRsmbLsbRsRibLsbRgRsmbLgbLhbLibLiLsRs
bLgbRsLsbLgbLsbLgbLsbLgbLgbLsbLibLibLsbLibRgRsmbLibRjLsbRsbLibRjbLobRg
bRgRsmbsbLhbLgRsbLgbRcbLcbLsbRjbLobLsbLhbLgbRjbLibLiLsbLsbRsbLgbLsbLgb
LsbLgLsbRgbLiRsLsbLgbRsbRsLsbLgbRebLsRiRsmbLjRsbLhbLibRsbLgLsbLsbLgbLi
LsLsmbLibLsbLsbLsLgLsbRsbRsbLgLsbLiLsbLgLsbRsLsbLsbLibLsbRsbLibLibLibL
sbRgbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bLgRsbRcbRiRsmbRsbRsbRsbRsbRgbRsbRgRsmbRsbRgbRgbRsbRsbRgbRgLsbLsbRgbRg
bLsbRibRsRsmbRsbRsbRgbRsbRgbRgbRsbRsbRgbRsbRgbRgbRsbRgbRgRsmbRgbRsbRsb
RgRsmbLsbRsbRgRsmbRgbRsbRgbRsbRgbRgbRsbRsbRsbRgRsmbRsbRgbRgbRsRsmbsbRs
bRgbRgbRgbRgbRsbRsbRgbRsbLgbRibRgbRsRsmbRsbRgbLsbRgbRgbLsbRsbRsbRgbRgb
RgbRgbRsLsbRgbRsLsbRgbRgbRsbRsRsmbRsbRsbRsbRsbRsbLjbRgbLsRsbRsbRsbRgbR
sLsbRsbRgbRsbRsbRsLsbRgbRsbRgbRgbLsLsmbRgbRgRsmbRgLsbRsbRgRsmbRsbLsbRg
bRgbRgbRsbRibRsbRibRsbRsbLsbRsbLsbRiRsmbRgRsmbLsbLsbRgbLsbLsbLsRibLjbR
ibRsbRgRsmbRsbRibRsbRgbLhbRgLsbRibRsbRgbRsbRgRsmbRhRsLsmbLiRsbRiRsmbRg
bRgbLgbRgRsmbRsbRsbRsRsmbLsbRsbRsbRhbRsbRgbRgbRgbLsbLibRgbRgbRsRsmbReL
sbRsbRsbRsbRsbRsbRobRgLsbRsbRsbLsbRgbRgbRgbLsbRibRsbRsbRgbRibRsbRsbLsb
RgbLsbRiLsbRhbLsbLibRibRibRiRsRsmmbLibRibRsbRsbRsbRsbRgbRgbRsbRiLsbLcb
RcbLsbRiRsmbLgbRiRsmbLsRsbRsRsmbRgbRsLsbRjbLjbLcbLibRjbRhbRcbRsbRgbRjb
RsbRiRsmbRgbRsbRgbRsbLsbRgLsbRibRebRhRsmbRiLsbRsbRsbRgbRgLsbRgbLibRibR
gbLjbRibRgbRhRsmbRibLibRibRhbRibRsbRsbRsRsmbRgbRsbRsbRgLsbLgbRgbRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bsbRgbLsbRsRsmbRgbRgRsmbRsRsRsmmbRgLsbRgRsmbRgbLsbRibLjbRibRgRsmbRgbRi
bRsbRgbRgbRgbRgbRgRsmbRgRsmbRgbRgbRgbRgbRgRsmbLsbRgbRgbRsbRsbRgLsbRgbR
sbRsRsmbLsRsbRsbRgbRgRsmbRsRsmbRgbLsbRibLgbLjbLibLcbRebRcbRsbLsRgbRsbR
gbRgbRjbRsbRsbRsLsbRjbRsbRsRgbsbRibRgbLsRsbRsbRsRsmbRgbRsbRgRsmbRsRsmb
RsRsmbRgbRsbRjbLobLgbLsbsbLsRsbLsbLgRsLsbLsbLsbLsbLgbLsbLsbLsbLsbRcbRs
RcbLsRsbLsbLsbRgbRgRsmbRgbLgbLcbLibRjbLibLsbLgbLsbLgRsbLgLsbLsLsmbLgRs
bLibLcbLcbLibRgbLjbLibRjbRoLsbLjbLcbRjbRsbRcbLjRsbLhbLibLgbRjbRsRibRib
LgbRibLsbRgRsmbRgbRgbRgbRgbRsbRgbRsbRgRsmbRsRsmbRgbRsbRgRsmbRgbRgbRiRs
mbRiRsmbRgRibRsbRgbRgbRgbRgLsbRgbRsRsmbsbRgbsbRgRsmbLsRsbRgbRgbLgbRibR
gbRgbRsbRgbRebRsbRgbRgbRgRsmbRsRsmbRjbLgbRibLsbRhbLsbLibRebLibLhbLgbLg
bLsbRsRsmbLjbRsbRcbRibLgbRhbRiRsmbRsbRgbRgRsmbRgbRsbRsbRgbRiRsRsmmbRsb
RibRsbRibLjbRibLgbRibLgbRjbLjbLibLgbLsbLsLcbRsbRcbRebLgLsbsbRgbRgbRsbR
gRsmbRgbRsRsmbRsRgRsRsmmbRgRsmbRsbRgbRsbRgbRgRsmbLsbRiRsmbLsbLsbRgRsmb
RgRsmbRgbRgbRgbRsbLsbRgbRsbRibLgRibRgbRgbRibLsbRjbRibLjbRiRsmbLgbRibRg
bRgbRjbRsRsRsmmbRgRsLsmbRgLsbRgbRgbRgRsmbRsLcbLiRsLsbLgbRsRsmbLgLsbLsL
smbRcbRiRsmbRsbRgbRgRsmbRgbRgbRgRsRsmmbRgbRgbRsbRgbRsRsmbRgbRgLsbRibRs
bLcbLibLgbRjbRobRjbLgbRsbRsbRsbRibRsbRiRsmbRgRgRsmbRibRsbRgbRgbRgLsbRj
bRgRsmbRgLsbRsRsmbRgLsbRgbRgbLhbLoRsLibsbRiRsmbRibRgLsbRsbRsRsmbRsRsmb
RsbRsbRibRgbLibLiRsLoRsRsmbLcbLiRsbRcbRgRsRiRgmbRgbRgRiRsmbRgbRgbRgbRi
bRibRsbRgRgbRiRsmbRsbRsbRgbRgRsRsmmbRgbRgbRibRgRsmbRsbRgRsmbRgRsmbRibR
sRsmbRsbRgbRgRsmbLsbRibRsbRiRsRiRsmmbRgRsmbRibRgbLsbRsbRsbRgRsLsmbRgbR
gbRgbLsbRgbRgbRsbRgbLsbRiRsRsmmbLgbRibLjLcbLgbLgLsbRsbReRsmbRiRsmbLgbR
gLsbRsLsbRgbRgbRsRsLsmbRgRsmbRgbRgbRgbRgbRgbRsbRgbRgbRgbRgRibRgbLsbRib
RsLgbRibRsbRgbRgbRsRsmbRsbRsbLsRgbRgbRsbRibRgbRgbRgbRgbRgbRgbRsbRgbRgb
RgRsmbRibRsbRgbsbRibLsRsbRibLsbRibLsbRgLsbRgbRgbRsbRibRsLsbRgbRsbRgbRg
bRsbRgRsmbLsbRsbRibRibLibRibRgbLsRsbRgbRsbRsLsbRgbRgbRsRibLsRsbRibLsbR
ibRhbLgbRgbRgbRgbRgbRsbRsbRgLsbRgbRgbLsRsbRgRsmbRsbRgbRjbsbRsbRsLsbRgb
RgbLgbLjRsbLiRsbsbLsbLgbLsbLsbLgbLsbLgbRhbRhbLsRsbRibLgbRibLsbRgbRgbRs
bRsbRgbRsbRgbRsbRgbLsbRibRsLsbRgRsmbRsbRsbRsbRgbRsbRgbRgbRgRsmbRsbRgbL
gbLhbLibRjRsmbLhbRjbRcbRsbRsbRibRsbRsbRsbRsbRgbRgbRgRsRsmmbRsbRsbRsbRg
bRgbRgbRgRsmbLsbRibLcbLibLsbLgbLsbRobRsRsmbRsbRgbRsbRgbRgbRgbRgbRgbRsR
smbRgbsbRsbLsRsbRgbRgbRgbRsbRgRsmbRgRsmbRgbRgbRgbRgLsbRibRgRsRsmmbRsRg
bRgbRsbRgbRgRsmbRsRsmbRgbRgbRgLsbRgbLsRgRsmbRgbRgRsmbRsbRgLsbRgRsmbRgb
RgbRgbRgbRgbLsbLjbLcRsbRjbRhbRibLsbRgbRsbRgLsbLsRsbRgbRgRsmbRgbRgbRgbR
gbRsbRgbRgbRsbRgbRsbRgbRgbRgbRsRsmbRgbRsRsmbRibRsbLcbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bRgbLsbRgbRibLcbLibRjbRoRsmbRibLjbRgRsmbRsbRgRsmbRsbRsbRsbRgbRsbLsRgbR
gbRsRsmbRgbRsbRsbRgbRgbRsbRsbRgbLjbLibRjbsbRibRgbRsRsmbLgbRgbLsbRgbRsb
RgbRsbRsbRsbRsbRsbLsRsbRibLjbRhbLjbRibLjbRibLjRsbRgbRsRsmbRgbRsbRebLgb
LcbRobRsbRgbRsbLsbRgRsmbLgbRibLjbLcbLibRibRsRibLgbRibLsbRsbRsLsbRgbRsb
RsbRgbLsbRgbLgbLjbRgLsbLibLsbRsbRibLgbLsbRsbRibLjbLsbRgRsmbLsLsmbLgbRs
bLibRgbLibRjbRjbLibRjbLibRebLgLsbLhbRjbRjbLcbLjbLibLsbLsbRgbRsRsmbRsbR
ebLibRibLjbRgRsRsmmbRsbRsbLsRsbRgbRsbLsbLibRsbRsLjbRsLsbRsRgbRgRsmbRsb
RsLsbRgbRsbRsbRgbRsbLibLgbRebLhbLibLibLibRcbRgbLsbRsbRsbRsbRgbLgbLhbRi
RsmbsbLjbRiRsmbRsbRsbRgbRjbRsbLsRsbLsbRsRsmbRgRsmbRgbRsbRgbRgbLsbRgbRg
RsmbRgRsLsmbLjbRcRsmbLcbRibRcbRjbLibLibRsRsmbLibRsbLgbLgbLgRsbLibLsbRi
bLsbLibRcbRibRsbRibLibRjbRsbRsbRsbRebRibRibRgbRsbRgbRsbRsbRcbLcbRjbLcb
RcbLcbLcbRibRibRibRgbLgbRiRsmbLsbRsbRgRsmbRsRsmbRsRsmbRgbRgbRgRsmbRgbL
gRsbLobLsLsmbLobRjbLsRsLsbRibLgRsbLsbRiRsmbLsbRgRsLsmbRgbRibLibLhbLibR
cRsmbRsbRibRcbLgbLsbRiRsmbLsbRgbLsbRgbRgbRsbRsbRsbRgbRsbLcbLibLsbRibLc
LsmbRiLsRcbRibLsbRsbRiRsmbRsbRgRsRsmmbRsbRsbRsbRgbRsbRgbRgRsmbLcLsmbLc
bRjRgbLgbLibRjbRhRsmbLibRjRsmbRhbRjbRibLsbRsbRibLibRiLsRsbRgbRgbRgbRgb
RsbRgbLgbRgbRibLjbRcbLjbRibLsbRgbRgbLsbRgRsmbRsbRgbRibLibRiRsmbLjbRiRs
mbLgbRjbLsbRjbRsbRsbRibLgbRsbRjbLsbRgbLgbRgbRsbRgbLcbLibLsbLibRjbsbLgb
LsbLjbLebRibsbRibsbLsbLsRibLgbRgbLsbRgbLsbRsRsmbRibLjbLibRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bLsbLsbLgbLsbLgLsbLibLgbRhLsbLsbLibLsRsbLsbLgLsbLsbLsLsmbLgbLgLsbLgLsb
LgbLgLsLsmbLsLsmbLgbLsbLgbLgbLsbLgbLgLsbLgbRjbRcbLsLsmbRgRsmbRsbRsbRgR
smbRgbRgbRgbRgbRsbRsLsbRgbRgLsbLsLsmbLcbRsLsbLiLsLsmbLgLsbLsLsmbLgLsbL
gLsbLgLsbLgbLgRsbLsbLgLsbLgRsbLgbLsLsmbLgbLgbLsbLgbRsbLgLsbLibRhbRcbRg
bRgbRgbRgRsmbLcbLiLsbLsbLgbLsbLgbLgbRsLgbLgbLgbLgbLgbLgbLsLsLsmmbLgLsb
LgbLsbLgbLgbLgRsbLsbLgLsbLsLsmbLgbLsLsmbLgbLgLsbLsbLgLsbLsLsmbLgbLgbLi
bRjbLiLsbLgbLsbLsLsmbLgbLobRobLgbLsbLgbLgbLsbLgbLgbLgLsbLsbReLsbLgLsbL
gbRsbLgbRhbLibLiLsbLiLsbRhbRhRhbLibLhbLgbLgbLsLgbLgLsbLsbLgLsbLgbLgLsb
LsbLgLsbLgbLgbLgbLgbLgLsbLgbLsLsmbLsbLibLsbLgbLgbLgLsbLgbLgbLgbLsbLgbL
gbRcbLcbRiRsmbLhLsbLsbLiLsLsmbLsbLgRsbLsbLgbLgbLgbLgbLsbLgbLgbRibLibLg
bLsLsLsmmbLgbLgbLsbLgLsbRjbLiLsLsmbLgbRibRcbRiRsmbLjbLcLsmbLibRebRoLsb
LjbLibLibRebLgbLgbLsbLgbLsbLgbLsbLsbLgLsbLsbLgbLsRsLsbLgbRsbLgbRebLsbL
sbLibLibRcRsmbLsbLhbLjbLsbLsLsmbLibLgbRiLsbLhbRibLibLgLsbRsbLjbRobRibR
gRsmbRsbLcbLiLsbLibLgbRgbLjbRgbLsLjbLgbLgbLgbLgLsbLgbRjbRjbRhbLcbLibRi
bLibRgbLibRjbLiLsbRjbRcbRebLibLjbLibRsbRgbLjbRibRjbRibLjbLhbRjbRibRgbL
sRsbLjbLcbRgbRsbLibLsLsmbLgbLsbLgLsbRebLibLsbLgbLsLsmbLsbLsLsmbLsbLsbL
gbLsbLgLsbLgbLsLsmbRsLgbLibRibRjbLcLsmbRcbLhLsbLsLsmbLsbLgLsbLsbLjbRcb
RibLibLsLsmbLsLgRsbLsLsmbLsbLgLsbLgbLiLsbRjbRcbRgbLhRsbLibRsRjbRibLjbL
ibLsLsmbLgLsbLsbLsbLsRsLsLsmbLsbLgbLgbLsLsmbLgLsbLsbLsLsmbLsLsmbLgbLgb
LgRsbLgLsRsbLgbLgbLsbLgbRgLsbLibLgbLsbRsLsbLiLsLsmbLsLsmbRsLsbLgbLgLsb
LgLsbLgbLgbLgbLsbLgLsbLsLsmbLsbLsbLgbLgbLgbLgbLsbLsbLgbLsbLgbLgbLgbLgR
sbLgbLgbRcbLcbLgLsLsmbLgLsbLgbLsbLgbLgRsbLgbLgbRsLgbRcbRhbLjbLibRsLibR
jLsbRhbRibRsRsLcmbLibLibLsbLsLsmbLibLsbRgbLiLsbLgLsbLsbLgRsbLsbLgLsbLg
LsbLsLsmbLgbRjbLjLsmbLgbRibRibRhbLibLibLibLgLsLsmbLsbLgLsbLsbLsLsmbLsb
LsLsmbLgLsbLgbLgbLgLsbLsLsmbLgbLsRsbLgRgbLgbLgRsbRcbRcbLhbLibLibRiLsbR
sRsmbLgLsbLsLsmbLgbLgbLgRsbLgbLsbLgbLgbLgbLgbLgbLgbLgLsbLgbLgbLgbRhRsm
bRibRibLgbRibRgbLjLcbLibLgbLsbLgbLgbLsbLgRsLsbLgLsbLgRsbLgbLgbLsLsmbLg
bLsbLgbLsbLgbLgbLgbRsbLgbLgbLgRsbLgbLgbLgRsbLgbLgbRsbLibsbRsbLibLgbLgb
RsLgLsbRcLsbRibLhbsbLgbLsLsmbLgLsbLgbLgbLgbLgbLgbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bRsbRgbLsRgbRsbRgRsmbRgRsmbRgbRgRsRsLsmmbRsbRgbRgbRgbRsbRsbRsRsmbRsbRg
bRgbRsbRsRsmbRgRsmbRsbRgRsmbRgLsbRsbRgbRgLsbRsLsbRgbRgRsmbRgbRhbLhbLib
RibRhRsmbLcbLgbLgbLgbLgbLsbLsbRebRhbRgbRgbRgbRgbRsbRgRsRiRgRsmmbRgRsmb
RgRsmbRgRsmbRgbRsbRgbRsbRgbRgRsmbLsLsmbRiRsmbRgRsmbRsRsmbRgRsRsmmbRgRs
RimbRibRgbRsbRgbRsRsmbRgbLiLhbLibLgbRobRibLjbRsbRhbLgbRibRjbRsbRsbRgRs
LsmbLgRsbRgRsRsmmbRgbRsbRgbRgbRgbRsbRsbLsRgbLsbRgRsmbRgbRgRsmbRiRsRimb
RsbRgbRgbRgbLgbRibLcLibLgbLgbLiRsbRhbRcbRgbRgRsmbsbRsRsmbRgLsbLsRsbLsR
gRsmbRgRsmbRgRsmbRsbLsRsbRgRsmbRgbRsbRgbRgRsmbRgbRsbRgRsmbLgbRiRsmbRgb
LsbRjbLhRsbRgRsRsmmbLsbRgbRgRsmbRsbRsbRiLsbLcbLhbLgbLgbLsbLibRjbRebRgR
smbRiRsmbLsRsbRgRsmbRgbRgbRgbRsRsmbRgRsmbRsRsmbRgRsmbRgLsbRgRsmbRgbRgL
sRsbRgLsbRsbRgbRsbRgbRsbRsRsmbRgbRgbRiRiRsRgRsmmbRibRgbRibRgbRgbLjbLsR
sbLcbLibLgbRhbLhbRcLsbRiRsmbLsbRibRsRsmbRgRsmbRgLsbRsbRsbLgbRsRsmbRgbR
gbRgbRsbRgbRsbRsbRgbRsbRgbRsbRgRsmbRgbRgRsmbRgRsmbRgbRiRsRsmmbRgbRgbRg
bRsbRgRsmbRsLsbRgbRsRsmbRsbRsRsmbRgbRgRsmbRgbRibRgbLsRsbRgRsmbRgRsmbLc
bLibLibLgLsbLsLsmbRjbRoLsbLgbLhbLgbRcbRgRsmbRgbRsbRsbRgbRgRsmbRgLsbRgR
smbRgRsmbRsbRibLjbRhbLgbRibRgbLobLibLsLsmbRsLsRsbLsbLgRsbLgbLgbLobLgRs
bLgbLgLsbLsbLgbLsLsmbRebRhbsbRsLsbRhbLgbRibRgbLibRibRgbLgbRgbRgLsRsbRg
bRgRsmbRsbRgRsRsmmbRsRsRsmmbRgRsmbRgbRgbRgLsbRsRsmbRgbRgbRgbRgRsmbRsbR
sRsLsmbRsRsmbRgLsbRgRsmbRgRsmbRgbRsbRgbRsbRgbLibLjbRsbLgLsbLgbRjbRcbLs
bRgbRsRsRsmmbRgbRgbRgbLgbRibLgbLhRsbLiLsbLibRsbLibRcbRhRsmbRgRsmbRsbRs
RsmbRsbRsRsmbRgRsmbRgbRgLsbRgRsmbRgRsmbRsbRgRsRsmmbRgRsmbRgbRgbRgbLjbL
hbLibLgbLgbLgbRgbLibRsLsRsbLibRcbRcRsmbLsbRiRsRsmmbRgRsmbRsbRsbRgbRsRs
mbRsRsmbRsbRgbRgbRsRsmbRsRsmbRgbRgRsmbRsRsmbRjbRsbRsbRgRsmbRgbRgRsmbRg
RsmbRgRsmbRsbRgRsmbRsRsmbRsbRsRsmbRsLsbRgRsmbRgbRgbRsLsbLsLobRebLsbLib
LsbRibRjbLsRsbRgbRsbRsRsmbRsRgbRgbRgbRgbRgRgbRgRsmbRgRsmbRgRsmbRsRsmbR
ibRgbRsRsmbRgbRgbRgbRcbRcRsmbRibRgbRgbRgbRgbRgbRsbRsbRsRsmbRgLsbRgRsLs
mbLjbLibLsLsmbLibLoLsmbRhbRibRsbRibRgbRgbRsRsmbRsbRsRsmbRgbRsbRgbRgRsm
bRgbRgRiRsmbRiRsmbRgRsmbRsbRsbRgRsmbRgbRgLsbLebLiRsbLiRsbLsLsmbLibRjbR
cbRiRsRsmmbLhbRcbRibRsbRsRsLsmbRgLsbRgbRgRgbRgRsmbRgbRgbRsbRgRsmbRsbRg
bRsRsmbRgLsbRgRsLsmbRgRsmbRsRsmbRsbLsbRgbRgLsbRgRsRsmmbRsRsmbRgbRgbRgb
RsRsmbRgbLsbLebLibLibLgbRcbRgRsmbRsbRsRsRsmmbRgRsRsmmbRgRsLsmbRgRsmbRg
bRgRsLsmbRgRsRgRsmmbRgbRgRgbRgRsmbRgbRsbRgRsmbRsbRgbRgbRsbRibLhLsbRcbL
ibLibLiRsbLgLsbLsRsbLsLsmbLgLsbLsLsmbLgRsRsmbRcbRcbLjbLhbRjbRcbRsbLsbR
iRsmbRgbRsRsmbRsbRgbRgLsbRgbRgbRgLsbRgbRsbRgbRsRsmbRsbRsRsLsmbRgbRgRsm
bRgbLobRgbRsbRgbRgbRgbRgbRgbLsbRibRgbRgRsmbRgRibRgbRgbRsbRgbRgRsmbRgbR
gbLcbLhLsbLgbLgbLibRhbsbRebRsbRiRsmbRsbRgRsmbRgbLobLibLsLsmbLgbRsbLgbR
sbLhbRcbLsRsbRibRgRsmbRsbRsRsmbRsRsmbRgRsmbRsbRgbRgbRgbRgbRgbRgbRgRsmb
RsRsRsmmbRgbRsbRgbRsRsmbRgbRibRgbRgRsmbRsbRgbRgRsmbRgbRgbRsbRgbRgRsmbR
sbRgbRgRsmbLsRgRsLsmbLjbLsbLcbLgbLgbLgLsbLsLsmbLsLsRsmbLgLsbLsRsbLgbRc
bRibRgRsLsmbRgbRgbRebRcbRiRsmbRsbRgbRsbRgbRsbRsbRgbRsbRsbRgRsmbRgRsmbR
gRsmbRsbRgRsmbRsRsmbRsbRgbLsbRgbRgbLcbRibRiRsmbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bRsbRsbLsbRibRhbLjbLsbRsbLgbRsbRgbRhbRgbLsbLsbLgbRhLsbRsbLgbRgbLsbRsbR
sbRgbLsbRgbRjLsbLsbRobRsbLebLiRsbLsbLsbLgbRgRsmbLsbRsbsbLsbLibLsbLsbLs
LsmbRgbLibRsbRsbLgLsbLsLsmbRsbLsbLsbLsbLsbRsbLgbLsbLsRsbLsRsbLgbLsbLgb
LgbLsRsbLgbLsbLsbRsRsmbLgbLsLsmbLsbLgRsbLgbLsbLgbLgbLgbLibLsbLgbLsbLsb
RsbRgbLcbLibLsbRsbRsLsbLiLsbLsbsbLsbLibLibLibRsbRgbRsbRsbRiRsmbsbRgbLs
bRibRiLsbRsbsbLsbRibRsbLjbLgbLcbRsbRgbLhbRgbLibRsbRsbLgRsbLsbLsbLsbLsb
LsbLgbLsbRjbRibRibRsbRgbLcbLgbRsbLgbLsbLsbLgbLgbLsbsbRgLsbLibLsbLgbLob
LgbRobLsRsbLgLsbLsRsLsbLsLsmbLsbLsbLsLsmbLgbsbLsbLgbLgbLgbRgbLgbLibLib
RsRsmbLgbLgbLsbLiRsbLsbLibLibRsbRsbLsbRgRsmbRibRsRsmbRsbRgbLjbRibLgbLs
bRibRgbRibRsLsbRsbRgbRsbRsbRgbRgbLjbLibLibLsbRsbLgbLibRibRsbLsLsmbLsbL
hLsbLsbLgbLsbLgLsbLgbRsbRgbLibRsLsbLgLsbLgLsbLgbLsbLgbLgbRgbLgbLsbLsbL
gbLgbLsbLsbLsbLsLsmbLgbLgbLsbLsbLgbLsbLsbLsbLsbLsbRsbLgRsbRsbLibLgbLgb
RsbRsbRgbLgbLgbRobLgRsLsbRsbLgbRsbLibLsbsbLgbLgbRjbLibLgbRsbLsbLsLsmbL
sRsLsbRsbLgLsLsmbLgbRebLgbLsbRjbLgLsbLgbLibRsbLgbLsbLsLsmbLgbLgbLgRsbL
sbLsbLsbLgbRcRsmbRibRibLjbLebLibRsbLibRjbLgbLhRsbRibLgbLgbLibLsbRsbLgL
sbLgbLgbLgbRsbRsbLibLsbRsbLgbLgbLsbLgbLgbLsbLsLsmbLsbLsbLgbLsbLsbLsRsL
sbLgbRsbLibLsbRsbLsbLsLsmbLsbLgLsRsbRsbLsbLgLsbLsLgbLsbLsbLgbRsbLgbLsb
LsbsbLsLsmbLsbLgLsLsmbLgbLsbLgRsbLgLsbRsbRsRsmbLsbLsbLsbLcbLibLgbLsbLs
bRgbLsbLsbLsbLcbLsbLsLsmbLsbLgbLgbRibsbLgbLsLsLsmmbLgbLsbRsbLsbsbLsbLs
bLsLsRsmbLgRsbLibLgbRsbLsbReRgbRgbRibRsbLgLsbRibRgbLgbRibRsbRsbLgbsbLe
bRsbLibLgbLsbLjLsmbLsbLjbLgbLsbLsbLhLsbLsbLgbRibRcbLjbLsbRcbRgbLgbRgbR
sbRsRsLsmbRjRsmbRgbRibLgbLibLgbLgbLsbsbLsbLsbLsbLsbLsbLgbLsbLgbLhbLsLs
mbRgbLsLsmbRsbLibRcbLsbLebLsbLsRsbLsbLibRgbLsbLgbLgbLsbLsbLsbLsbLsbLgb
LsLsmbLsRsbLgbLsRsbLsbLsbLgLsbLgbLsbLsbLgbLsbLsRsbLsRsbLgbLgbLsbLsbRsb
LsbLsbLgbLgbRsLsbRcbRgbRgbRsRsmbRsRsmbRibLibRcbLsbLsbRgbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bLsbRgbRsRsmbRhbRsRsmbRsbLsbRsLsbRsLsRsbLsRsbLsbsbLsbsbRsbRjbsbRsbRsbR
sbLsbLjRsbRgbLgbLebLgbLgRsbLibRgbLibRsbLsbLibRibLibLcbRibRsbLiLsbLibLs
bRsbLcbLibLsbRsbRgbLibRgbLgbLibRsbLsbLgLsbLsbLgbRgbLibRjbLiLsbLiLsLsmb
RgbLiRsbLsbLgLsRsbLgLsbLsbLgbRsLsbLgbRjbLiLsbLgbLjLsmbRibLgbLjLsmbRgbL
ibLjbRhbRibRhbRibLhbLiLsbRcbRibRcbLgbRibLsbLsbLjbLibLibLgbRhbRebRibRsb
RibLsbRsRsmbsbRgbRsbsbLibsbRgbsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bsbRsLsbRsbRsbRgbRsbLsbRsbRgbRsbRgbRgbRsbLgbsbRsRsmbLsbLsbRsRsmbLjbRsR
smbRsbLsbLsbRgbRsbRsbRgbRgbRsRsmbRgbRgbRsLsbLgbRibLhbLsLsmbLsbLsbLgLsb
LgLsbLsbLsbLsbLsbRibLsbRcbRsbsbLjbRsbRgbRgbRsbRgbRgbLgbRibRgbLsbRibLgb
RcLsbLibLibLibLgbLsRsbLsRsbLsbsbLsbRiLsbLgbLsbLgbLgbLsbLsbLsbLsbLsbLsb
LsbLsbsbLgbLgbLgbLsbLgbLsbRsbLiRsbLsbLsbLjbLsbRsRsmbLgLsbLgbLgbLsbLsbL
sbLgbLsbsbRsbRoLsRsbRjbLsbLsbRgbRsbRgbRgbLgbRibLjbLobLibRgbLgbRsbLgbLg
bRgLgRsbLgbRjbRibRibRgbRgbLsRsLsbRgbLcbRjbRibLcbLibRjbRibRgbRgLsbRgbLj
bLcbLgbLgbLsbRsbLgbLgRsbLsbsbLsbLsLsmbLsLsmbLsbLsbLsbLgbLgLsbLsbLgbLsb
LsLsmbLcbRibRjbRjbLsRsbRgbRsRiRsmbLjbRibLibLgbLsLsmbLsbLsLsmbLgbLsbRsb
RsRsmbLgbLsbLsbLgbLsbLsbLhbRgbLsbLsLsmbLsbLsbLsLsmbLgbLsLsLsmmbLgbLsbL
sbRsbRjbRgRsmbLcbRgbLsbRsbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bLsbRhbRsbRjbRhbLsbRgbLsbRgbRsbRgbRgbRsbRsbRsbLgbLcLsmbLhbRsRibLibRsbL
iLsbLsbRsbLgbLsbLibRsbRjbRjbRgbRgbRgRsmbLjbLcbLgbRgbLsbRsbRsLjbsbLsbRg
bRgLsRsbRgbsbLsbLsbLsbLsbLsbLsbLgbRsbLgbLsbLsbLsbLgbRcbRgbRibLgbLcLsmb
LiLsbLgbLgbLgbLgbLsbLsLjbLsLsmbRsbLsRsbLsbLgbLgbLgbRgbLsRsbLibLsbLsbLs
bLgLsbLsLgRsbRhbRcRsmbLsRibLgbRibLsbRgbRgbRsbRsbRsbRsbRsbRsbRgbLjbLhbL
ibRgbLibRgbLgbRsbLibLgbLsbLgbLsbLgbLsbRibRibRjbRsbRgbRsbRgbLobLgbLsbLg
bLsbLsbLgbRjbRgbRgbRibLgbRjbLcbLobLibLibRgLsbLsRsbLjbLsbLsbRsbLsbLsbLg
bLgbLsbRsbLhbRhbRgbRgbLjbLcbLibLsbLsbLibRsbLibRgbLcLsmbLgbRsbRjbsbRibL
ibLiLsbLsbLgbLsbLsbLgbLgbLsbLsbLsbLsbLgbLgbRgLsbLgbRsbRjbRgbRsbRsbsbsb
RsbRsRsmbRgbRsbRgbRsbRgbRsbRibLcbLcbRjbRcbRgbLcbRcbRjRsmbLcbLgbLgbLgbL
gbRjbRibLcbLibLibLgbLsbLgRsbLibLsbLsbLgbLgbLsbsbLsbLsbLsRsbRjbLcLsmbLi
LsbRjbLibLiLsbLsbLgbRjbLcbRgbLgbLsbLsbLsbLgbLgbLsbLgbRgbLsbLgbLsLsmbLg
bRgbLgLsbLsbLsLsmbRgbLjbLsbLgbLgLsbLgbRsbLsbLgbLsbLgbLgbLgbLgbLgbLgbRg
LsbRjbLcbsbRsbLsbLsbRsRsmbLgRsbLsbRsbLgbLsbLsbLgbLgLsbLibRgbLgbLgbsbLs
bLsbLsbRsbLsbLsbLsbLsbRsLsbLsLsmbLgbLgRsbLgbLsbLsbLgbLibRgRsmbLgLsbLgL
sbLgbRgbLiLsbRgbLibLgbLsbRsbLsbLjbLgbLsbLsbLsbLsbRsbLsLgbLgbLgbLgbRibR
iRsmbRibLjbLibLgbLgbRsbLibLsbRsbLgbLgLsbLsbLgRsbLsbLsbLsbLsbLgbLsbLgbL
gbRjbLibLsbRsbLsRsbLsLibLgbLgbLgLsbLgbLsbLsbLsbLsbLsbLgbRgbRsLsbLsbLgb
LgbLgbLgRsbRcbRebLgbLibLgbRgbLibRgbLjbRgLsbsbLsbLgbLsbLgbLsbLsbLsbLsbL
gbLsbLsbLgbLsbLsbLgbLsbLsbLsbsbLsbLsbLsbRgbsbLgbLgbRsbRjbLhLsRsbLgbLsb
LgbRcRsmbLsRebRsbsbLsbLsLsmbLoLsmbLgLsbLgbRsLgbLsbLsbLsbLgbRsbLsbLgbsb
RgbRgRsmbLiLsbRgbLibLsbLsbLsbLgbLsLsmbLsLsmbLsbLsLsmbLgbLgbLgbsbRsbRjR
smbsbRhbLsbRsRibRsbRgbRgbRsbRgbLobLsLsmbLsbLgRsbLsbsbLgbLgbRibLsRsbLgb
LgbLgbLsbLsbLsbLibLsbLsRsbLsbLsbRjbLcbRjbLiLsbRsbLibsbLsbLgbLgbLgbLgbL
sbRgbLgRsbRgLsbRibRgRsmbRsbRgbLgbRiLsbLibLcbLibLsbLsbRibRibLibLcb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bRibRgbLgbRhbLgLsbRibLjbLjLgbLibLgLsbLsbLgbLgbLgbLgbLsbLgbLsbLgbRjbRcR
smbRibLgRsbRibLgbRgbRsbLobRcbRcbLsbRibsbRgbLgbRjbRgLsRsbRsbRgbsbsbRibL
sbRibLsbRgRsRsmmbLsRsbRgLsbRsLsbRgbRsbRjbLsbRsbRsbRgbRgRsmbRsbRsRsmbRg
bRgbRgbRsbRsbRgRsmbRibLjbLiLsbLibLgbRcbRibRgbRgRsmbLsbRgbRsbRgbRgRsmbR
sRsmbRgbRgbsbRsRsLsmbRgbRsbRsbRgRsRsmmbRgbRsRsLsmbRgRsmbRgRsmbRgbsbLsR
sbRgRsmbRgbRgRsRsmmbRgbRgbRgbRgRsmbRsbRgbRibRgbRsbLsbRibLsbRsRsmbLsbRi
bLgLsbsbRcbLibLjbLgbLgbLgRsbRcbRgbRsbRsRsmbRgbRgbRgRsmbLsbRgbLsbRibRsR
smbRsbRgbRgbRsbRgbRgbRsbRgbRsbRgbRgbRgRsmbRgbRgbRgbRsRsmbRgbRgbRgbLgbL
cbLgbLgLsbLgbRsbLsbLgbLgbRebRobRibLsbRibLsbLobLcbLibRcbsbRiRsmbRgRsRsm
mbRgRsmbLsbRibLjbRiRsmbRgbLsbLgRsbRibRgRsmbRibLgbRibRibLjbRiRsmbLgbRib
RgbRsbLjbRibRgbRgbRsbLjbRgbRgbRgbLsbRibLgRsbRibLsbRibsbRsbRgbLsbRgbLsb
RibRgbLgbRibLcbLiLsbLgbRebRibRibLibRiRsmbRgbLibRiRsmbRgbRgLsbLsbLhbLib
LiLsbRcbRcLsbRsbRibRgbRsbRsRsmbRibLgbLebLgbLgbLgbLgLsRsbLgbLsbLobRhbRg
bLcbLibLgbRhbRiRsmbRgbRgbRgRsmbRgbRgbRgLsbRgbRsbLsbRiRsmbLgbRsRsmbRibL
sLsmbRibLgbRiRsmbRgbLsbRgbRibRgbLgbRibRsLsbRibRhbLgbLhbLibLibLgbLgbLsb
LsbLsbLgbLsbLgbLsbLsbLgbLgLsbLgbRsLsbRsbLgRsbRcbRjbRgbRgbLsbLsRsbRiRsR
smmbRibRibLgbLgbLhbLgbLgbLgbRsbLgbLgbLgbLgLsbLsbLgLsbLsRsbLgLsbLgbLgbL
sbLibRhbRhbRibRgbLsbLjbRhbRibRsbRsbRsbRgbRgbRsbRgbRgbRgbRgbRgbRsRsmbRg
RsmbLjbRibLibLibLgbLgbLgbLgbLgbLgLsbLsbLgbRsbRcbRgbRgbRgbRsbRgbRsbRgbR
gbRgRsmbRgbRgbRgbRgbRsbLsRsbRsbRgbRgbRgbRgbRsbRgbRsbRgbsbRsbRsRsmbRgRs
RsRsmmmbRsRsmbRgbRgbRgbRgbRgbRsbRgbRgbRsbRgbLjbRibLjRsbLsRibLjbRgbRiRs
mbLcbLgbLgbLgbLgbLsLsmbLsLsmbRsbLgbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bLibLsbRsbLsLsmbLgbLsbLiLsbLsLsmbLsbLibLsLsmbLgbLsbLsbLsbLibLsbRsbRsbR
sbLsbLsbLiLsbLibLsbLsbLibLgbLgbLsbLgbLgLsbLsbLibLgbLsbLiLsbLgbLsbLsLsm
bLsbRsbRsbLibLsbLgLsbLsbLsLsmbLsbLgbLgbLgbLibLgbLgbLsbLsbLsLsmbLjLsmbs
bRiRsmbsbsbRsLsbRsbLibLgbLsbLebLsbRibLibLibLibRsbRsbLgbLsbLgLsbLsbLsbR
sbLgbLsbLgbLibLgLsbLsbLsbLsbLsbLgbLsbLsbLgbLsLsmbLsbRsbLibLsbRsRsmbRsb
RsbLibLgLsbLibLsbLsbLsLsmbLiLsbLsbLibLsLsmbLgbLsbLiLsbLsbLsbLsbLsLsmbL
sbLsbLibLsbLibLsbLsbLibLsbLsbLgbLsbsbLgbLgbLsbLsbLgbLibLsbLgbLibRsLsbL
sbLgbLsbRgbRsbLibLibLsbLsbLsbLibLsbLibLiLsLsmbLsbLibLsLsmbLsbLsbLsbLib
LibLsLsmbLibRsRsmbRibLibLsbLibLsbLsbLsbRsLsbRsbLibLibRsbLibLsbLsbLibLs
bLgbLhbLsbLsbLsbLsbRgbLsbLjLgbLgbLgbLsbLsbLsLsmbLgbRsbLgbLsbLgbLsLsmbL
sbRgRsmbRsbLibLgbLsbLsbLsbLiLsbLsbLsbLsbLsLsmbLgbLsbLgbLgbLsbRsbLgbLsb
LsLsmbLsbLibLgbLibLsbLsbLgbLsbLsbLgbLibLsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bLsbLgbLgRsRsmbRgbsbsbLhbRibRibRsbRsRsmbRgbRgbRgbRibRibRsbRgbRsbRsbRsb
RsbRsLobLiLsbLgbLsbLgbLsbRsbLgbLgbRgbRjbRhRsmbRgbLjbLcLsmbLiLsbRgbLgbR
sbLgbLgbRsRsmbLgLsbLgbLsbLgbLsbLgbLsbLgbRgbLibRgbLgbRsbLgbLsbLgLsbLgbR
jbRcbRibRgbRgbLgbRcbLibLibLiLsLsmbLsbLgbLsbLgLsbLgbLsbLsLsmbLsbLsbRsbL
gLsbRgLsbLibRgbRsbLgbLgbRgLsbLgbRgbLiRsbRgRsmbLibRjbRsbLgbLsbLgbLsbLgL
sbLsbLsbLsRsbLsLsRsmbRsbLgbRgLsbLgbLgbRjbLhbLibRsbRgbRjbRibRibRibRgRsm
bLjbRgbRibLobLsbLgbRsbLibRsbLgbLgbLsbLgbLsbLgbRsbLgbRgbLiLsbRgbLgbLsbL
gLsbLsbLsbLgLsbRsbLgRsbRsbLgbLgLsbRjbLgbsbLgbRsbRgbRhbRibRgbLsbRcbRsbL
sLsmbLcbLsbLibRgbLibRsbLiLsbLsbLgbLsbLgbLsbLsLsmbLgbRsbLgbRsbLgbLibRgR
sRsmmbLibRjbRobLcbLjLsmbRibLibRsbLgbRsRsmbLsLsmbLsbLsbLjbLsbLsbLsbLsbL
gLsbLsbLsbLsbLgbRsbLgbLjRsbLgbRibLibRjbLiLsbLsbLsbLgbLgbRibRcbRiRsmbRs
RsmbRgbLgbRibRiRsmbRcbRiRsmbRgbRgbsbLsbRibRgbRgRsmbLcbLhRsbRgbRgbRibRg
bRgbRgbLcbLibLibLgbRgbRiRsLsmbRiRsmbLcbLgLsbLgbRgbRsbLhbRgbLibLsLsmbLg
bRsbLgbLgbRgbLsLsmbLgbLsbLgRsbLhbRibLibLsLsLsmmbRgLsbLibLjbLsbLsbRsLsb
LgbLsbLsbLgbRsbLibRjbRhbRibRsbRibLcbLiLsbLsbLsbLsbLgRsbLgLsLsmbRgRsmbL
gbLgbRjRsmbLibLsbsbLsLsmbRsbLsbLsbLsbRsbLsbLsbLgbLgbLgbLgbLgbLgbRcbLhb
LcbLiLsbRibLsbRcLsbRiRsmbLsbRgbLsbRibLgbLjbLibLgbRsLsbLgbLsbLgbLsbLsLs
mbLgbLgbLsbRsbLjbLsbRsbLsbLgbLsbLgbLgbRsbLgbLibLsRgbLgLsbLsRsbLsbLsbLg
bRgbLgbLgbRgbLibRgbLjbLsLsmbLsbLsbLsbLsbRsLsbRgbLsbLgbLsLsmbLibLibRibR
gbRjbRibRgLsRsbLjbLcbLgbLsbLgbLgbLsbLsbLgbRjbLiLsbLgbLibRibRgLsbRjbRhb
RgbLsLsmbRsbLsbLjbRoLsbLsbLgbRibRgbLcbLibRsbLgbLgbLsbLgbRsbLgbRsbLsbRs
bRgbLgbLjbLsbLsbLsbLsLsmbLsbLgbRsbLgbLibRobRhbRibRsbLgbRibRibLcbLibLib
LsbLsbLgbLsbLsbLgLsbRgbLgbLsbLgbLsbRgbLibRcbRcbRibRgRsmbLgbRgbRgbLgbRi
bLjbLebLibLsbLsbLgbLsbLgbLsbLgLsbRsLsbLibRjbLgbLiLsbRgbLiLsbLsLsmbLgbL
sbLgRsbRsbLgbLsbLsbLsbRsbLsbLgbLgbLsbLgbLgbLgbLgbRsLsbLgbLsbLsbLgbLsbL
gbLsbLsbLgbRsbLgbLgbRibRsLibLibRibLgbLgbLsbLsbLsRsbLgbLsbLjbLsbLgbRgLs
bLibLhbRsbLsbLgbLgbLsbLgbRgbLiRsLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bLjbRjbRibRgbRibRgbRsbLsbLgbRjbLcbRsRsmbRjbRiRsmbRsbRsbRiRsmbRsbLiLsbL
ebLibLjbRhbLibRgbLjbLcbRhbLjbRibRibLgLsbLgbLjLsmbLsRsbLiLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 25; Drug: Control Apo 0.5 然
bRsbRsbRgbRgbLhbRcbLibRibRgbRsbRgbRsbsbRsRsmbRsbRsbRsbRgbRgbRgbRgbRgbR
gbRsbRgbLsRsbLjRsbLsRibLjbRibRgbRgbRgbRsbRsbRgbRgbRsbRsbRsbsbLgRsbRgbL
jbRibRibRgbRsRgbRgbRsbRgbRgbRgbRibRgbRsbLsbLsbRgRsLsmbRgbLjRsbRhLsbLcb
LjbLcbLibRgbRibRsbLjbLcbRhbRcbRsRsmbsbLgLsbLjbRibRsRsmbRgbRsbRgRsRsRsR
smmmmbRgbRgbRgRgbRgbLsbRgbRgRsRsmmbRsbRgbRsbRgRgRgbRgRsmbRgRsmbRsbRsbR
jbRibRsbLibRgbRibRgbRgbRgbRgbRgbRsRsmbLsbsbRsRsmbRsbLgbRsbRibRgRsmbRib
RgbLibRcbLibRiRsLsmbLsLsmbRgbLsRsRsmbRsbRsbLgLsbRsbRibRsbRgbRgRsmbRgRg
bRgRgRiRsmbRgLsbRsbRgbRibRibRgbLsRgRsmbLibLibRjbRhbRgbRgLsLsmbRgbRsbRg
bLsRsbRsbRgbRgbRgbRibLibRibRgbLjbLcbRcRsmbRiLsbRgRsRsmmbRsbLgbRgbRgbRg
bRgRsRgRsmmbRgbRgbRsRsmbLsbRsbsbRsbRsbRsbRsRsmbRgbLsbRgRsmbRsbRgbRsbRs
RgRgbRsbLsRsbLsbRgbRsRsmbRgbRgbRgRsmbRgRiRgRsmbRgRgRgbRibLibRibRgbRgbR
gbRgbRsbRgRgRgbRgbRgbRgbLjbRiRsRsmmbLsbRsbRgRgRgRgRibRsbRsbRhbLjbRcbLi
bRibRjbLjbRjbRgbRgbRsbRgRsRsmmbRgbLsbLsbRgbLjbRcbLhbRcbRibLibRcbLgbRib
LjbLhbLcbRhbRcbLibRebLsbRgbRgRsmbRsbRsRsmbRgbRsbRsbRsbLsbRgRsmbRgRsmbR
gbRgbRjbLgbLcbLibRjbReLsbRibLcRsbLibRjRsmbRsbLjbRhbLjbRibRgbLgbRibRsbR
gbLsLsmbRgbLsbRjbRsbLjbRhLsLsmbLgbRgbRgRsmbRsRsmbRgRsmbRsbLsRsbLhbLibL
jbRiRsmbRcRsmbLsbRjbRgbRsbRgRsmbRgbRgbRgbRgbsbRgbRsbRgbRsbRgbRsbRgbRsb
RgRsmbLsbRibRgbRsbRsbRsbLsLsmbLjbLhbRjbRjbLjbRcbRgbRgbLsbRibRsbRjbLjbR
cbLjbRibRibRgbRibLgbRjbLgbRsbRgbRgRsmbRsbRgRsmbRgbLsbRgRsmbLsbsbLsbLsL
smbRibRsbRgbRgRsmbRsRsmbRgLsbRgbRsRsmbRgbRgbRgLsbLsLsmbRsbLsbLjbRibRgb
RsbRgbRibRgbLibRiRsmbRgRsLsmbRgbLsbRsbRsbRgRgbRgRsmbRgbRsbRhbLsbRgLsbR
sbRgbRgbRsRsmbLsbRgbRsbRgbRibLhbRhbRgRsmbRsbRgbRgbRsRsmbRsbRgbRgbRgbRs
bRsRsmbRgbLsRjbsbRsbRgbRgbRsbRsbRsRsmbRsbRgbRgbLgbRibLgRsbRiRsRgmbLibR
iRsmbRgbLjbLsbLcbsbsbRcbRhbLibRhbRibLibRibRgbRsbRibRgbLibRgbRgRsmbRgRs
RsmmbRsbRgbRgbRsRsmbLsbRsRsmbRhRsmbLibRibRibRgRsmbLibLgLsbLibLgbLgRsbR
hbLibRcbLgbsbRibRsLsbLsbRsbRsbRgbRsRsmbRsRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 26; Drug: Control Apo 0.5 然
bRsRsmbRgbRsbRgbRsRsmbRsLsbRgbLsbsbLsbRsbRgbRsbRgRsmbLjbRibLgbRgbRsRsm
bRsbRgbRsbRgbRsbRsbRgbRsRsmbLsbRgRsRsmmbLsbRibRsRsmbRsbRgbLsbRgbRgbRsb
RibLcbLcLsmbLibLgbLcLsmbLibLsbRibRsbRgbRsbRsbLsbRgbRgbRgbLsLsmbRiRgbRs
RsmbRgbRsbRgbRgbRgbRsbLsbRibLibRibLsbLjRsbLcbLibLhbLgbLgLsbLebLgLsbLgb
LsbRibLjbLcbLibRsRsmbLgbLgbLiLsbLgbLsbLiRsLsbLgbLsRsbLiLsLsmbRobRgbRsb
RgbRsbRsbRgRsmbRsbRgbRgRsmbRgbRgbRgbRgbRgRsmbLgbRibLjbRibRebRcbRcRsmbR
ibRgbRsbRsRsRsmmbRgbRsbRgRsRsmmbRsbRgbRgRsmbLgLsbRiRsmbRsbRgbRgbRgRsmb
RgbRgbRsRsmbRsbRgbLsRsbRsbRgbRgRsmbRgRsRsmmbRsbRgbLsbRibLgbLjbLjLsmbLc
RsbLibLcbLibRgRsmbRiRsmbRgbRibLibLsbLiLsbLibRhbRcbRhbRsbRgbRsRsmbRhbRs
RsmbRgbRsbRgbRsRsmbRgbRgbRsRsmbRgbRgbRsbRgRsLsmbRsRsmbRsbRgbRsbRsbRgbR
sbRsbRgbRsbRgbRsbRgRsLsRgmbRgbRgbRsbRgRsmbRsbRsbRgRsRsmmbLgRsbRibLjbLc
bLibRjbLcbRiRsmbRcbRgRsmbLsRsbRsbRgLsbRgbRgbRsbRgbRgbRgbRgRsmbRibRgbLg
RsbRibRsbRsbRibRgRsmbRsbRsbRibLgRsbRhbRsRsRsmmbLsRsbRsbRiRsRsRsmmmbRgb
RsbRgRsmbRgRsmbRsbRgbRgRsmbRsbRgRsmbLgbRibLgbRibRgRsRsmmbRgRsmbRgbRgbR
gbRgbRibRibLgRsbRobRibRibRgbRiRsmbRsbRgbRsbRgRsmbRgbRgbRgbRgbRgbRgbRsb
RgbRgbRgbRgLsbRsbRsbRsbRiRsmbLgbRsRibRsbLsbRgRsmbRgRsmbRgbRsbRgbRgRsmb
RgbRgbRsRsRsmmbRgbRsRsmbRgbRgbLgbRibRgRsmbLgbRiRsmbLgbRiRsmbLgbRibRsRs
mbRgbRsbRgbRsbLsRsbRsbRgbRsbRgLsbRsbRgbRgbRgbRsbRgbLgbRibLjLibLibRjbRc
RsmbRgbRgbRsRsmbRsbRibRgRsmbRsRsmbRgRsmbRgbRgbRebRibRcbLsRsbLiLsbLcbLc
b

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 27; Drug: Control Apo 0.5 然
bLsbLgbLgbLgbRgbLibRgbLgbLsbLsLsmbRsbLgbsbLsLsmbLgLsbLsbLsbLgbRgbLgLsb
LgbLsbLsbLsbLgbRsbLgbsbRgbLgbLsLsmbLgbLsRsbLsbLgbRgLsbLiLsbLgbLsbLsbLs
bRsbLgbRsbLgbRsLsbLgbRsLsbLgbLsbLgbRjbRibLjLsmbLibLibRsbLsLsmbLgbLgbLg
bLgbLsLsmbLgbLgbLgbLsbLgbLsbLgbLgbLgbRcbRgbRgbRgRsmbRiLsbLibLcbLgLsbLg
bRgbLibRsbLgbLgbRsbLibRjLsbLibLgbRgbLibRgbLgLsbLgbRsbLibRjRsmbLibRjbLi
bLgRsbRsLsbLgbLgbRcbRibRiRsmbRgbRsbLjbLhbLgbLsbLgRsbLgRsbRgbLsRsbLibRg
bLibRsbRsRsmbLibLsbLgbLsbLibLsbLgbLsbLsbLgbLiLsbRsbLgbLgbRsbLgbRjbLgbL
sLsLsmmbLgbRgbLgbsbLibLsbLibRsbLgLsbRgbLibRsLsbLgbLgbRsRsmbLgbRsbRgbRh
bLhbLgbLgbLsbLgbRsbRgRsmbLgbLgbLsRsLsLsmbLgbLsbLsbLgbLgbRgbLibRgbLsbLi
bLgbRgbLgbRsbLgbRsbLibRsbLgbRjbLibRsLsbLgLsbLsbLgbRsbsbLgbRsbLgbLsbLgb
LsbLsbLsbLgLsbLsbLsbLgbLgLsbLibRjbRhbLsRgbRgbRgbRgbLcbLibLgRsbLgbRjbLi
bRgbLgLsbRsbRebRgbRiRiLsbRcbRiLsbRgbRsbRsbRibRgbRgbRsbLcLsmbLibRgbLgbR
sbLgbRsbLgbLjbsbRsbLiLsbRsbLsbLsbLgbLgRsbLsbLsbLgbRibLcbLibLgbRsbLgbRj
bLiLsbRsbRjbLibLgbRibLsbLibLibRsbLgbLsbRsLsbLgbRsbLsbLgbLsbLgbLgbLsbLs
bLsbLsbLgbRjbRgLsbRgbRgbLcbRsbLiLsbLgRsbLsbLgbRgbLiRsbRsbLibLgbLsbLsbL
sbLgbLsbLsbLgbRgbLibLgbLsbRgbsbLibLsbRcbRibRsbRibLsbLjbLibLgbLgbLgbLgb
LsbLsLsmbRgbLibRgbLgLsbLgbRsLsbLgbLsbLgbRsLsbLgbLgbLsbLgbLibRjbLibLgLs
RsbLgbRgbRsbLibLgbRgbLiLsbRgbLibLsbLgbRsbLibRsbLgbLgbLsbLsbLsbLgLsbLgL
sbRjbRibRibRgbRiLsbLcbRcRsRsmmbRhbLgRsbRgbRibLiLsbRgRsmbRgbRsRgbRgbRgR
smbRgbRgbRgbLsbRgbRgRsmbRgbRibLjbLcbLibRsbLibRsbLgbRgLsbLibLhbLgbRsbLs
LsmbLgbLsLsmbLsbLsbRsbLgbLsLsmbsbRsbLsbsbLgbRsbLsbLgbLsLsmbLsbLsRsbLsL
smbLgbRgbLibRsbLgbRgbLgbLgRsRsRsLsRsmmbRibRgLsbRibLcbLsbLgbLgbLsbLsbRs
bRsbLibLsLsmbLgbLsLsmbLsbLgbLgbLgbLjLsmbLiLsbLibRgbLsbLgbRjbLhbLibLsLs
mbLsbLgbLgbLsLsmbLsbLgbLsLsmbLgbLsbLsbLgbLgbLsbLsLsmbRgbLgbLgbRgbLgbRg
bLibRsLsbLgbRsbLgbRsbLsbLsbLgbLsbLibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 28; Drug: Control Apo 0.5 然
bRgbRgbLgbRgbLgbLibLgbLsbRsbRibLsbLsLjbLibLibRgbLsbLibLgbLgbRgRsmbRibR
iRsmbRgbLgbRsbLsbRgbRgbRgbRgbLibLcbLibLgLsbLsbLgbLgbLgbLgbLibRgbRgbRib
RjRsmbRebRsbRcbLgbLsbLgbLsbRsRsRsmmbRgbLgbLsbLsbLsbRgbRsRsmbRsbLgLsbLg
bRgLsbRgbRjbLhbLsbLgbLiLsbRsbRsbRsbLiLsbLcbRsbRjRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 29; Drug: Control Apo 0.5 然
bRsbLsLsmbLsbLsbLsbLsbLgbLgbLsbLgbLsbLsbRcbRibRsbRibRsbRibLobLcbLgbLgb
RsbRibRgbRjbLhbLibLgbLsbRsbRjbLiLsbLgbLgbLsbLgbRsbLgbLgbRsbLgbLsbLgbLs
bLsbLsbRsRsmbLsbLgLsbLgLsbLsbLsbLsRsbLsbLgbLsRsbLsLsmbLgbRsbRsLsRsbLsb
LsbsbRsbLgbLsLsmbsbLgbLsbRcbRibLjbLhbLsbLsbLgbLsbLsbRibLsbLgbLgbRjbRsL
jbLsbLsbLsLsRsmbRsLsbLsLsmbLsbLsbsbLsbRsbLsbLsbLsbLsbLsbLsbLsbLgbLsbLg
bLgbLgLsRsbLgRsbRsbRhbRhbRibRsbRgbRgbLgbRibLcbLcbLgbLgLsbRsbRjRsmbRgbL
hbLibLgbLsbLiLsbLgbLgbLibRgbLjbLibLsbLsbLgbLsbRsRsmbRibRibRibRibLsRibR
hbRibRibRcbLsbRgRsmbRgbRgbLgbRibRhbRibLsLsmbLsbLsbLsbRgbLsbRgbRibRibRg
bLjLsmbLgbLibLjbLibLibLibLgbLibLsbLsbRibRibLgbLibLiLsbLibLsbRsbRsbRgbL
ibLibLgbRgbLibRgLsbLgbLsbRsbLsbLsbLsbLsRsbLsbLgbRjbLibLgLsbLgbLibRgbLg
LsbLgbLgbLgbLgLsbLgbLsbRibLcLsmbLgbLiLsbLgbLgLsbLgbRsbLsbLgbLsbLsbLsRj
bRhbRibRsbLsbRibLibLibLibLgbRsbLgRsbRgbLgbLgbLsbLsbLgbLsbLgbRsLsbLgbsb
sbLsLsmbLsbLgbRjbLhLsbRibRjbRgbRibRgbLsbRgRsmbLjbLibLibLgbLsLsmbLsbsbL
gLsbLsLsLsmmbLsLgbLgbLgbLsbLsbLsRsbLsLsmbLsbLsbLsLsmbLsbLgbLsbLsbLsbLg
bRgbLgbLgLsbLsbLgbLsbLsbLsbLsLsmbLsbLgbRgbLgbLgLsbLsbLsbLgbRjbRcbRibRg
bRgbRibLiLsbLgLsbLibLjbRibRgbRhRsmbLhbLibRjbRcbLibLjbLgbLiLsbLsbLsbLgb
LsLsmbLsbLsbLsbLsbLgbRgRsmbRibRibRgbRsbRsbRgbRsbLibLgbLibLsbLsbRsLsbLg
bLsbLsbLsbLsRsbLsbLsbLgRsbLgbLsbLsLsRsmbLsbLgbLsbLgbRsLsbLsbLsbLgbLsbL
gbLsbLgbLsbLgbLsbRcbRibRgbLsbRsRgbLjbLgLsbLgLsbLgbLsLsmbRsLgLsbLsbLgbL
gbLsbLsbRsbRgbRhbRibLsbRibLjbLcbLgbLgLsbLsbLsbLsLsmbLsRsbLsbLsLsmbLsLs
mbLsbRsbLsbLsbLsbLsbLgbLgbLgbLgbLsbLsbLsLsmbRgbRcbLebLibLgbLsbLgbRgbRs
bLgbLsRsbLsbLsbLsLsmbLgRsbLsbLsbLsLsLsmmbLsbLiRsbLgbLsbLsbLsbRgbRjbRhb
LjbRebLcbLibLgLsbRsbLsLsmbLgbLgbLsbLsRsbRsbLsbLsbLsbLgbRsbLsbLgbLsbLgb
LsbLsbLsbLsbLsbRhbRgbRibLjbLibRjRsmbLibLsbLsbLsbLsbLgLsbLsbLsbLgbLsLsm
bLsRsbLgbLsbLsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 30; Drug: Control Apo 0.5 然
bLebLobRobLebRsbLobLobRcbLgbLobLobLobRobRsbLebRobLebLgbLebLobRcbRobReb
LebLobRobRcbRebLebLcbLobLcbLhbRibLobRebRobRibRgbRhbRobRobRibRhbRebLebR
hbLebRebLgbLobLcbRibLsbRobLgbRcbLcbRcbRobRcbLhbRgbRebRebLobLobLebLebRo
bLebLebLgbLsbRcbLobLcbLebRobRobLcbLgbRobLobRobRcbLcbRobLobLgbLobRcbLgb
RobRobRcbLjbRobLobRebLgbRebRcbLobLcbRgbRebLobLobRobLebRobLobLobRebRgbL
cbLebRebLobLebRebRobLcbLebLibRcbLobRcbLebLebRobRsbLgbRebLsbRobLsbLebLh
bLobLibLibLobRibLebLebRcbRobLebRobLgbLcbRebRobLobLebLobLgbRobRebRcbRob
RobLibLhbLobRebRcbLhbLgbRobLobLcbLebLobLibLibRcbRobRibLsbLobLcbLibRcbR
ebRobRobRcbRobRebLibLebRobRcbLebRobLobLobRebLsbRibLcbRebRebLgbLhbRibRc
bLobRobLgbLobRobLobLobRsbLcbRobRebRgbRcbLcbRobLcbRebLebLibRobLcbRobReb
RgbRebRhbRobRcbLebLibLibLcbLobRgbRebRebLobRebRobRobLobRebLobRgbLebLebL
obLgbRibLgbLobRebRcbRebLobRebLcbLobLobRibLibLobRcbRibRcbLcbLsbRcbRobRo
bLebRcbRebLebLibLebRibRgbLebRobLobLsbRobRebLebRobRebRobLobLobLobRgbLob
RebLebRibRhbLcbLobRobRobLobRebRobRcbRobRobLobRobLobLebRgbLebLibLgbRobR
jbRgbRgbLobRsbLcbRgbRcbRobRibLebLobLobRibRcbLebLobLebRebRebLobLgbLcbRi
bLcbLobRobRebLcbRebLebLobRibLgbLsbLobRgbRcbRcbLobRibRebRgbRobLobRobReb
RobLobRsbRgbRebRgbRhbRcbRobLobLobRebLobRobRobRgbRobLobRjbLcbRobRobRebR
gbLobRcbLgbRebRcbRobRobRsbRebLcbLgbRobLobRobRsbRobRsbRobLobLobLobLobRg
bLebRcbRobLobLebLobRcbLsbRcbRcbLobLebLobRibRsbLcbRebRsbLgbRebRibRebReb
RjbLobRibRebRcbLebLobRsbLgbRibLobRcbLebLcbRsbLebRcbRobRibLebLcbRsbRobR
ebLibRcbLobRobRobLibLebRobRgbRibLobRgbLobRobRebRibLcbLobLobRebRcbLjbLe
bRebLcbRobLebRobLobRebLcbLobRebRobRebRobRobLobRebRgbLobRibLebRcbLsbLeb
RgbRobRobLibRibRebLebLebRcbRebRibLebLebRcbRobLobLcbRcbLobRsbRobLebRobR
obLobRsbRobRobLebLebLsbLcbLcbRebLebLcbLobRobLebRobRcbRjbLgbRobRobLcbRi
bLebRsbRcbLcbLcbLobLibLebLgbLibRebLibLebRibRobLcbRobRobLebLobLebLebReb
RibRcbLobLcbRebRobLebLcbLobLcbRobLebRebRobRobLobLobLebLebRgbRobRebLebL
obLebRgbRobLgbRebLebRhbLcbRobLibLobRebLebRobRebRobLcbLsbLobRebRsbLibLo
bLsbLobLgbRobLcbLcbLebRgbLsbRebLebLgbRobLobRebRgbRgbRobLebRobLcbLgbRgb
LhbRcbRobRobRobLebLcbLebRobRibRobRebRgbLobLcbRibLobLibRebRebRebRebLgbR
gbRebRcbLgbLgbLobLobLobLebLcbRcbLgbRcbLibRobLgbRibRebRebRgbLibLobRebLg
bRibRcbRcbRobRebLgbLcbRebLobRobRebRebRebLibRgbRebLobRcbLobLobLhbRcbLob
RebLobLobLebRobLobRebLgbRobLobRsbLebRobLobRobRobRebRobLobRobRebRobLjbR
ebLebLcbLebLebLgbLgbRibRebLobRcbRebRsbRobRjbLebLcbRcbLobRcbRebLebRebLh
bLobLebRebRebLcbRebLobRobRobRobLcbRobLebLgbLgbLebRebLibLsbRcbLcbLgbLcb
LgbRobLcbLibLebLobRebLob

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bLgbRsbLsbRsbRgbRsbLsbRibRsbRsbRibRsbRsbLsbsbRibRsbRibRibLjLsLsmmbRibR
sbRgbRsbLibRibRhbRgbLsbRsbRsRsmbLibRjRsmbLsbLsbLsbLsbRibLsRsbRibRibRib
LsbLsbRgRsmbRibRsbRgbRsbRgbRsbLgbLsbRgRsmbLsbLsbRiRsmbLibRibRsbRsbRibR
ibRsbLsbRsbRgRsmbRibRsbLiLsbRgbLebLsbLgbLsbLsLsmbRsbRgbRcbRibRibRsbRsb
RgbRsbRgbRibRgbRsbLsbLsbRibRsbRsbRgbLgbRsbLibRhbLibLsbLsbRsbRobRgRsmbL
sbRsbRsbRgbRsbRibRibLsbLsbRibRsbLsbRsbRsbLibRibLibLsLsmbLsbLgbRgbRjbRc
bRibRsbRsbLsbRgbRsbRgbRsbRgbLgbRibLsbRgbRsbRgbRjbRibRsbRsbRsbRibRgbRsb
RibRsbsbLsbRibRsbRibsbRiRsRsmmbRgbLsbRsbRsbRsbRsbRibRsbRibLsbRhbLiLsbL
gbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bLsbLsLsmbLsLsmbLsbLsLsmbLsbLsbLgbRsbLgbLsbRsLsbLgbLsbLsLsmbLsLsmbLgbL
sbLsbLsbLgLsbLsbLjbLsLsmbLsbLsbLsbLsRsbLgbLgbLgbLsbLgbLsLsmbLgbLgLibRg
RsmbRgbRgLsbRibRibLjbRgLsbLsbRibLjbRibRibRcbRgbLsbRibLsbLgbLsbLibLgbRs
LsbLsLsLsmmbLsLgbLgRsbLsbLsLsmbLgbLsLsmbLgbLsbLsbLgbLsbLgbLgbLsbLsLsmb
LibLgbLsbLsLsmbLibLgLsbRsbRgbLibLgLsbRsbLgbRsbRsbLibRsLsbLgbLsbLgbRsbL
gLsbLsbLgbLgbLgbRsbLgbLsbLsbLsbLgRsbLsbLgLsbLsLsmbLsbLgbsbRcbRibLhbLib
RibLcbRhbLcLsmbLibLgbLsbRsbLgbLgbLgbLsbLsbLibLsbLsbLsbLgbLgbLsbLgbRsLs
bLgbLsbLsLsmbLsbLgbRgbLiLsbLibLsbLsbLgbLsbLsbLsLsmbRsbLgbLgLsbLsLsmbLs
bLsbLsbRsbLgRsbRsbLsbLgRsLsbRsbLgLsbLsbLsbLsLsmbLgbLgbLsbLsbLsbLsLsmbL
sbLsbLsbLsbLsbLgbLsLsmbLsbLsbLsbLsbLsbLgbLibLgbRsbLsbLgbLsbLsbLsbLgLsb
LsbLsbLgbLgbLibLgLsbRsLsbLgbRgbLibRsbLibRsbRgLsbLibRsbLgbLgbRsbLgLsbLs
bLsbLsLsmbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLgbLsLsmbLsLgbLgbRsbLibRsbLiLs
bRsbLgbLsbLsbLsbLsbLsbLsbLsLsmbLgbLsbLgbLsbLsLsmbLgRsbLsbLgbLgbLgLsbLs
bLgRsbLsbLsbLsRsbLsbLgbLsbLgbLsRsbLsbLgbLsbLgbRjbLibRsbLsLsmbLgbLgbLsb
LgbRsbLgbLgLsbLsLsmbLsLsmbLsbLgbLgLsbRsLsLsmbLsLsmbLgLsLsmbRsbLgbLsbRs
bLgbLsLsmbLsbLsbLsbLgbLsbLsbLgbLsLsmbLsbLsRsbLsbLgbLgLsbLsbLsbLsbLgLsb
LsLsmbLsbLgbLgbRsbLgbRsbLsbLsbLsbLsbLgRsbLgbLgbLgLsbLgLsbLsbLgbLgbLsbL
sbLsbLgbLgbLsbLsbLgLsbLsbLsbLibRjbLibLgbRgLsbLiLsbRsbLiLsbRsbLibLsbLgb
LsRsbLgbLgbLibRsbRgLsbLibRibLiLsLsmbLgbRsbLgbLgbLsLsmbLsbLsRsbLsbLsbLg
bLgbLgbRjbLibLsbLibRsbLgbLgbRsbRsbLgbLsbLsbLsbLsbLsbLgRsbLsLsLsmmbLsbL
sLsmbLsbLsbLgbLgbLsbLsbLgbLsbLsRsbLsbLgbLgbLsbLsLsmbLgLsbLsbRsLgbLsLsm
bLsbLgbLsbLgbLgLsbLsbLgbLsbLsbLgLsLsmbLsbLgLsRsbRjRibRibRsLcbLibLgbRgb
RsbRsLsbLibLsbRgbLibLgbLgbRsbLgbRsbLsbLibLsLsmbLsbLgbRsbLgbLgbRsbRsRsm
bLhLsbRsLsbLsbLgbLgbLsbLgbRsbLiLsbLsLsmbLsbLgbLgbLsbRjbLibLgbRsLsbLgbL
sbLsbLsbLsbLgbLsbLsLsmbLsbLgbLsLsLsmmbLgbLsbLgbLsbLsLsmbLgbLsbRgbLibLs
RsbLsbLsbLsLsmbLsbLgLsbLsbLgLsbLsbLsbLgbLgLsbRsbRsbLibRjbRsbLibLgbLgbR
gRsmbRgbLibLibLsbLgLsLsmbLsRsbLgbLsbLsbLsbLsbLsbLgbLgbLgbRsbLsRsbLibRs
bLgbsbRsLsbLsbLgLsbLsRsbLsLsmbLgbLsbLsbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bLibRjbRcbRiRsmbRgbRgbLsbsbRsbRgbRsbRsbRgbRsRsmbRsbRsbRsbRsbLgbRgRsmbR
gbRhbLjbRcbRgbLgbRibRsbLsbRsbRsbRsbRgbLsbRgRsmbRgbRsbRsbRsbRgbRgbRgbRs
bRgbRgbRgbRgbRgbLhbLsRjbLcbRjbLibRjbLcbRhbLcbRjbLcbLcbLsbRsRiRsmbRgbRs
bRgbLsbRgRsmbLsRsbRsLsbRsbRsbRsbRsRsRsmmbRgbRsRsmbRsbRsbRgbRgbRgRsmbRg
bRsbRibLjbRibRiRsmbRgbLhbRibRibLebLcbLibRjbRjbLcbLcbLcbLibRgbLcbRjbRhb
LsbRgbRsbRsRsmbRsbLsbRgbRsbRgbRgbRsbRsbRsbRgbRgbRsbRsbRsbRsbRsbRgbLjbL
cLsmbRjbLjbRjRsmbRjRsmbRibLibRgbRgbRgbLiLsbLsbRgbRgbRgLsbRsbRgbLsbLgbR
gbRsbLgRsbRgbRgbRsbRgbRgbRsbLgbRgbRgbRsbRgbRgbRsbRsbRsRsmbRsbLjbLhbReb
RgbRibRgbRsbRgRsmbRgbLjbRsbRgbRgbRgbRgbRsbRgbRgRgbRgbRgbRsbRsbRsbLsbRg
LsbRgbRgbLjbLjbLgLsbLgbRsbLgbLibRcbLsRibRsRsmbLsbLsbRgbRsRsmbRsbRsRsmb
RgbRsbRgLsLsmbRsbRgbRgbRsbRsbRsbRgbRjLsbLjbRibRgbLibLcbLhbRjRsRsmmbLib
RcRsmbRcbLjbLjbRjRsmbRhbLhbLhbLjLsmbRcbRibRgbRiRsmbLiLsbRsRsmbRsbRsbRs
bRgbRgRsmbLsbLsbRgbRgbRgbLgbRgbRgRsRgmbRgbRsbRsbRsbRgbRgbRsLsbLjLsmbRj
bRjRsmbRgbRgbLibRjRsmbLcbLhbRgbRgRsmbRibRhbRibRhbRcRsmbRibRsbRsbsbRgbR
gbRgbRgbRgRsmbLjLsmbRgRsmbRgbLiLsbLhbLgbLgbRgbLibRibLhRsbLhbLhbLgbRsbL
gbLjbLgbLibRjbsbRcbRibLibRcbLgbLjbRibRsbRgRsmbsbRsbRgbRsbRgbLsbRsbRsbR
gbRgbRgRsmbsbRsbRgbLgbLsLibLgbLsbLgbLsbLgbRcbRcbLjbLgbRhbLsbRsRsRimbLg
RsbRsbRsbRsbRsbRsLsbRgRgRsmbRsRsmbRsbRgbRgbRsbRgRsmbRsbRsbRsbRgbLjbRjb
LjLsmbRjbRjbRgbRgbRsbRsbRgbLjbLhbRhbLibLibLhbRjbLibRjbLjbLcbLiLsbLgbsb
LjLsmbRgbRibRjbRjbRibLjbRibLsbRgRsmbRgbRsbRsbRsRsmbRsbRsRsmbRgbRsbRgbR
gbRgbRgbRsbRsbRsbRgbRsbRgbLcbLebLgLsbLibLgLgbLsbLibLgbRgbRgbLgbRgbLjbR
ibRiLsbRjbLebRcbLjbLiLsbLibRcRsmbRiRsmbRgbLjbLjbLjbRjbRcbLhbLibLibLcbR
cbRhbLjbRcbLgbLjbRcbRibRgbRsbRsbRgbRsbRsRsRsmmbRiRsmbRgbRgbRsbRsbLsbRs
bRgRsmbRgbLsbRgbLsbRgbRgbRsbRsRsmbRgRsmbRsLsbRgbRgbRgbRsbRsbRsbRgbLcbR
jLsbRjRsmbRibLibLibLhbLiLsbLgbLgbRjbLgLsbRgbLsRsbRgbRgbRsbRsbRsRsmbRgb
RsbLgLsbRgbRgRsmbRgbRgbRsbLsRsbRsbRgbRsRsmbRsbRgbRsbRgLeRsbLibRjbLcbLh
bRgbRibRiRibRgbRgbRsbRsbRsbRsbLsbRgbRgRsmbRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bLsRsbRiRsmbRsLsbRiRgbRiRsmbRibLsbRgbRibLjbRibRgbLgbRgbLgbRgLsbRibLjbR
hbRgbLsbLibRibLsbRsRsmbRgRsmbLsRsbRgbRgbLobLiRsbRgbLgbLgbRsbRibRgbRibR
ibRgbLjbRibLsbRsbLsbRgbRsbRgRsmbRsbRsbLsbRgbLsbLebLiRsbLibLsbLgLsbLgbR
gbLibLcLsmbRibRibRgbLsbsbRibRiRsmbRgbLsbRgbLcbLibLgRsbRibLsbLibLgbRgbL
ibRsRsmbLgbLgbLgbLgbRgbLibRgbLgbRgbLgbLgRsbRsbLsbLsbLgbLsbLsbLgbLgbLgb
LibRsbLibLibLgbLjbLsbReRsmbRgbRibRgbRgRsmbLjbRiRsmbLsbRgbLsRsbRgbRsLsb
RgbRsbRgbRgbLjbRiRsmbRiRsmbsbRgbLgbRgbLgbRgbLsRsbRgbRibLjbRjRsmbRgLsbL
gbRibsbRgbRsRsmbRsRsmbRgbLsLsmbRgbRsbRsbLcbLsLhbLgRsbRsbLgbRsbLgbLgbLi
bLibRsbRibLsbRsbLgbLibLsbLgbLgRsbRjRsmbLibRsbRsbRsLsRsbLibLgbRsbLibLsb
LgbRibLgbRsbRibLgLsbLibRibRebRsbRgbRibRgbLgbsbLjbLsbRcbRgbRsbRsbLsbLsL
smbLibRibRgbLsbLsLsmbLibRiRsmbLsbRsbLsLsmbLsbLgbLgbsbRgbRjbLsbRibRsbRg
bLgbRibLjbRibRsbsbLgbLibRibRgbRjLsbLhbRibRgbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bLgbRibRsbRsbRgbLjbLibLsLsmbRsLsLsmbLsbLsbLgbLgbLgbLsbLsbLgLsbLsbLsbLs
LsmbLibLsbLsbLiLsRsbLiLsbLibLsbRgbRhbRebRhRsmbRsbLibLibLsbLsbLibLgbLgL
sLsmbLgLsLsLsmmbLsbLsbLsbLgbLgbLsbLsbLsbLgbLgLsbLsbLsbLsLsmbLsRsbLgbLs
bRsbLgbLibRgbLgbLsbRsbLibRgbRebLsbLsbRebRgbRgbRgbLgbRgbRiRsLsmbLsLgbRj
bRgbRjbLibLgbLsLsmbLsbRjbRibRsbLsbLsbRsbLsRhbLsbRgbLibRibLjbRgbRibRgbR
ibLiLsbLibLsbLsLsLsmmbLibLibLsbRsbsbLebLibLsLsmbRsbRsbLsbLibLgLsbLsbLg
bLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bRgbLsbRgbRsbRsbLsRsbRsbRsbRsbLsbRsbLsRsbRgRsmbRsbRsbRgbRsbRsRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bRibLgbRsLsbRgbLsbsbLgbsbRsRsmbLgbRsbRsLsbLgbLsbLgbRsbRsbRsbLgbLsbsbLg
LsbRsLsbLgbLgLsbLsbsbLsbLgLsbRsbLsbLsLsmbLsbLgbLgLsbLsbLgbLgRsbRsbLsbL
sbLibLsbsbsbRiLsbRgbLgbRsbLsbLgLsbLsLsmbLgRsLsbLgRsbRgbRsLsbRsRsmbLiLs
bLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bRibRsbLiLsbRgbRsbRsbLgbRibRjRsRsmmbLgbRibRibRibLgbRibRgbRgRsmbRsbLibR
ibLibRibRiRsmbRibRsbRiLsbsbRsbRsbLgbRibRgbRsbRibRgbRibRibRsRsRsmmbLiLs
bLgbLgbLsLsmbLsbsbLsbRgbRgRsmbLjRsbLjLsmbLhb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bRibRgbRsbRibRiRsmbRjRgbRsbRsbRsbRsbRibRibLgbLsbRsbLebLsLsmbLibLsbLgLs
bLsLsmbLsbRsbRsRsmbRsbRjbRgbLcbLsbLhbLcLsmbLhbLibLgbRsRsmbRgRsmbLgRsbL
hbLsbLibLsbLsbLsbLsbLhbLgbLiLsbLsbLsbLiLsbLibLibLgbLibLgLsbRjRsmbRsbLi
bLibLibLibLsbLibLgLsbLgLsbLgbLsLsmbLibLsLsmbLiRsbLgLsbLgLsbLgbLgLsbLib
LsbLiLsbLsbLcbLsbLsbRsbLibLgbLibLgLsbLgbLiLsLsmbLsbLgbLsbLgLsbLgbLgbLs
LsmbLsbLibLsLsmbLibLgbRsbRsbRsbRsbLhbLsLsmbLgbLgLsbLsbRsbLiLsbLgLsbRgR
smbRsbLcLsmbLibLiLsbLgbRibRsbLgLsbLiRsbLsbLsbLsbLiLsbLgLsLsmbLsbLibLsb
LgbRsbRgbLiLsbLgbLsRsbLibLsLsmbLgbLsbRsbLhbLgbLgLsbLsbRgRsmbLsbLibLgbL
iLsbLsbRsbLsbLgbLsbLibLgbLgbLgLsbLibLsbLibLsbLiLsbLsLsmbLibLsbRibLiLsb
LsbRsbRgbRsbLibLsbLibLsbLiLsbLibLibRsbLhbLsbLsbLiLsbLgbLibLsbLsbLiLsbL
ibLsbLsbLibLsbRgbLiLsbLsbLiLsbLiLsbLsRsbLsbLsbLibLgbRsLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bLcbLebRibRjbRcbRibRibRcbRibRhbLibLibLsbRhbLjbRcbLsbLgbsbRhRsmbRgbLgbR
ibRgbLsbLsbRgRsmbRsRsmbRsbLsbRsbRsRgbRgRsRgLsmbRsRsmbRsbRsRsmbRsbRsRsm
bRiRsRgRiRsmmbRgRgbRgRgRsmbRgbRsRsmbRsbRgLgbRsbRgRgLsbLsRsbRsbRgbRgRgR
gRgRibRsbRgbLjbLjbLibLibRcbRobLibRibRibLgbRgbLsbRgbRgRsmbRsbRjbRsLsbRg
bLsbRgbRsRsmbRgRgRgRgbRgRsLsmbRsbRgbRgRgRiRgRsRiRimbRgbRsbRgbRgbLibLib
RjbRcbRibLhbRibRibLebLhbLibLgbLgLsbRsRsmbRcbRibRgbLsRsbRgRsRiRiRgRiRsm
mbRgbLsRsbRgbRgbRsbRgRgRgRgbRgRgRiRsRimbRgbLsbRgbRsRsmbRgbRhbLibRhbLib
RgbLsbRibLsbRsRsmbRgRgRgRgRiRsRgmbRsbRsbRgbLsbRgRsmbLjbRibRgRsmbLibRiR
smbRgRsmbRgbLibLjbRjRsLsmbRgRsmbRgbRgRgRsRgRgRsmmbRsbRgbLsbRibLhbRibRi
bRcbRhRsmbRibRibRsbRsRsmbRgRgRsRgRsmmbRgRgRsmbRgRgRsRgRgmbRgRsRsRgmmbR
gLsLsmbRibRgbLibRibLibRhbRgbRgRsmbRsbRsbRsbRsRgbRsRsRiRsRgRsRsRsRsmmmm
mmbRsbRibRgbRsbRsbRsRsmbRsRsmbRgRgbRgbRgRsmbRgbRsbRgRsRgRsRgRgRsmmmbRg
bRsLsRsbRgRsmbRgbRsbRsRsmbRsRsmbRgRsmbRsbRgRgRiRgRgRgbRgbRgbRiRgRgRgRg
RibRgbLgbRgbLsRsbRgRsmbRsRsmbRsbRsRsmbRgRgbRgRsRgRsmmbRibRsbRgbLsbRibL
jbRibLjbRibRjbLjbRjRsmbLjbRibLhbLjRsbLibRjbRjRsmbLjbLibRjRjbRcbLgbRhRs
mbRsRsmbRibRgbRhbRsbRibRsbRsbRibLsbRsRsmbRsRsmbRgRgRsRgRhmbRgRsmbRgbRg
RsmbRgRgRsmbRgRsRsmmbRgRsmbRgbRsbRsbRgbRgRsRiRsRgRgmmbRgbRcbLibLhbLiRs
bLsbRgbReRsmbRhRsmbRibRibRibRgRsmbRgbRgRgbRsRgRsRgRsRgRgRsRjmmmbRsRiRi
RsmbRsbRgRsRiRgRiRsmmbRgbRiLsRsbLjbLhbLibLibLiRsbRhbRebRibRsRsmbRgbRgb
RsRgbRsbRgRsmbRgbRsRsmbRsbRgRsLsmbRsbLjbRjbsbRibLjLsmbRibRibLibLebLibL
iLsbLsbLibRsbRibRjbRibRgbRibLgbLgbLsRsbLsbRibRgbRgbRgbRgbLsRsbLjbRiRsm
bLjbsbRibLgbRgbLsbRsbRsLsbRgRgbRgbRsRsmbRsRgbRgRgRsRsmmbRgRsmbRgRsmbRg
bRgbRgRsRsmmbRgbLjbLjbLhbRjbRibRibLjbLcbLgbLgbLgbLgbRjbRcbRibLsbLsbRgb
LsbRgbRsRsRgRsRgRgRgmmbRsRsmbRsbRsbRgbRsbRsbRgbLgbRsbLsRibLjbLcbLibLgb
LsbLgbRjbLhbRjbRcbLsRsbRsbRgbRsbRgbRsbRsbRibLjbLcbLgbLgbRsLsbLgbLgbLsb
LsbLgLsRsbLgbRebRhbRibRibRhbRibRgbRibRsbRsbRgbRgRsmbRsbRsbRsbRsbRgbRgb
RgbRsRsmbRsbRsRsmbRgbRsbRgbLsRsbRgbLsbRgbRsbRgbRsbRgRsmbRsbRsbRgbLsbRg
bRgbRgbRsbRsbLsbRsbRgRsmbRgbRsbRgbRgRgbRgRsmbRgbRgbRsbRgbRgbRsbRgbRsbL
jRsbRgRsmbLgbRibRsbRsbRgbRgRsRgRimbRsbRsRsmbRsbRgbRsbRgRgRgRsmbRgbRsbR
gbRsRsmbRsbRsbRgbRgbRgRgbRgbRsbRsbRsbRgbLjbLibLibRjbRibLibLjbLhbRjRsmb
RebRibLsbLgbLsbRsLsbRgbRsRsmbRsLsbRsbRsbRgbRsbRgbRgbRgRgRsRgRimbRsbRgb
RsbRgbLgLsbRibLgbRibLsbLsbRgbRsbRsbRgbRsRgRsRsmmbRsRsmbRsbRgbRgRgRgRgR
gRgRgRsRsRgRgRsmmmbRgRgRsRsmmbRgbRgRsRgmbRgRsmbRsbRgbRsRsmbRsbLsbRgRsm
bRsbRgbRgbRgbRgRsmbRgRgRsmbRgbRgbRsbRgbRgRsmbRsRsmbRgbLjLsmbRibLibLebL
iLsbLjRsbRjbLibLcbLiLsbLibLibLgbLsbLsbLsbLsbLgbLgbsbLibRhbRcbRhRsmbLgb
LjbLhbRcbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bRgbRsbLsbLgbLsbRgbRibRibRsbLsbLsbRibRgRsmbLsbLsbRgbRgbRsRsmbLsbLsbRib
LjbRcbRibRsbLgbLsbLsbRgRsmbRjbRgbLsbLsbLsbLsbRibRgbRgbRibRgbLgbRgRsmbR
ibRgbRibRgbLgbRibRgbRgbRgRsmbRsbLibRcbRsbRiRsmbLibLgbLsbRgbRsbRibRsbRg
LsbRgbsbLsRsbRibRgbLsRsbRsRsmbRgbRgbLsbRsbLsbRgbRsbRsbRsbLsbRsbRibRsbR
sRsmbsbLsbRsbRsbRibLsLsmbLgRsbLgbRgbRgRsmbRsbLsbRiRsmbRiRsmbLsRsbLibLg
bLgLsbLgLsbRsbRibLhLsbRsLsLcbRgbLibLsbLsbLgbLibLsbRsbLgbLgLsbLgbLsbLsb
RjbLibLsbRibLgbLgbLsbRibRibRgbRsbRgbLsbRsbLsbLgbRibRibRgbRgbRgbRgbLibL
sbLgbLsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bRjbRibRsbRsbLsbRhbRsRsmbRsbRsbRjbRsRsmbRgRgbLjbLiRsbLibLjbLsbLibRibLg
bLibLgbLgbRibLgLsbLiLsbLiLsbLgbLgbLsbLsbLgbLgbLsbLsbLgLsbLgbLibRgbRsbR
gbRibRcbRibLgbLcRsbLiLsbLsbLgRsbRibLibLibLgbLgbLgLsbLsbLsbsbRebRsbRgbL
sRsbLsbRgbRgbRcbRcRhLsbRgbRibLibLcbLibLsbRgbLibLgbRhbRjbRcRsmbLgbRiRsm
bLsbLsbRsbRgbRhbLhbLcbLibRjbLibLgbLsbRsbLgbLgbLgLsbLsbLsLsmbLgbLibRjRs
mbRcbRibLjRiLsbRgbLgbRibRibLjbLcbLibLsbLsbLsLsmbLsLsmbLsbLgbLjbRsbLsLs
mbLgbLgbLsbLjbLsLsmbLsLsLsmmbLgbRcbRibRibLibLhbLhbRhbLcbRjbRoRsmbRibLg
bRibRgLsbRsbRgbRsbRgbRsbRgLsbLjbRibRgbLibRibRgLsbLjbRhbLibRhbRibRibRsb
RibRgbLiLsbRhbRiRsmbRsbRgbRsbRsbLgRsbRiRsmbLjbRibRiLsbLibRsbLobLobLjbL
gbLhbRibLibLsbLgbRgbLgbRgbLibRgbLgbLgbRgbLgbRgbLibRibLiLsbLgbLgbLgbRsb
LsLobLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bLjLsmbRcbLiRsbRibRgbLjbLibLsLsmbLgbLibRcbLjbLiLsbLsLsRsmbLgbRgbLgbLgb
RsLsLsmbLsbLgRsbRsLsbLgbLgbLsLsmbLsbRsRsmbLgbLibRjbRhbLibLsbLibRibRsbR
sbRhbRgbRibLibRsbRgbRsbRsRsmbLgbRcbRiLsbLgbRsbLhLsbLgLsbLgbLjbRgbRiLsb
RsRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bRsbRgRsmbRsLsbRsbRgbRsbRgbRsbRgLsbLgbRgbLsRsbRgbRsRsmbRsbRgbRsbRsRsmb
RsbRsbRsbRgbRsbRgbRgbRsbRgbRsbRsbRsRsRsmmbRgRsmbLsbRgbRgRsmbLgbRibRsbR
sbRgbLcbLgbRgbLibRgbLsbLgLsbRgbLgbRsbLgbRcbRsbRgbLgbRsbRibLjbRiRsmbLsb
RgbRsbRsbRgbRsbRgbRsbRsbRsbRsbRgbRgRsmbRsbRsbRsbRgbRsbRsbRsbRsbLcbLcbL
gbLgbRsRsmbRgRsmbRjbRgbRgbRgbRsbRsRsmbRsbRgbRsbRgbRsRsmbRsbRsbRgbRgbRs
bRsbRgbLsbRgbRsbRgbRgbRsbLgLsbRgLsbRsbRsbRsbRsRsmbRsbRsbRgbRsbRsbRsbRs
bRgbRsbRgbRsbRsbRsbRgbRgbLsbRgbLsbRgRsmbRsbRgbRsbRgbRsbRgbLgbRsbRgbRsb
RgbRgbRgbRsbRgbRsbRgbRsbRsRsmbRgbLsbRsbLcbRiRsmbRgbRgbRgbRgbRgbLhbLibR
gbLibLgbRsbLgbLgbLgbRjbRibRgRsmbRsbRgbLsbRgbRsbRsbRgbRgbRgbRsbsbRgRsmb
RsbRsbRsbRgLsbRsbRsbRgbRsbRgbRsbRsbRsbRgbRsbRsbRgRsmbLgbRgRsRsmmbLsRsb
RsRsmbRgbRsbRgbRsbRgbRgbLsbRiRsmbRsbRsbRsbRgbRsbRgbRsbRsbRsRsmbRsbLsbR
sbRgbRgbRgbRibLjbLcbLgRsbRcbRgbRgbRgbRsbRsbRsbRsRsmbRsLsbRgbRsbLsRsbRs
bRsbRsbRgbLsbRgRsmbsbRsbRgbRgbRsbRsbRgbRgbRgbRsbRgbRsbRgbRsbRgbRsbRsLs
bRgRsLsmbRsbRsbRsbRsbRgLsbLsbRsbRsbRgbRsbRgbRgbRsbRsbRsbRgbRgbRsbRgRsm
bRgRsmbLsbRsRgbRgbRsbRsbRsbRsbRsbRgbRgbRsLsbRsbRsbRsbRsbRsbRsbLsbRsbRg
bRsbRsbRsbRsbRsbRsbRsbRsbLgbRgbLsbRsLsbRgbRgbRsbRsbRsbLsbRgRsmbRsbRgbR
sbRgbRsbRgLsbRsRsmbRsbRsbRgbRsbRsbRsbRgbRgbLgbRgbRgRsmbRgbRsbRsLsbRgbR
sbRsbRsbLsbRgbRsbRsbRgbRsbRsbRsbRsRsmbRsLsbRsbRgLsbLsbRgbLsbLjbLgbLhbL
ibRibRibRgbRsbRgbLgbRgbLsbRcbRibLibLsbLiLsbRobRibRib

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bRjbRjbRjRsRsmmbLgbRgRsmbLibLjLsmbRjRsmbLsbLgbLsbLsbLsbLgbRsbRsbLgbLgb
LgbRibRjbRgbLgbRjbRjLsbLgbLgbLibRsbLibLjLsmbRgRsmbRhbLibLsLsmbRgbRsRsm
bRgbRiRsmbLjbRsbLibLhbLibRgbRjbRjbLgbsbLsbRsbRgRsmbsbsbsbRiRsmbRibRgbR
gbRjbLgbLibRgbLjLsmbRjRsmbRjbLjLsmbsbRibRjRsmbRsbRjRsmbRsbRjRsmbRibRsb
RibRgbRibRsRsmbRsbLjbLjbLsbLsLib

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bRsbRgRsmbLgLsbRibLgbRibLgbRgbsbRsRsmbRgbLsbRgbLgbRibLgbRibLsbLsbRgbLg
bRgRsmbRsbRsRsmbRgRsmbLjbRibLcbLhbLibRsbLibLgbLsbRsLgbLsbRcbRibRsbLsbR
gRsmbLsbRgbLgbRgbRsbLjbRcRsmbLibLjbLibLgbLsLsmbLsbLgRsbLsRsbLsbLsbLsbL
gLsbRhRsmbRibLsbRgbLgbRgbRgbRsbRsbLsLsmbRgRsmbLsbLjbLsRsbLibLsbLsbLsbL
sbLgbLsLsmbLsbLsbLsbLsbLgbLgbRcRsmbRibRgbRsbRgbRgbLcbLgbLgbRsLgbLsbLgb
LsbRsbRcbRibRgbLsbRgRsmbRibLjbRibLgbLsRibLibRiRsmbLgbRibLjbLjRsbLiRsbL
gbsbLsbLsbLsbLgbLgbLsbLgbRgbRjbRibLjbRcbRibLgbRibRibLgbRibLgbLibLsbLgb
LgbLsbLsbLsbRsbLcRsbRgbLsbLjbRcbRibRsRsmbRsRsmbLsbRsbRgbLsLsmbRgbRsbRs
bRgRsmbRsLsbRgbRsbRgbRsRsmbRsRsmbRgbRgbRsbLgbRiRsmbLsbRsbRgRsmbRsbRgLs
bLjLsmbLjbLibLibLsbLgbLgbRgbsbRjbRcbRiRsmbLgbRibLsRsbRgbRsbRgRsmbRsRsm
bRsbLsbRsbRibLsbRgbRgbRsbRsbRgRsmbRsbRgbRsbRgbRgbRibLjbLjbLibLgbRcbRsb
LsbRgbLsRsbRsbRsbRsbRgbLsLsmbRsRsmbLsbRibRgbLsbLsbRgRsmbRgbLsbRibLjbRi
bLjbRgRsmbRgbRsbRgbRsLsbRgbRsbLibLibRibRibLsbRsbRsRsmbRgbRsbRsLsbRsbRs
bRgRsmbRgLsbRsbRgbRsLsbRsRsmbRgbRgbLsbRgRsmbLsbRgbsbRiRsmbLjbRiRsmbLjb
sbsbRibRgbLibsbLcbLgbLgbRcbRibLgbLsRsbRibRgbLjbLsbLcbLgbLibRjbRhbRsLsb
LsbsbRibRgbLibLjRsbLiRsbRjbRjbRibRgbLsRsbRsbRsbRsRsmbRgRsmbLsbRgRsRsmm
bRsRsmbRsRsmbRsbRgbRsbRgbRsbRgbLsRsbRgbLjbRibLhbLgLsbLgbLhbRibRcRsmbRg
bRsbLgbRiRsmbLsRsbRgRsmbLsbLsRsbRgbRgbRsbRsbRgbRgbRsbRgbLgbRibRgRsmbLg
bRgbRgbLgbRgbRgLsbRsRsmbRsRsmbRgRsmbRsRsmbLsbRgRsmbRgRsLsmbRsbRsLsbRsR
smbRgbRsbRsbLsbRgbRsRsmbLjbRibRgRsmbLjbRiRsmbRsbLjbsbsbRsRibLsbLsbRgRs
mbLsbRgRsmbLsbRgbLgbRgbLsbRgbLgbRibLjbRibRgbLgbRibLsbLgRsbRibLgLsbRibR
gbLjbsbRibRiRsmbLibLibLibLibLgbRjbRjbRibRgRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bLsbRsbRsbLgbLsbLgbLgbRsLgbLsbLgbLgbLsbLsbLgbLsLsmbLgbLsbLgbLgbLgbLgbL
gbLgbRcbRibRgbLgRsbRsbRgRsmbLsbRsbRgbLcbLcbRgbLcbRjbLsbLgLsbLgbRsLsbLg
bLsLsmbLsbLgbLsLsmbLgbLsbLsRsbLsLsmbLsbLgbRsbLgbRsbLgbLgbLgbLgbLsbLsbL
sbLsbLgbLgbLsbLgbLgRsbRgbRcbRibRiLsbRsbRgbRsbRgbRsRsmbRgLsbRsbLsbRgbRs
bRgbRsbRhbLcbLibLgbRsbLgLsbLsbLsbLsbLsRsbLgbLgbLgbLsbLgbLgbLgbLgbLgbRi
bRcbRibLsRsbRgRsmbRsLgbRgbRsRsmbRgRsmbRsbRibRgbLsbRibLjbRibLcLsmbLgLsb
RsbLgRsbLgbLgbLsbLsbLgbLgbLgbLgbLsbLgbRsLgRsbRibLibLibLsbLsbLgbLgbLsbL
sbLsbLgRsbLsbRobRgbRgbRsbRsbRsbRsbRgbRibRgRsmbLgbRibLgbRcbRgbLgbRibRsb
RgbLibRsbRsbRgbRgbRsbRsbRsbRgbRsbRgbLcbLgbLsbLgbLsbLsbLgbRsbLgLsbLsbLs
LsmbLsbLgbLgLsLsmbLgLsbLgbLsbLgbLgbLgbLgbLsbLsbLsbLsbLgLsbRsbLgbRjbRib
RgbRsbRsbRgbRsbRsbRsbRsbRsbRgRsmbRsbRgbLcRsbLibLgbLgbLsbLsLsmbLgbLgLsb
LgbLsbLgRsbLgbLgbLsbsbRsRgbRsbRibLsbRgRsmbRgbRgbLgbRiLsbRsbRibRgbLjbRi
bLjbLcbLgbLgbLgbRsbLgbRsLgLsbLgbLsbLgLsbLgLsbLgLgbLgbLgbLgbLgbLgbLgbLg
bLgbLgLsbLgbLgbLgbLsLsmbLgbLgbLgbLgbRjbLibRibLibLgLsbRjbRcbRibRsbRgRsm
bLsRgbRgbLgLsbLcbLibLsbLsbLsbLsLsmbLgbLibLgbLgbLgbLgbLgLibRsLsbLgbLgbL
sbLgLsbLgbLgbLsbLgbLsbLgbLgbLgbRjbRhbRibLsbRgRsmbRsRsRsmmbRgbRgbRsbRsb
RsbRgRsmbRgRsmbRgRgbRgRsmbRgbLhbLibLgbLgbLsbLgbLgbLgbLgbLgLsbLgLsbLgbL
sbLgbLgbLgbLgLsbLgbLgbLgbRjbLcbRibRjbRjbRibLjbLibLibLgbLsRsbLgbLsbLsLs
mbLsLsmbLgbLgLsbLgbLgbLsbLsbLhRibRibRiRsmbRsbRsbLjbLibLibLgbLgbLgbLgbL
gbLgbRjbLsRibRsRibLjbRgbRgRsmbRsbRsRsmbRsbLsbRsbRgbRgbRgRsmbRgbLjbRhRs
mbLebLiLsbLgbLsbLsbLgbLsbLgbLgbLsbLgbLsbLgbRsbLgbRsbLgbLsLsmbLsbLgLsbL
gbLgbLgbLsLsmbRsRsmbLgbLsbLgbRgbLsLibRibLsLsmbLibRibLibRibLibRibLibRjb
LhbRibLibLcbRgbLhbRgbLgbLgLsbLsbLsbLsbLsbLgbRsLsbLsbLgbLsRsbLsbLgLsbLg
RsbLgbLsbLgbLgLsbLgbLgbLgbLgbLgbLgbRjbRjbRibRgbRsbRgbRgbLsbRgLsbRibLcb
LhbLsbLsbRsbLgbLsbLgbLgbLsbLsbLgbLgbLgLsbLsRsbLsbLgbLgLsLsLsLsmmmbLsbL
gbLgbLgbRsbLgLsLsmbRsbLgRsbLgbRgbLgbLsbLgLgbLgbLgLsbLgbLgbRjLsbLibLgbR
sbRsbLgbLgbRgbLiLsbRsbLsbLgRsbLsbLsbRsbRcbRibLgbRiRsmbRibRcRsmbLibRiRs
mbLsbRsLsbLcbLgbLgbLgbLsbLsbLsbLsbLgbLsbLgLsbLgLsbLsLsmbLgLsbRsbLgbLsb
LgbLgbLsbLgbLgbRjbRcRsmbLsbRgRsmbRgbRsbRsbLsbRgbRsbRgbLjbLcbLsLsmbLsbL
gbLsbLsLsmbLgbLsLsmbLgRsbLgbLgbLgLsbLsbLgbLibLeLsLgLsbLgbLsbLsbLgLsbLg
RsbLgbLsLsmbLsLsmbLsbLgRsbLgbLgLsbLgLsbLsbLgbLsbLsRsLsbLgbLgbRgbLibLsb
LgbRgbLgLgbLgbLibRjbRebRibLgbRgbRsRsRgmbLsRsbRibLgbRgRsmbRsRsmbRgbRsbR
sbRgRsmbLjbLcbLgbLgLsbLsbLgLsbLsbLgLsbLgbLgbLgLsbLgbLgbLsbLsbLgbLgLsbL
sb

>ZF Recording 2016-03-21; tW: 300s; Start: 123005; End: 123505;
Recording: 6-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bRsLsbRsRsmbRsbRgbRgRsmbRsbRsRsmbRgbRgLsbLgLsbRgbRgbRsbRsbRgbRgbRgbRgb
RgbRgRsmbRgRsmbRsRibRgRsmbRibRgbRgbRgbRgbRgbsbRsbRsbLsbRsbRgbRgbRgRsmb
LsbsbRibRibLjbRibLjbLcbLiLsbRsbLgbLsLgbLibRcbRcbRsRsmbRgbRgbRsRsmbRgbR
iRsRsRgRimmbRsbRgRsRsmmbRgRibRgRsmbRgbRgLsbRgbRsbRsbRsbLsbLjbLiLsbLiLs
bRsbLgbLgbRjbRcbRgbRgRsmbRsbRsbRgbRsbLsbRsbRgbRsRsmbRsbRgbRgRsmbRgbRsb
RgbRsRsmbRsRgRsmbRgLsbLibLsbLibLibRjbRcbLgbRgbRgRsmbRsbRgbRgRsmbRgbRgb
RgRsmbRsRsmbRgRsmbRgbRgbRgbRgReLsRsbLjbRhbLsbRibRgbRgbRsbRsbRgbRgbRgRs
mbRsRsmbLgLsbLcLsLimbLgbLgRsbLsLgbRsbLsbLgLsbLgbLgbRcbRgbRgbRsRsmbRgLs
bRsLsbRsbRgRsmbRsRsRsRsmmmbRgRsmbRgbRibRgRsmbRgbRibRiRsmbRgRsmbRgRsRgR
smmbRsRsRiRsmmbRgbRsbRgRsmbRgRsmbRgRibRgbRgbRgbRsbRgbRgLsbRgbLsRsbLsLs
mbRgbRsbLsbRibRgbLsbLjbLibLiLsbLibRhbRjbRiRsRsmmbRgbRsbRsRsRsmmbRgRsRg
RsRsRgmmmbRiRsmbRgbRsbRsbRsRgRsmbRgLsbLsbRgRsmbRgbRgRsmbRgRgRsRsmmbRsR
gRsmbRgRiRsRgmbRgRsRsmmbRiRsmbRgbRgRibLsbRgbLjbLibLibLgbLsLsmbLgRsbLgb
LgLsbRsbLibRhbRcbRibRsbRgbRsbRgRsmbRgbRsbRgbRgbLibRhRsmbLjLsmbRhbLiLsb
LjLsmbRcLsbRsbRobRiRsmbLsbRibLsRsbRibLiLsbRcbLibRhbLjbRsRhbLjbRibRhbRc
RsRsmmbLgbRhbRiRsRsRsmmmbRgbRsbRgbRsbRibLgbRgbRsbRgbRgRsRgRgRsRsmmmbRi
RsmbRgRgbRgRgRgLsRsbRhRgRsRembRgbRgbRgbRgbRgbLgbRibLgRsbLhbLcbLsLsmbLi
bLgbRjbRcbRibRsbRsRsmbRgbRgRsmbRgbRgbRgRsmbRgRsmbRibRgRsRsmmbRsbRgbRgb
RsbRgRgbRgbRgRsmbRsRsmbRgbRiRebsbRsbRgbRsbRgbRsLsbRgbRsRsmbRgRsmbRgRsm
bRgbLgbLjbRibLibLiLsLgbRhbRibRgbRgbRsbRsbRgbRsbRsRgbRgRgRsmbRgRsmbRsbR
gbRgRsmbRgRsmbRgbRgbRgbRgbRgbRgbRsbRgbRgbLsbLsbRibLcbLhbLibLgbLsbLgbLs
bLgbLsbLgbLsbLgbRcRsmbRibLgbRibRgRsmbRgbRsRgRsmbRgRsmbRsRgRsmbRgbRgRsm
bRgRsmbRgbRgbRibRgbRgbRgbRgRsmbRgbRgbRgRsmbRiRiRsmbRgbRgbRgbRsbRsbRgbR
gRgRsmbRsbRgbRgbRgLsbRsbRsRsmbRgbRgbRgbRibLibLhRsbLgbLgbLgLsbLgbLsbRcb
RibRsbRgbRgbRgbRgbRsLsbRgbRgRsmbRgbRgbRgRsmbRibRibRgbRebRsRgbRgbRgbLsR
sbRgRsmbRgLsRsbRgbRsbRgbRgbRgbRgRiRsmbRgRsRimbRgbRgRsmbRiRiRsmbRgbRsbR
gbRsbRgRsmbRgRsmbRgbRibRgbRgbLgbLcbRcbRibRgbRsRsmbRsbRgbRsbRsRsmbRsRsR
smmbRgRsmbRgRsRgmbRgbRibRiRibRgbsbRiRiLsbRgbRgRsmbRgbRgbRgbRgRsmbRgbRg
bLsbRiRsmbLsbRgRsmbRgbRgbRsbRgbRgbRgbRgbRgbRgLsbRgbLgbsbRgRsmbRsbRibRc
bLibLibRibRibRiRsmbLsRsbRgRsmbRsbRgbRsbRgbRgbRsbRgbRgbLsbRgbRsbRgbLsbR
sbRiRsmbRgRsmbRgRsmbRsbRsbRgbRgbRgRsmbRgbRgbRgbRsbRgbLgbRsbRsRibLhbLsL
sLsmmbLsRsbLiLsbLibLiRsbRcbLiRsbLgbLsbLgbLibLgbLibLgbLibRobRgbRsbRgRsm
bRgRsmbRsRgRsRgRgRimbRgRsRgRiRsmmbRgRgRsmbRsbRgRsmbRgbRgbRgbRsLsbRgbRg
RsRsmmbRgbRiRsmbRgbRibRgbRsbRgRsmbRgLsbRgbRiRsmbRiLsbRgbRsbRsbRgbRgbRs
bLgbLcbLibLibRhbLibLiLsbRgbLibRjbLibRjRgbLibLgLsbLgLsbLgbLsbRebRsbRibR
gbRsbRgbRgRsmbRgbRgRgRgRiRsmbRiRsRiRsmmbRgRiRsmbRgbRgbRgbRgbRgRsmbRibR
gLsRsRgRsmbRgRgbRgbRgbRgRsRgmbRgbRgRsRgmbRiRsmbRgbRsbRgbRsbRgbRhbLibRc
RsmbLibRibRgbLsbRibRsbRsRsmbRgRsmbLgbRiLsbLjbRhbLibRhRsmbLgbLhbLibLgbL
sLibLgbRjbRcbLsLsLsmmbRiRsmbRgbRgbLhbLibLgbRibLibLibRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 1; Drug: Control Apo 0.5 然
bRibLcbLibLibLsbLibLsbLsbRcbRibRgbRgbLibRibLcbLobLsbLibLibLsbLgLsbRgbR
cbLobLobLiLsbRiRsmbLibLibLjbsbRsbLgbRsLsbLsbLsLgbLsbLsbLgbLgbLsbLgbLgL
sLsLsmmbRjLsbLcbRsRibLibLgLsbLsbLgbLsbRsbLsLsmbLsbLgbLsLsmbLgbLhbRebRi
RsmbLibLebLibRsbRgRsmbRgbLibLibLgbLsbLgbLsbLsbLsbLgbLgbLgbLgbRsbRgbLib
LgbRgbLiRsbRgbLibLgbRsbLgbLsbLsbLgbLsbLgbRgbLobRibRibLhbLgLsbLgbRsRsmb
LsbLibLgbRgbLsbLibLgbLsbLgbLgbLsbLgLsbLgbRibRjbRcbRhbRcbLibLsbLgbLsbLg
bLgbLibRgbLsbLsLibRibsbLibLgbRcbLjbLcbLsbLibLgbRibLsbLibRhbRibLgRsbRiR
smbLsLsmbRgbRsLsbRsbRgbRsbRgbRgLsbLsbRsbRsbRsbRsbRsbsbRsbRsbRsRsmbRgbL
sbRibLjbLobLibRjbRsbRjbRhbRibRobRibRgbRsbRjbRiRsmbRgbRsbRgbRgbLjbRsbRi
bRgbLgLsbRibRgbRgbLjbLobRgbLibLgbRsbLibLsbLgbRsbLgbLgbLsbLsbLsbRgbLgbL
gbLsbLgRsbLgLsbLsLsmbLsbLgbLsLsmbLgbsbLoRsRsmbRibLibLibLsbsbsbLibRgbLj
bLsbLsLsmbLsbLjbsbRsbLgbRgbLgLsbRsbLgbLsbLgbLgbRjbRhbLhbLibRibLibRsLsb
LgbRsbsbRsbLsbLsbLsLsmbLsbRsbLsbLsbLgbLsbLsbLsbLgLsRsbRsLsbLgLsRsbsbRs
bLgbLgbRjbLibRjRsmbRsLibsbRsLsbLgbLgbRjbLgbRsLgbRibRibLsLsmbRcbRhRsmbL
ibLibLgbLcRsbLibLsbLsbLsbRgbLsbLibLibRgRsmbLibRcbLibLhLsbLiLsbRsbLgbLs
bLgbRsbRsbLsbLgbLsbLsbLgbLsbRjbRcbRibLjbLsbRsRibLgbRsRgbLcbLibRsLsbLgb
LgbRsbLgbLgbLsbLgbLsbLsbLgLsbLgbLgbLsbLsbRsbLiRsbRibLhbRibLibLgbRgLsbL
gbLsbsbLsbLgbLgbLgbLsbLsLsmbLgbLsbLgbLgbLsbLsbLsbLgbLgLsbLsbLibLgbRgbR
sLsbLgLsbLsbLsLsLsRsmmbLsbLsbLsbLsbLgbLsLsmbLsbLgbLsbLgbLsbLgLsbLsLsmb
LsbLgLsbsbLsbLgbRgbRcbRibRgbRgbLjbsbsbRibsbsbsbRsRibLjbLcbLibLsbLsbRsb
sbLgbLsLsmbLgRsbLsRsbLsbRgbRjbRcbLcbRjbRhbsbsbLsRsRsmbRgbLeb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 2; Drug: Control Apo 0.5 然
bRebRgbRibLibRsbLibLibLgbRjbLibRgLsbRsLgbLsbLgbLibRgRsmbRsLiLsbLgbLibR
hbsbLgRsbLgbLgbLibRcbLibLibRsbLgbLsLsmbLgbRjLsbLibRiLsbLsLibRsbLgbLibL
gbLsbLsbLgbLsbRibLibRjbLhbRsbLgbLgbLgbLgbRsLsbLgbRsbLgLsbLsbLgRsbLsLgb
LgbRibLibLibLgbRibRibRhbLgbRibLgbRibRgLsbLjLsmbRhbLibRibLibLgLsbRjRsmb
RjbLhbLibLhbRhbLhbLhbLhbRiRsmbRibLebRibRgbRsbRibLibLhbLibRibLhbRibLibL
gLsbLibRhbRibRibLibRgbRibLjbRhbRgbLsbLibLibLibRjRsmbLibLsbLsbLsbRsbRsR
sRimb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 3; Drug: Control Apo 0.5 然
bLgbLsbRsbRsbLsbLiLsbRsbLgbsbRsbLgRsLsbLjbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 4; Drug: Control Apo 0.5 然
bRgbRgbRgRsmbLibLibLibLgbRgbRibRsbLibLibLgbLgbRsRsmbRgbRgbRibRgbLjbLcb
LibRsbLsbRsbLiLsbRsbRsbLibLibLibRsRsmbRsbLibRsbLsbLibLgbLsLsmbLsbLibLs
bLibLgLsRsbLibLgbLgLsbLsbLsbLgbRsbRjbLhbRsbLsbRgbLibLgbLibLiLsbLjLsmbL
sbRsbRsbLsbLjLsmbRjbRjbsbRgbRsbRibRibRsbLsbLiLsbRhbRjbRgRsmbLsbRgbLsbR
gbRgbRsbRibRibRsbRgbLsbLhbLjLsLsmmbRgbLibLsbRsbLibLsbLibsbLsbLiLsbRsbL
sbLibLsbLgbLsbLgRsbLsbLgbRsbRsbRgbLibLgbRsRsmbLcbLsbLsbRgRsmbLibLsbLgb
LsbLgbLgbLibLgbRjbLibRgbLjLsmbRjRsmbRsbLsbLgbRgbLibLsLsmbLsbLsbLsbRsbL
ibRsbRjbLobLgbLiLsbLibsbRgbLibRsbLsbLgbRsbRsbRjbRcRsmbRgRsmbRibRsbRibR
ib

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 5; Drug: Control Apo 0.5 然
bsbRsbRsbRsbRgbRsbRsbRsbRsbRgbRsbLsbRibRgbLcbLhRsbRcbRcbLjbLcbLibRgbLi
bLibLsbRjbLibLgbLgbLsbLiRsbRcbRiRsmbRgbLsbRibLgbRgbLsbRgbRsbRgbLsRsbRg
bRsbRgbRgbRgRsmbRgbRgLsbRsbRsRsmbRgbRsbRgbLsbRgbRsbRgbRsbRsLsbRgbRsbRs
bRsbRgbRgbRgbRgLsbRsbRsRsRsmmbRgRsmbRgbRsbRgbLgbLhbLibRcbRcbLjRsbLhbLi
bRibLhbLsbRhbLhbLsbLibLgbRibRjbRibRgbRsRsmbRgbRsbRsbRsbRsbRgbRgbRsRsRs
mmbRgbLgbRgbRgbRsbRgbLsLsmbRgbRgLsbRgbRgbRsbRsbRsbRsbRsbRsRsRsmmbRgbRs
bRsbRgbRsbRsbRsbRsbRsbRsbRsbRgRsmbRsbRibLibsbRibLgRsbRjbRgbLiLsbLibLib
LibRgbLibRsbLgbRsbLibLgbLibRjbRobLhbLibRsbLgLsbRgbLgLsbRsbLgbLcbLibRiR
smbLgbLcbRjbLcbLgbRsbRebRjRsmbRgbRgbRgbRsbRsbRgbRsbRgbRsbRgbRgbLsbRgbR
gbRsbRgbRgbRgbRgRsmbLsbRgbRsbRgbRsRsRsmmbRgLsbRgbRgbRgbRgbRsbRgRsmbRsb
RgbLcbLibLibLgbLibRjbRcbLibLibRcbRibRsbRgbRgbRsbRsbRgbRgbRsbRsbRgbRgbL
jbReRsmbRgbLjbRgbRjbLgbRgbRjbLjbLcLibLibRjLsbLibRhbLibLibRhbRobLjbLcbR
cRsmbLcbLibRibRsbRibRsbLibLiRsbRjbRobLhbLibRgbLibLsbRsbRibRibRgbRgbRgb
RgbRgbRsbRgbRsbRsbRgbRsbRgbRsbRsbRgRsmbRgbRgbRsbRgbRgbRgbLsbRgbRsbRgbR
gbRsbRsbRgbRsbRgbRgbRsRsmbLgbRhbLcbLcbRcbLibLibRsbLibRjbRcbRgbRgbRgRsm
bRgbRsbRgbRsRsRsmmbRsbRsbRgbRsbRgLsbRgbRgbRibLsbRgbRsbRgbRgbRsRsmbRsbR
sRsmbRgbLsLsmbRgbRgRsmbRsbRgbRsbRsbRgbLsbRgRsmbLgRsbRhbLibLcLsmbLibLhb
RibLgbLibRjbRcRsmbRsbRgbRsbRsbRgbRgRsmbRsbRsbRgbRsbRsLsbRgbRgbRsbRsbRs
bRsbRsbRsbRsbRgbRgbRgRsmbLsRsbRsbRgLsbRgRsmbRsRsLsmbRsRgbRsbRgbRsLsRsb
RgbRsLsbRgbRgbRgLsRsbRsbRgbRsbRgbLgRsbRgbRgbRsbRsbRgbRgRsmbRibRsbRgbRg
bRsbRgbRgbLjbLibLibRiLsbLibLibLibRibRjbLgRsbLibLibRcbRoLsbLgbRsbRjRsmb
LgbLcbLibRebRibRibRgRsmbRsRsmbRsRsRsLsmmbRsRsmbRsbRgbRsbRgbRsbRsLsbRsR
smbRgbRsbRsLsbRsbRsbRsbRgbRsbRsbLsbLjbRhbLibLcbLcbRcbLcbRcbRobLibLhLsb
LcRsbRebLibLgLsbRjbLgbLgLsbLgbLgRsbRcbRgbLsbRsRsmbRsRsmbRgbRsbRgbRsbRg
bLgbRibLgbRibRgRsmbRgbRsRsmbRsbRsbRgbRsbLgbRibLjbLcbLgbLgbRsbRjbLobLsb
RiRsmbRsbRsbRgbRsbRsbRsbRgLsbLhbLiLsbRcbRcbLebLibLibLibLibRhbLibLiLsbR
jbRcbRgbRsRgLsbRsbRsbRgbRgLsbLjbRibsbLcbLhRsbRgbRsbLgbLgbRcbRibLhbLcbL
gbRjbLibLibLgbLibRobLsbLhbLgbRsbLsbLgbLsbLsbLgbRsbLgbLsbLgRsbRcbRgbRsb
LsbRgbRgRsmbLsbLjbLibRcbRhbLgbLjbLibRcRsmbRibLjbRsRibRsRsmbRsbRsbRibLj
bLcbLibLsbRsbLsbLgbRsbRhbRgbRgRsmbRgbRsbRibLsbRgbRsRsmbRgbRsbRsbsbRsbR
sRsmbRgRsmbRsbRgbLsbLsRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 6; Drug: Control Apo 0.5 然
bRgbLgLsbRiRsmbRsLjbLjbLgbRgbRgbLibsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bRgRsmbRjRsRsmmbRjRgbsbRsbRgRsRsmmbRjLsbLgbRgbRsbLgbRsbRsbLsbRsbRibRgR
smbRibRsRsmbRgRsmbRibRibLgbLgbLsbLgLsbLgbLgbLgbLgLsbRibRgbLiLsbLibLgbR
sbRgbRgRsmbRjRsmbRibRjRsmbsbRgbRsbRsbLsbRgbLsbRgbLibLgbLgLsbLgbLgbLgbR
sbsbLsbRjRgbRgRsmbRgbRsbRgbRgbLibRgRsmbRsbLsLsLsmmbLgbLgbLsLsLsmmbLgbR
sbRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bRsbRgbLsbRgRsmbRhRsmbLiLsbRibRibLibRhRsmbRsbRibRsRsmbLgbRsbRcbLjbLcbL
hLsbRibLgbLibLsRsbLgbLjbLibRjbRebRibRgbRibLsbLsbRgbLgbRibRsbLsbRgLsbRs
bRsbRgbRsbLgbRhbRgbRsbLjbRcbLsbRibRsbRsbRgbRsRsmbRibRgLsbRgRsmbRsbRsbR
sbRiRsmbRgRsmbRsRsmbLsLsmbRibRgbRsbRsbRgRsmbLjbRiRsRsmmbLjbRibRsRsmbRs
bRsbRgbRsbRgbLgbRibRsbRgRsmbRsbRgbRsbRsbRgbRsRsmbRgbLsbRgbRsRsRsmmbRgL
sbRsbRgbRgRsRsmmbRsbLgLsbRibRsbRsbRsLsbRgbRsbRgbRsbRgbLsbRibRsbLsbRgbR
gbRsbRgbRsbRgbLsbRgbRsbRiRsmbRgbRgbRgbRgbRgbRsbRgbRsbRgbRsbRsbRgbLsbRi
bRgbRsRsmbRgbLsLsmbRgRsRsmmbRgbRsbRgbRsbRgbRsbRsbRgRsmbRsRsmbRgbRsRsmb
RsbRibRsbLsRsbRgLsbRgbRsbRgbRgbRgbRsbRsbRsbRsbLsbRgbLsbRgLsbRsRsmbRsbR
gRsmbLgRsbLgbRgRsmbRgbRsbLgbRiRsRsmmbLjbRiRsmbRsbRsbRsRsmbRgRsmbRsbLsb
RibRgLsRsbLibRibRgbLgbLsLsmbRiRsmbRsbRgRsmbRsbRiRsmbLgbRibRsbRsbRgRsmb
LsRsbRgbRsbRsbRgbRsLsbRjbRsbRsbsbLsbRibRsRsmbRgbLgbRiRsmbRsbRibLsbRgbR
gbRgbRgbRsbRgbRgbRsbRgbRsRsmbRsRsmbRgbLsbRiRsLsmbLsbRsbRibRsbRsbRsbRiR
smbRsbRgbRgLsbRgbRgbRsbRgbRsbRgbLsbRiRsmbRsbRiRsmbRsbRgbRgbRgbRsbRgbRs
bRgbRgbRsLsbRsbRgbRsRsmbRgbRsbLsRsbRiRsRsmmbLgLsbRibRsbLgbRgRsmbRsbRgb
RgbRgbRgbRsbRgbRgbRgbRgbLsbRgbRsRgLsbRgbLsbRgbRsbRgbRgbRgbLsbRhbRsbRsb
RibRgbLgbRibRgbRgbRsbRgbRsbRgLsbRsbRgbRsbRgbRsbRgbRsLsLsmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bRsbRgbLibLibLibLsbLibLibLsbLibLsbLibLgbLgbLiLsRsbLibRibLsbLsbRsLsbLjb
LobLgbLibLiLsbLsbLibLibLibLiLsbLibLgbLibLgbRibLibLgbLgbLibLibLibLjbLcb
LcbLibLibLebLjLsmbLcLsmbLibLsRsbLsbLgbLgbRjRsmbLibLsbLgRsbRgbLsbLsbLgL
sbLgbLsbRjbLibLgbRgbLibLsbLsbLgbLgLsbLibLjLsmbRcbLsbLgbLsbLgbLsbLibRsL
sRsbLgbLsbLsLsmbLgLsbRsbLgLsRsLsbRgbLgbLibLibLiLsbRibLsbLgbLsbLgbLibLg
bLgbLsRsbLsbLsbLibLgbLsbLgbLgbLsRsbLgbLiRsRsmbRgbRsbRsbLibLibLgbLsbRgb
LgbLgbLgLsbLgbLsbLsbLsLsRsmbLsLsmbLsbLsbLsbLgbLhbRhbLibLgbLsbLgbRgbLib
LgbLjLsLsmmbRibLhbRjbRsRsmbsbsbRjbLhbRgbRgbLgbLgbLibLibLgbLsbLiRsbLibL
hbLgbLibLgbLhbLcbLibRjbLgbLsbLjLsmbLsbLibRgbRsbLibLibLibLibLhbLgbRgbLc
bLhbLcbRibRsbLibLibLhbRsbLgbLibRsbLgRsRsLsmbLibLibLibLibLgLsbLsLsmbLhb
LsbLsbRibLgLsbLibLiLsbLibRsbLiLsbLgLsbLiLsbLibLgbRgbLiLsbLsRsbRibLibLs
bLsbLgRsbLsbLibLhbRjRsmbRsbLgbLhbLiLsLsmbLjLsLsmmbRibRibLcbRsbLebsbRsb
RgbLibLiLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bLgbLgbRsbLibRsbLgbLibRsbLsbLgRsbLsRsbLsRsbsbLsbLgbLsbsbLgLsbLsbsbLsLs
mbLsRsbRjbRcbRgbLsRibRibLcbLgbLsbLgbLsbLgbLsbLsbLsbLsbLgbLsbLsRsbLibLi
bLiRsbRibRcbLjbLsbRibRibLjbRgbRibLjRsbLsbRgbLcbLibLsbRgbRgbRibRibLjbLc
bLibLsLsmbLgLsbRsbLgbLsbLgbLsbLsbLsLsmbLgbLgbRcbRhRsmbRibRhbLhbLcbLiLs
bLsbRjbLibLgbRibLiRsbLgbRgbLibRgRsmbLgLsbLgbRsbLgbRgbLibLibLgbLgbRgRsm
bRibRjbRibLibLjbRjbsbLebLgbLgbRsbRsRsmbLsbLibLgbLibRsbRjbLibLibRsbLiRs
bRjbLiLsbRsbLgbRsbLsbLsbLsbLsbLsbLsbLsbLsRsbLgRsbLsbRsRsmbLgbLsLsmbRsb
LgLsbRsLsLsmbLgbRsbLgbLsbsbLsbLgbLsRsbLsbRsLsbRsbLgbRjbLgbLgbLsbLsbRjb
RiLsRsbRgRsmbRgbLcLsmbRjbRgbLebLibLsbLgbRibLjLsmbLjbLgLsbLsbRibLgbLgbR
sRsmbRibLjbRgbLebLibRsbLgLsbLsLsmbLsbLsRsbLsLsmbRsbLgLsbsbLsbLsLsmbLsb
LsbLsbLsbLsbsbRcLsbRibLhbLibLsbLsbLgbLsbLgLsbRsbRsbRsLsbLibRgbLibLibRj
LsbLibLgbLibLsbRjbLibRjbLibLgbLsLsmbLgbLsbLsRsbLsbLsbRsLsbLgLsbLsbLsbL
gLsbLgbLgLsbLsbLsbLsbRsLgbLsbLsbLgbLgbRgbLibRsLsbLgbsbLsbLsbLgbLsLsmbL
gbLsbRsLgbLibLibRhbLibRsbLibLgbRsbRjbLsbRsbLibLsbLsRsbLibRsbLsLsmbRsLg
LsbLgLsbLsLsmbLsbLgbRsLsbLgbLsRsbLibRibLgbLgbLgbLsbRgRsRsmmbsbLjLsmbRs
bLgbLsLsmbLibRjRsmbLgbLsbLgbLsLsmbLsLsmbLsLsmbLsLsmbLsbLgbLsLsmbLsbLsb
LsbsbRsbLgbLsbLgLsbLgbLgLsbLsLsmbLgbLsRsbLsLsmbLhbLibLibLibLjbLgbLsbLg
bsbLsRsbLsbLgbLgbLsbRibRibsbsbLjbRhRsmbLjLsmbLjLsmbRibRhbLjLsmbLjbsbLi
bLsbRsbRjbsbLhbLibRiRsRsmmbRsbLgbRsbLgbRsLsbLibLgbRgbLibRgbRcbRibRibRi
bRibLgLsbRcbRjbRibLgbLibRjbLibLjLsmbsbRjbLibLjLsLsmmbLhbLgbRiRsmbLiRsb
RibLibRibLibLhbLjbLjbRjbLgbRgbLibLibLibRsbRgbLibRgbLhbRgbRgbsbLgLsbLjL
sLsmmbRgbsbLgbsbLgbLsLsRsmbRjbLjLsmbLiLsbRjbLjbLgbRjbRibRibLjbRiLsbLiL
sb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bLsRsLsbRgbLgLsbLsbLgbLiLsRsbLjbRgbLibRsbLgbLsLsmbLgbLgbLsRsbLgbLsbLsb
RsLsbLgLsLsmbRoRsmbLsbLgbLgbLgbRsbLgRsbRsbRcbRiRsmbLgbRgbRgbRgbRgbRgbR
gbLsbRiRsmbRgbRgbRgbRgbRgbRsbRgbRsbRibLibLhbLibLsbLgbLsbLgbLgbLgbLgRsb
LsbLgbRsbLgRsLsbRsbLiLsbRgbLibRsbRsbRgLsbLibLibRgbLibRsbLibRsbLgbRgbLi
LsbRjbLobRgRsmbRibRibRsbRgbRjbRsRsmbRsRsmbRgbLjbRibLjbLibLibRsbLibsbsb
LsbRgbLibRjRsmbLibLsLgLsbLgbLgLsbRsbLgbRobRhbLsbRgbRibLsbRgbRibLibLjbL
ibLgbRgbLiLsbLgLsbRsbLgbLsbLgbLsbLsLgbLsbLsbLgbLgbLgbLgbLgbLsbLsRsbLgL
sRsbLgbLsbLgbLgbLgLsbLgbLgbLsRsbRcbRibLsbRgbRgbRsRsmbRgbLcbLcbLjbRibRs
bLibLsbLgLgbRsbLgbRsbLgLsLsmbLsbLgbRjbLsRobRibLsbRgbRsbRgRsmbRsbRsLsRs
bLsbRgbRgbRgbRgbRsbRsLsbRgRsmbLcbLibLibRgLsbLibLgbRiLsbLebLsRsbRiLsbLj
bLibRibLcbLgbLgbRebLhLsbLibLsbLgbLgRsbRjbRebRsbRgRsmbRgbRgbRsbRsbRgbRs
bRgbRsbRjbLcbLibLgLsbLibRgbRcLsbLibRobRsbLibLiLsbLjbRgbRgRsmbRgRsmbLsb
RgbRsRsmbRsbRsbRsbRsbRsbRjbLsbLjbLcbLgbRcRsLsmbLcbLibLgbLjbLjbLsbLibRj
bRsbLiLiRsbRjbRebRgbRsbLsbLsbLsbLgbRsLsbLgbLsbLsbLgbLsbRcbRsbRsbRsbRsb
RsbRsbRsbLhbLibLgbLgbLsbRcRsLsmbRgRsmbRgbRsbRsbRsbRsRsmbRsbLgbLcbLibLg
bLsbRgbLiLsbLgbLiLsbLsbLgLsbLsbLgbsbRcbLsbRgRsmbRgRsmbRgbLsbLjbLhbRjbL
iLsbLibLsbLgbLsbLgLsbRsbLibsbLibRobRibRgRsmbRsbRgbRsbRsbRsbRsbRgbRsbRs
RsmbRgbRsbRsbRgbRgbRsbLjbLhLsbLibRjRsmbLibLgbRjbLhbRibLibLiLsbLibRgbLi
bRsbLibLsbRhRsLsmbRhbLjbLibLibRsbRgbLibRjbLsbLibLsbLgbLgLsbLgbLsbLsbLs
RsbLsbLgbRsbLgLsbLgbRsbLgbRobRibLsbRgbRgbRsbRsRsmbRgbRgbLjLsmbLcbLibLi
bRsbLiLsbLsbLgbLsbLsLsmbLjbsbRsbLgbLgbLgbLsbRsbLgbLibRiRsmbLibLgbLsbLg
bLgbLgbLgbLgbLgbLsLsmbLgbRsLsbLgbLsLsmbLgbRsbLibLgbRjLsbLibLsbLibLibRj
bLibRgbLibLsbRgLsbLibLgbRsbRsbRjbLhbRgbLgbLgbLgbLgbLgbRoRsmbRgRsLsmbRs
bRsbRsRsmbLsbLjbLcbLsLsRsmbLibRjbLgbRsbLgLsbRjbLibRgbLgbRsbLgbLsbLgbRs
bLgbRgbLiLsbRgRsmbRibRiLsbRsbRgRsmbRgRsmbRsbRgRsmbRsbRsbRsbRsbRsbRhbLj
bLcbLgbLsbLgLsbLsLsRsmbLgbLsbLgbsbLsbRsbLgLsbLsLsmbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bRibRgbRgbRibLsbRjbRgbRsbRgbLjLsmbRgbRsbRibRhbRsRsmbLsbRjbRgbLjbRjbRib
RsbLsRsbRgbRgbRsbLgbRibRsbLsbLgbRibLjbRibRsbRibRgbLjbRibLgbLgbLibRgbLg
bLgbRgbLgbRgRsmbRjbRibRgbRsbRgRsmbRgbsbRsbRsbRsLsbsbRgbLsbRsbRsbRgbRgb
RgbRibRgbLjbRibLsbRsbRgbRsbRjbLgbRibRsbRsbRsbRsbRgbLsbRgbRgbRsbRgbRiLs
bRgbRsbRsbRgbRsbRjbRsbLsRsbRgbRsbRsbRjbRsbRgbRgbRibRgRsmbRjbRibRsbRgbR
sbRsbRsbsbRsbRgbRiRsmbsbRgbRiRsmbLhLsbLibRjbRcbRibRibRsbLsbRgbRgbRjbRj
bRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bRgRsmbRgbRsbRgbRsbRsbRgRsmbRsbRgbRsbRibRsbRgbRgbRsRibRsRsmbRibRsbRgbR
sbRgbRgbRgbRgbRgRsmbRgbRgbRgbRsbRgbRsbRgbRsbLcbLgLsbLsRsbLgbLgbRsbLsbL
gbRsLhbRcbRiRsmbRibLsbRgbRsbRibLgbRibLsbRibLsbRgbLsLsmbRibLgbLcLibRsbL
sLgbLgbLsbLgbLsbLgbRgbLgbLgbRgbLibRebRhbRcbRgbLsbLsbRgbRgRsmbRsbRgRsmb
RsbRgbRsbRgbRsbRsbRsbRsLsbLsbRgbRgbRsbRibRgbRgbRgbLsbRgRsmbRgbRgbRsbRg
bRsbsbRgbRgbsbRgbLsbRgbLsbRgbRsRsmbRgbRgbRsbRgRsRsmmbRgbRgbRsbRsbRgbRs
bRgRsmbLsbRibLsbRgRsmbRsbRsbRgbRsbRgbRgRsmbRgbRsRsmbRsbRgbRsbRsRsmbRsb
RgbRgbRgbRgbLsbRgRsmbRsbRgbRsRsmbRiRsmbRgRsmbRgbLgbRjbLjbRibLgbRibLjbR
ibLjbLhRsbLibRhbLibRcbRsbRhLsbLgbRsbRgbRgbRsbRgbRsbRgbRsbRgbRjbLsLsmbR
gRsmbRgbRgbRgbRsbRsbRgRsLsmbRgbRgbRsbRgbRgbRgbRgbRsRsmbRsbRibRsRsmbRgb
LgbLhbLhbRgLgbLgbLibRjbLgbLibRjbLgbRcbRcbLgbRgbRibLsbRgLsbRsbRgRsmbRgR
smbRgbRsbRsbRgbRgbRsbRgbRgbRgbRsbRgbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbLgbR
iRsmbLsbRibLsbRgbLgbRibLgRsbRibLibRibLgbRibRgbRgbLgbRsbRgRsmbRibLgbRjR
smbRsbLjbRibLsbRgbRsbRibRgbLgbRibLsbRjbRsbRsbRgbRgbRgbRsbRgbRsbRsbRsbR
sbRsLsbRgbRsbRsbRgRsmbRgbLgbRibLjLhbLhbRjbRjbRibRibRgRsmbRsbRsLsbRsbRg
bRgbRgbRgbRsbRsbRgRsmbRgRsmbRgbRsbRgRsmbRsRsmbRgRsmbRsbRiRsmbRgbRsbRgb
LsbRgRsmbRsbRgbRgLsbRgbRsbRsRsmbRgbRgRsmbRgbLjbRhbLsbLsRibRgbLsbRgbRsb
RgbRibRsLsbRgRsmbRjbRsbRgbRgbRjbRsRsmbRsbRsRsmbRgbRsbRgbRgbLsbRgbLsbRg
bLsbRgbRsRibRibLibLjLsmbLibRjbLcLibLibLiLsbLibRgbRsbRibRsbRgRsmbLsbRib
RsbRibLsbRiRsmbRsRsmbRgRsmbRsRsmbRsbRsRgbLsbRibRsbRsbRsbRgbRsRsmbRgbRs
bRgbRgbLsbRsbRsbLgbRiRsmbRsLgbRjbRsbRgbRgbRgRsmbRgbRgbLgbRibRgbRsbRsRs
mbRgRsmbRgbRsbRsRsmbRsbRgbRgbRsbRgbRsbRgbRsbRgbRgbRgbRgLsLcbLibLgbLibL
gbLcbRgbLsbLibRsLsbLibLgbLsbLgbLiLsbLgbRgbLcbRibRhbLjLgbLgbLgbLsbLgbRc
RsmbRgbRgbRgRsmbRgRsmbRgbRsRsRsmmbRsbRgbLsbRgRsmbRgLsbRibRsRsmbRgbRgbR
gRsmbRgbRsRsmbRiLsbRgbRibsbLsLsmbRgbRgbRgbRgRsmbRsbRgbRgbRgbLsbLoRsbLi
RsbLgbLgRsLsbRsRsmbLibRjbRhbLsbRiRsmbRsbRgbRgbRgRsmbRgbRgRsmbsbRsbRibR
sRsmbRgbRsbRgbRsRsmbRsbRgbRgbRgbRgbRibLsbRgbRsbRgbRsbRgbRgbRsbRgRsmbRs
bRsRsmbRgbRsbRgbRgbRsbLsbLsRsbRgbRgbLsbRibRgLcbLibRsbLgbLgbLsLsmbLsbLg
bsbRgbLgbLgbLibRebRcLsbRsRgRsmbRibRgbRgbRgRsmbRgbRgbRsbRgbRgbRsRsmbRgb
RgbRsbRgbRsLsbRsRsRgmbRgbRsbRgbRgbRsRsmbRgbRgbRsRsmbRibLgbRibLjLsmbRib
RgbRsbRgRsmbRibRgbRgbRsbRsbRgbRsRsmbRibRsbRsbRjbRgbRjbLsbRgbRgbRgLsbRs
bRgbLsbRibRgbRsLsbRibRgbRgbRgRsmbRgbRgbRsbRgbRgbRgbRgRsmbRgbRgRsmbRgbR
sbRgbRgbRgRsmbRsbRgbLjbLcbLiLsbRjbLhRsbRcbRcRsmbRsbRgbRsbRiLsbRsRsmbRg
bRsbRsbRgRsmbRgbRgbRgbsbRgbRsRsmbRgbRgbRgbRsbRgRsmbRgbRsbRgRsmbRgbRgRs
mbRsRsmbRsRjbLsbRsbRsbRgbRgbRgbRgbRgbRgbRgbRgbRsRsmbRgbRgRsmbLobRgRsmb
RibRgRsmbLsLsmbRiRsmbRgRsmbRgbRgRsmbRgbRgbRgLsRsbRgbRsbRsbRsRsmbRgbRgb
RgbRgbRgbRgbRgbRgbRsbRgbLsbRibRsbRsRsmbRgRsmbRsRsmbsbRgbRgbRgbRsRsmbRg
RsmbRgbRgbRsbRgbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bRcbRibRgbLjbRibLsbRsbRsbRsbRsbRgLsbRsRsmbLebLcLsLsmmbLgbRiRsRsmmbRibR
sRibRsbLcbLjbRsbRgbLobLgbRgbRsbRgbLjbLibLibLibRjRsRsmmbRjbLhbLgbRjbRcb
LjbLhbLibLcbLibRsbLibLibLgbLsbLgbLgbLibLsbRgbRgbRgbRiRsmbLhbLebRgbRsbR
sbRsbRsRsmbRgbRsbRgbRsLsbRsbRsRsmbRgbLsRsbRgbRgbLjbLibLgbRsbLibRjbLibR
cbRibLiLsbLsRibRibRgbLsbsbLsbRsbRiRsLgmbRsRsmbLobRsbRsbRsbRsbRgbRsbRgb
RgbRsbRsbRsbRgbRsbRgbRgbRsbLhbLibRebRibRibLjbRgbRgbLjbRgbRibLjbRiRsmbL
jRsbRibLgRsbRsbRsRsmbRibRgRsmbRsbRsbRgbRsbRgbRsbRgbRgbRgbLjbLjbLibRjbL
ibLiRsbRcbRibLgLsbRibRsbRsbRgLsbLsbRgRsmbRsbRsbRsbRgbRsbRgbRsbRgbRsbRs
bRgRsmbRgbRgbRsRsmbRgbLcbLgLsbLgbRcRsmbRgbLgbRiRsLsmbLgbRibLjbLhbLibRi
RsmbRgRsmbRebRgbRibLjbLibRjbRcbLibRsRsmbRiRsmbRgbRsRsmbRsLsbsbRsRsLsmb
RibRsbRgbRsbRgbRsbLsRgbLgLsbLhbLibRjbLiRsbLgbsbRcbRcbLgbRibLibRibLgbRg
RsmbRsbRgbRsbRgbLjbLjbLibLibRsbLibRsbRjbRcbLgbRiRsmbRsbLsbRgbRsbRgbRsb
RgbRgbRgbRsbRgbRgbRsbRcbLjbRcbLhbRiRsmbRebLiRsbRibRsbRgLsbLgbRgbRgbRgb
RsbRgRsmbRgbRgbRgbRgRsmbRgbRsRsmbRibRsbsbRcbLjbLcLsmbRcbLhbRsbRiRsmbRi
bLiLsbRibRsRsmbRsbRgbRgbRsbRgRsmbRsbRsbRgbRgRsmbRgbRgbRgbLgbRibLjbRcLs
bLjbLhbLibRsLsbLibRjbLsbRcbRiRsmbLsbRgbRsbRgLsbRsRsmbRgbLjbLibRhRsmbRh
bLjbLjRsbLgbLsbLibRjbLibRjbLhRsbRjbLcbLcLsLsLsmmmbLibRsbRsbRgRsRsmmbLc
bRjRsmbLibLibRsbRjbLhbLibLiLsbLsbLgbLsbRgbRjRsmbRsbRsbLjbRhbLibRjbsbRs
bLsbLsRsbLobLgbLgbRgbLgbRgRjbRibLsbLsbRibLsRsbRsbRgbRsbRgbLsRsbRgbRgbL
sbRgbLjbLjbLibRcbLcbLibLibLibLibLsbRibRgbLsbRsRsmbRjbsbLsbLsbRsbRjbLiR
sbRgbRsRsmbLsRgbLsbRgbRgbRsbRgbRsbRsbRsbRgbLsbRgRsmbLsbRsbRsbRsbLibRjb
LsbLebRoRsmbRgbRgRsmbRsbRgbRsbRsbRsRsmbRsbRgbRsbRgbRgbRgLsbRgRsmbRgbLs
bLsbRgbLsbRgRsmbLjbLcbRjbRcRsmbRsbRsbRgbRhbLgbRgbRgbRsbRgbRsbRgbRsbRsb
RgRsmbRsRsmbRsRsmbRgbRsbRgbRgbRgbRgbRgbRgbRsbLjbRsbRgLsbRiRsmbLcbLjbLh
bRjRsmbRcbRgRsmbRgbRsbRsbRgbRsbRgbRsbRsbRgbRgbRgbRgbRsbRsbRsbLjbsbLcbL
sbLibLsbLibRgRsmbRcRcbLhbRibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bLsbLgRsbLgbLgLsbLgbLgbLgbLgLsbLgbLsLsmbLgLsbLgbLsbLgbLsLsmbLgbLsbLgbL
sbRjbLebLibRhbsbLjbLibLibLgRsbLgbLgbLsbLsbLgbLgbLsbLgbLgbLsbLsRsbLgbLs
bLgbRjbLsRhbLhbLhbRiLsbsbRhbLjbLsRsbLhLsbLibLiLsbLsLsmbRgRsmbLgbLgLsbL
ibLgbLgRsbLgbLgbLgLsbLsbLgbLgLsbLgbLgLsbLgbLgbLgbLgRsbRsLgbRsRsmbLgLsR
sbLsLsmbLgLsbLsbLgbLgbLsLgbLsbLgRsbLgbLgLsbLgbLgbLgbLgbRcbLcbLibRjbRcb
LcbLibRgbLibLgRsbLsbLgLsbLgLsbLibRcLsbLibLiLsbLiLsLsmbRibLibLibLsbLgbL
gbLgbLsRsbLgRsbLsLsmbRgbLgbRsbLibLgLsbRjbLibRjbLiLsbLgbLgLsbLgLsbLgLsb
LgbLsbLgbLgbLgbLsbLgbLiRsLsbRhbRgbLibLgbLgbLgLsbLgbLgLsbLgbLsbLgbLgbLg
bLgbLgLsRsbLgbLgbLgbLsbLgLsbLgbLsbLgbLgbLgLsbLsLsLsmmbLgbLsLsmbLsbLgLs
bLgbLgRsbLsbLgbRgLsbLgbLgbLgRsbLsbLgbLgbLibLsbLiLsbRgRsmbRjbRibLhLsbRs
bLgbRgbLibRjbLiLsbLgbRgbLgbLsLsmbLgbLsRsbLgbLsbLsbLgbLsLsmbLsbLgLsbLsb
LgLsbLsRsbLgLsbLgbLsbLibRsbLgLsbRgbLibRebRibLsbLiLsbLgbLgbLgbLgbLgLsbL
gbLhbRhbLibRgRsmbRgbRiRsmbLcbLibLsLsmbLgbLsLsmbLgbLgbLgbLgbLgbLgLsbRjb
RcbLebLiLsbRebLgLsbLsbLiLsbRcbLhbLgbLsbLgRsbLgbLsLsmbLgbLgbLgbLsbLgbLg
bRjbRjbLebLgbLgbLsRsbLsLsmbLgbLgbLgbLsbLgbLgbLgbLsbLgbLgbLgLsbLsbRsLsb
LgbLgbLsbLgbLgbLgbLgLsbLgLsbLgbLgLsbLgLsbLsbLgLsbLgbLsLsmbLsbLgbRjbLiR
ebsbRsbLgLsRsbLgbLgbLsbLgRsbLsbLsLsmbLgbLgLsbLgbLgbLgbLgbLgRsbLgbLgbLg
bRsLsbLgLsbLgLsbLsbLsRsbLsLsRsmbLsLsmbLgbLgbLsLsmbLgbLgbLgbLgbRsRsmbsb
LibRjbRhbRgbRgbLcbLiLsbLgLsbsbLsLsmbLgLsbRsbLsbRsbLgbLgRsbLgbLgLsbLgbL
sbLgbLgbLgbLsLsmbLgLsbLsbLgbLsbLgbRjbRcbLjLsmbLibLgbLgbLgbLsbLgbLgbLgL
sbLgbLgbLgbLgbLsbLgbLgbLgbLgbLgLsbLgbRgbLibLsbLgLsbLgbLsbLgbLgbLgLsbLs
bLgbLgbLsLsmbLsLsmbLgRsLsbLgRsbLgbLgbLgbLgLsbLsLsmbLgbLgLsbLgbLgbLsLsm
bLsbLgLsbRjRjbLibLgLsbLsLsmbLsLsLsmmbLgbLsbLgbLsbLgbLgbLgLsbLgbLgbLgbL
gbLgbReLsbLhbLiLsbLibRibLsbLiLsbLibRiRsRsRsmmmbLibLgbRcbLiLsbLibLsRsbL
sRsbLgbLgbLgLsbLgbLgbLgbRcbRgbRibRiRsmbLjbLcLsmbLibLsbLibRibLsbLhLsbLg
bLsLsmbLsRsLsbLgbLsbLsbLsLsLsLhLsmmbRcbRibRibRsbRgbRgbRsbRgbRsbRsbRgbL
gbLcLsmbLhbRjbLibLgbRsbLgLsbLibRcbRhLsbLibLiLsbLiLsbRjbRjbRhbLjbLibLgb
LsbLibLgbLsLsmbLsLsmbLgLsbLgbLsLsmbLgbLgbLsLsmbLgbLgbLsLsmbLgbLgbLgbLs
bLgbLgbLgbLgLsbLgbRjbRcbLcbLcLsmbRibLgbLibLgbRsLsbLibRjbLibLgbRgbLibLg
LsbLsbLgbRcbRcbLibLhbLgbRsbLsRibLsbLgLsbLgbLgbLsbLgbLgLsbLsLsmbLsLgbLg
bLsbLsbLgbLgbLsbLsbLgbRgbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bRsbRgRsmbRsbRgRsmbRgRsmbRgbRgbRsbRgbRgbRgbRgRsmbLcbLiRsbLgLsbLgLsbRsb
LgbLgbRcbRibRsbRgbRsbRsbRgbRgbRgbReRsmbRgbRgbRgbRgbRgbLcbLibLgbLgbLsbR
obRiLsbLgRsbRibRgbRsbRsbRgbRgRsmbRgRsmbRiRsRimbRgRsRsmmbRgbRsbRgbRsbRg
RsmbRsbRsbRgbRgbRsbRgbRgbRgbRgbRibRsbRgbRgRsRsmmbRgLsbRsRsmbRgbRgbRgRs
mbLsLsRsmbRibLibLhbLiLsbLgbLgbRcbRsRgbRiRsmbRebReRsmbRgRsmbLsbsbRgbRgb
RsbRsbRgbRgRsmbRgRsmbRgbRgRsmbRgRgbRgbRgRsmbRgbLjbLcLsmbLibLgbLgbRcbRi
RsmbRibRgbRgbRsbRgbRgRsmbRgbLsbRibLjRsbLcbLgbLgbRobRibLgbRsbRgRsRsRsmm
mbRgLsbRsLsbRgbRgbRgbRsbRgbRgbRgbRsbRgbRgbLsbRgbRgbRgbRsRsmbLgbLhbLgRs
LsbRsRsmbLjbRsbRgbRhbRibLsLsmbsbRsbLsRsbRgLsbRgbRgbRgLsbRgbRgbRsRsmbRg
bRgRsmbRgbRgbLgRsbRgbRjbLiRsbLhbLgbLgbLgbRsLjbLsRsbRgbRgbLsbLgbRjbRiRs
mbRgRsmbRsRsmbRsRsmbRgbRjbRgLsRsbRsbLsbRebRjbLgbRiRsLsmbLgbRiRsLsmbRgb
RgbRgbRgbLjbRsbRjbLgbLjbRgbRsbRgbLsbRsRgRsLsmbRibRsbLhbLibLgLsbLgbLgbL
gbLgbLgRsbLsbLsbLsbRgLsbRgbRcbRibLsbRsbRgbRgRsmbRgbRgbRgbLcbsbLcbLgbLs
bLgbLsbLgRsbLsLsmbLgbRebRsbRsRsmbRibRgbLsbRgbLgbLjbLgRsbLsbLgbLgbRjbRs
RsmbRiRsRgRimbsbRgbRgRsmbRgbRsRsmbRgLsbRsLobLsRsbLsLsmbLgbLsbLgLsbRebR
sbRgbRgbRgbRgbRsbRsbRsbRgbLgbLgbLgbLgbLsbLgbRjRsmbRcRjbRsbRsbRibLsbRsb
RsbRgRsmbRgbRsRsmbRgRsmbRgbRiRsmbRgbRsbRgbRgbRsbRgbRgbRsbRgbRibLcbLgbR
sbRgRsmbRgRsmbLsLsmbRgbRsRsmbRgbRsRsmbRsbRgbRgbRgbRsRsmbRgbRgRsmbRsRsm
bRsbRgbRjRsmbRsbRgbRsRsmbRsbRsbRsRsmbRgbRgbLgbRebRgbRsbRgbRgRsmbRgbRsR
smbRsRsmbRjbRgbRgbRiRsmbRgRsRsmmbRgbsbRgbRgRsRsmmbRhRsmbRjbRgRsmbRgbRs
bRgbLsRsbRibRjbRgbRgbLsbLgbRjbsbRsbRgbRgRsmbRgbRgbLsRgbLjbLobLjbLgbRcb
RibsbRgLsbRgbLgRsbRsbRgbRsbRjbRgbRgRsRhmbsbRgbRgRsmbRsbRgbRsbRsRsmbRsR
smbRgbRgRsmbRgbRgbRibRgRsmbRgbsbRsbRgbRsbRgbRgbRsbRgbRsbRibRgbRgbRgbRg
bRgLsbRjbLcbLibLgbRcbRebLjbLibRebRsRsmbRgbRsRsLsmbRgRsmbRsRsLsmbRsbRib
LibRibRgbRsRsmbRgRsmbRjbLjbRibRiRsmbLgbRiRsLsRsmbRgbRgbRgbRgbRsbRgRsRs
mmbRgbRgRsmbRgbRgbRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bLsbRhbRgbLsbLiLsbLibLsbLgbLsbLsbLsbLsbLgbLgbLsbLgbLsbLgbLgbLgbLsbLgbL
sbLsbLsbLgbLgbLsbLsbLsbLsLsmbRsbLgbLsbLsbLsbLsRsbLgLsLsmbRcLsbRhbLgLsb
LjbLibLgbRgbRgbRcbRsbRgbRgbRsbRsbRsbLsbLcLsmbLgLsbLgbRoRsmbRgbRsbRcbLi
bLhbLgbLgbLgbLgbRsbLgbRjbLcbLsRsbLsLsmbRsbRsbRsbLgLsbLsbLsbLhbLgbLgbLs
bLgbLgbLgLsbLgLsbLsbLgbLsbLsLsmbLsbLgbLibRjbLibLgbRjbRcbLcbRsbLsbRgbLi
bsbRgbLgbLgbLgLsbLgRsbLsRsbLgRsbLsbLsbRsbLgbLsLsmbsbLsbRsbLjbRsbLgbLsb
LgbLsLsmbRsbRsbRsLgbLgbRobRgLsbLsRsbLsbLsbLsLsmbLgbLsLsmbRsRsmbLgbLsbL
gbRcRsmbRsbLiLsbLibLgbRsbLgbRgbLgLsbRgbLibLibRsbLsbLgbLgbLsbLsbLgbLsbL
sLsmbRsLsbLgbLsLsmbLgbLgbRsbRgbLibLsLsmbRgbLsbRibRgbRgbLsbRgbLsRsbRgbR
gbRgbRsRsmbsbRibRibRsbLsbRsbRgbLsbLsbRgbLgbRibRibRsbRgLsbRsbRsbLibRsLs
bRcbRhbLgbRibRgbLsbLsbLjbLibRibRcbRibRsbRibRsbLgbLsRsbRcbLsbRsRsmbRgbL
sbLjbLcbLibRsbLsbLsbRgbLibLgbsbRjbsbLibRjbLiLsbLsbLsbRsbLsbLgbLsbLsbLg
bLsRsbLgLsbLsbLsLsmbLgbLgbRsbLgbLgbLsbRsbLgbRgbLgRsbLsbLgLsbLsbLgbLsbR
sLsbLsbLgbLsbLgbRsbLibLibLsbLgbLsbLgbLsbLsbLgbLgRsbRsbLgbLgLsbRsbLgbRg
bLgRsbLgbLsLsRsmbLsbLsbLgbLsLgbRsLsbLibLsLsmbLgLsbRsRsmbRobRebRgbRgbRg
bRgbLgbRibLjLsmbRsRhbRgbLgbRgbRgRsmbRsbRsbRsbRibRgbRsbRgbRsbRsbRibLgbL
cbLgbLsbLgbLsLsmbLgbRsbLibRgbLgbLgbRsbLgLsbLsbLsbLsLsmbRsbLsbLgRsbLsbL
sbLgLsbLgbLgbLsbLsLsmbLsbRsbLgbLsbLgbLsbLgbsbLgbLsbLsLgbLsbLgbLsbLsbLi
bLiRsbLgbRibRsbLgLsbLgLsbLgbLsLsmbLsbLsbLgbLsbRsbLgbLsbLgbLsbLgbLgbLgL
sbLgbLgbRgbLgbLgbRsbLgbRsbLgLsbLsbLsbLgbLsbLsbLsbLgbLgbRgbLgbLgbLgbLcb
LibLsLsmbLgbLjLsmbLsbRibRibRibLgbRcbRgbLgbLjbRhbRibRgbRgRsmbsbLgbRgbLs
bLsbRjRsmbRcbLsbRiLsbLsRsbRsRsmbRibRgbRsbLsRsbRibRgbRsbLgbRibRibLhbLcb
LgbLsLsmbRsLsbLgbLgRsbLsbLgLsbLsbLsbLgbLgRsbRgbLibRsbLgbLgbRsbLgLsRsbL
gbLsbRsbLgbLgbRgbLgbLgRsbLsbLgRsbRsbLgbLsbLgbLgbRgLsbLgbLgLsbRgbLgbLgR
sbLgbLsbLsLsRsmbLgbLsbLsbLjbLibLgbRsbLgLsbLsbLgbLsbLsbLsbLgbRcbRgbRgbR
ibRibRgRsmbRgbRsbRgbLgbLsbRsbLibLibLsbRgbLibLgbLgbRsbRsbRsbLibLsbRiRsm
bLibsbLsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bRibLsbLgbLobLgbLgRsbLibLgbLsLsmbLgbRjbRcbLsbLjbLibLgbLgbRiLsbRcRsmbLc
LsmbLgbRgbLhbLibRgbRsbRsbRhbLsbRibRsbRibRsbRibRsRsmbRsRsmbRsLsbRsbLhbR
ibRibsbLsbLsbLsbRibRgbRibRsbLgbRiRsmbRibRgbRsbRsbRsbLjbLcbLgbRjbRibLjb
LcbLsLsmbLgbLgbLgbLsLsmbLsbLhLsbLsbRgbLjbRgbLibLsLsLsmmbRebRibRsbRgbLg
bRibRgbRsbLsbRgbRsbLsbRgbRsRsmbsbRsbRsbRhRsmbLjbsbLsbLsbLsbLgbRsRsmbRc
bRsbsbLjbRgbRhbRcbRibRjbRsbRcbRsbRsLsbRebRgbRsRsmbRibRgbRibRsbRgbRibLs
RsbLcbRsbRgbLgbLsbLgbRgbLsbRcbRjbLjbLsbRiRsmbLibLsbRsLsbsbsbRsbLgbLgbL
gbLgbLgbLsRsbLsbRibRibRibRsRsmbRsbRibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bRjbLcbLiLsbLcbLgbRsbsbLsLsmbLsbLsbLsbLsbRsLsbsbRibLsbLjRsbLcbRjbLjbLs
LsmbLsbLsbRsbRsbLgLsLsmbLgbLsbLsbRgbRjRsmbRibLiLsbLgbLgbRsbLgbRgbLjbRi
bRsbRsbRsbRgbRsbRsbRsbRsRsmbRgbRsbLgbRgbRsbRgbRgbRsbRgbLcbLgLsbLgbLgLs
LsmbRibRibLjbsbRsbsbLsbRibLsRsbsbsbLjbLsLibLsbLgbRsbLsbLsbLsbLsbLgbLsL
smbLsbLgRsbLsbLsbsbLsbLsbLsbsbLgLsbLsLsmbLgbLgbLsbLsLsmbLsbRgbLsbRsbLg
bRsLsbLgbLsbLsbsbLsbRsbLsbLjbsbLsbLsbLsbLsLsmbLgLsLsmbRsbLgLsbLsRjbsbs
bRsbLsbsbRsbRjbLsRsbRibRgbLgbRgbRsbLgbRsbRsbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bLsLsmbRsbRjbLsLibRjbRibRsbRgbLjbLibLgbLgbLgbLsbLgbRsbLibLibRgbLsbRsLs
bRsbLsbsbLsbsbLsbLsbLgLsbLgbLsbLsbLsLsmbLsbLgRsbLgbRjbRcbRgbRgbRsRsmbR
gbRsbRgbLjbLcRsbLibLsbLgbLgbLhbRgbLgbsbLsRsbRgbRgbRgbLgLsbsbLcbRibLibL
gbsbLsbLgbLsbLsbLgbLsbLgbLgbRibLgbLsbLsbRsRsmbRjbRjbRgbRgbRgbRgRsRsmmb
LjbLcbLibLsbsbsbLgbLsbLsbLgbLsbLsbLsbLsbLsbLgbLgbLsbLgbRgbLsbLsbsbRsbL
sbLsLsmbLsbLsLsRsmbLsbLgbLibLiRsbRjbLibRjbRcbLjbLcbRjbRibRgbRibLibLcbL
ibLsbLsbsbLsbLsbLgbLgbLgbLsbLsbRgbLibRsLsRsbLgbRsbLsbLsbLsLsmbLsbLgbLs
bLsbLsLsmbLsLgbLsbRgbRjbLgbLgbRjbLibLcbRsbLgLsLsmbLsbLsLsLsmmbLsLsmbLs
bLgbLgbLsbLsbLsbLsbRsbLibLsbRsbLgbLsbLhbRibLcLsmbRibLcbRibsbRjbRgbRsRs
RsmmbRjbLibRebLibLcbRsbsbLsbLsbLsbLgbLibLhbRgbRsbLjLsmbLgbRsbRgbLgbsbL
sbRsLsbLsbLsbLsbLsbLsbLsbLgbLgbRebLibLsbLgbLgbLsbLsbLsbLsbLsbLsbRsbRhR
ibRjbLibRibsbRibLsbRsbLsbRhRsmbLsbRsbRsLsbRjbRgRsmbRibLsbLsbRsRsmbRgbR
sbRjbRsRsLsmbLcbRibLgbLibLsbLsRsbLsbLsbRibLcbLsbRsbLsbLgbRjRibLcLsmbLi
LsbLibRgbLjbRiLsbLjbLsbRsbLgbLsbLsbLsbLgbLsbLsbLsbLsbRhbRibLibRibRibLs
bLsbLsbLgbLgbLsbLsbLsbLsbLgbRibRhbRcbLibLcbLgbLgLsbLgLsbLgbRjbLiLsbLsb
LsbLjbRiLsLsmbRiRsRsmmbRgRsmbRsbRgbRjbRsbLsbLcbLcRsbRibLibLgbLsbRcbRcb
LebsbRsLebLsbLsLsmbLsbLgbLibRsbLsbLgbLsRsRsmbLsbRsbLgbRsbLobLibRibRjbR
gbRgbLsbRgbRsbLcbLibLsbLgbLjbsbLsbLgbLsLsmbRsbLsbLgbLsbLsLsmbLgbLiLsbR
jbLgbLgLsbLgbLsbLsbLsbLgbLsbLsbLgLsbLibLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bLgRsLsbLsbLgbLgbRsRsmbRsbRcbRgbRgbRgbLgbRibRgbLsbRgbLsbLjLibLgbRebRgR
smbRgbLsbRgbRsbRibLgbRibLsLsmbLsbLjbRsbLgbRhbRibRgRsmbLsbRsLsbRgRgRsmb
RgbRgbRgbLsLsmbRsRgbLgRsLsbRgbRgbLsbRgbRsbRgbRsbLsbRsbLsbRsbRgbRgbRgbR
gbRgLsbLsbRsbRsbLsbLsLjbRebLebLgbLgbLgbLsbRcLsbRibRsRsmbRgRsmbLsRsbRgb
RgbLsbRiRsmbsbRsbRibLgRsbRibLsbRibRsbLsbRsRsmbRsLsbRiRsRsLsRsmmbRgbLgb
RgbLsbRgbLsRsbRsLsbRgbRgbRsbRsLsbLsbRgbRsbRiLsbRsbRgRsmbRibRgbRgbRgRsm
bLebLgbLgbLgbLgbRcbRiRsmbRsbsbsbRgRsmbLsbRgbRsbLsbRgRsRsmmbRgLsbRgbLsb
sbLgbRsbRsbRgbRgbRgbRgbRsbRsRsmbRsLsbRibLsbLsRgRsLsmbsbLgbLsRsbLsLiLsb
LgRsbRibRibRgbLsbRibRsbRgbRgbRgbRgbRsbRsbLsbLsbRgRsmbLsbRsRsmbRgRsmbRs
LsbRgbRsbRsRsRsmmbRgbRgbRgRsRsmmbRgbRgLsbRsbsbRsbRsRsmbRgbRgbRsbRgbRgR
sRsmmbRgRsmbRsbRsbLgbRiRsmbRgbRgbLsRsbRibLgbRibLgbLjbLibLgbLgbLsbLgbLg
LsbLibLgbLsRsbLsbRcbRibRgbLgbRibLsbRsbRgbLgbLjLibLgbLgbLgbLgLsbLsbRobR
ibRsbRgbRsbLsbRsRsmbRgbLgbLiRsbRcbRibLsbRibsbLsbRsbRgbRsbRgbRgbRgbRgbR
gbRsLsbRsbRgRsmbRgbRgbRsbRsRsmbRgbRgbRsbRgbLgbRibRsRsmbRsbRiRsmbLsLsmb
RibLsbRiRsmbLgbRibLgbRgbRibRgbRgbLsbLsbRibRgbLjLsmbRibRibLgRsbRibLgRsb
RgbRgbLsbRibLgLsbRibLjbLcbReLsbRibRsRsmbRibRgRsmbRsbRibRiRsmbLgbsbLhbR
gRsmbRgbRgbRsbRsbRgbLsbRiRsmbLgbRcbLgbRibLjbRcbRsbLgbRibRibLgbRgbRgLsb
LsbRgRsmbLsbRibLjbRiRsmbRgbLibRsbReRsmbLibRhRsmbRiRsRsmmbLgbLgbRhbRsbR
ibLsbLgbRibLgbRibRsbLibsbLsRsbRhRsmbLgbRiRsmbRiLsbLgbRibRsbRgbLsbRibLi
bRhbLgRsbRgbRgbLgbLsRsRsLsmbRibRibLsbLsbLibLiLsbLgRsbRjLsbRcbRibLibRib
RibLibRgRsmbRgbLgRsbRibLibRibLjbRibRgbRibLsbRibLibLgbLgbLgbLsbRjbLsbLo
LsmbLgbRibRibRgRsmbRgbLjLsmbLcbLibLgbRsLgbLgbLsbRcbRibLjbRcbRibLgbRibL
jbRibRsbRgbRgLsbRgRsRsmmbLibRhbLgRsbRsRibLgbRibRgbRgRsRsmmbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bRgbRsbRibRsLsbLgbLcbLsbLsbLgLsbLsRsbLgbLsbLsbLsbLibRsLsbLsbRjRsmbRsbL
hbLsbLgbLsbRgbLibLiLsbLsbLibLsbLibLsbLibLsbRsRsmbsbsbRsbLibLsbLsLsRsmb
LibLjLsmbRgbLsbLjLsmbLsbLsbLsbLsbLibLsbRsbRsbLsbLibLsbLiLsbLsbLsLsmbLs
LgbLibLgbLsRsbLsbLsbRsbRibLgbRgbsbLibLsLsmbLeLsbLsbLibLsbLibLsbLgbLgbL
gbLsbRsRsmbLiLsbRgRsmbLiLsbRsbLsbLiLsbRgbLsbLsRsbLibRsbLibLsbRgbRsbLsb
LgbLsbLsbLgbLgLsbsbLsLsmbLibLsbLibLsbRiRsmbLibLsbLgbRsbLibLgLsLsmbLsbL
sbLgbLsbLsbLibLsbRgbLibLgbLsbRgbLibRgbLgbLsbLgLsbLsRsbLsbLibLsbsbRgbRs
bLsbLibLgbLjbRgbLgbRibLibLsbLibLsbLgbRjbLibLibLibLgbLsbLibLgbLsbLsbRgL
sbLiLsbLibLgbLsLsmbLsbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bRsbRsbLsbRsbRsbLgbRcbRcbRhRsmbRjbRcbLsbRsbLgLsbRgbLjLsmbRgbLibLgbLgLs
bRgbRsbLjbLsbRsbRgbLibRjbLgbRsbLibRsbLgbRsbLgLsbRsbLgbRsbLibRgbRsLsbRj
bLsRsbLjbRsbLjbLsbLsbLgbLsbLgLsbLsbLsbLgbLgbLgbLgbLsbRsLsbLsLibRsbRsbL
sLsmbRsLsbRjbLcbRgbRgRsmbLjLsmbRjbRcRsmbRsbRgbRsbRgbLjbLcbLibLgLsbLgbR
gbLgLsbLgbRsRsmbLgbLsbLjbRsbLsbLsbRgbLgbLgbRgbLibLsbLsbLgbLgbLgbRgbRjL
sbRhbRsbRgbLsbRgbLsbRgbLebLibRsbLgbRsLsbLgbRsbLgRsbLhbRgbLibLsLsmbLsbL
sbLsbLsbLgbLgbRjbRcbRgRsmbLcbLibLgbLgbRjbLibLsbRsbLibLsbRgbLsbLsbLsLsm
bRsbLsRsbLsLsmbLjbLgbsbLgbLibLgLsbLsbLsbLgbLgLsbRibLsbRgbRsbLsbLsRsbLs
bLsbLgLsbRsRsmbLgbsbLgbLsbLgbLsRsbLsbLsbRsbRsRsmbLgbRsbRsbRsbLsbRsbLgb
LsbLsbLsRsbLgLsbLsbLgbRsRsmbLsbRgbLiRsbLgbRsRsmbRibRhbRiRsmbRgbRsLcbLi
bLibRgbRsbRsbLibLgbLgbRgbLgLsbRgbLibRsbLgbRsbLgbRgLsbLsbRgbRgbLibRsbsb
LgbLsbLgbLibRgbLibRsbLibLsbLgbLsbRjbLibLiRsbRibRsbLibsbLjbRsRsmbRsbLsb
RgbLgbRsLsbLgbLgbLgbLsRsbLgbLsLsmbLgRsbRibRibRibLgbRibLgbRibRgbLgbLhLs
LsmbLgbLsbLgbLsLsmbLsbLgbRgbLgbsbLsbRsLibRibRsbLgRsbLjbRsLsbLsbRsbLsbR
sLsbLsbLgbLsbLgbRcLsbRibRibLibLjbLibRgbLibLsbRsbLsbLgbLgbLgbRgbLibLgbL
ibRsbRgbRgbRiRsmbRgLsbRgbRibRibLjbLhbLibRgbLjbLsbLgbLgRsbLsLsmbRsbLgbL
sbLsbLgbLsbLsbsbLsbLsbLsbLsbLsbLgbLsbLgLsbRsbLgbLgbRcbRgRsmbRsbRgRsmbL
sbRgbLsbLcbLibLsbLsbLsbLgbLgLsbRsLsbLgbLgbRgbLgbLsbLsbLsbRgRsmbLiLsbLs
bRsbLsLsmbRjbLsLsmbLsLibRgbLibLsLsmbLgbLhbRgbLsbLibLsbLgbLsbRgbLibRgbL
gbRgbsbLibRsbLgLsbLgbRjbLibRsbLgbLsbLsLsmbLgbLsbsbLsRsbLibRibLibRgbLsb
LibLsbRgbLiLsbLsbLsLsmbLgRsbLsbLgbRsbLgLsbLgbRgbLgbRjbLibRibLiLsbLsbLg
bLsRsbLsLsmbLsbLsbLsLsmbLsLsmbLsbLsbLjbLsbRsbLgbLgbRsRsmbLsLsmbLjbLgbR
ib

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bRcbRibRibRsbRsbLsbLebLjbLiLsbRjbLebRhbRjbRibRjbRjbLhbRsbLsbLsbRsbRsLs
LsmbRgbRsbLibRgbLsbLibLsbRcbLebLjbLjbLgbLsbRcbRibLcbLibRjbLgbRjbRhbRhL
sbLsbRcRsmbRjRsmbLsbRcRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 25; Drug: Control Apo 0.5 然
bRsbRgbLsbRibLgbRiRsmbRibLibLsbRgbRsRsmbRsbRsRsmbRsbLsbLgbRsbRgbRsbLjb
RcbRgRgbLibLibLibRsbLibReRsLsmbRibRsbRsbsbRgRsRsmmbRsbsbRgbRgbRgbRsbRs
bRgbRgLsbRsRsmbRsbRsLsbRsbLgbLjbsbRsbRsbRgRsmbRgRgbRgRgbsbRsLsbLgbLsRs
bRibRgbLsbRgbLsbRibLgbRibLibRibRgRsmbLibLsRibRgRsmbRgRsLsmbRgbRjbRsbRg
bLsbRgbRgbRsbRsbRsRsmbRsbsbRiRsRimbRsbRsbRsbRgbRgbRgbRsbRsRsmbRgbRsbRg
bRsbLsbRgbRgbLiLsbRcbLsbLibLcbRebRobRjbLibLcbRcbRsRsmbLjbRsbRsbRgbRsbR
sRsmbRsbRsbRsbRsbRsbRgbRgbLjbRiRsmbRsbRgRsmbRgbLjbLcbRhRsmbRcbRsbRjbRs
bRsbRsbRgbRhRsmbLgbRgbRiLsbLjLsmbRhbLcbRebRjbLsLsLsmmbRgbLsbRsbRgbRgbL
sbRgbLsbRgbRsbLjbRibRgbRsbRgRsmbRsbRgbLsbRjbLgbLjbLhbsbRcbRibRgbRgRsRg
mbRgbLjbLibLibRjbRcbRibRsRsmbLsbRsLsbRsbRsbRgbRgRsmbRgbRgRsmbRsbRgRsmb
RsbsbRsbLgbLgbRibLibRhbRibRgbRgbLibLcbRjbRcbRibRgbLibRiLsbRsRsRsmmbRgb
RgbRgbLibRibRgRsmbRgbRsbsbRsbRsbRibRgRsmbRgbRgbRgRibRgbLsbRibRgbRibLgR
sbRibRhbLibRibRgbRsbLsbRgRsRsmmbRgbRgbRgbRgbRgbRgbRsbRibsbRibLjbRhbLjR
sbLcbLsbRsbRcbLsbRgbLcbLiLsbLibRjbRcbRgRsmbRgbRgbRsbRsRsmbRsbRsbRsbRsb
RgRgbRgbRgbRgRgRgRsmbRgbRgRgbRgbRgbLgbRgbRgbRgbRgRgbRibRsbRibsbRgbRgbR
gbRgRgRibRsRsmbRsbRsbLibRibRiRsmbRgbLibRiRsmbRgbRsbLibLhbRcbRibLsbLjbR
cbLjbRcbRibLibRgbRsbRiRsmbRsRsmbRgbLjbRibRsbLgRsbRibRsbRsbRibRhbLjbRhb
LjbRhbLjbRhbLgbRibLjbRgbLsLsmbRibLsbLsbRibRsbRgRsmbRsRsmbRsbRsbRsbRsbR
sbRsbLgbLjbRibRgbLsbLsRgbRsbRgbRgRsmbLhbLcbRjbRcbLibRhbRsbLsbLsbLsbsbL
gbRjbRsbRgbRsbRgbRsbRgbLsbRgbRsbRgbRsRsmbRsbLsbRsbRsbLsbRsbRsbRgbRgbRs
bRgbRgbRgbRgRibLgbLsRsbRsbRgbRgbRgbRsbRsbRgbRsRsmbLsbLgbLcbRcbRibRibRg
bLibRsRsmbRcbLjbRiRiLjbRsbRgLsbRgbLjbRibRibRgbLibRcbLjbRhRsmbRibRsbLsb
LhbRsbLcbLhbRcbRcbRgRsmbLgbRibRsbLsbLsbLjRsbRcbRibLibRgbLibLibLiRsbRjb
RcbRibRgbLjbRibRgbLgbRsbRibRsbLjbRiRsmbLjbRibLjbLhbLgbRsbLgbLsbRsbLgbL
gLsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 26; Drug: Control Apo 0.5 然
bLgbRibLjbLcbLgbLiRsbLebLsbLsbLsLsmbRcRsmbRiRsRsmmbRgbLgbLsLsmbLibLgbL
iRsbLhbLgbLsbRgbRhRsmbRsbLhbLcbLiRsbLibLgbLgbLgbLibLiRsbLsRsbLibLsbLiL
sbLcbRjbLibRebRcbLsbRsbRibRsRsmbRjbLsbRsbRgbLsbsbRsRsmbRgbLsbRibLsbRsb
RsbRgbRgRsmbRgbRgbRgbRgbLsbLsbRibLgbLhbRobLgbRjRsmbLhbLibLhbLsbLsbRsbR
ibLsbRibsbRsbRgbRsbRsbRsRsmbRgbRsbRgbRsbRsbRgbRgRsmbRgbRsbLsbRsRsmbRsb
RgbRgRsRgmbRgbRsbRgbLsbRibLsbRsbRgbLjbRibRsbLsbRibLgbRibRsbLsbLsRsbRiR
smbRsbRsbRgbRsbRgbRsbRgbRhRsmbRgbRsbRgbRsbRgbRgRsmbRgbRgbRgbRgbLjbLhbL
ebLebLiRsLsbLsbLcLsmbLcLsmbLgbRibLibRgRsmbRibRsbRgRsmbRsbRsbRgbRgbRgbL
jbRibRibLibRiRsmbRibRgbRgbRsbRibLgbRibRgbLjbRibRibLsbRibRsbRsLsbRiRsmb
RgRsmbRgbsbRgbRgbLgbRgbRsRsmbRsbRgbRsbRgbRgbRsbRgRsmbRgLsbRsRsmbRgbRgb
RibLsbRibLcbLiRsbReRsmbRibRsbRsbRgbRgLsbRsbLgbRcRsmbLgbLjbLibRjbRcbRsb
LsbRiRsmbRgbRiRsmbRsRsmbRgbRgbRgLsbRsbRgbRsbRgbRsRsmbRiRsRgLsmbRibLgRs
bLsbRhbLgbRibRgbRsbLsbLsbRibLgbRgbRibRsbLsbRibLsRsbRgbsbRgRsmbRgRsmbRs
bLgbRibRgbRgbLgbLcbRgbRjbRhRsLsmbRgbLsRsbRsbLsbRhRsmbRgbRsbRsbRgRsmbRi
bLgRsbRgbRgbRgbLsbRsbRgbRsbRsbLsbRhbRsbLsbLsbRibLgbRibLgbRibRsRsmbRgbR
sbRgbLsbRgbsbRsbRgbLgbLhbLibRcbRibLgbRiRsmbLgbRibRgbLsbRgbRgbLgbRiRsmb
RgbRgbRgbLsbLgbRibRgbLibRibRgbLgbRibLsbRsbRibsbRsRsmbRgbRgbRsbRsbRsbRg
bRsbRgbLibRcbRibLibLsbRhbLjbLcLsRsmbLibLibRjbRcbRibRsbLgbRibRiRsmbLsRs
bLibRjbRibLsbRsRsmbRgbRsbRsbRsRsmbRsbRgbLsbRgbLgbRiRsmbLsbRsbLhbLibLgb
LhbLgbRhbLibRibRhbRsbRgbRgbLgbRibRgbLibRgbRgbLsLsmbRsbRiLsbLgRsbRiRsmb
RsbRsbRgbRsbRsbRsbRgbRgRsmbLgbRibLjbRibRgRsmbLsbRsbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 27; Drug: Control Apo 0.5 然
bLgbRibLgbLgbRgbLgbLgbLsbLibLsbRgbLibRsRsmbLgbLsbLsbLgbLsbLsbLibLsbLib
RsRsmbLiLsbLsLsmbLgLsbLsbLsLsmbRsbLsbLibRgbLibRsLsbLgbLgbLsRsbLibRgbLg
bsbLsbLjRsLsbRjRsmbLsbLgLsbLsbLgbLsbLsbLsbLsbLgbLsbLsbLgbRsbLiRsbRgbLs
bRsbRsbLgbLgbRsbLgbLgbLsbRsbLibRsLsbRsbLsbLsbLgRsbLgbLgbRsbLgLsbRsbLsL
gbLibLsbRgbLiLsbLgbRsbLjbLsbLgbLsbLgbRsbLibRsRsmbLsbLsbLgbLsbLsLsmbLgb
RsbRcbRgbLjbLibLgbLsbLiLsbLibLgbRibLgbRibRibRgbRgbLgLsbRgbRgbLcbRsbLib
RgbLibsbLgbLsbLsbLsbRsLsbLgbLgbLsbLgbLsbLsbLsbLsbRsbLjLsmbRgbLibLsbLsb
LsLsmbLsbLsbLsbLsbRsbLgbLsbLgbLsLsmbLsbRsbLgbLgRsbLsbLibLgbLsbRsbLibRs
RsmbLsLsmbLsLsmbLibLsbLibRgbLgbLgbLsbLsbLsbLsLsmbLhbRgbLiLsbLgbLsbLibL
sbLgbRsbRsbLiLsbRgbLiLsbRsbLsbRgbLgLsbLgbLsbLsbRsLsbLgbLibLsbLgbLsRsbR
sbLgbLsLsmbRsRsmbLgbRsbLgbRsbLgbRgLsbLiLsbRsbLgbLgLsbLsbRsbLgbLgbsbLsb
LgbLsbLsbLgbLgbRgbLsbLgbRsbLibsbLgbLsbRgbLsbLibLgbRsLsbLgbLsLsmbLgbLsb
LibRsbLgLsbLsbLgbLsbLsbLgbRgbRcbRgbRgbLebLgbLgLsbLsbLgbLsbLgbLibLgbRhb
LibLsbLgLsbLgLsLsmbRsbLibRsbLiLsbRsbLgbLsbLgbRgbLibLsbLgbLgbRjbRebRibR
gbRgbRsbLeLsbLibLsLsmbLgbLgRsbRsbLibLsbLibRsbLsbLsLsmbLsbLsbLsbLsbLsbL
gbLsbLgbLsbLgbLsbLsbLsbsbRsbRjbRhbRibRgbsbLeLsbLiLsbLsbLgbLsLsmbLgbRjb
LibRgbLibsbRgLsbLibRsbLgbLsbLsbLsbRsLsbLgbLgbLsLsmbLgbLgbRsbLgbRcbRibL
ebLhbLgbLgbRsLsbLibRsbRsbLgbLsbLgLsbLsbLiLsbRsbLgbLgbLsLsRsmbLgbLibLgb
LgbLgbLgbLgbRsbRgbRibRjbLsbRgbLjbLcbLiRsbLsbLsLsRsmbLgbRsbLgbLsbLsLsmb
LsbLgbLsbLsLsmbLgbLsbLgbRgbLibRsbRsbLgLsbRsbLibLsbLgbRgbLibLsbRgLsbLib
RsbLgLsLsmbLsbLgbLsbLgbLsbLgLsbLsLsmbRsbLgbLgbRgbLiLsbRsLsbLibRgbLibRs
bRsbLibRsbsbsbLgbLsbLsbLgLsbLgbLsbLsbLsbLsbLgbRgbLibLibLgLsbRsbLgbLgbR
sbLibsbRsbLibRsbLgbRsbLgbRsbLgbRsbLgRsbLiLsbLgbLsbLgbRsLsbLgbRcbRibRib
LcbLgbLgbRebRgbLsbLibLsbLibRgLsbLibRsbLgbsbRgbLibLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 28; Drug: Control Apo 0.5 然
bRgbsbRgRsmbRsbRibRjbRgbRsbRsbRjRsmbRgRsmbRsbRsbRiRsmbRsbRsbRsbRsbLjLs
mbRibRgbRsbRgbLibLgbLgbLsbLsbLgbLsbRsbRjRsRsmmbLgbLjLsmbRibRibLgbLibLs
LsmbLsbLgbLgbLsLsmbLibRsbRgRsmbLibLsLcLsmbLsLsmbRjRsmbLibLjLsmbsbLgbLs
bLgbLgbLsbLgbRibLibLsbLgbRibRgbLgbRjRsmbLibRsbLsLsmbLsbLgbRsbRgbRsbLgb
LsbRsbLibLsbLsbLgbLsbLsbLgbLsbLhbLsLsmbLgbLsLsmbLgbsbLsbLgbRsbLgbRsbRs
bLjLsLsmmbRibRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 29; Drug: Control Apo 0.5 然
bRsbLjbsbRsbLsLsmbLgbLsbLsbLsbRsbLsbLsbLsbLsbLsbLsbLsbLsbRjbRcRsmbRgbL
sbRgbRibLjLebLgbLgbLgbLsbLgbLsbLsbRsbLsbLsbLgbLsLsmbsbLsLsmbRsbLsbLsbL
sbLsbLsbLsbLsbLgbLgbLsbRsLgbLsbLsbLsbLgbLsbLsbLsbRebRibRibLjbLjbLcLsmb
LgbLsbLsbLsbLsbRibRibRibRgbRibRhbRcbRgbRibLjbLibLgbLsbRgbRgLsbRjRsmbRi
bRgLsbLgbRgbRsRsmbRsbRsbRsbLsbRgbLgbLjbLcbLibLgbLsbLsbLsbLsbLsbLsbLsbL
sbLsLsmbLsbRsbRsLgbLgbLsbLjbLsbLsRsbLsLsmbLsbLsbLsbLgRsbLsbLsbLsbLsbLs
bLsbLsbLsbLsbLsbLsbRcbRibRibRsbRgbRgbRgbLcbLgbLsLsmbLsbLsbLgbLsLsmbLsL
smbLsRsbLsbLsbRsRsmbLsLsmbRsbRsbLsLsmbLsbLgbRsLsbLsbLsbLsbLsbLsLsmbLsb
LsbLgbLsbLsbRjbRibLcbLibLibLgbLsbRsbLgLsbLsbLsRsbRsbLsbLsbRgbRebRibRgb
LgbRgbRsbRgbRsbRsbRsbRsbRsbRgbRsbRiRcbRsbLgbLgbRibRhbRibLgbRiRsmbRgbRs
bLsbRgbLgbRgbLcbLgbRsbLgbLgbLsbLgLsbRsLsbLsbLgbLsLsmbLsbLsbRsbLsbLsbLs
LsmbLsRsbLsbLsbLsbLsbLsbLgLsLsmbLgbLsbLsbRsbRebRibLjbLibLibLgbLgbRgbRg
bLgbLgLsbLsLsmbLsRsbLgRsbLsbLsbLsLsmbLgbLsbLsbLsbLsLsmbLsbLsLsmbLsLsLs
mmbLgbLsLsmbLsbRsbRsRcbRibRgbRibRgbLsbRsbLgbLgbLsbLgbLgbRjbLhbRgbLsbLs
bLgRsbLsRsbLsLsmbLsbLgbLsbLjbsbRsbsbLsbLsbLsbRsbLgbLsbLsbLgbLgbRcbRibL
sRsbRibRibLgbLgbLiLsbRsbLgbLsLsmbLsbLgbLsbLsbLsbLsbLsbLsbLsRsbLsbLsbLg
bLibRsRsLsLsmmbLsbLsbRsRsmbLsbLsbLsbRsbRsbLgbLgbLsbLsbLgbLsLsmbLsbLsbL
sbLsbLsbLsbRcbRibRgbRibLebLgbLsbLgbLsbLsbLsbLsbLsbLgbRsbRsbLgbLsbLsLsm
bLgbLsbLsRsbLsLsmbLsbLsLsmbLsbLsbsbLsRsbLsRsbRsbLgbLsbLsLsmbLsbLsbLsbL
sbLsbLgbLsbLsbRibRibRiLsbLgbRgbLjbRjRsmbRibRibLjbLcbLibLgbLgbLsbLsbLsb
LsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLsbLgbRjRsRimbRgbRgRsmbRsbRgbRsbRsRsmbRg
bLjbLcbLhbLibLgbLgbLsbRgRsmbRgRsmbLhbLcRsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 30; Drug: Control Apo 0.5 然
bLebRibLebRobRobRcbRobLobLobLgbLcbLibRobRobRobLobRobLcbLobLobLibLibRob
RebLebRhbLobLcbLebLgbRebLibLebLibRobLobLcbRobLhbRcbRobLcbRebLibRcbLobL
ebLgbLcbRobLobLebLobRobLobLobLsbLebLebRebRgbLobRobLebLgbRibLebRobRobRo
bRcbRebRcbRcbLjbLcbRebLgbRebRcbLobLcbRobLebLobLobRcbLobRcbRobRcbLcbLgb
LcbLgbLsbRobLobRebRobRgbRcbLobLgbLsbRobRibLebRobRobRobRobLebRcbLobRhbL
ebLebLhbLobRjbLebLobRcbRebRsbRebRcbRebRsbLebLebLcbRsbLobRgbRcbRobRcbRe
bLobRhbLobLebLgbRebRobLobRcbRebLebLcbLgbLcbRobLcbRgbLobRobLibLobRgbLob
RsbRobLobLcbRgbRcbRebLobRebLebLcbLobRobRebLebLsbLcbRgbRsbLobLobRobLobR
ebLobRobRgbLcbRcbRobRobRobRcbLcbLsbRobLobLebRcbRebRebRebLobLobRebLcbRo
bRgbLebLcbLobLebRobRobRebRebRobRcbLobLibLobRobRobRcbLobLebLgbRhbRobRob
LobRgbLsbRebLobRebRebRobRibLibLcbLobRobRgbRcbLibLebLobLibRebRcbLebLobL
obLobLobLgbRebRjbLebRebRobRibLobRebLgbLobLobRsbLcbRebLebLcbRcbLobRcbRo
bRibLjbLobLhbRobRobRibLebRgbLebRobLobRebLobLcbRsbLobLsbLebRebLcbLobRob
RhbRcbLgbRebLobRobRobRobLebRcbRebLobLebRobLobRsbRebLobLobLobLobRcbLobR
ebLobRobLcbRobLobRibRibLobRobRcbRobLcbRobRibLhbLibLobLobRobRobLobLcbRi
bRobLobLgbRgbRobLibLobRcbRgbLgbLgbRobLcbRebRcbLsbLsbRcbLsbRgbLobLebLeb
RobLobLobLobRobRobLobLcbLobLebRcbRsbLobRcbRibLsbRsbLobLcbLobRsbLebLobR
ebRcbLcbRobLobRobRobRebLibLobLobRibLobLebLcbRobRcbLobLobRgbRobRgbLcbLe
bLobRobRcbLobRcbLibLobRjbLhbLobRebLcbRibLebLobLcbRobLebRsbRobRebLobLsb
RebLobRobLcbLsbRobLibRobRobLebRobRobRhbRjbLsbLobRobLebLcbLobRgbLgbLgbL
ibLcbLebLobRsbLobRgbRobLobRcbRobLibLebLobRcbLobLobLhbRcbLebLobLebLobRc
bRgbLcbLsbRcbLobRibLcbLgbRibRobRebRcbLobLibRobLcbLibLibLebLobRcbRsbLob
LhbLcbLebLobLcbRibRebRebLsbLobRcbLobRibLcbRobLsbLcbLibLebLsbRobRobRgbR
cbRobLobRgbLobRebLibRobRobLcbLebRibRibRebRobLcbRgbLgbLobRebRobLobRobRc
bLobRebRibLobLobRebLgbLcbRobRebRobLibRobRobRsbLobLobLebLcbRsbRobLibLhb
RobLebRobLebLobRgbRibLcbRebLcbRobRcbLobLobLobRebRobRobLcbRibRobLobLibR
ebRgbRebLobLsbRobRjbRgbRsbRobRobLebRobRobRobRebRebLcbRgbRcbRobRibRhbRo
bRcbLobLgbRcbLobRobRsbRibRsbRebRcbRsbLgbLebRsbRobLobLobRgbLibRebLebLeb
RcbRobLobLobRobRcbLebLobLibLcbLobLebRobRgbRcbLobLcbRebRobLebRcbLobRobL
cbLebLobLcbRobLobLebLibLcbLobRcbLobLobRebRgbLobLobRgbRobRgbLhbLobLobRo
bLebLobRobLsbLobRcbRobLebLcbRobLobRebLcbLobLebRobRobLobRobRcbLibRebRob
RobRebRcbRobRobLgbLsbLcbRobLobRjbRobRjbRcbLcbLobLsbRcbLobLibLibLcbRcbR
cbLibRobLcbRcbLobLobRhbRobLgbRcbLgbLebLebLcbLebLobLebLebLobLebRgbLobRg
bLobLcbLcbLobRebRobRcbLgbRsbRebRibRsbRgbRobLebRsbLebRibRcbRgbRobLobLob
LcbRcbRebRobLibLebLobLobRebRebRobLebRobRibRcbRobLobLcbRobRebRobLobRcbL
obLcbLobLcbRobRcbRcbLobRcbLebLcbLcbLobRcbLebLobRgbLobLhbLobLcbLgbRebLo
bRcbLebRobLobLobLebLebRobRobLobLobLebLobRebLeb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bLsbRgbRsbRiLsbsbLsbLsbLsbRgbRsbRsLsbRgRsmbLsbLsbLsbLsLsmbRgbRibLsbRib
LsbLsbRgbRibRsbLgbLsbRjbRsbRiRsmbRsbRsbRgbRsbRsbRsbLsbRibRgbLsbRgbRgbR
ibRsbRgbRgbRgbRibsbsbLsbRgRsmbRsRsmbRsbRgbLsbLgbRjbLgLsbRibRsbRibRibRs
bRsbsbRibRsbRibRsbRibsbRgbRgbRibRsRsmbRgbRibRsbRgbRsbLsbRgbRsbRsbRiRsm
bRgbRgbRiRsmbRsbRibRsbLsbRibsbRibRibRgbRibRsbRsbRsLsbRibRiLsbsbRgLsbRg
bLsbLsLsmbLsbLgbRsRibRsbRgbRsbLsbLsbRgbLjbRibRjRsmbLibRgRsmbRsbRgbRsbR
sbRgbRsbRsbsbRsbLsRsbLsbLsbRsRsmbRsRsRsRsLsLsmmmmbLsRsLsRsLsbRgRsmbRsb
RjbRsbRsbRgbRgbRgbLsbLibLgbLgbLjbLgbLsbLsbRgbLsbLsbLsLsmbsbLgbRgbLgbLi
b

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bRhbLibLibLibLibLsbRgbRsbRsbRsRgbRgbRgbRsbRgbLibLcbLibLsRsbLgbLibLgbLg
LsbRsbRsbLibRsbLsbLgbLsbLgbLsbsbRsbLsbLgLsLsmbRsbLgbLsRsbLgbLsbLgbRsLs
LsmbLsbLsbLsbLgLsbLgbRsbRsbLgbLsRsbLsLsmbLgbLsbLsbLsRsbLgbLsbLsLsmbLgb
RsbLgLsbRsLsbLsRsbLsbLsbLgbLibRsRsmbLibRsbLibRsbLgbLsbLgbLgbLsbRsLsbLs
bLgbLsbLsbLsbLsbLgbLsbLgLsbLgbLsbLsbLsbLsbLgbLsLsLsmmbLgbLgbRsbRsbLiLs
bLgbLgbLsbRsbLsbLsbLgRsbLsLsmbLgLsbLsbLgbLsbLsLsmbLsbLgbLsbLgbLsbLsbLg
bRsRjbLibRjbLhbLibLsbLgbRgbLsbRsbLgbLibLsbLsLsRsmbLgbLsbLsbLsbLsbLsLsm
bLsbLgLsbLsbLgbRsbLgLsbLsbLsLsmbLgbLgbLgbLsbRibLgbLibRsbLjbLsbLsLsmbLg
bLgLsRsbLsbLsbLgbLsbLsbLgLsRsbRsLsbLsLsmbLgLsbLsLsmbLsbRsLsLsmbLgLsbLs
LsRsmbLsbLgRsbLsbLsbLsbLgbLgLsbLsbLsLsmbLgLsbLsLsmbLsbLgbLgbRsbLgbLsbL
gbLsLsmbLgLsbLsbLsbLgbRjbLibLsbRsbLibLsbLsbRsbLgbLsbLgbLsLsmbLsbLsbLsL
sRsmbLsbLsbLsbLgbLgbsbRsbLgbLibRhRsmbLgbLsbLiLsLsmbLgbLsbRsbLgbLgbLsbL
sLsmbLsbLsbLsLsmbLsbLgbLgbRgLsbLgLsbLsbLsLsmbLsbLsbLsLsmbLsbLsbLgbsbLs
RsbLgRsbLgbLsLsmbLsbLsbLsbLgLsbRsbLgbLsbLsbLsbLsRsbLibLgbLsbLsLsmbRsbL
ibLsbLgbLgRsbLgRsbLsbLsbLsbLgbLsbLsbLsbLsbLgbRsbRsbLibLgLsbRsbRsLsbLib
LsbLsbLgbLgbRsbLgbLsLsmbLsbLgbLsbRsbLgbLibLsbRgbLibRsbLgbRsLsbRsbLgbLs
bRsLsbLgbLsbLgbLsbLsbLsLsmbLsbLsbLgbLibLibRsbLhbLhbLhLsbLiLsbLibLibLsb
LsbLgbLsbLgbsbRsbLgLsbLibLibLsLsmbRsbLsbLgbLgRsbLsLsmbLgbLsLsmbLsbLsbL
sbLgLsbLgbLgbLsbLgLsbLsbLgbLsbLgbRgbLibRjRsmbLibLibLsbLsbRsbLsbLiLsbLg
RsbRgLsbLibRsbLgbLgbRgbLibLsbLgbLsbLgbLsbRsLsLsmbLsbLsbLsbLsbLgRsbLgbL
gbLgLsbLsbLgbLsbLgbLsbLgbLsbLibLibLgbRibLsbRsbRsbLjbLgLsbLsLsmbLgLsbLs
bLgLsbRsLsbLsbLgbLgbRsbRsLsbLibLiLsbRsbLgbLsLsmbLgbLsbLsbLgbLsbLgbLibR
sbLgbLgbLsbRsbLibRsbRsLsbLgbLsbLsbLsbLgbLsbLsbLsLsmbLgLsLsmbLsbLsbLsbL
sbLgbLsLsmbLgbLsbLgbLgRsbLsbRjbLibRgbLibRsbLibLsbRsbLibLsbLgbLgLsbLsbL
ibLgbLibRhbRsbRsbRsbLhbRsbLsbLgbRsbLsbRsbLsRsbLgbLsLsmbLsbLgbLgLsbLibL
gbLibRgLsbLsbLibLgbRsLibLibLgbLgbRibRsbLhbLibLibLsbLsbRgbRgbLsRgbRgbRg
bRsbRgbRcbLebLiLsbLsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bRsbRsbRsbRgbRsbLsRsbRsbRsbRsbRsRsmbRsLsbRsbRsbRsbRsbRsbRgbRsbRgRsmbRg
bLcbLibRjbRcbLjbLibRcLsbRcbLiLsbLjbLibRjbRcbRgbLjbLjbLiRsbRcbRcbRibLib
LsbRjLsRibRgbRsbRgbRsbRsbRsRsmbLsbRgbRgbRsbRsbRgLsbRgLsbRgbRsbRgbLgbRg
bLsRsbRgbLsRgbRgbRsbRsbRgbRgbRsbLjbLibRjbRibRibLjbRibRgbRgbRgbLibLibRs
RgbRgbRibRgbLibRgbRgbRgbRsbRsbRsbLsbRsbRsbLibLcbRjbRcbRsbRiLsbRsbRgbRg
bRsbRsbRgbRsbRgbLsbRgRsmbLsRsbRgbRgbRgbRsbRsbRsbRsbRsbLsbLsbRgbRgbLjbL
ibLjbRcbLjbRcbRibRgbRgbLjbLcbLibLsbLsbLgbRcbRibLjbRibLjbRibRibRsbLibLj
bsbRhbRibRsLsbRgbLsbRgbRgbRsbRsbRsbRsbRgbRgbRsRsmbLgbLibLgbLgRsbRcbRsb
RgbRibRsbRsbRsbLsbRgbLsbLjbLibRibRibRgbLgbRgbRgbLsbRgbLgbRibLjbRibRibR
gbRgbLgbLhbLibRhbRibRibLcRsbLhbLsbLgbLsbLjLsmbRibRcLsbRgbRgbRsbRsbRgbR
gbLjbLjbLoLsmbRjbLibLgbRibRjbLjbRibLcbLebLiLsbRjbLibRebLcbLjbRjbLibRhb
LebRhbRjbLibRcbRibRibRibLjLsmbLibLibRibRhbRjbLjbRibRgbRgRsmbRsbRgbLsbR
sbRsbRsbRsbRsbRgbRgbRsbRsbRsbRsbRsbRsbLsbRsbRsbRsbRgRsRsmmbRsbRgbRgbRg
bRgbLsbRgRsmbRsbRgbRsbRsbRgbRsbRsbRgbRsbRsbRsbRsRsmbRgbRsbRsRsmbRgLsbR
jLsbRiRcbRcbRibRgbLjbRcbLjbLjbRcbRibRibRibRsbRsbRibRsbLjLsmbRibRiLsRsb
LsbLgLsbLsbLjbLibRgbLibRjbRsRsmbsbLibRhbRibRsbRsbRgbRsRsmbRsbRsbRsbRgb
RsbRsbRsbRsbRgbRsbRgbRsbRsbRsbRgbRsbLsbRgbRgRsmbLebRsbLibLiLsbRibRgRsm
bRgbRsbRgbRsbRgbRsbRsbRgbLsRsbRsbRsbRgbRsbRsbsbRjbLhbRjbRsbRibRibRsbRg
bRsRsmbLsbRsRsRsmmbRsbRsRsmbRsRsmbRsbRgbRsbRgbRsbRgbRsbRgbLsLsmbRgbRgb
RgbRsbRgbRsbRsbLsbRsLjbLibRcbRcbLjbRgRsmbRgbRsRgRgLsbRgbRgbRsRsmbRgRgb
RgbRgbRgbRsLcbLhLsbRgbLibLibRsbLgbRcbRgbRgbRsbRsbRgbRsRsmbRgbRsbLjbRib
RgbLsbRgbRsbRsbRsRsmbRsRsmbRsbRgbRsRsmbRgbRgbRgbRgbLjbLhbLibLsLsmbRsLs
bLsLgbRsbLgbRjRsmbRcbRibLjbRibRgbRsbRsbLibLibRjbRcbLjbRcbLibRibRgbRsbR
sbRsbRgRsmbRsbRgbRsbRgLsbRsbRsRsmbRsbRsRsmbRsbRgRsmbRgbRsbRsbRsRsmbRgb
RgbRgbLjLjbLhbLgbRibLgbLibRhbLibRjbLcbRcRsmbRibRibRibRsbRgbRsbRsbRsbRs
bRsbLsbRgbRgbRsbRsbRsbRsbRsbRgbLgbRgbRgbLsRsbRgbRsRsRsmmbRgbRsRsmbRgbR
gbLsbRsbRgbLcbLcbRhbRebRgRsmbRgbRsbLsbRgbRsbRsbRgbRsbRsbRgbRgbLsbLhLgb
LgLsbLgbRcbRsbRgbRsRsmbRgbRsRsmbRsbRsbRsbRgRsmbRgbRgbRsbRgbRsbRgbLcbLi
bLgbLsRibLibRsbLgbRjbLibRcbRibRsbRsbRsbRgRsmbRgbRsbRsbLsbRgLsRsbRgbLgR
sbRgbRgbRsRsmbRsbRgbRsbRsbRgbLjRsbRgbLsbRsbRgbRsRsmbRsbRsbRgbRgbRgbRsb
RsLsbRgbRgbLebLibLsbLgbRsbRibLhbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bLsbLgbRsbRsbLsbLsbLsLsmbLsbLgbRgbRsbLgLsbLgbLgbRibLsbsbLjbLgbLsbLsbLs
LsmbLsbRjbRsbRgbRgbLsRsbsbRiRsmbRsbRsRsmbRsbRsbRsbLsbLsbRsRsmbsbRsbRsR
smbRsbRsbRsbRsbRsRsmbLgbLsbRsbLjLsmbRgbRgbLibRgbRsbLsbsbRgLsbRsbLsbLgb
LjbRibLsbLjbLcbLibRsRsmbLgbLgbLsbLsRsbLgbRsbRgbRsRsmbRsbRsbRibsbRibRsb
LsbRsbRibRibLgLsbLsbLsbLsbLcbsbsbLgbLibLsbLgbLgbLsbRsbRgbRsbRgbRjbRibR
sRsmbRsbRsbRsbRgbRsbLgbRgbRsbsbRsbRgRsmbRsbRgbRsbRibRsRsRsmmbLsbLgLsbs
bRibsbRsRsmbRsRsmbRgbRgbLgbRgRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bLsbLgbLgbLsbLgbLsbLsLsLsmmbLsbLsLsmbLgbLsLsLsmmbLsbLsbRsbLibLibLhbRsb
RgbRibRsbRibLsbRsbRgbRgbLjLsmbLgbLsLsmbRgbLibLgbLgbLgbLgRsbLsbLsbLgbLs
LsmbLsbLsbLsbRsbRsLsbLgbsbLsbLgbLsbLsRsbLgLsbLsLsmbLsbLgbLsRsbLsbLsRsb
LsbLgbLgbLsbLgbLgbRibLgLsbRsLsbLsLsmbLsbLsbLgbRsRsmbLibLibLsbRsRsmbRsb
RsbLibLsbLsLsRsmbRsbRsbRsbRhbRsbLcbLgbLsLsmbLgbLgbLsLsmbRgbLibRsbsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bLibRjbRgbLjbRibLiRsbLgbLsbRsbRgbRsRsRsmmbLsbRsbRsbRgbLibRgbRsbRsbLsbR
sbLgbRjRsmbLgbLibLsRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bsbRsbRsbLibLsbRsbsbLgLsbLgbLsbsbLsLsmbLsLgbRiLsRsbLsbLsbsbRibRgbRsbRg
RsmbRgLsbRsbRsLsbRsbRgbRsbRsbsbsbRgbLsbRsRsmbRgbRsRsmbRgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bRsbRibLiLsbLgbLibRibRsbLsbLgbLgbsbRsbLsbLgbRsbRiRsmbLgLsbRgbLibLsbRsb
RsbLgLsbLsbLsbLsLibRsLsbRjbLibLgbLgbRibLibRsbLibLsbLsbLibRsbLsLsmbLsLs
mbLgbLgRsbRsRsRsmmbRsLsRsbLgbLsbLgbRsbLsbLsbRgbLibsbRjbLibLgbLgbRsRsmb
LsbLgbLgbLsbRsbRsbLsLsmbLibLsbRgbLgbLsbRsbLsbRsbLsbLgbLsbLgbLsLsmbLsbL
sbLsLsmbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bLjbRgbRsbLsbLibLsbLibLgbLsbRgbLsbLhbRsbLiLsbLgbLebLsbLsbRsbRsbLjLsmbL
ibLsbRibLobLsbsbLiLsbLsLsmbLibRgbLsbLibRsbLsbLhLsbRsLsbRsRsmbLibLsbLib
LsbRgbLibLsLsmbLibLsbLgbLsbRgbLibLsLsmbLiLsbLsbRgbRsbLiLsbLgbLiLsbLsbL
hbLsRsbRsbRsbLhbLibLgbLsbRhbLibLibRhbLhLsbLsbLgbLsbRsbLsbLsbLsbLgbLibL
sbLhLsbLibLsLsmbLibLsbLebLsbLsbLibLiLsbLsbRibLhbLsbLhLsbLsbRgbLgbLsLsm
bLsbRgbLibLibLsbLgLsLsmbLsbRgbLibLsbLibLsbLsbRsbLsLsmbLgbRjbLcbLsbLsbR
gbRsbLiLsbLsbRibLsbLhLsbLsbLsbLgbLsbLsbLgLsbLgbLsbRsbLsbLgLsbLsLsmbLiR
sbLsbLiLsbRibLibLibLsLsmbLsbLsbLibLsbLhbRibRsbRhRsmbLgLsbLhLsbLsbLiLsb
LsRsbRgbLibLsbLibLgLsLsmbLsbLsbLiLsbLgbLsLsmbLsLsLsmmbLgLsRsbLsbLibLgL
sbLsbLsbLsbLibLsbLibLibRibRgbLsbLgbLsbLgLsbLsLsmbLgbLiLsbLsbLibLsbRsbL
ibLiLsbLgLsbLiLsbLsbLsbLibLgLsbLsbLiLsbLsbRgbLsbLhbLcbRiRsmbLibLsbRgbR
cRsmbRgRsmbLsLsmbRibRibLsbRibLiLsbLibLsLsLsmmbLibLsbLjbLsbRibLsbLgLsbL
ibLsbLsbLibLsbLhbLsbLsbLsbLsbLsLsmbLcbLsbLsbRgbLiLsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bRsbLsbRsRsmbRgRsmbRgRgbRsRgbRsbRgRsmbRgRsRhRgRiRgRsRiRiRsRsmmmmbRgRsR
sRgRsmmmbRgRgbRgRsRgRsmmbRgbLjLsmbLjbLjbRiRsmbRibRiRsmbLgbLibLsbLcbRcb
RcbLsbRcbLibLibLsbLiLsbLibRibLcbRiRsmbRibRhRsmbRsbRsbRsRibRsbRibLsbLsR
sbRgbRsbRsbRsbRgbRsbRsbRgRgRsmbRgbRgbRgbRsbRsbRgbRsbRsRsmbRsbRsbRsbRsb
RsRsLsmbRgbRsbRsbRgLsLsmbRgbRgbLsbRgbRibLjbLcbLibLgbLibRibRjbRibRibRsb
RsbRsbRsbRgbRsbRsbRgRsmbRgbRsbRsbRsbLsRsbRsbRsbRgbRsRgbRgbRsLsbRsbRsRs
mbRgbRsbRgbRsbLsbRgbRsbRgbRsbRsbRgbRgLsbRgRgRgbRgbRgbRgbRgbRgRsRsmmbRs
bRgRsmbRgbRsbRgbLsRsRgbRsRgbRiRsmbLjbLjbRjbRjbRhRsmbLibRhbRiRsmbRibRgR
smbRibRjRsmbRsRsmbRgbLjbLibRibRiRsmbRgbRsRgbRgbRgbRgRsmbRgRsmbRsbRsRsm
bRsbRgbRgbRgbRgbRgbRsRgbRgRsmbLsbRgRsmbRsbRsbRsbRsbRsRsmbLsRsRsmbRsbRg
bRgbRgbRgbLsbRibLjbLhbLibLgbRgbRobRibRibLsbLsbLibLibLcbRgbRjbRcRsmbRib
LsbLsbLsbRhbLgbLsbRgbRgbRgbRsbRsbRsRiLsRibLjbLcbLgbLgbRebRcbRiRsmbLgbL
sRsbLsbLsbRsRsmbRiRsmbRsbLsbRgRsmbRsbRgbRsRsRsmmbRgRgRgRsmbRgRgRgRsmbR
gbRgbLibRiRsRsmmbRgbLibsbRibRgbLsRsbRsRsmbRsRsmbRsbRsbRgRsRsmmbRgRgRsm
bRgRsmbLjbsbRibRsbLsRsRsmbRgRsRsmmbRgRsmbRgRgRsRgRgmbRgbRsbRgbRgbLsbRg
RsmbRgRsRsmmbRiRsmbLjbRhbRhRsmbRsbRgbRgRsmbRsbRsbLsbLiLsbLgbLgbRcbRiRs
mbLsbLsbRibLibLjbRhbRibLhbRhbLgbLgbLgbLibRcbRcbLsbLsbLgbRgRsmbLsRsbLsR
sRgbRsbRsbRsbRgbRsbRsRsmbRsbRsbRsRsmbRsbRgbRgbRgbRibRsRsmbRsRsmbRgbRsR
gRgbRsbRgLsbRgbRgRsmbLgRsbRibRsbRgbRsbRsRsmbRsRsmbRgbRgbRsbRsRibRgbLsb
RibLjbRibRgRsmbLgbRibLibRibLjbRgbRsbRgbRsbRsbRsbRsbRsRsRsmmbRsRsmbRsbR
gbRsbRsRsRsmmbRsRgRsmbRsbRgbRgbRsbRgbRsbRgRgbRsbRgbRgbRsbRsbRsbRgbRsRs
mbRgbRibLjRsbLcbLibLgRsbRjbRjbRgRsmbRsbRgbRsbRsbRgbRgbRsbRsRsmbRgRgbRg
bRgbRsbLsbRgbRsRsRgRsRgRgRsmmmbRgRsRgmbRgbRgRsmbRgbRsRsmbLsbRgbRsbRgbL
jbLcbRiRsmbReRsmbRhbLibLhbLibLgLsbRjbLhbLibRiRsmbRibRibRsbRgbRgbLsRsbR
sRsmbRsRsmbRgReRiRgbRgRsmbRgRsmbRsbRsbRgRgRgRsRimbRgRsRsmmbRgRgRgRsRgR
sRgRgRsRgRgRgmmmbRgbRgbRsbRgRsmbRgbRgbLjbRibLibLhbLibLiRsbRgbRgbLibLcb
LgbLsbRibRgbRsRsmbRgbRsbRibRsbRibLsbLjbRcbLibLibRhbLgbRiLsbRsbRsRsmbRs
bRsRibRgbRgbRgRgRgRgRgbRgRgbRgRsRiRiRgRsRgRgmmbRgRsLsmbRgbLsbRibLgbLib
RhbRiRsmbRsRsmbLgbLcbLibLcbRibRgRsmbRibRibRibRgbRgRgRgRgbRsbRgbRgRsRsm
mbRgbRgbRsbRsRgbRsbRsbRsbRsRsRsmmbRsRsmbRgbRgbRgRgRiRsmbRibLgbRibRsRsm
bRgRsmbRsbRgLsbRsbRgbRsbRgbRsbRsbRgRgRgRiRgRgRsmbRgbRgbLjbRhbRcRsmbLhb
RhbLcbLibLgbLsbLgbLgbLsbRsbLgbLibLgbLibRibRgbRgbLgbLibLgbLgbRibLjLsmbL
ibRgbLgbLgbLgbLsbLsbLgbLibLibRibRgbLsbLjbLgbLgbLgbLgbLsbRsbRsbLgbRgbLg
bLgbLsbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bRhbRsbLibRiRsmbRgbRgbRsbLibRiRsmbRgbLsRsbLibLgbLgbLgbRiRsmbRibRibRsbL
ibLsLsmbRgbRsRsmbLsbLgbLgbLiLsbLsbLibsbRibRgRsmbLibRjRsmbRiRsmbLgbRsRs
mbLsbRsbLjLsmbLibLiLsbLgbLsbLsbRsbLgbLgLsbLsbLsbRsbLiLsbLibLibLsbRibRg
bRibRsbRgbsbLsbRibRgbRsbRibLibLsbLgbRibRibRgRsmbRiRsmbRgbRsRsmbLgbsbRi
bRibRsbRsbRibRsbRgbRgbRgLsbLjbLgLsRsbLsbLhbLiLsbLgbLsbsbLgLsbLgbLsbLgb
LsLsmbRibRsbLjLsmbLibLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bLhbRhbRcRsmbRhbRibRsbRsbLsbRgbRgbRgbLjbRibLsbLjbRgbRgbLsLsmbRgbRgbRsb
RgbLjbRiRsmbLjbRibRiRsmbLsbRgbRsbRsbRgbLgbRgRsmbLgRsbRgbLgbRibRsRsmbRs
bRsbRsRsmbRgbLsbLsbRsbRgbRgbRsbRsRsmbRsbRgRsmbRgRsmbLgbRibLsbRgbLjbRgb
RgRsmbLgLsbRgbRjbRsbRgbLsbRibLgbRgbRsbRsbRgbRgbRsbRibRgbRsbLjbRiRsmbLg
bRgbRgbRsbRsbRgbLgRsRibRgbLgLsbRibLgbRibRgbRgbLjbRibLcLsLsmmbLgbRgbLib
RjbRiLsbRsbRibLgbRgRsmbRsbRgbRibLsbRibLgbRiRsmbRgbLgbRgbRgbLjbRcbLibRi
bLgbRgbRsbRgbRsbRsbRgbRgbRibRibRgbLjbRibRibLibRibRgbLsbRgbLsbLsbLgbRgb
RsbRgbRgbLsbLsbRibRgbRsbRibRgbLibLhbLibLibLibLgbLgbLibRjbRhbRgbRgLsbRg
bRsbRsRsmbRsbLobLibRjbLibRgbLibLsbLgbRibLibLsLsmbLsbRgbLibLsLsmbRsbLiR
sLsbRjbLhbLsbLcbLsbLhbLibRibLgbLgLsbLibRcRsLsmbRiLsbLgbLsbLgbRhbRibRib
LsbRiRsmbLgLsbRhbLibRibLgbRibLhbRibLhbLjbRiRsmbRibsbLjLsmbLjbLhbLsbLsb
LgbsbLsbLgbLibLibLgbLsbRgbLgbLsbRsRsLsmbLsbLjbLsbLsbRsbLsbLsbLsbLsbReb
sbsbRibLgRsbLebLcbLibLibLiLsbRibRgbLibRibRibRsbRgRsmbLibLgLsbRsLsbLgLs
bLiLsbLgbRgbRjbRibLsbRibLgbRiRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bRibRsbLiLsbLibLcbLibLsbLibLsLsmbLsbLgbLgLsbsbLibRgRsmbRgbsbLibLgbLsLs
mbRsbRgbRsbRsbLsbsbRsbLibLsbRgbLibRgbRgbRgbLgbLhbRibLiLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bRibRsbRibRgbRgbLsbRsbLsbLsbLjbRibRibRsbRgbRgbRibLsbRgbRgbRgbRgRsmbLsb
RgbLsbRgbRgbLjbRhbLgbLsbRibRsbRgbRgRsmbLhbRgbRgbRgbRgRsmbRgbRibRgbRsbL
ibLjbRcbRibRibLsbRibRiRsmbLsbRgbRsbRsbRsLsbRgbRsRsmbRgbRsLsbRgbRsbRsbR
sRsmbRsbRsRsmbRgbRsbRsbRsbRsbRsbRsLsbRsbRsbRgRsmbRsbRsbRgbRgbRsbRgRsmb
LsRsbRgbRgbRsbRgbRgbRsbRsbRgbRgbRsbRsbRgbRsbRsbRgbRsbRsbLsRgbRsbRsRsmb
RgbRsbRgbRibLsbLsbRgRsmbRsbRsbRgbRsbRsbRgbLsbRgRsmbRsbRsbRgbRsbRsLsbRs
RsmbRsbLsbRgbRsbRsbRgbRsbRgbRibLjbLibLibRibRgbRibLgbLsbLsbRgbRgRsmbLjb
RiRsmbRgbLsbLsbRgRsmbRgbLsbRgbLsbRgbRgLsbRgbLsbRgbRsbRgbLgbRgbLsbRgbRs
bRgbRsbLsbRgbRsbRsbRsRsmbRgbRsbRsbRsbRsbRsbRsbRsbRsbRgbRgbRsbRgbLjbLcb
sbRjbRiRsRsRsmmmbRgbRsbRgbRsbRgbRsbRsRsmbRgbRsbRsbRgbLsbRsRsmbRgbRgbRs
bRsbRgbLsbRgbRsbRgbRsbRsbRsbRgbRsRsmbRsbRsbRsbLsbLhLsbLgLsbLgLsbRcRsmb
RsbRsbRgbRsbLgbRgLsbRsbRgbRsbLsbRgbRsbRsLsRsbRsbRsbRsbRsLsbRsbRgbRsRsm
bRsbRsbRsbRsbRsbRsLsbRgbLsbRgbRsbRgbRsbRgbRsbRgbLsbRgbRsbRsbRgbRsbRsbR
gbRsbRsbRsbRsRsmbRgRsmbRgRsmbRsbRsbRsbRsbRgbLsbRgbRgbRsbRsbRgbRsbRgbRs
bRsbRgbRgbRsbRsbRgbRsbRsbRgbRsbRsRsmbRsbRsbRgbRsbRgbRsbRsbLsbRgbRsbLjb
LgbRjbRibRgRsmbRsbLgbRgbRiRsmbRsRsmbLsbRgbRgbRsbRsbRgRsmbRsLsbRsRsmbRs
bRgbRsbRgbRsbRsbRgbRsbRgRsmbLsbRgbLgbRgRsmbLsbRgbRsbRsRgbRgbRsbRsbRsbR
gbRsbRsbRsbRgLsbRgbRsbRsbRsbRgbRsbRsbLsbLsbRgbRgbRsbLsbRgbRsRsmbRsbRsb
RsbRgbRsLsbRgbRgbRgbLgbRibLjbRibRsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bLgLsbLgbLsbLibRgbRjbRibRibRsbRibRibRgbLgbRiRsRsmmbRibRibRsbRibLgbsbsb
RsbLsbLibLgbsbRgbRjbRiRsmbsbLgbLgbLibRsbRgbLjbLibRsbRgbLibLibLibLibLgb
sbLgLsbLgbLibLibLibRibLgLsbRgbRsbLibsbRibRgRsmbRhbRibRgbRsbLsbRibLgbLg
bRibRsbRgbRgbRgbRibsbRsbRsbsbLjLsmbLsbLgbRgbLsbLgbLsbLgbLsbsbsbsbLibLs
bRsbLsbLsbRjRsmbRcbRibRsbLgbLsbRsbRibLjLsmbRsbRibRibLgLsbRgbRgbLjLsmbR
ibRsbLsbRhbLgbRibRiRibLgbRibRgbRsbRgbLgbLgbLibLibLsbLsbLsbRgbsbLjbLibL
sbLjLsmbRsbRgbRsbRsbRibRibRibRgbLsbLsbLgbLgbLgbLgbLgbLsbLgbLsbsbsbRgbL
ibLibLibLgbLgbLsbsbLibRibLcbLibLgbRibRsbRgbRgbRsbRsRsmbRibRgbRsbRsbRib
RsbLsbRibLjLsmbRjbRgRsmbRsbRibLsbRgbsbLcbLibLsbLjbRgbLgbLsbLgbsbLsbsbL
sbLgLsbLgbRgbLsbRsbLibLsbLiLsbLgbLgbRsbsbLgbLsbLsbLgbLgbLgbLibRsbRgbLi
bsbLgbLsRsbLsbsbLcbLsbLgbLsbRjRsmbLgbLsbLcbLsbLsbLgLsbLsbRgbLgbLgbLgbR
gbRsbRsbsbRjRsmbsbsbLsbLgbLhbLibLsLsmbLsbLgbRgbRibRjbRibRsbRibRgbLsbRs
bLsbRgRsmbLgbLsbLsbLjbLgbLsbRgRsmbLibsbLgbLgLsbLsbLsbLsbLsbLsbLibLjbRg
bLgbRjRgbLibRsbRsbLibLsbLibLgbRsbLibLsbLgbLibLsbRibRgbRsbRjbRibRgbLjbR
ibRiLsbLsbRsbRsbRsbRgbRgbRsbsbLsbRibLgbRsbRibRgRsmbRsbLgLsbRibRibRgbRg
bRibLsbLgbLgLsbLsbRgbRiRjbRsbLibLjbRcbRibRgbLsbRgbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bLjbRibRgLsbRgbRgbRsbRsbRibLgbRibRgbLgbRgbRgbRsRsmbRsbRsbRsbRgbRgRsmbL
sbRsbLsbRgbRgRsmbLsbRgbRibLjbRgbRgbRgbLjbRibLsbLgbRiRsmbLsbRgRsmbLsRsb
RgbRsbRsbRgbLsbRgRsRsmmbLsbRgRsmbLsbRibsbRibLsLsmbRgbRgRsmbLsbRgLsbLsb
RgbRsbRgbRsbLsbRsbRjbRsRsmbRibsbLjbRsRibRsbLcbLibLgbRibRjbRibLjRsbLibR
jbRcbRsbLsbRibRgbRgLsbLibLjbLjbRhbRibLjLsmbLibRebRiRsmbLgbRibRgbRgbLgb
RibRgbLjbRhbRhbLibRiRsmbLsbRibRgRsmbRhRsmbLhbLgbLgbRibRgbLjbRibLgbRibL
jbRgbLsbRibRgLsbLgbRgRsmbRgbLjRsbLjbRcbLsbRhbRgbRiRsmbLibLgbRhbRsbRgRs
mbRibLjbRgbRsbLgbLjbLjbLibsbRjbRibLsbRsbRsRsmbRgbLjbRgRsmbLjbRibLjbRib
LjbsbsbLsbRiRsmbRgbRhbRhbLibLgbRgbLgbRcbRgbRgbRgbRgbRiLsbLsbLgRsbRibLj
LsmbRgbRgbLgbRgbRgbRsLsbRgbRsbRgLsbRjbRiRsmbRsbRgbLibRibRibRsbLsbLgbLg
bRibLjbRsbLjbLjbRjbRibLgbRiRsmbRgbLgbsbRgbRsbLgbRjbLjbRsbLjbLibRcbRiRs
mbLsRsbRgbLjbLjLsmbRibRgbRibLsLsmbLsbRsbRsRsmbRhbLsbRgbRsbRgbRsbRgbRsb
LjRsbRgbRgbRgbRgbLibLibLjbLibRjbRhbRsbRgbRsbRgbRsbLsLsmbLjbLibLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bLsbRibRgbRsRsmbRsbRsbRsbRsbRsbRsbRgbRsbRsbRsbRgbRsbRgbRsbLsLsmbLcbLgb
LgbLgbLsbLsbLgbLsbLgbLgbLgbLgLsbLsLsmbLsbLgbLgbLsbLsbLgLsbLgbRsLsbLgbL
gbLsbLgLsbLgbRsbLgbLsbLsbLgbLgbLsbLsbLgbLsLsmbLgbLgbLgbRgbLgbLsbLgLsbL
gLsbLgLsbRhbLgLsLgbLgbLgbRsbLgLsbLgbLsLsmbLgbLsbRgbRcbRgRsmbRgRsRsmmbL
sbRgRsmbRgbRsbRsRsmbRgbRsRsmbRgbRsbRgbRibLjbRgbLcbLgbRsbLgLsRsbRsLsLsL
sLsmmmbLgbLgbLgbLgLsbLgbLsbLgbLgbLgbLsbLgbRsbLgbLsLgbLsbLsbLgbRsLgbLgL
sbLgbLgbLhRibRibRibRsbRgbRibLibLjbLiLsbLgRsLsRsbLsbLsbLsbLgbLgbLgbLsbL
sRsLsbLgbLgbRgbLgbLgbLgRsbLsLsmbLgLsbLsLsmbLgbLsbLgbLsLgbLgbLsLsmbLgbL
sLsmbLgbRjbLgbLgbLsbRgRsmbLibLsLsLsmmbLsbLgRsRsmbLgbLgbLsbLsbLgbLgLsbL
gbLgbLgbLsbRgbLibLgbLgbLsLsmbLsbLgRsbLsLgRsbRsLsbLibRibRcbRibLgbRibLgb
LhbRsbLibLgbLgRsbLsbLgLsbLgLsbLgbRsbLibRibLibLgbLsLsmbLgbLsbLsbLsbLgLs
bRsbLgbLsbLgbLgbLgbRgbLgbLgLsbLsLsmbLgbLgbRsLsbLgbLgbLgbLsbLgbLgbLibRj
bRcbRsbRgRsmbRgbLsbRgbRgbLgbLcbLibLsbLsbLsbLsbLgbLgbRsbLgbLsLsLsmmbLsL
sRsmbLgbLgbLgbLsbLibRjbsbLgbLgLsbLgbLsbLgbLibLgbLgbRjLsbRhbRibLsbRgRsm
bRsbRgbRsbRsbRsbRsbRsbRgbLjbLcbLiLsbLsbLsbLsbLsbLsbLgbLsLsmbLsLsmbLgbL
sbLgbLgbLgRsbLgLsbLsLsmbLsbLgbLgLsbLgbLgbLsbLgbLgbRgLsbLibRgbLgLsbLsbL
sbLgbLgbLgbLgbLgbLgbLgRsbLgbLgbLgbLgbRjRsLiLsmbRhbRibRgbLjbRgbRibRgbRg
bRsbRsbRgLsbRsbRsbRgbLcbLcLsmbRsbRsbLibLgbLsbLgbLsLsmbLsbLsbLsbLgbLibL
gbLsbLsbLsLsmbLsbLgbLgbLgLsbLgbRsbLgbLgbRjbRcLsbRiRsmbLsbRsbRgbRsbLsLs
mbRgbLjbLcLsmbLibRsLsbLgbLsbLsbLsbRsbLgbLsbLgbLsbLgbLsbLgRsbLsRsRsmbLg
bRjbsbRcbRgbRgbRgbLcbRsbLibLsLsmbLgbLsbLsLsRsmbLgLsbLgLsbLgbLgbRsbLgbL
sbLsbLsbLsLgbLsLsmbLsbLgbLgLsbLgLsbLgbLsbLgbLgLsbLsbLgbLgRsbLgLsbLgbLg
bRjbLibLgbRjbRjbRibRsRsmbRibRibRsbRgLsbLibRibLsbRcbRcbLibRibRsbLiRsbRg
bRcbLgbRgbRgbRsbRgbRgbLsbRgbLcbLsbLgbLsbLsbLsbLgbRsbLgbLgbLgbLgbLsbLsb
LgbLgRsbLsbLgbLgbLsLsmbRsbLgbLgbLgbLsbLgbRgbsbsbLjbRjbLibRgRsmbLibLibR
gbRcbRibRsRsmbRgbRsbRsbLsbRgbLjbRiRsmbLcLsmbLsbLgbLgbLsbLgbLsbLsbLsbLs
bLsLsmbLgRsbLgLsbLgLsbLgbLsbLibRjbRjLsbRgRsmbLsRsbRiRsmbRsbRgbRsbRsbRs
bRsRsmbRgbRsbRsLsbRsLsbRsbRgbRsbRsbRgbRsbLcbLgbLgLsbLsbLsbLsbLgbLsbLsb
LsbLgbLgbLgLsbLgRsbLgbLgbRgbLgbLgbLgbLgbLsbLgbLgLsbLgbLgbRsbRgbLgRsbLg
bLgbLgLsbLgbLgbLsRsbRsbRcRiRsmbRgbRsRsmbRgbRgRsmbRsbRsRsmbRgbLgbLhbLiL
sbLgbLsbLsbLgbLsRsbLgRsbLsbLgbLsLsmbRsbLgbLsbLgbLgbLsbLgbLsbLgbLsLsmbL
sLsmbLgbLgbLsbLgbLgLsbLgbRsbRcbRibRsbRgbRsRsmbRgbRsbRsbRgbRsbRgbRsbRsb
RsbRgbLjbRgbRsbRsbRgbRsbRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 123507; End: 124007;
Recording: 7-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bRsbLjbRiRebRsRsLsmbRibRsbRgRsRsRsRgRsRsmmmmmbRgbRsLsbRgbLsbRgbRsRgLsR
gRsRiLsmbRgbRgRgRsmbsbRibRgbRgRsmbRsbRsbRsbRgRiRiRgRsRimbRgbRgbRgbRgbR
gbRgbRgbRgbLgbRsRsRsmmbRibLcRsbRsLcRsbLibRibLibLiRsbLsbRibRcbRibRsbRgb
RgbRsRsmbRgbRsRsRsmmbRgbRgbRgRgRsmbRgRsmbRsbRgbRsbRsbRsbRgLsbRgbRsRjbL
sLsRsmbRgbRsbRgbLsbLjbRhbRhLibLibLibLiRsLsLsmbLsRsbLgbLgRsbRjbRhbRiRsm
bRsbRsbRsRsmbRgRgbRgbRgbRsbRgbRsbRsbRsRsRgmbRgRsRgRsRgmmbRgRsRsmmbRgbR
gRsmbRgbRgbRgbRsbRgbRgbLgbRgbLsLsmbLhbLibRhbLibLibLsbLgbLgbLgbLgRsbRob
RibRsbRgbRgbRsRsRsmmbRgRsRsmmbRgbRgRsmbRgRibRibRsbRiRsmbRsbRgbRgbRsbRs
bRgbRgbLgbRsbRibRsbRgbRsbRsbRsbRsRsmbRgbRgbRsbRsRsmbRsbRibLjbLhLiRsbLg
bLgbLgbLsRsbLgbRcRsmbRibRsRsmbRsbRsRsmbRgbLsbLsbRibRgRsmbRgbRgRsmbRgbR
sbRsbRgbRgbRsbRsRgbLsRsbRgRsmbRsRsmbRsRsmbsbRsbRgRsmbRgbRgbRgRsRgRsRiR
smmmbRgRibRibRgRsmbRgRsmbRgbRgbRiRsmbRsLsbRgbRgRsmbRsbRgbRgbRgbLsbLjbL
ibLibRcbRgbRiRsmbLsbRsRgbRsRsRgRsRgRiRgRsRiRimmmbRgRsmbRibLsbRgbRgbLsR
sbRgbRgbLhbLsRsRhbLibRcbLibLhLsbLjbRiRsmbRgbsbLiRsbLibRcRsmbRsbLcbLgbL
gbRiRobLgbLjbLibLcbRibRhbLgbLibLibLgbLgbLibRebRcRsmbRsLsbRgRsmbRsbRsbR
gRibRgRsRimbRgRgbRgbRgbRgbRsbRgbRsRsmbRsRsmbRgbRsbRgRsmbRjbsbLgbRibLhb
RhbLsRsbRiRsRsmmbRsbRsbRsbRgbRgbRsbRsbRsbRgRsmbRsbLsbRsbLjbRibLjbLjLsm
bLibLgbRibLibRjbRcbRgbRgRsmbRsbRsbRgLsbRgRsmbRgRsRgmbRsRiRgbRgRsmbRiRs
RsmmbRgRsmbRgRsmbRgRsmbLgbLjbRsbLibLsRsLsLibLgbRiRsmbRhbRgbRsbRgbRgRsm
bRgRsmbRsbRsbRsRsmbRsbRgbRsbRsbRsbRgbRgbRsbLgbRgbRgbLjbRsLsbRibRsbLgbR
gRsmbRjbRsLsbRgbRgbRsRsmbRgbRhbLibLjbLibLibRcbLcLsmbRcbRibLjbRsbRibLjb
RibRgbRsbRgbRsbRgbRsbRsbRsRsmbRsbRgbRgbRgRsmbRgRsmbRgRsmbRgbRgbRgbRgbR
gbRsRsmbRsRsmbRgbRgbRgRsRgRsmmbRsbRsRsmbRgbRgRsmbRgRiRsRgmbRgRsRiRsRsm
mmbRsRsmbRgRsmbRgRsmbRgbRgRsmbRibRgbRgbRgbRgRsRgLsRhmbRiLsbRgbRgRsmbLs
bRiRsmbLgbRibLgbRhbRsbLiLsbRhLsbRsRsmbRgbRgbRgbRgLsRsbRgbRgbRsbRgbRgbR
sbRsbRgbLjbLibLgbRjbLibRcbRhbRgRsmbLsbRgRsmbRgbRsbRgRibRgLsbRgLsbRgbRg
bRibRsRibRiRsmbRsbRgbRsbRsRsRgRgRsmmbRgbRgbRgRsmbRgRsmbRgbRgRsmbRgbRsb
RgbRgLsbRgRsmbRgbRgbRgRsmbRgRsmbRsRsmbRibRgRiRsRsmmbRgbRgLsbRjbRgbRgbR
gRsmbLjbRhbLibRibLsbRiRsRiRsLsRsmmbRsbRsbRsRsmbRgbRgLsbLgbLibLiRsLsbRc
bRiRsmbRgbRgbRsbRsbRgRsmbRgbRgbRgbRgbRsbRgbRgbRgbLgbsbRibLcbLobRcRsmbR
iRibsbLsbRgRsmbRsbRjbRibLibLhbLibRjbRcbRcLsbLiLsbLibLibRjbLibRibLibLsb
RsbRsbLgLsbLgRsbRjbRcRsmbRgbRgbRgbRsbRsRsmbRgbRgbLsbRgbRgbRgRsRsmmbLcb
LibRibRhbRiRsRsmmbRsLsbRgRgRgRsmbRsbRgRsmbRgRsRiRsmmbRgbRgbRgbRgRsmbLg
bRgbRsRsRsmmbRgRsmbRgbRgbRgRsmbRsRsmbRgbRgRibRgbRgbLgbRgbRgbLgbRibLjbL
cbLibRjbLibLibRjbLibLibLgbLgbLgbRcbRiRsmbLsbRgbRgbRgRsmbRsRsRsmmbRsRgR
smbsbRgRsRsRsmmmbRgRiRsLsRsmbRgbRgRsLsmbRgRsRgmbRsbRgRsmbRsbRgbRsLsbRg
bLgbRibLibLhbLibRjbLibLgLsbLgbLsbLgbLsbLgbLgbLgbsbRcbRibRgbRgbLsLsmbRs
RgRsmbRsbRgRgRiRsRgRsRgmmbRiRiRgbRgRsmbRgbRgbRgRsRgRsmmbRgbRsbRjbLsbRg
bRgbRsbRgRsmbRgbRgbRgbRibLsRsbRibRgbRsRsmbRsbRgRsmbRsbRgRsmbRgRsmbRgbR
gRsmbRgbRsbRsbRgbRgbRgRsRsmmbLgRsbRibRgbRgRsmbRsbRsbRgRsRsmmbRgRsmbRgb
RgRsmbRibRsbRgbRsbRiRsmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 1; Drug: Control Apo 0.5 然
bLibLgLsbLsbLgbLsbLsbLsbsbLsLsmbLgbLsLsmbLsbLsbLsLsmbLgbLsbLgbLsbLgbsb
LsbRobRibLcbLcbLibLgbLsbRsbLsLsmbLgbLsbLgbLsbLsbLgbRsLcbRhLsbLcbRsLsbR
cbRgbRibLcbLibLgbRsbLgbLgRsbLgbLsbLsbLgbLsbLgbLsbLgbLsLiRsbRibRcbRibLs
bRgbRibLgbRiLsbRgbLibRhLsbRcbRsbLsbRibRsbLgbRibRhRsmbRsbRgbRgbLjbLcbLg
bLgbLsbLgbLsbLgbLgRsbRjbLhRsRsmbRibRjbRibRgbLibRibRgLsbLgbRhbLjbRiRsmb
LcbLhbRsbLibLibRjbRibLcbLibLsbRsbLgbLgbLsbLgLsbLgbLgbLsbLgbLsbLsbLsbLs
bLsbLgbRjbLibLsbRjbLibRgbLibRgbLgbLsbLsbLgbLgbRjbLibLgbLsbRsbLsbLgbLgL
sbLgbLgLsbRgbLgbLgbRibLgbLiLsLsmbLsbLsbLsbLsbsbLsbRcbRibRibLgLsbLjLsmb
LibLsbLsbLsbLgLsbLgbLgbRibLibLgLsbRsbsbsbRsLsbLgbLsbLsbLsLsmbLsRsbLsbL
gbLgLsRsbRsbsbLsbLsbLsbLsbLgbRjbRobRiLsbRibLibLgbLgbRsbRibLobLibLsbRsb
RjbLibLgbLgLsbLsbLgbLgLsbLibLgbLgbRsbLgbLgbRsbLgbLsbLsbLsbLgbLsbLsbLgb
LgbRjbLoRsRsmbRibRibLcLsmbLiRsbLgLsbLgbRsbLgbRgbLgbRsbLgbLgbLgbRgbLibR
gLsbLibLgRsbRibLibRgbLibLgbRsbRibLgbLgbLgbLsbLsbLsbRjbLibRjRsmbLjbLibR
oRsRsmmbLsRcbRhbRgbRibRsbLgLsbLjbLibLgbRjbLhbLsLsmbRsbRibLibLgLsbRsbRi
RsmbLibLgbRsRsLsmbLjbLsbLsbLsbLsbLgbLgLsbLgbLgbLgbLgbLibLgbRiLsbLibLgb
RibLibLgbLsLsmbLsbLsLsmbRsbLsbRsbLsLsmbLgLsbLgbLsbLsLsmbLsbLgbLgLsbLgb
RjLibRcbLjLsmbLibLiLsbLgbLgRsbLsLsmbLgbLgbLsRsbLsbLgbLgbLgbLgbLcbLcbLi
bRsbLgbRsbLibLsbLsbLgbLsbLsbRsbLgLsbRsbLgbLsbLcbRsbRsbLjLsmbLsbLibRgbL
ibLhbRgbRibRgbLjLsmbLcbLgbLebLibLcLsmbLhLsbLjLsmbLibRhbLibLjLsmbLibLgb
LgbLgbLibLibLibRibLibLibLiLsbLibLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 2; Drug: Control Apo 0.5 然
bLsLsmbLgbLibRibLhbRsLsbRsbLebLsbLgbRsbRibLiRsbLsbsbRsbLibRsbLibRsbLgL
sbLgbRsbLibRjbLiLsbLibLsbLgbRgRsmbLgLsbLsbRsbLsbsbLibLgbRibRibRiRsmbLj
bRibLsbLebLcbRsbRibRcbRibLsRsbLjbLcbRsLsRsbLhbLcLsmbLsbsbRsbRibLsbRsbR
sLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 3; Drug: Control Apo 0.5 然
bLgRsbLgbRibRjbLgbLgbLgLsbRibLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 4; Drug: Control Apo 0.5 然
bRsbsbRsbLgRsbRibLgbRibRsRsmbRibLibRibRibLibRibRgbRsbRgbsbRsbLjbLhbRhb
RibRgbRibRgbLiLsbRibLsbRcbRibRhbLgLsbRiRsmbLsbLiLsbLgbRiRsmbRibRibLiLs
LsmbLibLcbRsbLibRibRjRsmbLibLibLgbLsbLibRgbLibRsbLiRsbRibRibLibLibLsbL
sbLsbRibLibLsbLgbLsbRjbLibLgLsbsbRgbLsbLibLgbRibLibLibLsbRsbLsbLgbRjLs
bRibRjbLibLebLsbLgbLgbLsbLsbLgbRsbRjbLibLiLsLsmbLjbRibRsbLjLsLsmmbLgbL
gbLgbLgLsbRibRibLsbLgbLsbLsbLibRjbRjbRhbLgLsbLsbRibLjbRjbLjbLibLibsbRg
bRibRjbLjLsLsmmbRjbRhbLibRibLjbLcbLibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 5; Drug: Control Apo 0.5 然
bLhbLibRjbRibRiRsLsmbLhbLcbLibLibRebRibRhbRgRsmbRgbRsbRsbRgbRsbRsRsRsm
mbRgbRgbRgbRsbLsbRhbLjbLcbLibLsbLgLsbRcbRgbRgRsmbRgbRgbLsbRgbRsRsmbRsb
RsLsbRibLhbRcbRibRgbRgbRgbRsRsmbRsbRsRsmbRsbRgbRgbRgbLgbRobLjbRcbLhbLo
bRcbLcbLgbLgbLgLsbRsbRebRgbRsbRsbRgbRgbRgbRgbLgbLjbLebRcbLcbLiLsbRhRsm
bRibRibLgbLebRibRibRsbRibRibRsbRgRsmbRsbRsbRsRsmbRsRsmbRgbRsbRgbRsRsmb
RsbRgbRgbRsbRgLsbLsLsmbRgRsmbRsRsmbRgbLibLcbRcbLiLsbLibRhbLiLsbLgbRibL
gLsbLgbLgbRcbRibRsbRsbRgbRsbRgRsmbRsbRsRsmbRgbRgbRgbRsbRsRsmbRgRsmbRsb
RsRsmbLgbRgLsbRsbRsbRsbRgLsbRsbRgbLsbRgbLgbRgbLcbLibRjbLibRcbRobRiRsmb
LebRgbRibLgbRgbRsbRgbRsbRgRsmbRsRsmbRgRsmbRibLjbLobLjbRibLcbRhbRebLibR
ebRhRsmbLjbLiRsbRoLsbsbRibRsbRgbRgbRgbRgRsmbRsRsmbRsbRsbLsbRjbLsbRgbRs
bRgLsbRgRsmbLsbRgRsmbRgbLibRjbLibRjbLsRsbLgbLgRsbLsLgbRgbLibRebLhbLgLs
bLsbLgbLsbLsbLgbLsRebRgRsmbLsbRgbRgbRgbRgbLsbLgbRjbRjbRsbRsbRgRsmbLsbR
gbRgLsbRgbRgbRgbRgbRsbLhLsbRebLcbRjbLhbRebRgbLsbRsbRgbRibLgbRgbRgbRsLs
bRsbRsbRgbRsRsmbRgbRsRsmbRsbRgbRgbRgbRgbRsbRgbRgbRgbLcbLhbRebLcbLgbRjb
RibRsbRsbRgbRsbRsbRgbRsbRgRsmbRgbRsbRsbRsbRsLsbRgbRgbRsbRsbRgbRsbRsbRg
bRsbRsbRsbRsbRgbLgbRgbRsbRsbRsbRgbRgbRsbRgRsmbRsbRsbRsRsRsmmbRgbRsLsbR
gbLibRgbRgbRsbRgbRgbRsRsmbRsbRsbRsbRsbRgbRsRsmbRsbRsbRsbRgLsbRgbRsbRsb
RgRsmbRgRsmbRsbRsRsmbLsRsbRsbRsRsLsmbRsRsmbRgbRsRsmbRgRsmbRsbRsbRsbRsR
smbRgbRgRsmbRsLsbRgbRgLsbLsbRgRsmbRsRsmbRgLsbLsbLcbLibLibRhbRobRgRsmbL
gbLibLiRsbLgbLgbLgbRcbLhbRcbRcbLgbRibLsbRgRsmbRgbRsbRsRsRsmmbRsRsmbRsb
RgbRsRsmbRsbRgbRsbRsbRsRsmbRgbRgbLsRsbRgRsmbRgbLsbRgbRgbRsbRsbLsbRsRsm
bRhbRibLibRiRsRsmmbLsbLgbRobLhbRobLebLjbLibLibRibRgbLjbLibLhbRjRjRsmbR
hbRsLsbRcbLgRsbRiRsmbLjbRhbLiRsbLebLcbRgbLibLjbRjbLibLjbRcbRobLibLibLg
bRibLibLibRjbLcbRhbRcbRsbRibRgbRgbRsRsmbRsbsbRsbRsRsmbRgRsmbLsbRgbRsbR
gbRsRsmbRsbLsbRgRsmbRsbRgbRsRsmbRsbRgbRsbRgbRsbRsbRsbRoLsRsbLhbLibLibR
gbRsRsmbLiRsbLibRjbLiLsbLgbRibLiRsbLibLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 6; Drug: Control Apo 0.5 然
bLsbRgbRgbLjLhbRgbLsbRgbLgbLgbsbsbRgbLhbLsbLgbLsbRsbLgbLgLsbRgbLgLsbLg
bLsLsmbLsbsbLsbLgbLgLsbLibLsbLgbLgbLibLibRsLsbLgbLgbLsbLibLiLsbLgbLjbL
ibLsbLsbLsbLgLsbLsbRgbLgbLsLsmbLiLsbLhLsbLgbLsbRgbLjLgbRgbRsbRgbRsbLsb
Lgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bLgbRjbRgbRsRsmbsbRgRsmbLsLsRsmbRgRsRsmmbRsbRgbRgRsmbRiRsmbRsbsbRibsbR
sRsRsmmbRsbRgbRsRsmbRgbRsRsmbRsbRgbRgbLsbLiLsbLgbLsLsmbRgbRgbRsbRgbRgb
RgbLsRsbLsbLsbLsbRsLsbRiRsmbRgbRgRsmbRgbRgbRsbRgbsbRsbRsRgbLsbLjbLgbRi
bRgbRgbLsbLsbRgbRibRgbRibRjRsmbRgbLsbRsbRgRsmbRibRgbRsLsbRiRsmbRsbRsbR
sbRgbLsbLgbLsbRibLibLibLibLgbLiLsbLgbLsLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bRgbRsRgRsmbRsRsmbRsbRibRsRsmbRsbRgbRgbRsRsLsmbRsbRgbRsbRsRsmbRsbRgbRg
bRgbRgbRsbRgbRgbRsbRgbRgbRgbRgbRsbRgbRgbRgbRgRsmbRgbRgbRgLsbRsRsmbRgbR
gbRgRsmbLsbRibRsbRgbRgbRsRsmbLgRsbRgbRsRsmbRgbLgbRibLsbLsbRiRsmbLgbRib
LgbRibLgbRiRsmbLsbRgRsRsmmbRsbRsbRgbRsbRsRgbRsbLgbRibRgbRsbRibRgbRsLsb
LjbRsbRiRsmbRsbRibRsbRsRsmbRgbRsbLsbRgbRgbRgbRsbRgbRsLsbLsbRibRgbRsbLs
bRibRsbRsbRgLsbRgbRgLsbRgbRsRsmbRgbRsbRsbRsbRgbRsbRsbRsbRgbRsbRsbRibLj
bLiLsbLgbLibRjbLibRgbLiRsbRjbLiLsbRsLsbLgbRhbRhbLibRsbRiRsmbLgbRibRgbL
gbRsbRsbRibRibRibRsbRsbRsbRjbRcbLibRsLsbRgRsmbLsbLsLsmbRibLibRiLsbRgbL
sbRgbRgbRsbRgRsmbRsbRsRsmbRgbRsbRsbLgbRibRgbRsbRsbLgbRibLgbRibLgbRgRsm
bLjbLsbRhbRiRsmbRibRibRsbRiLsbRgbRibLiRsbLcbLgbRhbLsbRibRsbLgbRibRgbRs
bLgLsbRgbRibRsbLsbRsRsmbRibRsRsmbRsbRibRgbRsRsmbRgbLgbsbRibRsbRsbLgbsb
Lcb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bLibLjRgbLcbLiLsbRibLiLsbLhbLcbLibLibRsbLsbLiLsbLsbLibLgbLibLjLsmbLhbL
gbLhbLibLjLgbRsLhbRibRgbLibLibLgbLibRgRsmbLjLsmbRhRsmbRibLibLebLjLsmbL
gbLgLsLsmbLibRsbLibLjbLibLhbLibLsbLgbLhbRsbRgbLhbRibRhbRibRhbRgbRibLgb
RgRsmbRsbRibLgbRibLibLibLiLsbLcbLcbRsbLibLibLibLgbLsbLibLgbLsbLebLgbLi
LsbLgbLhbLjLsmbLgbLgbRibRjbRjLsbRibLjLsLsmmbLibLibLgbReLsbLibLibLibLib
RjbLibLibRjbLcLsmbLibLsbLibLsLgbLgbLgLsbLgbLgbLibLibRjbLiLsbLsbRsbLibL
ibLibLsbLsLsmbLibLibLgbLsbRjbLibLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bLsbRjRsRsmmbLjbRjbRibLjbLcbRibLibsbLibRjbLiLsbRsRsmbLibRjbLcRsbRiRsmb
LibLsbLgbLsbLsbLsbLsLsmbLgLsbLsbLiLsbRjbLhbLcbLjLsmbLibRgbLiLsbRibRibL
jbLcRsbRjbLibLjLsmbLsbRibLibLibRsbLsbLibLsbLgbLgbLsbLgbRsbLibRhbRibLjb
LgbRibLjbRgbLebLibLiLsbLibRibLibLsbLhbRibLgbLsbLgLsbLsbLsbLgbRjbRcbRib
RgbLibRsbLsbRibLsbLobRobLjbRibRibRibLsbRgbRsbRsbRsLsbRsRsmbRsbRsbRsbRs
bRiLsbLjbLhbLibLibLibRsbLgbRcbRgRsmbRibLcLsmbLgbLgLsbRjbRgRsmbRgbRgbRg
bRsbRsbLcbLibLgbRgbLgbLgbLibLsbLgbRjbRcbLjbLibRjbLiLsbLsbLsLsmbLsbLsLs
mbLgbLsbLgLsbLsbLsbLsbLgbLgbLsbLsLsmbLsbLsLsmbRobRgbRgbLibLiRsbLgbLgbR
ibLiLsbRjbLgbRsbLgbLsbLsbLsRsbLsbLsRsbLsbLgLsbLgbRebLgbRjbRibRgbRgbRgb
RgbLcRsbLgbLgbLsLsmbLsbLgbRjbRjbRibRibRgbRjbRiRsmbLjbLebLibLgbLibLgbLs
bRsbLsRsbLsbLgLsbLsbLgbLgbLibLgLsbLibLiLsbLsbLgLsbLsbLsLsmbLsbLgbRhbRi
LsbLjLsmbLibLgbRgbLsbLgbRsbLgbLsbRjbLgbLsbLgRsbRsbLibRsbLgbLsbLsbRgbLi
bRjbRjbRibLjLsmbLibLsbLsbLibRsbRsbLgbRsRsmbLjbRsbLsbLsbLsbsbLsRsbLsbLg
LibLgLsbLgbLgLsbLgLsbLgbLgbRibLibLgbLgbLsbLgbLsbLsbLsbLsbLsbLsbLsbLgbR
jbLjLsmbLibLibRibLibLgbLsbRgbRsbLibLiLsbRsbLgbLgbLgLsbLsRsbRsbLgbLsbRs
LsbLgbLsRsbLsbLsLsmbLsbLsLsmbLgbLsbRsLsbLsbsbLgbLgbLgbLgbRjbsbRibLibLg
bLgbsbRgbRjbRjbRgbRibLebLibLibRjbLibRsbLibRgbLgLsbLgbRsbLsbLsbLsbLgLsb
LsbLjbLibRiRsmbLgbLgbRgbLgbLiLsbLsbLjbLibRiLsbLgLsbLgLsbLsbRibLgLsbLgb
LgbLgLsLsRsmbRgbRibRibRiLsbRibRgbRibLgRsbLsbRgbRjbRgbRgbRsbRibLjbLcbLg
bLsbLgbLsbLsbLsbLsLsmbRsbLgbLgbLibLsbLgbLsbLgbLsbLgbLsLsmbLsbLgbRgbLgb
RjbLjbRibLjbLgLsbLgbRjbLgLsbLgbLgbLgbLgLsbRjbRjbRgbRgbLhbRjbRcbLhbRibR
jbLhbLibLiLsbLgbRiRsmbLibLgbRibLgbLgLsbLgbLsbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bRsbRjbRibRgbRgbsbLoRsbLgRsbLgbLgbRgbLibLsbLhbRgLsbLiLsbLgbLsbLsLsmbLs
bLsbLgbRsbLgLsbRsbLgLsRsbLsbLgbLsbLgLsbLiLsbRcLsbRiRsmbLsbLcbLibRsbLib
RsbLibLsbLsRsbLgLsbRsbLjbsbRsbLgLsbLsbLsLgbLgbRjbLiLsbRcbRcbRibRgbRsbR
gbRgbLcbLhRsLsbsbsbLgbLiLsbLsbLgLsbLsbLibRgbLibLsLibRgRsmbLgbLsbLgbRsb
LgRsbLsbLjbRsbRsbLgLsbRsbLgbLsbLgbRgbLsLgbRsbLibsbLiLsbLibLsbLgbLsbLgL
sRsbLsRsbLgbLsbLsbRgbLibLgbRibLiLsbLgbLibRjbRcbRibLgbRgRsLsmbRsRsmbRgb
RsLsbRgbsbRsLsbRsRibRsRibRiLsbLebLibLibRsbRgLsbLibsbLsLsmbsbLsLsmbLgLs
bLsLsmbLgLsbLgbLgbLsbRsLsbLgLsbLsbLgbLsbLgLsbLgbLgLsbLsbLsbLgbLsLsmbRs
LsbLgRsbLgbLgLsbLgLsbRebRoLsbLcbLibLgLsbLsbLgLsRsbRgbLiLsbRcRsmbRgRsmb
RgbLsbLjbLcbLiLsbRsbLgLsbsbLsbLgbLsbLgLsbLgLsbLgbLgbRsLsbLsbRsbLiLsRsb
RsbLibLsbLgbRgbLibRgbLgbLsbLgbLsbLgbLsbLsbLgLsbLsLsmbLgbLsbLgbLsRsbLsb
LsbLgLsbLsbLgbLgbRgbLgbLsbLgLsbLsbLsbLsbRsbLgLsbRjbRcbRibLjbRibRsbRibR
cbRsRsmbLibsbRgLsbRibRibLgRsLsbRhbLibLhbLibRgbLibLgLsbLgbLibLsRsbRsRsm
bRgbRibRiLsbRsbRgbRgbLjbRsbLibLibLgbLgLsbLsbLgbLgRsbRcbRgbRsRgbRgbLsRg
RsmbRsbRgbLgbRibLjLhbsbLibLiLsbLgbRgbLgbLiLsbLibLsbRsLibLgbRgbLibRjbLi
bLgbRsRsmbLibRsRsmbLcbRebLibLibLcbLibRgbRjRsmbLhbLhbRgLsbLiLsbLibLiRsL
sbRsbRsbLsbLibRjbLcbRgRsmbLibRsLsbRsbLibLgbRsbLibRgLsbLibLgbRgbLgbLgbL
sbLgbRjbLhbRgbLibRgbLibLsbLgbLsbLgbLgbLibLibRiRsmbRgbLjbLsbLiLsbLhbRjb
LibLsLgRsbRsbLsbLgbRjbLibRjbLcbLsbRgbLibRsbLgLsbRgbLibLiLsbRsbRsLsbLgb
LgbLsbLgbLsbLjRsbLsbRjbLibRobLjbLiLsbRsbLibLgbLgbLgLsbRibLiRsbRsbRjbRg
RsmbRsbRsbRsbRgbRgbRsbRsLsbLsRsbLgbRgbRgbRgbRsbRgRsmbLsbLcbLibLsbLgbRg
bLibRgLsbLibLiLsLsLsmmbRgbLibLgbRiLsbLibLsbLgbRsbLgbLgLsbLgbLgRsbLsbLg
bRjbLibRsbLiRsbRsbLibRsLsbRsbLgbLsRsbLgRsbLgbLsbRsbLsLsmbLsbLsbLgbLsLs
mbLgbLsbLgLsbLsLsmbLgbLgbLiLsbRcRsmbRibRsbLibLibLiLsbRjLiLsbLsbLiLsbRj
bRoLsbLgbLsRibRgRsmbRgLsbRgbRsbRsbRgLsbRgRsmbRgbRgbLgbLcbLibRgbLibRgbL
iLsbLgLsbLsbLgbLgLsbLsbLgbRsbLibLgbRsbLiRsbRjRsmbLibRsbLgLsLsmbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bRgbRsbRgLsbRsbRgbRsbLibLibRibRibRgbRibLsLsmbRgbRibRgbRgbRgbRsbLsbRibR
gLsbRibRsbRibLsbRsbRgbRsbLiRsbLsbRibRsbRsbRgbRgbRsbRgbRgbRgbRsbRsbRsbR
gbRgbRsbRsbRsbRibRibLsbRsbLsbsbRgbRgbRibLgbRibRsRsmbRibRgbRibLgLsbLsbL
gbLsbLgRsRsmbLiLsbRsRsmbLsbLsbLjbLibLsbRsbRgbLibLsbRsbLsbLsbLgbLibLsbL
sbLsbLsbLsbLsbRgbRibRgbRsLsbRgRsmbLsbRsbRsbRsbRgbRsbRgbRsbRgbRibRsbsbL
sbRibLsbRsbRsbLsRgbRgLsbRsbLsbLsRibRsbLsbRjbRsbRsbRsbLsbLgbLibRjbLhLsb
LsbRgRsmbLibLcbRgbRhbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bsbLgbRibLjbLhbRibRiRsRsmmbsbRsbLsRsbRgRsmbRgbRgRsmbRgbRgRsmbRgbRsbRgb
RgbRgbRgbRsbLsbRgbRgbRgbRgbRibRsbRgbRibRsbRibRgbRibLjbRibLjbRsRsmbRiRs
mbRsbRgbRgbRgbRgRsmbRgRsmbRgbRgRsmbRgbRgbRsRsmbRgbRgbRgbRgRsmbRgRsmbRg
bRgRsmbLsRsbRgbRgLsbRgbLgbRibLsbRsbsbRsbRsRsRsmmbRgbRgRsmbRgbRsbRgbRgb
RgbRgbRgbRsRsmbRgRsmbRgbRsbLsbRgLsbRgbRgbRsbLjbLibRcbRgbRgbRsbRgbRgbLs
bRgRsmbRsbRgRsmbRsbRgbLsRsbRsbRgbRgbRgbRsbRjLsbLgbRibLsbRgbRgRsmbRgbRg
bRsbRsRsLsmbRsbRgRsmbRsbLsRsbRgbRgbRgRsmbRgbRgbRgbRgbRgbLsbRgbRibRgbRg
bRgbRgbRgbRgbRsbRgbRsbRgLsbRgbLsbRsbRgbRsRsmbRsbRsbRgbRibRgbRgRsmbRgbR
sRsmbRgRsRsmmbRsbRibLsbRibRsRsmbRibLsbRgRsmbRsbRsRsRsmmbRgbRgRsmbRgbRs
bRiLsbRgbLgRsbLjbLibLiRsbRjbLibRcbRhbRsbRjbRgbRsLsbRsbRgbRgbRsbRgbRgbR
gbRiRsRsmmbRgbRiRsmbRgbRgbRgbRgbRgbRgbRgbRgbRibLsbRibLsbRibLgbRibLcbLi
LsLgbLgbLsLgRsbLibRgbLibRjRsmbRhRsmbRgRsmbRgbRjbLsbRsLsbRibRgbRgbRgbRg
bRgbRsbRgRsmbRgbRsbRsbRiRgRsmbRgbRgbRgbRgbRgbRgbLsbRsbRgbRgbsbRsbRsbRi
bRsbRgbRgbRgRsRsmmbRgbRgbRsbRsRsLsRsmbRgbRgRsmbRgbRgbRgbLgbRibRgbLsbRg
RsmbRgbRibLibRibRgbLsbLsbRiRsmbLgLsbRiRsLsmbLsRsLsbRiRsmbLsbRgbRgRsmbR
gbRgbRgbRiLsbRgbRibRgbRsRsLsmbRgbRgbRgbRgbRgRsmbRgRsmbRiRsmbRgbRgRsmbR
gbRgRsmbRgbRgbRsbRgbRgRsmbRgbRgbRsbRsbRgbRsbRgbRgbRsbRgLsbRibRgbRgbLsb
RgbLgbLjbLcbRcRsmbRhbLsbRgRsmbRsRsLsmbRsRsmbLsbRibRsRsLsmbLsRgbRsbRsbR
sbsbRsbRgbRgbRgbRgbRgRsRsmmbRgbRsRsLsmbRgbRgbRgbRgbRgRsmbRgbRgbRgbRgbR
gbRsbRgbRgRsmbRibRgRsmbRgbRsbLjbRibRgRsmbRgbRgbRgbRgbRgbRgbRgbRsbRgRsm
bRgbRsbRgLsbRsbRgbLobLgbLgbLgbLgbLsRcRsmbRibRibRsbLgbRhbRsbRsbRgRsmbRg
LsbRgbRgRsmbRsbRgbRsRsmbRgbRgbRibRgbRgLsbRgRsmbRgRsmbRgRsmbRjbLsbRsbRi
RsRsmmbRgbRgbRgbRibRsbRgRsmbRsbRgRsmbRiLsbRjbRsRsmbRgRsmbRgbsbRsbRgRsm
bRgbRgbRgRsRsmmbRsRsmbRgbRsbRjbRsbRgbRgRsmbRsbLsLsmbRsRsmbRgRsmbLsbRib
RsbRgbRgbRgbRsbRibRsbLgbRsRsmbLsbRgbLsRgbRibRgbRgbRsbRibLsbRibLgRsbRgb
RgbRsRsmbRsRsmbRsbRgRsmbRsbRgbRgbRgbRsbRsbRgRsmbRgRsmbRsbRgbRjbRgbRiRs
LsmbRgbRgbRgRsmbRgLsbRsbRgbRsbRibRgRsmbRsbRsbLsbRgRsLsmbRsbRsbRgRsmbRi
bRgbRsRgRsmbRgbRgLsbLsbRgbRgbRsRgbRgbRjbLsbLsRsbRiRsmbRgRsmbLsbRibLjbL
sbLcLsmbLibRcbRibRgRsmbRgRsRsmmbRjbRgbRiRsmbRgbRgRsmbRiRsmbRgRsmbRibLs
LsmbRiLsbRsbRgbRgRsmbRibRsbRebRgRsmbRgRsRsmmbRgbRgbRgbRobRsbRgbLsLsmbL
oRsbRsRsRsmmbRgRsmbRgbRgbRsbLibRibLsRsbRgbRgbRhbLibRiRsmbLsbRibLsRsbRg
bRjbRsbRibRsbRgbRsbRjbRsbRgbRsbRgRsmbRsRsmbRsRsmbRgbLsbRjbRgbRgbRgbRsb
RgbRgbRsRsmbRsbRsbLsbRsRsmbRjbRgbRgbRiRsmbLobRgRsmbRgbLjbLcLsmbLibLgbs
bLsLsmbLgbLsbLgbRsRsmbLibRjbRcbLsbRjbRgbRgbRgbRsbRsbRsbRgbRsRsmbRgbRgb
RgRsmbRgRsmbLsbRgbRgbLsbRgbRgbRgRsmbRgbRsRsmbRsbRgbRgbRgRsmbRgbLsbRibL
sRsbRgRsmbRsbRgbLsRsbRibRgbRgbRsRsmbRgbRgbRgbLsbLcbLibLgbLgbLsbLgbRjbR
hLsbRgbRgbRgRsmbRgbRsRsmbRsRsmbRgRsmbRsRgRsmbRsRjbRsRsmbRibRgbRgbRgbRg
bRgbRgbRgRsmbRsbRiRsRsmmbRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bLsbRibLsbLobRgRsmbLsbRibLjbLibRjbLjbRcbRiRsmbLibRiRsmbRsbRgbRsRsRsmmb
RsRsmbRgbRsbRgbRsbRgbRgbRgbRgbRgRsmbRsbLhbLibRibRibRgbRibLjbRjbLsbRibL
jRsbRiRsRsmmbRsbRgbRgbRsbRsbRgbRgbRgbRsbRgRsLsmbLebLjbRibRibLsbRebRsLs
bLgbRsbRsbRjbLsbLsbRjbRsbRsbRsbRebRsbRsbLgbRgbRsbRgbLjbLibLibLsbLibRjb
LsbRcbRgRsmbLsbRibRsbRsRsmbRgRsmbRgbRsRsmbRsbRsbRsbRgbRgbRsbRsbRgbRsRs
mbRgRsmbRsbRsbRsbRsRsmbRsbRgbLsbRgbLsRsbRgbRsbRgbLsRsbRibLjbRibLjbRibL
jbRiRsmbRsbLjRsbsbsbLsRsbRcbRsbLsbLsRsbRhbLibRjbLhbRjbLibLibLcbLibLgbR
gbLibLjbRibLibRgbRsbRsbRibLgbLsRsbRgbRgbRsRsmbRsbsbsbRsbRsbRsLsbRsbLsb
LsbRsbLsbLsbRsRibLjbRsbRgbRiRsmbLsbRjbLgLsLsmbRgbRibLsbRsbLsbRsbRsbRgb
LiRsbLjbRgRsmbRhbLgbLibLsbLhbRgbRsbRgbLgbLjbLibLgbLibRcRsmbLhbRcbLhbRc
bRibLjbRibLsbRgbLsbRgbRibLjbLjLsmbLibRcbLjbRhbRcbRgbRsbLsbLibLsbLibRib
RgbLsbRsbLsbLcbLebLgbRgbRsbLjbLhbRsbRsLjbLgbRiRsRsmmbLcbLibRgbRibLibRi
bRcLsbLiLsbsbsbRgbLsbLsbRjbRsRsmbRjbLsbRgbLgbRgbLgLsbRgbLsbRsbRgbLsbRg
bRgbLgbRgRsmbLsbRsbRsbRsbRsRsmbRsbRsbLsbRiRsmbLgbLibLebRcbRcbLjbRibLjL
smbLibLibLibLiRsbLsbLiLsbRsbRibRsbRsbRgRsRsmmbRgbRibRsRsmbRsRsmbRgbRsb
LsRsbRsbRjbRsLsbRsRsmbRsbRsbRgbRgbRsRsmbRgbRgbRsRsmbRsbRgbLjbLebLibRjb
LcbRjbRcRsLsmbLgbRjbRebLjbRibRgbLsbLsbRibLibRiRsmbLgbRjbRsRsmbLgbRjbRg
bLsbRcbLibLsbRiRsmbRgbRsbRgbLsbRgbRgbRgbRsbRgbRgRsmbRgbRgbRsRsmbRsbRsb
LsbLhbRibRibRsbRibRsbRgbRsRsmbRsbRsRsmbRgbRsbRsbsbRgbLjbRhbLgbRiLsbLib
RibRibRibLgRsbLsbLgbLgbLibRjRsmbLibLsbLsRsbLsbRcbRhbRibLhbLsbLjbRcbRib
LgbsbRsbRsbRgLsRsbRsbRgbLjbRibRsRsmbRibLjbRibLjbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bLhbLibRibRsbLibLgLsbLsbLgbRcbRgbLjbLcLsmbLgbLsbLgLsbLsbLgbRjRsmbLibLg
bLgbRgbLsbRsbLiLsbLgbLgbLgbLsbLgbLsbLgbLiLsbLgbLgbLgbLgbLsbLsbLgLsbLsb
LgbRebRobLgbLgbLsLsmbLsLsmbLgbLgbLsbLgbLgbLsbLgbLgLsbLgbRibLgLsbLgLsLs
mbLsLsmbLgbLgbLgbLsbLgbLgbLgbLsbLsbLsRsbLsbLsbLgbLsbLgLsbLgLsbLgLsbLsb
LsbLgbLgbLgbLgbLgbLgbLsbLgbLsbLgbLgbRjbLhbLgLsbRiLsbLibLiLsbLsbLsLsmbL
gbLsRsbLgbLgLsbLsbLsbLgbLhbRibLgbLsbRsRsLsmbLhbLiLsRsbRibLibLgLsbLsLsL
smmbLgbLsLsLsmmbLgbLgbLsbLsbLsbLsbLsLsmbLgLsbLsbLgbLgbLgLsbLgbLsbLgbLs
RsbRsbLiLsbLgRsbLsbLgRsbLgbLsLsmbLgbLgLsbLgbLgLsbLgbLgLsbLsbLiRsLsbLgb
RgbLiLsbLgbRsbLiLsbLgbLgLsbLsbLsbLsbLibLgbLsLsmbLgbLgbLgbLgLsbLgLsbLgb
LgbLgbLgbLgbLgbLsLsmbLibLsbLgbLgRsbLgbLgbLgLsbLgbLsbLsbLgbLgbLgbLgbRsb
LgLsbLgbLsLsmbLgRsbLsbRsLgRsbRebLgbLibLgbLsbLgRsbRsbLgbLgbLgLsLsmbsbRg
LibLiLsbRcbLibLjbRobLiLsLsmbLgbLgbLsLsLsmmbLgbLgbLgbLgRsbRibLibLgLsbLj
bRibLsbLjbLgLsbLsLsmbLgbLgbLgbLgbLsbLjbRsbLgLsLsmbRsLsbLgbLgLsLsmbLsbL
gLsbRsLsbsbLgbLgbsbLsLsRsmbLgbLgbLgbLgLsLsmbLsLsmbLsbLgRsbLgbLgbLgbRsL
sbLsbLgbLgLsbLgbRgbLgbLsbLjbLgLsbLgbLgLsbRsbLiLsbRcbLibRjbLibRsbLiLsbL
gRsLsbLsbRibRhbLjbLjbLgRsbLsLsmbLgbLgbLgbLsbLgbLsbLgLsbLsbLgbLgbLgLsbL
sbLgbLsLsmbLsbLgLsbLgbLgbLgbLgLsbLgbLgbLgbLgbLsbLgbLsbLsbLgLsbRsbLgbLg
bRsbRgbLibRjbLiLsbLiLsbRgbRjbLcbLibRibLhbRgLsbLibLgbLsLsmbRgbLibLgbRgR
smbLibRibLibRsbLgLsbRsbLibRjbLibLsbLibRgbLgbRgLsbLsbLibLsbRsbLsbLgLsbL
gbLgRsbLgbLsbRsbLgLsbRsbLgbRsbLgbRjbLiLsbRibRsLsRsbsbLsLsmbLiLsbLgbRsL
sbRgLsbLiLsbRjbLsRhbRgbLhbLcbLgbLsbRgbLhbRjRsmbLcbRjbRsRcLsbLcbLibRibL
ibRgRsmbLibLgLsbRibLiLsbLgbRgbLgbLebLibLiLsbLibRgbRibLhbLgbLsbRsbLjbLg
RsbLsbRgbLgbLibRibLiLsbLibRgbLibLjLsmbRcLsbLjbLjLsmbRibLhbRibLgbLgbRgb
RgbRsbLcbLgLsLsmbRibLhb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bRgRsmbRgbRgRsLsmbRgbRgRsRsmmbRgRsmbRgbRgbRibRgLsbRgbRsRsmbRgbLsbRgbRg
RsRsRsmmmbRgRsmbRsRsmbRgRsmbRibLjbLcbLibLgbRcbRibRgRsRsmmbRsbRsbRsbLsR
sRsmbRsbRgRsmbRgbRgbRgbRsRsmbRgRsRiRsmmbRgbRgbRsRsmbRgRsmbRgbRgRsmbRsR
smbRgbRgbRgbRsRsRsmmbRsbRgRsmbRgbRsRsmbRgbRgbRgbRgbRgbRsbRgRsmbRgbRgRs
mbRgRsRhRsRimmbRgbRgRsRsmmbLjRsbRsRcbLibRsRsRimbRsRgbRsRsLsmbLsRsbRgbR
gbRsbRgbRgbRgbRsbRgRsLsmbLgbRibRgRsmbLsRsbRjbLgRsRsmbRsbRgRsmbRgbRgRsm
bRsbRgRsRsmmbLsRgRsRsRgRsLsmmmbRgRsRgRimbRiRsmbRgbRibRiRsmbRgRsmbLsbRi
RsmbRsbRgLsbRgbRsbRgRsmbRgRsmbRgbRgbRgbRgbRgbRsRsRsmmbRgRsLsmbRgbRgbRs
bRgbRsRsmbRgRsmbRgbRibRgbRgbRgbRsbRibLgbLibLgbLgbLgbRcbRhLsbLsRsbRibLj
bLcbRoRsmbRgRsmbLsLsRsmbRiRsmbRgRsmbRgbRsbRgRsmbRsRsLsmbRsbRgbLsRsbRgR
smbRsbRjbLsRsbLsRsbRgbRgLsLsmbRgbRgbRgbLsbRiRsmbRsRgRsmbRgbRsbRgbRsbRs
RsmbRsRsmbRgRsmbRgbRgbRiRsRiRsRsmmmbRgbRgbLsRsbRiRsmbRsbRibRsbRsRsmbRs
bRhRsmbLiRsbRhbRgbLgRsbRibRgbRgbLgbRibRgRsLsmbsbRsbRgbRgbRgbRgbRgRsmbR
gRsmbRgbRgbRgbRgbRgbRgRsmbRgLsbRgbRsbRjbRsbRgbRgRsmbRgbRgRsRsRsmmmbRgb
RgbRgRsmbRgbRgLsbRgRsRiRsRsmmmbRibRgbRgRsmbRgbRgbRgbRgbRgLsbRgbRgbRgbR
gbRgRsRsmmbRgbRsbLsbRibRgRsmbRgbRgbRebRgbRgbRibRgRsmbRsbRgbRsRsmbRsRsm
bRgbRgRsmbRgRsmbRgbRsbRgbRgRsmbLsbRiRsRsmmbLjbRcbLiRsbRhRsLsmbLsbLsRsb
RibLsbRsRsmbRiRsmbRsbRgbRsbRgbRgbRgbRgbRsRsmbRgbRgbRsbLsRsbRgbRgbRsRsm
bRgbRibLiRsbLcbLibLgbLgbLsbLsbLibRcbRcRsmbRgbRgbLsbRibRsRsmbLsRsbRiRsm
bLgbRibRgbLebRsbLgLsbLgbRebRsbRsRsRsLsmmbRgbRgRsmbRsbRgRsmbRgLsbRsbRgR
smbLjbRcbLsRsbRsbRibRiLsbLgbRiRsmbRgbsbRgRsmbRgbRsbRgbRgbRgbRsbRgRsmbL
sbRgRsmbRgbRsRsmbRsbRgbRsRsmbRsbRibRjbRsbLjbRibRibLgbLoRhbLgbRibRgbRgb
RgbLsRsbRibRgbRibLibLsRsLcbLgbLsbLgRsbLgRsbRjbRhbLjbRibRgRsmbRsRsmbRgR
smbRgbRsbRgRsmbRgbRgRsmbRgbRgbRgRsmbRsLsbRgbRsRsmbRgbRgRsmbRsRsmbRibRg
bRgRsRimbRiRsmbRgRsmbRgbRgRsmbRgRsRsmmbRgRsmbReRsmbRgRsRsmmbRgbRgbLsbR
iRsmbLjbLcLsmbLiLsbLgbRobRcbLgbRhbLjbRhbRsbRgbLsRsRibLcbLsbLgbRjbRgbLs
bRibRgRsmbRsbRobLsLsLsmmbLgbRjbRsbRgRsmbRgRsmbRgbRgbRsRsmbRsRsmbRjbRsL
sbRgbRgRsmbLgbLgbRjbLsRsRsRsmmbLsRsLsbRgRsRsmmbRsbRgRsmbRgbRgbRgRsRsmm
bRgbRiRsmbRsRsRsmmbRsRsmbRgRsRsmmbRiRsRsLommbLebRgLsbRibRgRsRsmmbRgbLc
LsmbLibLiLsbLgbLgLsbRcbRcbRiLsbRgbRgbRgLsbRiRiRiRgbLsbRgbRsbRgbRgRsmbR
gRsmbRgLsbLgbLiLsLsmbRebRiRsRsmmbRgbRgbLgbRibRjRsmbRsbLibRcbRsbLcLsmbL
gbLgbLsLsmbLgLsbLsbRcRsmbsbLjbLcbLibRcbRcbLibLibLibLsbRsRsmbLhRsRsmbRh
bRcRsmbLgbRgRsmbRjbLsbRgbLsLsmbRsRsmbRgbRgbRgbRgRsmbRgbRgRsmbRgbRgbRsb
RgbRsbRgRsmbRgRsmbRgRsmbRibRgbRgbRgbRgbRgbRgbRgRsmbRgbRgbRsbRjbRgbRgbR
gRsmbRsbRgRsmbRibLibLcLsmbLgbLgbLgbLgbRcbRgbRgbRgbRsRsmbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bLibRsbLsbLgbLsLgbRgbLgLsbRsbLsbLsbLsbLsLgbLsbLsbLsbLgLsbLgLsbLsbLsLsm
bLsbLgbLsLsmbLsRsbLgbLsbLsbLibLgbLsbLsbLgLsbLsbLgbLsLsmbLsRsbLgRsbRsLs
RsbLsbLgRsbLgbLsbLgbLgbLsbLsbLgRsbLsbLgLsbRsbLgLsbLsbLgbLsbRsbLgbLibLs
bLgbRgbLibLgbRsbsbRsbLibLsRsbLgbLsLsmbRsLsbRsbRsLsbLgLsbLsbLsLsmbLsbRs
LsbLsbLgbLgbRsbLsbLibLibLiRsbLsbLgbRsbLgbLjLsmbLibRsbRsbLgbLsbLsbLgbLs
bLsbLgbLsRsbLgbLsbLsbLsbLgbLhbRsLsbLgLsbLsbLsbLgbLsbLsbLgLsbLsbLgbLsbL
ibLgbRsRsmbLiLsbRcbRibRibRsRsmbRgbRsbRgRsmbRsbRsbLsbRgbRsbRgbRgbLgbLcb
LgbRsbLgbLgbLgbRibLibRsbLsbLsLgbLgbLsbLsbLsbLsbLgbLsbLsbLgbLsbRsLsbLgb
LgLsbLsbLsbLgRsbRjbRhbRhbLgbRibRgbLcbLibLgbRsbRsLsbLiLsbLgbLsLsmbLsRsb
LsbLgbLsbLsLsmbLgbLgbLsRsbLgLsbLsbLgbLsbLgbLsbLgLsbLgbLgbLgbLsbLsbLsLs
mbLiLsRsbRhbRsbLcbsbLsbLsbRsbRsbLibRgbLibRsbLgLsbLsbLgbLgbLgbLsLsmbLgL
sbLsbLsbLsbLsbLsbLsRsbLsbLsbLibLgRsbRsLsbLsLsmbLsbLgRsbLsbLgbLsbLgLsbL
sbLgbLsbRsbLiLsbLgbLsbLgLsbLsbLsbLsbLiLsbLiLsbLgbRiRsmbLsLsmbRjbRibLsR
sbRhbRgbRsbRsbRgLsbLgbRibLsbRgbLsbLsbRiRsmbRsRsmbLibRibRsbRibRgbRsbRsb
LsbLibLibLiRsbRgbLsbRsbLgbLibLgbLsbLsbLgbRgbLgbRsbLsRsbLgLsbLgbLgLsRsb
LgbLgbLgLsbLsRsbRsbLgbsbLgLsLsmbLsbLsbLsbLgbLsbLsLsmbLgbLsLsmbRsbRcbRh
bLgbRcbRgbRsbRgbRgbRgbLsbRgbRsbLsbRibRsbLsbRibRgbRsbRgRsmbLibLsbLhRsbL
gbLgLsbLsbLgbLgbRjbLibRgLsbLiLsbLsbLgbLsbLsbLgbRsbLibLgRsbLsbLgbLsbLsb
LgbLgbLgLsbRsbLgbLsLsmbLsbLsbLibLsbLgbLsbLsRsbLgbLgLsbLsbRcRsmbRibLsbs
bRgbLgbRgbLsbRgbRgbRsRsmbRgbRgRsmbLgbRgbRiRsmbRibRsLsRsbRsbLsbLsbRibRg
bLsbRsbRsbRgbRsbRsbRgbRsbRsbLcbLgbLgLsbLgbRsbLgbLgbLgbLsLsmbLsbLgLsRsb
LsLsmbLsbLsbLgRsbRibRcbLebLgbLgbRgbLgbLgLsbRgbLgbLgRsbLsbLgbRsLsbLgbLg
bLgLsbLibRhbLsbLibLsbRsbRsbLsbLsRsbLsRsbLgbLsbLsbLsbLgbLgbRgbRiRsmbRib
RgbRgbRgbRsbLsbRsbRsbRsLsbLjbLibLgbLgbRjbLibLgbsbLsbLgRsbRsLsbLsLsmbLg
bLsRsbLsbLsRsLsbLsbLgbLsLsmbLsLsmbLgbRsbLsbLgbLsbLsbLgbLsbLsbRsRsmbRhb
LebLibLsbLgbRiRsmbLsbLibLgbLsbsbLsbLsbLgbLsbLgRsbLgbLsbLiLsbLsbLsRsbLs
bLgRsLsbLsbLsbLgbLgbLsLsmbLsbLsbLsbLgbLsRsbLsbLsbLobLsbLsbLsLsmbLgbLsb
LgbLsLsmbLgbRsbLgbLibLibLibLgbRsRibRgLsbLgbRhbLsbRsbLjbRcbRibRibsbLsbL
gbLsbLsbRoRsmbRgbLsbLjbLhRsbLibRsbLgbRsLsbLsbLgbLsbLgbLgbLgbLgRsbRjbLi
bRgbLiLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bRjbLiLsbLgbLsbRgbLgbLibLebLsbLsbRsbRgbLibLibLsbLsbRsLsbLsbLgLsbLsbLsb
LsbLgbLgbLsRsbRgbLcbLsbRibLibLibLsbLgbLibLsbLgLsbRgRsmbLcbRhbRibReRsmb
LsbLsbRgbRsRsmbRgbRgbLiLsbLsbRgbRgbRsbLsbsbRibRibRgbLjLsmbRgbRsbRhbLsR
sbRsbLsbRsRsmbsbRsbRsbLsbRsbRsbLjbsbsbLgbRjbRsbLsbRiRsLsmbRebRibRebRiL
sRsbLebRgbRiRsmbRibsbRgbsbsbRgRsmbRgRsmbRsLsbRsbRgbRsbRsbLgbsbRsRsmbRs
RsmbRsbsbLjLibRsbRgbLsbLsbLeLsbsbLsLsmbLsbLsbLgLsLsmbLsLsRsmbRgbRjbLjb
RcbRiRsmbLjbRcbRsbRsLsbRsbLsbLsbLsLsmbRsbRsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bLgbLgbRjbRsbRsbLjbLgLsbLgbLgbLgbsbRsbLsbRgbRgbRgbLebLgbLebLgLsLsmbLsb
LsbLiLsbLsbRjbRsRsRsmmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bLsbLsLsmbLsbLsbLgbLgbLsbLsbLsbLsbLgbRjbRhbLjbLibRsbLsLsmbLgbRsbLsbLsb
LsbRsbLgRsbLgbLgLsbRcbLcbLibLgbLsLsmbRsRsmbLsbLsbsbLsbLsbLgRsbRsbLgbLs
LsmbLgbLsbLsbLsbLsLsmbLgbRobRsbRibRsbRgbRibLgbRiRsmbLcbLibLgbLsbLsbLsb
LsLsmbRsbLsbRsbRsbRibRibLcbRgbLsLsmbRsbLsRsbLhLsLsmbRibRgbLsbLibLebLsL
smbLsbLsbLsbLgbLgbLsbLgbLsbLsbLsbLgbRhbRibLsLjbRibRsbLcbLgbsbRsbLsbLgb
LgbLsbLgLsbLgbLgbLgbLsbLgbLsbLgbRjbLgbLgbLgLsbLsbLsbLsbRsbRjbRibLsbRgb
RsbRsbRgbLjbLcbLibLgbLsRsbLgLsbLsbsbLsbLgbLjRsbRsLsbLsbLsbLgbLsLsRsmbL
sbLgbRcbRibLjbLhLsbRsbLgbLgbRgbLgbsbLsRsbLsbLsbLgbLsbLsbRsbRsbLsbLgbLs
bLsbLsbLsbLsbLsbLsbLsbLgbLsbRgbRjbRibsbRgbLgLsbLjbLobLiRsbLsLgbLsbLsbL
sbLsbLgbLsbLibLibRgbLibRjbLsbLgbLsbRsLsbLjbLgLsbLsbLsbLsbLgbLgbLibRcbL
ibLhbRhbLibLgRsbLsbLsbRsbLsbLgbLsbRsbRsbLsbLgbLsbRsbLgLsbLgbLgbLgLsbLs
bLgRsLsbRjbRcbRgbRgbLcLsmbLgbRsbRsbLsLsmbLsLsmbLsbRsbRsLsbLsbLgbLgLsbL
gbLgbLgbLgbLsbLgLsbRjbLibLsbLsbLsLsmbLsLsmbRsbRgbLjbRsbLibRsbLgLsbLgLs
bLsbLibRibRjbRibLsbLjbLibLibLsLsmbLgLsbLgbLsbsbLsLsmbLsbsbRsbsbLsbLsbR
sbLgbLsbLsLsmbLgbLgbLsbLsbLsbRjbRhbRgbRgRsRsmmbRgbRsbRgRsmbLgbRgbRgbRi
LsbLsbLgbLgbLsbLgbLsbLsbLsbRsbLsbLgbLsbLsbLgbLgbLgLsbLgbLsRsbRjbRibRgb
RgbLsbRibLjbLcbLiLsbLsbLgbLsbLsLsmbRsbsbsbLsbLgbLsRsbLsbLgbLgbLsbRsbRs
LsLjbRsLsLsmbLsLgbRjbLibLibLsbLibLsbLgbLsbLgbLgbLsbLgLsbLgbLsbRsbLsbLs
bLsbLgbLgbLsbLsLsmbLgbRsbRiLsbRjbLsbLibLiLsbLsLsmbLgbLsbLsbLgbLgbLgbLs
bRjbLhbRgbLsRsbRsLsbLgbLgLsbLgbLsbLgbLiLsbRiRiRsmbRibsbLibLcbRsRsmbLgb
LgLsbLgLsbLgbLsLsmbLsbRobLsbRjRsmbLsbRcbRgbsbRibLsRsbRgbRgbRgbLgbRibLj
bLcbLiLsbLgLsbLgbLgbLsbRgbRjbRhbRiRsmbLgbsbRgbLgbLebLiLsbRsbRiRibLgbLc
b

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bLjLsmbRiRsLsmbLgbsbRhbLgbRibLjbRibRgbLgbLjbRibRiRsmbLibRibRsbRgRsmbRi
RsmbLibRibRibLgbRibLgbRiRsmbLgbRibLgbRibRibLibRibRgbRsRsmbRsbRibLgbRib
LgbRibLgbRhRsmbLibRcbRibLsLsmbLibReRsmbRsbRsbRiRsmbRibLgRsbLsbRibLjLob
RjbRsbLsbRhbLibLobLsbRsbRcRsmbRibLjRiRsmbLibRsbRhbLgbRibLgbRiRsRsmmbLg
bRibLsLsmbRgRsmbLsbRibRibRibLgbRhRsmbLiLsRsbLsbRhbLgbRibRgbLsbRibRgbRg
bRsbRgbLjbRiRsRsmmbLjLsRsmbLcbRcbRsbRibLgbRibLgRsbRiRsmbLgbRibRibLgbRi
bLcbRhbRibLsbRsbRiRsmbLsbRgbLsbRgbLsbLcRsbRgbRjRobRibLibLsbRhbRgbRgbLs
bLjbRibRgbRibLgLsbRgbRgRsmbRsRsmbRsbLsbRsLsbRgLsbsbLsbRgbRjbLsbRsRsmbR
sbRsbRjbRsbRsbRgbLsbRgbRgbLsbRgbLsbRgRsmbRibRgbRsRsmbRgbLgbRibLjbRibLi
bRhbLgRsbRibLgRsbRibLgbRibRsbRgbLsbRgRsmbRibLjbLibLgLsbLgbLsbLgLsbLgbL
sLsmbLgbLsbRsLgLsbRsbLgbLgbLjbRsLsbRsLjbLsbLsRsbLsbRsbLgbLsLsmbLsLsmbL
sRsbRcbRgRsLsmbLcbLibLgbLgbLgbLsbLsbRgbRjRcbRiRsRsmmbRsLsbRgbRsbRgbRgb
RgbRgbRsbRsbRsbRgbRsbRjbLsbLsRsbRgbRsbRsbRiRsmbLsbRibRgRsmbLgbRibLsbRg
bRsbRgbLgbRgbLgbRibRibLgbLebLiLsbLsbRsLsbLgbLgbLgbLgbLsbLgbLgbLgbLgbLs
LsmbLsbLgbLgbLsRsbsbRsbLsbLsbLgbLsbLsbLsbRobRgbLsRsRibLgbLebLgbLibLsbR
sbLiRsbRjbRsRibRgRsmbRibRsbRgbRgbRsbRsbRsbRjbRsbLsbRibLgbRsLsbRsbRsRsm
bRgbRsbRgbRsbRsbRgbRgbRsbRgRsmbLgbRsRgbsbRsbRsRsmbLcbLibLgbLsbLgbLgbRs
bLgbLgbLsbLgbLgbLsbRsLjbLsbLsLsmbLgRsLsbLgbLjbLsbRsbLsLsmbLgLsbRcbRgbR
sbLsbRgbLjbLcRsbRjbRibRgbRgRsmbRsbRsbRsbRsbRgbLgbRibRsbRgbRsbRgRsRsmmb
LsRsbRgbRgbLsLsmbRibLsbLsRgbRsRsmbLgbRibRgbRsRsmbRsbRsRsmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bLsbLsbLjbLsbLsbRgbLobLsbLcbLsLsmbLsbLsbLsbRsbLsbLgbsbLsbLibLgbLsbLsbL
sbLibLibLsbLsbLsbLsRsbRsbLiLsbLsLsmbLsbLsbRsbRsbRgbRibRibLsbRsbLsbRgbR
gbRsbLsbRgbRgbRhbLiLsbLsbLhbLiLsbLsbLgbLsbsbLgbLsbLiLsbRsbLibLsbLibLgb
LgbLsbLibLgbLsRsbLibLsbLibsbLgLsbLsbRjbLibLgLsbLobLcbRhbRibRsbRsbRgbLj
bRsLobLhbLsLsmbLgbLsbLibLsLsmbLibLsbLiLsbLsLsmbLibLibRebLiLsbRsbLjLsmb
RsbRjbLhbLjLsmbRgbLiLsbRibLibRibLjbLibRhbRjbRsbRsbRgbRgbLibLgbRjLsbRjR
smbRsRgbRsbRiLsbRgbRibRsbRibRgbRsbLgbLibRjbLibLibRhbRjbLhbRsbRjRsmbRcL
sbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bRgbRhbRgbsbLsRsbRgbLebLibLgbRgRsmbLhbRgLsbLsbLiLsbLsbRsbLsbLsbRsLsbLi
LsbRgbLsbLsbLsbLsbLgbLsbLsbLgbLsbRsbLibLiRsbRibLsRsbLibLcbLgbLhbLiLcbL
ibLcbLsbLgLsbRsRsmbRsbLibLhbLgbRgLsbLsbLsbLiLsbLhbLhbLsbLgbLibLgbLsbLs
bRsbRibRcbLsbLsbLjbRoLsbRgbLsbRgLsbRsLsRsbRsbLsbLjRsbsbRcbRhbRgbRsbLsb
LsbLsLsmbLsbLibLgbLsbRsbRsbRjbRibRcLsbRibLsRsbRjbRgbRcbRsbRjbRsbRibRib
LsbLsbRsbRsbRgbRgbLsbRiLsbLgbRgbRgbLsbRsbLsbLhRsbLcbLibLsRsbLgLsbRgbLi
bLsLsmbLsbRsbLibLsbLjbLibLsbRsbRgbLgbRsbLibLgbLgbLgbLsbRgbLsbLibRsbLsb
LgRsbRjbLibRgbRsbLsbLsbLgbLsbRsbRsRjbRcbLsRiRsmbRgbLcbLibRgLsbLiLsbLsR
gbLibRsbLgbRsbLgbRsbLibLgbLsbRsbLsbLsbLsLsmbLgbLsbLsLsmbLsbLgbLsRsbLsb
LsLsmbRsbRgbRjbRobRsLsbRibsbLsbRgbRsLsbRgbRsbRgbLcbLibLsRsbLsbLgbLsbRs
bLsbRgbRsbLsbLsbRsLsbLsbRsLsRsbRsbLibLsbLgbLsbLsbLsbLsLsmbLsLsmbLgLsbR
jbLibRgbLgbLsbLsbLgLsbLibLsbLsRsbRsbLgbLsbLgbLsbRsbLgbRjbLgbLgbLsbLgbL
sbLsbLjbLsLsmbLsbLsbLsbLgRsbRjbLcbLgbLsbLsbLibLsbLgbRsbLsbRsbRsbLsbLsL
smbLsbRsbLsRsbLsbRsRgbsbLibLsbLsbLgbRsbLsbLgbLgbLsbLgbLgRsbRsLsbRgRsmb
LsbLsLsmbLsLsmbLsbLsbLsbLsLsmbLgbLsbRsRsRsmmbLsLsmbLgbLsbLgRsbLsbLsbLs
bRsbLsbLibLsbsbLgRsbsbLsbLsbLsbLsbLgbLgbLsLsmbLgbRsbRgbLgbLgbRjbLsbLgb
LsbLsbLsRsLsbLsLsmbLgbLsbLsbLiLsbLgbRgLsbLgbLgbLsbsbLsbLsbLjbLgbRsbRsL
sbRsLsbLibRgbLibLsbLsbLgbLsbLgbLsbLgbLgbRibRcbLsbRsbRgbLsbRgbRgbLjbLob
LibRgbRjbLibLiRsbRgLsbLsLsmbRsbLgbLsbLgbLsbLgbLsbLgbRgbLgbLsbRsbRsbLgb
RgbLgbLgbLgLsbLgbLsbRsbLgbLgbLiLsbLsbRgbRjRsRimbRgbRibLgbRcbLibRiRsRsm
mbRgbLgRsbRibLsbRgbRgbRsbLibLcbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bRibLjbLgbLsbLibLgbRjbRjRsmbLgLsbRibRsbRibRsbLsbLjbRjbLibLcbLibRibLebL
cLsmbLibLjLsmbLgbLsbRibLibLgbRobLsbLebLgLsbLgbRsbRibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 25; Drug: Control Apo 0.5 然
bRiRgbRsbRibRsbRgbsbsbRsbRgbRgbRgRgbRgbRsLsbLgbRcbLhbLcbLcbLibLgbRcbRi
RsmbRibLibRibRibLibRcbLiLsbLibsbLcbLibLsbRsLsbLgRsbRsbRibRhbLgbRibLgbR
ibLsbRsLsbRsbsbLsbLgbRgbRsbRsbRgbRsRsmbRgbRsbRsbRsRsmbRgbRgbRgbRgbRgbR
sbRsbRgbRsbLjbRcbLibRiRsmbRgbRsbRjbLibRjbsbRibRgbLsbRgbRgbRsbRsbRsbRsb
RsbRgbRgbRgbRgbRsbRgbLgbLjbRcbLibRibRibRgbRsbRgbRsRsmbRsbRgbRsbLgRsbRg
RsRsmmbRgbRgbRgbLsLsmbRgbRsbRsRsmbRibRgbRgbRgLsbRgbRgRsmbRsbRsbRsbRsbR
gbRgbRgLsbRibLhbLjbLibRjbRcbLjbRcbLgbRiLsbRsbRsbsbRgbLgbRsbRsbRgbRsbRg
bRsRsmbRsbLgRsbRgbRgbRsRsmbLjbLhLsbRhbRibRsbRgRsmbRsbsbRsLsbRsbRgbRsLs
bLsRibLsbLjbRibRgbRgbLjbRcbRsLsbLsbRgbLjbRcbLgbRgbLsbLsRsbRgbRgbRgbRgb
RgbRgbRgRsmbRsbRgbRibRgRsmbRgbRcRsmbLgbRibLjbRcbLibLiLsbRcbRcbRibRgbLi
bRibRiRsmbRibRgbLhbRibRgbRgbRsbRsbRsbRgbRgbRgbRgbRgRiRsRsmmbRiRsmbRgbR
sbRgbRsbRgbRgbRgRsmbRsbRgRsmbRsbRgbRsbRsbRsbLgbLsbLsbRibRgbLibRibRgbRg
bRgbRjbLcLsmbLibRjbRcRsmbRibLjbRibLjbRiRsmbRgbLjbRibsbRsbLgRsRsmbLjbRs
bLsRsRsmbRgbRsbRsbRsbRgbRgbLsbRsbRsRsmbRgRiRgbRgRgbRgbRgbRgbRgbLgbRibR
ibRgbRgbLiLsbLgbLibLgbLgLsbLgbLsbLgbRjbRcLsbLibRiRsmbRgbRsbRgRsmbRsbRs
LsbRsRsmbLsbLgbLsbRsbRgbRgRsmbRgbRsbRgbRsbRgbRsbRibLjRsbRibRgbRsbRsbLg
bRsbRsRsmbRgbRgbRgbRgbRibLiRsbRibRgRsmbRgbLjbRhbLsbLjbRibLibRhbRgbRsbR
sbLjbLhbRcbRibRgbLgbRibsbRsbRgbRgbLjbRcbRibRgbRsbLsbRibRgbLsbRibLgRsRs
mbLsRsbRsbRgbLjbRcbLgbRsbRibRsbRgbRsbsbRsbLsbLgbRibLsbRgbRibRgbRsbLgbR
ibRibLsRsbRibLsbRsbRgRsmbLibRhbRgbRsbRgbLibLhbLibRjbLsbRcbRgbRsbRsbRsb
RsLsbLgRsbLjRsbRhbRgbRgbLibRibRiLsbRgRsmbRsbLjbRcbRsbRsbRgbLjbLobRhbRc
bLibRiRsmbRgRsmbRsbRsbRgRsmbRgbRgbRgbRgbRsbLgbRsbRsbRgRsmbRgRgRiRsmbRs
bRgbRibRgbRsbRgRsRsmmbRgRsmbRibRgbLhbLgbRcbRcbLgbRibRibRgbRsRsmbRsbRib
RgbRgbRsRsmbRgbRebRsbRgbRgbRgbRgRgbLgbLjbLcbRcbRibRibRsbLibRcRsmbRibRg
bLgbRibLcbLcbRebRiRsmbRibRsRsmbRgRsmbRgbRgbRgRsmbRsbRgbRgRsmbRgbRgbRgb
RsRsmbRsbRgbRsbRgRsmbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 26; Drug: Control Apo 0.5 然
bLgbRibRsRsRsLsmmbRsbRgRsmbLsbRgbLgbLhLsbRcbRibRsbLsbLsbRgRhbLgbRibRiR
smbRgbLgLsRsbRibRgbLgbRibRgbLibRcbRsbLibRsbRhbRgbLgbRibLsbRgLsbRsRsmbR
gbRsRsmbRsbRgbRsbRsRsmbRgLsbRsbRsbRgbLsbRgLsbRsbRsbLsbLsbRgLsbsbRsbLsb
RgbRsbRsbRsbRsbRgbRgbRgbLcbLjbLibRjbRcbRsRsmbRibLgbRsbRgbRiRsmbRsbLsbR
gbRgbRsbRgbRgbRibRsbLsbRgbRgbLgbRibRsbRsbRgbRsRsmbRsbRsbRgbRgRsRsmmbLs
LgbRibRsbRgbRgRsmbLgbRibRgRsmbRsRsmbLsbRgbRsRjbLsRsbRsbRgbRgbRgRsRsmmb
RsbRsRsmbRsRsmbRgbRsbRsbRsbRgbRsbRgbRgbRgbLibLjbLibRhbRiRsmbRsbRsbRjbR
sbRsbRgbRgRsmbRgbRsbRgRsmbLsbLsbRgbRgbRgbRsbLsbRgbRgbLsbRgbRgRsmbLjbRh
RsmbLgLsbsbRibRgRsRsRsmmmbRgbLjbRhbRibsbLibRgbRibRsbRsRsmbRsbRgbRsRsmb
RgRsmbRgRsmbRsbRsbRibLsbRgbRsRsmbRgbRgRsmbRsbRgbRgbRgRsmbRsbLhbRibRibR
gbRibLgbRsbRhRsmbRgbRsbRsRsmbRgbRgbRgRsmbLjbRiRsmbRibLsbRsbRibRsbRsbRg
LsbRsbRsbRgLsbRgbRgbRgbLibRibRgbRgbLsRsbRgbRgbRgbsbRsRsmbRgbRgRsmbRsbR
gbLgbRgbRsRsmbRsbRgRsLsmbRgbRgbsbRsbRsRsmbRsRsmbRgbLsbRgbRsbRibRgbRgbR
sRsmbRgbRgRsmbLsbRgLsbLjbRhbRjRsmbRgRsmbLibLsbLibLsbLibLibsbRjbRhbRibL
sRsLsbLsbRsRsmbRibRsbRgLsbRsbLsbRgbRgRsRsmmbLsbRgbRgbRgbRiRsmbRibRsbLi
bLsRsbLibLibRgbLhbRhbRsLsbsbRsbLsbRsRsmbRsbRsbsbRsRsmbRgbRgRsmbRgbRgbR
gbRgRsmbRsbLgbRibLiRsbRibRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 27; Drug: Control Apo 0.5 然
bRsLgbLgbLsbLgbRsbLsbLgLsbRsbLsbLgRsbLgLsbRcbsbRgbRibLjbLibLibRsbLiLsR
sLiLsbLgLsbLgLsbLsLsmbLsLsmbLgbRsbLgbRsbRsbLgLsLsmbRsbLgLsbLgbRsLsbLgb
RgbLibRgbLibLgbLgbLgbRjbLsbLibRsbLgLsbLgbLgbLgbLgbRgbLsbRsbLgbLsbLgLsb
LgbRsbLgbLgbLjbLsbRsLsbLgbLsbLgbLsbLgbLgLsbLgLsbLgbLsbLsbLgbLgbLgbRgbL
ibLgbRjbRhbRgbRibRibLhbRibRiRsmbRibLsbRsbRibRgbLibRsbRibRibRsbRgRgRsmb
RcLsbRibLgbRibRgbLsbRibLsbRgbLgbLcbLiLsbRgbLibLsbLgbLgbLsbLgbLgbLibRib
LsbRgbRjbRsbLcbLibRsbLsbLgbLsbRsbLibLsbLgLsbRsbLgbRsbLgbLsbLibRsbRsbLg
LsbRgbLibLgbRgLsbLgbLgLsbRgbRsLsbRsbLibRgbsbLiLsLsmbRsbLibRsbLgbLsbLsb
LgbLsbLsbLsbLsbLgbLibRgbLibRsLsbLibRgbRsLibRsbLgbLsbLgbLsbLgbLsbLsbLsL
smbLsbLsbLsbLsbLsbLsLsmbRsbLibRsbLibRgbLibRgbLjbRsbRgbLiLsbLgbLsbRsbsb
LsbRsbLibLsbLgbRsLsbLgbRsbLgbLsbLgbRsbLgbRsbLgbLsbRsRsmbRsLgbLsbLgbLsb
LgbLsbLgbLsbLgbRsbLsLgbLgbLgbLsbLgLsbLsbLsbLgLsbRsbLjbLsLsmbLsbLsLsmbL
sbLsbLsbRsbLibRsbsbLgbLsLsmbLsbLgLsbLgbLjbRjbLibLgLsbRsbRsbLibLgbRgbLi
bLsbLsbRsLsbLsLsmbLsbLsbLsbLsLsmbLsbLgbRjbLibLibRgbRsRsmbLgLsRsbLgbRsb
LgbRsbLjbRjbLibLsbLsbLsbLsbLsbLsbLgLsbRsbLgLsbRsbLgbRsbLibRsLsbLgLsbLs
bLgbLsLsmbLsbRsbLgbsbRsbLgbLgbLsbLsbLgbLsbLgbLsbLsbLsLsmbLsbRsRsmbLgbR
sbLgbLgbRgbLgLsbLgbRgLsLsmbLsbRsbLgbLgbLsbLsbRsbLgLsbRsLsbLibRsbLibRsb
LiRsbLgbRsbRgRsmbLibRgbLibLsbLgbLsbLgbRsbLibRsbRsbRjbRgbLebLibLgbLsLsm
bRsbLjLsmbLsLsmbRibLgbLgLsbLsbLgbLsRsbLjbRsbLsLsmbLsbRsbLsbLsbLgbLgbRs
bLsbLgLsbRsbLiLsbRibRsbRgRsmbRibLsRibLjbLebLibLgbRjLsbLibRsbLgLsLsmbLs
bLjbRgbLibLgbLsbLgbRsbLgbLsbLsbLgbRsRsmbLgbLgbRsbLgbRsbLgLsbRsLsbLibRj
LsbLibRgbLgbLsbLsbLgbLgbLsbLsLsmbLgbLgbRjbRhbRibRgbRgbRgbRsbLcbLiLsbLg
bLsbRsbLgbLsbLgbRgbLibRsRsmbLgbRsbLibLsLsmbLgbLsbLsbsbLsbLsbLgbLgbLsbL
sLsmbLsbRsLsbRjbRiLsbRgbRgbLsbRibLcLsmbLibLibLsbRsbLgbLgbLsbLsbLgLsbLg
b

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 28; Drug: Control Apo 0.5 然
bRibRsbRibRgRsmbRsbRsbRiRsRsmmbLibLgbRgbLsbRjbRgRsmbRgbRiRsmbRsbRgbRib
RgbLgbRgbRsbRibLiLsbRibRsbRsRsmbRsbLgbRibRibRgbsbRsbLibRgbRsRsRsmmbLgL
sbLibLgbLgbLsbRebLjbRebRgRsmbRibRibRjbRiRsmbRgbLibRiRsmbRsbLgbRsRsRsmm
bRhbLgbRiRsmbRhbRgbsbRsRsmbRgbRgbsbLsbLsLsmbRibRsbLsbRsRsmbLibRsbLgbRi
bRsbLjLsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 29; Drug: Control Apo 0.5 然
bRgbRgbRgbLgbLibLgbLsbLsbLsbLsbLsbLsbLsbLsLsmbLsLsmbLjbRsLsbLsbLsbLsLs
mbLgbLsbLsbRsbRhbRibRibRhbRgbRgbRsbRgbRgbRgbLjbLhbLsbLgbLsbLgbRgLsbLib
RsbRgbLibRsbLgbLsbRsbLsbLjbLsbLsRsbRsLsbLsbLsbsbRsbRgRcbRsbRsRsmbLsbLg
bRsRiLsbLjbRibRsbsbLjbRhbLibRibRibLgLsbRibRgbRsbRgLsbRgbRgbLsLsmbLgbRi
bRgbRibRgbRgRsmbRsbLsbRsbRgbRgbRibRibRibLibLgbRsbLsbLsbRjbRgbRibLgbRiR
smbRibRibLgbLsbRsbRgbLgbLgbLsbLsbLsbRsbLgLsbLgbRsbLgbRsbsbLsbLsbRsbsbL
sbLsbLsbLgbLsLsmbLsbLjbLsbRsbRjbRcbLsbRibLsLsmbLsbRgbRjbRsbRhbLibLhbsb
RgbLibLsbRsLsbLsLsmbLgbRsbsbLsLsmbLsRsbLsbLsbLgbLsbRsbLsLsmbLsbLsbLsbL
sbLsbLsbLsLsmbLgLsbLgbRsbLgbLsbLsbLsbLsbLsbRsbLjbRsbLjbLsRsbLsbLsbRsbR
sbLgbLsbLsbLsbRsbLgLsbLgbLsbLsLsmbLgbLsbLsbLsbLgbLsbLgLsbLsbLiRsRsmbRi
bRcbRibRgbLgbLjbRjbRgbRibRibLsbLsbRibRgbRgbLgbRgbRsRiRsmbRgbLibRgbRjbR
sRsmbRsbRgbRsbLsRgbRgbRsbRsbRsbRsbRsbLsbLibLibLgbRgbRjbLgbLgbLsbsbLsbL
sbLsbRsbLgRsbLgbRsbLsbLsbLsbLsbLsbLgbsbLsbLgbLsLsmbRsbLgLsbLgbLsbLsbLs
bLsbLsbLsbLsbLsbRgbLgbLgbRsbRsbRjbRsbLibRjbLgbLgbLgbLsbRsbLsbLgbRsbLsb
LgbLsLsmbLsbLsbRsbLgbLsbLsLsmbLsLsmbLsbLgbLsbLsLsmbLsbLgbLsLsLsmmbRgbR
jbRibRgbRgbLsbRgbLsbRgbLgbLgbLgbLsbLgbLsLsmbRjbLgbLgbLsLjbsbLsbLsRsbLs
LsmbLsbLsRsbLsLsmbLsbLgbRsbLgbLsbLgbLgbLsLsmbLsbLsbLsbLsbRgbRhbRibRiRs
mbRgRsmbLjbLhbRgbLgbLgbLsbLsbLsbLsbLgbLsbLsbLsbRsbRsbLsRsbLsbLsbLsLsmb
LgbRsbLsbRsbLsbLgbLsbLgLsbLsbLsbLsbLsLsmbLsbRhbLjLsmbLibLsbLgbLgbRgbLs
LgbLgbLsLsmbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsbLsbLgbLsLsmbLgbLsbLsbLsbRhbL
jbLibLgbLgbLgbRsbLgbRiRsmbLgbLgbLjbLsbLsbLsbLsbLsbLgbLgbsbRsbLgbLsbLsb
LgbLsbLsbLsLsmbLsbLsbLsbLgbRgbRibRgbRgbLsbRgbRibLjbLcbLibRsbLsbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 30; Drug: Control Apo 0.5 然
bRcbRobLobLcbRobLcbRobLebLebLebLobRebLobRcbRebLobLcbRsbRgbLobRgbRcbRib
LcbLcbLebLcbRcbLobLebRcbRcbRibRibRobRobLcbRobLsbLcbRobRcbLobRibLobRebR
obLcbLebLobLobLebLgbLibLebLobRobRibLobLcbLibRobRebLebLobLobRobRebRgbRe
bRobLebRebRobRibRobRibLebLebLebRobLobRobLibLcbLibLebLobRobLibRibLobReb
LobLebLobRgbLobRebRibRcbRobLebRobRgbLhbRebRobLobRobRebLcbRcbRebRobRebR
obLibRobLobLhbLcbLobLobRgbRcbRebRebLgbLcbLibRebRebRobLobLobRobRobRobLo
bLgbRobLobRcbRobRobLebLebRibRebRgbLcbRobLobRcbLcbRgbLcbRcbRgbLebLobRib
LobRobRebLcbRobLcbRobLobRcbRsbRobLhbRobRibRebRobLibRebRcbLibLcbLsbLgbR
obLcbLcbLebRobRobLcbLobRebRgbLcbRobLebRobRibLcbLibRebLibLobLgbRobRcbRc
bRobLobRebLobLsbLcbRcbLobRobLcbLobRgbRgbRcbLebRobRebLsbRsbRebLobRcbLcb
RebLobRobRgbLibRhbLcbLcbLcbRebLibRobRobLebRobLebRebLgbRcbRibRhbLobLobR
obRcbLebRobLobLhbLibLcbRebRobLibRobLgbLobLcbLcbLibRobRgbLsbLcbRcbLobLo
bRgbLgbRibLebRobLebLobLgbLibRibRcbLobRcbLcbRhbRhbLebLcbLcbLcbLcbRsbReb
LebLcbLobRebLobLebRebLcbRcbRcbRebRebLobLcbLibRobLibLcbRgbLobRobRebLsbL
obLcbRcbLibLobRebRebRobRobRibRobRebRsbRobRibRobLobLobRobLebRsbLebRhbLi
bRgbRobRsbLobLcbRgbRgbRobRcbRcbLibRobLcbLebRobLobLobLobLobLsbRsbLcbRob
LobRobRobRibRobRobRibLobLobRobRcbRebRgbLebRebLibRcbLcbRobRebLebLebLibR
ibLobLobLebRobRebLobRcbRebRobLgbRebRobLibRobRebLobRcbRebLobRobLcbRobRe
bLebLibRebRcbRobLobRcbRibRibLebRobRobRobRobLcbRcbLgbRcbLobRibLobRjbLob
LobLobLobRobLebLobLebRcbRobLobRsbRibLcbLibRcbLobLobLgbLebRobRobRobRebR
obLsbLobLebRibRebLebRobRcbLgbRebLobRobRibLebRcbLobRibRobRobLobRcbRcbRs
bRsbLcbRobLebRobLibLcbLobLcbLgbLobLobLjbRobRobLcbRibRcbLcbRobRebLebRob
LebRebLobLobLebRcbLebRobRobLibLcbLcbRcbLebLobLsbRebLobLcbLobLcbRobLcbL
obRobRgbRebRibRgbRobLibLcbLebRobLobLcbLobLebLcbLobLobLebLcbLcbRebLebRh
bLcbRcbLebRibLhbRcbRobRcbRcbRobRebRcbLcbLobLobRebLcbRobRebRebLcbRgbLeb
LobLgbLebRobRibLcbRgbLobLobRebLcbLobRobRobLibRobLebRebLobRobLibLobLsbL
ebLobRhbLobRobLobLobRobRebRobRebRibRibRobLobLcbRsbRobRibLobLobRcbLebRc
bLcbRebLebLibLebLcbLobLobRobLebRobLobLebLobRobLebLebLobRobRcbRebRgbLsb
RgbRjbRebLobLobLjbLebRobLibRobLibLobRsbRgbLcbLobLobLsbLobRebLobRobRgbR
ebRebRcbRibLebRgbRsbLsbLsbRebLobRobRibRgbRsbLcbLobRjbLebRsbRibLgbRebRc
bRsbRobRobRcbRhbLobLjbLobRcbLebLobRcbRgbLcbLjbRjbRcbRebLebLebLobLobLob
LcbRebRobRgbRobLobRebLebLsbLgbRjbRobRobLebRoLebLjbRebLobRebLobLjbLebRe
bRcbRsbLsbRobRobRsbLcbRobLibLobRebLjbRebRobRcbLjbLsbRebLebRobRobLsbRhb
RcbRobLebRobRebLibLobRcbLobRsbLsbRebRebLebLsbLsbLobLebRebRobRobLsbLobR
cbLcbRjbRebRobRebLcbRobLsbRcbLsbLobLsbRobLebLobLebRjbRobRsbRobRebRobRs
bLebRcbRebRebRobLibRebRebLebLibRjbRebLgbRjbLsbRobRebLgbRebLsbLobLobLcb
RsbRebLebRobLsbLebRgbReb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bLibRsbLgbLibLsbLsbLsbLsbLibLhbLgbLsbLgbRibRgbRsbRsbRgbLjbRsbRhbRsbRsb
RgbLsbLgbLgbLgbLgbLgRsbLsLsmbLgbRjbRjbRibLibRibLsbRsbRgbRsbRgbRgbRsbRs
bRjRsRsmmbRgbRsRsmbLsbLibRgbRiRsmbLsbRibLsRsbRsbLgbLsbRibRsbRgbLsbLsbR
hbLgLsbLgbRgbRiLsbsbLsbRibRiRsmbRibRsbLsRsbLsbRgbRsbRgbRsbRsLgbRibRsbR
gbRgbLhbRibRsRsmbRsbRgbRsbLgbLsbLgbLsbLgbsbRcLsbRsbsbRibLsbLgbLsLsRsmb
RiRsmbRibRsbLsbLsbRibRsRsmbRsbRsbLsbRgRsmbRsbRsbRsbLsbRgbLsbLsbLsbLjLs
mbRiRsmbRibLsbLsbRiRsmbRibRgbRsbRjbRibRsbLibRibRibRsbLgbRgbRsbLsbLsbLj
bLibLgbRsLsbsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bLgLsbLsbLgLsbLsbLsbLgbLsbRsbLgLsbRsbLgLsRsLsbLsbLsbLsbLsbLsLsmbLgbLsL
smbLsbLsbLsbLsbLsbLgbLsbLsbLgLsbRsbLgRsbLsRsbLsLsmbLsbLgRsbLibLgbLibRg
bLsbLsLsmbRsLsRsbRsbRibLjbLcbLsbLibLibRsbLgbLsbLgLsbLgbLsbLsbLibRsbLsb
LgbRsbLgLsbLsLsmbLgbLsbLsbLsbLgbLgLsbLsbLgbLsbLsbLsbLsbLsbLgbLsbRsbLib
LgbRsbLgbLiLsbLgbRsbLibLgbLhbRsbRsbRgRsmbRsRsmbRgbRgbRibLjbLcbLsbLibsb
LsbRgbLgbLsbLsbLsbLsLsmbLsLsmbLgbLgLsbLsbLgbLgbLsbLgbRsbLgbLsLsmbLsbLs
LsmbLsbLsbLgbLgbLsbLsbLsbLsbLsbLgLsbLsbLgbLsbLgbLsbLgLsbLgbLgRsbLgRsbL
gLsbLsLsmbLgbLsbLgbLsbLgbLsbLsbLsLsmbLsLsmbLgLsbLsLsmbLgLsbLgbLsLsmbLg
LsRsbLgbLgLsRsbLsbLsbLsbLsbLsbLgLsbLsbLsLsmbLgbLsbLsbLsbLsbLgbLibLgbRg
bLibRsLsbLgLsLsmbLsLsLsmmbLgbLsRsbLgbLsRsbLgbLgbRsbLsbLsbLgbLsbLgLsRsb
LsbLsbLgLsbLgbRjbLibRjbLibLibRibLgbLibRsbLibLsbLgbLsbLiLsbLgbLsbRgbLgb
LsbLibRsbLibLsbRgbLgbLsLsRsmbLgbLsbLsLsmbLsbLgbLgLsLsmbLsbLgLsbLsbLsbL
gbLgbLsbLsbLgbLsbLsbLgbRgbLibsbLsbLsLsmbLgbLsLsmbLsbLgbLgbLgbLgbLsbLsb
LgbLsbLgbLiLsbLsbLsbLsbLsbLgbLsbLsbLsbLgbLsbLsbLsLsRsmbLsbRsLsbLibLsbL
sbLgbLsLgLsbRsRsmbRsbLgbRsLsLsmbLgLsbLibRsLsbLsLsmbLgbLsbLsLsmbLsbLgbL
sbLsRsbLsLsmbLsLsmbLsbLgbLgbRgbLibRjbLibLsbRsbLibRsLsbLgbLsLsmbLgbLsbL
sLsmbLsLsmbLsbLsLsmbLsLsLsmmbLgbLsbRsbLgLsbLsbRsbLsbLgRsbLsbLgbLgbLsLs
mbLsbLgbLgbLgbRsbsbLibLgbLgbLsbRgLsbLibLgRsbRsbLibRsbLgbRsbLgbLsbLsbLg
LsbRsbLgbLsLsmbLgbLsLsmbsbLgbLgbLsbRgbLibLgbRgbLibLsbLgRsbLsLsLsRsmmbL
gbLsLsmbLsbLsbLsbLsbLsbRsbLgbLsLsmbLgbLgbLibLgLsbLsbRsbLgbLgbLgbLsbLsb
LsbLsRsLsbLgbLsbLsbLsbLgbLgLsLsmbLgbLgbLgbRsLsLsmbLiLsbLsRgbRsLsbLiLsb
LgLsbLsbLgbLgbLsbLgbLgbLgbLgbLgbLgLsbRgbLsbLsbLgbRsbLjbLsbLsbLgbLsLsmb
LgbLgbLsbLgbLgLsbLjRsbLibRibLgbLsbLsbLibRsLsbLgbLgbRsbLsbLgLsbLsbLgbLs
bLgbLsbLgbLgbLsbLsbLgbRgbLibLsRsbLsbLsbRsLgLsbLsbLgLsbLsbLsRsbLsbRsLsL
smbLsbLsbLgbLsbLgbLsRsbLgbLibLgLsbLgLsbRgbLsbLibLgLsbLgbLsbRsbRgbLibLg
bLsbRsbLibRsbLgbLsbRsLsbLsbLsbLgbLsLsmbLgbLgbLgRsbLsLsmbLsbLgbRgbLibLg
bLgbLsbLgbLiLsbRgbLsbLibLsLsmbLsLsmbLgbLsbLsRsbLgbLsLeLsLsmbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bLibLibLsLsmbLgbLsbLsbLsbLsbLsbLsbLsbLsbLgbLgbRcbRibLjbRgbLsbRsbRgbRsb
LsbRgLsbLgbRgbRgbLsbRsbRgbLsbRsRsmbRgbRsbRsbRsbRsbRsbRsbRgbRsbRsbRsbRs
bLjbLibLibLcbLibLibRjbLibLibLsbRsbsbLgbLgbRjbRhbRgbLgbRibRgbRgbLjbLgbR
jbRibRgbRgbRsbRsbLgRsbLibRsbLgbLobLgbLgbLgbLgbRsbLgbLgbLgbRsbLibRjbRcb
RibRsbRiRsmbRgbRsbRsbRsbRsbRsbRsbRsbRsbRgbRsbRsRsmbRsbRsbLsbRgRsmbRgRs
mbLsbRsRsmbRgbRsbRsbRgbRsRsmbRsLsbRgbRgbLsbRgbRibLjRsbRiRsmbRjbLjLsmbL
jbLgbRcbRibRgbRgbLhbLjbLhbRjbRjbRjbLjbRibLibRgLsbLjbRibRsRsmbRibLsbRgb
LjbLibLgbRjbLgbLibRjbLhbRcRsmbRcbRsbRibLhbLgbLjbLsbLibRsbRoRsmbRgbRsRs
mbLsRsbRsbRsbRsbRsbRsRsmbRsbRsRsmbRgbRsbRgbRsbRsRsmbRsbRsbRsRsmbRsbRsb
RgRsmbRgbRgbRsbRsRsRsLsmmbRsRsLsmbRsbRgbRsbRgLsbRgbLibLsbLibLcbRsbLsbL
sbLgbLsbLgbLsbLsbLsbLgbRjbRcbRgbRgbRsbRsbRsbRgbRsbRsbRgbRgbRsbRsbRsbRs
bRsbRgbRgbRgbRgbRgbLhbLcbLgbLsLsmbLsbLsbRgbLgbLgbLibRjRsmbRcbRibRsbLsb
RsbRsRsmbRsbRgbRsbRsbRsbRgbRgbRsbRgRsmbRsbRgbRsbRgbRgbLsRsbRgbRsbRsbRs
bRsRsmbRsLsbRgbRgRsmbLhbLcbRhbLjbLgbLsbRhbLjbLgbLjbRjbRcbLgbRibLsRsbRg
bRgbRsLsbRsbRsbLsbRgbRsbRsRsmbRgbRgbRsbRsbRsRsmbRgbRgRsmbLsbRjLsbRobLi
bLibRhbRgbLhbLibRsbRibRgbLibRgbRjbRhbRgbLsLsmbRgLsbLibLcbLiRsbRjbLcbRh
bLjbRcRsmbRcbRsbRgLsbLgbLgbRibRibLibRibRgbRsbRsbRgbRgRsmbLsRsRsmbRgbLs
bLgbLsLsmbRjRsmbRibRibLgbRsbRgbRgRsmbRgbLgbRsbRibRibRgbLibLgbRibRgLsbR
sbRgbLibRcbRibLgbLibLibRsbRibRsRsmbRiRsmbRsRgRsmbRsbRsRgbRgbRsbRsRsmbR
gbRgbRsRsmbRsbsbRsbRgbRsbRgLsbRsbRgbRgbRsbRsbRsbRsbRgbLgbRgbRgbRgbRsbR
sbRsbRgbRsRsmbRsbRgbRgbLjLsmbLjbRcbRibRgbRgbLsRsRhRiRiRsmbRsbLsLsmbRib
LsRsbRgRsmbLsbRiRsmbLsbRgbRgbRsbRgbLsRsbLsbRibRgbRsbRsbRsbRsbLsbRgbRgL
sbLsbRsbRgbLgbRgbRgbRsbRsbRgLsbLsRsbRsbRsbRsbRsbRgbRgbRsbRsRsmbRgbLcbL
sLcbRgbRgbLjbLibRibRibRibRibRsbRgRsmbRsRsmbRsbRgbRgbRsRgbRgbRsRsmbRgbR
sbRsbRsbRsbRgbRgbRsRsmbRgbRsbRsbRsbLebLjbRibLcbLcbLebLibLibRhbLibRjbRh
bRgbRgRsmbRgbLsbRgbLsbRgbRgbRsbRsbLsbRgbRgbRsbRsbLsbRgbRgbRgbRsbRgbRgb
RgbLsbRibLgbRjbLebRjbRibLibRibRgbLhbLjbLhbRjbLibRhRsRsmmbRcbLjbRsbRgbR
gbRgbRgbRgbLgbRgbRsbLibLibRibRgRgbRgbRsbRgbRsbRsbRsRsmbRsbRsbRgbLsbRgb
RsbRgbRgbRsbRgbRgbLsbLcbRsLhbRjbLibRhbRjbRibRgbRsbRgbRsbLsbRgbRsbRgbRg
RsRsRgRsmmmbRgbRsbRgbRsbRsbRsbRsbRsbRgbRgbRgbRgbRgbLhbLibRibRgbRsbRsbR
gbRgbRsbRsbRsbRsbRsbRgLsbRgbLhbLibLibRjRsmbRcbLhbLhbRebRhbRibLgbRibRgb
LsbRgbRsbLsbRsbLsRsbLsbRgbLsbRgbRsbLhbRebLibRgbRibRgbLgbRgbRgbLsbLsbRg
bRgbLsRsbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bRgbRsRsmbRgbRgbRsbRsRsmbRgbLsbRgbRsRsmbRgRsmbRsbRsbLgbRgbLibRibRsbRgb
RsbRgbLsRsbLsRsbRsbLsbRsbRgbRsbRsbRgbLsbRsRsmbLsRsbRsRsmbRibRsbRgbLsbL
sbRsRsmbRsbLsRsbLsbLibLsbRsbRgbRsRsmbRsbRgbRsbRsbRgbLsbLgLsbRsbRjbRsbL
jbRhRsmbLsbRsRsmbRsbLsbLsbRsbRgbRsLsbRsbRsbRsRsRsmmbRgbRsbLsbLsRsbRibR
gbLsbRsbRsbRsbRgbRsbRgbRsbRsbRsbRsbRsbRgbRsbRibRsRsmbLsbLgbRsbLsRsbLib
RgbRibRgRsmbsbRsbLsbRsbRsbRgbRsbRsbRsbRgbRsbLjbRibRsbsbLsbLsbRsRsmbRsb
RsbRgbLsbRgbLgLsbLsRsbRsRsmbRsRsmbRsbRsbLsRsbRsbLsLsmbsbRgbRgbRgbRibRs
bRsbRgbRsbRsbRsRsmbRsbRsbRsbRjbRgbRsbRsbsbRgbRsbRsbRsbRsbRgLsbRsbRsbRs
bRgbRsbRsLsbRgRsmbRsbRsbRsbRgbRsbsbRgbRsbRgbRsbLsRsbRsbRsRsmbRsbRsbRsb
RgbRsbRsbRgbLsbRibLsbLibLsbLibLgbLgLsbLsbLibRgbLibLsRsbRsbLgRsbLgbLsbs
bLgRsbLsbLsbRsLsbLgbLsbLsbRsbLgbLgbLgbLsbLsbLgRsbLgbRsbsbLgbLsbLgbLgbL
gLsbLsbLsbLibLsbRsbRgRsmbLsRsbLgbLsbLibLibLsbLgbLsbLsLsmbLsbLiRsbLsbsb
LgbLsLsmbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bLsLsmbLsbLeLsbRjbRibRiLsbLjbRibLsbRibRibLibLcbLiLsbRsbRsbRsbLsbRjbRib
LcbLhbRjbRjbRibRsbRgbRgRsmbRgbLgbRgbRibRgbLcbLhbRibRibLcbLiLsbLsbRsLsb
LsbLsbLsbLsLsmbLsbLsbLsbLsbLgLsbLgRsbRgLsbLibLgbLsbLgbRsbLsbLibRgbLjbR
jbRgbRsRibLjbRibRsbLibLibLsbLibLibLsLsmbLsbLsLgLsbLsbRibRgbRibLhb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bLgbsbRgbRsbRsRsmbLsbRsbRsRgbRsRgbLjbRsRsRsmmbRgbRsRsmbRsbRgbRjRsmbLjb
LibRibLibsbsbRsbLiLsbLhLsbLibRibLibLsLsmbLsbLsbRibLiLsbLibLsbLsbLibRsb
LibRebLeb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bRgbRgbsbRsRsRsmmbsbRgbRgbRgRsmbRsbLgLsbLsbLsLsmbLsLsmbLgbRsbRsbLsLsmb
LibRibRibRibRgbRsRsmbRgRsmbRsRsmbRibLjLsmbRgRsmbRibRgbRsbLsbRsbRgbLsbL
sbLsLsmbRsbsbsbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bLgbLsbRsbLibLgbRsbRsRsmbRgbLiLsbLsbLsbLgRsRsmbLsbLsbLgbLgbLsbLgbRsbLg
bLgbRsbLgbRsLsbLgbLsLsmbLgbLsLsmbLgbLsbLsbLgbLsbLgbLsbLgbLsbLsbLgbLsbL
gbLgbLsbLgLsbRsbLgLsbLsbLgbLgbLsbLgbRsbLgLsbLsbLsbLgbLgbLsbRgbLgbLgbLg
bLsbRsbLgbLsbRgbLgbRsbLgbLgRsbLgbLsbLgLsbLsbLgbRgbLgbRsbLgRsbLsbLjbRgb
LgLsbRsbLsbLgbRsLsRsbLgbRsLsbLgLsRsbLsbRsbLjLsmbRgbLibLgbRsbLsbRsbLsbL
gbLgbLsLsmbRsbLgLsbRsLsbLsbLgbLsbLsbLgbRsbLsbRgLsbLibRsbLsbRsbLgLsbLsL
smbLsbLsLsmbLgRsbLsbRgbLiRsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bLibLsbLsbLsbLsbLhbLsbLgbLsLsmbLsLsmbLiLsbLsLsmbLsbRgbLsbLsRsbLiLsbLsb
LsbLsbLibLsbLsbLsbRgbLebLsbLsbLsLsmbLibLiLsbLgbLsLsmbLgbLhbLsLsmbLsbLs
bRsbRjRsmbLgLsbLsbLiLsbLsbRsRsmbLiLsLsmbLsbLsbLebLsbRsbLsbLsbLebLsbLsb
LsbLiLsbLgLsbLgLsbLsLsmbRibLsRsbLiLsbLiLsbLsbRjbLcLsmbLibLsLsmbLgbLgbL
sbLgbLiLsLsmbLsbLsbLibLsLsmbLsbLsbLibLsbLsbRsbRsbLiLsbLgbLsLsmbRsbLsbL
hbLsbLsbRsLsbLsbLibLsbLibLgbLsbRsbLsRsbLiLsbRgbLibRsbLsbLiLsbLiLsbLsbL
sbLibLiLsbLsbLiLsbLsLsmbLsbLibLsbLsbRgLsbLeLsbLiLsbLsbRgbLsbLibLsbLsbL
ibLgbLsLsmbLsbLibLsLsmbLsRsbRjbLgLsLsmbLeLiLsbLsLgLsbRgbLibLiRsbLsbRsb
LiLsbLgbLsbLibLsbLsLsmbLhbRebLhbLibLsbLsbLiLsbLsLsmbRibRsbLiLsbLsbLibL
sbLsbLibLebRibRsbRibLsbLgbLhbLgbLgbLibLsbRsbLibLsbLsbRgbLcLsmbLjLgbLcL
smbRhbRiRsmbLgbLibLsbLhbLsLsmbLgbLsRsbLsbRgbLhbRsbLibLibLsbRibRgbLeLsb
LcbLsbLsbLsbLsLsmbLsbLibLsLsmbRgbLsbRsbLibLhbLgbRgbLsbLiLsbLsbLsLsmbLs
bLsbLsRsbLsbRsbLsbRgbLcbLiLsLsmbRsbRgbRsbRsbLibLibLsbLsbLsbLsLsmbRgbLi
bLsLsmbLibLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bLibRibLibLgbRjbRhbRhbRibRgbRiRsmbLibRibRgbLiLsbLgbLibLsbLhbRibRhbRibR
sbRsRsmbLsRsbRsbRgbRgRgRsRgRgmbRgbRgRgbRgbRgRsmbRgbRgRgRsmbRiLsbRgbLcb
RjRsmbRibRhbRibRcbRhRsmbRiRsmbRibLibRibRibLibLhLsbLhbLgbLgbLsbRgbRjbRs
bRibRgRsmbRsbRsbRsbRsRsmbRgbRgRgbRgbRsRsmbRgbRsbLsRsbRgbLjbLcbRjRsmbRi
bRibRsbLsbRgbRsbLsRsbRsbRgbRsRgbRgbRsRgRgRgbRgRsmbRgRsmbRgRsmbRgRsmbRs
bRsbRgbRsbRsbRsbRgRsmbRsLsbRsbRjbLjbLcbLgbLcbRibRiRsmbRjbRgRsmbRsbRsbR
sRgRgRiRsRsRgmmbRgLsbRgRsRsRsmmmbRsbRgbLsbRgbLebLibRjbRjbRjRsRsmmbLjbR
ibRgbRiRsmbRhbRcbRgRsmbRgRsRsmmbRibRgbRsbRsbRsRsmbRgbRsbLsRsbRsbRgRsmb
LsbRsbRsbRgbLsbRsbRsbRsbRgbRgbLsbRgRsmbLjbLjbLsbLsbRsLgbRcbRibRgbLsbLg
RsbRiRsmbRsbLsbRgbRsbLhbRiRsmbRsbRsbRsbRibLsRsbRsbRsbRgRsmbRgbRgRsmbRs
bRgbLsbLsbRsbRsbRsbRsbRgbRsbRgRsmbRsbRgbRsbRhbLibRhbLjbRhbLgbRibRibRsR
smbRsbLsbRibRibRibRiRsmbRibRgbRgbRsbRgbRsRsmbRgbRsbRsbRgRsRsRgRsRgRgRs
RgRsmmmmmbRgbRgRsRgRsmmbLsbRgbRsbRgbRsRsmbRgbRsbRgbRgbLibRjRsRsmmbRjRs
mbLibRebRhbRhRsmbRiRsmbRibLsbRsbRgbRsbRsbRgRgRsmbRsbRgRsmbRsRgRsRsRgmm
bRgRgRsmbRgRiRgRsReRgRsmmbRgbRibLjbRiRsmbLsbRgRgbRgbRsbRgRsmbRsRsmbRgb
RgRgRsmbRgbRsbRsbRgbRgbRgbLibLjbRibRhbRcbRibRibRibRgbRgbRsbRgbRgRgRsRi
RsRgmmbRgbRgRgRiRgbRgRiRsRiRgmbRgRsRgRsRsmmmbRibLgbLhbLsbLsbRhRsmbRiRs
mbLsRsbLsbRibLgbLibLsbLgRsbLgbRjbRoLsbRcbRsbLsbLibRibRiRsmbRibRhbRibLi
bRsbRibRsRjbsbLsbRsbRsbRsbLsRsbRgRsLsRsmbRsRsRsmmbRgRgRgRgbRgRsRgRsmmb
RgbRgbRibLhbRibLjbLcbLibLsbRibRibRjLsbRibLsbRsRsmbRsRsmbRgbRsbRsbRgRsm
bRgRgbRgRsRiRgRgmbRsbRgbLgbRibLjbLhbLibLgbRjbRjbRhbRibLsRsbLibLsbLjbLi
bLibRgbLsbLsLsLsmmbLibLsbLgbRgbRcbRgbLsbLgbRgbRsbRgbLgbRgbRsbRgRsmbRsL
sbRgRgbRgbRgbRsbRibLgbRibRsbRgbRsbRsRsmbRgbLsbLsbRgbRgbLibRibLjbLhbLhb
LhbRgbRibRiRsmbRgbRgbRsbRiRsRsmmbRgRsmbRgRsRsmmbRgRsmbRsbRgRsRgRsRiRiR
gRgRgRsmmmbRgbRibLibRjbLjbLcbLibRsbRsbRsbLsbLjRsLsbLgbLibRibRjbRjRsmbL
hbLibLibRibRibRcbLsbLgbRibLibLobLibLsbLgbLgbLsbRsbLibRgbLjbLsbRsbLgRsb
LsbLgbLsbLsbLsbLgbLsbLsbLsbLsbLsbLgbLgbLsbLsbLgLsbLsbLgbRjbLgRsbLgbLgb
RjbLjbRjbRcRsmbRiRsmbRhRsmbRibRhRsmbRcRsmbRibLsbLsbLsbRsbRgbRgRsmbRsbR
sRgbRsRgRhRsmbRgRgRgbRgbLsbRgbLjbLcbLibLibRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bRgRsmbRjRsmbLjbRsRsmbsbRibRiRsmbRgbLsbRgbRsbRcbLsbLsbRgbRiRsRsmmbsbRi
bRsbRsbRsbLsbsbRgbLsbRibRgbRgbRgbLjLsmbRibRsbRgbRsbRsbRgbLjLsmbRgbRhbR
sbRibLgRsbRsLsbRgbRgbLiRsbRsbRsbRgbRsbRgbRsbRgbRsbLgbRsbRibRsbRibRsbRg
bLibLibLgbLgbRjbRibRibRsbLsbRgbRibLibLsbLsbLhbRgbRibRibRsRsmbsbLsbRjRs
mbRgbLjbRhbLsbLsRsbRcbRsbRibRgbLsbRsbLibRgbRibRgbsbRsbLcbRgbLibLibLsbR
gbRsbLibLsbLiLsbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bLjbLsLsmbRgbLjbLgbRhRsmbRjbRhbLsbRibRsbLibRibLgbRsbRsbRgbRhbLebLgLsbL
ibLibLsbLjbLsbLgbLgbLsbLsbRsbLibLgbRjbLibLsbLsbLsbLsLsmbRsbsbLsbLsbLgb
RcbRhRsmbsbRgRsmbRsbRsbRibRibLgbRgbRibLcbLhbLjbRjbRcbRsbRsbRsbRsbRgbRc
RcRsLsmbRhbRgbLibRjbRhbRjbLiLsbLhbRibRjbRibRibLsLsmbLgbLsbLsbRjbRhbRiR
smbRsbRsbLsbRsbRgbRgbRibLcbLcRsbRsbsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bLibRibLibRsbRgbRiRsmbLibLibRsbLgbLsbRsRsmbLgbRiRsmbLeLsbLibLgbLgbRiRs
mbLibRgbRcbRiRsmbLsbRsbLsbLibRibLibRsbRsbRsRsmbRgbRsRgbRgbRsRsmbRgbRsb
LibLibLsbLgbLibLiLsbRsbLibLibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bRgRsmbLgbRgbRsbRgbLsbRgbLgbsbLibLgbLgbLgbLsbRsbRgbLibRjbRibRgbRgbLsbR
gbLgbRibLsbRgbRiRsmbLsbRsbRsbRgbRgbRgbRgbLsbRiRsmbRsbLsbRgbRsbRsbRsRsm
bRgbRsRsmbRsRsmbRgRsmbRsbRsbRsbRgbRgbRsbRgRsLsmbLsbRgbRgbLgbRgRsmbRsbR
gbRgbRsRsmbRgbRsbRgRsmbLsbRsbRsbRsbRsbRgbRgbRsbRgbRsbRgbRsbRgbRhLsbLiR
sbRsRgbRgbRsbLsbRgbRgbRgbRgbRsbRsbRsLsbRsbLsRsbRsbRgLsbRgbRsbRgbRsbRgb
RsbRsbRsbRgbRsbRgbLsbRgRsmbRsbRsRsmbRgbRsbRsLsbRsRsmbRsRsmbRgbRsLsbRsb
RsbRsbRgbRsbRgbRsbRgbRsbRgbLsbRgbRgRsmbLsbRgbRsbRgbRsbRsbRgbRgbRsbRgbR
sbRsbRgbRsbRgbRsbRsbRgbRgbRgbRgbLsbRibLjbRsRgbRgLsbRgbRgRsmbRsbRsRsmbR
gRsmbRgbRgbRsbRgbRsbRgRsmbRgbRsbRsbRsbRgbRsbRgRsmbRsRsmbRsbRsbRgbRsLsb
RgLsbRgbLjbRibRgbLsbRgRsmbRsbLsbRgbRsbRsRsmbRsbRsbRgbRsbRsbRgbLsbRgbRs
bRsbRgbRsRsmbRgbRsbRgbLsbRgbRsbRgRsmbRgbRsbRsbRsbRgbRsbRsbRsLsbRgbRsbR
sbRgbLgbRgbRgbLsbRgLsbRsbRgbRsbRsbRsbRsbRgbRsbRgbRsbRsbRsbRsbRsbRsRsmb
RsbRgbRgbRgRsmbRsbRsbRgRsmbLsbLgbRiRsmbLsbRsbRsbRsbRsbRgLsbRgbRsbRgbRg
RsmbRgbRsbRsbRgbRsbRsbRsbRsbRgbRsRsRsLsmmbRsbRsbRsbRsbRgbRsbRsbRgLsbRs
bRgbRgbRsRsLsmbRsbRgbLjbLcbLibLgbRgbLibLibLibLgbRsbLibLsRsbRgbRsRsmbRg
RsmbRgbRgLsbRsbRgbRsbRgRsmbLgbRsRsLsmbRibRsbLsbRgbRgbRsbRsRsmbRsbRsLsb
RgbRsbRsbRgbRsbRgbRgLsbRsbRgbRgbRgbLsbRgRsmbRgbRsbRgbRsRsmbRsbRgbRsbRg
bRgbRgbRsbRgbRgbRsbRgbLsbRibLjbLhbLgbLgbLgbLsbLhbRebRcbRsbRgbRsbRgbRsR
smbRgbRgbRsbRsbRgbRsbRsbRsbRsbRgbRgbRgbRgbRsbRgbRgLsbRsbRsbRsbRsRsmbRg
RsmbLgbRibLjbLjbLsbLsbRebRiRsmbLsbRgRsmbRgRsmbRsbRgbRgbRsRsmbRsbRsRsmb
RgRsmbRgRsmbRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bRgbRsLibLgbLibsbLgbLgbLsbLsbLgLsbLgbLgLsbLsRsbRsbRgbRsbRgbRibRiRsmbRi
bRsbRgbRsbRsbLgbRhbRibRsbRgbRgbRsRsmbLgbLsbLgbLgbLsbRsbLiRsbLsbLgbRsbL
sbLhbLgbRgRsmbRibRgRsmbLgbLjbLibLjbLgbLgbLsbLsbRsbLgbLsbRsbLsbRgbRgRsm
bRgbRgbRibRgbsbLsbLsbLjbRjbRibRgLsbLjbsbRiRsmbRgbRibRgbRsbLsbLgbLsbLsR
sbRsbRsbRjbRhbRgbsbLsbRsbRgbRsbRsbRsbRsbsbRcbRgbRgbRsbRsbLsbRsbLgbLjbL
ibRjbLhbRsRsmbLjbLgbLsbLsbLgbLgbLgbLsbsbLgbLgLsbRgRsmbRjRsmbLhbLibRsLs
bLsRsbLsRsbLgbLibLsbLgbRgbLgbLibLgbLsbsbLibRsbRsbLgbLjLsmbRgbLsbRibRjR
smbRibLgbRgbLgbRhbRgbRsbRsbLsbRgRsmbRsbLgbRibRgbRsbRibLsbLgbRgbRgbRibL
gbLsbRibLgbLsbRsbRsbLibLgbLsbRgbLgbLibLgbLgbRsbRsbRgbRcRsmbRsbRibRiRsm
bLsbLsbRgbRsbLsbRsbRibLsbLgbLgLsbLsRsbLcbLibRsbRsbsbRsbRgRsmbLjLsmbLib
LsbLgLsbLgbLsbRsbLhbLgbRgbsbLsbLgRsbLgbRsRsRsmmbLgbLgbLibsbLgbLjbLsRsb
LsbRgbRsbRgbRibRgbRibRibRgbLsbRgbLgbsbRiRsmbLgbRgbRsRsmbLjLsmbRibRgRsm
bRiRsmbLsbLsbRibLgbLsRsbLgbLgbRsRsmbLibLgbLgbLibLsbRgbRsLsbLsbLibLgbRs
bLsbLsbLgbLgbRsLsbRgbRjRsmbLibLsbLgbLsbLgbRsRsmbLgbLsbRgbLgbLgbLgbLsbL
gbLibsbRgbRgRsmbRiRsmbRgbRsbLsbLgbRibRsbRibRgbRiRsmbRsbRsbLsbLgbsbRgRs
mbLjbLgbLsbLgbLgbsbLgLsbLsbsbLsbLgbLibLsbRsbRsbLjLsmbLgbLsbLgbLsbLsbRg
RsmbLibsbLibLsbLsbRibLibLibLgbLsbRsbRgbRsbRjRsmbLgbRgbRsbRgbLgbLibLgbL
sbLgbLgbLgLsbRgbRgbLibLgbLsbLgLsbLsLsmbLgLsbRsbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bLsbRgbLibRcbRibLibRgbRgRsmbRsbRsRsmbRsRsmbRsRsmbRsbsbRgbRgbRsbRgbRsbR
gbLsbRgRsmbRsbRsbRsbRsbRgbLsbRgbRsbRgbLjbsbsbLibLgbLibRcRsmbRibLgbRgbR
sLsbRsRsmbRgRsmbRsRsmbLjRsbLcbLgbLgbRsbLsbLgbLgbLgbLgLsbRcbRgRsmbRsbRs
bRsbRgbRsbRsbLgbLcbLgbLgbLgbLsbLsbLsbLsbLsLsmbLsbLgRsbLgbLsbLsbRsbLgbR
hbRiRsmbRgRsmbLsbLsbRibRgbRsRsmbLgbRibLgbRiRsmbLsbRgRsmbRsbRgRsmbRsbRs
bRsbRsLsbRsbRsLsbRgbRgbLsbRgbRsbRgbLjbLibRsbLibRcbRiRsmbRgbRsbRgbRgRsm
bRsbRsbRsbRgbRgbRsbLsRgbRsbRgRsmbRsbRsbRsbRsLsbRgbLgbRibLjbLsbRibLsbRg
bRsbRgbRsbRgbRgLsbRgbRsbRsbRsbRsbRgbLsRsbRgRsRsmmbRsbRsbRsLsbRsbRsbLsb
RgRsmbLsbRgbLsbRgRsmbRsRsmbRgbRsRsmbRgbRsRsmbLsbRgRsmbRgbRgRsmbLgbRibR
sbLgbRibLsbRgbLsLsRsmbRibLjbRsRcbLibRsbRgRsmbRgbRsbRgRsmbRgRsmbLsLsmbR
ibRsbRgbRgbLsLsmbRibLgbRibLgbRgRsmbRsRsmbLsbRgRsmbRgbRsRsmbRgbRsbLsRsb
RgbRsbLsbRgbRsbRgbRgbLibLjbRjRsmbRibLgbRiRsmbLsbLsbRibRgbRgRsmbLjbLhLs
bLgbLgbRjbRcRsmbRibRsbRsbRgLsbRgbRibLgRsbRgRsmbRgbLsbRgbLjbRibRsbRibRs
bRgbRgbLibLjbLibRjbRhLsbRibRgRsmbLibRsbRsRsmbRiRsmbRgbLgbRibsbsbLgbRib
LgbRibLjbRibRgbRgRsmbRibLibLgbRibRjRsmbRgRsmbLgbLsbRibRgbLgbRibLjRsbRi
RsmbLsbsbRgRsmbRsRsmbRgbRibLibLgbRibRibRibLgRsbRiRsmbLsbLsLsRsmbRibRgb
LgbRibRgbRgRsmbLgbRjRsmbRgbRcbLcbRibRibLibRibLsbRibRgbRsRibRgbLsbRgRsm
bsbRgbsbRibRibRibLibRgbRibLgbLgbLibRgbRhb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bLgbLgbLsbLsbLsbLgLsbLsbLgLsbLsbLgbLgbLgbLsbLsbLgbLgLsbLsLsLsmmbLgbLsb
LsbLgbLsLgbLgRsbLgbLgbLgbLgbRjbRhbRgbsbRsRibRgbRgbLgbRgbLjbLibLsbLgRsb
LgLsbLsbLsRsbLsbLgbLgLsbLgLsbLgRsbLgbLgbLgbLgLsbLgRsbLgbLsbLgLsbLgbLgb
RsbLgbLgbLsLsmbLgbLgbLgbLsbLgbRsbLibLgLsLsmbLsbLgLsbLsbLgbRsLsLsmbLgbL
gbLsRsbLgbLsbLgLsbRsbLiRsbRgbLsLiLsbRjbLiLsbLsbLibLsbLgbLsbLsbLsbLgbLs
bLgbRgbLibRibLibRgbLiLsRsbRibRhbRibRgbLsbRibLgbRibLsbRgbLsRsbRsbRgbLcb
LcbLsbLgLsbLgbLsbLgbLsbLgbLsbLsLsmbLsbLgbLgbLgbLsbLgbRsRsmbLgbRsbLgbLg
bLgbLsbLgbRgRsmbLibRcbLsRcbRgbRgbRsbRsRsmbRgbLjLsmbRgbRiLsbRsbLcbLiLsb
RsbLgbLsbRsbLgbLgLsbLgbLgbLsLgbLgbLgbLgbLgbLgLgbLgbLgbLsbLsbLgbLgbRsbR
cbRsRibRgbRgbRgbRsRsmbRgbLjbLhbLibLsbLgbLsbLgLsbLsbLgbLgLsbRhbRibRgbRg
bLsbRgbLsbRgRsmbLjbRibLibLjbLibLgbLgbRsbLgbLgLsbLsbLgbLgbLgbLsbLgbLgbL
gbLgLsbLsbLsbLgLsbLsbLgLsbLgbRgbLibRcbRcbRsbRgbRgbRsRsRsmmbRgRsmbRsbRs
bRgbRsbRgbLcbRsbLgbLsbLsbLsbLsbLgLsLsmbLgbLgbLgbLiLiLeLeLeLsbLibRibLib
RsLsbRsbLgbRgbLibRsbRgbLjbRgbRibRgRsLsmbRgbLjbLjbLiLsbLsbRgbLsbLibLgbL
sbLsbRsbLjbRjbLibRgbRsbRsbLgbLgbRhbRibRgbRgbLjLsmbLibLgbRgbLibRsbRgbLi
bRgbLgbLgLsLsmbLsbLgbLsbLsLsmbLsbRsLsLsmbLsbLgbLgbLsLsmbLsbLgLsbLsbLsb
LsbLsbRsbLgbLgbRsRsmbLgbLgRsbLsRsbLsbLgbRjbLibRiRsmbRcbRgbRgRsmbLsRsbR
gbLjbLjbLhbRgbLibLsbLsbLgbLgbRsbLsbLgbLgbLgLgLsbRsLsbLsbLibRsbLgbRsbsb
LgLsbRsbLsLsmbLgbLgbLsbRsbLsbLsbRsbLsbLgbLgRsbLgRsbLgbLsbLsbLgLsbLgbLs
bLsbLsbLgbLibRgbLibRsbLgbLgbLsbLsbLsbRsbLibRgRsmbLhbRgbRibRgbRibLgbsbR
ibLgbRibRsbRsbRgbRsbRgbRsbRsbRgbRsbRgbRsbRsbRgbLcbLgbLsbLsbLsbLgRsLsbL
gbLgLsbLsbLsbLgRsbLgbLgbLgRsLsbLgLsbLsbLsbLgbLsbRsbLgbLsLsmbLgbLsLsmbL
gLsbLgbLgbLgbLgbLgbLgRsbLgbLgRsbLiLsbRibLibLsbLsbLgbLsbLgbLsbLgbLsbLsb
LsbLgbLgbLsbLsLsmbLgbLgbLgLsbLibRibLibLjbRjbLibLgbLgbRiRsRsmmbLibRsLsb
LsLsmbLgbLsbLsbLgLsbLgbLsbLsbLgLsbLgbLgbLsbLgbLsbLgbLsbLsbLgLsbLgLsbLg
LsbRsbLgbLsbLsbRsbRhRsmbRibRibLsbRibLjbRibLjbRcbLcbRibRgbRibRibLcbLhbR
sbLgbLgbLsLsmbLsbLgLsbLsLsmbLgbLgbLgLsbLgLsbLgbLgbLgLsbLgbLgbLsbLgLsbL
gLsbLgbLsbLsbLsbLsbLsbRsbLgLsbLgbLsLsmbLgLsLsLgmbLsbLgbLsbLgbLsbLgbLgb
LsLsmbLgbLgbLgbLgLsbLsbRcbRiRsRsmmbLsRsbRgbLsbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124008; End: 124508;
Recording: 8-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bRsRibRgbLgbRibRgbLjbRibRibLgbRibLsbRgbRgRsmbRgbRsbRgbRgRsmbRgRsmbRgbR
gRsmbRsbRgbRgRibRiRsmbRsLsbRibRsbRsbRgbRgbRsbRgLsbLjbRiRsmbRgbRsbRsRsL
smbRsbRgRsmbRgRsmbRgRsmbRgbRgRiRsRimbRgRsmbRibRgbRgRsRgReRsmmbRgRsmbRg
RgRsmbRibRgRgbRsRsmbRgRsmbRgRsmbRgbRgbRgbRibRgbRgbRgbRgbLgLsbRgbRgRsmb
LgbRiRsmbRjbRgbRsbRsRsmbLsbRgRsmbRgRsmbRsLsbRgbRgRsmbRgbRiRsmbRgRsmbLs
bLsRsRgRsmbRsbRjbRsbRgRsmbRgRsmbRgRsmbRgbRgbRgLsbRsbRgbRsRsmbRgbRibRgR
smbLsbRsbRsbRgRsmbRgbRgbRgbRgbRibRgbLsRsbRgRsmbRsLsbRsRsmbLsRsbLgbRiRs
mbRsRsmbRgbRgbRgbLgbLjbLiLsbLgbLiLsbRcbLiRsbLibRcbRcbLgbLjLsmbLgbLibRi
bLibLsbLibRjbLibLsbLibLiRsLsbRiLsbRhbRsbRgRsLsmbRgbRgbRgbRgRsmbRgbRgRs
mbRsbRgbRgbRsLsbRibRgbLjbLcbLgbLgLsbLsLsmbLgbLsbLgbRsbLgbRjbRcbRibRgRs
mbRgLsbRsbRgbRgRsRsmmbRgbLsRsRgbRsbLsbRgbRgRsRsmmbLsbRsbRgRsmbRgRsmbRg
bRgbRgbRgbRsRsmbRgRsRgmbRgbRjbRsRsLsmbRsbRsbRsRsRsRsmmmbRsRgRsmbRgRsmb
RgbRsbRgRsmbLgbRiRsmbRgbRgRgRsRimbRibRgbRgbLsRgRsmbLgbRibRgRsmbRsLsbRi
bLjbLibLibLibLsLsmbLsbLgLsbLgLsbLgbRsbLgbRcbRiRgbRgbRgbRsbRsbRsbRsbRsR
smbRsbRsbRgRgRiRsmbRgbRgRsRgmbRgbRgbRgRgbRgbRsbLsRsbLcbLgLsLsmbRcbRgbR
sbRsbRsRsmbRgbRgbRgRsRsmmbRgbRsbRgbRgbLsbRgbRsbRgbRsbRgbRsbRsbRgbRgRsm
bRgRsmbRgbRgbRgbRgbRgbLibLibLibRjRsmbRibLjbLibLibRhbLhbLgbRjbLibLibRcb
RsRcbRgbRgbRgbRsbRsbRgbRgbRsRsRsRgmmbRgbRsbLjbLibLibRsbLgbRsbLgbLgbLgb
RcbRiRsmbRgRgRgbRibRgbRgbRsbRgLsRgbRibRgbRgbRgRgbRgbRgbRgbRsbRgRsRgRiR
smmbRgbRgbRibRsbRsbRgbLjbRgbRsbRsbRgbRsbRsRsmbRsbRgbRgbRgRsmbRgbRgbRgb
RsbRsbRgbRsRsmbRgbRgRgRsmbRsbRibRgbRgbLgbRgbRibRgbLgbLjbLiRsbLsLsmbLgb
LsbLgbLsbLsbLgbRcbRibRsbRgbRgbRsbRsRgRsRsmmbLjbLibLibRjbRcbLjbRibLgbRh
bLgbRibRgbLgbLiRsbLgLsbLibRcbRcbLgLsbRgbRgbRgRsmbRsbRsbRgRsmbRgbRgRsRg
mbRgbRjbRgbRsRsmbRgRsmbRgbRgRsmbRgbRiLsbRgbRgRgRsRgRgmbRgbLsbRgRsmbRgR
gbRiRsmbRibRgRsmbRgbLsbRiLsRsbLjbLjbLibLibRibLhbLiLsbRgbLibRjbRcbLsbRi
bRibRsbRsbRgbLibLibLiLsbLsbLgbRjbRcbRgbRgbRgRsRgRsmmbRiRsRgRimbRgbLsRg
bRibRgRiRsRiRsRiRimmbRgbRgbRgbRiRiRsRiRjmbRgbRebLjbRibRgbRgbRsRsmbRsbR
gRsmbRsRgLsbRsLsbRgbRiRsmbRgbRgbRgRsmbRgbRgbLsbRgbRsbRsbRgbRjbRgbRsLsR
sbRgRsmbRgRsmbRgbRgbRsRsmbRsRsLsmbRgRsmbRgbRgbRsRsmbRsLgbRsbRibLibRhbL
gbRibLgbRibRgbRgbRsbRgbRsbRsbRgbRgRgRsRgLsmbRgRsRiRiRiRsRsmmmbRibRgRsm
bRiRsRgmbRgRhbRgbRiReRsmbRgRiRsReRsRsRiRiRsRgLsRsmmmmbRgRibRsRsmbRgRsm
bRgbRgRsmbRgbRibRibRsbRgRgbRsRiRsmbRgRsmbRjbRgRsmbRgRiRsRgmbRgbRgbRgRg
RibRiRsRgRsmmbRgbRibRgbRsbRiRsRsmmbRgbRgRsRgmbRgRsmbRsRsmbRsRsmbRgRsRs
mmbRgbRibRgRsmbRgRgRsRombReRsRsmmbRgbRgbRgbRgRsmbRgbRibRgRsRsmmbRibRgL
sRsRiRsRimbRibRgRsmbRgRgbRgRsmbRiRgRsmbRgbRibRgLsRsbRsbRgbRgbLsLsmbRgb
RgRsRgRsmmbRsbRsLsbRgRsmbRgbRibRsbRsbRjbRgbLgbRhbRgRsmbLibRsbRiRibRgbL
sRsbRgbRgbRgbLsbsbLgRsbRhbLibRcbLgbRgbRiRsmbRsbRsRgRsmbRsRsRsRimmbRgRi
RsmbRgRgRsmbRgbRgRgbRsRsRimbRgbRsRsmbRgbRiRsmbRgRsmbRibRgbRgbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 1; Drug: Control Apo 0.5 然
bsbRgbRsbLibLcbRgbLiRsbLgbLsbLgbRgbLibRibLsbLgbLsRsLsbLsLsmbLgLsbLsbLs
LsmbLgbLsbLsbLsLsmbLgbRjbLibLsLsmbRgbLibLsbLgRsbLsbRsbLgbLsbLsbLgbLgbL
sbLgbLgbLgbLgbLsLsmbLgbRgbRjbRibRhbRibRibRgbLsbRgbRsbLcbLgLsbRgbLcbLhb
RhbRgbRsbRgbRibLobRhbLjbLcbLibRibLibLibRsbLgbLgbLsbLsbLgbLsbLsbLsbRjbL
gLsRsbLibRgbLibRsbLibRgbLgLsbLgbLsbLsbLsbLgbLgbRsbLgbLsbLsbRsLsbLgLsbL
sLsmbLgbLsbLgbLsbLsbLsbLgbLsbLgbLgbRjbRcbRsbRibRibRgbRibRgbLibRgbRjRsm
bRiLsbRhbLeLsbRjRsmbRhRsmbRibRjRsmbRibRibRibRsbLibLcLsmbRjbLiLsbLgbRcb
RhbRjbRiRsmbRibLgLsbLibLibLsbRgbRibRiRsmbRsbLsbRsbRhbLsbLjbRsbRibLgbRi
bLsbRsbRgbRsbRsbLgbRsRsLsmbRsbRgbRsbRgRsmbRgbRsbRsbRgLsbRhbLibLjbLibLh
bRibRibRhbRcbRsbRcbRgbRgbLgbLibRsLsbLsbLgbLsbLgbLgbRibRsLibLgbLgbRgbLi
bRsRsmbLsbLgbLsbLgbLgbLgbLgbRgbLhbRibLibRgbLibRsbLhbRibRjbRibsbRibRgbR
ibsbRibLibLibRgbRiRsmbRibRebLgbLgbLgbLgbLsbRsbLibRgbLsbLjbsbsbRsbLgbRs
bLgbLsbsbRsLsbLgbLgbRsbRsLsRsbLgbLgbRibLhbRhbLibLgbLiLsbLibLgbLsbLgbLi
LsbLsbRgbLibRibLjbRjbRjbRhbRhbRiRsmbRgbLsbLibLgbLibLcLsmbLsbRibRsbRsbs
bRgbRibLgRsbRgRsmbLcbLiLsbLibLsLsLsmmbRsbLgRsbLsbLsLsmbLsbLsbLgbLsbLsR
sbLsRsbLsbLgbRgbLibRjbLcbRsbRsbRsbRgbRsRsmbRsRsmbRiLsbLgbLobLibRgbLibR
gbRjbLcbRibRibRhb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 2; Drug: Control Apo 0.5 然
bRebLibsbLsbLsRgbRsbRsbRsbRsbLgbRgbRiRsmbRsbLgbRgRsmbRsbRsbRsbRgbRsbRs
bRgbLgbRsbRibRsbRgbRsbLsbLsbRsbRsbLsbLsbLsbLsbLsbRgbRsbLsbRibsbsbRgRsm
bRsbRgRsmbRgbRsRsmbRsRsmbRsbRsLsbRgbLsLsmbLjbLiLsLsmbRgbLibLgbLibRsbLi
bRibLcLsmbRsbLsbLsbLgbLsLsLsmmbLsRsbLibLsbRsbLsLsmbLgbLgbRsbLgbRibLibR
sbLibLiLsbRsbLibLibRsbLgLsbRsbLiLsbLsbRsbRsLsbLibRsbRsRsmbLibLsbRiLsbL
cLsmbLibLsbRsbRsbRsbLhbRsLsbRjbRjbLcbLibLhb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 3; Drug: Control Apo 0.5 然
bLgbLsRsbLgbRjbLgbRjbLcLsmbLgbRgbLgbLgbLgLsbLibRsbLgbLgbLibLibLibLiLsb
LibLsbLgLsbRibLgbLsLsmbLgbRsbLiLsbLgbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 4; Drug: Control Apo 0.5 然
bLsbLjLsmbRibRjbRsbLibLibLibRibLibRibsbLgbRsbLibRsbLibRgbLgbLibLsbLsbL
gbLsbLsbLgbRjbLibLjLsmbRgbLibLsbLsbLsbRibLibLibRibLibLgLsbLsbRgbRgbRgb
RgbLgbRsbLibRsbLgbLsbLgbLgbRibRsLsbLibLiLsbsbsbLsbRsbLgbLsbRgbLjbsbLsb
LsLsmbLsbLgbLibLhbLgbsbRsbRgbLibLibLibRjbLibLsbLgbRgbLibLibLibRsbRsbLg
bLsbLsbLgbLsbLsbRjRsRsmmbRgRsmbRhbRsbLiLsbLiLsbLjLsmbLsbLsbLsLsmbRsbLg
bRsbRgbLiRsbLsbLgLsbRsbRsbRjRsRsmmbLgbLibLsLsmbLibLsbLsbRsbLjLsmbLsbLs
bRsbLgbLsbLibLsbLsbLibLsbLibLsbRsRsmbRgbRsbLsbLgbLibLgbRsbLgbLsbRsbRjb
LgbLiLsbRsbLgbLsbLsbRjbLibLibLiLsbLibLsbLebsbLsbLsbRgRsmbRsbRsbRibRsbR
ibLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 5; Drug: Control Apo 0.5 然
bLgRsbRibLsbRgbRsbRsRsRiRsmmbRibLcbLiLsbRjbRcbLjbLibLibLibLibLgbRgbLgb
LgbRjbRcbRsbRgbRgbRsRsmbRsbRsbRgRsmbLsbLsbRgRsRsmmbRsbRgbRsbRsbRsbRsbR
gbRgbRgbRgbLibLcRsbRhbLjbLibRcbRibRsbsbRgbLsbRgRsmbLsRsRsmbRgbRsbRgbLs
bRgbRgbLsbRgRsmbLsbRsbRsbRgbRgRsRsmmbRgbRgbLgbRgbRgRsmbRgbRgbRsbRsbRgb
RgbLgbRcLgbRsbRsbLcLsmbLibRgbLibRgRsmbLgLsbLsbLsbLgbLgRsbRcbRgbRsbRgbR
sbRgbRsLsbRsbRsbRgbRgbRgbRgbRsbRgRsmbRsbRsbRgLsbRsbRsbRgbLsbRsRsmbRgRs
mbRgbLgbRgbRgbLsbRsLsbRgbLsbRgbRsbRgLsbRgLsRsbRsRsmbRgRsmbRsbRsbRgbRsb
RsbLsbRsbRsRsmbRgbRgbRsbRgRsmbLjbLjbLiLsbRcbRgbRgbLsbRjbLjbRibLibLhbLi
bRcbRgbRgLsbRsbRsbRsRsmbRgbRsbRgbRsbRgLsbRsRsmbRgRsmbRsbRsbRgbRgbLsbRg
bLjbLjbLhbLibRibLibLibRjbRcbRsRsmbRgbRsRsmbRgbRsRsmbRgbRgbRgbRgbRhbLjb
LhbLibRcbLcLsmbRsbLibLsbLibRjbRibRgbRgbRsbRgbLgbRibLjbLsLjbLgbLibLibRc
bRobLhbLibLibRgbLgLsbRsbLgbRsRsmbLgbLgbLsbLsbLsbRsRsmbLgbRcRsmbRgbRgbR
sRsmbRsLsbRsbRgbRgbRsbRsbLsbRsbRgbLcbLibRibLibLibRjbRsLibLgRsbRjbLibLg
bLgbLgbLsbLgbLsbRcbRiRsmbRsbRsbRsRsmbRgbLgbRibRsbLsbRsbRgRsmbRgbRsbRgb
RgbRsbRgRsmbLjbLcbLgbLgbLgbLgbLgbLgbRcbRgbRgbRgLsbRsbRsbLsRsbRsbRsbRgb
RsbRsbRsbRsbRsRsmbRsbRgbRgbRsbRsbRgLsbRsbRsbRgbRsbRsRsmbRgbLsbRgbRsRsR
smmbRgLsRsbRsRsmbRsbRgRsRsmmbRsbRsbRgRsmbRgbRgbRsbRgRsmbRgbRgbRgbRsbRg
LsbRsbRsbRgRsmbRgRsmbsbLjbRcLsbLjbLibLibRebRiRsmbRgbRgbRgbRsLsbRsbRgbR
gbRsbRgRsmbLsbRgRsmbRsbRgbRgLsbRsbRsbRsbRgRsmbRsRsmbRgbRgbRgRsmbRsRsmb
RsbRgRsmbRgbRgbLcbRcbRsbRgbRgbRgbRsbRsRsmbRsbRgbLgbRgbRgbRgRsmbLsbLsRs
bRibLgbRgbRibRsRsmbLsRsbRgbRsbRgRsmbRgbRsbRgbRsbRsbRgRsmbRgbRgRsmbRsRs
mbRgbRsRgbRsbRsbLsbRsbLsRsbRibLsLsmbRibLcbLibRibLibRcbRibRsbRsbRgbRsbR
gbRgRsmbRgbLjbRibLsLsmbRgbRsbRgbRsbRgbRsRsmbRsbRsbRgbRgLsbRgbRgbLsRsbL
gbLibRcbLsbRgbRgRsmbRsbRsRsmbRgLsbRgbRsbRsbRgbRgbRsbRgbLsbRgbRsbRgRsmb
RsbRsbRgbRsRsmbRgLsbRgbRsRsmbRgbRsbRsRsmbRibLibRsLhbLsLiRsbRcbLhbRjbRi
bRibRsbRsRsmbRgRsmbLsbRiLsbRsbRgbRgbRgbLsbLsbRiRsmbRiRsmbRibRsbLhbLjbL
ibRcbRcbLibLibLibRcbRoLsbRsRsmbRibLsbRsbRgRsmbLjbRibRsbRsbLsRsbRsbRgbL
sbRsbRgbRgRsmbRgbRsbRgbRsbRgRsmbRsbRsbLsbRgbsbRsRsLcmbRcRsmbRgbRsbRgbR
sbRgbRsbRsbRgbRgbRsbRsbRgbLsRsbRibLsRgbRgLsbRsbLgbRsbRobLibRiRsmbRgbRg
RsmbRsbRsbRsbRsbsbRsbRgLsbRgRsmbRsbRgbLjRsbRibLjbLcLsmbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 6; Drug: Control Apo 0.5 然
bsbRsbRgbLsLsmbLsLsmbLsRsbLgbsbsbsbRgbLjbsbLebRgbRgbRhbRsRsmbRgRsmbRgR
smbLgbLiLsbLsbLsbLgLsLsmbLsbLhbLcbLgbLibLsbLgLsbLsbLgbLibLgbLibLsRsbRg
bRsbRgbRsbLjbLsLsmbsbsbsbsbsbLsRsbRsbsbLsbRgbLjbRgRebLgbLsbsbRibLsbsbR
gbsbLjLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bLsLgbLiLsbLibLgbLibLsbLgbLjLsmbLgbLgbRcbRjbReRsmbLjLsmbLibRhbRsbRsbRg
RsmbRgbRgbRcbRgRsmbRgbLjLsmbRjbRgbRsbRgbRgLsbRgbRgRsmbRsRsmbRjbLsbRebL
sbRsLsbRgbRsbRgbRgbRgLsRsbRsRsmbLsLsmbRsbRjRsmbRsRsLsmbRsbRgRsmbRsbRib
RjbLsbRgbRgbRgbRsbRiRsmbLsbRsbRibLibLsbRgLsbRibRsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bLjbLibLsRsbRjbRibRibLgbRiLsRsbLibRibRsbLhbRjbRibRsbRibRibRsbLgbLsbRsb
RibRgRsLsmbRgRsmbRsbLsbRgbRsbLgbRgbRgbLebRjbLibLsbLiLsbRsbLgbLsbLgRsbL
sbLgbRsLsbLsbRsbLgbLgRsbLibRsbRiRsmbLhbRsLsbLibLgLsbLgbLgbRsbLsRsRsRsm
mbsbLgbLiLsLsmbRsbLibLgbRsbLgbRsLsbLgbLsbLgbRsbLgbRjbRsLsbsbLsbLsLsmbL
sbsbLibLsbLsbLgbLgRsbLsbLgbLibRsbLgbLgbLgbLgbLgbLsbLsbRgbLiLsbRsbLgbLg
bLsbRsbRgbLgbLibLibLgLsbLsbLgbRsbRebRgbLsRgbLibLgbLgRsbRsbLgLsbLibLgbL
sbLsbLgbRgbLibLiRsbLibLsbRsRsRsmmbRgbRibRgbLgbLhbLiLsbLgbLgbLsbLgbLsLs
mbLgbRjbLgbLgbRsbRsbRjbRcbRiRsmbRsLsbRgbRgbLgbRgbRiRsRsmmbLsbRgRsmbRgL
sbRsbRgRsmbRgLsbRsbRsbRsbLsbRgRsmbRgbRsbRsbRsbRgbRsbRsbRsbRsbRsbRgbLsb
RgbRsbLgbRgbRgbRsbRgbRsbRgbRgbRsbRgbRsbRgbRgbRsbRgbRsbRgRsmbRsLsbLsbRg
RsmbRsRsmbRgbRsbRgbRsbRgRsmbRgbRgbRgRsmbRsbRgbRgbRgbRgbRsRsmbRgbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bLibLgLsbLsbLjbLsbLsbRjbRgbRgbLibRcbRcbLcbLibLibLgbLgLsbLsbRjbLibLgbLi
LsbLiLsbLgLsbLsbLsbRhbRgbRibRibLjLsmbLgLsLsmbLibLgbLiLsbLgbLsbLgbRjbRj
bLibLsbLibRgLsbRsbRsbLgbLgbLgLsbLgbRsbRsLsbLsbLgbLibLjLgbLibLgbLibLsbL
sbLibRsbLsbRjRsmbLgLsbLibLhbLcbLgLsbLibLjbLibLgbLsbRgbLgbLgbLibLgbLjLs
mbLsbLibLgbLibLibLsbLsbLgbLgbLgbLibLsbLsbLiLsbLgbLgbLibLjbLjbLgbLibLib
LibLgbLjbLgbLiLsbLgbLgbLgbLeLsbRsbLsbLibLiLsbLibLibLsbLgbLjLsmbLibLsbR
sbLibLjLsmbLsbLgbLsbLgbsbLibLgbRgbLjbRjRsmbLcbLgbLgLsbLibLibsbLgbLhLsL
smbLibLsbLgbLsbLsRsLsbLgLsbLibLibLibRsbLibLgbLsbLibLibLibRibRjbLsbLgbL
ibLibLiLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bLsbLsbLsbLgbLibRhbsbRsLibLsLsmbLgbRsbRsRsmbLgLsbRjLsbLibLsbLgbLgbLgbR
hbRibLjbLibLgbRjbLiLsbLibLgbRibLibLcbLiLsbLiLsbLjbLgbLsRsbRgbRibLjLsmb
LibLgbRgbLibRsbLgbRsbLsLsmbRsbRobRgbLgbLgbLsbLgbLsLsmbLgLsbRsbLgbLsbRs
bLsbLgbLsbRsLsbLsbLgLsbLsRjbLgbLsLsmbLgbLgbRsLsbLsbLgRsbRjbRgbRgbLjbLi
bRjbLibLjLsmbLiLsbRibLgLsbLgbRjRsmbLibRsbRgbLgbLsbLgLsbLsbLgRsbLgbLsbL
sbLgbLsRsbLibLibRsbLgbLsLsLsmmbLgbLsbLsRsbLgbLgbLjLsmbLgbRibLgbLgbLsbL
gbLgbRjbLibLibRgbLgLsbLgbRgRsmbLgbLgbLsLsmbLgbLsbLsbLsbLgLsbLibRjbLibL
ibLiLsbLgbRgbsbsbLsbRgbRibRgbRgRsmbLjbLcbLgbRsbLibLgbRibRibLgbRjbRgbLj
bLiLsbRjbLjLsmbRjbLibRsbLibRgbLibRsbRsbLgLsbLsbLsbLgbLsbLgbRjbLgbsbLgb
LgbRjbLgbRsbLsbLgbRsbLgbLsbsbLsLsmbsbLgRsbLsbLsLsmbLsbLgbLgbLgbRhbLibR
iLsbRibLjbLibLibRibRjRsRsmmbRsbRibLcbLibRgbLgbLhbRgbRjbLiRsbRsbRsbLibR
jbLibLgLsbLgbLiLsbLgbRgbLibLgbLgbLgbLsRsbLgbRjbRibRgbLjbRgbLhbLiLsbLgb
LgbLibRjbLgLsbLcbRibLgbRgbLibRgbLibLsbRsbLgLsbRjbLgLsbRjbRjbRjbLjbRibL
gbRjbRibLjLsmbLiLsbLgbLibRjbLibRsbLsRsbRsbLibRsbLibLgLsbRsLsbRsbLgbLsb
LsbLsLsmbLsbLsbLgLsbLgbLiLsbLibRjbLibRsRsmbLgbRjbsbLibLsbLsbLgbLiRsbLs
bLgRsbLsLsmbLsLsmbLgbRsbLiLsbLibRsbLgbLgLsbRsLsbLgRsbRjbRibRibRjbLjLsm
bLgbLjLsmbLgbLgbRgRsmbLibRjbLibRjbRjbLibRibRhbRhbLsRsbLsLsmbRsLsbLibLj
LsmbLsbLsbsbLsbLgbRgbRibRgbLjbRjbLjbLjLsmbRgbRjRsmbRibRcbRibRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bLgLsbLgbLsbLgbLgbLgLsbRgbLgLsbLhbRgbLiLsbLgbRsbLsLsmbLibRjbRcRoRiRcRs
LsRsmbRgLsbLgbRiRsmbRgbRgbRsbRsbRgbRgbRgbLcLsmbLgbLgbLgbLgLsbLgRsLsbRg
bLibRjbRcbLcLsmbLhbLobRcLsbLibRsbLcbRsbLibLibLsbLsbLgRsbRjbLibLsbLgbLs
bLgbRsbLgbLsbLgLsbRsbLibLsbLgbRgbRcbRiLsLsmbLcbLiLsbRgbLiLsbLibLsbLgbR
sbLgbRjRsmbLibRibLibRjbRobRibLoRsbRsbRgbRgbRgbRgbRsbRgLsbLcbLhbLgbLsLg
bLgbLgRsbRcbRhbRsbRgLsbRsbRsbLsbRsbRgbLgbRgbRgbRsbRgLsbRgbRgbRsRsmbRgb
RsbLsRibLcbLcRsbLiLsbRsbLgbLgLsLsmbLgbRhbRhbLsRsbRgbRiLsbLjbLcRsbRgbRg
bLjbRibLsbLjbLiRsbLsLgbLgRsbRgbLibLsbLjbRsLsbRsbLsbLibRjbLibLibLgbLsbL
gbLsbLgbLgLsbRcbRcbRgbRgbRsbRsbRsbRgbRgbRsbRgbLgLsRsbLjbLcLsmbLibLsbLs
bLgbLgbRjbRcbRibRsRsmbRgRsmbRgbRsbLgbLjbLcLsmbLgbLgbLgbRgLsbLibLsLsmbL
sbRsbLgbRcbLsRoLsbRibRsbRgbRsbRsbRsRsmbRsbRgbRsbRsbLsbRgLsRsbLjbLiLsbL
iLsbLgbRjbLibLsbLgLsRsbRsbLgbLgbLgbLgbLsRsbLgbLgbLsbRcbLcbLibLgbRjbLsL
ibLgRsbRhbLibLibLibLsbLgbLibLgbRgbLgLsbRgbLsLibRjbLibLgbLsbLsbLgbRgbLg
RsbRsbLjbRsbLgLsbLsbLgbLsbRgLsbLiLsbLibRjbLibLsbLsbRsbLsbLsbLebLsbLgLs
RsbLsbLgbLibRjbsbRcbRsRjbLibLgbLgbRgLsbLibRgLsbLgbRsbLsRsbLsbRjbLibLsb
LgLsbLgRsbLsbLgbLgRsbLgRsbRsbLsbRgbLibRjbLsLsmbLibLsbLgbRsLsbLgbLgbLsb
RgbLjbRsbLsbLsbLsLsLsmmbLgbRgbLgbLhbRibRcbRgbRsbRsbRsbRsbRgbLsbRgbRgbR
sLsbRgbRsbRsbRsbRsbRgbLjbLibLgbLgLsbLgbLgbLgbLsbLsbLgbLsbLsbLgLsbLsbLg
LsbLgbRgbLiLsbRjbLibRcbRcbRibRebRobRgbRgbRgbRgbRgbRsbRsbRsbRgbLgbRgbRg
LsbRgbRsbRsRsmbLcbLibRjbLcbLibRibLibRgbLiLsbRsLsLsmbLgbRsbLiRsbRgbLibL
gbLsbLgLsbLibLhbRgbLgbLibRgbLibLsbLgbLhbRgbLibLgbLibLgLsbLibRsLsbLsbLi
bRjbLibLgbRgLiLsbRsbLsLsmbLsbLgbRgbLiRsbLsbLibLgbRgbLgbLgbLsbLgbRsbLgL
sbRsRsRsmmbLgLsbRsLsbLgbLsbLgLsbLsbLgLsLsmbLsbLgbLsbLgLsbRgbRcbRibLsbL
sbRsbRsbsbLsbLsbLjLhLsbLgLsbLgLsbRibRcbRgRsmbRgbRsbRsRsmbRsLsbRsbRgbRg
bRgbLgbLcbLibRjbLgbLibLgbLgLsbLsLsmbLgbLgbsbLgbLsbLgbLsbLgLsbLsbRsLsbL
gbLsLsLsmmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bRsbLsbRsbRgRsmbRsbLsbRgbRgbRsbRibRsbRgbRsbLsbRsbRgLsbRsbRgLsbRsLsbRgb
RsRsmbLsbLibLjLsmbRiRsmbRsbLjbsbRibRsbLsbRibRgRsmbLsbRsbRibsbRgbRsbRsb
RgbRsbRgbRsbRgbRgbRsbRsbRsbLsRsbRgbRibLibRgbLibLjbRhbRcRsmbRibsbLgbLsb
LjbLibRgbRgbLiLsbLibLsLsmbLsbLsbRsbRsbLgbLibLgLsbLsLsmbLhLsbLsbRgbLibL
gbLcbLhbLsLsmbRjbLiRsbLsbRsbRsbRsRsmbRgbRsLsbRsLsbRsbRsbRgbRsbLsbLsbRg
LsbRsbsbLgbLsRsbRibRibRiRsmbLsbRibRgbRsbsbRsbRibRsbRibRsRsmbRgbRsbRsbR
gbRsLsbRibRsbRsRsmbRsbRsbRgbRgbRgbRiLsbLsbLsbLsLsmbRjbRgRsmbRsbLsbRsbR
gbRsbRsbRsbRsbRsbRsbRgbLgbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bRgbRsbRgRsmbRgbRgbRgbRgRsmbRgbRsbRsbRsRsmbRgRsmbRgbRsbRgRsmbRgbRibRgR
smbRsbRsbRsbRgbRsRsmbRgRsmbRgbRgRsmbRgbRgbRibRsbRgbRgbRgbRsbRgbRsbsbRj
RsmbRgLsbLsbLsbLsbRsbRgbRsRsmbRibLsbRibLsRsbRibLsbRgbRsLsbRsRsmbRjbRgb
RgbRgbRgbRsbRgbRgbRgbRgbRgbRsbRgRsmbRgRsmbRjbLsRsLsbRgbRgbLsbRsbRibRsb
RiRsmbLjbRiRsmbRsRsmbRgbRgbRgbRsRsmbRgbRgRsmbRsbRgbRgRsmbRgRsmbRsbRsRe
bLsbLcbLiLsbRhRsmbLgbRsbLsbLsbRgRsmbRsbRsRsmbRiRsLsmbRsbLgRsbRgbLsbRib
LsbRgbRiRsmbRsbRgbRsLsbRgbRsbRsbRiLsbRsbRgRsmbRgRsmbRiRsmbRsbRibRgbRgL
sbRsRsmbRgRsLsmbRsbRiRsmbLsRsbRgbRsbRsbLsRsLsbRgbRgbRsbRgbRgbRgbRgbRsR
smbRgbRgbRsbLgbRgbRgbRgRsmbRgbRgbRsbRgLsbLjbLhbLibLgbRsbLibRgRsmbLgbLi
bLibRhbRhLsbRsbRsbRgLsbRgRsmbRsbRsRsmbRgbRgRsmbRgRsmbRsbRgRsRsmmbRjbRs
RsmbRgbRjbRsbRsbRibRgbRgRsmbRsbRgbRgRsmbRgbRgbRgbRgbRgbRgRsRsmmbRsbRsR
gbRsbRgbRgbRsbRibRgbRsbRgRsmbRsbRgbRsbRgbLsbRsbRsbRsbRgbRjbLsbRibLjLcb
LcRsRhbRsbRgRsmbRgLsbRsbsbRgRsmbRcRsmbRebRhbLsRsbRibRsbRibRgbRgbRsRsmb
RgbRgbRgbRgbRgbRsbRsbRsbRgbLsbRiRsmbRgRsLsmbRsRsmbRgbRsbRgbRgbRgbRgbLc
bLibLgbLgbLgbRgbLibLibRobRibLgbRibRgbRsbRgbRgbRgRsmbRgbRgbRsbLsbRgbRgb
RgRsmbRgRsmbRgRsmbRgbRsbRgbLsbRibLgbRiRsmbLgbRibLgRsbRibLsbsbRibRgbRgb
RgbRsbRsRsmbRgbRgbRgbLjbLhbLiLsbRjRcbRsbRiRsmbRgbRgbRgbRgbRgbRgbRsRsmb
RgRsmbRgbRgRsmbRsLsbRibRgRsmbRgbRgbRgRsmbRsbRgbRgbRiLsbLhbLhbRcbRhLsbR
gbRgRsmbRsbRgLsRsbRsbRgRsmbRgbRsbRgbLsbRsbRgbRgbRgRsmbRgbRsbRgbRsbRgRs
mbLsLsmbRiRsmbLsbRibLsbRibRsRsmbRgbRgbRgbRgRsmbRgbRsbRgbRsRsmbRgRsmbRg
bRgbLcbRoRsmbRgRsmbRsbRsbRibLsbLsRiRsmbRgbRgbRjbRsRsmbRgbRsLsbRgRsmbRg
bRgbRibRgbRgbRsbRgbLsbRgbLgbRsRsmbRiRsmbRsbRsRsmbLjbRsRsmbRgLsbRsbLsbR
sbRsbRjbRiRsmbLsLsmbRibRsbLjbRibRsbRsbLgbRgbRgbRsRsmbRgRsmbRgbRsRsLsmb
sbRsbRgRsRsmmbRsbLsbRgbRgRsmbLgbRibRsbRibRibRsbRgbRibLgbRiRsmbRsRsmbRs
bRgLsbRgRsmbRsbRgbsbRgbRsbRgbRsbRsLsbRgbRgbRsbsbLobLobRgbRgbRgRsmbRgRs
mbRibRgRsmbRsRiLsbRsbRibRgRsmbRgbRobRcbRcRsmbRibRgbRsRsmbRgbRibRsbRiRs
RsmmbRsRsmbRsbRgbRiLsbRsbRgbRgRsmbRgbRgbRgbRgRsmbRsbRgRsRsmmbRiLsRsbRg
bsbRgbLsRgbRsbRsRgRsmbRsRgRsmbRsbRgbRibRgRsmbRgbRibRgbRgbRsRsmbRibRgbR
gbRgbLhbLibLgLgbLsbLgbsbLsbLiLsbRgbRjbRhRsmbRibLgbRibRgbRgbRgbRgbRsbRi
bRsbRsRsmbRgRsmbLsRsbRgbRgRsmbRgbRgbRgbRgRsmbRgbRgbRsRsmbRsRsmbRibRgbR
gbRgbRgbRsbRgRsmbRgRsmbLsbRiRsmbRsRsmbLgbRiRsmbRsbRgRsRsmmbRgRsmbRgbRg
RsmbRgbRgRsmbRgbRgbRsLsbRgbRgRsmbRgbRgbRgRsRsmmbRgbRsbRsbRibRsbRsbRgbR
gbRgbRsbRsbRgbLsbRibRsRsmbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bRcbRcbRjRsmbLsbLibLgbLgbRgbRcRsmbLjbRhbRgbRgbLsbRsbLjbLsbLcbRebLcbLhb
LibRiLsbLibLjbLgbLibRiLsLsLimbLibLgbLsbLibRsbRjRsRsmmbRsbRsbRgLsbRsbRg
bRsbRgbRsbRgRsmbRibLcbLsLsmbLhbRebsbLhRsbLcbLibRsbRibLgbLsbLgbRjbRsbRi
bLjbLcbLibRgbLibRjbLibLibRsRibRhbLjbLibLgbLsbRjbLcbLibLgbRgbLsbLgbRsbR
ibRhbLjbLjLhbRcbRibLjbRgbRibRgbLsbRsbRsbRjbLsbLsbRgbRsRsmbRgRsmbLjbLsL
jbLibLsbLebRebLsbRgRsmbLgRsbLgLgbLgRsbRjbsbsbRgRsmbsbRsbLsbLsbLibLjbLi
bLgRsLsbLgbLibLgbLgbLibLgbRjbRcbLjbLibLibLgLsbLsbLsLsmbLsbLsLsmbLsbLsb
LgbLsbLsbLgbLibRsRsmbRsbLsRsRsLgRsmbRgbRsLsLsmbRjbRiRsmbLcbRsbRcRsmbLi
LsbLjbLobLsbLsbLsLsmbLsbLsbLsbLgbLsbLsbLsbLgbLsbLsbLsbRsbLsbLsbLsbLiLg
RsbRjbRcbLgbRjbRsLsRsbRsbRsbRsbRgbRgbRsbRsbRsbRgRsmbRsbRgLsbRsbRsbRsbL
gbLibLgbLgbLgbLsbLgbLsbLsbLsbLsbLgbRsbLsbLsbRsbLgbsbRgbRsbRibRjbLsRsLs
bRsbRsbRgbRsbRsbRsbRsRgbLsbLibLibRcbLhbLgbRgbLsbLgbRsbsbLsbLjbRibRjbRi
bRsbLsbRgbRsbRsbRgbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsRsmbRsbRgbRsLsbLsbRgbR
gbLcbLgbLgbLgbLsbLsbLsbLsbLsbLgbLsbRsbLgbRgbRsLsbLgbLsbRsbLsbLsLsmbLhR
sbRcbsbLsbsbRsbRsbRibRsbRjbsbRsbRsbLgbLiLsbRjbLiLsbRsbLsbLsbLiRsbRjbRs
bRgbRsbRgbRgbRgRsmbRsbRgbRsbRgRsmbRgbLsbRgRsmbRsbRgbRgRsmbLsRsbRiRsmbR
ibRgRsmbRibLibRgbLjbRsRsmbRsbRgbRsbRsbRgLsbRsbLibLcbRibRjbRsbRgbRebLob
LjbRibLibRiRsmbRsbRsbRsbRsRsmbRsRsmbRsbRgRsmbLgbRibLgbRibLjbRibLgLsbRg
RsmbRsbRgbRsbRsRsmbRsRsmbRjbLjbRibLjbRibLsbsbRgbLsbsbRiRsmbRiRsmbRsbLs
LsmbLcbLhbRjbLcbRjbRhbRsbRibLjbRibLgbRibLsbLsbRgbLsLsRsmbLsbRgbRsbRgbR
sbRgbRgRsmbRsbRsRsmbLsRsbRgbRsRsRsmmbLgbRibLsbRgbLjbLhbRjbRebLjbRibRgb
RgbRgbRgbRsbRibLgbRibRsRsmbLsRsbRgLsbRgbRsRsmbRsbRgbRgbRsRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bLiLsbRjbLjbLsbLsbRsbsbLgLsbLsbLgbRsbLgLsbLibLsbRgbRiRsmbRgbRgLsbLjbLi
bLibRgRsmbLiLsLsmbRsLsbRsLgbRsbRsLsbLgLsbLgRsbLgbLgbRjbRcbRgbRgbRsbLsb
LibLgbRgbLibRgbLibRgLsbLibRgbLibLobLsbLgbLgbLsbLgbLsRsbLgbLgbRjbRjbRib
LjbLebLibRgbLibLsLsLsLsmmmbLsbLibLgbLgbLsLsmbLsRsbLibLsbLsLsmbLibLibRi
bLibLibRibLibLiRsbLgbRgbRgRsLiLsLsmmbLsLsmbLgbLgbLsbLgbLsbLgbLgbLsbLgb
LsbLsbLsbLgbLsLsmbLsLsmbLsbLgRsbLsbLsbLgbRsLsbRsRsLsmbLgLsbLsLsmbLsbLs
bLibRsLsbLibLibRgbLsbLgbLsbLsbLgbLgbLgRsbLsbLgbLgbRsbLgbRsLgbRibRsbLiL
sbLgbLsbRsbLibRcbRobLcbLibLgbLgbLsbLsLsmbLgLsbLgLsbRibLibLgbRibLsbLibL
gbLsLsmbLsbLgLsbLgbLgbLsRsbLgLsbLsLsmbLsLsmbLgLsbLsLsmbLsbLgLsbRjLsbRc
bLsRsbLcbsbLibLsLsmbLgLsbRibRgLsLhbLgbLibLsbLibRibRsbLiLsbRgbLiLsbLgbL
iLsbRibLgbLgbLsbRhbRiRsmbLsbRgRsLsmbRgRsmbLsbLcbLjbRcbLjbLibLgbLgbsbRs
bLsLgbLsLsmbRsLsbLsLsmbLsbLgLsbLgRsbLgRsbLsbLsbLsbLgLsLsmbRsbLgbLgbLgb
LsbRibsbLibLgRsbLsbLgbLsLsLsmmbLgbLgbLgbLgbRcbRgbRgbLjbLhbLibLsbLsbLgb
LgbLgbLgbLgbLsLsmbLsbLgbLsLsmbLgbLgLsbLsLsmbLsLsmbLgbLgbLgbRsbLgbLsbRs
LsLsmbLsLsmbLibLibRgRsmbLgbLibLgbRgbLcLsmbLgbRsbLibRjbLhbRjbLibLsLsmbR
gbLiLsbLgbLgbLsLsmbLibRcbLibLgLsbLgbRhbLibLibLibLsLsmbRgbLhbRjbLibLsRs
bLsbRsbLiLsbLgbRgbLibLibRibRsbLiRsbLiRsLsLsmbLsLsmbLgbLgbLsbLgbLgbLgbL
sbLgbLgbLsbLgbLgbLgRsbLgLsbLsbLgbLsbLgLsbLsbLsbLgbLgbLgbRgbLiLsRsbLsbL
gLsbLgbRsbRgbLibRgbRebLhbLsbRibLibLgbLibLsbLgbLgbLgbLsbLsbLsLgbRjbRcbR
ibLsLsmbLeLsbLibLsbLgbLsLsmbLsLsmbLgbLgRsbLgbLgbRsbLgbLsbLgbLgbLgbLjbR
jbLhLsbLsbLgbRjRsmbRsLsbLibLiLsbLsbLiLsbRibLibLsbLgbLsLsLsmmbLgbLgbLgb
LsLsmbLgRsbLsRsbLsbLgbLsbLgLsLsmbRsbLibRsbLgbRsbLiLsbRgbLibLsLsmbLsbLg
bLgbLgbLsbLgbLgbRgbLiRsbLsbLsLsLsmmbLgbLgbLsbLgRsbLsLsmbLgbRsLsbRgRsRs
mmbLibRsbLibLgbLibLgbLgLsbLgbRsLsLsmbLsLgbLgbLgLsbLgbLgbLgbLgbLsLsmbLg
bRsbLiLsbLsLsmbLgbLsbLgbLibLsbLiLsbRsbLgLsbLgLsRsbLsbLgbLsLsmbLsbLgbLg
bLgbLgLsbLgbLgbLsbLgLsbLsLsmbRsLsbLgLsbLsLsmbLgLsRsbLsLsmbLgbLgbLsbLsb
LgbLgbLgbLgbLgbLgbRgbLgbLgLsbLgbLgbLgRsbLgLsbLgbLgbLgbLsbLgbLsbLgRsbLg
LsbLgLsbLsbRhbLhbLibLgbLsbLgbLgLsbLgRsbLgbLgLsbLgbLgbLsbLgLsbLgbLgbRjb
LibRgLsbLibLgbLgbLsbLgbLgLsbLgbLsLsLsmmbLgbLgbLsbLgbLsRsbLgRsbLgLsbRgb
RgbRiLsbsbLhbLibRsLsLiRsbLgbLsbLgLsbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bRsbRgbRgbRgbLjbRibLsLsmbRibLgLsbRibLsbRcbRgbRsRsmbRsRgbRgbRgRsRsmmbRg
bRgbRsbsbRgbRgRsmbRgRsmbRgbRgbRibRjbLgbRibLjbLcbLgbLsbLgRsbRcbRibRgbRs
bRsRsmbRgbRgbRiRsmbRsRgRsmbRgRsmbRibRhbRiRsmbRgbRgbRgbRgbRgbRsbRgbRgbR
gRsRsRsmmmbLsbRibLcbLhLsbLgbsbLgbLgbLebRobLgbLsLgbLgbLgbLgbLgbLsbRsLsb
RobRsbRgbRsRsLsmbRgRsmbRgbRgRsmbRsbRgbRgRsRsmmbRgbRiRsmbRsbRsbRsRsmbRg
RsmbRjbLcbRhbRiLsbRgRsLsmbRgRsRsmmbRsbRsRsmbRsbRgbRgbRgbLsbRiLsbLjbLcL
smbRcbLsbRiRsmbRgbRgbRgRsmbRibRgbRgRsmbRgRsmbRjbRgRsmbLsbRibRsbRgbRgbR
sbRsbRgbRgbRibLibRibLgbLcbLgbLgLsbLgbLgbLgLsbLsLsmbLsRsbLsbLsbLgbsbRsb
RsbLsbRsbLgLsbLgbLgbLgbLgbLgbLgbLgLsbLsbLgbLgLsbLibRibRcbRibRsbRsbRgbR
gbRgbRgbRgbRgbRgbRgbRgbRgRsmbRgbRgRcRsmbLibLibLgbLgbRcbRhbRsbRgbLjbLcb
LibRjbRebLjbRcbRsRsmbRgbRsbRsbRgbRsRsmbRsbRgRsmbRiLsbRsbRebLobRgbRgRsm
bRsbRgbRgbRgbRgRsmbRsbLcLsmbRebRsRsmbRgbRsbRsbRgRsmbRgRsmbRsRsRsmmbLgb
RsbRsRsmbRgRsmbRsRsmbRgRsmbRgbRsbRgbRgbRjbRgbRsbRgbRgLsbRgLsbRgRsmbLgb
RibLsbRgRsmbRsRsmbRgbLsRsbRiRsmbRgbLibLgbLgbLgbRgbRobRgRsmbRgRsmbRsbRs
bRsbRgRsmbRgbRgRsRsmmbRgRsmbRgbRgLsbRgbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbR
sRsmbRgRsmbRgRsmbRgRsLsmbRgbRgbRgbRgbRibLsbLsLcbLibLgRsbLgLsbLibRcbRib
RgbRgbRgRsRgmbRgbRgbRgbRiRsmbRiRsmbRibRgbRgbRgbRgbRgRsmbRgLsbRgLsbRgbR
gRsmbRsbRgbRiRsmbRgbRgbLhbLcbLibLgbLgbLsRsbLgRsLsbLgbLsLsmbLgbLgRsLsbL
gbLsLsmbLgLsbRsbRjbLjLsmbRcbRhbRsbLsRsbLebLsbRjbRgRsLsmbRiRiRsmbRjbRsb
RsRgRsmbRgbRgbRiRsmbRgbRgbRsRsmbRgbRsRsmbRsRsRsmmbLsbRsRgRsmbLsbLibLgb
LsRsbRjbRjbRsbRgRsRsmmbRgbRibRsRsRsmmbRgbRgRsmbRgRsmbRgbRgRsmbRgbRgbRi
bRgRsmbRiRsmbRgbRgbRgRsmbRgbLgLsbLcbLibLgLsbRsRsmbRcRsmbRibRibRsbRgbLj
LsmbLcLsmbLgLsbLgbLgbRjbRjbRibRgbRsbRgbRgbRgRsmbRgbRgRsmbRgRsmbRsbRsbR
sRsmbRiRsRsmmbRiLsbRsRsmbRgRsmbRgbRgbRgbRgRsmbRsRgbRgbsbRgbRgRsRsmmbRs
bRgRsmbRgbRgbRgRsmbLsbRibRgbRgRsmbRgbRgbRiLsbLiRsbLcbLgbLgRsbLgLsbLgLs
bRcbRhbLjRsbRsbRibRsRsmbRsbRgbLcbLjbLsbRiRsRsmmbLgRsRsmbRgRsmbRgbRsbRs
bRsRsmbRgbRgbRgbRgbRgbLiLsbLgbRebRjbLjbRhRsmbRibRsLsbLcbRiRsmbLjbRsbLc
bLsbLhbLobLgbRobRgbRgbRsbLgRsbRgbRsbRgbRgRsmbRgbRsbRgbRgRsmbRsLsbRgbRg
bRsRsmbRgbRgbRsRsmbRgbRsRsLsmbRgbRgbRibRgbRgbRgbRgbRgRsmbRgbRgLsbRgbRg
bRgbLsbsbRgbRsbRgbRsbRgbRgRsmbLsRsbRgbRibLsbLsRiRsmbRgbRsbRgRsmbRsRsmb
RsbRibRgbRsRsmbRgRsmbRgbRsRsmbRgRsmbRgbRgbLsRgbRgbRgbLsbLjbLhbLgLsRsLs
bLgbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bRebRcbsbRobsbLgbRsbLjbLsbLibLsRsbLgbLgbLgbLgbLsLsmbLgbLgbLsbRsLsbLsbL
gbLgbLsbLgbLsbLgbLibRsbRsLsbRsbRsbLgLsbLgbLsbLsbLsRsbLsbLsbLsbLgbRsbLi
LsRsbLibLgbRgbLibRsbLgbLsbLsLsmbLgbLsbLgbLsbLsbLsbLsbLgbLsbLgLsbLgbLgb
RsbLgbRsbLgRsbLsbLsbLgLsbLgbLsbRgRsmbRsbLgLsbLibLsRsbLgbLgbLsLsmbLebLg
bLsbLsbLgbLsbLgbLgbLsbLsbLsbLjbLsbLsbLsbLgLsbLsbLgbLsbLgbLgbLsbLibRsbL
sRsbRgbRsbRhbLgbRsbRebLsbLsLsmbLsbLibLsbRsbLgbLsbLsLsmbsbLgbLsbLsbLsbL
sbLgbRjbLibLgRsbLgbLsbRsLsbRsLsbLgbLgbRgbLgbLsbLsRsbLgLsbRsRsmbLibRgLs
bLgLsbLsbLsbLsLsmbLsbLibRgbLibLgbLsbLsbLsbLgbLsbRebLobRgRebLsRsbLsbLsb
LgbLsbLsbLsLsmbLsLsLsmmbLgbLsRsbRsbRjbRcbRibLgbLjbLibLibLsbLiRsbRibLib
LgLsbLsbLgbRjbLiLsbLgRsbLsbRgbRibLgbLsLsmbLgbLsbLgbLsbLsbLsbLsbLgbLsbL
gbRsbLiLsbLgbRgbLibLsbLsbLgbLgbLibLsbLsLsmbRsbLsLsmbLgbRsLgbLsbLsLgbLg
LsbLgbLsLsmbLsLsmbLgbLgbLibRjLsRsbLiLsbLcbRibLsbLjbLibLgbLgbLgbLsbLsbL
sRsbLsbLgbLsbRsLsbRsLgbLgbLsRsbLgbRsLgbLsRsbLgbLsLsmbsbLgbLsLsmbLsLsLs
mmbLgbLsbLsLsmbLgbLgbLsbLsbLsLgbRjbRcRsmbRgbRgbRgbRsbRsbRsbLsbLiLsbLgb
LgbLgbLibLgbLsbLsbLsLsLsmmbLgbLsbLsbLgbLgRsbLsbRebLsbLsbLgbLsbLsbLibRg
bLgbLgbLibLcbLibLgLsbRsbLgbLsbLsbLsbRgRsmbLiLsbLsbRsbLjbLsLsmbLsbLebRs
bRiLsbLibLcbLgbRsbLgbLgbRsbLgLsbLibLgLsbLjbLsbLsbLsbLsbLsbLgbLgbLgbLsb
RsbLgLsbLsbLsLsmbLsbLsbLgLsbLgbLsbLsbLsbLsbLgbLgLsbRgbRobLsbLsbLgLsbLg
bRsbLgbLsbLsbLgbLsbLsbLsbLsRsbLsbRsbLgbLgbLgRsbLibRgbLsbRgLsbLsbLsbLgL
sbLsbLgbLsbLgbLsbLsbLsbLsbLgbLsLsmbLsbLgbLibLibLsbLibRibRsbLsbLibLgbRs
bLsbLgbLsLsmbLsLgbLgbLgbLsbLsbLgbLsbLgbLsbLgbRsbLgbLsbLgbLsLsmbLsbLsbL
sbLgbLgbLsbLgLsbLgbLgbRgbLiRsLsLsmbLibLgbRsbLgLsbLibLgRsbLsbRgRsmbLibL
sbLgbLsbLgRsbLjRsbRgbLibLsbLgbLibLiLsbLsbsbRsbLgbLiLsbRsbLibRsbLgbRjbR
jbLcbLhbRgbLibLibLibLsbLsbRsbRgbRsbLgbRibRibLsLsmbLjbRhRsmbRsRsmbRsbRg
bRibRgbRsbLsbRgRsmbRgbRsbRsbRsbLcbRsbLibLgbLibLsbRsbRgbLibLibRsLsbLgbL
gbLsbLsbLsbRsRsmbLsbLjbLgbRibRjbRhbRsbRsbRibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bRgbsbRjbLsbLsbsbsbLsbLgbLsbsbRjbRsbsbRgbRsbsbLsbsbLsRsbsbLsbsbsbRiRsm
bRsbRgRsLsmbRsbLjbLsbRsRjbRsbRgbLgbsbsbsbRsLhbRjbLibRsbsbRsbLhLsbRgbLi
bRsbLsbLsLsmbLibLibLsbRgbLibLibLibRsbLibLsLsmbLsbLgbRjbRsRcbRsbLsbRsbL
sbRsbLjbLjLsmbLgbRjbRibRibLgbLsbsbLsbLsbLsbLsbLsbLjbRsbLsbLcbLsRsRsmbR
sbLibRsbRsRsmbRgbReRsmbLjbRibLsbLsbLibsbLsRsbLibRjbLsLsmbLsbRsbLibRibR
ibLibRiRsmbReRsmbRsbRsRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bLcbLjbLsLsmbLsbRibRcbLjLsmbLibLgbLsLsmbRsbsbRsbsbsbLsRsbLsRsRsmbRsbLs
RsLsbsbRsbLsbLsLsmbLibRjbRsLsRsLsbsbLibRgbLsbRsRsmbRsLsbsbsbsbsbsbLsRs
bLcbLgbLsbLsbRsLsLsmbsbsbsbLsbLgbLsLsmbLsLsmbLgbLsbRgbLsbsbRjbLsbRcbRs
bsbRiRsmbRhRsmbLgLsbRibRgbLgbRgbRjbLsbRiLsbLjbRsbRobLibRgbRsbRibRibRib
LhbRgbLsbRgRsmbRibLiLsbRgbRhRsmbRibRibRsbRgbRgbRgbRsLsbLgbRibsbRsbLibR
jbLsbLeLsbLsLsmbLsbLgbLsbLsLsmbLgbLsbRsbLgbRgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bLsbLgbLgbLsbLsbLsbLgbRgbRcRgbRgbRgbLjRsbLobLsbRgbLsbRsLgbLsbLgbLgbLsb
LsbLsbLgbLsbRcbRibRgRsmbRgbRgbLcbLgbRsbLsLsmbLgbRsbLsbLsbLsbLgbLgLsbLs
RsbLgbLsbLsbLgbLgbRsbRcbRibRsLsbRsbRgbRgbLjbRgbRgbLcbLgLsbLsLsmbLgbLsb
LsbLsbLsLsmbLgLsbLsbLsbLibRjbRjbRgRsmbsbLibLgbLgbLgbLsbLgLsbLsbLsLsmbL
gbLgbLgbLgRsbRsbRsbLhbRgLsRsLibRjbRgbRgbLgbLgbLcbLsbLgbLgbsbLsLsmbLgbL
sbLgbLgbLgbLgbRgbRibRsbRgbRgbLgbRgbRgbLcbLgbLgbLsbLsbLsbLsbLsRsbLsbLsb
sbsbRsbRsbLjbLgLsbLgbLgbsbLgbLsbLsLsmbLgbLgLsbLgbLsbRibLhbLjbRsbLgbLsb
RhLsbRsbRsbLsbRsbRgbRsbRsbRgbRgbLjbLcLsmbLibRgbLibLsbLgbsbLsbLsbRjbRhb
RjRsmbLsbLhbLhbRsbRsbLsbLjbLsbLgLsbLsbLsbLsbLsbLsRsbLsbLsbLgbLgbLsbRhb
RgbRgbLsbRgbLjbLcbLgLsbLsbLgbLsbLsbLgLsbLsbLsbRsbLjbRsLsbLgbRsbLsbLjbL
sbLsbLgbLgbLsbLsLsmbLgbLgbRsbLsbLgbLgbsbLgLsbLsbLgbLgLsbLsbLsbLsbLsbRi
bRgbRgbRgLsbRsRsmbRsbRgbLsRjbLobLgbRsbLsbLsbLsbLsbRsbLsbLsbLsbLgbLiLsb
LgbLgLsbRjbRjbRibLjRsbLcbLgbRgbLsbLgbLgbLsLsmbLgbLgbLsbLgRsbRibRjbRibL
cbLcbRibLhbRgLsbLibLsbLsbLsbLsbLgLsbLsbLsbLgbLgbLsbLgbLgbRsbLgbLsbRsLs
RsLgbRsbLibRibLsbLsRjRibLjbLsLsmbLibRsbLsbLsbLsbLsbsbLsRsbLsbLsbLgbLsb
LsbLsbLjbLsbRjbLibLsbLgLsbLgbLsbLgbLgbLgbLsbLgbRcbRgRsmbLibLhbLsbLsbLg
bLibRjbLiLsbLgbLsbLgbLgbRibRhbRibLgRsbRjbLcbLibRsbRsbRsbRsbLgbLsbLsbLi
bRgbLibLsbRsLsbLgLsbLsbRgbRjbRgLsRsbRgbRgbLjLsmbLgbLgbRgRsmbLjbLsbLgbL
ibRgbLibLsbLsbLgbLsbLsbLgbLgbLsbLsbLsbLsbLsbLsbLsbLjbRjbRoLsRebLgRsbRg
RsLsmbLsbRgbLsbRgbLcLsLsmmbLhbRibLibLsbLsbLjLsmbRsbRsbLsLsmbLsbRsbRsbR
sbLsbRgbLiLsbLsbRhbLjbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bRgbLsbRgRsmbRsbRsbRsbRsbRiRsLsmbsbLsRsbRgRsmbRsRsLsmbRjbRsLsbRsbLsRsb
RiRsRsmmbRsRsRsmmbRsbRgRsmbRsRsmbRibRgbLsbRibLgbLjbLibLgbLsbLgbRgbRcbR
gbsbsbLsbRgbLsbsbRsbRgbRsbRsRsmbRjbRsbRsbRsbRjbsbLsbLsbRibLsbLsbRiLsRs
bRsbRgbLsbRgLsbLjbRiRsmbLjLsmbLsRsbRiRsmbLsbRsbRsLsbLsLsmbRgbRsbLsbRsR
smbRgbLobRjbRcRsmbRibRgbLsbRgRsmbRgbLsbRsLsbRibLgbRibLgbRibLgbRibLjbRi
bLgbRibLgbRibLjbRibRsRsmbRgbRgbLibRibRibLsbLgbRibRibLiLsbRhbLibRibRgbL
gbRiRsmbLsbRiLsbRgbRgbLgRsbRsbRgbLjLsmbRibRibLgbRibLgRsRiRsmbRiRsmbLib
RiRsmbRsbRibLibRibRgbRgbRgbLgbRibRgbLgbRibRgbRgbLgbRsbRiRsmbLgbLgbRibR
gbRgbRibLgbsbsbRgbRsbRibLjLsmbRibRgRsmbLgbLsbRhbRiRsmbRgbLgbRsbRgbLgbR
ibLiLsRsbRiRsmbLsbRjbLsbLjbRibRibRjRsmbLsbRibLhbRibRcbRsbsbsbRibRcbLgb
LsbRhbRjRsmbRsbRibRgbLsbLiLsbRibRsbRsRsmbRiRsmbLsbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bRsbRiRsmbRsbRgbLgbRiRsmbRsbLsbLgLsbRsRsmbRsbLsbLgbRsbRsbLgbRibRsbLsbR
sbRgbRsbRgbLsbRsRsmbRsbRsbRibRsbLsbRibRsbLsbRibRsbRsbLgbRibLgbRgRsRsmm
bLsbRgbRsbRgbLgbRibRsbLgbRibRsRsRsmmbRgbRgbRsbLsbRibLibLebLgbLsbLsLsmb
RgbLsbRgbLsbLsbRgbLibRgbLiLsbLsbLgLsLsmbLsbLgbLsbLsbLsbLgbLsbRsbLgbLsb
LsbLsbRsbLgbLsbsbLjbLgbLsbRgLsbLibRsbLsLsLsmmbLgbLsbLsbLsbLgbLsbLgbLsb
LsbLgbRsbLsbRsbLibLsbRsbLibLsbRsRsmbLiRsbLsbLsbLgLsbLsLsLsmmbLsRsbLgbL
sbLgbLsbLsbLgbLsbLsbRsbRsbsbLsbLgbLsbLsbLsRsbLebLgLsbLsbLsbLsbLgLsbLsb
LgLsbLsbLgbLsbLsbRiLsbRhbLsbRibLsbRgbRsbRgbRsRsmbRgbLsbRsbRgbLgbLjbLcb
LibLsLsmbLsbLgbLsbLgbLsbLsbLgLsbLsbLsbLgbLgbLgbLibLsbLsbLibLsbLgbLsbLs
bLsbLibLsbLgbLhbLsbRgbLibLgRsbRsbLgbLsbLgbRibRhbLsbRibRibLsbRgbRsbRgbL
gbLsRiLsbRsbRgbRgbLsbLibRhbLsbRibLsbRsbLsbLsbLsRsbRsbRsLsbRgbRsbRgRsmb
RibLjbRibRsbLsbRsRsmbLsbRgRsmbLsbRsbRibLsbRsbRsRsmbRibRsbRsbRsbLsbRgRs
mbRsLsLsmbRsbRsbRgbRsbLgLsbRsRiLsbsbRsbLjbRibLsbRjbLgbRibRsbLgbLsRsbRs
bRgbRibRsRsmbLsbLsLsmbRgbLsbLsLsmbRgbLjbLcbLiRsbLsbLsbLsbLsRsbLgbLsbRs
bLibRgbLgbLsbLgbRsbRsbRsbLsbLsRsbLgRsbRsbRgbRsLsbRgbLibRgbLibLsLsmbRsb
LgbLsbLebRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bLgbLsbLgbLsbLsbLgRsLgbLgRsbRgbLgbLsbLsbRsbLsbLsbRsbLgbLgbLgLsbLsLsmbL
sbLsbLsbLsbLjbRsLsbLgbLsbRsbRsLsLgbLibRoRsmbLjbLibLgbRsLgLsbLgbLsbLgbL
gLsbRgbRgbRgbLsLsmbLsbLsbLgbLsLsLsmmbRsbLgbRgRsmbLgLsbLgbRgbLibLsbLgbL
gbLgbRgbLsbLsbLsbLsbLsbLgbRgbLibRgbLgLsbLgbLsbLsLsmbLibRjbRcbRibLsbRsb
RibRibRgbLibLsbLhbLibLsbLsbLgbLsbLgbRsbLiLsbLjbLsRsbLgbRsbRsbLgLsbLsbL
ibRjbLibRgbLibLgLsbLsbLgbLgbRgbLibRsbLsLsmbLsbRsbRsbLsbLgbRsbRsbLhbLib
RgbLibLgbRgbLgbRsbLgbRsbLgbRgbRsbLsbLsbLibRjbRsbLgLsbRjbLgbRgbLgbRjbRj
bRhbRibLcbLcbRgbLsbRsbRhRsmbRsRgbLsbRibLjbLcbLibRibLgbLgbLsbsbRsRsmbLs
bsbsbLgbLgbLsbRsbLgbLgbRsbRjbRibLjbLgbLgbLsLjbRgbLibRjbRibRgbLjbLobLib
RgbLibRgbRgbRibRgbLsbRibLjbLcbLibRsbLibRsbRgbLiLsbLsbLgbRsbLgLsbRsbLgb
RgbLgbLsbLgbLibRjbLsbLgbRgbLibRiLsbLiLsbRgbLibRsLsbLgbRgbLibRibLibLgbL
sbLsbRsbRsbRgbLsbLsLsmbLgbLsbRsLsbLsbLgbLsbLgbLgbRsbLgbRsbLgbLgLsbLgbR
jbLibRsbLsbRjLsbLhbRibRjbLebRibRhbRibRgbRsbRgbLgbRiLsbRibLgbRgbRibLsbL
ebLcLsmbRibLsRsbLhbRgbLibRsbRsbLsbLsbLgLsbLgbLsbsbLsbLsbLgLsbRgbLibLsb
RsLsLsmbRjbLibLhbRjbLgbLsbLhbRgbLgLsbLgbRibRhLsbRgbsbLgbRibRibRgbLibRj
bRiRsmbRgbLebLgbLgbLgbRsbLgLsbLsbLgbRgbLibRgbRsbRgRsmbLibRjbsbLsbLsbLg
bRsRsmbLgbRsbLgbLgbLgbRgbLiLsRsbLgbRgbLsbRsbRsLsbLsbLgbLsbLsbLgbLsbLsb
LsbLsbRgbLsbLgbLgbLsbLibLgbLsbLsbLsbLsbLgbLsbRgbsbLsbRsbLsbRsbLibRsRsm
bLsLgLsRsbLsbLsLsmbLgbLgbLgbLsbLsbLsbLsLsmbLjbLsbsbLgbsbRsbLgbLgRsLsbR
sbLgRsbLibRibLibLsbLsbRsRsmbRjbRgbLgbRgbLsbRgbLibLgbLsbLsbLgbLgbRhbRib
RibRgbRsbRgbLjbLcbLcLsmbLgbRgRsmbLsbLgbLsbLcbRibLgbLgbLsbLsbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bsbsbLsRsbLsbLgbRhbLebLsbLsLsmbLgbRgRsmbLgbRsbLgRsbLhbsbRcbRibLeLsbRjR
smbRgRsmbRgbLjLsmbLcbLgRsbRsLsbLjbLibRibLsbLibLibLsbLhbLgbLibLcbLibLsb
LgLsRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 25; Drug: Control Apo 0.5 然
bLgbsbLgbLsRsbRgbRgbRsbRgbRgbRgbRsRgbRsbRgbLsbLjbRibRsbLiRsRsmbRhbLsbR
gbRgbLjbRibLgbRiRsRsmmbRgbRsbRsbRibLjbRibRsbRibRibLibRibLgbLjbRibRsRgb
LsbRibRsbRgbRgbRsbRsLsbRsbRsbLgbRcRsmbLgbRsbsbRgbRsbRgbRsRsmbRgbRgLsbR
gbRsbRgbRgbRgRsmbLiRsbRcbLgbRgbRgbRgbRsbLsbRsbLgbRgbRgbLhbRibRiRsmbRsR
smbRgbRgbRsbsbRsbRgbRgbRgbLhbRcbLibRsRibRgbRgRsmbLhbRjbRsbRgbRgRiRsmbR
gRgbRgbsbRgbRiRgRgbRgbRgRsmbRgRsmbRsbLsbsbRsbRgbRgbRgRsmbRgbLgbRgbRgbR
gbRgbRgRsmbRgbRgRibRgRsmbRgRsmbRgbRsbsbRgbRsbRgbLjbRibRgbRgLsRsbRgRgbR
gbLsbRgbLcbRcbLcbRibRibRsRsmbRgbRsbRgRsmbRiRgbRgRgRsRsmmbRgRgRsmbRsbRs
RsLsmbRgRsRsmmbRgbRsRsmbRgbRgbRgbRgbRgbRgRgbRjbRgbRgbRgbRgRgbRgbsbRgRs
mbRgbRgbRibRjbLjbRibRgRsRgRgRgmbRjbRgbLibRibRgRsmbRsbRjbRgRsmbRiRsmbLi
bRibRgbRsRsmbRcbLibRcbLgbRcbLgbRsbLgbRhbLgbRiRsRsmmbRsbRsbRgbRsbRgbLgb
RibRgbLjbRibLsbRiRsRsmmbRsbRgbLsbRgbRsbRsbRsbRgbRgbRibRgbRsLsbRsbRgbRg
bRgbRsLjbRibLsbLjbLhbLibRsRsmbsbRobRibRibLgbRibRsbRsbRsbRsbRsRsmbRgbRs
bLgbRgbLjbRibRgbRsbRgbRgbRgbRgbRsbRgbRsbRibRgbRgbRsbRsbLcbLgbLgRsbRcbR
cbLgbRibRgbRsbLiLsbRcbRgbRgRgRgbRgbRsbsbRgbRsbRgbRibLgbRibLjbRibLsbRsb
LhbRobLibRiRsmbRgbRsbRgbLjbRcbLgbRibRibRsbRsbLgbRebLgbRsbRjRsmbRgbRsbR
sbRibRgbRgbRsbRgbLibRhRsRsmmbRibRsbLibRibRgbRsbRgRsmbRsbLsbLjbRiRsmbRg
bLsbRgbRgRsmbRsbRgbLsbRibLsbRsRsmbRsbLsbRgbRsbRsbRiLsbLibRcbLgbRsbRibR
gbRibRibLsbRhRsmbLgbLsbLsbLjbRhbRsbRsRsmbRgRsmbRgbRsbRsbRsbRsbRgbRsbRs
bRgbRsbRgbRgRsmbLsbRgbRgbLsbRibRsbLsbLjbRibRibRgbLibRibLgRsbLjbsbRhbLi
bRibRgbRsbRgRsmbRgRsRgmbRgbsbRsbRsRsmbRgbRiRsRsmmbRgRsmbLibRhbRsbLgbRi
bRgRsRsmmbLsbLsbRgbRgbLjbRobLibRcbRibLhbRibRgRsmbLsbRsbLgbRgbRibLsbRgb
LebLhbRjRsmbRobRibLibLsbRsbRgbRibLsbLsbRsbLgbRibRsRsmbRgbRsbRsbRgbRgbR
sbLsbLibsbRcbLsbRgbRsbRgbRibRsbLsRsbRibLgbRibRgbLjbLsRsbRgbLsbRsbRsbsb
RgRibRgbLgRsbLjbRcbLcbRibRsbRiRsmbRsbRsbRgbRgRsmbRibRgbLsbRgRsmbRgbRib
LibRsbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 26; Drug: Control Apo 0.5 然
bsbLibLsbRibRiRsRsmmbLsbRibRsbRgbRsbLsbRibRgbLsbRsRsRsmmbRgbRgbRsbRsbR
ibRgbRibLibRibRgbRibRiRsmbLhbLhbLibLiRsbLiRsbLsbLibLibLgbRsbLgbLgRsbLh
bLgbLhbLhbLjbLgbLsbLibLsbRibRiRsmbLsRsbRsbRsbRgRsmbRsLsbRgRsmbRsRsmbRg
RsmbsbRsRsLsmbRsbsbRsbRgbRgbRsbRsbLsRsbRgbRgbRiRsmbLibRiRsmbLibRsbLcbL
ibLgbRjbLcbLcLsmbLibRsbRsbRiRsmbLgbRibRgbLsbRsbRgbRsRsmbRgbRibLgbRibLg
bRibRsbLsRgbRibLgbLjbLibLiLsbRjbRobLsbLibRcbRsbRgbRsbRgbRsbRgbRgbRsbRg
bRsbRsbLjbLhbRcbRgbsbRsRsmbRsRsmbRgRsmbRgbRsbRgbRgRsmbRgbRgbRgbRgbLsbR
gbRsbRsbRgbRsRsmbRgbRgbRgbRibRgbRsbRsRsmbRgbRgbRibRsbRgbRgbRsbRcbRibLe
bRcbLgbLibLibLhbLgbLsbRsRsmbRsbLibLiLsbLgbRgbLibLsbRjbLhbLibLcbLgbLjbL
iLsbLibLgbLgbRibLhbLcbLjbLsbLibRhRsmbRibLsbRibRsRsmbLgbLgbLcbLhbLibRhb
RcRsRsmmbRibRsbRiRsmbLgbRibLsbRgbsbRjbRsbRsLsbLsRgbRsbRgbRgbRsbRsbRsbR
gbRsbRsbRsbRgbRgRsmbRgLsbLcRsbLibLiLsbLsbRgbRebRhRsmbLsbRsLsbRgbRgbLsb
RibLgbRcbLsbLgbRgbRgbRgLsbRgbRsbRsbRgbRsbRgbLgbRgbRsbRgbRgbLgLsbRibRsR
smbLsbRibLsbRsbRsbLsbRsbLsRsbRgbLsRsbRibRsbRgbRsbRgRsmbLjLsmbRjRsmbLsb
LibLhbLiLsbLibRjRsmbRhbRsbRsbRgRsmbRsbLsRsbRsbRgbRsRsmbRgbRgbRgbRgbRsb
sbRgbRgbRgbRibLebLibLibRibLhbRhbRcbRsLsbLsbRgRsmbRgbRsbRgbRsbsbLgbRgbL
gbRibLsbRsbRgRsmbRgRsmbRgbRgRsmbRsbRsRsmbRgbRsbLoLsmbRibRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 27; Drug: Control Apo 0.5 然
bLgbRsbRsbLiLsbLsbLgbRsLsbLgbLgbLsbLsbLgbRsRsmbRhbRgRsmbRgbRgLsbLsbRhR
smbLjbRcbLcbLgbLgbLgLsbLgbRsbLgbLsbRsLgLsbRsbLsLibRgLsRsbLjbRsLsbRsbLg
bLsbLgLsbRgbLgLsbLgbRsLsbLgbLsLsmbRsbLgbRsbLgbLibLgbLsbRsbRsRsRsLsmmbL
ibLgbLgbLsbRsbLsbRsbRsbLgbLgbLsbLgbLsbLgbRjbRhbLeLsbLgbLgbRsbLgRsbLgbR
gbLibRjbLibLgbRgRsmbLibRsLsbLgbLsbLgbLgbLsbLgbLgbLsbLsbRsbLgbRsbLgbRgb
LibRgLsbLibRgbLgbLsbRsbLibLgbLsbLgbLsbLgbRsLsbLsbLgbLgbLsbLsbLgbLsbRsb
LjbLibLgbLgbLsbLgbLgbLsbLgbLgbRjbRcbRiRsmbRgbRgbLcbLibLsbLgbLsbLgbRsbL
ibRsbRsbLibRsbLgbLgbLsbLjbRsbLsbLgLsbsbLgLsbRsbLgLsbRsbLgLsLsmbRsbLgbL
gLsbLgbLgLsbRjbLebRsbLsbLibRsbLgbsbLsbLgRsbLsbLgbRsbLibRsLsbLgbLibLgbL
sbLibLgLsbRsbRgbLibRsbLiRsRsmbRgbLibLsLsmbLsbsbLgbRsLsbLgbRsbLgbLsbLiL
sbRsbLgbRsLsbLgbRsbLgbLgbLsbRsbLgLsbRsLsbLjbLsbRsbLgbLsbLgbRsLsbLgbRsb
LgbLsLsmbRsbLsbLgbLsLsmbLsbLsbLgbLsLsmbLgbLibLsbRsbLibLsLsRsmbLgbLgbRs
LsLsmbLsbRsbLiLsbsbLibRsbLibLsbLgbLsbRgbLibLsbLsbLgbRgbLibRgbLgbRsbLgb
LgbLsbLgbLsLsmbLgbRgbLibLgbLsbLgbLibLibLgbRsbRsbLgbLsbLibRgbLsRsbLibLs
bLgLsbLgRsbLsbRsbLgbLsbRsbLgbLgbRsbLgbLgbLgbLsbLgbLsbLgbLsbLsRsbRsLibR
jRsLsmbLibRsbLiLsbRgbLibRsbLgbRsRsmbLsbLgbLgbLiLsbRgLsbLiLsbLgbLsbLgbR
gbRjbRiLsbRgbRgbLebLibLgLsbRsbRcbRgLsLsmbLebLibLsbLsbRsbRsbLsbLibRsbRs
bsbLgbRsbRsLibLsbLgLsbLgbRsbLgbLsbLsbLsLsmbLgbRgbLibRjRsmbLibLgbRibLib
LsbLgbRsbLgbLgbLsbLgbLsbLgbLgbLsbLgbLsbLgbRsbLiLsLsmbLibLgbRibLsbLgbLj
bsbLgbRsbLibRgRsmbLibLsLsmbLgbLgbLgbRjbRcbRibRgRsmbLeLsbLibLgRsbLsbLgL
sbLsbLibRgbLibLgbRgbRiRsmbLebLibRsbLgbLgLsbLgbLgbRjbLibLgbRsbLgbRsbLjb
LsbRsLsbLiRsbLsRsbLgbsbRsbLibLsbsbLgbRsbLgbRsbLgbLsbRsbLgLsbRsbLiLsbLi
bLsbRgbLibRsLsbLsbLsbLsbLgbRsbLsbLgbLgbLsbLgbLgbLsbRsbLgbLsbLgbRibLibL
gbLibRgbLibLgbLcbLgbLgbLgbLgbLibLibRibRgLsbLgbLibRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 28; Drug: Control Apo 0.5 然
bRgbRsRsmbLsLsLsmmbLsLsmbRsRsmbLibLibRsbRsLsbRsRsmbRhRsmbRibRibsbRsbRi
bRgbRibLiLsbLsbLsLsmbRsbRsRsmbRgbRsbLgbRgbLgbRsbRsbRsbLibLgbLgLsbLibRg
bRgbRsbLgbLsbRgbLibLsbLjbLsbLibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 29; Drug: Control Apo 0.5 然
bLsbLsbRsbsbLjbLsbRsbLsbLsbsbRsbLsbsbLsbLsbLsLsmbLsbLsbRjbLjbLgbLgbLsb
LsbLsbRcbRibRibLjLsmbLgbLgLsbLgbLsbLsbLsbLsLsmbLsbRcbRibRibRebRibRibRi
bLjbLhLsbLcbRgbLgbLjbLsLsmbLsRsbLsbLsbRgbLsbRcbRsbRibRgRsmbRcbRibLsbLg
RsbRoRsmbRgRsmbRsbRsbLgbLcRsRsmbLiLsbLgLsbLsbLsbLsLsmbLsbLsbLsbLsbLgbL
gbLsRsLsbLgLsbLsbLgbLsbLsbRsbLgbLgbLsbLsLsmbRsbLsbLgbLsbLgbLsLsmbLsbRs
bRcbRibRibLgbRibRibLjbLcbRsbLgLsbLsLsmbLsbLgbLsLsmbLsbLsbLsbLsbLsbLsbL
sbLsbLsbLsbLsLsRsmbLsLsmbLsbLsbsbLsbLgbRsbsbLsbRsbLsbLgLsbLsbLgbLsLsmb
LsbLsbLsbLsbLsbRgbLgbLsbLjbRjbLgLsbLgLsbRiLsbLgbLsbLsbLsbRsbRsbLsLsmbL
sbLsbsbRsbLgLsbLsbLgbLsLsmbLgbLsbLibLsbLibLgbLsbLsbLsbLgbRjbRjbRjbRibL
jbLjbLibLibLgbRgbRjbLjbLgbLgbRsLsbsbLsLsmbLsbLsbLjbsbLsbLsbLgbLsLsmbLs
bLsbLsbLsbLsbLgbLgbLgbRsbRibLgbLgbRgbLjLsmbLgbRgbLjbRjbRcbRibRsbRibRgL
sbRsbLjbLsbLjLsmbLgbLgbRsbLiRsbLgbRgbRgbLsbLgbLjbRsLsbLsLsmbLsbLgbLsbR
sLsbRsbsbLgbLsbLsbLsbLgbRcbRibRibLgbLgLsbLgbLgbLgbRsbRsbLgbLsbLsbLsbRj
bRhbRibLgbRibLjbLhbLibLsbLgbLsbLsbRgbRgbLgbLjbLsbRsbLgbRsbRsbRsLsbLsbL
sbLsbLsLsmbLsLsmbsbLgbLsbLsbLsbLsbLsbLsbRebRibRibRjbLibLjbLjLsmbLjbRgb
LgbLgbLsbLsbLgbLsLsmbLsbRsbLibRibRgbRcbRgbRsbRgbLsRsbRgbLsbRgbRibLcbLc
bLsbLgbLgbRsbRgbLsbRsLibLsbLjbLsbLsLsmbLsbLsRsbLsbLsbLjbLsLsmbLsbRsbLs
bLsbLgbLgbLgbLhbLgbLsbRsbRgbRgbRibLjbLjbLjbLsbLgbRgbRsbLgbLgbLsbLsbLsb
LsbLsbLgbLjbLsbsbRibRibRibRibRibRgbRgbRjbRibLjbLcbLcbRibLgbLgbLsbLsbLg
bLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 30; Drug: Control Apo 0.5 然
bRsLjbRsbRsbLjbLsbRsbLsbLebLsbRsbLsbRsbLjbLsbLebLsbLebRjbLobRjbLsbLjbL
ebRsbRsbLsbRsbLebLebLsbRjbLsbLsbLsbLsbRsbLsbLsbRobRsbLsbLsbLobRsbLsbLs
bLsbRsbRjbLjbLjbRjbRjbRobRjbLsbRjbRsbLebRsbLebRsbRsbRsbRobLsbLsbLsbRsb
LsbRhbRsbLjbRobRsbRebRsbRsbsbLsbLebRsbLsbRsbLsbLjbLobLsbLjbLsbLsbLobLs
bRsbRsbLsbLebLebRsbLjbLobLsbRsbLebLsbLsbLsbLobLebRsbLobLjbRsbRobRobLsb
LobRsbRsbLebLsbLsLsmbRjbRsLsbRsbRsbRsbLsbRsbLjbRjbLebRobLsbLsbLeRsbLsb
LsbLsbRjbLsbRebRsbRsbLsbLsbLsRgbLsLsmbRsbRobRsbLsbLsbRsbRsbLsbLsbLsbLs
bLsbLsLsmbRsbRsbLsbLsbRsbLsbLebLjbLsbLsbRsRsmbLsbRjbLsbRobRobLsbRsbLsb
RsbRjbLsLobLsbRsbLsbLobRsbLsbRebRsbRsbLsbRsbLsbLsbLsbLebRebLsbRsbLsbLs
bLsbLsbLsbLsbRsbLsbLsbRjbLsbRsbLsRsbLsbRsbRsbLsbLsbLsbRsbLobRjbRobRsbR
sbLsbLsLsmbRsbLsbLsbLsbLsbRjbRjbLsbRsbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bLgbRjbRibLsRsbLgbLgLsbLibRsbLjbsbsbLsbsbLsbLsbRibsbsbsbLjLsmbLgbLsbLs
RsbLgLsbLsbLsbLgbLsbRgRsmbLibLsbRjbRoRsmbRgbRsRsmbRgbLsbRsbLsbRgbLsbLs
bLgRsbLgbLibLibLsbLsbLgbLsbRgbRjbRcbRibLiLsbRhbRcbRibLsbLsbRgRsRsmmbLc
bLgbLibLsbRibLibRcbRcbRiRsmbRsbRgbLsbLsbLobLgbRgbLgbLibLcbRgbRsbRsbRgb
RsbRgbRsbRgbRsbRsbRgbLjbRibsbLsRsbLsbLgbLgLsbLgbRgRsmbRgbRsbRsRsmbLsbR
gbRibRsRsmbRsRsmbRgbRsbRsbLsbLjLsmbRsbLsbRsbRgbRsbRsbLsbRibRsbLsbLjLsm
bRibLsRgbRibRsbsbRsbRgbRibRgbRsbsbRsbRgbLsbRhbRsbLjbLgbLsbLgbLcbLibRsR
smbLsbRgbLibLibRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bLsLsmbRsLsbLiRsLsbLsbsbLsbLsbLsLsmbLsLsmbLsLsmbLgbLsbLgLsbLsLsmbLgbRg
RsmbLiLsbLsbLgRsbLsbLgbLgbRsLgLsbLgbLiLsbLsbLgbLgLsbLgbLsbRgbLibLsbRsb
LgLsbLsbLgbLgbLsbLsbLsbLsbLsLsmbLgbLsbLgbRsLsbLgbLsbLgRsbLsLsLsmmbLsLs
LsmmbRsbLgbLsbLsbLgbLsbLgbLsbRsbLgbLsLsmbLsbLgbLgbLgLsRsbLsLsmbLsbLgbL
gbLgbLsLsLsmmbLgbLgbLgbLsbLgbLibLgbLsbLgLsbLgbLgbLsLsmbRsLsbLgLsbLgbLs
bRgbLgLsbLsbLgbLsbLgbLsLsmbLgbLsbLsbLsLsmbLgbLsLsmbLgRsbLgbLsbRsRsmbLi
bLsbLgbLsbRgbLgbLsbLgbLgbLgbLgbLsbLibRsbLibLsbLgbLsLsRsmbLgLsbLgbLgbLs
LsmbLgbLsbLsbLgbLibLgLsbRsbRsLsbLibRsbLibRsbLibRsbLibLsbLgbLgbLsbLsRsb
LsbRsbLgbLsbLibRgLsbLsbLibRsbLibRsLsbLgLsbLsLsmbLibRcbLcbLibLsbLgLsLsm
bLsbLsbLibLgLsLsmbLibLibRibRiLsbRibLibLhbLibRjbLibRsbRsbRsLsbLibRgbLiL
sbLgbLsbLgLsbLsbLobLibLhLsLsmbLiLsbLibLiLsbLsbRgbRsbLibLgLsbRgbLgbLsbL
sbLsLsmbLibLibLsbRsbLsbLiRsLsbRsLsbLsbLgbLsbLgbLsbLsbLgbRsbLgLsbRsbLgb
RsbLgLsLsmbRjbLsbLibLgbLgbLsbLsbLgbLgLsbLibLibRgbLsbRgbRjbRgbLjbLhbLsb
LsLsmbLibLsRsbLsbLgRsbLgbLgLsbLgbLgbLsbLsbLsLsmbLsbLgLsbLsbLgbLsbLgLsb
RsbLgbsbLgbLgbLsbLgbLsLsmbLgbLgbLgbLgLsbRgbLibRsLsbLgbLsbLibLsbLsbLgLs
bRsLsbLgLsLsmbLsbLgbLsbLsbLgbLgLsbLiLsbRsLsbLgbLgbLgbRgbLibLsbRsbLiLsL
smbLsbLgbLsbLgbRsLsbLgbRsbLsbLsLsmbLgbRsLsLsmbLgbLsbRsLsLsmbLsbLsbLsbL
sLsmbLgbLsbLgbLgbLgLsbLgbLgbLsbLgLsbLsbLgRsbLibRgbRjbLiLsbLibRsbLgLsbR
sbLibLgLsLsmbLgbLsbLsbLgbLsbLgbLgbLgbLiLsbLsLsmbRgLsbLibLgbRsbLgbLgbLs
LsmbLgbLsbLgbLsbLgLsbLsbLsbLsLsmbLsbLgbsbLsLsmbLgLsbLsbLgLsbLgLsbLsbLg
bLibLsbLgbLsbLibRsbRsbLibRsbLibLgLsbLsbRsbLiLsbLsbLsbRsbLgbLsLsmbLgbsb
LibLsbLsLsmbRsRsmbLgLsbLsbLgRsLebLsbLsbLsbRobLgbLgbLsLsmbLgbLgbLsbLsLs
mbLsbLgbLgbLiLsLsLsmmbLsbLgbLgbLsLsmbLgbLsbLgbLsbLgbLgbLgbRgbLibRgbLgb
LsbLgRsbLgbLsLsmbLgbLsbLgbLgbLsbLgbLgbRsLsLsmbLsLsmbLsbLsbLsLsLsmmbLsL
smbLsbLsLsmbLsbLsbLgbLsbLjbRsRsmbLgbLsLsmbRsLsbLsLsmbLsLsmbLgbLsbLsbLg
bLsbLgbLgbLsbLgRsbLsLsmbLgbRsbLgbsbLsbLsbLsbLgbLsLsmbLsbLgLsRsbLgbLgLs
bLsbLsbLsLsmbLsLgLsLsmbRsbLgbLgbLsbLsbLgLsbLsbLsLsmbLgbLsbRsbLsLsmbLsR
sbLgbLgbRsbLgbLsbLsbLsLgbLsbLsbLgbLsbLgbLsbLsRsbRsLsbLiLsbLsbLsbLgLsLs
mbRgbLibLsbLgLsbLsbLsbLgbLibRsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bRsbLjbRjbLgbRjbLjbRcbRibLhbRsbLsbRsbRgbRsbLgbRgbLsRsbRgbRgbLjbLjbRjbL
ibRhbRibRgbRsbLgbLsbLsbRgbRibRgbRsLsbRsbRsbRsbRgbLgbRgbRgbRgbLiRsbRibL
jbRhbRsRsmbLgbLgbRsLsbRgbRsbRgbLsbRgbLobRgbLsbRsbRgbRsbRsbRgbRsbRsbRsb
RgbRsbRsbRsbLsbRgbRgbRgRsmbRgbRgbLgbRgbRsbRgbLsbLsRsbRgbRgbRgbLjbRjbLj
bRibLjbLjbLgbLgbRjbLibRhbRibLsRjbLibRibLjbLibRjRsmbLiLsbRjbRjbRsbRibLs
bRgbRsbRsbRsbRsbRgbRibLjbRibRsbLsbRgbLsRsbRgbRsbRsbRsbRsbRsbRsbRsbRsbR
sbRsbRgbLsbRgbRsbLebRgbRgbRgbLsbRgbRgbRgbRgbRgbRsbRsbRibLibLhbRgbRgbRi
bRsbLjbLcbLibRibRjbLcbRjRsmbLibRjbLhbLgbLibLoRiRsmbRgbRsbRsbRsbLsbRgbR
sbRgbRgRsmbRgbRgRsmbRsbRgbLcbLgbLobRcbRiLsbRgbLsbLjbLibRiRsmbRibRgbLsb
RsbRgbRsbRgbLsbRgbRgbLgbRgbRgbRsbRsbRsbRgbRsbRgbLgbRgbRgbRgLsbRgbLhbLi
bLgbLgLsbRjbLsbLiLsbLgLsbRibLibLibRibRcRsmbLibRibRhRgRsmbRgbRgbRsbRsbR
sbRsbRgRsmbRsbRsbRsbRgbRgbRsbRgbRsbRgbRsbRgbRibRgbRsbRsbRsbRgbRgRsmbRg
bRsbLcbLiRsbLgbRcbLjbLhbRcbLjbLibLibRibRcRsmbRgbRgRsmbRsRsmbRsbRsbRsRs
mbRgbRsRsmbRsbRsbRsbRgbRgRgbRsbRgbLjbLhbLibRcbRoLsbLjbRjbLibRcbLjbRcbR
ibLebRsbRsbRcbRsbLsbRsbRgbRgbRsbRsbLsbLjbRcbLhRsRsmbRcbLjbRebLibRibRib
LibRsbRibRgbRsbRsbRsbRsLsbRgbRgbLsbRgbRsbRgbRgbRsbRgbLsbRgbRsbRsLsbRgb
RgbRgLsbRsRsmbRgbRgbLsbRgbRgbRgbRgbLibRhbRiRsmbRgbRsbLcbLjbLibLibRebRg
bRgbRgbRgbLsRsbRsbLsbRgbRsbLsbRgbRgbRsbRsbRgbLgbRgbRgRsmbRgbRsbRiRsmbR
sRsmbRsbRsbRsbRgbRsbRgbRgLsRsbRgbLcLsmbRhbLhbLibRjbLibLibRjbLhbLsLebRh
bRsbLgbLhbRcbRcLsbLibLhRsbLibLgbLibRgLsbLjLsmbRsbLgbRjLsbsbRobRsbsbRib
LsbLsbRgbRgRsmbRsbLsLsmbLibLgbRjbRibRgbRsbRgbRsbRgbRsbRgbLgLsbRgbRgbRg
bRgbRgbRsbRgbRsbRgbRsbRgbRgbRgbRsbRsbRgbRibLgbRgbRsbRgbLsRsbRgbRsbRgbL
sbRgbLgbRgbRgbRsRsmbRsRsmbRgbRgbRgbRsbLgbRibLibRcbLcbLjbLsbLsbLibLiRsb
RjRsmbRgbRibRgRsRsmmbRsbRsbRsRsmbRsbRgbRgbRsbRgbRgbRgbRgbLsRsbRsbRgbRg
bRsRsmbRsbRgbRgRgRgRsmbRgbRgbLjLjbRjbLsbLhbLjbRjbLjbRjRsmbRjRsmbRgbLsb
RsRsLsmbRsbRgRsmbRgbRsbRgbRgbLgbRgbRgbLebLibLgbLgbRibLcbRjbLgbLibRcbRi
bRsbRgbRsbRgbRgbRsbRsRsmbRsbRgbRsRsmbLgbLsbRiRsmbRsRsRsmmbRsLsbRsbRsbR
sbRsbRsbRsbRgbRgbRgbLsLsmbRgbLgbRgRsmbLsbRgbRsRsmbRsbRgbRsbRgbRsbRgRgb
RgRiLibLiLibLibRgbLibRsbLgbLgbRjbRcbRiRsmbRsbRgbRgRsmbRgRsRgmbRgbRgbLs
bRgbRgbRsRsmbRsbRsbRgbRsbRsbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bLsbLsbLgbLsbRsbLsbRsbLsbLsbLgRsbLgbLsbLgbLsRsbLsbLsRsbLgbLgbLgbRgRsmb
LsbRsbRsbRsbRhbLsbRsbRibRsbsbsbRgbRsbLsbRsbLsRsbRgbLsbLsbLsbRibRgRsmbL
sbLsbRsbRibRsbRsbRsbRsbRgbsbLsbRgLsbLgbLsbRgbRsbRgbRgbRgbRsbRsbLibRsbR
sRsmbRiRsmbRibLsbRsbRsbRgbLsbRsbRsbRgRsmbRsbRsbRgbRsbRsbRgbRsbRsbRgbLs
RsbRgbRgbRsRsmbLsRsbLsbRgbRsRsmbRsbLsbRsbRsbRsbRsbRgbRgbRgRsmbRsbLsRsb
LibRiRsmbsbRgbRgRsmbRsRsmbLsRsbLsbRsbLgbRibRsbRsbLsbRsbRsbRgLsbRsLsbRs
RsmbRsbRgbRsRsLsmbRsbRsbRgbRsbRsbRsbRgbRsRsmbRsbRsbRsbRsRsmbLsbRibLsbL
sbRibRgRsmbRgbRsbLibLjbLibLgbRsbLibLsbLgbLsbRsbLgbLsLsmbLsbLgRsbLsbLsb
LgbLsLsmbLsbLgbLgbLsbLsbLsbLgLsbLgbRsbLsbLgbLsbLsRsbLibLsbLsbLsbLgbLgb
LsbRgbRsbLiLsbLgbRsRsmbLsLsmbLgbLgbLsbRjRsmbLgbLjbRsbRgbLsbRjRsmbRsbRi
bRsbLsbLsbRibRsbRsbLsbRibRsbLsbRibRgbRsRsmbRibLsbsbLsbsbLsLsmbLsbLibLs
bLibLibLsRsbRsbRsbRsbLibLgbLsbLsbLgbLsbLsbLiLsbLgbLibLgbLsbLsRsbRsbRsb
RibRsbRsRsmbRgbLsbLsbLsbRsbRibLsbLsbLsbRibRsRsmbsbLsbRsbRsbLsbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bLibLsbLgbLsbLsRsbLsbLhbRsbLsbLcbLsLgbLsbLsbLsbLsLsmbLgbLgbLsbRsbLgRsb
LgbLsbLsLsmbLsbLsbLsbLsbLsbLhbRgbLibLgbLsLsmbLsbLsbRsbLsbLsbLgbLgbLsbL
iLsbLgbLsbLsLsmbLgbLsbLsbRsbLgbLsbLsbLsbLgbLsbLsbLsbLgbLsbRsbLsbLsLsmb
LsbLgbLsbLsbLsbLsbLgbLsLsmbLsbLsbLgbLsLsmbLsbLibLsLsmbRsbLsbLsbRsLhLsb
LsbLsbLsbLsbLibRsLsbLsLsmbLsbLgLsbRgbLgbLsbLsRsbLsLsmbLgbLsbLsbLsbLgRs
bLsbRsbLgbLsLsmbLsbLsbLsbLgbLsbLsbLsbLgbLsbRsbLsLsmbLgbLsLsmbLgRsbRgbL
gbLsbLgbLsbLgbRsbLgbLsbLsbLsbLgbLsbLgRsbRgbLibLgbRsbRgbRsbRsbLsbLgbLgb
LsbLsbLsbLsbLsbLsbLsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bLjbLhbLcbsbLibRsbRiRsmbLjbRjRgbLjbRibsbLiLsbLibLibLgbRibLibLsbRibLibR
sbLibRjbRibRibLgbRibRsbRgbLibRibsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bsbLsbLgbLsbLsbLsbRsbLgbLsRsbRsRsLsmbLgbRsLsbLsbRsbRsbRsLsbLsLsLsLsmmm
bsbRsbsbRsbLsLsmbRsbLsRsbRgbRsbLgbRsLsbLsLsmbLsbLsbLsLsLsmmbLsLsLsmmbL
sRsbsbRsbRsbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bLgbsbsbLgbLsbRibLibRsbLgbLibLsbLgbRgbLgbLgbLibLsbRgbLiLsbLsbLsbRsbLib
LsbRsbLibLgLsbRgbLgbLgRsRsmbLgbRsbLgbRsbLibLsLsmbRgbLiLsbLgbLgbRgbLgLs
bRsbLgLsbLgbLgbRsbLgbLgLsbRsbLibRsbLgbLsbLgbLsbLgbLgbRgbRsLgbRgbLiLsbL
ibRgLsbLibRsbLgbRjbLgbLsbLgRsbLsbLgbLsbLgbLgbRsbLgbLibRgbLiLsbRgbLiLsb
RsLsbLgbLgbLsbRgbLibLgbRgbLgbLgbLgbRsbLgbLgLsbRsLsbLgbLsbLsbLsbLgbLgbL
gbRiRsmbLgbLgbLgbRgbLiLsbRgbLgbLibRsbLsbLgbLsbLsbRgbLibLgLsbRgbLgbRgbL
gbLsLsmbRsbLgLsbLsbLgbLsbLsbLsRsbRsbLsbLgLsbRsbLgbRsbLsbRsbLgbLsbsbLsL
gbLsLsmbLsbLsRsbLsbLgLsbRsLsbRjbLgbLgbRgbLgLsbLgLsbLsbLsbLgbLsbLsbRsbL
gbRsbLibLgLsbRgbLgLsbLgbRsbRsbLibRgbLgbLgLsbRgbLgLsbRsbLgLsbLsbRsbLgbR
gbLgbRgbLgbLgbLsLsmbLgLsbLgRsbRgbLgbLgbRgbLgbLsbRsbLgbLsLsmbLgbsbLgbLs
bLsbLsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bLsbLiLsbLsbLsbLgbLsbLsbLiLsbLsbLibLsLsmbRhRsmbRsbLibRsLsbLsbLeLsbLsLs
mbLibLsLsmbLsbRgbLibLsbLibLgbRsbRgbRsbRhbLgLsbLsbLibLgbLibLsbLsbRgbRsb
RsbLcbLsbLsbLsbLsbLgLsLsmbLsbRgbRsbRsbRgbRsbRgbRsbRsbRiRsmbRsbRibLgbLs
bRgRsmbRsbRsbRgbLsbLsbLgRsbReRiRsRsmmbRiLsbRibRsbLgbRibLebRibRibRibReR
smbRsRsmbRsbRibLsbRgbLjbLsbLeLsbLsbRsbRsbRibRjbRcbRsbRgbRibRsbRsbRibRi
bRsbLsLsmbLhLsbLcbRibLhbLsbRsbRsbLgbRsbLsLsmbsbLgbLibLcbRibLgbLebLsbRi
RsmbRgbRgbRhbRhLsbRsbRibRsLsbLsbRgbLgbLjbLsbRsbRsbRibLgRsbLcbsbLsbRsbR
sRsmbLsbRsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bLsRsbRgbLsbLibLsbLgbLsbRsbLsbLgbRsRsmbRsbLgbLgbLgbLsbLgLsbLgbLsbLgbRs
bLibsbRcbsbLsRhbRibRhbLhbRibRibRhbLcbRiRsmbRjRsmbRgbLhbRjbLibRibLibRgb
LsbRgbLhbLibLhbLiRsbLcbRiRsmbLsRsbLsbLsbLibRsbRsbsbsbLhbLibLsbRsbLgbLg
bLsbLsbLibLibRgbLhbLgbRiRsmbLibLibRebRcbRibLgbLibRiRsmbLsbRsbRgbLsRsbR
gbLsRsbRsbRsbRsbRgbRhbRobLgbRhbRgbRibRsbRgbRsbRgbRsRsmbLsRsbRgbRsbRgbR
sbRsRsmbRgbRgbLgbLsbRgbLjLsmbRibsbRgbLsbLsRsbRgbRsbRgbLgbRgbRgbLibRsbs
bRsRibRibRsbLsbsbRsRsmbLsRsbRgbLsbRsbRsbRsRsmbLsbRgRsmbLsbRibLgbRibRsb
LsbRibRsbRgbRgbLhbLibLibLibLgRsbLgbRibRcbRhbRgRsmbLsbLsbLsbRgbRgbRsbRs
bRgbRsRsmbRsbRsbRsbRsbRsbRgbRibRcbLgbLgbLgbLsbLsbLhbLibRgbLsbLibsbLgLs
LsLsmmbRgbRsbLgbLgRsbLgRsbRsbLjbRsRsmbLgbsbsbLsbLsbLsLsRsmbLsLsmbLgbLg
LsbLgbLgLsbLsLsmbLgbLsbLsbLsbLgbLsbLgbLgbLgbLgbLgbRhbRcbRibLgbLgbRibRg
bLjLsmbLjbLibRjbLsbsbLibLgbLgbRgbLjbRsRsmbLjRsLsbRibRcbRgbRsbRgbRsbLsR
sbLsbRsbRibRgbLgbRgbRgbLjbRgRsmbLsbRgbLgbRibLjbLcbLibLgbLsbLsbLgbLgbLg
bLgbLgbLgbLgbLsbLgbLgbLgbLsbLgbLgbRgbLgbLjbRibLibLgLsbLgbLgbLgbLgbLgbL
gbLsbLgbRibLsbRcbRibRiRsmbRibRgbLgbLibLibRcbLjbLjLsmbRhRsmbRcbRjbLjbRc
bRibLgbLsbRibRgbRgbRsRsRsmmbLsbRgbRiRsmbLsRsRsmbLsRsbsbRgbRgbRgbLsbRgL
sbLjbLjbLhLsbLsbLsbLsbLgbLsLsmbLsLsmbLgbRjbsbLhbLgbRgbRgbRibRibLsbLjbR
ibLsbRsbRsbLsbRsbRsRgbRgbLibsbLjbRsbLhRsbLgLsbRsbLiLsbLsbRsbLibLgbRsRs
mbLsbLgLsbLgbLgbLgbLsbLgbRgbLibLsbRsbLibRsLgbRibRcbRgRsmbLsRsbLsbRsbRs
LsbRsRsmbRsRsmbRgRsmbLsbRgRsmbLsbRsbRgRsmbsbRgbLsbRgbRsbRsbRsRsmbRgbRs
bRgbLsbRsbRibRsRsmbLjbRibLibRhRsmbLjbRobRgbRgbLsbRsRsmbRgbRibLsbLsRsbR
gbLjbRcbLibRiRsmbLjbsbRsbLsbRhbRibRibRsbLsbRsbLibLiRsbLgLsbLsbLgbRgbLi
bLsbLgbLgbLsbLgbLsbLgbLgbLgbRgbRobRibRsbLsbRibRgbRgbRgbLsRsbLsRsbRgbRi
RsmbLjbRiRsmbLsbLgbRibRgbRsLsbRsbRsbRsLsbRsbRsRgbRsbRsbLsbRsbRsbRsbRsR
smbRsRsmbRibRgbRsbRsbRgRsmbLsbRgbRsbRgbRsRsmbRgbRsbLjbRiRsmbRibLibLibL
jbLibLsbLsbRsbLgbLgbLgLiLsLsmbRsbLsLgbLgbLsbRsLsbLsRsbLsbLgbLibLibRibL
jbRibLjbRcbLjbRcbRjRsmbRsbRibLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bRjbRsbLsbLgbLgbLibRjbsbsbLgbLgbRsLsbRsbRsbLibLibRsbLgbRjbLibLgbRjbRgb
LibRsRsmbRibLsbRgbRgbLjbRiLsRsbRsbRiRsmbLibLsbRgbRibLjbRhbRhbRibRsbLgb
LsbLibRjbRibRibLsbRsbLsbRsLsbRibLgbRiRsmbRsbRgbLjbRibRhbRgbRiRsmbRsbRg
bRiRsmbRibRsbRgbRibRsLsbRsbLsbLgbLgbRibLsbRgbRsbRgRsmbLsbLjbRiRsRsmmbR
iRsmbLjLsmbRibLsbRibRjRsmbLgbRibLsbLsbLgbLibLibLibRsLsLsmbsbRobRsbRsbR
sRsmbRsbRhRsmbRibRibLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bRebRibRsbRgRsmbRcbRibRibRibRhbRgbRsbRsbLsbLgbRibRgLsbLgbRibLibRibLsbR
ibRhbRcbRibRibRibLjbRcLsbLjbLjbLibLjRsbRsLsbLgbLsRsbLjbLibLgbRjRsmbLib
LsbLibRjbLjbLibLibRjbRobRibRibRgbLgbRhbLibLibLibLgbsbRobLjbRhbRgbRsbRi
bRcRsmbRibRjbLjbLibLsbLgbRsbLsbLsbLsLsmbLoLsmbLgbRobRibLgbRgbsbLsbRjbR
sbRsbRiRsmbRsbLsRsbRiRsmbLsbRgbRgbLgbRibLgRsbRiRsmbLsbRibLjbLcbLsbLsbR
sRsmbsbsbsbRgbRsbLsbRgbRgbLjbLhbRiLsbRgbRgbRgbLgbRibRgRsmbLgbRibRgbLgb
RgbRgbRsRsmbRgbLsbRibRsbsbRsbsbRsRsmbRsbRgRsmbRsbLsbRsbRgbRsbRsbRgbRsb
RgbRibLibRib

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bLgbRsbRgbLsbLgbsbRsbLibRjbRsbRsRsmbLibRebLcbLibLgbRebRsbRsRsmbRsbLibs
bRsbRsRsmbRsbRiRsmbRsbLibRibLsbLgbRgbRibRgbLibRobLsbRsbsbRsbRsbRsbLjLs
mbRhbLgbRibLjLsmbLsbLjbRcLsbRsbRsRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bRsbRgRsmbRgRsmbRsbRsbLsbRsRsmbRgRsmbRgbRsbRgbRsLsbRgbRgbRsbRsbRgbRsbL
sbRgbRsbRsbRsbRgbRsbRgbRsbRsbRsRsmbRgRsmbRgbRgbRsbRgbRgbRgbRsbRgbRgbRg
bLjbLjbLibRcRsmbLsbRibLgbRibRgbRgRsmbLgbLsbRgRsmbRgRsmbRsbRsbRsbLcbLgb
LgbLgbLsbLgbLsRsbLgbRibRebRibLsbLsbRsbRibLsbRgbRsbRgbRsbRgbRgbRibLsbLs
bRgbLsbRgbRgbRgbRsbRsbRgbLjbRibRsbRsbLsbRsbRgbRgbRgbRsRgbLgLsbRgbRsRsm
bRgbRgbRsbRgbRsbLgbRgbLjbLibRjRsmbReRsmbLsbRgRsmbLgbRiRsmbLgLsbRibRgbL
sbRgbRgbRgRsmbRsbRgbRsbRgRsLsmbLjbLgbLgbLgbLgbLibRcbRibRgRsmbRsRsmbLsb
RgbRgRsmbLsRsbRgbRsbRsbRgRsmbRsbRsLsbRsbRgbRgbRsLsbRgbRsbRgLsbRsbRsbRg
bRsbRgbRsbRsRsmbRsbRsbRgbRsbRgbRsbRgbRsbRsbRsbRsRsmbRgLsbLjLsmbLsRsbLg
bRjbRibRibLibRgbRsRibLsbLsbRgRsRsmmbRgLsbRsbRsbRsbRsRsmbRsRsmbRsbRsbRg
bRsbRsbRgbRsbRsbRgbRsbRsbRsbRgbRsbRsbRgbRgRsmbLsbRgbRsLsbRgbRgbRgbLsbR
ibRsbRgbRsRsmbRsbRsbRgbRsRsmbRgbRsbRsbRsbRsbRgbRgbLjLsmbRibRsRsmbLsbRs
bRgbRsLsbRgbRgbLsRsbRgbRsbRsbRsRsmbRsbRsbRsbRsbRsRsmbRgbRsbRsbRsbRsbRg
bRsbRgRsmbLsRsbRgbLgbRiRsmbRsRsmbLsbRgbLsbRgbRsRsmbRsbRgbRsbRsbRgbRsbR
gbRsbRsbRsbLsRgbLjLsmbRgbRgRsmbRgbRsbLsbRsbRgbRgbRibRsbRgbLjRsRsmbsbRi
bRgbLsRsbRsRsmbRgbRgbRgbRsbRsbRsbRgbRsbRsLsbRsbRgbRsbRgbRsbRgbRsbRibLs
bLsbRsLsbRgbRsbRsbRsLsbRgbRsbRsbRsbRgLsbRsbRgbRgbLjbLjbLgbLgbLgbLgbLsb
LsbLsbRcRsmbRgbRgbRgbRgbRgbLgbRgbRgRsmbRgbLsbRiRsmbRsRsmbRgbRsbRgbRsbR
gbRsbRgbLsbRibLjbRiRsmbLgbRgbRgbRgLsbLgbRgRsmbRgbRgbRcbRibRibRibRgbRsb
RsRsmbLsbRsbRgbRsbLgbRgbLsbRgbLgbLhbLibLibRebRhbRibRibRsbRgbRibRgbRgbR
gbRgbRgbRsbRgbRgbLgbRsbLgbRibRiRsmbRgbRgbLsbLsbRibRsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bRsbLgbLgbRsbLgbLibLgbLgLsbLsbLsbRibRgbLibLsbLsbLgbLgbLsbRibLgbsbLgbsb
LgbLsbLsbLibLgbLsbLgbLsbLibLgbRgbLgbRsbLsbRsbRjbRgbRibRsbRgbRsbRsRsmbR
sbLjbRgbRsbRsbLsLsmbRgRsmbRjLsbLsLsmbsbRgbRsbLsbsbLgbLibLibLsbLsbLsbLg
bLsbLjbRjbLibLsbRgbRgbLibLibRsbLgbRjbsbLgbLgbLsbLsbLsbRgbLibLibLsbLgbL
sbLgbLsbLsbRsbRgbRibRgbRjLsbRsbLsbLgbLgRsbRhbRgbRibRgbRsbLibLsbsbRiRsm
bRibRgbRgbRsbRgbLsbLgbRibRgbLgbRibRgRsmbRsbLgbRiRsmbRgbRgbRibRgRsmbRsb
RgbRsbRsRsmbRiLsbRibRgbRibRsbRcLsbLgbLgbRiRsmbRibRgbLgbRibRgbRiLsbRibR
ibLgbRjRsmbLsbLjbLsbRibLibLibLsbLibLibLsbRsLsbLgbLsbLgbLgbLsbLgbLgbLgb
LgbLgbsbRcbRibRibRsbRgbRsbRsbRsbRgbLgLsbRiRsmbRibLjbLibLgbLgbLsLsmbLsL
smbLgbLsLsmbLgRsbLgbLsRsbLsLsmbLgbLgbLsbLsbLgbLsLsmbLgbLgbLgbLsbLgbLgL
sbLsbLgRsbLsbLsLsmbLsbLgbLgbLsbLgLsbLsbLgbLgLsbLsbLsbLsbLgbLsLsmbLsbLg
bRjbLibRcLsbRgbRgbLgLsbLcbLiLsbLsbLgbLgbLsbLsbLsbLsbLsbLgbLgbLgbLsLsmb
LgbLsLsmbLsbLsbLgRsbLgLsbLsLsmbLsLsmbLibRgbRjbRiLsbRibLjbLibLsbRsbLsRs
bLibLsbLgLsbLgbLgbLgbLgbLgbLgbLsbLsbLgRsbLgbLgbLsbLsbLgbLsLgbLgbRjbLib
LsbLgbLgbLsbLsbLgRsbLsbLgbLgbLsbLsbRcbLcbLgbLgbLgbLsLgbLsbLsbLsbLsbLsb
LsbLgbLgbLsbLgbLgbLsbLgRsbLibLgbLsbLgbRcbRiRsmbRcbRibRibLgbLgbLgbLibLs
bLgbLgbLsbRsbLgbRgbLibLibLsRsbLibLgbRsbLsbLsbLibRgbRsbLibLgbLgbLgbRgRs
mbLgbLibRsbLgbLgRsbLsbLsbsbLgbLgbLsLsmbLgbLgLsbLsbLsLsmbLgbLgbLgbLgbLg
bLgbLsbLgbLsbLgbLgbLsbLsbLgLsbLibRibRcbRgbsbRgLsbRsRsmbRibLhbLcbLgbRsR
smbLibLgbLgbLsbLgRsbLsLsmbLgLsbLgbLsbLgbLsbLsbLsbLgbLsLsmbLgbLsbLiLcLs
LsmmbLgbLibRibLcbLibLgbRsbLgbLibLgbLgbLibLsbLgbLgbLsbRgbLgLgbRhbRibLhb
LgbLsbLgbLsbLsbLgbLsbLgbLsbLgbLsLsmbLgbRsbLgbLgbLsbLsbLsbLsbLgLsbLsbLs
bLgbLsbLgbLgbLgbLgbLgbLgbRsbLgbRcbRhbLcbLsbLgLsbLsbLsbLgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bLsbRgbRgbRgbRiRsmbLgbRibRsbRsbRjbLsbRsbRgbRgbRibLibRibLsRsbRsbRgbRgbL
jbRibLjbRsRsmbRsRsmbRibRibLcbLibLsLsmbRjbRgbRiRsmbRsbLgbRiRsmbLgbRgbLg
bRjbLsbRsbRgRsmbRgbRgbLgbRgRsmbLjbRibRgbLiRsbRibLjLsmbRgbRgRsmbLgRsbRi
bRsRsmbLiLsbRgbRgRsmbRsbRsbRsbRgbLsbLibRibRsRsmbRgbRsbRsbRgRsmbRgbLjLs
mbRsRibRgbLgbLjbLjLsmbLgLsbLsbLgbRsbLgbLibRjbRiRsmbRsbRgbRgbLsbLsbRsbR
sbRsbRsbRgbRgRsmbRgbRsbRgbRsRsmbRgbRsbRsRsmbRgRsmbRsbsbRibRgbLibRiRsmb
LsRgRsmbRgbRsbRsbLsbRgbRgbRsbRgbRgRsmbRsbRgRsmbLsbRgRsmbLsRsbRgLsbRgbR
gRsmbRsbLsbRgbLjbLibLgbRcRsmbRibLibRiLsbLgbRibRsbLsbsbRgbRsbLsbLsbRgbR
sbRsbRsbRsRsmbRgbRsbRsbRgbRsbRgLsbLgbRgRsmbLsbRsRsmbRgbRgbLgbRsbLsbRiR
smbRhbLsbLibRibRgbRsbRsRsmbRsbRgRsmbRsbRjbRsRsmbLsLsmbRsbRgbRsbLjLsmbR
gbLgbRibLgbRiRsLsmbRsRsmbRgbRsbRsbRsbRjbLgbRiRsmbRibRiRsmbLibLsbRibRgb
RiRsRsmmbRibRgbLibLibLjbRhbRibRsRibLjLsmbRibLgbRibRsRsmbRsbLsbRgbRsbRs
bRsRsmbRsbRsbRgRsmbRgbRsRsmbRgRsmbRsbRgbRsbLjbRibLgbRiRsmbRgbLgbRsbRib
LgbRgRsmbRsbRgbRgRsmbLibLgbLgbRjbRibLjbLiRsbRiRsmbRgbRgbRsbRsbLsbRgbLj
LsRsmbRjbLjbRibRsbRgbLibRgbRgbRsbRsbRgbRsbRgbLsbLjbLsbRibLjbLcbRsbRhbR
gbLjbRibRsbLjbsbLsbRibLsbLsbRgRsmbRsRsLsmbRsbLsRgbRsRsmbRsbRgbLjbLsbRg
bLjbRgRsmbLjbRiRsmbRibRsbRgbLgbsbsbRibLhbRibRgbLgbRibRsbRgbLjbRibRgbLi
bRgbRsbRsbLsbRibRsbRebRgbLgLsbRgbRgbRgbRibsbLibLsbLibLgbLibLgbRgbLibRs
bLgLsbRsbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bLgbRibLcbLibRsbLgbRgbsbLgbLsLsmbLsLsRsmbLgbLsbLgbLgbLsbLsbLsLsmbLgLsb
RsbLgbLgbLsbLsLsmbLsLsmbLgbLsbLsbLgLgbLsbLsbLgbRgbRjRiLsbRibRsbRgbRsbR
gRsmbLjLsmbLjbLhbLsbLgbLsRsbLgbLgbLsbLgbLsbLgbLgLgLsbLgRsbLibRgbRgbRjb
RibLgLsbLjbLibRsbLsbLsLsmbLgbLsbLsbLgbLsLsLsmmbLgbLgbLgbLsbLsbLgbLgbLi
LsbLgbLsbLsbLsbLgLsbLsbLsLsmbLgbLgLsbLgbLgbLsbLsLsmbLsLgbLgbLgbLgbLsbL
gbLgbLsbLgbLsbLsLsmbRsRsmbLsbLsbLsLsLsmmbLgbLsbLsbLibLsbLgbLgLsbLgbRsb
LsbLgbLgRsbRsbLgLsbLsbLgbLsbRsbLgbLsbLgbLgbLgbLsbLgbLgbLgbRsbLgbLsbLsb
LibLgbRjbLjbRgbLibLgLsbLhRibRcRibRsbLsLsmbRgbRgbLjbRibLgbLsRibLgbRibLs
bLjLsmbLjLsmbRgbLcbLhbRsbRsbRsbLgbLibRsbLsbLsbLsbLgbLsLsmbLsbLsbLgLsbL
sbLsbLsLsmbLsbLgbLsbLsLsmbLgbLsbLsbLgbLgbRsLsbLsbLgbRsbLsbLgbLgbLgbLsb
LsLsmbLibRjbRcbLcbRjbLibLgbLsbLsbLsbLsbLgbRgbLgbLsbLsbLgbLgLsRsbLgbRjb
RcbRibLsbRgbRsbRsbRgbRgbLjRsbLhbLibLgbRgbLgbLsbLsbLsbLsbLgLsbLsRsbLgbR
jbRobsbRgRsmbRgRsmbLgbRgbRsbRgRsmbLgbRiRsmbLsRsbRgbLgbLjbLibLgbLgbLgbR
sbRsbLgbLgbLgbLgLsbLsLsLsmmbLgbLgbLgbLsLsmbLsRsbLgbLgbRsbLgbRgbLgbRsLg
bLgbLgbLsLsmbLsbLsLsRcLsmbsbRgbRgbRgbLjLsmbRibLjbLjbLiRsbLgbLgLsbLgbLs
LsLsmmbLgbLgbLgbLgbLsbLsLsmbLsbLgbLgbLsbLsbLgbLgbLsLsmbLsLgbLgRsbLsbLg
bLgLsbLgbLsbLgLsbLsbLgbLgbRjbRhbRgbRgbLgbRgLsbRgbLjbLcbLgLsbLsbRsbLsbL
sbLsbLibLsbRgLsbLgLsbLsbLgRsbLgbLsLsmbLgbLgLsbLgbRsbLgbLgbRsbLsbLsbLsb
LibRsbLgbRgbRjbRcRsmbLsbRibRgbLcbRsLsbLgLsbLsbLgbLsbLgbLgbLsbLgLsbLgbL
sbLgbLsbLgbLsLsmbLgbLsbLsbLgRsbLsbLsRsbLsbLsbLgbLsLsmbLgLsLsmbLgbLsbLs
LsRsmbLgLsLsmbRsbLsbLgbLgbRgbLibLibRgbRjbRibLsbRibLebRgbLsbLgbLgbLsLsm
bLsRsbLgLsbLgRsbLsbLsRsbRsbLsbLgLsRsbLgbLsLsmbLsbLgbLgbRjbLibLibLgbRsb
LsbLgLsbLgbLsbLsbLsbLgbLsbLsbLgbLgbLgbLgbLsbLgbLgbLgbLsbLsbLsbLgbLgbLg
bRcbRhRsmbLsbRibRibLsbRgbLcbLibRsbLgbLsbLsbLgLsbLsRsbLsbLgbLsLsmbLsLgb
LgLsLgbLgbLsbLgbLsbLsbRsbLgbLsLsmbLsLsmbLsbLgLsbLsbLgbLgbLgbLgLsbLgbLs
RsbLgbLgbLibLsbLibRgbRjbRhbLsbRibRibLjbLcbLgbLsbLgbLsbLgbLsLsmbLsbLgLs
bLgRsbLgLsbLgbLgbLgbRsbLgbRsbLibRjbLibRgbLiLsbLsbLgbLgbLsLsmbLsLsmbLsb
LsbLgbLgLsbLgbLsbLgbLgbLsLsmbLsbLgbLgbLsbLsbLgbLibRjbRjbLjbLiLsbLgbLgL
sLsmbLsLsmbLgbLgbLsLsmbLibLsbLgRsbLsbLsLsmbLsbLsbLsLsmbLsbLgRsbLsbRsbL
gRsbLsbLgbLsbLsbLsbLgbLgbRsbLgbLgbLsbLsbRgLibRjbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 124510; End: 125010;
Recording: 9-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bLhLsbRcbRibLiRsRiRsmbRibLgbRibLibRhbRgRsmbLgbRibRsbRsRsmbRgRsmbRgbRgL
sRsbRgbRgbRgRsmbRgbRgbRibRgbRsbRgbRsbRgbRsbRsRsRgmbRgRibRiRsRsmmbRgRsR
sRsRgmmmbRgbRgbRgRsmbLebLobRgbRsbRgbRgbRgbsbRsbRsbRgbRgbRgbLgbRsbLibLj
bRcbRgbRibLsbRgbRsbRgRsmbLsRsbRgbRgbRsRsmbRgbRgLsbRgRsRiRsmmbRiRsRgmbR
iRsRgmbRgRgbRsRgRsmbRsbRgbRgbRiRiRsmbRgbLsbRsRgbRgbLsbRgRgbRibRebRibLs
bRsbsbLgbRiLsbRibLgLsbRgbRibRgbRsbRsbRgRsmbRsbRgLsLsmbRjRsmbLibLcLsmbL
ibLsbLibRcbRcbLibLibRsbLibRcbRobLsbRibRgbRsbRsRgRiRgbRgRsmbLsbRgRgRsRs
mmbRgbRgRsmbRgRsmbRgbRgRiRiRsRgRgRgmbRiRibRsRgbRiRsRimbRsRsRiRsRimmbRg
bRsRibRgbRsRsRhmbRgLsbRgbRibRgRsmbRiRsmbRiRsRgRsRsmmmbRjbRsbRgbRiRsmbL
sRgbRgbRibRgbLgLsbLsRsbRibRibLsbRgbRsRsmbLjbRibRiRsmbRsbRgbRgbRgRsmbRg
RgRgRsmbRgbRgbRgRsmbRgbRibRgbRgbRgRsmbRgbRgbRiRsmbRiRsmbLiLsbRcbLgbLjL
smbsbLibLibRcRoLsbRsbLsLgbLjbLibLibRcbRsLibLibRcRsmbRibRsbRiRsmbRgbRgb
RgbRibLgRsbRiRsmbRsbRgRsmbRgRgbRgRhRiRibRgbRiRsmbRgbRibRgbRsRsmbRsbRgR
sRsmmbRgbRibRgRsRsRsmmmbRibRgbRiRgRiRiRibRgLsbRgRsmbRgbRsbRsRsRgLsmbRi
bRjbRsbRgbsbLjbRibLjLsmbRiRsLsmbLsLsmbRgbRgbLsbRgRsmbRgbRsbRsbRsRsRiRi
mbLsRiRsmbRiRiRgbRgbRgbRgRgRiReRsmbRibRiRsmbRiRsmbRgRsmbRgbLsbLsbLsRhb
RibLibRibRibLgbRhbLsbRibRgbLsbRibRsbRgbRsbRsRsRsmmbRsLsLsmbRgbRgbRgRsm
bRgbRgbRgbRgRsmbRsbRgRsmbRsbRsRsmbRgRsRgRsmmbRgbRgbRgbRsbRgbRgbRgRsmbR
gRsmbRgbRgbRgbRgRsmbLjbRhbLibRsRsmbRgbLibRibRsbRsRgLsbRsbRsbRsbRgbRgbR
sbRgRsmbRgRsRgRsRsmmmbRjbRgbRgRibRibRgbRgbRgbRsRsmbRgbRgRgRsRsmmbRjbRs
bRgbRgbRsbRgbRgbLsLsmbRgbRibLibRcbLibRcRsmbLgbRiRsmbRgbRgLsbRgbRsbRgbR
gbRgbRibRgRsmbLgbRiRsmbRgbLsLsmbRgbRsRgbRsbLsbRgbRsbRsbRsbLsLsRsmbRsbR
sbRgRsmbRgbRgbRgbRgbRgbRgbRsRsmbRibLjbRibRcbLibLibLiLsbLibLgbRiRsmbRcb
RgRsLsmbLsbRgbLsbRibLsbRgbLsbRiRsmbRgbRgbRgRsRgRsRgLsmmbRiRsmbRgbRibRg
bRgRsmbRgRsmbRgbRgRibRgbRsRsmbRsRgbRsbRiRsmbRgbRgbRgRsmbLsbRibLjbRcbLj
bLibLiLsbRcbRiRsRsmmbRsbRgbRgRibRgRsmbRgRsRgmbRgRgbRgbRgbRgbRgbRsRsmbR
sbRgRsLsmbRsbRgbRsbRsbRgRsmbRgbRgbRsbRsbRgbRgRgbsbRgRiRsmbRsbRsbRgbLgb
RibRsbsbRgbRsRsRgRgRsmmbRjbRsbRsbRsRgRsmbRsRsRsmmbRgRsmbRsbRgbRgRsmbRs
RibRgbRgRsRjmbRgbRsRsRsmmbRgbRgbRgRsRimbRsbRgRhRgRsmbRsbRsbRgbRgbRsbRs
bRsbRibLjbRebLhRsbRhbRjbRiRsmbRgbLgbRiRsmbRsbRsLsbLsbRibLjbLjbRcbRsbLs
RsbRsbRgRgRsmbRsRsRgmbsbRsbRgRsmbRsbRsbsbRsbRsbRgRsRsmmbRgbRsbRgLsbRsb
RsbRgRiRsRgmbRsbRgbRiRsmbRgbRgbRsRiRsRjmbLsbRgRsRsmmbRgRiRgbRgRsmbRgbR
gbRsbRgbLjbRibLsbRibRgbReRsmbLgbRgbRgRsmbRgbRgRsmbRgbRgbRibRgRsmbRsRsm
bRgRsmbRsbRgbRgRibRhRsmbRgbRgbRgbRgRsRgRsmmbRgbRgbRgRsRgmbRiRiRsmbRibR
gRiRgRiRgbRiRibRgbRgRgbRsRibRiLsbLgbRgbRgRsmbLgbRibLjbLibLibRcbRhbLgbR
hRsmbLibRcbRibLibLsbRjbRibRhbLcbLjRcbRibLsbRgbRsbRgbRsbRibRsRsmbRgLsbR
ebRgbRgLsbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 1; Drug: Control Apo 0.5 然
bLgbRibRibRhbRibRgbRibRgbLibRcbLsbRgbRebLgbRibLsbRsbLibLibLgbLsbLgbRsb
LibLgbRgbLgbRsbLgbLsbLgbLsbRgbLgbLgbLsbLgbRgbLgbLsbLgbLgbRgbLgbLsbLgbL
gbLgbLgbLsLsmbLsbLsbLsbLsbLsbLsbLsbLgbRgbLibRjbLiLsbLgbLsLsmbRibLjLsmb
RgRsmbRsLsbLgbLgbLsbLgbRgbRjbRsbLcbRibLjbLibLjLsmbLibRibRjbLhbLjbRjbRi
bRsRsmbLebRibRiRsmbRibRibLibLsbLjbLjbLjLsmbRjRgbLibLibLibLibLgbLjLsmbL
sbRibRgbLhLsbLibLjLsmbLjLsmbLgbLibLsLsmbRibRjbLjbRjbLibRjbRebLsbLgbLiL
gLsbRjRsmbLcbRjbRhbRebRsbLsbRhRsmbLcbRcbLsLsmbLcbLcbLibLiLsbLgbLgLsbLj
LsmbLibRjbRebRcbLsbRgRsmbRjbLgbLgbRhbRjbRsbRgbLjLsmbLjbLgbLsbLsbLsbLgb
LibRebRjRgbRhb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 2; Drug: Control Apo 0.5 然
bLibRsLsbRjbLcbLiLsbRgbLibLgbLiLsLsmbLsLsmbRjbLcLsmbLibLsbLiLgbRibLhbR
hbLhbRsRsmbLgbRibLcbRsbRjbLcbLhbRsbLiLsbRibLibLibRjbLhbLhbRgbRsbRibLiL
sbRibRibRgbLsbRiLsbLsbLsbRibRsbRsRsRsmmbLsbRiLsbRgbLibRibLgbRiLsbLgbRi
bRiRsmbRgRsmbLsRsbRgRsmbRsbRgbRsbLsbRiRsmbLgbRibLsbRgbLsbRgbLsbRgbRgbL
sbRiRsmbLgRsbRibLsbRsbRiRsmbRsbRgbRsbRgRsmbRsbRsRsmbRgRsmbLgbRibRsbRsR
smbRgRsmbRsRsmbRgbRgRsmbRsRgbRgRsmbLsbRibRgbLgbRibRgbLibRibRgRsmbRsbRg
bRgRsmbRgbRsbRgRsmbRsbRiRsmbLsbRibRibRibLibRibsbRiRsmbRsbRgRsmbRgbRgbR
gbRgRsmbLsbRgbRsbRgbLsRsbRsbRsbRgbRgbRgbLsLsmbLibLgbLibLsLsmbLgLsbRsbL
ibRsbLgLsbLibRiLsbLhbRiRsmbLhbRibLhbRgbRhbRhbLgLsbRgbRibLsbRgLsbRgbRiL
sRsbLjbRibRgbRsbRgbRibRiLsRsbLcbRibRsRibLgbRibRsbRgbRsbRgbRsbRgbLgbRib
RgbLsbRgbRgbRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 3; Drug: Control Apo 0.5 然
bLsbsbLibRsbLsbLgbLgLsbLsbLsbLgbLibLibLgbLcbRgbRebRibRsbRibLjbRsRsmbLi
bRebRibRsbRsbRgLsbRjbsbRgbRgbRgbRsbRiLsbRgbRgbRhRsmbRibRsbLsbRibRsbRsb
LsbLsbRsbRsbRgbRgbRibRsbRsbRsbRgbRsbRibRsbRgbRsbLsbLgbRsbRgbRgRsmbRsRs
mbRsbRsbRibRsbRsbRsbRsbLsbLibLjLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 4; Drug: Control Apo 0.5 然
bRibRibLsbRsbRjbRibLsbRsRsmbRgbRsbRgbRcRsmbLsbRgbLibLgbLsbRibLebLibRib
RibRjbRgbLcbLibRsbRgbLsbLibRsbLibLsbLibLibLiLsbRsbRsbRgbLibLsbLsbLhbLg
bLibLsbRibLibRgbLibLibLsbRsbRsbRsbLgLsbLsbLibLibLgbLibLsbRibLgbLibLsbL
ibLgbRgbRjbLhbLsbLsbLiLsbLsbRgbLibLgbRjbLgbLibLsbLgbLibLsbLsbLsbLgbLgb
sbLibsbRibRibLsbRgbRcbRibLgbRgbLgbRibLsbsbRgbLgbRibRibRgbLjbRibLibRibR
gbRcRcbLsbRgbRjbLebLsbLiLsbRgbLibRgRsmbLibRgbLiLsbRgbLgbRsbLiRsbLsbLsb
LsbLsLsmbLgbLsbLsbLgRsbLsbLsbLsbRgLsbLoRsRsmbLgLsbLgbRgbRgbLsbLsbRgbRi
bRgbRibRjbRsbRibRgbLjbRibRibLjLgbLsbRgbRibRsbLjLsmbRgRsmbLsRsbLibLgbRg
bRhRsmbRsbRjbRgbLjbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 5; Drug: Control Apo 0.5 然
bLibRjbLibRcbRcbsbLjLsmbLjbRhbRcbLibLjbLcbRcbRjbRibRsbRsbRsbRsbRsbRsbR
gbRgRsmbRsbRsbRsbRgbRsbRibLsbRgRsmbRsbRgbRgbRgbRgbRgbRsbRgbLsbRgbRsRsm
bRgbLjbRhbLjbLibLibRcbRsRibRibLgbLjbLibLibLibRcbLiLsbLibLsLibRsbLgbLgb
RgbLiLsRsbRhbLibLibRjbLhbRhbRcRsmbRsbRgRsmbRsbRsbRsbRsbRsRsmbRsbRsRsmb
RgbLsRsbRgbRgbRsbRsbRgbRgbRsbRsRsmbRsbRgbRsRsmbRgbsbLjLsmbLcbLiLsbLgbR
ibLgbLgbLibRsbRjbLibRcbRgbRgRsmbRgbRsbLsbRibRibRiLebLibLgbLgbLgbRcbRib
RibRgbLgbRiRsmbLsbRsbRgbRsbRsbRsbRgbRgbLjbLiLsbRcbRgbRsbRsRsmbLsRsbRsb
RsbRsbRsbRgRsmbRsbRsbRsbRsbRgbRgbRsRsmbRsbRsbRsRsmbLsRsbRgbRgbRsbRsbRs
bRgbRsbRsbRsbRsbRibRgbRgbRsbLhbRhbRibLsbRsbRgbRsbRsRsmbRgbRsRsmbRgbRsb
RsbRgbRsbRgbRsbRsbRgbLgbLhbLibRcbLcbLibRjbLhbRiRsmbLibRjbRjbRgbRgbRsbR
sbRgbRgRsmbRgbRsRsmbRsbRgbRgbRgbRsbRgLsbRgLsbRgbRsbRsbRgbRsbRsbRgbsbRs
RsmbRsbRsbRgbRgbRgbRsbRgbRsRsmbRgbRgLsbRsbLsbRsRsmbRgbRgbRsbLcbLibRcRs
mbRibLjbLibRcbRibRsbLgRsbRiRsmbRgbLibRebLibRiRsmbRsbLgbLjRsbLibRcbRibL
gbRgLsbRgRsmbRsbRgbRsbRsbRgbRsbRsbRsbRgLsbLjbRibLsbRsbRgbRsbRgbRsbRsbR
sbRgLsbRgbRibLjRsbLjbLibLibRibRibRgbsbRsbRsbRgbRgbRsbRsbRsbRsbRgbRsbRs
bRgbLsbRsbRgbRsbRgbRsbRgbRgbRsRgbLgbRgbRibRgbLgbRiRsmbLgbRibLgbRibLsbR
gbRgRsmbRsRsmbRgbRgbRgRsmbRsLsbRgbRsbRsbRsRgRsmbRsbRsbRgbRgbRgbLsbRibL
hbLhbLibRhbLhLsbRibLhbRjbLibLsbLgLsRsbRgbLibRsbLibRjbRcbRgbsbRsbRgRsmb
RgbLsbLsbRgbRgRsmbLgbRibRsbRsbRgbRgbRsbRsbRgbRsbRsbRsbRgbLsbRgRsmbLsbR
gRsmbRgRjbRgbRsbRsRsmbRsRsmbRgbRsRsmbRsbRgbRibLjbLcbLsLibRjRsmbRjRsmbR
ibRsbRgbRgbRsbRsbRsbLsbRibLsbRgRsmbRgbRsbRsbRgbRsLsbRgLsbRsbRsRsmbRgbR
sbRsbRgbRgbRsbLgbRgRsmbRsbRsbRgLsbRsbRsbRsbRsbRgLsbLsbRsbRgbLcbLibRibL
gbLibRjbRoLsbLebLhbRjbRcbRsbRsbRgbRgbRsRsmbLjbLibRibRhbLcbLibRcbRobLsb
LsbRsbRsbRibRsbLgbRhbLibRhbRsbLsbLcbLgbRgbLgbLiLsbRjbLgbLgbLgbLgRsbRcb
RibRgbRsbRgbRsRgbRsbRgbRgbRgRsmbRgbRsbsbRgbLsbRgRsmbRgbRgbRgbRgbRsbRsb
RsbRgRsmbRsbRsbRsbRgbRsbRsbRsbRgbLsbRsRsmbRgbLsbLcbLibRsbLibLiRsbRjbRc
bRibRgbRsbRgbRsbRgbRgbRsRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 6; Drug: Control Apo 0.5 然
bsbLsbRjbLsbRsbsbLsbLsbLsbLsbLgRsbLsbLsbsbLgRsLsLsmbRsbLgbLjbLsbLsbLgb
LgbLsbRgbLsbLsbLsbsbLgbRsbLsbRsbRsbRsbLgbRsLsbLjRsbRsbRjbsbRsLsbRsbLsb
RsbLsRsLsLsmbRsbLsLsmbLsbRsRsmbRsbRsbLsbLgLsbRgbsbLsbLsbLsbLsbRsbLsbLs
bsbsbsbsbsbLsRsbLsLsLsmmbLsbLsbLsbLgLsbRgbLsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bLgbLgbLibLgbLgbRjbLjbLibRcRsRsmmbRibLsbLsbsbRibLsbRsbLgbRgbRgRsmbLibR
gbRibLsbRsbRgbRibRgbRgbRsbRgbRgbRgbLjLgbRgbRsRsmbRsbRsbLgbLsLsLsmmbRib
RsbRgbRsbLibLsbLsLsmbRjRsmbLsbLsbRgRsmbLsbsbLgbsbRgRsmbRgbRsbsbRibLsbs
bLsbRgLsbRibLsRsbRibRsbRgbRsbRsRsmbLsbLjbRiRsmbRgbRgbsbRsbsbsbLjbRgRsR
smmbRsbRgbRgRsmbRgbsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bRsLsbRgLsbRsbRgbRsbRgLsbRgbRsbRgbRgbRsRsmbRgbRsbRsbRgbRsRsmbRsbRsbRgb
RsbRgbRsLsbRgbRsbRgbRsbRsRsmbRgbRgbRgbRgbRgbRgbRgRsmbRgbRsbRibRiRsmbRg
RsmbRsbLjbRibRsRsmbRsRsmbRgbRsbRgbLsbRibRgbLsbLsbRibRibRsbRgbRsbRsbRgR
smbRsbRsbRgbLjLsmbRgbRiRsmbRsbRgRsmbRsbRgbRgbLsbRgRsmbRsRsmbRsRsmbLgbL
ibLgbLgbLsLgbLgbRsbRsbLgbsbLgbLgbRsbRcbRibLsbRgbLsbRgbRsRsRsmmbLgbRiRs
mbLgbRibRgbRsbRsRsmbsbRsLsbRgbRsbRgbRsbLsbRgbRsRsmbRibLsbRgRsmbRsbRgbR
sbRgbRsbRibRsbRsbRgbRsbRgRsmbRsbRgbLgLsbRgbRgRsmbLsbRgbRsRsmbLsRsbRibR
sbLsbRgbRgbRgbRgbRgbRgbRgRsmbRsbRgbRsbLsLsmbRgRsmbRsbRsbRgbRsbRgLsbRgb
RsRsmbRgLsbRsRsmbRsbRgRsmbRsbRsbRgbRgbRgbRsLsbRsbRgbRsbRsbRgbRgbRsLsbR
gbLsRsbRgbRgbRgbRsbRgbRgbRgbRgRsmbRsbRgbRgbRgbRsbRgbRsbRgbRsRsmbRgbRgb
RsbRgbRsRsmbRgbRgbLgbRibRgbRsbRsbRgbRsbRgbRsbRsRsmbRgRsmbRgLsbRgbRgbRg
bRsbRgbRgbRsRsmbRgbRsbRsbRgbRgbRsbRsbRgbRsRsmbRgbRgbRgRsmbRsbRgbRgRsmb
LsbRibRsRsRsmmbRsbRgbRgbRgbRgRsmbLgbRibRgbRgbRgbLsLsmbRibRsbRgbRsbRgbR
sbRsbRgbRsbRsbRgbRgbRgbRsbRsbLsbRgbRgbRsbRsbRsbRsbRgbRsLsbLsbRgRsmbRgb
RgbRsbRsbRgbRgbRsbRgbRgbRsbRsbRgRsmbRsbRgbRsbRsbRgbRsbRsbRiRsRsmmbRgbR
sbRgbRgbRgbLsbRibRgRsmbLsLsmbRibLsRsbRgbRgbRsbRibRsbRsbRgbRgbRgbRgbRsb
RsLsbRgbRgbRsbRgbRsbRsRsmbRgbRsbRgbRsbRgbRgbRsbLsbRibRsbRgRsmbRsbRgbRs
bRsbRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bLgbLsLsmbLgbLgbLibLgbLibLgbLgRsbLgbLibsbLibsbLgLsbRjbRibRhbLsbLibLjLs
mbLsbRsbLibLiRsbLibLibLsbRgRsmbLgbLsbLgbLgbRgbLibsbLcbLsbLgbLgbLgbLgLs
bRgbLgbLgbLibLgbLgLsbLsbLgbLibLsbLsbLsbLsbLgbRsbRsbLjLsmbLsLsmbLsbLgbL
ibLsbLsbLsbLsbLgbLgbLsbLsbLgbLsLsmbRsbLibLgbLgbLsbLgbLgbLgbRgRsmbRsbLi
bLibLsbLibLgRsbRjRsmbRsbLgbLibLsbLibLiLsbLiLsbLgbRsbLsbLgbLsbLgbLsbLsL
sRsmbLsbLsbLsbLgbLsbRgbRsbLgbLsbLsLsmbLgbLgRsbLsbLgbLgbLsbLgbLgbLsbLsL
smbLgbLsbRibLsbLgbLgLsbLsbLsbLgbLsbLsbLgbLsLsmbLgbLsbLsbRsbRsbLibLsbLi
bLgbLibLgbLgbLgbRsbRgbRiRsmbLgbLsbLgbLiLsbLiLsbLibLibLgbLgbLgbLgbLsbLg
bRsbLibLsbLjLsmbLsLsmbLgbLibLhbLsbLjLsLsmmbLgbLgbLsbLibLiLsbLibLgbLsbL
gbLgbLibsbLgbLiRsbLibLibLibLiLsbLgLsLsmbLgbLgbLsbLgLsbRgRsmbLgRsbLgbLg
bLibLibLsLgbLgLsbsbLcbRjbLjLsmbLsbRsRsmbRsRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bRjbLibRgbRjbRjbRcbRibRiRsmbRjRsmbLgbsbRgRsmbRgbLgbLsLjLsmbLgRsbRiRsmb
LibLgbRgbsbRsLsbRcRsmbRcbLgbRgbLsLsLsmmbLsbRsbRibRibRsbRibRgbLjbLibLgL
sbRsRsLsmbLgbLgLsbLgbLsbsbLgbRjbRibRgbLjbRjRsmbRjRsmbRjRgRsmbLiLsbRibL
ibLibLgLsbRjRsmbRibLsbRibLibRgbRsbRibRibLjbRibLjLsmbLjbLibRsbRjbRibRiR
smbLjLsmbRgbLjbRgbLcbLhbLsbLgbRjbLjbLgbLibRjRsmbLibLibLgbRiRsmbRibLjbL
jbRcbLcbLibLjLsmbLjbLjLsmbRibLjbLiLsbRjbRsbLibLsbRgRsmbRcLsbLjbRgbRibR
cRsmbRjRsmbRibLsbLgbLibRibLjbRibRibLjbRgbLjbRibLibLgbRgbRjbRjRsmbRjbLj
LsmbRjRsmbRiLsRcbRjbRgbRibLibLiLsLsmbRgbLcbLibLibLibRjbLjbLhbRcbRibLgR
ibLjLsmbRibRiLsbLjbLcLsmbLgbRjbLhbLibRhbLjbLiLsbLhbLhbLibRjRsmbRibRibL
jLsmbLcbsbsbLgbRsRsmbLgbLgRsbRibLjLsmbRsRsmbRjbRjbLibLibRjbLibRgbLgLsb
LgLsbLgbRjbLibRsbRsRcbRgbRgbRgRsmbRgbLsbRgbLjLsmbLgbLgbLgbRjbRibLjLsmb
LibRjbRibLjbRibRibLibRgbRgbLjbRibLcbRjbRjbLibRobLgbLgbRsbLgbLjLsmbRgLs
bLgbLgbLibRjbLibLgbLgbLgbLgbLsbLsbLgbLsLsmbLsbLgbLsbLsbLsbLgbLsbLsbLsb
LgbLibRjbLibLiLsbLgbRjbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bLsbLgbLibRgLsLsmbLsbRsRsmbLiLsbRcRsmbRgbRgbRsbRgbLjbLcbLibLibLcbRgLsL
smbLiLsbRsbLibRsbLgLsbRsbRsbLgbRsbLgLsRsRsmbRsbLgLsbRsbLgbLibRjbLhbRgb
LibLhbRsbLibLsLsmbLgRsRsmbRsbLgbRgbLgbLsbLiLsLsmbLsbLgLsbRsbLgbRsbLgbR
jbLiLsbLgbRgbLgLsbLsbLjRsbRjbLiLsbLsbLsbRsbLjbLsLsmbLsbLsbLgbRsbLsbLgb
LgLsRsbLgRsbLsbLgbsbRsbRjbRhbLcRsbLsLibRjbRibRgbRsbRsbRgRsmbRsRsmbRgbR
iLsbLjbLcbLiLsbRsbLgLsbRhRobLgbLgbLgbLgbLsbLgbRjbLibLgbLsbLgLsbLiRsbRg
RsmbRcbRibRsbRsbRsbRcLsbLcbLibLibLgRsbLgbLsbLgLsbLibRsbLgLsbLsbLgbLsbR
sLsLsmbLjbLsbRsLsbRsRsmbLgLsbLiRcRsmbRgbLsbRgRsLsmbRgLsRsbRgRsmbLcLsmb
LibLiLsbRibRjbLebLibLsbLsbsbLgbRgbLgbLgbRcbRibRgRsmbRgbLsLsRsmbLcLgbLg
bLsbLgbLsbLgbRsbLgbRsbLsbRsbLibLgbRsbLibLsbRsbLgbLgLsLsmbLgLsbRgbLibLg
bRgbLibRcbRibRsRsmbRgLsbRsbRgbRsbRgbLobLibLgbLgbRjbRcbRsbRgRsmbRgbRgbR
gbRgbRibRgbLsbRsRgbRjbRsbRsbRgbRgRsmbRgbRgRsmbRsbLgbLobLgbRgbLgLsbRgRs
mbLgbsbRjbLibLsbRcLsRcbLcbLjbRjbLsbRcbRibRgbRgLsbLcbLibLibRsbLgLsRsbRs
bLiLsbRsLsbLibLgbLgbLsbLgbRcbRibLhbLgbLgbRjbRcbLcbLibLgRsbRjbLibLgLsbR
gbLgbLgbRgbLsbLgbLgbRgbLibRgbLibRjbLibLgLsbRgbLibLsbRsbLgbLgbLibRgbLgb
RibLiLsbLgLsbRsbLgbLgbRibLibLgRsbRcbLsLsRsmbRibRcbLcbRjbRgLsbRgRsmbRgb
RsbRgbLhbLibLgbLsbLgRsbRobRibLsLsmbLcLsmbLiLsbRgbLibLsbLgbRiLsbLibLgbR
gbLibLgbRjbRcbLsbLibLgbLgbLgbRcLsbRibLjbRgbRiLsbRiRsmbRgbLsbRgbRgbRgLs
bLsRsbLcbLgbLgLsbLsbLgbRjbLibLgbRhLsbRgbRgbRsbRsbRsbRsbRsbRsbRsbRgbRsL
sbRgbRgbRgbLsRgbRgbRgbLcbLcbRjbRhbRibRgRsmbRsbRsbRgbLcbLhbLibRjbLibLsb
RsbLsLiLsbsbRjbLiLsbLsbLsLgLsbRsbLibLsbRgRsLiLsmbRgbLiLsbLsbLgLsbLgbRs
bLgbRsbLgbRgbLiLsbRibsbLjbRsbRgbRsLibRsLsbLgbRjLsbLibRgRsmbsbLibRgbLgb
LgbLgbLsbLgbLgbLsbRgbLiLsbLsbRjbLiLsbLgbRgbLiLsbLgbLiRsbLibLsbRgbLibLg
bLsbLsbRgLsbLibRsbLiLsbLgLsbLebLiLsbLgbRgbLibLsbLgbRjbLibLgbRgbRsLsbLg
bLgbRjbLibRjbLgbLiLsbRsbLgbLsbLgbLgbLsbLsbLgbRcbRcbRgbRgLsbLcbLgbRgLsb
LiLsbLsbLgbLsbLsbLsbLgbRsLsbLgbRjbsbRcbRgRsmbRgbRsbRgbLcbLiLsbRsbLsbLg
bLsbLsbLgLsbRsbLgbRgbLiLsbLsRsbLgLsbRsbLgbLsbLgbLsbLgbLsbLgbRcbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bLsbLsbLgbLjbLcbRjbRibRibRgbRgbRsbRibLsbLgbRgbRibRibRsbLsbRsbRsbRgbRsb
RsbRgbRsbRhbRgbRgbLgbLsbLibLjbLibRsbRjbRibRibRgbLgbRibRgbLsLsmbLgbRgbR
gbLsbRiRsmbRsbRgbRsbLjbRhbRiRsmbRsbRgbRsbRsbRgLsbRsbRgbRgbRgbRgbRsbRgb
sbLjLsmbRibLhbLsbLsbLgbRibLsbLgbLgLsbLgLsbLibLsbRsRsmbRgRsmbRgbRgbRiRs
mbRgRsmbLgbRibLsbLgbLsbRgbLibLibRsbRsbLgbLsbRgbLsbLjbLibLibLjbLgbsbRjb
LibRsRsmbRsLsbLsbLsbLibLgbRibLgbLsbLgbLgbRsbRgbRsbRjbRcbRsbLsbRgRsmbRs
bRgbRsbRgbRiRsmbRsbRsbRsbRsbRibRsbLgbRgbLsbLsbRgbRsRgbRsbLsbsbRgbRsbRs
bRgbLsbRsbRgbRsbLsbRgbRsbRsRsmbRsbRibRgbsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bRsRsmbRiRsmbRgRsmbRgbRgbLsRsRsmbRgbRgbRibLgRsRsmbRiRsLsmbRgbsbLsbLjbL
cbLgLsbLgbLgbLgbRgbLgbLibRjbLibLcRsbRebRhbRgbRgbRsbRsbLsbRsbRsLsbLsbRs
bLsbLsbRgRsmbRgRsmbRgbRgbRgRsmbRgbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgbRgb
RgbRgbRgbRgRsLsmbRgRsmbRibLgbRibRgbLjbsbLcbLiRsbLgLsbLsbLgbsbLgbLgbLgb
LgbRsbLgLsbRjLgbLibLsbLibLgbRsLgbLgbRgRsmbLgbLgRsLsbLsbLgbLsRsbLgbLgbR
jbLgbLgRsbLibRcbRhbRgbLgbRibLhbLiLsbLsLsmbRsbLgbLgLsbLgbLsbRsbLgLsbLgb
RcbRiRsRsmmbRsbRgbRsbRgRsmbRsRsmbRsbRsRsLsmbRsRsmbLsRsbRgbRsbLcbLibRcb
RcbLgRsbRibRsbRgbRgbRgLsbRgbRgRsmbRsbRgbRsbRsbRsRsmbLsbRgbRgbRgbRgbRib
RsbLobRcbRcRsRsmmbRibRsLoLiLsbLgbLgbRsbLgbLibRcbRobLsbRibLsbRibLsbRgRs
mbRgbRsbRibRsbRgbRgbRgbRgbRsbRsbRgbRgRsmbRgbLsbRsbRgbRsbRjbLsbRsLsRsbR
ibRgbRgbRgbRgbRgbRgbRgbLjRsLibLibLibLgbLgLsbLsbLsbLgbLsbLgbLgLsbLgbRjb
LgbRcRibRsbRgRsmbRgRsmbRsbRiRsRsmmbRgLsbRgbRsbRsbRsbRgbRgbRgbRsbRsbRsb
RgbRgbRgRsmbLgbRiLsbLhbLibRjbRhbRsbRgbRsbRibLsbLsbRsRsmbRsbLsbRjbRsbRs
bRgRsmbRgbRgLsbRgbRgbRgbRgbRsbLsbRsbRjbRsbsbRgRsmbRsbRibLibRibRjbRgbLs
LsmbRibLsbRibRgbRjbsbsbLsbRibLjbRibLgbRibLcbLibRcbRibLsbRgbRsbRgbRsRsm
bLgbRsbRsbRsbLsbRjbLsRsbRsLsbRgLsbRsbRsbRsbRjbRsLsbRgbRsbRjbRgbsbLsbRg
bRgLsbRsbRgbRsbRsbRsbRibRjbRsRsmbRsLsbRgbRsbRsbRgbLsbRsbRgLsbLsbRgbRgR
smbLsbRgbRsbRibRsbRsbRgbRsbRsbRsbRsbRsbRgRsmbLgbRibRgRsmbRsRsmbRsbRgbR
gbRibLgbRiRsmbLgbLobRjbRibRibLsbRgLsbRsbLsRgbRsbRgRsmbRsLsbRgbRsbRgbRs
bRsbRsLsbRgbRsbRgbRsbRgbRsbRsRsmbRgbLgRsbRsbRsbRsbRjbRsbRsbRgbRibLjbLh
bRjbRibRibLgbRibRgbRgbRgRsmbRsbRgbRsbRgLsbRsbRgLsbRgbRsbRsbLsbRjbLgbRg
RsmbRgRsmbRgRsmbRsbRgbRgRsmbLgLsbRibRsbRgbRsbRsbRsLsbRgbRgbRsbRgbLsbLs
bLsRsRiRsmbRgbRgbRsbRgbRsbRgbRsbRsbRsbRsbRgbRsbRsbRgbsbRsbRgRsmbRgbRsb
RsbLsbRgRsmbRgRsmbRsbRgbLsRsbRibRjRsmbRjbRsRsmbRsbRgbRsbRgbRsRsmbRgbRg
bRgbRsRsmbRgRsmbRsbRgbLsbRjbRsbRobRgbRsbRsRsmbLsbLsbRgRsmbRgbRgbRgbRgR
smbRgbRsbRgbLgbLhLiRsbLibReRsmbRibRibLsbRsbRibLsbRiLsLsmbRgbRgRsmbRgRs
mbRgbRgbRgbRgbRgbRgbLsRsbRsbRgbRgbRgbRsbRsbRgbRgbRgbRgRsmbRibRebRgbLgb
RibRgbRgRsmbRgRsmbRsLsbRsRsmbRsbRgbRgbRgRsmbRgRsmbRgbRgbRsbLsRsbRgbRgb
sbRsbLsRiRsmbRsLsbRgRsmbRgbRsbRgbLsRsbRgRsmbRsbRgbLsRsbRibRgbRgRsmbLsb
RgbLsLsmbRgRsmbRsbRsbRgbRsbRgRsmbRgbRgbLsbRgRsmbRgbRsRsmbRgbRsbRgbRiRs
mbRgbRgbLebLgLgbLgbLsLgLsbLsbLgbRibRcbRibRgbRgbRgbRsbRgbRsRsmbRgRsLsmb
RsbRsRsmbRibRgbRjbLsRsbRgbRsRgbRgbRgRsmbRgbRsbRsbRgbRsbRsbRsbRsbRsRsmb
LjbRibRsRsmbRsRsmbRsbRsbRgRsmbRgbRgbRsbRgbRsbRgRsmbLsLgbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bRgRsmbRgbLjbRibRgLsbLibRiRsmbRsbRgbRgRsmbLsbsbLsbRjbLhbLibRsbLibRjRsm
bRhbRjbRsbRsbLobLobRgbRgbLjbRiRsmbLsbLjbRiRsmbRiLsbLsbRibLgLsbRsbRiRsm
bLsbRjbRsbRsbRsbRsbLsbRgbRsbLjbsbRsbRsbRsRsmbRsbRgbRgbLjbLcbRjbLcbRgbL
ibsbRjbRcbLhRsbLiLsbRjbRcbRsRibRsbRgbLsbRgbRgRsmbRsbRsbRgbRgbRsbRsbRgb
RsbRsbRsbRgbRgbRsbRgbRgbRgRsmbLgbLjbLhbRcbRebLjbRibRgbLsbLsbRibLsbRgbL
sbLsRgLsbLsbRgLsRsbRgbLsRsbLsbRgRsmbRgbRgbLjbRibLjbLhbLibRjbRjbRgbRiRs
mbLsbRgbRsRsmbRsbRsRsmbRgbRsRsmbRsbRgbRgbRsRsmbLsbLjbLcbLgbRjRsmbLibRj
bLcbRcbRcbLhbRcbLjbRgbRiRsmbRgbLgbRgbRsbRgbRsbRgbRsbRsbRgRsmbRsbRgLsbR
sbRgbRgbRgbRsbRgbRgbRsLgbRiRsmbLjbRibRgbLsbRsbRibRsbRgLsbLgbRsRiRsmbLs
bRsRsLsmbRsbRibLsbRsbRgbRgbRgbRsbRsLsbRsRgbRsRsmbRgbLjRsbLibLibLibRjbL
iLsbRobRcRsmbLibRgbRibRgbLsRsbRgbLsbRgbRsLsbRsbRjbRsbLsbRjbLsbLcRsbRcb
LjRsbLibLjbLsbLibLsbRjbRcbLgbsbLgbRobRebRhbLebRgbRgbRgbRsbLsbRgbLsbRgb
RsbRsbRgbRsRsmbRgbRgbRgbRgbLibLgbRjbRebReRsmbRjbLcbLgbLgbRjbRebLibLibL
ibRjbLibLibRcLsbRjbLibLhbRhbRebLibLhbLibRjbRjbLsRjbLsbRsbRsbRsRsmbRsRs
mbRgbRsbRsbRgRsmbLibLjbsbRhRsRsmmbLcbsbRcbLjbRibRsRsmbRsRsmbLibRjbLibR
jbLgLsbLgbLsbLsbLgbLgbRcbRsRsmbRgbRsbRsbRsbRgRsmbRgbRsbRgbRgbLsbLgLsbL
jbLibRjbRjbLjbLibRgbRsbRgbRgbRsbRsbRgbRgbLjbLcRsLsbRebLhbRjbLcbRcbRjbL
iRsbLsRsbRsbLsRsbLgbRgRsmbRibRgbRgbRsbRgbRhbLibRibLgbRibLsbRibLibLibRe
RsmbRibLjbLjbLiLsbLibRjbRcbLjbLhbRcbRiLsbLjbLebRsLsRsbRsRsLsmbsbLebRjb
RgbRgbRsbRgbRsbRgLsbLgbLjbLibRcbRhbLgRsLsbRibLjbLjbRcbLjbLhbLgbLgbLsLs
mbRsLsbLgbLsbLsbLsbLgbRjbRcbRibLiRsbRiRsmbRsbRsbRsbRgbRsbRgbRsbRsRsmbR
sbRsbRsbRsbRgbRgbRgRsmbRgbRsbRgRsmbLgbRhbLibRibLsbRgbRgLsbLgbLsRibLjbs
bRibLiRsLsbLcbLibRsbLgbRgbLibLgbRhbRgbRgbRsRsmbRsbRsRsmbLsbLsbRgbRgbLs
bRsRgRsmbRsbRgLsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bRibLgbLgbLgbRsbLgbLgLsbLgbRsbLsbLiLsbLgbLsbRgbLibLsLsmbLgbRsbLibLgbRg
bLiLsRsbLsbLsLsmbLgRsbLgbLsbLgbLoLsmbLgbLgbLgbLgbLsbRsbLiLsRsbRgbLsLib
RgbLsLsLsmmbLiLsbLgbRgbLiLsbRsLsbLgbLsbLsbLsbLgbLgbLsbLgRsbLgbLgLsbRsL
sRsbLsLsmbLgLsbLgbLsbLgbLgbLgbLsbLgLsbLibRjbLibLibRibLgbLgLsbLsbLsbLsR
sbLgLsbLgbLgbLgbLgbLsbLsbLsbLibLgbLgbLgLsbLgbLgbLgbLgbLgbLgLsbRgbLgLsb
LgbLgbLsLgRsbLgbLgLsbRsbsbLgLsLsmbRsbLgbLsLsmbLgLsbLgbLgLsbLgbLgLsbLgL
sbLgbLibRgbLgbLgbLgbLgbLsbLgbRsbLibRjbLibLiLsbLsLsmbLgbLgbLgbLsbLgLsbL
gbLgbLgbLsbLgbRgbLibRjLsbLibRgbLiRsbLgbLgbLgbLgbLgbsbLgbLgLsbLgbLgbLsL
smbLgbLgbLsbRgbRsbLgbLgbLgbLgbLsLsmbLgbLgbLsbLsbLsbRjbLjbRcbLjLgLsbRib
RsbLibLgLsLsmbLgbLgbLgbLgLsLsmbLsLsmbRsLsbLibLgbLsLsmbLgbLgbLgbLgbLgRs
bRsbLibRsbLgLsbLsLsLsmmbLgbLsbLgbLgbLgbLsbRgbLibLgbLgbLgbLgbLgbLsbLgRh
bLobLgRsbLgLsbLgbLgbLgbLgbLgbLgbLgLsbLgbLgbLgbLgRsbLgbLgbRgbLiLsbLgbRs
bLiLsbLsbLgbLgbLgbLgbLgRsbLgRsbLgbRjbRibRibRgbRgRsmbRsRsmbLjbRgbLebLiL
sbLibRsLsbsbLiLsbLiLsbLgbLgbLgbLsbLgRsbLgbLgbLgbLgbLsLgbLgLsLsmbLsLsmb
LibLgLsbLsRsbLgbLgbLgbLgbLgRsbLgLsbLgbLsbLgLsbLsbLgbLgLsRsbLsLgbLgbLsb
LgbLsbLgbLgbLgRsbLgbLgLsbLgbLsbLgLsbLgbLsbLgLsbRgbLibLgbLsbRgbLiLsbLgb
RsbLgLsbLgbLgbLgLsbLgbLgbLgbLgbRjbRhRsmbLebLibLiLsLsmbRibLhbsbRsbLibLg
bRgbLgbLibLsbLgLsbLgLsLsmbLgLsbLgbRgbLibLgbRgRsmbsbLsbLiLsLsmbLgLsbLgR
sbLgbLgRsbLgbLgLsLsmbLgbLsbLgLsbLgLsbLgbLgRsbLsLsmbLgbLsbLgLsbLsbLgbLs
bLgbLgbLsLsmbLgbLgbLgLsbLsbLgRsbLgRsbLsbLibLgbLibRibLibLibRibLibLibLgL
sRsbRgLsbLibLsbLgbLsRsLsbLgLsbLsbLsbLgbLgbLgbLgbLgbLgbLgRsbLgbLgLsbRjb
LibLibLgbRgbLsbLhbLgLsbRiRsmbLiLsbLgRsbLgbLgbLgbLgbLsbLgbLgbLgbLiLsbRi
bRsbLhbLgLsLsmbLgbRjbLibLsbLibLgbLgbLgLsbRsLsbLgLsbLsbLgbLgbLsbLgRsbLg
bLsLsmbLsLsmbLgbLgLsbLgbRcbLcLsmbRsRsmbLsbLiLsbLsLsmbLgbLgbLgbLsRsbLgb
LsbLsbLgbLgbLgbLibRgLsbLibLiLsbRibLibLgRsbLgbLgbLgbLgbLgbLgbLgbLsbLsbL
sbLibLibRjbLhLsbRibLsbLibLgbLsbLgbLgRsbLgbLgbLgbLgbLgbLgbsbLsbLgbLgLsb
LgLsbLsbLsbLgbLgbLsbLsbLsbLiRsbLgbRgbLibLgLsbRgRsmbLibLgbLgRsbLgLsbLgb
LebLsbLgLsbLsbLgRsbLsLsmbLgbLsRsbLgbLgbLgLsbLsbLgLsbLsbLgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bRgbRsbLsbRibRgRsmbRgbRgbRgRsmbRsbRgbRgbRsRsmbRgRsmbRgbRgRsmbRgbLsRsbR
iRsmbRgRsmbRgbRgRsmbRgbRgRsmbRgRsmbRgRsmbRgbRgbRsRsmbRsRsmbRgbRsbRgLsb
RgbLjbRibLgbRibRibLgbRibRsbRgbRgRsmbRgRsLsmbRgRsmbRgbRgbRgRsmbRgbRsRsm
bRgbRsRsmbRebRiLsbRgbRsbRgbRsbRgbRgRsmbRgbRgbRgRsmbRgbRibRiRsRiRsmmbRi
RsRsmmbRibRgbRgbRgbRsbRibRgRsmbRgRsRsmmbRsbRgbRgbRgbRgRsmbRgRsmbRgRsmb
RgbRgRsmbRgbRgbRgbRgbRiRsmbRgbRiRsRsmmbRgbRgbRgRsmbRgbLibLsbLjLsmbLibL
gRsbLoRsbRcRsmbRiRsmbLsbRibRsbRgbLsRsbRgbRgRsRsmmbRgbRibRgRsmbRgbRsRsm
bRsbRgbRsbRgbRgbRgRsmbRgbRgbRgLsbRsRsmbRhRsmbRgbRsbRiRsmbRgbLsbRiRsmbR
gbRgbRgRsmbRgRsmbRgbRgRsmbRgbRgRsmbRgbRgbRsRsmbRgbRgRsmbRsbRgbRgbRgRsR
smmbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgbRgRsmbRgRsmbRgbRgbRgRsmbRsbRgbRgb
RgbRgLsbRsRsmbRgbRgRsmbRgbRgbRgbRsbRgbRgbRgbRgbRsbRgRsRsRsRsmmmmbRgRsm
bRgLsbRiLsbLcbLibLibRobRibRgRsRsmmbRsbRgbRgLsbRgRsmbRgbLsRgbRgbRibRsLs
bRgbRgbRgRsmbRibRhRhbRgRsmbRgbRgbRgbRgLsbRgLsRsbLsbRibRgRsLsmbRgbRgbRg
bRgbLcbLhRsbLiLsbLgLsbLgbLsbLgbLgbRiRsmbRgbRsbRsRsmbRgRsmbRgbRsbLjbRhb
RsbRsbRhbRibRjbRsbRsbLjbRiRsmbRgbRgbLebRibRibRiRsmbRgbRgRsmbRgbRgRsmbR
gbRgbRgbRsbRgRsLsRsmbRgbRgbRgbRgbRgRsRsmmbRgRsmbRsbRibLsRgRsmbRsbRgbRg
bLcbRsbLgbRebRgLsbRgbRjbRsRsmbLsLsmbRibRgbRgRsmbRsbRsRsmbRgbRgLsbRgRsm
bRsbRgRsmbRsRsmbLcbLibLgbLsbLsbRebRibRiRsmbRsbRgbRibLgRsbRgLsbRgbRsbRs
RsmbRiRsmbRjbRsRsmbRgRsmbRgbRebRoRsmbRibRgbRgbRgbLgbRiRsmbRgbRsbRjbRsb
RsbRjbLsbRibLsbRgbRgbRgbRsbRjbRsRsmbRgLsbRgbRgbRgRsmbRgbRsbRgbReLsRsbL
jLsmbRibLiRsLsbLobLibRsLsbLcbLgbLiLsRsbLcbLibLsbRibRibRgbRgRsmbRgbRgbL
sRsbRibLsbRiRsmbLsRsbRiRsmbRgRsRsmmbRgRsmbRgRsmbRsRibRgbRsbRgbRgbRgbRg
bRgbRsbRgbRgbRgbRgbRgbRgRsmbRjbLjbRgbRiRsmbRgbLobRiLsbRiRsmbRsbRjbLsRs
bRibRgbRgbRgRsmbLibLhbLgbLgbLgbLcbRcbRiRsRcRcRsmmbRgbLjbRgbRibLgRsbLeb
RebRobLsbRsbRgRsmbLgbRsbRiLsbLgbRibLsbsbRiRsmbRjbLsLsmbRgbRgRsmbRgbRgR
smbRgbRsbRgRsmbRgbRgRsmbRsbRsRjbLgbLibRoLsbRsbRgbRgbRgLsbRgbRibLgbRebR
gbRgbRgbRgbRgbRgbRgbRgbRgbLgbRgbLsbLjRsbRcRsmbLibRobLhLsbLcbsbRobRgRsm
bRgbRgbRgbRsbRgRsmbRsRsmbRgbRsRsmbRgbRsRsRsmmbRsbRsbRgbRgbRsRsmbRgbRgb
LcbLiLsbLsbLibRjbLcbRsRsmbRibRsRsmbRgRsmbRsbLsbRsRsmbRgLsbRsbRgRsmbRsR
smbRgRsmbRgbRebRsbRibRgbRgbRgRsmbLjbLhbLgbLgLsbLsbLsbRebRiRsmbRgbRsRsm
bRgbRgbRgLsbRgbRsLsRsbRgbRsbRsbRsbRgRsmbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bLsbLsbLibRjRsmbRsbRibRsbRibRgbLgbRibRibLcRsbRsLsbLgbLgbLsbLsbLgbLsLsm
bLgbLgRsbLsRsbLsLsmbLsbLgbLsLsmbLsLsmbLgbLsLsRsmbLsbLsbRsLibsbLibLgbLs
bLgbLsbLgbLsbLgbLgbLgbLsbLsbLiLsbRgRsmbRsbLibLgRsbRcbRibRgbLsRsbRibRgb
RsbRsbLsbLjbLcRsbLibRgbRsbLgbLgbLgbRsLsbLgbRsbLgbLgLsbLsbLgbLsbLsbLgbL
gbLgbLgbLgLsRsbRgLsbLgbLgRsbLsbRoRsmbLibRsLsbLgbLsbLgLsbLsbLgbLsbLgbLg
bLgLsbRsLsbRsbLgLsbLgRsbRebLgbLgbLsbLsbLsbLgbLgbLgbLsLsmbLsRsbLgRsbLgb
RjbRgbRsbRgbRsLsbRgbRsbRsbRebLsbLcbLibLgbLsbLsbLsbLsbLgbLgbLsbLgbRgbLg
LsbLsbLsLsLsmmbLgbLgbLgbLsbLsbLgbRsbLjbLsbLsLsmbLgbLsbLsbLsbLsbLsbLsbL
sbLsbLsbLsbRjbLjbsbLsbLsLsmbRsbLibLsbLgLsbRsLsbRsbRebRgbRgbRibRhbRiRsm
bLgbRibRibRgbRgbLgbRsbLsbLsbLhbRsbLgbRgbLibRgbLgbRsLsbLgbLsLsmbLsbLsbL
sbLsbLsbLgbLsbRsbLgbLsbRsbLgbLgRsbsbLsRsbLgbLsRsbLgLsbLsRsbLgbLsbRsLgb
LgbLsbLsbRsbLgRsbLgbLgLsbLsbLsbLsbLgbLgbLsRsLsbRgbRcbRibRgRsmbRgbRsbRs
bRgLsbRsbLsRsbRibLjbRiRsmbRgbRsbRsbRgbRgbLsbRsbRsbRibRsbRgbLcLhbLgLsbL
sbLgbRsbLibRsbRibLgbLgbLsbRsbLgbLsbLsbLsbLsbLsLsmbLsRsbLsbLsbLgLsbLsbL
gbLgbLgbLsbLsbLgbRsbLgbRsbLgLsbRsLgbLsLsmbLgRsbLsbLsRsbLsbLsbLsLsmbLgb
RsbLgLsbLsbLgbLsbLgbLgbLgbLgbLgbLsbLgLsbLsbLsbLgbLsbLgbRsbLgbLgbLsbLsb
LsbLgbLsbLgRsbLsbLgbRgbRibRibRsbRgbRgRsmbRsbRsbRsbRgbRgbLibRsRcbLgbLjb
LjbLiLsbLsLsmbLgbLsbRsbLiLsbLibRsbLibLgbLsbLgbLgbRgbLsbLibLgbRgbLibLsb
LgLsbLsbLsbLgbLsbLsbRsbLgbRgbLsbLgLsbLgLsbLsbLgLsbLsbLsbLgbLsbLsbLibLg
LsbLsbRsbLgbLgbLgbLibRsbLgLsbRsbLibRgbLibRsbLibRsbLgbLgbLgbLgRsbLgbLsb
LgRsbLsbLsbLgbLsbLsbLsbLsbRsbLgbLgbLsLsmbRsLgLsbLgbRgbLsLsmbRjbRcbRsbR
sbRsbRgbRgbRsbRsbRgbRibRhbRibLsLsmbLsLsmbLgbRsLsbLibLsbLgbRsbLgRsbLsbL
gbLsRsbLgbLsbLsbLsbLsbLgLsbRsLgbLgbLsbLgbLgRsbLsbLsbLsbLsbLsbLsbLibLib
RibRsbLcbLgbLsbLibsbLgbLsbRsbRsbRgbLibLgbLgbLsbLhbLiLsbLsbLgbRsbRsbLsb
LcbLibLiLsbLgbLgbLsbLcbRjRsmbLibLsbLsbLgLsLsmbLsbLgbRsbLgbLsbLsbRsRsRs
mmbLgbLsLsmbLgbsbLsLsmbRsRsmbLgRsbLgbLsRsbLgbLsbLgbLgLsbLsbLgbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bsbsbRgLsbLgbRsbRsbLsbRsbsbsbLsRsRsmbsbLsRsbsbsbsbsbRsbLsbRsLsLsmbRsbL
gbRibLsbsbLsbLsbRsbLsbRsRebRsbLsRsbsbRsbLgbRibsbLsLsmbLsbRsbLsbsbsbsbs
bsbsbLibLjbLsbRsbRibRsbsbRsbLjbRgbRibsbsbLjbLjbLsLsmbRcRsmbLsbRsbRjRsm
bLsbLsbsbsbsbsbsbsbLsbLsbLsRsRsRsmmbLsbLsRsRsLsmbRsbsbsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bLsbRgbLibRgbRjbLjbLgbRibLgbLgRsbLebLibRsbRibLsbRgRsmbsbRgRsmbRgbLjRsb
RgbRsRsmbsbRgbRgbLjbRgbRsRsmbRgbLsbLgbLgLsbLgbLgbLibLgbLgbRsLsbRebRibR
sbRgbRsbRsLsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bLgbLsLsmbLgbLsbLsbLsbLgbRsbRgbLibRjbRcbLgbLcbRgbRgbLjbLsbLsRsbLsLsmbL
sbLsbLsRsbLgbLsbLgbLgbLsbLsbLgbLsbLobRjbRibLebLcbRgbsbRsbLsLsmbLgbLsbs
bsbLsbLsbLsbLsbLsbLsbLsbLsRsbLsbLsLsmbLgbRsbLgbRjbRjbLibRiLsbRjbRiRsmb
RsbRgbLsbRgRsmbRgbLgbRibLcbLiLsbLsLsmbLsbLsbLgbLsbLgbRgbLgbRsbLgbLsbRs
bLsLsLgmbLgbLsLsmbLsbLsbLsbLsRsbLsbLsbLsbLsbLgbLgbLsbRsbRiRsmbLcLsmbLs
bLgRsRsmbRsbLgbRsbLgbLgbLibRgbLibLsbRebLsbLgLsbLsbLsbLsbLsbLgbRsbLgbsb
RcLsbLibLjbRsLgbLgbLsbLsbLgbLsbLsLsmbLgbLsbLsbLsRsbLgbRgLsbRiLsbLjLjbL
sbLsbLsbLgLsbLgbRsLsbRjbLhLsbRjbLibLsbLsbLsRjbRgbRgbLgbRjbLibLoLsmbLsb
LsbLsbLsbLsbLsbLgbLgbLsbLsbLgbLsbLsbLgbLgLsbRsbLgLsbLsbRsbLgbLsbLsLsmb
RsbLibRsbRibLjbRjbLcbRibLgbRgbLhbRgbLsLiRsLsbRsbLsbRsbLsbLsbLgbLibRgLs
bLgbLgbRsbRjbRebLcbLgbRjbRhbLibLiLsbLhbRsbRsbRgbsbsbRgbRebRgbLsbLcbLjb
LibLibLibLsbLjbRjbLgbRsbLgbsbLsbLiLsbLibRjbRsbRgbRsbLcLsmbRsbLsRsbRsbL
gbRsbLgbLsbLgbRjRsmbLibLgbLjbLsbLsbLjRsLsbRibLibLiLsbLsbRgbLsbLgbRoLsb
RcbRsbLsbRibRiRsmbRibLsbLsbRebRebRhbRibLsbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bLsbLsbLibLgbRcbRibLsbsbsbsbLsbRjRsRsmmbRsbRsbLsbLgLsbRiRsRsmmbsbRsbLs
LsmbsbsbsbLsbLsbsbLsLsmbsbRibRsbLsbsbRgbRsbRsbRgRsmbRsbRibLsbLibLgbLgL
sbLsLibLsbLibRsbRgbLibLsbLhbLgbRibLsbRibLsbLsbRsRsmbRibRsbLsbRhbRgbRgb
RgRsmbRsbRibLsbLsbRiLsbRibRsRsmbRibRsbsbRgRsmbRsLsRsbRgbRsbLgbLsbLsbRs
RsmbRibRsRsmbRsbLgbRibLsRsbRibRsbRgbRsbRgbRgRsmbRsbRsbRgbRsRsmbRsbLsbs
bRgbRhRsmbLsbRsbRsbLgbLsbRgbRibRiRsmbRibRsbRjbRsbRsRsmbRgbLsbRibRsRsmb
RibRgbRsbRgbRgbLsbRsRsmbRgbRsbLsbLgRsbLjbRsbLobLibRsbLibLsbLgbLsbLgRsL
sbRjbLibRsbRjbLcbRjbLibLiRsbLsbRgbLibRjRsmbLibRebLcbLsbLgbLgbLsbLsbLgL
sbRgLsLsmbLibLgbLgbRjbRcbRibLsbRibRsbRgbsbRgbRsbRgbRgbLsLsmbRgRsmbRgbR
sRsmbRsbRibLsbLsbRgbLjbRibRgbRgbLsbLgbRcRsmbRgbLsbRgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bLgbRsbLgbRsbLgbLsbRgbLibLsbRsbLsbLsbRgbRsbLjbLsLsmbLsbLsbsbRsbRgbLjbL
sLsmbLgbLsRsbLsbRsbRsbLgLsLsmbLgLsbLsbRgbLiLsbRsbRjLsbLibLsbRgbLgbLsbs
bLsbLjbRsRsmbLsLsLsmmbRgbLibLsbLgLsbLsLsmbLgLsbRsLsbLgbLibLsbRsbLibRgb
RsbLgbRsbLsbRgbLsLsmbRsbLsbLibLsbLsbRsbLgbRsbLgbRgbLibLgbLgbLsbLgLsbRj
bLibLgbLibLgbLsbRsbRhbLhbLsbLiLsbRgbLibRsbLgbRgbLjbLjLsRsmbRibLgbRibLi
bLsbRsRsmbRibLgbLibLsbsbLsbLsbLgbLsbLsbLsbLjLgbRjbLibRsbLiLsbLgbLgbLiL
sbRsbRgbRjbRibRsLsbRsLsbRsbRibLjLsmbRibRiRsmbLsbLiLsbRjRsmbLjLsLsmmbRg
bLgbLgbLsbLsbLgRsbRsbRsbLibLsbLibLgbLgbLsbLsbLgbLiLsbLgbLibLgRsbLgLsbL
gbLibRsRsmbLgbRsbLgbLsbLjbLsbLibLibLsbLsbLibLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bsbLibLsbLsbLibLgbRibLgbLgbLgLsbLsbLgLsbRgbRgbRsbRsbLibLgbRjbLgbLsbLsb
LgLsbLsbRsbLgbRgbLiLsbLsbLsbLgbRgbLjbLsbLsbRjbLsLsmbLsbLjbRsbsbsbLcbRi
bLgLsbRjbRhbRgbLgbLobLsbLsbLsbLibLibLgbRgbRgbRibRgbRibRgbLgbRgbRgbLcbL
sbLgbLgbLsbRiRsmbLsRsbLgbLsbLibRjbLsbRjbLibRgLsbLibRgbLibRsbLibRgbLibL
sbLsbLgbLiLsbRgbLibLgbLsbLsbLgbLsbLsbLgbLsbRsbLsbLgbsbLibLgbLgbRiRsmbL
ibRgbLcbRgbRjbRcbRgbLgbRibLcbLibLsbLgbRsbRgbLiLsbRsbRsbLgbRjbLibRsRsmb
LgLsbRsbLgbLsbRsbLsbRsbLsbRsbLsbLsbLibLsbLsbLgbRsbLgbRsLsbLgbRjbLibLsR
sbLgbRsbsbLgbLsRsbsbLibLsLsmbLsbLsbLsbLsRsbRgbLgbLgbLsbLgbRjbLiLsbLsbL
gbLsbRgbLsLsmbLsbRgLsbLsLsmbRsbLsbLsbRsRsmbLgLsbLgLsbLsbLgbLgbRjbLibLi
bRibLsbLibRjbsbsbLcbRibRibRsbLsRsbLsbRgbLjbLiRsbRsbLgLsbLsLsmbLsbRsbRs
bRsbLsbLibRsbLiRsbRgbLibRgbLgbLsbLsbLsbRsbLsLgLsbLgbRgbLgbRsbLsbLhbLcb
RsbRibLsbRsbLgLsbLgbLcbRsbRsbLgbRsbRsbLsbRjbRibRhbRhRsmbRibRsbRgbRiRsm
bRgbRgRsmbRsbRgbLcbLgbLgbLgLsbLsLsmbLsbLsbLsbLsLsmbLsLsmbLgbLsbLgbRsbL
sLsmbRcbRgbLjbLcLsmbLgbLgbRsLsbRsbLibRibLsbsbRgRsmbLsbLgLsbRgbLsbRsbLs
bLgbLsbLgLsbLsbLgbRgbsbLgLsbLgbLgbRsbRsRsmbRjbLibRibLibRgbLibRgbLjbLsb
LsbLgbLsbLsbLsbLgbLsbLgbRgbLgbRsbLibRiLsbLibLsbLsbRgbRsLsbLjbRgLsbRsbR
sbLgLsbLsbLsbLgLsLsmbLsbLsbLgbLsbLsbLsbLsbLsbLjbLgbsbLibRsRsLsmbLibLsb
LsbLsbLsLsmbLgbRsbLgbLgbRjRsmbLibLgbRgbLsRsbRgbLsLsmbLsbLsbLsbRsbLgbRs
LsbLgLsRsbLsbLsbLsbLsbLsbLgbLgbRsbRgbLsRsbLsbRsbRsbLjbLsRsbLsbLsbRjbLj
bLgRsbRsbLgbLsLsmbLgbRsbLibRsbLgbLsbLsbLgRsbRjbRcbRibRgbLjbRibRibLgbLs
bLsbLgbLcbLjbRibLsbRsbRsbLiLsbLhbRgbRsbLibRgbRsbRsbLgbLsbLsbLsbLsbLsbL
gbRsbLgbLgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bLsbLibLgbRibLhbLgbRsbLgbRsRsmbRgbRsbRibLebRsbRibLhRsbRcbRsbLhbRgbLjbL
ibLjLsmbRcLsbRsbRibRcbRsbRgbLebLibLibRsbRjbRgbRgbRgbRebRsRcbLebRjbRebR
iRsmbRsbRgbRgbLjbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 25; Drug: Control Apo 0.5 然
bRgbRgbRsbRgbRgRibRgbLgbRgbRgRsmbLcbRibRiRsRsmmbRgbRsbRsbRgbRsbLgbLgbR
sbRibRsbRibRgbLibRgbRibRibLibRiRsmbRgbLjbRibRgbRiRsmbRsbRgbRgbRgbRgRsm
bRgbRsbRsbRgbRsRsmbRgRgRgRsmbRgRsmbRibRgRsmbRgbRibRibLibRiRsmbLibLhbLi
bRjbRcbRibRgbRsbLsbRsbRjbRjbLibRibRibRsbRgbRgbLsbRsRsmbLsbLsbRibLgbRhb
RgbRsbRsbLhbLcbRhbRcRsmbLgbRibRsRsmbLgbRsbLsbRiRsmbRsbRgbRgbRsbRgbRgbR
gRgbRgbRgbRgbRgRgRsmbRgbLiLsbLcbRobRhLsbRsLsbRhbLjbRhbLibRsbRgbLgLsbRs
bRgbLsbRibRsbRgbRgbRsbRsRsmbRsbRsbLsbRsLsbRsbRsRsmbRgRgbRgbRgRibRgbRgR
gbRgbRgRsmbRgbRgbRgbLgbRibRgbRgbLjLsmbRgbRibRgRsmbLsbRibRgbRgRgLsbRsbR
gbRgbRsbLjbLjbRsbRcbRgbRgbLgbRsbRgRsmbRgbRgLsbRjbLibRsRjbRsLgbRjbRgbRg
bRsbRibLiRsbRjbRgbRgbRgbRsbRgbRsRgbsbRgbRgbLgbRiRsmbLsbRibRsbRgbLgbRjb
RsRsmbRgbRgbRsRgbRgRgRsmbRgRgbRgbsbRgbRgRsmbRsbRgbRgbRgbRgbRgbRsbRgbRs
RsmbLsLsmbRgbsbRsRgbRgRsmbRgbRgbRgbRgbRgbLsRsbLgbRibRgbRgRsmbRsbRgbLgR
sbLsbRjbRsbRibRgbLjbRibLjbLjbRebRcbLiLsbLhbRebRsRsmbRibRgbRsbRibRsRsmb
RgRsmbRsbRibRgRsmbRgbRsRsmbRgbRiRsRsmmbRiRsmbRibRsbRibLsbRjbLsRsbRibLj
bRsbRibRgbLgbRibRjbLibRibRjbRgbRgRsmbLgbRibRgbLjbRjbRsbRjbRsbRgbRgbRgb
RsbRgRsmbRsbLgbLgbLsRiRsmbRibRgbLibLjbLibLibLobLgbRibLiLsbRjbLjbLgbRsL
gbRcbRgbsbLsRibRgRsmbLsbLsbRgbRgbRgbLibRhbLjbRcbLgbRjbRgbRsbRgbRgbRsbR
gRgbRsbRgRsmbRsLsbRsbRsbRgbLgbRibLiRsRsmbRibLsbRsbRsLsRibLsRsbLsbRsRsm
bRsbRgbRsbRgbRsbRjbRsbRgbRsbRgLsbLgbRgbLsRsbRgbRsbRgbLsbRgbRgRsmbLiLsb
RibLjbRibLjbRibLjbRcbLiLsbRgbRibRsbRsLsbRsbLsbLsbRibRibLibRsbRibRgbRsb
RibRjbRsbRgbLsbRgLsbRgRsmbLsbRgbRgRsmbLsbRibRibLibRibRgbRgRsmbLsbsbRsb
RsbLgbRibRgRsmbRgbRsbLibLcbLgbLcbLhbRgbLiRsbRhbLgbRcbLjbRibRgRsmbRgbLj
LsLsmmbRgbLsbRsbRibRgbRgbRsbRsLsLsmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 26; Drug: Control Apo 0.5 然
bLhbLgbRcRsmbRgbRgRsmbRgRsmbRgbRsbRgbRjbRsbRsbRgbRgbRjbRsbRsLsbRiRsmbL
gbRibRgRsmbRsbRibLjbRiRsmbLgbRsbRibRsbLsbRibRsbRgbRgbLsbRsbRgbRsbRsbRg
bRgbLgbLcbLiLsbLgbLgbRgbLibLibRjbRcbRgbRgRsmbLgbRibLsbRgRsmbLgLsRsbRiR
smbLjbRsbRibLsbRgbRsbRsbRgbRgbLsbRibLgRsbRibRgRsmbRsbRgbRsbRgbLgbRibLi
RsbLcbLiLsbLgbRsbLgbLsbLibLcbLsbRsbRsbRsbRibLgbRhRsmbLibRhRsRsmmbLgRsb
RhbLsbLgbLsRhbLibRibRgbLsbRgbRsbLsLsmbLcLsmbLibRcRsmbRgbRsbRsRsRsmmbRs
bRsRsmbRsRsmbRsbRjbRsbLsbRgbRsbRgRsmbLgbRgbRgbLgbRibLjbLoRsbLiLsbLibLi
bRjbLebLjLgbRibLibRgbRibLgbLibLhbLibLsbRjRsmbRibRiRsmbLgbRsbRibRjbsbRs
RsRsLsmmbRsbRgRsmbRgbLsLsmbRibRibRgbLhbRibRiRsmbRsbLibRibRgbRsRsmbLgbR
gRsmbRibLibLgbRhbRebLibRibRsbLsbLhbRgbLibLgbLgbLibLibLgbLsbRgbRibLcbLe
bLhbRibRgbLibLhbLgLsbLibLgbLgbLibLibLjbLsbLsLsmbLgbLsbLgbLhbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 27; Drug: Control Apo 0.5 然
bRgbLibRgbLibLgbLibLsbRsbLibLsLsmbLibLgbRsLsbLgbLgRsbLgLsbRgbLibRjbRsb
LsbLgbLsbLsbLsbLsbLgbLsLsmbLgbLsbLiLsbLsbLgbLsbLgRsbLgbLsLsmbLgbRjbRcb
RgLsbsbRgbRsbRgbRgbLsbRgbRibRgLsbLjLsmbRgbRgbLjbLibLsbRgbLibRsbsbLgbRs
bLgbLgbLsbLgLsbLsbLsbLgbLgbRjbLibRgbRgbLibRsbLgbRsbLjbLcbRgLsbLibRsbLg
bLibRjbLgbLibLgbLsbLgbLsLsmbLsbLsbLsbRsbLgbLgbLsbLgLsLsmbRgbLgbRgRsmbL
ibRsbLsLsmbLsbLgbRsbLgbLsbLsbLgLsbLsbLgbRsbLsbLsLsmbLsbLsbLgbRgbLgbRsb
LjbLsbLsbRsbLgbLsbLsbLjbLsbLsbLgbLsbRgbLsRsbRcbRgbLcbLgbLsLsmbRsbLgbRs
bLgbRsbLgbLgbRgbLgbRsRsmbLjbsbRsLsbLgbLgbRsbLsbLgbLsbLsbLsbLgbLsbLsbLs
bLsRsbLsLsmbsbsbLgbRjbLibLgbRgLsbLiLsbLsbLsLsmbLsbLgbLsbLibRsbLibRsbLg
bLhbLgbLsbLsbRsbRsbRgbRgbRgbRibLibLhLsbLgLsbLgbRgbLibRgbLibRsbRgbLsLib
RsRsmbLsLsmbLsbLsbLsbLsbRjbsbsbLibRsRsmbLgbLsbLgLsbLsbLgbRsLsRsbRcbLcb
LibLgbLsbLsbLgbRgbLibRsbLibRsbsbLgbLgLsbRsbLgbRsbLgbLsbLsLsmbRsbLsbLsb
LsbLsbLgbLsbLgbLsbLgbLgbsbLsLsmbRsLsRsbLgLsbLgbRgbLibLsLsmbLsbLsbLibRs
bLgbRsbLgbLsbLgbLsLsmbLsbLgbLibLsLsmbRjbLgbLgRsbLsbLgbRsbRgbLgbLgbLsbL
gbLsbRsbLgbLsbLgbRsbLgbLgbRsLsbLgbLgbLibRsbRsbLibRsLsbLgRsbRsbLibLsbRg
RsmbLibLgLsbRsbLgbRsbLgbRsbLgLsbRsbLgLsbRsLsbLibLsbLsbLsLsmbLibLgbRjbL
ibLgbLgbRjRsmbLgbLgbLibLiLsbRgbLibLsbLgbLgLsbLsbLsRsbLibRsbLibLsLsmbRg
bLibLsbRsbLibRsbLgbRsbLibsbLsbLgbRgbLiLsbLsbLsbRgbRjbLjLsmbLgbLgLsbLsb
RsbLgbRsbLsbLsbLsbLgLsbLiRsbRsbLsbLgRsbLsLsmbRsbLgbLsLsmbLgbLsbLgbLgbL
sbLibLsbLgbRsbLgLsbRsbLgLsbRgbLgbRgbLgbLsLsmbLsbLgbLsbLsbLsbLsbLgbLsbL
gbRgbLgbLgbLsbLsbLgbRgRsmbLibRgbRjbRgbLjbLgbLgbLgRsbRsbLibRgbsbLgLsbRg
bLibRgbLgbLgRsbLsLsmbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 28; Drug: Control Apo 0.5 然
bRgbsbRiRsmbRsbRsbRsLsbRgLsbRgbRsRsmbLgLsLsmbRsbLsbLsLsmbLsLsmbLgbsbLi
bLgbLgbsbLgbLgbRjRsmbLibRjRsmbLibLibLsbRjRsmbRhRsmbRsbRgbRibRsbRiRsmbR
iRsmbRibRgbLibRibLsbRsbLgbLjLjbRgbRgRsmbLibRsbLsbLgbLsbRgbRibsbLibLiLs
bLgbLgbLjbRsbRiRsmbRgbRsRsRsmmbRsbRgbRsRsmbsbRgbRiRsmbRgbRiRsmbRsbRsbR
ibRgbRsbLsLsLsmmbsbRgbRgbRibRgbRsbRsbRsbRsbRgbRgbLsbLsLsmbLsLsLsmmbRjR
sRsmmbLgbsbRsbRsbRgbRibRgRsmbRsbRsbRsbRsbRgbLsbLsbLsbRsbRgRsmbsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 29; Drug: Control Apo 0.5 然
bLsbLgbLsbRsbLgbRsbRsbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsbLgbRsbLgLsbRsbLgbL
sLsmbLsbLsbRsLsbRsbLgbLsbLsbLgRsbLgbLgbRhbLsRibLgbLibLgbRjbLibRgbLsLsm
bLsbsbLsbRsbLgbLsbLgbLsbLsbLsbLsbLsbRjbRcbRibLjbLjbLibRgbLgbLsbLsbLsbL
sbRsLjbRsbLsbLsbRsbLjbRgbRcbsbsbRgbLgbRibLgbRibRgbLibRsbRiRsmbRibRhbRg
bRgbRiRsmbRgbRibRgbRgRsmbRgbRsbRgbLcbLibLgbLsLsmbLgbLsbLsbRsLgbLsbLsbL
sbLsbLsRsbLsbLsbRsbLsbRjbRgbRgbRgbRgbRsLsbRsbRsbRsbRsbRsbRsbLsbLjbLcbL
iRsbLgbLgbLsbLsRsbLsRsbLsbRsbsbRsRsmbsbRgbLcbRjLsbRibLjbLgbLgLsbLsbLsb
LsRsbRsbsbRsbLsbRsbLgbRsbLgLsbLgbLgbRgbLgbLsbLibLgbRibLsbLjbRibRjbRgbR
gRsmbRsbLcbLhbRibRjbRjbLcLsmbLgbLgbLsbLgbLsbLsbLsbLsbLsbLsbLsLsmbLsLsm
bLsbRsLsbRsbLibRgRsmbLgbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbRsLsRsbLgbLsbRgb
LsRsbRcRsmbRibRgbLjbLgbRgbLjLsmbLibLibLgbRjbLibLgbRgbLgbLsbLsLsmbLsbRs
bRsLsbLsbLgbLsbLsbLsbLjbRsbLsbLsbLsbRsbLgLsbLgLsbLsbLsbLsbLsbLsbLsbLsb
LgbLsbRsLsbsbsbLgbLibRibLgLsbRsLsbLjbLsLsmbLgLsbLgbLsbRsbLsRsbLsLsmbLg
bRsbLgbLsbLsbLsbLsbLibLgbRgbLibLsbRgbLsLgbLjbsbLsbLsLsmbRsbRsbLjbLsbLs
LsmbLsbLsbLsbLsbLsbLsbLsbRobRibLjbLgbLibLhbRgbLgbLgbLsbLgbLsbLsbLsbLsR
sbLsbRjbsbLhLsbRhbLibLjbRsLsbLjbLsbLsbLsbsbLsbLsbLsLsmbLgbLgbLsbLsbLsb
LsbLsbLiRsbRjbRcbRgbRiLsbRibRibRsbLsbRgbLiLsbLibLibLibLsLsmbRsLsbRgRsm
bLsbRibLjbLhbLgbLsbLgbLgbLgbRgbLibRsbLgbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsb
RebRibRibLibLjbLgbLgbLsbRgLsbLibRgLsbLgbLsbLgbRsLsbRsbRgbLibRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 30; Drug: Control Apo 0.5 然
bRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bsbRgbLgbLsbRgRsmbRsbLsbRsRsmbsbLsbsbRgbRsbLgRsbRgbLgbsbRibLsbRsbRsRsm
bRgbRsRsmbRsbRgbLsbLsbLjLsmbRibRgbRsbRibRsbRsbRsRjRsmbRsbRsbRsbLsbsbRg
bRsbLsbRgbRsbRsbLsbLsbRsbRsbRgRsmbRsbLsRsbRgbRsbLsbRsbRgbLsLsmbsbRibRs
bLsbsbsbRgRsmbRsbRibRgRsmbLsRsbLsbRsLsLsmbsbRibRsbRgbRsbRsbLgbRjbRgbLs
bLsbLsbLsbRiRsmbRgbRibRsbRsbRsbRibRsRsmbLsbRgbRsbRgRsmbRsRsmbLsRsbLibL
sRsbRibRsbLsbLsbRgbLgbRibRibRsbRsbRsbLgbRcbRsbRjRsmbLibLsbRsbRhbRiRsmb
LsbLgbRsbLsbRibLjbLsbLsRsbRjbRcbLsbRibRsbLsbRsbRsbLsRgRsmbRsbRgbRsbLsb
LhbRcRsmbRgbRsbLsbRgbRsbRgbLjbLibLgbLsLsmbLsbLgbRsbLsbRsbLgbLsbLibLsbR
ibLibLsbLibLhbLsbRsLsbLsbRibRsbLebLsbRjbRobLsbLsbRiLsbLsbRjbRsbLsbRgbR
sRsmbLsbLsbRibLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bRsRsmbLgbRsLsbLsbLsbLgbLsLsmbLgbLsRsbLsbLsbLsbLsbLgLsbLsLsmbLsLsLsmmb
LsbLgLsbLsbLgbLsbLsbLgLsbLsbLgbLgbLsRsLsLsmbLgbLgbLsLsmbLgbLsbLsbLgbLg
bLsbLsRsbLsLsmbLgbLsbLsbLsbLsbLsbLgbLsbLgbLgLsbLsbLgbLsLsmbLgbLgbLsbLg
bLgLsbLsLsmbLgLsbLsbRsbLjbLsRsbLsbLsLsmbLsbLgLsbLsbLgbLgbLgbLgbLgbLsbL
gbLsLsmbLsLsmbRsLsRsbLsLsmbLsbLsbLgLsbLgbLgRsbLsbLgbRgbLgLsbLgbRsRjbsb
LibLibRgbRsbLibRsLsbLgRsbLgbLsbsbLsbLsbLgbLsbLsbLgLsbLsbLsLsLsLsmmmbLs
bLgLsbLsbLsbLsbLgbLsbLgbLgbRsbLgbLgbLsbLsbLgbLgbLsbLsbLgbLgbLgbRgbLibL
gbLsbLsbLsbLsLsRsmbLgbLsLgbsbRsbLgbLsLsmbLgbLsbLgbRsbLgLsbLgbLsbRsbLgb
LgbLgLsbLsbRgbLibLgLgbLgbLgbLsLsmbLsbLsbLgbRsbLgbLsbLsbLgLsLsmbLsbLsbL
sbLgRsbLsbLgbLsbLsRsbLgbLsbLgbLsbLsLsLsmmbLsbLgLsbLsbLsbLgbLsbLsLhbLgL
sbLsLsmbLgbRsbLibRsLsbLsbLsbLsbLsbLgbLgLsbLsbLgLsbLgLsbLsbRgbLgbLsbLsb
LsLsmbLgbLgbLsbLsLsmbLgbLsLsmbLsLsmbLsbLgbLibRgbLiLsbLsbRibLsbLibLgbLs
bLsbLsLsmbLsbLgLsbLsbLgbLsLsmbLgbLsbLsLgLsLsmbLgbRsLsbRsbLgLsbLsbRsbLg
bLgbLgbLgbLgLsbLsbLsLsRsmbLgLsRsbLsbRsbLgbLgLsbLgbLsbRsbLgLsbLgbLgbLgb
RgbLsbLgbLgbLgbLsbLsbLgbLsbLgbLgbLgbLsLsmbLgLsbLgbLsLgLsbLgbRsbLiLsbRs
bLibRsbLgbLsLsmbLgbLsbLgbLgbLgbLgbLsbRsbLgbLgbLsLsmbLsbLsLsmbLibRsbLgR
sbLgbLsbLgbLsbLgbLgbRibLibRsbLsbLgbLgbLgRsbLsLsmbLsbLgLsbLsbLsbLgLsbLs
bLgbLgbLsbRsbLgLsbRsbLgbLsbRsbLsbLgbLgbLsbRsLsbRsLsbLgLsLsLsmmbLsbLgLs
bLsbLgbLsLsmbLgbLsbLgLsbLgbLiLsLsmbRibLgbLsbLsbLibLgLsbRgbLibLsbLgbLsb
LgbLsbLsbLsbLibLgbLsbLsLsmbRsLsbLsbLsbLibLsbRsbLgbLsbLsbLgbsbLsLsmbLgb
LgLsbLsbLsbLsbLgbLgbRsbLsbLgbRsLsbLgbLsbLsbLsLgLsbLsLsmbLsbLgLsbLgLsbR
sbLiLsbLsLsmbLgbLsbLgbLsbRsbLibLibRsbLsbLgbLsLsmbLibLsbLsbLgRsbLsLsmbL
gRsLsbLsbLgbLsLsmbLsbLgLsbLsbLgbLsbLsbLgbLsLsmbLgbLsbLsbLgLsbLgbLsbRsb
LsbLgLsbLsbLgbLsbLgbLsbLsbLgLsLsmbLsbLgbLgbLsbLgLsbLsbRsbRsRsmbLibLgbL
sbRsbLgbLgbLsLsmbRsbLsbLgbLgLsbLsLsmbLgbLsbLsbLgbLsbLsbLsbLsbLsbLgLsLs
mbLsbLgbLsbLgbLsLsmbLgbLsbLgbLgbLsbRgbLibRsbLsbLsbRjbLcbLgLsbRsbRsbLgb
LibLgLsbLjRsbRgLsbLsbLibLgLsbLsbLiLsbLibRgbRsbLsbRgbRjbRgbRsRsmbLsLsmb
RgbLgRsbRcbLiLsbLcbLgbLgLsbRgbsbLibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bLibRgbLibRsbLibRcbRibRsbRgbRgbRgbRsbLiLsbLibLgLsRsLsbLgbLsbLsbLgbLsbL
sbLgLsbLsbLsbLsbRsbLgbRjbRcbRibLjbRgbRgbRgbRsbRsbRgbRgbRsbRgbRgbLcbLib
RsRgbLgbLsbLgbRgbLibRjbLibLgbRgbLgbLsbLsbRsbRcbRibLsbRgbRsbRsbRgbRibRg
bRibLcbLibRibLibRsbLsbRsbLgbsbLgRsbLgbRsbLgbRsbLgbRgbRebRibLsRsbLsbLsL
smbLjbLibLgbRcbsbRgbRsbRgbRgbRsbRgbRibRgbLebLibRibRjbRibRsbLsbRsbRgbRs
bRsbRsbRsbRsbRgbLsLsmbLjbRjbRibRgbRgbLsbRsbRgLsbRgbLsbLsRsbRgbLjbLgbLg
bLgbLgbLgbLgRsbLgbRjbRcbLcbRibLiLsbLgbRgbLgbLhbRgbLibLibRgbLgbLgbRsbLg
RgbLgbLgbLsbLgLsbLgbRgbRebLhbLibRjbLibRsbLsbLibRsbRsLsbRsLsLsLgLsmbRsb
LgbLgbRsbLgbRsbLgbLjbRjbLibLgbLgbRjbLhbRsbRgbRsLiLsRsbLgbRsbRsbLgbRsbL
gbLsbLgbRsbLsbLgLsbRjbRgbLjLsmbLibLibRhbLibRibLibLgbRibLibLiRsbRsbRibR
jbRgbRibLsRsbRgbRsbRsbLsbRgbRgbRsbLsLsmbRsbRsRsmbRsbLsLsmbRgbRgbRsbRgb
LsbLsbRgbRgbLgbLjbLibLgbRibLgbLgbLgbRgbRjbRibLsbRgbRgbLsbRgbRsbRsbRsbR
sbRgbRsbRgLsbLjbLibLibLsLsmbLsbLsbLsbLsbLsbLgbLgbRjbRjbLcbRhbLibLsRsbL
ibRcbLjbRibRgbLjLsmbRgbLsbRibRsbsbLsLsmbLjbLiLsbLgbLibLgbLgbRgbLibLsRs
bLgbRibRibLjbRsbRibRibLsbRgbLsbRsbLgLsbLsLsLsmmbLgbRjbRibRibRgbLgbRgbR
gbLsbRsRsmbRsRsmbLsbRsbLsbLjbLgbLgbLgbLsbLjbLsbLjbRsbRgbRgRsLsmbRgbRgL
sbLjbRjbLjRsbRgbRgbRsLsbRsRsmbRsbRsbRsbLsbRsbRsbRsbRsbRgbRgRsmbRsbRsbR
sbRsbRibRibRgbLhbRibRibLibRibRsbRgbRsbRgbLsbLsbRgbLsLsmbRsbRgbRsbRsRsm
bRgRsmbRibRgbLgLsbRgbRsbRgbLsbRgbRgbRsRsmbLgbRgbRgbRsbRsbLsbRgbRgbLgbR
gbRgbLsRsbRgRsmbLsRsbRsbRsbRgbRgbRgRsmbRgbRgbLjbRibRgbRsbRsbRsbRgbRgbR
gbRibLjbLsbLibRgRsmbsbLsRsbRjbLibRcbLjbLibRjbRcbRcbsbsbRgbLgbRgbRibLjb
RgbRsRsmbRsbRsbRsbRgbRgbRsbRgbLjbRjbRgbLjbRgbRsbRsbRgbRgRsmbLgbRgRsmbR
gbRsbLsbRsbRsbRgbRgbRgbRjbLjbRjRjbRibLibLsbLsbRsbRgbRgbRgLsbRgbRgbsbRs
bLgbRgbRgbLgbRsbRiRsmbLsbRjbLsbLsbRgbRgbRsbLjbRibLjbLeLsbLibLgLsbRebLj
bRjRsmbRibLibRjLsRsbRibRsbRsbRsbRsRsmbRsbRsRsmbLsLsmbLsRsbRgbRgRsmbLsb
RgbRgbRgbRgbLgbRiLsbRgbLsbRgbLsbRgbRsbRgbRgbLjbRibLibLibLibLcbRjbLjbLe
LsbLiLsbLibRgbLsLsmbRsbLsbRibRibRgbLibRgbRgbRgbRsbRgbRsbLgbLgbRgbRibRg
bRsbLsLsmbRgbRgRsmbRsbRgbLjbRibLsbRgbRgbLsRsbRsRsmbRgbRibLibRjbRibRgbL
sbLibLgbRgbLibRgbLsbRsbRjbRibRibLgbRiRsmbLgbRibLgbRibRgbRgbRsbLgbRgbRg
bRgbLgbRgbLsbRsbRsbRsbRsbRgLsbLsLsmbLgbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bRsbRgbRsbLsbRsbLsbRgbRsbLgRsbRsbRgbRsbRsbLjLsLsmmbRibRsbRsRsmbRsRsmbL
gbRibRsbLsbLsbRibRsbRgbRsRsRsmmbRsRsmbRsbRsRsmbRsbRsRsmbRgbRsbRsbRsbRs
bRgbRsbRsbLsbRsbLsbRgbRsbLsbLsbsbRsbLsRsbLsbsbLjLjbRgbRibRsbRgbRsbLsbs
bRsbRgbRsbRsbLsLsmbLgbRgRsmbRsbRsbRsRsmbRsbRgbLsbRgbRgbRsRsmbsbLsbLjLs
mbRibLsbRsbRsbRsbLsbLibLgRsbLsbRsbRsbLsbRgbLgbLgLsbLibLsLsmbLgbRsbRgbR
gbRgRsmbRsbRsRsmbRsbsbLjbLsLsmbLsbRgbRsRsmbLsbRsRsmbLsRsbRsRsmbRsRsmbL
sbRsbRsbRsbRgbLsbRsbLsbRgbRsbRgbRgbLsbRsbRsbRgbRsbRgRsmbLgbsbRgbRsbRgR
smbRgbRsbLsbLsbRsRsmbRsbLsbLsbRiRsmbRsRsmbRgbRsbRsbRgbRsbRsbRsbRgbRsbL
sbLibLsbRsbRgbRgbRgbRgRsmbRsbLsbRsbLsRsbRgRsmbRsbRsRsmbRsbRibRgbLibRib
sbsbRsbRgRsmbRgbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bLsbLsLsmbLsbLgLsbLsbLsbLsbLsbLgbLgbLsbLibRgbRgbRcbLibRgbRsbRibLebLsLo
bRgbLsbLgbLgLsbLsbLsbLsbLgLsbRsLsbLgbLsbLgbLsbLsbLsbLsLsmbLsbLsbLsbLsb
LibLgLsbLgbLsbLsRsbRgLsbRsLsbRibLjbLsbLibLsbRsbRsLsbLsbRibLcbLgbLsbLsb
RsbLsbLgbLibRsbLsbLibLsLsmbLsbLsbLsbLsbLsbLgbLsLsmbLsbRsbsbLsbLsbLgbLg
bLsLsmbLsLsmbLgbRsbLsbLsRsbLsbLgbLibsbsbLjLiLsbLsbLsbLsbLsbLsbLsbRsRsm
bLgbLsbLsbRsbLsbLsbLiRsbLsbLsbLsbLgbLsLsmbLgbLgbLsbLsbLsbLgbLsbLsbLsRs
bLsbLjLsmbLgbLsbLsRsbRgbRsbLibLsbLsbLsbRgbLgbLsbLsbLsbRsLsbLgbLsbLsbLs
bLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bRgbRsbRsbRsbRgbLgbLgbLsbRibLsbRsbLgbLgbLsbRsbRsRsmbLgbRsbRsbLgbLsbLsb
LsbLgbRsbLsbRsbLsbLsbLsbLibRjbRebRsbRgLsbRgbLgbRgbRsbRsbsbRsbRgbLsRsbL
jbLibLsLgbRiRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bsbsbLsLsmbLsbLsRsLsbLsLsmbLsLsmbLsbLsLsmbLgbLsbLsLsRsmbLsLsmbLibRjbRc
bRibRgbRgRsmbLsLsmbLsbLjbRgbRgbRgbLcbLcLsmbRjRgbRgbRgbRibLibRibRsbRsbL
hLsbLsbLjbLibsbLsbLsRsbsbsbLsLsmbLsLsmbLsbLsbLsbRsbLgLsbLgbLsbRgbRsbLi
LsbRsbRgbLibRsbLgbRcRsmbRgLsbRsLhbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bLgLsLsmbLhbRsLsbRsbRjbLibLjLsLsmmbRiLsbLibLgbRiRsmbLiLsbLsbLsRsbRsbLg
bLsbLsbLsbLgbLgbLgbRiLsbLgbRgbLibRsbRsRsmbLgbLgbLsbLgbRsbLgbRsbLgLsbRs
bLibRsbLgLsbLsbLgLsbLsbLgbRgLsbLgbRsLsbLgLsbLgLsbLsbLsbLsbLgbLgbLgbRgb
LgbLgLsbLsbLgbRgbLibRgbLibLgbLgLsbRgbRibLibLgbRgbLibRsbRsbLibLsbLsbRgL
sbLgbRsLsbLgbRjbLibRgbLgbLsbRsLsbLsbLgbLsbRjbLgbLgbLsbRsbLsbLsbRsLsbLs
bLgbLsbLsbLsbLsbLgLsbLsbRsLsbLsbLgbLsbRsbRsbLgbLgbLsbLsbLgbRsLsbRsbLib
LsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bLsbRsbLiLsbLgbLsbLsbRgbRsbRgbRgRsmbRibRibLibRibRsLsbRgbRibRsbRibRsbRs
bRgbRibRjRsmbRgbRsbRsbRsbRsbRgbRcbRibRsbsbRiRsmbRsbRsbLsbRjRsRjLsmbLib
sbLsbLsLsmbRsbRcRsmbRsRsmbRibRibLsbRsbRcbRiRsmbRsbRgbReRsmbRsbRhRsmbRs
bLibRsbLcbLsbLsbLgbLsbLibLsbLebLsbRibRsbRsbRsbRibRsbRibRiRsmbRiLsbLsbR
sbRsbRsbRgbRsbLhbLeLsbLsbLsbRsRsmbRsbRibLsbLhLsbRsbLiLsbLsbLsbRsbLiLsb
LsbLsbRsbRsbLsLsmbLibLiLsbLsLsmbLsLsmbLgbLiLsbLsLgLsbLgLsbRibLgbLsbLiL
sbLsbLsbRgbLhLsbLsbLgbLgbLsbLsbLibLsbLgbLgbLsbLsbRsbLiLsbRgbReRsmbRsbL
hLsbLebLsbLsbLsbLsbLsbLibLsbRgbLcbLsbLsLsmbLibLsbRgbLhbLibRgbLsLsmbRhR
smbLhbLsbLeLsbRsbLsLsmbLsLsmbLibLsbLsbLgLsbLsbLsbLibLsbLsLsmbRjbLiLsbL
gbLsbLiLsbLsbLsbLsbLsbLibLgLsbRsLsbRgbLgbLibLsLsRsmbRsLsLsLgmbLgbLhbRg
bLsbLsbRsbLibLibLsbLsbLsbLsbLsbLhbLsbLsbLsbLiLsbLgbLgLsbLhbLsbLsbLgbLs
bLsbLibLsbLiLsbLsbRgbRebLibLhLsbLsbLhLsbRgbRsbLibRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bLgbLgbLsbLgbLgbLsbLgbRgbLgbLgbLsbLsbLgbLsbLgbLsbLgbLgbRibRgbLibRgbLib
RibLibLgbLebRhbRibLibLjbRgbRiRsmbRcbLgRsLsbLgbLibLibLgbLibLcbRiRsmbLsb
LhbLsbRibRibRcbRcbRibRgbRsbLsbLsbRibLgRsbRgbLsRsbLsbRsbRsbRsbRgLsbLsbR
sLsbRsRsLsRsmbRsbRsbRsbLsbRgbRsbLsbRsbRsRgbRgbRsbRsbRsbRsbRsbRsbLcbLiL
sLsmbLsbLgRsbLgbRsbRgbLibLibLgbLsbLgbLgbRgbLgbLgbLgRsbRgbLibLsbRgbLibL
gbLsbLsbLsbLgbLgbLgbLgbLsbLsbRgbLibLgbRhbRcbRibRgbLgbLibRcbRiRsmbRcbLg
bLgbLsbRgbLgbLsbLsbRsLibLgLsbLsbLgbLgRsbLsbLsLgbLsbLgbLsbLsLsmbLgbLgLs
bLgbLjbRobRibRibLsbRgbRhbLjbRjbRcRsmbLgbRjRsmbRhRsmbLgRsbRcbLibRhRsmbL
gbRsbRgRsmbRgbRsbRsbRsbRsRsRsLsmmbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsb
RsbRsbLsbRsbRgbLsbRgRsmbRsRsmbRgRsmbRgbRsbRsbLsbRsbRsbLsbRsbLsbRsbRsbL
sbRsbRsbRgbLgbRibLjbsbRibRgbLibLibRcbRibLjbRhbLgbRibLgbRiRsmbRgRsmbLiL
sbLsbRgRsmbRgbLsRsbRsLsbRsbRgbRgRsmbRsbRgbLsbLsbsbsbRsbRsbRsbRsRsmbRsb
RsRsmbRsbRgRgRsmbRsRsmbLjbLsRgbLebLibLgbLsbLgbLgbLgRsbRjLsRsbRcbRibLjb
RibRgbLsbRibRcbRhbRhbRibRgbRsbRgbRsbRsbRgRsmbRgRsRgRsmmbRgbRsbRsRsRgmb
RsbRgRgbRgRsmbRsbLsbRsRsRgRsmmbRgbRgRsmbRgbRsRsmbRgRgRgRiRsRsmmbRgbLsb
RgbRsbRgbRgbRgbRgbRgRsmbLibLcbRcRsmbRhbLibRhbLibLjbRsbLhbLiRsbLcbLgbLi
bLsbLibLgbLgRsbLsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLsLsmbLgbLsbLgbLsbLsbLgbR
gbLibRibRjRsmbLsbRsbRgbRsbRsbRgbRsbRsbRgRsmbRsbRsRgbLjbLjbLgbLibRcbRob
RcbLibRoRsmbRcbRibRcbLiLsbLibLsbRsbLibLgLsbRsbRgbLsbLgbLgbLsbLsbLsLgRs
bLgbLgbLsbLgbLsbLsbLsbLsbLgbLsbLsbLsbRsbLgbLsbLsbLgbLgbLgbLgbLjbLibRib
RcbRhbLiLsbRibLgbRibRhbLjLsmbRibRibRhbRcbLgbRcbLsRiRsmbRgbRgbRsRsmbRjR
smbRsbRsbRibRgRsmbRgbRsbRsbRsRsmbRsbRsRsmbRgbRsbRgbRsbRsbRsbRgRsRsmmbR
gRsmbRgbLsbRsbRsbRsbRsbRgRsmbRgbRsbRgbRsbLjbLgbLgRsbLgbLgRsbLsbLgbLebR
cLsbRhbLibLiLsbRibLsbRsbRiRsmbLsbRgRsRsLsRsmmbRsbRsbRgbRsbRsbRgbRsRsmb
RsbRgbRsbRsbRsRiRgLcbRcbRibLsRsbRgbRsbRsRsmbRsbRgbRgbsbRsbRgbLjbRhbLgb
LjbRibRgbLibRibLgbRibRsbRgRsmbRsLsbRsbRsbLsbRgbRgRsmbRsbRsbRsbRgbRsRsm
bRsRsmbRsbRgbRsbRsbRsbRsbRsbRgbRgbLsbRsbRgRsmbRgRsmbLsbLgRsbRgRsmbRgbR
sRsLsmbRgbLsRsbRgbLsbLsbRgbRsbRsRsmbRgRsmbRsRgRibRgbLsbRgbLjbLcbRjbRhb
LibRcbRiRsmbLgRsbLgbRsRsmbRibRgbRgbRsbRsRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bRgRsmbRgRsmbRgbRgbLcbRibRsbsbLibLgbLhLsbLsbRsbRgbRsbRsRsmbRsRsRsmmbRg
bRibRgbLibRibLibRibRgbRgbRsbRsbLgbLgbLsbLsbRsbLsRibRsbsbRgbLsbLsbsbRsb
LsbRibRgbLsbRsbRgbRgbRgbRsbRgRsmbRgbRjbRibRsRsmbLgbLgLsbLgbLibLsbLsbLg
bLibLsbsbLgLsbRgbRgbRsbLsbRibRgbRiRsmbLgLsbRsbRgbRsbLgbRibLjbLjbLibLcb
LsbLibRsbRibRiRsmbRjRsmbRibLjbRibRsbsbRsRsRsmmbRgbRsbLsbRgLsbRsbRsRsmb
RsbRibRsLsbRsbLgbRibRsRsmbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bRsbLsbRsbRsbLsbRsbRgbRsbRsRsmbRgRsmbRsbRgbLsbRgRsmbRgbRgbLibRgLsbRgRs
mbRgbLsbRgRsmbLjbsbRsbRsRsmbRsbRgbLsbRgRsmbRibRgbLgbRsbRibRgbRsbRsbLsb
LebRcbLsbRjbLibLgbLiRsbRsbRjbLhRsbLhbRsbLsbLgbLsbLgbLibsbLgbRjbRsRsRsm
mbLgbLgbLgbRibLibLibRgbLhbLsbLsbLsbRgbLsbLibRjbRcbRsLsbRsbRsbLsbRgbLgL
sbRgbRgbLgbRgbRiLsbLibLibRcbRibLjbRhRsmbLibRhbsbRiRsmbLibRibRsbsbRsRsm
bsbLsbsbRibRibRcbLhbRibLjbRibRsbRibLjbRibLjbRibRsbRibLgLsbRibLsbRsLsbR
ibLgbRjbRsRsmbLsbRgbRsbRibLjbLgLsbRhbRibLjbLibRibRhbLjbRiRsmbLgbRibRib
LibRibRibLgbRsbRgbRjbRsbRsbsbLsbRsbLsRsbRgbLgRsbRgbRsbRgRsmbRsbRsbLjbR
iRsmbLsbRiRsmbLgbRibRsbsbRgbsbLsbRsbRibRsbRsbRsbRsbLsbRibLjbLgbRjRsmbR
hbLgbRibRibLgRsbRibRsbRsbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bLgbLibRjbLgbLgbRsbRgbLibRsbRsbRsbLgbRsRsRsmmbRibLgbLjLsmbLsbRgbRsbRgb
LgbRgLsbLeLebLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bRgbRsRsmbRgLsbRsbRgbRsbRgbLsRsbRgbLsRsbRgbLgbRgbRsbRgbRsbRgbRsbRgbRsb
RsbRsbRgbRsbRsbRgbRsbRgbRsbRgbRsbRsbRgbLsbRgbRsbRsbRsbRsbRsbRsbLsRgbRs
RsmbRgbLgbRgbLsbRsbRgRsmbRsbRgbRsbRsRsmbRsbRgbRsbRsbRgbRsbRgRsmbLgbRiR
smbRsbRsbRgbRsRsmbRgbRsbRgRsmbLsRsbRgbRsbRsbRgbRsbRsbRgLsbLsbRgbRsbRsb
RgRsLsmbRgbLgbRibRsbLgbRgbRsLsbRgRsRsmmbRsbRsbRgbRsbRsbRsbRgbRsbRsbRsb
RsbRgbRsbRsbLjbRgbRsbRsLsbRsbRsbRgbRgbRsbRsbRgbRsbRgRsmbRsbRgbLgbRgRsm
bRsRsmbRsbRgbLsbRsbRsbRsbRgbRsbLsbRgRsmbRgbRsbRgbRsbRsbRsbRsbRgbRsbLjb
RibLsRsbRsLsbRgRsmbRsRsmbRgbRgbRsbRsbRgRsmbLgbRgbRsbRsbRsbRsLsbRsbRgbR
sbRgLsbRsLsbRsbRgbRsbRsbRgRsmbRgbLgbRiRsmbRsbRsbRgbRgbLjbLsbLhbLgbLgbR
sbLgbLsbLgbLgRsbLgRsbLgbRjbRibRgbLsbRsRsmbRgRsRsmmbRsbRsbRgbRgbLibRgbR
gbRgbRsbLsRsbRgbLsLsmbRsbRgbsbsbRsbRiLsbRsbLsbRibRsRsmbLgbRgbRsbRsbLgb
RsRsmbLsbRsbLsbRsbRgbLgbRibRsbLsbLsLsmbRsRsmbRsbRgLsbLibLsbLsbRibsbRjR
smb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bLgbLgbLsbLgbLgbLgbLsLsmbLsbLgbLgLsbLsbLsbLsbLgLsbLsRsLsbLgbLsLsmbLgLs
bLsbLgLsbLgbLsbLgLsbLgbLgbRjbRcbRiRsmbRgbRgbLjbLcbLibLsRsbLibLgbLsLsmb
LsbLsRsbLgLsbRsbLgbLgbLgbLsbLgbLgLsbLgbLgbLgbLgLsbLsbLgbLsLsmbLgRsbLgb
LgbLgLsbLsbLgbRgbLibRgbLibLgRsbRgbLibLgbLsbLgbLsbLgbLgbLhbRsbLsbLgbLib
RsLsbLgbRgbLibLsbLgRsbLgbLgbLsbLsLsLsmmbLgbLsLsmbLgbLsbLsbLgLsbRjbRjbL
gbLjLsmbLgbLgbLgLsbLgbLgLsbRgLsbLibLsbLsLsmbLsbLgRsbLsbLgbLsbLgbLgLsbL
sbLsbLgbLgbLsbLsbLsbLgbLsbLgbLgbLsbLsbLgRsbLsbLsbLsbsbLsLibLsbLgLsbLsb
LgbLgbLsbLgbLsbLgLsbLsbLsbLgbLgbLsbLgbLsbLgLsbRgbLibLibRgLsbRhbRibRiRs
mbRgbLhbLcbLibRsbLibRgbLibLsLsRsLsmbLgbLsbLgbLsLsmbLgLsbLgbLgbLsbLsbLg
LsbRsbLgbLgbLgbLsLsmbLsLsmbLsbLsbLsbLsbLsbLjbRjbRcRsmbRibLsbRhbRcbRibR
gbRibRgbLsbRibLgbLsRsbRcbLibLjbLibRsbLibRsbLiLsbRjLsbLibLsLsmbLgbLgbRj
bRibRgbRiLsbRcLsbRjRsmbRsbRgbRsbRjbRibRsbRgbLjbLcbRgbLibLgbLsbLgbLgbLg
bLsbLgbLgbLgbLsbLgbLsbLgbLsbLgbLsbLgbLibRibLibRsbLgRsbRjRsmbLiLsbLgbLs
bLgLsbLgbLgbLsbLsbLgbRsLsbLgbLsbLsbLgbLsbLgLsbLibLsbLgbRibLibLgbRjbLiL
ibRgLsbRjbRibRgbRgbLcbLibRsLsbLsbLgLsLsmbLsLsmbLgLsbLsbLsbLgbRsLsbLgbL
gbLsbLsLsmbLgbRgbLibLsLsmbLgbLsbLsLsmbLiLsbRgbLibLibRsLsbLgbRsLsbLgbLs
bLgbRgRsLsmbLibRgbLibRjRsmbLiLsbRgbLibLsbLgLsbLsLsmbLsbLgbLsbLgbLsbLgL
sbLgbLsbLgbLgbLgbLsbLgbLsbLgLsbLgbRgbRcRsmbRibRgbLjLjbLhbLsRsbLibLgRsb
LgRsbLsLsmbLcRsbRibLgbLibLsbLgbLsbLgbLsbLgbLgbLsbLgbLibRsbLibRsbLgLsbL
ibLsbLgLsbRgbLiLsbLibLgbRgbLibRsbLibRgbLibLsLsmbLgbLsbLsbLgbLgbLsbLsbL
gLsbLgbLgbLsbLgbLgbLgbLgbLsbLibRibLibLsbLsbLsbLsbLsbLgLsbLgbLsbLsbLsLs
mbLgbLgbRjbLibLsbLgbLgbLgbLsLsmbLgbLsbLgbLgLsbLgbLsbLgLsbRgbLibLsbLibR
jbLhbRsbLsLsmbLiLsbRgRsmbLibRsbLiRsbRgbLiLsbRsbLibLsLsmbLgbRgbLibLibLg
bLsbLsbLgRsLsbLgLsbLgbLsbLgbRjbRjbRibRibLsbRibLjRsbLcbLsLsmbLibLsbLgbR
sbLgbLgbLsbLgbLgbLsbRsbLibLgbLibRsbLgbLgbLsbLgbLgbLsbLsbLsLsmbLgRsbLsb
LsbLsbLsRsbLgbRsbLibLibLsbRjbLhbRgbLgbRsbLibRsbLgbRsbLgLsbLsbLsbLsbLgb
RsLsbLibRsbLgbLgbLgbRibLiLsbLgbLsbLgbLsbLsbLgbLgbLgbRjbRcbRgbRibRgbLcL
smbLibLsLibRjbLibLsbLgbLsbLsbLsRsbLibRsbLgbLsLsmbLgLsbLgLsbLsbLgbRhbRi
RsmbRhbLebLhbLibRsbLibLsbLgRsbRsLsbLgLgbLgLsbLgbLsbLsLsmbLsbLgbRgbLibR
sbLibLgLsLgLgbLsbLgbRjbRhbRgbRcb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bLsbRsbRgbRgbRgbRgbRibRhbRibRibRibRgbLgLsbsbRibRsbLsbRjbRsbRgbRsbRgRsR
smmbRsbLsbRgbRsbRsbRsbRsbRsRsmbRsLsbRsRsRsmmbRgbLsbRgRsmbRibLgbRsbRgbL
sbRgbLgbRibLgbRsLsbLgbRjRsmbLjbLgLsbLgbLgbRgbLgRsbLgbLsbLsbLsRsbLgbLgb
LsbLsLsmbLgbLsbLsLsmbLgbLsbLsbLsLsmbLsbLgRsbRebRsRhbLgbRgbRgRsLsmbRsbR
sbLsbLibLibLgLsbLgbLjbLsbLibsbRcbRibLsbRsbRgbRsbLsbRgbRgbsbLsbLcbLibLg
bLgRsbLgbLgLsbLgLsLsmbLsRsbRgRsmbLibLsbLsbLgbRsRsmbLsbLsbLgRsbRcbRgbRg
RsmbRsbRgbRgbRsbRsbRgbLibLjLsmbLibRhbRibRgbRsbRibLjbLiLsbRhbRibRsbRsbR
gbRsbRsbRgbRsbRsbLsbRsbRsbRsbLjRsbsbRibRgbRgRsmbRsbRsbLsbRibRsbRsRsmbR
sbLsbLsbRgRsmbRsbRsbRsbRsbLgbLsRibLgbRgbRgbRsbRsbRsbRgbRsbRgbLsbRibLgb
RiRsmbLgbRjRsmbLgbRgbLsbRsLsbRsbRgbRsRsmbRgbRsRsmbRgbLjbRgbLgbRiRsmbRs
bRgbLsbLgbRgbRgbRsbRgRsmbRsbLsbRgbRsbLsbRgbLsbRgbRsbLsLsmbRgbRsbRgbRgb
RgbLjbRibLjbLibRcbRsbRibLgbRibRsbRsLsbRsbRsbRsbRgbRsbLsbRgRsmbRsbRsbRg
RsRsmmbRsbLsbRgRsRsmmbRsbRsbRsbRsbRsbRgbRsbRgbRsbRgbRibLibRiRsmbRgbRsb
RsbRjbLsbRsbsbRibLgbRibRsRsmbRsbRsbRsbRgbRgLsbLgbRgbRgbLjbRgbRgbRsbRgb
LgbRibRsRsmbRgbLsbRibLibLsbLcLsmbsbLgbLgbLsbLsbLsbRibRhbRibRsRsmbRgbRs
bRsbRsbLsLsmbLsRgbRgbRsbLgbsbRsLsRsbLsbRsRiRsmbRsRsmbRgbRsbRgbRgLsbRgb
LgbRsbRiRsmbRsbRgbRgbLsbRgRsmbLhbRcbLsbLsbRibRgbLsbRgbRgbRgbRgRsmbLibR
iRsmbRibLsbRgbLsRsbRgRsmbLsbLobLibLgbLgbRsbLgLsbLsbLsbLsbRsLgbRcLsbRgb
RgbRsbRgbRgbRsbLgbRibLjbRiRsmbRsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bLjbLhbRsbLsLsmbLgLsbLgLsbLgbLsLsmbLsbLgbLsbLsbLsbLgbLsbLgLsbLsbLgbRgb
LsbLsbLgbLgbLsbLgLsbLgLsbLgLsbRsbLgbLsbRsLsbLgLsLsmbLgRsbLgbLsbLgLsbLg
bRsbRsbLiLsbRsbLgbLsbRsbLgLsbLgbLsLsmbLgbLsLsmbLsLsmbLgbLgbLiLsbLgbLgb
LsbLgRsbLsbLgbRgbLibRgRsmbRiLsbRibRgbLsbRibLjbLjRsbLibLgbLgbLsbLgbLgbR
sLgbLsbLgLeLeLsLebLiRsbRjbLibLsbRjbLjbLgbLibLsbsbLsbLgLsbLgLsbLgLsbLgb
LgbLgLsbLgLsbLgbLgLsbRsLsbRsLgbLsbRsbLgbLgbLgbLsbLgbLgbLsbLsLjbRibRjbR
cbLgbRjbRibLibRjbLhbLcbRgRsmbLibLsLsmbLgRsbLgbLgLsLsmbLsLsmbLsbLsbLgbL
gbRsbLsbLsbLgbLgbLgLsbLgLsbLgbLgbLgbLsLgbLiLsbLgbLsbRsbLibLgbLgLsbLgLs
LsmbLsbLsbLgLsbLgLsbLgLsbLgbLgbLsbLgbLgbLsLsmbLgbLgbLsbLgbLiLsbLsbLsbL
gbLgbRcRsmbRibRgbLibLibLiLsbRsbLsbLsbLsbLgbLgbLgbLgbLgbLgLsbLiLsbLgbLs
bLgLsbLsbLsbLsbLiLsLsmbLsbLiLsbLgLsbLgLsbLiLsbRsbLsLsmbLgbLgLsbRsRsmbL
gbLgbLgLsbLsbLgbLhLsLsmbRsbLgLsbLgbLgbLgbLgbLsbLsbLsbRsbLsbLgLsbLsLsmb
LgbRgbLgbRcbRgbRgbLgbRibRibRgbLjbLibLibLsbLsbLgbLgLgbLsbLsbLsbLsbLgbLs
LsmbLgbLgbLgLsLsRsRsmmbLgbLgbRsbRsbLgbRsbLgbRsbLgLsbLsLsmbLgbLgbLibLgL
sbLgbLsLsmbLsbLsbLgbRsLsLsRsmbLgbLgRsbRsLsbLgLsbLsbLsLsmbLgbLgbLgbLgbL
gLsbLgbLgbLgbRsbLgbRcbRibRsLsbRibRgbRsbRgRsmbLcRsbLibLsbLsbLsLsLsmmbRs
LsbLgbLsbLsLsRsmbLibLgbLgRsbLgbLgbLgbLgbLsLsmbLgLsbLsbLgLsbLibLsbLgbLg
bLgLsbLgLsbLsbLsbLsLgRsbLgbLgbLsbLsbLgbLgbLgLsbLgbLgbLgbLibLsbLgbLgbLs
LsmbLsbLgbLgbRsbLibLsLsmbRcbRgRsmbRsRsmbRsbRgbLjbLibLibLgLsbLsbLgbLsbL
sbLgbLgRsbLsbLsRsbLgbLgbLgbLsbLsbLsbLiLsbRgbLibLsbLgbRsbLsbLsbLgbLsRsb
LsbLsbLgbLgbLgLsbLgbLgbLibRjbRcbRgbRgbRsbRgbRibLibRibRibRibRibRsbLibRg
RsmbRsbRibRgbRiLsbRiRsmbRgbLjRsbRiLsbLgbRgbRibRgRsLsmbLsbRibRsRsmbLsbR
gbLjLsmbLjbLibRjbLhbLsbRsbLgRsbLgbRgbLgbLgbLgbLsbLsbRsbLgbLgbLsbRsLsbs
bLsbLgbLsbLsRsbLgbLgbLsbLsbLgbLgLsbRjbLsbRobRgbRgbRgbLgbRgbLsbLebLibRg
bLgbLsbLgbLgbLsbLgLsbLsbLgLsbLgbLgbLsLsmbLsLsmbLsbLgbLgbLgbLgbRgbLgbRj
bRcbLsbRgbRsbRgbRsbRgbLgbRibLsbLcbLibRsbLgbLsbLsbLsbLsbRsbLgbLsbLgbLsL
smbLsLsmbLsbLsbLibRjbRcbRibLsbRgbRgbLcbRobLgbLgbLsbLgbLgbLsLsmbRsbLgbL
gbRsbRcbRibRsRsmbRgbRsbRsbRgbLjbRgbRgbRgRsmbRgbLjbRibRsLsbRgbRsbRsbRgb
RgbRsbRgbLhbRhbRibRgRsmbLsRsbRgbLsRsbRgRsLsmbRibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125011; End: 125511;
Recording: 10-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bRsRgRsmbRsbRgRsmbRgRibRgbRgRsmbLsbRgbRgbRsbRgbRsbRsRibRibRgbRgbRiRsRs
mmbRgRsmbRsRsLsmbLsbRibRgbRsRsmbLsLsmbRsbRsbLgbRibRgbRsbRsRsmbRgbLsbRg
bRgbRgbRgbLibRcbRgbRgRsmbLibLgbLibLsLsmbRsLiLsbRjbLibLsbLibLiLsbLgbRjb
RcbRsbRibRgRsRgRgRiRimbRiRibRibRiRgbRsRsRiRsRsmmmbRiRiRiRsRgmbRibRgbRi
bRiLsbRsbRgRsmbRgbRiRibRgbRgbRgbRgRgRsRsmmbRibRsbRgbRiRsmbRgbRgRsmbRgR
smbRgbRgbRgRsLsmbLsbRiRsmbRiRsmbRiRsmbLsRibRgbRgRgbRiRsmbRsbRgRsmbRgbR
gbRibRgbRgbRgRsmbRgbRgbRgbRgbLcbLjLsmbRibRibLsRiRsmbRgRsmbRgRsmbRgbRgR
smbRgbRiRsmbRgbLsLsmbRibRgRsmbRgbRgRsmbRsbRsRsmbRgbRgbRgbRgRsmbRgRsmbR
gbRsbRibRgbRibRsRsRsRsmmmbRibRiRsRgmbRiRgRiRsmbRsbRsLsbRgRsRsRiRimmbRi
RsRgReRiRsRsRhRimmmbRiRgRsmbRgRsmbRgbRiRsmbsbRsbRiRsRimbRgbRgbRgbRgRgR
smbRgbRgbRgbRiRibRgbRibRgbRgRsmbRgRgbRibsbRsbRgRgRsRgmbRgRsmbRibRsbRib
RgRsmbRibRgbRgbRiRibRibRgbRgRsmbRgRsRgmbRsbRsbRsbRgRsmbRgbRibRgbRgbRiR
smbRgLsbRsbRsRibLsbRgbRibRgRsmbLsRiRibRiRsRsRgRgRgRsmmmbRgRsmbRgRsRsmm
bRgbRibRgbRgbRgbRsbRgbRsbRsbRsRgbRiRcbLibRibLjbRibLibLibRcbRiRsmbRsbRi
bLgbLgbRcbRsbRgbRgLsbRgbRsbRsbRjbRsbRgbLgbLsRsbRhRsmbLibLjbRhbRibRgbRg
RsmbRgbLgbRgbRgbLsLsmbRgbRgbRgbRsRsmbRgbRsbRsbRgbRsbRsRsmbRgRsmbRgbRgb
RgbLgbRiLsLsmbRgbRibLsRsbRsbRgRsmbRgbRgRsRgmbRgRsmbRibRgbRgbRgbRgbLjbR
ibRsbRsbRgRsmbRsbRsLsbRgRsRsmmbRgbRgbRiRsmbRgRiRgbRgbRsRsRiRsmmbRgRsRi
mbRibRgRsmbRgRsmbRgbRsbRsbLsRgbRgbLjbRibRhbLibRibLiLsbLibRcRcbLiLsbLiL
ibLgRsLsbRgbRibRgbLjbLsbLibLibLgbLibLgbLgbRsbLgbLgLsbLibRjLsbLibReLsbR
hbRibRsRsmbRsRsmbRgbRsbRsbRgRsmbRsbRgbRsbRsRgRsRgRsRiRsmmmbRgRsRgmbRgb
RgbRgRsmbRibRibRsbRgbRgbRgRsRsRsmmmbRjbRgRsmbRgbRgbRgbRgbRgbRibRgbRsbR
gbRsbRsbRgbLjbLibLibLgbLgbLibLibLibRibRgbRjbLsRsRsmbRsbRsRsmbRgRgLsbRs
RgRsRgRiRsRgRgRimmbRiRiRiRsmbRgRibRgRhRsRsmmbRgbRgbRgbRgLsbRibRgRiRiRg
RiRsmbRiRsmbRiRsRsmmbRibRiRsmbRiRiRiRiRsmbRgbRiRsRimbRiRsRgmbRgbRgRsRs
RimmbRsbRjbRibRgbRgbRgRsmbRsbRibRgbRgbRgbLibRibRiLsbLjbRhbLibLjbLiRsbL
ibLsbLgbLibRjRcbRgbRgLsbRgbRiRiRsmbRgbRgRgbRsRiRsmbsbLsRsbRgRsmbRgRsmb
RibRhRgRsRimbRibRibLjbRibRsbRgbRgbRgbLsbRhbRsbRiRsRgmbRgRsRsmmbRgRgRiR
hRibRgRgbRgbRgRgRsRsRsmmmbRsbRgbRgbRibRgbRibRgRgbRgRsmbRgbLiRsbRsbRjbR
sLsbRgbRgbRsbRgbRgbRgbLgbRhbLgRsbRibRsRsmbRsLsbRsbRgbRsbRgRsmbRgRsmbRg
RsRgmbRgRsmbRgRgbRgbRiRsRimbRgbRgRsmbRibRibRgbRgbRgbRgbRsbRgbRgbRgRsmb
RgbRsbRsbRgLsbRgbLgRsbRgRsmbRgbRsbRgbRgRsRgRgRiRsmmbRgRsmbRgRsLsmbRgRs
mbRibRibRiRgbRiRgbRsRgbRiRhbRgbRgRsmbRgRsRgmbRsRsLsmbRgbRgRsRsmmbRibRg
bRgbRgbRgbRgbRgbRgbLiLsbRhbRibLibRsbLibLibRibsbLibRcRcbLjRiRsmbRgRsmbR
gbRsbRgbRgLsbRgbRiRsmbRsLsbRsLsbRgRsRgRsmmbRgLsbRgRsmbRibRgbRibRgRsmbR
gbRsbRsbRgRgRsmbRibReRsRiRimbRgbRgbRgbRgbRiLsbRgbRibRgRsmbRibRgbRgRsmb
RsbRgbLgbRibRibLibRgbLgbLgbLibRjbRibRiLsbRgLsbRgRsRgmbRgRsmbRgbRgbRgbR
gbRgRgRibLsbRgRsLsmbRgLsbRgbRsRibRgbRgRsmbRsRgbRsbRgRibRsbRsbRgRsmbRgb
RgbRgbRgbRgbRsRsmbRgRgbRgbRibLgbRjbRsbRsRgbRgRgRsRgRsmmbRgbRgbRgbRgbRg
bRsRsmbLgLsbRgbRsbRsRsmbRgbRsbRsbRgRsmbRgRsmbRgRsmbRgRsmbRgRiRgRgbRgRs
mbRiRibRgRebsbRgRsmbLsbRjbRsbRgbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 1; Drug: Control Apo 0.5 然
bLibLibLsbsbLsbRgbRhbRebRibRjRsmbRsLsbLgbLibLibLibRjbRjRsmbLgLsbLjbLgb
LsbRjRsmbRibRgbRsbRsbRibRcbLgbRibLibLgbLsbLjbLgbLsbLibLhbLsbLgbLjbLgbL
jLsmbLjLsmbLgbRsRsmbRibLsbLibLsbRibRcbRjbRgbRsbLsbLcbLhbRjbRcbRibLgbRc
bRsbRgbRiLsbRgbLgbRhbRgbRibRsbRibRsbLgRsbLibLibRibRgbRibRcbsbRgbRibRsb
LsbLsbLsbLiLsbLibLgbLgbRsbLibRsbLibLsbLibLibLgbLsbLibLsbLsbLibLsbLibLi
bLgbLsbLgbLsbLibLsbLgbLgbLsbLgbLibLiLsbLsbLiLsbLgbLgbLiLsbLsbLibLgbLgb
LsbLibLsbLsbLibLibLgbLsbLgbLibLibLibLiLsbLsbLsbLibLibLsbLsbLgbLsbLsbRj
RsmbRebLsbRibRsbRibLsRsbRsbsbLgLsbLhbLcbLgbRjRsmbLibLsbsbRsbLgbRibRibR
ibLsbRgbLsbLsbsbRsRsmbRgbRgRsmbRobRsbRibRiRsmbLsbRgLsbRgbRsLsbRgbRibRs
bRsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 2; Drug: Control Apo 0.5 然
bRgbLsbRgbLsLsmbRibLsbRiRsmbLgRsbRsRsmbRgRsmbRsbRgRsmbLsbRgRsmbLgbRiRs
mbRsbRibLsbRiRsmbRgLsbLgbRibRibLgLsbRibRgbRsbRibRsLsbRibRgbRgbRgbRiRsm
bRsRsmbRibLsbRibRsbRibsbRibLgbRiRsmbRgbRsbRgbRgRsmbRgbLsbRgbLjbRibLjbR
hbLjbLcbRhbRcbRgbLgbRibRsbRgbRsbRgLsbRsbRgRsmbLsbRiRsmbRsbRgbRgbLjbRib
LjbRibLjbRhbLgbRibLgbRgRsmbRsbRsbRgbRsRsmbRgbRsbRibLgbRibRsRsmbLjbsbRs
bLsRsbLsbRhbLgLsbRsbRgbRgbLgbRgbRsbRgbLsbRgRsmbRsbRibLgbRiRsmbRgbLgbRi
bRsbRsbRsbRsRsmbRgLsRsRsmbLsbRibLsRsbRibRsbRsbRgbLsbRibRsbRibRsRsmbRsb
RsRsmbRsbRsbRgbLsbRgbRsbRgLsbLsbRiRsRsmmbLsbRibLgbRibRsbLsRsbRgRsmbRib
RsbRgRsmbRgbLsbRiLsbRsbLebRibLcbLsbRjbLcbLcbRibLebRsbLhbLibLebLibRgbLi
bRjbRibLibRibRsbRsRsmbRiRsmbLsbRgRsmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 3; Drug: Control Apo 0.5 然
bRgbRsbLgbLsbRgbRgbRsbRsbLsbLsbRibRsbLsRsbRibLsbRsbRsbRsbLsbRsbRibRsbL
iLsbRgbRsbLsbRgbRsbRgbRsbRsRsmbRjRsmbRsbLgbLgbLgbRjbLgbRibRsbRgbRsbRib
RgbRsbLsLsmbLgbLgLsbLgbLgbLibLgLsbRgbLsbLgbRsbLgbLibRsbRibRibLgbLgbLsb
LsbLgbRsbLgbLsbLsbLgbRsbLsbLsLsmbLsbLgRsbRsbLsbLsbLsbLgLsbLgRsbLiLsbLj
RsbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 4; Drug: Control Apo 0.5 然
bRjbRgbsbRsbRsbRhbRgbRgbRsbLjLsmbLgbRibLsbRibRgbRiLsbLiLsbLcRsbLibLibs
bLsbLgbLgbRibRebLjbLiLsLsmbRgbLibRjbLibRgbLibRibRjbLibReRsmbRgbRgbRgLs
bRgbLjbRgbRgbRgbLsbLsbRibLebLcbLibRsbLibRgbLibRjbRsbLjbLibLsLsmbRjbLhb
LibRjbLjLsmbLjLsmbLibRiLsbRibLsLgbLgLgbRjbLibRgbLgbLsLsmbLibLsLsmbLsbR
sRsRsmmbRsbLibLsbLsbRsbRsbRsLibLibLsbLibLiRsbRgbLibsbRibLibLibLsbRoRsm
bRgRsmbLjbLjbRhbLjbRiRsmbsbRjLsbLibRjbRsbLjbRibRibLjbRibLiLsbRjbLjbLcb
LgbLsbLjLgbRibLjbLsbLsbRjbRjbsbLgbRibRjbRibLhbRgbsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 5; Drug: Control Apo 0.5 然
bRgbRgbRsbRsbRsbRgbRsbRsbRsbRsbRgbRsbRgbLjbsbRgbRgRsmbLgbLsbRibRibRsbR
gbRsbLgbLibLibRebRgRsmbRibLsbRgRsmbRibLcbLibLibRibRcbRibLsbRsbRsbRsbRg
bRgbLgbRiRsmbLcbLibRjbLgbRhbRcbLibRcbRgLsbRibLiRsbLjbLiLsbRcbRgRsmbRsb
RsRsRsRsmmmbLsbRsbRsbRsbRsRsmbRsbRgRsmbRsRsmbRsbRsRsmbRsRsmbRgbRgbRgbR
gRsmbRgRsmbRgbRsbRgbRsbRsLsbRsbRgbRsRsmbRsbRsbRsbRgRsmbRsbRgbRgbRsbRsR
smbRgbRgbRgbLebLcbRibLibLgbRcbLcbRjbRoLsbLibLcbLgbRsbLgLsbLgbLgbLibRcR
smbRibLjbRibRsbRgbRsbRsbLsbRgbRsbRgRsmbRsRsmbLgbRgbRgRsmbLjbLcbLiLsbRe
RsmbLiRsbLibLgLsbRjbLibLgbLgbRjbLibLibLibRjbLibLsbRjbRibRsbLjbLibRcbRg
bRsbLsbRsLsbRgRsmbRsbRsbRsRsmbRgbRgbRsbRgbRgbRsRsmbRgbRsRsmbRsRsmbRsbR
gbRgRsmbRsbRsbRgbRsbRgLsbRsbRgbRgbLgbRsbRiRsmbLgLsbRibLjbRgRsRsmmbRgbR
sbRgbRsRsmbRgbRsRsmbRgbRsbRsbRgbLsbRsbRsRgbRsbRsRsmbLsbLjbLibLibRjbRcb
RibRsbRsbRsbRgLsbRsbRsRsmbRsbRsRsmbRsLsbRgRsmbRsRsmbRsLsbRsbRsRsmbLsbR
gRsRsmmbRsbRsbRgbRsbRgRsmbRsbRsbRgbRsbRsbRsRsLsmbRgbRgbRgbRsbRsbRsbRsb
LsRsbRsRsmbRgRsmbRgbLgbRgbLsbRsbRsbRibLgbRibLgbRsbRgbRsbLsRsbRsbRsRsRs
mmbRibLgLsbLibLcbRjbRcbLjbLhbRsLgLsbLibRcbRcbRgbLgLsbLsRgbRgbRgRsmbRsR
sRsmmbRsbRsbRgbRgbRsbLsRsbLgbRjLsbLjbLhLsbLibLibLibRsLsbLgbLgbRjbLhbRc
bsbLibLhbRibLiRsbLgbLgbRjbLsbRjbRibRsbRsLsbRgbRsbRsbRsRsmbRsbRsbRgRsmb
RsRsmbRgbRsbRgbRsRsmbRsbRgbRgbRgRsmbLgbRiRsmbRgRsLsmbLjbLjbLibLgbRsbLg
bLgbLgLsbRobRsbRgbRgbRsbRsbRgbRsbRsbRgbRsRsmbRgRsmbRgbRhLsbLgbLibLgRsb
LsbLgbLgbLibRjbLibRcLsbRibRsbRsbRiRsmbLgRsbRibLgbRsRsmbRgbRsbRibRgbRsb
LsLsmbRibRibLgbRibLsbRgbRsbRsRsmbRsbRsbRgbLgbRibRsbRgbRgbRsbRgbRsbRsbR
sbRsbRibLhbLcbRcbRgRsRsmmbRiRsRsmmbRsRsmbRsLsRsbRsbRsLsbRgRsmbRgbRsbRs
bRsbLgbRsbRgbRsbRgRsmbRsbRsbRgRsmbRsbLjbLibRcbRcbLibLcbLibRjbLgbLibRsL
sbRsbLgbLgbRcRsmbRgbRsbRsRsmbLsbLjbLgbLgbRcbRcRsRsRgmmbRgbLsRgbRsbRgbR
sbRgbRsbRgbRgbRsRsmbRgbLsRsbRibLsLsmbRhLsbLgbLjbLibLibRhbLibRjbRcbLsbR
gbLsbLjbLgbRebRibRsbRgbRgbRgbRsbRsbRsRsmbRsbRsbRsbRsbRsRsmbRsbRgbLgbRi
bRgbRsbLgLsbRibRgbRsbLjbLjbLibLibRhbRgbLibLibLgbRjbRhbRgbsbRsbRgbRgbRs
bRsbRsbRsbRgbRhbLgbRiRsmbRsLsbRsbRsbRsbRsbRsbRsbRsbRsbLsbRsbRsbRibLsbL
sbRibLsbLsbRhbLiRsRsmbRgRsmbRiRsmbLjbRhbLiLsbLjbLcbRcbRiRsmbRgbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 6; Drug: Control Apo 0.5 然
bRsbsbLgRsbRjbRsbLsLsmbRgbLjbRgbLjbsbRgbLgbRgbLsbRgbLgbLjbsbsbsbLsbLsb
RsbRsbLsbRgbLsbLgbsbRsRsmbRsbsbsbLgbRsbRsbRsbLsLsRsmbRgbLsbRgbLebLcbLs
bLsbLsbLsRsbRsbLgbsbLsbsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bRjRsmbRsRsmbLgbRgbRjRgbRgbRsbRsbsbLsbRgbRgLsbRibsbRgbRjRsmbRgbRibRsbL
sbRsbRsbRsRsmbRgbRgbRsbRgbLgbLgbLgRsbLebLsbLjLsmbLsbRgbRgbRsbLebLsbLib
LgbLgbLibLibRgbRibLsbRibRiRsmbRibRibLibRibLsbLgbRgbRibRiRsmbLgbRibRgbR
jRgLsbRgbRgRsmbRjRsmbRgbRsRsmbRsbLgbRgbRsbLjbRibRgbRibRjbLgbRiRsmbRgbR
sbRsbLsRsbLsbRsbRsRsmbRjLsbRsbLgbRibRgbRibRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bRgbRgbRsRsmbRibLsbRibLsbLsRiRsLsmbLsRsbRsbRgbRgbRgbLsLsmbRgRsmbRgbRsb
RgbRsbRgbRgbLsbRgbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgbRgbRsRsmbRgbRgbRgbR
gbRsbRgbLsbRibRgbLsbRibRsbRgLsbLsbRgRsmbRsbRgbRgRsmbRgbRgbRsbRgLsbRgRs
mbRgbRgbRgbRgbRgbRgLsbRgbRgLsbRgbRgbRsbRgbRgRsRsmmbLsbRibRsRsmbLsbRiLs
bRgbRgbRsLsbRiRsmbRsbRgbRsbRgbRgbRgbLgbRibRgbRsbLsLsmbRibRgLsbRsRsRsmm
bLsbRibRgbRgbRsbRibRsbRsRsRsmmbRgbRgbRsbRgbRgbRsRsmbRgbRgbRgbLsbRibRgb
RsbRgbRsLsbRgbRgRsmbRgbRgbRgRsmbRsRsmbRgbRsbRsbRgbRgRsmbRgbLsbLsRiRsmb
RgbsbLgbRibRsRsmbRsbRsRgRsmbRsbLsbRgRsRsmmbRgbRsbRgbRsbRsRsmbRgbRsbRsL
sbRgbRsbRiRsmbRsbRgbRsbLsRsbRgbRgbRgbRgRsmbRgbRgbRsbLsbRiRsmbRsbRgbLsb
RgbLsbRgbRgbRgRsmbLsbRgbRgbRgbRsbRgbRsRsmbRgbRsbRsbRgRsmbLsbLsbRgRsmbR
gbRsbLsbRgbRgbRgbRsbRgbRgbRsRsmbRgRsmbRsbLsbRgRsLsmbRsbRsbRgbRsRsmbRgb
RgbRsbRsbRgbRsbRgbLsbRgRsRsRsmmmbRsRsmbRgbRsbRcRebLjbLibRgbLgLsbLsLgLs
bRgbLiRsbLibRjRcbLiRsbRsbRiRsmbRgbRsbLsbRiRsmbLsRibLgbRiRsRsmmbRgRsmbL
ibRibRgLsbLjbRibRsbRgbLsbRgbRsRsmbRgbRsbRgbRsbRsRsRsmmbRgbRgbRgbRsbRgb
RibRgRsmbRsbRgRsmbRgbRsRsmbRgbLsbRiRsmbRsbRgRsmbRgbRgbRgbRsbRgbRgbRsbR
gbRsbRgRsmbLsLsRsmbRgbRgRsmbRgbRsRsmbRgbRgLsbRsbRgRsmbRgbRgbRsbRsbRsbR
gRsmbRgbLgbRibRsbRgbRsbRgbRsRsmbRgbRsbRgbRibRgbRsbRgbRgbRsbRgbRgbRgbRs
bRgbRgbRgbRgRsmbRgRsmbRgbRgbRgRsmbRgbRgbLsbRgLsbRgbRgbRgbRgbRgLsbRgbRg
bRgbRgbRgRsmbRgLsbRsbRgbRsRsmbRgbRgRsmbRsbRgbRgRsmbRgbRgbRgRsmbRgbRgbR
ibRgbRsRsmbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgRsmbRgRsmbRgbRgbRgbRgbRgbRgRsm
bRgbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgbRgLsbRgbRgbRgbRgbRsbRibR
sRsmbRibRgbRgbRgRsmbRgbRgbRsbRiRsLsmbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgbRgb
Rgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bLgbLgbLgbRsbLgbLsbRgbLjbLgbLjLsmbLsbRgbLibLgbLgbLgLsLsmbLsbLgbLcbLibL
ibLsbLsLsmbLsbsbLibLsbLgbLgLsbLgbRsbRsbRsbRsbLgLsbLsbLibLgbLsbLgbLibLs
LsLsmmbLgbRgbRgbRibLibLgbLgLsbLibLgbLibRsbLgbLgbLgbLgbLgbLgLsbLgLsbLgb
LjLsmbLgbLebLjLgbLjbLsbLibLjLsmbLjbRsbLsbLjbRgbRjRgbRsRsmbRsbLsbLsbLjb
LcbLhbLsbLsbLgbLgbLsbRsRsmbRgbRsbRgbLsbLibLibLibLgbLgbLibLsbLibLgbLsbL
gbLibLibLibLibLibLhbLgbLgLsLsmbLibLsbLibRsbRgbLibLjLsmbLibLsbLibLsbLgb
LgbLibLsbsbLgbLgLsbLgbLsbRjRsmbLgbLiLsbLsLsmbLsbLgbLsbLsLsmbLsLsmbLgLs
bLgbLgLsbLibLgbLhbLgbLcbLibLsLsmbLhbLhbLjLsmbLibLibLibLgbLibLsbLgbLsLs
mbLgbLhbLibLibLhbLgbLsbLgbLsbRiRsmbLgbRibLibRiRsmbLsbLsbRibLsbRsbRibLs
bLsbRgRsmbLsbLsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bRibRjbLjbLjbRjbLjbRibRibLibRibsbRgbRjRsmbRjbRjbLgbLgbRjRsmbLjbLsbLgLs
bLgbRgRsmbRjbRhbRhbLjbLebLibRjbLibRjbRjRsmbRgbRjbLjLsmbLibRjbRjLsbLjbR
jRsmbRjRsmbLsbRsbRjbLjLsmbLibRgbRjRsmbRjbLgbLgRsbRgbRgbRjRsmbRgLsbRjRs
mbLjLsmbLjbLjRsbRjbLibRcbRjbRjbRjbRjLsbRjbRjRsmbLjbLibLibLjbLhbLgbRjbR
cbLjbRibLjbLjLsmbRjbLjbRjLsbLjbRjbRjRsmbLjbLjbLjbLiLsbLgLsLsmbRibLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bRgbLcbRjbLcbLibLsbRgbLibRgbLiLsbRsbLgbLgbRjbLibRebLsRsbRibLgRsbRgbRgR
smbRsbRgLsLsmbLjbLiLsbLgbRgbLgbRsbLgbLsbLjbRsRsmbRsbLibRgbLgRsbLsbLsbL
sLgLsbLibRjbLibRgbLgbLgbLsbLgbLsLsmbLgbLsLsmbLgbRsbLgbRgbLibRgbLibRcbL
cbLiRsbLgRsbLgbRgLsbLibRsbLgbLsLsmbLgbLsbLgbLgbRsLsbLgbRsRsmbLgbRsbLgb
LsLsmbLsbLsbLgbRsbLgbLibRcRcLsbLhbsbLsbLibRgbsbsbRjbRibLsbLsLjbLhRsbRj
bLcbRjbRiRsmbRgbRgLsbRgLsbRsLsbRgbsbLcbLibLsLsLsmmbLgbLsbLsLsmbLgLsbRj
RsmbLibRjbLibRsLgbRsbLgbRgbRjbRibRgbsbLsRgbLebLiLsLsmbRsbLsbLsLibRjbLg
bLibRsbLgbRgbLgbLibRjRcbRibRsbLsRgbRsbRsbRsbRgbRgbRsbRgbLsbLcbLgbLgbRc
RsmbRgRsmbsbRsbRgRsmbRgbRgbRsbRsLsbLobLgLsLsmbLsbLgbLgLsLsmbLgbsbLsLsm
bRcbRgbRsbRgbRsbLobLobRsbRsbRgbRgbRgbLjLhbLiLsbLgbLgbLsLsmbLgRsbLgbLsb
LgLsbLgbLsLsmbLgLsbRgbLgbLsbLgbRebRibRsbRgbRgbRgbRsbRsbRsbLcbLibLgLsbL
gbRjbLgbLgbRjbLgbLibRgbRhbsbLcbLgbLgbLsbLgbLsLsmbLgbLgbLgbLgbLgbLsbLsb
LgbRsbLgbLgbRgbRsLibLibLgLsbRsbLgbLgLsbLgbLsbLgbLsbLsbLgbLgbLsbLgbRcbR
gRsmbRgbRgbLjbLcbRibLibLgbLibLsbRsbLsbLibRgbRsLibLsbLgLsbLgbLgbLsbLgbL
sbLgbRsbLjbRjbRibLjbRcbLjbLjLsLsmmbLibLgbRsbLgbLibRibLsLjbRibRibRobLhb
LhbLibRgbRsRsRsmmbLibRgbLgbRjbLsbRhbLebLibLgbRsbLibRcbRgbRgbRgRsmbRsbR
sbRgbLcbLibRjbLibLibRgbLiRsbRsbLibLibRibLgLsbLgbRsbLgbLgbLgbLsbLgbLgbL
sbLgbLibRsRsmbLgbLsbLgbRsLsbLgbRsbLsLsmbLsbLsbLjbRsRsmbLsbLsLsmbLgbLgb
RgbLibRgLsbLgbRsLsbLgbRsbLgbLiLsbLibRgbLgbLiLsbRibLcbRibRjbLcbLcbLhbLi
bLibRjbRiRibRsbRgbRibRjbLsbLibLjbLibLibLgbLsbLgbLsbLgbLgbLsLsmbLgbLgbR
ibLiLsbLsbRsLsbLgbLsbLgLsbLgbRsbLsbLgbLgbRsLsbLgRsbLgbLgbRgbLibRjbLiLs
bLibRcLsbRcbRibLgbRgLsbRgRsmbRgbRgbRsbRsbRsbLsbLcbLiLsbLsbLgLsbLgbLsRs
bRsbLgbRsbLgbLsbLgLsbRjLsbRcbLjLhbLibRgbLgbLgLsbRsbLgbsbRsbLgbLsbLgbLs
bLgbLsbLsbLsbLgbLsbRcbRiRsmbLgbRibRgbRsbRsbRcbLhLsbLgLsLsmbLsbLgbLgbRs
LsbRgbLgbLgbLgRsbRcbRcLsbRgbRgRsmbRsbRgbRgbRsbRsbRsbRsbLcbLibLgbLgbRcb
LibRjRsmbRobRibRgbRgbRgbRgLsbRsRsmbRsbRgRsmbRgRsmbRsbLjbLcbLibLgRsLsbR
gbRsLsbRsbLsLgbLiRsbRhbRjbRibRibRgbRsbRsbLsRgLsbRsbLcLgbLsbLgbLsbRcLsb
RgbRsbRgbRsRgbRsRsmbRsbRsRsmbRgbRsbRsLsbLjbLcbLgLgbLsLgLsbLgbRsbLib

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bRsbRgbRsRsmbRsbRsbRgRsmbLjLsmbLsbLsbRgbRsbRgbRsbRgbRsbRgbLgLsbLsbRibL
sbRgbRgbRsbRgbRgbLsbLsbRiRsmbLsbRsbRsbRgbRgbRgbRsbLibRgRsmbLsbRgbRgbLs
bLsbRgbRgbsbLsLsmbRsbRsbLgbLjbLgbsbLibLsbRsbRibLiLsbLibLsbsbLgbRsbRgbR
gbRgbRgbLsbRsbRgLsbRgbLsbsbRsRibLsbRgbLsbLsbRgbRsbRsRsmbRsbLjbRgbRibRs
bLsbRibRsbRgbRsbsbRgbLsbRsbRsbRgbRgbRgbRsbRibRsbLsbRgRsmbRsbRibLhbLibR
sbRsbRgbLgLsbRsbLibRsbRgbLsbRsbRibRsbRsbRgbRgbRsbRibLgLsbRsbRibLjbRibR
ibRsbLsbRgbRsbRsbRsbRibRsbRsbRsbRsRsmbRsbRibRsRsLsmbLsbRsRsmbRgbRgbRsb
RsLsbRgRsmbLsbLibLjLsmbsbLibRsbRgbRgbLebLiLsbLsbLsbsbLgbLsbRgRsmbRgRsm
bRgbRsbRgRsmbRsbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bLjbRibRcbLhbLjbRiLsbLjbRsRibLjbRibRsRsmbRgbRgbRgbRsbRsbRgLsbRsbRgRsLs
mbRgbRsRibRsbRgbRibRgbLsbRgRsmbRgRsmbRgbRsbRsbLobLjbLibLgbLgbLsbLgbLgb
RjbRhbLjbRibRibRgbRgbRgbRsbRsRsmbRgbRgbRsbLsRsbRsRgbRsbLsRsRsLsmbRjbRg
bRibRsbRgbRsbRiRsmbRgbRgbRsbLsbRsLsbRiRsmbRsLjRsbLiLsRsbRcRsRcRsmmbLib
RsRsRimbRsbRgbRgbRgRsmbRgbRsbRgbRsbsbRgbRsbRgRsmbRiRsmbRgbRsbRgbRgbRgR
smbRsbRgRsmbRgRsmbRgbRgbRsRsRsmmbRgbRgbRsbRibRgbRgRsmbRsbRgbLsbRiRsmbR
gbRgbRgbRgRsmbRgbRgbRgbRibRgbRibRsbRgRsmbRgRsmbRgRsmbRgRsmbRgRsmbRsbRs
bRgbRgbRgRsmbRgbRsRibLcbRjbRsbRsbRgRsmbRsbRgbRsbRsbRgbRsbRgRsRsmmbRsbs
bRsRsmbRibRsbRibLjbRgbRgbRsbLsRsbRsRsmbRgRsmbRgRsmbRjbRsRsmbRgbRgRsRsm
mbLsbRgbLsRgRsmbRjRsRsRsmmmbRgbRsbRgbRgbRgbRgbLsbRsRsLsmbRgbRsRsmbRgbs
bRgbLgbLsbsbRgbRgbRsRsmbRsbRsLsbRgRsmbRgbRgbRsLsbLsbRgRsmbRsbRsRsmbRsR
smbRsbRgbLsbRsbRgbRgbRsbRsbRsbRsbLjbRhbRjbsbRgbRsbRsbLsbRgLsbRjbLsbRsb
RgbRgbLsLsmbRsbsbsbRibsbRgbRsbLsbRgRsmbRgRsmbRsbRsRsmbRgbRgRsmbRsRjbRs
RsmbRsbRjbLsbRsbRsRsmbRgbsbRgbRgbRgbRgbRgbRsRsRsmmbRgbRsbRgbRgbRgbRgRs
mbRsRsmbRsRsmbRgbRgbRgbRgbRgbRsLsbRgbRsbRsRsmbRsRsmbRgbRgbRgbRgbRgbRgb
RgbLsRsbRgbLsbRibRsbRgbRsLsbRgbRsbLsbRgbRgbRsbRgRsRsmmbRgbRgRsmbRgRsmb
RsbLsbLibLgbLgbLibLoLsmbLsbRhRsmbRibRsLsbRiRsmbRgbRgRsmbRsbRsRsmbRgLsb
RgbRjbRsbRsbRgRsmbRgbRjbRgbRsRsmbRgbRgbRsbRgbRgbRgRsmbRgbRsbRsRsmbRgbR
gbRgbRgbsbsbRsbRsbRgbRgbRgbRibRgRsmbRibRsbLobRjbLjbLgbRsRsmbRsbRsRsmbR
sbRjbRsbRsLsbRsbRgbRsbRsbRgbRjbLsRsbRsbRgbRgbRsRsmbLsbRgRsmbRgRsmbRgbL
sbRsRsmbRgbRsbRsRsmbRgLsbLsLsmbRjbLsbRsbRsbRgRsmbRsRsmbRgRsmbRsbRgbLsb
RgbRgbRsbRgbRgRsmbRgbRgbRgRsmbRiRsmbLgbRibRibLibLgLsbLgLsbLgbLiRsbRibR
cbRgbRgbLgRsbRibRsbRgbRsRsmbRgbRgRsmbLsbRsbRgbRgRsmbRgRsmbRsbRsbRsbRgb
RgbRgbRsbRgbRgbRsbRibRsbRsRsmbRiRsmbsbRgRsmbRsRsmbLsbRgbRgbRgbRgbRgbRg
RsmbRsbRgbRsbLsLsmbRibRsbLsbsbRgRsmbRgbRgbRgRsmbLsbRibRsbRjbRsRsmbRsbR
sbRsbRgbRgbLgbRibRsbRsbRsRibRgbLjLoLsLiLsLsmmbLgbLsLsmbLsLsmbLgbLgbLgL
sLsmbLgbLsbLgbRcLsbRibRsbRjbLsbRsbRgbRgbRgRsmbRsbRgbRgRsmbRgRsRsmmbRsb
RjbRgbRgbRsbRibLsbRibLjbLhbLgLsbLgbRgbLgLsRsbLgbRgLibRcbRjbRsbLsRsbRgb
RgbRsbRgbLsRsbLjbRibRgRsmbRgbRsbRgbRsbRsbRgbRsRsmbLsbRhLibLhbLiRsbRjbL
gbLibLsLibLgRsbLhRsbRcbRibLsbRgLsbRsRsmbRsRsmbRgbRgbsbRgRsmbRgLsbRjbRs
bRgRsRsmmbRgbRibRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bRsRsmbRsRsmbRgbLjbRjbLjRsbRibLiLsbRiLsbLgbRiRsmbRsbLgbRgbRjbLgRsbRgbL
cbLibRjbLhbRjbRcbLibRiRsmbRgbLgRsbRibLsbRibRsbRsbRgLsbRsbRsbRgbRsbRgbR
sRsmbRgbLibLjbLiLsbRjbRebLjbRibRibLgbRsRsmbRsbRibRgbRgbRgbRgRsmbRgbRgL
sbRgbLgbLjbLibLgbRgbLjRsLsbsbLsRjbRcbLjbsbRibLgbRibRsRsmbRgbRgbLiRsbRi
bRgLsbLsbRibRsRsRsmmbRsbRsbRsRsmbRsbRsbRsbsbRsLsbRgRsmbRgRsmbLcbLibRhb
LhbLgbRjbRcRsmbRibLjbRiRsmbRsbRgbLsRsbRgbLjbRibLibRibRhLsLsmbLjbRibRsb
RjbLsbRsbLjbRiRsmbLjbRsbRibLjbRibRgRsmbRsRsmbRgRsmbRsbRgbRsbRsbRgbRgbR
gbRsbRsbRsbRsbRgbRsbRgRsmbRgbRgbRgbRsbLhbLhbRebLibLgbLgbLsbLiRsbRjbRcb
LsRsbRibLjRsbRibRgbRgbRsLsbRgbLgRsbRiRsmbLjbRibRiRsmbLibLsRsbRibRsbLgb
RiRsmbRgbRgbRsRsmbRsRsmbRgbRgRsmbRsbRgbRgRsmbRsbLibRgbLgbLebRcRsmbRjbR
sRebRsbRgbsbLsbLgRsbRsbLsbsbLsRsbRgbRibLsbRjbRgbLjbRsbRsbRibLjbsbLsbLj
bRebRjbRsbLsbRsbRjbRsRsmbRsbRsbRsbRsbRebLobLgbRcbRibRiRsmbRibLjbRhbLgb
RibLjbLjbLibRcbRebLibRibLsbRgRsRsmmbRsbRgbRsbRsbRgbRsbRgbRsbRgbLsbRibL
sbRgbLgbLjbLibLsbLibRcRsmbLsRsbRibLgbRsRibLsbRgbLsbRgbRsRsmbRibRsbRjbL
sbRsbLsbRsbLsRsbRibRsbRgbRsRsmbRgbRsRsmbRgbRgbRsRsmbRgbRsbRgbLsbRsbRib
LjbRibRsbLjLsmbRsbLhbRsLsbLibLsbRsRsmbLsbLsbLsbLgbRjbRhRsmbRibLsLsmbRs
bRibLibRgbLjbRibRgbRsRsmbRgbLsbRgbLsbRgRsmbLsRsLsbRgRsmbRsbRgRsmbRgbRs
bRgbLgbLjbLibLgbLsbLsbLgbLsbLsLsmbLgbLgbRoRsmbRibLjRsLsbRibRsbRsbLsRsb
RibLsRsbRgRsmbLsbLjbLibRibLgbRcbRibRgbLsbRsbRgbLsbRsRgbRgbRibRibRibLgb
RibRsbLsbRgbLsbRgbLsbRibLsbRgbRjbRsLsbRsbsbLsRsbRiRsmbRsbRsRsmbRibLsbR
ibRgbRgbLiLsbRgbRibLgbRibLibRibRibLsbRgbRsbRsbLsbRjbLjbRibRsbRsRsmbRjb
RgbRsbRjbLebLgbLgbLgLgLsbLjbRebLcbRsbLjbLcbLcLsLsmmbRibLjbRiRsmbRsbRgb
LsbLibLjbLjbRcbRgbRcbLibRgbLiLsbLiLsbLibRibLcbLjbRibsbLsbRsbsbRsbRcRsm
bRgbsbRsbRebRcbLgRsLsbLjbLiRsbLsLsmbLgLsbLsbLsbLsRsLsbLsLsmbLsbLsbLsbL
sbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bRgbLibLgLsbLiLsbRibLsbLibLgLsbLsbLsbLgLsbLsbRsbLgLsbLgLsbLgbLsbLgbLsb
LgbLgbRsbLgbLgLsbLgbLgbLgbLgbLgLsbLgbLsLsmbLgbLsbLgbLgbLgbLgbLsbLgbLgR
sbLgbLgbLsbLibLsLsmbLgbLgbRjbLibRgbLibLgbRgbLiLsbRsLsbLsLsmbLgLsbLgbLs
bLgbLgbLgbLsLsmbLgbLsbLgbLgbLgbLgbLgLsbLgLsRsbLgbLsbLsRsbLibRibLiLsbLi
bLgLsbLgLsbLsbLgbLgLsbLgbLgbLsbLsbLgbLgbRsLgbLgbLgbLgbLgbLgbLsbLgLsbLg
bLsbLgbLgbLgLsbLgbLgLsbLgbLgbRjbLibRjbRcbLhbLhbRibLibLibRsLsbLsbLgLsbL
gbLgRsbLsbRsLgbLgLsbLgbLgbLgbLibLgbRgbLgRsbLgbLsbLgbLgbLsLsmbLgLsbLgLs
bLgbLgbLgbLgLsbLsbLgbLgbLgbLgbLgLsRsbRsLsRsbLiLsbLgbLgRsbLgbLsLsmbLgbL
sbLgbLgLsbLsbLgbLgbLgRsLsbLgbLgbLgbLgbLgRsLsbLsbRgbLibLgLsbLsRsbLsbLib
LibRgbLibLgbRibRcbLebLiLsbLibRibLgLsbLiLsbLsbLgbLgLsbLgbLgRsbLgbLgbLsb
LsbLsLsmbLgbLgLsLsmbRgbLibRgbLibRibLiLsbLgLsbLgbRgbLibLsbLgbLsbLsbLgbL
gLsbLgbLgbLsLsmbLsbLgbLsLsmbLgLsLsmbLsLsmbLgLsbLgbLsbsbLsbLgLsbLsLsLsm
mbLgbLgLsbLgbRgbLiLsbLgbLsbRsbLgRsbLgbLgbLsbLsbLgbLgLsbLgbLsbLgbLgbLgb
LgbLgLsbRsLsbLgLsbLsRsbLgbLgbLgLsbLgbLgbLgbLsbLsbLgLsbLgbLgbLgbLgLsbLg
bLgbLsbLgRsbLgbLsLsmbLgLsRsbLgLsbRgbLibLgbRgbLebRcbLsbLsbRgbLibLgbLsbL
gbLgLsLsmbLgbLgbLgbLgLsbLsLsmbLgbLgLsbLgbLgbLgbLsLsmbLgbLgbLgRsbLgRsbL
gbLsbLgbLgLsbLgbLgLsbRjbLibRgbLibRjbRcLsbLjbLhbRgbLhLsbLgbLsLsmbLgbLsb
RoLsbLibRiLsbLibLsLsmbLsbLgbLgLsbLsLsmbLsLsmbLgbLsbLgRsbLsbLgbLibLsRsb
LgbLsbLgLsbLibLgbRgbLsLjbRobLiLsbLgbRsbLsbLgbLsbLsbLgRsbLgLsbLgLsbLsLs
mbLgbLgLsbLsbLsbLgbLgLsbLgbLgLsbLgbLgLsbLgbRjbLiLsLsLsmmbLgbRcbRgbRgbL
cbLsbLjbLcLsmbLsbRobLgLsbLibLgLsbLibRhbLgbLibLibRgbLsRsbLibLibLebRcbLi
bLiLsbLgbLgbLgLsbLgbLsLsmbRsLsbLgLsbRcbLsRgbRgbRgbRgbRsRsmbRgbLebLiLsL
smbRgbLibLsbLgLsbLgbLsbLibLgbLsLsmbLsLsmbLgbLgbRjRsmbLibLibRibRibLgbLi
bRgbLcbLebLebLhLsbRjbLibLibRsLsbLgbRsbRgbRsbLsLibLibLibRgbLibLsbRgbLib
LsLsmbLibRjbRhbRibLeLsbLibLsbLibRsLsbLsbLiLsbLgbRgLsbLiLsbLibRibRgRsmb
LiLsbLibLsbRsbRgbLibRgbLibLibRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bRgbRgbLsRsRsmbsbRiRsmbRgbRgLsRsbRgbRsbRsRsmbRsLsbRgRsmbRsRsmbRsLsbRgR
smbRsbRsRsLsmbRgbRgRsmbRsbRgLsbRsbRgbRgbRgbRgbRgRsmbRgbRgbRgRsmbRgbRgb
LjbRhbLgbRgRsmbRibLgbRgbRiRsmbRebLebRgRsmbRgbRgbRgbRgRsRsmmbLgbRiRsRsm
mbRibRsRsmbRgRsmbRsbRjbRgbLgRsRsLsmbLebLsbRgLsbRgRsmbRgbRgbRgbRgbRgbRg
bRgbRibRgbRgbRibRgbRgbRgRsmbRgbRgbRgbRgbRgRsRsRgmmbLobLgbRjbRsbRgbRgbR
sbRgbRgbRsbRgbRsbRcbLjbRibRgbLsRgbRsbRsbRgRsmbRibRebRgRsmbRgbRibLjbRhL
sbRgbRibLjbLcbLiLsbLgLsbLgbRjbRobRsbLgbLhbLgbLgbLsLgbRcRsmbRgbRiRsRsmm
bRgbRsbRgbRgbRsRsmbRgRsRsRsmmmbRgbRsbRgLsbRgbRgRsmbRgbRgRsmbRgbRgbRgbR
gbRsbRiRsmbRgbRgRsRsmmbRgbRgbRsbRsRsmbRebRsbLgbRsRsmbRiLsRsLsRsbRobRgb
RgbRgbRgRsmbRibRgbRgbRgRsmbRgRsmbRgbRhbLebRobLsbRibRsbRgbRgbRgbRgbRgbR
gbRgbRgbRgbRgbRibLibRibRibLsbRibRsRsmbRgbRsRsmbRsRsRsmmbRgbRgRsmbRgRsm
bRgRsmbRgbRsbRsbRgbRgbLsbRgbRsbRsbRgRsmbRsbRgLsbRgbRsLsbRgLsbRgbRgbRgb
RgLsbRsRsmbRsRsRsmmbRgRsmbRsbRsbRsbRgbRsbRgbRsbRgbRsRsmbRibRgbRgbRgbRg
bRsbRgRsmbRgbRsRsmbRgRsmbRsbRgbRgRsmbLsRsbRsRsmbRibRgRsmbRgbRsbRgbRgbR
sbRgbRgbRgbRgbRgRsRsmmbRgLsbRsRsmbLjRsRsmbRiRsmbRsbRibRcbRgLsbRgRsmbRs
RgLsbRsRsmbRgbRsbRsbRgRsmbRsbRsbRgbLgRsRsmbRgbRsbRgRsmbLsRsbRsbRgbRgbR
gbRgbRgbRgRsLsmbRsbRgbRgbRgRsmbLgbRibLsRsbRiLsbRsbRgbRsbRgRsmbLgbLibLg
bLgbRoRsmbRgbRgRsmbRgbRgRsmbRgbRsbLgbRsbRgbLcbLgbRebRgbRsLsbRgbRgbRsbR
gbRgRsRsmmbRgRsmbsbRibLjbRsRsmbRiRsmbLjLsRsRsmmbRibLjRibRjbRsbRgbRgRsm
bLsLsmbRibLgLsbRibRibRgbRgLsbRgbRgRsRsmmbRgbRgRsmbRjbRsbRgLsbLsLsmbRhb
LgbRibLgbRebRsbRgbRgbLjbRibRibLsbsbRsbRgRsmbRsRsmbRibLsbRgRsmbRsbLsbRi
bRsRsmbRgbRsbRgbRsRsmbLsRsbRiRsmbLgLsbRibLjbRibRsbRibLgLsbRgRsmbRgbRgb
RgRsmbRgbRsbRgRsmbRgRsmbRgbRgbRgbRgRsmbRgRsRsmmbRgbRgbRgRsmbRgLsbRibRg
RsmbRsbRsbRgbRsRsmbRiRsmbRiRsmbRgbLgLsbRibRgbRsRsmbRsRsmbRgbRsbRgbRsRs
mbRgRsmbRsbRsbRiRsmbRgRsmbRgbRgbRgbRsbRsbRgLsbRgbRgbRibLgbRibRsbRsbRsb
RibRsbRgbRgbRgbRgbRsRsmbRgRsmbRgbLsRsbRgbRsbRgbRsRsmbRsRsmbRgRsmbRgbRg
bRsbRgRsmbRsRsRsmmbRgbRgbRsbRgRsmbRgbRgbRsbRgLsRsbRsRsmbRgbRgbLgbLsRsL
sbRibRgbRgbRgRsmbLsbRibLsbRiLsRsbRgRsRsmmbRsRsmbRgbRgRsmbLebRcbRsRsmbR
jbRsbRgbLjbRiRsmbRgbRgbRgRsmbRgbRgbLsLsmbRibRibLjbLcLibLgbLgbLgRsbRcRs
mbRcbRgbRsRiRsmbRgbRsbRiRsmbRgbRgbRsRibRgbRiRsmbLsbRiRsmbRgbRgRsmbRgRs
mbRgRsmbRgbRgRsLsmbRsbRsbRjbRgbRsbRgbRgbRibRsRsmbRgbRgRsmbRsbRgbRgRsLs
mbRgRsmbRgRsmbRgbRgRsLsmbRjbRsLsbRgbRgbRgbRsRsmbRgbRgbRgRsmbRgRsmbLcbL
ibLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bRsbLgLsbLgbLgbRgbLgbLsRsbLgLsLsmbLsbLgbLsbLgbsbLgbLgbLgbLsbLsbLgbLsLs
mbLsbLsbLgbLgbLsbLsbLibRibRjbRgbRibRgbRgLsbRgbRsbLsRsbRgbRsbRgRsmbLsbR
sbRibRgbLgbRgbRibLsRsbLsbRgbRgRsmbRgbRsbRgLsbRsbRcbLgRsbRsbRibLgbRgRsm
bRibRgbLgbRibRsbRibRgbRsbRhRsmbLgbRhRsmbRgbLsbRgRsmbRiRsRsmmbRsbLhbLib
LgbRsbRsbLibLgbRsbLgbLsbLgbLgRsbLgbLsLsmbLgbLsbLgbLsbLgLsLsmbLgbLsbLsb
LgbLgbLsbLgbLgRsbLsLsmbLsbLgbLgRsbLsbLsLsmbLgbLsLsRsmbLgbLsbLsbLsbLsbL
gLsbLgRsbLgbLsbLsbLgLsLsmbLsbLsbRsbLgbLgbLsLsmbLgbLgRsbRcbRcbLjbRiLsbR
iRsRsmmbLsbRgbRsbRsbLsbRhbRsbLgRsbLjbLcbLibLgbLsLsmbLgbLibLsbLgbLsbLsb
LgbLgbLgbLsLsmbLgbLsbLgbLsbLsbLgbLsbLsbLsLsmbRsRsmbLgbLsbLgbRgbLibLgbL
ibLibLhbLgLsbLsbLgbLgbLgbLgbRgbLgbRibRibLgbLgbLgbLgbLgLsRsbLsbRsbLgbLg
bLgbLsbLsLsmbLgbLsbLgbRgbLsbRcRsmbLsbRgbRsbRgbRsbRgbRgbRibLebLibLgbLgb
RgLsbLibLsLsmbLgbRsbLgbLgbLgbRgbLibLgLsRsbLgRsbLsbLsbLgLsbLgbLsbLsbRsb
LiLsbLibRjbRcbRibRgbRgbRsRsmbRgbLcbLgbLsbLsbLgbRsbLgbRsbLibLsbLsbLgbLs
bLsbLsbLsbLsbLgLsbLgbLgbLgbLsbRsbLsbLsbLsbLsbLgbLsbLsbLgbLsbLsbLgbLgLs
bLsbLsRsbLgbLsbLsLgbLsbLsbLsbLsbLsbLsbLsbLgbRsLsLsmbRsbLgLsbLsbLsbLgbL
sbLsbLsbLsbLsbLsbLgLsRsbLsbLsbLgbLsbLsbLgbLgbRsbRsbLsbLsbLsbLsbLsbLsRs
LsbLgbRsbLgLsbLsbLsbLgbLsbLsbLsbLsLsmbLsbLsLsmbLsbLsbLsLsRsmbLsbLgbLsb
LsbLsbLgbLibLgbLgbRibLibLibLgbRsLsbRsbLiLsbLibLgbLsbLsLibLgbLsbLsbLsbL
gbLsbLsbLsbLgbLsbLsbLsbLgRsbLgLsbLsLsmbLgbLsRsbLsLsmbLgbLsRsbLsbLsbLgb
LsLsmbLsbLgbLsbLsbLsbLgbLsbLgLsbLgbLgLsbLsbLsbLsLsmbsbLsbLsLgLsbLgbLsb
LgbLibLsbRibLsbLhbLibLsbLsbRgbLcbLibLgbLjLsmbRgbLibLsbRsbRibRgbRsbRgRs
mbsbLsbRgbRsRsmbRsbRgbRsbRsbRgbLjbLcbLibRgbLsbLgbLgbLsbLsbLsRsbLsbLsbL
sLsmbLgbLgRsbLsbLsLgbLsbLsLsmbLsbLsbLgbRsbLgRsbLsLsmbLsbLgRsbLgRsbLsbL
gbLsLsmbLgbLsLsmbLsbLsLsmbLgRsbLgbRgbLibLgbLsLsmbLsbLsbLsbLsbLsbLsbRsb
LgLsbLgbRgbLiLsbLsbLsRsbLsRsbLgLsLsmbLgbLsRsbLgbLgbLsbLsbLsbLgLsLsmbLg
bLsbLgbRsbLsbLsLsmbLgbRsbLgLsbLgLsLsmbLsbLsLsmbLgbLsLsmbLsbLsbRsbLgLsb
LgbLsRsbLgRsbRsLsbLsLgbLsbLsbLsbLgbLsbLgbLsbLsbLgbLgbRsLsbLsbLsLsmbLsb
LsbLsbRgbLgbLgbLgLsbLsbRsbRsbLgbLgbLsbLsbLgbLsbLgLsbLibLgRsbLgbLgbLgbL
sbLibLgbLsbLibLsbLsbLibLsbLibLsbLgbLsLsmbLgbLsbRsLsbLsbLiLsbLgbLsbLgbL
sbLgbLgLsbLsbLsbLgbRsbLgbLgbLgbLsbLsbLgbLebRgbLgbLgRsbLiLsbLsbLsbRcbRg
bRgbRsbRgbLgbRgLsbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bRgbLgbRsbLsbRsbsbsbsbLsbLjbLhbLgbRgbRsbRsbRsRsRsmmbLsbLsRsLsbRsbRsbLs
bsbRsbLsbsbsbLibRjbRsbLjbRsbLsbLjbLsbRsbRsRsmbRibLsLsmbLjbsbLsbLsbLsbs
bRsbRiRsmbLjbLgbLibRibRjbRjbLgbLeLsbLibLibRibLibLebLsbLsLsmbLsbRibsbLi
LsbsbLibRjbRibRsbsbsbRjbLsbRhbLgbsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bRgbRsbRsbLibRibLgLsbRgbLsbRgbLsRsbLgLsbRibLibLgbLgbLsbLgbLgLsbLgbRjbR
ibRsbRsRibLsbRsbRsbRsbRgbRsbLgbRsbRsRsmbRsbRgbLgRsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bLgbLgbLjRsbLsbLsbLibRsbRjbRsbLsbLcbLebLibLsbsbLibLsbLgbsbLgbLsbLsbRsb
RsbRsRsmbLiLsbLgbRsbRsLsbLsbLsbLsbRsbLgbRjbLsLsmbLsLsmbLsbLsbsbLsbLhbL
gbLsbRsbLsRsbLibLsbLibLibLgbRsbRsbRsbRsbLjLsmbLibLsbLgbLgbLsbLsbLgbLgb
RgbRsbRsRsmbRsbLcbLgbRsbRibLsbLibRsLsbLgbRsbRgbRsbLsbLibLibLgLsbRjbLjb
RjbLgbLsbLgLsbLsbLgbLhLsbsbRsbLgbLgbLsbLsbLgbLsbRsbLgbLsbLebRsbLgRsbLs
bLsbLsbLsbRsbLgLsbRsbRsbLsbsbLsbsbRsbLgbLsbLsbLsbLgbLsbLgbLibLgbLsbRsb
LgbLgbLsbRsbLibLiLsbRjbLibRsLsbsbRgbLcbLibLgLsbLgbLibLsbRhbLgbRcbRebRg
bRgbLgbLgbsbLibRgbLgbLsbRsbLsbRsbLibLsbLsbLsLsmbLgbLsbRsbLsbLgbRsbLsbL
sbLsbLsbLsbLsbLsbLsbLsbLsbLsbLgLsbLibRgbLibLiLsbLibLiLsbLibRsbRjbRhbLs
bRgbLjbsbRsRsmbRsRcbRcbRgbRgbLsbRsbRsbLiLiLsLsmbRsbLgLsbRsbRsRsLsmbLib
LsbLgbRjbsbLsbLsbLsbLsbLsbLgbsbRgLhbRibRsLsbsbsbLjbsbLsbLsLsmbLsbLsbLs
bLgbLgbLsbLsbLsbLgbRcbRgbLcbLgLsbLgbLgbRibLgbLsRsbRsbLsLsmbLsLsmbLgbLs
bLgRsbLsbLsbLsbRgbRcRsmbRgRsmbRgRsRsmmbRgbLcLsmbLibLsbLgbLgbLsbLsbLsbL
sbLgbLsRsbLgbLsbLsbLsbRsbLsRsbRgbRgbLsbLgbRsbRcbLsbLgbRsbRgbRsbLgbLcLs
mbLjbLsbRsbLsLsRsmbRsbLsbLsbLsbLgbRsbRjbRgbLcbLgbLgLsbLsbLgbLsbRsbLsbL
sbLjbLgbRhbRgbRjbRsbRjbRsbRsbRsLsbRsbRjbLgbLjbLhbLgbRsLsbLjbLsRsbLsbLs
LsmbRsbsbLgbLsbLsbLgbLsLsmbRhbRgbLjbLibRgbLgLsLsmbLsbLgbLsbRsbLibRsbLs
LsmbLsRsbLsbRsbLgbRsbLgbLgLsbLsbLsbRjbLjbLsbLsbRsLsbLsbLgbLsbLgbLiLsbL
sbLgbRgbRjbLhbLibRgbRsbLsbLsbLgbRsLsbRsbLgbLsbLsbLgbLsbLsbLsLsmbLgbLsb
LsbLibRibLibLgbLjbLsbLsLsmbLgbLsbLsbLsbLsbLgLsbLsbLsbLgbLgbRsbRjbRgbLc
bRsbRsbRsbLsbLsbLgbsbLgbLgbRebRibRsLsbRgLsbRsbLsRibLjbRibLgLsbLsLsmbLs
bLsbRsbLsbLgbLgbLgbRsbLsLsmbRgbRcbRjbsbLsbLibsbLibRjRsmbLsLsRsmbLibRsb
LgbLsbLsbsbLsbLgbLgbLsLsmbLsbLsLsmbLgLsbRcbRibRibLcbRsLsbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bLgbRibRibLsbLibLsRsbRsbRibRgbRgRsmbRgbRsLsbLgbRibRgbRsbLsbRjbLgbRibRs
bLsbRibRsbLgLsbRiRsmbLsbLsbRibLsbRgRsmbLsbsbRgbLgLsbRsLsRibLgbRibLgbRi
bLibRsbLobLjbLsbLgbLgbLgLsbLsbLgbRhbRibRgRsRsmmbRibLsbRiLsbRsbLjbRsRsm
bLcbLibLgRsbLgbLgLsbLgbLsbLgbLgbLsbLgbLsbLsLsmbRhbRsbsbLsbRiRsmbLsbLsb
LcbLgbLgbLsbLsbLsbLgRsbRibRhbRgLsbRgbLsLsmbRibLsbRgbLcbReRsmbRibRgRsmb
RsbLgbRsRsRsRsmmmbLsLsmbRibRibRgbLgbRibRgRsmbLgbRibLsbRgRsmbRsbRgbLsbR
gbLsbRgbRgbRsbRgbRgbLgLsbLcbLgRsbLgbLgbLgLsbLsbLgbLgbLsbLsbLsbsbsbRjbL
cLsmbRibRiRsmbRsbRibRgbLgbRgbLsbLsRgRsmbLsbRgbRsbRgbRsbRsbLsbRsbRgbRsb
LhbLgbLgbLgbLsbRsbLgbLsbLgbLgbLsbLsbLsbLgbLsbLgbRsbLgbLgbRebRgbRibLjbL
sRsbRsRsmbLsLiLsRsbRsLsbLsLsmbLgLsbLsbLsbLsbRgbLgRsbLsbLgbLgbLgbLsbLgb
RjbLebRebRgbRibLibRgLsbRgbRgbRsbRsbsbLgbLobLgbLgbLgbLgbLgbLgRsbRsbReRs
mbRgbLcbsbLsbLsbLsbLsLsRsmbLsbLgbRsbRsbLsbsbLgbLgbLgbLgLsbLgbLgbLgLsbL
sRsbLgbLgbLgbLsbLgLsbLgbLgbLsbRhbRibLjbRcbLsbRgbRibLjbRibLjRsbLsbRibLg
bRibLsbRibRsRsmbLsbRibLsbRibRgbLsbRgbLjbRibRgbLsbRibRgbRsbRgbsbRiRsRsm
mbLsbRgbLsbRgbRgbRsbRgbLgbRibRsbLgbRiRsmbRibLgbLgbRhbRgbLgbRgbRibRgbRg
bRsbRgbRsLsbLgRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bLgbLsbLgbLgbLsbLiLsbRgRgbLibLgbLibLsbLhbLsbsbLibLsbLiLsbLsbLibLsbLibL
gbLsbRsbLibLjLsRsmbLsbLgbLsbLibLsbLgbLibLsLibLhbLsbLgbLibLgbLjLsLsmmbL
sbLsbRjbRjbLibLhLsbRsbLsbLgbLibLsbRjbRsLsbLibLsbLsbLiLsbLsbRjbLibLsbLi
bLsbRgbLsbRgRsmbLiLsbLsbLsbLibLsLsmbLsbLibLgbLsbLsbLibLsbLsbLebRgbLgbL
sbLibLsbRhbRsLibLiLsbLsLsmbLiLsbLsLsmbLsLsmbLsbLsLsLsmmbLsbLgbLsbLsbRs
bRsbLibLibLsbLsbLcbLsbLibLsbRgbLibRsLsbLsbRgbLiRsbLgbLsbLhLsbLsbRsbLgb
LibRgbLiLsbLsbRsbLgLsbLgbRibsbLibLiLsbLsbLsLsmbLibLsLsRsmbRsbRgbLibLsb
LgLsbLsbLiLsLsmbLsbLsbRsbLsbLeLsbRjbLibLsRsbLibLsRsbLsbLsLsmbLibLsLsmb
LibLsbLibLsbLgbLgbLsLgbLsbRsLsbRsbLiLsbLibLsbLhbLsbLsbLsbRgbLibLsbLsRs
bLibLsbLibRsbLsLsmbRsLsbLiLsbLsbLibLsbLsbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bLjbLsbLsbLgbLsbLsbLsbLgbRsbLsbLsbLsbRsbRjbLibLebLjbRsbRgRsmbLjbsbRgLs
bLibLsbRsbRcbRgRsmbRsbLsbRgbRsbLgbRibRcbLgLsbLsbLsbRjbRibRibRibRsbRsbR
gRsmbLsbRsbRgbRiRsmbRgbRibRgbLeLsbLgLsbLsRsbRsbRsbLibLsbLgLsbLsbRsRsmb
LsRsbLsbLsbLsbLgbLgLsbRgbLhbLsLsmbLsRsbLsbLgbLgbLgLsbRgbLibLsbRsbLgbLg
bRsbRsRsmbLgbLsRsbRsbLgbLgbRibRobRsRibRgbRibLjLsmbLcbLibRsbLgbRgbLibLg
bRgbLsbLjbLsLsmbRsbRsbLibRgbLgbLsbLgbRgbLibLgbLsLsmbRsbRsbLsbLsbLsbLsb
LsbLsLgLsbsbLgbLsbLsbLsbLsbLsbsbLsbLsbLsbRsbRsbRgLsbRjbLgbRjbLgbLsbLsR
sbLgbLsLsLsmmbLgbLsbLgbsbLsLsmbLgbLsbLsbRsbLsbLibLsbLsbLgRsbLsLsRsmbLg
bLsbLsbLgbLsbRsbRsbRjbLgbRsbLsbLibLsbsbsbLsbLgbRiLsbLgbLgbLgbLsbLsLsmb
RsbsbRsbLgbRibRsbLsbLsbRsbRsLsbLsbLgbRsbLgLsbLsbLsLsmbLgLsbRgRsmbLibLs
bLsbLsLsmbLsbRsbLsbRsbRsLsbRsLsbRsbLsbLsbLsbLsRsbLsbLgLsbLsbLsbsbsbRsb
LsRsbRgbLibRgbLgLsRsbRgbsbLsLibLsLsmbRsbLgbRsbLibRgbLibLsbLgbLsbRjbLcR
sbLhbRsbLsbLsLsmbLsbLcbLibLibLebLsbLgbLgLsbLiRsbLgLsbLsRsbLibRgbLibLgL
sbRsLsbLsLsmbLsbLgLsbLgLsbLsbLsLsmbLsbLibRgbLibLsbLsbLgbLgbLgbRibRjbRc
bRibRjbLgbLsbLgbLcbLibLibRiRsmbLibLgbLibLgLsbLgbLsbLgbLsbRsbLibRsbLsLs
mbLgbLgbLsbLgbRgbLsbLsbLgbLsbRsbLgLsbLsRsbLgbLgbRjbLiLsbLsbLgbRgbLiLsb
LgbRibLibLsbLsbLgbLsbLibLsbLsbLibRgbRjbLhLsbLibLgLsbRgbLibLsbLgLsRsLsb
LgbRgbLsbLibRgLsbLgbLsbLsbRsbLibRsbLibRsbLgbLgbLsbLgbLsbRsbLsbLsbRgbLs
LibLsbLiLsbRiLsbLiLsbLgbRsbLsbLgbLsbLgLsbLsbLgbLgbLibRiLsbLhbLsbRsbRgb
LgbLibLgLsbLsbLgbLsLsmbLsbLgbLsLsmbLsbRsbLgLsbRgbLibLgbRjbsbRobRibRgbR
gbLjbLcLsmbLibLgbRibLibLibLsbRgbRgbLcbRgbRsbLiLsbRsbRsLsbLsRsbLibRsbLg
LsbRsbLsbLgbLsbLsbLsbLsbLsbLsbLsRsbRsbLsRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bRsbLibRsbLsLsLsmmbLgbLsbLgbLsbLsbLsbLsbLgbRsbRsbLgbLibLgbRhRsmbLibLsR
sbRsbRjbRibLsLsmbRsbRsbRsbRcRsmbLibLsbLsbLibLsbRibLibRhbLsbLsbLgbRgbLj
bRjRsmbRebRsbRsbsbLjbRsLsbRjbRsbRsbRsbLcbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 25; Drug: Control Apo 0.5 然
bLgbRgbRibLibRiRsmbRgbRsbRgbsbRsbRsbRsbRsRsmbRsbRgbRsbRibLgbLgbRhRsmbL
jbRibRibRgbRibLibLjbRhRsmbRibLsbRgbRsRsmbRsbRsbRsbLgbLsbRgbLgbRgbRibRs
RsmbRsbRgbRsbRsbRibLibRibRgbLibRsbRibRgbLgLsbRsbRgbRgbRsbRgbRsbRsbLgbL
jbLsRibRibRgbLgbRibRsbRgbRsbRgLsbRsbRgbRsbRgbLjbRibRibLibLjbRcbRibRsbR
gbLjbRibRgbLjbRibLjbRsRibRibRgRsRsmmbLibLjLsmbLiRsbRjbRobRsbRsRsmbRgbR
ibRgbLgbRibLsRsbRsRsRsmmbRebLibRibLgbLgbRgbRgbLsLsmbRjbRibLhRsbRsbRgbL
sbRibLsRsbRgRsmbLsbRibLsbRsbRsbRsbRgRsmbRibRsbRsbRsLsbRsbRibRgbLibRiRs
mbRgbLsbLjbsbRiRsmbRibRsbRgbRgRsmbRsbRgbRsbRgLsbRsRsmbRsbRsbRgbLgbRibR
gbLsRsbRibRsRsRsRsmmmbRgbRsRsmbRgRsmbRgbRgbRsbRgbRsbRgbLjbRhbLgbRibLgb
RibRsbRgRsmbLsRgbLsbRsbRsbLgbRibRgbRgbRgbRsbRsbRgbRgbRsbLsbRibRsbRgbRg
bRsbRgbRgbRsRsmbRgRsmbRsbRgbLsRsbLgbRsRsmbRgRsmbRgbRgbRgbRsbRsbLgbRgbL
gbRibLgbRibRgbRsbRsbRgbRsbRgbRgLsbLjbRiRsmbLibRgbRsbRgRsmbRgbRgbRgRibR
sbRgbLsRsbLsRsbRgbLsRsbRiRsmbRgbRgbLgLsbRibLsbLsLsmbRgbRgbsbRibRgbRiRs
mbRgbRgbRsRsmbRgRsmbRsbRsRsRsmmbRsbRgRsmbRgbRgRsmbRsbRibRgRsmbRsRsmbRi
bLsbRibLgbRibLgbRsRsmbRsbLgRsbRgbLgRsbRhbRgbLgbRibRsRsRsmmbRsRsmbRsRsm
bLibRibRsbRgbRsbRgbLgLsbRgbRgRsRsmmbLsbLjbRiRsmbRgbRgbRibRsbRsRsmbLsbR
ibRibRsbLgbRibRjbLsbRgbLsbLsbRibRgbRgbRgbLiLsbRibLgbRibRgbRgbRsbLjbLib
LiLsRsbLgLsbLgbLibRibLibLcRsbLgLsbLsbLsbRibRgbLsbRsbRsbRsbRsbRibRsbRsb
LibRhbRsbRibLsRsbLsbLsLsLsmmbRsRgbLsbRjbLsbRsbRsbRsRsmbRgbRgbLjbRcbLib
RibRgRsmbRgRsRsmmbRsbRibLsbRibRsbsbRgbRsbRgbRgbLgbRibLsbRibLgbRibRibRs
bLibRcRsmbLgbRsbsbLsLsmbRsLsbLibRibRgbLsRsbRgbLjbRiRsmbLgbRiRsmbLjbRcb
LibLsbLjbLgbRcbRgbRsbRsbRiRsmbLjbRibLgbRibRsRsmbRgbRsbRsbRgbRsRsmbRsRs
mbRgbRsbLsbRibLsRsbRgbRsRsmbRibRsLsbLgbRgbRsbRsbRgbRgbRsbRgbRibLjbRibL
jbLibLibLgbLgbRcbRibRibLsbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 26; Drug: Control Apo 0.5 然
bLgbLiLsbLsbRsbLsbLjLsmbLibLgbLsbLgLsbLsRjbRsbLjbRiRsmbLsbLsbLcbLjLsmb
LiLsbRsbLibLgbRibRgbLibLgbRsbLgRsbLiLsLsmbLibLibLjLsmbLsbLhbLibRsbRebR
eRsmbRsbRebRjbRjRsmbRibRgbRhbRsbRibLgRsbRgRsmbLibRibLhbRibRsbRsbLibRgb
RsbLsbRibLgbLsbRgbLgbsbRcLsbLibLjLsmbLgbLsbLibRsbRjbLibLsbLsbLibRiRsmb
RcbLsbsbRcRsmbRsRsmbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 27; Drug: Control Apo 0.5 然
bLgLsbRjLsbLgbRjbLibRgbLibRsbLsRsbLgbLsbLsbLsbRsLsbLgbLgbLgbRjbsbLgbRs
bLibRsLsbLibLibLgbLsbRsbRjbRjbLibLibRsbLibRsbLibRsbLgbLsbLgLsbLsbLsbLs
bLgbRgbLibLgbLsbLgLsbLsbRsbLibLsbLgbLgbRgbLiLsbRgRsmbLibRgbLgbRsbLibRs
bLsbLsLsmbLgbLgbLsbLsbLsbLsbLsbLsbRcbRgbLebLibRgbLibLsbLgbRgLsbLibRgLs
LsmbLsLsmbRgbLibRsbLiRsbRsbLgbLsbLgbRsbLibLgbRgbLsbRjbLibLgbLgLsbRgbLg
bRsbLsLsmbLjbLsbLsbLsLsmbLsbLgbRsbLsbsbLsbLsbLsbLgbRsbLgbLgbRsbLsbLsbL
gbRsbRsbLgbLgbLsLsmbLgbRibRibRibRibLjbsbRgbLgbRgbRgRsmbLibLibLgbLjLsmb
RgbLibRsbLibRgbLibRsbLjbLsbLgbLsbRsbLsbLgbLsLsmbLsLsmbLgbLsbLsLsmbLgbL
gbLsbRsLsbLgbLgbLsbRsbLgbLsbLsbRgbLjbRsbRsLsbLgbLsbsbLsLsmbLgbRoRsmbRs
LsbLgbRsbLsLsmbLsbLsbLsbLsbLsbLsbLsbLsbLgbRgbLibRjbLiLsbLsbLibRgbLibRg
bLjbLsbRsbLibRsbLsbLsbLsLsmbLsbLsbLgbLsbLsbLgLsbLgbLgbRjbRjbLiLsbLsbLi
bRsbLsbLgRsLsbRsLsbLgLsbRsLsbLsbLsbLsbRsbLibRsbLsbLgLsbRsbLgbLsLsmbRsb
LsbLgbLsbLgbLibRgbLibRjbLibRjbLibLsRsbLibRgbRgbLibLibsbLsbRsRsmbLibLgb
LgLsbLgLsbLgLsbLsbLsbLiRsbRgbLgbLsbRsRsRsmmbLgbLsbRsbLgbLsbRsLsbLsbLsb
LsRsbLgLsRsbLsRsbRsbLgbLgbRsbLgbRsbLgbRsRsmbLgbLsbRsbLgbLgbRgbLibLgbRi
bLsbRibLibLibRsbRgRsmbLibRibLsbRsbRibRibRibRiLsbLsbRgbRsRsmbRsLsbRsbRi
bLcbLgbLgLsbLgbLgbRgRsmbLibLgbLibLiLsbRibLgbRgbRgbRgbLcbLibLgLsbLgbLgb
LsLsmbLgbLsbLsbLsbLiLsLsmbLiRsLsbLibRsbLcLsRsmbLsbLgLsLsmbRsbLibRsbLib
RsbRsbLibRsbLibRgbLibRsRsmbLibRgbLiLsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 28; Drug: Control Apo 0.5 然
bRibLsbRhRsmbLgbsbLiLsbRibRsbRibRsbRibRibRsRsmbRsRsmbRgbLibRjRjbLibLib
LjLgbLsbLsbLsbLsbRgbLcbRsbLsbLsbRibRsbRibRsbLgbRsbRjLsbRsbRgLsbRsbLiLs
bLsbLiLsbLibLsbLsbLsbLgRsbLgbLibLsbLgbLsbLibLsbRgbRsbLsbRibLsbLibLibLi
bLgLsbRibsbLsbRgLsbRgbLsLsLsmmbLsbLsbLgLsbLsbRiRsmbRsRsmbRhbRsbRgbRsbL
sbLibsbLsLsmbLsbLgbsbLsLsmbLsbLsbLsbLsbLgLsbLgbLsbLibLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 29; Drug: Control Apo 0.5 然
bRsbLsbLgLsbLgbLgbLsbLgbLsbLsbRjbRibRibRibRibRibRgbRibRgbRibRibRsbLsbR
ibRibRcbRgbRsbLsbLgbLgbRsbLgbRsbRsLsbLsbLsbLsLsLsmmbLsbLgbLsbLsbRsbLgb
LgbLsbLgbLsbLgbLsbLsbLgbRsbLsbLsbLsbLsbLsbLjbLsbLsRsbLsLsLsmmbLsbsbRsb
RsbLsLsmbLgbLsLsmbLgbLsbLgbLgRsbRgLsbLgbLibRgbLgbRsLsbLgLsbLsbLsbLsbLs
bLgbLgRsbLsbRjbLjbRibLgbLsLsmbLgbLsbLsbLsLsmbLsbLsbLsbLsbLsbsbRsbRsbLi
bRjbLgbLjbLgbLsbLgbRsRsmbLgbLgbLsbLsbLsbRsbLgbRsbLjbLibRiRsmbRsbRsRsmb
LibLsbLsbLsbRsbLjbLsbLsbLsbLsbRsLsbLsbLgbLsbLgbLsLsmbLsbLsbLsbLgbLgbRh
bRhRsmbLibRibRhbLibLcbRgbLgbLsbLsbLsbLsLsmbLsbLsbLjbLsbLsbRsbLjbRsbLsb
LsbLsbLsLsmbLsbLsbLgRsbLgbLgbRgLsbLgbLsbLsbRsbLgbRsbRsbLsbsbLsbRjbReLe
RsbRiRsmbRgbRibRibLgbRiRsmbRgbLjbRibLjbRibLgbLjbLjLsmbLgLsbLgbLgbRsbLi
bRgbLgbsbLsLsmbLjbRsLsbLjbLsbLsbLsLsmbRsbLsbRsbLsbsbLgbRsbLgbLgLsbLsbL
sbLsbLsbLgbLsbRjbLjbLibLgbLgbLgbRcbLgbLgbLsbRsbLsbLsbRsLsbRjbRibRgbRgb
RibLiLsbLgbLgbLgbLgbLgbLgbLgbRsbLgbLsbLgbLsbsbLsbLsLsmbRsbRgbRgbRcbRib
RgLsbLibLjbLjLsmbRjbLibLgbRsbRibRsbLgLsbRsbLsLsmbLsbLgLsbLgbRsbsbLsbLs
bLsbLsbLsLsmbLgbLgbLsbLgbLsbLsbRjbLhbRibRjbRiRsmbLcbLgbLgbRgbRgbRgbLjb
LcbLsbLibLsbLsbLgbLsbLsbRgbLsbLsbLgbLgbLsbLsbLsbLsLsmbLsbLsbLsbLgLsbLs
RsbLsbRsLsbRcbRibRgbRibRibLgbRibLsbRsRsmbRgbRgbLjLsmbLsRibLcLsmbLhbLgb
LsLgLsbLsLsmbLsbLsbLsbLsbLgbLsbLsbLsbLsbLsbLsbLgbLgbRsbLsLsmbLgLsbLsbL
sbLsbRsbLsbLsRsbLsbLgbLgbLsbLgbLsbLsbLsbLsbLsRsbLgLsbLgbLsbLsbLsbLsbLs
bLsbRsbLsLsmbLsbLsbLjbLsbsbRsbLsbLgbLsbLsbLsbLsbLsbLsbRsbLgbLsbLgbLsbL
sLsLsmmbLsbLsbLobLsbRhbRgbRgbsbRibLjbRhRsmbLjLsmbLcbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 30; Drug: Control Apo 0.5 然
bLsbRsbRsbRjbLjbRsLsbLjLsmbRsbLsLsmbRsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bRibLjLgbRjbRsbLhbLgbLsbLibLsbRjbRjbRibRibRibRsbLsbRsbLsbRgRsmbLsbLgbR
ibLjbRhRsmbRsbRibLsbLsbRsbRibRsbRiRsmbRsbRsbLsbLsbRibRsbRsRsmbRibLsbRs
bRsbLsbRgbRsbRgbRibLsbLsbRsRsmbLsbRibsbRsbRsbRibRgbRsbLsbLsbLsbLsbLgbR
iRsmbRsbLjLsmbRsbRsbLsbRibRgbLsbLgbsbRsbRibRgLsbRsbRibLsbRibRjbLibRsbL
ibRibRsbLsbRgbRgbLibRgRsmbLsbRsbRsbLsbLsbRsbRibRiRsLsmbRibLsbRsbRgbRsb
RsbsbRgbRsbRgbRibRsbLgbRsbRsbRgbRsbLjbRsbRsRsmbLsbLsbRibRsRsmbRibRsbRs
bLsLsmbRsbRibRsbRgbRsbRsbRgbRsbLgbRibLsbRgbRsbLsbRjbLgbRsbRibLsbRsbRgb
LsLsmbLsbRsbRibRgRsmbRsbRgbRsbsbRgbLgbRibLgbLibRibRsbLsbRjbRsbRsbLsbRi
bRsbRgbRsbLsbRsbRgbRgRsmbLsRsbRiRsmbRsbLsbLsbLsbLgLsbRibRibRsRsmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bLiLsLsmbLibRsbLgbLsbLgbLsbLgLsbLgbLsbLsbLgLsbLsRsbLsbLgLsbLibRsbLgbRg
bLiLsbRgbLibRgbLgLsbLgbLsbLgbRsbRsLsbLsbLibLsLsmbLgbLsbLsbLgbRgbLgbLsb
LgbLsbLgLsRsbLgRsbLsbLgbLsbLgbLsbLsLsmbLsbLsbLgbLsRsbLgbLibLgbRhbLiLsb
LsbLsbLgbRsbLsbLgbLsbRgbLgLsbLgbLsbLgbLsbLsLsmbLgLsbLsLsmbLgbLsLsmbLgb
LsLsmbRsLsbLgLsbRsbLiLsbRsbLsbRsbLsbLgbLsbLgLsbLgLsbRsLsbLgLsbLsbLsbLs
bLsbLsbLgbLsbLgbRsbRsLsbLgbLsbRsRsmbRsbLiLsbLsLsmbLsbLgLsbsbLsbLsLsmbL
sbLsbLsbLgLsbLsbLgbLsbLgbLsLsmbLgbLgbLgbLgbLibRsbRgbLsbLsbRsbLibLsbLsb
LgbLsLsmbLsbLgbLsLsmbLsLsmbLsbLsbLgbsbsbLiLsbLgbRgRsmbRsbLibLsbLgbLgbL
gbLsbLgbLgbRsbLsbLgbLgbRgbLibLiLsbRgLsbLibLsbLsLsmbLgLsRsbLgbLgbLgLsbL
sbLgbLsbLsbLgLsLsmbLgbLsbLsbLiLsbRsLsbLibLsbLsRsbLjbLsbLsLsmbLsLsmbLgb
LsbLgLsbLgbRsbsbLsbLsbLsbLgbLsbLsbLgRsLsbLsbLsLsmbLsbLsbLgLsbLsRsbLsLs
mbLgbLsbLgbLgbLsbRgbLgbLsLsmbLgbLsbLsLsRsmbLgbLsbRsbLibLsLsmbLsbLgbLsb
RsbLsbLibLsbLgbLsLsmbLsLsmbLsbLgbLsbLgbLsbLgLsbLgbLsbLibRsbLsbLsbLsbLs
RsRsmbLibRsbLsbLibLsbLgbLsbLsbLsbLsbLsbLgbLibRibLibRsbRgLsbLibRsbRsbLi
bRsLsbLsbLgbLsbLgbLsLsmbLsbLgbRsbRsbLgLsbLsbLgbLsbLsbLsLsmbLsbLgLsbLsb
LgLsLsmbLsLsLsmmbLgbLgRsbLibRgbLgLsbLsbRsbLgbLgbLgbLgbLsbLsbLsLsmbLsbL
gbLsbLgbRsLsbLsbLgLsbLsbLgbLsLsmbRgbLsbLibLgbRsbLsbLjbRsbLsbLgLsbLsLsm
bLgLsbRsbLgbLgLsLsmbRsLsbLgbLsbLgLsbLsLsmbRsbLiLsbRsLsbLgbLgbsbRsbLgbL
sLsmbLgbLgbRsbLgLsbLsbLsLsmbLgbLsbLgbLgbRjbRsLibLgbRsbLsbLibRgLsbLiLsb
LibLsbLsbLgbLgbLsLsmbLgbRgbLgLsbLsbLgbLgbLsbLgbRsbLgLsbLgbLsLsmbLsbLgb
LibLsbRsbLsbsbLsLsmbLiLsbRsLsbLgLsbRsbLgbLsbLgbRsbLiLsbLsLsmbLgbLsbLgb
LgbRsbLgLsbLgbLsbRsbLsbLgLsbLgLsbLgbLsbLgLsbRsbLibLgbLsbLibLsLsmbRsbLi
bLgLsbRgbLsbLgLsbLibLsRsbLsbLgbLsLsmbLsLsmbLsRsbLgbLgbLsLsRsRsmmbLgbLg
bLsbRsbLsLsmbLsbLsbLgbLsbLsLsmbLsbsbLsLgLsbLsbLgbRsLsLsmbLsLsmbLibLgbL
ibRgbLgbLsbLgbLgbRgbLibLsbLsbLgLsbRsbLgbLsbLgbLsbLsbLgbRgbLgbLibRsbRsb
LibRsbLgbLgbLsbLgbLsbLgbRsLsbLiLsLsmbLsbLibRsLsLsmbLibLsbLgLsbRgbLibLs
bRsbLibLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bRsbRibRsbLsbRibLjbRibLgbRibRsRsmbLsbRgbRsbRsbRsbLgbRgbRgbLgbRgbRsbRgb
RsbRgbLibRgRsmbRsbRsbRsbRsbLsbRgRsRgmbRgbRsbLsbRgLsbRsRgRsRsmmbRsbRsbR
gbRsLsbRgLsbRgbRgbLjLsmbsbRgbRgbLjbLcbLsbLgbLsbLgbLgbRjbRibRsbRsbRsbRg
bRgbRsbRsbRgRsRsmmbRsbRsbRiRsRgRgmbRsRsmbRgbLgbRiRsmbRgbRgbRgRgbRoLsbL
ibRhbLsRsbRibRgLsbRgbRsbRgbRsRiRsmbRgRgbRgbRgbRgbRsbLjbLibLibRjbRcbRib
RgbRsbLiLsbRjbRibRgRsmbRsbRgRsmbRgbRsbRsbRgbRgbRgbRgbRgbRgbRgbLgbRgbLs
bLjbRibRibLhbRibRgbRgbLibRgbLibRgRsmbRgbRsbLsRsbRsbRsRsmbRsbRsbRsbRgbR
gbRsbRsbRsbLsbRgbRibRgbRgbLibRgLsbRibRgbLibRgbRsbRgbRgbLibRgbLsbRgbRsb
RsRsmbRsbRgbLgRsLsbRibRgbLjLsmbRibRgbLgbRibLsbLjbRibRibRsbRgbRsbRibLib
LsbRsbRgbRgbsbLsbRgbRgbLsRsbRsbRgbRsbRgbRgbRsbRgbRsbRgbRgbRgbLgbRibRgb
RsbRsbLgbRgbRsbRgbRgbRgbLjbLgbLjbRcbLjbLibRhbRjRsmbRjbRibRgbRsbLsbLiLs
bLibRibLhRsbRgbLibLgbLgbLibRsbLjLsmbLsRsbLsbRibLgbLsbRjbRgbLgbRjbRibRi
bLibRibLsbRibLjbRjbLibLjLsmbRjbRgbRgbLjbRhbRebRhRsmbLjbLjRsbLcbLgbLjbL
jLsmbRjbRjbLgbLibRjbRjbLjbLjbLjbLjbLiLsbRcbRibRebRebRcbRhbLjLsmbLibLib
LjLsmbLjLgbLjbLjbRibRjbRebRhbLjLsmbLjbLibLjbRjbLjbRibLebRiRsmbLibLjbLi
bRjRgbRibLjbLibLibLjLsmbRibLjbRhbLjLsmbLjLgbLibLjLgbRjRsmbLjbRibRiRsmb
LibLhLibLibRjbLibLibLibRcbLcLsmbLebReb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bRibRsbRsbRsbRgbRsbLsLsmbRjRsmbRsbsbLsbRsbLsbsbRsbRibRgbLgbsbRgbRsbRib
RsRsmbLgbRgbRsbsbRsbLsbRgbRsbRsbRsbRibLsbLgbLsbLgLsLsmbRgbRsbLsRsbLsbL
gbRgbRgbRibRgRsmbRsbLjbLibRsbLsbLgLsbLsLsmbRgRsmbRsbRibLsLsmbLsbLgbLsb
LsbLsbRsRsmbRsbRsbLsbRsbRsbLsbRgbRsbRsbRgbRgbRgbRsbsbRsbRsbRsbRgbRsbRs
bRsbLsbLsbRsbRibRsbLsbRsbRgbRsbRsbLsbLsbRsbRsbLsbRgLsbRsbRgbRsRsmbRsbR
sbLsbRsbsbRsbRsbRsbRsbRgLsbRgRsmbRgbsbLsbsbRibRsbRgRsmbRsbRgbsbLsbLsbL
sbRsRsmbRibRsbRsbRsbRgbRgRsmbRgbRsRsmbRgbRsbLsRsbRsbRsbsbRibRsbRsbRsRs
mbLsbRgbRgbRgRsmbRsbRgbLsbLsbLsbRsbLsbLsbRgbRsbRsbRsbRibRsbRsbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bLsbLgbLgLsRsbLsbLsbRsbRsbLgLsbLgbLsLsmbLsbLsbLsbLsbLsbLgbLsRsbLibLgbL
gbLsbLsbLsbLcLsmbLsbLsbLsbLgbLgLsRsbRsbRsbLcLsmbLsLsmbLsbLsbLgbLgbLsbL
gbRsbRsbLgbLsbLsbLgbLsRsbLsbLgRsbRsbLibRgbLsbLsbLsbLsbLsbLgbLsbRsbLgbL
ibLsbRgbLsbLgbLsbLgbLsbLsbLsbLgbLsbLsLsmbLsbLgbLgbLgLsRsbRsbRibLjbLgbL
sbRsbLsbLsbLsbLgbLibLjLsmbLjbLsbRgRsLsRsmbsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bRjRgbLjbLcbRjbLibRjbLgbRsbLsbLsbsbRgRsmbLsbLsbLgbRsbLgbRjbRsbLsbRsRsm
b

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bRsbRsbRsbRgRsmbRsbRgbLsbLibRsbLiLsbsbRsbLsLsmbLsLsLsmmbsbLgLsLsmbRsRs
mbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bLsbLgLsbLsbLsbLsbLgbLsRsbLsbLsbLgbRgbLsbLgbLsbLsbLgbRsbLiRsbLsbRiLsbL
ibLsbLsbLsbLsbLibLsbLsbLsbLgbLsbLsbLgRsbRsbLgbLsbLsbLgbLsbLgLsbLsbLsbL
gbLsbRsbLgbLsbLsbLsbLsbLsbLsbLsbLsbLgLsbLsbRobLjbLibRsbLibRgbLgbRsbLsL
smbLgbRsbLgbLsbLsRsbLsRsbLgbLgbLgbLsbLsbLsRsbRgbLgbLsbLsbLibRsbLsLsmbL
gbLsRsbLgbLgbLsbRsbLsLsmbLsbLsbRsbLiLsbLsbLsbLgbLibLgbLgLsbRsLsbLgbLgb
LsbLsbLsbLgLsbLsbRsbLgRsbLgbLsbLgLsbLsbLgbLsLsmbLsbRsbLgbLsLsmbLgbRsbL
gbRsbLsbLsbRsbLgbLsLsmbLsbLobLhbLgbLjbLibLsbLsbLibLibRibLgbRsbLsbRgbLg
LsbRsbLgbRsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bRgbLcbLsbLiLsbLsbLgbLhbRgbRsLsbLsbRsbLgLsbLsbLcbLsLsmbLibRgbLsRsbRsbL
sbLsbLibLsLsmbLsbLiLsbLsLsmbLsbLsbLibLsLsmbLsbLgLsbLibLsbRsbLsbRgRsmbL
ibLgbLsbLgbLsbLsbLsbLibLsbLsbLgLsbLgbLgLsbLsbLsbLhbLsLsmbLsbRgbLcbLsbL
sbLsbLgbLsbLsbLcbRibRibLsbLsbLebLsbLsbLsbLsbLgbLsbLgLsbLsbRjbLibLsLsmb
LsbLibLsbLgbLsRsbRgbLsbLibLsbLibRibRsbLgbLsbLibLsbLsbLiLsbLsbLsbLsbLiL
sbLsbRsbLiLsbRsbLsbLsbLiLsbRsLsbLsLsRsmbRsbRsbLgbLgbLsbLsLsmbLsbLsLsmb
LibLibLsbLibRhbLsbLibLhLsbRsbRsbLsbRsbLsbRsbRsLiLsbLsbLgbLsbLsbRgbLibL
sbRjRgbLiLsbLsLsmbRjbLcbLsbLsbLsbLibLsbLsbLibLsbLibLsbLsbLgbLsbLgLsbLs
bLsbLibLsbRsLsbRsLsbLiLsbLsLsmbLebLsbRiRsmbLsbRsbLgbLibLsbLgbLebLsbLsb
LsLsmbLsLsmbLibLsbLibLsbLsLsmbLibLgbLsbLgbLsRsbLsbRsbLeLsbLiLsbLsbLiLs
bLsLsmbLsbRsbLiLsbLsbLibLsbLsLsmbLsbLiLsbRsLsbLsbLsbLsbRjRsmbLcLsmbLhb
LsbLsbLsbLsbLhbLsbLibLsLsmbRjbLsbLhbLsLsmbLsbRsRsmbLsLsmbLhbLsbLgbLsbL
sbLgLsbLsbRgbLiLsbLgbRsbLcLsmbRsbLsbLibLsLsmbLsbLgbLsbLsLsmbLiLsbLsLsm
bLsbLsbLsbRgbLhLsbRsbLsLsmbLsbLsLsRsmbLsbLgbLgbLsbLsbLibLsbLgbLgbLgbLs
RsbLsbLsbRgbLibLsLsmbLibLsbLsbLsbLiLsbLsbLsbRgLsbRjbRobRibLsbLgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bRgRsmbRibRgbRsbRgRsRgmbRgRgbRgbRgbRgRsLsmbsbRsLsbRsRjbLjbLhbRcbRibLib
RgbRgRsmbRsbRsbRgbRsRgbRgbRgbRsbRgbRsbRgRsmbRgbRgbRgRgRgbRgRsmbLjbRcbL
cbLebRjbRiRsRsmmbRibLibRhRsRsmmbLsbLhbRsbRibRibRsbRiRsmbLgbRsbRgbsbRsb
sbRsRsmbRsbRgbRgbRgbRgbRgRsmbRsRsRgRiRiRsRgRsmmmbRsbRgbRgbRgbRgRsRgRsm
mbRsbLsbRgbLjLsmbLebLibRgbRcbLhbRcbRcbLibRibRsbRsbRhRsmbRiRsmbRiRsmbRh
bRibRibLcbLcbLibLcbRiRsmbRcbRiRsmbRsbRsbRgRsRsRsmmmbRsbRgbRsbRgRgRsmbR
gbRsRsmbRgRsRsmmbRsbRgRgRsmbRgbRgRsmbRsRsmbRgbRsbRsRsmbRgRgRgRgRsmbRgb
LjbLcbLebRhRsmbRcbRgbRibLgbLgbRiRsmbLsbRsbRgbRsbRgRgRsRgmbRgbRsRsmbRsb
RgbRgRsmbRsbRgRgRibRgbLjbLjbLibRjbRibRsbRjbLsbsbRsbRgbRgbRgRhRibRgLgbL
jRsbRjbRibRgRsmbLjbRibRsbLibRibRgbRsbRsbRsbRgbRgbRsbRgbRgbRgbRgRsmbRgb
RgbRcbRgbLibLgbRsbRhbRgRsmbRibLibRibLsLibRhRsmbRhbRibRibLgbLgbLibLibLi
LsbLsbRgbRgbRsbLcbLiRsbRibRibRsLibLsbLgbLiRsbLsbRsbRibRgbRsbRsRsmbRgbR
sbRsbRsRsmbRsRgRsRiRsRiRgmmbRsRgbRgbLsbRsbRibLhbLjbLhbRhbsbRjbRibRgbRi
bRsbRsbRsbRsbRsbRsRsmbRsbsbRgbRgbLsbRgbLsRsRsmbRsRsRsRiRgRsRsRgmmmmbRg
bLsRsbRgbRsbRiRsmbLjbRibRgRsmbLsbRgbRgRsmbRgbRsRsmbRsbRsbLsbRgbLjbRhbL
jbRibRgbRibRsbLsbLsLibLibRhbRgbRgbRsbRgRsmbRsRsmbRgbLgbRsbRsbRsRgbRgbR
gRsmbRsbRsbRsbRgbLsbRgbRsbRsbRsbRsbRsLsbRsbRsbRsbRgRsmbRsbRsbRsbRsbRgb
LjbLcbRcRsmbRiRsmbRibLibLibRhbRiRsmbLibLjbLjbRcbRsLsRsbRibRgbRgbLebRib
RgRibRsRsmbRgbRgbRsbRsbRgbRsbRgRsRgmbRgbRgRgRgRgRsmbRgbRgbRgbRsRsmbLjR
sbLjbRibLjbLsRhbLibRjRsmbRgbRsbLgRsbLsbRiRsmbLgbLjbLhbRjbLibLhbRibRibR
jRsmbRgRsmbRsLsRsbRsRsmbRsbLsRsRsmbRgbRgRiRgbRsRsRsRsmmmbRgbRgRsmbRgbR
gbRsbLjbLgbLgbLgbRjbRcRsmbRhbLibRibLibRgbLgbLibLgbLgbLgbLsbLsbLsbLgbRg
bLibRjbRcbRibLsbRgbRgbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRgLsRgbRsbRsbLc
bLgLsbLgbLgbRsbRcbRibLjbLjLsmbRcbRibRsRsmbLgbLgbRhbRibLsbLibLgbLjbRcbR
ibLsbRibRsbLsbRsbRsbRsbRsbRsRsRgRsmmbRsRsmbRgRsmbRsbLsbRgRsRsRgmmbRsbR
gbRgbRgbRsbRgLsbLsbRgbLjbRcbRibLhbLibLibLibRibLibLhbRibRibRhbRibLsbLgb
RcbLgbRgbRsRsmbRgbRgbLgbRibLibLgbRibRgbRsbRgbRsRsmbRsbRsbRsbRsbRsbRgbR
sbLsbRgRsmbRsRsLsmbRsbLsbRsbRsRsmbRgbRsbRgbLibLgbLgbLgbRcbRiRsmbRgRsmb
RibRibRhRsmbRhbRibLsbRiRsmbRsbRiRsmbRgbRgRsmbLsbRjRsmbLsbRsRsmbLsbRgRs
mbRsbRgbRgRsRsmmbRsbRsbRsbRgbRsbRsbRgbRgbRgRsmbRsbRsbRsbRsbRgbRgbRgRib
RsRsLsmbRgRsmbRgbRgbRgbRsbRgRgbRgRgRsmbRgRsRsmmbRsRsmbRgRsRgRsmmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bRgbLebRcbRhbLhLsbLsRibLsbRibLibRibRibLhbRgbRibRibLsbRsbRibRgbLsbRsbRs
LsbRgRsmbRsbLiRsbRgbRjbRgRsmbLsbRgRsmbRgbLibRibLgbRibLsbRsbLgbRiRsmbRg
LsbRsbRgbRgbRgbRsbsbRsRsmbRsbRiLsbLibLhbLsbRjbLibLgLsbLgbLsbRsbLsbLgbL
sLsmbRibRsbLgbLsbLhbLsbLiRsbLsbRgbLibLsbLgbLgbLsbLiRsbRsbLgbLsbLibLsbL
sLsmbLsbLsbRgLsbRgbRibRibLibLgbLsbLiRsbLibLiLsbRgbLsbRsbRibLgLsbLgbLib
RgbLibRsbRgbLhbRibRjbRibLcbLiLsbLhbRsbLjbLsbRgbLibsbLsbLgbLsbRsbLgLsRs
bRgbLiRsbLsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bRsbLsbRsRsmbRsbLsbRsbRsbRgbRsbRgbLsbRsbRgbRsbLcbLibLsLsmbLsbLsbLsbRsb
LgbRhbRiRsmbRsbRgbRibLgbRsbLsbLgbRgbLsbsbRsRsmbRsbsbsbRgRsRsmmbRsbRsbR
sRsLsmbRsRsRsmmbRgbRgbLjbRibLibLhbLibRjbRhbLgbRgbRgbRsbsbRsbLsRsbRgbRs
bLsbLsLcbRcbRebLhLsbRsLibRjbLiLsbLibRsbLsbLsbRgbLibRjbLibLibLsbRebRiLs
bRiLsbLsRsbRgbRsbLsbRgbLsbLsRgbRgRsmbRgbRsbLgbLsbLsbRibRsRsmbRsbRsbRgb
RsbRsbRgbRsRsmbRsbRgbRsbRsbRsbRsbRgbLsbRgbRibLjbRgbLcLsmbLibLgbLsbLibL
gbLsbLsbLgbRsLgbLibRjbLibRjbLibLibRhbLiLsbLibRjbLibLsbLsLsmbLsbLibLcbL
gbLgbLsbLibLibRjbLibRjbRcRsmbLsbRsbRgbRgbRsbRsbRsbRsbRsbRgbLsbRibLgbRg
bRgbRgLsbRsbRsbRsbRjbRsbRsbRsbRsbRsbRsbRsbRgbRgbRgbLjbLibLgbLgLsbLgbLg
LsbRcbRibRibLsbRgbRgbRsbRsbRsbRsRsmbRgbLsbRgbRgbRsbRsRsmbRgbRgbLgLsbRg
bRsbRiRsmbLgbRgbRsRsmbRgbRgbLgbRgRsmbRibLjbRiRsmbLsbLsRsbRgbRsbRgRsmbR
gLsbLsbRgbRgbLsbRgRsmbRgbLjbRgbLsbRibLgRsbRgRsmbRsRsmbRsbRgbLsbRgbRsbL
sbRibRgbLgLsbRgbRgbLgbRgbRgLsbRsLsbsbRgbRsbRgRsmbLgbRgbRgbRibLjbRibLjb
LibLibLgbLhbLcbLgbRsbLgbRsbRibRibLhbLgbLsbLibRibLhbLsbLgbLsbLgbRsbLibR
jbLibRsbRcbRhbLgbRsbRgbRsbRgbRsbRsbRgbRgRsmbRgbLjbLcbLibLgbLgbRjbLibLg
bRgbLiLsbRsbLibRcbRcbLgbRgbRgbLsbRgbLsbRgbRibLcbLhRsLsbLibLibRibLhbRsb
RsLsbRcRsmbRsbRgbRgRsmbRgbRgbRsbRsbRsbLsbRgbsbLsbRgbLsbLsbRsbRsbRsLsbR
sbRsbRsbRgbRsbRsbRgbRgbRiRsmbRgbLsbRsbRebRgRsmbRsbRgbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bLgbLgbLsbLgLsbRsRgbRsRsmbLsbLibRgbRgbRsbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bRibRsbLsbLgbRgbRsbLsbRsbRsRsmbRsLsbRgbRsbRgLsbRsbRgbLhbRibRsRsmbRibRs
bLsbRsbRgbRsbRgbRsbRgbRsRsmbRsbRsbLgbLsbRjRsmbRsbRsbRsbRsbRsbRgbRsRsmb
RgbRsbRsbLsbRjbLjbRiRsmbRsbLsbRibLibRgbRibRsbRsbRsbRiRsmbLgbLsbRsbRgbR
sbRjRsmbRsbRsbsbsbLsLsmbLsbRgbLsbRsbLibRibLsRsbRsbLsbRgbRibRsbRsbRsbLs
bRgbRsbLsbRsLsbRgbLgRsbRgbRgbRsbRsRsmbRgRsmbLsbRsbLsbRsbRsbRsbRsbRgbLs
bRsRsmbRsRsmbRgbLiLsbLjbLiLsbLibRsbRjbRhRsmbLsbRibRgbRsbRgbRsbRsLsbRgb
RsbRgbRsbRgbRgbLgbLsbLgbRjbsbRsRsmbRgbRsbLgbRiRsRsmmbRsbLgbRibRsbRsbRg
bRsbLsbRsbRgbLsbLsbRsRsmbRsbRsbRsbRgbLsbRsbLsbRsbRsLsbRsbRgbRgbRsbRsbR
sbRsbRsRsmbRsbRsRsRsLsmmbRsbRsbRsbLsbRgbRsLsbRsRsmbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bRsbRsbLibLsbLibLsbRsbLibLgbLgbLsRsbLgbRsbLgbLsbLgbLgbLsbLgbLgbLgLsbLg
bRsLsbLgbLgbLsbLibRsbLgbLgbLibLgbLgbLsbLgbLsbLgbLgbLgbLsbLsLsmbLgbRjbR
cbRibLcRsLcbRgLsLsmbLgbLgLsbLgbLgbLgbRjbLibLsbLsLsmbLgbLgbLsbLgbLsLsmb
RcbRgbRjbLsRcbRhbRgbRjbRibLsbRiRsmbRhbLjLsmbRcRsmbRhbRgRsmbLsbRgbRibRg
bLsbRibRgbRibRgbRibRgbRibRgbLjbRgLsbRibLjbRibRsbRibRgbRibLjbRibRgbRgbL
sRsRsmbRgbRhRsmbLibRhRsmbRgbLsbRibRsbRibLgbRibLgbRibRgbLjLsmbRsbRibRib
RgLsbRsbRgbLsbRsRsmbRgbLgbRibLsLsmbRibLcLsmbLhbRgLibRsbLgbLgbLsRsbLgRs
bLgbLsbLgbLgbLgbLsbLgbLgbLgbLgLsbRebRiLsbLsLsmbLhbLibLgbLgbLgbLgbLibRs
RsLgmbLgbLsbLsbLgbLsbLgbLsLsmbLgLsbLgbLsbLgbLgbLgbLsbLgbRsbLgbRsbLgbLs
bLgLsbLsbLgbLsLsmbLsLgbLgRsbRsRsmbRcbRibRgbRgLsbLgbRibLibLjbLibRsbLiLs
bRsbLgbLgbLgbLgbLgbLsLsmbLgbLsbLgbLgbLsbLgbLsRsbLibRgRsmbLiLsbLsbLgLsb
LgbRsbLiLsbLgbLsbLgbLgbLsbLgbLsbLsbLgLsbLgbRgRsmbLibLsbLgLsbLsbLgRsbLs
bLgbLgbLsbLgbLgLsbRgbLibLsbLgRsbLsbLgbLgbLgbLgbRsbLiLsbLgbLsbLgbLgbLgb
LsbLibLgbLsbLgLsbLsLsmbLgbRsbRjbRibRibRsbRgLsLsmbLcLsLsmmbLibLgRsbLgbL
sLsmbLgbLgbRjbLibLgbLibLgbRgbLiLibRsbRibRebRgbLjbRsLsLibLgLsbLibLsLibL
sbRsbLibLsLsmbLgRsLsbLgbLsbLsbLsbLgLsbRgbLibLsLsmbLgbLgbLgbLgbLgLsbLsb
LgLsLsLsmmbRjLsbLibRibLibRsbLgbLsbLgbLgbLgbLibRgbLibRsLsbLgbLsbLsbRsbL
gbLsbLsLsmbLgbLiLsbLgRsbLsbLsbLsbLgLsbRsLsbLsbLgbLsbLgbLgLsbLsbLgbsbLi
LsbRgbLibRsbLgbLgLsbLgbLgbRsbLgbsbLgbLsbLgLsbRjbRjbLcLsmbRsbLibLgLsbLg
bLsbLgLsbRjbLibRjRsmbLhbRsLsbLibRsbLgbLgbRgbLibRsLsbLgLsLsmbLgbLsbRgbR
jbLhbLsbLgLsbLsbLsbLsbLsbLsbLgLsbRjbLibLsbLsRsbLgbLsbLgbLgbLgbRjLsbRsL
ibLgLsbLsLsmbLgbLsLsmbLgbLsbRsbLibLgbRgLsbLibRgbLiLsbLsbLgLsbLibLsLsLs
mmbLsbLjRsbLgbsbLsRsbLgbLsLsmbLgbLgbLibLhbLsbLjLsmbLsbRsbRgbRcbRsbRgbL
sbRgbLibRhLsRsbLibRcbRibRgbLsbLiLsLsmbLcbRibLgbLgbRsbLibLiRsbLgLsbRsbL
sbLgbLsbLsbLgbLibLgbRgbsbLhbLiLsbLibLgbLibLgbLsbRsbRhbRibRibLsbRgbLgbR
gbLjLsmbLsLsmbLsbRgbRibRibRibRgRsmbLgbRcbRgbLsbLgbLcbLcbsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bRgbRsRsmbRgRsmbRsLsbRgbRgbLjbRhbLibRibLsRsbLgbRibRgbLsbLjbsbLjbLibLgb
LsbLgLsbLsbLsbLsbLgbLsbLsbLsbLsbRcbRibRgbRgbLjLsmbRiRsmbLsbRgbLgbRgbRg
bRibRgbLgbRibLsbRgbLsbRibLjbRgbRgbRgbRgbLiRsbRibRgRsmbLjbRibRiRsmbLhbR
iRsLsmbLgLsbLgbLibLgbRsbLsLgbLgbLgLibRibRibRgRsRsmmbRibLibRibRsbLsbRgb
LsbRgbRsbLsbRgbLgbRibLgbRibLsbRsbRgRsmbRsbRsRsmbRgbRsbRsRsmbRgRsmbRsRs
mbRgRsmbRsRsmbRsRsmbLjbLgbRsRcbLjbRsbLsbRibRgbRsbLgRsbLhbLibRibRgbRgRs
mbRsRsmbRsRsmbLsbLjbLibRibRibRibLgbRgbRgbRibLibRgbRgbRsbRgbLgbRgbRsbRs
RsmbRsbRsbRgbLgbRgbLgbRgbRsbRsRsmbRgRsmbLgbRgbRsbLgbRibLsbRsbRsRsRsmmb
LsbRsRsLsmbRgbLsLsmbRsRsmbRgbRibRsbLsbRgbLsbRsbLgbLjbLgbLgbRibRcbLjbRi
bLgbLsbRgRsmbLsbRsbLgbLgbRiRsmbLjbRsbLjbLgbsbRjbRcbRsbRsLsbLjbsbRgbLgb
LjbsbLgbLgbLgLsbLsbLsbLsbsbLsbLsbLgRsbLgbRgbLsRebRcbRcRsmbRibRiRsmbRsb
RsRsmbRgbRsRsmbRsbRsbRsbRgbLsbRsbLsbRsbLsLsmbsbsbRibLjbLjbRibRibLjbRib
LgbLsbRgbRgbsbRgRsmbRibLjbRibLjbLibRjbRhRsmbRibLgbLgLsbRibRsbRgbRgbRgb
LgbRibLjbRgbRgbRgbsbRgbLjbRibLgbRibLjbRibLjbLjbRiRsRsmmbRgbRsbLsLsmbRs
bLsbLgbRibLjbsb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bLgbLibLsbLsbLgLsLsmbLsbLsbLgbLsbRsbLgLsbRsbRsLiRsbLsLsRsmbLgbLsRsbLsL
gLsbLgbLsbLibLgbLsbLgbRsbLgbLgbRgbLsbLgbRsbLsbLgbLgRsbLgbLsbLgbLgLsbLi
LsbLgbLsbLsbLgbLgbLsLsmbLsbLgLsbLibLgbLibRibRjbRibRgbRsbRgRsmbLsbLobLi
bLgbLsbLsbLgbLsbLsLsmbLgbLgbLgbLsbLgbRsbLibLgLsbLsRsbLgbLsLsLgLsmbLgbL
sbLsbLgbLgbLgbLgbRsbLgLsbLsLsRsmbLsbLgbLgbLgbLsLsmbLiLsbLgbLsbLgLsbLsb
LgbLsLsmbLgbLsbLsbLgbLgbLgbRsbLiLsbRibLibLsbLgbRsbLgbLgbLgbRjbRcbRibRg
bRibLjbLcLsmbLgbRsLgLsbLsbLsbLsbRsbLgLsbLsbLgbLgLsbLgRsbLsbRsbLibLsbLg
bLsbLgbLgbLgbRsbLiRsbRjbRhbRibRgbRgbLsbRibLcLsmbLibRsbLgRsbLgLsbLsbLsb
LgbLgLsLsmbLgbLgbLiLsbLibLgbLsbLgRsbLgbRsLsbLgbRgbLibRjbsbRhbRibRsbRgb
RsLsbRgbLjbLcbRjbLibLibLgRsbLgLsbLgbLsbLsLsLsmmbLgbLgbLgbLgbLibRgbLibR
sbLgbRsbLgLsLsmbLsLsmbLsbLgLsLsmbLsLsmbLgLsbLgLsLsmbLibLgbLsbLsbLgbLsb
LsbLgLsbLgLsLsmbRjbRibsbLgbLgbLgLsbLsLsmbLgbLsbLgbLgbLgLsbRgbLhbRibRjb
RibRgbRgbRgbLsbRibLjbRibLgbRgbRgbLjbLcbRsbLiLsbLgbLgbLgbLgbLiLsbLgbLsb
LsbLsbLsbLgbLgbLsbLgbRsbLgLsbLiLsbLgbLsbLgbLgbLgbLsLsmbLgLsbLgbRgbLsbL
gLsbLgbLsbLgRsbLsbLgbRsbLgbLsbLgbLgbLgLsbRcbRibRibRgLsbRgbReLcbRsbLsbL
gLsbLsLsmbLgbRsbLgbRsbLsbLgbRsbLgbLsbLsbLiLsbRsbLgLsbLsbLsbLiLsbLgbLgb
RsbLgbRsbLgbRsbLgbLsbLsLiRsbRsbLgLsbLsLsmbLsbLgRsLsRsbLsLsmbLgbLsbLsbL
gbLsbLsbLsbLibLsRcbRiLsbRsbRibLgbRgbRsbRgbsbRgbLcbLgbLgbLsbLgbLsbRsbLg
bLgbLsbLsbLgLsbLgLsbLgbLgLsbLsbLgLsLsmbLgLsbLsbLgbRhbRibRhRsmbRgbLgbRi
bRgbLsbRibLjbLhbLsbLibLgLsbLsbRsLsLsmbLgbLgbRsbLsbLsbLgLsbLsbLgLsbLgLs
bLsLsmbLgbLsbLgbLgLsbLgbLsbLgbLgLsbLibRjbRjbRgbRgbRgbRgbRsbRgbRgbRsRgb
RgbLcbLsbLcbRgbLibLgbLgRsLsbLsbLgbLgbLsbLsbLsbLsbLgLsbLsbRgLibRibRgbRg
bRibLgbRiLsbLjbRgbRgbRsbRsbRsbRgbRsbRsbRgRsLsmbRgbLhbLsbLgbLgbLsbLsbLs
LsmbLsbRsRsmbLgbLgbLsbLsbLgbLsbLsbLgbLsLsmbLgbLsbLsbLgLsbLgbLsbLgbLgbR
gbLibLgbLsbLiLsbLgLsRsbLsLsmbRcbRibLjbsbRibLjRsbLcbLibLgLsbLsbLsbLgLsb
LsbLsbLsbLsLsmbLgbLsbRsbLsbLsbLsbLsbLgbLsLsmbLgbLsbLsbLgbLgbLsbLgLsbLg
bLsbLgLsbLibRsbLgbLsbLgbLsLsmbLsbLgLsbRsbLgLsbLsbLgbLsbLsbLgbLsbLgbRsL
sRsbLsbLgbLsbLgbRsLsbLgLsbLsLsmbLsbLgRsbLgLsbLgbLibRcbRibLjbRibRgbLsbR
ibLjbLcbRsRsmbLgbRsbLibLgbLsbLgLsbLgLsbLsbLgbLsbLsbRsLsbLgbLsLsmbLsbLi
RsbLsLsmbLsbLgLsbLibLsLsmbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 125513; End: 130013;
Recording: 11-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bRiRsmbLgbRgbRsRsmbRsbRgRsLsmbRsbRsbRsbRsRsmbRgbRgbRgRsmbRgbRgbRgRsmbR
gbRgbRgRsmbRgbRgRgRsRimbRgbRgRsmbRgbRiRsmbRgbRgbRgbRgbRsbRgRsmbLgbsbLs
LsmbRsbRgbRsbRiLsRhLsbLibLibRgbRgbLibRcbRibLsbRgbRsbRsbRgbRgRsmbRsbRsb
RgbLsbLsRsbRsbRsRsmbRsbRgbRsbLsLsmbRibRsbRgRsmbRgRsmbRgRgbRgbRgRsmbRgb
RsRsmbRgbRsRsmbRgRsmbRgRsmbRsRjbRsRsRgmbRiRsmbRibRgbRibRgbRibRgbLsbRiR
sRgRgRsmmbRgbRgRsmbRsbRgbRsbRsbRgRibLjbRibLgbRcbLibRcbLgbLjbRhbRiRsmbR
ibLgbRibLjbLibLibLgbRsbLgbLgbRsbLiLsbRjbRcbRgLsbRgRsmbRgRsmbRgbRgbRgbR
sbRsbRgbRgbRgbRgbRgbRsbRsRsmbRgRgbRgbRgRsmbRgbRgbRgbRgbRsLsbLsLsmbRibR
hbLiLsLsmbRcbRsRiRsmbRcRsLsmbRiLsbRgbsbRgRgRgRsmbRgRsmbRgbRgRgbRgbRgbR
gbLgbLjbLibLgbLgbLsbLsbLsbLsRsbLgLsbLgLsbLgbRcbRibRsbRgRsmbRgRsRsRgmmb
RgbRgbRgbRsRgRgRiReRiRibRibRgbRsbRsbRsbLeRsbLiRsbRjbLibLgbLsbLgbLgLibL
gbLsbLgbLsbLgbLsbLsbLgbRsbLgbLsbLgbLgLsbRcbLsbRiRsmbRgbRgbRsLsbLsRsbRg
bRobRgbRgLsbRgbRsRsmbRgRsmbRsRcbLcbLsbLgLsbLibRibLibLibsbsbLgRsbLgbLgR
sbLgbLibRjbRcRsmbRgbRgbLsbRgbRsRsmbLjLibLibRsbRjbRgbRgbRsbRsbLsbRsLjbR
hbLjbRsbLibLibLgbRebRiRsmbRgbRsRgbLsbLibLgLsbLgbLsbRsLsbLcbsbRhbLgbRcb
RgbRgRsmbRgbRsbRgbRsRsLsmbRsRsmbRsbLsRibRgLgbRibRgbsbRgbRsbRsbRsbRsbRs
bRsbRgLsbLsbRgRsmbLsLsmbLjbRjbLjbRjbRgRsRsmmbLsRsRgbRsbRsRsmbRgbLsbRsb
RsLsRsbRgbRsbRsLsbRsbsbRgbRsRsmbRsRsRsmmbRsRsmbRsbRgbRiRsmbRgbLjbLsbLg
bRebRgRsmbRsbRsbRsbRgbRsRgRibLsbRsbRsbRsRsRgRsRsmmmbRsbRgbRsbLsLsmbLsb
sbRsbRgbRgbRgbRgRsmbRsbRgRsmbRsbRgRsRgRsRemmbRgRsReRgmbRsbRgbRgRgbRiRi
RsmbRsbRgRgRsRgRsmmbRgRsRgRsRsmmmbsbRsbRsLsRgLsRibRgRsmbRiLsbRsbRgRgbR
gbRgRgbRsRsmbRgRsmbRsRgbRiRsmbRgbRsbLsRsRsRsmmbLsbRgbsbRsRiRgbsbRgbRgR
sRgRgmbRgRjbRsRsmbRibLjbRibRgbLgbRgLsbRgRsRsRsmmmbRsbRsbRsbRsbRgbRsbRs
bRsbRsRsmbRgbRiRsmbRsRsmbRgbRgbRsbRsLsbRgLsbRsbRgRsmbRgbRsbRsbRgbRgbLg
bRsRgRsmbRgbsbLsLsmbRsLsbRgbLjbRgbRsbRsbRgbRsRsmbLgLsbRhbLhbLjLhbRhRsm
bRhbRibLgbsbRgRsRsmmbRsbRsbRsRsRsRsmmmbRgbLjbRsbLjbRiRsmbRibRsbRjbRsbR
sbRgRsmbRgRgRsmbLsbRsRsmbRsbRsbRsbRsRsLsmbRgRsmbRgbLibRjbRgbRibRgbLjbR
ibRgRsmbRsLsbLsbRsbRgLsbLsbRjbLgbRjbRibRgbLjbRhRsmbLgbLjbRibRgbRiRsmbR
sRgbRgbLsbRsLsbRsbRgbRgRsmbRgbRgRgbRsbRsRgbRsbRibRgbRgbRsbRgRsmbRgRsmb
RsbRsRgRsRsmmbRgRsmbRgRsRsmmbRsRsmbRgbRgRsRsmmbRgbRgbRsbRsbLsLsmbRsbLc
bLgLgbRjRcbRgRsmbRgLsbRsRsLsmbRsLsbRsbRsbRsbLibRgbRgbRsbRsbRsbRgbRsbRs
bRgbLsbRgbRsRsRsRgRgmmbRiRsmbRjRsRgRsmmbRgRsmbRgbRgbRgbRgbLjbRibLgbRib
LobRsbRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 1; Drug: Control Apo 0.5 然
bLjbLibLsbLgbLsbLibLsLsmbLgbLsbLsbLsbLgbRibRjbRhbRsbRibRsbRsbLgLsbRhbR
sbRgRsmbRsbLjLsmbLibLjbLsbLsbLibsbRsbRgbRgRsmbRgbRibLgbRhbRsbRibRsLsbL
gbsbLsbLcbLsbRsbLsbRsbRsbRgbRibRibLgbLsbLgbLjLsmbLgbLsbRibRibsbsbLibLi
bLgbRcRsmbRjRsmbRsbRsbRgbRsbRgbLcbLcbRibRcbRsbsbRgLsbRgbLcbLcbLibRgbLg
LsbRsRsmbLiRsbRgbRjLsbLcLsmbLgbLjLsmbLsbRibLibRgbRhbRsbRhRsmbRsLsbRjRs
RsmmbLsbLsbRjbLgbRsbLgLsbLibLsbRgbRsbRibsbRhbLsbRhbRibRgbRsbLgbLibLiLs
bLgbLibLgbRhbLibRibRibRibLgbLibLibRjbRibRsRsmbRsbRsbLsbLjbLsbLgLsbLibL
ibLibLjbLgbRjbRiRsmbRgbsbLsbLsbLgbLgbLibRibRibRhbRsbRsbsbRgbsbRgbRgbRg
bsbLsbLgbLjLsmbRjbRcRsRsmmbRsbRgbLsbLsbRibLsbRgRsmbRsbRsbLsRsbRsbLgLsb
LjLsmbLibLhbLgbLsbLjLsmbLibLjbLgbLsLsmbRjRsmbLibLiLsbLjbRibRibRibRibRi
Rsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 2; Drug: Control Apo 0.5 然
bRgbLgbRsbRsbRsbRsbRiRsmbRsbRibLibRiLsbRibRiRsmbLhbLiLgbLgLsLsmbRgLsbL
ibRjbLibRibLcRsbsbRibLibRgbLiLsbRjbLgbLcbRhbLhbRsbLibRhbLibLiLsbRiRsmb
RibRsbRiRsmbLsbRsbRgbRsbRgbLsbLsbRibLgRsbRibRgLsbLjbLjbRjbLhbLsbLgbLib
RibLiLsLsmbLgbRjbRjbRibRsRsmbRibLjbRibRsbRsbRibRhbRsLibRsbLsbRibRibLgb
RgRsmbRgbRgbRsbRsbLsbRibRsRsmbLsbRgbRsRsmbLgRsbRcbRsbLjbLcbLsbLhbRjbRc
bRibRgbLibRibRsRsmbRgbRsbRsRsmbRgRsmbRgRsmbRgbRgbLgLsbRsbRibRgbLgbRsRs
mb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 3; Drug: Control Apo 0.5 然
bLsbLsbLsbLsbLsbLsbLsbLibLgbLsbLsbLgbRsbRgbLgLsbRsbLsbLsLsmbRgbLsLsmbL
sbLjRsbRsLsbRsbRjbRjbRgbsbLsbLsbLsbRsLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 4; Drug: Control Apo 0.5 然
bRjbLibLgbLsbRgbRjbLsbRgbLjLgbRibsbRjLsbRcbRiRsmbLgbLsbLsbLibLibsbLgbL
sbRsbsbRgbRiRsmbLibRiRsmbRibRgbRjRsmbRjRsmbLibLjLsmbRsbRsbRgbRsbLjbsbL
jbLsbRsbRgbLibRsbRjRsmbLjbLgbLgbLsbRsbLibLsbRibLibLsbsbLsbRgbRgbRgbRib
RsbLjLsmbRgbRgbLibRibLhbRibRiLsbRiRsmbRsbRsbLsbRibLibLgbRjbRjbRibRibLj
bRibRcbRibRsbRgbLjLsmbRgbLsbRjbRgbRgbRibLjbRiRsmbRgbRiRsmbLcbRibRibLjL
jbRibRjbRibRcbRsbRsbRsbRibRibRibRibLjbRgRsmbRibRgbLibRgbRgbRsbRsbRgbRs
bLsbRibRgbLsbRgbRgbLgbRgbRgbRgbLibRgbRgbRsbRgbRgbRgbLgbRgbRgRsmbLsRsbR
sbRsbRsbRibRsbLibRibRgbRgbRsbRgbRjLsbLjbRgbRibLjbRgbRgbRsRsmbRsRsmbRgb
RibRgbLibRgbRgbLjbRibRgbLibRibRsbRgbRsbRsbRgbRgRsmbRsbLgbRgbRgbRgbRgbL
gbRibLgbRgbRgbRibRsbRsbRsLsbRibLsbLsbRibLgbRgLsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 5; Drug: Control Apo 0.5 然
bRgbRgRsmbRsbRsbRsLsbRsbRibLgbLibLibRcbRcbLibLjbLibRsRsmbLgbLgbLgbRsLs
bLgRsLsbRjbRoRsmbRsbRibLsRsbRiRsmbRsbRibLcbLibLgbRjbLgbLgbRcbLsbRgbRsb
RsbRsbRsbLsbRibLgbRiRsRsmmbLsbRgRsmbRgbRsbRgbRgbRgbRsbRsRsmbRsbRibLibR
hbLgLsbLjbLiRsbRobRibRgbRsRsmbRsLsbRsbRsRsmbRgbRsbRsbRgbRsbRgbLsbRgRsm
bRgbRsbRsbRibLibRhbLjbRobLsbLjbLibLgbLibLgbRjbRhRsLsmbLsbRibsbRsLsbRgb
RgbRsbRsbRsRsmbRsbRsbRsbRsRsmbRsRsmbRsbRgbRsRsmbRsRsmbRsbRsbRgbRgbRsbR
sbRsRsmbRgbRsbRsbLsRsbRsbRsRsRsmmbRgbRsbRsbLsRsbRgRsLsmbRsbRsbRsbRgbLj
bRiRsRsmmbRgbLgbRsLsbRiRsmbLsLsmbRibRsbRgbRsRsmbRsbRgbRgbRgbRsbRgbRsbR
sbRgbRgLsbRgRsmbRgbRsRsmbRgbRsbRibRgRsmbRsbRgRsmbRgLsbRsbRgRsmbLgbRiRs
mbRgbLibRgRsmbRgbRsRsmbLsbRgbRsbRgbRsbRsbRgbRsRsmbRsRgbLiRsbLjbLibLibR
ibLibRcbRiRsmbRgbRgbRgbRsbRgbRsbRsbRgbRgbLsbRgbLsRsbRgbLsLsmbRibRsLsbR
gbLcLsmbLibRoRsLsmbRibRsRsmbRgbRgbLibRcbRgbRgbRgbRsRsmbRsbRsbRsbRsRsRs
mmbRgbRsRsmbRgLsbRgLsbRiRsmbLjbsbLhbLibRjbLjbLibLsRcbRibLsbRsbRgbRgbRs
bRsRsmbRsbRgbRsbRgbRsbRgLsbRibRgbLgbRibRsbRsbRsbRgbRsbRsbsbRgRsRsRsmmm
bRgbLjbRibLiRsbRhbLgbLjbLiRsbRcbRsbRgRsmbRsLsbRgbRgRsmbRsbRgRsmbRsbRgb
LebRcbLjbLhbLibLiRsbLgbRgRsmbLhbRcbRcbRgbRgbRsbRgbRgbRgbRsbRgbRsLsRsbR
gbRgbRgbRgbRgbRgbRsbRgbRgbRsRsmbRgRsmbRsLsbRibRsbLjbLhbLibRcbLcbLibRjb
LibLibRhbLjbRcbRgbRsbRsRsmbRsbLsbRgbRgbRgbRgbRgbRsbRgbLsbRgbRgRsmbRgbL
jbRgbRgbRgRsmbLgbRibLsbRgbLjbRgbLjbRgRsmbLsbRgbRsbRsbRgbRgRsmbRgRsmbRg
LsbRsbRgRsmbRsbRsRsmbRgRsmbRgbLjbRhbLhbLiRsbLibRcbRsbRgbRgbRsRsmbRgRsm
bRibRgbRgbLibRibRgRsmbRibLgRsbRibRgRsmbLsRsbRgbRsbRsbRsbRsbRsbRgRsmbRg
bRsbRsbRsbRsbRiRsmbRibLjbLhbLibRsbLgbLsbLgbLsbLsbLsbRcbRgbRsbRgbRgRsmb
LjbRgbRgbRgRsmbRgRsmbRgbRgbRgbLgbLjbLjLsmbLgbRobRgbRsbRgbLsRsbRsbRsbLs
bLjbLcbRhbLjbLiLsbLsbLgLsbLgRsbLgbRsbLgbLsbLsbRcbRibRgbRgbRsLsbRsbRsbR
gbRsRsRsmmbRsRgbRgbRibRgLsbRgbRgbRsRsmbRsbRgLsbRgbRsbRgbRsbRgRsmbRgbRs
bRsbRsRsmbRgbRgRsmbRgbRsbRsbRgbLsbRgbRgRsRsmmbLsbRsbRsRgbRgbRgbRsbRsbR
sbRgbRgRsmbRsbRibLjbLhbRibRhbRgbLsbRgbRsbRgbRgbLgbRiRsmbLgbLsRibRsbRgR
smbRsbRsbRgbRgLsbRgbLgbRibLjbLibLibRebRiRsmbLcbLiLsbLsbRjRsmbRiLsbRgbR
sbRsbRsbRgRsmbRgbRgbRgbRgLsbRgbRsRsmbRgbRgbLgLsLsmbRibRgRsmbRibLcbLibL
gLsbLgbLgbLibRjbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 6; Drug: Control Apo 0.5 然
bLsLsLsmmbRsbLsbLgbRgRsmbRsbLsLsmbLsbLgbRsbsbRsRsmbLsLsmbLgLsbRsLsbRsb
LsbRsLsbRsLsbLsbLsLsmbLsbLsRsbLsbLsbsbLsbRsbLsbsbLsbRsbLsLsmbLsLsLsmmb
LsbLsbsbLsbLsbRsbLsbRjRsmbLjbLibRjbRgbRibLgbRibLsbLgbRgbRibRgbRibRgbRg
bRjbRgbRsbLsbRjbRgRsmbRgbRsbLgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bRsbRibRgRsmbRsbRgLsbRgbRsRsmbRsbsbRibRsbsbRiRsmbRgbRgbRgbRsRsmbLibRgR
smbLsbRibRibRibRsbRibRgbRsbRsRsmbRgbRgRsmbRjRsRsmmbRiRsmbRsbRsbRgbRgbL
hbRgbRibsbRgbLsRsbRcbLibLsbLsLsmbLjLsmbRgbRiRsmbLsbRibLibLsbRebRibLjbR
iRsmbRsbRsbRjbLjbRebRsbRsbsbRibLjLsmbRsRsRsmmbRjbLjbRjLsbRgbRsbRibLibL
gbRiRsmbRgbLgbRibLsRsbRibRsRsmbRibRsbLsbLgRsbRjbLcLsmbLsbLsbRiRsmbRgLs
bRcbLsbLgbLibRsbLgbLsbLsbLiLsbLsbLsRsbLgLsbLgbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bRsLsbRgLsbRgbRgbRgbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgRsmbRgbRibRgbRsbRgbLs
RsbRgLsbRgbRgbRgbRgbRgbRsbRgbRgbRgbRgbRsbRgRsmbRgRsmbRgRsmbRgbRgRsmbRs
RsmbRgbRgbRgLsbRgbRsbRgRsmbRgbRsbRgbRsbRgbRsbRgLsbRsbRgbRgbRgLsbRgbRgR
smbRgRsmbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbLsRgbRgbRgbRgRsmbRg
bRgbRsbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgRsmbRsbRsLsbRsLsbRibRgLsbRgbRgbRgb
RgbRgRsmbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgLsbRgRsmbRgRsmbRsbRgbRgbRgLsbRgb
RgbRsRsmbRgbRgbRgbRgbRsRsmbRibRgLsbRgRsmbRgbRgRsmbRsRsmbRgbRgbLsbRibRs
bRgbRsbRiLsbRsRsmbRgbRsbRiRsmbRsbLjbRibRsbLgbRibRsbLsbRgbRgbLsbRgbRgRs
mbLsbRgbRgbRsbRgbRgbRsbRiRsmbRsbRgbLsbRiRsRsmmbLsbRibRsbRgRsmbRsbRgbRs
LsbLjbsbRiRsLsmbRibLsbRibRgRsmbRgbLgbLjbLibRjbLiLsbLgbLgbRcbRgbRgbRsbL
sLsmbRibLjbRibLsbRibRibRsbRgbRsbLjbsbLcbsbRhbRiRsmbLsRsbRgLsbLsbRsbLsL
smbRibRgRsmbRgRsRsmmbLsbRibRgbLjbLcbLibLgLsbLsbLgbLgbLsbLgLsbRsbLgbLgb
LgbLsbLgLsLsmbLsbLsLsmbLgRsbLgbRsbLgbLgbRcbRiRsmbRsbRgbRsbLsbRgbRgLsbR
sbRibRsRsmbRgbRsbRgbRgbRsbRgRsmbLgbLcbRjbRhbRgbRgbRgbRgbRgbRgbRgRsmbRg
bRgRsmbRgbRsbRibLsLsmbRibRsbRgRsmbRgbRsbRsbRgbRgbRgbRsbRsLsbRiLsbRsbRg
bRgbRgbRgbRgbRgbRgbRgLsbRsRsmbRgbRgbRgbRsbRibRgbRgbRgRsmbRgbRsbRgbRgbR
sbRgRsmbRsRsmbRgLsbRgbRgRsmbRgRsmbRgbRsbRgRsmbRgLsbRgbRgbRgbRsbRgbRsbR
sbRgRsmbRsbRgbRsbRiRsmbRgbRgRsmbRgbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgRsm
bRgbRsbRgbRgRsmbRgbRgbRgRsmbRsbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgRsmbRgbRgb
RgbRgbRgbRgbRgbRgbRgbRgbRgRsmbRsbRgLsbRgRsmbRgRsmbRgbRgbRhbRsbRgbRgbRg
bRgbRgbRgbRgbRibRgbRgbRgbRsbRgLsbRgbRgbRgbRgbRgbRgbRgRsmbRgbRgbRebRsbR
gbRgRsmbRgRsmbRgbRsRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bRsbRsRsmbRsbRsRsmbRsbRibRsbLjbRgbLcbRhbRibRhbRgbRgbRibRhbRgbRgbLcbRjb
LibLgbLgbLgRsbLsbRsLsbLsbLsbLgbLsbLgbLsbLgbLgLsbLgbLhRsbRiLsbRcbLjbRcb
LjbRhbLhbLhbLibLhbRcRjbRibLcbLiLsbLgbLibLgLsbRsbRgbLibLsbRsbLsbLsbLsbL
gLsbLgbRsbRjbLibLgbLsbRsbLgbLgbLsbLsbLgbLgbLsbLgbRsbRgbLibLgbLsbLgbLsb
LgLsRsbLgLsbLhbRiLsbLibLibLhbRsbLjbRgbRiLsbLsbLgbRhbLgbLgbLibLgbLgbLib
LsbRgbLgbLgbLgbLgbLsbLgLsbLgbLsbLsbLsbLsbLsbLgLsbLsbLsLsmbLgRsbLgbLsbL
sbLgLsbLsbLsLsmbLgbLgbLgbRibLjbRiRsmbLibRibLjbRcbLibRgbRhbLgbRibRhbLib
LibsbLgbLgbLsbLgbLgRsbRsLsbLgbLgbLsbLgRsbLsbLgbLgLsbLsLsLsmmbLgbLibLib
LsbLsbLgbLsLsmbLgbRibLgbLsbLibLgbRsbRsbLgRsbLsbLgbLgbLsbLgLsbLgLsbLsbL
sbLsbRsbLgbLsbLgRsbLgbLgbRjRsmbLhbLsbRibLibLgbLgbLgbLsbLgbLsbLgbLsbRgb
LsbLibLgbLgbLsbLsLsmbLsbLsbLsRsbLsbLsbLgLsbLsbLsbLgbLgbLgbLsbLgbRgbRsb
LsbLgbLgbLgbLsRsbLsbLgLsbLsbLsbLsbLsbLsLsmbLsbLsbLgbLsbLgbLsbLsbLsRsbL
sbLsbLsbLsbLsbLgbLsLsmbLgLsbLgbLsbLgbRgbLibLgbRibLiLsbLgRsbLgbRibLcbLs
bLgbLgbLgbLgbRcbLiLsbRibLgbLgLsbLsbLibLgLsbLjRsbLhbRcbRjbLibLibRhbLsbL
ibLgLsbsbLibLgbLibRiLsbRjRsmbRibLibLibLibRibLgbLibLgbRgLsbLibLibRjbLib
LibLgRsbRgbRjbLibRjRsmbLjbLibLgRsbLhbLiLsbLgbLibLsbLgLsbLgLsbLsbRjRsmb
LibLibLibLib

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bLibLiLsbLjLgbLibRjbRibLjbRibRibLjbRsRsmbLibLjLsmbLjbLhbLjbLjbRibRjbRj
bRjbLjbLjbRjbLjbLebLjbLgbRjRsmbRjbRjbLjbLjbLhbLibRjbRjbRibLgbRibLjLsmb
LibLibRjRsmbLjbLibLgbRibRcbLibLjLsmbLgLsbLsbRjbLsbRcbLjbLjLsmbLibLgbLs
bRjbLibLgbLgLsbLsLsmbLgbRibRhbRiRsmbLgbLjbRjRsmbLibLjLsmbRcbRjbLjbRibL
jbRjbRjRsmbLibLjbLjLsmbLibLgbRjbRjbRhbLjbLjbLibLgbRjbLhRsbLibLibsbLsbL
gLsbLgbLibLjRsRsmbLibRgLsRsbLjbLjbLjbLibLibLibLjbLjbRjbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bLgbLgbLgbLsbLsbRjbRcbRsRiRsmbLsbRibRsbRgbRgbRsbRgbLsbLcbLibLgRsbLsLsm
bLgbLgLsbLsbLgbsbRsbLibRgbLgbRsbLiLsLsmbRsbLgbLgbLsbLsbLsbRsbLsLsmbLgb
RgbLgRsbLgbLsbLgLsbRjbRcbLjbLhbRhbLhbRjbRibRiRsmbRsbRgbRsbRgbRsbRgbLgR
sbLgLsbRgRsmbLiLsbLgbRjLsbLibRjLsRebLcLsmbLibLibRgLsbLjbRcbRcbRsbLhbLi
bLjbLsbLsbLgRsbLsbLgbRsbLgbLsbLibRjbLhbRgbLjbRsbLjbLgbLiLsbLgbRsbLgLsb
RsbLgbRsbLgbLgbLsbRcbLsbRcbLsbRibRjbLsbRsRebLcbLiLsbLibRgRsmbRsbRcbLsb
LgbLsbLgbLsLsmbLgbLsLsmbLgRsbRsbLjbRgbLjbRibLjbLibRsbRsbLgbLsbLibRgbLi
bRsbLgbLsbLgbRsbLsbLibLgbRibLibLsbLgbRgbLibLgbRibLibLobLsbRcRsmbLcbRjb
LcbLgbLsbLgRsbLsbLsbLgbRgbLsbLsbLgbLsbRgRsmbLibRsbLsRsbLgRsbRsbLgRsbLs
bRsLsbRsRsmbLibLsbLsbLgbLsLsmbLgbLsbLsbRgLsbLgbRobLjbRsbLibLibRoRiLsbL
sRsbRsbLjLibLjbLsbLsbLsbLgLsLsmbRsbLgLsbLsbLsLsmbLgLsbLsLsmbLgLsbLsbRg
bLibRsbLiLsbRgbLibLsbLgbLgRsbRsLsbLsbsbLsLsmbLgbRcbsbLcbLsbLiLsbRsbLib
LgLsLsmbLgbRgbLsbLibLsbLgbRsbLgbLsLsmbLsbsbLsbRsbLgbRsbRsbLgbRsLsbLgbL
sLsmbLgbLgbLgbRgbLibLsbLibLsLsmbLgLsbRgbLibLgLsbRibLibRsbLibRsbLibLsbL
gRsbLgbRsbLsLsmbLgbRsbRcbRgbLsbRibLjbsbRsLcbLibLsRsbRsLsbLgbRsbRgbLsbL
gbLsbLgbLsbLgbRsbLgbRsbLibsbsbRsbLgLsbRjbLibRcLsbLcbRgbLibRjbLibLiLsbR
ibLibLsbLibRsbLgLsbLsbLsbsbLsRsbLibLsbRjbLsbRobLcbLibRjbLibLcbRjLsbRib
LjLsmbRgLsbLhbRgbRibRgbRcbLhbLcbLgLsbLsbLgbLsbLgbLgbLsbLgbRgbLibLibRgb
LiLsbRgbLibLgbRgbRsbLjbLsbLgbLgLsbLsbLgbRsbRcRgbLsRibLgbRgbRgRsmbRsbRg
RsmbRsbRiLsbLcbLsbLsbRsbRhbsbLcbRgbLgbLibRgbLiLsbRsbLgbRjbLibRsRsmbLcb
RibLibLgbLsbLsbLsbLsbLsbLgRsbLsbRsbLiLsbLgbRibLgLsbLsbLgbLgLsbLsLsmbLg
RsbLgbRsbLgbLibRcbRhbLibLibRgbLibRgLsbLibLsbRjbLibRjbLibRjbsbRibRibRgR
sLsmbRgRsmbRgbRgbRgLsRsbLcbLibRjbLibRgbLiLsbRsbLibRsbLgbRgbRsbLibLgbLg
bRgbLgLsbRsbRsbLibRsbLibRsbLgLsbRsbLgbRsRsmbLgbRsbLibRgbLibRsbLgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bRiRsmbRsbLsbRgbRgbRsbLsbRgbLsRsbLgbLsbLibLibRjbRcRsmbRibLsbRgLsbRgbRs
bRibLsbRgbRsbRsbRsbRsbRsbRsbRgbRsbRsbsbRgbLsLsmbRsbRgLsbLsbRsbLgbRibLs
bRsbLsbLgbRibRsbRsLsbRibRsbRsbRsbRgbRsbRsRsRsmmbRsRsmbRsbRgbRsbRibRsbs
bRsbRsbRsbRsbRsbRsbRgLsbRgbRsbLsbRgbRsLsbLgbLsbLiLsbLibRgbLibRgbRsLsbL
sbLibLsbRsbRjbRjbRcbRibLsbLsbLsbLsbLhLsbLsbLgbLgbLibRsbLsbLibLsbRsLsbL
sbRjbRsbRsbRgbLsLsmbRgLsbRsbRibRsbLsbRgbRsbRibLsbRsbLsbLsbLsbRgRsmbRsb
LsbRgbRsbRsbRsRsmbRgbRsbLsRsbRsbsbRsRsmbRgbRsbRsbRsbRsbRgbRsbRsbRgbRib
RgbRsRsmbRgbRsbLsbLsbRsbRsbRsbRibRsRsmbLsbLsbRgbRsbRsbRsbRsbLjbRebRiRs
mbRsbRsbRsbRibRsbRsbRgbRsbRsbRsRsmbRsbRsbRsbRgbsbRgbLibLsbLsbRibLsbLsL
smbRgbRjbsbsbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bRiRsmbRgbRgbRgbRgRsmbRgbRgbRsbRgRsRsmmbRgbRgbRgbRgLsbRsLsbRgbRgbLsbRg
bRiRsmbRsbRgbRgbRgbRgbRgbRgbRgRsmbRsbRgRsmbRgbRiLsbRsbRsbRgbRsRsmbRgbR
gbRgbRsRsmbRgbLsbRiRsmbLgbLjLibRhbRhRsmbLjbRibRgbLsbRibLsbRgbRgbRsbRgb
LsbRgbRsRsmbRsRsmbRsLsbRsbRsRsmbRgbRgbRgbRsbRgbRsbRibRgbRgbRsbRsLsbRgb
RgbRsbRgbRgLsbLgbRiLsbLsRsbRibRsRsmbRgRsmbRgbRgbRsbRgbRgbRsbRsbRgRsLsm
bLsbRsRsRsmmbRgRsmbRgRsmbRgLsRsbRsRsRsmmbRsbRibRsRsmbRsbRgbRgbRgbRgRsm
bRsbRgbRgRsmbRiRsmbRsbLsbRsbRsRsmbLsbRgRsmbRsRsmbRgbRsbRgbRsbRgbRsbRgb
RgbRsbRsbRsbRsLsbRgRsmbRibLsbRibLgbRibLjbLcbLiLsbRsbLibRjbRjbRibRgbLcb
RebRsLoLsmbLibLobRsbLhbRhRsmbRibRsbRgLsbRsbRsLsbRgbRsRsmbRgbRgbRgbRsbR
gRsmbRsbRgbRgRsmbRgbRgbRgbsbRibLgbRgRsmbRsbRsbsbRgRsRsmmbRsbRsbRgbRsbR
gbRsRsmbRgRsRsmmbLsbRgRsRsmmbRgLsbRgRsmbRsbRgbRsbRgRsmbRibRgRsmbRsRsmb
RgRsmbLjLsmbRibRgbRsbLsbLsRgRsmbRgRsmbRgRsmbRsbRgbLsbRsbsbRsbRsRsmbRgb
RgbRsRsmbRsbRgbRsRsRsmmbRsLsbRgbRgLsbRgbsbLsbRgbRobRibRsbRgRsmbRsbRgbL
sbRgRsmbRsRsmbRgLsRsbRgbRsbRsbRsbRsbRsbRsbLsbRgbRgbRsbRgbRgbRsbRsbRsRs
mbRsbRgbRgbLsbRgRsRsmmbRsRsmbRsbLsRgbRgbRsbRgbRgbRgbRgbRsbRgbRsLsbRgbR
gbLsbRgRsmbRsbRsbsbRgRsmbRgbRsbRgLsbLsbRgbRsbRgRsmbRsbRibRsbLsbRsRsmbR
jbRgbLsbLgbRgbRgbRgbRsbRgbRsbRgbRgbRsbRgbRsRsmbRsbRsbRjbLsLsmbRsbRsbLs
bLsbRjbRgbRgbRgRsmbRgRsmbRgRsmbRsbRsbRgRsmbRgRsmbRsRsmbRgbRsbRgbRgbRsb
RsbRsbRebRgbRsbRgRsmbRsbRgbRsbRsbRgbRibRgLsLsmbRsbRsbRgbRsbRgbRsbRsbRs
bRjbRgbRsRsmbRgRsmbRgbLjbRibRsbRgRsmbRsRsmbRsbRgbRgbLhbRsRsmbRsbRsLsLs
mbRgbLsbRgbRgbRsbRgbRgbRsRsmbRgbRgbRsLsbRgbRsbRgbRgbRgLsbRsRsmbRsbRsbR
sbRsbRsbsbRsbRsbRgbRgbRsbRsbLsRibRgbRsbRgRsmbRsbRgbRgbRibRgbRgRsmbRibR
sbRsbRgbRsbRgbRsbRgbLsbRgLsbRgbRsbRgbRsbRgbRgbRsbRgbRgbRsRsmbRibRsbRsb
RsbLgRsbRsbRgbRgRsmbRgbRsbLsbRibLsbRibRgbRsRsmbRgbRsbRibRgbLcbRibRsbRg
LsbRsbLsbRiRsmbLgbRibLsbRibRsbRgbRgbRsbRgbRsbRsbRgbLgbRgbRsbRsRsmbRgbR
sbRgbsbRsbRgRsmbLsRsbRgbRgbRsbRsbRsRsmbRgRsmbRgbRsbRgRsmbRsRsmbLsbRhbL
jLsmbRiLsRsbLsbRgbRsbsbRgRsmbRsbRgbRsbRsbRsbRgRsmbRsRsmbLjbRibRiLsbRsb
RgRsmbRsbRsbRsbRgRsmbsbRgbRgRsmbRgbRgbRgbRsbRgbRgRsmbRgRsmbRgbRsLsbRgR
smbRsbLsbRgbRgbRgbRsbRgbRgbRsbRgRsmbRsbRgbLsbRgLsbLsRsbRsbRgbRgbRsbRgb
RsbLjbRgbRgbRsbRgRsmbRjRsmbRgbRsbRgbsbLobRgLsbRgbRsbRgbRsbRsbRgbRsbRgb
RgbRsbRibRgbRgbsbRgbRsRsmbRgbRsLsbRgRsmbRsbRgbRgbRgbRsbRgbRgbRjbLsRsRs
mbRgRsmbRgbRsbRjbRsbLsbsbRsRsmbRsbRgbRsbRsRsmbRsbRgbRsbRgbRsbRgbLsbRgR
smbRsbRgRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bRgbRsbRsbRsbLsbRsLobRebLobRsbRgbRsbRgbLgbLibLibLibLgbRsRsRsmmbRjbRcLs
bLjbRibRgbLsbRgbRgbLsRsbLsbLhbLgbLgbLgbRsbRsLgbLgbLgRsbRgbLsbsbRsbRsbR
jbRsbLsRsbRsbRgbRsbRsbRsRsmbRsbRsbRsbRgbRsbRgbRsbRgLsbRgbRibLgLsbLsbRg
bRsRsmbRsRsmbRsRsmbRibLjbLiRsbRsLgbRjbRsbRcbLjbLibRcbLjbLibRcbLhLsbRob
LjbLiLsbRjbRcbLjbRhbRibRsbRjbLibRsbRsbRibLsLsmbRibLsbRsbRgbLsbsbLsbLsb
LcbLebLgbLibLiRsbLgLsbLsLsmbLgbLgRsbLsbLgbLgbLgbLsbLgbLgbRcbRibRibRgRs
mbRgbLsRsbRgbLsbRibLgbRgbLsbRjbLsLsmbLsbRsbRsRsmbRsbRsbRsbRsbRsRsmbRgb
LjbLcLsmbLibLibRhbRcbLjbRhbLjbRhbLjbRibLjbRibRgRsmbRsbLsbRibLgRsbRibLg
bRsbRsRsRsmmbRsRsmbRsbRsbRsRsLsmbRibLsbRgbLjbRibLsRsbRgbLsbRgbLgbRibLs
bRgbRgbRgbLgbLsbLjLsmbLibLgbLiRsbRsbRcbRhRsmbLibRgRsmbRsbRjbRsbRsRsRsm
mbRsbRsbRsbRgbRibRibRgRsRsmmbLsbRgRsmbRsbRgbRsbRsbRjbLsRsbLsbRsbLsbRoR
smbLebLjbLibRjbLibRcbRsbRibLjbRibLsbLjbRgbRiRsmbLgbRibRsLsbRibRsbRgRsR
smmbLsbRsbRsbRgbRsRsLsmbRjbLsLsmbsbRsbRgbLsbRibRgbRgbRsbRsbRsbRgbLsRsb
sbRsLsRsbRiRsmbLibRibRsRsmbRsRsmbLsbRsbRsRsmbRsbRsbRgbRgbLibLibRjbRcbL
jbRibRgbRsbLsbRsbRgRsmbRgbRsbLgbRsbRsRsmbLsbRsbRsbRsbLgRsbLjbRibRgbRhb
RhbLcbLibRgbRgbRsRsmbRibRsbRgbLsLsmbRsRsmbLgbLjLsmbRebRgRsmbLsbRsbRsLs
RsbLsbRgbRsRsmbRsbRgLsbLjbRjbRibRibLjbRibLsbLgbRibRgRsmbLsbLsbRsbLobRi
RsmbRgbRsbRgbRibLjLsmbRsbRibRsbRgbLsbRgbRgbLjbLsRjLsbLibRibLjbRhbLiRsb
RsbRgbRsRsmbRsbRgbRsRsmbRsbRibLjbRiRsmbRibRgbLgbRiRsmbLibRibRibLgbRiRs
mbLsRsbRgbRsbRsbsbLsbLsLsmbRsbLibLiLsbLgbsbRjbRcbLjbsbRcbRcbRsbLsbLibR
ibRgbLcbLibLiLsbRiRsmbLjbRibLsbLgbLibLsbLsbLibRjRsmbRebRsbRcbLibRibLsR
sbRgbRsbLsbRibLsbLjbLibLibRiRsmbRebRjRsmbLibRgbRgbRsbRsbRsbRsbRsbLsbRg
bRsbRjbRgbsbRgbLjbRsbLhbLibRcRsmbsbRcbLibsbRibRibLgLsbRibLibRhbLgbLsbR
gRsmbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bRibRibLibLhbLiLsbLgbRgbRsbLibLgbLiLsbRjRsmbLgbLibLsLsmbLsbRibLeLsbLsb
LibLgLsbRjbLsbLeLsbRgbLgbLsLsmbLibLibLebLibLhbLsbLsbLebRgbLibRgbRjbLib
LibsbLiLsbLsbLsbRsbLibLsbRgbRsbLgbLibRjRsmbLiLsbLsbLgbLsbLgbLhbLibRgbR
sRsmbRibLhLsbRsbLjLgbLgbRjbLcbLebLhbLjLsmbsbRjRsLsRsmbRsbLjbLhbLcbLebL
ibLsbLsbLgLsbLiLsbLsLhLsbRibLibRsbLgLsbLibLsbLsbLibLibLsbLsLsmbLsbLiLs
bRsbLgbLsLsmbLgbLgLsbLsLsmbLsbRgRsmbLjbLsbLiLsbRgbLiLsbLiLsbLsLsmbRibR
gbLibLsLsmbRibLibLibRibLsbLibsbLgbLsbLibLebRibRsLsRsbLsbLibsbLsbLiLsbL
sLsmbLsbLsbLibRsbLhbLsbRsLsbRgbLsbLibLgLsbLgbRgbLsRsbLibLhLsLsmbLcLsmb
LibLibLibLiLsbLibLibLsbLibLsLsmbRjbLibLsbLgRsLsbLiLcbLibLcbLibLibRgbRs
bRsbsbLcbRsLsbLgLsbLsbLsRsLsbLibLgLsbLibRibLsbLgbLsbLibLibRibRjLsbLcbL
iLsbLibLgbLibLibLsbRgbLibLhbRjRsmbLsRjbLjLsmbRjbLiLsbLsbLsbLgLsbRjbLib
LhbLhbLsbRsbRsbLibRhbLjbLebRgbLibLibRibLsbLsbLsbRgbLiLsbLibLsbLibRgbLi
bLsbLiLsbRibRgbLgLsbLsbLibLibLibLgLsbLsbRgbLibLsLsmbLiLsbLiLsbRjbLhbRi
bRgbLiLsbLgLsRsbLgbLsbLsbRgbLiLsbLgbRibLiLsbLgLsbRgbLibRsbLibLgbLsLsmb
RgbLiLsbLibLgbRibLibRgbLibLgbRsbLibLgLsbRgLsbLibLgbLgbRgbLibLgLsbRsbLi
bRsbLhbLibRibLgbLibLgbRgbLiLsbLgbLgbLgbLgbLsbRgbLibLgbLibLgbLgbRgLsbLg
bLibLgbRgLsRsbLiLsbLgbLsbRsbRsLsbLibLgLsbLsbRiLsbLibLibRibLgbLgLsLsmbR
sbLibLsbLibLgbLgLsbRgRsLsmbLsbLgLsbLgbLsbLgbLgbLiRsbRgLsbRgbLibLsbLibL
gbRgbLibLsbsbLsLsmbLgbLgbRsLsbLjbRgRsmbLsRsbLiLsbLgbRsLsbRsRsmbsbLgbLi
RsbLsbLgbLgbLgbRgbLibLsbRsLsbLiLsbLgbLsLsmbLgbLsbLsLsmbLgbLsbLgLsbLsLs
mbLsbLgbRsbLibRsbLiLsbLsbLsbLgbLgbRgbLiLsbLgbLsbRsbLibLsLsmbLgbLsbLgbL
gbLgbLgbLgLsbRjRsmbLibLgbLibRjbLibLgbLsLsLsmmbLgbsbRgbLgLibLsbLgbLsbLg
bLgbLsbRgbLibsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bLsRsbRhbRcbRgRsmbRgbRgbRgRsmbRsLsRsbRsbRjbRgbRgbRgbRsbRgbLjbRcbLibRib
RgbRsLsbRgbRgLsbRgbRsbRgbRgbRibRgRsmbRgbRgbRgbRgbLgRsbLobLgbRcbRibRibL
sbRibRsbRibRsbLsbRibLgRsRsmbRsbRjbRsbLoRsbRgbRsRgbRgbRgbRsbRgRsRsmmbRg
bRgRsmbRgbRjbRsLsbRgbRsRsRsmmbRgbRgbRibLgbRiRsmbRibLgbRibRgbRobRgbRgbR
ebRebRgRsmbRsbRgbRsbRgbRgRsmbLsRjbRgbRsRsRsmmbRgbLgbRgLsbRsbRsbRgbRibL
ibRsRcRsmbRgRsmbRsbRgRsmbRgbLjbLibRcRsmbRibLgbRsbRsbRgbRgbRgRsmbRsbRgR
smbRgRsmbRsRsmbRsbRgbRgbRgRsRsRsmmmbRgbRsRsmbRjbRgRsLsmbRgbRgbLibRgbRg
bRjbRgbRiRsmbRgbLsbRgbRgLsbRgbRjbRsRsmbRgbRsRsmbRiRsLsmbRgRsmbLsbRjbsb
RgbLgbRiRsmbRgRsmbLgbRibLjbRibRsbRsRsmbRsbRgbRsbRjLsbLibLsbsbLjbRcbRgb
RsbRebRhbRsbLsbLjbRcbLgRsbLsbRsLsbRcbsbRsbRgbRsbRsRsmbRgbRgbRsLsbRsbRe
bLobRjbRjbRsRsmbRgbRsRsmbRgbRgLsbRsbLsbRjbLiRsbLgbLiRsbLcbRsbRiRsmbRsb
RgbRgRsmbRgbRgbRsbRgRsLsmbRsRsmbRsRsRsmmbRsRsmbRgbRgbRgbRgbRiRsmbRgbLj
LsmbRcbRcRjbLsLsmbRsbLjbLibLsbRcbRjRsmbRibRgRsmbRgbLsbRgbRsbRsbRgLsbRi
bRibRgRsmbRgbLjbRsRsmbRsbLsbLsbRsbRsRcRsmbRsbRjbLibRjbRhRsmbRgbRsbRsRs
mbRibRsbLsRsbRsLsbRgRsmbRibRsRsmbLsbRgRsmbRjbRgRsmbRsbRsbLgbRsRsmbRsbR
gbRsbRsbRgbRgbRsRsmbRsbRgbLsRgLsbRjbLsbRsbLgbRjbLsRsbRsbRgbRsLsbRgbRgb
RgbRsbRgbRgRsmbLgbRibRgbRsLsbRsbRsbRsbRsbRgbRsbRsRsmbLobRsbRgLsbRgbRib
RibRgbLjbRcbLgLsbRiRsmbRgbRgLsbRsRsmbRgbRsbRgbRgbRsbRgbRgbRgbRgbRgbRgb
RgbRgbRibLsbRibLgbRgRsmbRsbRgbRgbRgbRgbRgRsmbRgbRgLsbRsRsmbRgRsmbRgbRs
bRgbRgbRgLsbRgLsbRsbRgRsmbRgRsmbRgbRibLiRsbRibRgRsmbRsbRgLobRiRsmbRgbR
sbRgbRgbLsbRsbRsbRgbRgbRsbLsbRsRsmbRsbRgRsmbRgbRgbRgbRsbLsRsbRiRsLsmbR
gRsmbRgbRgbRgLsbRgbLgbRibRiRsmbLgbRibRiRsmbLiRsbRiRibRgbLsRsbRsbRgbRgb
RsRsmbRgbRsbRgbLsbRibRsbRibLsbRgRsmbRgbRgbRsRsmbRgbRgLsbRgbRgRsmbRgbRs
bRsbRgbRgbRsbRsRsmbRgbRgbRgbRgbRgbRgbRgbRgbRsbRsbRgRsRsmmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bRsbLgbLgRsbLsbLgLsbRsbsbLgbLsbLgbLsbLgRsbLsRsbLsbLsLsmbLgLsbLgbLsbLgb
LgbLsbLgbLgbRsbLgbLsRsbLgbLsLsmbLsbLgbLsbLgLsbLsbLgRsbLsbLgbRgbLibLhbL
sbLsbLibRsbLgbLsbLgbRsbLgbLgbLsLsmbLgbRhbRcbRibRgbRsbRsRgbRsbRibsbRibR
sbLcbLgbLgbRgbLibLgbRsbLgbLsbLibRsbLgLsbLsbLgLsbLsbLgbLgbLgbLsbLsRsbLg
bLgbLsLgbLgbRjbRcRsmbRgbRgbRgbRgbLsbRibRsbRgRsmbRsbRgbLsRsbLcbLgbRsbLg
bLgbLsbRhbLcbLgbLgbLsbLgbLsRsbLsbLgbRsLsbLsbRsbLiLsbLsbLgbLsbLsbLsbLgb
LgLsLsLsmmbLsLsRsmbLgbRibLsbLsbLgbLsbLgbLgbRsbLgRsbLobLcLsLsmmbLibRsbR
sbRjbLibLibLgbLsbLsbLgbLibRsbRsbLibLsbLgRsRsmbRsLsbLsLsmbLsRsbLsbLsbLs
bLgbLsbLgbLsbLsLsmbLgbLsbLgbLgbLgbLsRsbLsLsmbLsbLsbLsbLsbLgbLsLsmbLgbL
sbLgbLgbRsbRsbLsLgbRsbLgbLgbLgbLsRsbLsbLgRsbLsbLsbLgbsbRgbLsbLsbLgbLsL
smbLsLsmbLgbLgbLsbLgbLsRsbLsbLsbLsLsmbLsbLgbLgbRjbRjbRhbRibRibRsbRgbRg
bRgLsbRsbRsbRgbRsbLsbRibLjbRcbRsbLsbLsbRibRsbLsbRgbRsbRgLsbLjbLjbLcbRg
bLsbLibLsbLsLsRsmbLgbRsbLgbLgbLsbLgbLsLsmbLhbLgbLsRsbLiLsbLsbLibRcbLgb
LsbLgbLsbLgbLsbLgbRgbLgLsbLsbLgbLsLsmbLgRsbLgLsLsmbLsLsmbRgbLgbLsLsmbL
gbLsLsmbLsbLsbLgbLsbLsbLsbLgLsbLsLsmbLgbRsbLgRsbRsbLgRsbLgbLsbRobRobLg
bLibLsbLebLsbLibLcLsmbLgbLibLgbLsbLgbLgbLgLsbLsbLgbLsLsmbLgLsbRgbLgbLs
bLsbLsLsmbLgLsbLsbLgbLgbLgbLsLsmbLsLsmbLgRsbLsbLgLsbLsbLgbRsbLibLsbRjR
smbLgbLsbLgbLgbLgbLsbLsbLgRsbLsLsmbLsbLgRsbLsbLgbLsbLsbLgLsbLsbLsLsmbR
sbLsbLgLsbLsbLsbLgbLgbLibRibLiLsbRgbLsLsmbLiRsbLsLsmbLsbLsLsLsmmbLsRsb
LgbLsbLsbLsbLgbLsbRsbLgbLgbLsbLsbLsbsbLgbLgRsbLsbLsbRsbsbRjRsRsmmbLjbL
sbLgbLsbLgbLgbLibRgbRgbLgbLsbRgbRcbRgbLsbRsRsRsmmbRibRgbRgbRgbLsbRsbRs
bRibLibLsbRgbLjbLibLgbLjbsbLgbLibLgLsbRgbRsbLsbLgbLsLsmbLiLsbRsbsbLgbL
sLsmbLsbLgbLsbRsbLsbLgbLsbRsbLgRsbLsLsmbLsbRsRsmbLgLsbLsbLgbLgRsbLgbLg
bLsbLsbLsbLgLsbLsbLsRsbLsbLgbLgbLsbLsbLibLibLibLjbLibRjbLibLsbRsbLcbLi
bRsbLibLsbLgLsRsbLibRsbLgbLsbLsbLsbLsbLgbRsbLibLsbRsbLsbLgbLsLsmbLsbLs
bLgbLsbLsLsmbLsLsmbLgbLsbLsbLsbLsbLsbLgbLsbLsbLgLsLsmbLsbLgbLsLsRsmbRs
bLsbLgbRsbLsbLgbLsbLsbLgbLgbLsbRgbLhRsbLibLsLsmbRgbRsbLcbLsbRgbRsbLibL
sbLibRgLsbLiLsbLgbLsLsmbLsbLebLhbRjbRsRsmbLsbLgbLgbLsbLsbLiLsbLsbLsbLs
bLibRsbLgbLgbLibRsbLibLgRsRsmbLgbLgbLsbRsLsbRsRsmbLsbLiLsbLsbLgbRgbLsL
smbLsLsmbLgbLsRsbLsbLsbLgbLsLsmbLgbLsbLsbLgbLsbLgRsLsbLsbLgbLgbLgbLsRs
bLgbLgRsbLsbLsbLgRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bLjbLjbsbRsbLsbRsLsbsbLjLsmbsbRibsbRsbRsbsbLibsbsbsbsbRsbRsLsbLibLibRs
LsbsbsbRsbsbRsLsRsbLsbsbRjbRsbLsbReRsmbRiRsmbLibRebLsbLjLsmbRsbRsbRsRs
RsmmbRgbLgbRsRsmbRsbRsbRsLsRsbsbRsbsbLsbRsbLsbLgLsbRiRsmbsbLsbsbLsbLsb
sbRjLsbLibLeLsbLsbRhLsbRibLgbLsLsmbLiLsbLsbReRsmbRcRsmbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bRsLsbRsbRgLsRsbsbLgbsbRsbRsbRsbLgbsbLhbRcbsbsbRsbRsLsbRgbLgbRiRsmbLgb
RsbLsbRgbLsbRjRsmbRsbRsbRgLsbRsbLjbLgbRibLgbLsbLsbsbsbLsbLsLsmbRgbsbsb
LhbsbRsRsmbLsbsbsbsbsbsbsbLsbsbLsbLsbRsRsmbRgbRsLsbLsLsmbLsbRsRsmbLsbR
sbLgbRgbRsbsbsbLsRsbsbRsbRsbsbLsbLsbRsbLsRsbRgbLsbRgbRgbLjbRsbsbsbsbsb
RibLjbRsbRibRsbLsbRsbLgLsbsbRsRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bLgLsbRobLsbLsbLsLsmbLsbLgbRsbLgbLsbLgbRhbRibLjbLcbLsbLsbsbLsbLsbLgbLg
bLsLsmbLgbLjbLsbRcbRgbRjbLibLibLgbLgbLgbLsbRgbRcRibLcbRjbRibLjbLcbRgbs
bLsbLsbLsbLgbRgbLibRsbLiLsbLsbLsbLgbLibRsbsbLgbLsbLgbLsbLsbLgLsbLsbRsb
LsbLsbLgbLgbRcbLcbLiRsbsbLsLsmbLgbLgLsbLgbLgbLsbRcRsmbLibLibLgbLsbLsbL
sLsmbLsbLsbLsbLsRsbLjbRsbRsbRhbLobLgLsbLsbLgbLgbLsLsmbRibLcbRsbLjbLsbL
sbLsbLsbLgbLgbLsbLsbLsbRsbLsbLgbLsbLgbLibRgbLibLgbRsbRsbLjbRgbLjbLsbLg
bLsbLgbLgbRgbLgLsbRibRcbLsbRjbLgLsbLiLsbLgLsbLsbLsbLsbLgbRibRibRgbLjbR
ibLebLcbLgLsbLsbLsLsmbLgbLsbLsbLsbLsbLsbLjbRiLsbsbRsLjbLsbLgbLgbLgbLgb
LsbLsbRjbLebLgbRsLjbLsLsmbLsbLgbLibRjbLibLgbLgbLsbRsbRcbRgbRjbLcLsmbLs
bLiLsbRsbLgbsbsbRjRsmbLsLibLsbRsLsbLsbLgbLsbLsbLgbLsbRgbsbLsbRjRsmbLiL
sbRgbLgbLsLsmbLsbLsbLsbLsLsmbLsbLsbLgbRcLsbRsRsmbRjbRibRcbLcbLcbRibRjb
RgbRgbLcbLcRsbRgbLhLsbRjbRsbLsbRsLsbLsbLsbLsbRsbLsbLsbLsbLgbLgbLsbLsbL
gbRgbRsbRjRsmbRgbRgbRgbRgbRgRsmbLgbLcLsmbLgLsbLsbLgbLsbRsbsbLsbLsbLsbL
sbLsbLgbLsbLsbLgRsbLsbLgbLsbLsbLsbLsbLgRsbLsLsmbLgbLsbLsbsbLgbLsbLsbsb
LsbLibLgbLsbLgbRjLsbRjbRibRibRgbLsbRibLgbLcbLcRsbRibLibRsbLgbLsbRsbsbL
sRsbRsRsmbLsLsmbLsbRsbLgbLgbLgbLsbLsbLsbRobsbRsbLsbLsbLgbLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bRsbRgbsbLsbLgbRgbRgbLsbLsLsRsmbRiRsmbLsbRibRsbRsRsmbRgbLsbLsbRgbRsbLs
bLsbLsLsmbRsbRgbsbRibLibRibLsbLsbRgbRibRgbLsbRibRsbRibRsbRsbRgbRibRjbR
gbRgRsmbRgbRgRsmbRibRgRsmbRsRsmbRgbRsRsmbRgLsbLsbLsbLsbRibLsbRsbRibRib
RsbLsbLgLsbRibLsbRgbLsbLsbLsbLsbsbRgbRsbLsbLsbLcbsbsbRjbLebLgbLgbRsbLi
bRjbLiLsbLcLsmbRiRsLsmbLjbRgbLgbRibRcRsmbRiRsmbLjLsmbRibLsbRsbRgRsmbRg
LsbRsbRsRsmbRsbLsbsbRgbLgbRibRsbRsRsmbLgbRsbRsbRiRsmbLsbLgbLgbLgLsbRjb
LsbLsRibRsbLsbLjbRibRsbLsbRiLsbRsbLsRsbsbLsbRsbRsbRgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bLsbLibLsbLsLsmbRsbLibLsRsbLsLsLsmmbLsbLgbLsbLsbLjbLsbLibLsbLsRsbsbLiL
sLsmbLsbRgbRibLibLhbLibLsLsmbLgbLsbLgbLsbLibLsbRgbRsbLsbLgbLsbLsbRsbLi
LsbLsLsmbLsRsbLsbLsLsmbLgbLibRsbRgbRsbLhbLsbLibRibLibLibLsLsmbLsbLsbLi
bLsbLsbLsLsmbLiLsbLsbLsbRgbRsbLibLsbLsLsmbLsbRsbLiLsbLibLsbsbLsbLsbLsb
LibLibLsbLibLsbLsbLsbLsbLsLsmbRibLibLebLsbLsbLgbLsbLsLsmbLgbLsbLjbLsbL
sbRsbRsbLsbLsbLgLsbLsbLsbLsbLsLsmbLsLsmbRjbLjLsmbLibLsLsmbLibLsbLsbRsb
RsbLgbLiLsLsmbLsbLjbRibRsbLibLsbLhLsbLsbRjbRsbRsbLibLhbLsbLsbLsbLebRhb
RgbRibLibLibLgbLibLsbLsbsbLgbLsbsbRsRsmbLgbLgbsbLsLsmbLibLsRsbRsbLiLsb
LsbLibLsLsmbLsLsmbRsbRgbRsbRibRibLsbRibLsbLsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bRsLsRsbLsRsbLsbLsbLsbLsbLgbRsbLsbLsbLsbLsbRsbLsRsbsbLsbLgLsbRsbLgbRjb
LgbLgbRsbRjbLsbLgbLsbRgRsmbRjbLsRsbLjbLsbLgRsbRsbLsLgLsbRsRsmbLibLsbLs
bRsbLjbLsbLsbRsbLsbRsbLsbRjbLibLsbLsbLibRsbRsbRsbLsLsRsmbRjbLsbRsbLibR
gbLibRsbLgLsbRsbLgbLgbLsRjbRsbRgbLibLsbLgbLsRsbRjbsbLiRsbLsbLsbLgRsbRj
bLibRgRsmbLgbLgbLsbRgbLibLgbRgbLsbRgbRsbLsbLibLsbsbsbsbLgLsbRsbLibLsbL
gbRgbLibRgbLibRjbsbRsbLsbsbRgbRsLsRsbLjbRsbLgbRsbsbsbLibRsbLgLsbLsbLgb
LsbRsLsbLgbRjbLgbLibLibRsbRibLsbRgRibRgbLjLsmbRhbRibLsbLsRsbRsLsbRgbRi
LsbLiLsbLgbsbRgbLgbLgbLgbsbRiRsmbRsbLsbRgbsbRsbLhbRgbLsbLibLsbLgbLgbLg
LsRsbRjbRsbLgLsLsmbRjbLibRsRjbLibLsbLsbLgbLgbRsbLgbLsbLgbRjbRoLsbLobLi
bRsbLgLsbRgbLibRgbRsbRsbLsbLsbRsLsbRgbLgbLsbLgRsbLgbRjbLibLsbLsbRebLib
RjLsbLibLgbRgbLibLsbLsLsmbLibLsbRsRebRsLsbLgbLsLsmbRsbLibRgbLgbLgbLsbL
gbLsRsbLsLsmbLsbLsbLsbRsbRgbLibRjbRsbRjbLobLgbLsLsmbLsbLhbLsbLsbLgbLsb
LgLsbRgLsbRsbRsbLibLsbRsbRgbLibRjbRcbLjLsmbLgbLgbLgbLgbLsLsmbLsbRsbRsb
LgbLsLsmbLsbLsbRsbRgbsbLgbRsbLgLsbRsbLgRsbLgLsbLgbLsbLibLsbLsbRiRsRsLs
mmbLhbLgLsbRgbLibRjbsbLsbsbLsbLsbLgbLgbLgbLsbRjbRibRibLsbRibLjbLjbLibL
gbLgbLsbLsbRsbsbRsbLsbRsbLjbLsbRsbLsbLsbLsbLsLgbLsbLgbLsbLsbsbLsbsbLsb
sbRsRsmbRsbLsbLgbLsbLgbLsbsbLsbLsLsmbRsbRgbRiLsbRhbsbRhLsbLsbLjbLcb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bRhbRibLgbRebRjbLhbLjbRcbLhbLjbRjbRsbsbRsLsbRsLsbsbsbsbLsbsbLsbLjbRjbR
jbLsbLiLsbLgbRcbLsbLgbLsbRsLebLibLgbLsbRsLsbLgbRiRsmbLjbRsbRsbLibLgbRi
bRobRcbsbLsbLsbLibLsRsbRsbRhbLibRiRsmbLgLsbLsbRjbRgRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 25; Drug: Control Apo 0.5 然
bRsbRebRhbLsbRsbRgbRsbRibLsLsmbsbsbRiLsbRsbLjRsbLsRcbRsbRibRsbRibLgbRs
bLsbLsbLiLsbLibLcbLcbLsbLibRjbReRsmbLgbLsRibRibLgbRgbRiLsbRsbLgbRiRsmb
LgbRibLgbRhbLsbRsbRsbRibRsbRsbRgRsmbRsRsmbRsbsbRgbLjbRibRgbRsbRgbRsbRg
bRsbRsbRsbRsbRibLjbRibLsbRsRsmbRgbsbRgRsmbLgbLsbLjbLsbRsbRibRgRsLsmbLs
RsbRibRsbRsbRsbRgbRgbRgLsbRibLgLsbRibRgbRsbRsbRgbRsRgRsmbLsbRgbRsbLsbL
sbRsbRsbRgRsmbRsbRgbRgbRsRsmbRsbLsbLjbRhbRsbRgbRsbRgbRsbRgbLgRsbRsbRgb
LgbLjbRhbLsRsbRibRsbLgbRibLsbRgbRsRsmbRgbLjbRibRgbLibRsbLgbRsbRgbRgbRs
bRsbLsbRjbLgbLsbRgbLgbRsbRsbLjbRsbRsbRsbRgbRsbRsbRsbsbRsbRsbLgbLgbLsbR
sbLjbLgRsbRsbRsbRsRsmbRgbRsbRsRsmbRgRsLsmbRsbRsbsbRsRsmbsbsbRgbRsbRgbR
sbRsbRsbRsbRsbRsbRsbRgbRgRsmbRsbRsbRgbLjbRgRsmbRsbRsRsmbRsbRsRsmbsbLhb
RcbRibRsbLgbRsbRibRsbLsbLgbLgbRsRiRsmbRgRsmbLgRsbRibRsbRsbLcbRjbLcbLhL
sbLibLsbLibRgbRiRsmbRsbLgbRibLsbLgbLcLsmbLgbLgbRsbLgbRsbLgbLsbLgbLsbLg
bRjbRcbRcbLgbRgbRgRsmbRgRsmbRsbRsbLibLcbLcbLcbRsbRhRsmbLgbRsbRsbLibRsb
LgbRgbRebLjbRsbRibRsbRgbRgbRsbRgbRgbRsbRgbRsbRsbRgbRsbRjLsbRhbLjbRhbRi
bRsbRibLgRsbRgbLgRsbRsbLjbRibLgbLsRiRsmbRgbRsbRsRsmbRsbRsbRsbRsbRgbRib
RsbRgbLsbRcbRgbRsbRgbRgbLgRsbLjbRhbRsbLsbRiRsRsmmbRsbRgbLsbsbLsbLjbRsR
smbRibLjbRibRgbRsbRsRsmbRgbLsLsmbLsbLjbRibRiRsmbRgbRsbLjbRibLsRgbRgbLg
bRibRgbLsbLjbRgbRgbRgbRsbRgbRsbRgbRsbRsbRsbRsRsmbRgbRhbLgbRiRsmbRsRsmb
RgbRgbLebLgbRgbRgRsmbLgbRhbLjbRibRsbLjbRiRsmbRgbRsRsmbRgRsmbRsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 26; Drug: Control Apo 0.5 然
bRjbRsbLiRsbRibLgbRgbRibRsbLgbsbLsRsbsbLsbsbRibRcLsbRibRsbRgbRsbRiRsmb
LsbLsRsbRibRcbRibRibRgbRibRjLsbRibRcRsmbLsbRibRhbRgbRsbLgbRiLsbRsbRcbL
sRsbRgbRgbRibRsRsmbRgbRgLsbRiRsmbRiRsmbRibRibRibLgRsbRjbRsbRsbRgbRcRsm
bRhbRibRibRgbRsbLsLcb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 27; Drug: Control Apo 0.5 然
bLsbLgbLgLsbLsbLgbRsbLsbLsLgLsbRsbLgbRsbLsRsLsbLgbRsbLgRsbLgbLsbLgbLgb
LgbLgbLsbLsbLsbLsLsmbLgbLibLgLsbRibLibLibRibLsbLsbLibRsbLgbLsbLsbLgRsb
RsbLgbLsbLsbLgbLsbLsbLsbLsbLgbRsbLgbLibRsbLgbLsbLgLsbRgbLsbRsbLsbLgbRs
LsbLgLsbLsLsmbRsRsmbLsbLgbLsbLsbLsbLgbLgbLsLsmbLsbLgLsbLibLgbLgbRsRsmb
RsbLiLsbRsbLgbRsbLgbsbsbLsbsbLsbLgbLsbLsbLibLsbLgbRsbLgbLsbLsbLsbLgbLs
bRsbLibRgbLibLsbLjbLsbRsRsmbLgbRsbsbLsbLsbLsbLgbRsbLgbRgbLibRsbRsbRoRs
mbRjbRgbRgbRgbRjLsbRibLiLsbRgbRibRhbRgbRsbLibRgbRsbLsbRibRibRgRsmbRgbL
sbRsbRgbRgbRgbLjbLebLibLibLgbLibRsbLsbLgbRsbLgLsbRgbLibRibLibRsbLjbRsb
RsbLsbsbLgbRsbLiLsbRgbLibLgbLsbLsLsmbLsbLgbLgLsbLsbLgbLibRsbLibRgbLibR
gbLgLsbRgbLgbRgbLibsbsbLibRsbLgLsbLsbLsbLgbRsbLiLsbLibRsbRgbRsbLhLsbLi
bLibRgbLibLibRsbRsbLibRsbLibRsbLgbRsbLgbLgbLgbRsbRsbLsbLgbLsbLsbLgbRsb
RjLsbLsbLibLgbRibLibRsbLgbLsbLibRsLsbLsLsmbRsLsbLgbLsLsmbLibRsbLibLsbL
gbRsbsbLgbRsbLgLsbsbLgLsbRsbLsbLgbRsLsLsmbLgbRsbLgbLgRsbRsbLgbRsbLsbRj
bLcbLgbLsbLgbRsbLsbLsbLsbRsbLgbRgbLgLsbRgbLsbLgLsbRgbLgbRgLsbLgbLsbRsb
LgbLsbRsbLsbLsbLgbLsbLgbRsLsbLsbLsbLsbRsbLgbRgbLibRsbLjbLsbLgbRgbLibRg
bLsLsmbRgbLiLsbRsbsbLgbLsbLsbLgbLsbLgbRsLsbLsbLsbLsbRsbLgbLgbRjbRjbLeb
LiLsLsmbLgbRgbLibLsbLsbLgbRsbsbsbLsbLgbLgbLsbLgbRsbLibLsbLgbRsbLsbLgbL
sbLibLsbRjLsbLibsbRgbRsbLgbRsbLgbLsbLgbLsbLgbLsbLgbLsbLsbLsbLsbLsbRsbR
sbLsLgbLsbRsbLgbRsbLgbRsbLsbRsbLjbLsbLsbLsbLgbRsbLgbsbRsbLsbLsbLgbLgbL
sbRsbLgLsbRsbLsbLgbLgbRsbLsbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 28; Drug: Control Apo 0.5 然
bRsbRjRsmbRibRsLsbRibRgbsbLgLsbLhbRebLsRsbsbsbRgbLgLsbsbLibLibLsbLsbLs
RsbLsbLsLgbLsbLsbLgLsbLsbsbLgbRsbRsbRsbRsLibLiLsbRsbLsbLgbLsLsmbLcbLsb
LgbLsbLgbRjbRibRgbLibRibsbRsRsmbsbRgbRsRsRsmmbRsbLiLsbRibLibLibRibRibR
sbLgbRgbRsbRsbLibReb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 29; Drug: Control Apo 0.5 然
bLsbRsbRsLsbLjbLsbRsRsmbLgbLsbRsbLgbLgbLsbLsbLsbLsbLsbLsbLsbRcbRibRibR
ibLhbLgbLgbLsbRsbLgbLsbRsLsLsmbLsbLsbLsbLsLsmbLsbLsbLsRsbLsbLgbLsbLsbL
sbLsbRsbLgbLgbRsbRsbsbRjRhbRgbRgRsmbRibLhLsbRsbLgbLgbLsbsbLsbLsbLsbRsb
LjbLsLsmbRsbLsbLsbLsbsbLgbLsbLsLsmbLsbLgbLgbLgbRsbLgbRsRsmbLgbLgbsbLgb
LsbLsbRsbLsbRsLsbLsbLgbRsbsbLsLsmbRsbLgbLgbLsbLsbLgbRjbRjbRibLsLsmbRgb
LgbRgbRibRgbLgbLibRgbRgbLjbRcbLgbLgbsbRibLhbRibLiLsbLsbLjbLgbLgLsbLgLs
bLsbRsbLgbLsbLsbRsbLgbRsbLgbLgbLsbLsbLsbLgLsbLsbRgbLgbLsbLjbRsbLsRsbLs
bLsbLgLsbLsbLsRsbLibRjbRjbLjbLibLgbRgbLgbLgbLsbLsbLsbRcbRibLjbLjbRgbLi
bLgbLgRsbLsbLsbLgbLsbRgbLsbLjbLsLsmbLsLsmbLsbLsbLsRsbLsbLsbsbRsbLgbLgR
sbRsbLgbLsbLsbLgbRsbLgbLgbLgbLsbLsbLsbLgbLsbRsbLsbRsbLsbLgbLsbRgbLgbLs
bLsbLsbLgbLsLsmbRsbLgbLsbLsbLsbLsbLsbRjbRibRibLjbLibLgbLsbRsbLsLsmbLsb
LgbRsbLsbLsbLsbLsbLsbRjbRgbLcbRibLjbLsRsRsmbLsbLsbLsbsbLsbRsbRsbLgbLgb
LsbLsbLsbLsbLsbLsbLsbLsbLsbRgbRibRgbRgbRgbRsbRgbLjbLcbLgbLsbRgbLgbLgbL
gbLsbLsbRgbLjbLsbLjbLsbLsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLs
LsmbRsLsbRibRcbLjbLgbsbLgbRsbLsLsmbLsLsmbLsRsbLsbLjbRcbsbRibLjbRibLgbR
ibRcbRcbRjbsbLibLibLibRgbLgbLgbLgbRibRgRsmbRgbRgbRgbRibRibRgbLsbLgbRgb
RgbLgbLgbLgbLsbLgbLsbLsbLsbLjbLsbLsbLjbsbLsLsmbsbLsbLsbLsLsmbLgbLsbLsL
smbLgbLgbLgbLgbRsbRgbRibLjbLibLibLgbRgbLsbLsbLgLsbLsbLjbLsbLsbLsbLsLsm
bLjbsbLsLsmbLsbsbRsbLgbRsbLgbLsbLgbRibLgbLgbLsbRibLibLgbLgbLsbRgbRsbLg
bLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 30; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bLsRsbRsRgbLsbRgbLsbLsbRibRsbRsbLsbRibRibLibRhRsLsmbLsbRiLsbRsbLsRsbRh
bLsbRsbRgbRsRsmbRgRsmbRsbRibRsbRgRsmbRsbRiRsRsmmbRsbsbsbRgRsmbLgbRgbRs
bRsbRsbRsbRsRsmbLgbRgbLsbRiRsmbLgbRsbRibRibRsbLjbRibRhbRsbsbRgbLsbRsbR
ibLsbLsbRibRibRsRsmbRsbRibRjbLibRibRsbRsbRgbRsbRgbRsbLsbLsLsmbRibRsbLs
RsbLsbsbLgbRsbRgbRsbLgbRsbRiRsmbLsRsbLsbRiRsmbRsbRsbLsbRgbRsbRsbRsbRiR
smbLgbLsbRiRsmbLsbLsbLsbRgbRsbLsRibRsLsbRsbRsLsbLsbRgbRsRsmbRsbRsbRsbR
gbRsbLsbRsbRiRsmbRsLsbLsbLgbLsbRibRgbRsRsmbRgRsmbRsbRsbLibLsbLcbLibLsL
smbRsbLibRsbLsbRgRsmbRsbsbRibRhbRsbLjLsmbRibLsRsbLibRibRiLsbRsbRsbLjbL
ebLibLsbsbLgbRibRcbRibRsRsmbLjLsmbRcbRsbRsRsmbRsbRgbRcbRsbLsbRibLsbLsb
RgbRibLibRibLsbRhbRsbRsbLgbLibLgbLgbLsbLibRsbLgbLibLebLeLsbLsbRsbRgbsb
Lob

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bsbLsbLsbLjbLsLsmbsbLsbLsbsbLsbLibLsbRsbLibLsbsbLgbLgbLsbRsbLibLgLsbLs
bLiLsbLsbRsbLsbLibLsbLsLgLsbLgbLgLsbLsbLiLsbLsbRgbLsbLiLsbLsbLgbLhbLiL
sbLsbLsbLgbLsbLsbLibRsbLgbsbLsbLgbRsbLibRsLsbLgbLgLsbLsbLgLsbLgbRgbLgb
LgbLgbRsbRsbLiRsLsbLsRsLsbLgbRsLsbLibRsbLgbLibRsLsbLsLsmbRjbLhbLibRibL
sLsmbLsbLgbLsbLgbRjbLsLibLgLsbLsbLsbLsbLibLgbRsbLibLgbLsbsbRibLsLsmbLg
bLjbsbLsLsmbLgbRsLsbRobLsbRsLgbLgbRgbLsLsmbLsbLibLsbRgbLgLsRsbLsbLgLsb
LsbLgbsbLsbLgbRsbLgbLsLsmbLgbLgbLsbLsbLgbLgbRgLsbLsbLsLsmbLgbLsbLsLsmb
LsbLgbLsbLgbLsbLsbsbLsbLgbLgLsLsmbLsLsmbLgbLsbLsbLgbRsbLiLsbLsbRgLsbLs
bLibLsbLsLsmbRgbLjbLsLsmbRsRsmbLgbRsLsbLjbLsLsRsmbLgbLgbLsbLgbLsbLgbLs
LsmbLsLsmbLgRsbLcLsmbLcbLibLgbRsbLsbRsbLiLsbRsbLsbLsLsmbLgLsbLsbLgbsbR
sbLgbLsbLsLsLsRsmmbLgbLsbLsLsmbLgbLiLsbRibLsbLgbLsbLsbLsbLiRsbLsbLsLsm
bLgbLgbRsbLsbLgbLsLsmbLsLsmbLgbLsbLgLsbLgbLibRgbLsbLsbLgbLsbLgbLgbRsbL
iLsbLsbLsLsmbLgbLsbLgLsbLsbLsbLgbLsbLgbLsbLgbLsLsLsmmbLsbLgbLgbRsbLgLs
RsbLgRsbLgLsbLgbLgbLgbLsbLgbLgbLgbLsLsmbLgbLgbLsLsmbRsLsbLibLgLsbRsbLg
bLsbLsbLgbLgLsbLgLsLsmbLsLsmbLgbRsbLsbLibRsLsLsmbLgbLgbRsbLgbRsbLsRsbL
gLsbLsbLsbLgLsLsmbLsbLgbLgbLibLsbLsbRgbLibRgbLiLsbLgbRsbLgbLsLsmbLgbLs
bLgbLsbLsbLgbLgLsbLsbRsLsbLsLsmbLgbLgbLsLsmbLgbsbLsbLgLsRsbLsLsmbLgbLs
LsmbLsbLgLsbLsLsmbRsLsbLgLsbLgbRsbLgbLsbRsLsbLibLsbLsbLibRsbLsbLgLsbLg
bRgbLiLsbLgbLsbLgLsbRsbRsbLsbLibLsbLsbLsbLgbLgbLgbLsbLgbLgbLsbRgbLsbLs
bLgbLsbLsbLgbLsLsmbLgLsbLsbRgbLibRsbLsbLgbLgbLsbLgbLgbLsLsmbRsbLiLsLsm
bRsbLgLsbLsLsmbLsbLsbLgbLgLsbRgbLibLsLsmbRsbLsRsbLgbLgbLsbRsbLgRsbLsLs
mbLgbLsbRsbRsbLgLsbLsLsmbLibLsbRgbLibRsLgbLgbRsbLgbLsbLgLsbLsbRsbLgLsb
LsLsLsmmbRsLsbLgbLsLsmbLsbRsbRsbLsbLgLsRsbLsbsbLsbLsbLsbLsbLgbLsbLibRs
bLsbLsbLiLsRsbRgbLgbLgbLsbLgbLsbLgbLsbLgLsbsbLsbLsbLgbLgbLsbRsbLgbLsbL
sbLgbLgbLgbLgLsLsmbRibsbLhbLiLsbRgbLsbLibLsbLiLsbRsLsbLsbLibRsbLgbRsbL
gRsRsmbLsRsbLgbLsLsmbRgLsbLiLsbLgbRsLsbLgbLgbRgbLsbLgbLgbLsbLsLsmbLgLs
RsbLsbLgLobLsbLsLsmbLgbLsbLsbLgbLsbLgbLgbLsbLibRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bRjbRibLjbLjbsbLjbLjLsmbLjbLjbLjLsmbRjbLibLjbRcbRebRjRsmbRgbLibLjbLjbL
jLgbLjLsmbLjbRibLjLsmbLjLgLsbLjLsmbLebLjbLjbLjbRjbRjbLjbLgbRebRjbRibLj
bRiRsmbLcLsmbRjRsmbRibLjLsmbLjLsmbLcbLsLjbRsbLjbLjLsmbLjLsmbLjLsmbLjLs
mbRjbLhLsbLjbLjbRjRsmbLgbLibRjbLjLsmbLjLgbLibLhbRjRsmbLjLsmbLjLsmbRibR
jbLsRjbRjbRjRsmbLjLsmbLjbRjbRibRjRsmbLibRjbRibRgbRjbRibLjLsmbRjbRjbRcR
smbRjRsmbRgbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bLsbRsbRsbLsbRsbRsbRsRsmbRsbRsLsLsmbLjbRjRsRsmmbRsbsbRgbRgbRsbLsbLsLsm
bLsbRibLsbRgbRsRsmbRsbLjLsmbRsbRiRsmbsbLsRsbLsbRgbRsbRgbRsRsmbRsRsmbLg
bLsRsbRiRsmbRsbLsRsbRsbLsbRsbLgbRibRsbRgbRsbRsbRsRsmbRsRsRsmmbRgbRsbRg
bRsRsmbLgbRibRsbLsbLsbRgbRgbRgbRsbRsbLsbLsbLsbRibLsRsbRsbRiRsmbRsbRsbR
sbLsbRsbRsbRibLsRsbLsbRgRsmbRsbRsbRgbLsRsbRsbRsbRsRsmbRgbRsbRgbRsbRsbL
sbLsbRgbLsbRsbLsbLsbRsbRgbRsbLsRsbRsRsRsmmbLsbRgbRsbRsbRsbLsbRgbRsRsmb
RgbRgbRgRsmbRsbLsbLsbLsbRsbRsRsmbRsbRgbRsbRsbRsbRsRsmbLsbLsbRibRsbRibR
sbRsbLibRgbRibRsbRsbLsbRgbRgbRgbLsRsbLsbRgbRsRsmbRgRsmbRgbRgRsRsRsmmmb
RsRsmbRsbLsbRsbRibRsRsmbRsbRsbRgbLgbRgbRgbRgbRsbRgbRsbRsbLsbRsbRgRsmbR
sbRsbRsRsmbRsbRsbRsbRsbRsbRsbLsbLsbsbRsbRgbRsbRsbRsbRgbRsbRsbLsbRgRsmb
RsbRsbRsbLsRsLsbLsbLsbRsbRsbRibRgbRsbRsRsmbRsRsmbRgbRsbRsbLsbLsbRgbLsR
sbRsbRgbRgbRsRsmbRsbLsRsbRsbRsRsmbRgbRsbRsbRsbRsbRsbLsbRgRsmbRsbRsbRgb
LsbRsbRgbRsbLsbLsbRsbRsRsmbRsbRsRiRsmbLsbRgRsmbRsbLsbRibRgbRsbRsbRsRsm
bRsbRsbRgbLsbRibRsbLsbLsbRgbRsRsmbRsbsbRgbRsRsmbLsbLsbRsRsmbRgbLsbRsbR
gRsmbLsbLgbRsbRjRsmbRsbLsbLsbRibRsbLsbLsLsmbRgbRsbRsbLsLsmbLsbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bLgbLsbLsbLgbRsbRsRsmbLgbLsbLgbLsLsmbLgbRibRsLsbLcLsmbRsbRcbRsRsmbRsbR
cbLibLgbLcbLgbRjLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bRgbLsbsbLsbRsRsmbRsbRsbRjRsmbLjbRsbRgbRibLgbRsbRsbRsbRsbRsbRsbRgbLibL
gbLgbRjbLgbLibLhbLgbRebLsbLgLsbRsbRjbLibRsbRsbLibRsbRjbLhbLibLgbRsbLib
RgLsbLibRjbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bRsLsbLsLsmbRsbRsRsmbRsbRgbLsRsbRgbLsbLsRsbLsLsRsmbRgbRgbRsbRsbRsbRsbR
sbLsbsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bRgbRibLjbRibLjbLibRgbLibLsbLsLsmbLsbRsbLgbLibRsbLgbLsbRgbRgbLibRsbLib
LibRsbRsRsmbLibLsbRsbLgbLgbRjbRjbLibLsbLiLsbLsbRgbLgLsbLgbLgbLsbLgbRgb
RsbLhbLgbRsbLgLsbRsbLiLsbRibLibLibLsbLsLsmbRgbLgbRgbLsbLgbLsbRgbLsbLsb
LjLgbRibRibLgbRgbLsbRibLsbRsbRibLgbRibLjbRibRibRibRcbLcbLibRsbRgbRibRi
bRgbLibLib

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bLsbLjbRhRsmbRibRgbLsbRiLsbLsbLebLhLsbLsbRsbLsbRjbLebLsbRjbLibLsbLibRs
bRsbRgbLiLsLsmbLsbRsbLgLsbLsLsmbLsbLsbLgbLsbLsbLsbLsbLgbRjbLhbLsbLgbLs
bRsLsbRjbLibLsbLgbLsbLsbLgbLsbLsbLsbLsLsmbLsbLibLsbRsbRsbsbLibLgbLsLsm
bLgbLsLsmbLsbLsbLsbLiLsbLsLsmbLsbLsbLiLsbLsLsmbLsbLsbRgRsmbLcbLibLsbRj
bLsbLibLgLsbLsRsbRsbLiLsbLsbLgLsbLsbLsbLsbLgbLibLsbRibLsLsmbLibLsbLsbL
ibLibLsbLsbLiLsbLsbRgLsbLeLsbLibLsbLsLsmbLsbLiLsbLsbLhbLsLibRgbLsbLgbL
ebLiLsbLsbLsbLgbLsbLsbLsbLsbLibLgbLsbLsbLsbLjbLsbRsRsRsmmbRgbRjbLcbLsb
LgbLiLsbLhbLsbRibLgbRsbRgbRiRsmbRsbRibRsbRsbRgbLsbRibLsRsbRibRsbLsbRhb
RsbLsRsbRibRsRsmbRebLsbsbLsbRgRsmbRibRsbRibRibRsRsmbRibLsbLibLgbRibLib
LcLsLsmmbLsLsmbLsbRibLibLsbLsbLsbLibRsbRsbLsbLgLsbRsbRgbLsbLibLsbLgLsb
LsLsmbRgbRjbLcbLsbLgbLsbRgbLsbLgbLgbLsbLgLsbLsbRibRibLibLcLsmbRibLibLs
bLsbLiLsbLsbRsbLibLsbRsbLibLcbLibRgbRibLsbRibRibLsbRsbRsbRibLsbLsbLibL
ebRibLebRsbRsbRsbLibLsRsbLsbRsbLsbLiLsbLsbLsbRsbLgLsbLsbLibLsbRiLsbLcL
smbRjbLsbLsbLcbLsbRsLsRsbRsLsRsbLibLsbLsbRsbLcLsmbLsbLjbLiLsbRsbLsbRgb
RsbRsbRibLsbLebLsbLiLsbLgbLsbLsLsmbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bsbRgbRgbRgbRgbLgbRjRsmbLjLsmbRsbRcbLjbRcbRjbLjLsmbLibLgbRibLhLsbRgbRi
bRibRsbRibRhbRebLsbRibRsbRgbRibRgRgRgRsRgmbRgRsmbRsbRsbRgbRsRebRsbRgbR
ibLjbRebLhbRcbLgbRibRgbRgbRgbLsRsbRsbRsRsmbRsbRsbRsbRgbRsbRsbRsbRsbRgb
RgbRsbRsbRsbRsbRsbRgbLjbRibRibLibRgbLibRibRibLibLsbLgbRjbRibLibRgbRgbR
sbRsbRsbRsRsmbRsbRgbRgRsmbLsbRibRsbRgbLsbRsRsmbRsbLsRsRsmbRsbRsbLsbLjb
LgbRjbRjbRjRsmbLgbLjbRibRhbLibRibRsbLhLsbLhbLcbLsbRebRiRsmbRibLsRsbLsb
RsbRsRgRsmbRsLsbRgRsRsmmbRgbRgbLsbRsbRsbRsbRgbRsRsmbRgbRgbRsRsRsmmbRgb
RsRsmbRsbRsbLjbRibLhbRibLsRibLgbRsRgbRgRsmbRsbRsbRgbRsbRsbRsRsmbRsbRsb
sbRjRsmbRgRgbRsbRsRgRsmbRgbRsbRsbRsRsRgmbRgbRsLsbRsbRgbLjbRsbRhbLcbLhb
LibRhRsmbRhbRibLsbLsRsbRgbRgRsmbRgRiRsmbRgRsRsmmbRiRsRgmbRgRsmbRsbRgbR
sRsRgRsmmbRgRsmbRibLsRsbLsbRgbRsbRsbRsRsmbRsbRsRsmbRgRiRgRsRgRsRsmmmbR
gRsmbRiRsmbRgbRgbRiRsRgRsRgRgRsmmmbRgbLsbRibLjbRibLjLsmbLebLibRjRsmbRc
bRhbLibRibLhbRibRibRibRhbRhRsmbLsRsbRibLsbRgbRsRsmbRiRgRsRsRgRsRsRsRsR
sRsmmmmmmmmbRgRsLsmbRsbRsbRgbRsbRsbRsbLsbRsbRgbRgRsmbRsRsmbRgRgRibRsRg
LsbRgRsRgmbRsRsmbRgbRibLjbRibRsbRgbLsbRsbRsbRgbRgRsmbRgRgRgRiRiRgbRgRs
mbRsbRsbRgbLgbRjbLjbRhRsmbLhbRibRibLibLjbLibLcbLhbLibLibLsbLibRjbRcbRi
bLgbLibRcRsmbLibLjbLibLibLgbRsbLibLibLgLsbRiRsmbRibRgbRsbRgbLsbRhbLsbR
sbRgbRgRsmbRsRsmbRsbRsbRsRsmbRsbRsbRsbRsbRsbLsbRgbRsbRgRsmbRgRsmbRsRsm
bRgbLjLsmbRsRobRgbLibLibLjbLibLgbLsbLsbRgbLjbRsbLgbLgbLgRsbLibLsbLgbRs
bLjbRsbLgbRsbRjRsmbRjbLgbRibLsbLgbLgLsbRhbRibLgbLgbRibLgbLsbRibRsbRgbR
sbRsbRsbRsbRsbRsbRibLibRiRsmbLsbRsbRgbRsRsmbRsbRsbRsbRsbRgbRsbLsRsbRsb
RsRsmbRsRsmbRsbRsbRsbRsbRsRsmbRsbRgbLsRsbRgbLjbRgbLjbRgbRgRsmbLsRsbRsb
RgLsbRsbRsbRsbsbRsbRgRsmbRgbLibRgbRibRsbRgLsbRgbLgbRgbRgbRsbRgbRsbRsbR
sbRsbRgbLibRjbLjbRcbLgbRgbLsRgbRgbLjbRcRsLsmbLibLjbLgbLgbLsRsbLgbLgbLg
bLsbLgbLgbLibRgbLsbRgbRgRsmbRgbLsbRgbRgbRsbLsRsbRgbRsbRsbRsbRsbRsLsbRs
bRsbRgRgRgbLcLsLsmmbLjbLibLgbLgbLgbLgbLgbLsbLsbLsbLgbRsbRsbLgbLgbLsbLg
bLgRsbLsbLsbRgbLgbLgbLsbLgbLgbLgbLsbRgbLsbRibRgbLibRibRib

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bRsbLgbLgbLsbRsbRgbRibRibLsbRibLsbRgbRsbLsbRgbLsbLsbRgbLibRiRsmbLjbRib
LsbRibRsRsmbRsRsmbRgLsLsmbsbRsbLiRsbRgRsmbLsbLsbRibRsbRgbRgbRibLjbLsbR
sRsmbRiRsmbRsbsbRgLsbLsbRibRgbRgbRsLsbLsbLgbRsbRgbRgbLgbRsRsmbRibRsRsm
bRsbLsRsbLsbLgbRjbRjbRibRsbRhbLiLsbLsbLgbLsbLsbRgbRibRgbLsLsmbRsbRibRs
bLsbLsLsmbRgbRibLgbRibRgbLibRibRsbRgbRgbsbRibRgRsmbRsbLgbLsbRibRgbRsbR
sbRsbRsbLsbRgbsbRsbRibRgRsmbLsbRibRsbRgRsLsmbRibLibRib

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bRgRsmbRsbLsbRsbRiRsmbLgbRibLsbRsLsbRgbRgRsmbRsbLsbRsbRsRsmbLsbLsbLgbR
sbRgbLsbRibRsbRgbRgbLjbRibRsbRibRgbRsbRgbRgbLgbRgLsbLsbRsbRsbRibLgbLsR
iRsmbRgbRgbRgRsmbRsbRsbRgbRsbLsbRibLsbRsbRsbsbLsbRibRgbRhbLibRiRsmbRgb
LsbRgbRgbLgbRibLsbRgbRsbRgbsbLsbRsbRgbRsbLsbLsbRgbLgRsbRjbsbLsRsbRgbLg
bRibLgLsbRgbRibRgbLibRibRgbLibRibRgbLsbsbLsbRgbLsbRsbRgRsmbRgRsmbLgbRg
bRgbRsbLsbRgbRsbRgRsmbRibRsbRsbRsbRgRsmbLsbRgbRsbLsLsLsmmbRibLgRsbRibR
sbRsbRsbRgLsbRsbRibLibRhbLibRibRibLgbRsbRibRgbRsbLsbLsbRgbLsLsmbRgbsbR
sbRsbRgbRgbLgbRibLsbLsbRsRsmbRiLsRsbRsbsbRjbRsLsbRsbLsbLsbRsLsbRsRsmbs
bLsbRibRsbRgbRgRsmbLsbLsbRgRsmbRjLsbLibRsbRibRsbLsbRsbRgbRsbRsbRsRsRsm
mbRsbRgbLgLsbRiRsmbLjbRibRgbRgbLsbLjLjbLibRcbRcbRibLcbLsbRcbRcbRsbRibL
hbRiRsmbRcbLibRgbRibLjbLsRibLgbLsRsbsbRsbRsbRgRsmbRsRsmbRsbRgbRgRsmbRs
bLsbRsbRibRsbLsbRjLsbLibLjbLibLibRgbRibRcbRgRsmbRsbLgbRgRsmbRgbRgbLsbR
ibRgbLsbRgRsmbLgbRibRgbLgLsbRibLjbRibRibLgbRibRsbLsbRibRibLsbRibLsRibL
gbRibRgbLibLgbLibRjbLibRcbRcbLsbRgbRgbLjbRiRsmbLjbRibLjbRgbRsbRgbRsbLg
bLsLibLibRjbLibRcbRobRiRsRsmmbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bLgLsbRsRsmbLsLsmbLgbLgbRsbLgbRgbLiLsbRsbRibLsbRiRsmbLsbLsLsmbLgbReRcR
smbRcbLgbLgbRgbLcbLgbLgbLsRibLcbLibLgbRsbLgLsbRoRsmbRgbRgRsmbLgbRsRsLs
mbRiRsmbLiLsbRcRsmbLgbRiRsmbRibLsbRsbLsbRgbRibRibLgbRiLsbLsLsmbRibRgbR
gbLibLjbLcbLgbRsbRibLjbRibRibLsRibLgbRibLgRsbRiLsbLgbLiLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bsbLsbLsbRgLsbRsbRsbRsbRsbLsbRsbRsbRsbRsbRsRsmbLsbRgbLsbLsRsbRibRgbRsb
RsbLsbRgbLsbRsbRgbRgbRsbRsbLsbRsRsmbRgbRsbRgbRsbRsbRsbRsRsmbRgbRsbRgbR
sbRsbRgbRsbRgbRsbRsbRsbRsbRsbRsbRsbLsbRiRsmbRsbRgbLgbLgbLsbLibLibLsbRs
bLgRsbRsbLgbRsbRsbLgbRjRsRhmbRibRsbRgbRsbRsRsmbLsbRgbRsbRgRsmbRsbLsbRg
bRsbRsbRsbRgbRsbRsbRsbRsLsbRsbRsbRsRsmbRsbRsbRgbRgLsbLsbLsbRjbsbRgbLsb
RsbRsRsmbRsRsmbLiLsbRjbRsbRsbRsbLsbRgbRsbRsbRsRsmbRgbLgbRsbLsbsbsbRgRs
mbRsbRsbRgbRgbLibRgRsmbLjbLibRcbRgRsmbRsRsRsmmbRgbLgbLsbRsbRgbRsbRsbRs
bRsbRsbRsbRgbRsbLcLsRsmbLgbLgbLgbRsLgbLibRibRsbLibLgbRsbLsbLsbLsbRsbRs
bLgbLsbLcbRjbLibLibLsbLsbLsbLgbRgbLsbRsbRsbRgbRhbLsbLgbLsbRgbRgbRsbLsb
LsbRgbRsbRsbLsbLsbRgRsRsmmbRsbRsbRgbLsRsbRgLsbRsbRsbRsbRsbRsbRsRsmbRsb
RsbRsbRsbRsbRsbRsbRibLgbRsbRgbRsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bRsbRhRsmbRsbRgbLsRsbLsbRgbLibLibLhbRsLsbRgbRsbLibLiLsbLsLsRsmbRsbLsRs
bLcbLsbsbLsbLgbLsbLsRsbLgbLibLgbLsbLibLgbLsbRgRsmbLcbLcbRsbLsbRsbLibLi
bLsbLsbLsbRsbLibLsbLiLsbLgbRgbLibLsbLgbLgbLsbLibRsbLgbLgbLibRgLsbRibLi
bLgbLgbLgLsbRibLgbLibLsbLibLgbLibLsbLsLsmbRsbLjLsmbLjLsmbLsLsmbLgbLsbR
ibLsbRibLjbLsbLgbLgbLibLsbRsRsmbRsbLgbLsbLsbLiLsbRgbLgbLibLibLgbRsRsmb
LgbRibRgbLibLiLsRsbLibLsbLibLgLsbLibLsbLgbLsLsmbLibLgbLibRgbLhbLsbRibL
ibLsbLgbLsbRgbRsbLsbLibLgbLsbLibLgRsbLsbLgbRiRsmbLsbLgbLibLibLsbRjbLhb
LgbLiLsbLibLibLsbLgbLiLsbsbLsbLibRsbLsbLiLsbLsbsbRsbRsbLgbLgbLibLgbLgb
RsbRsbLgbLgbLsbRsbLibLgLsbRgRsmbLgbLibLgbRjbLsbLibLsbRibLgbLgbLgLsbLib
LsLsmbLgbLsbLsbLsbLibLgLsbLibRibRsbsbRibRgRsmbRjbRibLsLsRsmbLgLsbLsbLg
bLsbLhbRjbLhbLgLsbLsbLgbRsRsmbLgbLgbLgLsbLibLgbLsbRsbLsRsbRibLibRcLsbL
ibLsbRcbLjLsmbRibRgRsmbLsbRsbLibRibLjLsmbRjRsmbRsRgbLsbLsbRibRibLsbLsb
LsbRsbRgbLibLjbRsbsbLibLsbRgbLibLgbLsbsbRjRsmbRjRsmbLjbLibLgbLibLsbRgb
LjbLsbRsRsmbRcbRgbRsbLsbRsbRhRsmbLgbLgbRcbRhbRgbLgbRsbLsbRgbRibRibLsbL
sbRibRsbLgbLjbLcbLibRsbLsbRsbRgRsmbLjbLjbLsbRsRsmbsbLgbLsbLibLibLsbLib
LsbLgbRibRgbLsLsmbLgbLsbLiLsbLibLgbLsbRgbsbLibLsbLsbRsbLsbRgbRgbRgbRiR
smbRhLsRsbsbLsLsmbRsbLgbLsbRsRsmbRcbLsbRiRsmbsbLsbRibLgbRibRsbRsbsbRib
RibRsbRsbRiRsmbLsbLsbLgbLgbLibRgbRjRsmbLiLsbLibLsLsmbLibRgbsbRgbLibRib
LcbLibLsbLgLsbRgbLibRgbRsbLsbRgbLibLibRsbRibLibLsbLgbRsbRibLgbRsbRgbLh
bLiLsbLibLsbLsbLjLsmbLsLsmbLsbLibsbRgbLsLsmbLibLibRgbLibLgbRsbLgbRsbRg
bRjbLibRgbsbRgbLjLsmbLgbRcLsbRibRsbRsbLgbLjLsmbRsbLibLsbLgLsbLgbLgbRgb
LjLsmbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bLibsbsbsbRjbLsbRhbLjbLiLsbRcbRsbLjbRibLsLgbLjbRsbLibsbRhRsmbRsbLsbLib
LgbRjbLsRcbRsRsmbRibRibLgbRgbLsRsRsmbLsbRjbRjbRibLsbLgbRgbRgRsmbRgRsmb
RiRsmbRgbLjLsLsmmbLgbLgbRibLsbRgbLgbRibLgbRibLjLsmbRibLjbLjbRgbRibLsbs
bLsbRibLjbsbRgbRsbRgLsbsbRsbRgbLsbRibLgbLibLsbLsRsbsbsbLsbLsLsmbRjbRib
RjbLjbRibRsbLgbRibLsbLsbRgbLjLsmbRsbRsbRgbLgbLsbRsbRsRsmbRgLsbLsbRiRsm
bLgRsbRgbRsbLjbRgbLsbRsLsLsmbRsbLjbRhbLjbLjbRjRsmbRjRsmbLibLsRjLsRsbLs
RsbLjbRibLsbsbsbsbsbRibLsbLjbRibLjbsbLsbRibRgbLibRibRgbRsbLjbRgbRsbLsb
LjbRsbRjbRhbLjbsbsbRgRsmbLsLsmbRsbRsRsmbRcbRjLsbLiLsbRgbRsbRsbRsbLjbLj
bRibRgLsLsLsLsmmmbLebLcbRibRibRibRibRibLib

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bLgbLgbLsbRsbLgbLsbLsbLsbLgbLgbLsbRsbLgbLsLsmbRsbLgbLgbLsbRcbRibRiRsmb
RsbRgRsmbLjbRsbRgbRgbLsbRibRobRhbRibRibRgbRsbRgbRsLsbRibRgbLjbLjbLibLg
bLibRgbLibLgLsbLgbLsLsmbLgbLsLsmbLgRsbLgLsbLsbLgbLgbLsbLsbRsbLgLsbLsbL
sbLgbLsLsmbLgbLsRsbLgbRsbLsLsmbLgbLsbLgbLsbLgbLgLsbRgbLgbLgbLgbLsLsmbL
sbLsbLgbLsLsmbLgbLgLsLsmbLsLsmbLgbRjbRcbRibLgbRibLsbRsbRjLsbRobRjbLgbL
ibLsbLgbRgbLgbLsbLgbLgbLsbLsbLsbRsbLiLsbLibLsbLgbLgbLsLsmbLsLsmbLgbLgL
sbLsLsmbLgLsbLgLsbLsbLsbLgbLgbLgbLsLsmbLgLsbLsbLsbLgbLgbLgRsbLgLsbLgbL
gbLgbLiLsbLsbRsbLgbLgLsbLsLsmbLgbLgLsbLgbLgbLgbRsbRjbLhLsbRibRjbRibLcb
LibLsbLgbLgbLsbLsbLsbLsbLgbLsLsmbLsLsmbLgbLgbLgbLsLsmbLgLsbLsLsmbLsbLs
bLibRiRsmbLiLsbLgbRsRsmbLibRgbLgLsbLgbLsbLsbLgbLgLsbLgbRsbLgbLgRsbLgbL
gbRgRsmbLiRgRsmbLiRsbLgbLgbLgbRsbLgbRjbRhbRgbRsbRgbLsbRibLibLjbLibLgbR
sbLgbLsbLsbLgbLsbLsLsmbLgbLsbLsLsmbLgbLgbRsbLibRgbLibRgbLgbLgbLgbRjRsm
bLibLgbLsbLgbRsLsbLibRjbLibRiRsmbRjbRibLsLsmbRgbRsRsmbRsbRgbRgbRsbLibL
ibRsbLgbLsRsbLgbLsbLgbLgbLgLsbLsLsmbLgLsbLsRsbLgbLsLsmbLgbLgLsbLgbRjbL
ibRsbLgbLgLsbLsbLsbLsLsmbLsbLgbLsbLgLsbLgbLsLsmbLsbLsbLgLsbLsLsmbRgLsb
LibRjbRsbLibLgbLsbLgbLsbLgbRsbLsbLgbLsbRsLsbLgbLgbLgLsbLsbLgLsRsbLgbLs
bLgbRgbLgbRjbLibRcbRibLsbRgLsbRsbRibRsbRgbLjbLhbLgbLgbLgbLsbLgbRjbRibR
sbRgbRsbRgbLsbRibLjbRgbRiRsmbRibLjbLcbLsbLgbLgbLgbLsbLsbLsbLgbLsbRsbLg
LsbLgbLgbLsbRsLgbLgLsbLsbRsbLgbLgbLgbRsbLgbRsbLsbLgbLsLsmbLsbLgLsbLsbL
gLsbLsRsbLsbLgLsbLsbLgbLsbLgbRsbLibRjbLibLgbLgbRsbLsbLgbRsLsLsmbLgbRcb
RcbRsbRibLsbRibRsbRibLsbRibLjbRibLibLcLsmbLgbLgbLsbLsbRgbLgLsLsmbLsbLg
LsbLgLsLsmbLgRsbLsbLiLsbLsLsmbLgLsbLsbLsbLgbRsbRcbRgbRsbRgbLgbRsbRgbRg
bLgbLcbLibLsbLibRgbLgbLgbLsbLgbLsLsmbLgbRgbLgbLsbLgbLgLsbLsRsbLsbLgLsb
LibLsRsbLsbLgLsbLsLsmbLgbLsbRsbLgLsLsmbRsbLgbLsRsbLgRsbLgbLgbLsbLgbLsb
LgbLgbLgLsbRsbLgbLibRibRjLsbRibRgbRsbRgbRsbRgbRgbLcRsbLibLsbLgbRsbLsbL
sbLsLsmbLsLsmbLsbLgbLgbLgbLgbLgbRsbLsLsmbRsRsmbLsbsbLibRjbLibRsbLibLsb
LibRjRsmbLibLsRsbLgbLgbLsLsmbLgbLsbLsbLgbRjbLibRjbLibRibLibLgbLsbLgbRs
LgLsbLgbLsLsmbLsbLgbLsbLgbLgbRsbLiLsRsLsbRcbRgbRsbRgbLsbRgbLcbLibLsbLg
LsbLsbLsbLsbLgbLsLsmbLgbLgLsbLgbLgbLgbRsbLgbLgbLgbRsbLgbRsLsLib

>ZF Recording 2016-03-21; tW: 300s; Start: 130014; End: 130514;
Recording: 12-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bRsRsRgmbRsbRgReRsmbRgbRgbRgbRgbRgRsmbRgbRsbRgRsmbRgRsRgRsmmbRgRgRsRsR
gmmbRgRgRsmbRsbRgbRgbRgRsRgmbRsRsRgRsLsmmbRgbRgbRiRsmbRgbRgRsmbRibRgbR
gbLgRsbRgbLgbRiRsmbLsbRgbRsRsmbLsbRsRgRsmbRgRsLsmbRgRgbRgbRgRsmbRgRsmb
RsbRgRsmbRgRgRgRsRiRsRgRsRgRimmmbRgbRgbRsRsRgmbRsbRsbRsbRgbLgbLjbLibLg
bRcLsbRhbLgbRgRsmbRgbRsbRgbRgbRgbLsRsbRgbRgbRsbRiRiRsmbRgRsmbRgRsRgmbR
gRsmbRgRsmbRgbLjRsbRiRsmbRsRsmbRgRsmbRsRgRsRsRiRgmmbRgbRgbRgbRgbRiRsRg
mbRsbRgRsRiRimbRsbRgRgRsmbRgbRsbsbRgLsbRgRiRsRsRimmbRgRgbRgbRibRgbRsbR
sRsRgmbRgRsmbRgRgRiRgbRgRsmbRgRgRgbRsRsmbLsbRsRsmbRgRsmbRsRsmbRgRsmbRg
RsRgRgRgRsmmbRgbRsbLsbRgRsmbRgbRsbRiRsmbRgRsmbRgRgbRgRsRsRgRsmmmbRibRi
bLibRsbLjbLgbRcbRibRsRsmbRgbRgbRgRsmbRgbRgRsRgmbRibRsRsmbRsbRgLsbLsbRi
bRgRsRgRsRgmmbRibRgRgRsRsmmbRgRsRsRsRsmmmmbRgRsmbRsRsmbRsRsmbRsRgRsRsm
mbRgRsRgRsmmbRgbRgRgbRibRgbRsbRsRsmbRgRsRgRimbRgbRgRsRiRsRgmmbRgbRgbRs
RsmbRgbRgbRiRsmbRgRsRiRgmbRgbLjbRibRsbRsRsmbRsbRsRsmbRsRsRsmmbRgRsmbRg
RsRsRgRsLsRsmmmbRgbRgbRgbRgbLcbRhbRgRsmbRsbRgbRsRsmbRsbRgbRgRsRgRsmmbR
iRsRiRsmmbRgbRgbsbLsRsbRgRsRsmmbRgRsmbRgRsRgmbRgbRgbLsbRgbRgbLgbRiRsmb
RibLcbRibRsRsmbRjbRsbRsbRsbRgbLgbRiRsmbLjbRcbLiLsbRibRgRsmbRsbRgbRsbRg
RgRsmbLsRsbRsRsmbRgbRgRibRgRsmbRgbRsbRgRsmbRgbLjbRibRibLgbRibRsbRsRsmb
LsRsbRgbLsLsmbRiRsmbRsbRsbRgbRgRsmbRgbRsbRsbRgRsRsRiRsmmmbRgRsRsmmbRgR
smbRgbRsbRsbRgbRsRsRsmmbLsRibLsbRjbRgRsRsmmbRgbRgLsbRgbRgRsmbRiRgbRgRs
mbRsbRgbRsbRgRsmbRiRsmbRgRgRsmbRiRsmbRgbRsbRgRsRsmmbRgbRsbsbRsRsmbRgbR
sbRsbRsbRgbRgRsRiRsmmbRgbRgRsmbLjbRibRsbRibRsbRsbRgRsRiRiRimbRgbRgRsmb
RiRsRsRgRsmmmbRsbRsRsRgmbRgbRgLsbRgRsmbRgRsmbRgbRgRsmbRgRgbRsbRsRgRsmb
RgRsmbRgRsRsmmbRgbRgbRgbRibRgRsmbRgbRsbRgRsmbRjbRgbLsbRiRsmbRibRibLgRs
bLibLibRjbRcbRsbRibLsRsbRgbRsbRsbRgRgRsLsmbRgRsRiRgRsmmbRibRgbRgbLsbRi
RsmbRgbRsbRsRsmbRibRgbRgRsmbRgRgbRiRsmbRsRsmbRsbRgbLgbRibRiRsmbLhbRibR
gbRibRsbRsbRgbLsbRgRsmbLsbRibRgRsmbRgRgRiRsRsmmbRgbRgLsbsbRgRibRgbRgbR
sbRsbLsbRgRgRsmbRgLsbRiRsmbRgbRgbRsRgbRgbRgRsmbRsbRgbRgbRgRsmbRsbRsRsR
smmbRgRsLsmbRgRsRsmmbRgbsbRgbRgbLsbRiRsRgmbRgRsmbRibRgbRcbRibLibLibLgb
RhbRcbRsLgbRiRsmbRgbRsbRgRsmbLjbRibRsRsmbsbRsbReRgRsRsmmbRgRiRgbRgbRgb
RgbRgbLsbRgbsbsbRsLsbRjbLsbsbLgbRibRgbRgbRgbRsbRgbRgbRibRibLsLibRgRiRs
mbRsRsmbRgbRgRgRsmbRiRsmbRgRgbRgbRsRgbRsbRsRsmbRgbRgRsmbRgbRgbRgRsmbRi
bRgbRgbLjRsbRibRibLhbRobRgbRgbRibLhbRhbRsbLibRibLgbLiLsbLgbRcRsmbRiRsm
bRsbLsbRgRsmbRgbRgbRgbRgbLsbRsRgbRsRsRsmmbRsbRgRsRsmmbRgRsRgRsmmbRgRsm
bRgRsmbRgRsRsRimmbRgRgRgRgRsmbRgbRgRsmbRgbsbRgRsRgmbRgbRibRgbRgbLsbRgb
LsbRgbRgbLjbRibLgbRcbRibLibLsbRcbLibRibRsRsmbRsbRsRsmbRgbRgbRsRsRsmmbR
gbLjbRsbLsRgbsbRsbRsbRgRsmbRgRsRgRsmmbRgRsmbRgbRgbRgbRgRsmbLgRsbRgbRgR
smbRgRsmbRsbRgbRgbRgbRgbRgRsRsRimmbRgRgbRgLsbRgbRsRsmbRiRjbRgRsmbRgRsR
smmbRgRgRibRgbRgbLgbRiRsmbRgbRgbRgRgbRgbRgbRgLsbLjbRhRsmbRgbRsbRgRsmbR
gRgRgRsRsmmbRgbRiRibRgRsmbRgRibRgbRgbRsbRsRsRsmmbRiRsmbRjbRjRsRgmbRgbR
iRgbRgbRgbRsbRgbRibLsbRibRgRsmbRgRsmbRgRsmbRgbRgbRgbRiRsmbRgRsRsRgmmbR
sbRsRsRsRiRhmmbRsbRgRsRgmbRgbRgbRgbRgbRsbRiRsmbRgbRsbRgbRgRsmbRibRiRsm
bRibRsbRgRgRsmbRgbRsRsmbRgLsbRgRsRsRsmmmbRsbLsbRgbRibLgLsbRiRsmbRgbLib
RhbRsbRgLsbRgbRgbLibRiRsmbLgbRibLsRhbLjbRcbRgbLibRcLsRsbLsRsbRgbRsbRgR
smbRgbRgbsbRsLsbRgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 1; Drug: Control Apo 0.5 然
bLgbsbRsRsmbLgbLsbsbLsbRcRsmbRhbRsRsmbLsLsmbLsbRjbRjRsmbRsbLsbRiRsmbLs
bLjbRgbsbLsbRgbRsbRgbRgRsmbLsbRibRsbRsbRsbLsbLjLsmbLiLsLsmbLibLsbLgbLs
bRsbLgbLhbLsbLsbLibLcbLibLsbLsbLsbLebLibLgbLgbLsbLsbLsbLgbLibLgbLgbLgb
LgbLsbLsRsbRsbRsbLibLgLsbLsLsmbLgbsbLgbLgbLibLibLsLsmbLibLcbLgbsbsbRsb
RgbRgRsmbLgbLgbLgbLgbLgbLsbLgbsbLibLsbLibLhbLsbLsLsmbRgbLgbLsLsmbLgbLj
bRgbLsbLebLsbLgbRjRsmbRhbRibRsbRgbRsbLsbLsbLsbRibLgbRcLsbLsbRibRgbRsbs
bRgRsmbsbRibRgbRsRsmbRgbRsbRsbRsbRjbRsbsbLibLjLsLsmmbRgbLibLibLsbRgbRh
bRibRgbRsbLsbRhbRsbRgbLsbLgbLsbLsbRsbRibRsbRgbRgbRsbLsbRibLsbLsbRhbRsb
LsRsbLsbRibRsRsmbRsbRgbLjbRcbLsbsbRibRibRsbLsbRgbRsbRiRsmbRibRsbRgbRsb
RsRsmbRibLsbRgRsmbRsbRgbRsbRsbRgbRgbRgRsmbRsRsmbRgbLsbLsbRibsbRgbRgbRg
bRibsbRsbRsbRsbRsbRgbRhbRsbsbRibLgbRhbsbLibRcbRsbsbRgbRgbRsbRjRsRsmmbL
gbLsbRsbLgbRhbRsRsmbRgbRiRsmbLsbLgbRgbRsbsbsbRgbRsbLsRsbRgbRsbLsbRibRs
bRsbLsbRebRgRsmbRoLsLsmbLsbRsbLgbRibsbLsbLsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 2; Drug: Control Apo 0.5 然
bRibLsbRsbRsLsbRgbRsRsmbRsRsmbRgbRgbRsbRgbRgLsbRgbRibRsbRsbRsbRcRsmbRi
bLgbRibRibLgLsbRgbRibRsRsmbsbRgbRsbRgbRsLsbRgbRsbRsbRsbRsbLsbRiRsmbRsb
LgbRgbRsbRsRsmbRsbRgbLsbRgRsmbsbRsbRgRsmbLsbRgRsRsmmbRgbRgbRgRsmbLsbLs
LsmbRsbRibRgbRgbRgbRiRsmbRsbRsbLsbRsbRsbLsRsbRiRsmbRsbRgbLsRsbLsbRibRs
bRgbRgbRgRsmbLsRsbRgRsmbRgbRgbRgbRgbRgbRiRsmbRgbRsbRibsbRsLsbLoLsmbLgb
LobLibLgbRsbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 3; Drug: Control Apo 0.5 然
bRsbLsbRsbLsbLgbRsbRsbLgbLsbRjbReRsmbRsbRibRsbLgbRhbLgbRgbRibRsbRebRsb
RsbLgbRhbRsbLibRgbLsbRsbRsbRgLsbRgbRgbRgbsbRsbLgbRsbRsbLsbRjbRgbLsbRsb
RibRgbLsbLgbsbRgbRsbRibLiLsbRsbLjbRsbRsbLsbsbRgbRgbRgbRgbLsbLoLsmbLsbL
sbLsbLsbsbLsbRsbsbRsbsbLobsbLgbLgbLsbRibRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 4; Drug: Control Apo 0.5 然
bRgbLgbRgbRgRsmbRsRsmbRgLsbRsbRgbLsbRsbRgbLsbRibRsbRibRgbLgbRibLjbLsbR
iRsmbRgbRsbRibRgbRgbLsbLibRibRgbLsRsLsbRgRsmbLsbRsbRgbRsbRsbRsbRgbRgbR
gbRsRibLjbRiRsmbRsbLgbRibRgbRgbLgLsbLibRibRibLjbRibRgbRsbRgbLsbRgLsbLs
bRgbRsbRibRgbRgbRiRsmbLsbRgbRgbRsbLibRibLsbRgbLjbRibRibLibLsbRibRsRsmb
RibLibRgbLgbRiRsmbRsRsmbRgbLgbRgbRgbLjbRgbRgLsbsbRgbLsRsbRsbRgbLiLsbRi
bRsbRibLgbRgRsmbRsbRgbRsbRsbRiRsmbRgbRsbRgbRsbRgbRgbRgbLsbLjbRibRibRib
LjbRjbRgbLjbRgbRibRgRsmbLsbLibLsbRjbLsbsbRibLsbsbLsbLgbsbRgbRsbRgbRsbL
gbLsbRsbLgbLjbRibLgbRibLjbRjLsbRcRsmbLgbLiLsbsbRsbRibLjLsmbRsbRibRgbRg
bRibRsbLsbLgbLgbLsbRsbRibRsbLjLsmbLgbLgbLgbRgbRgbLibLgbLsbsbLsbLgbLgbL
ibRgbRsbRsbRjbRgLsbLibLgbLsbLjbRsbLgbLgLsbLgbLgbRsbRgbLhbLgbRsbRjbsbLj
bLsbRsLibRjbLibLoLsmbLsbLhbRcbRcRsmbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 5; Drug: Control Apo 0.5 然
bRsbRgbRsRsmbRsbLsRgbRgbRgbRsbRgbRgRsmbRsRsmbRgbRsRsmbRgbRgbLgbRiRsmbR
gbRgbLsbRibRgbRsbRgbRgbRgRsmbLjbRibLibRibLjbLhbLibRcbRhbLgbRgbRgbRsbRs
RsmbRsbRsbRsbRsbRsbRsbLsRsbLsbRsbRsbLsbRgbRibLjbRibRgbRsbRgbRgRsmbRsRs
mbRsbRsbRgRsmbLsbRgbRgbRsbRsbRsbRsLsbRsbRgbRgbRgbRgRsmbLgbRsbRibRgRsmb
LsRsbRgbRgbLgbRhbLibLcLsmbLibRgLsbLgbLgbLgbRsbLgLsbRjbRoLsbLibRibRgbRs
LsbsbRibLcbLibLiRsbLsbRjbRcbLjbLibLibLsbLgbLgbRcbRibLjbRgbRgRsmbRgRsmb
RsbRsbRsbRsbRgbRsRsmbRsRsmbRgbRsLsbRgbRgbRsRsmbRgbRgbRsbRsbRsLsbRsRsmb
LsRsbRsbRgRsmbRsRsLsmbRgRsmbRsbRsbRgbRsbLsRsbRgRsmbLgbRibLjbRibRgbRsbR
sRsmbLsbRibLsbRgbRsbRsbRgRsmbRhbLgbLsbRibRibRsbRgbRsRsmbLgbRcbRsbLhbLi
bLibRhbLgbLsbLibLjbRcbRcbLjbLcLsmbLibRjbLibLgLsbLgbLgRsbRjbLibRjRsmbLg
bLgbLsbLgbRibRcbRgbRsbRgLsbRsLsbRsbRgbRsbRgbRgbLgbLibRcbLjbLcbRibLibRj
bLgbLibRgbLibRgbLgLsbLgLsbRsbLgbLgRsbRgbLgbRcbRibRgbRsbLibLibLibRhbLib
LibRgbLjbRsbRibLibRobLibLgbLsbLsbLgbRjbRebRsbLjbLgbRjbLgbRjbLgLsbRgRsm
bRsbRsbRsbRgbRgbRgbRgbRgbRgbRsbLgbRjbsbRgbRsbRsbRgLsRsbRgRsmbRgbLsbRib
LjbsbRibRgbLgbRsbRjbLsbLibRibLibRgbLibRsbLgbLibRcbRcbRgRsmbLjbRibLsbRg
RsmbLgbRibLgbRibLibsbLjbRsbRcbsbsbRgbRsbRgbRsbLsbRsRsmbRgbLsbLgbLjLsRs
mbLibRcbLcbRsbLgbRjbLjbsbRgRsmbLjbRibLjbRibRgbRgbRsRsmbRsbRibRgbLsbRib
LjbRjbRgbRibRgbLgbRibLgRsbRgbLjbRjbLjbRsbRibLsRgRsmbRsRsRsRsmmmbRsRsmb
RsbsbRgbRsRsmbRgbLsbRsbRsRsmbRsbRsRsmbRgbRgbRgbRgbLjbRibLgbRgRsmbRiRsR
smmbRsbRsbLibRebLhbLgbLgbLibRjbRebRibLjbRsbRiRsmbLgbRgRsRsmmbRgbRgRsmb
RsbRsRsmbRsLsbRsbRsbRsbRibLcbLibLgbLgbLgbLsbLgRsbLgbRcbRibRibLsbRsbRgL
sbRsRsmbRsbRgbRgRsmbRsRsmbRsbRsbLsbsbLsbRiRsmbRibRsbRgbRgbRsRsmbRsbRsb
RsbLsbLgbRibLgbRiRsmbLsbRgRsmbRsRsRsmmbRsbRsRsmbLsbRibLjbRobRsLobReRsR
smmbRgRsRiRsRemmbRgbLgbRibLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 6; Drug: Control Apo 0.5 然
bRgbRiRsmbsbRgRsmbRgRsmbRgbRgbLsbLgbLsbRsbsbRsbRgbRsRsmbsbLsbRsbRsbsbL
sbsbRsbLsbLsbLsbLsbLsbLsbRsbLsbRsLsbsbRsbRsbLsbsbLsRsbsbsbsbsbRsLsbLsb
LsbRsbLsbRsbLsbRsRsmbRsbLsbRsbsbLsbLsbRsRsmbLsbLsLsmbRsbsbsbLsbLgRsbRs
bsbsbLsLsmbRsbsbRsbsbLsbRsLsbLsbRsbRsbsbsbLsbLsbLgbLsbLsbsbsbLgbLsbRgb
LsbsbLsbRsbLsLsmbsbLsbsbLsRsbLsLsmbsbLsLsmbLsbLsbLgbLsRsRsmbRsbLsbRgbs
bLiLsbRsbRgbsbLgRsbLsLjbRgbLgbRjbLcbLsLiRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 7; Drug: CNO 1 然 Apo 0.5 然
bLibRsbLgbRsbRgRsmbRcRsmbRiRsmbRsbLsbLsbLsLsmbLsbLgbRibRibRibRsbsbRgRs
mbRsRsmbRsRsmbRsbRsbRgbRsbRgbRgbRgRsmbRsbRgbRsbRgRsmbRgRsmbRsbRgbLsbRg
LsbRgbRsbRsbRgRsmbRibRgbsbRibRsRsmbRsbLsbRsLsLsmbRsbLsbsbRgbRgbRiRsmbR
sbsbRsRsmbRibRgbLsbRgbRgbRsRsRsRsmmmbLibLsbLsRsbRgbRsbRgbsbsbRgbLjLsmb
RgbLjbRgRsmbRsbRgbRsRsmbRiRsmbRgbRiRsmbRsbLsbLgbLgbLsbsbLgbLgLsLsmbLib
LsbLgLsbRsbRibLjbRjbRjbLgbsbRgbLsbRgbRibRibRsbsbRsbRgbRsbRsbRgbRgbRjbR
sRsmbLgbLgbLgbLgbLibLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 8; Drug: CNO 1 然 Apo 0.5 然
bRsbRsbRiRsmbLsbRgbRsRsRsmmbRsbRgRsmbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgb
RsbRgbRgbRsRsmbRgbRsRsmbRgbRgbRgbRgbRsRsmbRibRsbLgbRibRsbRgbRgbRsbRgbR
sRsmbRgbRsbRgbRsbRgRsRsmmbRsbRgbRgbRsLsbRgbRgbRsbRgbRgbRgbLsbRibRgLsbR
sbRgbRsLsbRgRsmbRgbRgbRgbRsbRsbRgbRsbRgbRgbLsLsmbRgbLsbRgbRgbRgbRgbRsb
RgbRsbRgRsRsmmbLgRsbRgbRsbRiRsmbRgRsRsmmbRgRsmbRsRsRsmmbRiRsmbRgbRsbRs
bRibRgbRsbRgRsmbRsbRgbRsbRibRsbRgbRsbRgRsmbRgbRgbRgRsmbRgbRgbRgbRgbRgb
RgbRgbLsbRiRsmbRgbRsbRibRgLsbRsbRgbRgbRsbRgbRsRsmbRgbRgRsmbRsbRgbRgbRs
bRgbRgRsmbRgbRibRibRsbRgbLsRsbRgbRgbRsbRgbRgbRgbRgbRgRsmbRgbRsbRgRsmbL
sbLgbRibRgbLsbRgbRsRsmbRsbRgRsmbRgbRgbRgbRsbRgbRsbRibRgRsmbRgbRsbRgbRs
bRgRsmbRgbRsbRgbRsbRgLsbRsbLsbRgRsmbRsbRgbRgbRgLsbRgbRsLsbRibRsbRibRsR
smbRgbRsbRgbRgbRgbRgRsmbRsbLsbsbRiRsmbRsLsbRgLsbRsbRibRgbRsbRgbRgbRgbR
gbLgbRibRgbRgbRgbRsLsbRgbRsRsmbRsRsmbRibRsbRgbRgbRgbLsbRibRgbRgbRgbRgb
RgRsmbLsLsmbRiRsmbLsbRibLgbRgbRgbLsbsbRsbRgRsmbRsRsmbRgbRsbRsbRgbRgbRg
bRgbRgbRsbRgbRsbLsbRiRsmbRsRsmbRgbLsbRiLsbsbRgbRgbRgbLsbRibRsbRsbRiRsR
smmbRsbRgbRsbRibRgbRgRsmbRgbRsbRgbRsbRgbRsbRgRsLsmbRgbRsbRgbRsbRgbRsbR
gbRgbRsbRgbLsLsmbRibRsbRsbRgRsmbRgbRgbLsbRgbLsbRiRsmbRgbRsbRgbRgbRgRsm
bRsbRsbRgbRsRsmbRgbLgRsLsbRgbRgLsbLgbRibRsbRsbRgbRsbRgbRgbRsbRgbRsbRgR
smbRgbRsRsmbRsbRgbRgbRsbRsbRsbRgbRsbRsbRgLsbRsbRgbRgbRgbRgbRsRsLsmbRiL
sbRgbRsbRgbRgbRgbRsbRgLsbRsbRgLsbRgbRgbRibRsbRibRgRsmbRgbLsRsbRgRsLsmb
RgRsmbRgbRsbRsbRsRsmbRibRsbRgbRgLsbRgRsmbRsbRgRsRsmmbRsbRgbRgbRgbRgbRg
RsmbRgbRsbRgbRsbRsbRgbRgbRgLsbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgRsmbR
gbRgbRoRsmbsbRsbRsbLgbLjbLjbLjbLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 9; Drug: CNO 1 然 Apo 0.5 然
bLgbLsLsmbRgbRjRsmbLsbRgbRsRsmbRgbLgbLjbLgbRibRibRibLcbRjRsmbLhbLiLsbL
ibLcbLibLgbLgbLibRgbRsbLsbLgLsbRjbRibRgbLsbLsbLibLibLgbLgbLibLgbLgbLib
LibLsbRsbLsLsmbRibRjbLibLgbLgbRgbLjbLsbLgLsbLgbLibLiLsbRjbLgbLgRsbLibL
ibLgbLibLibLibLsbsbLjLsmbLgLsbLsLsmbLgbLgbRgbLsbRjbLibLgbLgbLgbLsbRsbL
iLsbLibLjLgbLgLsbLgbLsbLgbLsbRjbRgbLjbLhbLgLsbLgbLgbLjbLibRsbLibLibLsb
LhbRjbRsbRsbLibLgbLgbLjLsmbLgbLebRsLsbLcbsbRibRiRsmbsbLsbRibLsbRobLibR
ibRsbRsbRgbRsLsbLgbReRcbLibLiRsbLsbLsbRgbLsbLibLgLsbLgbLgbLsbLgbRjbLsb
sbLsbLgbLgbLsbRgbLsLsmbLgbLgbLgbRsbRsbLsbLgbLsbLsRsbLgRsbLgRsbLgbLsLsm
bRsbLgbRsbLsbRsbsbLgbLsbLgbLgLsbLgbsbLgLsbLgbLsbRsLsbLibRgbRgbLibLsbLs
bLsLsmbLgbRobLsbRibRgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 10; Drug: CNO 1 然 Apo 0.5 然
bRjbRjbRibLibRjbRjbRjbRibRibLiLsbRjbLjLsmbLgbRibRiRsmbLibLibLibLgbLjbR
jbRjbLgbLgbRsbRsbLibRjbRibLgbRibLjbRcbRibRibsbRjbsbRgbRjRsmbLjbsbRjbRj
bLjbRjbRibRsbLibLhLsbLibLiRsbLgbLsbRgbLibLgbLgbLgbLsbLsbLsLsmbRsRsmbRj
RsmbRgbLgbRjRsmbsbRgbsbsbLibLgbLsbLsbLgbLgbsbLsbsbLsLsRsmbLsbLibLsbLsb
LsbRgbLgbLgbRsLsbLsbLsbRjbRiLsbRibRibRibRjRsmbRjbLibLibRibRgRsmbRibRgR
smbLjbLibRjRsmbRibRibLibRgbRsbLjLsmbLjbRjbRjRsmbRibRgbRsbRibsbLgbRobLg
bLibLgbLgbLgbLsbLsbLgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 11; Drug: CNO 1 然 Apo 0.5 然
bRjbRcbRibLjbLsbRsRgLsbRibsbLgRgRsmbRgbRsRsmbRgbLibLgbRsRibLgRsbLebLib
LgbRibsbRsbRjRcbRibRsLsbRgRsmbRgbRgbRsLibLiLsbLgbRjbLibLhbLgbRiRsmbLib
LgbLgbLgbRsbLgbRjbRcbRibLsbRsbLsbRsbRgRsmbLsbRibLcbLibLgbLibLgRsbRgbLi
LsLsRsmbRsbLgLsbLsbLgbLsLsmbLgbLsbLgbLgbRjbRibRibRgbRsbRsbRsbRsbRsbRsb
RsbLobRsbLcbLibLsbLgbRsbLsbLsbLsLsmbLgRsbLsRsbLibLibLgLsbRhbLibLsbLgLs
bLsbLgbRsbLgbRcbRgbRgbRgLsbRsbLibLebRgbRsbRgbLcbLibRgRsmbLgbLgbRjRsmbR
sLsbLibRjbLibRjLibRjbRsRhLsbRgRsmbRgbLsbRsbLsbRsbLsRgbLhbLiRsbLsbLgbRj
bLibRcLsbRibLcbLgRsbRibLsbLgbLsbLgbLibLgbLsbLgbLsLsmbLjbLsbRsRsmbLjbRj
bLsbLsbLibRsbLgbLgLsbRgLsbLibLsbLgbLsbLsbLsbRobRobLgbLsbLgLsbRsbLgbRsb
LgbRgbLibRjbLibRjbRibRgbRgbRgRsmbRsRsmbRgbRsRsmbRgbRgbLsLsmbLobLiLsbRs
bLgbLsbLgbLsbLgbLsLsmbLgRsbLsbLgbLsLsRsmbLgRsbLsbLsbsbRibLsbLgbRjbLibL
gbRsbRsbLsbLgbLjbRsbLsbLgbRjbLibLsbLsbLgLsbLgbLebLsbLgbLsbLgbRsbLgbRsL
sbLgbRgbLibRsbLibRiRoLsLsRcmbLhbLibRgbLibRjbLibRgbLsLsmbRgbLgbRjbLiLsb
LibLsbLsbLgLsbRjbLjbRcLsbRcbLsRjbLiLsbLibsbRgRsmbLiLsbRsRsLsmbLgbLsbLs
bRsLsbRjRsmbLcbLgbLgbLsbLsbLibRgbLibRsbLjbLsbRjbsbRibLeLjbLsRsbsbLgbLs
LsmbLgbLsbLgbLsbLgbRgbLibRjbRcbLcbLibRcbRsRiLsbLeLsbLhbLibRibLsbLibLgL
sbLsLsRsmbRsRsmbLiLsbLsbLgLsbRsbLgbLsbLsRsLsbLsbLsLsmbsbLgLsbRjbRsbLiR
sbRsbLsbLgbsbRsbLgbLsLsmbLsbLgLsbRsbLibLsbLsbLgbLsbLgbLsbLsbLgLsbRsbRs
bLgbLsLsmbLgbLsbLgLsbLsLsmbLgbLsLsmbRjbLcbRcbRiLsbLjbLhbLsbRiLsbLcbLib
RiLsbLgbLgbLgbLsbLgbLgbLsbLgbLsbLgbRgbRcbLcbLibRgbLibLgbRsbRgLsbLibRjb
LhbRsbLsbLibRsbLgbLsbLibRhLsbRibRsbRgbRsbRsbRsbRgRsmbRgbLcbLibLgLsbRsb
LibRiLsbLibRgRsmbLiLsbRjbLiLsbLiLsbLsbLgbRsRsmbLgbRsLsbLgbLsbLgbRjbLib
LgbLsbRsbRgRsmbLcLsmbLibRibLgbLiLsbRsbsbLibRsbLibRgLgbRjbLibRgbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 12; Drug: CNO 1 然 Apo 0.5 然
bsbRsLsbRsbRgbRsbRsbRibRsbRsbRgLsbRsbRsbRsbRsbLsbRsbRgbRgbRsbLsLsmbsbR
gbRgLsbsbRsbRsRsmbRgbLsbLsbLsbRsLsbRjbRsbRgbLsbRsbRsbRibRsbRsbRsbLsbRs
bRsbRsbLsbRsbRsbRgbLsbRsRsmbRsbLsbRsbLgRsbLsRibLibRgbRsbRsbRgbRsLsbRsb
sbLsLgbRgLsbRsbRsbLsbRgbRsbLsbRsbRgbRsbRsbRsbRsbLsbRsbRsbRsbRsbRsbRcbR
gbLobLgbLgbRgbLiLsbRsbRsbLibRsbRsLsbLibLsbLgbLgbLcbRibRcbLsbRibRsbRsbR
gbRsbRsbRgbRibRsbRsbRsbRsRsmbRgbLsbRsbRgRsmbRsbRsbRgbRgbRgbRsbLsbRibsb
LsbRsLsbRgbRsbRsbLjbRiRsmbRsbRsLsbRsbLsbRsbRsbRsbRsbRsLsbRsbRsbRsbRgbR
sRsmbLsbLjbRgbRsbRsbRgRsmbLsbRgbLsbRgbRgbRsbRgbLsbRsbLsbRgbRsbRgbRsbRg
bRgbRsbRsbRgbRgLsbRsbRsbRsbRgbRsbRibRsbRsRsmbRgbRgbLsRsbRsLsbRsbRsbRgR
smbRjbRsbRsbRgbLsbRsbsbLcbsbRibsbLsbLjbLibRcbRiRsmbRsRsLsmbRgbRsbRgbRs
bRsbRgRsmbRsbRsRsmbRgbRsbRsbLsRgbRsbLgbsbLsbLgLgLgbLgRsbLgbLibLcb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 13; Drug: CNO 3 然 Apo 0.5 然
bRsRsmbRgbRsRgbRsbRgbRsRsmbRgbRsbRgRsmbRsbRsbRsbLsbRsbLsbRsLsbRjbRsbLs
bRsbRsRsmbRgbRgbRsRsmbRgbRgbRgRsmbLgbRgRsmbRsRsLsmbRgbRsbRsbRsbLsbRibR
sbRsbRsRsRsmmbRgbRsRsRsmmbRgRsmbRsRsmbRsRsmbRsbRsbRgbLgbRgbRgbRsbRsbRs
RsmbRjbLsbRsbRgbRsbRjbLgbRgbLsbRgbRgbRgbRgbRsbRibRsRsmbRsRsmbRgRsmbRib
RgbLgbRibsbRsbRgbRgbRsRsmbLsRsbLsbRibRsRsmbRgbRsbRsbRsbLsbRgRsmbRgbRsR
smbRsbRgbRsbRibRsbRsRsmbRsRsmbRgRsmbRsbRsbRgbRgbRgRsmbRgbRsbRgbRgRsmbR
sbRgbRsbRgRsmbRsbRibRgbRgbRsbRsbRsbRgbRsbRsbRgbRgbRgbRgRsmbRgbRsbRsbLs
bRgbRsRsmbRsRsmbRsbRgbRgbRsbRjbRgbRsRgbRsbRgbRgRsmbRgRsmbRgLsbLsRsbRgb
RgbRsbRgbRgbRobRsRiRsmbLsRsbLebRsbRobRgbLsRgRsmbRgbRgRsRsmmbLsbRgbRgbs
bLsbRsRjbRgbRgbRgLsbRsRsmbRsLsbRibLsbRsbLsbRgbRgbRsbRsbRsbRgbRsbRgbRsb
sbRsbRgbRgbRgbRsbRsbRsbLsbsbRsbRgbRsbRsbRsbRgbRgbRsbRsbRsbRgbLsbRsbRgR
smbRgbRgbRsbRgbLsbRgRsmbRgbRgbLsbRiRsmbRsbRgRsmbRsbRgbRgbsbRgbRsRsmbRs
bRsbLsbRjbRsbRsbRsbRgbLsbRibRsbRibRgRsmbRsbRgRsRsmmbRsbRsbRsbRgbRsbRsR
smbLsbRgbRgbRgbRsbRsbRgbRgbRsLobLgbRjbLgbLiLsbLgbLsbLibRjbRebRsbRgbRgb
RsbLgbRsbRibRsbRsLsbRsbRjbsbRjbRgbRsbsbRsbRsRsmbRgbRgbLgbLgbLgbLgbRjbL
hbRcbLiRsbLiRsbLsbLgRsbLsbRcbRibRgbLgRsbLsbLsbRgbRsRsmbRgbRgbRgbRgLsbR
sbRgRsmbRsbRgRsmbRsbRsRsmbRgbRgRsRsRsmmmbRgRsmbRgbRgRsmbRsRsmbRgbRsRsm
bRgRsmbRgLsLsmbRgbRgRsmbLcLibLgbLsLsmbLsbLsRsbLibRjbRsbRgbRsbRgbRsbRsb
RgbLjbLcbRgbRhbLjbLebRhbLcbLgbRjbLsbLgbLgbLgbLgbLsbLgRsbRcbRebRgLsbLsR
sbRgbLsbRsLcbRibsbRsbRiRsmbLsbRibLsbRibLsbLsbRsbRsRsmbLobRjRsmbLgbRiRs
mbLsbsbRibLsbRgRsmbLsbLjbRsbRjbLsbRgRsmbRgbRsbRgRsmbLsbRgbRsbRgbRsbRsL
sRsbRibRgbRgbRsbRgbRsRsmbRsbRsbRsbRsbRgbRgRsmbRgbLsRgbRgbRibLcbRjbRsbL
ibRjbRgRsmbRsbRgbRsbRsbRsbRgRsmbRibRsbRibRsbRgbRgbRsbRgbRsbRsRsmbRjbRs
bRsbRgLsbRgbRgRsmbLsbRgbRgLsbRibRsbRgbRsbRgbLsbRiRsRsmmbLgbRibRsbRsRsR
smmbRsRsmbRsbRjbLsbRgbRsRsmbRgbRgbRsbRsbRsbLsRsbRsbRgbRsbRsbRibRsbRsRs
mbRsbRgRsmbRsbRsbRgbLibRgRsmbRsLsLsmbLgbLjbLiRsbRsbLgbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 14; Drug: CNO 3 然 Apo 0.5 然
bLiLsbLgLsbRsbLgbLsbLgbRcbRgbRibLgbRiRsmbRsbLsbRibRsbLsbRgbRgbLgbRgbRg
bRcbLjbRhRsmbLgbRibLsbLsLsmbRibLjbRibLgbRjbLsbLsRsbRsbRsbRsbRsbRobLiRs
bLibLibRhbRcbLibLibRcbRcbLsbLsbRsbRibRgbRgbLgbLjbLcbLibRebLhRsbRjbRcbL
jbRiRsmbLjbRhRsmbLibRgRsmbRibLsRsbRgbLjbLhbRcbLcLsmbLsbLibLibRsbLjLsmb
LsbRsLjbRgbLgbRgbRibRgbRibRsbRsbRgbLcbRgRsmbReRsmbLiRsbRsLsbRsbRhbLjbR
hbLibRibLgbRibLjbRgRsmbRibLjbLibRsbRcRsmbRsRibLjbLcbLibRjbRcbRgbLsbRsb
RsbRgbLsbRgbRgbRsRsmbLsbRgbLsbLsbLsbLjbLjbLibLgbRjbRcbLcRsbLhbLgbRjbRj
bRiLsbLiLsbLibRebRcRsmbLsLsmbLsbRsRsmbRsLsbLsbRibLjbRsRhRsmbLiLsbRgbRg
bLsLgbRibRgbLgbLibLibRjRsmbRcbRibRgbLibRsRsmbRsRibRsbsbRsbRgbLgbRsbRsb
RgbRsbRsbRsbRgbRsbRgRsmbLgbLsRgbLgbLjbRoLsbRsbLsRhbLjbRjbRibRgbLgbRibL
sbLsbRsbRsbRgRsRsmmbRsbLsbLsRgbRibRgbRgbRgbLgLsbRibLjbRibRgbRsbRgbLjbL
sRhbRjbLcbLsbRsbLsbRsLsbRsRibRgbLsbLgbLhLsbLibRsbRgbRiRsmbRjbRsbRcbLgb
RsbRsbRibLgbsbRibLgbRibLsbLsbLsbRgbRgbRgbLjbLjbLhLsbLibRcbRgbRibRsbRsb
RibLsbRgbRsRsmbRsbRgbRsbRsbRibLibLcbRsLibRjbRebRsbRibLsbLsbRibLsbRsbRg
bRsbRgbLgbLsRgLsbLgbRiRsmbRgbRgbLjbRgbRsbLsbRibRgRsmbLgbRgbRsbLsbRgbRs
RsmbRgbLsbRibRsbRjbLsbLsbLsbsbRsRsmbRibLsbRibRjLsbLhbRsbRibRibLibRsbRg
RsmbRsbRibLibRibLibRjbRsRsmbsbRjbRsbRsRsmbRsbRsbRibLgbLibLhbLibRgbLibR
cbRsRsmbRsbRsbRgbRgbLjbRgRsmbLjbRgRsmbLcRsbLibRjbLibLibRebLibRcbRcbLib
LsRhbLgbRibLjbRibRsbRgRsmbRgbRgbRgbRsbRgbsbsbRsbRsbsbLgbRsbRgbRsbRsbLs
RgbLsbLjbLibLgbLgbRjbRcbRsRsmbRiRsRsmmbRibLgbRibsbsbRgbLebRsbRibRibRgb
Rsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 15; Drug: CNO 3 然 Apo 0.5 然
bLhbRibRobLobLgbLsLsmbLgbLgbLgbLgbLgRsbLgbLgbLgbLgbLsbLsbLgbLgbLgbLsbL
sLsmbLgLsbLsbLgLsRsbLgbRibLibLsLsLsmmbLsbLgRsbLsLsRsmbRsLsbLgbLjbRibLi
bRgbLibLgbLsbLiLsbLiLsbRibLgbLibRgRsmbLibLibRgbLgbRsbLibLibLgbRsLsbRib
LibLgbLgLsbLsbLgbLgbLsLsmbRsLsbLgbLjLsmbRgbRsbLibRgRsmbLibLgbRsbLsbLiL
sbRsRsmbLsbLibLgbLsbLgbLgLsbRsbLsbLibLgbRsbLibLgbRgLsbLibRgbLibLiLsbLg
bRsbLibLsbLgbLsbLgbsbLsLsmbLsbLgbLsbRgbLibLibRibLibLgbRibRgbLsLibRsLsb
LgbLsbLsLsmbLgbLsbLgRsbLgbRgbLgbLgbLsbLgLsbLsbLsbLgbLgbRgbLibRgbLibLsb
RgbLgbLgbLgbLsRsbLsbLsLsmbLsRsbLgbLgbLsbLsLsmbLgbLgbLsLsmbLsbLgbLsbLgb
RgbLibLgbRgbRsbLgbLgbLgbLgbLsLsmbLgbLgRsbLgbLsbLgbRcbLsbLjbLiLsbRgbLiL
sbLgbRsbLgbLgRebRobLsbLibLgbLsLsmbLiLsbRgRsRsmmbRsLsbLgbLsbLsbLgbLgbLg
LsbRjbLibLgbLgbLebRsLsbLibLsLsmbLgbLgRsbLgLsbLgbLgbLgbLgbLgbLsbLsbLgbL
gbLsLsmbLgLsbLsLsmbLgbLgLsbRjbLhbRibLibLgbLsbRgbLibsbLgbLsbLsLsmbLibRg
bLsbLibLgbRgLsbLiLsbRsbRsLsbLsbLgbLgbLsbLgLsbLgbLgbLgbLgbRgLsbLiLsbRsL
sbsbLibLgbLsLsmbsbLsbRgbLibLgLsbLibRibRsbLibLgbLsbLgbLgbsbRsbLiLsbRgbL
sbLibLsbRsbLibLsbLsbLgbLgbRsLsbLibLsbLsbRsbLibLgbLgbLgbRibLgbLgbLibLsb
LgbRsLgLsbLgRsRsmbRgbLibLsbRjbLibLgbRgbLgbRsLgLsbRsbLgbLgbRgbLibLgLsbL
sLsmbLgbRibLibLsLsmbLsbRgbLgbLiLsbLgbRgbLsbLgbLsbLsbLsbLgLsbLgbLgbLsbL
sbRsbLibLgbRsbLsbLibLiLsbRgbRsbLgbLibLsbLgbLgbRsRsmbRsbLgbLibLsbLsbLgL
sbRgLsbLibLsbLsbLiLsbLgbRsLsbRsbLsbsbLibLgbLsbRsRsmbLibsbLgbRsbLibLgbR
gbLibRgbLibRsbLibLgLsbLsbRsLsbLgLsbLgRsbLgbLgRsbLgbLgbLgLsbLgbLgLsRsbL
sLsmbLgbLsbLgbRjbLiLsLsmbLgbRsLsbLibLgLsbRibLibRjbLsbRgbRibLjbLiLsbLib
LgbRgbLsbLsbLsbLibLgbLsbLgbLsbLsbLgLsbLgbLsbRgbLibLgLsbLsbRsbLsbLgbLsb
RgbLsbLibLgbRibLiLsbLsbLsbLgbLsbLibRjbRjbRibRsLsbRjbLjbLcbRgbLiLsbLgbL
sbRsbRgbLgbLibLibRgbLsbLgbsbLsbLgbRgbLiLsbsbRsbLsbLgbLsbLgbLgRsbLsbRsL
gLsbLsbRsLgbLsbLsbLgbLgbLgbLsbLgbLgbRibLibLsLsmbLgbLgbLgbLgbRgbRsbLgbL
sbLgLsbLgbLgbLsbLsLgbLgbLgbLsbLgbRsbLgbLgbLgbLgbLsbRgbLsLsmbLsbLgbRgbL
sLsmbLibRcbRibReb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 16; Drug: CNO 3 然 Apo 0.5 然
bRsbRsbRgbRsRsmbRgbRsbRsRgLsbRgRsRsmmbRgbRgRsmbRgbRsbRgRsmbRgbRgRsmbRg
bRgRsmbRgRsmbRgRsmbRgRsmbRgbRgbRgRsmbRgRsmbRgbRgLsbRgRsmbRgRsmbRgbRsbR
gbRgbRgRsmbRgbRgbRsLsbRgbRgbRsbRgbRgRsmbRsbRgbRgbRibLgbRiRsmbLjbLhbLgR
sbLgbLgbLhRsRsmbLcbRsbLjLsmbRhRsmbRiRsmbRiRsmbRsbRgRsmbRsbRgRsmbLsbRgb
LsRsbRiRsmbLsbRsbRgbRgbRsRsmbRgbLsRsbRgbRgRsmbRgbRsbRsbRsbRsbRgbRsbRgR
smbLsbRjbRsbRsbRsbRgRsmbRsbRsRsmbRgbsbRgbRgbRsbRgLsbRgbRsbRgRsmbRgbLjR
sbLhbLiRsbRobRgRsmbRsRsmbRsbRgbRgRsmbRgbRgbRsbRsRsmbRgRsmbRgbRgbRgRsmb
RgbRgbRsLsRsbRgbRsbRjbRgRsRsmmbRgbRgbRsbRsbLobRgRsmbRibRgbRgbRgbRgRsmb
RgbRgbRgRsmbRgbRgbRsbRibRsbRgbLsLsmbRgbRgbRsbRsRsmbRgbRgbRgbRgRsmbRsbR
iRsmbLsbRhbRsbRcRsmbLsbRibRgbRgRsmbRgbRgbRsbRsbRgbsbLsbRiRsmbRebLcbLgL
sbLgbLgbLiRsbRjbRjbRcbLhRsbRibLsbRiRsmbLgbRibRibLgbRsRsmbRsbRgbRgbRgbR
gRsmbLebLobRgbRgbRgbRgRsmbRgRsmbRgRsmbRgbRgbRsbRsbLsbRsbRgbRsRsLsmbRgR
sLsmbRgbRibRgbRgbRgbRgbRgbLjbRibRgLsbLoRsbRjbRsRsmbRgbRgbRgbRgbRgbRgRs
mbRgLsbRgRsmbRsbRgRsmbLgbRibRgbLsRsbRjbLsRsbRsbRgbRgRsmbRgbRgbRgbRibRg
bRsbRgRsmbLsbRjbLsbRsbRgbRgRsmbRsbRgRsmbRgbRgbRgRsmbRsbRgbRsbRgbRsbRgb
RgbLgbRibRiRsRsmmbLibRiRsmbLoLgbRiRsmbLsRsbRgbRsRsmbRsbRgbRsbRsbRgbRgR
smbRsbRgbRgbRgbRgbRjbRsbRgRsmbRgRsLsmbRgbRsbRgbRsbRsbRibLgRsLsbRibRgbR
gbRsbRsLsbRsbRgbRsRgbRgRsmbRgbRgbRgRsmbRgRsmbRsbRsbRgbRgbRsRsmbRgbRgbR
gRsmbRsRsmbRgRsmbLsbRgbRgbRgbRgRsmbRgRsmbLsbRgRsRsmmbRgRsmbRgbRgbRgbRg
LsbRgbRsRsmbLsbRsbRsRgbRsbRgLsbRgRsmbRgRsmbRsbRsRsmbRsbRsLsbRgbRgbRgbR
sbRgbRjbRsbRsRsmbRsbRgRsmbLsbRiRsRsmmbRsbRgRsmbRsbRgRsRsmmbRgbRsRsmbRs
bRjbRsbRgbLjbRiRsmbRsbLsbRiRsmbRsbRgbRgbLsRsbRsRsmbRjbRsbLjbRgbRsRjbRs
bRsbRgbRsbRsbRsbRsbLsbsbRiRsmbRiRsmbLsbRgbRgbRsbRgRsmbRsRsmbRgbRsRsmbR
ibRsRsmbRgbLibRibRsRsmbRsbRgbRgbRsbRgbRsbLsRsbRgbRgRsmbLsbRgbRgLsbRgLs
bRsbRgbRgbRgbRgRsmbRgbRgRsLsmbRgLsbRgbRsbRgbRgRsmbRgbRgbRjbRsRsmbLsbRi
bRgRsmbRiRsmbRgbRsRsmbRgbRgRsmbRsbRgbRsbRgRsLsmbLsbRebRgbRsLsbRsbRgbLs
bRgRsmbRgbRgbRsRsRsmmbRgbRgRsmbRsRsmbRibRsRsmbRgbRgRsmbRsbRgbRgbRsbRsR
smbLsRsRsmbRibRgRsRsmmbLibRibLsbRiLsbLgbRibRsRsmbRsRsmbRsbRsbRsRsRsmmb
RibRsbRsbRibLsRsbRjbLsRsRsmbRsbRjbRsRsmbRsbRibRsbRgbRsbRgbRsbRgbLsbRgb
RibRsRsmbRsRsmbRibRsRsmbLsLsmbLibRibRgbLsbLgbRgbRibRsRsLsmbRsbRgbRsbRg
LsbRgRsmbRiLiRsbRcRsmbRsbLgbRsRibRgbsbLibLhbLgbLgRsLsbLibLcbRsbRgRsmbL
jbLiLsbLgbLgbRgbRcRsmbRiRsmbLsbRgbRsbRgRsmbRsbRgbRgbRgRsmbLgRsbRibLibL
obRiRsmbRjbRsbRsRsmbRgbRgbRiRsmbRsbLsLsmbRibRgbLsRsbsbRgbRgRsmbRgRsmbL
gbRibLebLgbRibRgRsLsmbRcbLgbRibRgbRsbRiRsmbRjLsLsmbLibRsbLiLsbLgbLgbLg
bLibLcbRgbLsbLgbRsRsmbLjbRsbLjbLsLebRgbRgbRcbRibRibRib

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 17; Drug: CNO 3 然 Apo 0.5 然
bLgRsbRsbLsbRebLobLsbLgbLgbLgbLsbLgbLsbLsbLgbsbsbLsLsmbLsbLsLsmbLgLsLs
mbLgbLsLsmbRsbLgbLsLsLsmmbLgbRsbLsbLsbLsbRsLsbLgLsbLsbLgbLgbLsbLgbLsbL
sbRsLgRsbLgbLibRgbRsbLgbLibRgLsbLibLsbRsbLibLsbLsbLsbLsbRjbRcRsmbRgbRg
bLsRsbRsLsbRibRgbLgbRsbRhbLgbRibRgbLsbRgRsmbRgbLgbRibRsbRsbRsRsmbRgbLs
bRcLsbLsbLebRcbLcbRsbLgbLsbLiRsbLsbRsbLgbLgbLsbLsRsbLgLsbLsRsbLgRsLsbL
gLsbLsbLsbLsLsmbLsbLgbLsLsmbLsbLgLsbLgbLsbLgLsbLsLsmbRsbLgbRgbLibRjRsR
smmbLcbLgLsbLsRsbRsbLgLsbLsbLgbLsbLgbLsbRsLsbLgbLsLsmbLsLsmbLsbLsbLsbL
sbLgbLgbsbLsbsbLgLsbLsRsbLgbLgbLsbLsbLsbLgbLsLsmbLgbLgbLgbLgbRjbLcbLiL
sbLsbLiLsbRsbLibLsbLsbLibLgLsbLsbLgbRsRsmbLgLsbLsbLgbLsbLsLsmbLgbLgRsb
LgbLsbLsbLsbLgbRsbLgbLsbLgbLgbLsRsbLgbLsbLgbRsbLsbLibRsbRgbLibLgbLsLsm
bRjbLsRsbLibLgbLsbLgbRsbLgbLsbLgbLgbLsbLibLibLgRsLsbRsbLsbRibRibLjbRib
RgLsbLibRibRgbLsbRibRgbLjRsbRibRgbLsbRiRsmbRsbRgbLsbRgbRgbRsbRgbRgbLsL
smbRiLsbLcbLibLgbsbRsRsmbLsRsbLgLsbLgbLsbLsbLgbLsbLgbLsbLgbLgbRjbLhbRs
LsRsbLsbLibLgbRsbLgbLsRsbLgbLsbLgbLgbLsLsmbLgbLgLsbLsbLsbLsbLgbLsLsmbL
sLsmbLsbLsbLgbLsbLsLsmbLsbLsbLsLsLsmmbRsbsbLgbLsbLsRsbLsbLsbLgbLsbLsbL
sbLsbLsLsLsLsmmmbLsbLsbLgbLsbLsLsmbLgbLsLsRsmbLgbLsRsbLsbLsbLgbLsLsLsm
mbRsLsbLsbLgLsbsbLsLsmbLgbLsbLgbLsbLsbLsbLgLsbLsbLsbLgbLsbLsbLsbLsbLsb
LsbLgRsbLsbRsLsbLsbLgbRsRsmbLgLsbLgbLsbLsbRibLjbLsbLgbRsbLgbLsbLsbsbRs
bLsbLibLsbLsbLsbLsbLgbLsbLsbLgbLsRsbLsbLgRsbLgLsbLgbLsbLgLsbRsLsbLgbRs
bLsbRsRsLsmbLgRsbLsLsmbLgbLgbLgbLgbRgbLgLsbLibLsbLsbLsbLsbLgbLgbRgbLib
LsbLsbRsLsbLiRsbRsbLgLsRsbLsbLsbLsbLsLsmbLsbLsbLsbRjbLibLibLibLgbLiLsb
RibLsbRsLsbLibLibLsbLsbLsbLgbLsLsmbLgbLiRsbRsbRsbRsbRgbLgbRcbRibRibRsb
LsbLjbLsbRhRsmbRgbRgbLjbLcbLgbLgbLsbLsbLsbLgbsbRsbLsbLcbLsRsbLgLsbRgbL
sbLgbLibLgbLgbLsbRibLsLgbLsbLsRsbLgbLsbLsbLsbLgbLsRsbLsbLgLsbLsbLgbLgb
LsbLsbLsbLgLsbLgbLsRsbLgbRsLgLsbLsbLsRsbLsbLsLsmbLsbLsRsbLsbLsbLsbLibL
gbLsbLgbLsbLibLsbLsbLsbRsbRgbLsbsbRhbRgbRsRsmbLsbRibRgbRgbLsbLgLsbLsLs
mbRibLgbRcbRsbRsbRibLgbLcLsmbLibLsbRsbLhLsbRgbLsLsmbLiRsbRsbRsbLsbLiRs
bRgbLibRsbLgbLgbLsbLsbLgbLsbLsbLsbLgbLsbLsbLgbLsLsmbLsbLgbLsbLsbLsbLsb
LgbLgbLsRsbLsbLgbLgbLsLsmbRgbRoRsmbRgbRsbRgbRsbRgbRsbRgbRsRsmbRsbRgbsb
RibLcLsmbLgbLgbLsRsbLsRsbLsbLgbLsLsLsmmbLsbLgLsLsRsmbLgbRsLsbLgbLgbLgb
LsbLsbLsbLsbLsbLgLsLsmbLsLsmbLobsbLsbRgbRgbRgbRgbLgbRgbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 18; Drug: CNO 3 然 Apo 0.5 然
bLsbRibLsbLgbRsbRiRsmbRibLsbRsbRsbLsbsbLibsbRsbRsbRibsbsbLsRsRibRsLsbL
sbsbRsbRgbRsbLsRsbRgRsmbLgbRsbRsbRsbRsRsLsmbLsbLsbLiRsbRgbRsbLsbRibRiR
smbLsRsbRgbRsbLsbRiLsbsbLsbLgRsbLjLgbLhbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 19; Drug: CNO 10 然 Apo 0.5 然
bRgbLsbLgbLibLibLibRibRiRsmbLibLjbLsbLgLsbRsbLgbRgbLgbLsbRsbLgbLibRsbL
gLsbRebRsbRsbRgRsmbRsbRsRsmbRgbLgbLibsbLibLgbLgLsbRsbLsbRsbRsbLgbLsbLi
LsbLgLsbRsbLsbLgbRsbsbRgbLibRsbRjbLsbRsbLiLsbRsLsbLgbRsbsbLgRsbRsbRsbR
sbRsRsmbRgbLsbLsbRsbLsbLibLgRsbRjbLgbLgbLsbLsbRsRsmbRsbsbLsbLsbRsbRsbL
gbRsbLsbsbLgbsbLsLsmbLsbLsbLsbLgLsbRsbLgbRsbLgbsbRibLsbsbRgbRsbRsbLgbL
sbRsbLgbRsLsbRsbLgbRgbRgbLsbRsbRsRsRsLsmmbLsbLsbRsbLsbLhbLsbLgbRibLibR
sbLibRsbRjbRsbRibsbLoRsbRsbLsbLsbRcbRobLsbRgbRsbRsRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 20; Drug: CNO 10 然 Apo 0.5 然
bsbLgbLgbRgbLgbsbLobRcbsbsbLibLgbLsbLjbRjbLsLsmbLibRjbRibRibRibRiRsmbR
sLsbRgbLsbLjLsmbRgbLsbRsbLsbLcbRibLjbLsbLibRsbLsbLsbLsbLgbLsbLsbLsbLsb
LsbLsbRiLsbRcbsbRjbLsbLcbLibRsbRsLsbLibRsLsbLsLsmbRsbLsbLsbLgbLsbLgbLs
bLsbLsbRsLgbLsbRsLsbRsbLsLsmbRibRibRgbLjbLcbLgbLsbLgbLgbLsbRsbLgbLgRsb
sbLsbLsbLsbLgbLgbLsbLgbRgbLgbRsbLsbRjRsRimbLgbsbLjLsmbsbLgbRsLsbLjbRsb
LsbsbLsbLsbLsbLsRsbLgbLgbLsbLsbLgbRsbRgbRsbsbLiLsbRgbLgbLsLsmbRsbLgbLg
bLsbRcbRgbRgbLjbLebLsbLsbLsbLgbLsbLgbLsbLsbLgbLsbLsbLsbLsbsbLgbRsbRjbR
cbsbsbsbLsbRsbRsbRgbLcbLgbsbRsbRjbRsLjbLgbLsbsbRgbLgbRsbLsbRgbLibRsbLs
bLsLsmbsbLgbRjbLibRibLjbLibRsbLibRsbLsbLgbLsbLsbLsbRsbLgbLsbsbLsbLsbLs
bLsbLsbRsLsbLsbLsbLsbLsbLsbLsbLgbsbRsRsmbsbLhbRsRsLsmbLsbLgbLsbLsbLsbL
sRsbLsbLsbsbLsbLsLiLsbsbLgbLsRsbRibRibLsbRjbLsbRgbLgbLcLsmbLibLsbLgbRs
LsbLsbsbLsbLsbsbRsbRjbLcbRgbLgLsbLgbLibLsbRsbLsbLsbRjbRibLsbLsbLoLsmbL
gbRibRgbLebLgbLgbRgbRjbRgbLcbLibLsbLsbLsbLsbLsbLiLsbLsbLgbRsbLgbRsbRhb
RsbLsbLgbLsbLsbLgbRjbRcbLcLsmbLiLsbLibLgbRgbLsLgbsbLsbLiLsbLsbLgbLsbRs
bLgRebsbRebLobRsbRcbRgbRgbRgbRgRsmbLsbRgbRibLibLsLsmbLcLsmbsbRsbLgbsbL
sbRsbLgbLgbLsbsbsbLsbLsbLgbLgLsbLsbsbLgbLsbLsbLsbLsbLjbLgbsbLibRjbLibR
sbLibLgbLsbLgbsbLsLsmbLsLsmbLsLsmbsbLgbLsbLgbLgbLibRjbRebRsRsmbLjbLgbL
iLgbLgLsbLgbLgbLgbLsbLsLsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 21; Drug: CNO 10 然 Apo 0.5 然
bRibRsbRiLsbRsbRsbLgbRsbRsbRsbRsbLsbLsbLiLsbRebRsbRsbRgRsmbRsbLjbRhbLs
bLsbLgbLsbRsbRgRsRsmmbRgbRsbLsbRsbRibLsbRsbRsbRsbRsbRgLsLsmbRhbLibLibL
ibLgbRsbLibRgbLgbRsbLgbLgbRgbLcLsmbLgbRsbRgbLibRibRsbRcbRgRsmbRgbLsbLs
bsbRiRsmbRsbLsbLsbRibRsRsmbRgbRsRsmbRgbRsbLsbRsRsmbLsLsmbsbLgbRiRsmbLs
bRgRsmbLgbRibRgbRsbRsRsmbRgbRsbLgbRiRsmbRsbRsbRsbRsbLsbsbLsRsbRibRsRsm
bRgbRsbsbLsbsbRjbRgbRsbLsbRsbRsRsmbsbRgbRgbRsbsbRgbsbRsbRgRsmbRsbRsbLs
bRsbRiRsmbsbRibRgbLsLsmbRgbRiRsmbRsbRsbRsbRgbRsRsmbLsbsbRgbRsRsmbRgbRg
bLgbRibRibRgRsmbsbRgbRsbRsbRsbRgbLsbRsRsmbLgbRsRsmbRiRsmbRsbRgbRiRsmbR
sbRgbRgbRgbRgbRibLjbRibRibRibRsbLsbRibRsbLibLibLgbLgbLsbsbLibLgbRsbLjb
RsbRsRsmbRibRibLsbRibRsbRgRsmbRsbRgbRsbRsbRgbLsbRgbLsbRgbRsbLgbRgbLgLs
bLsRsRsmbRsbRgbRibRibRgbRibRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 22; Drug: CNO 10 然 Apo 0.5 然
bRcbRsbLsbLibRgbRibRsbRsbRsbRsbRiRsmbLsbRsbLibLibLhbLsbLsbLsbLgLsbsbsb
LsbRsRsmbLibRjbLibLsbLsbLgbLsbRgbRibLsbLebLgbLsbLsbLibLibLsbLibLibLsbL
sbLibLsbRgbLibLsbLgbLsLsmbLibLsLsLsmmbLsbLsbLibLsbLsbsbRiLsbLibLsbLsbL
iLsbLsLsmbLsbRibLsbLcLsmbsbLgbLsbRsRsmbRsbLsbLiLsbLsbLsbLgbLsLsmbLsbLs
bLiLsbLgbRgRsmbLgbLsbLibLsbLsbLiRsbsbRsLsbRsbLsbRsbRgbLsbLgbLsbLgbLsbs
bLebLsbRsLsbRsRsmbRibLibLiLsbsbsbRsbLsLsmbRsbLibLsbRgbLibLibLsbLsbsbsb
RsbRsbLcbLsbLiLsbLsbLsbLsbLsbLiLsbRsbLjLsmbLgbLgbLhLsbLsbLsRsLsbLsbLhL
sbLgbLcbLsbLgbLsbLsbLsbLsbLsbLsbRsbLiLsbLiLsbLsbLgbLsbLsLsmbLgbLsLsRsm
bLsbLgbLiLsbLsbLoLsLsmmbLsbLsbLsbLibLgbLibLgbLgbLgbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 23; Drug: CNO 10 然 Apo 0.5 然
bLibLgbLgbLgbLgbLsbLsbRsbRjbRhRsmbRgbLsbsbRgRsmbLsLsmbLsLsLcmbLiLsbLgR
sbRgbLsLsmbLibLsbLsbRsbLjbLsbRgbLgbLibRsbLsbLsbLgRsbRsbLsbsbRgbLgbsbLs
bLsbLsbLsLsmbLsbLsbRjbLibLgRsbLsbLgLsbLgbLsbLsbRjbLsLgLsbsbLgbRsbLgbRj
bLgbLsbLgbRsbsbLsbLsbRsbLgbRsbRsbRsbsbLgbRsbLgbLsbRsbRhbLsbsbLgbLsbRsR
smbLsbsbLsbLsbRsbLsLsmbRsbLibLgbRgbLibLsbLsbsbLsbRsbRsLsbLsbsbLgbLgbsb
LsbLjbRsLsbLsbLsbsbLgbLsbsbLsbRsbLsbLibRibRgbRgbRgbRgbRgbRgbLibLcbLgRs
bRgbLibLgbLsbLsbLgbLgLsbRsLsbLgRsbRsbLhbRiLsbLgbLsLsmbLsbLsbRsbLobLgLs
bRjbLsbRsbRsRsmbLibLibLsbRgbRgbLibLgbsbRsbRsbLsbRsRsmbLgbLsbLsLsmbLgbL
gbRgbLibLsbLsbRgbLsbRjbLsbLibRsbLsbLgbRsbLgbLsbRsLsbRsbRjbRcbRibRsbRgb
RgRsmbRiLsbRgbRgbLsbLsbRibRibsbLgbRhbRsbRgbLgbRgbRgbRgbRsbRgbLjbLcbLsb
LsbLgbLsRsbRsRsmbLsLsmbLgbRsRsmbLibLgbRgbLibRjbRgbRgLsbLsLsmbLsLsLsmmb
RgLsbLgLsbLsbLgbRgbLsLgbLgRsbLgbRobRibRgbRgbRsbRgbRsbRgbLcLsmbLibRgbLg
bLsbLgRsbRsbLibRgbLsbRsbRsbLsbRsbLsbLibRsbRsbLsbLsbLgbRgLgbRsbLsbLjbsb
RsbLsbsbsbLgbRsbLgRsbLibLsLsmbLsbLsbLgbLgbLgbLsbLsLsmbLsbLsRsbLsbLsLsm
bLsbRebRiLsbRgbRsbRgbRgbLiLsbsbRsbLsbLsbRgbLsLsmbRsRsmbRhbLiLsbLgbRsbL
gbLsbLgbLobLsbRsbRsbRgRsmbRgbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 24; Drug: CNO 10 然 Apo 0.5 然
bLhbRsbLjbLgbLsLsRsmbRiRsmbRsbLsLsmbLgbLsbLgbLsbLsbLgbsbRibRsLsbRsRsmb
LsbRsbRsbsbsbsbLgbLsbLsbRsLsbRgbLsRsbLsbLsbRjbLgbRsbLsbRsLsbLgbLsbsbRs
bRgbLsLsmbRsbLsRsbLgbRibsbsbsbRsLebsbRiRsmbRgbRsbLibsbRsRsmbRsLsbsbRib
LsbLsRsbLsbLsbLsRsbLgLsbLsbRibLibsbRsbLsbLsRsbLsLsmbRsbLiLsLsmbLsbLsRs
bLsbLsbRgbRsbRcbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 25; Drug: Control Apo 0.5 然
bRgbLsRsbRiRsmbLjbRibRgbLjbsbRgbRsbLgbRiRsmbRsbRgbLjbsbLsRgRsmbLsbsbRs
RsmbLgbRsRsmbRgbLsbRsbRsbRsbRsRsmbRsbRgbRsbRjbRgbRgbRibRgRsmbRsbRibLgL
sbRibRsRsmbRgbRsbRsbLsbLsbRibRgbRgbRsbRibRsbRsbsbRsRsmbRgbRsbRsbRsbLsb
RsbRsbRgbRgLsRsbLsbRibRgbLgbRibLsRsbLjbsbsbLjbRhbRsbRibLsbRgbRsbLsLsmb
LibRibRsbRgbRsbRgRsmbRsbLgbLjbRsLsbRsRiRsmbLsRsRsmbRibLsbRgbRsbLsbLjbR
ibRsbRgRsmbRgbRgbRgbRgbRsbRsbLjbRjbRgbLibRibRsRsmbRgRsmbRsbRcbRibLibRg
bRibRgbLsbLgbRgbRsbRiLsbLibRhbLsbRgRsmbRsbRibRsbRgbRgLsbLibRsbRgbLjbRs
bRcbLibRibRgbRsbRgbRsbRsRsmbRgbRgRsmbRsbRgbRgbRibLjbRsbRhbsbRsbRhbLsbR
gbRjbRgRsmbRgbLibRiRsRsmmbRgbRsbLjbRiRsmbRjbLgbLibRebRsbRgbRgRsmbRgRsm
bLgbRiRsmbLsbRibRgbLjbRibRibLibLsbRibLjbRgbRgbRsbRgbRgbRgbRsbRibLsbLsb
RsbRsRsmbRsbRsbRsbLjbsbRgbsbRsLsbRibRsbLsbRibLsLsRsmbRgbRsbLsbLsRsRsmb
RibRgbLgbRibLgbRjbRgLsbRgbLgbRibRgbRsbLgbLsbRsbRsRsmbRsRibRsbRgbRsbLgb
RhbLjbRiRsRsRsmmmbLgbLsbLsbLgbRiRsmbLjbRiRsmbRsbRgRsmbRsRsmbRibLsbRsbR
gbsbLjbRhbRsbRibRsbRsbRjbLgLsbLjbRgbRsbLjbRiRsmbRibRsbLgbRibRsbRgbRsbR
sbLsbRgRsRsmmbRsbRsRsmbRsbRsbRibRsbLsbRibLgbRibRgbRibLgbLiLjbRsLgLsbLg
LsbLgbLsbLgbRcbRcbRsbRgbRgRsmbRsbRgbLgbLsbRgbLgbRibLibRcbRgbLsbsbRcbLi
bRibRsRgbLsbRgbLgLsbRibLgbRibLsbRiRsmbRsbRibLjLsmbRiRsRsLsmmbLsbRgbRsb
RcbRiRsRsmmbLgbRibLsbLibLibLgbRsbRsbRsLsLsmbLgbLgbLgbLsLsmbLgbLsbLgbRs
bLgRsbRsbLgbLgbLgbRgbLibLgbLgRsbLsbLsbLgbLsbRsbLgbLsbRgbRgRsmbLgbRsbRj
RsmbLeLsbLgbLgbLgbLsbLgbLsLsmbLgbRsbLibLgLsbLgbLibRgbsbRgbRibRsbLsbRiR
smbRgbLibRibLjLsmbRsbRjbLsbLgbLibLjbLjbRebRcbRgbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 26; Drug: Control Apo 0.5 然
bRgbRebRgbLob

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 27; Drug: Control Apo 0.5 然
bLibLsbRsbLjbLsbLsbRsLsbLgbLgbLgbLsbLsbRsbRsbLibLsbLiLsbLibLgbLsbRibLs
LsmbLsbLgbLgbLibLibLiLsbRjbLsbRibLibsbLsLsmbLsLsmbRibRgbLsbRibRgbRhbRh
bRibLjbLjLsLsmmbRgbLjLsmbLjLsmbRjbRjbRiRsmbLjLsmbLjLsmbLsbRjbRibLjbLib
RgbLgbLibRjbLibLgRsbRibLsbLgbRsbLjbRsRsmbRsbLibLibLgbRibLibLgbLsLsmbRg
RsmbLibRsbLibRsbLibRsbLgbRgbLgbLgbLsLsmbLsbLsbRsbLgbRsbLsbLsLsmbLsbLsb
LsbLgbRgbLiRsbLsbRgbLibRsbLibLgbRgbLibLgbLgbLgRsbLsbLgbRsbLibLgbLjbRcb
LibLiLsbLiLsbRsbRhbLgbRjRsmbRibRcbLibRsbRgLsbLgLsbLibRsbLjLsmbRibLsbLi
bLgbRjbLiLsbsbRgbLibLsbLgbLsRsbLsLgbLsbLgbLgbRcbLhbRsLgbLgLsbLsbLsbLgL
sbRgbLibLsbRsbLiLsbLgbRgbLibLgbRjbLgbRsbLgbRgbLibLsbLgbLsbLsbLsbLsbLgb
RsbLibLsLsmbLjbRibLibLsbLgbLsbRgbLjbRsLsbRgLsbLibsbLiLsbRsbLsbLgbRsbLg
bRsbLgLsbLgbLgbLgbLgbLgbRsbLgbLgbRgbLjbRsbLgLsbLsbLsbLsbLgbLsbLgbRsbLg
bLibLgbRjbLibLgbLsbLsbRibLibLibRibLibLibRsbLsLjbsbRsbLsLsmbLgbLgbRsbLg
bRsbLgbLsbLsbLgbLgbLgbLgbRcbRgbsbRgbRgbRibRsbLhbLibLgbRjbsbLgbRsLsbLgb
RsbLgbRsbLgbRsbLiLsbRsbLgLsbRsbLsLiLsbRsbLgbLsLsmbLgbLibLsbLgbLsbLgbLs
bRsbLibRjRsmbLiLsbRsbLiLsbRgRsmbLjbLsbLsLsmbLsLsmbLsbLsbLsbRsbLgbRgbLi
bsbLgbRgbsbLgbLgbRsbRsbLibRgbLibRsbsbLibLsbRgbRobsbLibRjbsbLgbRgbLsbLi
bLgbRjbLibLgLsbRgRsmbLsbLibRjbsbLgLsbRgbsbLjbRgbsbRgbLsbRsbRgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 28; Drug: Control Apo 0.5 然
bLjbLsbLibRcRsmbRibRgRsmbsbRgbRibRgbRhbRgbRsbRgbRibRibRsRsmbLjLsmbRcbR
gbRsbRsbRsbLsbRjbRsbsbLgLsbRgbLsbRgbRsbLsLsmbsbRgbRgbLjLsmbRcbRsRsmbsb
RsRsmbLsbRgbRsbLsbLsbRsbRsbRsbRgbRibLsbLsbLgbLsbLsbRgbRsbRsbRibLsbRgRs
mbRsbRibRgbRsbLgbLsbRgbRsbLjLsmbRibRgbRgbRsbLsbRgbRgRsmbsbLsLsmbRsRsmb
RsbsbRgRsmbRibRobsbRjbRebRiRsmbRgbRgbRgRsmbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 29; Drug: Control Apo 0.5 然
bLsbLsbLsbLsbRsbsbLsbsbLjbLgbLsRsbRsbLgLsbLsbLsbLgbLsbLgLsbLsbLgbLsbLs
bLsLsmbLsLsmbsbLsLsmbLsbRgbLjbsbLsbLsbRsLsbLsbLgRsbLsbLsbRsbLgbRjbLgbR
hbLjbLjLsmbLibRsbLsbLgbLsbRgbLsbLsbLgbLgbLjbLsLsmbLsbLsbLsbRsbLsbLsbLs
bRsbLsbLsbLsbLsbLsbLgLsbLsbLsbLsbLsbLsbLsbLsbRsbLgbLgLsbLsbLsbLsbLsbRs
bLsbLsbLsbLsbRsbLsbLsbLjbsbLgbLsLsmbLsbLsbLsbLsLsmbLgbLsbRsbRgbRjbRhbR
sbRsbRgbRgbRgbRibRibRgbRsbLgbLgbLgbLgbRibLjbLsbLsbLsbLsLsmbLsbLsLsmbRs
bLsbLsbLjbLsbLsbLgbLgbLsRsbLgbLsbLsbLsbLsbLsbRobRgbRibRibLgbRgRsmbRgbR
gbLjbLhbLgbLgbLgbLsbLsbRsbLsbLgbRsbLgbLsbLsbsbLsbLsbLsLsmbLsLsmbRsbRsb
RsLsbLsLsmbLsbLsbLgbLsbLgbLgbLsRsbLgbLgbLsbRsbLgbLgbRgbLgbRsbLgbLsbLsb
LsbsbLsRebLgbLsbLsbLsbLsbLsbRsbLsLsmbLgLsbLgLsbLsbLgbLsbLgbLsbRjbLjbRj
bRcbRibLgRsbRibRibLjLsmbLjLsmbRgbRsbLsbLgbRgbLgbLgbRibLsbLgbLgbLgbRsbL
sLsmbLsbLsbRsbLsLsmbLsbLsbRsbsbsbLgbLsbLgbRgbRjbRiRsmbRibLibRibLibLibL
hbLsbLgbRsbLsbLgLsbLsbRsLsbLgbLgbLsbLgRsbRsbLsbLsbLsbLgbLsLsmbRsbLsbLg
RsbLjbRsLsbRsbLsbLgbLsbLgbLsbLsbLgbLsbLgbRcbRgbRgbRgbLjLsmbLjbRsbLibRg
bLsLsmbLgbRsbLgbLsbLsbLsbRgbLsLsmbLgbLsbLsbLgRsbsbRsbLsbRsbLsbRsbLsbLs
bLsbLsbLsbLsbLgLsRsbLsLsmbLsbLgbLsbLsbLsbLsbLsbLsbLgbRjbRiRsmbRjbRgbLj
bLhbRsbRsbLsbsbLsbLsLsmbLsbLsRsbRsbLsRsbLsbLgbLsbLsbLsbRsbLgbLsbLsbLgb
LsbLsbLsbLsbLsbRsbLgbLsLsRsmbLsbLsLsmbRsbLsbRsbRiRibRsRsmbRgbRgRsmbRgb
RgbRgRibsbRgbRgbRgbRsbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 30; Drug: Control Apo 0.5 然
bRsbLsbsbsbRsRsmbRsLsbsbLsbRsbLsbLsbRsbRgbRjbRebLgLsbLsbLibLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 31; Drug: CNO 1 然 Apo 0.5 然
bRgbLgbLgbLsRsbLsbLsLsmbLgbLgbLsbLsLsmbLsLsmbLsbLgbRebRibLgbRibRibLgbR
ibLgRsbRibRsbRgbLibRibLsbLgbRibLsbRsbLsLsLsmmbsbsbLsbRibRsbRsbRsbRsRsm
bRsbRgbRsbRsbLsbRgbRsbRibsbLjbRibRsbLsbLsLsmbLsbRsbRsbsbRsRsmbsbsbRibs
bLibRibRsbRsbLgbsbsbLsbRibRsbLsbLsbLsbRsbRsbRsbRsbRsbRsbRsbLsbRsbLsRsb
RsbRsbLsbRgbRsbRgRsmbRsbLsbLgbLsbLgbRibLsRsbLsbRsbRsbLsbLsbRsbRsbRgbRs
bLsbRsbRsbRsbRsbRgbRsbRsbLsbRjbLgbRgbLjbLgbRsbLsbRsbRsbLjbRiRsmbLsbRgb
RiRsmbRibRgbRsbLsbsbRsbLsbRobLsLsmbRsbRibLgbRibRsbRsbRgbRgRobLgbRjbLjb
LcbLibLgbLsbRjb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 32; Drug: CNO 1 然 Apo 0.5 然
bLsbLsbLgLsbLsLsmbRsbLgbRsbLsbLgbsbLgbLgbRsbLsbLibLsbLgbRsbLsLsmbLgLsb
LsLsmbLsbLsbLgbRsbsbLgbLgbLgbLsbLgbLgLsbLsbLsbLgLsbLsbRgbLsbLibLsLsmbL
gLsRsbLsbLibLsbLsbLsLsmbLsbLgbLsLsmbLgbLgLsRsbLgbLgbLsbRsLsbLgbLibLsbL
gbLgbLsbLibRgbRsbLibLibRsbLiLsbLsLsmbLsbLsLsmbLibLgbLsLsmbLsbLgbLgLsbL
sbLsbLgbLsLsmbLibLsbLsbLibLsRsbLgLsbLsbLgLsbLgbLgbLgLsbLsbRsbLgbLsLsmb
LsLsmbLsbLgLsbLsbLsbLsbLgbLibRjbLibLgbLsbRsbLibLibLsbLsbLsbLibRsbLgLsL
smbLsLsRsmbLgLsbLsbLgbLsbLgbLsbLsbLsLsmbLgbLsLsLsmmbRoLsbLsbRsbLgLsbLg
bLgbLsbLsbLgbRsbLsbLgbLgLsbLsLsmbLgbLgbLsLsmbLgbLibLgbLgbLsbRsbLiLsLiL
sbLgbLsRsbLibLgbLsbLgbRgbLgLsbLsbLjbRsbLgbLsbLsLsmbLsLsmbLgLsbRsbLgbLs
bLgbLgbLgbLgbRgbLsbLgLsbLgLsLsmbRsbLsbLsbRgbLibLsbLsbLgbLsbLgbLsbLgbLs
bLgbRgbLiLsbsbLsbLsbLsbLgLsbLsLsRsmbLgRsbLsLsmbLsbLsbLgbLgLsbLgLsbLsLs
mbLsbLgLsbLsLsmbLsbLibRibRsbsbLiLsbLibLibRgbLgbLsbLgLsbLibLgbLsbRgbLgb
LibRsLsbRjbLsbLibRsbLibLsbLsbLgbLsbLgbLgbLsbLgLsbLsbRsbRsbLibLibRgbLgb
LibLsbLgbLgbLibLgLsbRgRsmbLibLiLsbLsbLsbRsbLgLsLsLsmmbLsbLgbRsbLibLgbL
gLsbLgbLsbLsbLgbLgbsbLgbRsbLgbLsbRsRsmbLgbLsbLsbLsRsbLsbLgbRsbLibRjRsm
bLeLsbLsbLsbLsbRsbLgbLiLsbRsbLgbLsbLsbLsbLgLsbLgLsbRsbLgbLsbLgRsbLgbLg
bLsLsmbLsbLsbLgRsbLsbLsbLgbLgbRsbLgbLsbRjbRsbLgbRsbLiLsbLsbLgbLsbLgbLg
bLsbRsLsbLgbRsbLgbsbLgbLgLsbLgbLsbLsbLgLsbLsbLsRsbLgbRgbLibLsLsmbLsbLs
bLgLgbLgbLsbLsLsmbLsbLibLsbRsbLsbLsbLgbLsbLsbLgbLsRsbLsbLgbLgbLgbLsbLs
bLgbLsbLsbLgbLsbRgbLgbLgbLsbLgbLsbRgbLibRsbLgLsbLsbLsbRsbLsbLsbLsbLgLs
bRsLsbLgbLsbLgbLgbLsbLsLsmbRgbLhbsbRsbLsbLsbLsbLiLsbLsLsmbLgLsbLgbLsbL
sbLgbLgbLsbLsbLgbLgbLsLsmbRsLsbLgbLsbRsLsbLsbLsbLgbLgLsbLsbLsbLsbLjbLs
bsbLgbLsLsmbLgbLsbLgbLsbLsbLsbLgbLgbLgbRgLsbLibLsbLgbLgbLgbLibRibLsbLg
bsbRibLiLsbLsLsmbLibLsbLgLsbRsLsbRsbLgbRsLsbLgbLsbLsLsmbLgbLsbLsbsbLsR
sbLgbLsLsLsmmbLsbLsbLsbLsbLsbLsbLsbLgbRsbLiRsbRsbLsRsbLgbLsbLsbLgbLgbL
sbLsbLsbLgbLsbLgbLsbLsbLgbLgbLgbLobRhbLgLsbLgbRsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 33; Drug: CNO 1 然 Apo 0.5 然
bRjbRiRsmbLibLgLsbRibLiLsbLjLsmbRibRibLjLsmbRhbLjbLjLsmbLibLjbRcbLjbRi
bLjLsmbLjbRibRhbLjLsmbLjLsLsmmbLjbRcbRhbLjbRjbLibLebLsbLgLsbLjLgbRjbRj
RsmbsbLibLgLoRebLcbLibLgbLjLsmbLjbRjbRcbRjbRjbRjRsmbLcbLcbLibRibLebRib
LibsbLjbRibRhbRsbRjbLibRibLhbLgbRjbRibRhbLibRsLsbLibRgbRcbRsbRjbRcbLhL
sbLebRsbLjbRcbLjbRjbRebRhbRjbLibRibLcLsmbLibLibLjbsbRibLjLsmbRibLjbRhb
LebLcbRjbLebRjbRibRsbRgbReRsmbRebRjRsmbRibRhbRsLsbRjbLjbLhbRjbLjLsmbLh
bLhbRgRsmbRibLcbRibLibRgbLgbLebRsbRgbLibLibRibLibRsbRjbRjbRjRsmbRjbLjb
RobRibRjbLhbLgbRgbLgbLgRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 34; Drug: CNO 1 然 Apo 0.5 然
bRibRsbLsbLsbRgbRsbRsbRibRsbRgRsmbsbsbLibRebRiRsmbRsbRgbRhbRsbLsbLgbLs
bRsbRsbRcbRsbLjbRcbLsbRgbRsbLsbRsRsmbRsbRsRsmbRjRsRsmmbRgbRsbRgRsmbLsb
LsbLsRsbRgRsmbRsbRgbRgbRsbRgbRsbRgbRsRsmbLsbLsbLsbRgbRgbRsbLsbRsbRsbRg
bRgbRgbRsbsbLsbLsbLsbRsRsmbRsbLgbRibRsbRgbRsbsbRsbLsbLsLsmbRgRsmbLsRsb
sbRsRsmbRgbLsbRsbRsbRsbRsbRsbLsbRgbRsbRsbRsbRsbRsbRsbRgRsmbRsbLsbLjbRg
bLsbRibRsbRsbLsRsbRsbRgbRsbRgbRsbLgbRsbRibRibRsbRsRsmbRsRsmbRgbRsbRgbR
gbLsRsbsbLsbRsRsmbRgbRsRsmbRgbRibRsRsmbLsbRgbRsRsmbLsRsbRsbLhLsbLibLgb
LsbRsbRsbRsbRsbsbRsbRsbRsbLibLgbLgbLsbLsRsbLgbLgbLsRsbRsLsbLsRsbLgbLib
LsbRsbLgbLsbLsbLsbLgbLgbLsbLgbRjbRsbLjbLhbLgRsbLibRsbRgbsbLsbRsbLjLsmb
LsLsmbLgbLsbLgLsbLsbLsLsmbLgbLgbLsLsmbLgbRgRsmbLsbRsbLoLsmbLgbLgbRsbLs
bRsbRebRgRsmbLsRsbRsbRsbRsbRgbRsbRsbLsbRgbLsbRsbRgRsmbRsbLsRsbRsbRgLsb
RsbLsbLgbRgbRgRsmbLgbLsbRibRgRsRsmmbRsbLsbRibRgbLsbLsLsRsmbRsbRsbLsbRg
bRsbRsRsmbLgbRiRsmbLsRsbRsbLsRsbRgbRgbRsbRsbRgbRsRsmbRsbRgbLsbRsbRgbLs
RsbRgbRgRsmbRsbRsbRsbRsbRsbRsbRgbLgbRgbRibLsbLsRsbRgRsmbRgbLsbRgbLsRsb
RgbRgbRgbRsbLsbLsbRibRsbRsbLsbRsbLsbRsbRgbRgbRgbLgRsbRibLgbRgbRibRgbRs
bRibLsRsbRsbRsbRgbRsbLsbLsbLcbLgbRsbLgbRsbRsbLgbRsbLgRsbLsRsbRsbLgbLgb
RgbLibRsbLgbRsbLsbLgbLsbRsbLibLsbRsRsmbLgbLsbLgRsbLgbLobRsbRsbLgLsbRgb
RgbRgbRgbRgbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 35; Drug: CNO 1 然 Apo 0.5 然
bLsLsmbLgbsbLsbLjbRgbLsLsmbRjbLibsbRsbLibRibLgRgbRoRsmbRsbLgbRgbLibLsb
LiLsLsmbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 36; Drug: CNO 1 然 Apo 0.5 然
bLibLibLsbLibLibRsbLgbRsbRjRsmbLibsbLibsbRsbRgbRsLsbLiLsbLsbRgbRibRsbs
bsbRgbLsbsbLgbLsbsbRibRsbsbLibsbRgbLsbRibLjbsbRiRsmbLgbRsbRibRsbRsbRsR
gbRsbRsbsbRsbRsRsmbLsbRsRsmbRsbRhLsbRhbLsbRgbRgbsbRob

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 37; Drug: CNO 3 然 Apo 0.5 然
bLsbsbLsbRsbsbRsbLsLsmbsbsbRsRsmbRsRsRsmmbRsbRsbLjbLgbLjbLibRcbLjbRsbR
sbRsbRsbLsbRsRsmbRsbLsbsbLsbRsRsmbRsRsmbLebLibLgbLgbLiLsbLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 38; Drug: CNO 3 然 Apo 0.5 然
bLibLsbLgbRgbLgbRsbLgbRgbLgbLgbRsbRsbRsbLsbLsLsmbLgbRjbLibRsbRgbRgbLgb
RsbLgbRsbLgbLsbRgbRsbLiLsbLsbLsbLsbLjbRgbsbRsbRgbLibLgbsbsbsbLsbLibLsb
RsbRsbLsbLgbLsbRgbLgLsbLgbLsbRjbRebLjbLibRgbLjbLgbLsbRgRsmbRsLsbLibRsb
LgbRgbLibLsbLsbLgbRsbRsbLgbLgbRsbLgbLiLsbLsLsmbLsbLgbRsRsmbRsbRsbRsbLg
LsbLcRcbLsbRibLjbRibRgbLsLsmbRcbsbRcRsLsmbRsbLcb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 39; Drug: CNO 3 然 Apo 0.5 然
bLiLsRsLsbLsbRgbLsRsLsbLibLsbLgLsbLsbRsbsbLgRsbLsLsmbRsLsbLsbLgbLhbLgb
RsLsbLsbLibLsbLsbRsLsbLgbLibLibLsbRsbLsLsmbLgLsbLsbLsbLiLsbLsbLsbRsbLi
LsbLsbLiLsbLsbLsbLsbLiLsbRsbLiLsbLsbLsRsbRgbLsLsmbLhLsbLsbLsbLsbLibLsb
LsbLsbLsbLsLsmbLiLsbLgbLsbLsbLsbLiLsbLsbLsbRsbRsLsbLiLsbLsbRsbRsbLgbLi
bLsbLsRsLsbLsbLibLgbLsLsmbRhbLcbLsbRsbLsbLiLsbLsLsmbLiLsbLsbLsbRgbLsbL
eLsbLsbLibLgbRgRsmbLsbLiLsbLgLsbLsLsmbLgRsbLsbLsbLebRgLsbRgbLsbLsbLibs
bLiLsbLsbLsbLsbLgbLsRsbRgLsbLsbLgbLsbLsbLgbLgbsbLsbLsbLsLsmbLgbLibLsbR
ibLgbLsbLsbLiLsbLsbRsbRsbLgLsbLsbLsbLgbLgbLsLsmbLsbLsbLsbLiLsbLsbLiLsb
RibLsbRgbLcbLsbLsbLsbLibLsbLibLsbLsbLsbLsLsRsLsmbLibLgLsbLsbLsbLhbLsbL
sbRgLsbLsbLsbLhbLgbLsbLibLsbLsbLibLgLsbLsbLsbRsbLsbRjbLebLcbLsbLsbLibL
sLsmbLsbLsbLibLsbLsbLsbLibLsbLsbRsbLsbRibLhLsbLiLsbLsbLsbLgbRsbRsbLjLs
mbLsLsmbLsbLsbLsbLiLsbLsbLsbLibLsLsmbLsbRgbLebLsLsmbLsLsmbLsbLsbRjbLiR
sbLhLsbLsbRgRsmbLcbLsLsmbLhbRibLsbLsbLsbLiLsbLsbLsbLebLsbLsbLsbLsLsmbL
iLsbLsbLsbLsbLgbRgbLiLsbLsbRjRsmbLebLsbsbLgLsbLsbLsbLsbLiLsbLsbLsbLsLs
mbRgbRibRcbRibRibLsbLgbRgbRgRsmbRibRibRsbLsbRgbRsbLsbRgbLsLsmbRiRsmbRi
LsbLsLjbRcbRibLsbRsbRibLsRsbLsbRibLsbLjbLcbRibLiLsbLsbRjbLcLsmbLsbLsbR
gbLcLsmbRgbLhbRsbLsbLsLsmbLibLsbRgbLiLsbLsbLsbLsbLsbLgbRgbLhbRsbLsbLsb
LeLsbLoLsmbRsbRsbRgbRgRsmbRgbRsbRsbRsbRsbRgbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 40; Drug: CNO 3 然 Apo 0.5 然
bLgbLgbLcbRhbLibLibRgbRcbRoLsbLiLsbRebRibRibRjRsmbRibLhLsbLgbLsbRsbRiR
smbRgbRgRsLsLsmmbLsbRgRsLsmbRsbRsbRsbLsbRgbLsbsbRsbRsbRsbRsbRsbLsRsbRg
bLjbLcbLhbLgbRhbLhbLibRibRsRsmbRjbLibLgbLgbLsbLsbLsLibLgbLsbLsbLgbLsLs
mbLgbLgbLsbLsbLsbLgbLsbLibRjbRcbLjbLibLhbRjRsmbLjbLibLibRgbRcbLibLgbLg
bRibRgbLgbLgbRibRsbRgbRibLjbRcbLgbLgbRsbRiRsmbLsbRibRcbRgbLgbLgRsbLsbR
gbLibLsbLcbRjbRobLjLsmbRibRjbRjLsbLgbRjbRjRsmbRibLsbLsLsmbLsbLsbLgbLgb
RgbRgbLibLgLsbRjbRibLsRjbRjbRjbRhRsmbRhbLsbRibRgbRgbLgbLsbRsbRsbLgbRsb
LgRsbLgbLgbLgbRsbLsbLgbLgbRsRsmbLjbRgbLsbLsRsRsmbsbLsRsbLsLsmbRsLsbLsR
sLsbLsRsbRsbRsbLibRibRsbRjbRjbRjbRsLsRcbLcbRjRsmbRibRhbRcbRjbRjbLjbRhb
RebRcbRibLjbRibRjbLjbLjbRhbRibLgbLibsbLgbLsbLibLsLsmbRsbRjRsmbsbRhbRhL
sbRibLibRjRsmbRsLjbRebRcbRgbLsbRgbRsbRsbRsbLsbLsbLgbLibRhbRhbRjbRjRsmb
LjLsmbLibLjLsmbRcRsmbRiRsmbRibRsbRsbLsbRibRibLgbLgbRhbRgbLsbLjbRibRibs
bLgbRibRgbRsbLsbRsRsmbRgbLsbLjbRcbRiRsmbLsbLgbLgbRibRibRsbLibLsbLhbLib
RsbRsbLibRibLhbRibLsLhbLsbLhbLsbLibRibRjbRibLgbLsbRgbRibRibRiRsmbRibRi
bLgbLsbLsRsbLiLsbLgbRsbLgbLsbLgbLsbLsbLgbLgbLsbLgbLgbLgbRibLjbRjbLhbRi
bRjbRhRsmbLsRgbLsbRsbRgRsmbRsRsRsmmbsbRgbLjRsbRibLjLsmbRgbRgbRsLsbRsLs
RsbLsRsbRsbRgbRsbRsbRsbRsbRsRsmbLsbLsbLsbLsbLsbRjbRgbLibLjbLibLgbLgbLo
bLgbLgbLjbLgbLgbLgbLsbLgbLsbLsbLgLsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 41; Drug: CNO 3 然 Apo 0.5 然
bsbRsbsbRibRgbRgbRgbLibRsbRibRgRsmbLsbRgbRsbRsLsbRsbRibLsbLsbRgbLsbRgb
RgbLsbRgbRgbRgbRgbRsbLsRsbLsbLsbRgbRiRsmbRsbRsbRgbRsbRgbRsbRgbLibRgbRi
bLsbRgbLsbRsRsmbRibRgbRsbLgbRsbRibRgbRsbRibLsRsbRgbLsbRsbRibRsbRjRsmbL
sbLsbRgRsmbLsbRibRgbsbLsbLibRsbRibRsRgbRgLsRsbLsbRsRsRsmmbRsbLgbRgbLjb
RibLgbRgbsbRsbRibRjbRiLsbLsbLsbLsbRsbRsbRgbRsRsmbLibLsbRibRgbsbLsbRgbR
gbRibRiRsmbLsbRgbRsbRgbRgbRjRsmbRsbLjbRibRhbRibLibLsbRgbRsbRsRsmbRgbRs
RsmbRsRsmbRgbRsbsbRgbRsbRgbRgbLgbLsLsmbLsLsmbLsbLsbLsRobRsbRsbLsbRgbRg
LsbLgbRgbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 42; Drug: CNO 3 然 Apo 0.5 然
bRibRgbRibLgbRhbLgbRibRsbRcbLgbRcbLibRibLsbLjbLjbRcbRsbRgbRibLjbRhbLib
RibRgbLgbsbRsbRsbLsbRsbLgLsLsmbRsbRibLjLsmbRiRsmbRsRsmbRsbRsbRsbRibLgb
RibRsbRsbLsbRibRgbRsbLibRsbLsbRgbLsbLgRsbRsbsbRsbRgLsbLgLsbRgbRsbRgbLg
bRgbRgbRsbRgbLgRsbLsRsRibsbLjbRibLjbLsbRhbLjbLjRibRsbLsbLsbRibLibLibRc
bRibLgbRibLgRsbRgbRibRsLsbRsbLsbRibLsbsbLsbRjbRgbRibRsbRsbsbsbRhbRsbRs
bRsbRiLsbLjbRiRsmbLjLsmbRhbLgLsbRibRgbRsbLsbRiRsmbLjbRibLibRibRiRsmbLg
RsbLsbRjbRsbRsbLsbRibRsbsbsbsbRgbsbsbRibLjbRibsbLjbRibRsbRsRsmbsbRsbRg
bsbLjbLcbLibRoRsmbRibLibRoRsRsmmbRsRsmbRibRgbRgbRibLsbRgRiRsmbRgbRiRgb
RgbRib

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 43; Drug: CNO 10 然 Apo 0.5 然
bRsbLgbRgbLibRjLsbLibsbsbLgbLgbLgLsbLgLsbLgbRsbLgbRjbRsbLgbLgbsbRgbLgb
LgbRgbLibRgbLgbLgbLibLsbLibLsbRjbLiLsbLgLsLsmbLgbRgbLibRgLsbLgbLsbRsRs
mbLsbLgbLgbRsLsbLgLgRsbLgbRsbRsbLgbRsbLgbRgLsbLibRsbRsLsLsmbLgbLgbLgbR
jbLiLsbLgbLsbRsbLsLsmbLgLsbRsbLsbLgRsbLibRsbLsbLgbLgbLgRsbRsbLjbLgbRsb
LsLsmbLgLsbLsLsmbLsbLsbsbLibLgbRsbRsbRsbLsLsmbRsbRibRgbLsbRibLibsbRgbR
gbRsRgLsbLobLjbLibLgbLgbLsbLgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 44; Drug: CNO 10 然 Apo 0.5 然
bRjLsbRsbLsbLsbLsbsbRsbRibLsbLsbRsbRgbRsbRgbRsbRsbRgbRsbRsbRsbRgRsmbRs
RsmbRsbRibRsbRsbRsLsbRgbRsbRgbRsbRsbRsbRgbRsbRsbRsbRgRsmbRgbLsRsbLsbRs
RsmbRgbRsbRsbRjbLsbRsbRgRsmbRsbRgbRsbRsRsmbRgLsbRsbRsbRsbRsLsbRgbRsbRs
bRsbRsRsmbRgbRsbRgbRsRsmbRsRsmbRsbRsRsmbRsbRgbRgbLsbLsRsbRsbRgbRsbRsbR
sRsmbRsbRgRsmbRsbRsbRgbRsbRsbRsbRgbRsbRsbRsRsmbRsbRsbRgbRsbLsbRgRsmbRg
bRsbRsbRsbRgbRsbRsbRgbLjbLcbLgbLsLiLsbLibRjbLhLsbLsbLgbLsbLgbRgbLsbLsb
RjbRjLsbLsbRibRsbRgbRsbRgbRsRsmbRgbRsLsbRsbRsbRsbRsRsmbRsbRsbsbsbRsbsb
RsbRgbRsRsmbRsbLgbRiRsmbLsbLsbRgbRsbRgbLgbRsbRsbRgbRgbLsbLsbsbRsbRsRsm
bRgbRsbRgLsbRsbRsbRsbRsbRgbRsbRsLsbRsbRsLsbRgbRsbRgbLgbRgbRsLsbRsbRgbL
sbRsRsmbLgbRibRsbRgbLgbRsbRgbRsbLsRsbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsbRgR
smbLsbRsbRsLsbRsbRsbRsbRsbRsbRsbRgbRsbRsRsmbRsbRsbRgbRsbLsbLsRsbRsRsmb
sbRgbRsbRgRsmbRsbRgbRgbRsbRsbLgbLsbLjbLibLgbLgbLsbLgbRsbLhRsbLgbLsbRsb
RsRsmbRgbRsbRsb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 45; Drug: CNO 10 然 Apo 0.5 然
bLsbLgRsbLibLgbRsbRsbRsbLjbLsbLjbLsbLibRsbLsbLibRibRgbRsbRibRgbLsbLjLs
mbRibRibRsbRgbLsLsmbLgbLibLibLsbLgbLgbLsRsbLsbLjLsmbLsbRsbLgRsRsmbRsbL
hbLgbRgbRsbRibLgbLibLibLgbRsLsbLgbLgbLgbLibLgbRiRsmbLsbLgbsbLibRjbRsbL
ibLiRsbLibLgbRgbLgbLibLibRibLiLsbLibRsbRgbLibRibLhbLgLsbLjLsmbLibLiLsb
LsLsmbLgbLsbLgbLiLsbLsbRgbLibRsbRjRsmbLcLsmbLsbLhbLibLgbLgbLjbsbLgbLsb
LgbRgbLibLsbRsbLibLgbLsbRgbLsbLgbRibLibLsbLibLgbLsbLsbsbRgbLsbLiLsbLsb
LibLgbLgbRgbRsbRgbLsbLjLsmbLibLibLgbRsbRgbLibLibLibLsbRibsbRsbLiLsbLib
LsbLsbLsbLibLibLibRsbLsbLgbRgbRgbLjLsmbRgbLiLsbLiRsbLsbLibLsbLgbLsLsmb
LsbLiLsLsmbLgbLsbRsbsbRsbLgbLibLibLsbRgbRsbLibLgbLibRjbRjbLjbLhbLibLsb
RsbRsbLiLsRsbLsbLibLibLgbRjbsbLsbRgRsmbLibRsbLebLibLjLsmbLsbLsbRibLiLs
LsmbLsbLsbsbRibRsbRibRsbRibRgbRsbLsbLgLsbRgbLibLsbRiRsmbRibRibRibLsbLs
bLjLsmbRgbLibLibLgbLsbLgbLgbRsbRsbLgRsbRjRsmbsbLibLsbLibLibRgRsmbLibLi
bRsbRgbRgbRibLibLibLgbLibLsbLjbRgRsmbRsbLibLsbLibRsbLsRsbLibLibLsbRsRs
mbLibLibLgbLgbRgbRsbLibLiLsbLsbLgbRsbLsbLibLsbRsbLgbLsbRjbsbLjLsmbsbLi
bsbsbLsRsbLgLsbLibRgbLsbLiLsbLsbLibLiLsbLgbLsbRsbRgbRgbRgbRcRsmbRhbRib
LsbLsbLibLgbLsLsmbRsbLgbLgbLibLsLsmbLgLsbRgbRjRsmbLhbLiLsbRsbsbRjbLcbL
sRsbRgbLcLsmbLiRsbLsbLgbLsbRsbRgbRibLgLsbLgbLsbLiLsbLsbLsbRsbLcbRjRsmb
LcLsmbLhLhbRcbRcbRgbRgbLhbLibLjb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 46; Drug: CNO 10 然 Apo 0.5 然
bRibRsbRsRsmbRsbRsRgRsmbRgbLcbLibRebRjRsmbLibRsbsbRibRsbLjbRjbRibLjbLj
bRjbRhbRsbLibRsbRgbRsbRgbLhbRibRibRebRgbRsbRsbRgbRsbRibRgbLibRibLsbLgb
RibRgbLgbRgbLsRsbLsbLsbRsbRgbRgRsmbLibLjbRjbRibRibRsbLsbRsLsbRjbLgbRgb
RsRsmbRgbRsbRgLsbLjbLsbRsbRgRsmbRgbLibRgbRgbRsbsbRgbRgbsbsbRgRsmbRgbLg
bRibLgbRgbRgbLgbRibLsLsmbsbRgbRibRgbRsbRgbLsbRsbRgRsmbLsbRsRsmbRgbRgbR
iRsmbRibsbRsbLibRibLsbRibRsbLgbLibRjbRhbRibLjbLsbLgbLjbLibLgLsbLgbRjbR
hbRsbRgRsmbRgbRsRsmbRsbLsbRgbRsbLsbRsbLsbRsbRgRsmbRsbRgbRsbLgbRsLsbRgb
RgbLsbRsLsbRjbLsbRgbRgbRgLsbRibLibRibRsbRgbRsbRgRsmbRsbLgbRsbRibRgbLjb
RgbRgbRibRsbRsbLsbRibRsbRgbLibLsbLsbRiRsmbRsbRgbRsbRgbRgbLibRgRsmbLsbR
gRsmbRgbRgbRsbRgbLsbRgbLsRsbLsbRgbLgLsbRgbLsRsbRgbRgbRgLsbRsbRsbRsRsmb
RgbRsbRsLsbRgbRsbLjbRibLjbsbRiRsmbRgbLiRsbRibRsbsbRgbRsbRgbRgbRgbLgbRg
bRsLsbRsbRsbRsbRsbRsbRgRsmbRsRsmbRgbLibsbsbsbRgbRgbRibsbRibRibLibRibRg
RsmbRgbRsbRibRgbLobLsbRobLibLgbLgbRobLgbRgb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 47; Drug: CNO 10 然 Apo 0.5 然
bRgbRibLjbLsLsmbRiRsmbRgbLjbLebLgbRsbLibRsbLgbLsLsmbLsbLsbRsLsbLgbLgbL
sbLgLsbLsLsmbLgLsbLsbLsLsLsmmbLsLsmbLgLsbLsbLgLsbLsbLgbLgbLsLsmbLsLsLs
mmbLgbLibRibLhbRgRsmbLibRsbLgbLsRsbLgbLsbRsbLibRsRsmbLibLsbLibRgbLibLi
bRjbRcbRiRsmbLsbRjRsmbRibLibRibLgLsbRobLgbRgbRibRgbRjbLibRsbLsbRgRsmbR
sbLsbRibRibLjbRiRsmbRgbLjbLibLsbLgLsbLsbLgbLgbRgbLgbLgbRgbRsbLibLibLsL
smbLsbRgbLibRgbLiRsbRgbLsbLgbLgbLgbLsLsmbLgbRgbLgbLgbLgbRjbRibLjbRibLi
bLjbRibRhbRsbRgbLgbRsLsbRsbRgbRibRjRsmbRgbRsRsmbLjLsmbRsbRiRsmbsbLsbLg
bLsbLsbLsbRgbLhbRjbRjbRgbRsbRjbRgLsbRgbLgbLgbLgbRjbRsRsmbLgbRcLsbRcbRs
bLhbLjLsmbRgbRibRjbRsbRsbRgbLsbRgbLsbRjbsbRgbLgLsbRibRhbLibRsbRgbRgbRi
bLsbLgbLsbRsbRgbLgLsbRjbRibRgbRgRsLsmbRgbRibLcbLcbLgbRibRgbRsbsbRhbRib
RgbsbsbRsbRibRibsbRsbRibRibRsRsmbRgbRsbLsbLsbLjLsmbRgRsmbRgbRgLsbRsbRi
bRibRgbRsbsbRibRibRgbRsbRiRsmbsbLgLsbRcbsbRgbLgbRjbRjRsmbRibLsRsbsbLsb
LibLsbsbLsbsbLgLsbLsLsmbLsbRjbRhRsmbRsbRgbRsbRsbRsbRsbRjRsRsRsmmmbLgbR
sbRgbRibRgbRsbRsbRgbRibRgbRsbRsbLsbLjLsmbLsbRsbRgbRibLgbRcbLgbLibLibLj
LsmbRsLsbsbLcbLgbRsbRjbRgbRgbRibRcbRibRsbRgbRsRsmbRsbLgLsbRcbRsbRgbRgb
RgLsbRibLsbLibLsbRibRiRsmbRsbRsbRgbRsbRibLsbRsbRgbsbRgRsmbLsbLsbLgbLhb
LsbLibLgbLiLsbRgbLgLsbRsbLhbLgbLsbLgLsbRibLsbLibLibLsbRsbLibLgbLsbLiRs
bLsLsmbLgbLgbLsbLibLsbRsbLsbLsbLsbRsbLibRsbLsbLsbLibLsbLobLsbLgbRjRsmb
RgbRsbRsbRsbRsbRgbRsbRsRsmbRgRsmb

>ZF Recording 2016-03-21; tW: 300s; Start: 130516; End: 131016;
Recording: 13-1; Individual: 48; Drug: CNO 10 然 Apo 0.5 然
bRgbLgbRgbRgbRgbLsRsbRgbsbRgbRsbLsRsRsmbRsRsmbRgRsRgmbRgRsmbRgbRgRsRsR
gRsmmmbRgbRgRsmbRgbRgbLsbRgRsmbRgRsmbRgbRsbRsbLjbRsRibRibRgbRgbRgbRibR
gbLibRhbLjbRgbRgbRsRsmbRsRsmbRgRsmbRgbRgLsRsbRgRsmbRgRgRsmbRgbRgbLhbLi
RhRsmbLgbLjbLcbRhbLhbRcbRibRibLsbRsRsmbRsRsmbRgRsmbRgbRgbRgRsmbRgbRgbR
gbRgbRgbRjbRsbRgbLjbRibRsLgbRibRsbRsLsbRsbRgbRgRsmbRgbRibRgbRgRsmbLsbR
ibRgbLjbLhLsbLebRjbLgbRcbRgbRsRsmbRsLsbRgbRsbRgRsmbRgLsbRgbRgRsLsmbRsb
sbRgbRsbRgRsmbRgbRgbRsbRsRsmbRgRsRgmbRgLsbRsbRgRsRsRgmmbRibRgRsmbRgbRs
bRgRsRsmmbRgbRgbRjbRgbRgbRgbLsbRgbRgbLgbRibLgbRgbLsRgbRsbRgbRgbRsRsmbR
sbRsbRgbRgbRgbRgbRsbRgbRibRgbRibLhLsbRcbRgbLibsbLibLibRcRcbRsbLibRibRi
bRsbRsbRgbRgbRsbRsbRsbRsbRgRsmbRsbRsbRsRsmbRsbRsRsmbRgbRgbRgRsmbRgbRsb
RsbRgRsmbRgRsmbRgbLsRsbRgRsmbRsRgbsbRsbRsbRgRsmbRgbRjRsLsmbRgRsmbRgbRg
bRibRsbRgRsRsmmbRsRgbRsRsRsRsmmmbLsbRgbLsbRgbRgbRgRgbRgbRgRgbRgbRgRsmb
RsbRsbsbRgbRgbRibLibRibRsbRgLsbLsbRgRsmbLgbsbRgRsmbRgbRgbRsbRsbRgbRgRs
RsmmbRsbRsRsmbRsRsmbRsLsbRsRgRgbRgRsmbRgbRgRsmbRgbRgbRgbRgRsmbsbRsRsmb
RgRsmbRsRsmbRsbRgbRsRsRsLsmmbRgbRgbRsbRgbRgbRsbRsbRgRsmbRsbRsbRsRsmbRg
RsmbLsRsbRgbRsRsmbRgRsmbRgbRgbRgRsmbRgRgbRsbRsRsmbRgRiRsmbRgRsmbRsRgbR
sbRiRibRgbRsRgbRsRsRsRgRgmmbRgRsmbRgbRgRsmbRgbRgRsmbsbRsLsbRsRibRsbRgb
RgRsmbLsbRsbRsbRgRsmbRsbRgbRgRsmbRgbRgbRgbRgbRgRsmbRgRsRgRsmmbRgbRsRgR
sRgRsRgRiRsRgmmmbRgbRibRsbRgbRgbRgbRsbRgRsRsmmbLsRsbRgRsmbRgRgbRgRsRgR
smmbRgbRgRgbRgbRsRsmbRsbRsbRgRsRgRsRsmmmbRgRsRsRgRsRsRgmmmmbRibRgbRsRs
mbRgbRsbLgbRsRgRsLsmbRgbRsRsmbRgLsbRgRgRsmbRgbRibRgbRgbRgbRgRsmbRsRsmb
RgRsmbRgLsbRsRgRsLsmbRgbRgRibRgbRsbRgbRgbRsbRsbRgRgbRgRsmbRgbRsLsbRsbR
iRsmbRgRsmbRgbRgbRgbRgRsmbRgbRsbRibLgLsbLsbRibRibLhbRibRgbLgbRibRsbRjb
RsbRgbRsbRgbRgbRibLgbLhbLjbLgbLibLgbRcbRiRsLsRsRsmmbRgbRsRsmbRsbRsRsmb
RsbRgRsmbRgbRgbRibRgbRhbRgbRgbsbRgbRsbRgRsmbRsbRgRsmbLsbRibLjbLhbRhLsb
RgbRiRsmbRgbRgbRsbRgRsmbRsbRgbRsbRsbsbRsRsmbLsRsbRgbRgRsmbRgbRsRsmbRsb
RgRsmbRgbRgbRgRsRsmmbRgbRgbLsRibRsRgbLjbRiRsmbRgRsmbRgRsmbRsbRsbRsbRgb
RsbRsbRgRsmbLgbRibRgbLibRiRsmbRibsbRsRsmbRsRsRgmbRgRsmbRgbRsbRsbLgbRib
RgbRsbRsbRgbRgbLjbRibRiRsmbRhbLcbRhbLgLsbRcbRsbRgbRsbLsbRibLibRhbLgbRh
bLsbLsRsbRibRgbRsRsRsmmbLgbRgbRgbRgbRgbRgLsbRgRsRsRsmmmbRgbRgbRgRgbRgR
smbRgbLjbRibRsbLsRsbRgbRgRsmbRjbRsRsRgRimbRgbRgbRgRsmbRgbRgbLjbRibRibL
cbRhRsmbRgbRgbLibRcbLibRibRgRsmbLjbRibsbRgRsRsmmbRgbLgbRibRgbLjbRhbLjb
LibLgLsbLsbLsbRsbRsRsmbLsbRsbRcbRibRgbRsbRsRsmbRsbRgbRsbLsRsbRsRsmbRsb
RsbRgbRgbRgRsmbRsbRgbRsbRgbLgbRibRgbRsbsbRsRgRgbReRsRhRsmmbRgbRgRsLsmb
RgbRgRgRsRsmmbRgRgRibRiRgbRgbRgbLgbRibLibLhbRhbRibRsRsRgmbRsRsmbRgbRsR
smbRgbRsRsmbRsRgbRgbRgbRgbRsbRsbRsbRgbRsRsmbRsLsbRgRsRimbRsbRgRsmbRgbR
gRsmbRgbRgbRgbRgbLjbRibRgRsLsmbRgbRsRsRsLsmmbLsbRgbRgbRgbRjbRsbRsbRgbL
gbRibRsbRgbLjRsLsbRibsbLsbsbRsbRsRgbRgRgRsRgmbRgRsRgmbRgbRgRgbRsRgbRsb
RgRsmbRsbRsbRjbRsRsmbRgbRgRsRsRiRgmmbRsbRgRsmbRgbRsRgRsRgmbRgRsmbRsbRg
RgRibRibRgRgRsmbRgRgbLsRsbRgLsbRgbRibLibLgbsbRhbLjbRsbRibLgbRibRsRsmbR
ibRsbRgbLsbRgRsRsmmbRsbRgRgRsmbRgRsRsRimmbRgRsRsRgRsRgmmmbRsbRgRsmbRgR
gbRiRiLsbRgRsRgRsmmbRgRsmbRiRgbRgRsmbRgLjRjbReLsbLibLgbRcbRcbRgbRibRiR
smbLgb

